0.08808324.12130565.html.plaintext.txt	0	eating elicited orexin melanin concentrating hormone opioid mediated deborah j clegg ellen l air stephen c woods randy j seeley
0.08808324.12130565.html.plaintext.txt	1	department psychiatry university cincinnati medical center djc scw rjs cincinnati ohio 45267 0559 departments biomedical sciences cell biology neurobiology anatomy university cincinnati medical center ela cincinnati ohio 45267 0559
0.08808324.12130565.html.plaintext.txt	2	address correspondence requests reprints deborah j clegg phd department psychiatry university cincinnati medical center po box 670559 cincinnati ohio 45267 0559 e mail debbiecleggatucedu
0.08808324.12130565.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references melanin concentrating hormone mch orexin orexigenic peptidergic neurotransmitters produced primarily lateral hypothalamus two hypothalamic peptides neuropeptide y agouti related peptide increase food intake mechanism depends activation opioid receptors assessed whether mch orexin also elicits food intake via opioid receptor activation dose naloxone 03 mgkg ip effect reduced acute orexigenic effect third ventricular i3vt orexin 3 ngrat however dose naloxone effect i3vt mch 5 micrograt induced hyperphagia opioid system also linked food selection investigated whether mch orexin alters food choice rats simultaneous access two diets differing relative amounts fat carbohydrate whereas i3vt mch stimulated intake diets alter food choice i3vt orexin stimulated intake high fat diet data indicate despite several similarities mch orexin two lateral hypothalamic area peptides stimulate food intake recruiting different neural circuits exert different effects food choice
0.08808324.12130565.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references melanin concentrating hormone mch orexin orexigenic peptidergic neurotransmitters produced primarily lateral hypothalamus two hypothalamic peptides neuropeptide y agouti related peptide increase food intake mechanism depends activation opioid receptors assessed whether mch orexin also elicits food intake via opioid receptor activation dose naloxone 03 mgkg ip effect reduced acute orexigenic effect third ventricular i3vt orexin 3 ngrat however dose naloxone effect i3vt mch 5 micrograt induced hyperphagia opioid system also linked food selection investigated whether mch orexin alters food choice rats simultaneous access two diets differing relative amounts fat carbohydrate whereas i3vt mch stimulated intake diets alter food choice i3vt orexin stimulated intake high fat diet data indicate despite several similarities mch orexin two lateral hypothalamic area peptides stimulate food intake recruiting different neural circuits exert different effects food choice
0.08808324.12130565.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references mammals neurons located lateral hypothalamic area lha important controllers feeding behavioral arousal animals lesions lha exhibit hypophagia increased metabolic rate decreased arousal extreme weight loss 1 2 3 4 5 also fail respond appropriate adaptive behavioral physiological responses homeostatic challenges fasting 6 electrical stimulation lha results vigorous feeding response well see review ref 2 lha historically regarded hypothalamic feeding center considered important integrating site somatic autonomic controls ingestion related functional observations lha extensive anatomical projections within hypothalamus well throughout entire neuroaxis facilitating coordination metabolic motivational motor autonomic arousal processes important energy homeostasis 6
0.08808324.12130565.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references mammals neurons located lateral hypothalamic area lha important controllers feeding behavioral arousal animals lesions lha exhibit hypophagia increased metabolic rate decreased arousal extreme weight loss 1 2 3 4 5 also fail respond appropriate adaptive behavioral physiological responses homeostatic challenges fasting 6 electrical stimulation lha results vigorous feeding response well see review ref 2 lha historically regarded hypothalamic feeding center considered important integrating site somatic autonomic controls ingestion related functional observations lha extensive anatomical projections within hypothalamus well throughout entire neuroaxis facilitating coordination metabolic motivational motor autonomic arousal processes important energy homeostasis 6
0.08808324.12130565.html.plaintext.txt	7	neurons lha synthesize peptidergic transmitters stimulate feeding behavior specifically melanin concentrating hormone mch 7 orexins b also termed hypocretins 8 9 mch expressed predominately lha 10 11 several lines investigation implicate key regulator food intake body weight 7 12 13 14 first mch gene expression influenced changes energy balance adipocyte hormone leptin inhibits mch gene expression food restriction increases mch gene expression 15 second intracerebroventricular administration exogenous mch stimulates food intake 7 13 14 mice overexpress mch obese insulin resistant 13 finally mice targeted disruption mch gene reduced food intake body weight accompanied increased metabolic rate resulting little body fat 15
0.08808324.12130565.html.plaintext.txt	8	neurons lha synthesize peptidergic transmitters stimulate feeding behavior specifically melanin concentrating hormone mch 7 orexins b also termed hypocretins 8 9 mch expressed predominately lha 10 11 several lines investigation implicate key regulator food intake body weight 7 12 13 14 first mch gene expression influenced changes energy balance adipocyte hormone leptin inhibits mch gene expression food restriction increases mch gene expression 15 second intracerebroventricular administration exogenous mch stimulates food intake 7 13 14 mice overexpress mch obese insulin resistant 13 finally mice targeted disruption mch gene reduced food intake body weight accompanied increased metabolic rate resulting little body fat 15
0.08808324.12130565.html.plaintext.txt	9	orexin hypocretin system 8 9 comprised two peptides termed orexin orexin b two associated receptors intraventricular administration neutralizing antiorexin antibody suppresses spontaneous feeding fasted rats 16 intraventricular administration orexin dose dependently stimulates food consumption 9 16 17 18 changes feeding administration orexin b inconsistent 9 17 18 stronger case made role orexin energy homeostasis
0.08808324.12130565.html.plaintext.txt	10	orexin hypocretin system 8 9 comprised two peptides termed orexin orexin b two associated receptors intraventricular administration neutralizing antiorexin antibody suppresses spontaneous feeding fasted rats 16 intraventricular administration orexin dose dependently stimulates food consumption 9 16 17 18 changes feeding administration orexin b inconsistent 9 17 18 stronger case made role orexin energy homeostasis
0.08808324.12130565.html.plaintext.txt	11	although orexin mch expressing neurons made within different neurons lha 19 20 peptides increase energy intake regard similar agouti related protein agrp neuropeptide y npy peptides made population neurons within arcuate nucleus npy agrp administered exogenously increase food intake 21 22 23 24 25 26 axons lha project medial hypothalamus including arcuate agrpnpy neurons arcuate project lha 27 28 29 understanding functional interactions among peptides important npy agrp induced increases food intake dependent opioid receptor activation action blocked nonspecific opioid receptor antagonist naloxone 30 31 activation opioid system turn associated increased intake preferred high fat containing diets 32 consistent found agrp selectively increases intake high fat diet rats simultaneous access two diets differing relative amounts carbohydrate fat 31 hand administration npy reportedly increases consumption high carbohydrate diets 33 34 although attributed stimulation whichever diet individual rat prefers 35 36 purpose present experiments determine whether orexigenic action mch orexin depends upon activity opioid receptors whether peptides influence diet selection
0.08808324.12130565.html.plaintext.txt	12	although orexin mch expressing neurons made within different neurons lha 19 20 peptides increase energy intake regard similar agouti related protein agrp neuropeptide y npy peptides made population neurons within arcuate nucleus npy agrp administered exogenously increase food intake 21 22 23 24 25 26 axons lha project medial hypothalamus including arcuate agrpnpy neurons arcuate project lha 27 28 29 understanding functional interactions among peptides important npy agrp induced increases food intake dependent opioid receptor activation action blocked nonspecific opioid receptor antagonist naloxone 30 31 activation opioid system turn associated increased intake preferred high fat containing diets 32 consistent found agrp selectively increases intake high fat diet rats simultaneous access two diets differing relative amounts carbohydrate fat 31 hand administration npy reportedly increases consumption high carbohydrate diets 33 34 although attributed stimulation whichever diet individual rat prefers 35 36 purpose present experiments determine whether orexigenic action mch orexin depends upon activity opioid receptors whether peptides influence diet selection
0.08808324.12130565.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references animals male long evans rats harlan sprague dawley indianapolis weighing 380 440 g onset experiments individually housed plexiglas tubs maintained 12 h light 12 h dark cycle temperature controlled american association accedidation laboratory animal care accredited vivarium procedures approved internal animal care use committee university cincinnati rats maintained ad libitum pelleted food tap water unless otherwise noted rat implanted cannula aimed third cerebral ventricle i3vt coordinates cannula placement midline 22 mm posterior bregma 75 mm ventral dura bregma vertical coordinate 37 10 d recovery accuracy cannula placement verified i3vt infusion 10 ng angiotensin ii 1 microl physiological saline animals drank least 5 ml water within 1 h used experiments
0.08808324.12130565.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references animals male long evans rats harlan sprague dawley indianapolis weighing 380 440 g onset experiments individually housed plexiglas tubs maintained 12 h light 12 h dark cycle temperature controlled american association accedidation laboratory animal care accredited vivarium procedures approved internal animal care use committee university cincinnati rats maintained ad libitum pelleted food tap water unless otherwise noted rat implanted cannula aimed third cerebral ventricle i3vt coordinates cannula placement midline 22 mm posterior bregma 75 mm ventral dura bregma vertical coordinate 37 10 d recovery accuracy cannula placement verified i3vt infusion 10 ng angiotensin ii 1 microl physiological saline animals drank least 5 ml water within 1 h used experiments
0.08808324.12130565.html.plaintext.txt	15	drugs agrp 83 132 orexin mch purchased phoenix pharmaceuticals inc mountain view ca naloxone hydrochloride nalx purchased sigma st louis mo substances dissolved physiological saline also served control solution agrp 83 132 orexin mch saline administered i3vt 2 microl volume nalx control saline injected ip volume 03 mlkg
0.08808324.12130565.html.plaintext.txt	16	diets animals maintained pelleted rat chow harlan teklad indianapolis experiments 1 4 high fat hf low fat lf pelleted diets prepared dyets bethlehem pa used experiments 5 6 macronutrient compositions diets given table 1
0.08808324.12130565.html.plaintext.txt	17	diets animals maintained pelleted rat chow harlan teklad indianapolis experiments 1 4 high fat hf low fat lf pelleted diets prepared dyets bethlehem pa used experiments 5 6 macronutrient compositions diets given table 1
0.08808324.12130565.html.plaintext.txt	18	view table table 1 macronutrient composition low fat high fat regular chow diets kilocalories per gram percentage total kilocalories
0.08808324.12130565.html.plaintext.txt	19	experiment 1 previously determined 03 mgkg nalx ip effect food intake ie dose subthreshold 31 however dose administered conjunction i3vt agrp reliably reduced increase food intake elicited agrp 31 experiment 1 replication experiment confirm 03 mgkg nalx ip fact subthreshold cohort rats reconfirm attenuates agrp induced overeating rats assigned one four treatment groups n 8 9group matched preexperimental body weight food intake test day food removed 2 h lights thirty minutes lights rats two groups received ip injection 03 mgkg nalx rats two groups received equal volume saline ten minutes later one naloxone one saline group received i3vt injection 1 nmol agrp2 microl two groups received saline 2 microl dose agrp elicits reliable long lasting increase food intake 25 26 38 five minutes lights food returned cages intake measured 1 2 3 4 24 h water available times
0.08808324.12130565.html.plaintext.txt	20	experiment 2 experiment paralleled experiment 1 except mch used instead agrp body weight matched rats assigned one four treatment groups n 8 9group test day half rats received ip injection 03 mgkg nalx half received saline 10 min later half group received i3vt injection mch saline 5 microg 2 microl vol saline 2 microl vol
0.08808324.12130565.html.plaintext.txt	21	experiment 3 observed mch effective increasing food intake light dark period 14 experiment 2 repeated animals 10 d later except first injection occurred 7 h light phase animals counterbalanced previous treatment reassigned one four new groups ip nalx saline i3vt mch saline
0.08808324.12130565.html.plaintext.txt	22	experiment 4 orexin effective increasing food intake light dark period 18 experiment paralleled experiment 2 every way except orexin 3 ng2 microlrat substituted mch 10 ratsgroup
0.08808324.12130565.html.plaintext.txt	23	experiment 5 group rats n 20 adapted two diets hf lf simultaneously available ad libitum separate food hoppers cages 1 month matched average daily food intake body weight assigned one two groups receiving either saline 5 microg mch i3vt 2 microl injection volume following paradigm described experiment 3
0.08808324.12130565.html.plaintext.txt	24	experiment 6 experiment paralleled experiment 5 except rats received either saline 3 ng orexin i3vt 2 microl test day procedure identical described experiment 5 followed intake diet recorded 30 60 90 120 min
0.08808324.12130565.html.plaintext.txt	25	data analysis data analyzed parametric statistics repeated measures anova time repeated measure followed tukey hsd post hoc tests significance set p 005 two tailed test
0.08808324.12130565.html.plaintext.txt	26	data analysis data analyzed parametric statistics repeated measures anova time repeated measure followed tukey hsd post hoc tests significance set p 005 two tailed test
0.08808324.12130565.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references experiment 1 depicted fig 1 03 mgkg nalx ip alter food intake others observed i3vt agrp increased food intake 85 relative saline trend continued 24 h data depicted nalx significantly reduced agrp induced eating beginning first hour two way repeated measures anova yielded reliable interaction drug time f13 1252 p 005 tukey post hoc tests confirmed food intake agrp plus nalx agrp plus saline significantly different higher intake saline plus saline saline plus nalx p 005 fig 1 anorectic effect nalx agrp induced eating gone 4 h data shown
0.08808324.12130565.html.plaintext.txt	28	view larger version 12k figure 1 effect 03 mgkg nalx ip saline injected association i3vt injection saline 1 nmol agrp chow intake 1 h different saline plus saline p 005 different agrp plus saline p 005
0.08808324.12130565.html.plaintext.txt	29	experiment 2 mch 5 microg potently stimulated food intake level 70 greater produced saline dark depicted fig 2 03 mgkg nalx affect food intake nalx reduce mch induced eating two way repeated measures anova yielded reliable main effect drug f33 363 p 005 tukey post hoc tests confirmed food intake mch plus nalx mch alone significantly higher saline saline plus nalx p 005 fig 2
0.08808324.12130565.html.plaintext.txt	30	view larger version 13k figure 2 effect 03 mgkg nalx ip saline administered association i3vt injection saline 5 microg mch chow intake 1 h injections given 30 min onset dark phase different saline plus saline p 005
0.08808324.12130565.html.plaintext.txt	31	experiment 3 light period mch stimulated food intake level 85 greater saline occurred beginning dark phase nalx neither suppressed food intake reduced mch induced hyperphagia fig 3 two way repeated measures anova yielded reliable interaction drug time f39 595 p 001 tukey post hoc tests confirmed food intakes mch plus nalx mch alone significantly higher intake saline saline plus nalx p 005 fig 3
0.08808324.12130565.html.plaintext.txt	32	experiment 3 light period mch stimulated food intake level 85 greater saline occurred beginning dark phase nalx neither suppressed food intake reduced mch induced hyperphagia fig 3 two way repeated measures anova yielded reliable interaction drug time f39 595 p 001 tukey post hoc tests confirmed food intakes mch plus nalx mch alone significantly higher intake saline saline plus nalx p 005 fig 3
0.08808324.12130565.html.plaintext.txt	33	view larger version 13k figure 3 effect 03 mgkg nalx ip saline administered association i3vt injection saline 5 microg mch chow intake 1 h injections given light phase different saline plus saline p 005
0.08808324.12130565.html.plaintext.txt	34	experiment 4 orexin increased intake 85 relative saline nalx significantly reduced orexin induced eating second hour p 005 fig 4 two way repeated measures anova yielded reliable interaction drug time f39 4865 p 005 tukey post hoc tests confirmed food intake orexin plus saline orexin plus nalx different significantly higher intake saline saline plus nalx p 005 fig 4
0.08808324.12130565.html.plaintext.txt	35	view larger version 11k figure 4 effect 03 mgkg nalx ip saline administered association i3vt injection saline 3 ng orexin chow intake 1 h injections given light phase different saline plus saline p 005 different orexin plus saline p 005
0.08808324.12130565.html.plaintext.txt	36	experiment 5 day test day animals preferred hf diet lf diet consuming average 84 intake weight hf diet depicted fig 5 mch increased total food intake well total caloric intake manifest significant increase diets hence food intake food choice altered i3vt mch
0.08808324.12130565.html.plaintext.txt	37	view larger version 13k figure 5 intake hf lf diets 1 h light phase 5 microg mch i3vt saline p 001 p 001
0.08808324.12130565.html.plaintext.txt	38	view larger version 13k figure 5 intake hf lf diets 1 h light phase 5 microg mch i3vt saline p 001 p 001
0.08808324.12130565.html.plaintext.txt	39	experiment 6 day test day animals preferred hf diet lf diet consuming average 90 hf diet depicted fig 6 orexin stimulated intake hf diet level 176 saline control intake significantly greater extent intake lf diet p 005 therefore total caloric intake increased well proportion calories derived hf diet
0.08808324.12130565.html.plaintext.txt	40	view larger version 13k figure 6 intake hf lf diets 1 h light phase 3 ng orexin i3vt saline p 001
0.08808324.12130565.html.plaintext.txt	41	view larger version 13k figure 6 intake hf lf diets 1 h light phase 3 ng orexin i3vt saline p 001
0.08808324.12130565.html.plaintext.txt	42	discussion top abstract introduction materials methods results discussion references current results indicate although subthreshold dose naloxone nonselective opioid antagonist attenuate potent effects agrp orexin increase food intake dose alter effect mch stimulate food intake data consistent hypothesis orexigenic effect orexin critically depends activation opioid receptors downstream receptor whereas orexigenic action mch data also indicate although orexin mch increase food intake effects food choice quite distinct although orexin selectively stimulates consumption hf diet mch stimulates intake diet comparably thus mch increases caloric intake without altering source calories whereas orexin alters caloric intake diet selection
0.08808324.12130565.html.plaintext.txt	43	discussion top abstract introduction materials methods results discussion references current results indicate although subthreshold dose naloxone nonselective opioid antagonist attenuate potent effects agrp orexin increase food intake dose alter effect mch stimulate food intake data consistent hypothesis orexigenic effect orexin critically depends activation opioid receptors downstream receptor whereas orexigenic action mch data also indicate although orexin mch increase food intake effects food choice quite distinct although orexin selectively stimulates consumption hf diet mch stimulates intake diet comparably thus mch increases caloric intake without altering source calories whereas orexin alters caloric intake diet selection
0.08808324.12130565.html.plaintext.txt	44	results consistent hypothesis regard energy homeostasis agrp orexin share common underlying mechanism whereas mch acts different mechanism opioid system long implicated regulation food intake increased opioid activity brain leading increased caloric consumption 30 39 40 41 particular opioids modulate incentive value food opioid agonists increasing opioid antagonists decreasing 30 40 42 consistent opioids alter relative selection preference specific foods ss endorphin example increases intake preferred hf diet 43 44 likewise present experiments orexin selectively increased consumption preferred hf diet orexin stimulated intake pelleted chow attenuated prior administration naloxone hence conclude orexin like agrp uses opioid mediated circuits orexigenic action contrast comparably orexigenic dose mch alter diet selection mch elicited increase pelleted chow influenced naloxone therefore conclude opioid system downstream mediator mch orexigenic action
0.08808324.12130565.html.plaintext.txt	45	results consistent hypothesis regard energy homeostasis agrp orexin share common underlying mechanism whereas mch acts different mechanism opioid system long implicated regulation food intake increased opioid activity brain leading increased caloric consumption 30 39 40 41 particular opioids modulate incentive value food opioid agonists increasing opioid antagonists decreasing 30 40 42 consistent opioids alter relative selection preference specific foods ss endorphin example increases intake preferred hf diet 43 44 likewise present experiments orexin selectively increased consumption preferred hf diet orexin stimulated intake pelleted chow attenuated prior administration naloxone hence conclude orexin like agrp uses opioid mediated circuits orexigenic action contrast comparably orexigenic dose mch alter diet selection mch elicited increase pelleted chow influenced naloxone therefore conclude opioid system downstream mediator mch orexigenic action
0.08808324.12130565.html.plaintext.txt	46	considerable controversy surrounds contention macronutrient intake selectively regulated different central nervous system systems 45 including opioids 42 46 47 example drug treatment given cannot easily ascertained whether increase decrease one particular food choice relative another reflects preference aversion specific macronutrient eg fat vs carbohydrate whether reflects magnified minimized preexisting preference based upon palatability 48 regardless actual mechanism critical observation orexin mch influence food intake via distinct mechanisms dissociated use opioid antagonists andor considering food selection agrp orexigenic action also reduced naloxone agrp selectively increases intake preferred hf diet 31 conclude orexin agrp act common mechanism recent data laboratory 49 50 others 51 indicate orexigenic dose agrp increases fos activity lha dual label immunohistochemistry indicates increased activity orexin producing neurons importantly agrp increase fos activity mch producing neurons 50 51 hence functional anatomical data consistent pharmacological behavioral data
0.08808324.12130565.html.plaintext.txt	47	considerable controversy surrounds contention macronutrient intake selectively regulated different central nervous system systems 45 including opioids 42 46 47 example drug treatment given cannot easily ascertained whether increase decrease one particular food choice relative another reflects preference aversion specific macronutrient eg fat vs carbohydrate whether reflects magnified minimized preexisting preference based upon palatability 48 regardless actual mechanism critical observation orexin mch influence food intake via distinct mechanisms dissociated use opioid antagonists andor considering food selection agrp orexigenic action also reduced naloxone agrp selectively increases intake preferred hf diet 31 conclude orexin agrp act common mechanism recent data laboratory 49 50 others 51 indicate orexigenic dose agrp increases fos activity lha dual label immunohistochemistry indicates increased activity orexin producing neurons importantly agrp increase fos activity mch producing neurons 50 51 hence functional anatomical data consistent pharmacological behavioral data
0.08808324.12130565.html.plaintext.txt	48	agrp endogenous antagonist melanocortin 3 4 receptors 27 found lha well projection sites npyagrp neurons arcuate nucleus 20 29 present data allow determination whether agrp stimulates orexin neurons turn stimulate food intake acting via opioid receptors additionally data determine whether pathway orexin agrp opioid circuits whether relay sites involved integrate information agrp orexin inputs added facts agrp neurons arcuate cosynthesize npy npy elicited food intake also naloxone dependent hence npy agrp orexin appear share common circuit point
0.08808324.12130565.html.plaintext.txt	49	agrp endogenous antagonist melanocortin 3 4 receptors 27 found lha well projection sites npyagrp neurons arcuate nucleus 20 29 present data allow determination whether agrp stimulates orexin neurons turn stimulate food intake acting via opioid receptors additionally data determine whether pathway orexin agrp opioid circuits whether relay sites involved integrate information agrp orexin inputs added facts agrp neurons arcuate cosynthesize npy npy elicited food intake also naloxone dependent hence npy agrp orexin appear share common circuit point
0.08808324.12130565.html.plaintext.txt	50	last several years number identified peptides involved control food intake energy balance grown enormously much growth fueled application sophisticated molecular biological approaches pressing clinical need treat exponential growth obesity develop appropriate therapeutic strategies however alphabet soup peptides transmitters need organized functional circuits identification functional circuits depend intensive efforts delineate neuroanatomical relationship among systems well functional interactions present results demonstrate two peptides located within single hypothalamic subarea peptides appear regulated similarly energy balance stimulate food intake act via distinct behavioral neural mechanisms results point complexity homeostatic system designed much regulate intake rat ad libitum access single caloric source rather existence two lha subsystems influence food intake different ways emphasizes system great flexibility respond myriad environmental physiological challenges
0.08808324.12130565.html.plaintext.txt	51	last several years number identified peptides involved control food intake energy balance grown enormously much growth fueled application sophisticated molecular biological approaches pressing clinical need treat exponential growth obesity develop appropriate therapeutic strategies however alphabet soup peptides transmitters need organized functional circuits identification functional circuits depend intensive efforts delineate neuroanatomical relationship among systems well functional interactions present results demonstrate two peptides located within single hypothalamic subarea peptides appear regulated similarly energy balance stimulate food intake act via distinct behavioral neural mechanisms results point complexity homeostatic system designed much regulate intake rat ad libitum access single caloric source rather existence two lha subsystems influence food intake different ways emphasizes system great flexibility respond myriad environmental physiological challenges
0.08808324.12130565.html.plaintext.txt	52	footnotes work supported nih grants dk 17844 dk 56863 dk 54080 american diabetes association physician scientist training award ela obesity research center university cincinnati supported part procter gamble co
0.08808324.12130565.html.plaintext.txt	53	abbreviations agrp agouti related peptide hf high fat i3vt administered third ventricular lf low fat lha lateral hypothalamic area mch melanin concentrating hormone nalx naloxone hydrochloride npy neuropeptide y
0.08808324.12130565.html.plaintext.txt	54	accepted publication april 23 2002
0.08808324.12130565.html.plaintext.txt	55	references top abstract introduction materials methods results discussion references anand bk brobeck jr 1951 hypothalamic control food intake rats cats yale j biol med 24123 140 smith oaj 1961 food intake hypothalamic stimulation sheer de ed electrical stimulation brain austin university texas press 367 370 teitelbaum p epstein 1962 lateral hypothalamic syndrome recovery feeding drinking hypothalamic lesions psychol rev 6974 90 teitelbaum p cheng mf rozin p 1969 stages recovery development lateral hypothalamic control food water intake ann ny acad sci 157849 860medline teitelbaum p stellar e 1954 recovery failure eat produced hypothalamic lesions science 120894 895 bernardis ll bellinger ll 1996 lateral hypothalamic area revisited ingestive behavior neurosci biobehav rev 20189 287crossrefmedline qu d ludwig ds gammeltoft piper m pelleymounter ma cullen mj mathes wf przypek r kanarek r maratos flier e 1996 role melanin concentrating hormone central regulation feeding behaviour nature 380243 247crossrefmedline de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245medline skofitsch g jacobowitz dm 1985 immunohistochemical mapping galanin like neurons rat central nervous system peptides 6509 546crossrefmedline tritos na maratos flier e 1999 two important systems energy homeostasis melanocortins melanin concentrating hormone neuropeptides 33339 349crossrefmedline ludwig d mountjoy k tatro j gillette j frederich r flier j maratos flier e 1998 melanin concentrating hormone functional melanocortin antagonist hypothalamus j physiol 274e627 e633 rossi m choi sj o shea d miyoshi ghatei ma bloom sr 1997 melanin concentrating hormone acutely stimulates feeding chronic administration effect body weight endocrinology 138351 355abstractfree full text shimada m tritos n lowell b flier j maratos flier e 1998 mice lacking melanin concentrating hormone hypophagic lean nature 396670 674crossrefmedline yamanaka kunii k nambu tsujino n sakai matsuzaki miwa y goto k sakurai 2000 orexin induced food intake involves neuropeptide y pathway brain res 859404 409crossrefmedline edwards cm abusnana sunter d murphy kg ghatei ma bloom sr 1999 effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 160r7 r12 haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr 1999 effects single chronic intracerebroventricular administration orexins feeding rat peptides 201099 1105crossrefmedline broberger c de lecea l sutcliffe jg hokfelt 1998 hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402460 47430co2 45930co2 r 3943 stanley bg 1993 neuropeptide y multiple hypothalamic sites controls eating behavior endocrine autonomic systems energy balance colmers wf wahlestedt c eds biology neuropeptide y related peptides totowa humana press 457 509 clark jt kalra ps crowley wr kalra sp 1984 neuropeptide y human pancreatic polypeptide stimulate feeding behavior rats endocrinology 115427 429abstract billington cj briggs je grace m levine 1991 effects intracerebroventricular injection neuropeptide y energy metabolism j physiol 260r321 r327 rossi m kim m morgan d small c edwards c sunter d abusnana goldstone russell stanley smith d yagaloff k ghatei m bloom 1998 c terminal fragment agouti related protein increases feeding antagonizes effect melanocyte stimulating hormone vivo endocrinology 1394428 4431abstractfree full text hagan mm rushing pa pritchard lm schwartz mw strack van der ploeg ht woods sc seeley rj 2000 long term orexigenic effects agrp 83 132 involve mechanisms melanocortin receptor blockade j physiol 279r47 r52 ollmann m wilson b yang y kerns j chen y gantz barsh g 1997 antagonism central melanocortin receptors vitro vivo agouti related protein science 278135 138abstractfree full text hahn tm breininger jf baskin dg schwartz mw 1998 coexpression agrp npy fasting activated hypothalamic neurons nat neurosci 1271 272crossrefmedline cowley ma pronchuk n fan w dinulescu dm colmers wf cone rd 1999 integration npy agrp melanocortin signals hypothalamic paraventricular nucleus evidence cellular basis adipostat neuron 24155 163medline kotz cm grace mk briggs j levine billington cj 1995 effects opioid antagonists naloxone naltrexone neuropeptide y induced feeding brown fat thermogenesis rat neural site action j clin invest 96163 170medline hagan mm rushing pa benoit sc woods sc seeley rj 2001 opioid receptor involvement effect agrp 83 132 food intake food selection j physiol 280r814 r821 zhang m gosnell ba kelley ae 1998 intake high fat food selectively enhanced mu opioid receptor stimulation within nucleus accumbens j pharmacol exp ther 285908 914abstractfree full text wang j akabayashi dourmashkin j yu hj alexander jt chae hj leibowitz sf 1998 neuropeptide y relation carbohydrate intake corticosterone dietary obesity brain res 80275 88crossrefmedline stanley bg daniel dr chin leibowitz sf 1985 paraventricular nucleus injections peptide yy neuropeptide y preferentially enhance carbohydrate ingestion peptides 61205 1211crossrefmedline morley je levine gosnell ba kneip j grace m 1987 effect neuropeptide y ingestive behaviors rat j physiol 252r599 r609 brown cm coscina dv fletcher pj 2000 rewarding properties neuropeptide y perifornical hypothalamus versus nucleus accumbens peptides 211279 1287crossrefmedline chavez m kaiyala k madden lj schwartz mw woods sc 1995 intraventricular insulin level maintained body weight rats behav neurosci 109528 531crossrefmedline wirth mm giraudo sq 2001 effect agouti related protein delivered dorsomedial nucleus hypothalamus intake preferred versus non preferred diet brain res 897169 174crossrefmedline rudski jm grace m kuskowski ma billington cj levine 1996 behavioral effects naloxone neuropeptide y induced feeding pharmacol biochem behav 54771 777crossrefmedline kotz cm billington cj levine 1997 opioids nucleus solitary tract involved feeding rat j physiol 272r1028 r1032 levine grace m billington cj 1990 effect centrally administered naloxone deprivation drug induced feeding pharmacol biochem behav 36409 412crossrefmedline glass mj billington cj levine 1999 opioids food intake distributed functional neuronal pathways neuropeptides 33360 368crossrefmedline silva rm hadjimarkou mm rossi gc pasternak gw bodnar rj 2001 ss endorphin induced feeding pharmacological characterization using selective opioid antagonists antisense probes rats j pharmacol exp ther 297590 596abstractfree full text mckay ld kenney nj edens nk williams rh woods sc 1981 intracerebroventricular ss endorphin increases food intake rats life sci 291429 1434crossrefmedline seeley rj berthoud hr 2000 neural control macronutrient selection consensus controversy neural metabolic control macronutrient selection boca raton fl crc press 489 496 islam ak bodnar rj 1990 selective opioid receptor antagonist effects upon intake high fat diet rats brain res 508293 296crossrefmedline ookuma k barton c york da bray ga 1997 effect enterostatin opioids macronutrient selection consumption peptides 18785 791crossrefmedline glass mj billington cj levine 2000 opioids food reward macronutrient selection berthoud hr seeley rj eds neural metabolic control macronutrient intake danvers crc press vol 1407 423 hagan mm benoit sc rushing pa pritchard lm woods sc seeley rj 2001 immediate prolonged patterns agouti related peptide 83 132 induced c fos activation hypothalamic extrahypothalamic sites endocrinology 1421050 1056abstractfree full text jackman reed ja clegg dj woods sc seeley rj interactions melanin concentrating hormone mch c fos agouti related protein agrp administration society study ingestive behaviors philadelphia pa 2001 p 60 abstract zheng h corkern mm crousillac sm patterson lm phifer cb berthoud hr 2002 neurochemical phenotype hypothalamic neurons showing fos expression 23 h intracranial agrp j physiol regul integr comp physiol 282r1773 r1781
0.08808324.12130565.html.plaintext.txt	56	references top abstract introduction materials methods results discussion references anand bk brobeck jr 1951 hypothalamic control food intake rats cats yale j biol med 24123 140 smith oaj 1961 food intake hypothalamic stimulation sheer de ed electrical stimulation brain austin university texas press 367 370 teitelbaum p epstein 1962 lateral hypothalamic syndrome recovery feeding drinking hypothalamic lesions psychol rev 6974 90 teitelbaum p cheng mf rozin p 1969 stages recovery development lateral hypothalamic control food water intake ann ny acad sci 157849 860medline teitelbaum p stellar e 1954 recovery failure eat produced hypothalamic lesions science 120894 895 bernardis ll bellinger ll 1996 lateral hypothalamic area revisited ingestive behavior neurosci biobehav rev 20189 287crossrefmedline qu d ludwig ds gammeltoft piper m pelleymounter ma cullen mj mathes wf przypek r kanarek r maratos flier e 1996 role melanin concentrating hormone central regulation feeding behaviour nature 380243 247crossrefmedline de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245medline skofitsch g jacobowitz dm 1985 immunohistochemical mapping galanin like neurons rat central nervous system peptides 6509 546crossrefmedline tritos na maratos flier e 1999 two important systems energy homeostasis melanocortins melanin concentrating hormone neuropeptides 33339 349crossrefmedline ludwig d mountjoy k tatro j gillette j frederich r flier j maratos flier e 1998 melanin concentrating hormone functional melanocortin antagonist hypothalamus j physiol 274e627 e633 rossi m choi sj o shea d miyoshi ghatei ma bloom sr 1997 melanin concentrating hormone acutely stimulates feeding chronic administration effect body weight endocrinology 138351 355abstractfree full text shimada m tritos n lowell b flier j maratos flier e 1998 mice lacking melanin concentrating hormone hypophagic lean nature 396670 674crossrefmedline yamanaka kunii k nambu tsujino n sakai matsuzaki miwa y goto k sakurai 2000 orexin induced food intake involves neuropeptide y pathway brain res 859404 409crossrefmedline edwards cm abusnana sunter d murphy kg ghatei ma bloom sr 1999 effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 160r7 r12 haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr 1999 effects single chronic intracerebroventricular administration orexins feeding rat peptides 201099 1105crossrefmedline broberger c de lecea l sutcliffe jg hokfelt 1998 hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402460 47430co2 45930co2 r 3943 stanley bg 1993 neuropeptide y multiple hypothalamic sites controls eating behavior endocrine autonomic systems energy balance colmers wf wahlestedt c eds biology neuropeptide y related peptides totowa humana press 457 509 clark jt kalra ps crowley wr kalra sp 1984 neuropeptide y human pancreatic polypeptide stimulate feeding behavior rats endocrinology 115427 429abstract billington cj briggs je grace m levine 1991 effects intracerebroventricular injection neuropeptide y energy metabolism j physiol 260r321 r327 rossi m kim m morgan d small c edwards c sunter d abusnana goldstone russell stanley smith d yagaloff k ghatei m bloom 1998 c terminal fragment agouti related protein increases feeding antagonizes effect melanocyte stimulating hormone vivo endocrinology 1394428 4431abstractfree full text hagan mm rushing pa pritchard lm schwartz mw strack van der ploeg ht woods sc seeley rj 2000 long term orexigenic effects agrp 83 132 involve mechanisms melanocortin receptor blockade j physiol 279r47 r52 ollmann m wilson b yang y kerns j chen y gantz barsh g 1997 antagonism central melanocortin receptors vitro vivo agouti related protein science 278135 138abstractfree full text hahn tm breininger jf baskin dg schwartz mw 1998 coexpression agrp npy fasting activated hypothalamic neurons nat neurosci 1271 272crossrefmedline cowley ma pronchuk n fan w dinulescu dm colmers wf cone rd 1999 integration npy agrp melanocortin signals hypothalamic paraventricular nucleus evidence cellular basis adipostat neuron 24155 163medline kotz cm grace mk briggs j levine billington cj 1995 effects opioid antagonists naloxone naltrexone neuropeptide y induced feeding brown fat thermogenesis rat neural site action j clin invest 96163 170medline hagan mm rushing pa benoit sc woods sc seeley rj 2001 opioid receptor involvement effect agrp 83 132 food intake food selection j physiol 280r814 r821 zhang m gosnell ba kelley ae 1998 intake high fat food selectively enhanced mu opioid receptor stimulation within nucleus accumbens j pharmacol exp ther 285908 914abstractfree full text wang j akabayashi dourmashkin j yu hj alexander jt chae hj leibowitz sf 1998 neuropeptide y relation carbohydrate intake corticosterone dietary obesity brain res 80275 88crossrefmedline stanley bg daniel dr chin leibowitz sf 1985 paraventricular nucleus injections peptide yy neuropeptide y preferentially enhance carbohydrate ingestion peptides 61205 1211crossrefmedline morley je levine gosnell ba kneip j grace m 1987 effect neuropeptide y ingestive behaviors rat j physiol 252r599 r609 brown cm coscina dv fletcher pj 2000 rewarding properties neuropeptide y perifornical hypothalamus versus nucleus accumbens peptides 211279 1287crossrefmedline chavez m kaiyala k madden lj schwartz mw woods sc 1995 intraventricular insulin level maintained body weight rats behav neurosci 109528 531crossrefmedline wirth mm giraudo sq 2001 effect agouti related protein delivered dorsomedial nucleus hypothalamus intake preferred versus non preferred diet brain res 897169 174crossrefmedline rudski jm grace m kuskowski ma billington cj levine 1996 behavioral effects naloxone neuropeptide y induced feeding pharmacol biochem behav 54771 777crossrefmedline kotz cm billington cj levine 1997 opioids nucleus solitary tract involved feeding rat j physiol 272r1028 r1032 levine grace m billington cj 1990 effect centrally administered naloxone deprivation drug induced feeding pharmacol biochem behav 36409 412crossrefmedline glass mj billington cj levine 1999 opioids food intake distributed functional neuronal pathways neuropeptides 33360 368crossrefmedline silva rm hadjimarkou mm rossi gc pasternak gw bodnar rj 2001 ss endorphin induced feeding pharmacological characterization using selective opioid antagonists antisense probes rats j pharmacol exp ther 297590 596abstractfree full text mckay ld kenney nj edens nk williams rh woods sc 1981 intracerebroventricular ss endorphin increases food intake rats life sci 291429 1434crossrefmedline seeley rj berthoud hr 2000 neural control macronutrient selection consensus controversy neural metabolic control macronutrient selection boca raton fl crc press 489 496 islam ak bodnar rj 1990 selective opioid receptor antagonist effects upon intake high fat diet rats brain res 508293 296crossrefmedline ookuma k barton c york da bray ga 1997 effect enterostatin opioids macronutrient selection consumption peptides 18785 791crossrefmedline glass mj billington cj levine 2000 opioids food reward macronutrient selection berthoud hr seeley rj eds neural metabolic control macronutrient intake danvers crc press vol 1407 423 hagan mm benoit sc rushing pa pritchard lm woods sc seeley rj 2001 immediate prolonged patterns agouti related peptide 83 132 induced c fos activation hypothalamic extrahypothalamic sites endocrinology 1421050 1056abstractfree full text jackman reed ja clegg dj woods sc seeley rj interactions melanin concentrating hormone mch c fos agouti related protein agrp administration society study ingestive behaviors philadelphia pa 2001 p 60 abstract zheng h corkern mm crousillac sm patterson lm phifer cb berthoud hr 2002 neurochemical phenotype hypothalamic neurons showing fos expression 23 h intracranial agrp j physiol regul integr comp physiol 282r1773 r1781
0.09531622.15591134.html.plaintext.txt	0	expression class ii major histocompatibility complex molecules thyrocytes cause spontaneous thyroiditis mildly increases severity immunization hiroaki kimura miho kimura shey cherng tzou yen chun chen koichi suzuki noel r rose patrizio caturegli
0.09531622.15591134.html.plaintext.txt	1	address correspondence requests reprints patrizio caturegli md mph johns hopkins medical institutions department pathology ross building room 656 720 rutland avenue baltimore maryland 21205 e mail pcatatjhmiedu u d
0.09531622.15591134.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references class ii major histocompatibility complex mhc molecules classically expressed antigen presenting cells hematopoietic lineage also described epithelial cells association autoimmunity context however remains debatable whether class ii mhc molecules initiating event rather consequence autoimmune attack addition role epithelial class ii expression autoimmune attack begun unknown generated transgenic mice expressing thyroid follicular cells class ii transactivator master regulator genes class ii mhc pathway study used cohort 245 cbaj mice 127 wild type 118 transgenic basal conditions n 63 different time points immunization mouse thyroglobulin n 182 basal conditions transgenic mice similar wild type controls develop spontaneous autoimmune thyroiditis despite aberrant expression class ii mhc molecules thyrocytes immunization thyroiditis 8 severe transgenics controls 95 confidence interval 18 134 p 0033 especially florid stages disease findings suggest expression class ii mhc molecules epithelial cells sufficient initiate autoimmunity mildly modulates already established autoimmune attack target organ
0.09531622.15591134.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references class ii major histocompatibility complex mhc molecules classically expressed antigen presenting cells hematopoietic lineage also described epithelial cells association autoimmunity context however remains debatable whether class ii mhc molecules initiating event rather consequence autoimmune attack addition role epithelial class ii expression autoimmune attack begun unknown generated transgenic mice expressing thyroid follicular cells class ii transactivator master regulator genes class ii mhc pathway study used cohort 245 cbaj mice 127 wild type 118 transgenic basal conditions n 63 different time points immunization mouse thyroglobulin n 182 basal conditions transgenic mice similar wild type controls develop spontaneous autoimmune thyroiditis despite aberrant expression class ii mhc molecules thyrocytes immunization thyroiditis 8 severe transgenics controls 95 confidence interval 18 134 p 0033 especially florid stages disease findings suggest expression class ii mhc molecules epithelial cells sufficient initiate autoimmunity mildly modulates already established autoimmune attack target organ
0.09531622.15591134.html.plaintext.txt	4	introduction top abstract introduction materials methods results discussion references autoimmune diseases thyroid gland represented graves disease hashimoto thyroiditis collectively referred autoimmune thyroiditis common autoimmune diseases 1 excellent model organ specific autoimmunity 2 chronic conditions initiated loss immunological tolerance thyroid restricted self antigens tsh receptor thyroperoxidase thyroglobulin loss leads thyroid dysfunction via immune mediated inflammation ultimately clinical phenotype
0.09531622.15591134.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references autoimmune diseases thyroid gland represented graves disease hashimoto thyroiditis collectively referred autoimmune thyroiditis common autoimmune diseases 1 excellent model organ specific autoimmunity 2 chronic conditions initiated loss immunological tolerance thyroid restricted self antigens tsh receptor thyroperoxidase thyroglobulin loss leads thyroid dysfunction via immune mediated inflammation ultimately clinical phenotype
0.09531622.15591134.html.plaintext.txt	6	loss tolerance considered result combined effect environmental factors iodine gene variants example individuals g polymorphism noncoding 3 region cytotoxic lymphocyte antigen 4 gene 23 fold 145 fold increased risk developing graves disease hashimoto thyroiditis respectively 3 first described potent genetic influence known affect susceptibility autoimmune thyroiditis however major histocompatibility complex mhc association mhc autoimmunity originally reported 1971 first patients systemic lupus erythematosus 4 mice experimental autoimmune thyroiditis 5
0.09531622.15591134.html.plaintext.txt	7	loss tolerance considered result combined effect environmental factors iodine gene variants example individuals g polymorphism noncoding 3 region cytotoxic lymphocyte antigen 4 gene 23 fold 145 fold increased risk developing graves disease hashimoto thyroiditis respectively 3 first described potent genetic influence known affect susceptibility autoimmune thyroiditis however major histocompatibility complex mhc association mhc autoimmunity originally reported 1971 first patients systemic lupus erythematosus 4 mice experimental autoimmune thyroiditis 5
0.09531622.15591134.html.plaintext.txt	8	mhc located short arm human chromosome 6 spanning 36 megabases complete annotated dna sequence 6 main functions guide intracellular processing antigens display antigenic peptides plasma membrane recognition lymphocytes 7 gene dense region genome containing 224 loci 96 pseudogenes 128 expressed genes grouped three classes class ii mhc genes constitutively expressed hematopoietic cells involved antigen presentation dendritic cells macrophages b lymphocytes cortical thymic epithelial cells induced inflammatory stimuli many cell types endothelial cells hepatocytes ss cells pancreas thyrocytes little known biological significance observation although implicated allograft rejection 8 subsequently autoimmunity field bottazzo feldman hypothesized class ii mhc molecules aberrantly expressed epithelial cells confer antigen presenting functions favoring initiation autoimmune diseases 9 10
0.09531622.15591134.html.plaintext.txt	9	mhc located short arm human chromosome 6 spanning 36 megabases complete annotated dna sequence 6 main functions guide intracellular processing antigens display antigenic peptides plasma membrane recognition lymphocytes 7 gene dense region genome containing 224 loci 96 pseudogenes 128 expressed genes grouped three classes class ii mhc genes constitutively expressed hematopoietic cells involved antigen presentation dendritic cells macrophages b lymphocytes cortical thymic epithelial cells induced inflammatory stimuli many cell types endothelial cells hepatocytes ss cells pancreas thyrocytes little known biological significance observation although implicated allograft rejection 8 subsequently autoimmunity field bottazzo feldman hypothesized class ii mhc molecules aberrantly expressed epithelial cells confer antigen presenting functions favoring initiation autoimmune diseases 9 10
0.09531622.15591134.html.plaintext.txt	10	mhc also region associated greatest number human diseases ranging narcolepsy 11 primary immunodeficiencies 12 autoimmune conditions 13 14 strength association classically measured relative risks rr odds ratios varies low rr 25 myasthenia gravis person carrying dr3 allele 15 medium rr 30 dq8 type 1 diabetes 16 high rr 109 a29 birdshot retinochoroidopathy 17 graves disease mhc dr3 association mild rrs ranging 15 35 reviewed ref18 hashimoto thyroiditis contribution mhc haplotypes disease less definitive although may play role familial clustering thyroiditis diabetes 19
0.09531622.15591134.html.plaintext.txt	11	mhc also region associated greatest number human diseases ranging narcolepsy 11 primary immunodeficiencies 12 autoimmune conditions 13 14 strength association classically measured relative risks rr odds ratios varies low rr 25 myasthenia gravis person carrying dr3 allele 15 medium rr 30 dq8 type 1 diabetes 16 high rr 109 a29 birdshot retinochoroidopathy 17 graves disease mhc dr3 association mild rrs ranging 15 35 reviewed ref18 hashimoto thyroiditis contribution mhc haplotypes disease less definitive although may play role familial clustering thyroiditis diabetes 19
0.09531622.15591134.html.plaintext.txt	12	given biological plausibility replication findings strength many associations mhc molecules considered causal pathway leads autoimmune disease however important factors could confound described association first mhc loci found together frequencies much higher would expected random combination frequencies population thus possible genes causing disease mhc genes per se rather genes travel mhc example polymorphisms lmp2 lmp7 genes embedded within class ii region associated ankylosing spondylitis 20 addition allele associated particular disease also common normal unaffected population actually majority patients susceptible allele develop autoimmune disease finally unknown whether initiate autoimmunity mhc molecules expressed professional antigen presenting cells within secondary lymphoid organs rather nonhematopoietic cells target organ thyroid follicular cell case autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	13	given biological plausibility replication findings strength many associations mhc molecules considered causal pathway leads autoimmune disease however important factors could confound described association first mhc loci found together frequencies much higher would expected random combination frequencies population thus possible genes causing disease mhc genes per se rather genes travel mhc example polymorphisms lmp2 lmp7 genes embedded within class ii region associated ankylosing spondylitis 20 addition allele associated particular disease also common normal unaffected population actually majority patients susceptible allele develop autoimmune disease finally unknown whether initiate autoimmunity mhc molecules expressed professional antigen presenting cells within secondary lymphoid organs rather nonhematopoietic cells target organ thyroid follicular cell case autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	14	investigate whether mhc class ii molecules expressed thyrocytes play causal role autoimmune thyroiditis developed transgenic mice express specifically thyroid gland mhc class ii transactivator ciita master regulator mhc class ii pathway 21 22 experimental model temporal relationship exposure ie expression class ii mhc molecules thyrocytes disease ie autoimmune thyroiditis clear defined ab initio
0.09531622.15591134.html.plaintext.txt	15	investigate whether mhc class ii molecules expressed thyrocytes play causal role autoimmune thyroiditis developed transgenic mice express specifically thyroid gland mhc class ii transactivator ciita master regulator mhc class ii pathway 21 22 experimental model temporal relationship exposure ie expression class ii mhc molecules thyrocytes disease ie autoimmune thyroiditis clear defined ab initio
0.09531622.15591134.html.plaintext.txt	16	materials methods top abstract introduction materials methods results discussion references construction screening thyr ciita transgenic mice thyr ciita transgene made joining rat thyroglobulin promoter rat ciita type iv cdna jellyfish green fluorescent protein gfp part human gh gene source introns polyadenylation signal fig 1a gfp linked bicistronically ciita using internal ribosomal entry site ires allow easier detection transgene expression 65 kb transgene excised clai sacii digestion purified electroelution resuspended 10 ng microl 10 mm tris01 mm edta ph 74 transgene injected fertilized eggs cba x c57bl6 f1 females maintained hemizygous mating wild type cbaj mice jackson laboratory bar harbor
0.09531622.15591134.html.plaintext.txt	17	view larger version 53k fig 1 construction screening thyr ciita transgenic mice structure transgene rat thyroglobulin promoter rat type iv ciita internal ribosomal entry site ires jellyfish gfp part human gh source splice donor acceptor sequences indicated rectangles different shades primers used screening indicated arrows b pcr screening using primers ciita region top gfp region bottom positive plasmid control lane 1 100 bp dna marker lane 2 water control lane 3 wild type littermate lane 4 line c line d thyr ciita transgenic lanes 5 6 c southern blot screening hindiii dna marker lane 1 positive plasmid control lane 2 wild type littermate lane 3 line c ciita transgenic lane 4 line d ciita transgenic lane 5
0.09531622.15591134.html.plaintext.txt	18	founders identified southern hybridization eight micrograms tail genomic dna digested bamhi separated overnight electrophoresis transferred onto hybond n membranes amersham piscataway nj 305 bp dna fragment gfp gene used generate 32p labeled probe using random priming labeling kit invitrogen carlsbad ca hybridization carried overnight 60 c 025 m phosphate buffer ph 72 supplemented 7 sds 5 dextran sulfate containing 15 x 106 trichloroacetic acid precipitable counts per minute probe per milliliter hybridization buffer blots washed twice 2x standard saline citrate ssc 1x ssc 015 m nacl plus 0015 m sodium citrate washed 30 min 42 c 2x ssc01 sds 30 min room temperature 02x ssc01 sds blots wrapped plastic exposed overnight 70 c biomax ms autoradiographic films eastman kodak rochester ny establishment transgenic lines mice screened pcr tail genomic dna using one primer pair ciita region one gfp region primer sequences follows ciita forward primer 5 gtcaagtgttcttgaacagtag 3 ciita reverse primer 5 agtatggccttgcaggtaag 3 gfp forward primer 5 tgaaccgcatcgagctgaag 3 gfp reverse primer 5 tccagcaggaccatgtgatc 3 pcr products fractionated electrophoresis 15 agarose gel fig 1b mice contained ciita amplicon 451 bp gfp amplicon 305 bp labeled transgenic
0.09531622.15591134.html.plaintext.txt	19	founders identified southern hybridization eight micrograms tail genomic dna digested bamhi separated overnight electrophoresis transferred onto hybond n membranes amersham piscataway nj 305 bp dna fragment gfp gene used generate 32p labeled probe using random priming labeling kit invitrogen carlsbad ca hybridization carried overnight 60 c 025 m phosphate buffer ph 72 supplemented 7 sds 5 dextran sulfate containing 15 x 106 trichloroacetic acid precipitable counts per minute probe per milliliter hybridization buffer blots washed twice 2x standard saline citrate ssc 1x ssc 015 m nacl plus 0015 m sodium citrate washed 30 min 42 c 2x ssc01 sds 30 min room temperature 02x ssc01 sds blots wrapped plastic exposed overnight 70 c biomax ms autoradiographic films eastman kodak rochester ny establishment transgenic lines mice screened pcr tail genomic dna using one primer pair ciita region one gfp region primer sequences follows ciita forward primer 5 gtcaagtgttcttgaacagtag 3 ciita reverse primer 5 agtatggccttgcaggtaag 3 gfp forward primer 5 tgaaccgcatcgagctgaag 3 gfp reverse primer 5 tccagcaggaccatgtgatc 3 pcr products fractionated electrophoresis 15 agarose gel fig 1b mice contained ciita amplicon 451 bp gfp amplicon 305 bp labeled transgenic
0.09531622.15591134.html.plaintext.txt	20	analysis thyr ciita transgene expression thyroid specific expression ciita assessed fluorescent microscopy detect gfp rt pcr immunohistochemistry detect mch class ii gfp expression measured freezing thyroids cutting 10 microm sections microtome observing directly green fluorescence zeiss uv microscope
0.09531622.15591134.html.plaintext.txt	21	analysis thyr ciita transgene expression thyroid specific expression ciita assessed fluorescent microscopy detect gfp rt pcr immunohistochemistry detect mch class ii gfp expression measured freezing thyroids cutting 10 microm sections microtome observing directly green fluorescence zeiss uv microscope
0.09531622.15591134.html.plaintext.txt	22	messenger rna extracted thyroid lobes using oligodt magnetic beads dynal lake success ny treated rnase free dnase invitrogen reverse transcribed superscript ii invitrogen cdna cdna amplified pcr forward 5 gacattgaggccgaccacgtag 3 reverse 5 attggtagctggggtggaatttg 3 primers locus mouse h 2 complex primers glyceraldehyde 3 phosphate dehydrogenase forward 5 gcatcttgggctacactgag 3 reverse 5 tctcttgctcagtgtccttg 3 used adjust amount loading
0.09531622.15591134.html.plaintext.txt	23	messenger rna extracted thyroid lobes using oligodt magnetic beads dynal lake success ny treated rnase free dnase invitrogen reverse transcribed superscript ii invitrogen cdna cdna amplified pcr forward 5 gacattgaggccgaccacgtag 3 reverse 5 attggtagctggggtggaatttg 3 primers locus mouse h 2 complex primers glyceraldehyde 3 phosphate dehydrogenase forward 5 gcatcttgggctacactgag 3 reverse 5 tctcttgctcagtgtccttg 3 used adjust amount loading
0.09531622.15591134.html.plaintext.txt	24	immunohistochemistry performed zinc fixed paraffin embedded thyroid specimens five micrometer sections cut mounted onto superfrost plus slides fisher scientific pittsburgh pa deparaffinized rehydrated blocking antibody nonspecific binding 1 h 2 normal goat serum sections incubated overnight humid chamber 4 c biotin conjugated monoclonal antibody recognizing ak clone 10 36 pharmingen san diego ca sections washed pbs incubated 3 hydrogen peroxide 5 min block endogenous peroxidase peroxidase conjugated streptavidin dako carpinteria ca 30 min humid chamber reactions visualized addition diaminobenzidine substrate sigma chemical co st louis mo finally sections rinsed distilled water counterstained mayer hematoxylin polyscientific bay shore ny washed running tap water dehydrated increasing concentrations ethanol mounted cytoseal richard allan scientific kalamazoo mi
0.09531622.15591134.html.plaintext.txt	25	immunohistochemistry performed zinc fixed paraffin embedded thyroid specimens five micrometer sections cut mounted onto superfrost plus slides fisher scientific pittsburgh pa deparaffinized rehydrated blocking antibody nonspecific binding 1 h 2 normal goat serum sections incubated overnight humid chamber 4 c biotin conjugated monoclonal antibody recognizing ak clone 10 36 pharmingen san diego ca sections washed pbs incubated 3 hydrogen peroxide 5 min block endogenous peroxidase peroxidase conjugated streptavidin dako carpinteria ca 30 min humid chamber reactions visualized addition diaminobenzidine substrate sigma chemical co st louis mo finally sections rinsed distilled water counterstained mayer hematoxylin polyscientific bay shore ny washed running tap water dehydrated increasing concentrations ethanol mounted cytoseal richard allan scientific kalamazoo mi
0.09531622.15591134.html.plaintext.txt	26	induction experimental autoimmune thyroiditis evaluation thyroid pathology study population included total 245 mice cbaj background 127 wild type 81 females 46 males 118 thyr ciita transgenic 51 females 67 males sixty three mice 30 wild type 33 transgenic analyzed different time points 2 18 months age basal conditions without immunization d 0 table 1 remaining 182 mice 97 wild type 85 transgenic immunized twice d 0 7 via sc injection gel purified murine thyroglobulin 75 microg emulsified complete freund adjuvant contains 5 mgml mycobacterium tuberculosis strain h37 ra difco laboratories detroit mi mice killed different time points immunization indicated table 1 euthanasia tracheas attached thyroids removed fixed 2 3 d zinc based beckstead solution 23 processing embedding paraffin six eight nonsequential sections cut specimen stained hematoxylin eosin section greatest surface area selected digital imaging performed described 2 briefly acquisition images spot rt video camera mounted zeiss axioplot microscope images analyzed carnoy software area corresponding entire thyroid gland marked measured used denominator b areas mononuclear cell infiltration marked summed used numerator thyroid histopathology score expressed percentage total thyroid area infiltrated mononuclear cells ab x 100 experimental protocols conformed johns hopkins animal care use committee guidelines
0.09531622.15591134.html.plaintext.txt	27	induction experimental autoimmune thyroiditis evaluation thyroid pathology study population included total 245 mice cbaj background 127 wild type 81 females 46 males 118 thyr ciita transgenic 51 females 67 males sixty three mice 30 wild type 33 transgenic analyzed different time points 2 18 months age basal conditions without immunization d 0 table 1 remaining 182 mice 97 wild type 85 transgenic immunized twice d 0 7 via sc injection gel purified murine thyroglobulin 75 microg emulsified complete freund adjuvant contains 5 mgml mycobacterium tuberculosis strain h37 ra difco laboratories detroit mi mice killed different time points immunization indicated table 1 euthanasia tracheas attached thyroids removed fixed 2 3 d zinc based beckstead solution 23 processing embedding paraffin six eight nonsequential sections cut specimen stained hematoxylin eosin section greatest surface area selected digital imaging performed described 2 briefly acquisition images spot rt video camera mounted zeiss axioplot microscope images analyzed carnoy software area corresponding entire thyroid gland marked measured used denominator b areas mononuclear cell infiltration marked summed used numerator thyroid histopathology score expressed percentage total thyroid area infiltrated mononuclear cells ab x 100 experimental protocols conformed johns hopkins animal care use committee guidelines
0.09531622.15591134.html.plaintext.txt	28	measurement mouse thyroglobulin specific igg antibodies mice bled retroorbital venous plexus beginning immunization 10 14 21 28 35 70 100 d first immunization sera diluted pbs 1100 1400 incubated overnight immulon2 elisa plates dynex technologies chantilly va precoated mouse thyroglobulin 100 ngwell proper washing mouse thyroglobulin specific igg subclasses detected using secondary antibodies igg1 igg2a igg2b conjugated alkaline phosphatase color change p nitrophenol phosphate measured 405 nm using emax microplate reader molecular devices sunnyvale ca plate included homemade standard curve derived serial dilutions pool serum known mouse thyroglobulin antibodies standard curve allowed us express results arbitrary units rather absorbance thus adjusting intra interassay variability
0.09531622.15591134.html.plaintext.txt	29	measurement mouse thyroglobulin specific igg antibodies mice bled retroorbital venous plexus beginning immunization 10 14 21 28 35 70 100 d first immunization sera diluted pbs 1100 1400 incubated overnight immulon2 elisa plates dynex technologies chantilly va precoated mouse thyroglobulin 100 ngwell proper washing mouse thyroglobulin specific igg subclasses detected using secondary antibodies igg1 igg2a igg2b conjugated alkaline phosphatase color change p nitrophenol phosphate measured 405 nm using emax microplate reader molecular devices sunnyvale ca plate included homemade standard curve derived serial dilutions pool serum known mouse thyroglobulin antibodies standard curve allowed us express results arbitrary units rather absorbance thus adjusting intra interassay variability
0.09531622.15591134.html.plaintext.txt	30	flow cytometry analysis draining cervical lymph nodes cervical lymph nodes isolated mechanically disrupted prepare single cell suspension 15 min fc block 4 c lymphoid cells stained 30 min 4 c following monoclonal antibodies pharmingen san diego ca fluorescein isothiocyanate conjugated anti b220 anti cd69 anti cd8 phycoerythrin conjugated anti cd19 anti cd44 cy chrome conjugated anti cd4 anti cd3 data collected facscalibur cytometer becton dickinson san diego ca gated first forward side scatter cd4 compensated displayed using cellquest software becton dickinson
0.09531622.15591134.html.plaintext.txt	31	flow cytometry analysis draining cervical lymph nodes cervical lymph nodes isolated mechanically disrupted prepare single cell suspension 15 min fc block 4 c lymphoid cells stained 30 min 4 c following monoclonal antibodies pharmingen san diego ca fluorescein isothiocyanate conjugated anti b220 anti cd69 anti cd8 phycoerythrin conjugated anti cd19 anti cd44 cy chrome conjugated anti cd4 anti cd3 data collected facscalibur cytometer becton dickinson san diego ca gated first forward side scatter cd4 compensated displayed using cellquest software becton dickinson
0.09531622.15591134.html.plaintext.txt	32	assessment thyroid function total t4 tsh levels total t4 level measured commercial competitive ria gammacoat 125it4 diasorin stillwater mn mouse tsh measured highly sensitive double antibody ria developed f parlow 24 briefly assay employs highly purified rat tsh afp11542b iodinated ligand selected guinea pig antimouse tsh afp98991 primary antibody partially purified extract mouse pituitary containing tsh afp51718mp reference preparation cross reactivity either highly purified mouse fsh mouse lh mouse tsh ria less 1
0.09531622.15591134.html.plaintext.txt	33	assessment thyroid function total t4 tsh levels total t4 level measured commercial competitive ria gammacoat 125it4 diasorin stillwater mn mouse tsh measured highly sensitive double antibody ria developed f parlow 24 briefly assay employs highly purified rat tsh afp11542b iodinated ligand selected guinea pig antimouse tsh afp98991 primary antibody partially purified extract mouse pituitary containing tsh afp51718mp reference preparation cross reactivity either highly purified mouse fsh mouse lh mouse tsh ria less 1
0.09531622.15591134.html.plaintext.txt	34	statistical analysis statistical analysis performed two phases first phase analyzed cross sectionally whether mean severity thyroid lesions thyroid histopathology score differed wild type thyr ciita transgenic mice crude unadjusted effect covariate genotype outcome thyroid histopathology score calculated simple linear regression ignoring effect covariates net adjusted effect genotype thyroid histopathology score holding covariates fixed calculated multiple linear regression covariates relating thyroid histopathology score considered inclusion model addition genotype sex transgenic line day killing first immunization total t4 d 0 tsh d 0 thyroglobulin specific antibodies d 0 day killing immunization treated dummy variable d 0 chosen reference category using stepwise backward selection removed sex total t4 d 0 tsh d 0 thyroglobulin specific antibodies d 0 based p values greater 005 final multiple linear regression model therefore included genotype transgenic line day killing covariates used estimate mean thyroid histopathology score analysis residuals fitting regression model indicated nonnormality heteroscedasticity thus used bootstrapping 2000 replications estimate se around regression coefficient perform valid hypothesis testing regression analysis nonnormal thyroid histopathology scores also analyzed cumulative incidence thyroiditis transgenic controls labeling thyroiditis cases mice thyroid histopathology score greater 25 rrs time point immunization expressed ratio incidence thyroiditis transgenic incidence wild type mice confidence intervals around rrs calculated logarithmic scale results exponentiated fisher exact test used test null hypothesis rrs equal 1
0.09531622.15591134.html.plaintext.txt	35	statistical analysis statistical analysis performed two phases first phase analyzed cross sectionally whether mean severity thyroid lesions thyroid histopathology score differed wild type thyr ciita transgenic mice crude unadjusted effect covariate genotype outcome thyroid histopathology score calculated simple linear regression ignoring effect covariates net adjusted effect genotype thyroid histopathology score holding covariates fixed calculated multiple linear regression covariates relating thyroid histopathology score considered inclusion model addition genotype sex transgenic line day killing first immunization total t4 d 0 tsh d 0 thyroglobulin specific antibodies d 0 day killing immunization treated dummy variable d 0 chosen reference category using stepwise backward selection removed sex total t4 d 0 tsh d 0 thyroglobulin specific antibodies d 0 based p values greater 005 final multiple linear regression model therefore included genotype transgenic line day killing covariates used estimate mean thyroid histopathology score analysis residuals fitting regression model indicated nonnormality heteroscedasticity thus used bootstrapping 2000 replications estimate se around regression coefficient perform valid hypothesis testing regression analysis nonnormal thyroid histopathology scores also analyzed cumulative incidence thyroiditis transgenic controls labeling thyroiditis cases mice thyroid histopathology score greater 25 rrs time point immunization expressed ratio incidence thyroiditis transgenic incidence wild type mice confidence intervals around rrs calculated logarithmic scale results exponentiated fisher exact test used test null hypothesis rrs equal 1
0.09531622.15591134.html.plaintext.txt	36	second phase used multiple linear regression generalized estimating equations gee 25 analyze longitudinally thyroid function assessed total t4 tsh thyroglobulin antibodies evolved immunization thyr ciita transgenic controls gee allows analysis multiple values t4 tsh mouse corrects fact characteristics single animal time likely correlated one another gee analyses repeated measures participant clustered furthermore gee analysis takes account status changing value covariates time point outcomes used gee analysis total t4 tsh igg1 igg2a igg2b thyroglobulin specific antibodies covariates addition genotype sex transgenic line day killing
0.09531622.15591134.html.plaintext.txt	37	second phase used multiple linear regression generalized estimating equations gee 25 analyze longitudinally thyroid function assessed total t4 tsh thyroglobulin antibodies evolved immunization thyr ciita transgenic controls gee allows analysis multiple values t4 tsh mouse corrects fact characteristics single animal time likely correlated one another gee analyses repeated measures participant clustered furthermore gee analysis takes account status changing value covariates time point outcomes used gee analysis total t4 tsh igg1 igg2a igg2b thyroglobulin specific antibodies covariates addition genotype sex transgenic line day killing
0.09531622.15591134.html.plaintext.txt	38	statistical analyses performed using stata 8 stata corp college station tx
0.09531622.15591134.html.plaintext.txt	39	results top abstract introduction materials methods results discussion references transgene expression baseline phenotype ciita transgene expressed control rat thyroglobulin promoter 26 shown support transcription specifically thyroid follicular cells four 76 injected mice transgene integrated genome passed progeny two four founders named thyr ciita transgenic lines c d fig 1c maintained hemizygous expanded mating normal cbaj mice form cohort described present study
0.09531622.15591134.html.plaintext.txt	40	results top abstract introduction materials methods results discussion references transgene expression baseline phenotype ciita transgene expressed control rat thyroglobulin promoter 26 shown support transcription specifically thyroid follicular cells four 76 injected mice transgene integrated genome passed progeny two four founders named thyr ciita transgenic lines c d fig 1c maintained hemizygous expanded mating normal cbaj mice form cohort described present study
0.09531622.15591134.html.plaintext.txt	41	specific expression transgene thyroid gland assessed fluorescent microscopy showed characteristic green positivity gfp specifically within thyroid follicular cells fig 2a rt pcr revealed aberrant expression class ii mhc transcripts thyrocytes thyr ciita transgenic thyrocytes wild type littermates fig 2 b c immunohistochemistry confirmed protein level expression class ii mhc molecules transgenic thyrocytes fig 2d wild type thyrocytes fig 2e
0.09531622.15591134.html.plaintext.txt	42	view larger version 120k fig 2 thyroid expression function thyr ciita transgene frozen section thyr ciita transgenic thyroid observed uv microscope direct green fluorescence x25 magnification 1 min exposure inset represents background autofluorescence wild type thyroid x25 magnification 5 min exposure b specific expression mhc class ii ak mrna transgenic thyroids assessed rt pcr c control gel expression common housekeeping gene glyceraldehyde 3 phosphate dehydrogenase b c gels minus sign indicates rt reaction performed absence reverse transcriptase control possible genomic dna contamination rna samples lane 1 100 bp dna marker lane 2 water control lanes 3 4 wild type littermate lanes 5 6 line c thyr ciita transgenic lanes 7 8 line d thyr ciita transgenic d specific expression mhc class ii ak protein transgenic thyroids assessed immunohistochemistry note diffuse cytosolic plasma membrane brown staining epithelial cells lining thyroid follicles thyr ciita transgenics nuclei negative colored blue hematoxylin counterstain e wild type control shown comparison
0.09531622.15591134.html.plaintext.txt	43	thyr ciita transgenic mice developed normally normal litter size life span t4 levels 415 microgdl plus minus 108 tsh levels 1039 u plus minus 391 none 63 mice 30 wild type 33 transgenic analyzed histologically d 0 showed signs thyroid pathology fig 3a developed antibodies mouse thyroglobulin fig 4 thus basal conditions thyr ciita transgenic mice despite ectopic expression mhc class ii molecules thyrocytes different wild type littermates develop spontaneous autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	44	thyr ciita transgenic mice developed normally normal litter size life span t4 levels 415 microgdl plus minus 108 tsh levels 1039 u plus minus 391 none 63 mice 30 wild type 33 transgenic analyzed histologically d 0 showed signs thyroid pathology fig 3a developed antibodies mouse thyroglobulin fig 4 thus basal conditions thyr ciita transgenic mice despite ectopic expression mhc class ii molecules thyrocytes different wild type littermates develop spontaneous autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	45	view larger version 85k fig 3 thyroid histopathology different time points immunization mouse thyroglobulin d thyroids ciita transgenic mice d 0 10 b 14 c 21 d e f d 35 thyroids wild type e ciita transgenic f g h thyroids ciita transgenic mice d 70 g 100 h
0.09531622.15591134.html.plaintext.txt	46	view larger version 16k fig 4 time series thyroglobulin specific antibodies immunization igg2a isotype b igg2b c igg1 difference antibody levels wild type transgenics therefore data represent pooled mean plus minus se genotypes numbers graph represent mice analyzed time point
0.09531622.15591134.html.plaintext.txt	47	thyroid histopathology immunization mouse thyroglobulin immunized 182 mice 97 wild type 85 transgenic mouse thyroglobulin assessed severity thyroid lesions thyroid histopathology score different time points thereafter groups mice thyroid lesions already present although minimal 12 total thyroid area d 10 post immunization fig 5 increased 65 d 14 reached peak 90 d 21 figs 3 c d 5 wild type mice thyroid histopathology score decreased approximately 45 remained around value d 100 fig 5 thyr ciita transgenic instead score remained higher became significantly higher controls d 35 simple linear regression assessing crude effect genotype score revealed transgenic mice tended severe disease average score 5 higher seen wild type although difference marked p 0046 multiple linear regression showed holding transgenic line day killing constant thyr ciita transgenic mice average thyroid histopathology score 8 higher seen wild type 95 confidence interval 18 134 p 0033 overall results indicate thyr ciita transgenics developed thyroiditis moderately severe wild type controls pronounced separation transgenic wild type seen d 35 figs 3 e f 5b transgenics average thyroid histopathology score 80 compared wild type score 55 p 0032 wilcoxon rank sum test groups mice scores observed d 14 28 35 70 100 significantly higher observed d 0 10 figs 3 h 5a p 00001 comparing d 14 28 35 70 100 d 10 0
0.09531622.15591134.html.plaintext.txt	48	thyroid histopathology immunization mouse thyroglobulin immunized 182 mice 97 wild type 85 transgenic mouse thyroglobulin assessed severity thyroid lesions thyroid histopathology score different time points thereafter groups mice thyroid lesions already present although minimal 12 total thyroid area d 10 post immunization fig 5 increased 65 d 14 reached peak 90 d 21 figs 3 c d 5 wild type mice thyroid histopathology score decreased approximately 45 remained around value d 100 fig 5 thyr ciita transgenic instead score remained higher became significantly higher controls d 35 simple linear regression assessing crude effect genotype score revealed transgenic mice tended severe disease average score 5 higher seen wild type although difference marked p 0046 multiple linear regression showed holding transgenic line day killing constant thyr ciita transgenic mice average thyroid histopathology score 8 higher seen wild type 95 confidence interval 18 134 p 0033 overall results indicate thyr ciita transgenics developed thyroiditis moderately severe wild type controls pronounced separation transgenic wild type seen d 35 figs 3 e f 5b transgenics average thyroid histopathology score 80 compared wild type score 55 p 0032 wilcoxon rank sum test groups mice scores observed d 14 28 35 70 100 significantly higher observed d 0 10 figs 3 h 5a p 00001 comparing d 14 28 35 70 100 d 10 0
0.09531622.15591134.html.plaintext.txt	49	view larger version 22k fig 5 thyroid histopathology score distribution mean scores thyr ciita transgenic wild type littermates d 0 several time points immunization b individual scores thyr ciita transgenic wild type littermates d 35 immunization
0.09531622.15591134.html.plaintext.txt	50	addition severity also incidence thyroiditis tended greater thyr ciita transgenic mice although time point difference reach statistical significance table 2
0.09531622.15591134.html.plaintext.txt	51	view table table 2 incidence experimental autoimmune thyroiditis wild type thyr ciita transgenic mice immunization mouse thyroglobulin
0.09531622.15591134.html.plaintext.txt	52	antibody response thyroglobulin immunization mouse thyroglobulin longitudinal data regression analysis demonstrated igg1 igg2b isotypes specific mouse thyroglobulin followed similar pattern reached similar levels thyr ciita transgenic controls began increase d 14 post immunization became significantly higher d 21 reached peak d 28 p 00096 vs d 21 p 0001 vs d 35 fig 4 b c igg1 igg2b gradually decreased d 35 70 100 still remaining significantly higher d 0
0.09531622.15591134.html.plaintext.txt	53	antibody response thyroglobulin immunization mouse thyroglobulin longitudinal data regression analysis demonstrated igg1 igg2b isotypes specific mouse thyroglobulin followed similar pattern reached similar levels thyr ciita transgenic controls began increase d 14 post immunization became significantly higher d 21 reached peak d 28 p 00096 vs d 21 p 0001 vs d 35 fig 4 b c igg1 igg2b gradually decreased d 35 70 100 still remaining significantly higher d 0
0.09531622.15591134.html.plaintext.txt	54	igg2a isotype attained higher levels igg1 igg2b isotypes showed different trend also reached peak d 21 continued stay high d 70 significant difference observed d 21 28 35 70 although mean value looked higher d 70 fig 4a igg2a levels decreased d 100 still remaining significantly higher d 0 p 00001 igg2a levels differ thyr ciita transgenic controls
0.09531622.15591134.html.plaintext.txt	55	igg2a isotype attained higher levels igg1 igg2b isotypes showed different trend also reached peak d 21 continued stay high d 70 significant difference observed d 21 28 35 70 although mean value looked higher d 70 fig 4a igg2a levels decreased d 100 still remaining significantly higher d 0 p 00001 igg2a levels differ thyr ciita transgenic controls
0.09531622.15591134.html.plaintext.txt	56	lymphocyte activation draining cervical lymph nodes immunization mouse thyroglobulin shown experimental models type 1 diabetes mellitus activation islet specific cd4 cells precedes onset diabetes occurs draining pancreatic lymph nodes within islets 27 observations also confirmed primate experimental allergic encephalomyelitis human multiple sclerosis 28 therefore looked cd4 cell activation markers increased expression cd69 cd44 diminished display cd62l cervical lymph nodes draining thyroid gland immunization mouse thyroglobulin d 0 activated cd4 cells fig 6a thyr ciita transgenic wild type littermates d 35 immunization significant increase d 0 p 0001 percentage activated cd4 cells fig 6b difference however transgenic wild type
0.09531622.15591134.html.plaintext.txt	57	lymphocyte activation draining cervical lymph nodes immunization mouse thyroglobulin shown experimental models type 1 diabetes mellitus activation islet specific cd4 cells precedes onset diabetes occurs draining pancreatic lymph nodes within islets 27 observations also confirmed primate experimental allergic encephalomyelitis human multiple sclerosis 28 therefore looked cd4 cell activation markers increased expression cd69 cd44 diminished display cd62l cervical lymph nodes draining thyroid gland immunization mouse thyroglobulin d 0 activated cd4 cells fig 6a thyr ciita transgenic wild type littermates d 35 immunization significant increase d 0 p 0001 percentage activated cd4 cells fig 6b difference however transgenic wild type
0.09531622.15591134.html.plaintext.txt	58	view larger version 25k fig 6 flow cytometry analysis draining cervical lymph nodes markers cell activation expression cd69 cd44 gated cd4 cells 35 d b immunization mouse thyroglobulin four six lymph nodes collected mouse pooled analysis performed 11 thyr ciita transgenic mice seven wild type controls
0.09531622.15591134.html.plaintext.txt	59	thyroid function immunization mouse thyroglobulin longitudinal regression analysis showed total t4 significantly decreased average 41 microgdl d 0 average 22 microgdl d 14 p 00001 t4 remained significantly low d 35 difference among d 14 21 28 35 increased normal levels d 70 p 0183 vs d 0 d 100 p 0206 vs d 0 fig 7a holding covariates constant transgenic line sex days killing thyroglobulin specific antibodies difference thyr ciita transgenic wild type total t4 levels total t4 poor predictor thyroid histopathology score p 0842 multiple linear regression analysis decrease total t4 d 14 present rise tsh suggesting decrease represents recovery phase euthyroid sick syndrome induced immunization procedure
0.09531622.15591134.html.plaintext.txt	60	thyroid function immunization mouse thyroglobulin longitudinal regression analysis showed total t4 significantly decreased average 41 microgdl d 0 average 22 microgdl d 14 p 00001 t4 remained significantly low d 35 difference among d 14 21 28 35 increased normal levels d 70 p 0183 vs d 0 d 100 p 0206 vs d 0 fig 7a holding covariates constant transgenic line sex days killing thyroglobulin specific antibodies difference thyr ciita transgenic wild type total t4 levels total t4 poor predictor thyroid histopathology score p 0842 multiple linear regression analysis decrease total t4 d 14 present rise tsh suggesting decrease represents recovery phase euthyroid sick syndrome induced immunization procedure
0.09531622.15591134.html.plaintext.txt	61	view larger version 19k fig 7 thyroid function total t4 levels tsh levels b ciita transgenic wild type littermates several time points immunization mouse thyroglobulin dotted lines indicate normal reference range cbaj mice 5th 95th percentile range 262 599 microgdl t4 63 182 uml tsh
0.09531622.15591134.html.plaintext.txt	62	tsh began increase 21 d immunization became significantly higher d 0 d 35 p 0045 d 70 p 0031 returned normal levels d 100 fig 7b holding covariates constant thyr ciita transgenic tended higher tsh levels although difference reach statistical significance p 0078 similarly observed thyroid pathology greatest distinction wild type thyr ciita transgenic observed d 35 post immunization fig 5b among humoral predictors measured study total t4 tsh igg1 igg2a igg2b thyroglobulin antibodies tsh best predictor thyroid histopathology score multiple linear regression showed every 100 u increase serum tsh score increased 61 95 confidence interval 42 80 p 000001
0.09531622.15591134.html.plaintext.txt	63	discussion top abstract introduction materials methods results discussion references mhc molecules undoubtedly associated autoimmune diseases 13 cases ankylosing spondylitis 29 birdshot retinochoroidopathy 30 strength association high ie rrs around 100 little doubt causative role mhc molecules pathway leading autoimmunity yet quoting beck j trowsdale case argued particular mhc allele necessary sufficient cause autoimmune disease 31 also unknown importance location whether mhc molecules play causal role expressed secondary lymphoid organs rather parenchymal cells organ targeted autoimmune attack 32
0.09531622.15591134.html.plaintext.txt	64	discussion top abstract introduction materials methods results discussion references mhc molecules undoubtedly associated autoimmune diseases 13 cases ankylosing spondylitis 29 birdshot retinochoroidopathy 30 strength association high ie rrs around 100 little doubt causative role mhc molecules pathway leading autoimmunity yet quoting beck j trowsdale case argued particular mhc allele necessary sufficient cause autoimmune disease 31 also unknown importance location whether mhc molecules play causal role expressed secondary lymphoid organs rather parenchymal cells organ targeted autoimmune attack 32
0.09531622.15591134.html.plaintext.txt	65	focused class ii mhc molecules used experimental autoimmune thyroiditis classical model organ specific autoimmunity class ii molecules primarily expressed antigen presenting cells hematopoietic lineage also induced endothelial epithelial cells observation raised question whether nonhematopoietic parenchymal cells function antigen presenting cells whether required damage target organ much work comes transplantation field generated conflicting results one side lakkis et al 33 found mice lacking secondary lymphoid organs spleen lymph nodes mucosa associated lymphoid tissues incapable rejecting either skin allografts primarily vascularized cardiac allografts suggesting secondary lymphoid organs required initiating immune response similarly teshima et al 34 using model graft vs host disease bone marrow chimeras expressing mhc molecules antigen presenting cells epithelial endothelial cells found graft capable inducing epithelial damage target organs skin gut liver host expressed mhc molecules host antigen presenting cells host target epithelium studies consistent recent direct visual evidence immune response indicating naive cells constantly roam secondary lymphoid organs encounter antigen presenting cells taken antigen target organs brought lymphoid organs 35 36 37 38 studies also consistent notion naive cells possess receptors necessary homing secondary lymphoid organs rather nonlymphoid organs notion nonprofessional antigen presenting cells usually lack costimulatory molecules required complete cell activation side however kreisel et al 39 showed naive cd8 cells indeed activated vitro vivo nonprofessional antigen presenting cells likely endothelial cells lead prompt rejection cardiac allograft suggesting endothelial expression mhc molecules direct pathogenic immune responses independently expression mhc molecules professional antigen presenting cells
0.09531622.15591134.html.plaintext.txt	66	focused class ii mhc molecules used experimental autoimmune thyroiditis classical model organ specific autoimmunity class ii molecules primarily expressed antigen presenting cells hematopoietic lineage also induced endothelial epithelial cells observation raised question whether nonhematopoietic parenchymal cells function antigen presenting cells whether required damage target organ much work comes transplantation field generated conflicting results one side lakkis et al 33 found mice lacking secondary lymphoid organs spleen lymph nodes mucosa associated lymphoid tissues incapable rejecting either skin allografts primarily vascularized cardiac allografts suggesting secondary lymphoid organs required initiating immune response similarly teshima et al 34 using model graft vs host disease bone marrow chimeras expressing mhc molecules antigen presenting cells epithelial endothelial cells found graft capable inducing epithelial damage target organs skin gut liver host expressed mhc molecules host antigen presenting cells host target epithelium studies consistent recent direct visual evidence immune response indicating naive cells constantly roam secondary lymphoid organs encounter antigen presenting cells taken antigen target organs brought lymphoid organs 35 36 37 38 studies also consistent notion naive cells possess receptors necessary homing secondary lymphoid organs rather nonlymphoid organs notion nonprofessional antigen presenting cells usually lack costimulatory molecules required complete cell activation side however kreisel et al 39 showed naive cd8 cells indeed activated vitro vivo nonprofessional antigen presenting cells likely endothelial cells lead prompt rejection cardiac allograft suggesting endothelial expression mhc molecules direct pathogenic immune responses independently expression mhc molecules professional antigen presenting cells
0.09531622.15591134.html.plaintext.txt	67	expressed via transgenesis transcriptional regulator ciita specifically nonprofessional antigen presenting cell thyrocyte ciita transcription factor defective causes severe primary immunodeficiency called bare lymphocyte syndrome 22 entirely attributable absence class ii mhc expression ciita true coactivator bind directly dna mediates function class ii mhc promoter interaction proteins 40 considered master regulator necessary sufficient expression genes mhc class ii pathway 21 although recently shown control genes outside mhc 41 ciita three different isoforms synthesized different cell specific promoters 42 promoter 1 used dendritic cells promoter 3 b lymphocytes promoter 4 nonhematopoietic cells previously shown vitro promoter 4 mediates interferon induced transcription ciita thyrocytes 43 thus used type 4 isoform ciita present study
0.09531622.15591134.html.plaintext.txt	68	expressed via transgenesis transcriptional regulator ciita specifically nonprofessional antigen presenting cell thyrocyte ciita transcription factor defective causes severe primary immunodeficiency called bare lymphocyte syndrome 22 entirely attributable absence class ii mhc expression ciita true coactivator bind directly dna mediates function class ii mhc promoter interaction proteins 40 considered master regulator necessary sufficient expression genes mhc class ii pathway 21 although recently shown control genes outside mhc 41 ciita three different isoforms synthesized different cell specific promoters 42 promoter 1 used dendritic cells promoter 3 b lymphocytes promoter 4 nonhematopoietic cells previously shown vitro promoter 4 mediates interferon induced transcription ciita thyrocytes 43 thus used type 4 isoform ciita present study
0.09531622.15591134.html.plaintext.txt	69	basal conditions ciita transgenic mice differ wild type littermates develop spontaneously autoimmune thyroiditis despite aberrant expression class ii mhc molecules thyrocytes findings agreement recent report li et al 44 shows thyroidal expression class ii molecules driven tsh receptor promoter lead apparent thyroid autoimmunity phenomenon seem limited thyroid gland stuve et al 45 expressed ciita fact specifically central nervous system using promoter glial fibrillary protein herkel et al 46 expressed liver using c reactive protein promoter cases despite aberrant expression class ii mhc molecules astrocytes hepatocytes mice develop spontaneous autoimmunity taken together observations strongly suggest expression class ii mhc molecules nonprofessional antigen presenting cells sufficient initiate autoimmune disease postulate expression likely results inflammatory stimuli interferon lipopolysaccharide released immune cells infiltrate target organ rather initiating event recruits immune cells target organ
0.09531622.15591134.html.plaintext.txt	70	basal conditions ciita transgenic mice differ wild type littermates develop spontaneously autoimmune thyroiditis despite aberrant expression class ii mhc molecules thyrocytes findings agreement recent report li et al 44 shows thyroidal expression class ii molecules driven tsh receptor promoter lead apparent thyroid autoimmunity phenomenon seem limited thyroid gland stuve et al 45 expressed ciita fact specifically central nervous system using promoter glial fibrillary protein herkel et al 46 expressed liver using c reactive protein promoter cases despite aberrant expression class ii mhc molecules astrocytes hepatocytes mice develop spontaneous autoimmunity taken together observations strongly suggest expression class ii mhc molecules nonprofessional antigen presenting cells sufficient initiate autoimmune disease postulate expression likely results inflammatory stimuli interferon lipopolysaccharide released immune cells infiltrate target organ rather initiating event recruits immune cells target organ
0.09531622.15591134.html.plaintext.txt	71	addition basal conditions also interested analyzing role class ii molecules thyrocytes autoimmune response upon immunization thyr ciita transgenic mice developed thyroiditis moderately severe greater incidence observed wild type littermates difference severity although higher transgenics time points became significantly higher d 35 immunization results suggest thyrocytes expressing class ii mhc molecules play secondary role initiation phase serve better targets facilitate greater immunopathology process already begun lack significant difference thyroiditis severity earlier time points d 10 28 explained fact immunization protocol used effective inducing thyroid lesions majority mice incidence comprised 86 95 wild type 100 transgenic
0.09531622.15591134.html.plaintext.txt	72	addition basal conditions also interested analyzing role class ii molecules thyrocytes autoimmune response upon immunization thyr ciita transgenic mice developed thyroiditis moderately severe greater incidence observed wild type littermates difference severity although higher transgenics time points became significantly higher d 35 immunization results suggest thyrocytes expressing class ii mhc molecules play secondary role initiation phase serve better targets facilitate greater immunopathology process already begun lack significant difference thyroiditis severity earlier time points d 10 28 explained fact immunization protocol used effective inducing thyroid lesions majority mice incidence comprised 86 95 wild type 100 transgenic
0.09531622.15591134.html.plaintext.txt	73	notion class ii mhc molecules epithelial cells modulatory role autoimmune attack begun intriguing may possible relevance hashimoto thyroiditis graves disease 47 diseases fact collectively referred autoimmune thyroiditis expression class ii molecules may indicate particularly severe stage disease question difficult assess humans use mouse model essential allows us analyze disease period time rather single time point
0.09531622.15591134.html.plaintext.txt	74	notion class ii mhc molecules epithelial cells modulatory role autoimmune attack begun intriguing may possible relevance hashimoto thyroiditis graves disease 47 diseases fact collectively referred autoimmune thyroiditis expression class ii molecules may indicate particularly severe stage disease question difficult assess humans use mouse model essential allows us analyze disease period time rather single time point
0.09531622.15591134.html.plaintext.txt	75	greater severity thyroid lesions displayed thyr ciita transgenic result greater number function activated cells considering cd4 cells cervical lymph nodes expressed similar levels activation markers wild type transgenics difference likely explained fact thyrocytes expressing class ii mhc molecules better recognized autoreactive cd4 cells cells already expanded words thyrocytes may serve endogenous immunogens potentiate expand reactivity cells initially selected thyroglobulin immunization protocol well established cell activation requires formation specialized cell cell junction antigen presenting cell called immunological synapse facilitates outcome immune recognition 48 center synapse occupied cell receptorcd3 complexes cd4 coreceptors cell side mhcpeptide complexes antigen presenting side also center costimulatory molecules cd28 cd40 ligand cells b7 cd40 antigen presenting cells periphery synapse instead occupied integrins lymphocyte function associated antigen 1 cd2 cells intercellular adhesion molecule 1 cd58 antigen presenting cells function efficiently antigen presenting cell thyrocytes aberrantly express mhc class ii molecules also express costimulatory molecules integrins thyrocytes patients graves disease hashimoto thyroiditis shown express integrins intercellular adhesion molecule 1 cd58 49 50 costimulator cd40 51 52 expression thyrocytes b7 probably potent costimulator less firmly established although reported hashimoto thyroiditis 53 differentiated thyroid tumors 54 b7 costimulation could also supplied trans professional antigen presenting cells parenchymal cells 55 thus theory thyrocytes aberrantly expressing class ii mhc molecules possess signal transduction circuitry necessary full cell activation although unknown whether individual components associate supramolecular activation complex show expression thyrocytes class ii mhc insufficient initiate autoimmune thyroiditis results emphasize importance location initiation immune response location likely requires interaction autoreactive cell antigen presenting cells within secondary lymphoid organs
0.09531622.15591134.html.plaintext.txt	76	greater severity thyroid lesions displayed thyr ciita transgenic result greater number function activated cells considering cd4 cells cervical lymph nodes expressed similar levels activation markers wild type transgenics difference likely explained fact thyrocytes expressing class ii mhc molecules better recognized autoreactive cd4 cells cells already expanded words thyrocytes may serve endogenous immunogens potentiate expand reactivity cells initially selected thyroglobulin immunization protocol well established cell activation requires formation specialized cell cell junction antigen presenting cell called immunological synapse facilitates outcome immune recognition 48 center synapse occupied cell receptorcd3 complexes cd4 coreceptors cell side mhcpeptide complexes antigen presenting side also center costimulatory molecules cd28 cd40 ligand cells b7 cd40 antigen presenting cells periphery synapse instead occupied integrins lymphocyte function associated antigen 1 cd2 cells intercellular adhesion molecule 1 cd58 antigen presenting cells function efficiently antigen presenting cell thyrocytes aberrantly express mhc class ii molecules also express costimulatory molecules integrins thyrocytes patients graves disease hashimoto thyroiditis shown express integrins intercellular adhesion molecule 1 cd58 49 50 costimulator cd40 51 52 expression thyrocytes b7 probably potent costimulator less firmly established although reported hashimoto thyroiditis 53 differentiated thyroid tumors 54 b7 costimulation could also supplied trans professional antigen presenting cells parenchymal cells 55 thus theory thyrocytes aberrantly expressing class ii mhc molecules possess signal transduction circuitry necessary full cell activation although unknown whether individual components associate supramolecular activation complex show expression thyrocytes class ii mhc insufficient initiate autoimmune thyroiditis results emphasize importance location initiation immune response location likely requires interaction autoreactive cell antigen presenting cells within secondary lymphoid organs
0.09531622.15591134.html.plaintext.txt	77	conclusion study reports expression class ii mhc molecules epithelial thyroid cells required initiation autoimmune attack thyroid initiation seems mainly mediated professional antigen presenting cells secondary lymphoid organs immune recognition begun however aberrant expression class ii nonprofessional antigen presenting cells facilitate disease progression yields severe disease additional studies required fully explain intriguing association mhc molecules autoimmune diseases
0.09531622.15591134.html.plaintext.txt	78	conclusion study reports expression class ii mhc molecules epithelial thyroid cells required initiation autoimmune attack thyroid initiation seems mainly mediated professional antigen presenting cells secondary lymphoid organs immune recognition begun however aberrant expression class ii nonprofessional antigen presenting cells facilitate disease progression yields severe disease additional studies required fully explain intriguing association mhc molecules autoimmune diseases
0.09531622.15591134.html.plaintext.txt	79	acknowledgments grateful drs william d m baldwin james tonascia critical revisions manuscript
0.09531622.15591134.html.plaintext.txt	80	footnotes work supported national institutes health grant dk55670 pc
0.09531622.15591134.html.plaintext.txt	81	first published online december 9 2004
0.09531622.15591134.html.plaintext.txt	82	abbreviations ciita class ii transactivator gee generalized estimating equations gfp green fluorescent protein mhc major histocompatibility complex rr relative risk
0.09531622.15591134.html.plaintext.txt	83	accepted publication december 2 2004
0.09531622.15591134.html.plaintext.txt	84	references top abstract introduction materials methods results discussion references jacobson dl gange sj rose n graham nmh 1997 epidemiology estimated population burden selected autoimmune diseases united states clin immunol immunopathol 84223 243crossrefmedline caturegli p rose nr kimura m kimura h tzou sc 2003 studies murine thyroiditis new insights organ flow cytometry thyroid 13419 426crossrefmedline ueda h howson jm esposito l heward j snook h chamberlain g rainbow db hunter km smith di genova g herr mh dahlman payne f smyth d lowe c twells rc howlett healy b nutland rance everett v smink lj lam ac cordell hj walker nm et al 2003 association cell regulatory gene ctla4 susceptibility autoimmune disease nature 423506 511crossrefmedline grumet fc coukell bodmer jg bodmer wf mcdevitt ho 1971 histocompatibility hl antigens associated systemic lupus erythematosus possible genetic predisposition disease n engl j med 285193 196medline vladutiu ao rose nr 1971 autoimmune murine thyroiditis relation histocompatibility h 2 type science 1741137 1139medline mungall aj palmer sa sims sk edwards ca ashurst jl wilming l jones mc horton r hunt se scott ce gilbert jg clamp bethel g milne ainscough r almeida jp ambrose kd andrews td ashwell ri babbage ak bagguley cl bailey j banerjee r barker dj barlow kf et al 2003 dna sequence analysis human chromosome 6 nature 425805 811crossrefmedline kumanovics takada lindahl kf 2003 genomic organization mammalian mhc annu rev immunol 21629 657crossrefmedline dallman mj mason dw 1983 induction ia antigens murine epidermal cells rejection skin allografts transplantation 36222 224medline bottazzo gf pujol borrell r hanafusa feldmann m 1983 role aberrant hla dr expression antigen presentation induction endocrine autoimmunity lancet 21115 1119medline mirakian r hammond lj bottazzo gf 1998 pathogenesis thyroid autoimmunity bottazzo feldmann hypothesis immunol today 1997 98crossrefmedline lin l hungs m mignot e 2001 narcolepsy hla region j neuroimmunol 1179 20crossrefmedline kralovicova j hammarstrom l plebani webster ad vorechovsky 2003 fine scale mapping igad1 genome wide genetic linkage analysis implicate hla dqdr major susceptibility locus selective iga deficiency common variable immunodeficiency j immunol 1702765 2775abstractfree full text price p witt c allcock r sayer d garlepp m kok cc french m mallal christiansen f 1999 genetic basis association 81 ancestral haplotype a1 b8 dr3 multiple immunopathological diseases immunol rev 167257 274medline klein j sato 2000 hla system second two parts n engl j med 343782 786free full text carlsson b wallin j pirskanen r matell g smith ci 1990 different hla dr dq associations subgroups idiopathic myasthenia gravis immunogenetics 31285 290medline pociot f mcdermott mf 2002 genetics type 1 diabetes mellitus genes immun 3235 249crossrefmedline levinson rd gonzales cr 2002 birdshot retinochoroidopathy immunopathogenesis evaluation treatment ophthalmol clin north 15343 350 viimedline tomer y davies tf 2003 searching autoimmune thyroid disease susceptibility genes gene mapping gene function endocr rev 24694 717abstractfree full text levin l ban y concepcion e davies tf greenberg da tomer y 2004 analysis hla genes families autoimmune diabetes thyroiditis hum immunol 65640 647crossrefmedline maksymowych wp tao vaile j suarez almazor m ramos remus c russell 2000 lmp2 polymorphism associated extraspinal disease hla b27 negative caucasian mexican mestizo patients ankylosing spondylitis j rheumatol 27183 189medline mach b 1999 perspectives immunology regulating regulator science 2851367free full text reith w mach b 2001 bare lymphocyte syndrome regulation mhc expression annu rev immunol 19331 373crossrefmedline beckstead jh 1995 simple technique preservation fixation sensitive antigens paraffin embedded tissues addendum j histochem cytochem 43345free full text schneider mj fiering sn pallud se parlow af st germain dl galton va 2001 targeted disruption type 2 selenodeiodinase gene dio2 results phenotype pituitary resistance t4 mol endocrinol 152137 2148abstractfree full text diggle pj liang ky zeger sl 1995 analysis longitudinal data oxford uk clarendon press musti ursini vm avvedimento ev zimarino v di lauro r 1987 cell type specific factor recognizes rat thyroglobulin promoter nucleic acids res 158149 8166abstract hoglund p mintern j waltzinger c heath w benoist c mathis d 1999 initiation autoimmune diabetes developmentally regulated presentation islet cell antigens pancreatic lymph nodes j exp med 189331 339abstractfree full text de vos af van meurs m brok hp boven la hintzen rq van der valk p ravid r rensing boon l hart ba laman jd 2002 transfer central nervous system autoantigens presentation secondary lymphoid organs j immunol 1695415 5423abstractfree full text sims wordsworth bp brown ma 2004 genetic susceptibility ankylosing spondylitis curr mol med 413 20medline lehoang p ozdemir n benhamou tabary edelson c betuel h semiglia r cohen jh 1992 hla a292 subtype associated birdshot retinochoroidopathy j ophthalmol 11333 35medline beck trowsdale j 2000 human major histocompatability complex lessons dna sequence annu rev genomics hum genet 1117 137crossrefmedline lakkis fg 2003 alloimmune response initiated j transplant 3241 242crossrefmedline lakkis fg arakelov konieczny bt inoue y 2000 immunologic ignorance vascularized organ transplants absence secondary lymphoid tissue nat med 6686 688crossrefmedline teshima ordemann r reddy p gagin liu c cooke kr ferrara jl 2002 acute graft versus host disease require alloantigen expression host epithelium nat med erratum 2002 81039 8575 581crossref monks cr freiberg ba kupfer h sciaky n kupfer 1998 three dimensional segregation supramolecular activation clusters cells nature 39582 86crossrefmedline wulfing c davis mm 1998 receptorcytoskeletal movement triggered costimulation cell activation science 2822266 2269abstractfree full text grakoui bromley sk sumen c davis mm shaw allen pm dustin ml 1999 immunological synapse molecular machine controlling cell activation science 285221 227abstractfree full text itano aa jenkins mk 2003 antigen presentation naive cd4 cells lymph node nat immunol 4733 739crossrefmedline kreisel d krupnick gelman ae engels fh popma sh krasinskas balsara kr szeto wy turka la rosengard br 2002 non hematopoietic allograft cells directly activate cd8 cells trigger acute rejection alternative mechanism allorecognition nat med 8233 239crossrefmedline ting jp trowsdale j 2002 genetic control mhc class ii expression cell 109suppls21 s33 reith w 2003 complexin new targets ciita nat immunol 4819 820crossrefmedline muhlethaler mottet otten la steimle v mach b 1997 expression mhc class ii molecules different cellular functional compartments controlled differential usage multiple promoters transactivator ciita embo j 162851 2860abstractfree full text mori aoki pietrarelli m nakazato m caturegli p kohn ld suzuki k 2000 class ii transactivator suppresses transcription thyroid specific genes biochem biophys res commun 27858 62crossrefmedline li ys kanamoto n hataya y moriyama k hiratani h nakao k akamizu 2004 transgenic mice producing major histocompatibility complex class ii molecules thyroid cells develop apparent autoimmune thyroid diseases endocrinology 1452524 2530abstractfree full text stuve o youssef slavin aj king cl patarroyo jc hirschberg dl brickey wj soos jm piskurich jf chapman ha zamvil ss 2002 role mhc class ii transactivator class ii expression antigen presentation astrocytes susceptibility central nervous system autoimmune disease j immunol 1696720 6732abstractfree full text herkel j jagemann b wiegard c lazaro jf lueth kanzler blessing m schmitt e lohse aw 2003 mhc class ii expressing hepatocytes function antigen presenting cells activate specific cd4 lymphocytes hepatology 371079 1085crossrefmedline weetman ap 2003 autoimmune thyroid disease propagation progression eur j endocrinol 1481 9abstractfree full text dustin ml 2002 immunological synapse arthritis res 4suppl 3s119 s125 zheng rq abney er grubeck loebenstein b dayan c maini rn feldmann m 1990 expression intercellular adhesion molecule 1 lymphocyte function associated antigen 3 human thyroid epithelial cells graves hashimoto diseases j autoimmun 3727 736medline bonita re rose nr rasooly l caturegli p burek cl 2002 adhesion molecules susceptibility factors spontaneous autoimmune thyroiditis nod h2h4 mouse exp mol pathol 73155 163crossrefmedline faure gc bensoussan lejzerowicz d bene mc aubert v leclere j 1997 coexpression cd40 class ii antigen hla dr graves disease thyroid epithelial cells clin immunol immunopathol 84212 215crossrefmedline metcalfe ra mcintosh rs marelli berg f lombardi g lechler r weetman ap 1998 detection cd40 human thyroid follicular cells analysis expression function j clin endocrinol metab 831268 1274abstractfree full text battifora m pesce g paolieri f fiorino n giordano c riccio torre g olive d bagnasco m 1998 b71 costimulatory molecule expressed thyroid follicular cells hashimoto thyroiditis graves disease j clin endocrinol metab 834130 4139abstractfree full text shah r banks k patel dogra terrell r powers pa fenton c dinauer ca tuttle rm francis gl 2002 intense expression b7 2 antigen presentation coactivator unfavorable prognostic indicator differentiated thyroid carcinoma children adolescents j clin endocrinol metab 874391 4397abstractfree full text mandelbrot da kishimoto k auchincloss jr h sharpe ah sayegh mh 2001 rejection mouse cardiac allografts costimulation trans j immunol 1671174 1178abstractfree full text article abstract full text pdf versions article 14631154 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles kimura h articles caturegli p articles citing article pubmed pubmed citation articles kimura h articles caturegli p
0.09531622.15591134.html.plaintext.txt	85	references top abstract introduction materials methods results discussion references jacobson dl gange sj rose n graham nmh 1997 epidemiology estimated population burden selected autoimmune diseases united states clin immunol immunopathol 84223 243crossrefmedline caturegli p rose nr kimura m kimura h tzou sc 2003 studies murine thyroiditis new insights organ flow cytometry thyroid 13419 426crossrefmedline ueda h howson jm esposito l heward j snook h chamberlain g rainbow db hunter km smith di genova g herr mh dahlman payne f smyth d lowe c twells rc howlett healy b nutland rance everett v smink lj lam ac cordell hj walker nm et al 2003 association cell regulatory gene ctla4 susceptibility autoimmune disease nature 423506 511crossrefmedline grumet fc coukell bodmer jg bodmer wf mcdevitt ho 1971 histocompatibility hl antigens associated systemic lupus erythematosus possible genetic predisposition disease n engl j med 285193 196medline vladutiu ao rose nr 1971 autoimmune murine thyroiditis relation histocompatibility h 2 type science 1741137 1139medline mungall aj palmer sa sims sk edwards ca ashurst jl wilming l jones mc horton r hunt se scott ce gilbert jg clamp bethel g milne ainscough r almeida jp ambrose kd andrews td ashwell ri babbage ak bagguley cl bailey j banerjee r barker dj barlow kf et al 2003 dna sequence analysis human chromosome 6 nature 425805 811crossrefmedline kumanovics takada lindahl kf 2003 genomic organization mammalian mhc annu rev immunol 21629 657crossrefmedline dallman mj mason dw 1983 induction ia antigens murine epidermal cells rejection skin allografts transplantation 36222 224medline bottazzo gf pujol borrell r hanafusa feldmann m 1983 role aberrant hla dr expression antigen presentation induction endocrine autoimmunity lancet 21115 1119medline mirakian r hammond lj bottazzo gf 1998 pathogenesis thyroid autoimmunity bottazzo feldmann hypothesis immunol today 1997 98crossrefmedline lin l hungs m mignot e 2001 narcolepsy hla region j neuroimmunol 1179 20crossrefmedline kralovicova j hammarstrom l plebani webster ad vorechovsky 2003 fine scale mapping igad1 genome wide genetic linkage analysis implicate hla dqdr major susceptibility locus selective iga deficiency common variable immunodeficiency j immunol 1702765 2775abstractfree full text price p witt c allcock r sayer d garlepp m kok cc french m mallal christiansen f 1999 genetic basis association 81 ancestral haplotype a1 b8 dr3 multiple immunopathological diseases immunol rev 167257 274medline klein j sato 2000 hla system second two parts n engl j med 343782 786free full text carlsson b wallin j pirskanen r matell g smith ci 1990 different hla dr dq associations subgroups idiopathic myasthenia gravis immunogenetics 31285 290medline pociot f mcdermott mf 2002 genetics type 1 diabetes mellitus genes immun 3235 249crossrefmedline levinson rd gonzales cr 2002 birdshot retinochoroidopathy immunopathogenesis evaluation treatment ophthalmol clin north 15343 350 viimedline tomer y davies tf 2003 searching autoimmune thyroid disease susceptibility genes gene mapping gene function endocr rev 24694 717abstractfree full text levin l ban y concepcion e davies tf greenberg da tomer y 2004 analysis hla genes families autoimmune diabetes thyroiditis hum immunol 65640 647crossrefmedline maksymowych wp tao vaile j suarez almazor m ramos remus c russell 2000 lmp2 polymorphism associated extraspinal disease hla b27 negative caucasian mexican mestizo patients ankylosing spondylitis j rheumatol 27183 189medline mach b 1999 perspectives immunology regulating regulator science 2851367free full text reith w mach b 2001 bare lymphocyte syndrome regulation mhc expression annu rev immunol 19331 373crossrefmedline beckstead jh 1995 simple technique preservation fixation sensitive antigens paraffin embedded tissues addendum j histochem cytochem 43345free full text schneider mj fiering sn pallud se parlow af st germain dl galton va 2001 targeted disruption type 2 selenodeiodinase gene dio2 results phenotype pituitary resistance t4 mol endocrinol 152137 2148abstractfree full text diggle pj liang ky zeger sl 1995 analysis longitudinal data oxford uk clarendon press musti ursini vm avvedimento ev zimarino v di lauro r 1987 cell type specific factor recognizes rat thyroglobulin promoter nucleic acids res 158149 8166abstract hoglund p mintern j waltzinger c heath w benoist c mathis d 1999 initiation autoimmune diabetes developmentally regulated presentation islet cell antigens pancreatic lymph nodes j exp med 189331 339abstractfree full text de vos af van meurs m brok hp boven la hintzen rq van der valk p ravid r rensing boon l hart ba laman jd 2002 transfer central nervous system autoantigens presentation secondary lymphoid organs j immunol 1695415 5423abstractfree full text sims wordsworth bp brown ma 2004 genetic susceptibility ankylosing spondylitis curr mol med 413 20medline lehoang p ozdemir n benhamou tabary edelson c betuel h semiglia r cohen jh 1992 hla a292 subtype associated birdshot retinochoroidopathy j ophthalmol 11333 35medline beck trowsdale j 2000 human major histocompatability complex lessons dna sequence annu rev genomics hum genet 1117 137crossrefmedline lakkis fg 2003 alloimmune response initiated j transplant 3241 242crossrefmedline lakkis fg arakelov konieczny bt inoue y 2000 immunologic ignorance vascularized organ transplants absence secondary lymphoid tissue nat med 6686 688crossrefmedline teshima ordemann r reddy p gagin liu c cooke kr ferrara jl 2002 acute graft versus host disease require alloantigen expression host epithelium nat med erratum 2002 81039 8575 581crossref monks cr freiberg ba kupfer h sciaky n kupfer 1998 three dimensional segregation supramolecular activation clusters cells nature 39582 86crossrefmedline wulfing c davis mm 1998 receptorcytoskeletal movement triggered costimulation cell activation science 2822266 2269abstractfree full text grakoui bromley sk sumen c davis mm shaw allen pm dustin ml 1999 immunological synapse molecular machine controlling cell activation science 285221 227abstractfree full text itano aa jenkins mk 2003 antigen presentation naive cd4 cells lymph node nat immunol 4733 739crossrefmedline kreisel d krupnick gelman ae engels fh popma sh krasinskas balsara kr szeto wy turka la rosengard br 2002 non hematopoietic allograft cells directly activate cd8 cells trigger acute rejection alternative mechanism allorecognition nat med 8233 239crossrefmedline ting jp trowsdale j 2002 genetic control mhc class ii expression cell 109suppls21 s33 reith w 2003 complexin new targets ciita nat immunol 4819 820crossrefmedline muhlethaler mottet otten la steimle v mach b 1997 expression mhc class ii molecules different cellular functional compartments controlled differential usage multiple promoters transactivator ciita embo j 162851 2860abstractfree full text mori aoki pietrarelli m nakazato m caturegli p kohn ld suzuki k 2000 class ii transactivator suppresses transcription thyroid specific genes biochem biophys res commun 27858 62crossrefmedline li ys kanamoto n hataya y moriyama k hiratani h nakao k akamizu 2004 transgenic mice producing major histocompatibility complex class ii molecules thyroid cells develop apparent autoimmune thyroid diseases endocrinology 1452524 2530abstractfree full text stuve o youssef slavin aj king cl patarroyo jc hirschberg dl brickey wj soos jm piskurich jf chapman ha zamvil ss 2002 role mhc class ii transactivator class ii expression antigen presentation astrocytes susceptibility central nervous system autoimmune disease j immunol 1696720 6732abstractfree full text herkel j jagemann b wiegard c lazaro jf lueth kanzler blessing m schmitt e lohse aw 2003 mhc class ii expressing hepatocytes function antigen presenting cells activate specific cd4 lymphocytes hepatology 371079 1085crossrefmedline weetman ap 2003 autoimmune thyroid disease propagation progression eur j endocrinol 1481 9abstractfree full text dustin ml 2002 immunological synapse arthritis res 4suppl 3s119 s125 zheng rq abney er grubeck loebenstein b dayan c maini rn feldmann m 1990 expression intercellular adhesion molecule 1 lymphocyte function associated antigen 3 human thyroid epithelial cells graves hashimoto diseases j autoimmun 3727 736medline bonita re rose nr rasooly l caturegli p burek cl 2002 adhesion molecules susceptibility factors spontaneous autoimmune thyroiditis nod h2h4 mouse exp mol pathol 73155 163crossrefmedline faure gc bensoussan lejzerowicz d bene mc aubert v leclere j 1997 coexpression cd40 class ii antigen hla dr graves disease thyroid epithelial cells clin immunol immunopathol 84212 215crossrefmedline metcalfe ra mcintosh rs marelli berg f lombardi g lechler r weetman ap 1998 detection cd40 human thyroid follicular cells analysis expression function j clin endocrinol metab 831268 1274abstractfree full text battifora m pesce g paolieri f fiorino n giordano c riccio torre g olive d bagnasco m 1998 b71 costimulatory molecule expressed thyroid follicular cells hashimoto thyroiditis graves disease j clin endocrinol metab 834130 4139abstractfree full text shah r banks k patel dogra terrell r powers pa fenton c dinauer ca tuttle rm francis gl 2002 intense expression b7 2 antigen presentation coactivator unfavorable prognostic indicator differentiated thyroid carcinoma children adolescents j clin endocrinol metab 874391 4397abstractfree full text mandelbrot da kishimoto k auchincloss jr h sharpe ah sayegh mh 2001 rejection mouse cardiac allografts costimulation trans j immunol 1671174 1178abstractfree full text article abstract full text pdf versions article 14631154 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles kimura h articles caturegli p articles citing article pubmed pubmed citation articles kimura h articles caturegli p
0.09531622.15591134.html.plaintext.txt	86	home help feedback subscriptions archive search table contents endocrinology endocrine reviews j clin end metab molecular endocrinology recent prog horm res endocrine journals
0.0967214.12399421.html.plaintext.txt	0	combined blockade micro opioid receptors prevents acute orexigenic action agouti related protein brugman d j clegg c woods r j seeley
0.0967214.12399421.html.plaintext.txt	1	department animal physiology sb university groningen 9750 aa haren groningen netherlands department psychiatry djc scw rjs university cincinnati cincinnati ohio 45267
0.0967214.12399421.html.plaintext.txt	2	address correspondence requests reprints randy j seeley phd department psychiatry university cincinnati cincinnati ohio 45267 0559 e mail randyseeleyatucedu u d
0.0967214.12399421.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references agouti related protein agrp endogenous antagonist melanocortin 3 4 receptor hypothalamus central administration agrp produces robust increase food intake effect blocked administration nonspecific opioid receptor antagonist results implicate opioid receptors critical mediating effects agrp determine opioid receptor subtype critical first determined highest i3vt administered third ventricle dose two specific opioid antagonists binaltorphine ss funaltrexamine influence food intake rats pretreated either two antagonists i3vt agrp access high fat diet neither micro specific antagonist effect block effects agrp food intake however administration micro receptor antagonists significantly reduce effect agrp current results implicate opioid receptors critical downstream mediators potent effects agrp increase food intake indicate either micro receptor activation sufficient agrp effect
0.0967214.12399421.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references agouti related protein agrp endogenous antagonist melanocortin 3 4 receptor hypothalamus central administration agrp produces robust increase food intake effect blocked administration nonspecific opioid receptor antagonist results implicate opioid receptors critical mediating effects agrp determine opioid receptor subtype critical first determined highest i3vt administered third ventricle dose two specific opioid antagonists binaltorphine ss funaltrexamine influence food intake rats pretreated either two antagonists i3vt agrp access high fat diet neither micro specific antagonist effect block effects agrp food intake however administration micro receptor antagonists significantly reduce effect agrp current results implicate opioid receptors critical downstream mediators potent effects agrp increase food intake indicate either micro receptor activation sufficient agrp effect
0.0967214.12399421.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references considerable evidence links central nervous system cns melanocortin mc system control food intake body weight 1 2 mcs family peptides include ss msh acth msh agonist mc3 4 receptors central administration msh synthetic analogs mtii reduce food intake body weight 3 4 unique feature mc system addition well documented role endogenous agonists also important role endogenous antagonists various mc receptors first antagonist described mc system agouti signaling protein asp asp acts periphery alter mc1 receptor signaling regulate peripheral skin hair color 5 overexpression asp results yellow coat color via mc1 receptor 6 overexpression asp also results increased food intake obesity via interaction mc3 4 receptors cns 4
0.0967214.12399421.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references considerable evidence links central nervous system cns melanocortin mc system control food intake body weight 1 2 mcs family peptides include ss msh acth msh agonist mc3 4 receptors central administration msh synthetic analogs mtii reduce food intake body weight 3 4 unique feature mc system addition well documented role endogenous agonists also important role endogenous antagonists various mc receptors first antagonist described mc system agouti signaling protein asp asp acts periphery alter mc1 receptor signaling regulate peripheral skin hair color 5 overexpression asp results yellow coat color via mc1 receptor 6 overexpression asp also results increased food intake obesity via interaction mc3 4 receptors cns 4
0.0967214.12399421.html.plaintext.txt	7	given asp normally found cns role asp regulating mc receptor signaling brain unlikely however homolog asp termed agouti related protein agrp made arcuate nucleus hypothalamus population neurons adjacent overlapping neurons produce msh 7 8 9 agrp acts antagonist mc3 mc4 receptors 7 10 hence agrp opposes actions msh consistent agrp msh precursor proopiomelanocortin regulated opposite directions energy balance leptin food deprivation decreases proopiomelanocortin gene expression whereas increases agrp gene expression arcuate nucleus 11 12 13 overexpression agrp results obese phenotype similar mice overexpress asp 10
0.0967214.12399421.html.plaintext.txt	8	given asp normally found cns role asp regulating mc receptor signaling brain unlikely however homolog asp termed agouti related protein agrp made arcuate nucleus hypothalamus population neurons adjacent overlapping neurons produce msh 7 8 9 agrp acts antagonist mc3 mc4 receptors 7 10 hence agrp opposes actions msh consistent agrp msh precursor proopiomelanocortin regulated opposite directions energy balance leptin food deprivation decreases proopiomelanocortin gene expression whereas increases agrp gene expression arcuate nucleus 11 12 13 overexpression agrp results obese phenotype similar mice overexpress asp 10
0.0967214.12399421.html.plaintext.txt	9	biologically active fragment agrp administered third ventricle i3vt rats increase food intake lasts 6 d 14 15 although short term effects agrp seem depend antagonism identified mc receptors long term effects 14 moreover like neuropeptide y npy orexigenic effect agrp blocked nonspecific opioid receptor antagonist naloxone 16 17 thus potent effects agrp increase food intake depend critically activation opioid receptors opioid receptors come three identified subtypes micro 18 micro strongly implicated control food intake 19 thus aim experiments assess role specific opioid receptor subtypes mediating effects agrp increase food intake
0.0967214.12399421.html.plaintext.txt	10	biologically active fragment agrp administered third ventricle i3vt rats increase food intake lasts 6 d 14 15 although short term effects agrp seem depend antagonism identified mc receptors long term effects 14 moreover like neuropeptide y npy orexigenic effect agrp blocked nonspecific opioid receptor antagonist naloxone 16 17 thus potent effects agrp increase food intake depend critically activation opioid receptors opioid receptors come three identified subtypes micro 18 micro strongly implicated control food intake 19 thus aim experiments assess role specific opioid receptor subtypes mediating effects agrp increase food intake
0.0967214.12399421.html.plaintext.txt	11	materials methods top abstract introduction materials methods results discussion references animals male long evans rats harlan indianapolis experiment 1 taconic farms inc germantown ny experiment 2 weighing 350 450 g onset experiments individually housed maintained temperature controlled 21 plus minus 1 c room 12 h light 12 h dark cycle total 60 rats used
0.0967214.12399421.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references animals male long evans rats harlan indianapolis experiment 1 taconic farms inc germantown ny experiment 2 weighing 350 450 g onset experiments individually housed maintained temperature controlled 21 plus minus 1 c room 12 h light 12 h dark cycle total 60 rats used
0.0967214.12399421.html.plaintext.txt	13	surgery guide sleeve plastics one guide 22 g catalog c313g obdurator 18 g catalog c313 dc aimed third cerebral ventricle implanted coordinates midline 22 mm posterior bregma 75 mm ventral dura bregma vertical coordinates paxinos watson 1986 minimum 10 d recovery accuracy placement verified injection i3vt 10 ng angiotensin saline injector inserted guide sleeve rats drank 5 ml hour injection used experiments
0.0967214.12399421.html.plaintext.txt	14	surgery guide sleeve plastics one guide 22 g catalog c313g obdurator 18 g catalog c313 dc aimed third cerebral ventricle implanted coordinates midline 22 mm posterior bregma 75 mm ventral dura bregma vertical coordinates paxinos watson 1986 minimum 10 d recovery accuracy placement verified injection i3vt 10 ng angiotensin saline injector inserted guide sleeve rats drank 5 ml hour injection used experiments
0.0967214.12399421.html.plaintext.txt	15	chemicals agrp83 132 purchased phoenix pharmaceuticals inc belmont ca binaltorphimine norbni hydrochloride ss funaltrexamine ss fna hydrochloride purchased sigma st louis mo norbni widely used selective antagonist opioid receptors 20 21 ss fna widely used selective micro opioid receptor antagonist 18 22 selective antagonist action ss fna unique time course becoming selective action apparent 20 h administration 23 thus experiments ss fna actually administered 20 h food intake measurements agrp dissolved physiological saline served control solution norbni ss fna dissolved 100 methanol served control solution solutions administered i3vt 2 microl vol
0.0967214.12399421.html.plaintext.txt	16	feeding schedule animals access high fat hf modified ain 93m purified pelleted rodent diet dyets inc bethlehem pa see table 1 diet composition 2 h day starting lights remaining 22 h rats access pelleted laboratory chow harlan teklad indianapolis paradigm used produces reliable 2 h intakes agrp ligands opioid receptors potently influence intake preferred hf diet diets 24 consequently opioids important mediating effects agrp likely observed hf feeding alternative paradigms water available ad libitum body weights baseline food intake measured throughout experiment
0.0967214.12399421.html.plaintext.txt	17	feeding schedule animals access high fat hf modified ain 93m purified pelleted rodent diet dyets inc bethlehem pa see table 1 diet composition 2 h day starting lights remaining 22 h rats access pelleted laboratory chow harlan teklad indianapolis paradigm used produces reliable 2 h intakes agrp ligands opioid receptors potently influence intake preferred hf diet diets 24 consequently opioids important mediating effects agrp likely observed hf feeding alternative paradigms water available ad libitum body weights baseline food intake measured throughout experiment
0.0967214.12399421.html.plaintext.txt	18	view table table 1 macronutrient composition pelleted rodent chow hf diet
0.0967214.12399421.html.plaintext.txt	19	experiment 1 dose response determination opioid receptor antagonist first goal determine subthreshold dose opioid antagonists use subsequent experiments end focused low end dose effect curve accurately determine highest dose norbni clearly subthreshold ie effect food intake four groups naive rats n 5 6group administered norbni i3vt 1 h presentation hf diet 0 1 5 10 nmol subsequent consumption hf diet chow measured data analyzed one way anova followed dunnet tests compare dose vehicle control
0.0967214.12399421.html.plaintext.txt	20	experiment 1 dose response determination opioid receptor antagonist first goal determine subthreshold dose opioid antagonists use subsequent experiments end focused low end dose effect curve accurately determine highest dose norbni clearly subthreshold ie effect food intake four groups naive rats n 5 6group administered norbni i3vt 1 h presentation hf diet 0 1 5 10 nmol subsequent consumption hf diet chow measured data analyzed one way anova followed dunnet tests compare dose vehicle control
0.0967214.12399421.html.plaintext.txt	21	experiment 2 dose response determination micro opioid receptor antagonist rats experiment 1 used experiment 2 7 d experimental manipulations baseline intakes body weight returned normal occurred within 48 h analogous experiment 1 determined i3vt dose effect curve micro selective antagonist ss fna administering 0 01 05 1 5 nmol doses 20 h access hf diet measuring subsequent hf chow consumption data analyzed one way anova followed dunnet tests compare dose vehicle control
0.0967214.12399421.html.plaintext.txt	22	experiment 2 dose response determination micro opioid receptor antagonist rats experiment 1 used experiment 2 7 d experimental manipulations baseline intakes body weight returned normal occurred within 48 h analogous experiment 1 determined i3vt dose effect curve micro selective antagonist ss fna administering 0 01 05 1 5 nmol doses 20 h access hf diet measuring subsequent hf chow consumption data analyzed one way anova followed dunnet tests compare dose vehicle control
0.0967214.12399421.html.plaintext.txt	23	experiment 3 effect norbni agrp83 132 induced food intake experimental day rats received two i3vt injections first occurred 1 h second contained norbni highest subthreshold dose determined experiment 1 vehicle second injection contained either saline agrp 1 nmol second injection occurred 30 min lights therefore 30 min access hf diet rat n 22 tested twice 7 d apart two four conditions 1 methanol saline 2 norbni 5 nmol saline 3 methanol agrp 1 nmol 4 norbni 5 nmol agrp 1 nmol 2 x 2 design agrp vs saline within subjects factor whereas norbni vs methanol subjects factor condition order counterbalanced across subjects food intake measured every 30 min access hf diet 2 h hf diet replaced chow chow intake recorded remaining 22 h data analyzed using mixed model anova followed tukey post hoc tests
0.0967214.12399421.html.plaintext.txt	24	experiment 3 effect norbni agrp83 132 induced food intake experimental day rats received two i3vt injections first occurred 1 h second contained norbni highest subthreshold dose determined experiment 1 vehicle second injection contained either saline agrp 1 nmol second injection occurred 30 min lights therefore 30 min access hf diet rat n 22 tested twice 7 d apart two four conditions 1 methanol saline 2 norbni 5 nmol saline 3 methanol agrp 1 nmol 4 norbni 5 nmol agrp 1 nmol 2 x 2 design agrp vs saline within subjects factor whereas norbni vs methanol subjects factor condition order counterbalanced across subjects food intake measured every 30 min access hf diet 2 h hf diet replaced chow chow intake recorded remaining 22 h data analyzed using mixed model anova followed tukey post hoc tests
0.0967214.12399421.html.plaintext.txt	25	experiment 4 effect ss fna agrp83 132 induced food intake experiment 4 used separate group naive animals n 18 design exactly parallels experiment 3 except selective opioid antagonist ss fna maximally subthreshold dose determined experiment 2 01 nmol methanol given 20 h agrp saline administration food intake measured every 30 min access hf diet 2 h hf diet replaced chow chow intake recorded remaining 22 h data analyzed using mixed model anova followed tukey post hoc tests
0.0967214.12399421.html.plaintext.txt	26	experiment 4 effect ss fna agrp83 132 induced food intake experiment 4 used separate group naive animals n 18 design exactly parallels experiment 3 except selective opioid antagonist ss fna maximally subthreshold dose determined experiment 2 01 nmol methanol given 20 h agrp saline administration food intake measured every 30 min access hf diet 2 h hf diet replaced chow chow intake recorded remaining 22 h data analyzed using mixed model anova followed tukey post hoc tests
0.0967214.12399421.html.plaintext.txt	27	experiment 5 effect combined norbni ss fna agrp83 132 induced food intake goal determine whether combined blockade micro opioid receptors attenuates agrp induced food intake rats experiment 3 experiment 4 used experiment least 7 d rest food intake body weight returned baseline levels test day animals received three separate injections twenty hours receiving either agrp saline rats received injection either methanol ss fna 01 nmol methanol norbni 5 nmol injected 1 h final injection saline agrp 1 nmol lights animals given access hf diet 2 h food intake measured every 30 min 2 h hf diet replaced chow chow intake measured remaining 22 h animal run one condition n 6 7group data analyzed two way anova followed tukey post hoc tests
0.0967214.12399421.html.plaintext.txt	28	experiment 5 effect combined norbni ss fna agrp83 132 induced food intake goal determine whether combined blockade micro opioid receptors attenuates agrp induced food intake rats experiment 3 experiment 4 used experiment least 7 d rest food intake body weight returned baseline levels test day animals received three separate injections twenty hours receiving either agrp saline rats received injection either methanol ss fna 01 nmol methanol norbni 5 nmol injected 1 h final injection saline agrp 1 nmol lights animals given access hf diet 2 h food intake measured every 30 min 2 h hf diet replaced chow chow intake measured remaining 22 h animal run one condition n 6 7group data analyzed two way anova followed tukey post hoc tests
0.0967214.12399421.html.plaintext.txt	29	results top abstract introduction materials methods results discussion references experiment 1 effect norbni food intake dose effect curve norbni depicted fig 1 one way anova 2 h cumulative intake significant f3 18 3211 p 005 injection 10 nmol norbni significantly reduced intake hf diet first 2 h dark phase compared vehicle p 005 total 2 h intake representative intake earlier times data shown 5 nmol dose reliable effect 2 h intake therefore highest subthreshold dose use subsequent experiments see fig 1 dose norbni reduced chow intake subsequent 22 h data shown experiments methanol used vehicle conditions methanol shown toxic neurons determine whether methanol could independently influence food intake rats compared food intake day beginning injections methanol alone condition methanol alone day rats ate 138 plus minus 096 g whereas noninjection day rats consumed 142 plus minus 11 g p 005 paired sample test indicating paradigm methanol alone significant effect intake
0.0967214.12399421.html.plaintext.txt	30	view larger version 19k figure 1 mean 2 h intake hf diet various doses norbni p 005 compared vehicle treatment
0.0967214.12399421.html.plaintext.txt	31	view larger version 19k figure 1 mean 2 h intake hf diet various doses norbni p 005 compared vehicle treatment
0.0967214.12399421.html.plaintext.txt	32	experiment 2 effect ss fna food intake dose effect curve ss fna depicted fig 2 one way anova 2 h cumulative intake significant f3 18 3334 p 005 post hoc analyses revealed injection 1 nmol ss fna significantly suppressed 2 h intake hf diet compared vehicle p 005 nonsignificant trend p 006 05 nmol dose inhibit food intake see fig 2 consequently chose use 01 nmol highest clearly subthreshold dose experiments chow intake following 22 h reduced dose ss fna
0.0967214.12399421.html.plaintext.txt	33	view larger version 16k figure 2 mean 2 h intake hf diet various doses ss fna p 005 compared vehicle treatment
0.0967214.12399421.html.plaintext.txt	34	view larger version 16k figure 2 mean 2 h intake hf diet various doses ss fna p 005 compared vehicle treatment
0.0967214.12399421.html.plaintext.txt	35	experiment 3 effect norbni agrp83 132 induced food intake previously reported 17 agrp significantly increased intake hf diet f1 16 802 p 001 see fig 3 subsequent chow intake data shown effect norbni influence food intake f1 16 13 p 005 significant interaction agrp norbni f1 16 072 p 005 see fig 3 thus unlike subthreshold doses nonspecific opioid antagonist naloxone norbni reduce agrp orexigenic effect 2 h noted baseline food intakes uninjected days vehicle injected days lower experiments 3 4 5 experiments 1 2 experiments 3 4 5 run summer months ambient temperature ambient humidity higher february experiments 1 2 run despite vivarium temperature humidity controlled observed experiments animal rooms higher levels humidity summer reduces consumption hf diet importantly dose norbni determined subthreshold experiment 1 remained subthreshold experiment 3 despite lower baseline food intakes
0.0967214.12399421.html.plaintext.txt	36	view larger version 23k figure 3 mean 2 h intake hf diet i3vt agrp vehicle pretreatment subthreshold dose 5 nmol selective opioid receptor antagonist norbni p 005 compared vehiclevehicle condition
0.0967214.12399421.html.plaintext.txt	37	view larger version 23k figure 3 mean 2 h intake hf diet i3vt agrp vehicle pretreatment subthreshold dose 5 nmol selective opioid receptor antagonist norbni p 005 compared vehiclevehicle condition
0.0967214.12399421.html.plaintext.txt	38	experiment 4 effect ss fna agrp83 132 induced food intake similar occurred experiment 3 agrp significantly increased intake hf diet see fig 4 f1 14 1029 p 001 subsequent chow intake data shown ss fna alter food intake f1 14 25 01 alter increase 2 h food intake caused agrp see fig 4 interaction f1 14 004 p 08 act alter agrp effect time point data shown thus unlike subthreshold doses nonspecific antagonist naloxone ss fna reduce agrp orexigenic effect
0.0967214.12399421.html.plaintext.txt	39	view larger version 25k figure 4 mean 2 h intake hf diet i3vt agrp vehicle pretreatment subthreshold dose 01 nmol micro selective opioid receptor antagonist ss fna p 005 compared vehiclevehicle condition
0.0967214.12399421.html.plaintext.txt	40	view larger version 25k figure 4 mean 2 h intake hf diet i3vt agrp vehicle pretreatment subthreshold dose 01 nmol micro selective opioid receptor antagonist ss fna p 005 compared vehiclevehicle condition
0.0967214.12399421.html.plaintext.txt	41	experiment 5 effect combined norbni ss fna agrp83 132 induced food intake vehicle treated rats two methanol injections one saline injection showed normal 2 h food consumption comparable baseline food intake experiments indicating complicated procedure stressful well handled animals observed experiments 3 4 agrp significantly increased hf diet f1 17 700 p 002 see fig 5 chow intake data shown compared baseline condition combined administration norbni ss fna significantly attenuated effect agrp increase intake hf diet interaction f1 17 747 p 001 see fig 5 importantly occurred despite fact combined administration two opioid receptor antagonists doses effect food intake absence agrp f1 17 367 p 005 effect agrp increase 22 h chow intake altered combined opioid receptor antagonists data shown
0.0967214.12399421.html.plaintext.txt	42	experiment 5 effect combined norbni ss fna agrp83 132 induced food intake vehicle treated rats two methanol injections one saline injection showed normal 2 h food consumption comparable baseline food intake experiments indicating complicated procedure stressful well handled animals observed experiments 3 4 agrp significantly increased hf diet f1 17 700 p 002 see fig 5 chow intake data shown compared baseline condition combined administration norbni ss fna significantly attenuated effect agrp increase intake hf diet interaction f1 17 747 p 001 see fig 5 importantly occurred despite fact combined administration two opioid receptor antagonists doses effect food intake absence agrp f1 17 367 p 005 effect agrp increase 22 h chow intake altered combined opioid receptor antagonists data shown
0.0967214.12399421.html.plaintext.txt	43	view larger version 23k figure 5 mean 2 h intake hf diet i3vt agrp vehicle pretreatment subthreshold doses combined norbni ss fna p 005 compared vehiclevehicle treatment
0.0967214.12399421.html.plaintext.txt	44	view larger version 23k figure 5 mean 2 h intake hf diet i3vt agrp vehicle pretreatment subthreshold doses combined norbni ss fna p 005 compared vehiclevehicle treatment
0.0967214.12399421.html.plaintext.txt	45	discussion top abstract introduction materials methods results discussion references agrp83 132 i3vt elicits robust increase food intake lasts long 6 d 14 previously reported subthreshold dose general opioid receptor antagonist naloxone injected simultaneously agrp could attenuate acute hyperphagic effect without altering unique long term effects agrp results implicate opioid receptor activation mediating ability agrp acutely increase food intake 17 current data extend results interesting anticipated way unlike results naloxone highest subthreshold doses either micro selective antagonist alone reduce ability agrp increase intake however micro antagonists combined doses effect food intake administered without agrp significantly attenuated ability agrp increase intake hf diet like naloxone effect associated acute effects agrp combined micro receptor antagonism could block long term effects agrp
0.0967214.12399421.html.plaintext.txt	46	discussion top abstract introduction materials methods results discussion references agrp83 132 i3vt elicits robust increase food intake lasts long 6 d 14 previously reported subthreshold dose general opioid receptor antagonist naloxone injected simultaneously agrp could attenuate acute hyperphagic effect without altering unique long term effects agrp results implicate opioid receptor activation mediating ability agrp acutely increase food intake 17 current data extend results interesting anticipated way unlike results naloxone highest subthreshold doses either micro selective antagonist alone reduce ability agrp increase intake however micro antagonists combined doses effect food intake administered without agrp significantly attenuated ability agrp increase intake hf diet like naloxone effect associated acute effects agrp combined micro receptor antagonism could block long term effects agrp
0.0967214.12399421.html.plaintext.txt	47	data therefore consistent hypothesis acute effect agrp increase food intake depends activation opioid receptors however data also indicate either micro opioid receptor activation sufficient mediate effects agrp receptor subtypes blocked agrp longer activate critical aspects cns circuitry necessary increase food intake acutely result potentially analogous npy suprathreshold doses either micro receptor antagonists reduce orexigenic effect npy 25 however experiments determined whether combined micro receptor blockade would inhibit npy induced feeding
0.0967214.12399421.html.plaintext.txt	48	data therefore consistent hypothesis acute effect agrp increase food intake depends activation opioid receptors however data also indicate either micro opioid receptor activation sufficient mediate effects agrp receptor subtypes blocked agrp longer activate critical aspects cns circuitry necessary increase food intake acutely result potentially analogous npy suprathreshold doses either micro receptor antagonists reduce orexigenic effect npy 25 however experiments determined whether combined micro receptor blockade would inhibit npy induced feeding
0.0967214.12399421.html.plaintext.txt	49	npy agrp largely colocalized within arcuate nucleus hypothalamus 8 9 26 mrna elevated fasting also obob dbdb mice 27 moreover acute effects npy agrp associated recruitment many brain regions 28 consequently current data extend similarity npy agrp include recruiting opioid receptor subtypes
0.0967214.12399421.html.plaintext.txt	50	npy agrp largely colocalized within arcuate nucleus hypothalamus 8 9 26 mrna elevated fasting also obob dbdb mice 27 moreover acute effects npy agrp associated recruitment many brain regions 28 consequently current data extend similarity npy agrp include recruiting opioid receptor subtypes
0.0967214.12399421.html.plaintext.txt	51	several lines evidence implicate opioid system control food intake 29 microinjection experiments identified numerous sites every level neuroaxis opioid agonist antagonists affect food intake review see ref 30 particular whereas opioid agonists antagonists increase decrease food intake respectively also influence food choice micro selective antagonists found decrease intake hf diet greater extent decrease intake high carbohydrate diet 31 controversy exists however whether effect opioids alter animal choice macronutrients simply drive organism consume already preferred food 32 regardless interpretation consistent important role opioid receptor subtypes mediating effects agrp similar occurs manipulation opioid receptor signaling administration agrp selectively increases intake preferred hf diet 17 additionally stimulation micro receptors nucleus accumbens preferentially enhances hf feeding 33 strong parallels agrp opioid receptor ligands food intake food selection strengthen hypothesis two systems interact important way influence food intake food choice
0.0967214.12399421.html.plaintext.txt	52	several lines evidence implicate opioid system control food intake 29 microinjection experiments identified numerous sites every level neuroaxis opioid agonist antagonists affect food intake review see ref 30 particular whereas opioid agonists antagonists increase decrease food intake respectively also influence food choice micro selective antagonists found decrease intake hf diet greater extent decrease intake high carbohydrate diet 31 controversy exists however whether effect opioids alter animal choice macronutrients simply drive organism consume already preferred food 32 regardless interpretation consistent important role opioid receptor subtypes mediating effects agrp similar occurs manipulation opioid receptor signaling administration agrp selectively increases intake preferred hf diet 17 additionally stimulation micro receptors nucleus accumbens preferentially enhances hf feeding 33 strong parallels agrp opioid receptor ligands food intake food selection strengthen hypothesis two systems interact important way influence food intake food choice
0.0967214.12399421.html.plaintext.txt	53	opioid system encompasses number distributed receptor populations well number endogenous ligands receptors experiments opioid receptor antagonists delivered third ventricle hence close hypothalamus however given lipophyllic nature compounds rostral caudal flow cerebrospinal fluid ventricular system likely antagonists could interact opioid receptors variety neuroanatomical sites 34 although experiments therefore cannot determine exact location critical micro opioid receptors clues derived areas show increases fos like immunoreactivity third ventricular administration agrp two hours agrp administration fos increased accumbens shell lateral septum paraventricular dorsomedial nuclei hypothalamus 24 h fos increased accumbens shell lateral septum central nucleus amygdala lateral hypothalamus nucleus solitary tract 35 regions show evidence micro receptor binding andor expression nucleus solitary tract lateral hypothalamus show high levels binding receptors 33 36 37 future research need address whether activation either micro receptor subtypes sufficient produce agrp effects neuroanatomical sites occurs result activation disparate sites
0.0967214.12399421.html.plaintext.txt	54	opioid system encompasses number distributed receptor populations well number endogenous ligands receptors experiments opioid receptor antagonists delivered third ventricle hence close hypothalamus however given lipophyllic nature compounds rostral caudal flow cerebrospinal fluid ventricular system likely antagonists could interact opioid receptors variety neuroanatomical sites 34 although experiments therefore cannot determine exact location critical micro opioid receptors clues derived areas show increases fos like immunoreactivity third ventricular administration agrp two hours agrp administration fos increased accumbens shell lateral septum paraventricular dorsomedial nuclei hypothalamus 24 h fos increased accumbens shell lateral septum central nucleus amygdala lateral hypothalamus nucleus solitary tract 35 regions show evidence micro receptor binding andor expression nucleus solitary tract lateral hypothalamus show high levels binding receptors 33 36 37 future research need address whether activation either micro receptor subtypes sufficient produce agrp effects neuroanatomical sites occurs result activation disparate sites
0.0967214.12399421.html.plaintext.txt	55	separate related question endogenous opioid ligand ligands blocked specific receptor antagonists increased release agrp administration search specific functions opioid ligands hampered fact interact multiple subtypes opioid receptors 20 38 recent demonstration opioid receptor subtypes make heterodimers 39 nevertheless ss endorphin dynorphin high affinity micro opioid receptors 40 41 42 ss endorphin made arcuate nucleus hypothalamus 43 cells hypothesized express mc3 receptor 44 45 nucleus solitary tract region high mc4 receptor expression thus possible agrp given third ventricle could exert direct effects one ss endorphin populations food intake stimulated ss endorphin significantly dose dependently attenuated pretreatment either micro selective antagonists 46 47 reported silva et al 47 antagonists worked high equimolar doses relative ss fna conceivable could exerting effects multiple rather specific opioid receptors none antagonist doses used silva study completely eliminated ss endorphin induced feeding proposed analogous findings agrp blockade multiple opioid receptors might necessary produce effect dynorphin made paraventricular nucleus lateral area hypothalamus regions express high levels mc4 receptor 48 group berthoud colleagues 35 shown agrp induced fos lateral hypothalamus colocalized orexin immunoreactivity dynorphin heavily colocalized orexin lateral hypothalamus 49 provides direct evidence agrp activate dynorphin containing neurons use either mice targeted deletion ss endorphin 50 51 dynorphin could clarify role two opioid peptides orexigenic actions agrp
0.0967214.12399421.html.plaintext.txt	56	separate related question endogenous opioid ligand ligands blocked specific receptor antagonists increased release agrp administration search specific functions opioid ligands hampered fact interact multiple subtypes opioid receptors 20 38 recent demonstration opioid receptor subtypes make heterodimers 39 nevertheless ss endorphin dynorphin high affinity micro opioid receptors 40 41 42 ss endorphin made arcuate nucleus hypothalamus 43 cells hypothesized express mc3 receptor 44 45 nucleus solitary tract region high mc4 receptor expression thus possible agrp given third ventricle could exert direct effects one ss endorphin populations food intake stimulated ss endorphin significantly dose dependently attenuated pretreatment either micro selective antagonists 46 47 reported silva et al 47 antagonists worked high equimolar doses relative ss fna conceivable could exerting effects multiple rather specific opioid receptors none antagonist doses used silva study completely eliminated ss endorphin induced feeding proposed analogous findings agrp blockade multiple opioid receptors might necessary produce effect dynorphin made paraventricular nucleus lateral area hypothalamus regions express high levels mc4 receptor 48 group berthoud colleagues 35 shown agrp induced fos lateral hypothalamus colocalized orexin immunoreactivity dynorphin heavily colocalized orexin lateral hypothalamus 49 provides direct evidence agrp activate dynorphin containing neurons use either mice targeted deletion ss endorphin 50 51 dynorphin could clarify role two opioid peptides orexigenic actions agrp
0.0967214.12399421.html.plaintext.txt	57	exact role opioid system control food intake remains uncertain given large number different receptors ligands however likely role one dimensional rather encompasses number aspects ingestive behavior 19 present data point specific role micro opioid receptors mediating effects hypothalamic mc system intimate relationship mc system points long term regulation energy balance one important roles played opioid system future research need address functional interactions opioid system hypothalamic peptides also explore potential involvement opioid system etiology treatment disorders energy balance regulation obesity
0.0967214.12399421.html.plaintext.txt	58	exact role opioid system control food intake remains uncertain given large number different receptors ligands however likely role one dimensional rather encompasses number aspects ingestive behavior 19 present data point specific role micro opioid receptors mediating effects hypothalamic mc system intimate relationship mc system points long term regulation energy balance one important roles played opioid system future research need address functional interactions opioid system hypothalamic peptides also explore potential involvement opioid system etiology treatment disorders energy balance regulation obesity
0.0967214.12399421.html.plaintext.txt	59	footnotes work supported funds nih dk 54080 dk 17844 dk 56863 funds procter amp gamble cincinnati oh
0.0967214.12399421.html.plaintext.txt	60	abbreviations agrp agouti related protein asp agouti signaling protein cns central nervous system ss fna ss funaltrexamine hf high fat i3vt administered third ventricle mc melanocortin norbni binaltorphine npy neuropeptide y
0.0967214.12399421.html.plaintext.txt	61	accepted publication july 22 2002
0.0967214.12399421.html.plaintext.txt	62	references top abstract introduction materials methods results discussion references cone rd 1999 central melanocortin system energy homeostasis trends endocrinol metab 10211 216crossrefmedline benoit sc schwartz mw baskin dg woods sc seeley rj 2000 cns melanocortin system involvement regulation food intake body weight horm behav 37299 308crossrefmedline thiele van dg yagaloff k fisher schwartz m burn p seeley r 1998 central infusion melanocortin agonist mtii rats assessment c fos expression taste aversion j physiol 274r248 r254 fan w boston b kesterson r hruby v cone r 1997 role melanocortinergic neurons feeding agouti obesity syndrome nature 385 165 168 cone rd lu d koppula vage di klungland h boston b chen w orth dn pouton c kesterson ra 1996 melanocortin receptors agonists antagonists hormonal control pigmentation recent prog horm res 51287 320medline ollmann mm lamoreux ml wilson bd barsh gs 1998 interaction agouti protein melanocortin 1 receptor vitro vivo genes dev 12316 330abstractfree full text fong mao c macneil kalyani r smith weinberg d tota m van dpl 1997 art protein product agouti related transcript antagonist mc 3 mc 4 receptors biochem biophy res commun 237629 631crossrefmedline hahn tm breininger jf baskin dg schwartz mw 1998 coexpression agrp npy fasting activated hypothalamic neurons nat neurosci 1271 272crossrefmedline chen p li c haskell luevano c cone rd smith ms 1999 altered expression agouti related protein colocalization neuropeptide y arcuate nucleus hypothalamus lactation endocrinology 1402645 2650abstractfree full text ollmann m wilson b yang y kerns j chen y gantz barsh g 1997 antagonism central melanocortin receptors vitro vivo agouti related protein science 278135 138abstractfree full text schwartz mw seeley rj weigle ds burn p campfield la baskin dg 1997 leptin increases hypothalamic proopiomelanocortin pomc mrna expression rostral arcuate nucleus diabetes 462119 2123abstract elias cf aschkenasi c lee c kelly j ahima rs bjorbaek c flier js saper cb elmquist jk 1999 leptin differentially regulates npy pomc neurons projecting lateral hypothalamic area neuron 23775 786crossrefmedline mizuno kleopoulos bergen h roberts j priest c mobbs c 1998 hypothalamic pro opiomelanocortin mrna reduced fasting obob dbdb mice stimulated leptin diabetes 47294 297abstract hagan mm rushing pa pritchard lm schwartz mw strack van der ploeg ht woods sc seeley rj 2000 long term orexigenic effects agrp 83 132 involve mechanisms melanocortin receptor blockade j physiol 279r47 r52 rossi m kim m morgan d small c edwards c sunter d abusnana goldstone russell stanley smith d yagaloff k ghatei m bloom 1998 c terminal fragment agouti related protein increases feeding antagonizes effect melanocyte stimulating hormone vivo endocrinology 1394428 4431abstractfree full text kotz cm grace mk briggs j levine billington cj 1995 effects opioid antagonists naloxone naltrexone neuropeptide y induced feeding brown fat thermogenesis rat neural site action j clin invest 96 163 170 hagan mm rushing pa benoit sc woods sc seeley rj 2001 opioid receptor involvement effect agrp 83 132 food intake food selection j physiol regul integr comp physiol 280r814 r821 schmidhammer h 1998 opioid receptor antagonists prog med chem 35 83 132 glass mj billington cj levine 1999 opioids food intake distributed functional neural pathways neuropeptides 33360 368crossrefmedline takemori ae ho naeseth js portoghese ps 1988 binaltorphimine highly selective opioid antagonist analgesic receptor binding assays j pharmacol exp ther 246255 258abstract levine grace m billington cj portoghese ps 1990 binaltorphimine decreases deprivation opioid induced feeding brain res 53460 64crossrefmedline leventhal l kirkham tc cole jl bodnar rj 1995 selective actions central micro opioid antagonists upon sucrose intake sham fed rats brain res 685205 210crossrefmedline ward sj portoghese ps takemori ae 1982 pharmacological characterization vivo novel opiate ss funaltrexamine j pharmacol exp ther 220 494 498 koch je bodnar rj 1994 selective alterations macronutrient intake food deprived glucoprivic rats centrally administered opioid receptor subtype antagonists rats brain res 657191 201crossrefmedline kotz cm grace mk billington cj levine 1993 effect norbinaltorphimine ss funaltrexamine naltrindole npy induced feeding brain res 631325 328crossrefmedline broberger c de lecea l sutcliffe jg hokfelt 1998 hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402460 47430co2 602abstract hagan mm benoit sc rushing pa pritchard lm woods sc seeley rj 2001 immediate prolonged patterns agouti related peptide 83 132 induced c fos activation hypothalamic extrahypothalamic sites endocrinology 1421050 1056abstractfree full text glass mj billington cj levine 1999 opioids food intake distributed functional neuronal pathways neuropeptides 33360 368crossrefmedline glass mj grace m cleary jp billington cj levine 1996 potency naloxone anorectic effect rats dependent diet preference j physiol 271r217 r221 islam ak bodnar rj 1990 selective opioid receptor antagonist effects upon intake high fat diet rats brain res 508293 296crossrefmedline giraudo sq grace mk billington cj levine 1999 differential effects neuropeptide y micro agonist damgo palatability vs energy brain res 834160 163crossrefmedline zhang m gosnell ba kelley ae 1998 intake high fat food selectively enhanced micro opioid receptor stimulation within nucleus accumbens j pharmacol exp ther 285908 914abstractfree full text schroeder rl weinger mb vakassian l koob gf 1991 methylnaloxonium diffuses rat brain slowly naloxone direct intracerebral injection neurosci lett 121173 177crossrefmedline zheng h corkern m crousillac patterson l phifer c berthoud h 2002 neurochemical phenotype hypothalamic neurons showing fos expression 23 hours following intracranial agrp j physiol 282r1773 r1781 mansour fox ca burke meng f thompson rc akil h watson sj 1994 micro opioid receptor mrna expression rat cns situ hybridization study j comp neurol 350412 438medline mansour fox ca thompson rc akil h watson sj 1994 micro opioid receptor mrna expression rat cns comparison micro receptor binding brain res 643245 265medline rothman rb bykov v mahboubi long jb jiang q porreca f de costa br jacobson ae rice kc holaday jw 1991 interaction ss funaltrexamine 3hcyclofoxy binding rat brain evidence ss fna alkylates opioid receptor complex synapse 886 99medline gomes jordan ba gupta trapaidze n nagy v devi la 2000 heterodimerization micro opioid receptors role opiate synergy j neurosci 20rc110 chang kj cooper br hazum e cuatrecasas p 1979 multiple opiate receptors different regional distribution brain differential binding opiates opioid peptides mol pharmacol 1691 104abstract schulz r wuster m herz 1979 supersensitivity opioids following chronic blockade endorphin action naloxone naunyn schmiedebergs arch pharmacol 30693 96medline akil h hewlett wa barchas jd li ch 1980 binding 3h ss endorphin rat brain membranes characterization opiate properties interaction acth eur j pharmacol 641 8crossrefmedline watson sj akil h richard 3rd cw barchas jd 1978 evidence two separate opiate peptide neuronal systems nature 275226 228medline haskell luevano c chen p li c chang k smith ms cameron jl cone rd 1999 characterization neuroanatomical distribution agouti related protein immunoreactivity rhesus monkey rat endocrinology 1401408 1415abstractfree full text bagnol d lu xy kaelin cb day ollmann m gantz akil h barsh gs watson sj 1999 anatomy endogenous antagonist relationship agouti related protein proopiomelanocortin brain j neurosci 19rc26 olson ga olson rd kastin aj 1990 endogenous opiates 1989 peptides 111277 1304crossrefmedline silva rm hadjimarkou mm rossi gc pasternak gw bodnar rj 2001 ss endorphin induced feeding pharmacological characterization using selective opioid antagonists antisense probes rats j pharmacol exp ther 297590 596abstractfree full text watson sj khachaturian h taylor l fischli w goldstein akil h 1983 pro dynorphin peptides found neurons throughout rat brain immunocytochemical study proc natl acad sci usa 80891 894abstract chou tc lee ce lu j elmquist jk hara j willie jt beuckmann ct chemelli rm sakurai yanagisawa m saper cb scammell te 2001 orexin hypocretin neurons contain dynorphin j neurosci 21rc168 rubinstein m mogil js japon m chan ec allen rg low mj 1996 absence opioid stress induced analgesia mice lacking ss endorphin site directed mutagenesis proc natl acad sci usa 933995 4000abstractfree full text bernstein hg keilhoff g seidel b stanarius huang pl fishman mc reiser m bogerts b wolf g 1998 expression hypothalamic peptides mice lacking neuronal nitric oxide synthase reduced ss end immunoreactivity arcuate nucleus neuroendocrinology 68403 411crossrefmedline
0.0967214.12399421.html.plaintext.txt	63	references top abstract introduction materials methods results discussion references cone rd 1999 central melanocortin system energy homeostasis trends endocrinol metab 10211 216crossrefmedline benoit sc schwartz mw baskin dg woods sc seeley rj 2000 cns melanocortin system involvement regulation food intake body weight horm behav 37299 308crossrefmedline thiele van dg yagaloff k fisher schwartz m burn p seeley r 1998 central infusion melanocortin agonist mtii rats assessment c fos expression taste aversion j physiol 274r248 r254 fan w boston b kesterson r hruby v cone r 1997 role melanocortinergic neurons feeding agouti obesity syndrome nature 385 165 168 cone rd lu d koppula vage di klungland h boston b chen w orth dn pouton c kesterson ra 1996 melanocortin receptors agonists antagonists hormonal control pigmentation recent prog horm res 51287 320medline ollmann mm lamoreux ml wilson bd barsh gs 1998 interaction agouti protein melanocortin 1 receptor vitro vivo genes dev 12316 330abstractfree full text fong mao c macneil kalyani r smith weinberg d tota m van dpl 1997 art protein product agouti related transcript antagonist mc 3 mc 4 receptors biochem biophy res commun 237629 631crossrefmedline hahn tm breininger jf baskin dg schwartz mw 1998 coexpression agrp npy fasting activated hypothalamic neurons nat neurosci 1271 272crossrefmedline chen p li c haskell luevano c cone rd smith ms 1999 altered expression agouti related protein colocalization neuropeptide y arcuate nucleus hypothalamus lactation endocrinology 1402645 2650abstractfree full text ollmann m wilson b yang y kerns j chen y gantz barsh g 1997 antagonism central melanocortin receptors vitro vivo agouti related protein science 278135 138abstractfree full text schwartz mw seeley rj weigle ds burn p campfield la baskin dg 1997 leptin increases hypothalamic proopiomelanocortin pomc mrna expression rostral arcuate nucleus diabetes 462119 2123abstract elias cf aschkenasi c lee c kelly j ahima rs bjorbaek c flier js saper cb elmquist jk 1999 leptin differentially regulates npy pomc neurons projecting lateral hypothalamic area neuron 23775 786crossrefmedline mizuno kleopoulos bergen h roberts j priest c mobbs c 1998 hypothalamic pro opiomelanocortin mrna reduced fasting obob dbdb mice stimulated leptin diabetes 47294 297abstract hagan mm rushing pa pritchard lm schwartz mw strack van der ploeg ht woods sc seeley rj 2000 long term orexigenic effects agrp 83 132 involve mechanisms melanocortin receptor blockade j physiol 279r47 r52 rossi m kim m morgan d small c edwards c sunter d abusnana goldstone russell stanley smith d yagaloff k ghatei m bloom 1998 c terminal fragment agouti related protein increases feeding antagonizes effect melanocyte stimulating hormone vivo endocrinology 1394428 4431abstractfree full text kotz cm grace mk briggs j levine billington cj 1995 effects opioid antagonists naloxone naltrexone neuropeptide y induced feeding brown fat thermogenesis rat neural site action j clin invest 96 163 170 hagan mm rushing pa benoit sc woods sc seeley rj 2001 opioid receptor involvement effect agrp 83 132 food intake food selection j physiol regul integr comp physiol 280r814 r821 schmidhammer h 1998 opioid receptor antagonists prog med chem 35 83 132 glass mj billington cj levine 1999 opioids food intake distributed functional neural pathways neuropeptides 33360 368crossrefmedline takemori ae ho naeseth js portoghese ps 1988 binaltorphimine highly selective opioid antagonist analgesic receptor binding assays j pharmacol exp ther 246255 258abstract levine grace m billington cj portoghese ps 1990 binaltorphimine decreases deprivation opioid induced feeding brain res 53460 64crossrefmedline leventhal l kirkham tc cole jl bodnar rj 1995 selective actions central micro opioid antagonists upon sucrose intake sham fed rats brain res 685205 210crossrefmedline ward sj portoghese ps takemori ae 1982 pharmacological characterization vivo novel opiate ss funaltrexamine j pharmacol exp ther 220 494 498 koch je bodnar rj 1994 selective alterations macronutrient intake food deprived glucoprivic rats centrally administered opioid receptor subtype antagonists rats brain res 657191 201crossrefmedline kotz cm grace mk billington cj levine 1993 effect norbinaltorphimine ss funaltrexamine naltrindole npy induced feeding brain res 631325 328crossrefmedline broberger c de lecea l sutcliffe jg hokfelt 1998 hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402460 47430co2 602abstract hagan mm benoit sc rushing pa pritchard lm woods sc seeley rj 2001 immediate prolonged patterns agouti related peptide 83 132 induced c fos activation hypothalamic extrahypothalamic sites endocrinology 1421050 1056abstractfree full text glass mj billington cj levine 1999 opioids food intake distributed functional neuronal pathways neuropeptides 33360 368crossrefmedline glass mj grace m cleary jp billington cj levine 1996 potency naloxone anorectic effect rats dependent diet preference j physiol 271r217 r221 islam ak bodnar rj 1990 selective opioid receptor antagonist effects upon intake high fat diet rats brain res 508293 296crossrefmedline giraudo sq grace mk billington cj levine 1999 differential effects neuropeptide y micro agonist damgo palatability vs energy brain res 834160 163crossrefmedline zhang m gosnell ba kelley ae 1998 intake high fat food selectively enhanced micro opioid receptor stimulation within nucleus accumbens j pharmacol exp ther 285908 914abstractfree full text schroeder rl weinger mb vakassian l koob gf 1991 methylnaloxonium diffuses rat brain slowly naloxone direct intracerebral injection neurosci lett 121173 177crossrefmedline zheng h corkern m crousillac patterson l phifer c berthoud h 2002 neurochemical phenotype hypothalamic neurons showing fos expression 23 hours following intracranial agrp j physiol 282r1773 r1781 mansour fox ca burke meng f thompson rc akil h watson sj 1994 micro opioid receptor mrna expression rat cns situ hybridization study j comp neurol 350412 438medline mansour fox ca thompson rc akil h watson sj 1994 micro opioid receptor mrna expression rat cns comparison micro receptor binding brain res 643245 265medline rothman rb bykov v mahboubi long jb jiang q porreca f de costa br jacobson ae rice kc holaday jw 1991 interaction ss funaltrexamine 3hcyclofoxy binding rat brain evidence ss fna alkylates opioid receptor complex synapse 886 99medline gomes jordan ba gupta trapaidze n nagy v devi la 2000 heterodimerization micro opioid receptors role opiate synergy j neurosci 20rc110 chang kj cooper br hazum e cuatrecasas p 1979 multiple opiate receptors different regional distribution brain differential binding opiates opioid peptides mol pharmacol 1691 104abstract schulz r wuster m herz 1979 supersensitivity opioids following chronic blockade endorphin action naloxone naunyn schmiedebergs arch pharmacol 30693 96medline akil h hewlett wa barchas jd li ch 1980 binding 3h ss endorphin rat brain membranes characterization opiate properties interaction acth eur j pharmacol 641 8crossrefmedline watson sj akil h richard 3rd cw barchas jd 1978 evidence two separate opiate peptide neuronal systems nature 275226 228medline haskell luevano c chen p li c chang k smith ms cameron jl cone rd 1999 characterization neuroanatomical distribution agouti related protein immunoreactivity rhesus monkey rat endocrinology 1401408 1415abstractfree full text bagnol d lu xy kaelin cb day ollmann m gantz akil h barsh gs watson sj 1999 anatomy endogenous antagonist relationship agouti related protein proopiomelanocortin brain j neurosci 19rc26 olson ga olson rd kastin aj 1990 endogenous opiates 1989 peptides 111277 1304crossrefmedline silva rm hadjimarkou mm rossi gc pasternak gw bodnar rj 2001 ss endorphin induced feeding pharmacological characterization using selective opioid antagonists antisense probes rats j pharmacol exp ther 297590 596abstractfree full text watson sj khachaturian h taylor l fischli w goldstein akil h 1983 pro dynorphin peptides found neurons throughout rat brain immunocytochemical study proc natl acad sci usa 80891 894abstract chou tc lee ce lu j elmquist jk hara j willie jt beuckmann ct chemelli rm sakurai yanagisawa m saper cb scammell te 2001 orexin hypocretin neurons contain dynorphin j neurosci 21rc168 rubinstein m mogil js japon m chan ec allen rg low mj 1996 absence opioid stress induced analgesia mice lacking ss endorphin site directed mutagenesis proc natl acad sci usa 933995 4000abstractfree full text bernstein hg keilhoff g seidel b stanarius huang pl fishman mc reiser m bogerts b wolf g 1998 expression hypothalamic peptides mice lacking neuronal nitric oxide synthase reduced ss end immunoreactivity arcuate nucleus neuroendocrinology 68403 411crossrefmedline
0.09719374.15994572.html.plaintext.txt	0	modafinil modulates anterior cingulate function chronic schizophrenia sean spence mrcpsych russell d green mbchb
0.09719374.15994572.html.plaintext.txt	1	modafinil modulates anterior cingulate function chronic schizophrenia sean spence mrcpsych russell d green mbchb
0.09719374.15994572.html.plaintext.txt	2	sheffield cognition neuroimaging laboratory scanlab academic clinical psychiatry division genomic medicine university sheffield
0.09719374.15994572.html.plaintext.txt	3	academic unit radiology university sheffield
0.09719374.15994572.html.plaintext.txt	4	scanlab academic clinical psychiatry division genomic medicine university sheffield sheffield uk
0.09719374.15994572.html.plaintext.txt	5	correspondence dr sean spence sheffield cognition neuroimaging scanlab academic clinical psychiatry division genomic medicine university sheffield longley centre norwood grange drive sheffield s5 7jt uk tel 44 0 114 22 61519 fax 44 0 114 22 61522 e mail saspenceatsheffieldacuk
0.09719374.15994572.html.plaintext.txt	6	declaration interest study supported investigator led award sas cephalon uk mdh supported wellcome trust uk
0.09719374.15994572.html.plaintext.txt	7	abstract top abstract introduction method results discussion clinical implications acknowledgments references background schizophrenia associated widespread cognitive deficits impact social function modafinil promotes wakefulness reported enhance cognition
0.09719374.15994572.html.plaintext.txt	8	aims study acute effects modafinil administration upon brain activity cognitive performance people chronic schizophrenia
0.09719374.15994572.html.plaintext.txt	9	method randomised double blind placebo controlled crossover design 19 patients received either modafinil 100 mg placebo prior undertaking working memory task functional magnetic resonance imaging
0.09719374.15994572.html.plaintext.txt	10	results seventeen patients completed study another underwent acute relapse 4 days post drug modafinil administration associated significantly greater activation anterior cingulate cortex working memory task anterior cingulate cortex signal correlated cognitive performance although subset patients exhibited enhancement
0.09719374.15994572.html.plaintext.txt	11	results seventeen patients completed study another underwent acute relapse 4 days post drug modafinil administration associated significantly greater activation anterior cingulate cortex working memory task anterior cingulate cortex signal correlated cognitive performance although subset patients exhibited enhancement
0.09719374.15994572.html.plaintext.txt	12	conclusions modafinil modulates anterior cingulate cortex function chronic schizophrenia beneficial cognitive effects may restricted subset patients requiring characterisation
0.09719374.15994572.html.plaintext.txt	13	introduction top abstract introduction method results discussion clinical implications acknowledgments references schizophrenia associated widespread cognitive impairments affecting memory vigilance impact upon independent living velligan et al 1997 amelioration impairments might improve quality life therefore studied effects putative cognitive enhancer modafinil upon prefrontal function people chronic schizophrenia modafinil 2 diphenylmethylsulphinyl acetamide novel agent promotes wakefulness licensed uk usa treatment narcolepsy cephalon 1999 us modafinil narcolepsy multicenter study group 2000 british medical association 2004 precise mode action uncertain although animal models shown elicit early gene expression anterior hypothalamus lin et al 1996 anterior cingulate cortex scammell et al 2000 findings congruent properties recently modafinil reported enhance short term verbal memory people schizophrenia turner et al 2004
0.09719374.15994572.html.plaintext.txt	14	method top abstract introduction method results discussion clinical implications acknowledgments references basis animal studies chose probe cognitive functions would engage higher executive regions particularly anterior cingulate cortex implicated vigilance however view uncertain mechanism action modafinil emerging evidence possible risk psychosis exacerbation narendran et al 2002 utilised relatively small dose drug study conducted 28 august 2002 4 july 2003
0.09719374.15994572.html.plaintext.txt	15	participants right handed males aged 18 60 years premorbid iq 70 national adult reading test nart nelson oconnell 1978 dsm iv american psychiatric association 1994 diagnosis schizophrenia prominent negative symptomatology rating 3 least one item scale assessment negative symptoms sans andreasen 1983 included exclusion criteria prominent positive symptomatology marked delusions andor hallucinations recent history mental state instability changes psychotropic medication admission hospital within 3 months assessment significant history neurological endocrine cardiovascular disorder hypersensitivity modafinil concurrent prescription stimulant medication concurrent substance misuse contraindications magnetic resonance imaging scanning metallic implants foreign bodies claustrophobia
0.09719374.15994572.html.plaintext.txt	16	participants right handed males aged 18 60 years premorbid iq 70 national adult reading test nart nelson oconnell 1978 dsm iv american psychiatric association 1994 diagnosis schizophrenia prominent negative symptomatology rating 3 least one item scale assessment negative symptoms sans andreasen 1983 included exclusion criteria prominent positive symptomatology marked delusions andor hallucinations recent history mental state instability changes psychotropic medication admission hospital within 3 months assessment significant history neurological endocrine cardiovascular disorder hypersensitivity modafinil concurrent prescription stimulant medication concurrent substance misuse contraindications magnetic resonance imaging scanning metallic implants foreign bodies claustrophobia
0.09719374.15994572.html.plaintext.txt	17	thirty two patients approached 21 agreed participate following full explanation study nineteen satisfied detailed assessment inclusion exclusion criteria participants underwent psychiatric brief psychiatric rating scale overall gorham 1962 sans scale assessment positive symptoms andreasen 1984 beck depression inventory beck et al 1961 mini mental state examination folstein et al 1975 physical including electrocardiogram neuropsychological assessment simpson angus scale simpson angus 1970 abnormal involuntary movements scale guy 1976 barnes akathisia scale barnes 1989
0.09719374.15994572.html.plaintext.txt	18	thirty two patients approached 21 agreed participate following full explanation study nineteen satisfied detailed assessment inclusion exclusion criteria participants underwent psychiatric brief psychiatric rating scale overall gorham 1962 sans scale assessment positive symptoms andreasen 1984 beck depression inventory beck et al 1961 mini mental state examination folstein et al 1975 physical including electrocardiogram neuropsychological assessment simpson angus scale simpson angus 1970 abnormal involuntary movements scale guy 1976 barnes akathisia scale barnes 1989
0.09719374.15994572.html.plaintext.txt	19	written informed consent obtained patient study approved north south sheffield research ethics committees also rotherham doncaster south humber research ethics committees study funded investigator led award company sponsored trial research indemnity provided sheffield care trust reciprocally participating national health service trusts clinical trial insurance provided university sheffield
0.09719374.15994572.html.plaintext.txt	20	written informed consent obtained patient study approved north south sheffield research ethics committees also rotherham doncaster south humber research ethics committees study funded investigator led award company sponsored trial research indemnity provided sheffield care trust reciprocally participating national health service trusts clinical trial insurance provided university sheffield
0.09719374.15994572.html.plaintext.txt	21	procedures utilised randomised double blind placebo controlled crossover design patients studied 2 days 1 week apart day patients received oral modafinil 100 mg placebo 2 h prior functional magnetic resonance imaging fmri scanning administration scanning times predicated drugs pharmacokinetics humans peak plasma levels occur 2 4 h post acute oral dosing cephalon 1999 robertson hellriegel 2003 randomisation performed pharmacist member research team achieved drawing labelled counters ensured approximately equivalent numbers patients received modafinil placebo day 1 vice versa day 2 patients required smoke consume caffeine prior scanning admitted 24 h observation scanning procedure outcome measures difference fmri signal working memory task modafinil placebo conditions difference behavioural performance accuracy intra scanner task modafinil placebo conditions patient wise bivariate correlation first two measures
0.09719374.15994572.html.plaintext.txt	22	procedures utilised randomised double blind placebo controlled crossover design patients studied 2 days 1 week apart day patients received oral modafinil 100 mg placebo 2 h prior functional magnetic resonance imaging fmri scanning administration scanning times predicated drugs pharmacokinetics humans peak plasma levels occur 2 4 h post acute oral dosing cephalon 1999 robertson hellriegel 2003 randomisation performed pharmacist member research team achieved drawing labelled counters ensured approximately equivalent numbers patients received modafinil placebo day 1 vice versa day 2 patients required smoke consume caffeine prior scanning admitted 24 h observation scanning procedure outcome measures difference fmri signal working memory task modafinil placebo conditions difference behavioural performance accuracy intra scanner task modafinil placebo conditions patient wise bivariate correlation first two measures
0.09719374.15994572.html.plaintext.txt	23	psychological paradigm inside scanner patients performed standard working memory task 2 back callicott et al 1998 difficult task required subjects monitor update temporally tag contents working memory manoach 2003 series numbers 1 4 presented visually pseudo random order one every 2 colour coding stimuli cued patients indicate pressing button either number currently presented screen 0 back baseline condition number presented two trials earlier ie 2 back active condition stimuli delivered using presentation neurobehavioral systems inc california usa software running personal computer via video projector mirror located inside scanner bore patients responded pressing one four buttons intra scanner box optically connected computer system via interface new micros inc texas usa alternating blocked 0 back2 back design 15 consecutive 0 back stimuli lasting 30 followed 15 consecutive 2 back stimuli also lasting 30 sequence repeated six times hence functional scans lasted 6 min total
0.09719374.15994572.html.plaintext.txt	24	psychological paradigm inside scanner patients performed standard working memory task 2 back callicott et al 1998 difficult task required subjects monitor update temporally tag contents working memory manoach 2003 series numbers 1 4 presented visually pseudo random order one every 2 colour coding stimuli cued patients indicate pressing button either number currently presented screen 0 back baseline condition number presented two trials earlier ie 2 back active condition stimuli delivered using presentation neurobehavioral systems inc california usa software running personal computer via video projector mirror located inside scanner bore patients responded pressing one four buttons intra scanner box optically connected computer system via interface new micros inc texas usa alternating blocked 0 back2 back design 15 consecutive 0 back stimuli lasting 30 followed 15 consecutive 2 back stimuli also lasting 30 sequence repeated six times hence functional scans lasted 6 min total
0.09719374.15994572.html.plaintext.txt	25	patients practised task prior entering scanner three times order minimise automation procedure different performance levels permitted previous studies incorporated wide range accuracy among patients schizophrenia callicott et al 1998 performance relatively poor meyer lindenberg et al 2001 bertolino et al 2003 whereas others set stringent thresholds callicott et al 2000 2003 comparison healthy control group necessarily requires comparable levels performance across groups study wished compare patients performances modafinil hence allowed range performance accuracy partly pragmatic given deliberately studying people chronic schizophrenia prominent negative symptomatology likely recipients putative cognitive enhancers also design led required range performance across group detect changes performance within subjects exposed modafinil hence avoiding ceiling effects allow post hoc correlations performance per se manoach et al 1999 callicott et al 2000 2003
0.09719374.15994572.html.plaintext.txt	26	patients practised task prior entering scanner three times order minimise automation procedure different performance levels permitted previous studies incorporated wide range accuracy among patients schizophrenia callicott et al 1998 performance relatively poor meyer lindenberg et al 2001 bertolino et al 2003 whereas others set stringent thresholds callicott et al 2000 2003 comparison healthy control group necessarily requires comparable levels performance across groups study wished compare patients performances modafinil hence allowed range performance accuracy partly pragmatic given deliberately studying people chronic schizophrenia prominent negative symptomatology likely recipients putative cognitive enhancers also design led required range performance across group detect changes performance within subjects exposed modafinil hence avoiding ceiling effects allow post hoc correlations performance per se manoach et al 1999 callicott et al 2000 2003
0.09719374.15994572.html.plaintext.txt	27	functional image acquisition analysis 120 functional imaging time points 3264 mm contiguous t2 weighted slices acquired using echo planar imaging 15 system eclipse philips ohio sheffield university repetition time3 echo time40 ms field view 240 mm plane matrix128 x 128
0.09719374.15994572.html.plaintext.txt	28	functional image acquisition analysis 120 functional imaging time points 3264 mm contiguous t2 weighted slices acquired using echo planar imaging 15 system eclipse philips ohio sheffield university repetition time3 echo time40 ms field view 240 mm plane matrix128 x 128
0.09719374.15994572.html.plaintext.txt	29	images analysed using spm99 httpwwwfilionuclacuk blood oxygenation level dependent bold response measured fmri thought represent vascular marker neuronal activation logothetis et al 2001 following timing movement correction spatial normalisation smoothing gaussian kernel 6 mm full width half maximum friston et al 1995 used boxcar wave convolved synthetic haemodynamic response function model bold response patient two fmri data sets modafinil placebo individual data set first level voxel wise contrast activation working memory v baseline undertaken generated contrast images used second order random effects group analysis
0.09719374.15994572.html.plaintext.txt	30	random effects analyses allow quantitative inferences drawn regarding average behaviour population patients selected across different scanning sessions analysis mandatory psychopharmacological designs main effect interest exists distinct scanning sessions ie modafinil v placebo friston et al 1999 individual contrast images entered data points whole group analysis covariance ancova compared brain activation working memory v baseline conditions modafinil activation working memory v baseline placebo order scanning whether modafinil received day 1 day 2 comprised nuisance covariate produced group parametric brain map statistics stereotactic space montreal neurological institute mni evans et al 1993 showing brain areas activated working memory baseline conditions modafinil compared placebo emphasise intra session effects working memory v baseline modelled first level main inter session effect modafinil v placebo modelled second level random effects analysis
0.09719374.15994572.html.plaintext.txt	31	random effects analyses allow quantitative inferences drawn regarding average behaviour population patients selected across different scanning sessions analysis mandatory psychopharmacological designs main effect interest exists distinct scanning sessions ie modafinil v placebo friston et al 1999 individual contrast images entered data points whole group analysis covariance ancova compared brain activation working memory v baseline conditions modafinil activation working memory v baseline placebo order scanning whether modafinil received day 1 day 2 comprised nuisance covariate produced group parametric brain map statistics stereotactic space montreal neurological institute mni evans et al 1993 showing brain areas activated working memory baseline conditions modafinil compared placebo emphasise intra session effects working memory v baseline modelled first level main inter session effect modafinil v placebo modelled second level random effects analysis
0.09719374.15994572.html.plaintext.txt	32	also produced two subsidiary brain maps demonstrating brain areas activated working memory baseline placebo modafinil using two single group ancovas scanning order nuisance covariate hence able ensure expected pattern cortical activation obtained 2 back irrespective drugplacebo condition
0.09719374.15994572.html.plaintext.txt	33	also produced two subsidiary brain maps demonstrating brain areas activated working memory baseline placebo modafinil using two single group ancovas scanning order nuisance covariate hence able ensure expected pattern cortical activation obtained 2 back irrespective drugplacebo condition
0.09719374.15994572.html.plaintext.txt	34	study hypothesis driven set significance threshold p 001 uncorrected height extent activation also designated small volume sphere diameter 10 mm could used correct multiple comparisons family wise error method activation priori region interest anterior cingulate cortex observed uncorrected threshold purposes reporting neuroanatomical labelling stereotactic coordinates activated areas transformed mni space system talairach tournoux 1988
0.09719374.15994572.html.plaintext.txt	35	study hypothesis driven set significance threshold p 001 uncorrected height extent activation also designated small volume sphere diameter 10 mm could used correct multiple comparisons family wise error method activation priori region interest anterior cingulate cortex observed uncorrected threshold purposes reporting neuroanatomical labelling stereotactic coordinates activated areas transformed mni space system talairach tournoux 1988
0.09719374.15994572.html.plaintext.txt	36	brain activationbehavioural performance correlations patient calculated measure performance percentage accuracy working memory task study days hence difference score modafinil placebo conditions taking anterior cingulate cortex region interest also estimated magnitude fmri signal change derived beta parameters spm99 working memory task v baseline study days patient allowed us calculate difference anterior cingulate cortex signal change working memory task modafinil placebo conditions ran patient wise bivariate correlations difference behavioural performance modafinil v placebo difference anterior cingulate cortex signal change modafinil v placebo
0.09719374.15994572.html.plaintext.txt	37	brain activationbehavioural performance correlations patient calculated measure performance percentage accuracy working memory task study days hence difference score modafinil placebo conditions taking anterior cingulate cortex region interest also estimated magnitude fmri signal change derived beta parameters spm99 working memory task v baseline study days patient allowed us calculate difference anterior cingulate cortex signal change working memory task modafinil placebo conditions ran patient wise bivariate correlations difference behavioural performance modafinil v placebo difference anterior cingulate cortex signal change modafinil v placebo
0.09719374.15994572.html.plaintext.txt	38	results top abstract introduction method results discussion clinical implications acknowledgments references adverse events image quality analysed data 17 19 patients entering study one patient complete study due relapse acute psychosis 4 days first scanning day ethical considerations required disclosure randomisation status revealing received modafinil clinically significant adverse event occurred study data another patient could analysed technical problems second session fmri images
0.09719374.15994572.html.plaintext.txt	39	demographic data patients predominantly middle aged males ill approximately 15 years table 1 sixteen single none paid employment five performed voluntary work 16 received maximum disability living allowance eight lived accommodation three parents two supported group projects four rehabilitation units patients receiving oral antipsychotics n13 atypical one case four patients received intramuscular typical depot medication 17 patients none changed medication study period nine patients received modafinil day 1 placebo day 2 eight received reverse
0.09719374.15994572.html.plaintext.txt	40	demographic data patients predominantly middle aged males ill approximately 15 years table 1 sixteen single none paid employment five performed voluntary work 16 received maximum disability living allowance eight lived accommodation three parents two supported group projects four rehabilitation units patients receiving oral antipsychotics n13 atypical one case four patients received intramuscular typical depot medication 17 patients none changed medication study period nine patients received modafinil day 1 placebo day 2 eight received reverse
0.09719374.15994572.html.plaintext.txt	41	view table table 1 demographic clinical characteristics included patients
0.09719374.15994572.html.plaintext.txt	42	behavioural measures statistical comparisons prespecified except indicated used non parametric tests analyse group behavioural accuracy data working memory task placebo modafinil conditions normally distributed placebo conditions response accuracy control 0 back condition 19 88 median 71 differ significantly modafinil range 11 99 median 71 wilcoxon signed rank test z012 p091 placebo conditions response accuracy 2 back task 5 85 median 26 differ significantly modafinil range 4 79 median 22 wilcoxon signed rank test z097 p033
0.09719374.15994572.html.plaintext.txt	43	behavioural measures statistical comparisons prespecified except indicated used non parametric tests analyse group behavioural accuracy data working memory task placebo modafinil conditions normally distributed placebo conditions response accuracy control 0 back condition 19 88 median 71 differ significantly modafinil range 11 99 median 71 wilcoxon signed rank test z012 p091 placebo conditions response accuracy 2 back task 5 85 median 26 differ significantly modafinil range 4 79 median 22 wilcoxon signed rank test z097 p033
0.09719374.15994572.html.plaintext.txt	44	brain activations functional image analysis showed modafinil placebo days patients exhibited activations 2 back condition relative 0 back predicted brain regions tables 2 3 specifically prefrontal anterior cingulate parietal cortices callicott et al 2000 2003 meyer lindenberg et al 2001
0.09719374.15994572.html.plaintext.txt	45	view table table 2 brain areas exhibiting greater activation working memory baseline placebo condition
0.09719374.15994572.html.plaintext.txt	46	view table table 3 brain areas exhibiting greater activation working memory baseline modafinil condition
0.09719374.15994572.html.plaintext.txt	47	view larger version 74k fig 1 brain area anterior cingulate cortex exhibited greater activation working memory task modafinil placebo group data displayed canonical t1 weighted image upper panels supra threshold voxels shown yellow p5001 order demonstrate regional specificity finding data also displayed statistical threshold within glass brain lower panels
0.09719374.15994572.html.plaintext.txt	48	view larger version 74k fig 1 brain area anterior cingulate cortex exhibited greater activation working memory task modafinil placebo group data displayed canonical t1 weighted image upper panels supra threshold voxels shown yellow p5001 order demonstrate regional specificity finding data also displayed statistical threshold within glass brain lower panels
0.09719374.15994572.html.plaintext.txt	49	functional image analysis comparing modafinil placebo condition revealed working memory task performance associated significantly greater activation solely anterior cingulate cortex fig 1 talairach coordinates x6 mm y38 mm z15 mm 131 supra threshold voxels peak z score314 p 001 uncorrected height extent activation activation remained significant correction multiple comparisons within defined region interest p 005 examining separate modafinil placebo brain maps working memory v baseline contrast confirmed focal difference due greater anterior cingulate cortex activation working memory baseline performance modafinil x6 mm y38 mm z18 mm 50 voxels z379 p 001 uncorrected height activation converse namely greater activation baseline working memory placebo
0.09719374.15994572.html.plaintext.txt	50	functional image analysis comparing modafinil placebo condition revealed working memory task performance associated significantly greater activation solely anterior cingulate cortex fig 1 talairach coordinates x6 mm y38 mm z15 mm 131 supra threshold voxels peak z score314 p 001 uncorrected height extent activation activation remained significant correction multiple comparisons within defined region interest p 005 examining separate modafinil placebo brain maps working memory v baseline contrast confirmed focal difference due greater anterior cingulate cortex activation working memory baseline performance modafinil x6 mm y38 mm z18 mm 50 voxels z379 p 001 uncorrected height activation converse namely greater activation baseline working memory placebo
0.09719374.15994572.html.plaintext.txt	51	patient wise differences anterior cingulate cortex activation fig 1 behavioural performance modafinil placebo conditions positively significantly correlated fig 2 spearmans 042 one tailed p 005 however correlation reflect straightforward relationship improved activation improved performance rather reflected increased fmri signal majority patients modafinil session concomitant improvement memory performance half decreased signal minority patients response modafinil exhibited reduced performance drug fig 2 hence patient group whole relationship degree anterior cingulate cortex activation memory task modulated increaseddecreased drug level cognitive performance although subgroup patients exhibited enhanced cognition association increased anterior cingulate cortex activation patient exhibiting reduced anterior cingulate cortex activity improved cognitively
0.09719374.15994572.html.plaintext.txt	52	patient wise differences anterior cingulate cortex activation fig 1 behavioural performance modafinil placebo conditions positively significantly correlated fig 2 spearmans 042 one tailed p 005 however correlation reflect straightforward relationship improved activation improved performance rather reflected increased fmri signal majority patients modafinil session concomitant improvement memory performance half decreased signal minority patients response modafinil exhibited reduced performance drug fig 2 hence patient group whole relationship degree anterior cingulate cortex activation memory task modulated increaseddecreased drug level cognitive performance although subgroup patients exhibited enhanced cognition association increased anterior cingulate cortex activation patient exhibiting reduced anterior cingulate cortex activity improved cognitively
0.09719374.15994572.html.plaintext.txt	53	view larger version 8k fig 2 modafinil v placebo working memory task correlation difference anterior cingulate activation behavioural performance patient n17 x axis shows difference accuracy intra scanner working memory task modafinil placebo conditions y axis shows corresponding difference estimated functional magnetic resonance imaging fmri signal change positive values indicate greater accuracygreater fmri signal change modafinil placebo
0.09719374.15994572.html.plaintext.txt	54	post hoc examination data revealed five patients exhibiting improvements anterior cingulate cortex fmri signal 2 back performance four receiving typical neuroleptics depot sulpiride one receiving olanzapine five patients received typicals majority responded positively modafinil physiologically cognitively conversely 12 patients receiving atypicals one exhibited pattern moreover post hoc analysis confirmed positive correlation anterior cingulate cortex signal performance change significant five patients receiving typical antipsychotics spearmans 100 p calculated conversely patients excluded group analysis latter longer significant 12 patients receiving atypicals 003 one tailed p047 exclusion subjects whose performance level chance placebo led exclusion three four subjects receiving depots reduction anterior cingulate cortexperformance correlation trend significance 058 one tailed p006 hence possible receiving depot medication derived greatest benefit modafinil perhaps consequence greater initial deficit contributed findings
0.09719374.15994572.html.plaintext.txt	55	post hoc examination data revealed five patients exhibiting improvements anterior cingulate cortex fmri signal 2 back performance four receiving typical neuroleptics depot sulpiride one receiving olanzapine five patients received typicals majority responded positively modafinil physiologically cognitively conversely 12 patients receiving atypicals one exhibited pattern moreover post hoc analysis confirmed positive correlation anterior cingulate cortex signal performance change significant five patients receiving typical antipsychotics spearmans 100 p calculated conversely patients excluded group analysis latter longer significant 12 patients receiving atypicals 003 one tailed p047 exclusion subjects whose performance level chance placebo led exclusion three four subjects receiving depots reduction anterior cingulate cortexperformance correlation trend significance 058 one tailed p006 hence possible receiving depot medication derived greatest benefit modafinil perhaps consequence greater initial deficit contributed findings
0.09719374.15994572.html.plaintext.txt	56	investigated post hoc deficitbenefit hypothesis found exhibiting improved working memory performance modafinil demonstrated significantly worse performance verbal fluency task initial assessment compared patients responders generated 7 18 words 1 min median 10 non responders generated 4 25 words median 115 mann whitney u test z219 p003 correlations intra scanner working memory task performance specific symptom ratings
0.09719374.15994572.html.plaintext.txt	57	investigated post hoc deficitbenefit hypothesis found exhibiting improved working memory performance modafinil demonstrated significantly worse performance verbal fluency task initial assessment compared patients responders generated 7 18 words 1 min median 10 non responders generated 4 25 words median 115 mann whitney u test z219 p003 correlations intra scanner working memory task performance specific symptom ratings
0.09719374.15994572.html.plaintext.txt	58	finally way validating sample described successive reports repeatedly described positive correlations 2 back accuracy right dorsolateral prefrontal cortex activity people schizophrenia compared normals callicott et al 1999 2000 examined correlates performance per se 2 back task found right dorsolateral prefrontal cortex implicated conditions placebo x44 mm y41 mm z9 mm 21 voxels z275 p 001 uncorrected height activation modafinil x44 mm y49 mm z18 mm 62 voxels z315 p 001 uncorrected height activation
0.09719374.15994572.html.plaintext.txt	59	finally way validating sample described successive reports repeatedly described positive correlations 2 back accuracy right dorsolateral prefrontal cortex activity people schizophrenia compared normals callicott et al 1999 2000 examined correlates performance per se 2 back task found right dorsolateral prefrontal cortex implicated conditions placebo x44 mm y41 mm z9 mm 21 voxels z275 p 001 uncorrected height activation modafinil x44 mm y49 mm z18 mm 62 voxels z315 p 001 uncorrected height activation
0.09719374.15994572.html.plaintext.txt	60	discussion top abstract introduction method results discussion clinical implications acknowledgments references neural response administered single low dose modafinil people chronic schizophrenia assessed working memory fmri data reveal specific effect drug upon area frontal lobe called anterior cingulate cortex importantly effect specific active memory condition baseline state anterior cingulate cortex involved wide range executive functions bush et al 2000 activated working memory protocols previous studies callicott et al 2000 2003 meyer lindenberg et al 2001 activation people chronic schizophrenia appears enhanced modafinil fig 1
0.09719374.15994572.html.plaintext.txt	61	cognitive response despite enhanced anterior cingulate cortex activation group level working memory performance patients exhibit enhanced cognition group whole effect modafinil upon working memory protocol therefore might posited increased anterior cingulate cortex activation either unrelated cognition indicative reduced efficiency cognitive processing callicott et al 2000 manoach 2003 greater anterior cingulate cortex activation occurs without increase cognitive performance brain function might said less efficient presence modafinil however important note cognitive function improve minority patients although might posited expected statistically merely manifestation variation around mean feature data runs counter interpretation positive correlation anterior cingulate cortex activation cognitive improvement fig 2 modafinil simply made anterior cingulate cortex function less efficient expect correlation negative positive correlation implies magnitude anterior cingulate cortex activation cognitive performance indeed related context modafinil exposure exhibiting greater anterior cingulate cortex response also exhibit greater cognitive enhancement working memory
0.09719374.15994572.html.plaintext.txt	62	cognitive response despite enhanced anterior cingulate cortex activation group level working memory performance patients exhibit enhanced cognition group whole effect modafinil upon working memory protocol therefore might posited increased anterior cingulate cortex activation either unrelated cognition indicative reduced efficiency cognitive processing callicott et al 2000 manoach 2003 greater anterior cingulate cortex activation occurs without increase cognitive performance brain function might said less efficient presence modafinil however important note cognitive function improve minority patients although might posited expected statistically merely manifestation variation around mean feature data runs counter interpretation positive correlation anterior cingulate cortex activation cognitive improvement fig 2 modafinil simply made anterior cingulate cortex function less efficient expect correlation negative positive correlation implies magnitude anterior cingulate cortex activation cognitive performance indeed related context modafinil exposure exhibiting greater anterior cingulate cortex response also exhibit greater cognitive enhancement working memory
0.09719374.15994572.html.plaintext.txt	63	accounting responders interest exhibiting greater physiological cognitive response modafinil tended receiving typical neuroleptic medications depots sulpiride numbers small may rationale finding neurotransmitter systems implicated promotion wakefulness modafinil include dopaminergic serotonergic systems although antipsychotics share antagonism dopaminergic system especially d2 receptor typicals atypicals differ affinities receptors particularly 5ht2a keefe et al 1999 animal models modafinils effect increasing alertness attenuated 5ht2a antagonism shelton et al 1995 hence possible atypical antipsychotic treatment antagonising 5ht2a might constrain cognotropic effects modafinil hypothesis deserving study alternatively ability atypicals enhance cognition albeit limited extent keefe et al 1999 might curtail improvement modafinil
0.09719374.15994572.html.plaintext.txt	64	accounting responders interest exhibiting greater physiological cognitive response modafinil tended receiving typical neuroleptic medications depots sulpiride numbers small may rationale finding neurotransmitter systems implicated promotion wakefulness modafinil include dopaminergic serotonergic systems although antipsychotics share antagonism dopaminergic system especially d2 receptor typicals atypicals differ affinities receptors particularly 5ht2a keefe et al 1999 animal models modafinils effect increasing alertness attenuated 5ht2a antagonism shelton et al 1995 hence possible atypical antipsychotic treatment antagonising 5ht2a might constrain cognotropic effects modafinil hypothesis deserving study alternatively ability atypicals enhance cognition albeit limited extent keefe et al 1999 might curtail improvement modafinil
0.09719374.15994572.html.plaintext.txt	65	safety number caveats study findings first reasons described deliberately utilised relatively low dose modafinil may sub optimal nevertheless one participants underwent psychotic relapse 4 days post drug cannot determine whether modafinil responsible although covert non adherence concurrent medication cannot excluded receiving oral antipsychotic must wary seeking exculpate test medication however psychotic reaction single dose modafinil unprecedented knowledge although cases psychosis emerging de novo receiving multiple doses manufacturers prescribing information reports one healthy male volunteer developed ideas reference paranoid delusions auditory hallucinations association multiple daily 600 mg doses modafinil sleep deprivation evidence psychosis 36 hours drug discontinuation cephalon 1999 british national formulary mention psychosis either contraindication consequence modafinil exposure
0.09719374.15994572.html.plaintext.txt	66	safety number caveats study findings first reasons described deliberately utilised relatively low dose modafinil may sub optimal nevertheless one participants underwent psychotic relapse 4 days post drug cannot determine whether modafinil responsible although covert non adherence concurrent medication cannot excluded receiving oral antipsychotic must wary seeking exculpate test medication however psychotic reaction single dose modafinil unprecedented knowledge although cases psychosis emerging de novo receiving multiple doses manufacturers prescribing information reports one healthy male volunteer developed ideas reference paranoid delusions auditory hallucinations association multiple daily 600 mg doses modafinil sleep deprivation evidence psychosis 36 hours drug discontinuation cephalon 1999 british national formulary mention psychosis either contraindication consequence modafinil exposure
0.09719374.15994572.html.plaintext.txt	67	recent study 20 patients schizophrenia exposed single dose 200 mg modafinil drug elicited exacerbation psychosis turner et al 2004 however anecdotal accounts schizophrenic relapse following repeated dosing narendran et al 2002 rosenthal bryant 2003 multi dosing studies centres may help clarify magnitude putative risk
0.09719374.15994572.html.plaintext.txt	68	recent study 20 patients schizophrenia exposed single dose 200 mg modafinil drug elicited exacerbation psychosis turner et al 2004 however anecdotal accounts schizophrenic relapse following repeated dosing narendran et al 2002 rosenthal bryant 2003 multi dosing studies centres may help clarify magnitude putative risk
0.09719374.15994572.html.plaintext.txt	69	clinical implications limitations top abstract introduction method results discussion clinical implications acknowledgments references clinical implications schizophrenia associated cognitive impairments impact upon social function cognitive enhancer modafinil might reduce impairments patients chronic schizophrenia exhibited increased anterior cingulate activation response modafinil performing working memory protocol also exhibited improved memory performance patients exhibiting improved memory performance modafinil receiving concomitant typical antipsychotic medication
0.09719374.15994572.html.plaintext.txt	70	limitations many neuroimaging studies number subjects examined relatively small impact memory improvement upon day day function outside scanner remains demonstrated patients may derive cognitive benefit modafinil require characterisation
0.09719374.15994572.html.plaintext.txt	71	limitations many neuroimaging studies number subjects examined relatively small impact memory improvement upon day day function outside scanner remains demonstrated patients may derive cognitive benefit modafinil require characterisation
0.09719374.15994572.html.plaintext.txt	72	acknowledgments top abstract introduction method results discussion clinical implications acknowledgments references thank patients participated study dr c w lawson radiography colleagues royal hallamshire hospital ms anne connors pharmacist nursing staff rowan ward clinical academic unit ms karen roy initial advice sponsor involved scientific discussions regarding study design role data collection data analysis data interpretation writing report decision submit paper publication grateful university sheffield sheffield care trust insurance indemnification study
0.09719374.15994572.html.plaintext.txt	73	references top abstract introduction method results discussion clinical implications acknowledgments references american psychiatric association 1994 diagnostic statistical manual mental disorders 4th edn dsm iv washington dc apa
0.09719374.15994572.html.plaintext.txt	74	british medical association 2004 british national formulary london british medical associationroyal pharmaceutical society great britain
0.09719374.15994572.html.plaintext.txt	75	british medical association 2004 british national formulary london british medical associationroyal pharmaceutical society great britain
0.09719374.15994572.html.plaintext.txt	76	cephalon 1999 prescribing information provigil modafinil tablets west chester pa cephalon inc
0.09719374.15994572.html.plaintext.txt	77	cephalon 1999 prescribing information provigil modafinil tablets west chester pa cephalon inc
0.09719374.15994572.html.plaintext.txt	78	guy w 1976 early clinical drug evaluation unit assessment manual psychopharmacology revised edition washington dc department health education welfare
0.09719374.15994572.html.plaintext.txt	79	us modafinil narcolepsy multicenter study group 2000 randomised trial modafinil treatment excessive daytime somnolence narcolepsy neurology 54 1166 1175abstractfree full text
0.09719374.15994572.html.plaintext.txt	80	received publication may 18 2004 revision received october 19 2004 accepted publication october 21 2004
0.09719374.15994572.html.plaintext.txt	81	received publication may 18 2004 revision received october 19 2004 accepted publication october 21 2004
0.09719374.15994572.html.plaintext.txt	82	article abstract full text pdf submit response alert article cited alert eletters posted alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager google scholar articles spence articles hunter m d articles citing article pubmed pubmed citation articles spence articles hunter m d
0.09719374.15994572.html.plaintext.txt	83	home help feedback subscriptions archive search table contents psychiatric bulletin advances psychiatric treatment rcpsych journals
0.09784351.9373235.html.plaintext.txt	0	evolving views major histocompatibility complex
0.09784351.9373235.html.plaintext.txt	1	department pediatrics yale child health research center yale university school medicine department genetics boyer center molecular medicine yale university school medicine new haven ct
0.09784351.9373235.html.plaintext.txt	2	introduction introduction references
0.09784351.9373235.html.plaintext.txt	3	major histocompatibility complex mhc extended cluster genes remarkable number importance immunological functions encode historically interest mhc emanated tissue transplantation experiments hence reference histocompatibility know highly conserved region encodes genes many important varied functions immune nonimmune nature one family mhc genes human leukocyte antigen hla genes polymorphic yet discovered hundreds alleles described far110 serotyping polymorphisms permitted genetic mapping loci early disease association studies addition polymorphisms permitted extensive population studies revealing number interesting mhc associations phenomena recent cdna selections2 genomic sequencing cosmid screenings shown existence large number genes mhc including number expressed selectively cells immune system2 8 review discuss recent data considerably expands number immune related genes encoded mhc review factors may underlie large scale organization
0.09784351.9373235.html.plaintext.txt	4	major histocompatibility complex mhc extended cluster genes remarkable number importance immunological functions encode historically interest mhc emanated tissue transplantation experiments hence reference histocompatibility know highly conserved region encodes genes many important varied functions immune nonimmune nature one family mhc genes human leukocyte antigen hla genes polymorphic yet discovered hundreds alleles described far110 serotyping polymorphisms permitted genetic mapping loci early disease association studies addition polymorphisms permitted extensive population studies revealing number interesting mhc associations phenomena recent cdna selections2 genomic sequencing cosmid screenings shown existence large number genes mhc including number expressed selectively cells immune system2 8 review discuss recent data considerably expands number immune related genes encoded mhc review factors may underlie large scale organization
0.09784351.9373235.html.plaintext.txt	5	mhc includes coding regions well known eponymous polymorphic surface antigens hla class class ii type respectively present antigen cd8 cd4 cells intervening class ii class region human mhc class iii region includes genes several components complement system910 genes class ii region found encode components cytoplasmic proteasome degrades proteins peptides11 well peptide transporters loading peptides onto class proteins12 class ii region also encodes dm gene facilitates loading assembly class ii proteins1314 centromeric class region cluster genes encoding three inflammation related proteins tumor necrosis factor tnf lymphotoxin lta lymphotoxin ltb15 18 remarkably list immune system related genes chromosome segments potentially derived duplications parts mhc grown substantially within last year
0.09784351.9373235.html.plaintext.txt	6	mhc includes coding regions well known eponymous polymorphic surface antigens hla class class ii type respectively present antigen cd8 cd4 cells intervening class ii class region human mhc class iii region includes genes several components complement system910 genes class ii region found encode components cytoplasmic proteasome degrades proteins peptides11 well peptide transporters loading peptides onto class proteins12 class ii region also encodes dm gene facilitates loading assembly class ii proteins1314 centromeric class region cluster genes encoding three inflammation related proteins tumor necrosis factor tnf lymphotoxin lta lymphotoxin ltb15 18 remarkably list immune system related genes chromosome segments potentially derived duplications parts mhc grown substantially within last year
0.09784351.9373235.html.plaintext.txt	7	mhc major biomedical interest contribution transplant rejection variation individuals susceptibility variety autoimmune disorders19 23 number cases clear susceptibility determined variation protein sequence class ii molecules however discussed possibility must still entertained polymorphism immune system related genes mhc also contribute diseases
0.09784351.9373235.html.plaintext.txt	8	mhc major biomedical interest contribution transplant rejection variation individuals susceptibility variety autoimmune disorders19 23 number cases clear susceptibility determined variation protein sequence class ii molecules however discussed possibility must still entertained polymorphism immune system related genes mhc also contribute diseases
0.09784351.9373235.html.plaintext.txt	9	addition role influencing propensity known autoimmune diseases insulin dependent diabetes mellitus multiple sclerosis systemic lupus erythematosus myasthenia gravis rheumatoid arthritis reviewed thomson 199523 mhc contains genes contributing several hereditary disorders either autoimmune nature role autoimmunity uncertain include ankylosing spondyloarthropathies clear association class allele hla b27 narcolepsy equally clearly associated certain class ii alleles mhc also includes genes steroid 21 hydroxylase hemochromatosis deficiency 21 hydroxylase causes adrenogenital syndrome hemochromatosis one common simple mendelian disorders man recently major quantitative trait locus dyslexia mapped distal mhc actively pursued several groups2425
0.09784351.9373235.html.plaintext.txt	10	addition role influencing propensity known autoimmune diseases insulin dependent diabetes mellitus multiple sclerosis systemic lupus erythematosus myasthenia gravis rheumatoid arthritis reviewed thomson 199523 mhc contains genes contributing several hereditary disorders either autoimmune nature role autoimmunity uncertain include ankylosing spondyloarthropathies clear association class allele hla b27 narcolepsy equally clearly associated certain class ii alleles mhc also includes genes steroid 21 hydroxylase hemochromatosis deficiency 21 hydroxylase causes adrenogenital syndrome hemochromatosis one common simple mendelian disorders man recently major quantitative trait locus dyslexia mapped distal mhc actively pursued several groups2425
0.09784351.9373235.html.plaintext.txt	11	mhc extensively studied large number excellent reviews exist range related topics11012192026 50 present review largely restricted newest developments recognition complexity role human mhc immuno hematologic systems relationship among segments mhc
0.09784351.9373235.html.plaintext.txt	12	mhc extensively studied large number excellent reviews exist range related topics11012192026 50 present review largely restricted newest developments recognition complexity role human mhc immuno hematologic systems relationship among segments mhc
0.09784351.9373235.html.plaintext.txt	13	subregion mhc contains unusual concentration genes related inflammation
0.09784351.9373235.html.plaintext.txt	14	convention mhc divided three contiguous regions approximate location genes shared characteristics fig 1 centromeric chromosome 6p class ii region contains 17 known hla class ii genes pseudogenes5 contiguous class iii region encodes several components complement system telomeric class iii region class region encodes 18 hla class related genes pseudogenes recently number genes putatively involved inflammation identified central mhc telomeric end class iii region presented group genes may roles various aspects stress inflammation infection suggest concentration genes sufficiently distinct designated class iv region
0.09784351.9373235.html.plaintext.txt	15	convention mhc divided three contiguous regions approximate location genes shared characteristics fig 1 centromeric chromosome 6p class ii region contains 17 known hla class ii genes pseudogenes5 contiguous class iii region encodes several components complement system telomeric class iii region class region encodes 18 hla class related genes pseudogenes recently number genes putatively involved inflammation identified central mhc telomeric end class iii region presented group genes may roles various aspects stress inflammation infection suggest concentration genes sufficiently distinct designated class iv region
0.09784351.9373235.html.plaintext.txt	16	view larger version 16k fig 1 map mhc showing proposed class iv region physical map organization human mhc selected genes expressed hla class class ii genes rectangles positioned horizontal meridian genes putative immune function triangles genes circles elevated horizontal meridian blow view proposed class iv region shown beneath physical distances approximate derived sources referenced text unpublished data symbols known genes conventional abbreviations defined text5 znf 173 znf 178 zinc finger genes map vicinity hla a6102
0.09784351.9373235.html.plaintext.txt	17	view larger version 16k fig 1 map mhc showing proposed class iv region physical map organization human mhc selected genes expressed hla class class ii genes rectangles positioned horizontal meridian genes putative immune function triangles genes circles elevated horizontal meridian blow view proposed class iv region shown beneath physical distances approximate derived sources referenced text unpublished data symbols known genes conventional abbreviations defined text5 znf 173 znf 178 zinc finger genes map vicinity hla a6102
0.09784351.9373235.html.plaintext.txt	18	tnf family cluster cluster genes three related cytokines tnf lta ltb lies telomeric end class iii region42 shortly centromeric class related genes tnf extensively studied47 plays important role inflammation bacterial51 viral infection52 tumor cachexia immune response produced variety cells including prominently monocytes macrophages cell subsets mice variants tnf gene affect levels tnf production associated variations level susceptibility renal disease lupus like syndrome53 polymorphisms human tnf gene associated increased susceptibility fatal cerebral malaria54 rheumatoid arthritis inflammatory bowel disease55 perhaps autoimmune disorders56 59
0.09784351.9373235.html.plaintext.txt	19	lta also called tnf actions similar tnf cellular basis pattern expression considerably limited remarkably deletion lta gene leads specific absence lymph nodes peyers patches splenic germinal centers mice6061 whereas mice lacking tnf develop lymph nodes peyers patches lack splenic primary b cell follicles62 deletion p55 tnf receptor results normal lymph node development architecture normal migration lymphocytes lamina propria epithelium small intestine organized peyers patches absence germinal centers63 based observations speculated effect lta development lymphoid organs may mediated distinct receptors functioning organ specific context
0.09784351.9373235.html.plaintext.txt	20	lta also called tnf actions similar tnf cellular basis pattern expression considerably limited remarkably deletion lta gene leads specific absence lymph nodes peyers patches splenic germinal centers mice6061 whereas mice lacking tnf develop lymph nodes peyers patches lack splenic primary b cell follicles62 deletion p55 tnf receptor results normal lymph node development architecture normal migration lymphocytes lamina propria epithelium small intestine organized peyers patches absence germinal centers63 based observations speculated effect lta development lymphoid organs may mediated distinct receptors functioning organ specific context
0.09784351.9373235.html.plaintext.txt	21	ltb also called tnf c membrane bound molecule forms heterotrimer lta18 lta ltb complex induce activation nf b certain cell lines binding ltb receptor member tnf receptor family6465 nf b pleiotropic transcription factor capable activating expression great variety genes critical immunoinflammatory response65 lta ltb complex also weakly cytotoxic tumor cells appear induce apoptosis
0.09784351.9373235.html.plaintext.txt	22	ltb also called tnf c membrane bound molecule forms heterotrimer lta18 lta ltb complex induce activation nf b certain cell lines binding ltb receptor member tnf receptor family6465 nf b pleiotropic transcription factor capable activating expression great variety genes critical immunoinflammatory response65 lta ltb complex also weakly cytotoxic tumor cells appear induce apoptosis
0.09784351.9373235.html.plaintext.txt	23	b144 d6s49e within 15 kb upstream human tnf cluster gene designated b144 lst 1 leukocyte specific transcript66 homologue partial cdna first identified mouse67 transcript gene expressed exclusively monocytes macrophages cells expression gene rna level increased various activating stimuli particular interferon ifn probable gene product encoded open reading frame whose cognate amino acid sequence 50 identical humans mouse amino acid sequence contains long hydrophobic region near n terminus otherwise shows apparent relationship proteins known function interpretation open reading frame regulation gene complicated remarkable degree alternative splicing seen mrna products
0.09784351.9373235.html.plaintext.txt	24	b144 rna actually ensemble related sequences derived four alternative 5 exons 3 internal exons well several forms 3 exon exons 5 6 may associated 5 exons may separately jointly omitted final mrna product result 24 forms mrna may seen u937 monocyte cells forms could encode altered forms putative protein others affect 5 untranslated region gene also peculiar one spliced form apparently ga dinucleotide first bases 5 end intron first two bases introns generally gt occasional gc b144 splice site highly unusual perhaps unique mouse gene also seems multiple alternative splice forms cultured cells amount b144 mrna cells quite substantial would surprising protein formed significant amounts although presently publications characterizing putative protein
0.09784351.9373235.html.plaintext.txt	25	b144 rna actually ensemble related sequences derived four alternative 5 exons 3 internal exons well several forms 3 exon exons 5 6 may associated 5 exons may separately jointly omitted final mrna product result 24 forms mrna may seen u937 monocyte cells forms could encode altered forms putative protein others affect 5 untranslated region gene also peculiar one spliced form apparently ga dinucleotide first bases 5 end intron first two bases introns generally gt occasional gc b144 splice site highly unusual perhaps unique mouse gene also seems multiple alternative splice forms cultured cells amount b144 mrna cells quite substantial would surprising protein formed significant amounts although presently publications characterizing putative protein
0.09784351.9373235.html.plaintext.txt	26	1c7 d6s2570e second gene 1c7 preferentially expressed monocytes certain hematopoietic cell lines lies immediately adjacent b14468 3 ends two mrna templates come within bases overlapping gene encodes least three differentially spliced mrnas mrna encodes potential leader sequence internal membrane anchor segment three forms differ length sequence carboxy terminal intracytoplasmic domain encoded product weak similarity surface antigens ctla4
0.09784351.9373235.html.plaintext.txt	27	aif 1 recently another mhc encoded monocyte lymphocyte specific cdna called aif 1 identified elevated level expression experimental cardiac transplants69 72 separately gene characterized termed g173 gene transcript lies shortly centromeric b144 highly conserved rodents humans mrna upregulated interferon expressed subset macrophages infiltrating allografts putative amino acid translation lacks hydrophobic leader sequence however strong homology ef hand protein motif found calcium binding proteins involved neutrophil activation74 also myeloid chemoattractant protein75 cytokine genes encode leader sequences remains possible aif 1 protein may secreted released injured cells function gene remains unknown
0.09784351.9373235.html.plaintext.txt	28	b like nfkbil1 region mhc telomeric tnf cluster gene protein contains certain motifs similar seen b called b like ikbl76 role b negative regulation nf b hence inflammatory response well known paradigm transcriptional control involving regulation phosphorylation ubiquitination protein degradation analogy mhc encoded ikbl molecule candidate regulator inflammatory responses although described widely expressed rather surprisingly functional data available molecule
0.09784351.9373235.html.plaintext.txt	29	ski2w centromeric hsp70 genes43 lies ski2w77 79 gene encoding protein substantial similarity yeast ski2 superkiller 2 protein80 including rna helicase motifs ski2 makes yeast cells resistant killer toxin rna viruses virtue ability block translation nonpolyadenylated noncapped viral mrnas targeted degradation8182 gene plays partially redundant essential role normal yeast growth83 antiviral effect well homologies yeast gene remains possible one role human gene mediator antiviral effects particularly rna viruses use nonpolyadenylated rna life cycle
0.09784351.9373235.html.plaintext.txt	30	mic family mic mhc class related family8485 group homologous genes pseudogenes interspersed distal class iii class region mhc structure genes predicted coding products resemble class genes clearly divergent family also characterized large first introns members group known expressed mrna mic b whose genes lie telomeric ikbl gene centromeric hla b mic protein expressed properly folded independently 2 microglobulin preferentially expressed intestinal mucosa86 curiously transcription mic upregulated heat shock thus gene shares properties class genes per se least one functional feature would relate heat shock genes located centromerically
0.09784351.9373235.html.plaintext.txt	31	overall central mhc complement region class iii class region least seven genes implicated degree inflammatory responses also eighth gene 1c7 yet studied functionally whose pattern expression consistent similar role addition ikbl molecule near one end cluster least potential candidate role inflammation bat1 gene d6s81e also region encodes rna helicase conceivably could play role complex splicing b144 well genes87 centromeric end region number genes unknown function broad expression also genes three heat shock proteins88 whose expression may elevated inflammation heat shock proteins also implicated mediating antiviral effects prostaglandins89 overall suggest segment mhc given separate designation class iv region recognition multiple potential roles inflammation stress responses
0.09784351.9373235.html.plaintext.txt	32	overall central mhc complement region class iii class region least seven genes implicated degree inflammatory responses also eighth gene 1c7 yet studied functionally whose pattern expression consistent similar role addition ikbl molecule near one end cluster least potential candidate role inflammation bat1 gene d6s81e also region encodes rna helicase conceivably could play role complex splicing b144 well genes87 centromeric end region number genes unknown function broad expression also genes three heat shock proteins88 whose expression may elevated inflammation heat shock proteins also implicated mediating antiviral effects prostaglandins89 overall suggest segment mhc given separate designation class iv region recognition multiple potential roles inflammation stress responses
0.09784351.9373235.html.plaintext.txt	33	additional immune related genes distributed entire mhc
0.09784351.9373235.html.plaintext.txt	34	genes mentioned paragraphs cited reviews encode substantial number structurally remotely related totally unrelated proteins expressed specifically within function interacting cells immune system gene linkage consequence duplication divergence seem adequate explanation clustering ascertainment bias conceivable explanation intensity immune system gene cluster investigated explanation seems progressively less likely immune system genes divergent structure discovered within cluster recent finding distal mhc additional three four genes different families expressed selectively immunocytes seems make coincidence argument almost untenable genes unknown function yet unknown degree polymorphism potential contribution association mhc haplotypes propensity autoimmune disorders interest recently detected immune system genes distal mhc include following
0.09784351.9373235.html.plaintext.txt	35	genes mentioned paragraphs cited reviews encode substantial number structurally remotely related totally unrelated proteins expressed specifically within function interacting cells immune system gene linkage consequence duplication divergence seem adequate explanation clustering ascertainment bias conceivable explanation intensity immune system gene cluster investigated explanation seems progressively less likely immune system genes divergent structure discovered within cluster recent finding distal mhc additional three four genes different families expressed selectively immunocytes seems make coincidence argument almost untenable genes unknown function yet unknown degree polymorphism potential contribution association mhc haplotypes propensity autoimmune disorders interest recently detected immune system genes distal mhc include following
0.09784351.9373235.html.plaintext.txt	36	ubiquitin like gene ubiquitin 76 amino acid peptide whose sequence remarkably conserved among eukaryotes expressed almost cells body generic function become attached proteins target degradation proteasome system ubiquitin plays role diverse variety cellular processes including chromatin structure cell cycle control modification cell receptors dna repair processes gene silencing activation degradation nf b90 however curious ubiquitin initially studied peptide might transcellular effects modulating activity immunocytes
0.09784351.9373235.html.plaintext.txt	37	several genes encoding ubiquitin homologues discovered including least two non mhc genes implicated function immune system one isg1591 94 encodes protein homologous ubiquitin dimer expressed unstimulated cells induced ifn variety cell types interferon treatment newly synthesized isg15 found intracellularly pulse chase experiments show 24 hours 50 labeled isg15 found extracellularly question whether protein transcellular effect vivo remains unaddressed95
0.09784351.9373235.html.plaintext.txt	38	several genes encoding ubiquitin homologues discovered including least two non mhc genes implicated function immune system one isg1591 94 encodes protein homologous ubiquitin dimer expressed unstimulated cells induced ifn variety cell types interferon treatment newly synthesized isg15 found intracellularly pulse chase experiments show 24 hours 50 labeled isg15 found extracellularly question whether protein transcellular effect vivo remains unaddressed95
0.09784351.9373235.html.plaintext.txt	39	primary product isg15 gene contains extension eight amino acids beyond c terminal diglycine characteristic ubiquitin96 c terminal extension rapidly removed intracellularly primary translation product demonstrated effect cells contrast processed product active low nanogram per milliliter level inducing ifn production cells97 peptide also induces remarkable proliferation activation natural killer nk cells b cell depleted mononuclear cell populations98 effect nk cells requires presence cells cannot accounted ifn interferon itself98
0.09784351.9373235.html.plaintext.txt	40	primary product isg15 gene contains extension eight amino acids beyond c terminal diglycine characteristic ubiquitin96 c terminal extension rapidly removed intracellularly primary translation product demonstrated effect cells contrast processed product active low nanogram per milliliter level inducing ifn production cells97 peptide also induces remarkable proliferation activation natural killer nk cells b cell depleted mononuclear cell populations98 effect nk cells requires presence cells cannot accounted ifn interferon itself98
0.09784351.9373235.html.plaintext.txt	41	nakamura et al99 investigating ubiquitin homologue synthesized cells acts nonantigen specific suppresser factor b cells isolation sequencing protein known mnsf monoclonal nonspecific suppressor factor followed cloning cdna showed protein ubiquitin homologue despite apparent larger molecular weight isolated cells100
0.09784351.9373235.html.plaintext.txt	42	nakamura et al99 investigating ubiquitin homologue synthesized cells acts nonantigen specific suppresser factor b cells isolation sequencing protein known mnsf monoclonal nonspecific suppressor factor followed cloning cdna showed protein ubiquitin homologue despite apparent larger molecular weight isolated cells100
0.09784351.9373235.html.plaintext.txt	43	distal mhc encodes molecule known fat10 homologous ubiquitin divergent isg15 mnsf either two ubiquitin homology ubiquitin extends preservation c terminal diglycine appears necessary transfer ubiquitin molecules well internal lysines flanking sequence ubiquitinylation occurs molecule strongly expressed rna level b lymphoblastoid lines ifn inducible others vivo found thymus lesser degree spleen expressed jurkat cells variety cell lines mouse homologue exists 50 conservation amino acid sequence experimental investigations function fat10 beginning unpublished data
0.09784351.9373235.html.plaintext.txt	44	distal mhc encodes molecule known fat10 homologous ubiquitin divergent isg15 mnsf either two ubiquitin homology ubiquitin extends preservation c terminal diglycine appears necessary transfer ubiquitin molecules well internal lysines flanking sequence ubiquitinylation occurs molecule strongly expressed rna level b lymphoblastoid lines ifn inducible others vivo found thymus lesser degree spleen expressed jurkat cells variety cell lines mouse homologue exists 50 conservation amino acid sequence experimental investigations function fat10 beginning unpublished data
0.09784351.9373235.html.plaintext.txt	45	transcription factor like gene family distal mhc encodes family least five genes share c terminal homology domain butyrophilin6101 dubbed ctb box 102 extends 100 amino acids length103 butyrophilin protein coats fat globules milk encoded distal mhc function conserved ctb box domain unknown although degree conservation suggests may motif interaction second protein family proteins proteins family encoded genes strictly within mhc somewhat divergent n terminal structures one generally expressed gene znf173 acid finger protein 102 several earmarks transcription factor including paired zinc fingers acidic domain two members family znf178 960 205 encode proteins resembling znf173 lacking acidic domain could potentially act transcriptional activator one 960 205 limited pattern expression including undefined cell types within spleen unpublished data august 1995
0.09784351.9373235.html.plaintext.txt	46	transcription factor like gene family distal mhc encodes family least five genes share c terminal homology domain butyrophilin6101 dubbed ctb box 102 extends 100 amino acids length103 butyrophilin protein coats fat globules milk encoded distal mhc function conserved ctb box domain unknown although degree conservation suggests may motif interaction second protein family proteins proteins family encoded genes strictly within mhc somewhat divergent n terminal structures one generally expressed gene znf173 acid finger protein 102 several earmarks transcription factor including paired zinc fingers acidic domain two members family znf178 960 205 encode proteins resembling znf173 lacking acidic domain could potentially act transcriptional activator one 960 205 limited pattern expression including undefined cell types within spleen unpublished data august 1995
0.09784351.9373235.html.plaintext.txt	47	tssp discussed telomeric boundary mhc recently extended include region around hemochromatosis locus olfactory receptor cluster hemochromatosis locus fig 1 gene yet another orphan protein immune system whose mrna far found thymus unpublished data july 1996 aptly called thymus specific serine protease tssp predicted protein hydrophobic leader sequence suggesting either membrane bound secreted lacks clear internal membrane anchor sequence latter likely interest immunologists learn function gene
0.09784351.9373235.html.plaintext.txt	48	fat 9 recently rna transcript encoded fat 9104 gene containing sequences one human mhc olfactory receptor like genes detected spleen mrna closer examination showed olfactory receptor antisense sequence included probable 3 untranslated region novel fat 9 transcript unpublished data june 1995 transcript putatively encodes protein 130 amino acids northern blots found predominantly lymph nodes compared spleen thymus bone marrow variety tissues organs encoded protein obvious homologies proteins database therefore fat 9 seems represent yet another example mhc gene functions specifically immune system
0.09784351.9373235.html.plaintext.txt	49	genes within mhc may involved specifically immune processes homology murine class ii region human class ii striking except insertion 60 kb murine class ii region containing h2k genes46 murine ke5 gene lies centromeric h2k reported expressed lymphatic tissues105 ke5 lies within collagen gene mapping centromeric h2k reported expressed lymphatic tissue functional significance unclear recently described hcgviii transcript4 reported expressed intestine lymphoid tissues yet another candidate gene specific functions immune system
0.09784351.9373235.html.plaintext.txt	50	genes within mhc may involved specifically immune processes homology murine class ii region human class ii striking except insertion 60 kb murine class ii region containing h2k genes46 murine ke5 gene lies centromeric h2k reported expressed lymphatic tissues105 ke5 lies within collagen gene mapping centromeric h2k reported expressed lymphatic tissue functional significance unclear recently described hcgviii transcript4 reported expressed intestine lymphoid tissues yet another candidate gene specific functions immune system
0.09784351.9373235.html.plaintext.txt	51	addition several genes whose expression limited immunocytes number broadly expressed genes mhc potential less specific roles immune system one example pbx2 also known g17 located approximately 250 kb telomeric hla dra88106 although functional data available pbx2 non mhc pbx gene implicated human leukemia presumably formation oncogenic fusion product via chromosome 119 translocation107 experiments suggest pbx genes modify specificity clustered homeobox genes forming heterodimers directly bind dna clustered homeobox genes expressed different patterns various stages lineages hematopoietic system may modulate expansion various hematopoietic precursors108
0.09784351.9373235.html.plaintext.txt	52	addition several genes whose expression limited immunocytes number broadly expressed genes mhc potential less specific roles immune system one example pbx2 also known g17 located approximately 250 kb telomeric hla dra88106 although functional data available pbx2 non mhc pbx gene implicated human leukemia presumably formation oncogenic fusion product via chromosome 119 translocation107 experiments suggest pbx genes modify specificity clustered homeobox genes forming heterodimers directly bind dna clustered homeobox genes expressed different patterns various stages lineages hematopoietic system may modulate expansion various hematopoietic precursors108
0.09784351.9373235.html.plaintext.txt	53	view concentration immune related genes appears unlikely clustering immune functions within mhc coincidence partly discussed suggestion may regional subspecialization immune functions within mhc beyond simply explained local gene duplication description strikingly apt well studied antigen presentation functions proximal mhc could also apply cluster complement components cluster inflammation stress response genes
0.09784351.9373235.html.plaintext.txt	54	view concentration immune related genes appears unlikely clustering immune functions within mhc coincidence partly discussed suggestion may regional subspecialization immune functions within mhc beyond simply explained local gene duplication description strikingly apt well studied antigen presentation functions proximal mhc could also apply cluster complement components cluster inflammation stress response genes
0.09784351.9373235.html.plaintext.txt	55	large fraction immune system related genes mhc ifn responsive although proposals concerning reasons clustering quite speculative question arises whether clustering may promoted long range gene control perhaps level chromatin organization dna looping
0.09784351.9373235.html.plaintext.txt	56	large fraction immune system related genes mhc ifn responsive although proposals concerning reasons clustering quite speculative question arises whether clustering may promoted long range gene control perhaps level chromatin organization dna looping
0.09784351.9373235.html.plaintext.txt	57	alternative proposal cause clustering diverse genes immune system particular allelic forms one locus create proteins interact preferentially products one another allelic form second locus109 two alleles would therefore preferentially co inherited hypothesis simplest form difficulty evidence protein protein interactions products several relevant immune system genes
0.09784351.9373235.html.plaintext.txt	58	alternative proposal cause clustering diverse genes immune system particular allelic forms one locus create proteins interact preferentially products one another allelic form second locus109 two alleles would therefore preferentially co inherited hypothesis simplest form difficulty evidence protein protein interactions products several relevant immune system genes
0.09784351.9373235.html.plaintext.txt	59	consideration population genetics mhc suggests alternative explanation clustering genes class ii alleles general show high rate accumulation various forms mutation least peptide binding regions45 extensively discussed others class i3741 class ii alleles also subject gene conversion like events110 112 well recombination point mutations high degree polymorphism believed driven selection particular alleles response rapidly evolving parasites kinship recognition see certain allelic variants influence predisposition toward various diseases including common autoimmune disorders possible particular haplotype expanded population genes alleles act either protect environmental stress modifiers potential adverse effects particular class class ii alleles also selected example inconceivable class ii allele associated early onset severe autoimmune disease might become associated alleles linked genes protective effect particular autoimmune disorder consequences could even include paradoxical effect alleles protective development disease would found higher incidence affected individuals controls
0.09784351.9373235.html.plaintext.txt	60	consideration population genetics mhc suggests alternative explanation clustering genes class ii alleles general show high rate accumulation various forms mutation least peptide binding regions45 extensively discussed others class i3741 class ii alleles also subject gene conversion like events110 112 well recombination point mutations high degree polymorphism believed driven selection particular alleles response rapidly evolving parasites kinship recognition see certain allelic variants influence predisposition toward various diseases including common autoimmune disorders possible particular haplotype expanded population genes alleles act either protect environmental stress modifiers potential adverse effects particular class class ii alleles also selected example inconceivable class ii allele associated early onset severe autoimmune disease might become associated alleles linked genes protective effect particular autoimmune disorder consequences could even include paradoxical effect alleles protective development disease would found higher incidence affected individuals controls
0.09784351.9373235.html.plaintext.txt	61	mating preferences mhc large number alleles peptide binding regions classical mhc surface antigen genes commonly attributed selection immune resistance parasites1 however kin recognition43 potential effects mating preferences relative fertility frequency abortions could also favor high level heterozygosity expansion rare alleles odorant determining genes mhc peptide binding regions class class ii antigens mechanism odorant determining molecules effects could contribute selection diversity regions regard portions olfactory receptor genes show relatively high level nonsynonymous substitutions compared synonymous nucleotide substitutions113114 reminiscent similar phenomenon coding regions peptide binding segments mhc class class ii genes ig related genes115 flowering plant self incompatibility loci116117
0.09784351.9373235.html.plaintext.txt	62	shortly distal hla f gene human mhc contains group genes encode 7 transmembrane segment receptors olfactory receptor family104 fig 1 role receptors olfaction specific expression olfactory receptor epithelium yet directly shown although similarity genes receptors known expressed olfactory tissue makes plausible suggestion physiologically genes curiosity reports urine odorants determine several types reproductive behavior including fetal retention mating type preference mouse differences odor determined genes linked mhc
0.09784351.9373235.html.plaintext.txt	63	shortly distal hla f gene human mhc contains group genes encode 7 transmembrane segment receptors olfactory receptor family104 fig 1 role receptors olfaction specific expression olfactory receptor epithelium yet directly shown although similarity genes receptors known expressed olfactory tissue makes plausible suggestion physiologically genes curiosity reports urine odorants determine several types reproductive behavior including fetal retention mating type preference mouse differences odor determined genes linked mhc
0.09784351.9373235.html.plaintext.txt	64	studies mice congenic except mhc suggest 50 total difference odorant stimulus strains mice may caused genes mhc mice distinguish odor urine two strains differ mutation single class gene118 humans also distinguish urine odors mice different mhc haplotypes119 cross breeding studies mice suggest preference mice certain mhc determined odors may learned rather genetically irreversibly determined120 yet known mouse mhc also olfactory receptor genes claimed humans evidence preference particular mhc determined variations sweat odors121 preference may change hormonal status individual however clear data literature showing mhc determined mating type preference humans122 caution raised precise interpretation mouse experiments123 also curious subset olfactory receptor like genes expressed sperm number species124 occurrence olfactory receptors within mhc may favor selection certain receptor alleles matched subset mhc determined odorants haplotypes carry certain matched alleles would selective advantage population
0.09784351.9373235.html.plaintext.txt	65	studies mice congenic except mhc suggest 50 total difference odorant stimulus strains mice may caused genes mhc mice distinguish odor urine two strains differ mutation single class gene118 humans also distinguish urine odors mice different mhc haplotypes119 cross breeding studies mice suggest preference mice certain mhc determined odors may learned rather genetically irreversibly determined120 yet known mouse mhc also olfactory receptor genes claimed humans evidence preference particular mhc determined variations sweat odors121 preference may change hormonal status individual however clear data literature showing mhc determined mating type preference humans122 caution raised precise interpretation mouse experiments123 also curious subset olfactory receptor like genes expressed sperm number species124 occurrence olfactory receptors within mhc may favor selection certain receptor alleles matched subset mhc determined odorants haplotypes carry certain matched alleles would selective advantage population
0.09784351.9373235.html.plaintext.txt	66	odorant discrimination learned could implications population genetics mhc species odorant attraction repulsion important depending manner psychological imprinting social population structure species imaginable learned haplotype discrimination could stronger driving force heterozygosity genetically determined haplotype discrimination could individual might learn discriminate self haplotypes also haplotypes present early environment also diversification mhc alleles result selection kin recognition evolving parasites mutually exclusive mechanisms
0.09784351.9373235.html.plaintext.txt	67	odorant discrimination learned could implications population genetics mhc species odorant attraction repulsion important depending manner psychological imprinting social population structure species imaginable learned haplotype discrimination could stronger driving force heterozygosity genetically determined haplotype discrimination could individual might learn discriminate self haplotypes also haplotypes present early environment also diversification mhc alleles result selection kin recognition evolving parasites mutually exclusive mechanisms
0.09784351.9373235.html.plaintext.txt	68	infertility fetal loss recurrent spontaneous abortions infertility reported associated sharing hla antigens husband wife although also number negative studies125 128 subject somewhat controversial studies difficult outbred nature human population polymorphism mhc particular possible synergistic additive effect one locus within mhc would difficult detect populations recent investigators suggested different regions mhc may affect different aspects fertility125 including suggestion homozygosity dr may affect fertilization implantation homozygosity hla b may affect fetal loss128
0.09784351.9373235.html.plaintext.txt	69	scarcity homozygotes higher expected ratio heterozygosity homozygosity mhc loci seen several different populations129 131 suggested consequence loss mhc homozygotes due increased susceptibility infections alternatively may due undefined disadvantage pregnancy accruing fetuses histocompatible mother however reduction homozygotic individuals seen even developed countries127128 current generation would expected show significant reduction homozygotes due fetal wastage postnatal morbidity due infection
0.09784351.9373235.html.plaintext.txt	70	studies reduced reproductive effectiveness couples sharing hla alleles studies homozygosity single mhc loci would fully reflect effects might seen comparisons made entire haplotypes studies south dakota hutterite population valuable regard individuals reproductively isolated group derived relatively small number individuals north european origin apparently fewer 70 founders132 also traditionally large families group reduction number individuals sharing mhc haplotypes one third statistically expected level quite remarkable127132 suggests diversity mhc haplotypes may favored reasons parasite resistance perhaps mechanism avoiding inbred populations
0.09784351.9373235.html.plaintext.txt	71	studies reduced reproductive effectiveness couples sharing hla alleles studies homozygosity single mhc loci would fully reflect effects might seen comparisons made entire haplotypes studies south dakota hutterite population valuable regard individuals reproductively isolated group derived relatively small number individuals north european origin apparently fewer 70 founders132 also traditionally large families group reduction number individuals sharing mhc haplotypes one third statistically expected level quite remarkable127132 suggests diversity mhc haplotypes may favored reasons parasite resistance perhaps mechanism avoiding inbred populations
0.09784351.9373235.html.plaintext.txt	72	studies limited population amerindians suggests production viable offspring discriminates mhc homozygosity rather concordance maternal fetal haplotypes133 one studies parents sharing mhc haplotype produced excess offspring heterozygous haploidentical mother less expected number mhc homozygous offspring could occur zygotes homozygous mhc region markedly less viable example recessive lethal alleles mhc effect would extend across number haplotypes requiring unlikely occurrence mutually complementing sets recessive lethals haplotype133 view absence comments contrary individuals born homozygous mhc haplotypes apparently show congenital abnormalities suggest developmental difficulties addition hedrick134 presented quantitative arguments likelihood recessive lethal alleles explaining population deficits mhc homozygotes
0.09784351.9373235.html.plaintext.txt	73	studies limited population amerindians suggests production viable offspring discriminates mhc homozygosity rather concordance maternal fetal haplotypes133 one studies parents sharing mhc haplotype produced excess offspring heterozygous haploidentical mother less expected number mhc homozygous offspring could occur zygotes homozygous mhc region markedly less viable example recessive lethal alleles mhc effect would extend across number haplotypes requiring unlikely occurrence mutually complementing sets recessive lethals haplotype133 view absence comments contrary individuals born homozygous mhc haplotypes apparently show congenital abnormalities suggest developmental difficulties addition hedrick134 presented quantitative arguments likelihood recessive lethal alleles explaining population deficits mhc homozygotes
0.09784351.9373235.html.plaintext.txt	74	preferential occurrence heterozygosity would compatible principle kin recognition effects avoid breeding could operative level mating type preference preferential fertilization ovum sperm different mhc haplotype decreased survival zygote embryo consequence homozygosity mhc loci speculative explanation consistent hutterite amerindian data might selective failure fertilization ova haplotype identical sperm presumably would occur consequence gamete marking accomplished postmeiosis gene expression
0.09784351.9373235.html.plaintext.txt	75	preferential occurrence heterozygosity would compatible principle kin recognition effects avoid breeding could operative level mating type preference preferential fertilization ovum sperm different mhc haplotype decreased survival zygote embryo consequence homozygosity mhc loci speculative explanation consistent hutterite amerindian data might selective failure fertilization ova haplotype identical sperm presumably would occur consequence gamete marking accomplished postmeiosis gene expression
0.09784351.9373235.html.plaintext.txt	76	immune attack fetal cells could consistent mechanisms self recognition used nk cells killing nk cells inhibited presence complete set self class antigens therefore homozygous fetal cells would susceptible killing incomplete set maternal self antigens however fetuses histocompatible mother well cell killing would also inhibited recognition foreign antigens fetal cells presumably recognition would mediated cell receptor
0.09784351.9373235.html.plaintext.txt	77	immune attack fetal cells could consistent mechanisms self recognition used nk cells killing nk cells inhibited presence complete set self class antigens therefore homozygous fetal cells would susceptible killing incomplete set maternal self antigens however fetuses histocompatible mother well cell killing would also inhibited recognition foreign antigens fetal cells presumably recognition would mediated cell receptor
0.09784351.9373235.html.plaintext.txt	78	hemochromatosis gene example recombination suppression
0.09784351.9373235.html.plaintext.txt	79	hereditary hemochromatosis recognized 20 years ago recessive disorder linked mhc class region reviewed chu et al135 prevalence rate 3 51000 whites hemochromatosis counted among common autosomal recessive diseases underlying pathophysiology unknown von recklinghausen172 others century ago originally described triad diabetes hepatomegaly skin hyperpigmentation although know clinical manifestations caused iron overload resulting malregulated dietary iron absorption precise molecular pathway remains unknown recent identification hla like gene mutation frequently associated disease136 well observation 2 microglobulin deficient mice develop similar iron overload syndrome137 suggests immune system functionally linked iron metabolism
0.09784351.9373235.html.plaintext.txt	80	hereditary hemochromatosis recognized 20 years ago recessive disorder linked mhc class region reviewed chu et al135 prevalence rate 3 51000 whites hemochromatosis counted among common autosomal recessive diseases underlying pathophysiology unknown von recklinghausen172 others century ago originally described triad diabetes hepatomegaly skin hyperpigmentation although know clinical manifestations caused iron overload resulting malregulated dietary iron absorption precise molecular pathway remains unknown recent identification hla like gene mutation frequently associated disease136 well observation 2 microglobulin deficient mice develop similar iron overload syndrome137 suggests immune system functionally linked iron metabolism
0.09784351.9373235.html.plaintext.txt	81	early genetic mapping studies reproducibly independently showed genetic localization hemochromatosis gene vicinity distal mhc studies within pedigrees linkage showed phenotype segregated hla gene138139 studies large populations linkage disequilibrium showed strong association hla a3 allele140 143 additional studies showed hla a3 single marker extended haplotype spans distance hla b beyond hla a144 almost always associated phenotype mapping studies mendelian traits diastrophic dysplasia linkage disequilibrium studies able pinpoint gene location less 60 kb145 surprising given linkage disequilibrium hla a3 feder et al136 found hemochromatosis gene hfe candidate mutation 4 megabases mb telomeric hla considerable distance view genetic data
0.09784351.9373235.html.plaintext.txt	82	early genetic mapping studies reproducibly independently showed genetic localization hemochromatosis gene vicinity distal mhc studies within pedigrees linkage showed phenotype segregated hla gene138139 studies large populations linkage disequilibrium showed strong association hla a3 allele140 143 additional studies showed hla a3 single marker extended haplotype spans distance hla b beyond hla a144 almost always associated phenotype mapping studies mendelian traits diastrophic dysplasia linkage disequilibrium studies able pinpoint gene location less 60 kb145 surprising given linkage disequilibrium hla a3 feder et al136 found hemochromatosis gene hfe candidate mutation 4 megabases mb telomeric hla considerable distance view genetic data
0.09784351.9373235.html.plaintext.txt	83	hfe gene shares approximately 58 homology hla a2 amino acid level less 45 similarity nucleotide level retains many structural hallmarks mhc class molecules signal sequence 1 2 domains peptide binding ig like 3 domain transmembrane region cytoplasmic region single mutation described cys282tyr disrupts disulfide bridge 3 domain class genes posited associate 2 microglobulin eighty three percent unrelated american patients found homozygous mutation feder report carrier frequency 64 normal controls presumably cys282tyr mutation interferes association hfe 2 microglobulin class molecules shown important intracellular transport protein endoplasmic reticulum cell surface involvement class gene iron transport supported studies showing iron overload mice homozygous knockout 2 microglobulin137 however mechanistic connection intestinal iron absorption known function class genes obscure although extensively searched autoimmunity part pathophysiology hemochromatosis
0.09784351.9373235.html.plaintext.txt	84	hfe gene shares approximately 58 homology hla a2 amino acid level less 45 similarity nucleotide level retains many structural hallmarks mhc class molecules signal sequence 1 2 domains peptide binding ig like 3 domain transmembrane region cytoplasmic region single mutation described cys282tyr disrupts disulfide bridge 3 domain class genes posited associate 2 microglobulin eighty three percent unrelated american patients found homozygous mutation feder report carrier frequency 64 normal controls presumably cys282tyr mutation interferes association hfe 2 microglobulin class molecules shown important intracellular transport protein endoplasmic reticulum cell surface involvement class gene iron transport supported studies showing iron overload mice homozygous knockout 2 microglobulin137 however mechanistic connection intestinal iron absorption known function class genes obscure although extensively searched autoimmunity part pathophysiology hemochromatosis
0.09784351.9373235.html.plaintext.txt	85	northern blot analysis shows hfe 4 kb mrna weakly expressed many tissues published cdna smaller mrna 27 kb presumably missing 13 kb 5 untranslated region cys282tyr mutation single described mutation consistently associated disease bearing chromosomes second much less common mutation described well appear increase risk disease presumably mutations hfe yet discovered analysis region far proven elusive
0.09784351.9373235.html.plaintext.txt	86	northern blot analysis shows hfe 4 kb mrna weakly expressed many tissues published cdna smaller mrna 27 kb presumably missing 13 kb 5 untranslated region cys282tyr mutation single described mutation consistently associated disease bearing chromosomes second much less common mutation described well appear increase risk disease presumably mutations hfe yet discovered analysis region far proven elusive
0.09784351.9373235.html.plaintext.txt	87	interestingly feder et al find linkage disequilibrium 6p213 markers hemochromatosis chromosomes lacking cys282tyr mutation lack linkage disequilibrium interpreted evidence additional nonlinked locus causing hemochromatosis phenotype follow studies australia jazwinska et al146 recently reported severest phenotype found patients ancestral haplotype spanning region hla b beyond hla f fig 1 patients homozygous cys282tyr mutation suggested second modifier gene close hfe varied haplotype contrast feder et al found united states hemochromatosis phenotypes associated homozygote cys282tyr heterozygote cys282tyr homozygote non cys282tyr mutations could differentiated clinical grounds although association cys282tyr mutation hemochromatosis compelling argument causation explanation non cys282tyr patients lacking possible cases non cys282tyr hemochromatosis caused alternative mutations hfe however proof awaits cloning remaining 17 kb hfe cdna identification alternative mutations curiously new syndrome liver iron overload normal transferrin saturation recently described pippard147 moirand et al148 discovery adds weight speculation feder et al mutations genes may cause clinical picture indistinguishable hemochromatosis
0.09784351.9373235.html.plaintext.txt	88	interestingly feder et al find linkage disequilibrium 6p213 markers hemochromatosis chromosomes lacking cys282tyr mutation lack linkage disequilibrium interpreted evidence additional nonlinked locus causing hemochromatosis phenotype follow studies australia jazwinska et al146 recently reported severest phenotype found patients ancestral haplotype spanning region hla b beyond hla f fig 1 patients homozygous cys282tyr mutation suggested second modifier gene close hfe varied haplotype contrast feder et al found united states hemochromatosis phenotypes associated homozygote cys282tyr heterozygote cys282tyr homozygote non cys282tyr mutations could differentiated clinical grounds although association cys282tyr mutation hemochromatosis compelling argument causation explanation non cys282tyr patients lacking possible cases non cys282tyr hemochromatosis caused alternative mutations hfe however proof awaits cloning remaining 17 kb hfe cdna identification alternative mutations curiously new syndrome liver iron overload normal transferrin saturation recently described pippard147 moirand et al148 discovery adds weight speculation feder et al mutations genes may cause clinical picture indistinguishable hemochromatosis
0.09784351.9373235.html.plaintext.txt	89	hemochromatosis phenotype cys282tyr mutation common mhc haplotype a3b7 widespread distribution among white populations including great britain france italy germany sweden norway australia united states135 high prevalence distribution strongly suggest mutation arose ancestral chromosome ancient event perhaps celtic scandinavian population based estimated incidence hemochromatosis high carrier frequency frequency cys282tyr mutation estimated cys282tyr mutation may present least 50 100 million individuals given plausible value coefficient selection mutation must occurred much 100 generations ago
0.09784351.9373235.html.plaintext.txt	90	hemochromatosis phenotype cys282tyr mutation common mhc haplotype a3b7 widespread distribution among white populations including great britain france italy germany sweden norway australia united states135 high prevalence distribution strongly suggest mutation arose ancestral chromosome ancient event perhaps celtic scandinavian population based estimated incidence hemochromatosis high carrier frequency frequency cys282tyr mutation estimated cys282tyr mutation may present least 50 100 million individuals given plausible value coefficient selection mutation must occurred much 100 generations ago
0.09784351.9373235.html.plaintext.txt	91	physical distance hla hemochromatosis gene 4 megabases rate recombination region comparable average rate genome one would expect 4 meioses would result separation hla hfe markers recombination frequency linkage disequilibrium dissipated relatively short period time yet possible explanations preservation linkage disequilibrium 4 mb region include multiple identical hfe mutations haplotypic background recent origin hfe mutation recombination suppression perhaps simultaneous selection hla alleles hla a3 hemochromatosis mutation first two explanations less likely possibility identical hfe mutation could occur multiple times haplotypic background suggests might inherently unstable sequence hfe gene trinucleotide repeat known expand successive generations cpg dinucleotide case hfe mutation associated common haplotype a3b7 g transition nucleotide 845 open reading frame causes cys282tyr missense mutation furthermore work others shown mutation stable families yet examples spontaneous mutations type reported
0.09784351.9373235.html.plaintext.txt	92	physical distance hla hemochromatosis gene 4 megabases rate recombination region comparable average rate genome one would expect 4 meioses would result separation hla hfe markers recombination frequency linkage disequilibrium dissipated relatively short period time yet possible explanations preservation linkage disequilibrium 4 mb region include multiple identical hfe mutations haplotypic background recent origin hfe mutation recombination suppression perhaps simultaneous selection hla alleles hla a3 hemochromatosis mutation first two explanations less likely possibility identical hfe mutation could occur multiple times haplotypic background suggests might inherently unstable sequence hfe gene trinucleotide repeat known expand successive generations cpg dinucleotide case hfe mutation associated common haplotype a3b7 g transition nucleotide 845 open reading frame causes cys282tyr missense mutation furthermore work others shown mutation stable families yet examples spontaneous mutations type reported
0.09784351.9373235.html.plaintext.txt	93	simultaneous selection alleles multiple loci recombination suppression difficult explanations dismiss possible certain genetic advantage offered combination alleles genes distributed region including hla genes even perhaps extending hfe gene however simultaneous coselection alleles ends region responsible maintenance linkage disequilibrium intervening alleles might consistently retained haplotype observed among hemochromatosis chromosomes genes found distal region might interact proximal hla genes thereby promote selection
0.09784351.9373235.html.plaintext.txt	94	simultaneous selection alleles multiple loci recombination suppression difficult explanations dismiss possible certain genetic advantage offered combination alleles genes distributed region including hla genes even perhaps extending hfe gene however simultaneous coselection alleles ends region responsible maintenance linkage disequilibrium intervening alleles might consistently retained haplotype observed among hemochromatosis chromosomes genes found distal region might interact proximal hla genes thereby promote selection
0.09784351.9373235.html.plaintext.txt	95	linkage disequilibrium portions mhc particularly region hla hla b suggest either recombination suppression coselection alleles several loci may operative combinations alleles130 a1b8 haplotype long renowned high disequilibrium149 occurs 7 french families illustrating high association alleles two loci may exhibit investigators studying interpreted data suggestive selection although distinction made coselection operating several loci recombination suppression region contrast a2 show linkage disequilibrium hla b alleles suggesting selection phenomenon low recombination rate apply possible haplotypes studies syntenic region mouse suggest significant recombination suppression haplotype specific150
0.09784351.9373235.html.plaintext.txt	96	linkage disequilibrium portions mhc particularly region hla hla b suggest either recombination suppression coselection alleles several loci may operative combinations alleles130 a1b8 haplotype long renowned high disequilibrium149 occurs 7 french families illustrating high association alleles two loci may exhibit investigators studying interpreted data suggestive selection although distinction made coselection operating several loci recombination suppression region contrast a2 show linkage disequilibrium hla b alleles suggesting selection phenomenon low recombination rate apply possible haplotypes studies syntenic region mouse suggest significant recombination suppression haplotype specific150
0.09784351.9373235.html.plaintext.txt	97	linkage data distal hla somewhat limited genethon sex averaged linkage map151 shows recombinants 186 meioses derived eight ceph families studied markers adjacent interspersed hla hfe major hemochromatosis mutation strong linkage disequilibrium markers near hla a3b7 hemochromatosis haplotype comprises 40 hemochromatosis bearing chromosomes141 compared genome wide averages recombination region hemochromatosis mutation bearing chromosomes suppressed common extended haplotype described normal european control populations associated a1b8 extends least 4 mb hla b recombination suppression coselection favorable alleles plausible explanations persistence linkage disequilibrium haplotypes three independent histone clusters mapping region136 fig 1 unpublished data july 1996 may also relevant recombination suppression
0.09784351.9373235.html.plaintext.txt	98	linkage data distal hla somewhat limited genethon sex averaged linkage map151 shows recombinants 186 meioses derived eight ceph families studied markers adjacent interspersed hla hfe major hemochromatosis mutation strong linkage disequilibrium markers near hla a3b7 hemochromatosis haplotype comprises 40 hemochromatosis bearing chromosomes141 compared genome wide averages recombination region hemochromatosis mutation bearing chromosomes suppressed common extended haplotype described normal european control populations associated a1b8 extends least 4 mb hla b recombination suppression coselection favorable alleles plausible explanations persistence linkage disequilibrium haplotypes three independent histone clusters mapping region136 fig 1 unpublished data july 1996 may also relevant recombination suppression
0.09784351.9373235.html.plaintext.txt	99	haplotype specific heterogeneity rate recombination tempting consider may modulated haplotype specific local sequences preferred sites recombination identified class ii class iii regions mouse150 human genome152 seem general feature throughout mhc153 cases rate recombination within relatively short region less 2000 bases may elevated several orders magnitude average rate genome whole therefore mhc recombinants obtained laboratory crosses particular pair strains may occur within hotspot150 hotspot thought resolution point joint molecules two dna duplexes become separated phenomenon complex particular hot spot operative certain haplotypes genetic backgrounds may sex specific150 recombination may152 may require perfect homology across hotspot154 differences hotspot activity may due variation number copies relatively simple repetitive sequences present tandem arrays recombination site155 recombination occurs number copies least one set repeats chromosomes activity hotspot seems require instigator sequences present haplotypes located distance region recombination actually occurs150
0.09784351.9373235.html.plaintext.txt	100	haplotype specific heterogeneity rate recombination tempting consider may modulated haplotype specific local sequences preferred sites recombination identified class ii class iii regions mouse150 human genome152 seem general feature throughout mhc153 cases rate recombination within relatively short region less 2000 bases may elevated several orders magnitude average rate genome whole therefore mhc recombinants obtained laboratory crosses particular pair strains may occur within hotspot150 hotspot thought resolution point joint molecules two dna duplexes become separated phenomenon complex particular hot spot operative certain haplotypes genetic backgrounds may sex specific150 recombination may152 may require perfect homology across hotspot154 differences hotspot activity may due variation number copies relatively simple repetitive sequences present tandem arrays recombination site155 recombination occurs number copies least one set repeats chromosomes activity hotspot seems require instigator sequences present haplotypes located distance region recombination actually occurs150
0.09784351.9373235.html.plaintext.txt	101	recent work yeast mating type loci also shown chromosomal regions may exhibit regulated activation recombination regulation may involve short regions cis active dna sequence together trans acting proteins area recombination activated may several orders magnitude larger cis active dna sequences interact relevant proteins particular 700 bp sequence identified activates recombination along 90000 bp region yeast chromosome156 occurs cells one two mating types perhaps consequence expression mating type specific dna binding protein region recombination actually occurs 17000 bases removed 700 bp instigator sequence phenomenologically similar deduced mhc detailed mechanisms cases remain worked
0.09784351.9373235.html.plaintext.txt	102	recent work yeast mating type loci also shown chromosomal regions may exhibit regulated activation recombination regulation may involve short regions cis active dna sequence together trans acting proteins area recombination activated may several orders magnitude larger cis active dna sequences interact relevant proteins particular 700 bp sequence identified activates recombination along 90000 bp region yeast chromosome156 occurs cells one two mating types perhaps consequence expression mating type specific dna binding protein region recombination actually occurs 17000 bases removed 700 bp instigator sequence phenomenologically similar deduced mhc detailed mechanisms cases remain worked
0.09784351.9373235.html.plaintext.txt	103	class ii class iii regions human mouse roughly colinear good correspondence presence linear order specific genes two species persuasive evidence exists chromosomes 1q22 23 9q343 contain multigene segments dna paralogous class ii iii perhaps iv regions mhc chromosome 6157 example gene one three members rxr steroid receptor family located centromeric class ii region chromosome 6 chromosomes 1 9 presumably paralogous positions similar situation occurs respect pbx genes notch homologue genes several homologues shared least two three chromosomal regions chromosome 1 duplication particularly striking falls region class like cd1 genes lie also otf3 maps mhc hla e otf2 maps unknown site chromosome 1 recently new class gene called mr1 identified long arm chromosome 1158 although reported location somewhat telomeric remainder mhc like genes referred yet known whether mr1 polymorphic expressed protein level unfortunately regions chromosomes 1 9 mapped sufficient resolution see closely organization paralogous regions match either present mhc plausible model precursor mhc among things observations raise interesting possibility additional immune system genes located paralogous regions chromosomes 1 9 perhaps 19 class like zinc 2 glycoprotein gene located
0.09784351.9373235.html.plaintext.txt	104	class ii class iii regions human mouse roughly colinear good correspondence presence linear order specific genes two species persuasive evidence exists chromosomes 1q22 23 9q343 contain multigene segments dna paralogous class ii iii perhaps iv regions mhc chromosome 6157 example gene one three members rxr steroid receptor family located centromeric class ii region chromosome 6 chromosomes 1 9 presumably paralogous positions similar situation occurs respect pbx genes notch homologue genes several homologues shared least two three chromosomal regions chromosome 1 duplication particularly striking falls region class like cd1 genes lie also otf3 maps mhc hla e otf2 maps unknown site chromosome 1 recently new class gene called mr1 identified long arm chromosome 1158 although reported location somewhat telomeric remainder mhc like genes referred yet known whether mr1 polymorphic expressed protein level unfortunately regions chromosomes 1 9 mapped sufficient resolution see closely organization paralogous regions match either present mhc plausible model precursor mhc among things observations raise interesting possibility additional immune system genes located paralogous regions chromosomes 1 9 perhaps 19 class like zinc 2 glycoprotein gene located
0.09784351.9373235.html.plaintext.txt	105	discussed class ii class genes show extensive allelic variability due point mutations intra locus recombinations intra locus gene conversion like events addition relationship class regions various mammals complex multiple cycles expansion contraction must occurred account genetic structure region inter intra species differences36159160 human mhc overall contains least 28 class related genes gene fragments including 18 19 analyzed geraghty et al161 5 mic genes pseudogenes84 least 2 class segments near mic b respectively class related sequence class ii region162 hemochromatosis gene hfe one genes confidently ortholog specific mouse gene reflection massive changes created cycles expansion contraction since divergence progenitors two mammals
0.09784351.9373235.html.plaintext.txt	106	discussed class ii class genes show extensive allelic variability due point mutations intra locus recombinations intra locus gene conversion like events addition relationship class regions various mammals complex multiple cycles expansion contraction must occurred account genetic structure region inter intra species differences36159160 human mhc overall contains least 28 class related genes gene fragments including 18 19 analyzed geraghty et al161 5 mic genes pseudogenes84 least 2 class segments near mic b respectively class related sequence class ii region162 hemochromatosis gene hfe one genes confidently ortholog specific mouse gene reflection massive changes created cycles expansion contraction since divergence progenitors two mammals
0.09784351.9373235.html.plaintext.txt	107	one striking feature divergence murine human class regions resulted presence functional subfamilies class genes species missing thus mouse contains family tl genes largely unknown function29 also h2 m genes interesting property binding specifically formyl methionine containing peptides occur amino terminus bacterial mitochondrial proteins163 types class genes detected probably completely missing humans conversely humans nonclassical class heavy chain genes including hla g gene164 expressed specific locations placental fetal cells165 may serve prevent nk cell rejection fetuses166 also early stages embryogenesis167 recently mouse class genes found may preferentially expressed early development quite unclear whether homologues either structure evolutionary relationship even function human hla g gene described humans also family five genes pseudogenes termed mic85 perb168 genes encode least one expressed product mic protein polymorphic induced heat shock expressed preferentially intestinal mucosa precise function yet known comparable products undetectable mouse
0.09784351.9373235.html.plaintext.txt	108	one striking feature divergence murine human class regions resulted presence functional subfamilies class genes species missing thus mouse contains family tl genes largely unknown function29 also h2 m genes interesting property binding specifically formyl methionine containing peptides occur amino terminus bacterial mitochondrial proteins163 types class genes detected probably completely missing humans conversely humans nonclassical class heavy chain genes including hla g gene164 expressed specific locations placental fetal cells165 may serve prevent nk cell rejection fetuses166 also early stages embryogenesis167 recently mouse class genes found may preferentially expressed early development quite unclear whether homologues either structure evolutionary relationship even function human hla g gene described humans also family five genes pseudogenes termed mic85 perb168 genes encode least one expressed product mic protein polymorphic induced heat shock expressed preferentially intestinal mucosa precise function yet known comparable products undetectable mouse
0.09784351.9373235.html.plaintext.txt	109	mic genes clearly structurally related class genes terms structure proteins encode position seven introns located homologous positions coding sequences structure mic genes differs class genes contain long 10 kb first intron intron contains first exon transcript derived complementary strand spliced form transcript one mic pseudogenes detected contains additional exons dna upstream mic transcription initiation site168 complex two interspersed genes pseudogenes occurs twice centromeric hla b three times hla e hla f distal mhc accounting least part observation repeated blocks sequence regions mhc
0.09784351.9373235.html.plaintext.txt	110	mic genes clearly structurally related class genes terms structure proteins encode position seven introns located homologous positions coding sequences structure mic genes differs class genes contain long 10 kb first intron intron contains first exon transcript derived complementary strand spliced form transcript one mic pseudogenes detected contains additional exons dna upstream mic transcription initiation site168 complex two interspersed genes pseudogenes occurs twice centromeric hla b three times hla e hla f distal mhc accounting least part observation repeated blocks sequence regions mhc
0.09784351.9373235.html.plaintext.txt	111	mouse mhc complex apparently lacks genes mic series human lacks extensive series tl genes mouse location genes b302 mog suggests either entire region human mhc hla hla f compressed less 150 kb mouse contains single h2m class gene169 inversion occurred one end point lying b302 mog evidence remarkably extensive rearrangements deletions expansions occurred vertebrate mhc class region
0.09784351.9373235.html.plaintext.txt	112	hemochromatosis gene containing region chromosome 6p located 4 mb telomeric hla f hemochromatosis region also appears originated large duplication involving histone genes136 perhaps ret finger like gene170 addition class gene exact duplication region defined yet apparently lacks olfactory receptor genes located nearest class gene proximal histone gene cluster
0.09784351.9373235.html.plaintext.txt	113	hemochromatosis gene containing region chromosome 6p located 4 mb telomeric hla f hemochromatosis region also appears originated large duplication involving histone genes136 perhaps ret finger like gene170 addition class gene exact duplication region defined yet apparently lacks olfactory receptor genes located nearest class gene proximal histone gene cluster
0.09784351.9373235.html.plaintext.txt	114	indicated paragraphs mhc exhibits several singular characteristics including clustering genes disparate structure function within immuno hematopoietic system evidence rapid evolution relative nonrepetitive sequence portions genome evidence variation rates intra mhc recombination speculate phenomena may related following way class class ii genes mhc particular appear subject selective pressures diversification operate short time scale relative evolutionary events environmental stresses may also put selective pressure alleles immune system genes addition resulting rapid shifts allele abundance composition class class ii genes whether due parasite driven selection effects mhc procreation may result emergence autoimmune phenomena putting secondary selective pressure genes immune system diminish incidence consequences autoimmunity also extreme divergence class regions mammals compared even class ii region raises question whether evolutionary pressures class genes beyond arising presentation peptides cell receptor
0.09784351.9373235.html.plaintext.txt	115	indicated paragraphs mhc exhibits several singular characteristics including clustering genes disparate structure function within immuno hematopoietic system evidence rapid evolution relative nonrepetitive sequence portions genome evidence variation rates intra mhc recombination speculate phenomena may related following way class class ii genes mhc particular appear subject selective pressures diversification operate short time scale relative evolutionary events environmental stresses may also put selective pressure alleles immune system genes addition resulting rapid shifts allele abundance composition class class ii genes whether due parasite driven selection effects mhc procreation may result emergence autoimmune phenomena putting secondary selective pressure genes immune system diminish incidence consequences autoimmunity also extreme divergence class regions mammals compared even class ii region raises question whether evolutionary pressures class genes beyond arising presentation peptides cell receptor
0.09784351.9373235.html.plaintext.txt	116	presence immune system genes chromosomal region therefore linkage disequilibrium classical mhc genes provides opportunity simultaneous selection optimal alleles genes among variety chromosomes carrying newly selected class ii allele diminishes rate disruption favored combinations alleles would result recombination reassortment chromosomes meiosis recombination rates mhcs would optimal low rate recombination sufficient generate favorable combinations alleles low enough limit genetic burden recombinant nonoptimal chromosomal segments171 however different mhc regions exhibit heterogeneous rates recombination controlled least part sequences within mhc permits recombination alleles generate among others favorable combinations chromosomal segments may relatively locked recombination suppression chromosomal segments would advantageous thus expanded generating extended haplotypes show linkage disequilibrium population considerations could apply occurrence olfactory receptor genes linked mhc class genes particular determinants odor reviewed might coselection receptors responsive nonresponsive class determined odors
0.09784351.9373235.html.plaintext.txt	117	presence immune system genes chromosomal region therefore linkage disequilibrium classical mhc genes provides opportunity simultaneous selection optimal alleles genes among variety chromosomes carrying newly selected class ii allele diminishes rate disruption favored combinations alleles would result recombination reassortment chromosomes meiosis recombination rates mhcs would optimal low rate recombination sufficient generate favorable combinations alleles low enough limit genetic burden recombinant nonoptimal chromosomal segments171 however different mhc regions exhibit heterogeneous rates recombination controlled least part sequences within mhc permits recombination alleles generate among others favorable combinations chromosomal segments may relatively locked recombination suppression chromosomal segments would advantageous thus expanded generating extended haplotypes show linkage disequilibrium population considerations could apply occurrence olfactory receptor genes linked mhc class genes particular determinants odor reviewed might coselection receptors responsive nonresponsive class determined odors
0.09784351.9373235.html.plaintext.txt	118	mhc long known play major role determination genetic susceptibility autoimmune disorders large part due polymorphisms class ii genes however least cases evidence strong non class ii genes mhc also play role predisposition autoimmunity identification additional genes region modify propensity autoimmune diseases could important diagnostic therapeutic implications recent years analyses mhc encoded transcripts shown within mhc 10 different structurally diverse families genes whose patterns expression indicate specific role immune system number different mhc genes functioning immune response extensive regions linkage disequilibrium seen instances mhc make particularly difficult use positional genetic approaches assign disease contributions particular gene products short understanding regulation function protein level effect amino acid nucleotide sequence variations could predicted perhaps best genetic approach look sense changes codons variation known promoter elements gene test large populations see correlation disease manifestations independent disequilibrium class ii genes could difficult number reasons least extensive degree linkage disequilibrium consequent occurrence extended haplotypes region
0.09784351.9373235.html.plaintext.txt	119	mhc long known play major role determination genetic susceptibility autoimmune disorders large part due polymorphisms class ii genes however least cases evidence strong non class ii genes mhc also play role predisposition autoimmunity identification additional genes region modify propensity autoimmune diseases could important diagnostic therapeutic implications recent years analyses mhc encoded transcripts shown within mhc 10 different structurally diverse families genes whose patterns expression indicate specific role immune system number different mhc genes functioning immune response extensive regions linkage disequilibrium seen instances mhc make particularly difficult use positional genetic approaches assign disease contributions particular gene products short understanding regulation function protein level effect amino acid nucleotide sequence variations could predicted perhaps best genetic approach look sense changes codons variation known promoter elements gene test large populations see correlation disease manifestations independent disequilibrium class ii genes could difficult number reasons least extensive degree linkage disequilibrium consequent occurrence extended haplotypes region
0.09784351.9373235.html.plaintext.txt	120	increasing amount genomic sequence data mhc emerging available directly sanger centre ftpftpsangeracukpubhumanchr6 tapasin transmembrane glycoprotein mediates calreticulin bound mhc class molecule interactions tap recently mapped close mhc173
0.09784351.9373235.html.plaintext.txt	121	submitted march 27 1997 accepted june 16 1997 jrg supported march dimes birth defects research foundation clinical research grant 6 fy96 0272 national institutes health nih grant r29 dk45819 05 smw supported nih outstanding investigator award ca42556 11 address reprint requests jeffrey r gruen md yale child health research center department pediatrics yale university school medicine 464 congress ave new haven ct 06520 8081 name given feder et al hla h nomenclature confusing previously dubbed hfe years ago anticipation discovery hla h already used designate mhc class gene several years earlier mapped hla hla g refer new gene simply hfe remainder review
0.09784351.9373235.html.plaintext.txt	122	authors thank drs frank black chris bowlus nancy ruddle judith kidd gordon shepherd ruma raha chowdhury helpful comments corrections manuscript also thank colleagues helpful discussions materials provided drs duncan campbell peter lengyel john trowsdale
0.09784351.9373235.html.plaintext.txt	123	authors thank drs frank black chris bowlus nancy ruddle judith kidd gordon shepherd ruma raha chowdhury helpful comments corrections manuscript also thank colleagues helpful discussions materials provided drs duncan campbell peter lengyel john trowsdale
0.09784351.9373235.html.plaintext.txt	124	references introduction references 1 parham p ohta population biology antigen presentation mhc class molecules science 27267 1996abstract 2 parimoo patanjali sr shukla h chaplin dd weissman sm cdna selection efficient pcr approach selection cdnas encoded large chromosomal dna fragments proc nat acad sci usa 889623 1991abstract 3 goei vl parimoo capossela chu tw gruen jr isolation novel non hla gene fragments hemochromatosis region 6p213 cdna hybridization selection j hum genet 54244 1994medline order article via infotrieve 4 pichon l giffon chauvel b carn g bouric p el kahloun legall jy david v physical map hla ahla f subregion identification two new coding sequences immunogenetics 43175 1996medline order article via infotrieve 5 campbell rd trowsdale j map human major histocompatibility complex immunol today 1843 1997 6 gruen jr nalabolu sr chu tw bowlus c fan wf goei vl wei h sivakamasundari r liu yc xu hx parimoo nallur g ajioka r shukla h bray ward p pan j weissman sm transcription map major histocompatibility complex mhc class region genomics 3670 1996medline order article via infotrieve 7 fan w cai w parimoo lennon gg weissman sm identification seven new human mhc class region genes around hla f locus immunogenetics 4497 1996medline order article via infotrieve 8 lepourcelet m andrieux n giffon j pichon l hampe galibert f mosser j systematic sequencing human hla ahla f region establishment cosmid contig identification new gene cluster within 37 kb sequence genomics 37316 1996medline order article via infotrieve 9 aguado b milner cm campbell rd genes mhc class iii region functions proteins encode browning m mcmichael eds hla mhc genes molecules function oxford uk bios scientific publishers 1996 p 39 10 klein j natural history major histocompatibility complex new york ny wiley 1986 11 trowsdale j molecular genetics hla class class ii regions browning m mcmichael eds hla mhc genes molecules function oxford uk bios scientific publishers 1996 p 22 12 cresswell p androlewicz mj ortmann b assembly transport class mhc peptide complexes ciba found symp 187150 1994medline order article via infotrieve 13 cresswell p antigen presentation getting peptides mhc class ii molecules curr biol 4541 1994medline order article via infotrieve 14 ceman rudersdorf ra petersen jm demars r dma dmb genes class ii region human mhc needed class ii associated antigen processing j immunol 1542545 1995abstractfree full text 15 nedospasov sa hirt b shakhov dobrynin vn kawashima e accolla rs jongeneel cv genes tumor necrosis factor tnf alpha lymphotoxin tnf beta tandemly arranged chromosome 17 mouse nucleic acids res 147713 1986abstract 16 muller u jongeneel cv nedospasov sa lindahl kf steinmetz m tumour necrosis factor lymphotoxin genes map close h 2d mouse major histocompatibility complex nature 325265 1987medline order article via infotrieve 17 gardner sm mock ba hilgers j huppi ke roeder wd mouse lymphotoxin tumor necrosis factor structural analysis cloned genes physical linkage chromosomal position j immunol 139476 1987abstractfree full text 18 browning jl ngam ek lawton p demarinis j tizard r chow ep hession c obrine greco b foley sf ware cf lymphotoxin beta novel member tnf family forms heteromeric complex lymphotoxin cell surface cell 72847 1993medline order article via infotrieve 19 campbell rd milner cm mhc genes autoimmunity curr opin immunol 5887 1993medline order article via infotrieve 20 corzo d salazar m granja cb yunis ej advances hla genetics exp clin immunogenet 12156 1995medline order article via infotrieve 21 tomlinson ip bodmer wf hla system analysis multifactorial genetic disease trends genet 11493 1995medline order article via infotrieve 22 tisch r mcdevitt h insulin dependent diabetes mellitus cell 85291 1996medline order article via infotrieve 23 thomson g hla disease associations models study complex human genetic disorders crit rev clin lab sci 32183 1995medline order article via infotrieve 24 cardon lr smith sd fulker dw kimberling wj pennington bf defries jc quantitative trait locus reading disability chromosome 6 science 266276 1994medline order article via infotrieve 25 grigorenko el wood fb meyer ms hart la speed wc shuster pauls dl susceptibility loci distinct components developmental dyslexia chromosomes 6 15 j hum genet 6027 1997medline order article via infotrieve 26 bodmer wf evolution function hla region cancer surv 225 1995medline order article via infotrieve 27 campbell rd trowsdale j map human mhc immunol today 14349 1993medline order article via infotrieve 28 cresswell p assembly transport function mhc class ii molecules ann rev immunol 12259 1994medline order article via infotrieve 29 flaherty l elliott e tine ja walsh ac waters jb immunogenetics q tl regions mouse crit rev immunol 10131 1990medline order article via infotrieve 30 girdlestone j transcriptional regulation mhc class genes eur j immunogenet 23395 1996medline order article via infotrieve 31 gunther e current status molecular genetic analysis rat major histocompatibility complex folia biologica 42129 1996medline order article via infotrieve 32 hughes al origin evolution hla class pseudogenes mol biol evol 12247 1995abstract 33 kasahara m kandil e saltercid l flajnik mf origin evolution class gene family mammalian class genes encoded outside major histocompatibility complex res immunol 147278 1996medline order article via infotrieve 34 kaufman j volk h wallny hj minimal essential mhc unrecognized mhc two extremes selection polymorphism immunol rev 14363 1995medline order article via infotrieve 35 kronenberg m brines r kaufman j mhc evolution long term investment defense immunol today 154 1994medline order article via infotrieve 36 le bouteiller p hla class chromosomal region genes products facts questions crit rev immunol 1489 1994medline order article via infotrieve 37 lienert k parham p evolution mhc class genes higher primates immunol cell biol 74349 1996medline order article via infotrieve 38 lunney jk current status swine leukocyte antigen complex vet immunol immunopathol 4319 1994medline order article via infotrieve 39 browning m mcmichael hla mhc genes molecules function oxford uk bios scientific publishers 1996 40 mcdevitt h evolution mhc class ii allelic diversity immunol rev 143113 1995medline order article via infotrieve 41 parham p rise fall great class genes semin immunol 6373 1994medline order article via infotrieve 42 peelman lj chardon p vaiman m mattheeuws m van zeveren van de weghe bouquet y campbell rd detailed physical map porcine major histocompatibility complex mhc class iii region comparison human mouse mhc class iii regions mammalian genome 7363 1996medline order article via infotrieve 43 potts wk wakeland ek evolution mhc genetic diversity tale incest pestilence sexual preference trends genet 9408 1993medline order article via infotrieve 44 teitell m cheroutre h panwala c holcombe h eghtesady p kronenberg m structure function h 2 tla region class mhc molecules crit rev immunol 141 27 1994medline order article via infotrieve 45 thomson g hla population genetics baillieres clin endocrinol metab 5247 1991medline order article via infotrieve 46 trowsdale j man bird beast comparative organization mhc genes immunogenetics 411 1995medline order article via infotrieve 47 van ostade x tavernier j fiers w structure activity studies human tumour necrosis factors protein eng 75 1994abstract 48 watkins di mhc nonhuman primates curr topics microbiol immunol 188145 1994medline order article via infotrieve 49 watkins di evolution major histocompatibility class genes primates crit rev immunol 151 1995medline order article via infotrieve 50 parham p adams ej arnett kl origins hla abc polymorphism immunol rev 143141 1995medline order article via infotrieve 51 acton rd dahlberg ps uknis klaerner hg fink gs norman jg dunn dl differential sensitivity escherichia coli infection mice lacking tumor necrosis factor p55 interleukin 1 p80 receptors arch surg 1311216 1996abstract 52 czarniecki cw role tumor necrosis factor viral disease antiviral res 22223 1993medline order article via infotrieve 53 jacob co lewis gd mcdevitt ho mhc class ii associated variation production tumor necrosis factor mice humans relevance pathogenesis autoimmune diseases immunol res 10156 1991medline order article via infotrieve 54 mcguire w hill av allsopp ce greenwood bm kwiatkowski d variation tnf alpha promoter region associated susceptibility cerebral malaria nature 371508 1994medline order article via infotrieve 55 louis e satsangi j roussomoustakaki m parkes m fanning g welsh k jewell d cytokine gene polymorphisms inflammatory bowel disease gut 39705 1996abstract 56 daser mitchison h mitchison muller b non classical mhc genetics immunological disease man mouse key role pro inflammatory cytokine genes cytokine 8593 1996medline order article via infotrieve 57 elliott mj feldmann m maini rn tnf alpha blockade rheumatoid arthritis rationale clinical outcomes mechanisms action int j immunopharmacol 17141 1995medline order article via infotrieve 58 mulcahy b waldron lynch f mcdermott mf adams c amos ci zhu dk ward rh clegg shanahan f molloy mg ogara f genetic variability tumor necrosis factor lymphotoxin region influences susceptibility rheumatoid arthritis j hum genet 59676 1996medline order article via infotrieve 59 verjans gm messer g weiss eh van der linden sm kijlstra polymorphism tumor necrosis factor region relation disease overview rheum dis clin n 18177 1992medline order article via infotrieve 60 matsumoto m mariathasan nahm mh baranyay f peschon jj chaplin dd role lymphotoxin type tnf receptor formation germinal centers science 2711289 1996abstract 61 matsumoto m lo sf carruthers cj min j mariathasan huang g plas dr martin sm geha rs nahm mh chaplin dd affinity maturation without germinal centres lymphotoxin alpha deficient mice nature 382462 1996medline order article via infotrieve 62 pasparakis m alexopoulou l episkopou v kollias g immune inflammatory responses tnf alpha deficient mice critical requirement tnf alpha formation primary b cell follicles follicular dendritic cell networks germinal centers maturation humoral immune response j exp med 184184 1996 63 neumann b luz pfeffer k holzmann b defective peyers patch organogenesis mice lacking 55 kd receptor tumor necrosis factor j exp med 184259 1996abstract 64 armitage rj tumor necrosis factor receptor superfamily members ligands curr opin immunol 6407 1994medline order article via infotrieve 65 mackay f majeau gr hochman ps browning jl lymphotoxin beta receptor triggering induces activation nuclear factor beta b transcription factor cell types j biol chem 27124934 1996abstractfree full text 66 holzinger de baey messer g kick g zwierzina h weiss eh cloning genomic characterization lst1 new gene human tnf region immunogenetics 42315 1995medline order article via infotrieve 67 tsuge shen fw steinmetz m boyse ea gene h 2sh 2d interval major histocompatibility complex transcribed b cells macrophages immunogenetics 26378 1987medline order article via infotrieve 68 nalabolu sr shukla h nallur g parimoo weissman sm genes 220 kb region spanning tnf cluster human mhc genomics 31215 1996medline order article via infotrieve 69 russell wallace af hancock ww sayegh mh adams dh sibinga ne wyner lr karnovsky mj upregulation cytokines associated macrophage activation lewis f344 rat transplantation model chronic cardiac rejection transplantation 59572 1995medline order article via infotrieve 70 utans u quist wc mcmanus bm wilson je arceci rj wallace af russell allograft inflammatory factory 1 cytokine responsive macrophage molecule expressed transplanted human hearts transplantation 611387 1996medline order article via infotrieve 71 utans u arceci rj yamashita y russell cloning characterization allograft inflammatory factor 1 novel macrophage factor identified rat cardiac allografts chronic rejection j clin invest 952954 1995medline order article via infotrieve 72 utans u liang p wyner lr karnovsky mj russell chronic cardiac rejection identification five upregulated genes transplanted hearts differential mrna display proc nat acad sci usa 916463 1994abstract 73 olavsen mg thomson w cheng j campbell rd characterization novel gene g1 class iii region human mha tsuji k aziawa m sasazuki eds proceedings 11th international histocompatibility workshop vol 2 oxford uk oxford press 1993 p 190 74 hessian pa edgeworth j hogg n mrp 8 mrp 14 two abundant ca2 binding proteins neutrophils monocytes j leukoc biol 53197 1993abstract 75 devery jm king nj geczy cl acute inflammatory activity s100 protein cp 10 activation neutrophils vivo vitro j immunol 1521888 1994abstractfree full text 76 albertella mr campbell rd characterization novel gene human major histocompatibility complex encodes potential new member kappa b family proteins hum molec genet 3793 1994abstract 77 dangel aw shen l mendoza ar wu lc yu cy human helicase gene ski2w hla class iii region exhibits striking structural similarities yeast antiviral gene ski2 human gene kiaa0052 emergence new gene family nucleic acids res 232120 1995abstract 78 albertella mr jones h thomson w olavesen mg campbell rd localization eight additional genes human major histocompatibility complex including gene encoding casein kinase ii beta subunit csnk2b genomics 36240 1996medline order article via infotrieve 79 lee sg lee park sh kang c song k identification characterization human cdna homologous yeast ski2 genomics 25660 1995medline order article via infotrieve 80 liang hitomi m hu yh liu y tartakoff dead box family protein required nucleocytoplasmic transport yeast mrna mol cell biol 165139 1996abstract 81 masison dc blanc ribas jc carroll k sonenberg n wickner rb decoying cap mrna degradation system double stranded rna virus polya mrna surveillance yeast antiviral system mol cell biol 152763 1995abstract 82 widner wr wickner rb evidence ski antiviral system saccharomyces cerevisiae acts blocking expression viral mrna mol cell biol 134331 1993abstract 83 johnson aw kolodner rd synthetic lethality sep1 xrn1 ski2 sep1 xrn1 ski3 mutants saccharomyces cerevisiae independent killer virus suggests general role genes translation control mol cell biol 152719 1995abstract 84 bahram spies mic gene family res immunol 147328 1996medline order article via infotrieve 85 bahram bresnahan m geraghty de spies second lineage mammalian major histocompatibility complex class genes proc nat acad sci usa 916259 1994abstract 86 groh v bahram bauer herman beauchamp m spies cell stress regulated human major histocompatibility complex class gene expressed gastrointestinal epithelium proc nat acad sci usa 9312445 1996abstractfree full text 87 peelman lj chardon p nunes m renard c geffrotin c vaiman m van zeveren coppieters w van de weghe bouquet y choy ww strominger jl spies bat1 gene mhc encodes evolutionarily conserved putative nuclear rna helicase dead family genomics 26210 1995medline order article via infotrieve 88 snoek m jansen m olavesen mg campbell rd teuscher c van vugt h three hsp70 genes located c4 h 2d region possible candidates orch 1 locus genomics 15350 1993medline order article via infotrieve 89 santoro mg heat shock proteins virus replication hsp70s mediators antiviral effects prostaglandins experientia 501039 1994medline order article via infotrieve 90 hochstrasser m protein degradation regulation ub judge cell 84813 1996medline order article via infotrieve 91 haas al ahrens p bright pm ankel h interferon induces 15 kilodalton protein exhibiting marked homology ubiquitin j biol chem 26211315 1987abstractfree full text 92 feltham n fahey d knight e jr growth inhibitory protein secreted human diploid fibroblasts partial purification characterization j biol chem 2622176 1987abstractfree full text 93 farrell pj broeze rj lengyel p accumulation mrna protein interferon treated ehrlich ascites tumour cells nature 279523 1979medline order article via infotrieve 94 korant bd blomstrom dc jonak gj knight e jr interferon induced proteins purification characterization 15000 dalton protein human bovine cells induced interferon j biol chem 25914835 1984abstractfree full text 95 dcunha j ramanujam wagner rj witt pl knight e borden ec vitro vivo secretion human isg15 ifn induced immunomodulatory cytokine j immunol 1574100 1996abstract 96 knight e jr fahey d cordova b hillman m kutny r reich n blomstrom d 15 kda interferon induced protein derived cooh terminal processing 17 kda precursor j biol chem 2634520 1988abstractfree full text 97 recht m borden ec knight e jr human 15 kda ifn induced protein induces secretion ifn gamma j immunol 1472617 1991abstractfree full text 98 dcunha j knight e jr haas al truitt rl borden ec immunoregulatory properties isg15 interferon induced cytokine proc nat acad sci usa 93211 1996abstractfree full text 99 nakamura m ogawa h tsunematsu characterization monoclonal nonspecific suppressor factor mnsf use monoclonal antibody j immunol 1381799 1987abstractfree full text 100 nakamura m xavier rm tanigawa y ubiquitin like moiety monoclonal nonspecific suppressor factor beta responsible activity j immunol 156532 1996abstract 101 vernet c boretto j mattei mg takahashi m jack lj mather ih rouquier pontarotti p evolutionary study multigenic families mapping close human mhc class region j mol evol 37600 1993medline order article via infotrieve 102 chu tw capossela coleman r goei vl nallur g gruen jr cloning new finger protein gene znf173 within class region human mhc genomics 29229 1995medline order article via infotrieve 103 pham dinh d mattei mg nussbaum jl roussel g pontarotti p roeckel n mather ih artzt k lindahl kf dautigny myelinoligodendrocyte glycoprotein member subset immunoglobulin superfamily encoded within major histocompatibility complex proc nat acad sci usa 907990 1993abstractfree full text 104 fan w liu yc parimoo weissman sm olfactory receptor like genes located human major histocompatibility complex genomics 27119 1995medline order article via infotrieve 105 janatipour m naumov y ando sugimura k okamoto n tsuji k abe k inoko h search mhc associated genes human five new genes centromeric hla dp yet unknown functions immunogenetics 35272 1992medline order article via infotrieve 106 aguado b campbell rd novel gene g17 located human major histocompatibility complex encodes pbx2 homeodomain containing protein genomics 25650 1995medline order article via infotrieve 107 kamps m look baltimore d human t1 19 translocation pre b produces multiple nuclear e2a pbx1 fusion proteins differing transforming potentials genes dev 5358 1991abstract 108 lawrence h sauvageau g humphries r largman c role hox homeobox genes normal leukemic hematopoiesis stem cells 14281 1996abstract 109 porter rr complement components coded major histocompatibility complexes biological activities immunol rev 877 1985medline order article via infotrieve 110 huang mm erlich ha goodman mf arnheim n analysis mutational changes hla locus single human sperm human mut 6303 1995 111 devlin jj weiss eh paulson m flavell ra duplicated gene pairs alleles class genes qa2 region murine major histocompatibility complex comparison embo j 43203 1985abstract 112 slightom jl blechl ae smithies o human fetal g gamma gamma globin genes complete nucleotide sequences suggest dna exchanged duplicated genes cell 21627 1980medline order article via infotrieve 113 hughes al hughes mk adaptive evolution rat olfactory receptor gene family j mol evol 36249 1993medline order article via infotrieve 114 singer ms weisingerlewin y lancet d shepherd gm positive selection moments identify potential functional residues human olfactory receptors recep channels 4141 1996medline order article via infotrieve 115 hughes al rapid evolution immunoglobulin superfamily c2 domains expressed immune system cells mol biol evol 141 1997abstract 116 richman ad uyenoyama mk kohn jr allelic diversity gene genealogy self incompatibility locus solanaceae science 2731212 1996abstract 117 clark ag kao th excess nonsynonymous substitution shared polymorphic sites among self incompatibility alleles solanaceae proc natl acad sci usa 889823 1991abstract 118 yamazaki k beauchamp gk shen fw bard j boyse ea distinctive change odortype determined h 2dl mutation immunogenetics 34129 1991medline order article via infotrieve 119 gilbert yamazaki k beauchamp gk thomas l olfactory discrimination mouse strains mus musculus major histocompatibility types humans homo sapiens j comp psychol 100262 1986medline order article via infotrieve 120 yamazaki k beauchamp gk kupniewski d bard j thomas l boyse ea familial imprinting determines h 2 selective mating preferences science 2401331 1988medline order article via infotrieve 121 wedekind c seebeck bettens f paepke aj mhc dependent mate preferences humans proc r soc london b biol sci 260245 1995medline order article via infotrieve 122 jin k speed tp thomson g tests random mating highly polymorphic locus application hla data biometrics 511064 1995medline order article via infotrieve 123 hughes al hughes mk natural selection peptide binding regions major histocompatibility complex molecules immunogenetics 42233 1995medline order article via infotrieve 124 vanderhaeghen p schurmans vassart g parmentier m specific repertoire olfactory receptor genes male germ cells several mammalian species genomics 39239 1997 125 jin k ho hn speed tp gill tr reproductive failure major histocompatibility complex j hum genet 561456 1995medline order article via infotrieve 126 hoshiai h ishikawa m noda k takahama k fukaya yajima influence hla antigens reproduction among japanese population study haplotypes 247 families berliner munchener tierarztliche wochenschrift 172139 1994 127 kostyu dd hla fertile territory developmental genes crit rev immunol 1429 1994medline order article via infotrieve 128 ober c current topic hla reproduction lessons studies hutterites placenta 16569 1995medline order article via infotrieve 129 degos l colombani j chaventre bengtson b jacquard selective pressure hl polymorphism nature 24962 1974medline order article via infotrieve 130 klitz w thomson g borot n chambon thomsen evolutionary population perspectives human hla complex evol biol 2635 1992 131 hedrick pw thomson g maternal fetal interactions maintenance hla polymorphism genetics 119205 1988abstractfree full text 132 dawson dv ober c kostyu dd extended hla profile inbred isolate schmiedeleut hutterites south dakota genet epidemiol 1247 1995medline order article via infotrieve 133 black fl mother child hla compatibility ratios children amerinidian parents share common haplotypes j hum genet 37133 1985medline order article via infotrieve 134 hedrick pw evolution hla possible explanations deficiency homozygotes two populations hum hered 40213 1990medline order article via infotrieve 135 chu tw bowlus cl gruen jr disorders iron metabolism related disorders rimoin dl connor jm pyeritz re emery aeh eds emery rimoins principles practice medical genetics ed 3 edinburgh uk churchill livingston 1997 p 2047 136 feder jn gnirke thomas w tsuchihashi z ruddy da basava dormishian f domingo r jr ellis mc fullan hinton lm jones nl kimmel kronmal gs lauer p lee vk loeb db mapa fa mcclelland e meyer nc mintier ga moeller n moore morikang e wolff rr prass ce quintana l starnes sm schatzman re brunke kj drayna dt risch nj bacon br wolff rk novel mhc class like gene mutated patients hereditary haemochromatosis nat genet 13399 1996medline order article via infotrieve 137 rothenberg voland jr beta2 knockout mice develop parenchymal iron overload putative role class genes major histocompatibility complex iron metabolism proc nat acad sci usa 931529 1996abstractfree full text 138 simon m alexandre jl fauchet r genetet b bourel m genetics hemochromatosis prog med genet 4135 1980medline order article via infotrieve 139 kravitz k skolnick m cannings c carmelli d baty b amos db johnsson mendell n edwards c cartwright g genetic linkage hereditary hemochromatosis hla j hum genet 31601 1979medline order article via infotrieve 140 jazwinska ec lee sc webb si halliday jw powell lw localization hemochromatosis gene close d6s105 j hum genet 53347 1993medline order article via infotrieve 141 raha chowdhury r bowen dj stone c pointon jj terwilliger jd shearman jd robson kjh bomford worwood m new polymorphic microsatellite markers place haemochromatosis gene telomeric d6s105 hum mol genet 41869 1995abstract 142 gandon g jouanolle chauvel b mauvieux v le treut feingold j le gall jy david v yaouanq j linkage disequilibrium extended haplotypes hla d6s105 region implications mapping hemochromatosis gene hfe hum genet 97103 1996medline order article via infotrieve 143 yaouanq j perichon m chorney m pontarotti p le treut el kahloun mauvieux v blayau m jouanolle chauvel b moirand r nouel o le gall jy feingold j david v anonymous marker loci within 400 kb hla generate haplotypes linkage disequilibrium hemochromatosis gene hfe j hum genet 54252 1994medline order article via infotrieve 144 raha chowdhury r bowen dj burnett ak worwood m allelic associations homozygosity loci hla b d6s299 genetic haemochromatosis j med genet 32446 1995abstract 145 hastbacka j de la chapelle kaitila sistonen p weaver lander e linkage disequilibrium mapping isolated founder populations diastrophic dysplasia finland nat genet 2204 1992medline order article via infotrieve 146 jazwinska ec cullen lm busfield f pyper wr webb si powell lw morris cp walsh tp haemochromatosis hla h nat genet 14249 1996medline order article via infotrieve 147 pippard mj detection iron overload lancet 34973 1997medline order article via infotrieve 148 moirand r mortaji loreal o paillard f brissot p deugnier y new syndrome liver iron overload normal transferrin saturation lancet 34995 1997medline order article via infotrieve 149 thomsen m neubegauer m arnaud j borot n sevooon baur m cambon thomsen m recombination fractions hla system based data set provinces francasises indications haplotype specific recombination rates eur j immunogenet 2133 1994medline order article via infotrieve 150 shiroishi koide yoshino m sagai moriwaki k hotspots homologous recombination mouse meiosis adv biophys 31119 1995medline order article via infotrieve 151 dib c faure fizames c samson d drouot n vignal millasseau p marc hazan j seboun e lathrop m gyapay g morissette j weissenbach j comprehensive genetic map human genome based 5264 microsatellites nature 380152 1996medline order article via infotrieve 152 cullen m erlich h klitz w carrington m molecular mapping recombination hotspot located second intron human tap2 locus j hum genet 561350 1995medline order article via infotrieve 153 yoshino m sagai lindahl kf toyoda y shirayoshi y matsumoto k sugaya k ikemura moriwaki k shiroishi recombination class iii region mouse major histocompatibility complex immunogenetics 40280 1994medline order article via infotrieve 154 yoshino m sagai moriwaki k shiroishi meiotic recombination lmp2 hotspot tolerates minor sequence divergence homologous chromosomes immunogenetics 4380 1996medline order article via infotrieve 155 yoshino m sagai lindahl kf toyoda y moriwaki k shiroishi allele dependent recombination frequency homology requirement meiotic recombination hot spot mouse major histocompatibility complex genomics 27298 1995medline order article via infotrieve 156 wu xh haber je 700 bp cis acting region controls mating type dependent recombination along entire left arm yeast chromosome iii cell 87277 1996medline order article via infotrieve 157 katsanis n fitzgibbon j fisher e paralogy mapping identification region human mhc triplicated onto human chromosomes 1 9 allows prediction isolation novel pbx notch loci genomics 35101 1996medline order article via infotrieve 158 hashimoto k hirai m kurosawa y gene outside human mhc related classical hla class genes science 269693 1995medline order article via infotrieve 159 venditti cp chorney mj class gene contraction within hla subregion human mhc genomics 141003 1992medline order article via infotrieve 160 schmidt cm orr ht hla g transgenic mice model studying expression function maternalfetal interface immunol rev 14753 1995medline order article via infotrieve 161 geraghty de koller bh hansen ja orr ht hla class gene family includes least six genes twelve pseudogenes gene fragments j immunol 1491934 1992abstractfree full text 162 abdulla alderton rp glynne rj gut ig hosking lk jackson kelly newell wr radley e sanseau p thorpe kl trowsdale j beck dna sequencing mhc class ii region chromosome 6 sequencing effort sanger centre dna sequence 75 1996medline order article via infotrieve 163 fischer lindahl k hermel e loveland wang cr maternally transmitted antigen mice model transplantation antigen annu rev immunol 9351 1991medline order article via infotrieve 164 heinrichs h orr ht hla non b c class genes structure expression immunol res 9265 1990medline order article via infotrieve 165 kovats main ek librach c stubblebine m fisher sj demars r class antigen hla g expressed human trophoblasts science 248220 1990medline order article via infotrieve 166 pazmany l mandelboim o valesgomez m davis dm reyburn ht strominger jl protection natural killer cell mediated lysis hla g expression target cells science 274792 1996abstractfree full text 167 jurisicova casper rf maclusky nj mills gb librach cl hla g expression preimplantation human embryo development proc nat acad sci usa 93161 1996abstractfree full text 168 pichon l hampe giffon carn g legall jy david v new non hla multigene family associated perb11 family within mhc class region immunogenetics 44259 1996medline order article via infotrieve 169 jones ep xiao h schultz ra flaherty l trachtulec z vincek v larin z lehrach h lindahl kf mhc class gene organization 15 mb yac contigs h2 m region genomics 2740 1995medline order article via infotrieve 170 amadou c ribouchon mt mattei mg jenkins na gilbert dj copeland ng avoustin p pontarotti p localization new genes markers distal part human major histocompatibility complex mhc region comparison mouse new insights evolution mammalian genomes genomics 269 1995medline order article via infotrieve 171 franklin lewontin rc gene unit selection genetics 65707 1970free full text 172 von recklinghausen fd uber haemochromatose berl klin wschr 26925 1899 173 ortmann b copeman j lehner pj sadasivan b herberg ja grandea ag riddell sr tampe r spies trowsdale cresswell p critical role tapasin assembly function multimeric mhc class tap complexes science 2771306 1997abstractfree full text 1997 american society hematology
0.09784351.9373235.html.plaintext.txt	125	references introduction references 1 parham p ohta population biology antigen presentation mhc class molecules science 27267 1996abstract 2 parimoo patanjali sr shukla h chaplin dd weissman sm cdna selection efficient pcr approach selection cdnas encoded large chromosomal dna fragments proc nat acad sci usa 889623 1991abstract 3 goei vl parimoo capossela chu tw gruen jr isolation novel non hla gene fragments hemochromatosis region 6p213 cdna hybridization selection j hum genet 54244 1994medline order article via infotrieve 4 pichon l giffon chauvel b carn g bouric p el kahloun legall jy david v physical map hla ahla f subregion identification two new coding sequences immunogenetics 43175 1996medline order article via infotrieve 5 campbell rd trowsdale j map human major histocompatibility complex immunol today 1843 1997 6 gruen jr nalabolu sr chu tw bowlus c fan wf goei vl wei h sivakamasundari r liu yc xu hx parimoo nallur g ajioka r shukla h bray ward p pan j weissman sm transcription map major histocompatibility complex mhc class region genomics 3670 1996medline order article via infotrieve 7 fan w cai w parimoo lennon gg weissman sm identification seven new human mhc class region genes around hla f locus immunogenetics 4497 1996medline order article via infotrieve 8 lepourcelet m andrieux n giffon j pichon l hampe galibert f mosser j systematic sequencing human hla ahla f region establishment cosmid contig identification new gene cluster within 37 kb sequence genomics 37316 1996medline order article via infotrieve 9 aguado b milner cm campbell rd genes mhc class iii region functions proteins encode browning m mcmichael eds hla mhc genes molecules function oxford uk bios scientific publishers 1996 p 39 10 klein j natural history major histocompatibility complex new york ny wiley 1986 11 trowsdale j molecular genetics hla class class ii regions browning m mcmichael eds hla mhc genes molecules function oxford uk bios scientific publishers 1996 p 22 12 cresswell p androlewicz mj ortmann b assembly transport class mhc peptide complexes ciba found symp 187150 1994medline order article via infotrieve 13 cresswell p antigen presentation getting peptides mhc class ii molecules curr biol 4541 1994medline order article via infotrieve 14 ceman rudersdorf ra petersen jm demars r dma dmb genes class ii region human mhc needed class ii associated antigen processing j immunol 1542545 1995abstractfree full text 15 nedospasov sa hirt b shakhov dobrynin vn kawashima e accolla rs jongeneel cv genes tumor necrosis factor tnf alpha lymphotoxin tnf beta tandemly arranged chromosome 17 mouse nucleic acids res 147713 1986abstract 16 muller u jongeneel cv nedospasov sa lindahl kf steinmetz m tumour necrosis factor lymphotoxin genes map close h 2d mouse major histocompatibility complex nature 325265 1987medline order article via infotrieve 17 gardner sm mock ba hilgers j huppi ke roeder wd mouse lymphotoxin tumor necrosis factor structural analysis cloned genes physical linkage chromosomal position j immunol 139476 1987abstractfree full text 18 browning jl ngam ek lawton p demarinis j tizard r chow ep hession c obrine greco b foley sf ware cf lymphotoxin beta novel member tnf family forms heteromeric complex lymphotoxin cell surface cell 72847 1993medline order article via infotrieve 19 campbell rd milner cm mhc genes autoimmunity curr opin immunol 5887 1993medline order article via infotrieve 20 corzo d salazar m granja cb yunis ej advances hla genetics exp clin immunogenet 12156 1995medline order article via infotrieve 21 tomlinson ip bodmer wf hla system analysis multifactorial genetic disease trends genet 11493 1995medline order article via infotrieve 22 tisch r mcdevitt h insulin dependent diabetes mellitus cell 85291 1996medline order article via infotrieve 23 thomson g hla disease associations models study complex human genetic disorders crit rev clin lab sci 32183 1995medline order article via infotrieve 24 cardon lr smith sd fulker dw kimberling wj pennington bf defries jc quantitative trait locus reading disability chromosome 6 science 266276 1994medline order article via infotrieve 25 grigorenko el wood fb meyer ms hart la speed wc shuster pauls dl susceptibility loci distinct components developmental dyslexia chromosomes 6 15 j hum genet 6027 1997medline order article via infotrieve 26 bodmer wf evolution function hla region cancer surv 225 1995medline order article via infotrieve 27 campbell rd trowsdale j map human mhc immunol today 14349 1993medline order article via infotrieve 28 cresswell p assembly transport function mhc class ii molecules ann rev immunol 12259 1994medline order article via infotrieve 29 flaherty l elliott e tine ja walsh ac waters jb immunogenetics q tl regions mouse crit rev immunol 10131 1990medline order article via infotrieve 30 girdlestone j transcriptional regulation mhc class genes eur j immunogenet 23395 1996medline order article via infotrieve 31 gunther e current status molecular genetic analysis rat major histocompatibility complex folia biologica 42129 1996medline order article via infotrieve 32 hughes al origin evolution hla class pseudogenes mol biol evol 12247 1995abstract 33 kasahara m kandil e saltercid l flajnik mf origin evolution class gene family mammalian class genes encoded outside major histocompatibility complex res immunol 147278 1996medline order article via infotrieve 34 kaufman j volk h wallny hj minimal essential mhc unrecognized mhc two extremes selection polymorphism immunol rev 14363 1995medline order article via infotrieve 35 kronenberg m brines r kaufman j mhc evolution long term investment defense immunol today 154 1994medline order article via infotrieve 36 le bouteiller p hla class chromosomal region genes products facts questions crit rev immunol 1489 1994medline order article via infotrieve 37 lienert k parham p evolution mhc class genes higher primates immunol cell biol 74349 1996medline order article via infotrieve 38 lunney jk current status swine leukocyte antigen complex vet immunol immunopathol 4319 1994medline order article via infotrieve 39 browning m mcmichael hla mhc genes molecules function oxford uk bios scientific publishers 1996 40 mcdevitt h evolution mhc class ii allelic diversity immunol rev 143113 1995medline order article via infotrieve 41 parham p rise fall great class genes semin immunol 6373 1994medline order article via infotrieve 42 peelman lj chardon p vaiman m mattheeuws m van zeveren van de weghe bouquet y campbell rd detailed physical map porcine major histocompatibility complex mhc class iii region comparison human mouse mhc class iii regions mammalian genome 7363 1996medline order article via infotrieve 43 potts wk wakeland ek evolution mhc genetic diversity tale incest pestilence sexual preference trends genet 9408 1993medline order article via infotrieve 44 teitell m cheroutre h panwala c holcombe h eghtesady p kronenberg m structure function h 2 tla region class mhc molecules crit rev immunol 141 27 1994medline order article via infotrieve 45 thomson g hla population genetics baillieres clin endocrinol metab 5247 1991medline order article via infotrieve 46 trowsdale j man bird beast comparative organization mhc genes immunogenetics 411 1995medline order article via infotrieve 47 van ostade x tavernier j fiers w structure activity studies human tumour necrosis factors protein eng 75 1994abstract 48 watkins di mhc nonhuman primates curr topics microbiol immunol 188145 1994medline order article via infotrieve 49 watkins di evolution major histocompatibility class genes primates crit rev immunol 151 1995medline order article via infotrieve 50 parham p adams ej arnett kl origins hla abc polymorphism immunol rev 143141 1995medline order article via infotrieve 51 acton rd dahlberg ps uknis klaerner hg fink gs norman jg dunn dl differential sensitivity escherichia coli infection mice lacking tumor necrosis factor p55 interleukin 1 p80 receptors arch surg 1311216 1996abstract 52 czarniecki cw role tumor necrosis factor viral disease antiviral res 22223 1993medline order article via infotrieve 53 jacob co lewis gd mcdevitt ho mhc class ii associated variation production tumor necrosis factor mice humans relevance pathogenesis autoimmune diseases immunol res 10156 1991medline order article via infotrieve 54 mcguire w hill av allsopp ce greenwood bm kwiatkowski d variation tnf alpha promoter region associated susceptibility cerebral malaria nature 371508 1994medline order article via infotrieve 55 louis e satsangi j roussomoustakaki m parkes m fanning g welsh k jewell d cytokine gene polymorphisms inflammatory bowel disease gut 39705 1996abstract 56 daser mitchison h mitchison muller b non classical mhc genetics immunological disease man mouse key role pro inflammatory cytokine genes cytokine 8593 1996medline order article via infotrieve 57 elliott mj feldmann m maini rn tnf alpha blockade rheumatoid arthritis rationale clinical outcomes mechanisms action int j immunopharmacol 17141 1995medline order article via infotrieve 58 mulcahy b waldron lynch f mcdermott mf adams c amos ci zhu dk ward rh clegg shanahan f molloy mg ogara f genetic variability tumor necrosis factor lymphotoxin region influences susceptibility rheumatoid arthritis j hum genet 59676 1996medline order article via infotrieve 59 verjans gm messer g weiss eh van der linden sm kijlstra polymorphism tumor necrosis factor region relation disease overview rheum dis clin n 18177 1992medline order article via infotrieve 60 matsumoto m mariathasan nahm mh baranyay f peschon jj chaplin dd role lymphotoxin type tnf receptor formation germinal centers science 2711289 1996abstract 61 matsumoto m lo sf carruthers cj min j mariathasan huang g plas dr martin sm geha rs nahm mh chaplin dd affinity maturation without germinal centres lymphotoxin alpha deficient mice nature 382462 1996medline order article via infotrieve 62 pasparakis m alexopoulou l episkopou v kollias g immune inflammatory responses tnf alpha deficient mice critical requirement tnf alpha formation primary b cell follicles follicular dendritic cell networks germinal centers maturation humoral immune response j exp med 184184 1996 63 neumann b luz pfeffer k holzmann b defective peyers patch organogenesis mice lacking 55 kd receptor tumor necrosis factor j exp med 184259 1996abstract 64 armitage rj tumor necrosis factor receptor superfamily members ligands curr opin immunol 6407 1994medline order article via infotrieve 65 mackay f majeau gr hochman ps browning jl lymphotoxin beta receptor triggering induces activation nuclear factor beta b transcription factor cell types j biol chem 27124934 1996abstractfree full text 66 holzinger de baey messer g kick g zwierzina h weiss eh cloning genomic characterization lst1 new gene human tnf region immunogenetics 42315 1995medline order article via infotrieve 67 tsuge shen fw steinmetz m boyse ea gene h 2sh 2d interval major histocompatibility complex transcribed b cells macrophages immunogenetics 26378 1987medline order article via infotrieve 68 nalabolu sr shukla h nallur g parimoo weissman sm genes 220 kb region spanning tnf cluster human mhc genomics 31215 1996medline order article via infotrieve 69 russell wallace af hancock ww sayegh mh adams dh sibinga ne wyner lr karnovsky mj upregulation cytokines associated macrophage activation lewis f344 rat transplantation model chronic cardiac rejection transplantation 59572 1995medline order article via infotrieve 70 utans u quist wc mcmanus bm wilson je arceci rj wallace af russell allograft inflammatory factory 1 cytokine responsive macrophage molecule expressed transplanted human hearts transplantation 611387 1996medline order article via infotrieve 71 utans u arceci rj yamashita y russell cloning characterization allograft inflammatory factor 1 novel macrophage factor identified rat cardiac allografts chronic rejection j clin invest 952954 1995medline order article via infotrieve 72 utans u liang p wyner lr karnovsky mj russell chronic cardiac rejection identification five upregulated genes transplanted hearts differential mrna display proc nat acad sci usa 916463 1994abstract 73 olavsen mg thomson w cheng j campbell rd characterization novel gene g1 class iii region human mha tsuji k aziawa m sasazuki eds proceedings 11th international histocompatibility workshop vol 2 oxford uk oxford press 1993 p 190 74 hessian pa edgeworth j hogg n mrp 8 mrp 14 two abundant ca2 binding proteins neutrophils monocytes j leukoc biol 53197 1993abstract 75 devery jm king nj geczy cl acute inflammatory activity s100 protein cp 10 activation neutrophils vivo vitro j immunol 1521888 1994abstractfree full text 76 albertella mr campbell rd characterization novel gene human major histocompatibility complex encodes potential new member kappa b family proteins hum molec genet 3793 1994abstract 77 dangel aw shen l mendoza ar wu lc yu cy human helicase gene ski2w hla class iii region exhibits striking structural similarities yeast antiviral gene ski2 human gene kiaa0052 emergence new gene family nucleic acids res 232120 1995abstract 78 albertella mr jones h thomson w olavesen mg campbell rd localization eight additional genes human major histocompatibility complex including gene encoding casein kinase ii beta subunit csnk2b genomics 36240 1996medline order article via infotrieve 79 lee sg lee park sh kang c song k identification characterization human cdna homologous yeast ski2 genomics 25660 1995medline order article via infotrieve 80 liang hitomi m hu yh liu y tartakoff dead box family protein required nucleocytoplasmic transport yeast mrna mol cell biol 165139 1996abstract 81 masison dc blanc ribas jc carroll k sonenberg n wickner rb decoying cap mrna degradation system double stranded rna virus polya mrna surveillance yeast antiviral system mol cell biol 152763 1995abstract 82 widner wr wickner rb evidence ski antiviral system saccharomyces cerevisiae acts blocking expression viral mrna mol cell biol 134331 1993abstract 83 johnson aw kolodner rd synthetic lethality sep1 xrn1 ski2 sep1 xrn1 ski3 mutants saccharomyces cerevisiae independent killer virus suggests general role genes translation control mol cell biol 152719 1995abstract 84 bahram spies mic gene family res immunol 147328 1996medline order article via infotrieve 85 bahram bresnahan m geraghty de spies second lineage mammalian major histocompatibility complex class genes proc nat acad sci usa 916259 1994abstract 86 groh v bahram bauer herman beauchamp m spies cell stress regulated human major histocompatibility complex class gene expressed gastrointestinal epithelium proc nat acad sci usa 9312445 1996abstractfree full text 87 peelman lj chardon p nunes m renard c geffrotin c vaiman m van zeveren coppieters w van de weghe bouquet y choy ww strominger jl spies bat1 gene mhc encodes evolutionarily conserved putative nuclear rna helicase dead family genomics 26210 1995medline order article via infotrieve 88 snoek m jansen m olavesen mg campbell rd teuscher c van vugt h three hsp70 genes located c4 h 2d region possible candidates orch 1 locus genomics 15350 1993medline order article via infotrieve 89 santoro mg heat shock proteins virus replication hsp70s mediators antiviral effects prostaglandins experientia 501039 1994medline order article via infotrieve 90 hochstrasser m protein degradation regulation ub judge cell 84813 1996medline order article via infotrieve 91 haas al ahrens p bright pm ankel h interferon induces 15 kilodalton protein exhibiting marked homology ubiquitin j biol chem 26211315 1987abstractfree full text 92 feltham n fahey d knight e jr growth inhibitory protein secreted human diploid fibroblasts partial purification characterization j biol chem 2622176 1987abstractfree full text 93 farrell pj broeze rj lengyel p accumulation mrna protein interferon treated ehrlich ascites tumour cells nature 279523 1979medline order article via infotrieve 94 korant bd blomstrom dc jonak gj knight e jr interferon induced proteins purification characterization 15000 dalton protein human bovine cells induced interferon j biol chem 25914835 1984abstractfree full text 95 dcunha j ramanujam wagner rj witt pl knight e borden ec vitro vivo secretion human isg15 ifn induced immunomodulatory cytokine j immunol 1574100 1996abstract 96 knight e jr fahey d cordova b hillman m kutny r reich n blomstrom d 15 kda interferon induced protein derived cooh terminal processing 17 kda precursor j biol chem 2634520 1988abstractfree full text 97 recht m borden ec knight e jr human 15 kda ifn induced protein induces secretion ifn gamma j immunol 1472617 1991abstractfree full text 98 dcunha j knight e jr haas al truitt rl borden ec immunoregulatory properties isg15 interferon induced cytokine proc nat acad sci usa 93211 1996abstractfree full text 99 nakamura m ogawa h tsunematsu characterization monoclonal nonspecific suppressor factor mnsf use monoclonal antibody j immunol 1381799 1987abstractfree full text 100 nakamura m xavier rm tanigawa y ubiquitin like moiety monoclonal nonspecific suppressor factor beta responsible activity j immunol 156532 1996abstract 101 vernet c boretto j mattei mg takahashi m jack lj mather ih rouquier pontarotti p evolutionary study multigenic families mapping close human mhc class region j mol evol 37600 1993medline order article via infotrieve 102 chu tw capossela coleman r goei vl nallur g gruen jr cloning new finger protein gene znf173 within class region human mhc genomics 29229 1995medline order article via infotrieve 103 pham dinh d mattei mg nussbaum jl roussel g pontarotti p roeckel n mather ih artzt k lindahl kf dautigny myelinoligodendrocyte glycoprotein member subset immunoglobulin superfamily encoded within major histocompatibility complex proc nat acad sci usa 907990 1993abstractfree full text 104 fan w liu yc parimoo weissman sm olfactory receptor like genes located human major histocompatibility complex genomics 27119 1995medline order article via infotrieve 105 janatipour m naumov y ando sugimura k okamoto n tsuji k abe k inoko h search mhc associated genes human five new genes centromeric hla dp yet unknown functions immunogenetics 35272 1992medline order article via infotrieve 106 aguado b campbell rd novel gene g17 located human major histocompatibility complex encodes pbx2 homeodomain containing protein genomics 25650 1995medline order article via infotrieve 107 kamps m look baltimore d human t1 19 translocation pre b produces multiple nuclear e2a pbx1 fusion proteins differing transforming potentials genes dev 5358 1991abstract 108 lawrence h sauvageau g humphries r largman c role hox homeobox genes normal leukemic hematopoiesis stem cells 14281 1996abstract 109 porter rr complement components coded major histocompatibility complexes biological activities immunol rev 877 1985medline order article via infotrieve 110 huang mm erlich ha goodman mf arnheim n analysis mutational changes hla locus single human sperm human mut 6303 1995 111 devlin jj weiss eh paulson m flavell ra duplicated gene pairs alleles class genes qa2 region murine major histocompatibility complex comparison embo j 43203 1985abstract 112 slightom jl blechl ae smithies o human fetal g gamma gamma globin genes complete nucleotide sequences suggest dna exchanged duplicated genes cell 21627 1980medline order article via infotrieve 113 hughes al hughes mk adaptive evolution rat olfactory receptor gene family j mol evol 36249 1993medline order article via infotrieve 114 singer ms weisingerlewin y lancet d shepherd gm positive selection moments identify potential functional residues human olfactory receptors recep channels 4141 1996medline order article via infotrieve 115 hughes al rapid evolution immunoglobulin superfamily c2 domains expressed immune system cells mol biol evol 141 1997abstract 116 richman ad uyenoyama mk kohn jr allelic diversity gene genealogy self incompatibility locus solanaceae science 2731212 1996abstract 117 clark ag kao th excess nonsynonymous substitution shared polymorphic sites among self incompatibility alleles solanaceae proc natl acad sci usa 889823 1991abstract 118 yamazaki k beauchamp gk shen fw bard j boyse ea distinctive change odortype determined h 2dl mutation immunogenetics 34129 1991medline order article via infotrieve 119 gilbert yamazaki k beauchamp gk thomas l olfactory discrimination mouse strains mus musculus major histocompatibility types humans homo sapiens j comp psychol 100262 1986medline order article via infotrieve 120 yamazaki k beauchamp gk kupniewski d bard j thomas l boyse ea familial imprinting determines h 2 selective mating preferences science 2401331 1988medline order article via infotrieve 121 wedekind c seebeck bettens f paepke aj mhc dependent mate preferences humans proc r soc london b biol sci 260245 1995medline order article via infotrieve 122 jin k speed tp thomson g tests random mating highly polymorphic locus application hla data biometrics 511064 1995medline order article via infotrieve 123 hughes al hughes mk natural selection peptide binding regions major histocompatibility complex molecules immunogenetics 42233 1995medline order article via infotrieve 124 vanderhaeghen p schurmans vassart g parmentier m specific repertoire olfactory receptor genes male germ cells several mammalian species genomics 39239 1997 125 jin k ho hn speed tp gill tr reproductive failure major histocompatibility complex j hum genet 561456 1995medline order article via infotrieve 126 hoshiai h ishikawa m noda k takahama k fukaya yajima influence hla antigens reproduction among japanese population study haplotypes 247 families berliner munchener tierarztliche wochenschrift 172139 1994 127 kostyu dd hla fertile territory developmental genes crit rev immunol 1429 1994medline order article via infotrieve 128 ober c current topic hla reproduction lessons studies hutterites placenta 16569 1995medline order article via infotrieve 129 degos l colombani j chaventre bengtson b jacquard selective pressure hl polymorphism nature 24962 1974medline order article via infotrieve 130 klitz w thomson g borot n chambon thomsen evolutionary population perspectives human hla complex evol biol 2635 1992 131 hedrick pw thomson g maternal fetal interactions maintenance hla polymorphism genetics 119205 1988abstractfree full text 132 dawson dv ober c kostyu dd extended hla profile inbred isolate schmiedeleut hutterites south dakota genet epidemiol 1247 1995medline order article via infotrieve 133 black fl mother child hla compatibility ratios children amerinidian parents share common haplotypes j hum genet 37133 1985medline order article via infotrieve 134 hedrick pw evolution hla possible explanations deficiency homozygotes two populations hum hered 40213 1990medline order article via infotrieve 135 chu tw bowlus cl gruen jr disorders iron metabolism related disorders rimoin dl connor jm pyeritz re emery aeh eds emery rimoins principles practice medical genetics ed 3 edinburgh uk churchill livingston 1997 p 2047 136 feder jn gnirke thomas w tsuchihashi z ruddy da basava dormishian f domingo r jr ellis mc fullan hinton lm jones nl kimmel kronmal gs lauer p lee vk loeb db mapa fa mcclelland e meyer nc mintier ga moeller n moore morikang e wolff rr prass ce quintana l starnes sm schatzman re brunke kj drayna dt risch nj bacon br wolff rk novel mhc class like gene mutated patients hereditary haemochromatosis nat genet 13399 1996medline order article via infotrieve 137 rothenberg voland jr beta2 knockout mice develop parenchymal iron overload putative role class genes major histocompatibility complex iron metabolism proc nat acad sci usa 931529 1996abstractfree full text 138 simon m alexandre jl fauchet r genetet b bourel m genetics hemochromatosis prog med genet 4135 1980medline order article via infotrieve 139 kravitz k skolnick m cannings c carmelli d baty b amos db johnsson mendell n edwards c cartwright g genetic linkage hereditary hemochromatosis hla j hum genet 31601 1979medline order article via infotrieve 140 jazwinska ec lee sc webb si halliday jw powell lw localization hemochromatosis gene close d6s105 j hum genet 53347 1993medline order article via infotrieve 141 raha chowdhury r bowen dj stone c pointon jj terwilliger jd shearman jd robson kjh bomford worwood m new polymorphic microsatellite markers place haemochromatosis gene telomeric d6s105 hum mol genet 41869 1995abstract 142 gandon g jouanolle chauvel b mauvieux v le treut feingold j le gall jy david v yaouanq j linkage disequilibrium extended haplotypes hla d6s105 region implications mapping hemochromatosis gene hfe hum genet 97103 1996medline order article via infotrieve 143 yaouanq j perichon m chorney m pontarotti p le treut el kahloun mauvieux v blayau m jouanolle chauvel b moirand r nouel o le gall jy feingold j david v anonymous marker loci within 400 kb hla generate haplotypes linkage disequilibrium hemochromatosis gene hfe j hum genet 54252 1994medline order article via infotrieve 144 raha chowdhury r bowen dj burnett ak worwood m allelic associations homozygosity loci hla b d6s299 genetic haemochromatosis j med genet 32446 1995abstract 145 hastbacka j de la chapelle kaitila sistonen p weaver lander e linkage disequilibrium mapping isolated founder populations diastrophic dysplasia finland nat genet 2204 1992medline order article via infotrieve 146 jazwinska ec cullen lm busfield f pyper wr webb si powell lw morris cp walsh tp haemochromatosis hla h nat genet 14249 1996medline order article via infotrieve 147 pippard mj detection iron overload lancet 34973 1997medline order article via infotrieve 148 moirand r mortaji loreal o paillard f brissot p deugnier y new syndrome liver iron overload normal transferrin saturation lancet 34995 1997medline order article via infotrieve 149 thomsen m neubegauer m arnaud j borot n sevooon baur m cambon thomsen m recombination fractions hla system based data set provinces francasises indications haplotype specific recombination rates eur j immunogenet 2133 1994medline order article via infotrieve 150 shiroishi koide yoshino m sagai moriwaki k hotspots homologous recombination mouse meiosis adv biophys 31119 1995medline order article via infotrieve 151 dib c faure fizames c samson d drouot n vignal millasseau p marc hazan j seboun e lathrop m gyapay g morissette j weissenbach j comprehensive genetic map human genome based 5264 microsatellites nature 380152 1996medline order article via infotrieve 152 cullen m erlich h klitz w carrington m molecular mapping recombination hotspot located second intron human tap2 locus j hum genet 561350 1995medline order article via infotrieve 153 yoshino m sagai lindahl kf toyoda y shirayoshi y matsumoto k sugaya k ikemura moriwaki k shiroishi recombination class iii region mouse major histocompatibility complex immunogenetics 40280 1994medline order article via infotrieve 154 yoshino m sagai moriwaki k shiroishi meiotic recombination lmp2 hotspot tolerates minor sequence divergence homologous chromosomes immunogenetics 4380 1996medline order article via infotrieve 155 yoshino m sagai lindahl kf toyoda y moriwaki k shiroishi allele dependent recombination frequency homology requirement meiotic recombination hot spot mouse major histocompatibility complex genomics 27298 1995medline order article via infotrieve 156 wu xh haber je 700 bp cis acting region controls mating type dependent recombination along entire left arm yeast chromosome iii cell 87277 1996medline order article via infotrieve 157 katsanis n fitzgibbon j fisher e paralogy mapping identification region human mhc triplicated onto human chromosomes 1 9 allows prediction isolation novel pbx notch loci genomics 35101 1996medline order article via infotrieve 158 hashimoto k hirai m kurosawa y gene outside human mhc related classical hla class genes science 269693 1995medline order article via infotrieve 159 venditti cp chorney mj class gene contraction within hla subregion human mhc genomics 141003 1992medline order article via infotrieve 160 schmidt cm orr ht hla g transgenic mice model studying expression function maternalfetal interface immunol rev 14753 1995medline order article via infotrieve 161 geraghty de koller bh hansen ja orr ht hla class gene family includes least six genes twelve pseudogenes gene fragments j immunol 1491934 1992abstractfree full text 162 abdulla alderton rp glynne rj gut ig hosking lk jackson kelly newell wr radley e sanseau p thorpe kl trowsdale j beck dna sequencing mhc class ii region chromosome 6 sequencing effort sanger centre dna sequence 75 1996medline order article via infotrieve 163 fischer lindahl k hermel e loveland wang cr maternally transmitted antigen mice model transplantation antigen annu rev immunol 9351 1991medline order article via infotrieve 164 heinrichs h orr ht hla non b c class genes structure expression immunol res 9265 1990medline order article via infotrieve 165 kovats main ek librach c stubblebine m fisher sj demars r class antigen hla g expressed human trophoblasts science 248220 1990medline order article via infotrieve 166 pazmany l mandelboim o valesgomez m davis dm reyburn ht strominger jl protection natural killer cell mediated lysis hla g expression target cells science 274792 1996abstractfree full text 167 jurisicova casper rf maclusky nj mills gb librach cl hla g expression preimplantation human embryo development proc nat acad sci usa 93161 1996abstractfree full text 168 pichon l hampe giffon carn g legall jy david v new non hla multigene family associated perb11 family within mhc class region immunogenetics 44259 1996medline order article via infotrieve 169 jones ep xiao h schultz ra flaherty l trachtulec z vincek v larin z lehrach h lindahl kf mhc class gene organization 15 mb yac contigs h2 m region genomics 2740 1995medline order article via infotrieve 170 amadou c ribouchon mt mattei mg jenkins na gilbert dj copeland ng avoustin p pontarotti p localization new genes markers distal part human major histocompatibility complex mhc region comparison mouse new insights evolution mammalian genomes genomics 269 1995medline order article via infotrieve 171 franklin lewontin rc gene unit selection genetics 65707 1970free full text 172 von recklinghausen fd uber haemochromatose berl klin wschr 26925 1899 173 ortmann b copeman j lehner pj sadasivan b herberg ja grandea ag riddell sr tampe r spies trowsdale cresswell p critical role tapasin assembly function multimeric mhc class tap complexes science 2771306 1997abstractfree full text 1997 american society hematology
0.099135764.12639939.html.plaintext.txt	0	gonadotropin releasing hormone neurons coexpress orexin 1 receptor immunoreactivity receive direct contacts orexin fibers rebecca e campbell kevin l grove m susan smith
0.099135764.12639939.html.plaintext.txt	1	address correspondence requests reprints dr m susan smith oregon national primate research center oregon health science university beaverton oregon 97006 e mail smithsuatohsuedu u d
0.099135764.12639939.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references orexins produced neurons lateral hypothalamic area implicated regulation feeding reproductive function orexins stimulate lh secretion steroid primed ovariectomized female rats suppress lh secretion nonprimed ovariectomized rats aim present study characterize neuroanatomical pathway orexin might modulate lh secretion rat using double triple label immunofluorescence coupled confocal microscopy found 75 85 gnrh neurons contacted orexin fibers triple labeling synaptophysin provided additional confirmation close contacts furthermore 85 gnrh neurons colocalized orexin receptor 1 ox r1 ox r1 expressing gnrh neurons contacted orexin terminals providing basis functional neuroanatomical pathway gnrh nerve terminals median eminence however express ox r1 additional study investigated coexpression neuropeptide y y4 like receptors orexin fibers relation gnrh neurons evidence y4 receptor stimulation results lh release studies laboratory show y4 like immunoreactivity majority orexin cell bodies lateral hypothalamic area orexin fibers scattered throughout hypothalamus present study found although y4 positive orexin fibers present area gnrh neurons never come close contact gnrh neurons together data suggest y4 receptor modulation lh release likely indirect orexin cell bodies orexin modulates gnrh neurons directly via ox r1
0.099135764.12639939.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references orexins produced neurons lateral hypothalamic area implicated regulation feeding reproductive function orexins stimulate lh secretion steroid primed ovariectomized female rats suppress lh secretion nonprimed ovariectomized rats aim present study characterize neuroanatomical pathway orexin might modulate lh secretion rat using double triple label immunofluorescence coupled confocal microscopy found 75 85 gnrh neurons contacted orexin fibers triple labeling synaptophysin provided additional confirmation close contacts furthermore 85 gnrh neurons colocalized orexin receptor 1 ox r1 ox r1 expressing gnrh neurons contacted orexin terminals providing basis functional neuroanatomical pathway gnrh nerve terminals median eminence however express ox r1 additional study investigated coexpression neuropeptide y y4 like receptors orexin fibers relation gnrh neurons evidence y4 receptor stimulation results lh release studies laboratory show y4 like immunoreactivity majority orexin cell bodies lateral hypothalamic area orexin fibers scattered throughout hypothalamus present study found although y4 positive orexin fibers present area gnrh neurons never come close contact gnrh neurons together data suggest y4 receptor modulation lh release likely indirect orexin cell bodies orexin modulates gnrh neurons directly via ox r1
0.099135764.12639939.html.plaintext.txt	4	introduction top abstract introduction materials methods results discussion references neuropeptides orexin orexin b also known hypocretin 1 hypocretin 2 recently characterized 1 2 implicated regulation arousal states energy metabolism neuroendocrine reproductive function reviews see refs 3 4 5 peptides derived common precursor expression identified neuronal cell bodies lateral hypothalamic area lha although orexin expressing cell bodies restricted area send widespread projections throughout brain spinal cord orexin actions mediated via g protein coupled receptors two different subtypes ox r1 ox r2 ox r2 nonselective receptor binds orexin b ox r1 highly selective orexin 2 complementary widespread projections orexin fibers 6 ox r1 ox r2 mrna protein found widely expressed brain 7 8 9 10
0.099135764.12639939.html.plaintext.txt	5	recent physiological neuroanatomical studies suggest orexin may play important role control hypothalamo pituitary gonadal axis example shown central administration orexin stimulates lh secretion 11 however similar orexigenic peptides neuropeptide y npy orexin shown bimodal effects lh secretion orexin stimulating lh secretion steroid primed ovariectomized rats inhibiting lh secretion absence ovarian steroids 11 12 also demonstrated immunoneutralization orexin brain completely abolishes lh prl surges icv administration orexin leads dose dependent recovery fasting suppressed lh surges 13 addition tissue explant studies shown orexin stimulates gnrh release hypothalamus intact male rats female rats proestrus 14 recently study employing low dose estrogen replacement ovariectomized rats resulting serum levels similar observed diestrus demonstrated low dose estrogen potentiates suppressive effects centrally administered orexin lh secretion 15 suggesting orexin inhibitory diestrus low estrogen states excitatory surge conditions although orexin clearly implicated regulation gnrhlh secretion neuroanatomical pathway orexin may mediating effects rat remains determined first aim present study investigate whether orexin fibers project come close contact gnrh neurons whether gnrh neurons express ox r1 rat
0.099135764.12639939.html.plaintext.txt	6	recent physiological neuroanatomical studies suggest orexin may play important role control hypothalamo pituitary gonadal axis example shown central administration orexin stimulates lh secretion 11 however similar orexigenic peptides neuropeptide y npy orexin shown bimodal effects lh secretion orexin stimulating lh secretion steroid primed ovariectomized rats inhibiting lh secretion absence ovarian steroids 11 12 also demonstrated immunoneutralization orexin brain completely abolishes lh prl surges icv administration orexin leads dose dependent recovery fasting suppressed lh surges 13 addition tissue explant studies shown orexin stimulates gnrh release hypothalamus intact male rats female rats proestrus 14 recently study employing low dose estrogen replacement ovariectomized rats resulting serum levels similar observed diestrus demonstrated low dose estrogen potentiates suppressive effects centrally administered orexin lh secretion 15 suggesting orexin inhibitory diestrus low estrogen states excitatory surge conditions although orexin clearly implicated regulation gnrhlh secretion neuroanatomical pathway orexin may mediating effects rat remains determined first aim present study investigate whether orexin fibers project come close contact gnrh neurons whether gnrh neurons express ox r1 rat
0.099135764.12639939.html.plaintext.txt	7	similar orexin npy found elicit bimodal effects lh release likely acting y1 16 17 18 y4 17 19 20 21 y5 22 23 receptor subtypes recently laboratory reported majority orexin cell bodies lha expressed y4 like immunoreactivity y4 ir orexin fibers also positive y4 ir 19 others shown activation y4 receptors y4 agonist 1229u91 high affinity ligand y4 receptor rat pancreatic polypeptide rpp stimulates gnrh neurons turn lh release intact male rats 20 important basal release lh female rat 17 conversely infertile leptin deficient obob mouse crossed y4 knockout mouse fertility partially restored suggesting y4 receptor involved suppressing reproductive function 21 taken together data suggest effects y4 activation lh release may mediated via orexin therefore second aim present study characterize neuroanatomical relationship y4 positive orexin fibers gnrh neurons
0.099135764.12639939.html.plaintext.txt	8	similar orexin npy found elicit bimodal effects lh release likely acting y1 16 17 18 y4 17 19 20 21 y5 22 23 receptor subtypes recently laboratory reported majority orexin cell bodies lha expressed y4 like immunoreactivity y4 ir orexin fibers also positive y4 ir 19 others shown activation y4 receptors y4 agonist 1229u91 high affinity ligand y4 receptor rat pancreatic polypeptide rpp stimulates gnrh neurons turn lh release intact male rats 20 important basal release lh female rat 17 conversely infertile leptin deficient obob mouse crossed y4 knockout mouse fertility partially restored suggesting y4 receptor involved suppressing reproductive function 21 taken together data suggest effects y4 activation lh release may mediated via orexin therefore second aim present study characterize neuroanatomical relationship y4 positive orexin fibers gnrh neurons
0.099135764.12639939.html.plaintext.txt	9	materials methods top abstract introduction materials methods results discussion references animals tissue male virgin cycling female rats simonsen laboratories gilroy ca housed individually maintained 12 h light 12 h dark cycle lights 0700 h constant temperature 23 plus minus 2 c food water available ad libitum animal procedures approved oregon national primate research center institutional animal care use committee
0.099135764.12639939.html.plaintext.txt	10	materials methods top abstract introduction materials methods results discussion references animals tissue male virgin cycling female rats simonsen laboratories gilroy ca housed individually maintained 12 h light 12 h dark cycle lights 0700 h constant temperature 23 plus minus 2 c food water available ad libitum animal procedures approved oregon national primate research center institutional animal care use committee
0.099135764.12639939.html.plaintext.txt	11	immunocytochemical studies animals n 4 5 male female rats used experiment killed pentobarbital anesthesia cardiac infusion ice cold pbs followed ice cold paraformaldehyde napo4 buffer ph 74 brains removed saturated 25 sucrose frozen cooled isopentane stored 80 c sectioning microtome one six series tissue sections 25 microm collected animal
0.099135764.12639939.html.plaintext.txt	12	double triple label immunofluorescence immunofluorescent labeling previously reported 18 22 performed floating sections double triple label orexin gnrh one synaptophysin ox r1 y4 performed using cocktail primary antibodies goat polyclonal orexin antibody santa cruz biotechnology santa cruz ca used concentration 110000 19 mouse monoclonal gnrh antibody kind gift h f urbanski oregon national primate research center beaverton used concentration 1500 22 rabbit polyclonal synaptophysin antibody dako corp carpinteria ca used concentration 1200 rabbit polyclonal ox r1 antibody kind gift g hervieu smithkline beecham foods international harlow essex uk used concentration 1500 9 24 ox r1 antibody extensively characterized shown specific evidenced agreement patterns receptor mrna protein expression 9 specific detection receptor cell line transfected ox r1 9 loss specific staining following preabsorption antiserum immunogen peptide 24 rabbit polyclonal y4 antibody kind gift j ffrench mullen used 110000 concentration 19 specificity antibody confirmed showing similar expression patterns mrna protein determined western blot combination double triple labeling primary antibodies titrated establish maximum dilutions provided robust signals minimum nonspecific staining
0.099135764.12639939.html.plaintext.txt	13	double triple label immunofluorescence immunofluorescent labeling previously reported 18 22 performed floating sections double triple label orexin gnrh one synaptophysin ox r1 y4 performed using cocktail primary antibodies goat polyclonal orexin antibody santa cruz biotechnology santa cruz ca used concentration 110000 19 mouse monoclonal gnrh antibody kind gift h f urbanski oregon national primate research center beaverton used concentration 1500 22 rabbit polyclonal synaptophysin antibody dako corp carpinteria ca used concentration 1200 rabbit polyclonal ox r1 antibody kind gift g hervieu smithkline beecham foods international harlow essex uk used concentration 1500 9 24 ox r1 antibody extensively characterized shown specific evidenced agreement patterns receptor mrna protein expression 9 specific detection receptor cell line transfected ox r1 9 loss specific staining following preabsorption antiserum immunogen peptide 24 rabbit polyclonal y4 antibody kind gift j ffrench mullen used 110000 concentration 19 specificity antibody confirmed showing similar expression patterns mrna protein determined western blot combination double triple labeling primary antibodies titrated establish maximum dilutions provided robust signals minimum nonspecific staining
0.099135764.12639939.html.plaintext.txt	14	first double labeling orexin gnrh performed briefly floating tissue sections removed cryoprotectant washed 005 m potassium pbs kpbs tissue incubated blocking buffer kpbs 04 triton x 100 2 normal donkey serum 20 min reduce background incubated cocktail orexin gnrh primary antibodies 48 h 4 c following washes kpbs tissue incubated 1 h cocktail fluorescent secondary antibodies orexin visualized tetramethyl rhodamine isothiocyanate tritc conjugated donkey antigoat antibody 1200 jackson immunoresearch laboratories inc west grove pa gnrh visualized fluorescein isothiocyanate fitc conjugated donkey antimouse antibody 1200 jackson immunoresearch laboratories inc
0.099135764.12639939.html.plaintext.txt	15	first double labeling orexin gnrh performed briefly floating tissue sections removed cryoprotectant washed 005 m potassium pbs kpbs tissue incubated blocking buffer kpbs 04 triton x 100 2 normal donkey serum 20 min reduce background incubated cocktail orexin gnrh primary antibodies 48 h 4 c following washes kpbs tissue incubated 1 h cocktail fluorescent secondary antibodies orexin visualized tetramethyl rhodamine isothiocyanate tritc conjugated donkey antigoat antibody 1200 jackson immunoresearch laboratories inc west grove pa gnrh visualized fluorescein isothiocyanate fitc conjugated donkey antimouse antibody 1200 jackson immunoresearch laboratories inc
0.099135764.12639939.html.plaintext.txt	16	subsequently double labeling gnrh ox r1 performed previous experiment gnrh visualized fitc conjugated donkey antimouse antibody 1200 ox r1 visualized tritc conjugated donkey antirabbit antibody 1200 jackson immunoresearch laboratories inc
0.099135764.12639939.html.plaintext.txt	17	subsequently double labeling gnrh ox r1 performed previous experiment gnrh visualized fitc conjugated donkey antimouse antibody 1200 ox r1 visualized tritc conjugated donkey antirabbit antibody 1200 jackson immunoresearch laboratories inc
0.099135764.12639939.html.plaintext.txt	18	triple label experiments gnrhorexinsynaptophysin gnrhox r1orexin gnrhorexiny4 carried similar manner triple label experiment gnrh visualized fitc conjugated donkey antimouse antibody 1200 first triple label experiment orexin visualized tritc conjugated donkey antigoat antibody 1200 synaptophysin visualized cy5 conjugated donkey antirabbit antibody 1200 jackson immunoresearch laboratories inc second triple label experiment ox r1 visualized tritc conjugated donkey antirabbit antibody 1200 orexin visualized cy5 conjugated donkey antigoat antibody 1200 final triple label experiment used cy5 conjugated donkey antirabbit antibody 1200 visualize y4 tritc conjugated donkey antigoat antibody 1200 visualize orexin enhance signal y4 ir blast technique biotinylated tyramide enhancement used reported previously 18 19 sections experiments mounted onto subbed slides cover slipped glycerol sealed
0.099135764.12639939.html.plaintext.txt	19	triple label experiments gnrhorexinsynaptophysin gnrhox r1orexin gnrhorexiny4 carried similar manner triple label experiment gnrh visualized fitc conjugated donkey antimouse antibody 1200 first triple label experiment orexin visualized tritc conjugated donkey antigoat antibody 1200 synaptophysin visualized cy5 conjugated donkey antirabbit antibody 1200 jackson immunoresearch laboratories inc second triple label experiment ox r1 visualized tritc conjugated donkey antirabbit antibody 1200 orexin visualized cy5 conjugated donkey antigoat antibody 1200 final triple label experiment used cy5 conjugated donkey antirabbit antibody 1200 visualize y4 tritc conjugated donkey antigoat antibody 1200 visualize orexin enhance signal y4 ir blast technique biotinylated tyramide enhancement used reported previously 18 19 sections experiments mounted onto subbed slides cover slipped glycerol sealed
0.099135764.12639939.html.plaintext.txt	20	confocal laser microscopy confocal laser microscopy previously described 18 22 used analyze double triple label images colocalization close contacts tsc sp confocal system leica corp germany consisting rbe inverted microscope leica corp ar laser producing light 488 nm visualization fitc kr laser producing light 568 nm visualizing tritc hene laser producing light 647 nm visualization cy5 used scan images various objectives x25 numerical aperture 075 x40 numerical aperture 125 used scan capture images experiment fluorophore signals checked individually bleed apposing detector bleed eliminated adjusting laser intensity detector window width assess colocalization two signals series continuous optical sections 025 microm 05 microm intervals along z axis tissue section scanned fluorescent signal signals obtained fluorophore one series optical sections stored separately series 512 x 512 pixel images stacks individual optical slices 025 microm 05 microm resolution analyzed using metamorph imaging system universal imaging corp west chester pa determine colocalization contacts confocal images presented projections stacks optical images individual slices indicated brightness contrast images adjusted photoshop match microscope visualization adobe systems inc san jose ca
0.099135764.12639939.html.plaintext.txt	21	confocal laser microscopy confocal laser microscopy previously described 18 22 used analyze double triple label images colocalization close contacts tsc sp confocal system leica corp germany consisting rbe inverted microscope leica corp ar laser producing light 488 nm visualization fitc kr laser producing light 568 nm visualizing tritc hene laser producing light 647 nm visualization cy5 used scan images various objectives x25 numerical aperture 075 x40 numerical aperture 125 used scan capture images experiment fluorophore signals checked individually bleed apposing detector bleed eliminated adjusting laser intensity detector window width assess colocalization two signals series continuous optical sections 025 microm 05 microm intervals along z axis tissue section scanned fluorescent signal signals obtained fluorophore one series optical sections stored separately series 512 x 512 pixel images stacks individual optical slices 025 microm 05 microm resolution analyzed using metamorph imaging system universal imaging corp west chester pa determine colocalization contacts confocal images presented projections stacks optical images individual slices indicated brightness contrast images adjusted photoshop match microscope visualization adobe systems inc san jose ca
0.099135764.12639939.html.plaintext.txt	22	data analysis double label studies gnrhorexin gnrhox r1 one series tissue sections 10 12 sections 150 microm interval sections used animal n 4 5 animals gnrh neurons analyzed entire cell body including proximal dendritic processes visible section triple label studies representative sections several animals examined studies performed primarily proof principle ie gnrh neurons expressing ox r1 contacted orexin fibers gnrhox r1orexin orexin contacts observed gnrh neurons represent potential synaptic contacts gnrhorexinsynaptophysin triple label gnrhorexiny4 scattered y4 positive orexin fibers area gnrh neurons
0.099135764.12639939.html.plaintext.txt	23	data analysis double label studies gnrhorexin gnrhox r1 one series tissue sections 10 12 sections 150 microm interval sections used animal n 4 5 animals gnrh neurons analyzed entire cell body including proximal dendritic processes visible section triple label studies representative sections several animals examined studies performed primarily proof principle ie gnrh neurons expressing ox r1 contacted orexin fibers gnrhox r1orexin orexin contacts observed gnrh neurons represent potential synaptic contacts gnrhorexinsynaptophysin triple label gnrhorexiny4 scattered y4 positive orexin fibers area gnrh neurons
0.099135764.12639939.html.plaintext.txt	24	results top abstract introduction materials methods results discussion references double label studies showed orexin fibers red surrounded gnrh neurons green made close contact yellow color indicates colocalization fig 1 c sections four brains analyzed 500 gnrh neurons results showed 75 85 gnrh neurons brain contacted orexin fibers differences observed male female animals using synaptophysin protein localized synaptic vesicles marker synaptic contacts orexin fiber butons colocalized synaptophysin associated gnrh neurons fig 1 d f shown stack images d individual optical slices 025 microm resolution e f spine orexin fiber red colocalized synaptophsyin blue makes close contact gnrh neuron white represents triple labeling additional double label studies showed gnrh neurons colocalized ox r1 ir indicated yellow color low high power examples fig 2 b consistent robust innervation gnrh neurons orexin ox r1 ir colocalized 85 plus minus 2 gnrh neurons examined 485 neurons five brains triple label confirmed orexin fibers shown blue made contacts onto gnrh neurons expressing ox r1 ir fig 2 c d
0.099135764.12639939.html.plaintext.txt	25	view larger version 56k figure 1 orexin fibers come close contact gnrh neurons low power fluorescent photomicrograph demonstrating gnrh neurons green surrounded orexin fibers red higher power examples individual gnrh neurons b c show orexin fibers making close contact arrowheads indicate apparent close contacts b c colocalization pixels results yellow color d example orexin fiber red spine arrowhead colocalized synaptophysin blue makes close contact gnrh cell body green white pixels indicate triple label overlap yellow pixels indicate colocalization red green pixels e f serial 025 microm resolution optical slices demonstrating triple labeling arrowhead white scale bars 50 microm b e 25 microm
0.099135764.12639939.html.plaintext.txt	26	view larger version 56k figure 1 orexin fibers come close contact gnrh neurons low power fluorescent photomicrograph demonstrating gnrh neurons green surrounded orexin fibers red higher power examples individual gnrh neurons b c show orexin fibers making close contact arrowheads indicate apparent close contacts b c colocalization pixels results yellow color d example orexin fiber red spine arrowhead colocalized synaptophysin blue makes close contact gnrh cell body green white pixels indicate triple label overlap yellow pixels indicate colocalization red green pixels e f serial 025 microm resolution optical slices demonstrating triple labeling arrowhead white scale bars 50 microm b e 25 microm
0.099135764.12639939.html.plaintext.txt	27	view larger version 69k figure 2 gnrh neurons express ox r1 ir receive close contacts orexin fibers low power example double label gnrh neurons green ox r1 expressing neurons red medial preoptic area hypothalamus yellow color indicates colocalization b higher power example ox r1 expressing gnrh greenyellow neuron single labeled ox r1 neuron red shown c d two representative examples triple label gnrh neurons green expressing ox r1 ir single label red colocalization gnrh yellow orexin fibers blue make apparent close contacts ox r1 expressing regions gnrh neurons indicated white arrows yellow arrow indicates orexin fiber contact onto single label ox r1 neuron red white scale bars 50 microm b d 25 microm
0.099135764.12639939.html.plaintext.txt	28	view larger version 69k figure 2 gnrh neurons express ox r1 ir receive close contacts orexin fibers low power example double label gnrh neurons green ox r1 expressing neurons red medial preoptic area hypothalamus yellow color indicates colocalization b higher power example ox r1 expressing gnrh greenyellow neuron single labeled ox r1 neuron red shown c d two representative examples triple label gnrh neurons green expressing ox r1 ir single label red colocalization gnrh yellow orexin fibers blue make apparent close contacts ox r1 expressing regions gnrh neurons indicated white arrows yellow arrow indicates orexin fiber contact onto single label ox r1 neuron red white scale bars 50 microm b d 25 microm
0.099135764.12639939.html.plaintext.txt	29	ox r1 expression orexin innervation also investigated region gnrh terminals median eminence shown fig 3 although ox r1 expression red region orexin fibers appear innervate dorsolateral blue coexpression ox r1 gnrh green little interaction orexin fibers gnrh nerve terminals
0.099135764.12639939.html.plaintext.txt	30	view larger version 77k figure 3 gnrh nerve terminals median eminence express ox r1 b two representative images triple label gnrh fibers green ox r1 red orexin fibers blue colocalization ox r1 gnrh fibers apparent orexin fibers minimal interaction gnrh nerve terminals white scale bars 25 microm
0.099135764.12639939.html.plaintext.txt	31	view larger version 77k figure 3 gnrh nerve terminals median eminence express ox r1 b two representative images triple label gnrh fibers green ox r1 red orexin fibers blue colocalization ox r1 gnrh fibers apparent orexin fibers minimal interaction gnrh nerve terminals white scale bars 25 microm
0.099135764.12639939.html.plaintext.txt	32	additional triple label study carried investigate whether y4 positive orexin fibers make close contacts gnrh neurons scattered y4 positive orexin fibers observed vicinity gnrh cell bodies figure 4 depicts three gnrh cell bodies surrounded orexin fibers white arrows indicate two fibers y4orexin positive yellow arrows indicate orexin positive fibers identified coming close contact gnrh neurons although multiple close contacts orexin fibers gnrh shown previously fig 1 y4 positive orexin fibers never came close contact gnrh neurons
0.099135764.12639939.html.plaintext.txt	33	additional triple label study carried investigate whether y4 positive orexin fibers make close contacts gnrh neurons scattered y4 positive orexin fibers observed vicinity gnrh cell bodies figure 4 depicts three gnrh cell bodies surrounded orexin fibers white arrows indicate two fibers y4orexin positive yellow arrows indicate orexin positive fibers identified coming close contact gnrh neurons although multiple close contacts orexin fibers gnrh shown previously fig 1 y4 positive orexin fibers never came close contact gnrh neurons
0.099135764.12639939.html.plaintext.txt	34	view larger version 46k figure 4 y4 positive orexin ir fibers near gnrh neurons make close contacts triple label demonstrates gnrh neurons green surrounded orexin fibers red y4 positive orexin double label fibers white indicated white arrows noted y4 expression orexin fibers changed original color magenta white make visible photographs beaded appearance y4 positive orexin neurons may exaggerated blast technique enhance y4 staining although similar appearance also observed single label orexin fibers see figs 1 2 orexin single label fibers coming close contact gnrh neurons indicated double label yellow pixels marked yellow arrows white scale bar 25 microm
0.099135764.12639939.html.plaintext.txt	35	view larger version 46k figure 4 y4 positive orexin ir fibers near gnrh neurons make close contacts triple label demonstrates gnrh neurons green surrounded orexin fibers red y4 positive orexin double label fibers white indicated white arrows noted y4 expression orexin fibers changed original color magenta white make visible photographs beaded appearance y4 positive orexin neurons may exaggerated blast technique enhance y4 staining although similar appearance also observed single label orexin fibers see figs 1 2 orexin single label fibers coming close contact gnrh neurons indicated double label yellow pixels marked yellow arrows white scale bar 25 microm
0.099135764.12639939.html.plaintext.txt	36	discussion top abstract introduction materials methods results discussion references present study provides evidence functional neuroanatomical pathway orexin system gnrh neurons rat gnrh neurons express ox r1 contacted orexin fibers figs 1 2 appears interaction orexin fibers gnrh nerve terminals fig 3 immunoreactivity orexin fibers ox r1 presented present study confirms previous findings demonstrating orexin immunoreactive fibers 6 ox r1 mrna 7 immunoreactivity 9 present septal medial preoptic regions gnrh neurons located data support previously reported findings ovine hypothalamus orexin fibers originating lha found close contact gnrh neurons 25 however although present study found 75 85 gnrh neurons contacted orexin fibers approximately 85 gnrh neurons expressed ox r1 previous study found contacts 30 gnrh neurons discrepancy two studies may due several things including species differences rodent sheep case important investigate orexin innervation gnrh neurons species especially primate another discrepancy may due differences sensitivity antibodies used two studies obtained different sources present study shows dense networks fine immunoreactive fibers figs 1a 4 orexin fibers demonstrated ovine hypothalamus 25 much less dense yet another discrepancy might due differences sensitivity confocal microscopy analysis generally accepted although confocal microscopy provide good approximation synaptic interactions limitations technique preclude degree certainty obtained using electron microscopy
0.099135764.12639939.html.plaintext.txt	37	several lines evidence support contention orexin modulates neuroendocrine function addition number studies indicating steroid dependent effects central orexin administration lh release 11 12 15 studies using vitro explants indicate stimulatory effects orexin hypothalamic level 14 also reported orexin stimulates gnrh release hypothalamic explants collected male rats female rats proestrus data suggest stimulatory effects orexin lh release via direct stimulation gnrh secretion indeed present findings provide functional neuroanatomical pathway orexin may stimulate gnrh neurons subsequent lh release via direct contact ox r1 gnrh cell bodies nerve terminals within ox r1 exclusively coupled gq11 subtype g proteins 5 26 suggesting orexin action via ox r1 gnrh neurons excitatory however orexin also shown inhibit lh secretion absence gonadal steroids 12 although mechanism gonadal steroids modulate orexin effects lh secretion remains determined possible inhibitory actions orexin gnrh neurons indirect involving activation neurons within preoptic area also express ox r1 fig 2 turn may inhibitory actions gnrh neurons
0.099135764.12639939.html.plaintext.txt	38	several lines evidence support contention orexin modulates neuroendocrine function addition number studies indicating steroid dependent effects central orexin administration lh release 11 12 15 studies using vitro explants indicate stimulatory effects orexin hypothalamic level 14 also reported orexin stimulates gnrh release hypothalamic explants collected male rats female rats proestrus data suggest stimulatory effects orexin lh release via direct stimulation gnrh secretion indeed present findings provide functional neuroanatomical pathway orexin may stimulate gnrh neurons subsequent lh release via direct contact ox r1 gnrh cell bodies nerve terminals within ox r1 exclusively coupled gq11 subtype g proteins 5 26 suggesting orexin action via ox r1 gnrh neurons excitatory however orexin also shown inhibit lh secretion absence gonadal steroids 12 although mechanism gonadal steroids modulate orexin effects lh secretion remains determined possible inhibitory actions orexin gnrh neurons indirect involving activation neurons within preoptic area also express ox r1 fig 2 turn may inhibitory actions gnrh neurons
0.099135764.12639939.html.plaintext.txt	39	name implies orexin activity necessary normal feeding behavior central injection orexin stimulates food intake satiated rats 27 28 whereas neutralization orexin antiorexin antibody dose dependently suppresses spontaneous feeding fasted rats 29 furthermore orexin mrna increased fasting 2 data suggest orexin neurons able sense nutritional state animal shown repeatedly changes metabolic status animal tightly linked changes reproductive function therefore ability orexin modulate feeding behavior reproductive function along present neuroanatomical findings suggests orexin system key position serve integrating signal energy balance reproductive function
0.099135764.12639939.html.plaintext.txt	40	name implies orexin activity necessary normal feeding behavior central injection orexin stimulates food intake satiated rats 27 28 whereas neutralization orexin antiorexin antibody dose dependently suppresses spontaneous feeding fasted rats 29 furthermore orexin mrna increased fasting 2 data suggest orexin neurons able sense nutritional state animal shown repeatedly changes metabolic status animal tightly linked changes reproductive function therefore ability orexin modulate feeding behavior reproductive function along present neuroanatomical findings suggests orexin system key position serve integrating signal energy balance reproductive function
0.099135764.12639939.html.plaintext.txt	41	addition orexin neurons known coexpress long form leptin receptor ob rb rat 30 sheep 25 leptin peripheral metabolic signal released adipocytes important denoting adiposity energy balance brain also leptin shown play role regulating reproductive function administration leptin restores fasting induced suppression lh secretion sheep primates 31 32 33 however gnrh neurons express ob rb previously suggested similar findings ovine hypothalamus 25 direct projections ob rb expressing orexin neurons gnrh neurons may provide one potential neuroanatomical circuit leptin regulates gnrh activity
0.099135764.12639939.html.plaintext.txt	42	addition orexin neurons known coexpress long form leptin receptor ob rb rat 30 sheep 25 leptin peripheral metabolic signal released adipocytes important denoting adiposity energy balance brain also leptin shown play role regulating reproductive function administration leptin restores fasting induced suppression lh secretion sheep primates 31 32 33 however gnrh neurons express ob rb previously suggested similar findings ovine hypothalamus 25 direct projections ob rb expressing orexin neurons gnrh neurons may provide one potential neuroanatomical circuit leptin regulates gnrh activity
0.099135764.12639939.html.plaintext.txt	43	npy another neuropeptide system may important integrating signal energy balancefood intake reproductive function 34 similar effects orexin npy also elicits steroid dependent effects lh secretion 35 orexin neurons lha receive direct synaptic contacts npy neurons projecting arcuate nucleus turn send reciprocal projections arcuate nucleus npy neurons 36 currently evidence implicating y1 16 17 18 y4 17 19 20 21 y5 22 23 receptor subtypes npy modulation neuroendocrine reproductive function direct relevance y4 ir mrna colocalized orexin neurons lha 19 data coupled present findings gnrh neurons express ox r1 contacted orexin fibers demonstrate unique potential neuronal circuit whereby npy acting y4 receptor exert effects lh release via modulation orexin present study also showed y4 positive orexin fibers never observed close contact gnrh neurons major actions y4 receptor appear postsynaptic effects orexin cell bodies within lha taken together data suggest orexin neurons receiving critical input via y4 leptin receptors may provide important link regulation energy balance reproductive function
0.099135764.12639939.html.plaintext.txt	44	npy another neuropeptide system may important integrating signal energy balancefood intake reproductive function 34 similar effects orexin npy also elicits steroid dependent effects lh secretion 35 orexin neurons lha receive direct synaptic contacts npy neurons projecting arcuate nucleus turn send reciprocal projections arcuate nucleus npy neurons 36 currently evidence implicating y1 16 17 18 y4 17 19 20 21 y5 22 23 receptor subtypes npy modulation neuroendocrine reproductive function direct relevance y4 ir mrna colocalized orexin neurons lha 19 data coupled present findings gnrh neurons express ox r1 contacted orexin fibers demonstrate unique potential neuronal circuit whereby npy acting y4 receptor exert effects lh release via modulation orexin present study also showed y4 positive orexin fibers never observed close contact gnrh neurons major actions y4 receptor appear postsynaptic effects orexin cell bodies within lha taken together data suggest orexin neurons receiving critical input via y4 leptin receptors may provide important link regulation energy balance reproductive function
0.099135764.12639939.html.plaintext.txt	45	number questions remain concerning modulatory effects y4 orexin system gnrh neurons first endogenous ligand brain y4 receptor clear npy much lower affinity y4 receptor 37 pancreatic polypeptide family ligands recent study characterizing expression y4 ir orexin neurons also found administration rpp endogenous ligand y4 receptor induced robust cfos activation orexin neurons 19 furthermore rpp stimulated modest increase food intake robust drinking response 19 similar responses orexin data suggest stimulation y4 receptor rpp excitatory orexin neurons however effects y4 reproductive function shown stimulatory 17 20 inhibitory 21 similarly effects orexin reported stimulatory inhibitory reproductive function 11 12 13 14 15 therefore possible actions y4 receptor gnrhlh axis mediated via orexin system
0.099135764.12639939.html.plaintext.txt	46	number questions remain concerning modulatory effects y4 orexin system gnrh neurons first endogenous ligand brain y4 receptor clear npy much lower affinity y4 receptor 37 pancreatic polypeptide family ligands recent study characterizing expression y4 ir orexin neurons also found administration rpp endogenous ligand y4 receptor induced robust cfos activation orexin neurons 19 furthermore rpp stimulated modest increase food intake robust drinking response 19 similar responses orexin data suggest stimulation y4 receptor rpp excitatory orexin neurons however effects y4 reproductive function shown stimulatory 17 20 inhibitory 21 similarly effects orexin reported stimulatory inhibitory reproductive function 11 12 13 14 15 therefore possible actions y4 receptor gnrhlh axis mediated via orexin system
0.099135764.12639939.html.plaintext.txt	47	summary data provide neuroanatomical evidence direct link orexin system gnrh neurons findings suggest orexin plays direct role neuroendocrine control reproduction may also uniquely positioned integrate signals associated energy balance regulation additional studies necessary establish relative importance novel neuronal circuitry regulation reproductive function normal cyclicity well metabolic changes
0.099135764.12639939.html.plaintext.txt	48	summary data provide neuroanatomical evidence direct link orexin system gnrh neurons findings suggest orexin plays direct role neuroendocrine control reproduction may also uniquely positioned integrate signals associated energy balance regulation additional studies necessary establish relative importance novel neuronal circuitry regulation reproductive function normal cyclicity well metabolic changes
0.099135764.12639939.html.plaintext.txt	49	footnotes work supported nih grants hd 14643 hd 18185 rr 00163
0.099135764.12639939.html.plaintext.txt	50	abbreviations fitc fluorescein isothiocyanate immunofluorescence kpbs potassium pbs lha lateral hypothalamic area median eminence npy neuropeptide y ox r orexin receptor rpp rat pancreatic polypeptide tritc tetramethyl rhodamine isothiocyanate y4 ir y4 like immunoreactivity
0.099135764.12639939.html.plaintext.txt	51	accepted publication january 6 2003
0.099135764.12639939.html.plaintext.txt	52	references top abstract introduction materials methods results discussion references de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett 2nd fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline sakurai 2002 roles orexins regulation feeding wakefulness neuroreport 13987 995medline sutcliffe jg de lecea l 2002 hypocretins setting arousal threshold nat rev neurosci 3339 349crossrefmedline beuckmann ct yanagisawa m 2002 orexins neuropeptides energy homeostasis sleepwake regulation j mol med 80329 342crossrefmedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text trivedi p yu h macneil dj van der ploeg lh guan xm 1998 distribution orexin receptor mrna rat brain febs lett 43871 75crossrefmedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk 2001 differential expression orexin receptors 1 2 rat brain j comp neurol 4356 25crossrefmedline hervieu gj cluderay je harrison dc roberts jc leslie ra 2001 gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103777 797crossrefmedline cluderay je harrison dc hervieu gj 2002 protein distribution orexin 2 receptor rat central nervous system regul pept 104131 144crossrefmedline pu jain mr kalra ps kalra sp 1998 orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78133 136crossrefmedline tamura irahara m tezuka m kiyokawa m aono 1999 orexins orexigenic hypothalamic neuropeptides suppress pulsatile secretion luteinizing hormone ovariectomized female rats biochem biophys res commun 264759 762crossrefmedline kohsaka watanobe h kakizaki y suda schioth hb 2001 significant participation orexin potent orexigenic peptide preovulatory luteinizing hormone prolactin surges rat brain res 898166 170crossrefmedline russell sh small cj kennedy ar stanley sa seth murphy kg taheri ghatei ma bloom sr 2001 orexin interactions hypothalamo pituitary gonadal axis endocrinology 1425294 5302abstractfree full text furuta m funabashi kimura f 2002 suppressive action orexin pulsatile luteinizing hormone secretion potentiated low dose estrogen ovariectomized rats neuroendocrinology 75151 155crossrefmedline leupen sm besecke lm levine je 1997 neuropeptide y y1 receptor stimulation required physiological amplification preovulatory luteinizing hormone surges endocrinology 1382735 2739abstractfree full text jain mr pu kalra ps kalra sp 1999 evidence stimulation two modalities pituitary luteinizing hormone release ovarian steroid primed ovariectomized rats may involve neuropeptide y y1 y4 receptors endocrinology 1405171 5177abstractfree full text li c chen p smith ms 1999 morphological evidence direct interaction arcuate nucleus neuropeptide y npy neurons gonadotropin releasing hormone neurons possible involvement npy y1 receptors endocrinology 1405382 5390abstractfree full text campbell re smith ms allen se grayson ffrench mullen j grove kl orexin neurons lateral hypothalamic area express neuropeptide y y4 receptor activated rat pancreatic polypeptide rpp j neurosci press raposinho pd broqua p hayward akinsanya k galyean r schteingart c junien j aubert ml 2000 stimulation gonadotropic axis neuropeptide y receptor y1 antagonisty4 agonist 1229u91 male rat neuroendocrinology 712 7crossrefmedline sainsbury schwarzer c couzens m jenkins oakes sr ormandy cj herzog h 2002 y4 receptor knockout rescues fertility obob mice genes dev 161077 1088abstractfree full text campbell re ffrench mullen jm cowley ma smith ms grove kl 2001 hypothalamic circuitry neuropeptide y regulation neuroendocrine function food intake via y5 receptor subtype neuroendocrinology 74106 119crossrefmedline raposinho pd broqua p pierroz dd hayward dumont y quirion r junien jl aubert ml 1999 evidence inhibition luteinizing hormone secretion central administration neuropeptide y npy rat predominantly mediated npy y5 receptor subtype endocrinology 1404046 4055abstractfree full text backberg m hervieu g wilson meister b 2002 orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15315 328crossrefmedline iqbal j pompolo sakurai clarke ij 2001 evidence orexin containing neurones provide direct input gonadotropin releasing hormone neurones ovine hypothalamus j neuroendocrinol 131033 1041crossrefmedline van den pol gao xb obrietan k kilduff ts belousov ab 1998 presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text ida nakahara k katayama murakami n nakazato m 1999 effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821526 529crossrefmedline haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr 1999 effects single chronic intracerebroventricular administration orexins feeding rat peptides 201099 1105crossrefmedline yamada h okumura motomura w kobayashi y kohgo y 2000 inhibition food intake central injection anti orexin antibody fasted rats biochem biophys res commun 267527 531crossrefmedline hakansson m de lecea l sutcliffe jg yanagisawa m meister b 1999 leptin receptor stat3 immunoreactivities hypocretinorexin neurones lateral hypothalamus j neuroendocrinol 11653 663crossrefmedline finn pd cunningham mj pau ky spies hg clifton dk steiner ra 1998 stimulatory effect leptin neuroendocrine reproductive axis monkey endocrinology 1394652 4662abstractfree full text nagatani guthikonda p thompson rc tsukamura h maeda ki foster dl 1998 evidence gnrh regulation leptin leptin administration prevents reduced pulsatile lh secretion fasting neuroendocrinology 67370 376crossrefmedline nagatani zeng y keisler dh foster dl jaffe ca 2000 leptin regulates pulsatile luteinizing hormone growth hormone secretion sheep endocrinology 1413965 3975abstractfree full text smith ms grove kl 2002 integration regulation reproductive function energy balance lactation model front neuroendocrinol 23225 256crossrefmedline kalra sp dube mg pu horvath tl kalra ps 1999 interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 2068 100abstractfree full text horvath tl diano van den pol 1999 synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 191072 1087abstractfree full text bard ja walker mw branchek ta weinshank rl 1995 cloning functional expression human y4 subtype receptor pancreatic polypeptide neuropeptide y peptide yy j biol chem 27026762 26765abstractfree full text
0.099135764.12639939.html.plaintext.txt	53	references top abstract introduction materials methods results discussion references de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett 2nd fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline sakurai 2002 roles orexins regulation feeding wakefulness neuroreport 13987 995medline sutcliffe jg de lecea l 2002 hypocretins setting arousal threshold nat rev neurosci 3339 349crossrefmedline beuckmann ct yanagisawa m 2002 orexins neuropeptides energy homeostasis sleepwake regulation j mol med 80329 342crossrefmedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text trivedi p yu h macneil dj van der ploeg lh guan xm 1998 distribution orexin receptor mrna rat brain febs lett 43871 75crossrefmedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk 2001 differential expression orexin receptors 1 2 rat brain j comp neurol 4356 25crossrefmedline hervieu gj cluderay je harrison dc roberts jc leslie ra 2001 gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103777 797crossrefmedline cluderay je harrison dc hervieu gj 2002 protein distribution orexin 2 receptor rat central nervous system regul pept 104131 144crossrefmedline pu jain mr kalra ps kalra sp 1998 orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78133 136crossrefmedline tamura irahara m tezuka m kiyokawa m aono 1999 orexins orexigenic hypothalamic neuropeptides suppress pulsatile secretion luteinizing hormone ovariectomized female rats biochem biophys res commun 264759 762crossrefmedline kohsaka watanobe h kakizaki y suda schioth hb 2001 significant participation orexin potent orexigenic peptide preovulatory luteinizing hormone prolactin surges rat brain res 898166 170crossrefmedline russell sh small cj kennedy ar stanley sa seth murphy kg taheri ghatei ma bloom sr 2001 orexin interactions hypothalamo pituitary gonadal axis endocrinology 1425294 5302abstractfree full text furuta m funabashi kimura f 2002 suppressive action orexin pulsatile luteinizing hormone secretion potentiated low dose estrogen ovariectomized rats neuroendocrinology 75151 155crossrefmedline leupen sm besecke lm levine je 1997 neuropeptide y y1 receptor stimulation required physiological amplification preovulatory luteinizing hormone surges endocrinology 1382735 2739abstractfree full text jain mr pu kalra ps kalra sp 1999 evidence stimulation two modalities pituitary luteinizing hormone release ovarian steroid primed ovariectomized rats may involve neuropeptide y y1 y4 receptors endocrinology 1405171 5177abstractfree full text li c chen p smith ms 1999 morphological evidence direct interaction arcuate nucleus neuropeptide y npy neurons gonadotropin releasing hormone neurons possible involvement npy y1 receptors endocrinology 1405382 5390abstractfree full text campbell re smith ms allen se grayson ffrench mullen j grove kl orexin neurons lateral hypothalamic area express neuropeptide y y4 receptor activated rat pancreatic polypeptide rpp j neurosci press raposinho pd broqua p hayward akinsanya k galyean r schteingart c junien j aubert ml 2000 stimulation gonadotropic axis neuropeptide y receptor y1 antagonisty4 agonist 1229u91 male rat neuroendocrinology 712 7crossrefmedline sainsbury schwarzer c couzens m jenkins oakes sr ormandy cj herzog h 2002 y4 receptor knockout rescues fertility obob mice genes dev 161077 1088abstractfree full text campbell re ffrench mullen jm cowley ma smith ms grove kl 2001 hypothalamic circuitry neuropeptide y regulation neuroendocrine function food intake via y5 receptor subtype neuroendocrinology 74106 119crossrefmedline raposinho pd broqua p pierroz dd hayward dumont y quirion r junien jl aubert ml 1999 evidence inhibition luteinizing hormone secretion central administration neuropeptide y npy rat predominantly mediated npy y5 receptor subtype endocrinology 1404046 4055abstractfree full text backberg m hervieu g wilson meister b 2002 orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15315 328crossrefmedline iqbal j pompolo sakurai clarke ij 2001 evidence orexin containing neurones provide direct input gonadotropin releasing hormone neurones ovine hypothalamus j neuroendocrinol 131033 1041crossrefmedline van den pol gao xb obrietan k kilduff ts belousov ab 1998 presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text ida nakahara k katayama murakami n nakazato m 1999 effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821526 529crossrefmedline haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr 1999 effects single chronic intracerebroventricular administration orexins feeding rat peptides 201099 1105crossrefmedline yamada h okumura motomura w kobayashi y kohgo y 2000 inhibition food intake central injection anti orexin antibody fasted rats biochem biophys res commun 267527 531crossrefmedline hakansson m de lecea l sutcliffe jg yanagisawa m meister b 1999 leptin receptor stat3 immunoreactivities hypocretinorexin neurones lateral hypothalamus j neuroendocrinol 11653 663crossrefmedline finn pd cunningham mj pau ky spies hg clifton dk steiner ra 1998 stimulatory effect leptin neuroendocrine reproductive axis monkey endocrinology 1394652 4662abstractfree full text nagatani guthikonda p thompson rc tsukamura h maeda ki foster dl 1998 evidence gnrh regulation leptin leptin administration prevents reduced pulsatile lh secretion fasting neuroendocrinology 67370 376crossrefmedline nagatani zeng y keisler dh foster dl jaffe ca 2000 leptin regulates pulsatile luteinizing hormone growth hormone secretion sheep endocrinology 1413965 3975abstractfree full text smith ms grove kl 2002 integration regulation reproductive function energy balance lactation model front neuroendocrinol 23225 256crossrefmedline kalra sp dube mg pu horvath tl kalra ps 1999 interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 2068 100abstractfree full text horvath tl diano van den pol 1999 synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 191072 1087abstractfree full text bard ja walker mw branchek ta weinshank rl 1995 cloning functional expression human y4 subtype receptor pancreatic polypeptide neuropeptide y peptide yy j biol chem 27026762 26765abstractfree full text
0.100268394.15123537.html.plaintext.txt	0	differential roles cholecystokinin receptors energy balance rats mice sheng bi karen scott alan kopin timothy h moran
0.100268394.15123537.html.plaintext.txt	1	department psychiatry behavioral sciences johns hopkins university school medicine sb kas thm baltimore maryland 21205 molecular pharmacology research center department medicine tufts new england medical center ask boston massachusetts 02111
0.100268394.15123537.html.plaintext.txt	2	address correspondence requests reprints dr bi department psychiatry behavioral sciences johns hopkins university school medicine 720 rutland avenue ross 618 baltimore maryland 21205 e mail sbiatjhmiedu u d
0.100268394.15123537.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references although cholecystokinin cck receptors cck ar mediate feeding inhibitory actions cck rats mice absence cck ar results species specific phenotypes lack cck ar otsuka long evans tokushima fatty oletf rats results hyperphagia obesity suggested demonstrated increases meal size elevated levels dorsomedial hypothalamic dmh neuropeptide y npy gene expression may contribute phenotype contrast oletf rats cck ar mice normal total daily food intake develop obesity assess basis underlying different phenotypes rats mice lacking cck ar characterized meal patterns cck ar mice determined whether cck ar mice exhibited alteration dmh npy gene expression demonstrate although cck ar mice show similar dysregulation meal size oletf rats elevation dmh npy mrna expression levels fact intact mice cck ar dmh furthermore intact rats npy cck ar colocalized dmh neurons parenchymal injection cck dmh reduces food intake regulates dmh npy mrna expression results suggest although cck ar plays role mediation cck actions control meal size rats mice cck ar seems contribute modulating dmh npy levels rats deficit cck action control dmh npy gene expression may play major role obese phenotype oletf rats
0.100268394.15123537.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references although cholecystokinin cck receptors cck ar mediate feeding inhibitory actions cck rats mice absence cck ar results species specific phenotypes lack cck ar otsuka long evans tokushima fatty oletf rats results hyperphagia obesity suggested demonstrated increases meal size elevated levels dorsomedial hypothalamic dmh neuropeptide y npy gene expression may contribute phenotype contrast oletf rats cck ar mice normal total daily food intake develop obesity assess basis underlying different phenotypes rats mice lacking cck ar characterized meal patterns cck ar mice determined whether cck ar mice exhibited alteration dmh npy gene expression demonstrate although cck ar mice show similar dysregulation meal size oletf rats elevation dmh npy mrna expression levels fact intact mice cck ar dmh furthermore intact rats npy cck ar colocalized dmh neurons parenchymal injection cck dmh reduces food intake regulates dmh npy mrna expression results suggest although cck ar plays role mediation cck actions control meal size rats mice cck ar seems contribute modulating dmh npy levels rats deficit cck action control dmh npy gene expression may play major role obese phenotype oletf rats
0.100268394.15123537.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references cholecystokinin cck peptide found brain gastrointestinal tract cck released duodenum jejunum response intraluminal presence nutrient digestive products proposed serve feedback function short term control food intake peripheral cck administration reduces food intake dose related manner across range experimental situations variety species 1 2 3 4 actions cck food intake specific reduction meal size 5 feeding inhibitory effects exogenously administered cck appear mimic physiological role endogenous cck administration cck antagonists results increase food intake 6 7 8 9 increase manifested increase meal size 10 11 feeding inhibitory actions exogenously administered endogenously released cck mediated interaction cck cck 1 receptors cck ar 7
0.100268394.15123537.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references cholecystokinin cck peptide found brain gastrointestinal tract cck released duodenum jejunum response intraluminal presence nutrient digestive products proposed serve feedback function short term control food intake peripheral cck administration reduces food intake dose related manner across range experimental situations variety species 1 2 3 4 actions cck food intake specific reduction meal size 5 feeding inhibitory effects exogenously administered cck appear mimic physiological role endogenous cck administration cck antagonists results increase food intake 6 7 8 9 increase manifested increase meal size 10 11 feeding inhibitory actions exogenously administered endogenously released cck mediated interaction cck cck 1 receptors cck ar 7
0.100268394.15123537.html.plaintext.txt	7	although satiety actions peripheral cck well characterized role brain cck control food intake controversial initial work reported continuous picomole infusions cck cerebral ventricles sheep suppressed feeding 12 results rodent models mixed although studies identified feeding inhibitory actions central ventricular cck administration issues dosage access peripheral sites raised 13 14 recently blevins et al demonstrated infusing smaller doses cck 8 specific brain sites resulted site specific feeding inhibitory actions rat 15 anorexic dose cck 8 increase plasma cck 8 levels sufficiently suppress feeding peripheral mechanism 16
0.100268394.15123537.html.plaintext.txt	8	although satiety actions peripheral cck well characterized role brain cck control food intake controversial initial work reported continuous picomole infusions cck cerebral ventricles sheep suppressed feeding 12 results rodent models mixed although studies identified feeding inhibitory actions central ventricular cck administration issues dosage access peripheral sites raised 13 14 recently blevins et al demonstrated infusing smaller doses cck 8 specific brain sites resulted site specific feeding inhibitory actions rat 15 anorexic dose cck 8 increase plasma cck 8 levels sufficiently suppress feeding peripheral mechanism 16
0.100268394.15123537.html.plaintext.txt	9	recent data otsuka long evans tokushima fatty oletf rats 17 68 kb deletion cck ar gene resulting absence cck ar 18 suggested peripheral central roles cck acting cck ar control food intake 19 oletf rats peripheral cck satiety deficit rats feeding response peripherally exogenous cck administration 20 consistent lack intact peripheral cck satiety signaling food intake oletf rats characterized significant chronic increases meal sizes response increase meal number decreased decrease compensatory result oletf rats hyperphagic 20 although increase meal size oletf rats consistent absence peripheral cck signaling overall hyperphagia obesity surprising pair feeding oletf rats intake long evans tokushima otsuka leto control rats completely prevents obesity demonstrating increased body weight secondary hyperphagia depend metabolic alterations pair feeding prevented increased body weight also normalized elevated levels leptin insulin alterations arcuate nucleus neuropeptide y npy proopiomelanocortin pomc gene expression oletf rats 21 pair feeding also revealed seems primary deficit dorsomedial hypothalamic dmh npy mrna expression oletf rats dmh npy mrna expression significantly elevated pair fed normal weight oletf rats elevation also found 5 wk old preobese oletf rats 21 suggested dysregulation dmh npy gene expression may combination peripheral satiety deficit contribute hyperphagia obesity oletf rats 21
0.100268394.15123537.html.plaintext.txt	10	recent data otsuka long evans tokushima fatty oletf rats 17 68 kb deletion cck ar gene resulting absence cck ar 18 suggested peripheral central roles cck acting cck ar control food intake 19 oletf rats peripheral cck satiety deficit rats feeding response peripherally exogenous cck administration 20 consistent lack intact peripheral cck satiety signaling food intake oletf rats characterized significant chronic increases meal sizes response increase meal number decreased decrease compensatory result oletf rats hyperphagic 20 although increase meal size oletf rats consistent absence peripheral cck signaling overall hyperphagia obesity surprising pair feeding oletf rats intake long evans tokushima otsuka leto control rats completely prevents obesity demonstrating increased body weight secondary hyperphagia depend metabolic alterations pair feeding prevented increased body weight also normalized elevated levels leptin insulin alterations arcuate nucleus neuropeptide y npy proopiomelanocortin pomc gene expression oletf rats 21 pair feeding also revealed seems primary deficit dorsomedial hypothalamic dmh npy mrna expression oletf rats dmh npy mrna expression significantly elevated pair fed normal weight oletf rats elevation also found 5 wk old preobese oletf rats 21 suggested dysregulation dmh npy gene expression may combination peripheral satiety deficit contribute hyperphagia obesity oletf rats 21
0.100268394.15123537.html.plaintext.txt	11	cck ar knockout mice demonstrate different phenotype oletf rats contrast oletf rat cck ar knockout mice normal total daily food intake maintain normal body weight well adult life 22 although mice insensitive feeding inhibitory action peripheral exogenous cck deficit appear affect overall food intake data interpreted suggest cck essential controlling overall food intake involved long term maintenance body weight 22
0.100268394.15123537.html.plaintext.txt	12	cck ar knockout mice demonstrate different phenotype oletf rats contrast oletf rat cck ar knockout mice normal total daily food intake maintain normal body weight well adult life 22 although mice insensitive feeding inhibitory action peripheral exogenous cck deficit appear affect overall food intake data interpreted suggest cck essential controlling overall food intake involved long term maintenance body weight 22
0.100268394.15123537.html.plaintext.txt	13	investigate basis underlying different phenotypes rats mice lacking cck ar characterized meal patterns cck ar mice determined whether cck ar mice demonstrated alterations dmh npy gene expression findings studies led us compare distribution cck ar mouse rat brains determine relationship npy cck ar rat dmh neurons data demonstrate distribution cck ar differs mice rats may account difference phenotype rats mice lacking cck ar
0.100268394.15123537.html.plaintext.txt	14	investigate basis underlying different phenotypes rats mice lacking cck ar characterized meal patterns cck ar mice determined whether cck ar mice demonstrated alterations dmh npy gene expression findings studies led us compare distribution cck ar mouse rat brains determine relationship npy cck ar rat dmh neurons data demonstrate distribution cck ar differs mice rats may account difference phenotype rats mice lacking cck ar
0.100268394.15123537.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references meal patterns cck ar knockout mice cck ar mice generated previously described 22 cck ar cck ar mice individually housed home cages maintained 12 h light 12 h dark cycle lights 0600 h procedures approved institutional animal care use committee johns hopkins university tufts new england medical center animal research committee beginning experiments adult cck ar cck ar mice transferred test cages wire grid floor prevent pellet hoarding test cages contained feeding devices coulbourn instruments allentown pa delivered 20 mg chow pellets pellet dispensers controlled infrared pellet sensing photo beams med associates inc georgia vt individual pellets delivered response removal previous pellet animals ad libitum access pellets water animals adapted testing apparatus feeding paradigm 10 d experimental data collection point pellet spillage decreased less 10d data recorded 24 hd computer meal defined acquisition least five pellets preceded followed least 10 min feeding 23 meal size defined number pellets delivered meal data dark cycle light cycle total 24 h variables total intake meal size meal frequency saved computer analyzed tongue twister software version 142 dr houpt florida state university tallahassee fl data mouse average data generated 3 continuous days
0.100268394.15123537.html.plaintext.txt	16	materials methods top abstract introduction materials methods results discussion references meal patterns cck ar knockout mice cck ar mice generated previously described 22 cck ar cck ar mice individually housed home cages maintained 12 h light 12 h dark cycle lights 0600 h procedures approved institutional animal care use committee johns hopkins university tufts new england medical center animal research committee beginning experiments adult cck ar cck ar mice transferred test cages wire grid floor prevent pellet hoarding test cages contained feeding devices coulbourn instruments allentown pa delivered 20 mg chow pellets pellet dispensers controlled infrared pellet sensing photo beams med associates inc georgia vt individual pellets delivered response removal previous pellet animals ad libitum access pellets water animals adapted testing apparatus feeding paradigm 10 d experimental data collection point pellet spillage decreased less 10d data recorded 24 hd computer meal defined acquisition least five pellets preceded followed least 10 min feeding 23 meal size defined number pellets delivered meal data dark cycle light cycle total 24 h variables total intake meal size meal frequency saved computer analyzed tongue twister software version 142 dr houpt florida state university tallahassee fl data mouse average data generated 3 continuous days
0.100268394.15123537.html.plaintext.txt	17	situ hybridization mouse brain five week old male cck ar cck ar mice decapitated brains removed rapidly frozen coronal sections 14 microm cut via cryostat mounted superfrost plus slides fisher scientific fairlawn nj fixed 4 paraformaldehyde full length rat cck ar cdna 24 synthesized rt pcr subcloned pcdna1 vector linearized appropriate restriction enzyme antisense sense riboprobe cck ar labeled 35sutp amersham pharmacia biotech piscataway nj using vitro transcription systems promega corp madison wi previously described 25 35s labeled antisense riboprobe npy transcribed rat npy precursor cdna 26 standard situ hybridization conducted brian sections paraventricular nucleus pvn dmh regions 058 206 mm caudal bregma 27 selected examining cck ar mrna expression well brain sections dmh region 170 206 mm caudal bregma 27 selected examining npy mrna expression sections treated acetic anhydride incubated standard hybridization buffer containing 108 cpmml 35s labeled probe overnight incubation temperature set 55 c npy 58 c cck ar probe hybridization sections washed three times 2x standard saline citrate ssc treated 20 microgml ribonuclease sigma aldrich corp st louis mo 37 c 30 min rinsed 2x ssc twice 55 c npy 58 c cck ar finally washed twice 01x ssc 55 c npy 58 c cck ar 15 min time slides dehydrated gradient ethanol air dried exposed bmr 2 film eastman kodak co rochester ny 1 5 d autoradiography slides examined histologically cresyl violet staining
0.100268394.15123537.html.plaintext.txt	18	situ hybridization mouse brain five week old male cck ar cck ar mice decapitated brains removed rapidly frozen coronal sections 14 microm cut via cryostat mounted superfrost plus slides fisher scientific fairlawn nj fixed 4 paraformaldehyde full length rat cck ar cdna 24 synthesized rt pcr subcloned pcdna1 vector linearized appropriate restriction enzyme antisense sense riboprobe cck ar labeled 35sutp amersham pharmacia biotech piscataway nj using vitro transcription systems promega corp madison wi previously described 25 35s labeled antisense riboprobe npy transcribed rat npy precursor cdna 26 standard situ hybridization conducted brian sections paraventricular nucleus pvn dmh regions 058 206 mm caudal bregma 27 selected examining cck ar mrna expression well brain sections dmh region 170 206 mm caudal bregma 27 selected examining npy mrna expression sections treated acetic anhydride incubated standard hybridization buffer containing 108 cpmml 35s labeled probe overnight incubation temperature set 55 c npy 58 c cck ar probe hybridization sections washed three times 2x standard saline citrate ssc treated 20 microgml ribonuclease sigma aldrich corp st louis mo 37 c 30 min rinsed 2x ssc twice 55 c npy 58 c cck ar finally washed twice 01x ssc 55 c npy 58 c cck ar 15 min time slides dehydrated gradient ethanol air dried exposed bmr 2 film eastman kodak co rochester ny 1 5 d autoradiography slides examined histologically cresyl violet staining
0.100268394.15123537.html.plaintext.txt	19	cck binding assay wild type mouse autoradiographic cck binding assay conducted previously described 28 adult male wild type littermates cck ar mice killed decapitation brains removed rapidly frozen isopentane 70 c coronal sections 20 microm pvn 058 122 mm caudal bregma dmh regions 146 206 mm caudal bregma cut via cryostat mounted cold gelatin coated slides 27 differentiate cck ar cck br compared ability cck ar antagonist devazepide cck br agonist desulfated cck 8 dcck displace binding site 125i labeled cck 8 binding inhibited devazepide dcck binding occurring cck ar contrast binding inhibited dcck devazepide binding occurring cck br thus preincubation 50 mm tris hcl buffer ph 74 containing 05 bsa 20 min 24 c slides incubated standard binding buffer containing 50 pm 125ibolton hunter labeled cck 8 perkinelmer boston ma 2 h 24 c either alone presence 10 nm devazepide 100 nm dcck 100 microm sulfated cck 8 incubation slides washed ice cold 50 mm tris hcl buffer ph 74 containing 05 bsa six times 10 min time washed slides completely air dried exposed bmr 2 film eastman kodak co 5 7 d
0.100268394.15123537.html.plaintext.txt	20	cck binding assay wild type mouse autoradiographic cck binding assay conducted previously described 28 adult male wild type littermates cck ar mice killed decapitation brains removed rapidly frozen isopentane 70 c coronal sections 20 microm pvn 058 122 mm caudal bregma dmh regions 146 206 mm caudal bregma cut via cryostat mounted cold gelatin coated slides 27 differentiate cck ar cck br compared ability cck ar antagonist devazepide cck br agonist desulfated cck 8 dcck displace binding site 125i labeled cck 8 binding inhibited devazepide dcck binding occurring cck ar contrast binding inhibited dcck devazepide binding occurring cck br thus preincubation 50 mm tris hcl buffer ph 74 containing 05 bsa 20 min 24 c slides incubated standard binding buffer containing 50 pm 125ibolton hunter labeled cck 8 perkinelmer boston ma 2 h 24 c either alone presence 10 nm devazepide 100 nm dcck 100 microm sulfated cck 8 incubation slides washed ice cold 50 mm tris hcl buffer ph 74 containing 05 bsa six times 10 min time washed slides completely air dried exposed bmr 2 film eastman kodak co 5 7 d
0.100268394.15123537.html.plaintext.txt	21	dual immunohistochemistry rat coronal sections 14 microm brains leto oletf rats obtained otsuka pharmaceuticals otsuka japan prepared described fixed 4 paraformaldehyde dual immunohistochemistry modified procedure previously described 29 sections incubated primary antibody mixtures containing 11000 mouse anti npy monoclonal antibody gift dr eric grouzmann centre hospitalier universitaire vaudois lausanne switzerland 30 12000 rabbit antirat cck ar antibody targeted amino acid sequence shmstsappp corresponding c terminal rat cck ar accurate chemical scientific corp westbury ny 4 c overnight three washes secondary antibodies added slides goat antimouse conjugated fluorescein 1 ng microl roche indianapolis detecting npy peptide biotin labeled goat antirabbit igg 1250 nen life science products inc boston ma detecting cck ar cck ar signal amplified tsa tyramide signal amplification biotin system nen life science products inc stained streptavidin texas red conjugate 1500 nen life science products inc according manufacturer protocol sections examined lsm 410 confocal microscope zeiss new york ny using 488 nm laser excite fluorescein 543 nm laser excite texas red
0.100268394.15123537.html.plaintext.txt	22	dual immunohistochemistry rat coronal sections 14 microm brains leto oletf rats obtained otsuka pharmaceuticals otsuka japan prepared described fixed 4 paraformaldehyde dual immunohistochemistry modified procedure previously described 29 sections incubated primary antibody mixtures containing 11000 mouse anti npy monoclonal antibody gift dr eric grouzmann centre hospitalier universitaire vaudois lausanne switzerland 30 12000 rabbit antirat cck ar antibody targeted amino acid sequence shmstsappp corresponding c terminal rat cck ar accurate chemical scientific corp westbury ny 4 c overnight three washes secondary antibodies added slides goat antimouse conjugated fluorescein 1 ng microl roche indianapolis detecting npy peptide biotin labeled goat antirabbit igg 1250 nen life science products inc boston ma detecting cck ar cck ar signal amplified tsa tyramide signal amplification biotin system nen life science products inc stained streptavidin texas red conjugate 1500 nen life science products inc according manufacturer protocol sections examined lsm 410 confocal microscope zeiss new york ny using 488 nm laser excite fluorescein 543 nm laser excite texas red
0.100268394.15123537.html.plaintext.txt	23	dmh cannulation cck 8 injection rat fifteen male long evans rats charles river laboratories wilmington ma weighing 275 300 g implanted chronic indwelling dmh cannulas animals individually housed hanging wire mesh cages maintained 12 h light 12 h dark cycle feeding schedule regular chow food removed cages 2 h lights returned cages dark onset water always available time surgery rats anesthetized im mixture ketamine 100 mgkg xylazine 20 mgkg placed stereotaxic device 26 gauge stainless steel guide cannula plastic one wallingford ct implanted dmh following coordinates 33 mm caudal bregma 03 mm lateral midline 81 mm ventral skull surface 15 31 coordinates chosen based results pilot experiments 33 gauge stainless steel obturator inserted cannula maintain patency surgery rats given penicillin 60000 u im prevent postoperative infection banamine 1 mgkg im pain relief
0.100268394.15123537.html.plaintext.txt	24	dmh cannulation cck 8 injection rat fifteen male long evans rats charles river laboratories wilmington ma weighing 275 300 g implanted chronic indwelling dmh cannulas animals individually housed hanging wire mesh cages maintained 12 h light 12 h dark cycle feeding schedule regular chow food removed cages 2 h lights returned cages dark onset water always available time surgery rats anesthetized im mixture ketamine 100 mgkg xylazine 20 mgkg placed stereotaxic device 26 gauge stainless steel guide cannula plastic one wallingford ct implanted dmh following coordinates 33 mm caudal bregma 03 mm lateral midline 81 mm ventral skull surface 15 31 coordinates chosen based results pilot experiments 33 gauge stainless steel obturator inserted cannula maintain patency surgery rats given penicillin 60000 u im prevent postoperative infection banamine 1 mgkg im pain relief
0.100268394.15123537.html.plaintext.txt	25	7 d postoperative recovery 15 cannulated rats randomly divided two groups lights one group eight animals injected 03 microl artificial cerebrospinal fluid acsf 147 mm na 27 mm k 12 mm ca2 085 mm mg2 1538 mm cl group seven animals injected 500 pmol cck 8 bachem torrance ca 03 microl acsf dmh injections made gilmont micrometer syringe attached polyethylene tubing 33 gauge stainless steel injector plastic one tip injector extended 10 mm past tip guide cannula injections made 10 injection remained place additional 20 removal chow food returned immediately injection food intakes measured 30 min 1 h 2 h 4 h 22 h returning food cages 7 d period recovery rats given second dmh injections acsf cck 8 500 pmol treatment ie rat previously received cck 8 administration given acsf injection time vice versa food intake measured described first injections thus rat received acsf cck 8 administration served control comparison cck 8 feeding effect
0.100268394.15123537.html.plaintext.txt	26	7 d postoperative recovery 15 cannulated rats randomly divided two groups lights one group eight animals injected 03 microl artificial cerebrospinal fluid acsf 147 mm na 27 mm k 12 mm ca2 085 mm mg2 1538 mm cl group seven animals injected 500 pmol cck 8 bachem torrance ca 03 microl acsf dmh injections made gilmont micrometer syringe attached polyethylene tubing 33 gauge stainless steel injector plastic one tip injector extended 10 mm past tip guide cannula injections made 10 injection remained place additional 20 removal chow food returned immediately injection food intakes measured 30 min 1 h 2 h 4 h 22 h returning food cages 7 d period recovery rats given second dmh injections acsf cck 8 500 pmol treatment ie rat previously received cck 8 administration given acsf injection time vice versa food intake measured described first injections thus rat received acsf cck 8 administration served control comparison cck 8 feeding effect
0.100268394.15123537.html.plaintext.txt	27	feeding tests 15 animals 10 additional dmh cannulated rats body weight matched randomly divided two groups acsf control n 12 cck 8 treatment n 13 assessing whether cck 8 injection dmh affected hypothalamic npy mrna expression animals maintained feeding schedule described regular chow removed cages 2 h lights returned cages dark onset access water ad libitum rats received either acsf cck 8 injections described without access chow food injections two hours injections rats killed overdose sodium pentobarbital brains removed rapidly frozen subsequent analyses hypothalamic npy gene expression 25 32 33
0.100268394.15123537.html.plaintext.txt	28	feeding tests 15 animals 10 additional dmh cannulated rats body weight matched randomly divided two groups acsf control n 12 cck 8 treatment n 13 assessing whether cck 8 injection dmh affected hypothalamic npy mrna expression animals maintained feeding schedule described regular chow removed cages 2 h lights returned cages dark onset access water ad libitum rats received either acsf cck 8 injections described without access chow food injections two hours injections rats killed overdose sodium pentobarbital brains removed rapidly frozen subsequent analyses hypothalamic npy gene expression 25 32 33
0.100268394.15123537.html.plaintext.txt	29	described series 14 microm coronal brain sections ranging 26 36 mm caudal bregma cut 31 mounted slides series six section 1 slide 1 section 2 slide 2 etc section 7 slide 1 etc fixed 4 paraformaldehyde site dmh injection rats anatomically examined via cresyl violet staining process brain sections data rats incorrect cannula placements excluded subsequent statistical analyses
0.100268394.15123537.html.plaintext.txt	30	situ hybridization determination hypothalamic npy mrna expression conducted described quantitative analysis situ hybridization data performed nih scion image software nih bethesda md autoradiographic images first scanned using epson professional scanner epson long beach ca saved via computer subsequent analyses scion image software using autoradiographic 14c microscales amersham pharmacia biotech standard data animal mean product hybridization area x density background density subtracted obtained four sections reflecting level gene expression region 32 34 mm posterior bregma example one section 32 mm one 3284 mm one 3368 one 3452 mm posterior bregma 31 data group normalized acsf treated controls 100 data presented mean plus minus sem
0.100268394.15123537.html.plaintext.txt	31	situ hybridization determination hypothalamic npy mrna expression conducted described quantitative analysis situ hybridization data performed nih scion image software nih bethesda md autoradiographic images first scanned using epson professional scanner epson long beach ca saved via computer subsequent analyses scion image software using autoradiographic 14c microscales amersham pharmacia biotech standard data animal mean product hybridization area x density background density subtracted obtained four sections reflecting level gene expression region 32 34 mm posterior bregma example one section 32 mm one 3284 mm one 3368 one 3452 mm posterior bregma 31 data group normalized acsf treated controls 100 data presented mean plus minus sem
0.100268394.15123537.html.plaintext.txt	32	statistical analysis data analyzed test two groups comparison p 005 taken statistically significant difference
0.100268394.15123537.html.plaintext.txt	33	results top abstract introduction materials methods results discussion references altered meal patterns cck ar mice shown table 1 cck ar mice slightly significantly increased total daily food intake compared wild type control mice however diurnal pattern intake meal patterns altered cck ar mice although cck ar cck ar mice consumed majority food intake dark period 831 total intake knockout 758 wild type mice respectively cck ar mice significantly elevated food intake dark period p 005 tended decrease food intake light period p 005 compared wild type mice meal pattern analysis revealed cck ar mice significant increase overall average meal size compared wild type mice table 1 cck ar mice consumed 353 food per meal wild type mice alteration meal patterns mainly occurred dark period majority food consumed meal sizes elevated light period although meal frequency differ significantly two groups cck ar mice appeared slightly decreased meal numbers total daily light periods compared wild type mice thus similar oletf rats absence cck ar mice resulted dysregulation control meal size however contrast oletf rats cck ar mice able maintain normal daily food intake whether difference due smaller magnitude meal size increase cck ar mice oletf rats 35 vs 80 20 another explanation addressed next series experiments
0.100268394.15123537.html.plaintext.txt	34	results top abstract introduction materials methods results discussion references altered meal patterns cck ar mice shown table 1 cck ar mice slightly significantly increased total daily food intake compared wild type control mice however diurnal pattern intake meal patterns altered cck ar mice although cck ar cck ar mice consumed majority food intake dark period 831 total intake knockout 758 wild type mice respectively cck ar mice significantly elevated food intake dark period p 005 tended decrease food intake light period p 005 compared wild type mice meal pattern analysis revealed cck ar mice significant increase overall average meal size compared wild type mice table 1 cck ar mice consumed 353 food per meal wild type mice alteration meal patterns mainly occurred dark period majority food consumed meal sizes elevated light period although meal frequency differ significantly two groups cck ar mice appeared slightly decreased meal numbers total daily light periods compared wild type mice thus similar oletf rats absence cck ar mice resulted dysregulation control meal size however contrast oletf rats cck ar mice able maintain normal daily food intake whether difference due smaller magnitude meal size increase cck ar mice oletf rats 35 vs 80 20 another explanation addressed next series experiments
0.100268394.15123537.html.plaintext.txt	35	view table table 1 meal parameters cck ar cck ar mice
0.100268394.15123537.html.plaintext.txt	36	npy mrna expression detected dmh mouse prior work demonstrated dmh npy mrna expression elevated adult pair fed young preobese oletf rats 21 study determined whether mice lacking cck receptors displayed similar alteration dmh npy shown fig 1 npy mrna expression evident arcuate nucleus cck ar cck ar mice dmh npy mrna expression detectable either cck ar cck ar mice 5 wk age fig 1 oletf rats elevated dmh npy gene expression
0.100268394.15123537.html.plaintext.txt	37	npy mrna expression detected dmh mouse prior work demonstrated dmh npy mrna expression elevated adult pair fed young preobese oletf rats 21 study determined whether mice lacking cck receptors displayed similar alteration dmh npy shown fig 1 npy mrna expression evident arcuate nucleus cck ar cck ar mice dmh npy mrna expression detectable either cck ar cck ar mice 5 wk age fig 1 oletf rats elevated dmh npy gene expression
0.100268394.15123537.html.plaintext.txt	38	view larger version 66k fig 1 situ hybridization npy mrna 35sutp labeled npy riboprobe cck ar cck ar mice within hypothalamus npy mrna expression evident arcuate nucleus dmh cck ar cck ar b mice 5 wk age
0.100268394.15123537.html.plaintext.txt	39	cck ar absent dmh mouse absence dmh npy mrna expression cck ar mice raises possibility dmh npy may differentially controlled rats mice cck binding situ hybridization studies demonstrated presence cck ar rat dmh 28 34 35 determine whether differences distribution cck ar rat mouse brains determined distribution cck ar mouse hypothalamus using 125i labeled cck 8 binding autoradiography situ hybridization histochemistry 35s labeled cck ar riboprobe autoradiographs cck binding assay mouse brain revealed within hypothalamus cck ar binding sites present pvn fig 2 c cck br binding sites found ventromedial hypothalamus fig 2 e g cck binding activity detected dmh fig 2 e g consistent binding data situ hybridization histochemistry revealed cck ar mrna highly expressed pvn fig 3a expressed dmh mice fig 3b evidence cck ar mrna expression arcuate nucleus fig 3b although cck binding activity detected fig 2 e g thus neither cck binding assay cck ar mrna expression determination detected presence cck ar dmh mouse
0.100268394.15123537.html.plaintext.txt	40	cck ar absent dmh mouse absence dmh npy mrna expression cck ar mice raises possibility dmh npy may differentially controlled rats mice cck binding situ hybridization studies demonstrated presence cck ar rat dmh 28 34 35 determine whether differences distribution cck ar rat mouse brains determined distribution cck ar mouse hypothalamus using 125i labeled cck 8 binding autoradiography situ hybridization histochemistry 35s labeled cck ar riboprobe autoradiographs cck binding assay mouse brain revealed within hypothalamus cck ar binding sites present pvn fig 2 c cck br binding sites found ventromedial hypothalamus fig 2 e g cck binding activity detected dmh fig 2 e g consistent binding data situ hybridization histochemistry revealed cck ar mrna highly expressed pvn fig 3a expressed dmh mice fig 3b evidence cck ar mrna expression arcuate nucleus fig 3b although cck binding activity detected fig 2 e g thus neither cck binding assay cck ar mrna expression determination detected presence cck ar dmh mouse
0.100268394.15123537.html.plaintext.txt	41	view larger version 111k fig 2 autoradiographs 50 pm 125ibolton hunter labeled cck 8 binding wild type mouse brain d 094 mm posterior bregma e h 194 mm posterior bregma 27 four conditions alone e 10 nm devazepide b f 100 nm dcck c g 100 microm sulfated cck 8 scck d h within hypothalamus 10 nm devazepide blocked 125icck 8 binding pvn b 100 nm dcck blocked 125icck 8 binding ventromedial nucleus vmh 125icck 8 binding found dmh
0.100268394.15123537.html.plaintext.txt	42	view larger version 103k fig 3 situ hybridization cck ar mrna 35sutp labeled cck ar antisense riboprobe wild type mouse brain within hypothalamus cck ar mrna expressed pvn slightly arcuate nucleus b dmh b hybridization signal detected incubation sense probe c scale bar 350 microm
0.100268394.15123537.html.plaintext.txt	43	colocalization npy cck ar dmh neurons rats previous data demonstrated npy mrna expression elevated dmh specifically compact subregion young preobese adult pair fed oletf rats lacking cck ar 21 presence cck ar rat dmh suggests dmh npy gene expression may normally regulated brain cck interaction cck ar investigate whether npy cck ar colocalized dmh neurons performed double immunostaining anti npy anti cck ar antibodies rat brain showed fig 4 leto oletf dmh contained npy immunostaining neurons fig 4 d green cck ar immunostaining neurons detected dmh leto controls fig 4b red absence cck ar immunoreactivity oletf rats fig 4e consistent absence cck ar model confocal microscopic analysis revealed npy cck ar colocalized dmh neurons fig 4 c g orange shown high magnification fig 4g cck ar staining found surface npy neurons
0.100268394.15123537.html.plaintext.txt	44	colocalization npy cck ar dmh neurons rats previous data demonstrated npy mrna expression elevated dmh specifically compact subregion young preobese adult pair fed oletf rats lacking cck ar 21 presence cck ar rat dmh suggests dmh npy gene expression may normally regulated brain cck interaction cck ar investigate whether npy cck ar colocalized dmh neurons performed double immunostaining anti npy anti cck ar antibodies rat brain showed fig 4 leto oletf dmh contained npy immunostaining neurons fig 4 d green cck ar immunostaining neurons detected dmh leto controls fig 4b red absence cck ar immunoreactivity oletf rats fig 4e consistent absence cck ar model confocal microscopic analysis revealed npy cck ar colocalized dmh neurons fig 4 c g orange shown high magnification fig 4g cck ar staining found surface npy neurons
0.100268394.15123537.html.plaintext.txt	45	view larger version 90k fig 4 dual immunohistochemistry leto control oletf rat brains anti npy anti cck ar antibodies leto oletf rats npy immunostaining evident dmh neurons green d cck ar immunostaining neurons detected dmh leto controls red b oletf rats e npy cck ar colocalized dmh neurons leto control rats orange c g confocal microscopic analysis scale bar 20 microm
0.100268394.15123537.html.plaintext.txt	46	brain cck acts dmh npy neurons inhibit food intake finding npy cck ar colocalization dmh neurons overexpression dmh npy rats lacking cck ar suggest brain cck may normally play role controlling npy gene expression dmh npy neurons test hypothesis understand basis brain cck actions food intake assessed whether injection cck dmh affected hypothalamic npy gene expression shown fig 5 npy mrna expression significantly regulated parenchymal injection cck dmh exogenous cck administration resulted 27 reduction npy mrna expression ipsilateral compact subregion dmh fig 5 also found relative controls arcuate npy mrna expression significantly reduced 24 cck injected rats fig 5 data confirm cck within dmh capable directly regulating npy gene expression
0.100268394.15123537.html.plaintext.txt	47	brain cck acts dmh npy neurons inhibit food intake finding npy cck ar colocalization dmh neurons overexpression dmh npy rats lacking cck ar suggest brain cck may normally play role controlling npy gene expression dmh npy neurons test hypothesis understand basis brain cck actions food intake assessed whether injection cck dmh affected hypothalamic npy gene expression shown fig 5 npy mrna expression significantly regulated parenchymal injection cck dmh exogenous cck administration resulted 27 reduction npy mrna expression ipsilateral compact subregion dmh fig 5 also found relative controls arcuate npy mrna expression significantly reduced 24 cck injected rats fig 5 data confirm cck within dmh capable directly regulating npy gene expression
0.100268394.15123537.html.plaintext.txt	48	view larger version 68k fig 5 effects cck injection dmh npy mrna expression dmh cck injection decreased npy gene expression dmh b c arcuate nucleus b c rat compared acsf treated controls values mean plus minus sem n 6 7 p 005 compared acsf treated group scale bar 1 mm
0.100268394.15123537.html.plaintext.txt	49	well altering npy mrna expression found exogenous injection cck dmh resulted reduction 30 min food intake intake dropped 237 plus minus 021 g vehicle controls n 9 157 plus minus 031 g cck treated group n 10 p 005
0.100268394.15123537.html.plaintext.txt	50	discussion top abstract introduction materials methods results discussion references together data provide complete understanding consequences cck ar deficiency mice previously demonstrated oletf rats lacking cck ar deficit ability limit size spontaneous meals disruption regulation npy mrna expression dmh suggested alterations may contribute hyperphagia obesity oletf rats 19 current results demonstrate cck ar mice also altered meal patterns however contrast oletf rat overall food intake affected cck ar mice thus although rats mice lacking cck ar demonstrate deficit peripheral cck satiety actions leading increased meal size overall control food intake energy balance appears differ assessment distribution cck ar mouse brain revealed cck ar binding activity cck ar mrna expression dmh normal mice previous work consistently shown rat dmh contains cck ar 28 34 35 furthermore contrast findings elevated npy gene expression dmh young preobese adult pair fed oletf rats 21 npy mrna expression detected dmh either cck ar cck ar mice moreover cck ar mice normal levels npy mrna expression arcuate nucleus npy mrna expression reduced ad libitum fed oletf rats normalized pair feeding 21 finally potential role altered dmh npy expression hyperphagia obesity oletf rats suggested demonstrations npy cck ar colocalized dmh neurons intact rats cck plays role controlling dmh npy gene expression together results suggest differential distribution brain cck ar determines different phenotypes expressed rats mice lacking cck ar
0.100268394.15123537.html.plaintext.txt	51	discussion top abstract introduction materials methods results discussion references together data provide complete understanding consequences cck ar deficiency mice previously demonstrated oletf rats lacking cck ar deficit ability limit size spontaneous meals disruption regulation npy mrna expression dmh suggested alterations may contribute hyperphagia obesity oletf rats 19 current results demonstrate cck ar mice also altered meal patterns however contrast oletf rat overall food intake affected cck ar mice thus although rats mice lacking cck ar demonstrate deficit peripheral cck satiety actions leading increased meal size overall control food intake energy balance appears differ assessment distribution cck ar mouse brain revealed cck ar binding activity cck ar mrna expression dmh normal mice previous work consistently shown rat dmh contains cck ar 28 34 35 furthermore contrast findings elevated npy gene expression dmh young preobese adult pair fed oletf rats 21 npy mrna expression detected dmh either cck ar cck ar mice moreover cck ar mice normal levels npy mrna expression arcuate nucleus npy mrna expression reduced ad libitum fed oletf rats normalized pair feeding 21 finally potential role altered dmh npy expression hyperphagia obesity oletf rats suggested demonstrations npy cck ar colocalized dmh neurons intact rats cck plays role controlling dmh npy gene expression together results suggest differential distribution brain cck ar determines different phenotypes expressed rats mice lacking cck ar
0.100268394.15123537.html.plaintext.txt	52	actions peripheral cck control meal size well characterized peripheral cck produces dose related suppression meal size results earlier appearance behavioral satiety sequence 11 actions exogenous peptide appear mimic physiological role endogenous cck administration cck antagonists results increase food intake feeding inhibitory actions exogenously administered endogenously released cck depend upon actions cck ar cck mediated inhibition food intake blocked cck ar antagonists unaffected cck br antagonists 7 current finding increased meal size cck ar mice demonstrates action endogenous cck control meal size mice consistent prior data antagonists previous findings oletf rat also lacks cck ar 10 11 20 thus data provide additional molecular biological support physiological role endogenous cck short term control food intake magnitude change meal size cck ar mice quite bit smaller 80 increase found oletf rats lacking cck ar difference may reflect relative difference contribution cck meal termination rats mice
0.100268394.15123537.html.plaintext.txt	53	actions peripheral cck control meal size well characterized peripheral cck produces dose related suppression meal size results earlier appearance behavioral satiety sequence 11 actions exogenous peptide appear mimic physiological role endogenous cck administration cck antagonists results increase food intake feeding inhibitory actions exogenously administered endogenously released cck depend upon actions cck ar cck mediated inhibition food intake blocked cck ar antagonists unaffected cck br antagonists 7 current finding increased meal size cck ar mice demonstrates action endogenous cck control meal size mice consistent prior data antagonists previous findings oletf rat also lacks cck ar 10 11 20 thus data provide additional molecular biological support physiological role endogenous cck short term control food intake magnitude change meal size cck ar mice quite bit smaller 80 increase found oletf rats lacking cck ar difference may reflect relative difference contribution cck meal termination rats mice
0.100268394.15123537.html.plaintext.txt	54	current data demonstrate cck ar mice altered diurnal feeding patterns oletf rats lacking cck ar increased food intake characterized increased meal size dark light periods response increased meal size meal number decreased dark period decrease compensatory 20 however analyses feeding patterns cck ar mice revealed increased food intake dark period characterized increase meal size food intake tended decreased light period characterized reduction meal frequency leading absence significant changes total food intake data suggest cck acting cck ar plays differential role circadian activities rats mice
0.100268394.15123537.html.plaintext.txt	55	current data demonstrate cck ar mice altered diurnal feeding patterns oletf rats lacking cck ar increased food intake characterized increased meal size dark light periods response increased meal size meal number decreased dark period decrease compensatory 20 however analyses feeding patterns cck ar mice revealed increased food intake dark period characterized increase meal size food intake tended decreased light period characterized reduction meal frequency leading absence significant changes total food intake data suggest cck acting cck ar plays differential role circadian activities rats mice
0.100268394.15123537.html.plaintext.txt	56	even though rats mice lacking cck ar peripheral cck satiety deficits resulting increased meal size total daily food intake body weight normal cck ar mice whereas oletf rats lacking cck ar shown hyperphagic become obese although may reflect differential ability compensate smaller rather larger increases meal size present data also suggest difference phenotype may outcome different distribution brain cck ar rats mice potential importance differential distribution derives findings intact rats npy cck ar colocalized dmh neurons cck plays role modulating dmh npy exogenous administration cck dmh regulates dmh npy mrna expression results consistent previous findings demonstrating npy gene expression regulated dmh oletf rats lack cck ar 21 although pair feeding oletf rats prevented increased body weight normalized altered arcuate npy pomc gene expression pair feeding resulted significantly elevated npy gene expression dmh elevation npy mrna expression dmh also documented young preobese oletf rats 21 therefore cck acting cck ars dmh appears suppress dmh npy gene expression rat suppression inhibits energy intake dmh cck injection reduces food intake hyperphagic obese oletf rat deficit cck npy signaling pathway resulting lack cck ar production cck acting cck ar appear play role controlling dmh npy mouse
0.100268394.15123537.html.plaintext.txt	57	even though rats mice lacking cck ar peripheral cck satiety deficits resulting increased meal size total daily food intake body weight normal cck ar mice whereas oletf rats lacking cck ar shown hyperphagic become obese although may reflect differential ability compensate smaller rather larger increases meal size present data also suggest difference phenotype may outcome different distribution brain cck ar rats mice potential importance differential distribution derives findings intact rats npy cck ar colocalized dmh neurons cck plays role modulating dmh npy exogenous administration cck dmh regulates dmh npy mrna expression results consistent previous findings demonstrating npy gene expression regulated dmh oletf rats lack cck ar 21 although pair feeding oletf rats prevented increased body weight normalized altered arcuate npy pomc gene expression pair feeding resulted significantly elevated npy gene expression dmh elevation npy mrna expression dmh also documented young preobese oletf rats 21 therefore cck acting cck ars dmh appears suppress dmh npy gene expression rat suppression inhibits energy intake dmh cck injection reduces food intake hyperphagic obese oletf rat deficit cck npy signaling pathway resulting lack cck ar production cck acting cck ar appear play role controlling dmh npy mouse
0.100268394.15123537.html.plaintext.txt	58	failed detect npy mrna expression dmh either cck ar cck ar mice situ hybridization determination dmh npy mrna expression ad libitum fed rats normally low elevated experimental situations lactation 36 response chronic food restriction 25 rat clear differences controls dmh arcuate nucleus npy expressing neurons arcuate nucleus npy containing neurons express ob rb long form leptin receptors npy expression leptin control 37 elevated leptin levels reduce npy mrna expression whereas food deprivation increases arcuate npy gene expression contrast dmh npy containing neurons express leptin receptors dmh npy mrna expression increase response acute food deprivation 25 moreover within dmh region altered npy expression response variety treatments appears differ current data demonstrating reduction dmh npy expression cck localized compact subregion consistent previous findings 21 25 whereas lactating rats smith 36 reported although slight increase npy mrna expression compact area dmh npy mrna expression mainly induced diffuse portion dmh however yet clear whether npy mrna expression different subregions dmh differentially regulated controls dmh npy expression mouse extensively investigated evidence npy expressing neurons mouse comes data demonstrating induction dmh npy expression several obesity models disrupted melanocortin signaling lethal agouti yellow ay melanocortin 4 receptor knockout mc4r mice 38 diet induced obese mice 39 data suggest interactions melanocortin signaling metabolic status control dmh npy functions mouse
0.100268394.15123537.html.plaintext.txt	59	failed detect npy mrna expression dmh either cck ar cck ar mice situ hybridization determination dmh npy mrna expression ad libitum fed rats normally low elevated experimental situations lactation 36 response chronic food restriction 25 rat clear differences controls dmh arcuate nucleus npy expressing neurons arcuate nucleus npy containing neurons express ob rb long form leptin receptors npy expression leptin control 37 elevated leptin levels reduce npy mrna expression whereas food deprivation increases arcuate npy gene expression contrast dmh npy containing neurons express leptin receptors dmh npy mrna expression increase response acute food deprivation 25 moreover within dmh region altered npy expression response variety treatments appears differ current data demonstrating reduction dmh npy expression cck localized compact subregion consistent previous findings 21 25 whereas lactating rats smith 36 reported although slight increase npy mrna expression compact area dmh npy mrna expression mainly induced diffuse portion dmh however yet clear whether npy mrna expression different subregions dmh differentially regulated controls dmh npy expression mouse extensively investigated evidence npy expressing neurons mouse comes data demonstrating induction dmh npy expression several obesity models disrupted melanocortin signaling lethal agouti yellow ay melanocortin 4 receptor knockout mc4r mice 38 diet induced obese mice 39 data suggest interactions melanocortin signaling metabolic status control dmh npy functions mouse
0.100268394.15123537.html.plaintext.txt	60	finding decreased arcuate well dmh npy mrna expression response dmh cck injection surprising consistent previous studies rat 28 34 failed identify cck ar binding activity arcuate nucleus mouse absence arcuate cck receptors implies dmharcuate interaction controls arcuate npy although main hypothalamic output dmh thought pvn projections dmh arcuate nucleus identified 40 projections may basis arcuate npy reduction response dmh cck injection
0.100268394.15123537.html.plaintext.txt	61	finding decreased arcuate well dmh npy mrna expression response dmh cck injection surprising consistent previous studies rat 28 34 failed identify cck ar binding activity arcuate nucleus mouse absence arcuate cck receptors implies dmharcuate interaction controls arcuate npy although main hypothalamic output dmh thought pvn projections dmh arcuate nucleus identified 40 projections may basis arcuate npy reduction response dmh cck injection
0.100268394.15123537.html.plaintext.txt	62	role dmh feeding control long suggested bellinger colleagues 41 demonstrated small dmh electrolytic excitotoxic lesions dmhl result hypophagia hypodipsia reduced body weight reduced linear growth rat pair feeding experiments one group sham operated rats pair fed computerized feeding system presented food pellets amount pattern yoked dmhl rats demonstrated altered body weight dmhl rats primarily result altered food intake 42 despite findings particular contribution dmh interacts hypothalamic nuclei involved energy balance well understood findings rat suggest basis dmhl induced hypophagia may elimination npy ergic output output normally control cck acting cck ar although distribution mediation cck ar human brain unclear data primates demonstrated dmh contains cck ar binding site monkey 43 central injection cck ar b receptor agonist inhibits food intake baboon 44 findings suggest dmh cck ar may play role food intake control humans polymorphism cck ar gene patients obesity diabetes reported various studies 45 46 47 48 providing support role
0.100268394.15123537.html.plaintext.txt	63	role dmh feeding control long suggested bellinger colleagues 41 demonstrated small dmh electrolytic excitotoxic lesions dmhl result hypophagia hypodipsia reduced body weight reduced linear growth rat pair feeding experiments one group sham operated rats pair fed computerized feeding system presented food pellets amount pattern yoked dmhl rats demonstrated altered body weight dmhl rats primarily result altered food intake 42 despite findings particular contribution dmh interacts hypothalamic nuclei involved energy balance well understood findings rat suggest basis dmhl induced hypophagia may elimination npy ergic output output normally control cck acting cck ar although distribution mediation cck ar human brain unclear data primates demonstrated dmh contains cck ar binding site monkey 43 central injection cck ar b receptor agonist inhibits food intake baboon 44 findings suggest dmh cck ar may play role food intake control humans polymorphism cck ar gene patients obesity diabetes reported various studies 45 46 47 48 providing support role
0.100268394.15123537.html.plaintext.txt	64	interpreted current data support view different phenotypes oletf rats cck mice derive differential role central cck ar energy balance rats mice oletf rats targeted deletion cck ar arose spontaneous mutation quite possible genetic alterations oletf rat alone combination alterations cck ar signaling account hyperphagia obesity diabetes 49 however additional genetic defects yet identified
0.100268394.15123537.html.plaintext.txt	65	interpreted current data support view different phenotypes oletf rats cck mice derive differential role central cck ar energy balance rats mice oletf rats targeted deletion cck ar arose spontaneous mutation quite possible genetic alterations oletf rat alone combination alterations cck ar signaling account hyperphagia obesity diabetes 49 however additional genetic defects yet identified
0.100268394.15123537.html.plaintext.txt	66	summary present results suggest although rats mice lacking cck ar demonstrate deficit meal size control differential distribution cck ar rat mouse brains may determine divergent effects cck ar gene disruption rat brain cck acting cck ar appears play role regulating dmh npy gene expression dmh cck inhibits npy mrna expression food intake absence cck ar oletf rats deficit control dmh npy gene expression resulting increased dmh npy gene expression increased food intake eventually obesity contrast found evidence presence cck ar dmh mouse thus cck ar contribute control dmh npy gene expression absence central deficit mice lacking cck ar able compensate absence cck satiety signaling become hyperphagic obese
0.100268394.15123537.html.plaintext.txt	67	summary present results suggest although rats mice lacking cck ar demonstrate deficit meal size control differential distribution cck ar rat mouse brains may determine divergent effects cck ar gene disruption rat brain cck acting cck ar appears play role regulating dmh npy gene expression dmh cck inhibits npy mrna expression food intake absence cck ar oletf rats deficit control dmh npy gene expression resulting increased dmh npy gene expression increased food intake eventually obesity contrast found evidence presence cck ar dmh mouse thus cck ar contribute control dmh npy gene expression absence central deficit mice lacking cck ar able compensate absence cck satiety signaling become hyperphagic obese
0.100268394.15123537.html.plaintext.txt	68	acknowledgments oletf leto rats generous gifts otsuka pharmaceutical tokushima japan
0.100268394.15123537.html.plaintext.txt	69	footnotes work supported national institute diabetes digestive kidney diseases grants dk 57609 thm dk 046767 ask national institute mental health grant mh067638 sb
0.100268394.15123537.html.plaintext.txt	70	abbreviations acsf artificial cerebrospinal fluid cck cholecystokinin cck ar cholecystokinin receptor dcck desulfated cholecystokinin 8 dmh dorsomedial hypothalamic dmhl dmh electrolytic excitotoxic lesion leto long evans tokushima otsuka npy neuropeptide y oletf otsuka long evans tokushima fatty pomc proopiomelanocortin pvn paraventricular nucleus ssc standard saline citrate
0.100268394.15123537.html.plaintext.txt	71	accepted publication april 22 2004
0.100268394.15123537.html.plaintext.txt	72	references top abstract introduction materials methods results discussion references gibbs j young rc smith gp 1973 cholecystokinin decreases food intake rats j comp physiol psychol 84488 495medline anika sm houpt tr houpt ka 1981 cholecystokinin satiety pigs j physiol 240r310 r318 gibbs j falasco jd mchugh pr 1976 cholecystokinin decreased food intake rhesus monkeys j physiol 23015 18abstractfree full text kissileff hr pi sunyer fx thornton j smith gp 1981 c terminal octapeptide cholecystokinin decreases food intake man j clin nutr 34154 160abstract west db fey d woods sc 1984 cholecystokinin persistently suppresses meal size food intake free feeding rats j physiol 246r776 r787 shillabeer g davison js 1984 cholecystokinin antagonist proglumide increases food intake rat regul pept 8171 176crossrefmedline moran th ameglio pj schwartz gj mchugh pr 1992 blockade type type b cck receptors attenuates satiety actions exogenous endogenous cck j physiol 262r46 r50 reidelberger rd o rourke mf 1989 potent cholecystokinin antagonist l 364718 stimulates food intake rats j physiol 257r1512 r1518 silver aj flood jf song morley je 1989 evidence physiological role cck regulation food intake mice j physiol 256r646 r652 moran th ameglio pj peyton hj schwartz gj mchugh pr 1993 blockade type type b cck receptors postpones satiety rhesus monkeys j physiol 265r620 r624 smith gp gibbs j 1994 satiating effect cholecystokinin ann ny acad sci 713236 241medline della fera ma baile ca 1979 cholecystokinin octapeptide continuous picomole injections cerebral ventricles sheep suppress feeding science 206471 473medline schick rr yaksh tl go vl 1986 intracerebroventricular injections cholecystokinin octapeptide suppress feeding rats pharmacological characterization action regul pept 14277 291crossrefmedline crawley jn 1985 clarification behavioral functions peripheral central cholecystokinin two separate peptide pools peptides 6suppl 2129 136 blevins je stanley bg reidelberger rd 2000 brain regions cholecystokinin suppresses feeding rats brain res 8601 10crossrefmedline blevins je hamel fg fairbairn e stanley bg reidelberger rd 2000 effects paraventricular nucleus injection cck 8 plasma cck 8 levels rats brain res 86011 20crossrefmedline kawano k hirashima mori saitoh y kurosumi m natori 1992 spontaneous long term hyperglycemic rat diabetic complications otsuka long evans tokushima fatty oletf strain diabetes 411422 1428abstract takiguchi takata y funakoshi miyasaka k kataoka k fujimura y goto kono 1997 disrupted cholecystokinin type receptor cckar gene oletf rats gene 197169 175crossrefmedline bi moran th 2002 actions cck controls food intake body weight lessons cck receptor deficient oletf rat neuropeptides 361 11crossrefmedline moran th katz lf plata salaman cr schwartz gj 1998 disordered food intake obesity rats lacking cholecystokinin receptors j physiol 274r618 r625 bi ladenheim ee schwartz gj moran th 2001 role npy overexpression dorsomedial hypothalamus hyperphagia obesity oletf rats j physiol 281r254 r260 kopin mathes wf mcbride ew nguyen m al haider w schmitz f bonner weir kanarek r beinborn m 1999 cholecystokinin receptor mediates inhibition food intake yet essential maintenance body weight j clin invest 103383 391abstractfree full text castonguay tw kaiser ll stern js 1986 meal pattern analysis artifacts assumptions implications brain res bull 17439 443crossrefmedline wank sa harkins r jensen rt shapira h de weerth slattery 1992 purification molecular cloning functional expression cholecystokinin receptor rat pancreas proc natl acad sci usa 893125 3129abstract bi robinson bm moran th 2003 acute food deprivation chronic food restriction differentially affect hypothalamic npy mrna expression j physiol 285r1030 r1036 higuchi h yang hy sabol sl 1988 rat neuropeptide y precursor gene expression mrna structure tissue distribution regulation glucocorticoids cyclic amp phorbol ester j biol chem 2636288 6295abstractfree full text franklin kbj paxinos g 1997 mouse brain stereotaxic coordinates san diego academic press moran th robinson ph goldrich ms mchugh pr 1986 two brain cholecystokinin receptors implications behavioral actions brain res 362175 179crossrefmedline broberger c 1999 hypothalamic cocaine amphetamine regulated transcript cart neurons histochemical relationship thyrotropin releasing hormone melanin concentrating hormone orexinhypocretin neuropeptide y brain res 848101 113crossrefmedline grouzmann e comoy e walker p burnier m bohuon c waeber b brunner h 1992 production characterization four anti neuropeptide y monoclonal antibodies hybridoma 11409 424medline paxinos g watson c 1986 rat brain stereotaxic coordinates 2nd ed san diego academic press sergeyev v broberger c gorbatyuk o hokfelt 2000 effect 2 mercaptoacetate 2 deoxy d glucose administration expression npy agrp pomc mch hypocretinorexin rat hypothalamus neuroreport 11117 121medline seoane lm lopez m tovar casanueva ff senaris r dieguez c 2003 agouti related peptide neuropeptide y somatostatin producing neurons targets ghrelin actions rat hypothalamus endocrinology 144544 551abstractfree full text woodruff gn hill dr boden p pinnock r singh l hughes j 1991 functional role brain cck receptors neuropeptides 19suppl45 56 honda wada e battey jf wank sa 1993 differential gene expression cck cck b receptors rat brain mol cell neurosci 4143 154crossref smith ms 1993 lactation alters neuropeptide y proopiomelanocortin gene expression arcuate nucleus rat endocrinology 1331258 1265abstract schwartz mw woods sc porte jr d seeley rj baskin dg 2000 central nervous system control food intake nature 404661 671medline kesterson ra huszar d lynch ca simerly rb cone rd 1997 induction neuropeptide y gene expression dorsal medial hypothalamic nucleus two models agouti obesity syndrome mol endocrinol 11630 637abstractfree full text guan xm yu h trumbauer m frazier e van der ploeg lh chen h 1998 induction neuropeptide y expression dorsomedial hypothalamus diet induced obese mice neuroreport 93415 3419medline thompson rh canteras ns swanson lw 1996 organization projections dorsomedial nucleus hypothalamus pha l study rat j comp neurol 376143 17333co2 m 442crossrefmedline bellinger ll castonguay tw bernardis ll 1994 hormone somatic changes rats pair fed growth retarded dorsomedial hypothalamic nuclei lesioned rats brain res bull 34117 124crossrefmedline hill dr woodruff gn 1990 differentiation central cholecystokinin receptor binding sites using non peptide antagonists mk 329 l 365260 brain res 526276 283crossrefmedline figlewicz dp nadzan sipols aj green pk liddle ra porte jr d woods sc 1992 intraventricular cck 8 reduces single meal size baboon interaction type cck receptors j physiol 263r863 r867 inoue h iannotti ca welling cm veile r donis keller h permutt ma 1997 human cholecystokinin type receptor gene cytogenetic localization physical mapping identification two missense variants patients obesity non insulin dependent diabetes mellitus niddm genomics 42331 335crossrefmedline miller lj holicky el ulrich cd wieben ed 1995 abnormal processing human cholecystokinin receptor gene association gallstones obesity gastroenterology 1091375 1380medline funakoshi miyasaka k matsumoto h yamamori takiguchi kataoka k takata y matsusue k kono shimokata h 2000 gene structure human cholecystokinin cck type receptor body fat content related cck type receptor gene promoter polymorphism febs lett 466264 266crossrefmedline marchal victorion vionnet n escrieut c dematos f dina c dufresne m vaysse n pradayrol l froguel p fourmy d 2002 genetic pharmacological functional analysis cholecystokinin 1 cholecystokinin 2 receptor polymorphism type 2 diabetes obese patients pharmacogenetics 1223 30crossrefmedline watanabe tk okuno oga k mizoguchi miyakita tsuji yamasaki y hishigaki h kanemoto n takagi takahashi e irie y nakamura y tanigami 1999 genetic dissection oletf rat model non insulin dependent diabetes mellitus quantitative trait locus analysis oletf x bn x oletf genomics 58233 239crossrefmedline
0.100268394.15123537.html.plaintext.txt	73	references top abstract introduction materials methods results discussion references gibbs j young rc smith gp 1973 cholecystokinin decreases food intake rats j comp physiol psychol 84488 495medline anika sm houpt tr houpt ka 1981 cholecystokinin satiety pigs j physiol 240r310 r318 gibbs j falasco jd mchugh pr 1976 cholecystokinin decreased food intake rhesus monkeys j physiol 23015 18abstractfree full text kissileff hr pi sunyer fx thornton j smith gp 1981 c terminal octapeptide cholecystokinin decreases food intake man j clin nutr 34154 160abstract west db fey d woods sc 1984 cholecystokinin persistently suppresses meal size food intake free feeding rats j physiol 246r776 r787 shillabeer g davison js 1984 cholecystokinin antagonist proglumide increases food intake rat regul pept 8171 176crossrefmedline moran th ameglio pj schwartz gj mchugh pr 1992 blockade type type b cck receptors attenuates satiety actions exogenous endogenous cck j physiol 262r46 r50 reidelberger rd o rourke mf 1989 potent cholecystokinin antagonist l 364718 stimulates food intake rats j physiol 257r1512 r1518 silver aj flood jf song morley je 1989 evidence physiological role cck regulation food intake mice j physiol 256r646 r652 moran th ameglio pj peyton hj schwartz gj mchugh pr 1993 blockade type type b cck receptors postpones satiety rhesus monkeys j physiol 265r620 r624 smith gp gibbs j 1994 satiating effect cholecystokinin ann ny acad sci 713236 241medline della fera ma baile ca 1979 cholecystokinin octapeptide continuous picomole injections cerebral ventricles sheep suppress feeding science 206471 473medline schick rr yaksh tl go vl 1986 intracerebroventricular injections cholecystokinin octapeptide suppress feeding rats pharmacological characterization action regul pept 14277 291crossrefmedline crawley jn 1985 clarification behavioral functions peripheral central cholecystokinin two separate peptide pools peptides 6suppl 2129 136 blevins je stanley bg reidelberger rd 2000 brain regions cholecystokinin suppresses feeding rats brain res 8601 10crossrefmedline blevins je hamel fg fairbairn e stanley bg reidelberger rd 2000 effects paraventricular nucleus injection cck 8 plasma cck 8 levels rats brain res 86011 20crossrefmedline kawano k hirashima mori saitoh y kurosumi m natori 1992 spontaneous long term hyperglycemic rat diabetic complications otsuka long evans tokushima fatty oletf strain diabetes 411422 1428abstract takiguchi takata y funakoshi miyasaka k kataoka k fujimura y goto kono 1997 disrupted cholecystokinin type receptor cckar gene oletf rats gene 197169 175crossrefmedline bi moran th 2002 actions cck controls food intake body weight lessons cck receptor deficient oletf rat neuropeptides 361 11crossrefmedline moran th katz lf plata salaman cr schwartz gj 1998 disordered food intake obesity rats lacking cholecystokinin receptors j physiol 274r618 r625 bi ladenheim ee schwartz gj moran th 2001 role npy overexpression dorsomedial hypothalamus hyperphagia obesity oletf rats j physiol 281r254 r260 kopin mathes wf mcbride ew nguyen m al haider w schmitz f bonner weir kanarek r beinborn m 1999 cholecystokinin receptor mediates inhibition food intake yet essential maintenance body weight j clin invest 103383 391abstractfree full text castonguay tw kaiser ll stern js 1986 meal pattern analysis artifacts assumptions implications brain res bull 17439 443crossrefmedline wank sa harkins r jensen rt shapira h de weerth slattery 1992 purification molecular cloning functional expression cholecystokinin receptor rat pancreas proc natl acad sci usa 893125 3129abstract bi robinson bm moran th 2003 acute food deprivation chronic food restriction differentially affect hypothalamic npy mrna expression j physiol 285r1030 r1036 higuchi h yang hy sabol sl 1988 rat neuropeptide y precursor gene expression mrna structure tissue distribution regulation glucocorticoids cyclic amp phorbol ester j biol chem 2636288 6295abstractfree full text franklin kbj paxinos g 1997 mouse brain stereotaxic coordinates san diego academic press moran th robinson ph goldrich ms mchugh pr 1986 two brain cholecystokinin receptors implications behavioral actions brain res 362175 179crossrefmedline broberger c 1999 hypothalamic cocaine amphetamine regulated transcript cart neurons histochemical relationship thyrotropin releasing hormone melanin concentrating hormone orexinhypocretin neuropeptide y brain res 848101 113crossrefmedline grouzmann e comoy e walker p burnier m bohuon c waeber b brunner h 1992 production characterization four anti neuropeptide y monoclonal antibodies hybridoma 11409 424medline paxinos g watson c 1986 rat brain stereotaxic coordinates 2nd ed san diego academic press sergeyev v broberger c gorbatyuk o hokfelt 2000 effect 2 mercaptoacetate 2 deoxy d glucose administration expression npy agrp pomc mch hypocretinorexin rat hypothalamus neuroreport 11117 121medline seoane lm lopez m tovar casanueva ff senaris r dieguez c 2003 agouti related peptide neuropeptide y somatostatin producing neurons targets ghrelin actions rat hypothalamus endocrinology 144544 551abstractfree full text woodruff gn hill dr boden p pinnock r singh l hughes j 1991 functional role brain cck receptors neuropeptides 19suppl45 56 honda wada e battey jf wank sa 1993 differential gene expression cck cck b receptors rat brain mol cell neurosci 4143 154crossref smith ms 1993 lactation alters neuropeptide y proopiomelanocortin gene expression arcuate nucleus rat endocrinology 1331258 1265abstract schwartz mw woods sc porte jr d seeley rj baskin dg 2000 central nervous system control food intake nature 404661 671medline kesterson ra huszar d lynch ca simerly rb cone rd 1997 induction neuropeptide y gene expression dorsal medial hypothalamic nucleus two models agouti obesity syndrome mol endocrinol 11630 637abstractfree full text guan xm yu h trumbauer m frazier e van der ploeg lh chen h 1998 induction neuropeptide y expression dorsomedial hypothalamus diet induced obese mice neuroreport 93415 3419medline thompson rh canteras ns swanson lw 1996 organization projections dorsomedial nucleus hypothalamus pha l study rat j comp neurol 376143 17333co2 m 442crossrefmedline bellinger ll castonguay tw bernardis ll 1994 hormone somatic changes rats pair fed growth retarded dorsomedial hypothalamic nuclei lesioned rats brain res bull 34117 124crossrefmedline hill dr woodruff gn 1990 differentiation central cholecystokinin receptor binding sites using non peptide antagonists mk 329 l 365260 brain res 526276 283crossrefmedline figlewicz dp nadzan sipols aj green pk liddle ra porte jr d woods sc 1992 intraventricular cck 8 reduces single meal size baboon interaction type cck receptors j physiol 263r863 r867 inoue h iannotti ca welling cm veile r donis keller h permutt ma 1997 human cholecystokinin type receptor gene cytogenetic localization physical mapping identification two missense variants patients obesity non insulin dependent diabetes mellitus niddm genomics 42331 335crossrefmedline miller lj holicky el ulrich cd wieben ed 1995 abnormal processing human cholecystokinin receptor gene association gallstones obesity gastroenterology 1091375 1380medline funakoshi miyasaka k matsumoto h yamamori takiguchi kataoka k takata y matsusue k kono shimokata h 2000 gene structure human cholecystokinin cck type receptor body fat content related cck type receptor gene promoter polymorphism febs lett 466264 266crossrefmedline marchal victorion vionnet n escrieut c dematos f dina c dufresne m vaysse n pradayrol l froguel p fourmy d 2002 genetic pharmacological functional analysis cholecystokinin 1 cholecystokinin 2 receptor polymorphism type 2 diabetes obese patients pharmacogenetics 1223 30crossrefmedline watanabe tk okuno oga k mizoguchi miyakita tsuji yamasaki y hishigaki h kanemoto n takagi takahashi e irie y nakamura y tanigami 1999 genetic dissection oletf rat model non insulin dependent diabetes mellitus quantitative trait locus analysis oletf x bn x oletf genomics 58233 239crossrefmedline
0.10528083.15870395.html.plaintext.txt	0	genome wide analysis gene transcription hypothalamus jocelyn m bischof rachel wevrick
0.10528083.15870395.html.plaintext.txt	1	department medical genetics university alberta edmonton alberta canada
0.10528083.15870395.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion grants references genomic regions containing loci predisposing obesity related traits mapped human population screens mouse genetic studies identification susceptibility genes increasingly facilitated bioinformatic methods hypothesized candidate genes prioritized expression levels tissues central importance obesity objective develop combined bioinformatics molecular paradigm identify novel genes candidates murine human obesity genetic modifiers based differential expression patterns hypothalamus compared murine tissues used bioinformatics tools search publicly available gene expression databases using criteria designed identify novel genes differentially expressed hypothalamus used rna methods determine expression sites levels expression hypothalamus murine brain identified chromosomal location novel genes mice humans compared locations genetic loci predisposing obesity related traits developed search strategy correctly identified set genes known important hypothalamic function well candidate gene prader willi syndrome previously identified differentially expressed hypothalamus using strategy identified characterized set 11 genes previously known differentially expressed murine hypothalamus results demonstrate feasibility combined bioinformatics molecular approaches identification genes candidates obesity related disorders humans mice
0.10528083.15870395.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion grants references genomic regions containing loci predisposing obesity related traits mapped human population screens mouse genetic studies identification susceptibility genes increasingly facilitated bioinformatic methods hypothesized candidate genes prioritized expression levels tissues central importance obesity objective develop combined bioinformatics molecular paradigm identify novel genes candidates murine human obesity genetic modifiers based differential expression patterns hypothalamus compared murine tissues used bioinformatics tools search publicly available gene expression databases using criteria designed identify novel genes differentially expressed hypothalamus used rna methods determine expression sites levels expression hypothalamus murine brain identified chromosomal location novel genes mice humans compared locations genetic loci predisposing obesity related traits developed search strategy correctly identified set genes known important hypothalamic function well candidate gene prader willi syndrome previously identified differentially expressed hypothalamus using strategy identified characterized set 11 genes previously known differentially expressed murine hypothalamus results demonstrate feasibility combined bioinformatics molecular approaches identification genes candidates obesity related disorders humans mice
0.10528083.15870395.html.plaintext.txt	4	hypothalamus candidate genes bioinformatics gene expression microarray
0.10528083.15870395.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion grants references obesity major health issue facing developed nations today despite years population studies genetic determinants healthy body weight poorly understood 1 likewise although increased understanding role hypothalamic pituitary adrenal axis obesity proteins implicated development andor function organ system identified characterized specific proteins hormones receptors responsible control appetite long term maintenance body weight 18 24 increasing number studies rely mapping obesity modifier loci mice humans choosing candidate genes within mapped region study 11a 20 still studies examine changes gene expression mice undergoing dietary challenges obesity gene knockout versus wild type mice yet reliability effective choice candidate genes depends prior knowledge gene expression function searchable databases often knowledge exists readily available researchers unfamiliar complexities bioinformatic databases
0.10528083.15870395.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion grants references obesity major health issue facing developed nations today despite years population studies genetic determinants healthy body weight poorly understood 1 likewise although increased understanding role hypothalamic pituitary adrenal axis obesity proteins implicated development andor function organ system identified characterized specific proteins hormones receptors responsible control appetite long term maintenance body weight 18 24 increasing number studies rely mapping obesity modifier loci mice humans choosing candidate genes within mapped region study 11a 20 still studies examine changes gene expression mice undergoing dietary challenges obesity gene knockout versus wild type mice yet reliability effective choice candidate genes depends prior knowledge gene expression function searchable databases often knowledge exists readily available researchers unfamiliar complexities bioinformatic databases
0.10528083.15870395.html.plaintext.txt	7	search obesity candidate genes used combined bioinformatic molecular biology approach identify novel genes important function hypothalamus hypothalamus complex region brain involved homeostatic processes including limited energy balance identified set genes already known important hypothalamic function set genes previously associated hypothalamus propose genes may important function hypothalamus may provide new source hypothalamus specific regulatory elements may important disorders hypothalamic function obesity furthermore genes identified search candidate genes obesity related traits genetically mapped chromosomal intervals reside
0.10528083.15870395.html.plaintext.txt	8	search obesity candidate genes used combined bioinformatic molecular biology approach identify novel genes important function hypothalamus hypothalamus complex region brain involved homeostatic processes including limited energy balance identified set genes already known important hypothalamic function set genes previously associated hypothalamus propose genes may important function hypothalamus may provide new source hypothalamus specific regulatory elements may important disorders hypothalamic function obesity furthermore genes identified search candidate genes obesity related traits genetically mapped chromosomal intervals reside
0.10528083.15870395.html.plaintext.txt	9	materials methods top abstract introduction materials methods results discussion grants references bioinformatics genomics institute novartis research foundation gnf murine gene expression atlas updated gnf symatlas version 103 originally developed tool high throughput analysis transcriptional activity biological samples 25 26 expression specific genes within 45 diverse murine tissues including hypothalamus quantified hybridization affymetrix mouse u74a high density oligonucleotide arrays made available searchable line database filtered murine dataset select genes levels expression median hypothalamus moderately high level expression median five tissues according gnf symatlas database duplicate samples andor duplicate hybridizations performed tissue values integrated error bars measurement configuration database possible generate estimates statistical significance rather search criteria left deliberately broad risk including genes fact show much specificity hypothalamic expression analyzed might expected database search alone median defined specific gene across tissues bias genes low moderate levels gene expression overall first search performed geneatlas version 1 dataset 25 second search performed geneatlas version 2 dataset mouse geneatlas gnf1m 26 data set correlation search performed identify genes high value hypothalamus set 400 value nonbrain tissues low value set 1 regions brain correlation 098 preoptic region part hypothalamus allowed value expression preoptic area well genome localization selected murine hypothalamic genes identified may 2004 mouse mus musculus draft genome data build 33 assembly national center biotechnology information ncbi genomic localization human orthologs deduced using ncbi database unigene gene
0.10528083.15870395.html.plaintext.txt	10	materials methods top abstract introduction materials methods results discussion grants references bioinformatics genomics institute novartis research foundation gnf murine gene expression atlas updated gnf symatlas version 103 originally developed tool high throughput analysis transcriptional activity biological samples 25 26 expression specific genes within 45 diverse murine tissues including hypothalamus quantified hybridization affymetrix mouse u74a high density oligonucleotide arrays made available searchable line database filtered murine dataset select genes levels expression median hypothalamus moderately high level expression median five tissues according gnf symatlas database duplicate samples andor duplicate hybridizations performed tissue values integrated error bars measurement configuration database possible generate estimates statistical significance rather search criteria left deliberately broad risk including genes fact show much specificity hypothalamic expression analyzed might expected database search alone median defined specific gene across tissues bias genes low moderate levels gene expression overall first search performed geneatlas version 1 dataset 25 second search performed geneatlas version 2 dataset mouse geneatlas gnf1m 26 data set correlation search performed identify genes high value hypothalamus set 400 value nonbrain tissues low value set 1 regions brain correlation 098 preoptic region part hypothalamus allowed value expression preoptic area well genome localization selected murine hypothalamic genes identified may 2004 mouse mus musculus draft genome data build 33 assembly national center biotechnology information ncbi genomic localization human orthologs deduced using ncbi database unigene gene
0.10528083.15870395.html.plaintext.txt	11	expression studies rna situ hybridization performed using digoxigenin labeled antisense rna probes 20 microm cryosections embryonic day 185 mouse embryos previously described 16 probes hcrt a26100 dscr1l2 impact pnck derived pcr fragments amplified reverse transcribed adult mouse hypothalamus mrna recombinant taq dna polymerase invitrogen cloned pbluescript vector invitrogen hcrt probe includes positions 7 573 hypocretin hcrt mrna nm010410 a26100 probe includes positions 432 1004 riken cdna 2610042l04 gene 2610042l04rik mrna nm025940 dscr1l2 probe includes positions 177 638 syndrome critical region gene 1 like 2 dscr1l2 mrna nm022980 impact probe includes positions 504 955 imprinted ancient impact mrna nm008378 pnck probe includes positions 697 1252 pregnancy upregulated nonubiquitously expressed ca2calmodulin kinase pnck mrna nm012040 magel2 probe includes positions 984 1754 genbank accession number nm013779 previously described 16 studies involving animals performed according guidelines use care laboratory animals university alberta
0.10528083.15870395.html.plaintext.txt	12	results top abstract introduction materials methods results discussion grants references major goal human genome project identify expressed sequences expressed sequence tags ests rna isolated tissues cell lines clustering ests groups unigene clusters sequence identity resulting unigene database could queried gene name discover tissues gene expressed recently public databases allowed investigators perform converse query discover expression levels transcripts particular tissue respect expression levels tissues however results two large scale gene array experiments documenting expression levels genes wide range mouse tissues including hypothalamus recently published specifically labeled cdna mouse tissue hybridized affymetrix genechip microarrays profile expression levels 36000 genes tissues study multitissue comparisons performed normalize expression levels input searchable gene expression database gnf database made available novartis research foundation 8 25 major advantage previous studies used subtractive methods derive hypothalamic cdnas levels expression compared tissues parts brain genes expressed highly specifically hypothalamus easily identified queried database identify genes differentially expressed murine adult hypothalamus
0.10528083.15870395.html.plaintext.txt	13	results top abstract introduction materials methods results discussion grants references major goal human genome project identify expressed sequences expressed sequence tags ests rna isolated tissues cell lines clustering ests groups unigene clusters sequence identity resulting unigene database could queried gene name discover tissues gene expressed recently public databases allowed investigators perform converse query discover expression levels transcripts particular tissue respect expression levels tissues however results two large scale gene array experiments documenting expression levels genes wide range mouse tissues including hypothalamus recently published specifically labeled cdna mouse tissue hybridized affymetrix genechip microarrays profile expression levels 36000 genes tissues study multitissue comparisons performed normalize expression levels input searchable gene expression database gnf database made available novartis research foundation 8 25 major advantage previous studies used subtractive methods derive hypothalamic cdnas levels expression compared tissues parts brain genes expressed highly specifically hypothalamus easily identified queried database identify genes differentially expressed murine adult hypothalamus
0.10528083.15870395.html.plaintext.txt	14	strategy identification hypothalamic transcripts reasoned genes important hypothalamic development function likely transcribed hypothalamic precursor tissues mature hypothalamus laboratory mouse model particularly amenable studies brain function similarities anatomy human hypothalamus widespread use obesity studies performed three searches using different criteria query gnf expression database genes highly expressed postnatal murine hypothalamus first search gnf database used low specificity criteria required high expression hypothalamus least 8 times median expression level 45 mouse tissues search identified set genes already studied role hypothalamic function pro opiomelanocortin pomc hcrt also identified many genes broadly expressed nervous system microtubule associated protein notably genes important obesity andor hypothalamic function identified conditions eg widely expressed nhlh2 second search gnf database used high specificity criteria first search high expression hypothalamus least eight times median expression tissues addition second search required low expression 3 times median least 40 tissues second search identified five genes including arginine vasopressin pomc hcrt oxytocin major roles endocrine regulation hypothalamus significantly high specificity search also identified magel2 developmentally regulated inactivated genetic obesity disorder prader willi syndrome formulated third search intermediate specificity expression hypothalamus eight times median level tissues fewer five tissues three times median level expression third search gnf database identified set 15 genes highly expressed hypothalamus moderately highly expressed 5 murine tissues table 1 screen 1 repeated third search using updated database 2004 version mouse geneatlas third search gnf database search geneatlas 2004 identified genes high expression hypothalamus low expression elsewhere brain used correlation function searchable symatlas database within geneatlas symatlas search refined allow either high low expression preoptic region functionally overlaps hypothalamus last search still using intermediate specificity criteria identified 7 genes 3 identified gnf intermediate specificity search table 1 screen 2 total 19 genes
0.10528083.15870395.html.plaintext.txt	15	strategy identification hypothalamic transcripts reasoned genes important hypothalamic development function likely transcribed hypothalamic precursor tissues mature hypothalamus laboratory mouse model particularly amenable studies brain function similarities anatomy human hypothalamus widespread use obesity studies performed three searches using different criteria query gnf expression database genes highly expressed postnatal murine hypothalamus first search gnf database used low specificity criteria required high expression hypothalamus least 8 times median expression level 45 mouse tissues search identified set genes already studied role hypothalamic function pro opiomelanocortin pomc hcrt also identified many genes broadly expressed nervous system microtubule associated protein notably genes important obesity andor hypothalamic function identified conditions eg widely expressed nhlh2 second search gnf database used high specificity criteria first search high expression hypothalamus least eight times median expression tissues addition second search required low expression 3 times median least 40 tissues second search identified five genes including arginine vasopressin pomc hcrt oxytocin major roles endocrine regulation hypothalamus significantly high specificity search also identified magel2 developmentally regulated inactivated genetic obesity disorder prader willi syndrome formulated third search intermediate specificity expression hypothalamus eight times median level tissues fewer five tissues three times median level expression third search gnf database identified set 15 genes highly expressed hypothalamus moderately highly expressed 5 murine tissues table 1 screen 1 repeated third search using updated database 2004 version mouse geneatlas third search gnf database search geneatlas 2004 identified genes high expression hypothalamus low expression elsewhere brain used correlation function searchable symatlas database within geneatlas symatlas search refined allow either high low expression preoptic region functionally overlaps hypothalamus last search still using intermediate specificity criteria identified 7 genes 3 identified gnf intermediate specificity search table 1 screen 2 total 19 genes
0.10528083.15870395.html.plaintext.txt	16	view table table 1 intermediate search gnf gene expression atlas detect genes highly expressed hypothalamus expressed low levels tissues
0.10528083.15870395.html.plaintext.txt	17	selection novel hypothalamic genes 19 genes two searches gnf databases 3 genes identified searches table 1 nature search engine provided gnf changed 2002 release 2004 release two search criteria directly comparable common two searches requirement high expression hypothalamus low expression regions brain interested identifying genes known important hypothalamus first set aside genes whose role hypothalamic function well described included genes encoding neuropeptide signaling molecules hcrtorexin pro opiomelanocortin oxytocin agouti related protein arginine vasopressin 4 neuroendocrine role calcitonin calcitonin receptor growth hormone secretion hypothalamuspituitary previously suggested 17 previously identified magel2 specifically expressed developing murine hypothalamus although function tissue yet known 16 magel2 particular interest human ortholog magel2 one set genes inactivated genetic obesity disorder prader willi syndrome 9 15 finally mutations patched ptch1 result holoprosencephaly developmental delay humans alternatively cause basal cell nervous syndrome homozygously inactivated somatic cells ptch1 antagonist signaling molecule hedgehog functions patterning neural tube known specific role hypothalamus
0.10528083.15870395.html.plaintext.txt	18	selection novel hypothalamic genes 19 genes two searches gnf databases 3 genes identified searches table 1 nature search engine provided gnf changed 2002 release 2004 release two search criteria directly comparable common two searches requirement high expression hypothalamus low expression regions brain interested identifying genes known important hypothalamus first set aside genes whose role hypothalamic function well described included genes encoding neuropeptide signaling molecules hcrtorexin pro opiomelanocortin oxytocin agouti related protein arginine vasopressin 4 neuroendocrine role calcitonin calcitonin receptor growth hormone secretion hypothalamuspituitary previously suggested 17 previously identified magel2 specifically expressed developing murine hypothalamus although function tissue yet known 16 magel2 particular interest human ortholog magel2 one set genes inactivated genetic obesity disorder prader willi syndrome 9 15 finally mutations patched ptch1 result holoprosencephaly developmental delay humans alternatively cause basal cell nervous syndrome homozygously inactivated somatic cells ptch1 antagonist signaling molecule hedgehog functions patterning neural tube known specific role hypothalamus
0.10528083.15870395.html.plaintext.txt	19	gene expression profiles remaining 11 genes fell 2 categories 1 novel genes function predicted sequence similarity known genes 2 novel genes known function limited similarity known genes table 2 examined unigene clusters associated novel genes est sets made hypothalamus rna represented mouse est databases expected see representation hypothalamic cdnas within unigene clusters corresponding genes indeed 11 genes corresponding ests derived whole brain specifically including hypothalamus 4 diencephalon 2 table 2 information unigene clusters point genes particularly hypothalamus specific contrast unigene cluster arginine vasopressin example 12 19 ests derived hypothalamus used est profileviewer function unigene test whether expression profile derived ests overlapped derived geneatlas databases seven eleven novel genes major contribution ests brain pituitary gland hypothalamus included brain sample est profile viewer one case itih3 majority unigene ests derived liver small minority brain consistent geneatlas distribution shows highest expression itih3 liver remaining expression preoptic hypothalamus samples one case dscr1l2 unigene ests distribute tissue specific pattern although examination developmental timing expression also using function unigene demonstrated vast majority ests derived egg opposed preimplantation embryos postimplantation embryonic stage contrast geneatlas 2004 expression profile shows little tissue specificity dscr1l2 transcript also contrasts geneatlas 2002 expression profile showed specific expression hypothalamus similarly pitpnm1 showed conflicting expression profiles geneatlas 2002 geneatlas 2004 est profileviewer one commonality expression eye
0.10528083.15870395.html.plaintext.txt	20	view table table 2 est expression profile murine gene targeting studies
0.10528083.15870395.html.plaintext.txt	21	cases preliminary expression patterns novel genes determined rna protein based methods already published information readily available jax bioinformatics server references original publications proposed igsf1 also known inhbpp120 may involved pituitary function male female mice mutant igsf1 viable fertile 3 insulin receptor substrates including irs4 function insulin signaling absence irs4 causes mild defects growth reproduction glucose homeostasis irs4 null mutant mouse line 5 basis mouse knockout model ptprz shown role oligodendrocyte survival recovery demyelinating disease 11 pnck 6 nsg1 21 ptpro 2 suggested roles developing nervous system whereas function itih3 studied liver function predicted brain 2 function predicted impact although human ortholog impact suggested candidate gene bipolar affective disorder 10 14 also information putative function gene represented unigene cluster mm321089 gene name a2610042l04
0.10528083.15870395.html.plaintext.txt	22	cases preliminary expression patterns novel genes determined rna protein based methods already published information readily available jax bioinformatics server references original publications proposed igsf1 also known inhbpp120 may involved pituitary function male female mice mutant igsf1 viable fertile 3 insulin receptor substrates including irs4 function insulin signaling absence irs4 causes mild defects growth reproduction glucose homeostasis irs4 null mutant mouse line 5 basis mouse knockout model ptprz shown role oligodendrocyte survival recovery demyelinating disease 11 pnck 6 nsg1 21 ptpro 2 suggested roles developing nervous system whereas function itih3 studied liver function predicted brain 2 function predicted impact although human ortholog impact suggested candidate gene bipolar affective disorder 10 14 also information putative function gene represented unigene cluster mm321089 gene name a2610042l04
0.10528083.15870395.html.plaintext.txt	23	rna situ hybridization first verified 11 selected genes indeed expressed murine hypothalamus rt pcr rna samples adult mouse hypothalamus data shown localized expression specific hypothalamic nuclei rna situ hybridization using standard mouse atlas label sections 13 probe hcrt displayed strong signal lateral anterior hypothalamus consistent known abundance rna transcripts region brain fig 1 27 consistent earlier embryonic expression magel2 suprachiasmatic nucleus 16 detected magel2 transcripts anterior hypothalamus suprachiasmatic nucleus fig 1 selected four genes emerged bioinformatic analysis little else known four genes displayed high levels expression hypothalamus compared surrounding brain tissue rna situ hybridization fig 1 probes a2610042l04 pnck detected abundant expression anterior hypothalamus whereas probe dscr1l2 detected strongest expressions dorsal medial hypothalamus ventromedial hypothalamus arcuate nucleus probe impact detected highest expression arcuate nucleus
0.10528083.15870395.html.plaintext.txt	24	view larger version 194k fig 1 expression candidate genes late embryonic hypothalamus cryosections embryonic day 185 mouse brain hybridized digoxigenin labeled antisense rna situ hybridization probes hcrt magel2 dscr1l2 impact a2610042l04 pnck hybridization signals detected anterior hypothalamus ah arcuate nucleus arc dorsomedial hypothalamus dmh suprachiasmatic nucleus scn ventromedial hypothalamus vmh 3v third ventricle infidibular recess oc optic chiasm sections oriented ventral aspect bottom scale bar 250 microm
0.10528083.15870395.html.plaintext.txt	25	gene mapping used ncbi databases map 11 selected genes chromosomal regions mouse genome ncbi build 33 human genome ncbi build 35 table 3 correlated map positions selected genes genomic positions published loci influencing obesity related traits either human mammals 23 table 3 updated published line obesity gene map database 11a identified eight traits body mass index fat mass percent body fat mapped chromosomal regions selected genes human studies weight gain obesity identified cases obesity traits identified mapping within mouse rat pig chromosomal region homologous human chromosome bands containing selected genes include traits mapped interval contained three chromosome bands would contain large number candidate genes way identified 13 obesity related traits mouse 11 rat 1 pig 1 correlated map positions 6 11 selected genes traits related obesity weight gain except a2610042l04 poorly characterized predicted mouse gene chromosome 14 selected genes regions mammalian genome genetic evidence obesity related trait exists
0.10528083.15870395.html.plaintext.txt	26	view table table 3 obesity traits near candidate genes
0.10528083.15870395.html.plaintext.txt	27	discussion top abstract introduction materials methods results discussion grants references use microarray based systems accelerated high throughput gene expression profiling tissues interest disease processes previous studies designed identify cdnas enriched hypothalamus used subtractive hybridization 7 est cataloguing 12 although methods identify genes expressed hypothalamus intrinsic biases toward highly expressed genes methods subtractive hybridization methodologies also intrinsic sequence specific biases contrast high throughput gene expression profiling provides robust unbiased searchable resource freely available research community examined relative expression levels estimated 30000 genes murine hypothalamus determined affymetrix microarray technology made available novartis research foundation 8 identified set genes previously recognized important hypothalamic function highly preferentially expressed murine hypothalamus exciting think database available time cloned magel2 1999 analysis could facilitated selection human magel2 candidate gene extreme obesity seen prader willi syndrome
0.10528083.15870395.html.plaintext.txt	28	discussion top abstract introduction materials methods results discussion grants references use microarray based systems accelerated high throughput gene expression profiling tissues interest disease processes previous studies designed identify cdnas enriched hypothalamus used subtractive hybridization 7 est cataloguing 12 although methods identify genes expressed hypothalamus intrinsic biases toward highly expressed genes methods subtractive hybridization methodologies also intrinsic sequence specific biases contrast high throughput gene expression profiling provides robust unbiased searchable resource freely available research community examined relative expression levels estimated 30000 genes murine hypothalamus determined affymetrix microarray technology made available novartis research foundation 8 identified set genes previously recognized important hypothalamic function highly preferentially expressed murine hypothalamus exciting think database available time cloned magel2 1999 analysis could facilitated selection human magel2 candidate gene extreme obesity seen prader willi syndrome
0.10528083.15870395.html.plaintext.txt	29	identified 11 genes whose expression enriched hypothalamus previously associated development hypothalamus function candidate genes could involved number interrelated processes partially mediated hypothalamus besides energy fluid balance circadian rhythm reproduction stress responses temperature regulation 1 definitive proof involvement obesity rather functions hypothalamus would come demonstration gene dysregulation various models obesity including genetic diet induced obesity concentrated obesity large number studies providing genetically mapped obesity related traits genes identified could equally well roles disorders hypothalamic function regions brain including cortex hindbrain important roles food intake 22 major roles neurological functions gut liver pancreas adipose tissues also major roles appetite parallel studies could reveal novel obesity susceptibility genes highly specifically expressed tissues expressed brain hypothalamus
0.10528083.15870395.html.plaintext.txt	30	identified 11 genes whose expression enriched hypothalamus previously associated development hypothalamus function candidate genes could involved number interrelated processes partially mediated hypothalamus besides energy fluid balance circadian rhythm reproduction stress responses temperature regulation 1 definitive proof involvement obesity rather functions hypothalamus would come demonstration gene dysregulation various models obesity including genetic diet induced obesity concentrated obesity large number studies providing genetically mapped obesity related traits genes identified could equally well roles disorders hypothalamic function regions brain including cortex hindbrain important roles food intake 22 major roles neurological functions gut liver pancreas adipose tissues also major roles appetite parallel studies could reveal novel obesity susceptibility genes highly specifically expressed tissues expressed brain hypothalamus
0.10528083.15870395.html.plaintext.txt	31	susceptibility obesity part genetically determined variations genes may contribute familial obesity information available cellular physiological function proteins encoded genes however highly variable furthermore size intervals obesity traits mapped also highly variable genetic molecular studies would clarify possible roles candidate genes obesity example candidate gene located within region specific mouse strains human subjects shown genetic predisposition obesity could sequenced coding regulatory sequence variants variants could tested larger populations association obesity related traits including traits genetically mapped chromosomal intervals genes reside finally investigations physiological cellular functions proteins identified bioinformatic screens may elucidate role specific genes gene products hypothalamic function genetic predisposition obesity
0.10528083.15870395.html.plaintext.txt	32	susceptibility obesity part genetically determined variations genes may contribute familial obesity information available cellular physiological function proteins encoded genes however highly variable furthermore size intervals obesity traits mapped also highly variable genetic molecular studies would clarify possible roles candidate genes obesity example candidate gene located within region specific mouse strains human subjects shown genetic predisposition obesity could sequenced coding regulatory sequence variants variants could tested larger populations association obesity related traits including traits genetically mapped chromosomal intervals genes reside finally investigations physiological cellular functions proteins identified bioinformatic screens may elucidate role specific genes gene products hypothalamic function genetic predisposition obesity
0.10528083.15870395.html.plaintext.txt	33	grants top abstract introduction materials methods results discussion grants references research performed support canadian institutes health research pilot project grant obesity healthy body weight request applications rwevrick r wevrick senior scholar alberta heritage foundation medical research
0.10528083.15870395.html.plaintext.txt	34	acknowledgments acknowledge sharee kuny megan oneill helpful discussions
0.10528083.15870395.html.plaintext.txt	35	footnotes article published online print see web site date publication httpphysiolgenomicsphysiologyorg
0.10528083.15870395.html.plaintext.txt	36	footnotes article published online print see web site date publication httpphysiolgenomicsphysiologyorg
0.10528083.15870395.html.plaintext.txt	37	address reprint requests correspondence r wevrick dept medical genetics 8 42 medical sciences bldg univ alberta edmonton alberta canada t6g 2h7 e mail rachelwevrickatualbertaca u d
0.10528083.15870395.html.plaintext.txt	38	references top abstract introduction materials methods results discussion grants references barsh gs farooqi orahilly genetics body weight regulation nature 404 644 651 2000crossrefisimedline beltran pj bixby jl masters ba expression ptpro mouse development suggests involvement axonogenesis differentiation nt 3 ngf dependent neurons j comp neurol 456 384 395 2003crossrefisimedline bernard dj burns kh haupt b matzuk mm woodruff tk normal reproductive function inhbpp120 deficient mice mol cell biol 23 4882 4891 2003abstractfree full text ellacott kl cone rd central melanocortin system integration short long term regulators energy homeostasis recent prog horm res 59 395 408 2004abstractfree full text fantin vr wang q lienhard ge keller sr mice lacking insulin receptor substrate 4 exhibit mild defects growth reproduction glucose homeostasis j physiol endocrinol metab 278 e127 e133 2000abstractfree full text gardner hp rajan jv ha si copeland ng gilbert dj jenkins na marquis st chodosh la cloning characterization chromosomal localization pnck ca2calmodulin dependent protein kinase genomics 63 279 288 2000crossrefisimedline gautvik km de lecea l gautvik vt danielson pe tranque p dopazo bloom fe sutcliffe jg overview prevalent hypothalamus specific mrnas identified directional tag pcr subtraction proc natl acad sci usa 93 8733 8738 1996abstractfree full text genomics institute novartis research foundation gene expression atlas gnf symatlas httpsymatlasgnforgsymatlas goldstone ap prader willi syndrome advances genetics pathophysiology treatment trends endocrinol metab 15 12 20 2004crossrefisimedline hagiwara y hirai m nishiyama k kanazawa ueda sakaki y ito screening imprinted genes allelic message display identification paternally expressed gene impact mouse chromosome 18 proc natl acad sci usa 94 9249 9254 1997abstractfree full text harroch furtado gc brueck w rosenbluth j lafaille j chao m buxbaum jd schlessinger j critical role protein tyrosine phosphatase receptor type z functional recovery demyelinating lesions nat genet 32 411 414 2002crossrefisimedline human genetics laboratory obesity gene map database httpobesitygenepbrcedu hu rm han zg song hd peng yd huang qh ren sx gu yj huang ch li yb jiang cl fu g zhang qh gu bw dai m mao yf gao gf rong r ye m zhou j xu sh gu j shi jx jin wr zhang ck wu tm huang gy chen z chen md chen jl gene expression profiling human hypothalamus pituitary adrenal axis full length cdna cloning proc natl acad sci usa 97 9543 9548 2000abstractfree full text jacobowitz dm abbott lc chemoarchitectonic atlas developing mouse brain boca raton fl crc 1998 kosaki k suzuki kosaki r yoshihashi h itoh m goto y matsuo n human homolog mouse imprinted gene impact resides pericentric region chromosome 18 within critical region bipolar affective disorder mol psychiatry 6 87 91 2001crossrefisimedline lee kozlov hernandez l chamberlain sj brannan ci stewart cl wevrick r expression imprinting magel2 suggest role prader willi syndrome homologous murine imprinting phenotype hum mol genet 9 1813 1819 2000abstractfree full text lee walker cl wevrick r prader willi syndrome transcripts expressed phenotypically significant regions developing mouse brain gene expr patterns 3 599 609 2003crossrefisimedline lengyel toledo al czepielewski ma vieira jg chacra ar calcitonin suppresses growth hormone gh response growth hormone releasing hormone ghrh man j endocrinol invest 12 25 29 1989isi michaud jl developmental program hypothalamus disorders clin genet 60 255 263 2001crossrefisimedline rankinen perusse l weisnagel sj snyder ee chagnon yc bouchard c human obesity gene map 2001 update obes res 10 196 243 2002abstractfree full text saberan djoneidi d picart r escalier d gelman m barret tougard c glowinski j levi strauss m 21 kda polypeptide belonging new family proteins expressed golgi apparatus neural germ cells j biol chem 273 3909 3914 1998abstractfree full text schwartz gj biology eating behavior obesity obes res 12 suppl 2 102s 106s 2004abstractfree full text snyder ee walts b perusse l chagnon yc weisnagel sj rankinen bouchard c human obesity gene map 2003 update obes res 12 369 439 2004abstractfree full text spiegelman bm flier js obesity regulation energy balance cell 104 531 543 2001crossrefisimedline su ai cooke mp ching ka hakak y walker jr wiltshire orth ap vega rg sapinoso lm moqrich patapoutian hampton gm schultz pg hogenesch jb large scale analysis human mouse transcriptomes proc natl acad sci usa 99 4465 4470 2002abstractfree full text su ai wiltshire batalov lapp h ching ka block d zhang j soden r hayakawa m kreiman g cooke mp walker jr hogenesch jb gene atlas mouse human protein encoding transcriptomes proc natl acad sci usa 101 6062 6067 2004abstractfree full text van den pol patrylo pr ghosh pk gao xb lateral hypothalamus early developmental expression response hypocretin orexin j comp neurol 433 349 363 2001crossrefisimedline
0.10528083.15870395.html.plaintext.txt	39	references top abstract introduction materials methods results discussion grants references barsh gs farooqi orahilly genetics body weight regulation nature 404 644 651 2000crossrefisimedline beltran pj bixby jl masters ba expression ptpro mouse development suggests involvement axonogenesis differentiation nt 3 ngf dependent neurons j comp neurol 456 384 395 2003crossrefisimedline bernard dj burns kh haupt b matzuk mm woodruff tk normal reproductive function inhbpp120 deficient mice mol cell biol 23 4882 4891 2003abstractfree full text ellacott kl cone rd central melanocortin system integration short long term regulators energy homeostasis recent prog horm res 59 395 408 2004abstractfree full text fantin vr wang q lienhard ge keller sr mice lacking insulin receptor substrate 4 exhibit mild defects growth reproduction glucose homeostasis j physiol endocrinol metab 278 e127 e133 2000abstractfree full text gardner hp rajan jv ha si copeland ng gilbert dj jenkins na marquis st chodosh la cloning characterization chromosomal localization pnck ca2calmodulin dependent protein kinase genomics 63 279 288 2000crossrefisimedline gautvik km de lecea l gautvik vt danielson pe tranque p dopazo bloom fe sutcliffe jg overview prevalent hypothalamus specific mrnas identified directional tag pcr subtraction proc natl acad sci usa 93 8733 8738 1996abstractfree full text genomics institute novartis research foundation gene expression atlas gnf symatlas httpsymatlasgnforgsymatlas goldstone ap prader willi syndrome advances genetics pathophysiology treatment trends endocrinol metab 15 12 20 2004crossrefisimedline hagiwara y hirai m nishiyama k kanazawa ueda sakaki y ito screening imprinted genes allelic message display identification paternally expressed gene impact mouse chromosome 18 proc natl acad sci usa 94 9249 9254 1997abstractfree full text harroch furtado gc brueck w rosenbluth j lafaille j chao m buxbaum jd schlessinger j critical role protein tyrosine phosphatase receptor type z functional recovery demyelinating lesions nat genet 32 411 414 2002crossrefisimedline human genetics laboratory obesity gene map database httpobesitygenepbrcedu hu rm han zg song hd peng yd huang qh ren sx gu yj huang ch li yb jiang cl fu g zhang qh gu bw dai m mao yf gao gf rong r ye m zhou j xu sh gu j shi jx jin wr zhang ck wu tm huang gy chen z chen md chen jl gene expression profiling human hypothalamus pituitary adrenal axis full length cdna cloning proc natl acad sci usa 97 9543 9548 2000abstractfree full text jacobowitz dm abbott lc chemoarchitectonic atlas developing mouse brain boca raton fl crc 1998 kosaki k suzuki kosaki r yoshihashi h itoh m goto y matsuo n human homolog mouse imprinted gene impact resides pericentric region chromosome 18 within critical region bipolar affective disorder mol psychiatry 6 87 91 2001crossrefisimedline lee kozlov hernandez l chamberlain sj brannan ci stewart cl wevrick r expression imprinting magel2 suggest role prader willi syndrome homologous murine imprinting phenotype hum mol genet 9 1813 1819 2000abstractfree full text lee walker cl wevrick r prader willi syndrome transcripts expressed phenotypically significant regions developing mouse brain gene expr patterns 3 599 609 2003crossrefisimedline lengyel toledo al czepielewski ma vieira jg chacra ar calcitonin suppresses growth hormone gh response growth hormone releasing hormone ghrh man j endocrinol invest 12 25 29 1989isi michaud jl developmental program hypothalamus disorders clin genet 60 255 263 2001crossrefisimedline rankinen perusse l weisnagel sj snyder ee chagnon yc bouchard c human obesity gene map 2001 update obes res 10 196 243 2002abstractfree full text saberan djoneidi d picart r escalier d gelman m barret tougard c glowinski j levi strauss m 21 kda polypeptide belonging new family proteins expressed golgi apparatus neural germ cells j biol chem 273 3909 3914 1998abstractfree full text schwartz gj biology eating behavior obesity obes res 12 suppl 2 102s 106s 2004abstractfree full text snyder ee walts b perusse l chagnon yc weisnagel sj rankinen bouchard c human obesity gene map 2003 update obes res 12 369 439 2004abstractfree full text spiegelman bm flier js obesity regulation energy balance cell 104 531 543 2001crossrefisimedline su ai cooke mp ching ka hakak y walker jr wiltshire orth ap vega rg sapinoso lm moqrich patapoutian hampton gm schultz pg hogenesch jb large scale analysis human mouse transcriptomes proc natl acad sci usa 99 4465 4470 2002abstractfree full text su ai wiltshire batalov lapp h ching ka block d zhang j soden r hayakawa m kreiman g cooke mp walker jr hogenesch jb gene atlas mouse human protein encoding transcriptomes proc natl acad sci usa 101 6062 6067 2004abstractfree full text van den pol patrylo pr ghosh pk gao xb lateral hypothalamus early developmental expression response hypocretin orexin j comp neurol 433 349 363 2001crossrefisimedline
0.11059638.15044362.html.plaintext.txt	0	differential effects adrenalectomy melanin concentrating hormone orexin deborah l drazen lique m coolen april d strader matthew d wortman stephen c woods randy j seeley
0.11059638.15044362.html.plaintext.txt	1	address correspondence requests reprints deborah l drazen genome research institute university cincinnati 2170 east galbraith road building 43 third floor cincinnati ohio 45237 e mail debbiedrazenatucedu u d
0.11059638.15044362.html.plaintext.txt	2	address correspondence requests reprints deborah l drazen genome research institute university cincinnati 2170 east galbraith road building 43 third floor cincinnati ohio 45237 e mail debbiedrazenatucedu u d
0.11059638.15044362.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references removal glucocorticoids adrenalectomy adx reduces food intake body weight rodents prevents excessive weight gain many genetic dietary models obesity glucocorticoids play key role promote positive energy balance normal pathological conditions least part altering sensitivity hypothalamic peptides hyperphagia central neuropeptide y administration example attenuated adx evidence glucocorticoids influence mch orexin activity present study feeding responses third ventricular mch orexin measured rats bilateral adx sham surgery adx rats significantly less sensitive orexigenic action third ventricular mch whereas orexin induced hyperphagia unaffected replacement corticosterone drinking water adx rats reversed effects adx mch sensitivity although found significant populations glucocorticoid receptors lateral hypothalamus none colocalized either mch orexin containing cell bodies furthermore whereas adx significantly reduced hypothalamic mch orexin gene expression could restored glucocorticoids drinking water collectively present data suggest glucocorticoids may promote food intake part potentiating orexigenic actions mch without affecting actions orexin glucocorticoids act indirectly influence effects mch food intake
0.11059638.15044362.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references removal glucocorticoids adrenalectomy adx reduces food intake body weight rodents prevents excessive weight gain many genetic dietary models obesity glucocorticoids play key role promote positive energy balance normal pathological conditions least part altering sensitivity hypothalamic peptides hyperphagia central neuropeptide y administration example attenuated adx evidence glucocorticoids influence mch orexin activity present study feeding responses third ventricular mch orexin measured rats bilateral adx sham surgery adx rats significantly less sensitive orexigenic action third ventricular mch whereas orexin induced hyperphagia unaffected replacement corticosterone drinking water adx rats reversed effects adx mch sensitivity although found significant populations glucocorticoid receptors lateral hypothalamus none colocalized either mch orexin containing cell bodies furthermore whereas adx significantly reduced hypothalamic mch orexin gene expression could restored glucocorticoids drinking water collectively present data suggest glucocorticoids may promote food intake part potentiating orexigenic actions mch without affecting actions orexin glucocorticoids act indirectly influence effects mch food intake
0.11059638.15044362.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references obesity major risk factor many diseases including diabetes mellitus hypertension cardiovascular disease cancers 1 among myriad factors mediating regulation food intake body weight glucocorticoid cortisol corticosterone rats secreted adrenal cortex glucocorticoids lipophilic molecules freely cross blood brain barrier interact receptors distributed throughout central nervous system including nuclei hypothalamus critical energy balance regulation 2 glucocorticoids long term effects food intake obesity 3 rodents forms genetic obesity associated increased glucocorticoid levels whereas lack glucocorticoids linked hypophagia reduced body weight 4 central infusion glucocorticoids also leads increase food intake body weight 5 humans change glucocorticoid status also alter body weight example individuals addison disease exhibit anorexia weight loss due adrenal insufficiency whereas patients cushing disease glucocorticoid excess syndromes increased food intake visceral adiposity reviewed ref 2 rodents adrenalectomy adx reverses many forms obesity whereas glucocorticoid replacement restores obese state 4 6 glucocorticoid administration adrenal intact animals increases food intake weight gain 4 7
0.11059638.15044362.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references obesity major risk factor many diseases including diabetes mellitus hypertension cardiovascular disease cancers 1 among myriad factors mediating regulation food intake body weight glucocorticoid cortisol corticosterone rats secreted adrenal cortex glucocorticoids lipophilic molecules freely cross blood brain barrier interact receptors distributed throughout central nervous system including nuclei hypothalamus critical energy balance regulation 2 glucocorticoids long term effects food intake obesity 3 rodents forms genetic obesity associated increased glucocorticoid levels whereas lack glucocorticoids linked hypophagia reduced body weight 4 central infusion glucocorticoids also leads increase food intake body weight 5 humans change glucocorticoid status also alter body weight example individuals addison disease exhibit anorexia weight loss due adrenal insufficiency whereas patients cushing disease glucocorticoid excess syndromes increased food intake visceral adiposity reviewed ref 2 rodents adrenalectomy adx reverses many forms obesity whereas glucocorticoid replacement restores obese state 4 6 glucocorticoid administration adrenal intact animals increases food intake weight gain 4 7
0.11059638.15044362.html.plaintext.txt	7	addition important metabolic effects periphery glucocorticoids act several hypothalamic nuclei associated control energy balance several studies elucidated actions glucocorticoids activity paraventricular arcuate nuclei arc 8 less explored whether glucocorticoids also act upon neuropeptide systems within lateral hypothalamus lh long known activity lh associated increased food intake weight gain one reasonable hypothesis powerful effects glucocorticoids stimulate positive energy balance act part stimulating neuropeptide systems within lh
0.11059638.15044362.html.plaintext.txt	8	addition important metabolic effects periphery glucocorticoids act several hypothalamic nuclei associated control energy balance several studies elucidated actions glucocorticoids activity paraventricular arcuate nuclei arc 8 less explored whether glucocorticoids also act upon neuropeptide systems within lateral hypothalamus lh long known activity lh associated increased food intake weight gain one reasonable hypothesis powerful effects glucocorticoids stimulate positive energy balance act part stimulating neuropeptide systems within lh
0.11059638.15044362.html.plaintext.txt	9	first neuropeptide systems lh melanin concentrating hormone mch 19 amino acid polypeptide originally isolated salmon pituitaries 9 neuroanatomical studies rats demonstrate mch gene expression limited lh zona incerta extensive fiber projections throughout brain 10 mch produced prepro mch along two putative peptides neuropeptides ei ge 11 known mch receptor rats slc 1 g coupled protein receptor present throughout brain periphery 12 13 central mch involved many different physiological functions including reproduction stress activity importantly energy balance reviewed ref 14 food restriction increases mch expression central injection mch promotes feeding 15 addition mch deficient mice reduced body weight lean due hypophagia increase metabolic rate 16 central administration mch also elicits increase water intake independent food intake 17
0.11059638.15044362.html.plaintext.txt	10	first neuropeptide systems lh melanin concentrating hormone mch 19 amino acid polypeptide originally isolated salmon pituitaries 9 neuroanatomical studies rats demonstrate mch gene expression limited lh zona incerta extensive fiber projections throughout brain 10 mch produced prepro mch along two putative peptides neuropeptides ei ge 11 known mch receptor rats slc 1 g coupled protein receptor present throughout brain periphery 12 13 central mch involved many different physiological functions including reproduction stress activity importantly energy balance reviewed ref 14 food restriction increases mch expression central injection mch promotes feeding 15 addition mch deficient mice reduced body weight lean due hypophagia increase metabolic rate 16 central administration mch also elicits increase water intake independent food intake 17
0.11059638.15044362.html.plaintext.txt	11	second peptide system contained lh orexins also known hypocretins originate prepro orexin prepro hypocretin reviewed ref 18 orexin influences variety endocrine autonomic metabolic functions including control food intake wakefulness motor activity metabolic rate blood pressure 19 orexin 33 amino acid peptide increases food intake body weight dose dependent manner injected brain 20 conversely administration orexin receptor antibody reduces food intake fasted rats 21 similar mch fasting regulates orexin mrna expression 22 orexin containing neurons project widely central nervous system hypothalamic nuclei important control feeding orexin receptors located ventromedial hypothalamus vmn lh arc paraventricular nucleus pvn reviewed ref 18
0.11059638.15044362.html.plaintext.txt	12	given profound effects glucocorticoids feeding orexigenic hypothalamic peptides goal present study assess potential role glucocorticoids influence effects mch orexin food intake tested hypothesis glucocorticoids promote actions peptides lateral hypothalamus part complex hypothalamic system regulates energy balance result present study first investigated effects third ventricular i3vt administration mch orexin food intake adx rats sham operated controls next examined influence glucocorticoids expression mch orexin mrna using semiquantitative pcr adx causes deficiency circulating hormones addition glucocorticoids also examined whether glucocorticoid replacement could reverse effects observed adx finally assessed potential colocalization mch orexin protein glucocorticoid receptors within lh determine whether glucocorticoids may act directly neuronal populations
0.11059638.15044362.html.plaintext.txt	13	given profound effects glucocorticoids feeding orexigenic hypothalamic peptides goal present study assess potential role glucocorticoids influence effects mch orexin food intake tested hypothesis glucocorticoids promote actions peptides lateral hypothalamus part complex hypothalamic system regulates energy balance result present study first investigated effects third ventricular i3vt administration mch orexin food intake adx rats sham operated controls next examined influence glucocorticoids expression mch orexin mrna using semiquantitative pcr adx causes deficiency circulating hormones addition glucocorticoids also examined whether glucocorticoid replacement could reverse effects observed adx finally assessed potential colocalization mch orexin protein glucocorticoid receptors within lh determine whether glucocorticoids may act directly neuronal populations
0.11059638.15044362.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references animals male long evans rats weighing 267 329 g obtained harlan harlan indianapolis housed university cincinnati rats housed individually clear plastic cages ad libitum access pelleted rat chow water unless otherwise specified temperature controlled vivarium 12 h light 12 h dark schedule adx sham surgery animals access 09 nacl solution addition tap water research animals studies presented conducted association assessment accreditation laboratory animal care international approved facilities conducted approval institutional animal care use committee
0.11059638.15044362.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references animals male long evans rats weighing 267 329 g obtained harlan harlan indianapolis housed university cincinnati rats housed individually clear plastic cages ad libitum access pelleted rat chow water unless otherwise specified temperature controlled vivarium 12 h light 12 h dark schedule adx sham surgery animals access 09 nacl solution addition tap water research animals studies presented conducted association assessment accreditation laboratory animal care international approved facilities conducted approval institutional animal care use committee
0.11059638.15044362.html.plaintext.txt	16	procedures third ventricular cannulation animals surgically implanted 22 gauge plastics one roanoke va cannula tip third ventricle described previously 23 rats anesthetized ketamine 86 mgkg ipxylazine 129 mgkg verification cannula placement accomplished i3vt injection 10 ng angiotensin ii 1 microl 09 saline animals drink 5 ml water within 60 min treatment included experiments
0.11059638.15044362.html.plaintext.txt	17	procedures third ventricular cannulation animals surgically implanted 22 gauge plastics one roanoke va cannula tip third ventricle described previously 23 rats anesthetized ketamine 86 mgkg ipxylazine 129 mgkg verification cannula placement accomplished i3vt injection 10 ng angiotensin ii 1 microl 09 saline animals drink 5 ml water within 60 min treatment included experiments
0.11059638.15044362.html.plaintext.txt	18	adrenalectomy short incision made skin rostral kidney perirenal fat located prominent adrenal veins located adrenals isolated surrounding fat capsule removed animals allowed recover least 10 d experiments began adx also removes mineralocorticoids necessary sodium retention adx animals access isotonic 09 saline addition tap water maintain balanced design sham animals also access fluids adx verified measuring plasma corticosterone levels ria tail blood sampled completion behavioral testing 1 h lights 100 microl tip tail determination plasma corticosterone levels animals plasma levels 1 microldl removed study
0.11059638.15044362.html.plaintext.txt	19	corticosterone ria plasma corticosterone levels determined ria using rabbit antiserum raised corticosterone 21 hemisuccinate b3 163 endocrine sciences tarzana ca assay sensitivity 05 microldl intraassay coefficient variation 2 5 experiments
0.11059638.15044362.html.plaintext.txt	20	experiment 1 effect adx feeding response mch behavioral procedures rats sham n 10 adx n 9 adapted schedule food water saline removed cages 5 h end light cycle experimental days 1 h food fluid removed animals received i3vt infusion 2 microl either mch american peptide co sunnyvale ca dissolved 09 saline saline alone via hamilton syringe food returned immediately injection food fluid weighed 30 min 2 h animal received three doses mch 25 5 10 microg vehicle alone order counterbalanced across subjects using latin square procedure animals allowed least 3 d without injections experimental days
0.11059638.15044362.html.plaintext.txt	21	experiment 1 effect adx feeding response mch behavioral procedures rats sham n 10 adx n 9 adapted schedule food water saline removed cages 5 h end light cycle experimental days 1 h food fluid removed animals received i3vt infusion 2 microl either mch american peptide co sunnyvale ca dissolved 09 saline saline alone via hamilton syringe food returned immediately injection food fluid weighed 30 min 2 h animal received three doses mch 25 5 10 microg vehicle alone order counterbalanced across subjects using latin square procedure animals allowed least 3 d without injections experimental days
0.11059638.15044362.html.plaintext.txt	22	experiment 2 effect adx response mch corticosterone replaced rats adx animals saline drinking fluid replaced solution 09 saline 40 microgml corticosterone cort 05 alcohol keep corticosterone solution providing adx rats corticosterone solution results plasma corticosterone levels comparable sham operated controls 24 rats access solution 5 d behavioral testing food intake subsequently determined 30 min 2 h groups rats sham n 10 adx cort n 8 i3vt administration either 50 microg mch saline order treatments counterbalanced across subjects tail blood sampled completion behavioral testing 1 h lights 100 microl tip tail determination plasma corticosterone levels
0.11059638.15044362.html.plaintext.txt	23	experiment 2 effect adx response mch corticosterone replaced rats adx animals saline drinking fluid replaced solution 09 saline 40 microgml corticosterone cort 05 alcohol keep corticosterone solution providing adx rats corticosterone solution results plasma corticosterone levels comparable sham operated controls 24 rats access solution 5 d behavioral testing food intake subsequently determined 30 min 2 h groups rats sham n 10 adx cort n 8 i3vt administration either 50 microg mch saline order treatments counterbalanced across subjects tail blood sampled completion behavioral testing 1 h lights 100 microl tip tail determination plasma corticosterone levels
0.11059638.15044362.html.plaintext.txt	24	experiment 3 effect adx feeding response orexin procedures surgical procedures verifications performed described experiment 1 adx animals maintained plasma corticosterone levels less 1 microldl
0.11059638.15044362.html.plaintext.txt	25	experiment 3 effect adx feeding response orexin procedures surgical procedures verifications performed described experiment 1 adx animals maintained plasma corticosterone levels less 1 microldl
0.11059638.15044362.html.plaintext.txt	26	behavioral procedures rats sham n 10 adx n 9 adapted schedule food water saline removed cages 5 h end light cycle experimental days 1 h food removed animals received i3vt infusion 2 microl either orexin phoenix pharmaceuticals inc mountain view ca dissolved 09 saline saline alone via hamilton syringe food returned immediately injection food fluid weighed 1 2 h animal received three doses orexin 15 30 60 nmol saline alone order counterbalanced across subjects using latin square procedure animals allowed least 3 d without injections experimental days
0.11059638.15044362.html.plaintext.txt	27	experiment 4 effect adx corticosterone replacement hypothalamic mch orexin expression procedures half group adx animals 09 saline solution replaced corticosterone solution 5 d drinking water see three groups rats semiquantitative pcr analysis sham n 13 adx n 7 adx cort n 9 animals killed 1 h lights brief exposure co2 followed rapid decapitation removal fresh brain tissue
0.11059638.15044362.html.plaintext.txt	28	experiment 4 effect adx corticosterone replacement hypothalamic mch orexin expression procedures half group adx animals 09 saline solution replaced corticosterone solution 5 d drinking water see three groups rats semiquantitative pcr analysis sham n 13 adx n 7 adx cort n 9 animals killed 1 h lights brief exposure co2 followed rapid decapitation removal fresh brain tissue
0.11059638.15044362.html.plaintext.txt	29	rna isolation cdna synthesis brains rapidly removed decapitation placed rna later ambion austin tx stored 4 c 24 h stored 80 c use gene measurement mediobasal hypothalami dissected total rna extracted using tri reagent molecular research center cincinnati oh rna samples deoxyribonuclease treated using deoxyribonuclease free ambion austin tx superscript iii first strand synthesis system invitrogen life technologies carlsbad ca used synthesize cdna 5 microg total rna
0.11059638.15044362.html.plaintext.txt	30	rna isolation cdna synthesis brains rapidly removed decapitation placed rna later ambion austin tx stored 4 c 24 h stored 80 c use gene measurement mediobasal hypothalami dissected total rna extracted using tri reagent molecular research center cincinnati oh rna samples deoxyribonuclease treated using deoxyribonuclease free ambion austin tx superscript iii first strand synthesis system invitrogen life technologies carlsbad ca used synthesize cdna 5 microg total rna
0.11059638.15044362.html.plaintext.txt	31	semiquantitative expression mch orexin mrna real time pcr primers designed amplify portion rat mch orexin genes using primer3 primer design software 25 primer sequences 5 3 forward atatgagcctctcttac reverse gtcgtcttctacgttcctga mch forward ttccttctacaaaggttccct reverse tagcagcagcagcagcgtca orexin constitutively expressed ribosomal protein l32 used obtain relative quantification gene primer sequences l32 forward catcgtagaaagagcagcac reverse gcacacaagccatctattcat master mix including cdna prepared 5 microg total rna see using superscript iii first strand synthesis kit invitrogen life technologies 10 microm primer bio rad sybr green supermix used pcrs pcrs performed using bio rad icycler richmond ca final volume 25 microl pcr conditions measurements l32 orexin consisted two step reaction annealing temperature 58 c extension time 30 sec 40 cycles pcr conditions measurements mch 60 c 30 sec 40 cycles standard curve genes performed using dilution series spanning 7 orders magnitude dilution factor 5 pcr efficiencies l32 mch orexin 95 100 correlation coefficients standard curves 0997 100 standard curves calculated slope plot threshold cycle vs log starting concentration samples run triplicate normalized constitutively expressed ribosomal protein l32 data expressed mean plus minus sem mch orexin relative l32 using ct method applied biosystems foster city ca user bulletin 2 december 1997
0.11059638.15044362.html.plaintext.txt	32	semiquantitative expression mch orexin mrna real time pcr primers designed amplify portion rat mch orexin genes using primer3 primer design software 25 primer sequences 5 3 forward atatgagcctctcttac reverse gtcgtcttctacgttcctga mch forward ttccttctacaaaggttccct reverse tagcagcagcagcagcgtca orexin constitutively expressed ribosomal protein l32 used obtain relative quantification gene primer sequences l32 forward catcgtagaaagagcagcac reverse gcacacaagccatctattcat master mix including cdna prepared 5 microg total rna see using superscript iii first strand synthesis kit invitrogen life technologies 10 microm primer bio rad sybr green supermix used pcrs pcrs performed using bio rad icycler richmond ca final volume 25 microl pcr conditions measurements l32 orexin consisted two step reaction annealing temperature 58 c extension time 30 sec 40 cycles pcr conditions measurements mch 60 c 30 sec 40 cycles standard curve genes performed using dilution series spanning 7 orders magnitude dilution factor 5 pcr efficiencies l32 mch orexin 95 100 correlation coefficients standard curves 0997 100 standard curves calculated slope plot threshold cycle vs log starting concentration samples run triplicate normalized constitutively expressed ribosomal protein l32 data expressed mean plus minus sem mch orexin relative l32 using ct method applied biosystems foster city ca user bulletin 2 december 1997
0.11059638.15044362.html.plaintext.txt	33	experiment 5 visualization glucocorticoid receptor mch orexin tissue preparation adult male rats n 4 deeply anesthetized using pentobarbital 200 mgkg perfused transcardially 100 ml 09 nacl followed 500 ml 4 paraformaldehyde 01 m phosphate buffer pb ph 73 brains removed postfixed 1 h room temperature fixative placed 20 sucrose 01 m pb stored 4 c coronal sections 35 microm cut freezing microtome richard allen kalamazoo mi collected four parallel series cryoprotectant solution 30 sucrose 30 ethylene glycol 01 m pb 26 stored 20 c processing
0.11059638.15044362.html.plaintext.txt	34	experiment 5 visualization glucocorticoid receptor mch orexin tissue preparation adult male rats n 4 deeply anesthetized using pentobarbital 200 mgkg perfused transcardially 100 ml 09 nacl followed 500 ml 4 paraformaldehyde 01 m phosphate buffer pb ph 73 brains removed postfixed 1 h room temperature fixative placed 20 sucrose 01 m pb stored 4 c coronal sections 35 microm cut freezing microtome richard allen kalamazoo mi collected four parallel series cryoprotectant solution 30 sucrose 30 ethylene glycol 01 m pb 26 stored 20 c processing
0.11059638.15044362.html.plaintext.txt	35	immunocytochemistry incubations performed room temperature gentle agitation free floating sections washed extensively 01 m pbs incubations sections incubated 10 min 1 h2o2 blocked 1 h incubation solution pbs containing 01 bsa 04 triton x 100 primary antibody incubations performed incubation solution overnight room temperature staining sections washed thoroughly 01 m pb mounted onto glass slides 03 gelatin ddh2o coverslipped dpx electron microscopy sciences fort washington pa immunocytochemical controls included omission primary antibodies sections containing hypothalamus incubated overnight rabbit polyclonal antibody recognizing glucocorticoid receptor 1200 pa1 511a affinity bioreagents golden co followed 1 h incubations biotinylated goat antirabbit igg 1600 vector laboratories burlingame ca avidin horseradish peroxidase complex 11000 abc elite kit vector laboratories burlingame ca finally sections incubated 10 min 002 diaminobenzidine sigma aldrich st louis mo 01 m pb containing 0012 hydrogen peroxide 008 nickel sulfate resulting blue black reaction product next sections incubated overnight rabbit polyclonal antibody orexin 11000 phoenix pharmaceuticals belmont ca rabbit anti mch 1150000 phoenix pharmaceuticals biotinylated goat antirabbit igg 1600 vector laboratories burlingame ca abc described finally sections incubated 10 min 002 diaminobenzidine 01 m pb containing 0012 hydrogen peroxide resulting reddish brown reaction product
0.11059638.15044362.html.plaintext.txt	36	data analysis food intake data experiments 1 3 analyzed using mixed model anova experiment 2 analyzed using one way anova experiment 5 analyzed using two tailed tests pair wise comparisons mean differences conducted using tukey honestly significant difference post hoc comparisons differences group means considered statistically significant p 005 experiment 5 mch orexin positive cells examined coexpression glucocorticoid receptor throughout hypothalamus digital images immunostained sections captured using digital camera magnafire optronics goleta ca attached leica microscope leica microsystems wetzlar germany images imported adobe photoshop 70 adobe systems san jose ca compose figures images adjusted altered way except occasional adjustment brightness
0.11059638.15044362.html.plaintext.txt	37	data analysis food intake data experiments 1 3 analyzed using mixed model anova experiment 2 analyzed using one way anova experiment 5 analyzed using two tailed tests pair wise comparisons mean differences conducted using tukey honestly significant difference post hoc comparisons differences group means considered statistically significant p 005 experiment 5 mch orexin positive cells examined coexpression glucocorticoid receptor throughout hypothalamus digital images immunostained sections captured using digital camera magnafire optronics goleta ca attached leica microscope leica microsystems wetzlar germany images imported adobe photoshop 70 adobe systems san jose ca compose figures images adjusted altered way except occasional adjustment brightness
0.11059638.15044362.html.plaintext.txt	38	results top abstract introduction materials methods results discussion references experiment 1 set rats percent body weight change mean plus minus sem presurgery time experiments performed 399 plus minus 38 sham vs 223 plus minus 44 adx weight gain significantly less adx sham p 005 one way anova mch significantly increased food intake 5 10 microg sham animals 30 min 2 h p 005 cases whereas adx animals mch increased food intake 10 microg dose 2 h p 005 mch increased food intake 5 10 microg greater extent sham compared adx animals 30 min 2 h p 005 see table 1 assessed absolute change food intake animals injected vehicle food intake significantly greater sham compared adx animals 5 10 microg 30 min 2 h p 005 cases see fig 1 total fluid intake water 09 nacl solution significantly increased 5 10 microg mch sham animals 30 min 2 h 10 microg adx animals 30 min 2 h p 005 ten micrograms mch increased fluid intake greater extent sham animals compared adx animals time points p 005 see table 2
0.11059638.15044362.html.plaintext.txt	39	view table table 1 mean plus minus sem 30 min 2 h food intake g rats treated i3vt mch
0.11059638.15044362.html.plaintext.txt	40	view larger version 10k fig 1 mean plus minus sem 30 min b 2 h food intake rats received either bilateral adx surgery sham surgery treated i3vt mch vehicle data represented absolute change animals injected vehicle significantly different paired sham p 005
0.11059638.15044362.html.plaintext.txt	41	view table table 2 mean plus minus sem 30 min 2 h total fluid water 09 nacl solution intake ml rats treated i3vt mch
0.11059638.15044362.html.plaintext.txt	42	experiment 2 plasma corticosterone concentrations significantly reduced undetectable levels adx compared sham animals 117 plus minus 17 microgdl assessed 1 h lights p 005 adx cort animals plasma corticosterone concentrations similar sham animals 83 plus minus 28 microgdl p 005 administration 5 microg mch significantly increased food intake sham adx cort animals p 005 cases mch increased food intake similar extent sham adx cort animals 30 min see fig 2 2 h data shown p 005 cases
0.11059638.15044362.html.plaintext.txt	43	view larger version 12k fig 2 mean plus minus sem 30 min food intake rats received either sham surgery adx surgery consecutive 5 d corticosterone drinking water 27 mgml treated i3vt 5 microg mch vehicle significantly different saline treated rats p 005
0.11059638.15044362.html.plaintext.txt	44	experiment 3 set rats percent body weight change mean plus minus sem presurgery time experiments performed 516 plus minus 31 sham vs 315 plus minus 23 adx weight gain significantly less adx sham p 005 one way anova orexin 3 nmol significantly increased food intake p 005 extent p 005 sham adx animals 1 2 h see table 3 assessed absolute change food intake animals injected vehicle 1 h 2 h food intake similar sham adx animals 30 nmol see fig 3
0.11059638.15044362.html.plaintext.txt	45	view table table 3 mean plus minus sem 1 2 h food intake g rats treated i3vt orexin
0.11059638.15044362.html.plaintext.txt	46	view larger version 12k fig 3 mean plus minus sem 1 h b 2 h food intake rats received either adx sham surgery treated i3vt orexin vehicle data represented absolute change animals injected vehicle
0.11059638.15044362.html.plaintext.txt	47	experiment 4 hypothalamic mrna expression mch relative l32 control significantly reduced adx adx cort animals compared sham animals p 005 cases see fig 4a hypothalamic expression orexin relative l32 control also significantly reduced adx adx cort animals compared sham animals p 005 cases see fig 4b
0.11059638.15044362.html.plaintext.txt	48	view larger version 15k fig 4 hypothalamic expression mch b orexin mrna relative l32 control data represented percentage sham expression significantly different sham animals p 005
0.11059638.15044362.html.plaintext.txt	49	experiment 5 expression glucocorticoid receptor gr mch orexin similar distributions previously described 10 18 27 although gr observed neurons close vicinity neurons expressing orexin mch observed colocalization gr orexin gr mch lh see fig 5
0.11059638.15044362.html.plaintext.txt	50	experiment 5 expression glucocorticoid receptor gr mch orexin similar distributions previously described 10 18 27 although gr observed neurons close vicinity neurons expressing orexin mch observed colocalization gr orexin gr mch lh see fig 5
0.11059638.15044362.html.plaintext.txt	51	view larger version 176k fig 5 lack colocalization gr orexin b mch c d gr observed neurons close vicinity neurons expressing orexin mch indicated arrows scale bar 100 microm
0.11059638.15044362.html.plaintext.txt	52	discussion top abstract introduction materials methods results discussion references results present study suggest well established orexigenic actions mch influenced glucocorticoid status whereas orexin another lateral hypothalamic orexigenic peptide specifically whereas adx attenuated orexigenic actions mch actions orexin unaffected effect adx sensitivity mch reversed corticosterone replacement suggesting effect specific glucocorticoid deficiency associated adx
0.11059638.15044362.html.plaintext.txt	53	discussion top abstract introduction materials methods results discussion references results present study suggest well established orexigenic actions mch influenced glucocorticoid status whereas orexin another lateral hypothalamic orexigenic peptide specifically whereas adx attenuated orexigenic actions mch actions orexin unaffected effect adx sensitivity mch reversed corticosterone replacement suggesting effect specific glucocorticoid deficiency associated adx
0.11059638.15044362.html.plaintext.txt	54	addition examining effect glucocorticoids hyperphagic actions mch orexin examined actions glucocorticoids alter mrna expression mch orexin accord previous data adx reduced hypothalamic mch mrna orexin mrna 28 29 however reductions observed mch orexin restored 5 d corticosterone replacement drinking water despite regimen achieving glucocorticoid levels comparable sham operated animals data suggest gene expression changes lateral hypothalamic peptides glucocorticoid dependent depend nonglucocorticoid aspects adx previous reports described mch mrna increased sham controls adx rats treated dexamethasone 28 similarly dexamethasone administration restored orexin mrna adx 29 although commonly used dexamethasone binding properties glucocorticoids 30 makes much harder assess whether physiological levels glucocorticoid replacement achieved work necessary address whether methodological differences underlie differences current data reports groups nevertheless tempting speculate mineralocorticoids may significant effects lateral hypothalamus particularly true case mch reported mch potent rapid effect increase water intake even absence available food 17 making possible osmoregulatory aspects mineralocorticoids may influence fluid ingestion via actions mch
0.11059638.15044362.html.plaintext.txt	55	addition examining effect glucocorticoids hyperphagic actions mch orexin examined actions glucocorticoids alter mrna expression mch orexin accord previous data adx reduced hypothalamic mch mrna orexin mrna 28 29 however reductions observed mch orexin restored 5 d corticosterone replacement drinking water despite regimen achieving glucocorticoid levels comparable sham operated animals data suggest gene expression changes lateral hypothalamic peptides glucocorticoid dependent depend nonglucocorticoid aspects adx previous reports described mch mrna increased sham controls adx rats treated dexamethasone 28 similarly dexamethasone administration restored orexin mrna adx 29 although commonly used dexamethasone binding properties glucocorticoids 30 makes much harder assess whether physiological levels glucocorticoid replacement achieved work necessary address whether methodological differences underlie differences current data reports groups nevertheless tempting speculate mineralocorticoids may significant effects lateral hypothalamus particularly true case mch reported mch potent rapid effect increase water intake even absence available food 17 making possible osmoregulatory aspects mineralocorticoids may influence fluid ingestion via actions mch
0.11059638.15044362.html.plaintext.txt	56	glucocorticoid receptors present regions hypothalamus important regulation food intake body weight including arc pvn lh 27 suggesting glucocorticoids may directly influence activity responsiveness numerous neuropeptide systems regulating feeding despite fact large population glucocorticoid receptor positive cells within lh evidence located either mch orexin containing neurons consistent data gene expression experiments changes mch orexin expression appeared tied glucocorticoid action
0.11059638.15044362.html.plaintext.txt	57	glucocorticoid receptors present regions hypothalamus important regulation food intake body weight including arc pvn lh 27 suggesting glucocorticoids may directly influence activity responsiveness numerous neuropeptide systems regulating feeding despite fact large population glucocorticoid receptor positive cells within lh evidence located either mch orexin containing neurons consistent data gene expression experiments changes mch orexin expression appeared tied glucocorticoid action
0.11059638.15044362.html.plaintext.txt	58	collectively data make several interesting points first data provide another dissociation mch orexin systems lh although systems cell bodies almost exclusively lh act regulate food intake appear separate neural circuits data indicate actions mch stimulate food intake glucocorticoid dependent whereas actions orexin addition mch added extensive list regulatory peptides whose effects altered glucocorticoids thus appears glucocorticoids broad effects number central nervous system circuits linked control food intake
0.11059638.15044362.html.plaintext.txt	59	collectively data make several interesting points first data provide another dissociation mch orexin systems lh although systems cell bodies almost exclusively lh act regulate food intake appear separate neural circuits data indicate actions mch stimulate food intake glucocorticoid dependent whereas actions orexin addition mch added extensive list regulatory peptides whose effects altered glucocorticoids thus appears glucocorticoids broad effects number central nervous system circuits linked control food intake
0.11059638.15044362.html.plaintext.txt	60	present data also allow speculation glucocorticoids influence actions mch increase food intake mch projections many brain regions important regulation energy balance 10 example slc 1 first identified mch receptor rodents mrna immunoreactivity observed arc pvn lh vmn 13 possible glucocorticoids exert effects mch food intake system acting target cells mch example strong signals slc 1 gr observed pvn making potential candidate site action glucocorticoids reduce mch ability increase food intake 13 27
0.11059638.15044362.html.plaintext.txt	61	present data also allow speculation glucocorticoids influence actions mch increase food intake mch projections many brain regions important regulation energy balance 10 example slc 1 first identified mch receptor rodents mrna immunoreactivity observed arc pvn lh vmn 13 possible glucocorticoids exert effects mch food intake system acting target cells mch example strong signals slc 1 gr observed pvn making potential candidate site action glucocorticoids reduce mch ability increase food intake 13 27
0.11059638.15044362.html.plaintext.txt	62	data indicating melanocortin system antagonizes mch system consistent mch msh exert opposing antagonistic effects food intake 31 studies demonstrate administration either agouti related protein agrp shu9119 increases mch mrna orexin mrna 32 adx increases melanocortin tone rodent models 33 34 possible speculate increase melanocortin tone may antagonize orexigenic effects mch leading present effects adx mch orexin
0.11059638.15044362.html.plaintext.txt	63	data indicating melanocortin system antagonizes mch system consistent mch msh exert opposing antagonistic effects food intake 31 studies demonstrate administration either agouti related protein agrp shu9119 increases mch mrna orexin mrna 32 adx increases melanocortin tone rodent models 33 34 possible speculate increase melanocortin tone may antagonize orexigenic effects mch leading present effects adx mch orexin
0.11059638.15044362.html.plaintext.txt	64	another possibility mch exerts effects via actions arc alter release neuropeptide y npy andor agrp glucocorticoid receptors found neurons 35 potent orexigenic effects npy agrp blocked glucocorticoid deficiency 34 36 recent reports indicate arc potent site mch increase food intake hypothalamic explants administration mch increases release npy suggesting mch may act activation npy neurons affect feeding 37 data lead hypothesis reduced action mch glucocorticoid deficiency could due decreased actions npy andor agrp reverse may also true proposed npy andor agrp exert effects via recruiting mch neurons lh 38 double label immunohistochemistry demonstrates mch neurons receive innervation npy immunoreactive fibers 39 data also suggest mch neurons may express npy receptors 40 evidence encourages hypothesis effect adx reduce orexigenic actions mch may responsible alteration npy actions adx future research identify glucocorticoid receptor populations responsible ability glucocorticoids dramatically alter effects variety neuropeptides mch npy msh agrp
0.11059638.15044362.html.plaintext.txt	65	another possibility mch exerts effects via actions arc alter release neuropeptide y npy andor agrp glucocorticoid receptors found neurons 35 potent orexigenic effects npy agrp blocked glucocorticoid deficiency 34 36 recent reports indicate arc potent site mch increase food intake hypothalamic explants administration mch increases release npy suggesting mch may act activation npy neurons affect feeding 37 data lead hypothesis reduced action mch glucocorticoid deficiency could due decreased actions npy andor agrp reverse may also true proposed npy andor agrp exert effects via recruiting mch neurons lh 38 double label immunohistochemistry demonstrates mch neurons receive innervation npy immunoreactive fibers 39 data also suggest mch neurons may express npy receptors 40 evidence encourages hypothesis effect adx reduce orexigenic actions mch may responsible alteration npy actions adx future research identify glucocorticoid receptor populations responsible ability glucocorticoids dramatically alter effects variety neuropeptides mch npy msh agrp
0.11059638.15044362.html.plaintext.txt	66	acknowledgments grateful jennifer schurdak jennifer adelman expert technical assistance also thank dr randall sakai measurements corticosterone
0.11059638.15044362.html.plaintext.txt	67	footnotes work supported several grants national institutes health dk54080 dk17844 procter gamble co
0.11059638.15044362.html.plaintext.txt	68	abbreviations adx adrenalectomy agrp agouti related protein arc arcuate nucleus cort corticosterone gr glucocorticoid receptor i3vt third ventricular lh lateral hypothalamus mch melanin concentrating hormone npy neuropeptide y pb phosphate buffer pvn paraventricular nucleus vmn ventromedial nucleus
0.11059638.15044362.html.plaintext.txt	69	accepted publication march 15 2004
0.11059638.15044362.html.plaintext.txt	70	references top abstract introduction materials methods results discussion references bray ga 2003 risks obesity prim care 30281 299medline visser dt hu z pasterkamp rj morimoto m kawatam m 1996 alteration glucocorticoid receptor immunoreactivity rat forebrain following short term long term adrenalectomy brain res 729216 222crossrefmedline strack sebastian rj schwartz mw dallman mf 1995 glucocorticoids insulin reciprocal signals energy balance j physiol 268142 149 zakrzewska ke cusin sainsbury rohner jeanrenaud f jeanrenaud b 1997 glucocorticoids counterregulatory hormones leptin diabetes 46717 719abstract zakrzewska ke cusin stricker krongrad boss o ricquier d jeanrenaud b rohner jeanrenaud f 1999 induction obesity hyperleptinemia central glucocorticoid infusion rat diabetes 48365 370abstractfree full text freedman mr horowitz ba stern js 1986 effect adrenalectomy glucocorticoid replacement development obesity j physiol 250r595 r607 green pk wilkinson cw woods sc 1992 intraventricular corticosterone increases rate body weight gain underweight adrenalectomized rats endocrinology 130269 275abstract dallman mf strack akana sf bradbury mj hanson es scribner ka smith m 1993 feast famine critical role glucocorticoids insulin daily energy flow front neuroendocrinol 14303 347crossrefmedline kawauchi h kawazoe tsubokawa m kishida m baker bi 1983 characterization melanin concentrating hormone chum salmon pituitaries nature 305321 323medline bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245medline nahon jl presse f bittencourt jc sawchenko pe vale w 1989 rat melanin concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed dorsolateral hypothalamus endocrinology 1252056 2065abstract chambers j ames rs bergsma d muir fitzgerald lr hervieu g dytko gm foley jj martin j liu ws park j ellis c ganguly konchar cluderay j leslie r wilson sarau hm 1999 melanin concentrating hormone cognate ligand orphan g protein coupled receptor slc 1 nature 400261 265crossrefmedline hervieu gj cluderay je harrison d meakin j maycox p nasir leslie ra 2000 distribution mrna protein products melanin concentrating hormone mch receptor gene slc 1 central nervous system rat eur j neurosci 121194 1216crossrefmedline griffond b baker bi 2002 cell molecular cell biology melanin concentrating hormone int rev cytol 213233 277medline qu d ludwig ds gammeltoft piper m pelleymounter ma cullen mj mathes wf przypek r kanarek r maratos flier e 1996 role melanin concentrating hormone central regulation feeding behaviour nature 380243 247crossrefmedline shimada m tritos na lowell bb flier js maratos flier e 1998 mice lacking melanin concentrating hormone hypophagic lean nature 396670 674crossrefmedline clegg dj air el benoit sc sakai rs seeley rj woods sc 2003 intraventricular melanin concentrating hormone stimulates water intake independent food intake effects intraduodenal glucose fructose antropyloric motility appetite healthy humans 284r494 r499 kirchgessner al 2002 orexins brain gut axis endocr rev 231 15abstractfree full text preti 2002 orexins hypocretins role appetite arousal orexins hypocretins role appetite arousal 31199 1206 dube mg kalra sp kalra ps 1999 food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842473 477crossrefmedline yamada h okumura motomura w kobayashi y kohgo y 2000 inhibition food intake central injection anti orexin antibody fasted rats biochem biophys res commun 267527 531crossrefmedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline chavez m seeley rj woods sc 1995 comparison effects intraventricular insulin intraperitoneal licl three measures sensitive emetic agents behav neurosci 109547 550crossrefmedline wilkinson cw engeland wc shinsako j dallman mf 1981 nonsteroidal adrenal feedback demarcates two types pathways crf acth release j physiol 240e136 e145 rozen skaletsky hj 2000 primer3 www general users biologist programmers krawetz misener eds bioinformatics methods protocols methods molecular biology totowa nj humana press 365 386 watson jr re wiegand sj clough rw hoffman ge 1986 use cryoprotectant maintain long term peptide immunoreactivity tissue morphology peptides 7155 159crossrefmedline morimoto m morita n ozawa h yokoyama k kawata m 1996 distribution glucocorticoid receptor immunoreactivity mrna rat brain immunohistochemical situ hybridization study neurosci res 26235 269crossrefmedline presse f hervieu g imaki sawchenko pe vale w nahon jl 1992 rat melanin concentrating hormone messenger ribonucleic acid expression marked changes development stress glucocorticoid stimuli endocrinology 1311241 1250abstract stricker krongrad beck b 2002 modulation hypothalamic hypocretinorexin mrna expression glucocorticoids biochem biophys res commun 296129 133crossrefmedline spencer rl young ea choo ph mcewen bs 1990 adrenal steroid type type ii receptor binding estimates vivo receptor number occupancy activation varying level steroid brain res 51437 48crossrefmedline ludwig d mountjoy k tatro j gillette j frederich r flier j maratos flier e 1998 melanin concentrating hormone functional melanocortin antagonist hypothalamus j physiol 274e627 e633 hanada r nakazato m matsukura murakami n yoshimatsu h sakata 2000 differential regulation melanin concentrating hormone orexin genes agouti related proteinmelanocortin 4 receptor system biochem biophys res commun 26888 91crossrefmedline makimura h mizuno tm roberts j silverstein j beasley j mobbs cv 2000 adrenalectomy reverses obese phenotype restores hypothalamic melanocortin tone leptin deficient obob mice diabetes 491917 1923abstract drazen dl wortman md schwartz mw clegg dj van dijk g woods sc seeley rj 2003 adrenalectomy alters sensitivity central nervous system melanocortin system diabetes 522928 2934abstractfree full text harfstrand cintra fuxe k aronsson m wikstrom ac okret gustafsson ja agnati lf 1989 regional differences glucocorticoid receptor immunoreactivity among neuropeptide y immunoreactive neurons rat brain acta physiol scand 1353 9medline stanley bg 1989 suppression neuropeptide y elicited eating adrenalectomy hypophysectomy reversal corticosterone brain res 50132 36crossrefmedline abbott cr kennedy ar wren rossi m murphy kg seal lj todd jf ghatei ma small cj bloom sr 2003 identification hypothalamic nuclei involved orexigenic effect melanin concentrating hormone endocrinology 1443943 3949abstractfree full text schwartz mw gelling rw 2002 rats lighten mch antagonist nat med 8779 781crossrefmedline elias cf saper cb maratos flier e tritos na lee c kelly j tatro jb hoffman ge ollmann mm barsh gs sakurai yanagisawa m elmquist jk 1998 chemically defined projections linking mediobasal hypothalamus lateral hypothalamic area j comp neurol 402442 45930co2 r 3985abstractfree full text
0.11059638.15044362.html.plaintext.txt	71	references top abstract introduction materials methods results discussion references bray ga 2003 risks obesity prim care 30281 299medline visser dt hu z pasterkamp rj morimoto m kawatam m 1996 alteration glucocorticoid receptor immunoreactivity rat forebrain following short term long term adrenalectomy brain res 729216 222crossrefmedline strack sebastian rj schwartz mw dallman mf 1995 glucocorticoids insulin reciprocal signals energy balance j physiol 268142 149 zakrzewska ke cusin sainsbury rohner jeanrenaud f jeanrenaud b 1997 glucocorticoids counterregulatory hormones leptin diabetes 46717 719abstract zakrzewska ke cusin stricker krongrad boss o ricquier d jeanrenaud b rohner jeanrenaud f 1999 induction obesity hyperleptinemia central glucocorticoid infusion rat diabetes 48365 370abstractfree full text freedman mr horowitz ba stern js 1986 effect adrenalectomy glucocorticoid replacement development obesity j physiol 250r595 r607 green pk wilkinson cw woods sc 1992 intraventricular corticosterone increases rate body weight gain underweight adrenalectomized rats endocrinology 130269 275abstract dallman mf strack akana sf bradbury mj hanson es scribner ka smith m 1993 feast famine critical role glucocorticoids insulin daily energy flow front neuroendocrinol 14303 347crossrefmedline kawauchi h kawazoe tsubokawa m kishida m baker bi 1983 characterization melanin concentrating hormone chum salmon pituitaries nature 305321 323medline bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245medline nahon jl presse f bittencourt jc sawchenko pe vale w 1989 rat melanin concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed dorsolateral hypothalamus endocrinology 1252056 2065abstract chambers j ames rs bergsma d muir fitzgerald lr hervieu g dytko gm foley jj martin j liu ws park j ellis c ganguly konchar cluderay j leslie r wilson sarau hm 1999 melanin concentrating hormone cognate ligand orphan g protein coupled receptor slc 1 nature 400261 265crossrefmedline hervieu gj cluderay je harrison d meakin j maycox p nasir leslie ra 2000 distribution mrna protein products melanin concentrating hormone mch receptor gene slc 1 central nervous system rat eur j neurosci 121194 1216crossrefmedline griffond b baker bi 2002 cell molecular cell biology melanin concentrating hormone int rev cytol 213233 277medline qu d ludwig ds gammeltoft piper m pelleymounter ma cullen mj mathes wf przypek r kanarek r maratos flier e 1996 role melanin concentrating hormone central regulation feeding behaviour nature 380243 247crossrefmedline shimada m tritos na lowell bb flier js maratos flier e 1998 mice lacking melanin concentrating hormone hypophagic lean nature 396670 674crossrefmedline clegg dj air el benoit sc sakai rs seeley rj woods sc 2003 intraventricular melanin concentrating hormone stimulates water intake independent food intake effects intraduodenal glucose fructose antropyloric motility appetite healthy humans 284r494 r499 kirchgessner al 2002 orexins brain gut axis endocr rev 231 15abstractfree full text preti 2002 orexins hypocretins role appetite arousal orexins hypocretins role appetite arousal 31199 1206 dube mg kalra sp kalra ps 1999 food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842473 477crossrefmedline yamada h okumura motomura w kobayashi y kohgo y 2000 inhibition food intake central injection anti orexin antibody fasted rats biochem biophys res commun 267527 531crossrefmedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline chavez m seeley rj woods sc 1995 comparison effects intraventricular insulin intraperitoneal licl three measures sensitive emetic agents behav neurosci 109547 550crossrefmedline wilkinson cw engeland wc shinsako j dallman mf 1981 nonsteroidal adrenal feedback demarcates two types pathways crf acth release j physiol 240e136 e145 rozen skaletsky hj 2000 primer3 www general users biologist programmers krawetz misener eds bioinformatics methods protocols methods molecular biology totowa nj humana press 365 386 watson jr re wiegand sj clough rw hoffman ge 1986 use cryoprotectant maintain long term peptide immunoreactivity tissue morphology peptides 7155 159crossrefmedline morimoto m morita n ozawa h yokoyama k kawata m 1996 distribution glucocorticoid receptor immunoreactivity mrna rat brain immunohistochemical situ hybridization study neurosci res 26235 269crossrefmedline presse f hervieu g imaki sawchenko pe vale w nahon jl 1992 rat melanin concentrating hormone messenger ribonucleic acid expression marked changes development stress glucocorticoid stimuli endocrinology 1311241 1250abstract stricker krongrad beck b 2002 modulation hypothalamic hypocretinorexin mrna expression glucocorticoids biochem biophys res commun 296129 133crossrefmedline spencer rl young ea choo ph mcewen bs 1990 adrenal steroid type type ii receptor binding estimates vivo receptor number occupancy activation varying level steroid brain res 51437 48crossrefmedline ludwig d mountjoy k tatro j gillette j frederich r flier j maratos flier e 1998 melanin concentrating hormone functional melanocortin antagonist hypothalamus j physiol 274e627 e633 hanada r nakazato m matsukura murakami n yoshimatsu h sakata 2000 differential regulation melanin concentrating hormone orexin genes agouti related proteinmelanocortin 4 receptor system biochem biophys res commun 26888 91crossrefmedline makimura h mizuno tm roberts j silverstein j beasley j mobbs cv 2000 adrenalectomy reverses obese phenotype restores hypothalamic melanocortin tone leptin deficient obob mice diabetes 491917 1923abstract drazen dl wortman md schwartz mw clegg dj van dijk g woods sc seeley rj 2003 adrenalectomy alters sensitivity central nervous system melanocortin system diabetes 522928 2934abstractfree full text harfstrand cintra fuxe k aronsson m wikstrom ac okret gustafsson ja agnati lf 1989 regional differences glucocorticoid receptor immunoreactivity among neuropeptide y immunoreactive neurons rat brain acta physiol scand 1353 9medline stanley bg 1989 suppression neuropeptide y elicited eating adrenalectomy hypophysectomy reversal corticosterone brain res 50132 36crossrefmedline abbott cr kennedy ar wren rossi m murphy kg seal lj todd jf ghatei ma small cj bloom sr 2003 identification hypothalamic nuclei involved orexigenic effect melanin concentrating hormone endocrinology 1443943 3949abstractfree full text schwartz mw gelling rw 2002 rats lighten mch antagonist nat med 8779 781crossrefmedline elias cf saper cb maratos flier e tritos na lee c kelly j tatro jb hoffman ge ollmann mm barsh gs sakurai yanagisawa m elmquist jk 1998 chemically defined projections linking mediobasal hypothalamus lateral hypothalamic area j comp neurol 402442 45930co2 r 3985abstractfree full text
0.11429769.11978759.html.plaintext.txt	0	different rpgr exon orf15 mutations canids provide insights photoreceptor cell degeneration qi zhang1 gregory m acland1 wen x wu2 jennifer l johnson1 sue pearce kelling1 brian tulloch3 raf vervoort34 alan f wright3 gustavo d aguirre1
0.11429769.11978759.html.plaintext.txt	1	1baker institute 2department biomedical sciences cornell university ithaca new york usa 3mrc human genetics unit western general hospital edinburgh uk 4laboratory glycobiology developmental genetics center human genetics university leuven leuven belgium
0.11429769.11978759.html.plaintext.txt	2	ddbjemblgenbank accession nos
0.11429769.11978759.html.plaintext.txt	3	abstract top abstract introduction results discussion methods references canine disease x linked progressive retinal atrophy xlpra similar human rp3 x linked form retinitis pigmentosa maps region x chromosome analysis physical map xlpra rp3 intervals shows high degree conservation terms genes order found different mutations exon orf15 rpgr gene two distinct mutant dog strains xlpra1 xlpra2 microdeletions resulting premature stop frameshift mutation result different retinal phenotypes allele specific consistent mutation phenotype associated frameshift mutation xlpra2 severe manifests retinal development phenotype resulting xlpra1 nonsense mutation expressed normal photoreceptor morphogenesis splicing rpgr mrna transcripts retina complex either exon orf15 exon 19 terminal exon retina predominant transcript contains orf15 terminal exon expressed normal mutant retinas frameshift mutation dramatically alters deduced amino acid sequence protein aggregates endoplasmic reticulum transfected cells cellular molecular results two canine rpgr exon orf15 mutations implications understanding phenotypic variability found human rp3 families carry similar mutations
0.11429769.11978759.html.plaintext.txt	4	abstract top abstract introduction results discussion methods references canine disease x linked progressive retinal atrophy xlpra similar human rp3 x linked form retinitis pigmentosa maps region x chromosome analysis physical map xlpra rp3 intervals shows high degree conservation terms genes order found different mutations exon orf15 rpgr gene two distinct mutant dog strains xlpra1 xlpra2 microdeletions resulting premature stop frameshift mutation result different retinal phenotypes allele specific consistent mutation phenotype associated frameshift mutation xlpra2 severe manifests retinal development phenotype resulting xlpra1 nonsense mutation expressed normal photoreceptor morphogenesis splicing rpgr mrna transcripts retina complex either exon orf15 exon 19 terminal exon retina predominant transcript contains orf15 terminal exon expressed normal mutant retinas frameshift mutation dramatically alters deduced amino acid sequence protein aggregates endoplasmic reticulum transfected cells cellular molecular results two canine rpgr exon orf15 mutations implications understanding phenotypic variability found human rp3 families carry similar mutations
0.11429769.11978759.html.plaintext.txt	5	introduction top abstract introduction results discussion methods references vision begins highly specialized photoreceptor cells retina cells adjacent retinal pigment epithelium rpe interact synergy maintain retinal function viability multiplicity mutations identified cause naturally occurring experimental degeneration 1 human diseases predominantly associated early rod photoreceptor degeneration collectively termed retinitis pigmentosa rp responsible genes involved phototransduction maintaining photoreceptor structure rpe retinoid metabolism however remains large number diseases caused genes whose function poorly understood including rp3 form x linked rp xlrp caused mutations rp gtpase regulator rpgr gene 2
0.11429769.11978759.html.plaintext.txt	6	introduction top abstract introduction results discussion methods references vision begins highly specialized photoreceptor cells retina cells adjacent retinal pigment epithelium rpe interact synergy maintain retinal function viability multiplicity mutations identified cause naturally occurring experimental degeneration 1 human diseases predominantly associated early rod photoreceptor degeneration collectively termed retinitis pigmentosa rp responsible genes involved phototransduction maintaining photoreceptor structure rpe retinoid metabolism however remains large number diseases caused genes whose function poorly understood including rp3 form x linked rp xlrp caused mutations rp gtpase regulator rpgr gene 2
0.11429769.11978759.html.plaintext.txt	7	xlrp population prevalence 1 25 000 represents severe class rp early onset night blindness visual field loss eventual loss central acuity 34 five xlrp loci identified causal mutations established rp2 5 rp3 2 rp3 region spans 500 600 kb xp211 includes tcte1l srpx rpgr otc 2 locus accounts approximately 60 90 affected xlrp pedigrees although previous studies found rpgr mutations 20 families 267 recently novel protein coding sequences identified regions formerly regarded introns rpgr one exon orf15 mutational hot spot mutations exon account majority rp3 cases 8
0.11429769.11978759.html.plaintext.txt	8	xlrp population prevalence 1 25 000 represents severe class rp early onset night blindness visual field loss eventual loss central acuity 34 five xlrp loci identified causal mutations established rp2 5 rp3 2 rp3 region spans 500 600 kb xp211 includes tcte1l srpx rpgr otc 2 locus accounts approximately 60 90 affected xlrp pedigrees although previous studies found rpgr mutations 20 families 267 recently novel protein coding sequences identified regions formerly regarded introns rpgr one exon orf15 mutational hot spot mutations exon account majority rp3 cases 8
0.11429769.11978759.html.plaintext.txt	9	role rpgr retinal function unknown first 10 exons encode domain highly conserved species consisting six tandem repeats 52 54 amino acids homologous repeat structure rcc1 protein 2 rpgr knockout mice exons 4 6 replaced selectable marker results lack rpgr expression develop slowly progressive post developmental photoreceptor degeneration 9 rcc1 domain used bait yeast two hybrid screens resulting identification two interacting proteins delta subunit rod specific cyclic gmp phosphodiesterase 10 rpgr interacting protein rpgrip 1112 rpgrip co localizes rpgr photoreceptor outer segment 12 connecting cilium 13 may involved structural transport functions respectively
0.11429769.11978759.html.plaintext.txt	10	role rpgr retinal function unknown first 10 exons encode domain highly conserved species consisting six tandem repeats 52 54 amino acids homologous repeat structure rcc1 protein 2 rpgr knockout mice exons 4 6 replaced selectable marker results lack rpgr expression develop slowly progressive post developmental photoreceptor degeneration 9 rcc1 domain used bait yeast two hybrid screens resulting identification two interacting proteins delta subunit rod specific cyclic gmp phosphodiesterase 10 rpgr interacting protein rpgrip 1112 rpgrip co localizes rpgr photoreceptor outer segment 12 connecting cilium 13 may involved structural transport functions respectively
0.11429769.11978759.html.plaintext.txt	11	little known function c terminal half rpgr particularly exon orf15 mutations located 8 alternative approach address question functional role domain identify species naturally occurring mutations region examine resultant phenotypes comparative genomic approach possible dogs sufficient resources map positionally clone disease genes 14
0.11429769.11978759.html.plaintext.txt	12	little known function c terminal half rpgr particularly exon orf15 mutations located 8 alternative approach address question functional role domain identify species naturally occurring mutations region examine resultant phenotypes comparative genomic approach possible dogs sufficient resources map positionally clone disease genes 14
0.11429769.11978759.html.plaintext.txt	13	canine progressive retinal atrophy pra comprises several naturally occurring retinal diseases similar phenotype rp six distinct autosomal one x linked loci identified 15 xlpra siberian husky spontaneous animal model xlrp 1617 disease mapped short arm x chromosome showed recombinants rpgr prior recognition novel orf15 exon human rpgr characterized rpgr splice variants found mutations 18
0.11429769.11978759.html.plaintext.txt	14	canine progressive retinal atrophy pra comprises several naturally occurring retinal diseases similar phenotype rp six distinct autosomal one x linked loci identified 15 xlpra siberian husky spontaneous animal model xlrp 1617 disease mapped short arm x chromosome showed recombinants rpgr prior recognition novel orf15 exon human rpgr characterized rpgr splice variants found mutations 18
0.11429769.11978759.html.plaintext.txt	15	original xlpra disorder renamed xlpra1 distinguish second disease xlpra2 mapping locus recombination events located disease interval microsatellite markers associated tcte1l otc 19 markers define less 1 cm zero recombination region homologous rp3 interval containing tcte1l srpx rpgr otc orthologs present study completed cloning characterization canine rpgr including 10 kb intron 15 containing exon orf15 found three distinct microdeletions exon orf15 canids one benign two disease associated provide insights structure function rpgr c terminal domain human disease
0.11429769.11978759.html.plaintext.txt	16	original xlpra disorder renamed xlpra1 distinguish second disease xlpra2 mapping locus recombination events located disease interval microsatellite markers associated tcte1l otc 19 markers define less 1 cm zero recombination region homologous rp3 interval containing tcte1l srpx rpgr otc orthologs present study completed cloning characterization canine rpgr including 10 kb intron 15 containing exon orf15 found three distinct microdeletions exon orf15 canids one benign two disease associated provide insights structure function rpgr c terminal domain human disease
0.11429769.11978759.html.plaintext.txt	17	results top abstract introduction results discussion methods references comparative mapping xlpra1xlpra2 rp3 construct physical map used published human gene sequence data rp3 interval retrieve canine bacs made contig extending xk otc established gene order xlpra rp3 regions fig 1 found recombinations 364 2107 flanking markers 19 effectively reducing interval 550 kb region extending tcte1l otc including srpx rpgr among four genes excluded tcte1l direct cdna sequencing focused efforts canine ortholog exon orf15
0.11429769.11978759.html.plaintext.txt	18	results top abstract introduction results discussion methods references comparative mapping xlpra1xlpra2 rp3 construct physical map used published human gene sequence data rp3 interval retrieve canine bacs made contig extending xk otc established gene order xlpra rp3 regions fig 1 found recombinations 364 2107 flanking markers 19 effectively reducing interval 550 kb region extending tcte1l otc including srpx rpgr among four genes excluded tcte1l direct cdna sequencing focused efforts canine ortholog exon orf15
0.11429769.11978759.html.plaintext.txt	19	view larger version 29k figure 1 comparative linkage physical maps rp3 xlpra intervals linkage distances expressed centimorgans cm orientation xp given tel cen rp3 flanking region hsxp211 linkage map based genemap99 physical map meindl et al 2 sequences al121578 al121577 af241726 taken ncbi nucleotide database note contig gap srpx otc b xlpra flanking region linkage map taken zhang et al 19 bac sizes estimates physical map consistent human data terms conserved orthologs order xp
0.11429769.11978759.html.plaintext.txt	20	view larger version 29k figure 1 comparative linkage physical maps rp3 xlpra intervals linkage distances expressed centimorgans cm orientation xp given tel cen rp3 flanking region hsxp211 linkage map based genemap99 physical map meindl et al 2 sequences al121578 al121577 af241726 taken ncbi nucleotide database note contig gap srpx otc b xlpra flanking region linkage map taken zhang et al 19 bac sizes estimates physical map consistent human data terms conserved orthologs order xp
0.11429769.11978759.html.plaintext.txt	21	cloning rpgr exon orf15 identification three microdeletions canids primers intron 14 exon 16 used amplify 10 kb intron 15 bac clone positive rpgr product cloned directly sequenced using vector primers followed gene specific primer walking exon orf15 genbank accession af385629 transcribed continuously exon 15 extends 28 kb intron 15 unusually rich purines 70 repetitive sequences stop codon taa polya signal aauaaa positions 1717 1719 2805 2810 respectively two unstable signals auuua recognition sites rnase e activity 20 found 3 utr humans dog exon encodes set charged amino acids arg lys asp glu alternated glycines encoded proteins identical number glutamic aspartic acid residues similar isoelectric point 401 versus 405 however instead repetitive eeegegege sequence humans 8 dog sequence contains geeegeeee gegeeeeg eeegeeegee repeats c terminal 35 amino acids highly conserved human dog premature stop codons mutant exon orf15 sequences xlpra1 2 encode proteins lacking c terminal tail
0.11429769.11978759.html.plaintext.txt	22	cloning rpgr exon orf15 identification three microdeletions canids primers intron 14 exon 16 used amplify 10 kb intron 15 bac clone positive rpgr product cloned directly sequenced using vector primers followed gene specific primer walking exon orf15 genbank accession af385629 transcribed continuously exon 15 extends 28 kb intron 15 unusually rich purines 70 repetitive sequences stop codon taa polya signal aauaaa positions 1717 1719 2805 2810 respectively two unstable signals auuua recognition sites rnase e activity 20 found 3 utr humans dog exon encodes set charged amino acids arg lys asp glu alternated glycines encoded proteins identical number glutamic aspartic acid residues similar isoelectric point 401 versus 405 however instead repetitive eeegegege sequence humans 8 dog sequence contains geeegeeee gegeeeeg eeegeeegee repeats c terminal 35 amino acids highly conserved human dog premature stop codons mutant exon orf15 sequences xlpra1 2 encode proteins lacking c terminal tail
0.11429769.11978759.html.plaintext.txt	23	three microdeletions found canids 100 bp region nucleotides 1001 1100 exon orf15 red wolves three nucleotide deletion eliminates glutamic acid alter remainder protein cause disease see five nucleotide deletion delgagaa 1028 1032 identified xlpra1 xlpra2 two nucleotide deletion delga 1084 1085 identified 51 nucleotides 3 site xlpra1 deletion figs 2 3
0.11429769.11978759.html.plaintext.txt	24	three microdeletions found canids 100 bp region nucleotides 1001 1100 exon orf15 red wolves three nucleotide deletion eliminates glutamic acid alter remainder protein cause disease see five nucleotide deletion delgagaa 1028 1032 identified xlpra1 xlpra2 two nucleotide deletion delga 1084 1085 identified 51 nucleotides 3 site xlpra1 deletion figs 2 3
0.11429769.11978759.html.plaintext.txt	25	view larger version 30k figure 2 mutation analyses exon orf15 canids wild type nucleotide sequence mutation region canine exon orf15 encompassing nucleotides 1001 1100 three deletions illustrated top lines electropherograms show deletions affected carrier dogs xlpra1 b xlpra2 c
0.11429769.11978759.html.plaintext.txt	26	view larger version 30k figure 2 mutation analyses exon orf15 canids wild type nucleotide sequence mutation region canine exon orf15 encompassing nucleotides 1001 1100 three deletions illustrated top lines electropherograms show deletions affected carrier dogs xlpra1 b xlpra2 c
0.11429769.11978759.html.plaintext.txt	27	view larger version 27k figure 3 segregation deletions xlpra1 xlpra2 b pedigrees xlpra1 carrier normal 1 mutant 2 alleles slower migrating heteroduplex bands h small size difference normal mutant alleles xlpra2 pcr products tested sample genetically normal dog mixed denaturing 98 degrees c 10 minutes incubated 68 degrees c 1 hour dog two lanes sample alone mixed test normal samples show heteroduplex h shown normal 1 affected 2 alleles compound heterozygous female c produces offspring xlpra1 xlpra2 alleles 1 3 wild type allele 2 4 xlpra1 xlpra2 respectively
0.11429769.11978759.html.plaintext.txt	28	view larger version 27k figure 3 segregation deletions xlpra1 xlpra2 b pedigrees xlpra1 carrier normal 1 mutant 2 alleles slower migrating heteroduplex bands h small size difference normal mutant alleles xlpra2 pcr products tested sample genetically normal dog mixed denaturing 98 degrees c 10 minutes incubated 68 degrees c 1 hour dog two lanes sample alone mixed test normal samples show heteroduplex h shown normal 1 affected 2 alleles compound heterozygous female c produces offspring xlpra1 xlpra2 alleles 1 3 wild type allele 2 4 xlpra1 xlpra2 respectively
0.11429769.11978759.html.plaintext.txt	29	xlpra1 mutation causes frameshift immediate premature stop truncated protein missing 230 c terminal amino acids causing slight decrease isoelectric point 389 versus 401 normal mutation scanning also found five nucleotide deletion samoyed breed clinically similar x linked retinal degeneration data shown xlpra2 mutation results frameshift significantly changes deduced peptide sequence causing increased isoelectric point 430 versus 401 leads inclusion 34 additional basic residues prematurely terminating translation 71 amino acids downstream produced several compound heterozygotes showed severe clinical phenotype either xlpra1 xlpra2 hemizygotes heterozygotes see figure 3c illustrates independent segregation two mutant alleles male progeny compound heterozygote
0.11429769.11978759.html.plaintext.txt	30	exon orf15 deletions determine retinal phenotype severe abnormalities retinal structure function found xlpra allele specific previously reported photoreceptors xlpra1 retina developed functioned normally 17 retinal function remained normal 6 months age later decrease amplitude dark adapted rod cone responses fig 4ia1 3 morphologically xlpra1 photoreceptors remained normal young adulthood thereafter rods showed distinct irregularities outer segments followed degeneration cone abnormalities appeared less severe proportionally larger number cones remained visual cell layer late disease fig 4iia d affected males showed end stage retinal disease 4 years age
0.11429769.11978759.html.plaintext.txt	31	exon orf15 deletions determine retinal phenotype severe abnormalities retinal structure function found xlpra allele specific previously reported photoreceptors xlpra1 retina developed functioned normally 17 retinal function remained normal 6 months age later decrease amplitude dark adapted rod cone responses fig 4ia1 3 morphologically xlpra1 photoreceptors remained normal young adulthood thereafter rods showed distinct irregularities outer segments followed degeneration cone abnormalities appeared less severe proportionally larger number cones remained visual cell layer late disease fig 4iia d affected males showed end stage retinal disease 4 years age
0.11429769.11978759.html.plaintext.txt	32	view larger version 122k figure 4 erg pathology ii situ hybridization iii normal xlpra panel shows responses scotopically balanced red blue stimuli white light 5 hz rod 30 hz cone stimuli xlpra1 erg develops normally a1 70 days remains normal early adulthood amplitudes decrease age a2 13 years a3 25 years xlpra2 shows rod cone responses reduced amplitude abnormal waveform early b1 70 days b2 4 months 1 year b3 rod responses nearly absent distinct cone signals prolonged timing remain xlpra1 d 25 years xlpra2 e2 years carriers retain normal erg waveforms lower amplitudes especially xlpra2 c normal control vertical lines arrows light stimulus onset calibration marker 100 microv 50 ms except rod flicker 100 ms ii xlpra1 retina rpe normal 94 months developing outer segment os abnormalities b 13 months degeneration occurs subsequently rate severity varies affected animals c 15 months d 3 years remaining cones prominent oblique arrows xlpra2 retina develops abnormally outer segments disorganized disoriented early e 1 month photoreceptors degenerate rapidly f 4 months g 7 months h 19 years xlpra1 carrier outside areas patchy retinal degeneration shows lower number normal surviving photoreceptors 5 years xlpra2 carrier j k 1 year shows patchy degeneration j horizontal bracket abnormally developed photoreceptors compound heterozygote l 97 months shows advanced degeneration calibration bar 50 microm horizontal arrowhead external limiting membrane iii paired brightfield a1 b1 c1 d1 combined brightfieldepipolarization a2 b2 c2 d2 images normal b 10 months xlpra1 retinas 33 c 11 d months hybridized antisense c d sense b exon orf15 probes nucleotides 800 1451 normal mutant show pattern intensity hybridization peripheral retina older mutant d label present photoreceptor number decreased wavy lines panels c12 represent photographic apposition rpe retina calibration bar d2 26 microm arrows cone
0.11429769.11978759.html.plaintext.txt	33	view larger version 122k figure 4 erg pathology ii situ hybridization iii normal xlpra panel shows responses scotopically balanced red blue stimuli white light 5 hz rod 30 hz cone stimuli xlpra1 erg develops normally a1 70 days remains normal early adulthood amplitudes decrease age a2 13 years a3 25 years xlpra2 shows rod cone responses reduced amplitude abnormal waveform early b1 70 days b2 4 months 1 year b3 rod responses nearly absent distinct cone signals prolonged timing remain xlpra1 d 25 years xlpra2 e2 years carriers retain normal erg waveforms lower amplitudes especially xlpra2 c normal control vertical lines arrows light stimulus onset calibration marker 100 microv 50 ms except rod flicker 100 ms ii xlpra1 retina rpe normal 94 months developing outer segment os abnormalities b 13 months degeneration occurs subsequently rate severity varies affected animals c 15 months d 3 years remaining cones prominent oblique arrows xlpra2 retina develops abnormally outer segments disorganized disoriented early e 1 month photoreceptors degenerate rapidly f 4 months g 7 months h 19 years xlpra1 carrier outside areas patchy retinal degeneration shows lower number normal surviving photoreceptors 5 years xlpra2 carrier j k 1 year shows patchy degeneration j horizontal bracket abnormally developed photoreceptors compound heterozygote l 97 months shows advanced degeneration calibration bar 50 microm horizontal arrowhead external limiting membrane iii paired brightfield a1 b1 c1 d1 combined brightfieldepipolarization a2 b2 c2 d2 images normal b 10 months xlpra1 retinas 33 c 11 d months hybridized antisense c d sense b exon orf15 probes nucleotides 800 1451 normal mutant show pattern intensity hybridization peripheral retina older mutant d label present photoreceptor number decreased wavy lines panels c12 represent photographic apposition rpe retina calibration bar d2 26 microm arrows cone
0.11429769.11978759.html.plaintext.txt	34	contrast retinal development aberrant xlpra2 erg abnormalities evident 5 6 weeks age responses low amplitude abnormal waveform deteriorated age fig 4ib1 3 relative preservation cone flicker responses rod function severely compromised cone signals abnormally small older animals increased timing parallel photoreceptor morphogenesis abnormal outer segments highly disorganized disoriented develop fig 4iie visual cell degeneration present 4 months progresses fig 4iifg 2 years end stage degeneration present affected animals fig 4iih cone abnormalities less severe proportionally larger number cones remained late disease
0.11429769.11978759.html.plaintext.txt	35	contrast retinal development aberrant xlpra2 erg abnormalities evident 5 6 weeks age responses low amplitude abnormal waveform deteriorated age fig 4ib1 3 relative preservation cone flicker responses rod function severely compromised cone signals abnormally small older animals increased timing parallel photoreceptor morphogenesis abnormal outer segments highly disorganized disoriented develop fig 4iie visual cell degeneration present 4 months progresses fig 4iifg 2 years end stage degeneration present affected animals fig 4iih cone abnormalities less severe proportionally larger number cones remained late disease
0.11429769.11978759.html.plaintext.txt	36	heterozygotes retinal functional abnormalities reflected underlying photoreceptor pathology low amplitude responses present young adult carriers either genotype fig 4ic e progressive loss function found xlpra2 data shown foci patchy retinal degeneration remaining photoreceptors xlpra1 heterozygotes normal fig 4iii case xlpra2 since carrier retina failed develop normally surviving photoreceptors showed severe structural abnormalities compare fig 4iii j k severe pathology xlpra2 carriers indicates mutation kills mutant photoreceptors early development produces collateral damage surviving normal ones allele expressed already compromised retina compound heterozygote disease severe fig 4iil
0.11429769.11978759.html.plaintext.txt	37	heterozygotes retinal functional abnormalities reflected underlying photoreceptor pathology low amplitude responses present young adult carriers either genotype fig 4ic e progressive loss function found xlpra2 data shown foci patchy retinal degeneration remaining photoreceptors xlpra1 heterozygotes normal fig 4iii case xlpra2 since carrier retina failed develop normally surviving photoreceptors showed severe structural abnormalities compare fig 4iii j k severe pathology xlpra2 carriers indicates mutation kills mutant photoreceptors early development produces collateral damage surviving normal ones allele expressed already compromised retina compound heterozygote disease severe fig 4iil
0.11429769.11978759.html.plaintext.txt	38	expression profile rpgr splice variants protein normal mutant retinas understand disease mechanism resulting exon orf15 mutations characterized rpgr alternative splicing detail examined expression normal mutant retina using probes different regions rpgr cdna fig 5
0.11429769.11978759.html.plaintext.txt	39	view larger version 24k figure 5 schematic representation genomic organization canine rpgr drawn scale location probes used identify retinal expressed transcripts b 18 c new transcript orf15 terminal exon note brackets c identify exons orf 14 exons 14 14a orf15 exon 15 transcribed portion intron 15 8 asterisk identifies approximate position microdeletions associated xlpra1 xlpra2
0.11429769.11978759.html.plaintext.txt	40	view larger version 24k figure 5 schematic representation genomic organization canine rpgr drawn scale location probes used identify retinal expressed transcripts b 18 c new transcript orf15 terminal exon note brackets c identify exons orf 14 exons 14 14a orf15 exon 15 transcribed portion intron 15 8 asterisk identifies approximate position microdeletions associated xlpra1 xlpra2
0.11429769.11978759.html.plaintext.txt	41	exon orf 15 transcribed rcc1 like domain exon 14a rpgr expression examined using normal retinal rna sample loaded separate lanes gel hybridized probes corresponding different exons fig 6a probes exons 3 10 14a orf15 detected two novel common bands 89 50 kb suggesting exons part transcript exon orf15 transcribed also demonstrate exon 14a expression retina transcription frame exon orf15 fig 6a
0.11429769.11978759.html.plaintext.txt	42	exon orf 15 transcribed rcc1 like domain exon 14a rpgr expression examined using normal retinal rna sample loaded separate lanes gel hybridized probes corresponding different exons fig 6a probes exons 3 10 14a orf15 detected two novel common bands 89 50 kb suggesting exons part transcript exon orf15 transcribed also demonstrate exon 14a expression retina transcription frame exon orf15 fig 6a
0.11429769.11978759.html.plaintext.txt	43	view larger version 61k figure 6 rpgr expression antisense rna probes different exons rpgr hybridized total retinal rna 20 microglane probe locations follows exons 3 10 nucleotides 258 1330 exons 16 19 nucleotides 1681 2374 exon14a nucleotides 1842 2428 exon orf15 nucleotides 803 1603 b rpgr expression different tissues antisense probes exons 3 10 top exons 16 19 middle hybridized dog tissue blot containing 20 microg total rnalane bottom panel shows blot hybridized 18s cdna probe c expression rpgr normal 77 months xlpra1 2 non allelic autosomal retinal diseases affected samples pre degenerate stages 4 6 weeks age antisense rna probes hybridized total retinal rna 20 microglane normal pre degenerate retinas xlpra1 prcd xlpra2 rcd1 rcd1 prcd samples serve disease controls animals age affected non allelic autosomal retinal diseases comparable phenotype xlpra1 prcd xlpra2 rcd1 15 bottom panel shows hybridization 18s cdna probe blot d western blot rpgr retinal tissues normal affected dogs proteins 50 microg total proteinlane cytosol top membrane bottom fractions labeled dr 39 rpgr 254 antibodies respectively sample source age listed lane
0.11429769.11978759.html.plaintext.txt	44	tissue expression profile reveals orf15 retina predominant terminal exon using probes exons 3 10 16 19 found respectively 32 28 kb bands northern blots fig 6b 28 kb band ubiquitously expressed tissues 32 kb band appears represent non specific binding since consistently found repeat blotting tissues exon 3 10 probe shows two major high molecular size transcripts 89 50 kb expression cerebellum similar retina low levels brain regions fig 6b 89 kb transcript hardly detectable liver heart results obtained exon orf15 probe data shown size 5 kb transcript expressed predominantly retina matches expected sequence length 5284 bp exon orf15 used terminal exon
0.11429769.11978759.html.plaintext.txt	45	tissue expression profile reveals orf15 retina predominant terminal exon using probes exons 3 10 16 19 found respectively 32 28 kb bands northern blots fig 6b 28 kb band ubiquitously expressed tissues 32 kb band appears represent non specific binding since consistently found repeat blotting tissues exon 3 10 probe shows two major high molecular size transcripts 89 50 kb expression cerebellum similar retina low levels brain regions fig 6b 89 kb transcript hardly detectable liver heart results obtained exon orf15 probe data shown size 5 kb transcript expressed predominantly retina matches expected sequence length 5284 bp exon orf15 used terminal exon
0.11429769.11978759.html.plaintext.txt	46	xlpra mutant retinas express rpgr transcripts examined expression pre degenerate 4 6 weeks age xlpra retinas using probes exons 3 10 orf15 age retinas show cellular degeneration although abnormalities outer segment structure present xlpra2 addition normals also used controls retinas animals age non allelic autosomal retinal diseases comparable phenotypes xlpra1 prcd xlpra2 rcd1 15 affected controls probes detected bands 89 5 kb xlpra1 transcript abundance normal although distinct message found xlpra2 probes found slightly lower levels expression fig 6c results indicate rpgr exon orf15 transcribed mutant retinas
0.11429769.11978759.html.plaintext.txt	47	xlpra mutant retinas express rpgr transcripts examined expression pre degenerate 4 6 weeks age xlpra retinas using probes exons 3 10 orf15 age retinas show cellular degeneration although abnormalities outer segment structure present xlpra2 addition normals also used controls retinas animals age non allelic autosomal retinal diseases comparable phenotypes xlpra1 prcd xlpra2 rcd1 15 affected controls probes detected bands 89 5 kb xlpra1 transcript abundance normal although distinct message found xlpra2 probes found slightly lower levels expression fig 6c results indicate rpgr exon orf15 transcribed mutant retinas
0.11429769.11978759.html.plaintext.txt	48	used situ hybridization examine expression exon orf15 retina predominant transcript comparable intense accumulation silver grains found normal xlpra1 affected retinas tissues available xlpra2 animals label found rpe photoreceptor inner segments nuclear layers cone inner segments showed dense clusters label difference label intensity distribution found normal xlpra1 affected animals compare fig 4iiia12 c12 d12 older affected animals label intensity reduced secondary loss visual cells remaining cells showed normal label distribution fig 4iiid12 control sense probe showed low diffuse labeling normal fig 4iiib12 mutant data shown
0.11429769.11978759.html.plaintext.txt	49	used situ hybridization examine expression exon orf15 retina predominant transcript comparable intense accumulation silver grains found normal xlpra1 affected retinas tissues available xlpra2 animals label found rpe photoreceptor inner segments nuclear layers cone inner segments showed dense clusters label difference label intensity distribution found normal xlpra1 affected animals compare fig 4iiia12 c12 d12 older affected animals label intensity reduced secondary loss visual cells remaining cells showed normal label distribution fig 4iiid12 control sense probe showed low diffuse labeling normal fig 4iiib12 mutant data shown
0.11429769.11978759.html.plaintext.txt	50	western analysis antibody dr 39 raised peptides human rpgr exons 13 14 detected 100 kda band cytosol membrane fractions fig 6d top panel also found 95 kda major band smaller 90 kda band membrane fraction rpgr 254 antibody raised c terminal 254 residues rpgr fig 6d lower panel could identify specific bands cytosolic fraction using antibody however differences found control mutant samples indication antibodies failed detect proteins containing exon orf15
0.11429769.11978759.html.plaintext.txt	51	rpgr photoreceptor specific proteins normally expressed mutant retina used different rpgr antibodies obtained results normal mutant retinas fig 7 polyclonal rpgr 33606 antibody intensely labeled outer segments fig 7a12 results previously reported 12 contrast antibody dr 39 intensely labeled inner segments inner nuclear ganglion cells fig 7a34 intensity distribution labeling normal mutant retina even photoreceptor degeneration started fig 7c34 d34 three antibodies opsin pde rod cgmp channel protein subunit produced labeling normal mutant fig 7 columns 5 7 even eyes showed disease associated pathology normal labeling photoreceptor specific proteins examined indicates polarized distribution mutant visual cells altered
0.11429769.11978759.html.plaintext.txt	52	rpgr photoreceptor specific proteins normally expressed mutant retina used different rpgr antibodies obtained results normal mutant retinas fig 7 polyclonal rpgr 33606 antibody intensely labeled outer segments fig 7a12 results previously reported 12 contrast antibody dr 39 intensely labeled inner segments inner nuclear ganglion cells fig 7a34 intensity distribution labeling normal mutant retina even photoreceptor degeneration started fig 7c34 d34 three antibodies opsin pde rod cgmp channel protein subunit produced labeling normal mutant fig 7 columns 5 7 even eyes showed disease associated pathology normal labeling photoreceptor specific proteins examined indicates polarized distribution mutant visual cells altered
0.11429769.11978759.html.plaintext.txt	53	view larger version 113k figure 7 expression photoreceptor proteins normal xlpra1 b disease stage c early disease xlpra2 d dogs following ages 96 months b 33 months c 113 months d 7 weeks columns 1 2 5 7 16 weeks columns 3 4 c 2 microm dgd sections d 10 microm cryosections columns 1 2 3 4 paired nomarski 13 immunofluorescence 24 images using rpgr 33606 dr 39 antibodies columns represent single images sections labeled antibodies opsin pde rod cgmp channel protein subunit pattern intensity labeling found normal mutant retinas calibration bar 50 microm
0.11429769.11978759.html.plaintext.txt	54	view larger version 113k figure 7 expression photoreceptor proteins normal xlpra1 b disease stage c early disease xlpra2 d dogs following ages 96 months b 33 months c 113 months d 7 weeks columns 1 2 5 7 16 weeks columns 3 4 c 2 microm dgd sections d 10 microm cryosections columns 1 2 3 4 paired nomarski 13 immunofluorescence 24 images using rpgr 33606 dr 39 antibodies columns represent single images sections labeled antibodies opsin pde rod cgmp channel protein subunit pattern intensity labeling found normal mutant retinas calibration bar 50 microm
0.11429769.11978759.html.plaintext.txt	55	xlpra2 mutant proteins aggregate er examined subcellular localization normal mutant exon orf15gfp fusion proteins using transfected cos7 cells signal normal protein mainly cytoplasmic diffuse faint nuclear presence fig 8b similar results obtained following transfection gfp vector alone fig 8a exon orf15 nonsense mutation xlpra1 fig 8c contrast frameshift mutation xlpra2 showed intense accumulation protein aggregates distinct perinuclear subcellular compartment fig 8d e1 faint diffuse signal rest cytoplasm minimal signal nucleus staining endoplasmic reticular er specific marker confirms co localization aggregates er fig 8e1 3
0.11429769.11978759.html.plaintext.txt	56	xlpra2 mutant proteins aggregate er examined subcellular localization normal mutant exon orf15gfp fusion proteins using transfected cos7 cells signal normal protein mainly cytoplasmic diffuse faint nuclear presence fig 8b similar results obtained following transfection gfp vector alone fig 8a exon orf15 nonsense mutation xlpra1 fig 8c contrast frameshift mutation xlpra2 showed intense accumulation protein aggregates distinct perinuclear subcellular compartment fig 8d e1 faint diffuse signal rest cytoplasm minimal signal nucleus staining endoplasmic reticular er specific marker confirms co localization aggregates er fig 8e1 3
0.11429769.11978759.html.plaintext.txt	57	view larger version 90k figure 8 transient expression different gfp exon orf15 constructs cos7 cells similar distribution cells expressing vector wild type b xlpra1 gfp exon orf15 c constructs however xlpra2 construct results gfp fluorescence aggregates around nucleus d xlpra2 gfp exon orf15 protein aggregates e1 er e2 co localize e3
0.11429769.11978759.html.plaintext.txt	58	view larger version 90k figure 8 transient expression different gfp exon orf15 constructs cos7 cells similar distribution cells expressing vector wild type b xlpra1 gfp exon orf15 c constructs however xlpra2 construct results gfp fluorescence aggregates around nucleus d xlpra2 gfp exon orf15 protein aggregates e1 er e2 co localize e3
0.11429769.11978759.html.plaintext.txt	59	discussion top abstract introduction results discussion methods references physical mapping xlpra interval shows strong homology region xp humans dogs terms genes order mapped two distinct x linked retinal disorders region found disease associated mutations rpgr exon orf15 specificity mutations confirmed finding sequence abnormalities characterized rpgr transcripts 18 present study additionally scanned presence mutations 137 dogs 211 chromosomes 20 different breeds found deletions xlpra1 siberian husky samoyed xlpra2 mongrel derived affected carrier dogs thus confirming mutations polymorphisms also scanned 20 wolves 29 chromosomes 19 red wolves 1 black wolf found deletion two aged heterozygous red wolves asymptomatic based lack retinal disease phenotype females deletion likely rare benign polymorphism 8
0.11429769.11978759.html.plaintext.txt	60	discussion top abstract introduction results discussion methods references physical mapping xlpra interval shows strong homology region xp humans dogs terms genes order mapped two distinct x linked retinal disorders region found disease associated mutations rpgr exon orf15 specificity mutations confirmed finding sequence abnormalities characterized rpgr transcripts 18 present study additionally scanned presence mutations 137 dogs 211 chromosomes 20 different breeds found deletions xlpra1 siberian husky samoyed xlpra2 mongrel derived affected carrier dogs thus confirming mutations polymorphisms also scanned 20 wolves 29 chromosomes 19 red wolves 1 black wolf found deletion two aged heterozygous red wolves asymptomatic based lack retinal disease phenotype females deletion likely rare benign polymorphism 8
0.11429769.11978759.html.plaintext.txt	61	hotspot rpgr mutations humans occurs approximately 1 kb purine rich region exon orf15 frame mutations premature stop associated disease 34 novel rp3 mutations reported recently 23 one two four five nucleotide deletions resulted frameshift premature termination translation 8 proposed purine rich region may adopt unusual non b dna conformations show sequence motifs similar dna polymerase arrest sites found near deletion hotspots lead microdeletions following slipped strand mispairing events 2122 found similar microdeletions present study suggesting rpgr exon orf15 appears mutation hotspot canids
0.11429769.11978759.html.plaintext.txt	62	hotspot rpgr mutations humans occurs approximately 1 kb purine rich region exon orf15 frame mutations premature stop associated disease 34 novel rp3 mutations reported recently 23 one two four five nucleotide deletions resulted frameshift premature termination translation 8 proposed purine rich region may adopt unusual non b dna conformations show sequence motifs similar dna polymerase arrest sites found near deletion hotspots lead microdeletions following slipped strand mispairing events 2122 found similar microdeletions present study suggesting rpgr exon orf15 appears mutation hotspot canids
0.11429769.11978759.html.plaintext.txt	63	studies demonstrate nature rpgr exon orf15 deletions determine retinal phenotype disorders distinct remained even though diseases present mixed breed dogs genetic background indicates phenotype results differences two mutant proteins vivo normal retinal development xlpra1 argues c terminal 230 amino acids encoded exon orf15 vital functional structural differentiation rods cones argument proposed role rcc1 like domain since photoreceptor development normal rpgr knockout mouse 9 however severe disease develops young adult animals indicates rpgr plays essential role photoreceptor viability contrast abnormal retinal development occurs xlpra2 rapid degeneration ensues suggests mutation disrupts critical differentiation rods cones causes early degeneration
0.11429769.11978759.html.plaintext.txt	64	studies demonstrate nature rpgr exon orf15 deletions determine retinal phenotype disorders distinct remained even though diseases present mixed breed dogs genetic background indicates phenotype results differences two mutant proteins vivo normal retinal development xlpra1 argues c terminal 230 amino acids encoded exon orf15 vital functional structural differentiation rods cones argument proposed role rcc1 like domain since photoreceptor development normal rpgr knockout mouse 9 however severe disease develops young adult animals indicates rpgr plays essential role photoreceptor viability contrast abnormal retinal development occurs xlpra2 rapid degeneration ensues suggests mutation disrupts critical differentiation rods cones causes early degeneration
0.11429769.11978759.html.plaintext.txt	65	analysis heterozygous retinas provides insights role mutant alleles retinal development maintenance random x inactivation 23 approximately 50 retinal cells express mutant normal rpgr expression mutant gene examined milieu half photoreceptors genetically normal carriers either disease show ophthalmoscopically visible patchy retinal degeneration indication mosaicism hallmark retinal random x inactivation 24 changes variable extent severity evident carriers time young adults time advanced age abnormalities stationary xlpra1 xlpra2 carriers often show progressive disease results advanced retinal degeneration 5 6 years age older contrast lack disease aged heterozygous red wolves suggests three nucleotide deletion benign polymorphism
0.11429769.11978759.html.plaintext.txt	66	analysis heterozygous retinas provides insights role mutant alleles retinal development maintenance random x inactivation 23 approximately 50 retinal cells express mutant normal rpgr expression mutant gene examined milieu half photoreceptors genetically normal carriers either disease show ophthalmoscopically visible patchy retinal degeneration indication mosaicism hallmark retinal random x inactivation 24 changes variable extent severity evident carriers time young adults time advanced age abnormalities stationary xlpra1 xlpra2 carriers often show progressive disease results advanced retinal degeneration 5 6 years age older contrast lack disease aged heterozygous red wolves suggests three nucleotide deletion benign polymorphism
0.11429769.11978759.html.plaintext.txt	67	severe retinal disease phenotype canine xlpra comparable reported human patients rpgr mutations given caveat least humans limited number phenotype genotype correlation studies reported exception two reports retrospectively represent mutations exon orf15 2526 others limited primarily exons 1 10 eg 427 studies show comparably severe clinical phenotypes xlrp patients found two canine models also majority carriers show clinical disease varying mild severe impaired night vision visual field loss 324 families disease sufficiently severe females considered semidominant 28 examination exon orf15 identified null alleles four nine families j m rozet personal communication 26 july 2001
0.11429769.11978759.html.plaintext.txt	68	severe retinal disease phenotype canine xlpra comparable reported human patients rpgr mutations given caveat least humans limited number phenotype genotype correlation studies reported exception two reports retrospectively represent mutations exon orf15 2526 others limited primarily exons 1 10 eg 427 studies show comparably severe clinical phenotypes xlrp patients found two canine models also majority carriers show clinical disease varying mild severe impaired night vision visual field loss 324 families disease sufficiently severe females considered semidominant 28 examination exon orf15 identified null alleles four nine families j m rozet personal communication 26 july 2001
0.11429769.11978759.html.plaintext.txt	69	expression studies rpgr shown alternative splicing complex species specific variants may exist splice variants reported rpgr mainly exon 13 especially brain testes 1825 additionally alternative exon usage introns found frequently rpgr transcripts example exon 14a intron 14 mouse 25 dog 18 exons 15a 15b1 15b2 orf15 intron 15 human mouse cow dog 8 present study exon 19a mouse intron 18 25 alternative splicing exon usage suggests different rpgr protein isoforms produced specific functions vivo exon 16 19 probe mainly detected 89 kb band failed detect 5 kb band recognized probes exons 3 10 exon 14a orf15 result suggests exon orf15 used terminal exon 5 kb band alternatively spliced exons 16 19 89 kb band found putative consensus splice donor site conserved human dog located stop codon 3 coding region exon orf15 may splice exon orf15 exons 16 19 translate polypeptide frame include exon orf15 exons 16 19 case putative protein regain c terminal isoprenylation site ctil located alternative terminal exon 19 2
0.11429769.11978759.html.plaintext.txt	70	expression studies rpgr shown alternative splicing complex species specific variants may exist splice variants reported rpgr mainly exon 13 especially brain testes 1825 additionally alternative exon usage introns found frequently rpgr transcripts example exon 14a intron 14 mouse 25 dog 18 exons 15a 15b1 15b2 orf15 intron 15 human mouse cow dog 8 present study exon 19a mouse intron 18 25 alternative splicing exon usage suggests different rpgr protein isoforms produced specific functions vivo exon 16 19 probe mainly detected 89 kb band failed detect 5 kb band recognized probes exons 3 10 exon 14a orf15 result suggests exon orf15 used terminal exon 5 kb band alternatively spliced exons 16 19 89 kb band found putative consensus splice donor site conserved human dog located stop codon 3 coding region exon orf15 may splice exon orf15 exons 16 19 translate polypeptide frame include exon orf15 exons 16 19 case putative protein regain c terminal isoprenylation site ctil located alternative terminal exon 19 2
0.11429769.11978759.html.plaintext.txt	71	higher molecular weight mrna bands reported previously including 36 kb testes 5 89 95 20 kb eye brain 25 present study recently 6 kb band reported human retina orf15 exon 3 19 probes 29 89 kb band match known sizes rpgr sequences suggests additional undiscovered exons alternative polyadenylation sites used rpgr processing addition exon orf15 probe consistently detected two bands similar intensity 89 kb another slightly smaller size fig 6a suggests different splice variants may exist spatial relevance predominant 5 kb splice variant expressed retina mutations found exon orf15 may explain observed phenotype confined retina
0.11429769.11978759.html.plaintext.txt	72	transfection data emphasize differences expression profiles two mutant exon orf15 proteins vitro xlpra1 premature stop mutant behaves similarly wild type protein whereas xlpra2 frameshift protein aggregates er compartment examining transfection results attach significance presence absence gfp nuclear labeling since may result protein cleavage small proportion constructs gfp enters nucleus weak nuclear localization vector aggregation xlpra2 mutant exon orf15 protein may result additional abnormal residues impair proper folding vitro results consistent phenotypic differences found two diseases based presence retinal transcripts exon orf15 normal xlpra mutant retinas different phenotypes two diseases propose xlpra1 mutation causes loss function critical visual cells development essential later sustained viability contrast xlpra2 mutation affects photoreceptors early development devastating consequences retina
0.11429769.11978759.html.plaintext.txt	73	transfection data emphasize differences expression profiles two mutant exon orf15 proteins vitro xlpra1 premature stop mutant behaves similarly wild type protein whereas xlpra2 frameshift protein aggregates er compartment examining transfection results attach significance presence absence gfp nuclear labeling since may result protein cleavage small proportion constructs gfp enters nucleus weak nuclear localization vector aggregation xlpra2 mutant exon orf15 protein may result additional abnormal residues impair proper folding vitro results consistent phenotypic differences found two diseases based presence retinal transcripts exon orf15 normal xlpra mutant retinas different phenotypes two diseases propose xlpra1 mutation causes loss function critical visual cells development essential later sustained viability contrast xlpra2 mutation affects photoreceptors early development devastating consequences retina
0.11429769.11978759.html.plaintext.txt	74	results studies highlight importance rpgr exon orf15 photoreceptor function viability indicate different retinal phenotypes result mutations novel exon situation similar human rp3 families finally show value canine model tools available comparative genomic analysis aid understanding gene function diseases importance humans species
0.11429769.11978759.html.plaintext.txt	75	results studies highlight importance rpgr exon orf15 photoreceptor function viability indicate different retinal phenotypes result mutations novel exon situation similar human rp3 families finally show value canine model tools available comparative genomic analysis aid understanding gene function diseases importance humans species
0.11429769.11978759.html.plaintext.txt	76	methods top abstract introduction results discussion methods references animals pedigrees tissue collection two different outcrossed pedigrees used develop meiotic map canine xp fine map xlpra1 xlpra2 identify disease causing mutations rpgr procedures involving tissue collection done anesthesia immediately following euthanasia barbiturate overdose blood samples red wolves collected sedation ophthalmic examination wolves maintained display breeding zoo nature center also examined tested members pedigree samoyed dogs x linked retinal degeneration clinically identical xlpra1
0.11429769.11978759.html.plaintext.txt	77	methods top abstract introduction results discussion methods references animals pedigrees tissue collection two different outcrossed pedigrees used develop meiotic map canine xp fine map xlpra1 xlpra2 identify disease causing mutations rpgr procedures involving tissue collection done anesthesia immediately following euthanasia barbiturate overdose blood samples red wolves collected sedation ophthalmic examination wolves maintained display breeding zoo nature center also examined tested members pedigree samoyed dogs x linked retinal degeneration clinically identical xlpra1
0.11429769.11978759.html.plaintext.txt	78	canine bac library screening meiotic radiation hybrid rh physical mapping rpci81 canine bac library used httpwwwchori orgbacpacmcanine81htm canine specific probes tcte1l srpx rpgr otc prepared pcr using degenerate primers purified bac dna digested identify microsatellite markers hybridization experimental details meiotic rh mapping described 19 contig built bac clones positive tcte1l srpx rpgr otc extended end sequencing size bac clones determined using noti digestion fingerprinting ecorv separation pulsed field gel electrophoresis blast search end internal sequences exons conserved regions human dog also used contig assembly
0.11429769.11978759.html.plaintext.txt	79	cloning canine rpgr intron 15 exon orf15 mutation identification intron 15 sequence amplified long range pcr forward primer rgf9 intron 14 5 gaaagtaagcatggtctctatccacc 3 reverse primer rgr1 exon 16 5 caagttcctcagccatatcctctgg 3 10 kb pcr product cloned topo xl vector invitrogen carlsbad ca mutation analyses flanking primers designed normal sequence used scan mutation pcr conditions 98 degrees c 2 min 34 cycles 98 degrees c 30 62 degrees c 30 72 degrees c 1 min primer pairs listed pcr products separated 8 polyacrylamide gel
0.11429769.11978759.html.plaintext.txt	80	cloning canine rpgr intron 15 exon orf15 mutation identification intron 15 sequence amplified long range pcr forward primer rgf9 intron 14 5 gaaagtaagcatggtctctatccacc 3 reverse primer rgr1 exon 16 5 caagttcctcagccatatcctctgg 3 10 kb pcr product cloned topo xl vector invitrogen carlsbad ca mutation analyses flanking primers designed normal sequence used scan mutation pcr conditions 98 degrees c 2 min 34 cycles 98 degrees c 30 62 degrees c 30 72 degrees c 1 min primer pairs listed pcr products separated 8 polyacrylamide gel
0.11429769.11978759.html.plaintext.txt	81	forward primer rgf14 5 aaggggaggagaaaggggaggct 3
0.11429769.11978759.html.plaintext.txt	82	reverse primer rgr13 5 tccctcttcctcctccccttcata 3
0.11429769.11978759.html.plaintext.txt	83	reverse primer rgr12 5 tcccctacttcctcttccctctca 3
0.11429769.11978759.html.plaintext.txt	84	sequencing done taq cycle sequencing using dyedeoxy terminators applied biosystems abi 377 automated dna sequencer
0.11429769.11978759.html.plaintext.txt	85	electroretinography erg morphology studies ergs recorded isofluorane anesthetized dogs stimuli conditions designed enable separate evaluation rod cone mediated responses 30 preparation eyecups morphological examination utilized triple fixation protocol 30 one micrometer sections plastic embedded retina extending optic disc superior inferior periphery used analysis
0.11429769.11978759.html.plaintext.txt	86	electroretinography erg morphology studies ergs recorded isofluorane anesthetized dogs stimuli conditions designed enable separate evaluation rod cone mediated responses 30 preparation eyecups morphological examination utilized triple fixation protocol 30 one micrometer sections plastic embedded retina extending optic disc superior inferior periphery used analysis
0.11429769.11978759.html.plaintext.txt	87	immunocytochemistry situ hybridization immunocytochemistry done using normal affected retinas collected light fixed 4 paraformaldehyde processed dgd control xlpra1 cut 2 microm 31 oct control xlpra2 cut 10 microm using standard methods different antibodies rpgr retinal proteins used identified target source reference rpgr polyclonal rpgr 254 c terminal 254 amino acids rpgr partial exon 14 exons 15 19 9 b polyclonal rpgr 33606 human rcc1 like domain residues 96 116 coded partial exon 4 5 12 c polyclonal dr 39 targets 13 amino acids coded human rpgr exons 13 14 f manson opsin monoclonal r2 12n 32 pde polyclonal anti mouse 31 rod cgmp channel protein subunit monoclonal anti bovine 33 exception polyclonal rpgr 33606 antibody rpgr antibodies required antigen retrieval step heating slides 001 m citric acid 10 min microwave 70 power antibodies directed exon orf15 polyclonal antibodies synthetic peptides human nos 1877 1878 mouse nos 1875 1876 f manson used lack specificity data shown
0.11429769.11978759.html.plaintext.txt	88	immunocytochemistry situ hybridization immunocytochemistry done using normal affected retinas collected light fixed 4 paraformaldehyde processed dgd control xlpra1 cut 2 microm 31 oct control xlpra2 cut 10 microm using standard methods different antibodies rpgr retinal proteins used identified target source reference rpgr polyclonal rpgr 254 c terminal 254 amino acids rpgr partial exon 14 exons 15 19 9 b polyclonal rpgr 33606 human rcc1 like domain residues 96 116 coded partial exon 4 5 12 c polyclonal dr 39 targets 13 amino acids coded human rpgr exons 13 14 f manson opsin monoclonal r2 12n 32 pde polyclonal anti mouse 31 rod cgmp channel protein subunit monoclonal anti bovine 33 exception polyclonal rpgr 33606 antibody rpgr antibodies required antigen retrieval step heating slides 001 m citric acid 10 min microwave 70 power antibodies directed exon orf15 polyclonal antibodies synthetic peptides human nos 1877 1878 mouse nos 1875 1876 f manson used lack specificity data shown
0.11429769.11978759.html.plaintext.txt	89	situ hybridization paraformaldehyde fixeddgd embedded sections 2 microm hybridized antisense sense rna probes prepared linearized exon orf15 plasmid dna slides coated kodak ntb2 emulsion exposed 1 4 weeks 4 degrees c developed stained toluidine blue probes synthesized using maxiscript kit ambion austin tx labeled 35s utp 1250 cimmol nen life science
0.11429769.11978759.html.plaintext.txt	90	situ hybridization paraformaldehyde fixeddgd embedded sections 2 microm hybridized antisense sense rna probes prepared linearized exon orf15 plasmid dna slides coated kodak ntb2 emulsion exposed 1 4 weeks 4 degrees c developed stained toluidine blue probes synthesized using maxiscript kit ambion austin tx labeled 35s utp 1250 cimmol nen life science
0.11429769.11978759.html.plaintext.txt	91	western northern blots western analysis rpgr cytosolic membrane fractions done using antibodies rpgr 254 dr 39 procedure described previously 3435 retinal tissues homogenized centrifuged separate cytosolic fraction crude pellets containing cell nuclei membranes sonicated centrifuged proteins 50 microglane separated 10 sds page bands nylon membrane imobilon visualized using enhanced chemiluminescence western blotting detection kit amersham
0.11429769.11978759.html.plaintext.txt	92	western northern blots western analysis rpgr cytosolic membrane fractions done using antibodies rpgr 254 dr 39 procedure described previously 3435 retinal tissues homogenized centrifuged separate cytosolic fraction crude pellets containing cell nuclei membranes sonicated centrifuged proteins 50 microglane separated 10 sds page bands nylon membrane imobilon visualized using enhanced chemiluminescence western blotting detection kit amersham
0.11429769.11978759.html.plaintext.txt	93	northern analysis method detailed previously 33 twenty micrograms total rna separated 1 agarose066 m formaldehyde gel transferred nylon membrane single strand rna probe prepared using maxiscript vitro transcription kit ambion pcr products corresponding different parts rpgr transcripts ligated pcrii topo dual promoter vector invitrogen linearized plasmid dna used antisense probe synthesis using 32putp probes northern analysis made different regions rpgr using following pcr primers
0.11429769.11978759.html.plaintext.txt	94	northern analysis method detailed previously 33 twenty micrograms total rna separated 1 agarose066 m formaldehyde gel transferred nylon membrane single strand rna probe prepared using maxiscript vitro transcription kit ambion pcr products corresponding different parts rpgr transcripts ligated pcrii topo dual promoter vector invitrogen linearized plasmid dna used antisense probe synthesis using 32putp probes northern analysis made different regions rpgr using following pcr primers
0.11429769.11978759.html.plaintext.txt	95	rpgr3 forward 5 ggcagtaacaactggggtcagttag 3
0.11429769.11978759.html.plaintext.txt	96	rpgr10 reverse 5 ctctccctctctcttcgccgca 3
0.11429769.11978759.html.plaintext.txt	97	rgr16 reverse 5 atctccctgaaggatctgtgccg 3
0.11429769.11978759.html.plaintext.txt	98	rpgr27 forward 5 gacataggtaatgactcaggccag 3
0.11429769.11978759.html.plaintext.txt	99	rpgr28 reverse 5 aatttggacagtatgtgttcggtc 3
0.11429769.11978759.html.plaintext.txt	100	rgf8 forward 5 aagaaccagaggatatggctgagg 3
0.11429769.11978759.html.plaintext.txt	101	rgr16 reverse 5 gtggccttaa ctgttcagtg ttgg 3
0.11429769.11978759.html.plaintext.txt	102	genbank accession numbers exon14a nucleotides1842 2428 exons 16 19 nucleotides 1681 2374 sequences af148800 af148798 respectively
0.11429769.11978759.html.plaintext.txt	103	transfection expression normal mutant rpgr exon orf15 cos7 cells dmem 5 fcs penicillin 100 uml streptomycin 130 microgml 37 degrees c 5 co2 transfected using 6 microl fugene 6 roche added 20 microg dna green fluorescent protein gfp vector gfp vector containing one three canine orf15 sequences wild type xlpra1 xlpra2 48 h incubation cells washed pbs fixed methanol 2 min 20 degrees c fixed cells incubated anti golgi clone 58k 9 sigma anti er anti kdel bioquote primary antibodies visualized texas red conjugated secondary jackson labs slides mounted vectashield vector laboratories inc burlingame ca containing dapi 10 microgml
0.11429769.11978759.html.plaintext.txt	104	transfection expression normal mutant rpgr exon orf15 cos7 cells dmem 5 fcs penicillin 100 uml streptomycin 130 microgml 37 degrees c 5 co2 transfected using 6 microl fugene 6 roche added 20 microg dna green fluorescent protein gfp vector gfp vector containing one three canine orf15 sequences wild type xlpra1 xlpra2 48 h incubation cells washed pbs fixed methanol 2 min 20 degrees c fixed cells incubated anti golgi clone 58k 9 sigma anti er anti kdel bioquote primary antibodies visualized texas red conjugated secondary jackson labs slides mounted vectashield vector laboratories inc burlingame ca containing dapi 10 microgml
0.11429769.11978759.html.plaintext.txt	105	acknowledgements authors grateful staff rds facility julie alling assistance tissue sections barbara zangerl providing unpublished microsatellite data keith watamura assistance figures dr swaroop helpful discussions kathie weeks staffs wnc nature center ross park zoo help red wolf project drs p ferreira f manson li p hargrave d farber r molday providing antibodies work supported neinih grants ey06855 ey13132 foundation fighting blindness british retinitis pigmentosa society guide dogs blind association van sloun fund canine genetic research baker institute inherited eye disease gift fund
0.11429769.11978759.html.plaintext.txt	106	acknowledgements authors grateful staff rds facility julie alling assistance tissue sections barbara zangerl providing unpublished microsatellite data keith watamura assistance figures dr swaroop helpful discussions kathie weeks staffs wnc nature center ross park zoo help red wolf project drs p ferreira f manson li p hargrave d farber r molday providing antibodies work supported neinih grants ey06855 ey13132 foundation fighting blindness british retinitis pigmentosa society guide dogs blind association van sloun fund canine genetic research baker institute inherited eye disease gift fund
0.11429769.11978759.html.plaintext.txt	107	footnotes correspondence addressed james baker institute animal health college veterinary medicine cornell university ithaca ny 14853 usa tel1607 256 5620 fax 1607 256 5689 email gda1atcornelledu
0.11429769.11978759.html.plaintext.txt	108	footnotes correspondence addressed james baker institute animal health college veterinary medicine cornell university ithaca ny 14853 usa tel1607 256 5620 fax 1607 256 5689 email gda1atcornelledu
0.11429769.11978759.html.plaintext.txt	109	af385629 af148800 af148798
0.11429769.11978759.html.plaintext.txt	110	references top abstract introduction results discussion methods references 1 phelan jk bok d 2000 brief review retinitis pigmentosa identified retinitis pigmentosa genes mol vis 6 116 124isimedline
0.1154272.14871886.html.plaintext.txt	0	reductions circulating anabolic hormones induced sustained sleep deprivation rats carol everson1 william r crowley2
0.1154272.14871886.html.plaintext.txt	1	1department neurology medical college wisconsin milwaukee wisconsin 53226 2department pharmacology toxicology university utah health sciences center salt lake city utah 84112
0.1154272.14871886.html.plaintext.txt	2	submitted 5 december 2003 accepted final form 2 february 2004
0.1154272.14871886.html.plaintext.txt	3	abstract top abstract materials methods results discussion grants references main systemic disorders resulting prolonged sleep deprivation laboratory animals negative energy balance low circulating thyroid hormones host defense impairments low thyroid hormones previously found caused altered regulation level hypothalamus possible pituitary involvement present studies investigated effects sleep deprivation major anabolic hormonal systems plasma growth hormone gh concentrations major secretory bursts characterized insulin like growth factor igf evaluated integrative marker peripheral gh effector activity prolactin prl assessed basal concentrations stimulating pituitary exogenous thyrotropin releasing hormone leptin studied linkage metabolic signs sleep loss correspondence altered neuroendocrine regulation disease states last plasma corticosterone measured investigate degree hypothalamic pituitary adrenal activation sleep deprivation produced disk water method well established means selective deprivation sleep noninterference normal waking behaviors hormone concentrations determined sham comparisons intervals baseline experimental periods lasting least 15 days partially totally sleep deprived rats results indicate high amplitude pulses gh nearly abolished concentrations gh igf prl leptin suppressed sleep deprivation corticosterone concentration relatively unaffected features results low gh low igf indicate failed negative feedback point hypothalamic mechanisms containing foci responsible peripheral signs
0.1154272.14871886.html.plaintext.txt	4	abstract top abstract materials methods results discussion grants references main systemic disorders resulting prolonged sleep deprivation laboratory animals negative energy balance low circulating thyroid hormones host defense impairments low thyroid hormones previously found caused altered regulation level hypothalamus possible pituitary involvement present studies investigated effects sleep deprivation major anabolic hormonal systems plasma growth hormone gh concentrations major secretory bursts characterized insulin like growth factor igf evaluated integrative marker peripheral gh effector activity prolactin prl assessed basal concentrations stimulating pituitary exogenous thyrotropin releasing hormone leptin studied linkage metabolic signs sleep loss correspondence altered neuroendocrine regulation disease states last plasma corticosterone measured investigate degree hypothalamic pituitary adrenal activation sleep deprivation produced disk water method well established means selective deprivation sleep noninterference normal waking behaviors hormone concentrations determined sham comparisons intervals baseline experimental periods lasting least 15 days partially totally sleep deprived rats results indicate high amplitude pulses gh nearly abolished concentrations gh igf prl leptin suppressed sleep deprivation corticosterone concentration relatively unaffected features results low gh low igf indicate failed negative feedback point hypothalamic mechanisms containing foci responsible peripheral signs
0.1154272.14871886.html.plaintext.txt	5	growth hormone thyroxine prolactin insulin like growth factor leptin corticosterone
0.1154272.14871886.html.plaintext.txt	6	sleep considered critical maintenance health 2 14 49b 77a support life 18 35 54 clinical states associated abnormal sleep include pulmonary cardiovascular disorders cerebrovascular disease thrombotic disease epilepsy arthritis mood disorders chronic pain shortened life span reviewed refs 39 49a physical consequences sleep deprivation localized evidence studies laboratory animals suggest multitropic factors immune hormonal systems contribute absence localization
0.1154272.14871886.html.plaintext.txt	7	sleep considered critical maintenance health 2 14 49b 77a support life 18 35 54 clinical states associated abnormal sleep include pulmonary cardiovascular disorders cerebrovascular disease thrombotic disease epilepsy arthritis mood disorders chronic pain shortened life span reviewed refs 39 49a physical consequences sleep deprivation localized evidence studies laboratory animals suggest multitropic factors immune hormonal systems contribute absence localization
0.1154272.14871886.html.plaintext.txt	8	three principal consequences prolonged sleep deprivation rat progressively deepening negative energy balance 8 18 23 reduced thyroid hormone concentrations 8 19 20 abnormal control microorganisms 22 sleep deprived rats become strikingly progressively hyperphagic gain weight negative energy balance due malabsorption calories 8 diabetes 18 may metabolic response infectious processes abnormal control microorganisms discovered detection live pathogenic bacteria normally sterile body tissues 16 22 deficiency host defense system earliest clinically biologically significant sign far discovered occurring within five experimental days outward appearance animal healthy metabolic changes marked later become third principal feature hypothyroxinemia manifested progressive decline thyroxine t4 triiodothyronine t3 t4 eventually reaching levels assay detection cases 20 average 3 wk signs result advanced morbidity scrawny feeble appearance decreased food intake peak consumption hypothermia 8 18 primary bacteremia poor absent inflammatory responses 16 subsequent lethality 53
0.1154272.14871886.html.plaintext.txt	9	three principal consequences prolonged sleep deprivation rat progressively deepening negative energy balance 8 18 23 reduced thyroid hormone concentrations 8 19 20 abnormal control microorganisms 22 sleep deprived rats become strikingly progressively hyperphagic gain weight negative energy balance due malabsorption calories 8 diabetes 18 may metabolic response infectious processes abnormal control microorganisms discovered detection live pathogenic bacteria normally sterile body tissues 16 22 deficiency host defense system earliest clinically biologically significant sign far discovered occurring within five experimental days outward appearance animal healthy metabolic changes marked later become third principal feature hypothyroxinemia manifested progressive decline thyroxine t4 triiodothyronine t3 t4 eventually reaching levels assay detection cases 20 average 3 wk signs result advanced morbidity scrawny feeble appearance decreased food intake peak consumption hypothermia 8 18 primary bacteremia poor absent inflammatory responses 16 subsequent lethality 53
0.1154272.14871886.html.plaintext.txt	10	recent findings alterations thyroid hormones sleep deprived rats point brain essential site sleep deprivation effects progressive decline plasma t4 sleep deprived rats accompanied increase plasma thyroid stimulating hormone tsh whereas low plasma t4 normally potent stimulant pituitary tsh secretion 71 challenge tests tsh release pituitary exogenous administration hypothalamic peptide thyrotropin releasing hormone trh revealed normal stimulated release tsh appropriate increase circulating t4 t3 20 examination paraventricular nucleus pvn hypothalamus revealed eventual tripling trh transcript levels experimental animals suggesting compensatory response low t4 presumably increased negative feedback hypothalamus even tsh failed respond increased trh biosynthesis 19 data suggest trh stimulation tsh inhibited one locus sleep deprivations effects trh translation release hypothalamus
0.1154272.14871886.html.plaintext.txt	11	recent findings alterations thyroid hormones sleep deprived rats point brain essential site sleep deprivation effects progressive decline plasma t4 sleep deprived rats accompanied increase plasma thyroid stimulating hormone tsh whereas low plasma t4 normally potent stimulant pituitary tsh secretion 71 challenge tests tsh release pituitary exogenous administration hypothalamic peptide thyrotropin releasing hormone trh revealed normal stimulated release tsh appropriate increase circulating t4 t3 20 examination paraventricular nucleus pvn hypothalamus revealed eventual tripling trh transcript levels experimental animals suggesting compensatory response low t4 presumably increased negative feedback hypothalamus even tsh failed respond increased trh biosynthesis 19 data suggest trh stimulation tsh inhibited one locus sleep deprivations effects trh translation release hypothalamus
0.1154272.14871886.html.plaintext.txt	12	relatively little known regarding neuroendocrine consequences sustained sleep deprivation whether broad pituitary hypothalamic involvement one objectives present series experiments determine whether chronic sleep deprivation also affects secretion growth hormone gh prolactin prl alteration pleiotropic functions could provide future avenues discovery sleep deprivation specifically results health consequences linkage gh prl secretion non rapid eye movement nrem sleep repeatedly demonstrated humans plasma peak gh concentration generally coincides sleep onset delayed sleep delayed smaller gh peaks generally coincide subsequent slow wave sleep phases 52 56 64 73 prl concentrations elevated sleep even sleep delayed 74 short term sleep deprivation 24 36 h blunts amplitude major gh secretory periods time 10 11 whereas sleep sleep deprivation associated return normal amplitudes 11 59 73 similarly gh pulses rats abolished short term sleep deprivation 3 h 34 whether abolishment would persist beyond 3 h whether acute reaction unknown proximal hypothalamic mechanisms regulating gh secretion pituitary growth hormone releasing hormone ghrh somatostatin somatotropin release inhibiting factor srif operate reciprocal manner previous studies shown short term sleep deprivation 6 8 h reduce content ghrh hypothalamus 26 result increased ghrh mrna pvn increased srif mrna arcuate nucleus hypothalamus 69 whether changes important hypophysioportal stimulation gh secretion unknown whereas hypotheses exist role regulation sleep behavior 26 furthermore ghrh binding receptor mrna levels decreased 50 hypothalamus rats sleep deprived 8 h whereas pituitary levels remain unchanged latter findings interpreted indicating downregulation receptors response ghrh release 27 addition role lactation prl major anabolic hormone cytokine 5 short term sleep deprivation sleep fragmentation humans associated lower nocturnal prl levels sleep occurs 74 77 prl considered sleep promoting laboratory animals 50 80 reduced 24 72 h 48 h sleep deprivation combined ie confounded constant forced locomotion 33 deficiency prl results grossly reduced immunocompetency laboratory animals 49 sleep deprived rats share resemblance
0.1154272.14871886.html.plaintext.txt	13	relatively little known regarding neuroendocrine consequences sustained sleep deprivation whether broad pituitary hypothalamic involvement one objectives present series experiments determine whether chronic sleep deprivation also affects secretion growth hormone gh prolactin prl alteration pleiotropic functions could provide future avenues discovery sleep deprivation specifically results health consequences linkage gh prl secretion non rapid eye movement nrem sleep repeatedly demonstrated humans plasma peak gh concentration generally coincides sleep onset delayed sleep delayed smaller gh peaks generally coincide subsequent slow wave sleep phases 52 56 64 73 prl concentrations elevated sleep even sleep delayed 74 short term sleep deprivation 24 36 h blunts amplitude major gh secretory periods time 10 11 whereas sleep sleep deprivation associated return normal amplitudes 11 59 73 similarly gh pulses rats abolished short term sleep deprivation 3 h 34 whether abolishment would persist beyond 3 h whether acute reaction unknown proximal hypothalamic mechanisms regulating gh secretion pituitary growth hormone releasing hormone ghrh somatostatin somatotropin release inhibiting factor srif operate reciprocal manner previous studies shown short term sleep deprivation 6 8 h reduce content ghrh hypothalamus 26 result increased ghrh mrna pvn increased srif mrna arcuate nucleus hypothalamus 69 whether changes important hypophysioportal stimulation gh secretion unknown whereas hypotheses exist role regulation sleep behavior 26 furthermore ghrh binding receptor mrna levels decreased 50 hypothalamus rats sleep deprived 8 h whereas pituitary levels remain unchanged latter findings interpreted indicating downregulation receptors response ghrh release 27 addition role lactation prl major anabolic hormone cytokine 5 short term sleep deprivation sleep fragmentation humans associated lower nocturnal prl levels sleep occurs 74 77 prl considered sleep promoting laboratory animals 50 80 reduced 24 72 h 48 h sleep deprivation combined ie confounded constant forced locomotion 33 deficiency prl results grossly reduced immunocompetency laboratory animals 49 sleep deprived rats share resemblance
0.1154272.14871886.html.plaintext.txt	14	also unknown present whether sustained sleep deprivation affects secretion adipocyte derived hormone leptin acts hypothalamus leptin endocrine actions pleiotropic effects include major role regulation energy balance reviewed refs 24 25 31 several lines evidence suggest link hormone different pathophysiological changes resulting sleep deprivation example decreased leptin concentrations occur decreased fat reserve impairments immunity reviewed ref 25 consequences sleep deprivation hand increases leptin secretion associated increased sympathetic activation 58 elevated metabolic rate 45 decreased body weight 12 also produced prolonged sleep deprivation reviewed ref 17 leptin also increases response exposure bacterial cell components reviewed ref 30 would expected event resulting bacterial translocation efforts control posttranslocation survival sleep deprived animals 22 humans substantially reduced leptin concentrations found narcoleptic patients abnormal sleep architecture 36 60 mildly reduced leptin concentrations found normal subjects conditions acute sleep reduction 62
0.1154272.14871886.html.plaintext.txt	15	also unknown present whether sustained sleep deprivation affects secretion adipocyte derived hormone leptin acts hypothalamus leptin endocrine actions pleiotropic effects include major role regulation energy balance reviewed refs 24 25 31 several lines evidence suggest link hormone different pathophysiological changes resulting sleep deprivation example decreased leptin concentrations occur decreased fat reserve impairments immunity reviewed ref 25 consequences sleep deprivation hand increases leptin secretion associated increased sympathetic activation 58 elevated metabolic rate 45 decreased body weight 12 also produced prolonged sleep deprivation reviewed ref 17 leptin also increases response exposure bacterial cell components reviewed ref 30 would expected event resulting bacterial translocation efforts control posttranslocation survival sleep deprived animals 22 humans substantially reduced leptin concentrations found narcoleptic patients abnormal sleep architecture 36 60 mildly reduced leptin concentrations found normal subjects conditions acute sleep reduction 62
0.1154272.14871886.html.plaintext.txt	16	objective present studies determine whether chronic sleep deprivation changes regulation gh prl leptin nature alterations effects sleep deprivation determined concentrations insulin like growth factor igf principal physiological mediator many gh actions concentrations corticosterone high levels associated endocrine abnormalities disease states reviewed ref 44 end employed well established procedure producing sleep deprivation 9 examined effects hormonal secretory patterns intervals first two thirds typical survival period rats times advanced morbidity present results indicate abnormally low concentrations gh igf prl leptin appropriately increased prl release stimulated results provide evidence altered hormonal regulation level hypothalamus implicate suppression anabolic hormones among important health consequences sleep deprivation
0.1154272.14871886.html.plaintext.txt	17	objective present studies determine whether chronic sleep deprivation changes regulation gh prl leptin nature alterations effects sleep deprivation determined concentrations insulin like growth factor igf principal physiological mediator many gh actions concentrations corticosterone high levels associated endocrine abnormalities disease states reviewed ref 44 end employed well established procedure producing sleep deprivation 9 examined effects hormonal secretory patterns intervals first two thirds typical survival period rats times advanced morbidity present results indicate abnormally low concentrations gh igf prl leptin appropriately increased prl release stimulated results provide evidence altered hormonal regulation level hypothalamus implicate suppression anabolic hormones among important health consequences sleep deprivation
0.1154272.14871886.html.plaintext.txt	18	materials methods top abstract materials methods results discussion grants references animals surgical procedures procedures carried accordance national institutes health guidelines care use animals approved animal study protocol normal male sprague dawley rats aged 25 plus minus 2 sd wk weighing 559 plus minus 130 sd g time surgery obtained harlan laboratories frederick md indianapolis surgical procedures including catheter insertions performed single episode anesthesia avoid confounding effects anesthesia surgery sleep deprivation period
0.1154272.14871886.html.plaintext.txt	19	materials methods top abstract materials methods results discussion grants references animals surgical procedures procedures carried accordance national institutes health guidelines care use animals approved animal study protocol normal male sprague dawley rats aged 25 plus minus 2 sd wk weighing 559 plus minus 130 sd g time surgery obtained harlan laboratories frederick md indianapolis surgical procedures including catheter insertions performed single episode anesthesia avoid confounding effects anesthesia surgery sleep deprivation period
0.1154272.14871886.html.plaintext.txt	20	rats anesthetized ketamine hydrochloride 100 mgkg ip xylazine hydrochloride 24 mgkg im atropine sulfate 01 mgkg im supplementary doses ketamine hydrochloride 10 mgkg ip provided needed surgery included implantation cortical eeg muscle electrodes electrophysiographic determination sleep stages wakefulness described previously 9 enable repeated sampling blood freely moving animals venous catheter inserted external jugular advanced right atrium described previously 9 20 23 catheter sutured neck muscles threaded subcutaneously exit scalp back head anchored electrode head plug assembly catheter tubing extended along 45 cm eeg recording cable attached swivel commutator counterbalanced boom assembly permitted daily blood sampling without handling animal catheters flushed daily heparinized saline containing small amount ampicillin 125 wtvol beginning 4 days surgery 75 units streptokinase 150 microl heparinized saline infused 1 mlmin fill catheter lumen procedures reduce occurrence fibrin clot blockages rats permitted least 7 days recovery surgery study
0.1154272.14871886.html.plaintext.txt	21	rats anesthetized ketamine hydrochloride 100 mgkg ip xylazine hydrochloride 24 mgkg im atropine sulfate 01 mgkg im supplementary doses ketamine hydrochloride 10 mgkg ip provided needed surgery included implantation cortical eeg muscle electrodes electrophysiographic determination sleep stages wakefulness described previously 9 enable repeated sampling blood freely moving animals venous catheter inserted external jugular advanced right atrium described previously 9 20 23 catheter sutured neck muscles threaded subcutaneously exit scalp back head anchored electrode head plug assembly catheter tubing extended along 45 cm eeg recording cable attached swivel commutator counterbalanced boom assembly permitted daily blood sampling without handling animal catheters flushed daily heparinized saline containing small amount ampicillin 125 wtvol beginning 4 days surgery 75 units streptokinase 150 microl heparinized saline infused 1 mlmin fill catheter lumen procedures reduce occurrence fibrin clot blockages rats permitted least 7 days recovery surgery study
0.1154272.14871886.html.plaintext.txt	22	rats sleep deprived serve yoked comparison housed apparatus described week allotted recovery rats fed ad libitum balanced purified diet isocaloric normal augmented protein 407 protein 447 carbohydrate 43 fat 103 minerals fiber vitamins 38 calg metabolizable energy used previous studies comparison 19 20 23 food water intake body weight recorded daily special food tubes waste receptacle afforded accurate measurement food consumption 9 ambient light constant diminish influence circadian rhythm factors study 15 ambient temperature kept constant 28 degrees c within thermoneutral zone rats 63 means thermostatically controlled heat lamps
0.1154272.14871886.html.plaintext.txt	23	rats sleep deprived serve yoked comparison housed apparatus described week allotted recovery rats fed ad libitum balanced purified diet isocaloric normal augmented protein 407 protein 447 carbohydrate 43 fat 103 minerals fiber vitamins 38 calg metabolizable energy used previous studies comparison 19 20 23 food water intake body weight recorded daily special food tubes waste receptacle afforded accurate measurement food consumption 9 ambient light constant diminish influence circadian rhythm factors study 15 ambient temperature kept constant 28 degrees c within thermoneutral zone rats 63 means thermostatically controlled heat lamps
0.1154272.14871886.html.plaintext.txt	24	procedure producing sleep deprivation yoked controls experimental apparatus procedures used present experiments bergmann rechtschaffen method 9 subsequent minor modifications method validated selectivity sleep deprivation 8 9 18 23 53 features benign arousal stimulus freedom movement comparison conditions partial full sleep opportunities described detail illustrated elsewhere 9 23 briefly two animals housed identical experimental conditions either side large round platform 46 cm diameter divided plexiglas wall one rat designated sleep deprivation rat designated yoked animal subjected experimental variables yet allowed opportunities sleep beneath around platform shallow water serves soft boundary rats almost always avoid water stay platform eat sleep explore normally recording eeg variables rats freely moving conditions accomplished connecting long recording cable attached head electrode assembly 360 degrees commutator counterbalanced boom assembly
0.1154272.14871886.html.plaintext.txt	25	procedure producing sleep deprivation yoked controls experimental apparatus procedures used present experiments bergmann rechtschaffen method 9 subsequent minor modifications method validated selectivity sleep deprivation 8 9 18 23 53 features benign arousal stimulus freedom movement comparison conditions partial full sleep opportunities described detail illustrated elsewhere 9 23 briefly two animals housed identical experimental conditions either side large round platform 46 cm diameter divided plexiglas wall one rat designated sleep deprivation rat designated yoked animal subjected experimental variables yet allowed opportunities sleep beneath around platform shallow water serves soft boundary rats almost always avoid water stay platform eat sleep explore normally recording eeg variables rats freely moving conditions accomplished connecting long recording cable attached head electrode assembly 360 degrees commutator counterbalanced boom assembly
0.1154272.14871886.html.plaintext.txt	26	7 day period basal measurements platform rotated one time per hour 6 acquaint rats platform movement method produces consistent amount sleep reduction studies 16 18 21 23 baseline conditions sleep occurs average 53 time sleep comprises 48 nrem sleep comparable human stages 1 4 6 paradoxical sleep ps also known rapid eye movement sleep baseline period experimental period begins detection sleep onset sleep deprived rat programmed microprocessing amplitude changes cortical eeg cortical theta electromyographic variables results 6 forced locomotion rats sufficient produce arousal repeated upon subsequent sleep onset sleep deprived rat resulting wakefulness sustained 90 total time 10 time consists mostly transitional sleep fragmented high amplitude nrem sleep ps comprises 1 total time
0.1154272.14871886.html.plaintext.txt	27	7 day period basal measurements platform rotated one time per hour 6 acquaint rats platform movement method produces consistent amount sleep reduction studies 16 18 21 23 baseline conditions sleep occurs average 53 time sleep comprises 48 nrem sleep comparable human stages 1 4 6 paradoxical sleep ps also known rapid eye movement sleep baseline period experimental period begins detection sleep onset sleep deprived rat programmed microprocessing amplitude changes cortical eeg cortical theta electromyographic variables results 6 forced locomotion rats sufficient produce arousal repeated upon subsequent sleep onset sleep deprived rat resulting wakefulness sustained 90 total time 10 time consists mostly transitional sleep fragmented high amplitude nrem sleep ps comprises 1 total time
0.1154272.14871886.html.plaintext.txt	28	yoked rat may sleep platform stationery sleep deprived rat engaged behaviors trying sleep yoked animals awake 58 time obtain nrem ps sleep 38 3 total time respectively yoked animal frequently awakened asleep sleep normally occupies 50 time yoked rat paired sleep deprived rat may fall asleep thus triggering platform rotation yoked rats therefore partially sleep deprived usually exhibit several signs direction sleep deprived rats degree eg ref 18 yoked animals considered important showing severe morbidity death sleep deprived rats due experimental conditions extraneous sleep loss matched groups 54 addition yoked rats viewed comprising part dose response curve wherein partial sleep deprivation intermediate sleep loss total sleep loss
0.1154272.14871886.html.plaintext.txt	29	yoked rat may sleep platform stationery sleep deprived rat engaged behaviors trying sleep yoked animals awake 58 time obtain nrem ps sleep 38 3 total time respectively yoked animal frequently awakened asleep sleep normally occupies 50 time yoked rat paired sleep deprived rat may fall asleep thus triggering platform rotation yoked rats therefore partially sleep deprived usually exhibit several signs direction sleep deprived rats degree eg ref 18 yoked animals considered important showing severe morbidity death sleep deprived rats due experimental conditions extraneous sleep loss matched groups 54 addition yoked rats viewed comprising part dose response curve wherein partial sleep deprivation intermediate sleep loss total sleep loss
0.1154272.14871886.html.plaintext.txt	30	eight sets experiments one pair sleep deprived yoked rats carried determination plasma igf leptin corticosterone changes food intake body weight subset four experiments serial blood sampling protocols followed determination basal stimulated prl secretion characteristics pulsatile gh secretion duration experiment 4 6 wk period included least 7 days recovery surgery 7 days baseline conditions 15 experimental days addition operated animals intended serve back animals apparatus postsurgery recovery period catheter become nonpatent one first two rats five animals used purpose continued study home cage animals determinations plasma igf leptin corticosteroids changes food intake body weight home cage control animals subjected daily procedures rats housed apparatus except housed cylindrical cages 30 cm od 30 cm high permitted uninterrupted sleep
0.1154272.14871886.html.plaintext.txt	31	eight sets experiments one pair sleep deprived yoked rats carried determination plasma igf leptin corticosterone changes food intake body weight subset four experiments serial blood sampling protocols followed determination basal stimulated prl secretion characteristics pulsatile gh secretion duration experiment 4 6 wk period included least 7 days recovery surgery 7 days baseline conditions 15 experimental days addition operated animals intended serve back animals apparatus postsurgery recovery period catheter become nonpatent one first two rats five animals used purpose continued study home cage animals determinations plasma igf leptin corticosteroids changes food intake body weight home cage control animals subjected daily procedures rats housed apparatus except housed cylindrical cages 30 cm od 30 cm high permitted uninterrupted sleep
0.1154272.14871886.html.plaintext.txt	32	general procedure sampling blood measurement blood hormone concentrations blood specimens collected starting time day according rotating schedule permitted determination factors study intervals across baseline experimental periods igf leptin corticosterone determined one times consecutive 4 day interval experimental period whereas pulsatile gh basal stimulated prl release determined weekly briefly small amount blood aspirated clear catheter clots initial 100 units heparin 01 ml vehicle infused 2 min 01 015 ml heparin whole blood withdrawn discarded blood sample drawn placed microcentrifuge tube ice volume drawn replaced equivalent volume heparinized saline injected catheter minimize hypovolemia specimens centrifuged cold 8000 g 10 min plasma pipetted chilled microcentrifuge tubes subsequent storage 80 degrees c help prevent anemia red blood cells rbcs resuspended heparinized saline injected catheter flushed heparinized saline general protocol applied plasma samples stored determination igf leptin corticosterone elaborated protocols described
0.1154272.14871886.html.plaintext.txt	33	general procedure sampling blood measurement blood hormone concentrations blood specimens collected starting time day according rotating schedule permitted determination factors study intervals across baseline experimental periods igf leptin corticosterone determined one times consecutive 4 day interval experimental period whereas pulsatile gh basal stimulated prl release determined weekly briefly small amount blood aspirated clear catheter clots initial 100 units heparin 01 ml vehicle infused 2 min 01 015 ml heparin whole blood withdrawn discarded blood sample drawn placed microcentrifuge tube ice volume drawn replaced equivalent volume heparinized saline injected catheter minimize hypovolemia specimens centrifuged cold 8000 g 10 min plasma pipetted chilled microcentrifuge tubes subsequent storage 80 degrees c help prevent anemia red blood cells rbcs resuspended heparinized saline injected catheter flushed heparinized saline general protocol applied plasma samples stored determination igf leptin corticosterone elaborated protocols described
0.1154272.14871886.html.plaintext.txt	34	determination major gh secretory periods basal pulsatile gh assessed subset four sleep deprived yoked pairs means blood collection animal every 20 min across 6 h period 57 65 previous studies determined gh secretory pattern affected constant illumination 65 protocol determination gh secretory pulses sleep deprived yoked rat conducted one time 7 day baseline period 6 7 day intervals experimental period total amount blood drawn rat 07 mlh volume rbc replacement given throughout 6 h period blood collected day sampling gh secretory episodes
0.1154272.14871886.html.plaintext.txt	35	determination major gh secretory periods basal pulsatile gh assessed subset four sleep deprived yoked pairs means blood collection animal every 20 min across 6 h period 57 65 previous studies determined gh secretory pattern affected constant illumination 65 protocol determination gh secretory pulses sleep deprived yoked rat conducted one time 7 day baseline period 6 7 day intervals experimental period total amount blood drawn rat 07 mlh volume rbc replacement given throughout 6 h period blood collected day sampling gh secretory episodes
0.1154272.14871886.html.plaintext.txt	36	determinations basal prl secretory periods stimulated prl release prl secretion exhibits low amplitude pulsatility 40 42 therefore measurements integrated time better reflect basal prl secretion singular determinations blood sampled six times 10 min intervals 50 min period based data lopez et al 42 lafuente et al 40 prl pulse lasts 16 25 min would expected occur every 40 min protocol conducted subset experiments major gh secretory periods determined different days baseline period one time per week experimental period total volume blood drawn protocol 18 ml volume rbc replacement prl challenge tests intravenous trh bolus injection completed one time baseline period one time per week experimental period experimental subgroup blood sampled immediately 10 20 40 min intravenous administration trh 10 microgkg based previous studies 40 48 total volume blood drawn 21 ml volume rbc replacement
0.1154272.14871886.html.plaintext.txt	37	determinations basal prl secretory periods stimulated prl release prl secretion exhibits low amplitude pulsatility 40 42 therefore measurements integrated time better reflect basal prl secretion singular determinations blood sampled six times 10 min intervals 50 min period based data lopez et al 42 lafuente et al 40 prl pulse lasts 16 25 min would expected occur every 40 min protocol conducted subset experiments major gh secretory periods determined different days baseline period one time per week experimental period total volume blood drawn protocol 18 ml volume rbc replacement prl challenge tests intravenous trh bolus injection completed one time baseline period one time per week experimental period experimental subgroup blood sampled immediately 10 20 40 min intravenous administration trh 10 microgkg based previous studies 40 48 total volume blood drawn 21 ml volume rbc replacement
0.1154272.14871886.html.plaintext.txt	38	hormone assays plasma gh prl antisera reference hormone provided dr f parlow national hormone pituitary program national institute diabetes digestive kidney diseases low detection limit gh assay 24 pgml high detection limit 466 583 pgml low high sensitivities prl 06 16 ngml respectively intra assay coefficients variation cvs gh prl 10 determinations basal plasma igf leptin corticosteroids performed using commercial ria enzyme immunoassay kits sensitivity range igf 127 4714 ngml diagnostic systems laboratories webster tx intra interassay cvs 4 low high detection limits leptin 05 50 ngml linco research st charles mo intra interassay cvs 4 6 respectively low high detection limits corticosterone 20 2000 ngml diagnostic systems laboratories intra interassay cvs 5 6 respectively determinations made duplicate values fell range assay detection set equal lower upper limit sensitivity respectively
0.1154272.14871886.html.plaintext.txt	39	data analysis apart baseline period data rat experimental period truncated 16 days experimental conditions continued longer permitted values igf leptin corticosterone food intake changes body weight partitioned four consecutive 4 day intervals ie bins data averaged across 4 day interval rat averaged within intervals experimental group data compared means unbalanced two way repeated measures anova one yoked subject eliminated study electrode assembly became detached skull resulting imbalance number subjects per group occasionally missing values within subject across time typically result indwelling catheter nonpatency day blood collection particular factor insufficient specimen volume analysis missing values given 4 day bin replaced interpolation extrapolation isolated instances interpolations extrapolations limited two 1 yoked 1 home cage data points leptin igf one data point corticosterone subject values excluded toto given analysis two 4 day values missing exclusions included one yoked rat determination leptin igf one sleep deprived rat determination food intake one animal sleep deprived yoked home cage groups analysis corticosterone analyses statistical significance considered p 005 post hoc comparisons performed means students tests comparisons included analysis changes group particular time points baseline specific 4 day interval groups particular time point paired tests used possible comparison unpaired means performed occasions data could paired exclusion subject nonsignificant statistical differences designated significant variance given mean plus minus se unless specifically noted mean plus minus sd
0.1154272.14871886.html.plaintext.txt	40	characteristics gh pulsatile secretion analyzed ultra statistical algorithm separate small peaks background variation according guidelines described van cauter 72 ultra cv assay used determine whether increments decrements chronological data points within range expected variation number cvs used determines threshold significant change typically two three cvs applied 72 way increments decrements hormonal concentration may considered part pulse values criterion threshold assay variability thus limiting false positive pulses analysis used three times cv radioactive counts per minute ranged 44 58 constant algorithm signifying significant change previous subsequent values across values within particular assay characterization gh prl secretion based following parameters given lafuente et al 40 1 minimum maximum values observed 2 integrative value average value samples collected period observation 3 absolute amplitude difference concentration peak minimum values 4 relative amplitude ratio absolute amplitude minimum value pulses gh detected ultra additionally assessed frequency instances two peaks captured 6 h sampling period parameters characterizing prl gh concentrations compared priori students test p 005 considered statistically significant
0.1154272.14871886.html.plaintext.txt	41	characteristics gh pulsatile secretion analyzed ultra statistical algorithm separate small peaks background variation according guidelines described van cauter 72 ultra cv assay used determine whether increments decrements chronological data points within range expected variation number cvs used determines threshold significant change typically two three cvs applied 72 way increments decrements hormonal concentration may considered part pulse values criterion threshold assay variability thus limiting false positive pulses analysis used three times cv radioactive counts per minute ranged 44 58 constant algorithm signifying significant change previous subsequent values across values within particular assay characterization gh prl secretion based following parameters given lafuente et al 40 1 minimum maximum values observed 2 integrative value average value samples collected period observation 3 absolute amplitude difference concentration peak minimum values 4 relative amplitude ratio absolute amplitude minimum value pulses gh detected ultra additionally assessed frequency instances two peaks captured 6 h sampling period parameters characterizing prl gh concentrations compared priori students test p 005 considered statistically significant
0.1154272.14871886.html.plaintext.txt	42	results top abstract materials methods results discussion grants references physiological variables sleep deprived rats became hyperphagic fig 1a eventually consuming nearly two times basal amounts food group sleep deprived vs yoked f112 64 p 005 group x time sleep deprived vs home cage f330 55 p 001 yoked animals also exhibited increased food consumption time 40 50 group x time interaction yoked vs home cage control f330 88 p 001 despite increased food intake sleep deprived rats showed evidence weight loss relative yoked rats group x time f339 62 p 001 especially home cage controls f333 445 p 001 latter gained weight without increase food intake fig 1b body weight losses 2 5 sleep deprived rats first 8 days observation eventually body weight dropped 10 days 13 16
0.1154272.14871886.html.plaintext.txt	43	results top abstract materials methods results discussion grants references physiological variables sleep deprived rats became hyperphagic fig 1a eventually consuming nearly two times basal amounts food group sleep deprived vs yoked f112 64 p 005 group x time sleep deprived vs home cage f330 55 p 001 yoked animals also exhibited increased food consumption time 40 50 group x time interaction yoked vs home cage control f330 88 p 001 despite increased food intake sleep deprived rats showed evidence weight loss relative yoked rats group x time f339 62 p 001 especially home cage controls f333 445 p 001 latter gained weight without increase food intake fig 1b body weight losses 2 5 sleep deprived rats first 8 days observation eventually body weight dropped 10 days 13 16
0.1154272.14871886.html.plaintext.txt	44	view larger version 18k fig 1 mean percentage change means plus minus se individual baseline values food intake body weight b sleep deprived food intake n 7 body weight n 8 yoked n 7 operated home cage control n 5 rats 4 day intervals experimental period
0.1154272.14871886.html.plaintext.txt	45	basal gh igf concentrations basal gh secretion determined analysis blood specimens collected every 20 min 6 h periods four sleep deprived four yoked animals baseline four sleep deprived three yoked animals days 4 6 four sleep deprived two yoked animals days 11 14 experimental period different group numbers reflect varying success maintaining catheter patency 30 days surgery 5 399 data points comprising secretory gh profiles analyzed missing values replaced interpolation
0.1154272.14871886.html.plaintext.txt	46	basal gh igf concentrations basal gh secretion determined analysis blood specimens collected every 20 min 6 h periods four sleep deprived four yoked animals baseline four sleep deprived three yoked animals days 4 6 four sleep deprived two yoked animals days 11 14 experimental period different group numbers reflect varying success maintaining catheter patency 30 days surgery 5 399 data points comprising secretory gh profiles analyzed missing values replaced interpolation
0.1154272.14871886.html.plaintext.txt	47	analysis gh secretory periods revealed near abolishment major gh peaks sleep deprived rats representative profiles gh secretory periods baseline experimental period shown yoked rat sleep deprived rat fig 2 baseline period high amplitude gh peaks ie 300 ngml 50 maximal values measured detected eight animals occasional intermediate peaks ie 150 300 ngml additionally detected animals pulses detected baseline 60 considered large pulses 300 ngml 8 considered intermediate 32 considered small 150 ngml experimental period sleep deprived rats high amplitude pulses one intermediate amplitude pulse single individual observed remaining 94 pulses considered small contrast large pulses continued observed yoked subjects time point comprised 52 pulses overall frequency pulses determined using ultra regardless amplitude appreciably different among conditions per 6 h period study 36 plus minus 16 sd pulses baseline conditions compared 30 plus minus 10 sd yoked rats 34 plus minus 11 sd sleep deprived rats
0.1154272.14871886.html.plaintext.txt	48	analysis gh secretory periods revealed near abolishment major gh peaks sleep deprived rats representative profiles gh secretory periods baseline experimental period shown yoked rat sleep deprived rat fig 2 baseline period high amplitude gh peaks ie 300 ngml 50 maximal values measured detected eight animals occasional intermediate peaks ie 150 300 ngml additionally detected animals pulses detected baseline 60 considered large pulses 300 ngml 8 considered intermediate 32 considered small 150 ngml experimental period sleep deprived rats high amplitude pulses one intermediate amplitude pulse single individual observed remaining 94 pulses considered small contrast large pulses continued observed yoked subjects time point comprised 52 pulses overall frequency pulses determined using ultra regardless amplitude appreciably different among conditions per 6 h period study 36 plus minus 16 sd pulses baseline conditions compared 30 plus minus 10 sd yoked rats 34 plus minus 11 sd sleep deprived rats
0.1154272.14871886.html.plaintext.txt	49	view larger version 17k fig 2 pulsatile growth hormone gh concentrations representative cases yoked animal sleep deprived animal paired together experimental conditions baseline period weeks 1 2 experimental period data truncated 6 4 h purposes illustration show peak concentrations major gh secretory periods abolished rats totally sleep deprived
0.1154272.14871886.html.plaintext.txt	50	four eight animals displayed one high amplitude gh pulse 6 h time frame blood sampling baseline conditions sleep deprivation thus allowed calculation frequency major gh secretory episodes animals baseline peak peak interpulse interval high amplitude gh episodes five animals 31 plus minus 02 sd h n 4 experimental period yoked animals 32 plus minus 07 sd h n 2 considered equivalent previous investigations animal models 57 65 comparison could made sleep deprived animals high amplitude pulses uniformly abolished experimental period
0.1154272.14871886.html.plaintext.txt	51	four eight animals displayed one high amplitude gh pulse 6 h time frame blood sampling baseline conditions sleep deprivation thus allowed calculation frequency major gh secretory episodes animals baseline peak peak interpulse interval high amplitude gh episodes five animals 31 plus minus 02 sd h n 4 experimental period yoked animals 32 plus minus 07 sd h n 2 considered equivalent previous investigations animal models 57 65 comparison could made sleep deprived animals high amplitude pulses uniformly abolished experimental period
0.1154272.14871886.html.plaintext.txt	52	average gh value determinations 6 h sampling period integrative measurement gh secretion fig 3 sleep deprived animals displayed significant decrease gh concentration experimental period compared baseline period week 1 paired t3 123 p 0001 week 2 paired t3 100 p 0005 compared yoked animals week 1 unpaired t5 92 p 0001 week 2 unpaired t4 56 p 0005 decrease baseline gh concentrations week 1 71 sleep deprived animals 38 yoked animals yoked animals statistically different baseline
0.1154272.14871886.html.plaintext.txt	53	view larger version 43k fig 3 integrative gh concentration expressed average value gh determined 19 consecutive blood samples collected 6 h sampling period means plus minus se baseline experimental conditions sleep deprived rats n 4 bar yoked rats n 4 baseline n 3 week 1 n 2 week 2 comparisons statistically significant baseline weeks 1 2 sleep deprived rats sleep deprived rats yoked rats weeks 1 2
0.1154272.14871886.html.plaintext.txt	54	significant decrease plasma igf concentrations sleep deprived rats shown fig 4 consistent absence high amplitude pulses overall suppression gh concentration concentrations plasma igf significantly lower sleep deprived rats compared yoked rats f111 158 p 001 home cage rats f111 324 p 001 yoked animals group show suppression igf time except insofar igf concentrations elevated home cage animals percent change baseline yoked vs home cage f111 128 p 001 sleep permitted ad libitum positive correlation igf concentration body weight r 074 p 0001
0.1154272.14871886.html.plaintext.txt	55	significant decrease plasma igf concentrations sleep deprived rats shown fig 4 consistent absence high amplitude pulses overall suppression gh concentration concentrations plasma igf significantly lower sleep deprived rats compared yoked rats f111 158 p 001 home cage rats f111 324 p 001 yoked animals group show suppression igf time except insofar igf concentrations elevated home cage animals percent change baseline yoked vs home cage f111 128 p 001 sleep permitted ad libitum positive correlation igf concentration body weight r 074 p 0001
0.1154272.14871886.html.plaintext.txt	56	view larger version 18k fig 4 change plasma igf expressed percent change individual values grouped baseline means plus minus se sleep deprived n 8 yoked n 6 operated home cage n 5 rats baseline consecutive 4 day intervals experimental period group differences sleep deprived yoked sleep deprived home cage yoked home cage statistically significant 2 way repeated measures anova
0.1154272.14871886.html.plaintext.txt	57	basal stimulated prl concentrations basal prl secretion determined animal subset baseline week 1 ie days 4 6 week 2 days 11 14 experimental period sampling blood six times 50 min period four animals comprised results group except last time period three animals comprised yoked group due nonpatency one catheter resulting baseline values plus minus sd 8 animals comparable previous reports male rats 40 42 minimum 077 plus minus 083 maximum 214 plus minus 173 average 126 plus minus 103 ngml weeks 1 2 experimental period sleep deprived rats showed significant decrease baseline average prl concentration compared yoked rats weeks 1 2 1 tailed paired tests 24 38 respectively p 005 fig 5 week 2 sleep deprived animals also displayed significant decrease maximum prl value expressed percentage change baseline 577 plus minus 188 mean plus minus sd compared 1524 plus minus 774 mean plus minus sd yoked animals paired t3 26 1 tailed p 005 also week 2 sleep deprived animals showed significant percentage decrease baseline absolute prl amplitude 499 plus minus 385 mean plus minus sd compared 164 plus minus 346 mean plus minus sd yoked animals paired t2 29 1 tailed p 005 decreases prl parameters suggest diminished secretion lower amplitude sleep deprivation
0.1154272.14871886.html.plaintext.txt	58	basal stimulated prl concentrations basal prl secretion determined animal subset baseline week 1 ie days 4 6 week 2 days 11 14 experimental period sampling blood six times 50 min period four animals comprised results group except last time period three animals comprised yoked group due nonpatency one catheter resulting baseline values plus minus sd 8 animals comparable previous reports male rats 40 42 minimum 077 plus minus 083 maximum 214 plus minus 173 average 126 plus minus 103 ngml weeks 1 2 experimental period sleep deprived rats showed significant decrease baseline average prl concentration compared yoked rats weeks 1 2 1 tailed paired tests 24 38 respectively p 005 fig 5 week 2 sleep deprived animals also displayed significant decrease maximum prl value expressed percentage change baseline 577 plus minus 188 mean plus minus sd compared 1524 plus minus 774 mean plus minus sd yoked animals paired t3 26 1 tailed p 005 also week 2 sleep deprived animals showed significant percentage decrease baseline absolute prl amplitude 499 plus minus 385 mean plus minus sd compared 164 plus minus 346 mean plus minus sd yoked animals paired t2 29 1 tailed p 005 decreases prl parameters suggest diminished secretion lower amplitude sleep deprivation
0.1154272.14871886.html.plaintext.txt	59	view larger version 19k fig 5 mean percentage change plus minus se individual baseline values prolactin average value across 50 min observation periods sleep deprived n 4 yoked n 4 baseline week 1 n 3 week 2 rats weeks 1 2 experimental period statistical significance groups
0.1154272.14871886.html.plaintext.txt	60	stimulated release prl trh administration assessed measurement prl plasma collected 10 20 40 min trh administration four animals comprised results group except last time period two animals comprised yoked group nonpatency two catheters data yoked subjects week 2 insufficient statistical tests shown comparison absolute relative amplitudes time 0 peak concentration differ sleep deprived rats compared baseline yoked animals relative amplitude shown fig 6a average value prl 40 min trh stimulation significantly changed baseline 56 plus minus 25 mean plus minus sd week 1 paired t3 30 p 005 51 plus minus 16 mean plus minus sd week 2 paired t3 39 p 0025 see fig 6b average value prl yoked rats trh stimulation showed strong tendency toward decreased amounts compared baseline values two yoked animals showed higher post trh average prl values week 1 compared individual baseline values occur sleep deprived animals studied
0.1154272.14871886.html.plaintext.txt	61	stimulated release prl trh administration assessed measurement prl plasma collected 10 20 40 min trh administration four animals comprised results group except last time period two animals comprised yoked group nonpatency two catheters data yoked subjects week 2 insufficient statistical tests shown comparison absolute relative amplitudes time 0 peak concentration differ sleep deprived rats compared baseline yoked animals relative amplitude shown fig 6a average value prl 40 min trh stimulation significantly changed baseline 56 plus minus 25 mean plus minus sd week 1 paired t3 30 p 005 51 plus minus 16 mean plus minus sd week 2 paired t3 39 p 0025 see fig 6b average value prl yoked rats trh stimulation showed strong tendency toward decreased amounts compared baseline values two yoked animals showed higher post trh average prl values week 1 compared individual baseline values occur sleep deprived animals studied
0.1154272.14871886.html.plaintext.txt	62	view larger version 23k fig 6 change plasma prolactin prl concentration bolus dose thyrotropin releasing hormone trh change expressed ratio change amplitude relative pre trh concentration means plus minus se b average value prl 40 min poststimulation period means plus minus se group means shown sleep deprived n 4 yoked n 4 baseline week 1 n 3 week 2 experimental period rats statistical significance groups
0.1154272.14871886.html.plaintext.txt	63	plasma leptin corticosterone concentrations leptin concentrations suppressed early continuously sleep deprived yoked animals compared operated home cage controls percent change group x time interactions sleep deprived vs home cage f333 36 p 0025 yoked vs home cage f327 30 p 005 fig 7 sleep deprived yoked animals differ average leptin value across 4 day intervals sleep deprived yoked animals 12 plus minus 007 se ngml operated comparison animals showed evidence increased leptin concentrations correspond postsurgery weight gain increasing adiposity r 061 p 0001 significant differences plasma corticosterone concentrations found group interaction group time absolute concentrations corticosterone baseline consecutive 4 day intervals experimental period shown fig 8
0.1154272.14871886.html.plaintext.txt	64	plasma leptin corticosterone concentrations leptin concentrations suppressed early continuously sleep deprived yoked animals compared operated home cage controls percent change group x time interactions sleep deprived vs home cage f333 36 p 0025 yoked vs home cage f327 30 p 005 fig 7 sleep deprived yoked animals differ average leptin value across 4 day intervals sleep deprived yoked animals 12 plus minus 007 se ngml operated comparison animals showed evidence increased leptin concentrations correspond postsurgery weight gain increasing adiposity r 061 p 0001 significant differences plasma corticosterone concentrations found group interaction group time absolute concentrations corticosterone baseline consecutive 4 day intervals experimental period shown fig 8
0.1154272.14871886.html.plaintext.txt	65	view larger version 22k fig 7 change plasma leptin expressed percent change individual values grouped baseline means plus minus se sleep deprived n 8 yoked n 6 operated home cage n 5 rats baseline consecutive 4 day intervals experimental period group comparisons sleep deprived yoked groups home cage group statistically significant 2 way repeated measures anova
0.1154272.14871886.html.plaintext.txt	66	view larger version 33k fig 8 mean basal plasma corticosteroid concentrations mean plus minus se sleep deprived n 7 yoked n 6 operated home cage n 4 rats baseline consecutive 4 day intervals experimental period group differences group x time interactions statistically significant
0.1154272.14871886.html.plaintext.txt	67	discussion top abstract materials methods results discussion grants references major findings present studies prolonged sleep deprivation rats produced profound decreases circulating gh igf prl leptin suppressions occurred within early phase chronic sleep deprivation time overt appearance animals relatively healthy reduced secretion hormones sustained throughout experimental period occurred conjunction weight loss dramatically increased food consumption latter reported previously 18 23 considered together prior demonstration laboratory sleep deprivation produces hypothyroxinemia central origin 20 present results indicate sleep deprivation results sustains wide range neuroendocrine disruptions nature disruptions points altered central regulation level hypothalamus
0.1154272.14871886.html.plaintext.txt	68	discussion top abstract materials methods results discussion grants references major findings present studies prolonged sleep deprivation rats produced profound decreases circulating gh igf prl leptin suppressions occurred within early phase chronic sleep deprivation time overt appearance animals relatively healthy reduced secretion hormones sustained throughout experimental period occurred conjunction weight loss dramatically increased food consumption latter reported previously 18 23 considered together prior demonstration laboratory sleep deprivation produces hypothyroxinemia central origin 20 present results indicate sleep deprivation results sustains wide range neuroendocrine disruptions nature disruptions points altered central regulation level hypothalamus
0.1154272.14871886.html.plaintext.txt	69	gh secretion assessed measurement major gh secretory periods subgroup sleep deprived yoked comparisons studied intensive blood sampling protocols freely moving conditions sleep deprived animals showed diminished circulating gh prevailing absence major secretory gh bursts observed baseline periods igf considered main effector molecule gh secretion many tissues also consistently suppressed sleep deprived rats 31 42 throughout 4 day interval observation concomitant robust food intake measurement circulating igf levels well nourished subjects believed reflect 24 h secretion gh pituitary gland reviewed ref 43 yoked animals partial sleep deprivation conditions showed strong tendency overall decrease baseline gh concentration showed evidence relatively well preserved major gh secretory periods high amplitude pulses relatively unchanged duration frequency taken together results provide evidence diminished gh availability effector activity periphery totally sleep deprived rats
0.1154272.14871886.html.plaintext.txt	70	gh secretion assessed measurement major gh secretory periods subgroup sleep deprived yoked comparisons studied intensive blood sampling protocols freely moving conditions sleep deprived animals showed diminished circulating gh prevailing absence major secretory gh bursts observed baseline periods igf considered main effector molecule gh secretion many tissues also consistently suppressed sleep deprived rats 31 42 throughout 4 day interval observation concomitant robust food intake measurement circulating igf levels well nourished subjects believed reflect 24 h secretion gh pituitary gland reviewed ref 43 yoked animals partial sleep deprivation conditions showed strong tendency overall decrease baseline gh concentration showed evidence relatively well preserved major gh secretory periods high amplitude pulses relatively unchanged duration frequency taken together results provide evidence diminished gh availability effector activity periphery totally sleep deprived rats
0.1154272.14871886.html.plaintext.txt	71	prl gh share 40 homology gh substitute prl deficiency extent reviewed ref 7 sleep deprived animals also showed large reduction 52 basal circulating prl first days sleep deprivation maintenance suppressed concentrations experimental period comparison yoked animals partial sleep deprivation variously affected individual instances sometimes increased prl concentration challenge tests pituitary secretion prl trh administration yielded initial prl response proportional normal sleep deprived yoked rats however total amount poststimulation prl secreted 40 min significantly less sleep deprived rats baseline period reflecting diminished basal concentrations yoked animals conditions partial sleep deprivation tended show direction change post trh prl concentrations totally sleep deprived rats
0.1154272.14871886.html.plaintext.txt	72	experimental groups sleep deprived rats partially sleep deprived yoked rats showed significant reductions circulating leptin concentrations finding effectively ruled hyperleptinemia plausible mediator sleep deprivation signs activation sympathetic nervous system increased energy expenditure loss weight suppression igf rather plasma levels leptin appeared reflect energy stores became inadequate eventually manifested animals increased food consumption failure gain weight leptin considered critical peripheral hormonal signal status body energy stores brain functions within long term homeostatic system balancing food intake energy expenditure requiring time gear adaptive responses negative energy balance reviewed ref 25
0.1154272.14871886.html.plaintext.txt	73	experimental groups sleep deprived rats partially sleep deprived yoked rats showed significant reductions circulating leptin concentrations finding effectively ruled hyperleptinemia plausible mediator sleep deprivation signs activation sympathetic nervous system increased energy expenditure loss weight suppression igf rather plasma levels leptin appeared reflect energy stores became inadequate eventually manifested animals increased food consumption failure gain weight leptin considered critical peripheral hormonal signal status body energy stores brain functions within long term homeostatic system balancing food intake energy expenditure requiring time gear adaptive responses negative energy balance reviewed ref 25
0.1154272.14871886.html.plaintext.txt	74	low leptin increased corticosterone concentrations reciprocal responses negative energy balance starvation reviewed ref 24 experimentally induced insulin deficient diabetes 4 states increased glucocorticoids known alter functions carried hypothalamic pituitary axis suppress immunity reviewed ref 44 present results suggest reciprocal relationship associated circumstances extend de facto sleep deprived state rats rendered diabetic 4 rats fasted 4 72 h 46 75 76 increases corticosterone typically three fivefold rats studies behavioral stress increases corticosterone ninefold 29 51 prl increased 67 comparison present study sleep deprived rats showed mild tendency increased corticosteroid concentrations 50 recorded various times two groups result replicates previous findings 8 20 corroborates mild unchanged values found results human studies selective sleep deprivation 37 38 70 although changes corticosteroid receptors sensitivity catabolism cannot yet ruled corticosterone concentration sleep deprived rats appears consistent may expected mobilize fuel support metabolic cellular requirements hypothalamic pituitary adrenal axis thus appear overactivated implying corticosterone modulatory role either suppression anabolic hormones suppression immunity sleep deprived rats
0.1154272.14871886.html.plaintext.txt	75	low leptin increased corticosterone concentrations reciprocal responses negative energy balance starvation reviewed ref 24 experimentally induced insulin deficient diabetes 4 states increased glucocorticoids known alter functions carried hypothalamic pituitary axis suppress immunity reviewed ref 44 present results suggest reciprocal relationship associated circumstances extend de facto sleep deprived state rats rendered diabetic 4 rats fasted 4 72 h 46 75 76 increases corticosterone typically three fivefold rats studies behavioral stress increases corticosterone ninefold 29 51 prl increased 67 comparison present study sleep deprived rats showed mild tendency increased corticosteroid concentrations 50 recorded various times two groups result replicates previous findings 8 20 corroborates mild unchanged values found results human studies selective sleep deprivation 37 38 70 although changes corticosteroid receptors sensitivity catabolism cannot yet ruled corticosterone concentration sleep deprived rats appears consistent may expected mobilize fuel support metabolic cellular requirements hypothalamic pituitary adrenal axis thus appear overactivated implying corticosterone modulatory role either suppression anabolic hormones suppression immunity sleep deprived rats
0.1154272.14871886.html.plaintext.txt	76	studies necessary characterize mechanisms underlying suppression gh prl igf leptin elucidated present studies inappropriately low tsh shown previously 19 20 however several lines evidence suggest hypothalamus primary locus affected sleep deprivation possible secondary pituitary involvement example normal conditions decrease igf associated increase gh release via long negative feedback loop brain reviewed refs 47 55 specific feedback mechanisms igf gh mechanisms hypothalamus well elucidated believed involve increased inhibitory tone srif reduced ghrh reviewed ref 68 normally operate reciprocal manner regulate gh secretion reduced igf negative feedback hypothalamus fail increase gh would suggest increased srif tone andor decreased ghrh evidence consistent framework finding gardi et al 26 short term sleep deprivation rats reduces amounts ghrh tends increase amounts srif hypothalamus findings toppila et al 69 show increases srif mrna arcuate nucleus short term sleep deprivation
0.1154272.14871886.html.plaintext.txt	77	studies necessary characterize mechanisms underlying suppression gh prl igf leptin elucidated present studies inappropriately low tsh shown previously 19 20 however several lines evidence suggest hypothalamus primary locus affected sleep deprivation possible secondary pituitary involvement example normal conditions decrease igf associated increase gh release via long negative feedback loop brain reviewed refs 47 55 specific feedback mechanisms igf gh mechanisms hypothalamus well elucidated believed involve increased inhibitory tone srif reduced ghrh reviewed ref 68 normally operate reciprocal manner regulate gh secretion reduced igf negative feedback hypothalamus fail increase gh would suggest increased srif tone andor decreased ghrh evidence consistent framework finding gardi et al 26 short term sleep deprivation rats reduces amounts ghrh tends increase amounts srif hypothalamus findings toppila et al 69 show increases srif mrna arcuate nucleus short term sleep deprivation
0.1154272.14871886.html.plaintext.txt	78	prl different pituitary hormones target organs supply feedback hormones primary influence prl secretion inhibition hypothalamus present study absolute concentration prl diminished sleep deprived rats yet exogenous stimulation hypothalamic peptide trh led prl response comparable relative amplitude baseline comparison conditions suggesting prl synthesis storage primary reason low circulating prl finding consistent previous studies showed appropriate pituitary response tsh release trh administration 20 points insufficient stimulation pituitary sleep deprivation manner would resulted maintenance normal peripheral prl concentrations
0.1154272.14871886.html.plaintext.txt	79	prl different pituitary hormones target organs supply feedback hormones primary influence prl secretion inhibition hypothalamus present study absolute concentration prl diminished sleep deprived rats yet exogenous stimulation hypothalamic peptide trh led prl response comparable relative amplitude baseline comparison conditions suggesting prl synthesis storage primary reason low circulating prl finding consistent previous studies showed appropriate pituitary response tsh release trh administration 20 points insufficient stimulation pituitary sleep deprivation manner would resulted maintenance normal peripheral prl concentrations
0.1154272.14871886.html.plaintext.txt	80	possible decrease circulating leptin consequent sleep deprivation induced negative energy balance contributes reductions gh prl secretion inappropriately low tsh concentrations associated hypothyroxinemia leptin exerts negative feedback directly hypothalamus reviewed refs 25 31 low circulating leptin conditions negative energy balance induced experimental means potent signal increased mrna expression secretion neuropeptide y agouti related peptide hypothalamus reduced signaling melanocyte stimulating hormone precursor proopiomelanocortin reviewed ref 25 changes relevant determining mediation increased food intake causal direction altered regulation neuroendocrine peptides development negative energy balance diminished leptin associated abolition gh secretory peaks administration leptin associated restoration peaks 66 affecting ghrh srif 78 similarly decreased leptin resulting food deprivation associated decreased circulating thyroid hormones prl administration leptin conditions reverses hormonal changes 1 28 41 79 however present results suggest leptin may necessary sufficient factor reduction hormones since partially sleep deprived rats showed equivalent reductions leptin secretion less interference pituitary hormone secretion growing body evidence indicates central integration leptin signaling central control leptin concentrations
0.1154272.14871886.html.plaintext.txt	81	possible decrease circulating leptin consequent sleep deprivation induced negative energy balance contributes reductions gh prl secretion inappropriately low tsh concentrations associated hypothyroxinemia leptin exerts negative feedback directly hypothalamus reviewed refs 25 31 low circulating leptin conditions negative energy balance induced experimental means potent signal increased mrna expression secretion neuropeptide y agouti related peptide hypothalamus reduced signaling melanocyte stimulating hormone precursor proopiomelanocortin reviewed ref 25 changes relevant determining mediation increased food intake causal direction altered regulation neuroendocrine peptides development negative energy balance diminished leptin associated abolition gh secretory peaks administration leptin associated restoration peaks 66 affecting ghrh srif 78 similarly decreased leptin resulting food deprivation associated decreased circulating thyroid hormones prl administration leptin conditions reverses hormonal changes 1 28 41 79 however present results suggest leptin may necessary sufficient factor reduction hormones since partially sleep deprived rats showed equivalent reductions leptin secretion less interference pituitary hormone secretion growing body evidence indicates central integration leptin signaling central control leptin concentrations
0.1154272.14871886.html.plaintext.txt	82	hormonal changes sleep deprived rats may viewed either dysfunctional adaptive responses one hand abundant evidence diseases central locus hypothalamic dysfunction produce peripheral effects changes neuroendocrine regulation reviewed ref 47 hand low leptin suppression anabolic hormones may viewed adaptive responses negative energy balance evidenced progressive food intake body weight changes sleep deprived rats suggestions central effects sleep deprivation considered dysfunctional rather adaptive come examples contrast sleep deprived starved rats quite opposite starved rats declines t4 t3 sleep deprived rats consistent metabolic activation downregulation ratio t3 t4 dramatically increased 8 indicating strong preference metabolically active form thyroid hormone without increase reverse t3 metabolically inactive pathway also contrast starvation sleep deprivation associated 100 fold increase t4 t3 conversion enzyme 5 deiodinase type ii brown adipose tissue 3 consistent experimental hypothyroidism 13 61 suggesting central changes regulation anabolic hormones produce state peripheral mechanisms show activities consistent compensation
0.1154272.14871886.html.plaintext.txt	83	hormonal changes sleep deprived rats may viewed either dysfunctional adaptive responses one hand abundant evidence diseases central locus hypothalamic dysfunction produce peripheral effects changes neuroendocrine regulation reviewed ref 47 hand low leptin suppression anabolic hormones may viewed adaptive responses negative energy balance evidenced progressive food intake body weight changes sleep deprived rats suggestions central effects sleep deprivation considered dysfunctional rather adaptive come examples contrast sleep deprived starved rats quite opposite starved rats declines t4 t3 sleep deprived rats consistent metabolic activation downregulation ratio t3 t4 dramatically increased 8 indicating strong preference metabolically active form thyroid hormone without increase reverse t3 metabolically inactive pathway also contrast starvation sleep deprivation associated 100 fold increase t4 t3 conversion enzyme 5 deiodinase type ii brown adipose tissue 3 consistent experimental hypothyroidism 13 61 suggesting central changes regulation anabolic hormones produce state peripheral mechanisms show activities consistent compensation
0.1154272.14871886.html.plaintext.txt	84	clinical implications suppression hormones based many pleiotropic actions deficiency prl induced hypophysectomy reduces circulating prl 50 control values associated normocytic anemia grossly reduced immunocompetence decreased body weight several abnormalities 49 shared sleep deprived animals gh widespread effects growth metabolism tissues including increasing dna rna protein synthesis mitosis reviewed ref 43 suppression leptin would expected extend beyond effects energy balance include numerous effects example leptin deficient obob mice show many endocrine metabolic abnormalities including decreased body temperature immune defects reviewed ref 25 decreases igf would expected diminish many effector functions include autocrine paracrine growth factor mediation mitosis differentiation chemotaxis apoptosis many tissues reviewed ref 43 administration igf burn injury improves body weight gut mucosal weight stimulates mucosal dna protein content reduces incidence bacterial translocation 32 endocrine immune systems intricately linked hormonal changes may contributing decreased resistance infectious disease animal model deficiencies gh igf prl thyroid hormones leptin induced sleep deprivation affect health provide one explanation absence localization specific sleep deprivation effects low basal prl lack reciprocal relationships igf gh leptin corticosterone point hypothalamus locus sleep deprivation effects key factors interact presentation integrated signals pituitary
0.1154272.14871886.html.plaintext.txt	85	clinical implications suppression hormones based many pleiotropic actions deficiency prl induced hypophysectomy reduces circulating prl 50 control values associated normocytic anemia grossly reduced immunocompetence decreased body weight several abnormalities 49 shared sleep deprived animals gh widespread effects growth metabolism tissues including increasing dna rna protein synthesis mitosis reviewed ref 43 suppression leptin would expected extend beyond effects energy balance include numerous effects example leptin deficient obob mice show many endocrine metabolic abnormalities including decreased body temperature immune defects reviewed ref 25 decreases igf would expected diminish many effector functions include autocrine paracrine growth factor mediation mitosis differentiation chemotaxis apoptosis many tissues reviewed ref 43 administration igf burn injury improves body weight gut mucosal weight stimulates mucosal dna protein content reduces incidence bacterial translocation 32 endocrine immune systems intricately linked hormonal changes may contributing decreased resistance infectious disease animal model deficiencies gh igf prl thyroid hormones leptin induced sleep deprivation affect health provide one explanation absence localization specific sleep deprivation effects low basal prl lack reciprocal relationships igf gh leptin corticosterone point hypothalamus locus sleep deprivation effects key factors interact presentation integrated signals pituitary
0.1154272.14871886.html.plaintext.txt	86	grants top abstract materials methods results discussion grants references portions work presented 16th european sleep research society congress reykjavik iceland june 2002 principal research support provided national institutes health nih ns 38733 additional support provided nih grants hl 59271 hd 13703 veterans administration university tennessee memphis tn provided facilities part research
0.1154272.14871886.html.plaintext.txt	87	grants top abstract materials methods results discussion grants references portions work presented 16th european sleep research society congress reykjavik iceland june 2002 principal research support provided national institutes health nih ns 38733 additional support provided nih grants hl 59271 hd 13703 veterans administration university tennessee memphis tn provided facilities part research
0.1154272.14871886.html.plaintext.txt	88	acknowledgments express appreciation christa d laatsch jason scott technical assistance
0.1154272.14871886.html.plaintext.txt	89	acknowledgments express appreciation christa d laatsch jason scott technical assistance
0.1154272.14871886.html.plaintext.txt	90	footnotes address reprint requests correspondence c everson medical college wisconsin neurology research 151 va medical center bldg 70 d 117 5000 west national ave milwaukee wi 53295 e mail ceversonatmcwedu u d
0.1154272.14871886.html.plaintext.txt	91	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.1154272.14871886.html.plaintext.txt	92	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.1154272.14871886.html.plaintext.txt	93	references top abstract materials methods results discussion grants references ahima rs prabakaran d mantzoros c qu d lowell b maratos flier e flier js role leptin neuroendocrine response fasting nature 382 250 252 1996crossrefisimedline aurell j elmqvist d sleep surgical intensive care unit continuous polygraphic recording sleep nine patients receiving postoperative care br med j clin res ed 290 1029 1032 1985medline balzano bergmann bm gilliland ma silva je rechtschaffen refetoff effect total sleep deprivation 5 deiodinase activity rat brown adipose tissue endocrinology 127 882 890 1990abstract barber m kasturi bs austin patel kp mohankumar sm mohankumar ps diabetes induced neuroendocrine changes rats role brain monoamines insulin leptin brain res 964 128 135 2003crossrefisimedline ben jonathan n mershon jl allen dl steinmetz rw extrapituitary prolactin distribution regulation functions clinical aspects endocr rev 17 639 669 1996isimedline bergmann bm everson ca kushida ca fang vs leitch ca schoeller da refetoff rechtschaffen sleep deprivation rat v energy use mediation sleep 12 31 41 1989isimedline bergmann bm kushida ca everson ca gilliland ma obermeyer w rechtschaffen sleep deprivation rat ii methodology sleep 12 5 12 1989isimedline brandenberger g gronfier c chapotot f simon c piquard f effect sleep deprivation overall 24 h growth hormone secretion abstract lancet 356 1408 2000crossrefisimedline brun j chamba g khalfallah y girard p boissy bastuji h sassolas g claustrat b effect modafinil plasma melatonin cortisol growth hormone rhythms rectal temperature performance healthy subjects 36 h sleep deprivation j sleep res 7 105 114 1998crossrefisimedline chen g koyama k yuan x lee y zhou yt odoherty r newgard cb unger rh disappearance body fat normal rats induced adenovirus mediated leptin gene therapy proc natl acad sci usa 93 14795 14799 1996abstractfree full text croteau w davey jc galton va st germain dl cloning mammalian type ii iodothyronine deiodinase selenoprotein differentially expressed regulated human rat brain tissues j clin invest 98 405 417 1996abstractfree full text cureton lane ra fontaine dk sleep pediatric icu empirical investigation j crit care 6 56 63 1997medline eastman c rechtschaffen circadian temperature wake rhythms rats exposed prolonged continuous illumination physiol behav 31 417 427 1983crossrefisimedline everson ca sustained sleep deprivation impairs host defense j physiol regul integr comp physiol 265 r1148 r1154 1993abstractfree full text everson ca clinical manifestations prolonged sleep deprivation sleep science integrating basic research clinical practice monographs clinical neuroscience edited schwartz wj basel karger 1997 p 34 59 everson ca bergmann bm rechtschaffen sleep deprivation rat iii total sleep deprivation sleep 12 13 21 1989isimedline everson ca nowak ta hypothalamic thyrotropin releasing hormone mrna responses hypothyroxinemia induced sleep deprivation j physiol endocrinol metab 283 e85 e93 2002abstractfree full text everson ca reed hl pituitary peripheral thyroid hormone responses thyrotropin releasing hormone sustained sleep deprivation freely moving rats endocrinology 136 1426 1434 1995abstract everson ca smith cb sokoloff l effects prolonged sleep deprivation local rates cerebral energy metabolism freely moving rats j neurosci 14 6769 6778 1994abstract everson ca toth la systemic bacterial invasion induced sleep deprivation j physiol regul integr comp physiol 278 r905 r916 2000abstractfree full text everson ca wehr ta nutritional metabolic adaptations prolonged sleep deprivation rat j physiol regul integr comp physiol 264 r376 r387 1993abstractfree full text flier js clinical review 94 whats name search leptins physiologic role j clin endocrinol metab 83 1407 1413 1998free full text friedman jm function leptin nutrition weight physiology nutr rev 60 s1 s14 s85 s87 2002 gardi j obal fj fang j zhang j krueger jm diurnal variations sleep deprivation induced changes rat hypothalamic ghrh somatostatin contents j physiol regul integr comp physiol 277 r1339 r1344 1999abstractfree full text gardi j taishi p speth r obal fj krueger jm sleep loss alters hypothalamic growth hormone releasing hormone receptors rats neurosci lett 329 69 72 2002crossrefisimedline gonzalez lc pinilla l tena sempere m aguilar e leptin116 130 stimulates prolactin luteinizing hormone secretion fasted adult male rats neuroendocrinology 70 213 220 1999crossrefisimedline hajos korcsok e robinson dd yu jh fitch cs walker e merchant km rapid habituation hippocampal serotonin norepinephrine release anxiety related behaviors plasma corticosterone levels repeated footshock stress rats pharmacol biochem behav 74 609 616 2003crossrefisimedline halle m persson pb role leptin leptin receptor inflammation j physiol regul integr comp physiol 284 r760 r762 2003free full text himms hagen j physiological roles leptin endocrine system differences mice humans crit rev clin lab sci 36 575 655 1999isimedline huang kf chung dh herndon dn insulinlike growth factor 1 igf 1 reduces gut atrophy bacterial translocation severe burn injury arch surg 128 47 53 1993abstract inoue honda k wada m effects total sleep deprivation serum lh fsh prl male rats reference age strain differences rep inst med dent engineer 14 175 176 1980 kimura f tsai cw ultradian rhythm growth hormone secretion sleep adult male rat j physiol 353 305 315 1984abstract kleitman n sleep wakefulness chicago il univ chicago press 1963 kok sw meinders ae overeem lammers gj roelfsema f frolich m pijl h reduction plasma leptin levels loss circadian rhythmicity hypocretin orexin deficient narcoleptic humans j clin endocrinol metab 87 805 809 2002abstractfree full text kollar e slater g palmer j doctor r mandell stress subjects undergoing sleep deprivation psychosom med 28 101 113 1966isimedline kollar ej pasnau ro rubin rt naitoh p slater gg kales psychological psychophysiological biochemical correlates prolonged sleep deprivation j psychiatry 126 488 497 1969isimedline kripke df garfinkel l wingard dl klauber mr marler mr mortality associated sleep duration insomnia arch gen psychiatry 59 131 136 2002abstractfree full text lafuente marco j esquifino ai physiological roles thyrotrophin releasing hormone vasoactive intestinal peptide pulsatile secretory patterns prolactin pituitary grafted female rats j endocrinol 142 581 586 1994abstract legradi g emerson ch ahima rs flier js lechan rm leptin prevents fasting induced suppression prothyrotropin releasing hormone messenger ribonucleic acid neurons hypothalamic paraventricular nucleus endocrinology 138 2569 2576 1997abstractfree full text lopez f dominguez jr sanchez franco f negro vilar role dopamine vasoactive intestinal peptide control pulsatile prolactin secretion endocrinology 124 527 535 1989abstract macgillivray mh disorders growth development endocrinology metabolism 4th ed edited felig p frohman la new york mcgraw hill 2001 p 1265 1316 miller wl chrousos gp adrenal cortex endocrinology metabolism 4th ed edited felig p frohman la new york mcgraw hill 2001 p 387 524 mistry swick ag romsos dr leptin rapidly lowers food intake elevates metabolic rates lean obob mice j nutr 127 2065 2072 1997abstractfree full text mitev y almeida patchev v pituitary adrenal function hypothalamic beta endorphin release vitro following food deprivation brain res 30 7 10 1993 molitch neuroendocrinology endocrinology metabolism 4th ed edited felig p frohman la new york mcgraw hill 2001 p 111 171 mueller gp chen hj meites j vivo stimulation prolactin release rat synthetic trh proc soc exp biol med 144 613 615 1973 nagy e berczi hypophysectomized rats depend residual prolactin survival endocrinology 128 2776 2784 1991abstract national commission sleep disorders research wake america national sleep alert executive summary executive report united states congress secretary us department health human services washington dc national commission sleep disorders research 1993 p 1 76 national institutes health treatment sleep disorders older people nih consensus development conference washington dc national institutes health 1990 obal fj kacsoh b bredow guha thakurta n krueger jm sleep rats rendered chronically hyperprolactinemic anterior pituitary grafts brain res 755 130 136 1997crossrefisimedline ohata h arai k shibasaki effect chronic administration crf1 receptor antagonist cra1000 locomotor activity endocrine responses stress eur j pharmacol 457 201 206 2002crossrefisimedline parker dc sassin jf mace jw gotlin rw rossman lg human growth hormone release sleep electroencephalographic correlation j clin endocrinol metab 29 871 874 1969isimedline rechtschaffen bergmann bm everson ca kushida ca gilliland ma sleep deprivation rat x integration discussion findings sleep 12 68 87 1989isimedline rechtschaffen gilliland ma bergmann bm winter jb physiological correlates prolonged sleep deprivation rats science 221 182 184 1983isimedline ross r miell j freeman e jones j matthews d preece m buchanan c critically ill patients high basal growth hormone levels attenuated oscillatory activity associated low levels insulin like growth factor clin endocrinol oxf 35 45 54 1991 sassin jf parker dc mace jw gotlin rw johnson lc rossman lg human growth hormone release relation slow wave sleep sleep walking cycles science 165 513 515 1969isimedline sato m murao k niimi m tamaki m takahara j effects long term infusion growth hormone gh releasing factor pulsatile gh secretion male rat life sci 54 79 86 1994crossrefisimedline satoh n ogawa y katsuura g numata y tsuji hayase m ebihara k masuzaki h hosoda k yoshimasa y nakao k sympathetic activation leptin via ventromedial hypothalamus leptin induced increase catecholamine secretion diabetes 48 1787 1793 1999abstract scheen aj byrne mm plat l leproult r van cauter e relationships sleep quality glucose regulation normal humans j physiol endocrinol metab 271 e261 e270 1996abstractfree full text schuld blum wf uhr m haack m kraus holsboer f pollmacher reduced leptin levels human narcolepsy neuroendocrinology 72 195 198 2000crossrefisimedline silva je larsen pr interrelationships among thyroxine growth hormone sympathetic nervous system regulation 5 iodothyronine deiodinase rat brown adipose tissue j clin invest 77 1214 1223 1986isimedline spiegel k laproult r copinschi g van cauter e impact sleep length 24 h leptin profile abstract sleep 24 a74 2001 szymusiak r satinoff e maximal rem sleep time defines narrower thermoneutral zone minimal metabolic rate physiol behav 26 687 690 1981crossrefisimedline takahashi y kipnis dm daughaday wh growth hormone secretion sleep j clin invest 47 2079 2090 1968isimedline tannenbaum g martin j evidence endogenous ultradian rhythm governing growth hormone secretion rat endocrinology 98 562 570 1976abstract tannenbaum gs gurd w lapointe m leptin potent stimulator spontaneous pulsatile growth hormone gh secretion gh response gh releasing hormone endocrinology 139 3871 3875 1998abstractfree full text terry lc saunders audet j willoughby jo brazeau p martin jb physiologic secretion growth hormone prolactin male female rats clin endocrinol oxf 6 19s 28s 1977medline thissen jp underwood le ketelslegers jm regulation insulin like growth factor starvation injury nutr rev 57 167 176 1999isimedline toppila j alanko l asikainen m tobler stenberg d porkka heiskanen sleep deprivation increases somatostatin growth hormone releasing hormone messenger rna rat hypothalamus j sleep res 6 171 178 1997crossrefisimedline tyler db marx w goodman j effect prolonged wakefulness urinary excretion 17 ketosteroids proc soc exp biol med 62 38 40 1946 utiger rd thyrotropin releasing hormone thyrotropin secretion j lab clin med 109 327 335 1987isimedline van cauter e estimating false positive false negative errors analyses hormonal pulsatility j physiol endocrinol metab 254 e786 e794 1988abstractfree full text van cauter e kerkhofs m caufriez van onderbergen thorner mo copinschi g quantitative estimation growth hormone secretion normal man reproducibility relation sleep time day j clin endocrinol metab 74 1441 1450 1992abstract van cauter e spiegel k hormones metabolism sleep sleep science integrating basic research clinical practice edited schwartz wj basel karger 1997 p 144 174 van haasteren ga linkels e klootwijk w van toor h rondeel jm themmen ap de jong fh valentijn k vaudry h bauer k visser tj de greef wj starvation induced changes hypothalamic content prothyrotrophin releasing hormone protrh mrna hypothalamic release protrh derived peptides role adrenal gland j endocrinol 145 143 153 1995abstract vila r adan c grasa mm masanes rm esteve m cabot c fernandez lopez ja remesar x alemany m effect food deprivation rat plasma estrone fatty acid esters diabetes obes metab 1 353 356 1995crossref von treuer k norman tr armstrong sm overnight human plasma melatonin cortisol prolactin tsh conditions normal sleep sleep deprivation sleep recovery j pineal res 20 7 14 1996isimedline watanabe h habu leptin regulates growth hormone releasing factor somatostatin alpha melanocyte stimulating hormone neuropeptide y release rat hypothalamus vivo relation growth hormone secretion j neurosci 22 6265 6271 2002abstractfree full text watanabe h schioth hb suda stimulation prolactin secretion chronic acute administration leptin rat brain res 887 426 431 2000crossrefisimedline zhang sq inoue kimura m sleep promoting activity prolactin releasing peptide prrp rat neuroreport 12 3173 3176 2001crossrefisimedline
0.1154272.14871886.html.plaintext.txt	94	references top abstract materials methods results discussion grants references ahima rs prabakaran d mantzoros c qu d lowell b maratos flier e flier js role leptin neuroendocrine response fasting nature 382 250 252 1996crossrefisimedline aurell j elmqvist d sleep surgical intensive care unit continuous polygraphic recording sleep nine patients receiving postoperative care br med j clin res ed 290 1029 1032 1985medline balzano bergmann bm gilliland ma silva je rechtschaffen refetoff effect total sleep deprivation 5 deiodinase activity rat brown adipose tissue endocrinology 127 882 890 1990abstract barber m kasturi bs austin patel kp mohankumar sm mohankumar ps diabetes induced neuroendocrine changes rats role brain monoamines insulin leptin brain res 964 128 135 2003crossrefisimedline ben jonathan n mershon jl allen dl steinmetz rw extrapituitary prolactin distribution regulation functions clinical aspects endocr rev 17 639 669 1996isimedline bergmann bm everson ca kushida ca fang vs leitch ca schoeller da refetoff rechtschaffen sleep deprivation rat v energy use mediation sleep 12 31 41 1989isimedline bergmann bm kushida ca everson ca gilliland ma obermeyer w rechtschaffen sleep deprivation rat ii methodology sleep 12 5 12 1989isimedline brandenberger g gronfier c chapotot f simon c piquard f effect sleep deprivation overall 24 h growth hormone secretion abstract lancet 356 1408 2000crossrefisimedline brun j chamba g khalfallah y girard p boissy bastuji h sassolas g claustrat b effect modafinil plasma melatonin cortisol growth hormone rhythms rectal temperature performance healthy subjects 36 h sleep deprivation j sleep res 7 105 114 1998crossrefisimedline chen g koyama k yuan x lee y zhou yt odoherty r newgard cb unger rh disappearance body fat normal rats induced adenovirus mediated leptin gene therapy proc natl acad sci usa 93 14795 14799 1996abstractfree full text croteau w davey jc galton va st germain dl cloning mammalian type ii iodothyronine deiodinase selenoprotein differentially expressed regulated human rat brain tissues j clin invest 98 405 417 1996abstractfree full text cureton lane ra fontaine dk sleep pediatric icu empirical investigation j crit care 6 56 63 1997medline eastman c rechtschaffen circadian temperature wake rhythms rats exposed prolonged continuous illumination physiol behav 31 417 427 1983crossrefisimedline everson ca sustained sleep deprivation impairs host defense j physiol regul integr comp physiol 265 r1148 r1154 1993abstractfree full text everson ca clinical manifestations prolonged sleep deprivation sleep science integrating basic research clinical practice monographs clinical neuroscience edited schwartz wj basel karger 1997 p 34 59 everson ca bergmann bm rechtschaffen sleep deprivation rat iii total sleep deprivation sleep 12 13 21 1989isimedline everson ca nowak ta hypothalamic thyrotropin releasing hormone mrna responses hypothyroxinemia induced sleep deprivation j physiol endocrinol metab 283 e85 e93 2002abstractfree full text everson ca reed hl pituitary peripheral thyroid hormone responses thyrotropin releasing hormone sustained sleep deprivation freely moving rats endocrinology 136 1426 1434 1995abstract everson ca smith cb sokoloff l effects prolonged sleep deprivation local rates cerebral energy metabolism freely moving rats j neurosci 14 6769 6778 1994abstract everson ca toth la systemic bacterial invasion induced sleep deprivation j physiol regul integr comp physiol 278 r905 r916 2000abstractfree full text everson ca wehr ta nutritional metabolic adaptations prolonged sleep deprivation rat j physiol regul integr comp physiol 264 r376 r387 1993abstractfree full text flier js clinical review 94 whats name search leptins physiologic role j clin endocrinol metab 83 1407 1413 1998free full text friedman jm function leptin nutrition weight physiology nutr rev 60 s1 s14 s85 s87 2002 gardi j obal fj fang j zhang j krueger jm diurnal variations sleep deprivation induced changes rat hypothalamic ghrh somatostatin contents j physiol regul integr comp physiol 277 r1339 r1344 1999abstractfree full text gardi j taishi p speth r obal fj krueger jm sleep loss alters hypothalamic growth hormone releasing hormone receptors rats neurosci lett 329 69 72 2002crossrefisimedline gonzalez lc pinilla l tena sempere m aguilar e leptin116 130 stimulates prolactin luteinizing hormone secretion fasted adult male rats neuroendocrinology 70 213 220 1999crossrefisimedline hajos korcsok e robinson dd yu jh fitch cs walker e merchant km rapid habituation hippocampal serotonin norepinephrine release anxiety related behaviors plasma corticosterone levels repeated footshock stress rats pharmacol biochem behav 74 609 616 2003crossrefisimedline halle m persson pb role leptin leptin receptor inflammation j physiol regul integr comp physiol 284 r760 r762 2003free full text himms hagen j physiological roles leptin endocrine system differences mice humans crit rev clin lab sci 36 575 655 1999isimedline huang kf chung dh herndon dn insulinlike growth factor 1 igf 1 reduces gut atrophy bacterial translocation severe burn injury arch surg 128 47 53 1993abstract inoue honda k wada m effects total sleep deprivation serum lh fsh prl male rats reference age strain differences rep inst med dent engineer 14 175 176 1980 kimura f tsai cw ultradian rhythm growth hormone secretion sleep adult male rat j physiol 353 305 315 1984abstract kleitman n sleep wakefulness chicago il univ chicago press 1963 kok sw meinders ae overeem lammers gj roelfsema f frolich m pijl h reduction plasma leptin levels loss circadian rhythmicity hypocretin orexin deficient narcoleptic humans j clin endocrinol metab 87 805 809 2002abstractfree full text kollar e slater g palmer j doctor r mandell stress subjects undergoing sleep deprivation psychosom med 28 101 113 1966isimedline kollar ej pasnau ro rubin rt naitoh p slater gg kales psychological psychophysiological biochemical correlates prolonged sleep deprivation j psychiatry 126 488 497 1969isimedline kripke df garfinkel l wingard dl klauber mr marler mr mortality associated sleep duration insomnia arch gen psychiatry 59 131 136 2002abstractfree full text lafuente marco j esquifino ai physiological roles thyrotrophin releasing hormone vasoactive intestinal peptide pulsatile secretory patterns prolactin pituitary grafted female rats j endocrinol 142 581 586 1994abstract legradi g emerson ch ahima rs flier js lechan rm leptin prevents fasting induced suppression prothyrotropin releasing hormone messenger ribonucleic acid neurons hypothalamic paraventricular nucleus endocrinology 138 2569 2576 1997abstractfree full text lopez f dominguez jr sanchez franco f negro vilar role dopamine vasoactive intestinal peptide control pulsatile prolactin secretion endocrinology 124 527 535 1989abstract macgillivray mh disorders growth development endocrinology metabolism 4th ed edited felig p frohman la new york mcgraw hill 2001 p 1265 1316 miller wl chrousos gp adrenal cortex endocrinology metabolism 4th ed edited felig p frohman la new york mcgraw hill 2001 p 387 524 mistry swick ag romsos dr leptin rapidly lowers food intake elevates metabolic rates lean obob mice j nutr 127 2065 2072 1997abstractfree full text mitev y almeida patchev v pituitary adrenal function hypothalamic beta endorphin release vitro following food deprivation brain res 30 7 10 1993 molitch neuroendocrinology endocrinology metabolism 4th ed edited felig p frohman la new york mcgraw hill 2001 p 111 171 mueller gp chen hj meites j vivo stimulation prolactin release rat synthetic trh proc soc exp biol med 144 613 615 1973 nagy e berczi hypophysectomized rats depend residual prolactin survival endocrinology 128 2776 2784 1991abstract national commission sleep disorders research wake america national sleep alert executive summary executive report united states congress secretary us department health human services washington dc national commission sleep disorders research 1993 p 1 76 national institutes health treatment sleep disorders older people nih consensus development conference washington dc national institutes health 1990 obal fj kacsoh b bredow guha thakurta n krueger jm sleep rats rendered chronically hyperprolactinemic anterior pituitary grafts brain res 755 130 136 1997crossrefisimedline ohata h arai k shibasaki effect chronic administration crf1 receptor antagonist cra1000 locomotor activity endocrine responses stress eur j pharmacol 457 201 206 2002crossrefisimedline parker dc sassin jf mace jw gotlin rw rossman lg human growth hormone release sleep electroencephalographic correlation j clin endocrinol metab 29 871 874 1969isimedline rechtschaffen bergmann bm everson ca kushida ca gilliland ma sleep deprivation rat x integration discussion findings sleep 12 68 87 1989isimedline rechtschaffen gilliland ma bergmann bm winter jb physiological correlates prolonged sleep deprivation rats science 221 182 184 1983isimedline ross r miell j freeman e jones j matthews d preece m buchanan c critically ill patients high basal growth hormone levels attenuated oscillatory activity associated low levels insulin like growth factor clin endocrinol oxf 35 45 54 1991 sassin jf parker dc mace jw gotlin rw johnson lc rossman lg human growth hormone release relation slow wave sleep sleep walking cycles science 165 513 515 1969isimedline sato m murao k niimi m tamaki m takahara j effects long term infusion growth hormone gh releasing factor pulsatile gh secretion male rat life sci 54 79 86 1994crossrefisimedline satoh n ogawa y katsuura g numata y tsuji hayase m ebihara k masuzaki h hosoda k yoshimasa y nakao k sympathetic activation leptin via ventromedial hypothalamus leptin induced increase catecholamine secretion diabetes 48 1787 1793 1999abstract scheen aj byrne mm plat l leproult r van cauter e relationships sleep quality glucose regulation normal humans j physiol endocrinol metab 271 e261 e270 1996abstractfree full text schuld blum wf uhr m haack m kraus holsboer f pollmacher reduced leptin levels human narcolepsy neuroendocrinology 72 195 198 2000crossrefisimedline silva je larsen pr interrelationships among thyroxine growth hormone sympathetic nervous system regulation 5 iodothyronine deiodinase rat brown adipose tissue j clin invest 77 1214 1223 1986isimedline spiegel k laproult r copinschi g van cauter e impact sleep length 24 h leptin profile abstract sleep 24 a74 2001 szymusiak r satinoff e maximal rem sleep time defines narrower thermoneutral zone minimal metabolic rate physiol behav 26 687 690 1981crossrefisimedline takahashi y kipnis dm daughaday wh growth hormone secretion sleep j clin invest 47 2079 2090 1968isimedline tannenbaum g martin j evidence endogenous ultradian rhythm governing growth hormone secretion rat endocrinology 98 562 570 1976abstract tannenbaum gs gurd w lapointe m leptin potent stimulator spontaneous pulsatile growth hormone gh secretion gh response gh releasing hormone endocrinology 139 3871 3875 1998abstractfree full text terry lc saunders audet j willoughby jo brazeau p martin jb physiologic secretion growth hormone prolactin male female rats clin endocrinol oxf 6 19s 28s 1977medline thissen jp underwood le ketelslegers jm regulation insulin like growth factor starvation injury nutr rev 57 167 176 1999isimedline toppila j alanko l asikainen m tobler stenberg d porkka heiskanen sleep deprivation increases somatostatin growth hormone releasing hormone messenger rna rat hypothalamus j sleep res 6 171 178 1997crossrefisimedline tyler db marx w goodman j effect prolonged wakefulness urinary excretion 17 ketosteroids proc soc exp biol med 62 38 40 1946 utiger rd thyrotropin releasing hormone thyrotropin secretion j lab clin med 109 327 335 1987isimedline van cauter e estimating false positive false negative errors analyses hormonal pulsatility j physiol endocrinol metab 254 e786 e794 1988abstractfree full text van cauter e kerkhofs m caufriez van onderbergen thorner mo copinschi g quantitative estimation growth hormone secretion normal man reproducibility relation sleep time day j clin endocrinol metab 74 1441 1450 1992abstract van cauter e spiegel k hormones metabolism sleep sleep science integrating basic research clinical practice edited schwartz wj basel karger 1997 p 144 174 van haasteren ga linkels e klootwijk w van toor h rondeel jm themmen ap de jong fh valentijn k vaudry h bauer k visser tj de greef wj starvation induced changes hypothalamic content prothyrotrophin releasing hormone protrh mrna hypothalamic release protrh derived peptides role adrenal gland j endocrinol 145 143 153 1995abstract vila r adan c grasa mm masanes rm esteve m cabot c fernandez lopez ja remesar x alemany m effect food deprivation rat plasma estrone fatty acid esters diabetes obes metab 1 353 356 1995crossref von treuer k norman tr armstrong sm overnight human plasma melatonin cortisol prolactin tsh conditions normal sleep sleep deprivation sleep recovery j pineal res 20 7 14 1996isimedline watanabe h habu leptin regulates growth hormone releasing factor somatostatin alpha melanocyte stimulating hormone neuropeptide y release rat hypothalamus vivo relation growth hormone secretion j neurosci 22 6265 6271 2002abstractfree full text watanabe h schioth hb suda stimulation prolactin secretion chronic acute administration leptin rat brain res 887 426 431 2000crossrefisimedline zhang sq inoue kimura m sleep promoting activity prolactin releasing peptide prrp rat neuroreport 12 3173 3176 2001crossrefisimedline
0.119480975.15905320.html.plaintext.txt	0	sex difference response melanin concentrating hormone neurons lateral hypothalamic area glucose revealed expression phosphorylated cyclic adenosine 35 monophosphate response element binding protein kazutaka mogi toshiya funabashi dai mitsushima hiroko hagiwara fukuko kimura
0.119480975.15905320.html.plaintext.txt	1	department neuroendocrinology km tf dm hh fk yokohama city university graduate school medicine kanazawa ku yokohama 236 0004 international university health welfare fk amity nogizaka minamiaoyama minato ku tokyo 107 0062 japan
0.119480975.15905320.html.plaintext.txt	2	address correspondence requests reprints dr toshiya funabashi department neuroendocrinology yokohama city university graduate school medicine 3 9 fukuura kanazawa ku yokohama 236 0004 japan e mail toshiyaatmedyokohama cuacjp u d
0.119480975.15905320.html.plaintext.txt	3	address correspondence requests reprints dr toshiya funabashi department neuroendocrinology yokohama city university graduate school medicine 3 9 fukuura kanazawa ku yokohama 236 0004 japan e mail toshiyaatmedyokohama cuacjp u d
0.119480975.15905320.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references sex differences feeding behavior rats looked possible sex difference response glucose melanin concentrating hormone mch neurons lateral hypothalamic area using phosphorylated camp response element binding protein pcreb marker neural activity intact male rats female rats diestrus 2 proestrus estrus fed normally fasted 48 h injected saline glucose 400 mgkg thereafter preparations subjected immunohistochemical processing double staining mch pcreb fasting increased ratio mch neurons pcreb double stained cells male female rats fasted rats glucose injection decreased ratio double stained cells promptly females males magnitude decrease caused glucose greater proestrus estrus diestrus 2 gonadectomy males enhanced females attenuated response mch neurons glucose testosterone estrogen replacement males females respectively restored response mch neurons glucose demonstrated sex differences response mch neurons glucose correlated well gonadal steroid milieu thus mch neurons may play important role sex differences feeding behavior
0.119480975.15905320.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references sex differences feeding behavior rats looked possible sex difference response glucose melanin concentrating hormone mch neurons lateral hypothalamic area using phosphorylated camp response element binding protein pcreb marker neural activity intact male rats female rats diestrus 2 proestrus estrus fed normally fasted 48 h injected saline glucose 400 mgkg thereafter preparations subjected immunohistochemical processing double staining mch pcreb fasting increased ratio mch neurons pcreb double stained cells male female rats fasted rats glucose injection decreased ratio double stained cells promptly females males magnitude decrease caused glucose greater proestrus estrus diestrus 2 gonadectomy males enhanced females attenuated response mch neurons glucose testosterone estrogen replacement males females respectively restored response mch neurons glucose demonstrated sex differences response mch neurons glucose correlated well gonadal steroid milieu thus mch neurons may play important role sex differences feeding behavior
0.119480975.15905320.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references sex differences feeding behavior long recognized many species example analyses spontaneous patterns feeding shown size single meal smaller females males total volume daily food intake also smaller females males 1 2 addition size single meal varies estrous cycle decreasing around time ovulation females including humans 1 3 4 although sex differences attributable gonadal steroid hormones testosterone andor estrogen 5 6 7 8 9 neural mechanism still unclear example although cholecystokinin reported involved estrogen induced decrease food intake 10 still controversy whether cholecystokinin mediates estrogen induced anorexia 11 12 also known whether cholecystokinin mediates testosterone induced hyperphagia
0.119480975.15905320.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references sex differences feeding behavior long recognized many species example analyses spontaneous patterns feeding shown size single meal smaller females males total volume daily food intake also smaller females males 1 2 addition size single meal varies estrous cycle decreasing around time ovulation females including humans 1 3 4 although sex differences attributable gonadal steroid hormones testosterone andor estrogen 5 6 7 8 9 neural mechanism still unclear example although cholecystokinin reported involved estrogen induced decrease food intake 10 still controversy whether cholecystokinin mediates estrogen induced anorexia 11 12 also known whether cholecystokinin mediates testosterone induced hyperphagia
0.119480975.15905320.html.plaintext.txt	8	recent studies identified distinct neurons lateral hypothalamic area lha containing melanin concentrating hormone mch neurons 13 generate hunger 14 15 neuropeptide y npy produced neurons arcuate nucleus hypothalamus 16 another neuropeptide prominently induces feeding 17 18 hypothalamic circuit lha arcuate nucleus thus important component central system controlling feeding behavior 19 circuit judging studies genetically disrupted orexigenic neuropeptides mch neurons lha play key role mice lacking gene encoding mch lean 20 whereas mice overexpressing mch gene susceptible obesity 21 also suggested mch neurons involved glucosensing system hypothalamic mch mrna levels increased hypoglycemic conditions fasting insulin injection 2 deoxy d glucose treatment 14 22 23 contrast mch mice lacking gene encoding prepro orexin npy display normal growth 24 25 26
0.119480975.15905320.html.plaintext.txt	9	recent studies identified distinct neurons lateral hypothalamic area lha containing melanin concentrating hormone mch neurons 13 generate hunger 14 15 neuropeptide y npy produced neurons arcuate nucleus hypothalamus 16 another neuropeptide prominently induces feeding 17 18 hypothalamic circuit lha arcuate nucleus thus important component central system controlling feeding behavior 19 circuit judging studies genetically disrupted orexigenic neuropeptides mch neurons lha play key role mice lacking gene encoding mch lean 20 whereas mice overexpressing mch gene susceptible obesity 21 also suggested mch neurons involved glucosensing system hypothalamic mch mrna levels increased hypoglycemic conditions fasting insulin injection 2 deoxy d glucose treatment 14 22 23 contrast mch mice lacking gene encoding prepro orexin npy display normal growth 24 25 26
0.119480975.15905320.html.plaintext.txt	10	probable sex differences feeding behavior least part attributable sex differences neurons involved feeding behavior mch neurons lha play important role regulation feeding behavior hypothesized might sex difference activity mch neurons lha fasting andor glucose injection support view hypothalamic mch neurons suggested involved estrogen induced weight loss male rats 27 therefore examined response mch neurons iv injection glucose 48 h fasting adult male female rats using expression phosphorylated camp response element binding protein pcreb immunoreactivity marker neural activity assumption sex difference mch neurons existed also examined whether could affected gonadal steroid hormones testosterone andor estrogen
0.119480975.15905320.html.plaintext.txt	11	probable sex differences feeding behavior least part attributable sex differences neurons involved feeding behavior mch neurons lha play important role regulation feeding behavior hypothesized might sex difference activity mch neurons lha fasting andor glucose injection support view hypothalamic mch neurons suggested involved estrogen induced weight loss male rats 27 therefore examined response mch neurons iv injection glucose 48 h fasting adult male female rats using expression phosphorylated camp response element binding protein pcreb immunoreactivity marker neural activity assumption sex difference mch neurons existed also examined whether could affected gonadal steroid hormones testosterone andor estrogen
0.119480975.15905320.html.plaintext.txt	12	present study used pcreb marker neural activity increased generally used c fos increase expression c fos needs transcription andor translation occur 28 takes long time see changes would difficult examine acute changes response glucose contrast creb constitutively expressed transcription factor immediately activated phosphorylation via camp calcium dependent cascade 29 30 thus thought pcreb suitable marker examine neural activity changes within short period response dynamic changes blood glucose concentrations
0.119480975.15905320.html.plaintext.txt	13	present study used pcreb marker neural activity increased generally used c fos increase expression c fos needs transcription andor translation occur 28 takes long time see changes would difficult examine acute changes response glucose contrast creb constitutively expressed transcription factor immediately activated phosphorylation via camp calcium dependent cascade 29 30 thus thought pcreb suitable marker examine neural activity changes within short period response dynamic changes blood glucose concentrations
0.119480975.15905320.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references animals adult male female wistar rats charles river laboratories yokohama japan maintained constant temperature 24 26 c controlled lighting conditions lights 0500 1900 h food water available ad libitum daily vaginal smears taken female rats exhibiting two consecutive 4 d estrous cycles used experiments 1 2 forty eight hours saline glucose injection silicone cannula iv injection implanted right atrium rats ether anesthesia procedure interfere estrous cycle number rats used group indicated figures animal housing surgical procedures accord guidelines laid institutional animal care use committee yokohama city university school medicine
0.119480975.15905320.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references animals adult male female wistar rats charles river laboratories yokohama japan maintained constant temperature 24 26 c controlled lighting conditions lights 0500 1900 h food water available ad libitum daily vaginal smears taken female rats exhibiting two consecutive 4 d estrous cycles used experiments 1 2 forty eight hours saline glucose injection silicone cannula iv injection implanted right atrium rats ether anesthesia procedure interfere estrous cycle number rats used group indicated figures animal housing surgical procedures accord guidelines laid institutional animal care use committee yokohama city university school medicine
0.119480975.15905320.html.plaintext.txt	16	determination blood glucose insulin concentrations determine changes blood glucose insulin concentrations glucose injection 400 mgkg intact males orchidectomized orx males females proestrus diestrus 2 ovariectomized ovx females implanted silicone cannula right atrium ether anesthesia male female rats castrated 4 wk experiment cannula implantation fasted 48 h injected 400 mgkg glucose dissolved 200 microl saline first blood sampling 100 microl control rats injected volume saline thereafter blood sampled 5 10 15 30 60 120 min injection though cannula equal volume heparinized saline 2 iuml injected sampling another control blood samples obtained intact males orx males females proestrus ovx females fasted blood glucose concentrations determined instant blood glucose assay apparatus accu chek comfort roche tokyo japan serum insulin concentrations measured elisa kit morinaga institute biological sciences yokohama japan
0.119480975.15905320.html.plaintext.txt	17	determination blood glucose insulin concentrations determine changes blood glucose insulin concentrations glucose injection 400 mgkg intact males orchidectomized orx males females proestrus diestrus 2 ovariectomized ovx females implanted silicone cannula right atrium ether anesthesia male female rats castrated 4 wk experiment cannula implantation fasted 48 h injected 400 mgkg glucose dissolved 200 microl saline first blood sampling 100 microl control rats injected volume saline thereafter blood sampled 5 10 15 30 60 120 min injection though cannula equal volume heparinized saline 2 iuml injected sampling another control blood samples obtained intact males orx males females proestrus ovx females fasted blood glucose concentrations determined instant blood glucose assay apparatus accu chek comfort roche tokyo japan serum insulin concentrations measured elisa kit morinaga institute biological sciences yokohama japan
0.119480975.15905320.html.plaintext.txt	18	experiment 1 sex difference activity mch neurons determine whether sex difference activity mch neurons male female rats fed normally injected iv 200 microl saline fedsaline group male female rats fasted 48 h given iv injection 200 microl saline fastsaline group glucose fastglucose group 400 mgkg dissolved 200 microl saline 1000 1200 h injection made silicon cannula right atrium described dose glucose used present study based previous study showed treatment could reverse inhibition pulsatile lh secretion caused insulin induced hypoglycemia 31 females three groups composed rats diestrus 2 d2 group proestrus p group estrus e group prepared check effect stage estrous cycle rats d2 group fasted day estrus p group fasted day last diestrus 1 e group fasted day last diestrus 2 thus 12 groups rats four groups containing three treatment groups prepared processed blindly immunohistochemistry
0.119480975.15905320.html.plaintext.txt	19	experiment 1 sex difference activity mch neurons determine whether sex difference activity mch neurons male female rats fed normally injected iv 200 microl saline fedsaline group male female rats fasted 48 h given iv injection 200 microl saline fastsaline group glucose fastglucose group 400 mgkg dissolved 200 microl saline 1000 1200 h injection made silicon cannula right atrium described dose glucose used present study based previous study showed treatment could reverse inhibition pulsatile lh secretion caused insulin induced hypoglycemia 31 females three groups composed rats diestrus 2 d2 group proestrus p group estrus e group prepared check effect stage estrous cycle rats d2 group fasted day estrus p group fasted day last diestrus 1 e group fasted day last diestrus 2 thus 12 groups rats four groups containing three treatment groups prepared processed blindly immunohistochemistry
0.119480975.15905320.html.plaintext.txt	20	groups rats killed 5 min saline glucose injection iv injection overdose pentobarbital 100 mgkg perfusion cardiac ventricle quickly started 2 paraformaldehyde 4 acrolein phosphate buffer pb ph 75 approximately 4 c perfusion brains removed cranium fixed overnight 4 c pb containing 2 paraformaldehyde incubated overnight 4 c 30 sucrose pb brains frozen powdered dry ice stored 70 c immunohistochemical processing
0.119480975.15905320.html.plaintext.txt	21	groups rats killed 5 min saline glucose injection iv injection overdose pentobarbital 100 mgkg perfusion cardiac ventricle quickly started 2 paraformaldehyde 4 acrolein phosphate buffer pb ph 75 approximately 4 c perfusion brains removed cranium fixed overnight 4 c pb containing 2 paraformaldehyde incubated overnight 4 c 30 sucrose pb brains frozen powdered dry ice stored 70 c immunohistochemical processing
0.119480975.15905320.html.plaintext.txt	22	experiment 2 time dependent changes activity mch neurons glucose injection examine time dependent changes activity mch neurons iv glucose injection male rats fasted 48 h injected iv glucose 400 mgkg dissolved 200 microl saline 1000 1200 h rats killed 15 30 60 min glucose injection fastglucose 15 min group fastglucose 30 min group fastglucose 60 min group iv injection overdose pentobarbital female rats diestrus 2 fasted 48 h day estrus similarly killed subsequent procedures obtain brains described experiment 1
0.119480975.15905320.html.plaintext.txt	23	experiment 2 time dependent changes activity mch neurons glucose injection examine time dependent changes activity mch neurons iv glucose injection male rats fasted 48 h injected iv glucose 400 mgkg dissolved 200 microl saline 1000 1200 h rats killed 15 30 60 min glucose injection fastglucose 15 min group fastglucose 30 min group fastglucose 60 min group iv injection overdose pentobarbital female rats diestrus 2 fasted 48 h day estrus similarly killed subsequent procedures obtain brains described experiment 1
0.119480975.15905320.html.plaintext.txt	24	experiment 3 effects testosterone estrogen response mch neurons glucose determine whether gonadal steroid hormones affected response mch neurons glucose male female rats castrated ether anesthesia used experiment 4 wk later orx ovx rats implanted sc silicone tube inside diameter 20 mm outside diameter 30 mm length 30 mm containing 100 testosterone crystals orxt group ovxt group silicone tube inside diameter 20 mm outside diameter 30 mm length 15 mm containing 20 17ss estradiol crystals orxe2 group ovxe2 group silicone tube inside diameter 20 mm outside diameter 30 mm length 30 mm containing cholesterol alone orx group ovx group control silicone tubes previously soaked saline 24 h facilitate rapid hormone release shown previously tube containing dose 17ss estradiol produced serum 17ss estradiol concentration equivalent observed proestrus intact female rats 32 tube containing testosterone produced serum testosterone concentration equivalent observed intact male rats 33 implantation tubes rats fed normally rats fasted 48 h normally fed rats injected iv 200 microl saline fedsaline group fasted rats injected iv 200 microl saline fastsaline group glucose fastglucose group 400 mgkg dissolved 200 microl saline 1000 1200 h rats killed 5 min iv injection thus total 18 groups rats six groups containing three treatment groups orx orxt orxe2 ovx ovxt ovxe2 groups x fedsaline fastsaline fastglucose groups prepared subsequent procedures obtain brains described experiment 1
0.119480975.15905320.html.plaintext.txt	25	experiment 3 effects testosterone estrogen response mch neurons glucose determine whether gonadal steroid hormones affected response mch neurons glucose male female rats castrated ether anesthesia used experiment 4 wk later orx ovx rats implanted sc silicone tube inside diameter 20 mm outside diameter 30 mm length 30 mm containing 100 testosterone crystals orxt group ovxt group silicone tube inside diameter 20 mm outside diameter 30 mm length 15 mm containing 20 17ss estradiol crystals orxe2 group ovxe2 group silicone tube inside diameter 20 mm outside diameter 30 mm length 30 mm containing cholesterol alone orx group ovx group control silicone tubes previously soaked saline 24 h facilitate rapid hormone release shown previously tube containing dose 17ss estradiol produced serum 17ss estradiol concentration equivalent observed proestrus intact female rats 32 tube containing testosterone produced serum testosterone concentration equivalent observed intact male rats 33 implantation tubes rats fed normally rats fasted 48 h normally fed rats injected iv 200 microl saline fedsaline group fasted rats injected iv 200 microl saline fastsaline group glucose fastglucose group 400 mgkg dissolved 200 microl saline 1000 1200 h rats killed 5 min iv injection thus total 18 groups rats six groups containing three treatment groups orx orxt orxe2 ovx ovxt ovxe2 groups x fedsaline fastsaline fastglucose groups prepared subsequent procedures obtain brains described experiment 1
0.119480975.15905320.html.plaintext.txt	26	immunohistochemistry thirty micrometer frozen coronal sections cut bright cryostat jencons ltd leighton buzzard uk every fourth section used study sections incubated 1 sodium borohydride pbs 03 h2o2 20 methanol pbs incubated overnight rabbit polyclonal antibody pcreb diluted 1900 cell signaling technology beverly ma pbs containing 15 normal goat serum 01 triton x 100 next day incubated biotinylated antirabbit igg diluted 1200 pbs containing 15 normal goat serum 005 triton x 100 thereafter incubated streptavidin biotin peroxidase complex vectastain elite abc kit vector laboratories inc burlingame ca bound peroxidase visualized incubating sections 30 min 005 33 diaminobenzidine h2o2 double staining sections incubated overnight rabbit polyclonal antibody mch diluted 11800 phoenix pharmaceuticals belmont ca pbs containing 15 normal goat serum 01 triton x 100 additionally incubated biotinylated antirabbit igg diluted 1200 pbs containing 15 normal goat serum 005 triton x 100 cy3 labeled streptavidin amersham biosciences little chalfont uk finally mounted glass slides dehydrated graded alcohol cleared xylene coverslipped permount fisher scientific fairlawn nj total eight series immunohistochemical procedures performed incubation time 33 diaminobenzidine staining experimental conditions checked carefully reproducibility
0.119480975.15905320.html.plaintext.txt	27	immunohistochemistry thirty micrometer frozen coronal sections cut bright cryostat jencons ltd leighton buzzard uk every fourth section used study sections incubated 1 sodium borohydride pbs 03 h2o2 20 methanol pbs incubated overnight rabbit polyclonal antibody pcreb diluted 1900 cell signaling technology beverly ma pbs containing 15 normal goat serum 01 triton x 100 next day incubated biotinylated antirabbit igg diluted 1200 pbs containing 15 normal goat serum 005 triton x 100 thereafter incubated streptavidin biotin peroxidase complex vectastain elite abc kit vector laboratories inc burlingame ca bound peroxidase visualized incubating sections 30 min 005 33 diaminobenzidine h2o2 double staining sections incubated overnight rabbit polyclonal antibody mch diluted 11800 phoenix pharmaceuticals belmont ca pbs containing 15 normal goat serum 01 triton x 100 additionally incubated biotinylated antirabbit igg diluted 1200 pbs containing 15 normal goat serum 005 triton x 100 cy3 labeled streptavidin amersham biosciences little chalfont uk finally mounted glass slides dehydrated graded alcohol cleared xylene coverslipped permount fisher scientific fairlawn nj total eight series immunohistochemical procedures performed incubation time 33 diaminobenzidine staining experimental conditions checked carefully reproducibility
0.119480975.15905320.html.plaintext.txt	28	histological analysis counting performed investigator blind experimental conditions expectations initially used every fourth section lha thus approximately 10 sectionsrat stained mch pcreb antibodies using fluorescence microscope five sections per rat finally selected counting mch immunoreactive cells mch neurons pcreb immunoreactive cells pcreb cells dorsolateral hypothalamic group lha distribution mch neurons varies anterior posterior diencepalon group lha comprises numerically predominant grouping mch expressing cells diencephalon 13 sections carefully matched across animals experimental groups number mch neurons lha square region 17 x 10 mm counted bilaterally fluorescence microscope 20 x 10 magnification mch cells nucleus clearly visible surrounded fluorescent cytoplasmic staining counted sections pcreb cells also observed number mch neurons expressing pcreb immunoreactive nuclei double stained neurons fig 1 counted cells defined double stained mch pcreb blue black nucleus surrounded fluorescent cytoplasm 20 x 10 magnification average ratio percentage number double stained neurons number mch neurons rat calculated average number mch neurons per section rat average percentage double stained neurons per section rat used statistical analysis male rats female rats p group experiment 1 counted number pcreb cells lha
0.119480975.15905320.html.plaintext.txt	29	histological analysis counting performed investigator blind experimental conditions expectations initially used every fourth section lha thus approximately 10 sectionsrat stained mch pcreb antibodies using fluorescence microscope five sections per rat finally selected counting mch immunoreactive cells mch neurons pcreb immunoreactive cells pcreb cells dorsolateral hypothalamic group lha distribution mch neurons varies anterior posterior diencepalon group lha comprises numerically predominant grouping mch expressing cells diencephalon 13 sections carefully matched across animals experimental groups number mch neurons lha square region 17 x 10 mm counted bilaterally fluorescence microscope 20 x 10 magnification mch cells nucleus clearly visible surrounded fluorescent cytoplasmic staining counted sections pcreb cells also observed number mch neurons expressing pcreb immunoreactive nuclei double stained neurons fig 1 counted cells defined double stained mch pcreb blue black nucleus surrounded fluorescent cytoplasm 20 x 10 magnification average ratio percentage number double stained neurons number mch neurons rat calculated average number mch neurons per section rat average percentage double stained neurons per section rat used statistical analysis male rats female rats p group experiment 1 counted number pcreb cells lha
0.119480975.15905320.html.plaintext.txt	30	view larger version 96k fig 1 representative photographs double stained neurons lha fluorescent mch immunoreactive neurons top arrowheads pcreb immunoreactive nuclei bottom arrowheads tissue section magnification x400 fastsaline group left panels fastglucose group right panels male female p rats experiment 1 shown
0.119480975.15905320.html.plaintext.txt	31	data analyzed one way anova followed fisher protected least significant difference post hoc test comparisons treatment groups animal group differences considered significant p 005
0.119480975.15905320.html.plaintext.txt	32	data analyzed one way anova followed fisher protected least significant difference post hoc test comparisons treatment groups animal group differences considered significant p 005
0.119480975.15905320.html.plaintext.txt	33	results top abstract introduction materials methods results discussion references control ie fasted intact males orx males females proestrus ovx females blood glucose insulin levels 1038 plus minus 15 mgdl n 4 1273 plus minus 54 pgml 1074 plus minus 24 n 5 mgdl 1433 plus minus 121 pgml 1013 plus minus 24 mgdl n 4 1306 plus minus 113 pgml 1050 plus minus 27 mgdl n 4 1323 plus minus 143 pgml respectively significant differences glucose f313 0811 p 01 insulin f313 0398 p 05 observed shown table 1 one way anova saline injected group showed significant effect saline injection blood glucose concentrations male group f621 0811 p 05 orx group f621 061 p 05 p group f621 161 p 01 ovx group f628 229 p 005 suggesting control procedure used present study affect blood glucose concentrations however blood glucose concentrations significantly increased glucose injection groups one way anova time point showed significant difference blood glucose concentrations among groups table 2 addition area curve auc calculated rat significantly different among groups f419 0562 p 05 suggests changes blood glucose concentrations glucose injection uniform among groups insulin concentrations also significantly increased glucose injection groups one way anova time point showed significant difference insulin concentrations among groups table 2 insulin concentrations intact male orx groups significantly higher d2 p ovx groups time points glucose injection fact auc insulin significantly different among groups f419 909 p 0002 post hoc comparison showed auc intact male orx groups significantly greater d2 p ovx groups p 005 result suggested insulin secretion response glucose male rats greater female rats good accord previous reports sex difference glucose tolerance 34 35
0.119480975.15905320.html.plaintext.txt	34	view table table 1 changes blood glucose concentrations milligrams per deciliter saline injection
0.119480975.15905320.html.plaintext.txt	35	view table table 2 changes blood glucose insulin concentrations 400 mgkg glucose injection
0.119480975.15905320.html.plaintext.txt	36	rats overall distribution mch neurons red fluorescent cytoplasm good accord previous report 13 experiments average number mch neurons per section approximately 500 groups number vary experiment data shown intact male p groups number pcreb expressing cells slightly larger mch neurons expressing pcreb table 3 changes number pcreb cells similar mch neurons expressing pcreb indicated results suggest mch neurons population cells expressing pcreb lha
0.119480975.15905320.html.plaintext.txt	37	rats overall distribution mch neurons red fluorescent cytoplasm good accord previous report 13 experiments average number mch neurons per section approximately 500 groups number vary experiment data shown intact male p groups number pcreb expressing cells slightly larger mch neurons expressing pcreb table 3 changes number pcreb cells similar mch neurons expressing pcreb indicated results suggest mch neurons population cells expressing pcreb lha
0.119480975.15905320.html.plaintext.txt	38	view table table 3 changes number pcreb expressing cells lateral hypothalamic area male rats female rats proestrus
0.119480975.15905320.html.plaintext.txt	39	experiment 1 female rats e d2 groups exhibited regular 4 d estrous cycle monitored vaginal smear experiments almost 40 female rats fasted 48 h p group however diestrus like vaginal smear day supposed proestrus data rats showing perturbed cycle discarded rats showing proestrous vaginal smear included p group
0.119480975.15905320.html.plaintext.txt	40	experiment 1 female rats e d2 groups exhibited regular 4 d estrous cycle monitored vaginal smear experiments almost 40 female rats fasted 48 h p group however diestrus like vaginal smear day supposed proestrus data rats showing perturbed cycle discarded rats showing proestrous vaginal smear included p group
0.119480975.15905320.html.plaintext.txt	41	fedsaline groups pcreb cells blue black nuclei scattered lha arcuate nucleus hypothalamus data shown ratio double stained neurons approximately 10 fig 2
0.119480975.15905320.html.plaintext.txt	42	view larger version 33k fig 2 effects 48 h fasting glucose injection 48 h fasting ratio percentage mch immunoreactive neurons expressing pcreb immunoreactive nuclei experiment 1 groups rats examined 5 min saline glucose injection columns vertical lines indicate mean sem respectively numbers parentheses refer number rats numbers columns body weights mean plus minus sem time testing p 005 vs treatment groups see text details statistics d2 diestrus 2 p proestrus e estrus
0.119480975.15905320.html.plaintext.txt	43	fastsaline groups large number pcreb cells observed lha arcuate nucleus hypothalamus data shown ratio double stained neurons approximately 40 fig 2 one way anova showed significant effect treatment ratio double stained neurons animal group intact male group f212 745 p 001 p group f212 935 p 001 e group f212 553 p 005 d2 group f211 1138 p 001 groups post hoc comparison showed significantly greater ratio double stained neurons fastsaline group fedsaline group fig 2 p 005 results indicated 48 h fasting significantly increased ratio double stained neurons animal groups
0.119480975.15905320.html.plaintext.txt	44	fastglucose group number pcreb cells lha varied among animal groups data shown post hoc comparison male group showed significantly greater ratio double stained neurons fastglucose group fedsaline group p 005 significant difference fastglucose group fastsaline group indicating glucose injection affect increase ratio double stained neurons caused fasting intact male rats fig 2 contrast pcreb cells relatively lha female groups glucose injection data shown post hoc comparisons female groups showed significantly smaller ratio double stained neurons fastglucose group fastsaline group fig 2 p 005 p e groups ratio double stained neurons differ fastglucose group fedsaline group indicating glucose injection completely blocked fasting induced increase ratio double stained neurons fig 2 d2 group contrast ratio double stained neurons significantly greater fastglucose group fedsaline group fig 2 p 005 indicating 48 h fasting glucose injection less effective d2 group p e groups
0.119480975.15905320.html.plaintext.txt	45	fastglucose group number pcreb cells lha varied among animal groups data shown post hoc comparison male group showed significantly greater ratio double stained neurons fastglucose group fedsaline group p 005 significant difference fastglucose group fastsaline group indicating glucose injection affect increase ratio double stained neurons caused fasting intact male rats fig 2 contrast pcreb cells relatively lha female groups glucose injection data shown post hoc comparisons female groups showed significantly smaller ratio double stained neurons fastglucose group fastsaline group fig 2 p 005 p e groups ratio double stained neurons differ fastglucose group fedsaline group indicating glucose injection completely blocked fasting induced increase ratio double stained neurons fig 2 d2 group contrast ratio double stained neurons significantly greater fastglucose group fedsaline group fig 2 p 005 indicating 48 h fasting glucose injection less effective d2 group p e groups
0.119480975.15905320.html.plaintext.txt	46	experiment 2 data experiment 2 analyzed data experiment 1 fastsaline fastglucose groups intact male rats d2 group female rats fig 3
0.119480975.15905320.html.plaintext.txt	47	view larger version 22k fig 3 time dependent changes ratio percentage mch immunoreactive cells expressing pcreb immunoreactive nuclei fastsaline fastglucose groups male female d2 rats experiment 2 groups rats fasted 48 h examined 5 min saline injection 15 30 60 min glucose injection columns vertical lines indicate mean sem respectively numbers parentheses refer number rats numbers columns body weights mean plus minus sem time testing p 005 vs fastsaline groups
0.119480975.15905320.html.plaintext.txt	48	intact male rats pcreb cells lha fastglucose 15 min group fastglucose 30 min group ratio double stained neurons less 10 fig 3 upper panel number pcreb cells relatively large fastglucose 60 min group one way anova showed significant effect treatment ratio double stained neurons intact male rats f420 545 p 001 post hoc comparison intact male rats showed significantly smaller ratio double stained neurons fastglucose 15 min group fastglucose 30 min group fastsaline group p 005 results indicated glucose injection significantly decreased ratio double stained neurons 15 30 min injection intact male rats effect disappeared 60 min injection
0.119480975.15905320.html.plaintext.txt	49	d2 group female rats pcreb cells lha fastglucose 15 min group ratio double stained neurons approximately 10 fig 3 lower panel number pcreb cells relatively large fastglucose 30 min group fastglucose 60 min group one way anova showed significant effect treatment ratio double stained neurons d2 group f419 1130 p 001 post hoc comparison d2 group showed significantly smaller ratio double stained neurons fastglucose 5 min group fastglucose 15 min group fastsaline group p 005 results indicated glucose injection significantly decreased ratio double stained neurons 5 15 min injection female rats effect disappeared 30 min injection
0.119480975.15905320.html.plaintext.txt	50	experiment 3 fedsaline groups fastsaline groups ratios double stained neurons approximately 10 40 respectively fig 4 one way anova showed significant effect treatment ratio double stained neurons animal group orx group f210 1514 p 0001 orxt group f210 461 p 005 orxe2 group f212 3814 p 00001 ovx group f29 662 p 005 ovxt group f211 1103 p 0005 ovxe2 group f29 641 p 005 animal groups post hoc comparison showed significantly greater ratio double stained neurons fastsaline group fedsaline group fig 4 p 005 ratio double stained neurons fedsaline groups fastsaline groups experiment 3 comparable experiment 1 results indicated 48 h fasting significantly increased ratio double stained neurons regardless presence absence gonadal steroid hormones
0.119480975.15905320.html.plaintext.txt	51	view larger version 24k fig 4 effects testosterone estrogen ratio percentage mch immunoreactive neurons expressing pcreb immunoreactive nuclei fedsaline fastsaline fastglucose groups experiment 3 groups rats examined 5 min saline glucose injection columns vertical lines indicate mean sem respectively numbers parentheses refer number rats numbers columns body weights mean plus minus sem time testing p 005 vs treatment groups see text details statistics e2 implantation 17ss estradiol crystals implantation testosterone crystals
0.119480975.15905320.html.plaintext.txt	52	effects glucose injection varied among groups orx orxe2 groups post hoc comparisons showed ratio double stained neurons fastglucose group significantly smaller fastsaline group p 0001 ratio double stained neurons fastglucose group different fedsaline group p 05 orxt groups post hoc comparison showed ratio double stained neurons fastglucose group different fastsaline group fedsaline group p 05 results indicated orchidectomy estrogen replacement decreased ratio double stained neurons 5 min glucose injection testosterone replacement blocked orchidectomy induced decrease ratio double stained neurons male rats
0.119480975.15905320.html.plaintext.txt	53	effects glucose injection varied among groups orx orxe2 groups post hoc comparisons showed ratio double stained neurons fastglucose group significantly smaller fastsaline group p 0001 ratio double stained neurons fastglucose group different fedsaline group p 05 orxt groups post hoc comparison showed ratio double stained neurons fastglucose group different fastsaline group fedsaline group p 05 results indicated orchidectomy estrogen replacement decreased ratio double stained neurons 5 min glucose injection testosterone replacement blocked orchidectomy induced decrease ratio double stained neurons male rats
0.119480975.15905320.html.plaintext.txt	54	ovxt ovxe2 groups post hoc comparisons showed ratio double stained neurons fastglucose group significantly smaller fastsaline group p 005 ratio double stained neurons fastglucose group different fedsaline group p 05 ovx groups post hoc comparison showed ratio double stained neurons fastglucose group different fastsaline group p 05 ratio double stained neurons fastglucose group significantly larger fedsaline group p 005 results indicated ovariectomy increased ratio double stained neurons 5 min glucose injection testosterone estrogen replacement blocked ovariectomy induced increase ratio double stained neurons female rats
0.119480975.15905320.html.plaintext.txt	55	ovxt ovxe2 groups post hoc comparisons showed ratio double stained neurons fastglucose group significantly smaller fastsaline group p 005 ratio double stained neurons fastglucose group different fedsaline group p 05 ovx groups post hoc comparison showed ratio double stained neurons fastglucose group different fastsaline group p 05 ratio double stained neurons fastglucose group significantly larger fedsaline group p 005 results indicated ovariectomy increased ratio double stained neurons 5 min glucose injection testosterone estrogen replacement blocked ovariectomy induced increase ratio double stained neurons female rats
0.119480975.15905320.html.plaintext.txt	56	discussion top abstract introduction materials methods results discussion references present study demonstrated sex differences response mch neurons glucose using expression pcreb marker neural activity fasting 48 h activated mch neurons similar manner male female rats inactivation mch neurons glucose 48 h fasting occurred rapidly female rats male rats sex differences could attributed gonadal steroid hormones including testosterone estrogen taking account orexigenic effect mch 14 15 glucostatic theory feeding 36 findings provide molecularneurotransmitter basis neurons controlled glucose lha suggest mch neurons lha play important role sex differences feeding behavior acting creb pathway 29 30
0.119480975.15905320.html.plaintext.txt	57	discussion top abstract introduction materials methods results discussion references present study demonstrated sex differences response mch neurons glucose using expression pcreb marker neural activity fasting 48 h activated mch neurons similar manner male female rats inactivation mch neurons glucose 48 h fasting occurred rapidly female rats male rats sex differences could attributed gonadal steroid hormones including testosterone estrogen taking account orexigenic effect mch 14 15 glucostatic theory feeding 36 findings provide molecularneurotransmitter basis neurons controlled glucose lha suggest mch neurons lha play important role sex differences feeding behavior acting creb pathway 29 30
0.119480975.15905320.html.plaintext.txt	58	although hypoglycemia caused treatments fasting insulin injection 2 deoxy d glucose injection increases expression hypothalamic mch mrna 14 22 23 little information second messenger system would stimulated hypoglycemic conditions example fos expression increased lha insulin induced hypoglycemia mch neurons expressed fos protein 22 37 thus unclear whether fos proteins involved control expression mch mrna lha hypoglycemia experiment 1 showed normal feeding conditions male female rats stages estrous cycle examined approximately 10 mch neurons expressed pcreb immunoreactive nuclei lha indicating small population mch neurons active lha however found fasting 48 h increased ratio double stained neurons approximately 40 sexes furthermore showed fasting induced increase independent presence testosterone estrogen first demonstration mch neurons express pcreb nuclei response fasting good accord results previous study showing fasting 48 h increased pcreb levels nuclear extracts rat hypothalamus although neurons expressed pcreb shown 38 analog camp agents increase levels endogenous camp promote phosphorylation creb 29 reported elicit vigorous feeding response microinjected lha 39 thus pcreb reliable marker activation mch neurons 48 h fasting phosphorylation creb probably promoted increase camp may contribute least part orexigenic activity mch neurons thus suggest sex difference fasting induced activation mch neurons
0.119480975.15905320.html.plaintext.txt	59	although hypoglycemia caused treatments fasting insulin injection 2 deoxy d glucose injection increases expression hypothalamic mch mrna 14 22 23 little information second messenger system would stimulated hypoglycemic conditions example fos expression increased lha insulin induced hypoglycemia mch neurons expressed fos protein 22 37 thus unclear whether fos proteins involved control expression mch mrna lha hypoglycemia experiment 1 showed normal feeding conditions male female rats stages estrous cycle examined approximately 10 mch neurons expressed pcreb immunoreactive nuclei lha indicating small population mch neurons active lha however found fasting 48 h increased ratio double stained neurons approximately 40 sexes furthermore showed fasting induced increase independent presence testosterone estrogen first demonstration mch neurons express pcreb nuclei response fasting good accord results previous study showing fasting 48 h increased pcreb levels nuclear extracts rat hypothalamus although neurons expressed pcreb shown 38 analog camp agents increase levels endogenous camp promote phosphorylation creb 29 reported elicit vigorous feeding response microinjected lha 39 thus pcreb reliable marker activation mch neurons 48 h fasting phosphorylation creb probably promoted increase camp may contribute least part orexigenic activity mch neurons thus suggest sex difference fasting induced activation mch neurons
0.119480975.15905320.html.plaintext.txt	60	also examined changes activity mch neurons glucose injection 48 h fasted rats experiment 1 found significant decrease ratio double stained neurons induced 5 min female rats stages estrous cycle examined contrast female rats mch neurons male rats failed respond glucose within 5 min additional time course studies experiment 2 demonstrated mch neurons male rats responded glucose 15 30 min glucose injection whereas female rats stage insensitive glucose mch neurons responded 5 15 min study found clear sex difference response mch neurons glucose response mch neurons glucose delayed male rats compared female rats due differences blood glucose concentrations sex difference blood glucose concentrations glucose injection intact male female rats furthermore due sex differences insulin secretion response glucose sex difference effect castration insulin secretion thus could explain results experiment 3 one possible reason delay decrease pcreb may sensitivity mch neurons glucose male rats less female rats thus mch neurons respond increase glucose concentrations blood resulting delay decrease pcreb according glucostatic theory increase glucose blood signal meal termination 33 dietary glucose may inactivate orexigenic activity mch neurons induce meal termination rapidly female rats male rats may account sex difference meal size smaller females males 1 2 although glucose sensing neurons may respond physiological changes blood glucose regulate integrative metabolic functions counterregulatory responses food intake metabolic rate 40 glucostatic theory sufficient explain complex regulation feeding behavior 41 glucose obviously one several peripheral metabolic signals involved regulation feeding behavior physiological conditions 42 hence speculate inactivation mch neurons metabolic signals feeding faster females males
0.119480975.15905320.html.plaintext.txt	61	also examined changes activity mch neurons glucose injection 48 h fasted rats experiment 1 found significant decrease ratio double stained neurons induced 5 min female rats stages estrous cycle examined contrast female rats mch neurons male rats failed respond glucose within 5 min additional time course studies experiment 2 demonstrated mch neurons male rats responded glucose 15 30 min glucose injection whereas female rats stage insensitive glucose mch neurons responded 5 15 min study found clear sex difference response mch neurons glucose response mch neurons glucose delayed male rats compared female rats due differences blood glucose concentrations sex difference blood glucose concentrations glucose injection intact male female rats furthermore due sex differences insulin secretion response glucose sex difference effect castration insulin secretion thus could explain results experiment 3 one possible reason delay decrease pcreb may sensitivity mch neurons glucose male rats less female rats thus mch neurons respond increase glucose concentrations blood resulting delay decrease pcreb according glucostatic theory increase glucose blood signal meal termination 33 dietary glucose may inactivate orexigenic activity mch neurons induce meal termination rapidly female rats male rats may account sex difference meal size smaller females males 1 2 although glucose sensing neurons may respond physiological changes blood glucose regulate integrative metabolic functions counterregulatory responses food intake metabolic rate 40 glucostatic theory sufficient explain complex regulation feeding behavior 41 glucose obviously one several peripheral metabolic signals involved regulation feeding behavior physiological conditions 42 hence speculate inactivation mch neurons metabolic signals feeding faster females males
0.119480975.15905320.html.plaintext.txt	62	currently know glucose acts mch neurons however judging electrophysiological study showing neurons lha respond changes glucose concentration vitro 43 direct effect glucose mch neurons likely effects afferent signals glucose sensors localized different central peripheral structures also likely 41 44 hypothalamus npy neurons arcuate nucleus shown glucose sensitive neurons vitro electrophysiological study 45 considering hypothalamic circuit involving lha arcuate nucleus 19 probable glucose affects mch neurons indirectly via npy neurons arcuate nucleus
0.119480975.15905320.html.plaintext.txt	63	currently know glucose acts mch neurons however judging electrophysiological study showing neurons lha respond changes glucose concentration vitro 43 direct effect glucose mch neurons likely effects afferent signals glucose sensors localized different central peripheral structures also likely 41 44 hypothalamus npy neurons arcuate nucleus shown glucose sensitive neurons vitro electrophysiological study 45 considering hypothalamic circuit involving lha arcuate nucleus 19 probable glucose affects mch neurons indirectly via npy neurons arcuate nucleus
0.119480975.15905320.html.plaintext.txt	64	also found present study response mch neurons glucose varied depending stage estrous cycle ie magnitude decrease number double stained neurons glucose injection greater proestrus estrus diestrus 2 additional time course study confirmed ratio double stained neurons diestrus 2 decreased 15 min glucose injection approximately 10 similar levels proestrus estrus 5 min glucose injection indicating response mch neurons glucose diestrus 2 delayed discussed decrease activity mch neurons related meal termination follows meal termination occurs rapidly proestrus estrus diestrus 2 support meal size smaller proestrus estrus diestrus 2 4 therefore mch neurons may also participate fluctuation feeding behavior estrous cycle
0.119480975.15905320.html.plaintext.txt	65	findings experiment 3 indicate sex difference mch neurons least part attributable presence gonadal steroid hormones adults presence testosterone males estrogen females critical male female type responses mch neurons glucose male rats found orchidectomy significantly enhanced response mch neurons glucose testosterone replacement attenuated effect orchidectomy decreased food intake 46 effect reversed testosterone replacement orx rats 7 47 48 speculate testosterone attenuates response mch neurons metabolic signals increases food intake males contrast estrogen replacement cause significant effect orchidectomy induced enhancement response glucose male rats result good accord report food intake orx rats relatively insensitive influence estrogen compared ovx rats 8 results present study male rats therefore suggest estrogen could longer enhance response mch neurons glucose orchidectomy caused response reach maximum
0.119480975.15905320.html.plaintext.txt	66	findings experiment 3 indicate sex difference mch neurons least part attributable presence gonadal steroid hormones adults presence testosterone males estrogen females critical male female type responses mch neurons glucose male rats found orchidectomy significantly enhanced response mch neurons glucose testosterone replacement attenuated effect orchidectomy decreased food intake 46 effect reversed testosterone replacement orx rats 7 47 48 speculate testosterone attenuates response mch neurons metabolic signals increases food intake males contrast estrogen replacement cause significant effect orchidectomy induced enhancement response glucose male rats result good accord report food intake orx rats relatively insensitive influence estrogen compared ovx rats 8 results present study male rats therefore suggest estrogen could longer enhance response mch neurons glucose orchidectomy caused response reach maximum
0.119480975.15905320.html.plaintext.txt	67	female rats ovariectomy attenuated response mch neurons glucose estrogen replacement prevented ovariectomy induced attenuation response results good accord previous studies ovariectomy adult female rats increased food intake 7 46 effect reversed estrogen replacement 6 thus easily hypothesized estrogen enhances response mch neurons metabolic signals females causes decreases food intake body weight support estrogen inhibited expression mch mrna lha female 49 male 27 rats contrast effect testosterone orx rats testosterone enhanced response mch neurons ovx rats estrogen effect testosterone ovx rats could explained postulating testosterone enhances response mch neurons converted estrogen support speculation suggested male rats reduced food intake weight gain seen high dose testosterone treatment due aromatization testosterone estrogen 8 light previous reports females sensitive effect estrogen food intake males 8 50 males sensitive effect testosterone food intake 47 50 present study indicates dominant effect testosterone response mch neurons females testosterone induced attenuation estrogen induced enhancement males contrast dominant effect testosterone response mch neurons estrogen induced enhancement testosterone induced attenuation hence present study may provide neural basis sex difference feeding behavior although mechanisms action estrogen testosterone need determined future studies
0.119480975.15905320.html.plaintext.txt	68	female rats ovariectomy attenuated response mch neurons glucose estrogen replacement prevented ovariectomy induced attenuation response results good accord previous studies ovariectomy adult female rats increased food intake 7 46 effect reversed estrogen replacement 6 thus easily hypothesized estrogen enhances response mch neurons metabolic signals females causes decreases food intake body weight support estrogen inhibited expression mch mrna lha female 49 male 27 rats contrast effect testosterone orx rats testosterone enhanced response mch neurons ovx rats estrogen effect testosterone ovx rats could explained postulating testosterone enhances response mch neurons converted estrogen support speculation suggested male rats reduced food intake weight gain seen high dose testosterone treatment due aromatization testosterone estrogen 8 light previous reports females sensitive effect estrogen food intake males 8 50 males sensitive effect testosterone food intake 47 50 present study indicates dominant effect testosterone response mch neurons females testosterone induced attenuation estrogen induced enhancement males contrast dominant effect testosterone response mch neurons estrogen induced enhancement testosterone induced attenuation hence present study may provide neural basis sex difference feeding behavior although mechanisms action estrogen testosterone need determined future studies
0.119480975.15905320.html.plaintext.txt	69	recent reports demonstrating estrogen attenuates neuroendocrine responses hypoglycemia women 51 female rats 52 suggest estrogen enhances effects glucose brain light results present study estrogen may enhance glucose transport metabolism brain 53 54 55 suggests one mechanism estrogen exerts widely reported protective effects brain 56 enhancing glucose transport metabolism
0.119480975.15905320.html.plaintext.txt	70	recent reports demonstrating estrogen attenuates neuroendocrine responses hypoglycemia women 51 female rats 52 suggest estrogen enhances effects glucose brain light results present study estrogen may enhance glucose transport metabolism brain 53 54 55 suggests one mechanism estrogen exerts widely reported protective effects brain 56 enhancing glucose transport metabolism
0.119480975.15905320.html.plaintext.txt	71	footnotes work supported part grant yokohama foundation advancement medical science km
0.119480975.15905320.html.plaintext.txt	72	first published online may 19 2005
0.119480975.15905320.html.plaintext.txt	73	abbreviations auc area curve lha lateral hypothalamic area mch melanin concentrating hormone npy neuropeptide y orx orchidectomized ovx ovariectomized pb phosphate buffer pcreb phosphorylated camp response element binding protein
0.119480975.15905320.html.plaintext.txt	74	accepted publication may 10 2005
0.119480975.15905320.html.plaintext.txt	75	references top abstract introduction materials methods results discussion references de castro jm 1987 circadian rhythms spontaneous meal pattern macronutrient intake mood humans physiol behav 40437 446crossrefmedline laviano meguid mm gleason jr yang zj renvyle 1996 comparison long term feeding pattern male female fischer 344 rats influence estrous cycle j physiol 270r413 r419 dye l blundell je 1997 menstrual cycle appetite control implications weight regulation hum reprod 121142 1151crossrefmedline eckel la houpt ta geary n 2000 spontaneous meal patterns female rats without access running wheels physiol behav 70397 405crossrefmedline bell dd zucker 1971 sex differences body weight eating organization activation gonadal hormones rat physiol behav 727 34crossrefmedline blaustein jd wade gn 1976 ovarian influences meal patterns female rats physiol behav 17201 208crossrefmedline gentry rt wade gn 1976 androgenic control food intake body weight male rats j comp physiol psychol 9018 25medline gentry rt wade gn 1976 sex differences sensitivity food intake body weight running wheel activity ovarian steroids rats j comp physiol psychol 90747 754medline varma m chai jk meguid mm laviano gleason jr yang zj blaha v 1999 effect estradiol progesterone daily rhythm food intake feeding patterns fischer rats physiol behav 6899 107crossrefmedline geary n 1999 estradiol cck satiation peptides 221251 1263crossref wager srdar sa gannon m levine 1987 effect cholecystokinin food intake gonadectomized intact rats influence sex hormones physiol behav 4025 28crossrefmedline flanagan cato lm king jl blechman jg o brien mp 1998 estrogen reduces cholecystokinin induced c fos expression rat brain neuroenedocrinology 67384 391crossref bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245crossrefmedline qu d ludwig ds gammeltoft piper m pelleymounter ma cullen mj mathes wf przypek r kanarek r maratos flier e 1996 role melanin concentrating hormone central regulation feeding behaviour nature 380243 247crossrefmedline rossi m choi sj o shea d miyoshi ghatei ma bloom sr 1997 melanin concentrating hormone acutely stimulates feeding chronic administration effect body weight endocrinology 138351 355abstractfree full text allen ys adrian te allen jm tatemoto k crow tj bloom sr polak jm 1983 neuropeptide y distribution rat brain science 221877 879medline clark jt kalra ps crowley wr kalra sp 1984 neuropeptide y human pancreatic polypeptide stimulate feeding behavior rats endocrinology 115427 429abstract stanley bg magdalin w seirafi thomas wj leibowitz sf 1993 perifornical area major focus patchily distributed hypothalamic neuropeptide y sensitive feeding systems brain res 604304 317crossrefmedline schwartz mw woods sc porte jr d seeley rj baskin dg 2000 central nervous system control food intake nature 404661 671medline shimada m tritos na lowell bb flier js maratos flier e 1998 mice lacking melanin concentrating hormone hypophagic lean nature 396670 674crossrefmedline ludwig ds tritos na mastaitis jw kulkarni r kokkotou e elmquist j lowell b flier js maratos flier e 2001 melanin concentrating hormone overexpression transgenic mice leads obesity insulin resistance j clin invest 107379 386abstractfree full text bahjaoui bouhaddi m fellmann d griffond b bugnon c 1994 insulin treatment stimulates rat melanin concentrating hormone producing neurons neuropeptides 27251 258crossrefmedline sergeyev v broberger c gorbatyuk o hokfelt 2000 effect 2 mercaptoacetate 2 deoxy d glucose administration expression npy agrp pomc mch hypocretinorexin rat hypothalamus neuroreport 11117 121medline erickson jc clegg ke palmiter rd 1996 sensitivity leptin susceptibility seizures mice lacking neuropeptide y nature 381415 421crossrefmedline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451crossrefmedline willie jt chemelli rm sinton cm yanagisawa m 2001 eat sleep orexin regulation feeding wakefulness annu rev neurosci 24429 458crossrefmedline mystkowski p seeley rj hahn tm baskin dg havel pj matsumoto wilkinson cw peacock kinzig k blake ka schwartz mw 2000 hypothalamic melanin concentrating hormone estrogen induced weight loss j neurosci 208637 8642abstractfree full text ji rr rupp f 1997 phosphorylation transcription factor creb rat spinal cord formalin induced hyperalgesia relationship c fos induction j neurosci 171776 1178abstractfree full text montminy mr bilezikjian l 1987 binding nuclear protein cyclic amp response element somatostatin gene nature 328175 178crossrefmedline dash pk karl ka colicos ma prywes r kandel er 1991 camp response element binding protein activated ca2calmodulin well camp dependent protein kinase proc natl acad sci usa 885061 5065abstractfree full text d funabashi sano uemura minaguchi h kimura f 1999 effects glucose related substrates recovery electrical activity gonadotropin releasing hormone pulse generator decreased insulin induced hypoglycemia estrogen primed ovariectomized rat brain res 82071 76crossrefmedline mitsushima d tin tin win shwe kimura f 2003 sexual dimorphism gabaergic control gonadotropin release intact rats neurosci res 46399 405crossrefmedline steiner ra bremner wj clifton dk 1982 regulation luteinizing hormone pulse frequency amplitude testosterone adult male rat endocrinology 1112055 2061abstract crace cj swenne milner rdg 1989 long term follow early protein calorie malnutrition young rats sex difference glucose tolerance serum insulin levels metabolism 38933 938crossrefmedline galipeau dm yao l mcneill jh 2002 relationship among hyperinsulinemia insulin resistance hypertension dependent sex j phyisol 283h562 h567 mayer j 1953 glucostatic mechanism regulation food intake n engl j med 24913 16medline bahjaoui bouhaddi m fellmann d bugnon c 1994 induction fos immunoreactivity prolactin like containing neurons rat lateral hypothalamus insulin treatment neurosci lett 16811 15crossrefmedline sheriff chance wt fischer je balasubramaniam 1997 neuropeptide y treatment food deprivation increase cyclic amp response element binding rat hypothalamus mol pharmacol 51597 604abstractfree full text gillard er khan grewal rs mouradi b wolfsohn sd stanley bg 1998 second messenger camp elicits eating anatomically specific action perifornical hypothalamus j neurosci 182646 2652abstractfree full text yang x j funabashi kow l m mobbs cv 2004 glucokinaseap 1 glucose transduction mechanism ventromedial hypothalamic satiety center matschinsky fm magnuson ma eds frontiers diabetes vol 16 basel karger 313 326 levin dunn meynell aa routh vh 1999 brain glucose sensing body energy homeostasis role obesity diabetes j physiol 276r1223 r1231 havel pj 2001 peripheral signals conveying metabolic information brain short term long term regulation food intake energy homeostasis exp biol med 226963 977abstractfree full text orsini jc armstrong dl wayner mj 1992 responses lateral hypothalamic neurons recorded vitro moderate changes glucose concentration brain res bull 29503 505crossrefmedline niijima 1986 neural control blood glucose level jpn j physiol 36827 841medline muroya yada shioda takigawa m 1999 glucose sensitive neurons rat arcuate nucleus contain neuropeptide y neurosci lett 264113 116crossrefmedline kakolewski jw cox vc valenstein es 1968 sex differences body weight changes following gonadectomy rats psychol rep 22547 554medline rowland dl perrings ts thommes ja 1980 comparison androgenic effects food intake body weight adult rats physiol behav 24205 209crossrefmedline chai j k blaha v meguid mm laviano yang z j varma m 1999 use orchidectomy testosterone replacement explore number meal size relationship male rats j physiol 276r1366 r1373 murray jf baker bi levy wilson ca 2000 influence gonadal steroids pre pro melanin concentrating hormone mrna female rats j neuroendocrinol 1253 59crossrefmedline czaja ja 1984 sex differences activational effects gonadal hormones food intake body weight physiol behav 33553 558crossrefmedline sandoval da ertl ac richardson tate db davis sn 2003 estrogen blunts neuroendocrine metabolic responses hypoglycemia diabetes 521749 1755abstractfree full text adams jm legan sj ott ce jackson ba 2005 modulation hypoglycemia induced increases plasma epinephrine estrogen female rat j neurosci res 79360 367crossrefmedline shi j zhang yq simpkins jw 1997 effects 17b estradiol glucose transporter 1 expression endothelial cell survival following focal ischemia rats exp brain res 117200 206crossrefmedline luine vn khylchevskaya ri mcewen bs 1975 effect gonadal hormones enzyme activities brain pituitary male female rats brain res 86283 292crossrefmedline hamba h sokoloff l 1984 acute administration high doses estrogen increases glucose utilization throughout brain brain res 291391 394crossrefmedline wise pm 2003 estrogens protective risk factors brain function prog neurobiol 69181 191crossrefmedline article abstract full text pdf versions article 14683325 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles mogi k articles kimura f articles citing article pubmed pubmed citation articles mogi k articles kimura f
0.119480975.15905320.html.plaintext.txt	76	references top abstract introduction materials methods results discussion references de castro jm 1987 circadian rhythms spontaneous meal pattern macronutrient intake mood humans physiol behav 40437 446crossrefmedline laviano meguid mm gleason jr yang zj renvyle 1996 comparison long term feeding pattern male female fischer 344 rats influence estrous cycle j physiol 270r413 r419 dye l blundell je 1997 menstrual cycle appetite control implications weight regulation hum reprod 121142 1151crossrefmedline eckel la houpt ta geary n 2000 spontaneous meal patterns female rats without access running wheels physiol behav 70397 405crossrefmedline bell dd zucker 1971 sex differences body weight eating organization activation gonadal hormones rat physiol behav 727 34crossrefmedline blaustein jd wade gn 1976 ovarian influences meal patterns female rats physiol behav 17201 208crossrefmedline gentry rt wade gn 1976 androgenic control food intake body weight male rats j comp physiol psychol 9018 25medline gentry rt wade gn 1976 sex differences sensitivity food intake body weight running wheel activity ovarian steroids rats j comp physiol psychol 90747 754medline varma m chai jk meguid mm laviano gleason jr yang zj blaha v 1999 effect estradiol progesterone daily rhythm food intake feeding patterns fischer rats physiol behav 6899 107crossrefmedline geary n 1999 estradiol cck satiation peptides 221251 1263crossref wager srdar sa gannon m levine 1987 effect cholecystokinin food intake gonadectomized intact rats influence sex hormones physiol behav 4025 28crossrefmedline flanagan cato lm king jl blechman jg o brien mp 1998 estrogen reduces cholecystokinin induced c fos expression rat brain neuroenedocrinology 67384 391crossref bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245crossrefmedline qu d ludwig ds gammeltoft piper m pelleymounter ma cullen mj mathes wf przypek r kanarek r maratos flier e 1996 role melanin concentrating hormone central regulation feeding behaviour nature 380243 247crossrefmedline rossi m choi sj o shea d miyoshi ghatei ma bloom sr 1997 melanin concentrating hormone acutely stimulates feeding chronic administration effect body weight endocrinology 138351 355abstractfree full text allen ys adrian te allen jm tatemoto k crow tj bloom sr polak jm 1983 neuropeptide y distribution rat brain science 221877 879medline clark jt kalra ps crowley wr kalra sp 1984 neuropeptide y human pancreatic polypeptide stimulate feeding behavior rats endocrinology 115427 429abstract stanley bg magdalin w seirafi thomas wj leibowitz sf 1993 perifornical area major focus patchily distributed hypothalamic neuropeptide y sensitive feeding systems brain res 604304 317crossrefmedline schwartz mw woods sc porte jr d seeley rj baskin dg 2000 central nervous system control food intake nature 404661 671medline shimada m tritos na lowell bb flier js maratos flier e 1998 mice lacking melanin concentrating hormone hypophagic lean nature 396670 674crossrefmedline ludwig ds tritos na mastaitis jw kulkarni r kokkotou e elmquist j lowell b flier js maratos flier e 2001 melanin concentrating hormone overexpression transgenic mice leads obesity insulin resistance j clin invest 107379 386abstractfree full text bahjaoui bouhaddi m fellmann d griffond b bugnon c 1994 insulin treatment stimulates rat melanin concentrating hormone producing neurons neuropeptides 27251 258crossrefmedline sergeyev v broberger c gorbatyuk o hokfelt 2000 effect 2 mercaptoacetate 2 deoxy d glucose administration expression npy agrp pomc mch hypocretinorexin rat hypothalamus neuroreport 11117 121medline erickson jc clegg ke palmiter rd 1996 sensitivity leptin susceptibility seizures mice lacking neuropeptide y nature 381415 421crossrefmedline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451crossrefmedline willie jt chemelli rm sinton cm yanagisawa m 2001 eat sleep orexin regulation feeding wakefulness annu rev neurosci 24429 458crossrefmedline mystkowski p seeley rj hahn tm baskin dg havel pj matsumoto wilkinson cw peacock kinzig k blake ka schwartz mw 2000 hypothalamic melanin concentrating hormone estrogen induced weight loss j neurosci 208637 8642abstractfree full text ji rr rupp f 1997 phosphorylation transcription factor creb rat spinal cord formalin induced hyperalgesia relationship c fos induction j neurosci 171776 1178abstractfree full text montminy mr bilezikjian l 1987 binding nuclear protein cyclic amp response element somatostatin gene nature 328175 178crossrefmedline dash pk karl ka colicos ma prywes r kandel er 1991 camp response element binding protein activated ca2calmodulin well camp dependent protein kinase proc natl acad sci usa 885061 5065abstractfree full text d funabashi sano uemura minaguchi h kimura f 1999 effects glucose related substrates recovery electrical activity gonadotropin releasing hormone pulse generator decreased insulin induced hypoglycemia estrogen primed ovariectomized rat brain res 82071 76crossrefmedline mitsushima d tin tin win shwe kimura f 2003 sexual dimorphism gabaergic control gonadotropin release intact rats neurosci res 46399 405crossrefmedline steiner ra bremner wj clifton dk 1982 regulation luteinizing hormone pulse frequency amplitude testosterone adult male rat endocrinology 1112055 2061abstract crace cj swenne milner rdg 1989 long term follow early protein calorie malnutrition young rats sex difference glucose tolerance serum insulin levels metabolism 38933 938crossrefmedline galipeau dm yao l mcneill jh 2002 relationship among hyperinsulinemia insulin resistance hypertension dependent sex j phyisol 283h562 h567 mayer j 1953 glucostatic mechanism regulation food intake n engl j med 24913 16medline bahjaoui bouhaddi m fellmann d bugnon c 1994 induction fos immunoreactivity prolactin like containing neurons rat lateral hypothalamus insulin treatment neurosci lett 16811 15crossrefmedline sheriff chance wt fischer je balasubramaniam 1997 neuropeptide y treatment food deprivation increase cyclic amp response element binding rat hypothalamus mol pharmacol 51597 604abstractfree full text gillard er khan grewal rs mouradi b wolfsohn sd stanley bg 1998 second messenger camp elicits eating anatomically specific action perifornical hypothalamus j neurosci 182646 2652abstractfree full text yang x j funabashi kow l m mobbs cv 2004 glucokinaseap 1 glucose transduction mechanism ventromedial hypothalamic satiety center matschinsky fm magnuson ma eds frontiers diabetes vol 16 basel karger 313 326 levin dunn meynell aa routh vh 1999 brain glucose sensing body energy homeostasis role obesity diabetes j physiol 276r1223 r1231 havel pj 2001 peripheral signals conveying metabolic information brain short term long term regulation food intake energy homeostasis exp biol med 226963 977abstractfree full text orsini jc armstrong dl wayner mj 1992 responses lateral hypothalamic neurons recorded vitro moderate changes glucose concentration brain res bull 29503 505crossrefmedline niijima 1986 neural control blood glucose level jpn j physiol 36827 841medline muroya yada shioda takigawa m 1999 glucose sensitive neurons rat arcuate nucleus contain neuropeptide y neurosci lett 264113 116crossrefmedline kakolewski jw cox vc valenstein es 1968 sex differences body weight changes following gonadectomy rats psychol rep 22547 554medline rowland dl perrings ts thommes ja 1980 comparison androgenic effects food intake body weight adult rats physiol behav 24205 209crossrefmedline chai j k blaha v meguid mm laviano yang z j varma m 1999 use orchidectomy testosterone replacement explore number meal size relationship male rats j physiol 276r1366 r1373 murray jf baker bi levy wilson ca 2000 influence gonadal steroids pre pro melanin concentrating hormone mrna female rats j neuroendocrinol 1253 59crossrefmedline czaja ja 1984 sex differences activational effects gonadal hormones food intake body weight physiol behav 33553 558crossrefmedline sandoval da ertl ac richardson tate db davis sn 2003 estrogen blunts neuroendocrine metabolic responses hypoglycemia diabetes 521749 1755abstractfree full text adams jm legan sj ott ce jackson ba 2005 modulation hypoglycemia induced increases plasma epinephrine estrogen female rat j neurosci res 79360 367crossrefmedline shi j zhang yq simpkins jw 1997 effects 17b estradiol glucose transporter 1 expression endothelial cell survival following focal ischemia rats exp brain res 117200 206crossrefmedline luine vn khylchevskaya ri mcewen bs 1975 effect gonadal hormones enzyme activities brain pituitary male female rats brain res 86283 292crossrefmedline hamba h sokoloff l 1984 acute administration high doses estrogen increases glucose utilization throughout brain brain res 291391 394crossrefmedline wise pm 2003 estrogens protective risk factors brain function prog neurobiol 69181 191crossrefmedline article abstract full text pdf versions article 14683325 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles mogi k articles kimura f articles citing article pubmed pubmed citation articles mogi k articles kimura f
0.119480975.15905320.html.plaintext.txt	77	home help feedback subscriptions archive search table contents endocrinology endocrine reviews j clin end metab molecular endocrinology recent prog horm res endocrine journals
0.11980948.12663466.html.plaintext.txt	0	ghrelin directly interacts neuropeptide y containing neurons rat arcuate nucleus ca2 signaling via protein kinase n type channel dependent mechanisms cross talk leptin orexin daisuke kohno12 hong zhi gao13 shinji muroya14 sakae kikuyama2 toshihiko yada1
0.11980948.12663466.html.plaintext.txt	1	1 department physiology jichi medical school school medicine minamikawachi tochigi japan 2 department biology school education waseda university nishi waseda shinjuku ku tokyo japan 3 department anatomy school medicine kagoshima university kagoshima japan 4 department psychiatry kagoshima university school medicine kagoshima japan
0.11980948.12663466.html.plaintext.txt	2	abstract top abstract research design methods results discussion references ghrelin newly discovered peptide released stomach neurons hypothalamic arcuate nucleus arc potently stimulates growth hormone release food intake neuropeptide y npy neurons arc play important role stimulation food intake present study aimed determine whether ghrelin directly activates npy neurons explore signaling mechanisms whether neurons respond ghrelin could regulated orexin leptin also examined isolated single neurons arc rats measured cytosolic ca2 concentration ca2i fura 2 fluorescence imaging ghrelin 10 12 10 8 moll concentration dependently increased ca2i occurred 35 arc neurons approximately 80 ghrelin responsive neurons proved npy containing immunocytochemical staining 58 glucose sensitive neurons judged responses lowering glucose concentrations ca2i responses ghrelin markedly attenuated inhibitors protein kinase pka protein kinase c blocker n type l type ca2 channels orexin increased ca2i leptin attenuated ghrelin induced ca2i increases majority 80 ghrelin responsive npy neurons results demonstrate ghrelin directly interacts npy neurons arc induce ca2 signaling via pka n type ca2 channel dependent mechanisms integration stimulatory effects ghrelin orexin inhibitory effect leptin may play important role regulation activity npy neurons thereby feeding
0.11980948.12663466.html.plaintext.txt	3	abstract top abstract research design methods results discussion references ghrelin newly discovered peptide released stomach neurons hypothalamic arcuate nucleus arc potently stimulates growth hormone release food intake neuropeptide y npy neurons arc play important role stimulation food intake present study aimed determine whether ghrelin directly activates npy neurons explore signaling mechanisms whether neurons respond ghrelin could regulated orexin leptin also examined isolated single neurons arc rats measured cytosolic ca2 concentration ca2i fura 2 fluorescence imaging ghrelin 10 12 10 8 moll concentration dependently increased ca2i occurred 35 arc neurons approximately 80 ghrelin responsive neurons proved npy containing immunocytochemical staining 58 glucose sensitive neurons judged responses lowering glucose concentrations ca2i responses ghrelin markedly attenuated inhibitors protein kinase pka protein kinase c blocker n type l type ca2 channels orexin increased ca2i leptin attenuated ghrelin induced ca2i increases majority 80 ghrelin responsive npy neurons results demonstrate ghrelin directly interacts npy neurons arc induce ca2 signaling via pka n type ca2 channel dependent mechanisms integration stimulatory effects ghrelin orexin inhibitory effect leptin may play important role regulation activity npy neurons thereby feeding
0.11980948.12663466.html.plaintext.txt	4	ghrelin endogenous ligand growth hormone secretagogue ghs receptor ghsr synthesized abundantly stomach much lesser extent hypothalamic arcuate nucleus arc 1 peripheral intracerebroventricular icv injection ghrelin releases growth hormone stimulates food intake increases body weight mice rats humans 1 8 icv injection antighrelin igg suppresses starvation induced feeding 3 daily pattern plasma ghrelin levels normal humans characterized preprandial rise postprandial fall 9 findings suggested ghrelin plays physiological role meal initiation
0.11980948.12663466.html.plaintext.txt	5	ghrelin endogenous ligand growth hormone secretagogue ghs receptor ghsr synthesized abundantly stomach much lesser extent hypothalamic arcuate nucleus arc 1 peripheral intracerebroventricular icv injection ghrelin releases growth hormone stimulates food intake increases body weight mice rats humans 1 8 icv injection antighrelin igg suppresses starvation induced feeding 3 daily pattern plasma ghrelin levels normal humans characterized preprandial rise postprandial fall 9 findings suggested ghrelin plays physiological role meal initiation
0.11980948.12663466.html.plaintext.txt	6	neuropeptide y npy containing neurons localized arc implicated stimulation food intake injection npy hypothalamus rats potently stimulates food intake 10 npy secretion hypothalamus increased fasting 11 regarding possible link ghrelin npy neurons arc shown ghsr mrna expressed 94 npy neurons arc double labeling situ hybridization histochemistry 12 systemic icv administration ghrelin causes arc neurons express fos egr 1 313 15 90 fos positive neurons express npy mrna 13 moreover ghrelin increases expression npy mrna 3 5 icv administration npy y1 antagonist suppresses ghrelin stimulated food intake 3 515 findings suggest npy neurons arc could important effector orexigenic action ghrelin
0.11980948.12663466.html.plaintext.txt	7	neuropeptide y npy containing neurons localized arc implicated stimulation food intake injection npy hypothalamus rats potently stimulates food intake 10 npy secretion hypothalamus increased fasting 11 regarding possible link ghrelin npy neurons arc shown ghsr mrna expressed 94 npy neurons arc double labeling situ hybridization histochemistry 12 systemic icv administration ghrelin causes arc neurons express fos egr 1 313 15 90 fos positive neurons express npy mrna 13 moreover ghrelin increases expression npy mrna 3 5 icv administration npy y1 antagonist suppresses ghrelin stimulated food intake 3 515 findings suggest npy neurons arc could important effector orexigenic action ghrelin
0.11980948.12663466.html.plaintext.txt	8	second messenger systems ghsr fully elucidated signaling pathways artificial ghs act ghsr pituitary cells investigated ghrp 2 ghs increases intracellular camp levels ovine rat pituitary somatotropes 1617 ghrp 6 stimulates gh release rat pituitary cells activating protein kinase c pkc 1718 thus post ghsr pathway could involve gs andor gq proteins however intracellular signaling ghrelin orexigenic action effector neurons well understood therefore first aim present study examine whether ghrelin directly interacts npy neurons arc explore signal transduction mechanisms special attention toward ca2 signaling
0.11980948.12663466.html.plaintext.txt	9	second messenger systems ghsr fully elucidated signaling pathways artificial ghs act ghsr pituitary cells investigated ghrp 2 ghs increases intracellular camp levels ovine rat pituitary somatotropes 1617 ghrp 6 stimulates gh release rat pituitary cells activating protein kinase c pkc 1718 thus post ghsr pathway could involve gs andor gq proteins however intracellular signaling ghrelin orexigenic action effector neurons well understood therefore first aim present study examine whether ghrelin directly interacts npy neurons arc explore signal transduction mechanisms special attention toward ca2 signaling
0.11980948.12663466.html.plaintext.txt	10	leptin adipocyte derived potent anorexic peptide leptin receptor present npy neurons arc leptin exerts anorexic effect partly suppression npy neurons 19 coinjection leptin decreases stimulatory effect ghrelin feeding free fed rats 3 orexin b orexigenic peptides produced cell bodies located lateral hypothalamus 20 orexin 1 receptor localized npy containing neurons arc 21 orexin induced feeding inhibited npy y1 andor y5 receptor antagonists 22 24 suggesting orexin could elicit feeding via npy neurons therefore second aim present study examine whether subset npy neurons arc could serve common target ghrelin leptin orexins
0.11980948.12663466.html.plaintext.txt	11	leptin adipocyte derived potent anorexic peptide leptin receptor present npy neurons arc leptin exerts anorexic effect partly suppression npy neurons 19 coinjection leptin decreases stimulatory effect ghrelin feeding free fed rats 3 orexin b orexigenic peptides produced cell bodies located lateral hypothalamus 20 orexin 1 receptor localized npy containing neurons arc 21 orexin induced feeding inhibited npy y1 andor y5 receptor antagonists 22 24 suggesting orexin could elicit feeding via npy neurons therefore second aim present study examine whether subset npy neurons arc could serve common target ghrelin leptin orexins
0.11980948.12663466.html.plaintext.txt	12	found ghrelin increases ca2i 80 npy neurons via mechanisms involving protein kinase pka n type ca2 channels majority ghrelin activated npy neurons also regulated orexin leptin
0.11980948.12663466.html.plaintext.txt	13	research design methods top abstract research design methods results discussion references animals preparation single neurons arc adult male sprague dawley sd rats maintained 12 h lightdark cycle given conventional food water ad libitum arc isolated brain 5 7 week old sd rats single neurons prepared according procedures reported previously 2526 slight modifications briefly rats anesthetized intraperitoneal injection carbamic acid ethyl ester 900 mgkg decapitated brain removed brain slices containing arc prepared whole arc left right sides punched dissected tissues washed 10 mmoll hepes buffered krebs ringer bicarbonate buffer hkrb containing 10 mmoll glucose incubated hkrb supplemented 20 unitsml papain sigma chemical st louis mo 0015 mgml deoxyribonuclease 075 mgml bsa 15 min 36 degrees c shaking water bath followed gentle mechanical trituration 5 10 min trituration cell suspension centrifuged 100g 5 min pellet resuspended hkrb distributed onto coverslips cells kept 18 degrees c moisture saturated dishes 10 h animal protocols approved jichi medical school institute animal care use committee accord japanese physiological society guidelines animal care
0.11980948.12663466.html.plaintext.txt	14	research design methods top abstract research design methods results discussion references animals preparation single neurons arc adult male sprague dawley sd rats maintained 12 h lightdark cycle given conventional food water ad libitum arc isolated brain 5 7 week old sd rats single neurons prepared according procedures reported previously 2526 slight modifications briefly rats anesthetized intraperitoneal injection carbamic acid ethyl ester 900 mgkg decapitated brain removed brain slices containing arc prepared whole arc left right sides punched dissected tissues washed 10 mmoll hepes buffered krebs ringer bicarbonate buffer hkrb containing 10 mmoll glucose incubated hkrb supplemented 20 unitsml papain sigma chemical st louis mo 0015 mgml deoxyribonuclease 075 mgml bsa 15 min 36 degrees c shaking water bath followed gentle mechanical trituration 5 10 min trituration cell suspension centrifuged 100g 5 min pellet resuspended hkrb distributed onto coverslips cells kept 18 degrees c moisture saturated dishes 10 h animal protocols approved jichi medical school institute animal care use committee accord japanese physiological society guidelines animal care
0.11980948.12663466.html.plaintext.txt	15	measurements ca2i single arc neurons 2 12 h cell preparation ca2i measured radiometric fura 2 microfluorometry combination digital imaging previously reported 2526 briefly following incubation 2 micromoll fura 2am dojin chemical kumamoto japan 1 h 18 degrees c cells mounted chamber superfused hkrb 1 mlmin 33 degrees c fluorescence images due excitation 340 380 nm detected every 80 intensified charge coupled device iccd camera ratio image produced argus 50 system hamamatsu photonics hamamatsu japan ratio values converted ca2i according calibration curves 27 agents dissolved dmso distilled water stock diluted superfusate hkrb le11000 control experiments 01 dmso administered alone effect ca2i arc neurons
0.11980948.12663466.html.plaintext.txt	16	measurements ca2i single arc neurons 2 12 h cell preparation ca2i measured radiometric fura 2 microfluorometry combination digital imaging previously reported 2526 briefly following incubation 2 micromoll fura 2am dojin chemical kumamoto japan 1 h 18 degrees c cells mounted chamber superfused hkrb 1 mlmin 33 degrees c fluorescence images due excitation 340 380 nm detected every 80 intensified charge coupled device iccd camera ratio image produced argus 50 system hamamatsu photonics hamamatsu japan ratio values converted ca2i according calibration curves 27 agents dissolved dmso distilled water stock diluted superfusate hkrb le11000 control experiments 01 dmso administered alone effect ca2i arc neurons
0.11980948.12663466.html.plaintext.txt	17	data taken cells identified neurons procedures reported previously 2526 briefly single cells immunoreactive microtubule associated protein 2 neuron specific marker showed relatively large diameter 10 microm clear round nuclei phase contrast microscope data taken cells fulfilled criteria neurons
0.11980948.12663466.html.plaintext.txt	18	data taken cells identified neurons procedures reported previously 2526 briefly single cells immunoreactive microtubule associated protein 2 neuron specific marker showed relatively large diameter 10 microm clear round nuclei phase contrast microscope data taken cells fulfilled criteria neurons
0.11980948.12663466.html.plaintext.txt	19	immunocytochemistry identification npy neurons ca2i measurement cells fixed 4 paraformaldehyde overnight incubated first rabbit antiserum npy diasorin stillwater mn dilution 110000 24 h 4 degrees c followed biotinylated antibodies raised rabbit igg vector laboratories burlingame ca diluted 200 fold 1 h avidin peroxidase complex vector 1 h sections developed 33 diaminobenzidine control experiments carried omitting primary antiserum
0.11980948.12663466.html.plaintext.txt	20	immunocytochemistry identification npy neurons ca2i measurement cells fixed 4 paraformaldehyde overnight incubated first rabbit antiserum npy diasorin stillwater mn dilution 110000 24 h 4 degrees c followed biotinylated antibodies raised rabbit igg vector laboratories burlingame ca diluted 200 fold 1 h avidin peroxidase complex vector 1 h sections developed 33 diaminobenzidine control experiments carried omitting primary antiserum
0.11980948.12663466.html.plaintext.txt	21	correlation ca2i immunocytochemical data performed procedure reported previously 25 27 brief end ca2i imaging took phase contrast photographs cells microscopic field subjected ca2i measurements based photographs cells ca2i recorded correlated corresponding immunocytochemical results
0.11980948.12663466.html.plaintext.txt	22	correlation ca2i immunocytochemical data performed procedure reported previously 25 27 brief end ca2i imaging took phase contrast photographs cells microscopic field subjected ca2i measurements based photographs cells ca2i recorded correlated corresponding immunocytochemical results
0.11980948.12663466.html.plaintext.txt	23	criteria ca2i responses inhibition determination response amplitude ghrelin forskolin 12 0 tetradecanoylphorbol 13 acetate tpa orexin administered 4 5 min 20 min superfusion solution amplitudes ca2i increases response agents calculated subtracting prestimulatory basal ca2i levels peak ca2i levels increases ca2i took place within 5 min addition agents amplitudes 150 nmoll larger considered responses repetitive additions ghrelin twice induced repeated ca2i increases therefore test effects drugs second challenge ghrelin performed presence drugs alternatively pretreatment neurons drugs performed second challenge ghrelin amplitude ca2i response second addition ghrelin reduced le40 compared control ca2i response first addition ghrelin without drugs considered inhibition
0.11980948.12663466.html.plaintext.txt	24	criteria ca2i responses inhibition determination response amplitude ghrelin forskolin 12 0 tetradecanoylphorbol 13 acetate tpa orexin administered 4 5 min 20 min superfusion solution amplitudes ca2i increases response agents calculated subtracting prestimulatory basal ca2i levels peak ca2i levels increases ca2i took place within 5 min addition agents amplitudes 150 nmoll larger considered responses repetitive additions ghrelin twice induced repeated ca2i increases therefore test effects drugs second challenge ghrelin performed presence drugs alternatively pretreatment neurons drugs performed second challenge ghrelin amplitude ca2i response second addition ghrelin reduced le40 compared control ca2i response first addition ghrelin without drugs considered inhibition
0.11980948.12663466.html.plaintext.txt	25	solutions chemicals measurements carried hkrb solution composed 129 mmoll nacl 50 mmoll nahco3 47 mmoll kcl 12 mmoll kh2po4 18 mmoll cacl2 12 mmoll mgso4 10 mmoll hepes ph 74 ghrelin provided dr kangawa later obtained peptide institute osaka japan conotoxin gvia orexin obtained peptide institute fura 2 acetoxymethylester dojin chemical kumamoto japan nitrendipine yoshitomi pharmaceutical industries osaka japan h89 h85 seikagaku tokyo japan calphostin c bisindolylmaleimide calbiochem la jolla ca chemicals sigma
0.11980948.12663466.html.plaintext.txt	26	data presentation statistical analysis data presented mean plus minus se n number neurons study based least seven neurons prepared least three rats total 535 neurons examined student paired unpaired test used evaluate differences values p 005 considered significant
0.11980948.12663466.html.plaintext.txt	27	data presentation statistical analysis data presented mean plus minus se n number neurons study based least seven neurons prepared least three rats total 535 neurons examined student paired unpaired test used evaluate differences values p 005 considered significant
0.11980948.12663466.html.plaintext.txt	28	results top abstract research design methods results discussion references ghrelin increases ca2i arc neurons major populations npy neurons glucose sensitive neurons single neurons isolated arc superfused hkrb subjected ca2i measurements fura 2 fluorescence imaging addition ghrelin 10 10 moll 4 5 min superfusion solution increased ca2i 114 330 neurons examined 35 fig 1a randomly selected responsive neurons peak ca2i responses significantly higher basal ca2i peak ca2i 4853 plus minus 262 nmoll 14 vs basal ca2i 907 plus minus 88 nmoll 14 p 0001 ghrelin induced ca2i increase took place long lasting 7 30 min manner majority neurons fig 1a among 59 neurons responded ghrelin 48 neurons 81 proved npy containing subsequent immunocytochemical staining using anti npy antibody fig 1a c hand among 14 neurons responded ghrelin 8 neurons 58 exhibited ca2i increases response lowering glucose concentration 10 28 mmoll thus showing glucose sensitive neurons fig 2a b results indicate ghrelin directly targets npy neuron glucose sensitive neuron arc former constitutes dominant population 81 among ghrelin responsive neurons
0.11980948.12663466.html.plaintext.txt	29	results top abstract research design methods results discussion references ghrelin increases ca2i arc neurons major populations npy neurons glucose sensitive neurons single neurons isolated arc superfused hkrb subjected ca2i measurements fura 2 fluorescence imaging addition ghrelin 10 10 moll 4 5 min superfusion solution increased ca2i 114 330 neurons examined 35 fig 1a randomly selected responsive neurons peak ca2i responses significantly higher basal ca2i peak ca2i 4853 plus minus 262 nmoll 14 vs basal ca2i 907 plus minus 88 nmoll 14 p 0001 ghrelin induced ca2i increase took place long lasting 7 30 min manner majority neurons fig 1a among 59 neurons responded ghrelin 48 neurons 81 proved npy containing subsequent immunocytochemical staining using anti npy antibody fig 1a c hand among 14 neurons responded ghrelin 8 neurons 58 exhibited ca2i increases response lowering glucose concentration 10 28 mmoll thus showing glucose sensitive neurons fig 2a b results indicate ghrelin directly targets npy neuron glucose sensitive neuron arc former constitutes dominant population 81 among ghrelin responsive neurons
0.11980948.12663466.html.plaintext.txt	30	view larger version 27k fig 1 ghrelin increases ca2i npy neurons arc b ghrelin 10 10 moll increased ca2i single arc neuron proved npy containing subsequent immunocytochemical staining anti npy antibody arrow b scale bar 20 microm bar tracing specifies period exposure ghrelin glucose concentration 10 mmoll throughout measurement c among 59 neurons exhibited ca2i increases response ghrelin 48 neurons 81 npy containing neurons
0.11980948.12663466.html.plaintext.txt	31	view larger version 20k fig 2 ghrelin increases ca2i glucose sensitive neurons arc ghrelin responsive neurons exhibited ca2i increases response lowering glucose concentration 10 28 mmoll showing glucose sensitive neurons result shown representative eight neurons arc n 8 bars tracing specify periods exposure agents indicated unless otherwise specified glucose concentration 10 mmoll b among 14 neurons responded ghrelin 8 neurons 57 glucose sensitive neurons
0.11980948.12663466.html.plaintext.txt	32	concentration dependent effects ghrelin increase ca2i ghrelin concentration range 10 14 10 8 moll administered single arc neurons ghrelin 10 14 moll increased ca2i none 32 neurons 0 10 12 moll 8 38 neurons 21 10 10 moll 114 330 neurons 35 10 8 moll 16 39 neurons 41 showing concentration dependent effect fig 3a b neuron exemplified fig 3a 10 10 moll ghrelin induced oscillatory ca2i increase 10 8 moll ghrelin sustained ca2i increase larger amplitude
0.11980948.12663466.html.plaintext.txt	33	concentration dependent effects ghrelin increase ca2i ghrelin concentration range 10 14 10 8 moll administered single arc neurons ghrelin 10 14 moll increased ca2i none 32 neurons 0 10 12 moll 8 38 neurons 21 10 10 moll 114 330 neurons 35 10 8 moll 16 39 neurons 41 showing concentration dependent effect fig 3a b neuron exemplified fig 3a 10 10 moll ghrelin induced oscillatory ca2i increase 10 8 moll ghrelin sustained ca2i increase larger amplitude
0.11980948.12663466.html.plaintext.txt	34	view larger version 17k fig 3 concentration dependent effects ghrelin increase ca2i arc neurons sequential addition ghrelin 10 10 moll 10 8 moll increased ca2i arc neuron b concentration response relationship response expressed percentage cells exhibited ca2i increases response ghrelin numbers point indicate number neurons responded number neurons examined
0.11980948.12663466.html.plaintext.txt	35	inhibition ghrelin induced ca2i increases ca2 free condition n type ca2 channel blocker second addition ghrelin neuron carried absence ca2 presence drugs ca2 free condition added ca2 01 mmoll egta ca2i increase response ghrelin abolished seven neurons fig 4a e f bringing ca2 back hkrb ca2i response ghrelin restored showing inhibition reversible ghrelin induced ca2i increase also inhibited n type ca2 channel blocker conotoxin giva 500 nmoll reversible manner 12 13 neurons fig 4b e mean amplitude ca2i increase ca2i amp significantly reduced compared response second addition ghrelin without blocker control 511 plus minus 277 nmoll 13 blocker vs 3575 plus minus 733 nmoll 9 control p 0005 fig 4f contrast l type ca2 channel blocker nitrendipine 2 micromoll failed affect ghrelin induced ca2i increase majority neurons n 12 suppressed response minor fraction neurons n 5 ca2i amp 2590 plus minus 432 nmoll 17 fig 4c e blocker endoplasmic reticulum er ca2 pump thapsigargin 1 micromoll effect ghrelin induced ca2i increase ca2i amp 4185 plus minus 828 nmoll 9 moderately elevated basal ca2i fig 4d e
0.11980948.12663466.html.plaintext.txt	36	inhibition ghrelin induced ca2i increases ca2 free condition n type ca2 channel blocker second addition ghrelin neuron carried absence ca2 presence drugs ca2 free condition added ca2 01 mmoll egta ca2i increase response ghrelin abolished seven neurons fig 4a e f bringing ca2 back hkrb ca2i response ghrelin restored showing inhibition reversible ghrelin induced ca2i increase also inhibited n type ca2 channel blocker conotoxin giva 500 nmoll reversible manner 12 13 neurons fig 4b e mean amplitude ca2i increase ca2i amp significantly reduced compared response second addition ghrelin without blocker control 511 plus minus 277 nmoll 13 blocker vs 3575 plus minus 733 nmoll 9 control p 0005 fig 4f contrast l type ca2 channel blocker nitrendipine 2 micromoll failed affect ghrelin induced ca2i increase majority neurons n 12 suppressed response minor fraction neurons n 5 ca2i amp 2590 plus minus 432 nmoll 17 fig 4c e blocker endoplasmic reticulum er ca2 pump thapsigargin 1 micromoll effect ghrelin induced ca2i increase ca2i amp 4185 plus minus 828 nmoll 9 moderately elevated basal ca2i fig 4d e
0.11980948.12663466.html.plaintext.txt	37	view larger version 35k fig 4 ghrelin induced ca2i increases inhibited ca2 free condition blocker n type ca2 channels d ghrelin induced ca2i increases abolished ca2 free condition n 7 markedly inhibited conotoxin gvia b blocker n type ca2 channels n 12 including 8 npy containig neurons slightly suppressed unaltered nitrendipine c blocker l type ca2 channels thapsigargin d inhibitor ca2 pump er failed significantly affect ghrelin induced ca2i increases e incidence response control test conditions expressed percentage cells exhibited ca2i responses second addition ghrelin cell numbers bar indicate number neurons responded number neurons examined f amplitude ghrelin induced ca2i increases control conditions ca2 free conditions conotoxin number bar indicates number neurons examined p 0001 control ca2 free groups p 0005 control conotoxin groups
0.11980948.12663466.html.plaintext.txt	38	ghrelin induced ca2i increase inhibited inhibitor pka pkc pretreatment neurons pka inhibitor h89 10 micromoll ca2i response ghrelin markedly significantly inhibited ca2i amp 1437 plus minus 345 nmoll 11 h89 vs 3575 plus minus 733 9 control p 005 fig 5a e f contrast h85 10 micromoll related compound h89 without inhibitory action pka significant effect ghrelin induced ca2i increase ca2i amp 3122 plus minus 527 nmoll 12 fig 5b e f neither calphostin c 100 nmoll bisindolylmaleimide 2 micromoll specific pkc inhibitors affected ghrelin induced ca2i increase ca2i amp 3485 plus minus 763 nmoll 10 calphostin c 4260 plus minus 1481 4 bisindolylmaleimide fig 5c e
0.11980948.12663466.html.plaintext.txt	39	ghrelin induced ca2i increase inhibited inhibitor pka pkc pretreatment neurons pka inhibitor h89 10 micromoll ca2i response ghrelin markedly significantly inhibited ca2i amp 1437 plus minus 345 nmoll 11 h89 vs 3575 plus minus 733 9 control p 005 fig 5a e f contrast h85 10 micromoll related compound h89 without inhibitory action pka significant effect ghrelin induced ca2i increase ca2i amp 3122 plus minus 527 nmoll 12 fig 5b e f neither calphostin c 100 nmoll bisindolylmaleimide 2 micromoll specific pkc inhibitors affected ghrelin induced ca2i increase ca2i amp 3485 plus minus 763 nmoll 10 calphostin c 4260 plus minus 1481 4 bisindolylmaleimide fig 5c e
0.11980948.12663466.html.plaintext.txt	40	view larger version 33k fig 5 ghrelin induced ca2i increases inhibited pka inhibitor pretreatment 10 micromoll h89 pka inhibitor inhibited ghrelin induced ca2i increases arc neurons n 9 including 7 npy containing neurons whereas pretreatment 10 micromoll h85 analog h89 without inhibitory action pka little effect b neither 100 nmoll calphostin c c 2 micromoll bisindolylmaleimide d specific pkc inhibitors affected ghrelin induced ca2i increases e incidence responses control conditions inhibitors expressed percentage cells exhibited ca2i responses second addition ghrelin cell f amplitude ghrelin induced ca2i increases control conditions pretreated h89 h85 p 005 control h89 groups h89 h85 groups significant difference control h85 groups
0.11980948.12663466.html.plaintext.txt	41	forskolin tpa increase ca2i ghrelin responsive neurons adenylate cyclase activator forskolin 10 micromoll increased ca2i 14 16 88 ghrelin responsive neurons ca2i amp 3775 plus minus 367 nmoll 16 fig 6a c pkc activator tpa 100 nmoll also increased ca2i 11 17 65 ghrelin responsive neurons ca2i amp 3376 plus minus 648 nmoll 17 fig 6b c thus ghrelin responsive neurons highly overlapped neurons responding forskolin lesser extent responding tpa furthermore forskolin tpa increased ca2i similar pattern ghrelin
0.11980948.12663466.html.plaintext.txt	42	forskolin tpa increase ca2i ghrelin responsive neurons adenylate cyclase activator forskolin 10 micromoll increased ca2i 14 16 88 ghrelin responsive neurons ca2i amp 3775 plus minus 367 nmoll 16 fig 6a c pkc activator tpa 100 nmoll also increased ca2i 11 17 65 ghrelin responsive neurons ca2i amp 3376 plus minus 648 nmoll 17 fig 6b c thus ghrelin responsive neurons highly overlapped neurons responding forskolin lesser extent responding tpa furthermore forskolin tpa increased ca2i similar pattern ghrelin
0.11980948.12663466.html.plaintext.txt	43	view larger version 29k fig 6 forskolin tpa increase ca2i ghrelin responsive neurons 10 micromoll forskolin adenylate cyclase activator 100 nmoll tpa pkc activator b increased ca2i ghrelin responsive neurons c incidence ca2i responses forskolin tpa ghrelin responsive neurons expressed percentage
0.11980948.12663466.html.plaintext.txt	44	ghrelin orexin increase ca2i neurons ghrelin orexin 10 10 moll sequentially administered increased ca2i neurons arc similar pattern comparable amplitudes fig 7a among 17 neurons examined 12 neurons including 8 npy containing neurons responded ghrelin orexin 3 neurons responded ghrelin 2 neurons responded orexin fig 7b thus ghrelin responsive neurons extensively overlapped orexin responsive neurons 80 fig 7b
0.11980948.12663466.html.plaintext.txt	45	ghrelin orexin increase ca2i neurons ghrelin orexin 10 10 moll sequentially administered increased ca2i neurons arc similar pattern comparable amplitudes fig 7a among 17 neurons examined 12 neurons including 8 npy containing neurons responded ghrelin orexin 3 neurons responded ghrelin 2 neurons responded orexin fig 7b thus ghrelin responsive neurons extensively overlapped orexin responsive neurons 80 fig 7b
0.11980948.12663466.html.plaintext.txt	46	view larger version 16k fig 7 ghrelin orexin increase ca2i npy neurons ghrelin responsive neurons also exhibited ca2i responses 10 10 moll orexin b twelve neurons responded ghrelin orexin 3 neurons ghrelin 2 neurons orexin among 17 neurons responded either two peptides ghrelin orexin responsive neurons included eight npy containing neurons
0.11980948.12663466.html.plaintext.txt	47	ghrelin induced ca2i increase counteracted leptin 10 10 moll ghrelin administered 20 min ca2i increased continuous manner eight responsive neurons arc examined fig 8a continuous ca2i increase markedly reduced subsequent administration 10 10 moll leptin 11 14 79 ghrelin responsive neurons fig 8b c ghrelin leptin responsive neurons included seven npy containing neurons 10 10 moll leptin administered first ghrelin added ghrelin induced ca2i increase also reduced three nine responding neurons leptin little effect basal ca2i 10 mmoll glucose fig 8d
0.11980948.12663466.html.plaintext.txt	48	ghrelin induced ca2i increase counteracted leptin 10 10 moll ghrelin administered 20 min ca2i increased continuous manner eight responsive neurons arc examined fig 8a continuous ca2i increase markedly reduced subsequent administration 10 10 moll leptin 11 14 79 ghrelin responsive neurons fig 8b c ghrelin leptin responsive neurons included seven npy containing neurons 10 10 moll leptin administered first ghrelin added ghrelin induced ca2i increase also reduced three nine responding neurons leptin little effect basal ca2i 10 mmoll glucose fig 8d
0.11980948.12663466.html.plaintext.txt	49	view larger version 33k fig 8 ghrelin increases ca2i leptin suppresses npy neurons ghrelin administered alone 20 min increased ca2i continuously arc neurons n 8 b c leptin 10 10 moll suppressed ghrelin induced ca2i increases 11 14 ghrelin responsive neurons ghrelin leptin responsive neurons included seven npy containing neurons d leptin 10 10 moll added advance suppressed ca2i responses subsequent administration ghrelin n 3
0.11980948.12663466.html.plaintext.txt	50	discussion top abstract research design methods results discussion references study presents novel findings neuronal signaling mechanisms orexigenic action ghrelin hypothalamus first demonstrated ghrelin concentration dependently increases ca2i npy containing neurons glucose sensitive neurons arc ca2i increase often results depolarization plasma membrane key signal triggering release neurotransmittershormones gene expression 2728 therefore ca2i increase good indicator neuronal activation therefore findings strongly suggest ghrelin directly activates npy neurons glucose sensitive neurons arc neuronal systems implicated stimulation feeding previously showed majority glucose sensitive neurons arc npy neurons 25 second ghrelin induced ca2i increase depends ca2 influx n type ca2 channels camp pka pathway third target neurons ghrelin arc extensively overlap orexin leptin
0.11980948.12663466.html.plaintext.txt	51	discussion top abstract research design methods results discussion references study presents novel findings neuronal signaling mechanisms orexigenic action ghrelin hypothalamus first demonstrated ghrelin concentration dependently increases ca2i npy containing neurons glucose sensitive neurons arc ca2i increase often results depolarization plasma membrane key signal triggering release neurotransmittershormones gene expression 2728 therefore ca2i increase good indicator neuronal activation therefore findings strongly suggest ghrelin directly activates npy neurons glucose sensitive neurons arc neuronal systems implicated stimulation feeding previously showed majority glucose sensitive neurons arc npy neurons 25 second ghrelin induced ca2i increase depends ca2 influx n type ca2 channels camp pka pathway third target neurons ghrelin arc extensively overlap orexin leptin
0.11980948.12663466.html.plaintext.txt	52	reported concentration leptin cerebrospinal fluid measured radioimmunoassay 16 x 10 11 moll orexin 8 x 10 11 moll 29 although concentration ghrelin cerebrospinal fluid available ghrelin transported blood brain barrier rate similar peptides including leptin 30 estimated ghrelin concentration brain 10 12 moll values may reflect physiological concentrations peptides brain concentration ghrelin leptin orexin used present study 10 10 moll close values therefore effects observed could physiological
0.11980948.12663466.html.plaintext.txt	53	reported concentration leptin cerebrospinal fluid measured radioimmunoassay 16 x 10 11 moll orexin 8 x 10 11 moll 29 although concentration ghrelin cerebrospinal fluid available ghrelin transported blood brain barrier rate similar peptides including leptin 30 estimated ghrelin concentration brain 10 12 moll values may reflect physiological concentrations peptides brain concentration ghrelin leptin orexin used present study 10 10 moll close values therefore effects observed could physiological
0.11980948.12663466.html.plaintext.txt	54	previously shown ghsr ghrelin receptor abundant npy neurons arc 12 ghrelin induced food intake inhibited antagonist npy y1 receptor 3 515 reports suggested involvement npy neurons ghrelin signaling pathway orexigenic effect present study clearly demonstrated ghrelin directly activates substantial population 35 arc neurons high 80 ghrelin responsive neurons npy containing neurons
0.11980948.12663466.html.plaintext.txt	55	previously shown ghsr ghrelin receptor abundant npy neurons arc 12 ghrelin induced food intake inhibited antagonist npy y1 receptor 3 515 reports suggested involvement npy neurons ghrelin signaling pathway orexigenic effect present study clearly demonstrated ghrelin directly activates substantial population 35 arc neurons high 80 ghrelin responsive neurons npy containing neurons
0.11980948.12663466.html.plaintext.txt	56	pharmacological experiments study signaling mechanisms ghrelin immunocytochemical identification npy neurons following ca2i measurements carried experiments h89 conotoxin however examined 7 17 ghrelin responsive neurons pharmacological experiment major population 80 ghrelin responsive neurons proved npy containing fig 1 result obtained may largely solely reflect npy neurons ghrelin induced ca2i increases inhibited ca2 free condition blocker n type ca2 channels slightly suppressed blocker l type ca2 channels thapsigargin inhibitor ca2 pump er consequently ca2 release er effect ghrelin induced ca2i increases results n type ca2 channel blocker obtained mainly immunocytochemically identified npy neurons data indicate ghrelin increases ca2i mainly via ca2 influx n type ca2 channels shown n type ca2 channels involved release npy stimulated high potassium 31 reported npy y2 receptor npy neurons linked decrease ca2 currents due inhibition n type ca2 channels 32 thus n type ca2 channels could play pivotal role regulation ca2 influx ca2i npy neurons
0.11980948.12663466.html.plaintext.txt	57	pharmacological experiments study signaling mechanisms ghrelin immunocytochemical identification npy neurons following ca2i measurements carried experiments h89 conotoxin however examined 7 17 ghrelin responsive neurons pharmacological experiment major population 80 ghrelin responsive neurons proved npy containing fig 1 result obtained may largely solely reflect npy neurons ghrelin induced ca2i increases inhibited ca2 free condition blocker n type ca2 channels slightly suppressed blocker l type ca2 channels thapsigargin inhibitor ca2 pump er consequently ca2 release er effect ghrelin induced ca2i increases results n type ca2 channel blocker obtained mainly immunocytochemically identified npy neurons data indicate ghrelin increases ca2i mainly via ca2 influx n type ca2 channels shown n type ca2 channels involved release npy stimulated high potassium 31 reported npy y2 receptor npy neurons linked decrease ca2 currents due inhibition n type ca2 channels 32 thus n type ca2 channels could play pivotal role regulation ca2 influx ca2i npy neurons
0.11980948.12663466.html.plaintext.txt	58	second messenger systems ghrelin npy neurons adequately elucidated present study adenylate cyclase activator forskolin pkc activator tpa increased ca2i indicating camp pka pkc pathways capable activating ca2 signaling furthermore specific pka inhibitor h89 nonspecific inhibitor h85 pkc inhibitors significantly suppressed ghrelin induced ca2i increase results pka inhibitor obtained mainly immunocytochemically identified npy neurons results reveal pka required ghrelin activate ca2 signaling npy neurons arc two possible explanations role pka first basal activity pka may required ghrelin produce ca2 signaling second ghrelin ghsr system may activate gs adenylate cyclase camp pka cascade turn leads ca2 influx ca2i increase pka mediated facilitation ca2 influx ca2i increase indicated cardiac muscle pancreatic ss cells 2833 shown pka indispensable creb phosphorylation camp response element mediated gene expression npy neurons fasted state 34 ghrelin could couple fasting activation pka release peptide greatly stimulated fasting 9 findings present study others indicate pka important ghrelin induced activation npy neurons whether ghrelin induced ca2 signaling npy neurons depends basal pka activity requires activation pka peptide remains clarified
0.11980948.12663466.html.plaintext.txt	59	second messenger systems ghrelin npy neurons adequately elucidated present study adenylate cyclase activator forskolin pkc activator tpa increased ca2i indicating camp pka pkc pathways capable activating ca2 signaling furthermore specific pka inhibitor h89 nonspecific inhibitor h85 pkc inhibitors significantly suppressed ghrelin induced ca2i increase results pka inhibitor obtained mainly immunocytochemically identified npy neurons results reveal pka required ghrelin activate ca2 signaling npy neurons arc two possible explanations role pka first basal activity pka may required ghrelin produce ca2 signaling second ghrelin ghsr system may activate gs adenylate cyclase camp pka cascade turn leads ca2 influx ca2i increase pka mediated facilitation ca2 influx ca2i increase indicated cardiac muscle pancreatic ss cells 2833 shown pka indispensable creb phosphorylation camp response element mediated gene expression npy neurons fasted state 34 ghrelin could couple fasting activation pka release peptide greatly stimulated fasting 9 findings present study others indicate pka important ghrelin induced activation npy neurons whether ghrelin induced ca2 signaling npy neurons depends basal pka activity requires activation pka peptide remains clarified
0.11980948.12663466.html.plaintext.txt	60	present study ghrelin orexin increased ca2i neurons arc majority ghrelin responsive neurons 80 also responded orexin vise versa 86 showing two populations responders highly overlapped ghrelin orexin responsive neurons included eight npy containing neurons orexin 1 receptor reportedly expressed 90 npy neurons 35 results clearly demonstrate presence subset npy neurons serves common target ghrelin orexin shown fasting lowering glucose concentrations increase level ghrelin 9 activate orexin neurons 2636 suggesting release two peptides regulated parallel finding indicates ghrelin orexin may also cooperate common effector site npy neurons arc could result efficient stimulation npy mediated neural signaling feeding
0.11980948.12663466.html.plaintext.txt	61	present study ghrelin orexin increased ca2i neurons arc majority ghrelin responsive neurons 80 also responded orexin vise versa 86 showing two populations responders highly overlapped ghrelin orexin responsive neurons included eight npy containing neurons orexin 1 receptor reportedly expressed 90 npy neurons 35 results clearly demonstrate presence subset npy neurons serves common target ghrelin orexin shown fasting lowering glucose concentrations increase level ghrelin 9 activate orexin neurons 2636 suggesting release two peptides regulated parallel finding indicates ghrelin orexin may also cooperate common effector site npy neurons arc could result efficient stimulation npy mediated neural signaling feeding
0.11980948.12663466.html.plaintext.txt	62	found leptin suppresses ghrelin induced ca2i increase majority ghrelin responsive neurons 79 ghrelin leptin responsive neurons included seven npy containing neurons thus npy neurons arc regulated reciprocally ghrelin leptin accord report 57 fos positive cells ventromedial arc due intraperitoneal injection ghrelin also immunoreactive leptin receptor 37 recently reported action leptin antagonize camp elevation 38 40 possible mechanism leptin counteracts effect ghrelin dependent camp pka demonstrated present study action leptin could also involve phosphoinositide 3 kinase 38 41 furthermore found orexin induced ca2i increase npy neurons arc inhibited leptin ty personal communications thus npy neurons regulated directly cooperatively ghrelin orexin leptin important regulators feeding
0.11980948.12663466.html.plaintext.txt	63	found leptin suppresses ghrelin induced ca2i increase majority ghrelin responsive neurons 79 ghrelin leptin responsive neurons included seven npy containing neurons thus npy neurons arc regulated reciprocally ghrelin leptin accord report 57 fos positive cells ventromedial arc due intraperitoneal injection ghrelin also immunoreactive leptin receptor 37 recently reported action leptin antagonize camp elevation 38 40 possible mechanism leptin counteracts effect ghrelin dependent camp pka demonstrated present study action leptin could also involve phosphoinositide 3 kinase 38 41 furthermore found orexin induced ca2i increase npy neurons arc inhibited leptin ty personal communications thus npy neurons regulated directly cooperatively ghrelin orexin leptin important regulators feeding
0.11980948.12663466.html.plaintext.txt	64	conclusion data demonstrate ghrelin directly interacts npy neurons arc elicit ca2 signaling via pka n type ca2 channel dependent mechanisms could serve major neuronal signaling mechanism ghrelin stimulates npy release thereby feeding ghrelin responsive neurons highly overlapped orexin leptin responsive neurons integration stimulatory effects ghrelin orexin inhibitory effect leptin may play important role regulation activity npy neurons thereby feeding
0.11980948.12663466.html.plaintext.txt	65	conclusion data demonstrate ghrelin directly interacts npy neurons arc elicit ca2 signaling via pka n type ca2 channel dependent mechanisms could serve major neuronal signaling mechanism ghrelin stimulates npy release thereby feeding ghrelin responsive neurons highly overlapped orexin leptin responsive neurons integration stimulatory effects ghrelin orexin inhibitory effect leptin may play important role regulation activity npy neurons thereby feeding
0.11980948.12663466.html.plaintext.txt	66	acknowledgments work supported grant aid scientific research japan society promotion science 12470231 grants japan diabetes foundation national cardiovascular research institute asahi life foundation adult diseases institute ty
0.11980948.12663466.html.plaintext.txt	67	footnotes address correspondence reprint requests dr toshihiko yada department physiology division integrative physiology jichi medical school school medicine minamikawachi kawachi tochigi 329 0498 japan e mail tyadaatjichiacjp u d
0.11980948.12663466.html.plaintext.txt	68	footnotes address correspondence reprint requests dr toshihiko yada department physiology division integrative physiology jichi medical school school medicine minamikawachi kawachi tochigi 329 0498 japan e mail tyadaatjichiacjp u d
0.11980948.12663466.html.plaintext.txt	69	received publication 17 september 2001 accepted revised form 13 january 2003
0.11980948.12663466.html.plaintext.txt	70	arc arcuate nucleus er endoplasmic reticulum ghs growth hormone secretagogue ghsr ghs receptor hkrb hepes buffered krebs ringer bicarbonate buffer icv intracerebroventricular npy neuropeptide y pka protein kinase pkc protein kinase c tpa 12 0 tetradecanoylphorbol 13 acetate
0.11980948.12663466.html.plaintext.txt	71	references top abstract research design methods results discussion references kojima m hosoda h date y nakazato m matsuo h kangawa k ghrelin growth hormone releasing acylated peptide stomach nature 402656 6601999medline tschop m similey dl heiman ml ghrelin induces adiposity rodents nature 407908 9132000medline nakazato m murakami n date y kojima m matsuo kangawa k matsukura role ghrelin central regulation feeding nature 409194 1982001medline shintani m ogawa y ebihara k aizawa abe m miyanaga f takaya k hayashi inoue g hosoda k kojima m kangawa k nakao k ghrelin endogenous growth hormone secretagogue novel orexigenic peptide antagonizes leptin action activation hypothalamic neuropeptide yy1 receptor pathway diabetes 50227 2322001abstractfree full text asakawa inui kaga yuzuriha h nagata ueno n makino fujimiya m niijima fujino ma kasuga m ghrelin appetite stimulatory signal stomach structural resemblance motilin gastroenterology 120337 3452001medline wren small cj ward hl murphy kg dakin cl taheri kennedy ar roberts gh morgan dg ghatei ma bloom sr novel hypothalamic peptide ghrelin stimulates food intake growth hormone secretion endocrinology 1414325 43282000abstractfree full text wren seal lj cohen ma bynes ae frost gs murphy kg dhillo ws ghatei ma bloom sr ghrelin enhances appetite increases food intake humans j clin endocrinol metab 865992 59952001abstractfree full text inui ghrelin orexigenic somatotrophic signal stomach nat rev neurosci 2551 5602001medline cummings de purnell jq fravo rs schmidova k wisse weigle ds preprandial rise plasma ghrelin levels suggests role meal initiation humans diabetes 501714 17192001abstractfree full text stanley bg kyrkouli se lampert leibowitz sf neuropeptide y chronically injected hypothalamus powerful neurochemical inducer hyperphagia obesity peptides 71189 11921986medline kalra sp dube mg sahu phelps cp kalra ps neuropeptide y secretion increases paraventricular nucleus association increased appetite food proc natl acad sci u 8810931 109351991abstract willesen mg kristensen p romer j co localization growth hormone secretagogue receptor npy mrna arcuate nucleus rat neuroendocrinology 70306 3161999medline wang l saint pierre dh tache y peripheral ghrelin selectively increases fos expression neuropeptide y synthesizing neurons mouse hypothalamic arcuate nucleus neurosci lett 32547 512002medline hewson ak dickson sl systemic administration ghrelin induces fos egr 1 proteins hypothalamic arcuate nucleus fasted fed rats j neuroendocrinol 121047 10492000medline lawrence cb snape ac baudoin fm luckman sm acute central ghrelin gh secretagogues induce feeding activate brain appetite centers endocrinology 143155 1622002abstractfree full text wu d chen c zhang j bowers cy clarke ij effects gh releasing peptide 6 ghrp 6 ghrp 2 intracellular adenosine 35 monophosphate camp levels gh secretion ovine rat somatotrophs j endocrinol 148197 2051996abstract chen c growth hormone secretagogue actions pituitary gland multiple receptors multiple ligands clin exp pharmacol physiol 27323 3292000medline cheng k chan ww butler b barreto jr smith rg evidence role protein kinase c d trp ala trp d phe lys nh2 induced growth hormone release rat primary pituitary cells endocrinology 1293337 33421991abstract friedman jm halaas jl leptin regulation body weight mammals nature 395763 7701998medline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 5851998medline suzuki r shimojima h funahashi h nakajo yamada guan jl tsurugano uehara k takeyama y kikuyamas shioda orexin 1 receptor immunoreactivity chemically identified target neurons rat hypothalamus neurosci lett 3245 82002medline jain mr horvath tl kalra ps kalra sp evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 8719 242000medline yamanaka kunii k nambu tsujino n sakai matsuzaki miwa y goto k sakurai orexin induced food intake involves neuropeptide y pathway brain res 859404 4092000medline dube mg horvath tl kalra ps kalra sp evidence npy y5 receptor involvement food intake elicited orexin sated rats peptides 211557 15602000medline muroya yada shioda takigawa m glucose sensitive neurons rat arcuate nucleus contain neuropeptide y neurosci lett 264113 1161999medline muroya uramura k sakurai takigawa m yada lowering glucose concentrations increases cytosolic ca2 orexin neurons rat lateral hypothalamus neurosci lett 309165 1682001medline yada sakurada m ihida k nakata m murata f arimura kikuchi m pituitary adenylate cyclase activating polypeptide extraordinarily potent intra pancreatic regulator insulin secretion islet ss cells j biol chem 2691290 12931994abstractfree full text yada itoh k nakata m glucagon like peptide 1 7 36amide rise cyclic amp increase cytosolic free ca2 rat pancreatic ss cells enhancing ca2 channel activity endocrinology 1331685 16921993abstract nishino ripley b overeem nevsimalova lammers gj vankova j okun m rogers w brooks mignot e low cerebrospinal fluid hypocretin orexin altered energy homeostasis human narcolepsy ann neurol 50381 3882001medline banks wa kastin aj huang w jaspan jb maness lm leptin enters brain saturable system indipendent insulin peptides 17305 3111996medline king pj widdowson ps doods hn williams g regulation neuropeptide y release neuropeptide y receptor ligands calcium channel antagonists hypothalamic slices j neurochem 73641 6461999medline chen x dimaggio da han sp westfall tc autoreceptor induced inhibition neuropeptide y release pc 12 cells mediated y2 receptors j physiol 273h1737 h17441997abstractfree full text trautwein w hescheler j regulation cardiac l type calcium current phosphorylation g proteins annu rev physiol 52257 2741990medline shimizu albergine m ippolito dl beavo ja downregulation fasting induced camp response element mediated gene induction leptin neuropeptide y neurons arcuate nucleus j neurosci 211238 12462001abstractfree full text backberg m hervieu g wilson meister b orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15315 3282002medline moriguchi sakurai nambu yanagisawa m goto k neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264101 1041999medline traebert m riediger whitebread scharrer e schmid ha ghrelin acts leptin responsive neurones rat arcuate nucleus j neuroendocrinol 14580 5862002medline zhao az bornfieldt ke beavo ja leptin inhibits insulin secretion activation phosphodiesterase 3b j clin invest 102869 8731998abstractfree full text zhao az shinohara mm huang d shimizu m eldar finkelman h krebs eg beavo ja bornfield ke leptin induces insulin like signaling antagonizes camp elevation glucagon hepatocytes j biol chem 27511348 113542000abstractfree full text zhao az huan jn gupta pal r sahu phosphatidylinositol 3 kinase phosphodiesterase 3b cyclic amp pathway hypothalamic action leptin feeding nat neurosci 5727 7282002medline shanley lj irving aj rae mg ashford ml harvey j leptin inhibits rat hippocampal neurons via activation large conductance calcium activated k channels nat neurosci 5299 3002002medline
0.11980948.12663466.html.plaintext.txt	72	references top abstract research design methods results discussion references kojima m hosoda h date y nakazato m matsuo h kangawa k ghrelin growth hormone releasing acylated peptide stomach nature 402656 6601999medline tschop m similey dl heiman ml ghrelin induces adiposity rodents nature 407908 9132000medline nakazato m murakami n date y kojima m matsuo kangawa k matsukura role ghrelin central regulation feeding nature 409194 1982001medline shintani m ogawa y ebihara k aizawa abe m miyanaga f takaya k hayashi inoue g hosoda k kojima m kangawa k nakao k ghrelin endogenous growth hormone secretagogue novel orexigenic peptide antagonizes leptin action activation hypothalamic neuropeptide yy1 receptor pathway diabetes 50227 2322001abstractfree full text asakawa inui kaga yuzuriha h nagata ueno n makino fujimiya m niijima fujino ma kasuga m ghrelin appetite stimulatory signal stomach structural resemblance motilin gastroenterology 120337 3452001medline wren small cj ward hl murphy kg dakin cl taheri kennedy ar roberts gh morgan dg ghatei ma bloom sr novel hypothalamic peptide ghrelin stimulates food intake growth hormone secretion endocrinology 1414325 43282000abstractfree full text wren seal lj cohen ma bynes ae frost gs murphy kg dhillo ws ghatei ma bloom sr ghrelin enhances appetite increases food intake humans j clin endocrinol metab 865992 59952001abstractfree full text inui ghrelin orexigenic somatotrophic signal stomach nat rev neurosci 2551 5602001medline cummings de purnell jq fravo rs schmidova k wisse weigle ds preprandial rise plasma ghrelin levels suggests role meal initiation humans diabetes 501714 17192001abstractfree full text stanley bg kyrkouli se lampert leibowitz sf neuropeptide y chronically injected hypothalamus powerful neurochemical inducer hyperphagia obesity peptides 71189 11921986medline kalra sp dube mg sahu phelps cp kalra ps neuropeptide y secretion increases paraventricular nucleus association increased appetite food proc natl acad sci u 8810931 109351991abstract willesen mg kristensen p romer j co localization growth hormone secretagogue receptor npy mrna arcuate nucleus rat neuroendocrinology 70306 3161999medline wang l saint pierre dh tache y peripheral ghrelin selectively increases fos expression neuropeptide y synthesizing neurons mouse hypothalamic arcuate nucleus neurosci lett 32547 512002medline hewson ak dickson sl systemic administration ghrelin induces fos egr 1 proteins hypothalamic arcuate nucleus fasted fed rats j neuroendocrinol 121047 10492000medline lawrence cb snape ac baudoin fm luckman sm acute central ghrelin gh secretagogues induce feeding activate brain appetite centers endocrinology 143155 1622002abstractfree full text wu d chen c zhang j bowers cy clarke ij effects gh releasing peptide 6 ghrp 6 ghrp 2 intracellular adenosine 35 monophosphate camp levels gh secretion ovine rat somatotrophs j endocrinol 148197 2051996abstract chen c growth hormone secretagogue actions pituitary gland multiple receptors multiple ligands clin exp pharmacol physiol 27323 3292000medline cheng k chan ww butler b barreto jr smith rg evidence role protein kinase c d trp ala trp d phe lys nh2 induced growth hormone release rat primary pituitary cells endocrinology 1293337 33421991abstract friedman jm halaas jl leptin regulation body weight mammals nature 395763 7701998medline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 5851998medline suzuki r shimojima h funahashi h nakajo yamada guan jl tsurugano uehara k takeyama y kikuyamas shioda orexin 1 receptor immunoreactivity chemically identified target neurons rat hypothalamus neurosci lett 3245 82002medline jain mr horvath tl kalra ps kalra sp evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 8719 242000medline yamanaka kunii k nambu tsujino n sakai matsuzaki miwa y goto k sakurai orexin induced food intake involves neuropeptide y pathway brain res 859404 4092000medline dube mg horvath tl kalra ps kalra sp evidence npy y5 receptor involvement food intake elicited orexin sated rats peptides 211557 15602000medline muroya yada shioda takigawa m glucose sensitive neurons rat arcuate nucleus contain neuropeptide y neurosci lett 264113 1161999medline muroya uramura k sakurai takigawa m yada lowering glucose concentrations increases cytosolic ca2 orexin neurons rat lateral hypothalamus neurosci lett 309165 1682001medline yada sakurada m ihida k nakata m murata f arimura kikuchi m pituitary adenylate cyclase activating polypeptide extraordinarily potent intra pancreatic regulator insulin secretion islet ss cells j biol chem 2691290 12931994abstractfree full text yada itoh k nakata m glucagon like peptide 1 7 36amide rise cyclic amp increase cytosolic free ca2 rat pancreatic ss cells enhancing ca2 channel activity endocrinology 1331685 16921993abstract nishino ripley b overeem nevsimalova lammers gj vankova j okun m rogers w brooks mignot e low cerebrospinal fluid hypocretin orexin altered energy homeostasis human narcolepsy ann neurol 50381 3882001medline banks wa kastin aj huang w jaspan jb maness lm leptin enters brain saturable system indipendent insulin peptides 17305 3111996medline king pj widdowson ps doods hn williams g regulation neuropeptide y release neuropeptide y receptor ligands calcium channel antagonists hypothalamic slices j neurochem 73641 6461999medline chen x dimaggio da han sp westfall tc autoreceptor induced inhibition neuropeptide y release pc 12 cells mediated y2 receptors j physiol 273h1737 h17441997abstractfree full text trautwein w hescheler j regulation cardiac l type calcium current phosphorylation g proteins annu rev physiol 52257 2741990medline shimizu albergine m ippolito dl beavo ja downregulation fasting induced camp response element mediated gene induction leptin neuropeptide y neurons arcuate nucleus j neurosci 211238 12462001abstractfree full text backberg m hervieu g wilson meister b orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15315 3282002medline moriguchi sakurai nambu yanagisawa m goto k neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264101 1041999medline traebert m riediger whitebread scharrer e schmid ha ghrelin acts leptin responsive neurones rat arcuate nucleus j neuroendocrinol 14580 5862002medline zhao az bornfieldt ke beavo ja leptin inhibits insulin secretion activation phosphodiesterase 3b j clin invest 102869 8731998abstractfree full text zhao az shinohara mm huang d shimizu m eldar finkelman h krebs eg beavo ja bornfield ke leptin induces insulin like signaling antagonizes camp elevation glucagon hepatocytes j biol chem 27511348 113542000abstractfree full text zhao az huan jn gupta pal r sahu phosphatidylinositol 3 kinase phosphodiesterase 3b cyclic amp pathway hypothalamic action leptin feeding nat neurosci 5727 7282002medline shanley lj irving aj rae mg ashford ml harvey j leptin inhibits rat hippocampal neurons via activation large conductance calcium activated k channels nat neurosci 5299 3002002medline
0.12693419.14871884.html.plaintext.txt	0	sleep enhances nocturnal plasma ghrelin levels healthy subjects andrea dzaja mira dalal hubertus himmerich manfred uhr thomas pollmacher andreas schuld
0.12693419.14871884.html.plaintext.txt	1	sleep enhances nocturnal plasma ghrelin levels healthy subjects andrea dzaja mira dalal hubertus himmerich manfred uhr thomas pollmacher andreas schuld
0.12693419.14871884.html.plaintext.txt	2	max planck institute psychiatry 80804 munich germany
0.12693419.14871884.html.plaintext.txt	3	submitted 18 november 2003 accepted final form 5 february 2004
0.12693419.14871884.html.plaintext.txt	4	abstract top abstract materials methods results discussion references ghrelin endogenous ligand growth hormone secretagogue receptor shown promote slow wave sleep sws non rem sleep stages 3 4 plasma levels ghrelin dependent food intake increase sleeping subjects early part night unknown whether sleep affects ghrelin levels whether circadian networks involved therefore studied effect sleep deprivation nocturnal ghrelin secretion healthy male volunteers plasma levels ghrelin cortisol human growth hormone hgh measured two experimental sessions 24 h subjects allowed sleep 2300 0700 kept awake throughout night sleep ghrelin levels increased early part night decreased morning nocturnal increase blunted sleep deprivation ghrelin levels increased slightly early morning ghrelin secretion first hours sleep correlated positively peak hgh concentrations conclude nocturnal increase ghrelin levels likely caused sleep associated processes circadian influences first hours sleep ghrelin might promote sleep associated hgh secretion contribute promotion sws
0.12693419.14871884.html.plaintext.txt	5	abstract top abstract materials methods results discussion references ghrelin endogenous ligand growth hormone secretagogue receptor shown promote slow wave sleep sws non rem sleep stages 3 4 plasma levels ghrelin dependent food intake increase sleeping subjects early part night unknown whether sleep affects ghrelin levels whether circadian networks involved therefore studied effect sleep deprivation nocturnal ghrelin secretion healthy male volunteers plasma levels ghrelin cortisol human growth hormone hgh measured two experimental sessions 24 h subjects allowed sleep 2300 0700 kept awake throughout night sleep ghrelin levels increased early part night decreased morning nocturnal increase blunted sleep deprivation ghrelin levels increased slightly early morning ghrelin secretion first hours sleep correlated positively peak hgh concentrations conclude nocturnal increase ghrelin levels likely caused sleep associated processes circadian influences first hours sleep ghrelin might promote sleep associated hgh secretion contribute promotion sws
0.12693419.14871884.html.plaintext.txt	6	growth hormone cortisol circadian rhythm slow wave sleep sleep deprivation
0.12693419.14871884.html.plaintext.txt	7	ghrelin 28 amino acid polypeptide discovered endogenous ligand growth hormone secretagogue receptor 11 ghrelin synthesized mainly stomach endocrine cells also identified tissues including hypothalamus 7 10 12 ghrelin stimulates growth hormone secretion increases food intake appetite promotes body weight gain 17 37 38 recent findings suggest ghrelin might involved regulation sleep humans promoting slow wave sleep sws 35
0.12693419.14871884.html.plaintext.txt	8	ghrelin 28 amino acid polypeptide discovered endogenous ligand growth hormone secretagogue receptor 11 ghrelin synthesized mainly stomach endocrine cells also identified tissues including hypothalamus 7 10 12 ghrelin stimulates growth hormone secretion increases food intake appetite promotes body weight gain 17 37 38 recent findings suggest ghrelin might involved regulation sleep humans promoting slow wave sleep sws 35
0.12693419.14871884.html.plaintext.txt	9	plasma ghrelin levels increase fasting decline within 1 h food intake 4 furthermore ghrelin levels observed increase night sleeping subjects decrease morning hours awakening thus breakfast 4
0.12693419.14871884.html.plaintext.txt	10	plasma ghrelin levels increase fasting decline within 1 h food intake 4 furthermore ghrelin levels observed increase night sleeping subjects decrease morning hours awakening thus breakfast 4
0.12693419.14871884.html.plaintext.txt	11	time course sleeping subjects suggests existence mechanism regulating ghrelin production dependent food intake possible candidates circadian rhythms regulating numerous endocrine networks example secretion cortisol leptin 5 13 turn related insulin blood glucose levels 27 alternatively sleep might directly influence ghrelin production demonstrated example secretion growth hormone pituitary 28
0.12693419.14871884.html.plaintext.txt	12	time course sleeping subjects suggests existence mechanism regulating ghrelin production dependent food intake possible candidates circadian rhythms regulating numerous endocrine networks example secretion cortisol leptin 5 13 turn related insulin blood glucose levels 27 alternatively sleep might directly influence ghrelin production demonstrated example secretion growth hormone pituitary 28
0.12693419.14871884.html.plaintext.txt	13	dissect diurnal variations sleep related influences ghrelin production performed study 24 h pattern ghrelin secretion healthy males two experimental sessions 0900 1000 following morning subjects allowed sleep sleep deprived balanced order nocturnal ghrelin secretion compared two conditions using within subjects design
0.12693419.14871884.html.plaintext.txt	14	dissect diurnal variations sleep related influences ghrelin production performed study 24 h pattern ghrelin secretion healthy males two experimental sessions 0900 1000 following morning subjects allowed sleep sleep deprived balanced order nocturnal ghrelin secretion compared two conditions using within subjects design
0.12693419.14871884.html.plaintext.txt	15	materials methods top abstract materials methods results discussion references experimental subjects investigated 10 healthy nonobese male volunteers age 28 plus minus 31 yr body mass index 240 plus minus 29 kgm2 range 205 295 kgm2 sleep sleep deprivation conditions written informed consent obtained participants inclusion study approved independent ethics committee subjects underwent detailed medical history evaluation sleeping habits physical examination laboratory investigations electroencephalogram eeg electrocardiogram exclude acute chronic diseases subjects personal family history psychiatric disorders history symptoms sleep disorder use medication alcohol substance abuse dependence included furthermore excluded subjects history recent irregular sleep wake schedules eg shift work intercontinental flights within previous 4 wk control regular sleep wake behavior subjects kept sleep log week experimental sessions
0.12693419.14871884.html.plaintext.txt	16	materials methods top abstract materials methods results discussion references experimental subjects investigated 10 healthy nonobese male volunteers age 28 plus minus 31 yr body mass index 240 plus minus 29 kgm2 range 205 295 kgm2 sleep sleep deprivation conditions written informed consent obtained participants inclusion study approved independent ethics committee subjects underwent detailed medical history evaluation sleeping habits physical examination laboratory investigations electroencephalogram eeg electrocardiogram exclude acute chronic diseases subjects personal family history psychiatric disorders history symptoms sleep disorder use medication alcohol substance abuse dependence included furthermore excluded subjects history recent irregular sleep wake schedules eg shift work intercontinental flights within previous 4 wk control regular sleep wake behavior subjects kept sleep log week experimental sessions
0.12693419.14871884.html.plaintext.txt	17	experimental procedure study performed using balanced randomized within subject design every subject participated two 24 h experiments subjects totally sleep deprived time allowed sleep 2300 0700 time interval two sessions border02 wk adjust experimental settings subjects spent night session 2300 0700 sleep laboratory 0800 electrodes eeg electromyogram electrooculogram recordings placed according standardized criteria 20 subjects remained semirecumbent position received standardized meals four different time points subjects received standardized diet hospital kitchen 1800 kcal24 h containing 30 fat 60 carbohydrates 10 protein subjects allowed eat additional food measurements started 0900 subjects stayed bed 25 h 1000 next morning artificial light intensity always 200 lux lights turned subjects allowed sleep 2300 0700 sleep condition sleep deprivation another person stayed continuously room subject prevent lapses sleep standardized meals served 0800 1200 1900 0800 next morning water freely available whole experimental session
0.12693419.14871884.html.plaintext.txt	18	blood sampling blood samples taken hourly via intravenous catheter placed antecubital vein kept patent continuous 09 saline infusion containing 400 iu na heparinl rate 30 mlh minimize disturbances sleep continuity blood sampling done wall via long line room adjacent sleep laboratory blood collected tubes stored ice contained na edta 1 mgml blood aprotinin 300 kallikrein inhibitor unitsml blood immediately withdrawal blood centrifuged 2600 g 7 min 4 degrees c plasma aliquoted frozen 20 degrees c various assays performed
0.12693419.14871884.html.plaintext.txt	19	sleep recordings ensure sleep deprivation successful polygraphic recordings obtained throughout 24 h records visually scored 30 epochs standardized criteria 20 experienced person blind experimental condition sleep deprivation none subjects displayed rapid eye movement rem sleep non rem sleep stages 2 4 sleep parameters sleep phase sleep condition shown table 1 sleep quality distribution different sleep stages comparable data studies healthy male volunteers underwent sleep recordings intermittent blood sampling 15 19 26 table 1
0.12693419.14871884.html.plaintext.txt	20	view table table 1 sleep parameters sleep condition
0.12693419.14871884.html.plaintext.txt	21	determination ghrelin human growth hormone cortisol plasma levels total plasma ghrelin levels determined radioimmunoassay phoenix pharmaceuticals mountain view ca limit detection 80 pgml intra interassay coefficients variation 13 human growth hormone hgh plasma levels determined using radioimmunoassays purchased nichols institute diagnostics san juan capistrano ca limit detection 15 ngml intra interassay coefficients variation 7 plasma cortisol levels determined means radioimmunoassay icn biomedicals carson ca limit detection 02 ngml intra interassay coefficients variation 7
0.12693419.14871884.html.plaintext.txt	22	determination ghrelin human growth hormone cortisol plasma levels total plasma ghrelin levels determined radioimmunoassay phoenix pharmaceuticals mountain view ca limit detection 80 pgml intra interassay coefficients variation 13 human growth hormone hgh plasma levels determined using radioimmunoassays purchased nichols institute diagnostics san juan capistrano ca limit detection 15 ngml intra interassay coefficients variation 7 plasma cortisol levels determined means radioimmunoassay icn biomedicals carson ca limit detection 02 ngml intra interassay coefficients variation 7
0.12693419.14871884.html.plaintext.txt	23	statistics compare nocturnal hormone plasma levels sleep condition sleep deprivation condition anova repeated measures performed time condition sleep vs sleep deprivation within subject factors avoid many posteriori tests would imply strong reduction level significance five time points 2300 0700 included 2300 0100 0300 0500 0700 anova hormone averages measured plasma concentrations sleep period considered baseline values conditions tested significance separate anova hormone baseline plasma concentrations differed significantly two conditions corresponding values sleep period normed baseline values anova application additionally ghrelin levels compared conditions recently developed methodology comparison stability hormone concentration curves 36 finally peak level hgh 2300 0300 determined associated ghrelin concentrations 2300 0300 area curve interval well using pearsons correlation coefficient level statistical significance set 005 one subject excluded statistical analysis blood samples available 2300 0500 sleep condition due technical reasons figures data depicted means plus minus se table data given means plus minus sd
0.12693419.14871884.html.plaintext.txt	24	results top abstract materials methods results discussion references condition reveal significant effect baseline values considered hormones sleep condition ghrelin levels rose sharply around midnight slowly declined next morning contrast subjects sleep deprived ghrelin levels increased steadily plateau early morning hours declined breakfast fig 1 anova repeated measures revealed significant difference conditions respect nocturnal 2300 0700 ghrelin secretion f432 665 p 001 confirmed z score 231 p 005 comparison hormone curves sleep sleep deprivation aforementioned stability testing 36
0.12693419.14871884.html.plaintext.txt	25	results top abstract materials methods results discussion references condition reveal significant effect baseline values considered hormones sleep condition ghrelin levels rose sharply around midnight slowly declined next morning contrast subjects sleep deprived ghrelin levels increased steadily plateau early morning hours declined breakfast fig 1 anova repeated measures revealed significant difference conditions respect nocturnal 2300 0700 ghrelin secretion f432 665 p 001 confirmed z score 231 p 005 comparison hormone curves sleep sleep deprivation aforementioned stability testing 36
0.12693419.14871884.html.plaintext.txt	26	view larger version 19k fig 1 plasma levels ghrelin human growth hormone hgh cortisol 9 healthy subjects sleep sleep deprivation arrows indicate food intake black bar indicates time subjects allowed sleep kept awake respectively
0.12693419.14871884.html.plaintext.txt	27	anova also revealed significant difference nocturnal hgh secretion conditions f432 81 p 001 confirming well established hgh peak around sleep onset strong attenuation sleep deprivation fig 1 peak hgh level night sleep positively correlated ghrelin secretion first 4 h sleep r 0705 p 005 fig 2 similar nonsignificant ns relationship r 0433 ns obvious hgh ghrelin levels suppressed sleep deprivation day ghrelin hgh plasma levels increased meals declined thereafter fig 1
0.12693419.14871884.html.plaintext.txt	28	view larger version 11k fig 2 scatter plot hgh peak vs area curve auc ghrelin secretion 2300 0300 sleep 9 healthy subjects pearsons correlation coefficient revealed significant positive correlation r 071 p 001
0.12693419.14871884.html.plaintext.txt	29	cortisol levels across 24 h experimental period showed well known circadian variability maximum morning nadir night anova repeated measures revealed significant differences two conditions f432 23 ns
0.12693419.14871884.html.plaintext.txt	30	cortisol levels across 24 h experimental period showed well known circadian variability maximum morning nadir night anova repeated measures revealed significant differences two conditions f432 23 ns
0.12693419.14871884.html.plaintext.txt	31	discussion top abstract materials methods results discussion references present study investigated influence nocturnal sleep compared sleep deprivation ghrelin plasma levels healthy volunteers confirmed finding cummings et al 4 sleeping subjects ghrelin levels rise early part night decline morning breakfast discovered however increase blunted sleep deprivation subjects stayed awake ghrelin levels rose slowly steadily reach plateau early morning decrease breakfast relative increase 25 nocturnal wakefulness similar effects 12 h fast observed day 1 suppressive effect sleep deprivation ghrelin levels suggests bell shaped time course observed sleep might due influence circadian rhythms rather might related sleep hence nocturnal ghrelin secretion shows similarities hgh production promoted sleep well particularly sleep onset 3 addition peak hgh levels correlated positively ghrelin secretion first hours sleep fig 2 supporting idea tight interaction
0.12693419.14871884.html.plaintext.txt	32	discussion top abstract materials methods results discussion references present study investigated influence nocturnal sleep compared sleep deprivation ghrelin plasma levels healthy volunteers confirmed finding cummings et al 4 sleeping subjects ghrelin levels rise early part night decline morning breakfast discovered however increase blunted sleep deprivation subjects stayed awake ghrelin levels rose slowly steadily reach plateau early morning decrease breakfast relative increase 25 nocturnal wakefulness similar effects 12 h fast observed day 1 suppressive effect sleep deprivation ghrelin levels suggests bell shaped time course observed sleep might due influence circadian rhythms rather might related sleep hence nocturnal ghrelin secretion shows similarities hgh production promoted sleep well particularly sleep onset 3 addition peak hgh levels correlated positively ghrelin secretion first hours sleep fig 2 supporting idea tight interaction
0.12693419.14871884.html.plaintext.txt	33	sleep related growth hormone secretion probably caused increased production hypothalamic growth hormone releasing hormone ghrh acting pituitary 28 ghrelin contrast produced mainly stomach splanchnic organs 1 14 small quantities might also produced hypothalamus review see ref 9 unlikely contribute systemic levels 34 hence almost certain increased ghrelin levels found sleeping subjects due peripheral production yet unclear present brain might act ghrelin producing cells despite positive correlation ghrelin hgh secretion causative role hgh unlikely number studies demonstrated hgh administration affect ghrelin levels 2 8 16 30 studies investigating interaction ghrelin production feeding suggest influence vagal cholinergic efferents ghrelin production transmission ghrelin signal brain vagal afferents 29 30 studies indicate negative influence vagus ghrelin secretion therefore increased parasympathetic tone occurring sleep 30 unlikely explain increased ghrelin secretion opposite would rather expected hence although present results clearly demonstrate increased ghrelin levels sleep question remains solved sleeping brain stimulates ghrelin secretion first glance easy understand production appetite stimulating hormone increased sleep however interaction among metabolic endocrine sleep regulating networks complex ghrelin numerous functions ghrelin recently shown increase sws effect probably dependent ghrh receptor 33 35 therefore ghrelin might represent peripheral feed forward signal support sws initiation andor maintenance first hours night sleep concert central sws promoting actions ghrh 18 similarly ghrelin potent growth hormone secretagogue 11 might reinforce central ghrh signal enhanced hgh production idea supported correlation hgh ghrelin production shown fig 2 studies interactions sleep neuroendocrine factors date back late 1960s eg ref 31 recently particularly intriguing link sleep regulation appetite became evident orexins hypothalamic peptides initially thought mainly regulate food intake also potent arousing properties 21 play crucial role pathophysiology narcolepsy narcolepsy characterized excessive daytime sleepiness cataplexy sudden short lasting loss muscle tone triggered emotions acquired complete loss hypothalamic orexin production hypothalamus patients 21 addition sleep related symptoms patients display various endocrine metabolic abnormalities obesity hypoleptinemia 23 25 like ghrelin plasma levels orexin cerebrospinal fluid levels increased night 6 ghrelin induced food intake mediated orexinergic pathways 22 therefore might great interest investigate ghrelin baseline conditions association sleep sleep deprivation association meals narcoleptic patients conclude ghrelin production enhanced night sleep healthy humans correlates increased release hgh occurring parallel although underlying mechanisms remain elucidated present study supports idea ghrelin novel important player within sleep neuroendocrine interplay
0.12693419.14871884.html.plaintext.txt	34	sleep related growth hormone secretion probably caused increased production hypothalamic growth hormone releasing hormone ghrh acting pituitary 28 ghrelin contrast produced mainly stomach splanchnic organs 1 14 small quantities might also produced hypothalamus review see ref 9 unlikely contribute systemic levels 34 hence almost certain increased ghrelin levels found sleeping subjects due peripheral production yet unclear present brain might act ghrelin producing cells despite positive correlation ghrelin hgh secretion causative role hgh unlikely number studies demonstrated hgh administration affect ghrelin levels 2 8 16 30 studies investigating interaction ghrelin production feeding suggest influence vagal cholinergic efferents ghrelin production transmission ghrelin signal brain vagal afferents 29 30 studies indicate negative influence vagus ghrelin secretion therefore increased parasympathetic tone occurring sleep 30 unlikely explain increased ghrelin secretion opposite would rather expected hence although present results clearly demonstrate increased ghrelin levels sleep question remains solved sleeping brain stimulates ghrelin secretion first glance easy understand production appetite stimulating hormone increased sleep however interaction among metabolic endocrine sleep regulating networks complex ghrelin numerous functions ghrelin recently shown increase sws effect probably dependent ghrh receptor 33 35 therefore ghrelin might represent peripheral feed forward signal support sws initiation andor maintenance first hours night sleep concert central sws promoting actions ghrh 18 similarly ghrelin potent growth hormone secretagogue 11 might reinforce central ghrh signal enhanced hgh production idea supported correlation hgh ghrelin production shown fig 2 studies interactions sleep neuroendocrine factors date back late 1960s eg ref 31 recently particularly intriguing link sleep regulation appetite became evident orexins hypothalamic peptides initially thought mainly regulate food intake also potent arousing properties 21 play crucial role pathophysiology narcolepsy narcolepsy characterized excessive daytime sleepiness cataplexy sudden short lasting loss muscle tone triggered emotions acquired complete loss hypothalamic orexin production hypothalamus patients 21 addition sleep related symptoms patients display various endocrine metabolic abnormalities obesity hypoleptinemia 23 25 like ghrelin plasma levels orexin cerebrospinal fluid levels increased night 6 ghrelin induced food intake mediated orexinergic pathways 22 therefore might great interest investigate ghrelin baseline conditions association sleep sleep deprivation association meals narcoleptic patients conclude ghrelin production enhanced night sleep healthy humans correlates increased release hgh occurring parallel although underlying mechanisms remain elucidated present study supports idea ghrelin novel important player within sleep neuroendocrine interplay
0.12693419.14871884.html.plaintext.txt	35	acknowledgments gratefully acknowledge statistical advice dr alexander yassouridis helpful comments dr axel steiger furthermore thank gabriele kohl expert technical assistance dorothea skottke assistance preparing manuscript
0.12693419.14871884.html.plaintext.txt	36	acknowledgments gratefully acknowledge statistical advice dr alexander yassouridis helpful comments dr axel steiger furthermore thank gabriele kohl expert technical assistance dorothea skottke assistance preparing manuscript
0.12693419.14871884.html.plaintext.txt	37	footnotes address reprint requests correspondence schuld max planck institute psychiatry kraepelinstrasse 10 80804 munich germany e mail schuldatmpipsyklmpgde u d
0.12693419.14871884.html.plaintext.txt	38	footnotes address reprint requests correspondence schuld max planck institute psychiatry kraepelinstrasse 10 80804 munich germany e mail schuldatmpipsyklmpgde u d
0.12693419.14871884.html.plaintext.txt	39	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.12693419.14871884.html.plaintext.txt	40	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.12693419.14871884.html.plaintext.txt	41	references top abstract materials methods results discussion references ariyasu h takaya k tagami ogawa y hosoda k akamizu suda m koh natsui k toyooka shirakami g usui shimatsu doi k hosoda h kojima m kangawa k nakao k stomach major source circulating ghrelin feeding state determines plasma ghrelin like immunoreactivity levels humans j clin endocrinol metab 86 4753 4758 2001abstractfree full text barkan al dimaraki ev jessup sk symons kv ermolenko m jaffe ca ghrelin secretion humans sexually dimorphic suppressed somatostatin affected ambient growth hormone levels j clin endocrinol metab 88 2180 2184 2003abstractfree full text born j muth fehm hl significance sleep onset slow wave sleep nocturnal release growth hormone gh cortisol psychoneuroendocrinology 13 233 423 1988crossrefisimedline cummings de purnell jq frayo rs schmidova k wisse weigle ds preprandial rise plasma ghrelin levels suggests role meal initiation humans diabetes 50 1714 1719 2001abstractfree full text czeisler ca klerman eb circadian sleep dependent regulation hormone release humans recent prog horm res 54 97 130 1999medline dalal ma schuld haack m uhr m geisler p eisensehr noachtar pollmacher normal plasma levels orexin hypocretin 1 narcoleptic patients neurology 56 1749 1751 2001abstractfree full text date y kojima m hosoda h sawaguchi mondal ms suganuma matsukura kangawa k nakazato m ghrelin novel growth hormone releasing acylated peptide synthesized distinct endocrine cell type gastrointestinal tracts rats humans endocrinology 141 4255 4261 2000abstractfree full text hansen tk dall r hosoda h kojima m kangawa k christiansen js jorgensen jol weight loss increases circulating levels ghrelin human obesity clin endocrinol oxf 56 203 206 2002crossrefisimedline horvath tl diano sotonyi p heiman m tschop m minireview ghrelin regulation energy balance hypothalamic perspective endocrinology 142 4163 4169 2001abstractfree full text kojima m hosoda h date y nakazato m matsuo h kangawa k ghrelin growth hormone releasing acylated peptide stomach nature 402 656 660 1999crossrefisimedline kojima m hosoda h matsuo h kangawa k ghrelin discovery natural endogenous ligand growth hormone secretagogue receptor trends endocrinol metab 12 118 122 2001crossrefisimedline korbonits m bustin sa kojima m jordan adams ef lowe dg kangawa k grossman ab expression growth hormone secretagogue receptor ligand ghrelin normal abnormal human pituitary neuroendocrine tumors j clin endocrinol metab 86 881 887 2001abstractfree full text licinio j mantzoros c negrao ab cizza g wong ml bongiorno pb chrousos gp karp b allen c flier js gold pw human leptin levels pulsatile inversely related pituitary adrenal function nat med 3 575 579 1997isimedline moller n nygren j hansen tk oslashrskov h frystyk j nair ks splanchnic release ghrelin humans j clin endocrinol metab 88 850 852 2003abstractfree full text mullington j korth c hermann dm orth galanos c holsboer f pollmacher dose dependent effects endotoxin human sleep j physiol regul integr comp physiol 278 r947 r955 2000abstractfree full text murdolo g lucidi p di loreto c parlanti n de cicco fanelli c perriello g mughetti d pippi r brozzetti santeusanio f de feo p circulating ghrelin levels visceral obese men modified short term treatment low doses gh replacement j endocrinol invest 26 244 249 2003isimedline nakazato m murakami n date y kojima m matsuo h kangawa k matsukura role ghrelin central regulation feeding nature 409 194 198 2001crossrefisimedline obal f alt j taishi p gardi j krueger jm sleep mice nonfunctional growth hormone releasing hormone receptors j physiol regul integr comp physiol 284 r131 r139 2003abstractfree full text pollmacher schuld kraus haack m hinze selch d mullington j experimental immunomodulation sleep sleepiness humans ann ny acad sci 917 488 499 2000abstractfree full text rechtschaffen kales manual standardized terminology techniques scoring system sleep stages human subjects bethesda md natl inst neurological diseases blindness 1968 sakurai orexin link energy homeostasis adaptive behaviour curr opin clin nutr metab care 6 353 360 2003crossrefisimedline salomon rm ripley b kennedy js johnson b schmidt d zeitzer jm nishino mignot e diurnal variation cerebrospinal fluid hypocretin 1 orexin levels control depressed subjects biol psychiatry 54 96 104 2003crossrefisimedline scammell te neurobiology diagnosis treatment narcolepsy ann neurol 53 154 166 2003crossrefisimedline schuld blum wf uhr m haack m kraus holsboer f pollmacher reduced leptin levels human narcolepsy neuroendocrinology 72 195 198 2000crossrefisimedline schuld hebebrand j geller f pollmacher increased body mass index patients narcolepsy lancet 355 1274 1275 2000isimedline schuld mullington j hermann d hinze selch d fenzel holsboer f pollmacher effects granulocyte colony stimulating factor night sleep humans j physiol regul integr comp physiol 276 r1149 r1155 1999abstractfree full text simon c gronfier c schlienger jl brandenberger g circadian ultradian variations leptin normal man continuous enteral nutrition relationship sleep body temperature j clin endocrinol metab 83 1893 1899 1998abstractfree full text steiger sleep endocrine regulation front biosci 8 s358 s376 2003isimedline sugino hasegawa y kikkawa y yamaura j yamagishi m kurose y kojima m kangawa k terashima y transient ghrelin surge occurs feeding scheduled meal fed sheep biochem biophys res commun 295 255 260 2002crossrefisimedline sugino yamaura j yamagishi m kurose y kojima m kangawa k hasegawa y terashima y involvement cholinergic neurons regulation ghrelin secretory response feeding sheep biochem biophys res commun 304 308 312 2003crossrefisimedline takahashi y kipnis dm daughaday wh growth hormone secretion sleep j clin invest 47 2079 2090 1968isimedline toshinai k date y murakami n shimada m mondal ms shimbara guan jl wang qp funahashi h sakurai shioda matsukura kangawa k nakazato m ghrelin induced food intake mediated via orexin pathway endocrinology 144 1506 1512 2003abstractfree full text trinder j kleiman j carrington m smith breen tan n kim y autonomic activity human sleep function time sleep stage j sleep res 10 253 264 2001crossrefisimedline van der toorn fm janssen jamj de herder ww broglio f ghigo e van der lely aj central ghrelin production substantially contribute systemic ghrelin concentrations study two subjects active acromegaly eur j endocrinol 147 195 199 2002isimedline weikel jc wichniak ising m brunner h friess e held k mathias schmid da uhr m steiger ghrelin promotes slow wave sleep humans j physiol endocrinol metab 284 e407 e415 2003abstractfree full text wiedemann k jahn h yassouridis kellner m anxiolytic like effects atrial natriuretic peptide cholecystokinin tetrapeptide induced panic attacks preliminary findings arch gen psychiatry 58 371 377 2001abstractfree full text wren seal lj cohen ma brynes ae frost gs murphy kg dhillo ws ghatei ma bloom sr ghrelin enhances appetite increases food intake humans j clin endocrinol metab 86 5992 5995 2001abstractfree full text wren small cj ward hl murphy kg dakin cl taheri kennedy ar roberts gh morgan dga ghatei ma bloom sr novel hypothalamic peptide ghrelin stimulates food intake growth hormone secretion endocrinology 141 4325 4328 2000abstractfree full text
0.12693419.14871884.html.plaintext.txt	42	references top abstract materials methods results discussion references ariyasu h takaya k tagami ogawa y hosoda k akamizu suda m koh natsui k toyooka shirakami g usui shimatsu doi k hosoda h kojima m kangawa k nakao k stomach major source circulating ghrelin feeding state determines plasma ghrelin like immunoreactivity levels humans j clin endocrinol metab 86 4753 4758 2001abstractfree full text barkan al dimaraki ev jessup sk symons kv ermolenko m jaffe ca ghrelin secretion humans sexually dimorphic suppressed somatostatin affected ambient growth hormone levels j clin endocrinol metab 88 2180 2184 2003abstractfree full text born j muth fehm hl significance sleep onset slow wave sleep nocturnal release growth hormone gh cortisol psychoneuroendocrinology 13 233 423 1988crossrefisimedline cummings de purnell jq frayo rs schmidova k wisse weigle ds preprandial rise plasma ghrelin levels suggests role meal initiation humans diabetes 50 1714 1719 2001abstractfree full text czeisler ca klerman eb circadian sleep dependent regulation hormone release humans recent prog horm res 54 97 130 1999medline dalal ma schuld haack m uhr m geisler p eisensehr noachtar pollmacher normal plasma levels orexin hypocretin 1 narcoleptic patients neurology 56 1749 1751 2001abstractfree full text date y kojima m hosoda h sawaguchi mondal ms suganuma matsukura kangawa k nakazato m ghrelin novel growth hormone releasing acylated peptide synthesized distinct endocrine cell type gastrointestinal tracts rats humans endocrinology 141 4255 4261 2000abstractfree full text hansen tk dall r hosoda h kojima m kangawa k christiansen js jorgensen jol weight loss increases circulating levels ghrelin human obesity clin endocrinol oxf 56 203 206 2002crossrefisimedline horvath tl diano sotonyi p heiman m tschop m minireview ghrelin regulation energy balance hypothalamic perspective endocrinology 142 4163 4169 2001abstractfree full text kojima m hosoda h date y nakazato m matsuo h kangawa k ghrelin growth hormone releasing acylated peptide stomach nature 402 656 660 1999crossrefisimedline kojima m hosoda h matsuo h kangawa k ghrelin discovery natural endogenous ligand growth hormone secretagogue receptor trends endocrinol metab 12 118 122 2001crossrefisimedline korbonits m bustin sa kojima m jordan adams ef lowe dg kangawa k grossman ab expression growth hormone secretagogue receptor ligand ghrelin normal abnormal human pituitary neuroendocrine tumors j clin endocrinol metab 86 881 887 2001abstractfree full text licinio j mantzoros c negrao ab cizza g wong ml bongiorno pb chrousos gp karp b allen c flier js gold pw human leptin levels pulsatile inversely related pituitary adrenal function nat med 3 575 579 1997isimedline moller n nygren j hansen tk oslashrskov h frystyk j nair ks splanchnic release ghrelin humans j clin endocrinol metab 88 850 852 2003abstractfree full text mullington j korth c hermann dm orth galanos c holsboer f pollmacher dose dependent effects endotoxin human sleep j physiol regul integr comp physiol 278 r947 r955 2000abstractfree full text murdolo g lucidi p di loreto c parlanti n de cicco fanelli c perriello g mughetti d pippi r brozzetti santeusanio f de feo p circulating ghrelin levels visceral obese men modified short term treatment low doses gh replacement j endocrinol invest 26 244 249 2003isimedline nakazato m murakami n date y kojima m matsuo h kangawa k matsukura role ghrelin central regulation feeding nature 409 194 198 2001crossrefisimedline obal f alt j taishi p gardi j krueger jm sleep mice nonfunctional growth hormone releasing hormone receptors j physiol regul integr comp physiol 284 r131 r139 2003abstractfree full text pollmacher schuld kraus haack m hinze selch d mullington j experimental immunomodulation sleep sleepiness humans ann ny acad sci 917 488 499 2000abstractfree full text rechtschaffen kales manual standardized terminology techniques scoring system sleep stages human subjects bethesda md natl inst neurological diseases blindness 1968 sakurai orexin link energy homeostasis adaptive behaviour curr opin clin nutr metab care 6 353 360 2003crossrefisimedline salomon rm ripley b kennedy js johnson b schmidt d zeitzer jm nishino mignot e diurnal variation cerebrospinal fluid hypocretin 1 orexin levels control depressed subjects biol psychiatry 54 96 104 2003crossrefisimedline scammell te neurobiology diagnosis treatment narcolepsy ann neurol 53 154 166 2003crossrefisimedline schuld blum wf uhr m haack m kraus holsboer f pollmacher reduced leptin levels human narcolepsy neuroendocrinology 72 195 198 2000crossrefisimedline schuld hebebrand j geller f pollmacher increased body mass index patients narcolepsy lancet 355 1274 1275 2000isimedline schuld mullington j hermann d hinze selch d fenzel holsboer f pollmacher effects granulocyte colony stimulating factor night sleep humans j physiol regul integr comp physiol 276 r1149 r1155 1999abstractfree full text simon c gronfier c schlienger jl brandenberger g circadian ultradian variations leptin normal man continuous enteral nutrition relationship sleep body temperature j clin endocrinol metab 83 1893 1899 1998abstractfree full text steiger sleep endocrine regulation front biosci 8 s358 s376 2003isimedline sugino hasegawa y kikkawa y yamaura j yamagishi m kurose y kojima m kangawa k terashima y transient ghrelin surge occurs feeding scheduled meal fed sheep biochem biophys res commun 295 255 260 2002crossrefisimedline sugino yamaura j yamagishi m kurose y kojima m kangawa k hasegawa y terashima y involvement cholinergic neurons regulation ghrelin secretory response feeding sheep biochem biophys res commun 304 308 312 2003crossrefisimedline takahashi y kipnis dm daughaday wh growth hormone secretion sleep j clin invest 47 2079 2090 1968isimedline toshinai k date y murakami n shimada m mondal ms shimbara guan jl wang qp funahashi h sakurai shioda matsukura kangawa k nakazato m ghrelin induced food intake mediated via orexin pathway endocrinology 144 1506 1512 2003abstractfree full text trinder j kleiman j carrington m smith breen tan n kim y autonomic activity human sleep function time sleep stage j sleep res 10 253 264 2001crossrefisimedline van der toorn fm janssen jamj de herder ww broglio f ghigo e van der lely aj central ghrelin production substantially contribute systemic ghrelin concentrations study two subjects active acromegaly eur j endocrinol 147 195 199 2002isimedline weikel jc wichniak ising m brunner h friess e held k mathias schmid da uhr m steiger ghrelin promotes slow wave sleep humans j physiol endocrinol metab 284 e407 e415 2003abstractfree full text wiedemann k jahn h yassouridis kellner m anxiolytic like effects atrial natriuretic peptide cholecystokinin tetrapeptide induced panic attacks preliminary findings arch gen psychiatry 58 371 377 2001abstractfree full text wren seal lj cohen ma brynes ae frost gs murphy kg dhillo ws ghatei ma bloom sr ghrelin enhances appetite increases food intake humans j clin endocrinol metab 86 5992 5995 2001abstractfree full text wren small cj ward hl murphy kg dakin cl taheri kennedy ar roberts gh morgan dga ghatei ma bloom sr novel hypothalamic peptide ghrelin stimulates food intake growth hormone secretion endocrinology 141 4325 4328 2000abstractfree full text
0.14533791.15976062.html.plaintext.txt	0	orexin modulates mitral cell activity rat olfactory bulb patch clamp study slices immunocytochemical localization orexin receptors alexandre b hardy josiane aioun christine baly karyn julliard monique caillol roland salesse patricia duchamp viret
0.14533791.15976062.html.plaintext.txt	1	orexin modulates mitral cell activity rat olfactory bulb patch clamp study slices immunocytochemical localization orexin receptors alexandre b hardy josiane aioun christine baly karyn julliard monique caillol roland salesse patricia duchamp viret
0.14533791.15976062.html.plaintext.txt	2	laboratoire de neurosciences et systemes sensoriels abh kaj pd v centre national de la recherche scientifique unite mixte de recherche 5020 universite claude bernard 69366 lyon cedex 07 laboratoire neurobiologie de l olfaction et prise alimentaire ja cb mc rs equipe recepteurs et communication chimique institut national de la recherche agronomique 78352 jouy en josas france
0.14533791.15976062.html.plaintext.txt	3	address correspondence requests reprints patricia duchamp viret laboratoire de neurosciences et systemes sensoriels centre national de la recherche scientifique unite mixte de recherche 5020 universite claude bernard 50 avenue tony garnier 69366 lyon cedex 07 france e mail pduchampatolfacuniv lyon1fr u d
0.14533791.15976062.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references orexin b involved feeding behaviors recently fibers containing peptides found rat olfactory bulb fibers originate lateral posterior hypothalamus perifornical area distributed glomerular mitral cell granule cell layers orexin receptors mainly expressed mitral cells present study rt pcr experiments done determine orexin receptor expression early postnatal life rats immunocytochemical experiments performed clarify structural ultrastructural localization orexin receptors olfactory bulb furthermore functional electrophysiological approach examined action orexin mitral cell excitability spontaneous activity using vitro patch clamp techniques rt pcr results show mrna two type receptors type 1 orexin receptors type 2 orexin receptors expressed olfactory bulb rat 10 d adult stage ages immunocytochemical data show orexin 1 receptors localized cell bodies periglomerular mitraltufted granule cells immunoreactivity also demonstrated mitraltufted cell dendrites arborizing glomerulus mitraltufted granule cell processes running external plexiform layer functionally orexin produced either direct tetrodotoxin insensitive depolarization one group mitral cells 7 another group 30 indirect tetrodotoxin sensitive hyperpolarization actions mediated type 1 orexin receptors response antagonized sb 334867 selective antagonist mitral cell recordings performed bicuculline aminobutyric acid gabaa receptor antagonist indicate orexin induced indirect hyperpolarization partly mediated gabaa receptors granule cells periglomerular cells express orexin receptors gabaergic cells could involved hyperpolarization mechanisms could support indirect hyperpolarization mitral cells dopamine interneuron solicitation proposed results provide data allow us better understand neural communication regulation mechanisms hypothalamic feeding centers olfactory bulb
0.14533791.15976062.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references orexin b involved feeding behaviors recently fibers containing peptides found rat olfactory bulb fibers originate lateral posterior hypothalamus perifornical area distributed glomerular mitral cell granule cell layers orexin receptors mainly expressed mitral cells present study rt pcr experiments done determine orexin receptor expression early postnatal life rats immunocytochemical experiments performed clarify structural ultrastructural localization orexin receptors olfactory bulb furthermore functional electrophysiological approach examined action orexin mitral cell excitability spontaneous activity using vitro patch clamp techniques rt pcr results show mrna two type receptors type 1 orexin receptors type 2 orexin receptors expressed olfactory bulb rat 10 d adult stage ages immunocytochemical data show orexin 1 receptors localized cell bodies periglomerular mitraltufted granule cells immunoreactivity also demonstrated mitraltufted cell dendrites arborizing glomerulus mitraltufted granule cell processes running external plexiform layer functionally orexin produced either direct tetrodotoxin insensitive depolarization one group mitral cells 7 another group 30 indirect tetrodotoxin sensitive hyperpolarization actions mediated type 1 orexin receptors response antagonized sb 334867 selective antagonist mitral cell recordings performed bicuculline aminobutyric acid gabaa receptor antagonist indicate orexin induced indirect hyperpolarization partly mediated gabaa receptors granule cells periglomerular cells express orexin receptors gabaergic cells could involved hyperpolarization mechanisms could support indirect hyperpolarization mitral cells dopamine interneuron solicitation proposed results provide data allow us better understand neural communication regulation mechanisms hypothalamic feeding centers olfactory bulb
0.14533791.15976062.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references many animal behaviors triggered odorant cues environment particular food odors among major determinants food choice food learning clear several years olfactory system involved feeding behavior nutritional status animal shown influence reactivity food odors mitral cells main output neurons olfactory bulb 1 2 3 4 5 example demonstrated fasted rats 70 mitral cells stimulated food odor stimulation vs 12 nonfood odor whereas fed animals 11 responded food odors 6
0.14533791.15976062.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references many animal behaviors triggered odorant cues environment particular food odors among major determinants food choice food learning clear several years olfactory system involved feeding behavior nutritional status animal shown influence reactivity food odors mitral cells main output neurons olfactory bulb 1 2 3 4 5 example demonstrated fasted rats 70 mitral cells stimulated food odor stimulation vs 12 nonfood odor whereas fed animals 11 responded food odors 6
0.14533791.15976062.html.plaintext.txt	8	conversely shown odors regulate food intake behavior indeed le magnen 7 showed rats increased food intake satiated presented differently odorized foods moreover everyday experience humans animals food odors attractive feeding whereas stimuli may become neutral even aversive feeding sensory olfactory inputs thus crucial nutrition behavior humans animals olfactory system involvement begins food search step olfactory sensitivity levels provide signal detection allows animals follow concentration gradient toward food source olfactory system contributes palatability analysis food appetence animal food defined internal physiological status
0.14533791.15976062.html.plaintext.txt	9	conversely shown odors regulate food intake behavior indeed le magnen 7 showed rats increased food intake satiated presented differently odorized foods moreover everyday experience humans animals food odors attractive feeding whereas stimuli may become neutral even aversive feeding sensory olfactory inputs thus crucial nutrition behavior humans animals olfactory system involvement begins food search step olfactory sensitivity levels provide signal detection allows animals follow concentration gradient toward food source olfactory system contributes palatability analysis food appetence animal food defined internal physiological status
0.14533791.15976062.html.plaintext.txt	10	hypothalamic feeding centers 8 analyze metabolic cues turn regulate appetite centers send direct specific projections olfactory structures especially olfactory bulb ob first integrative relay system 9 10 11 12 13 discovery orexin oxa b oxb hypocretin ii 11 13 two peptides derived prepropeptide contained neurons localized lateral hypothalamus perifornical area provided new insights regulation mechanisms feeding orexin ox neurons lateral hypothalamus perifornical area controlled changes circulating nutriment activated natural hypoglycemic conditions 14 insulin induced ones 15 whereas inhibited glucose signals related ingestion food 15 16 17 18 19 data led classification ox neurons lateral hypothalamus perifornical area glucose sensitive neurons 20 furthermore ox neurons stimulated increase circulating lipids thus ox neurons negatively related glucose level inversely related circulating fat 21 latter relation suggesting role peptide increased activity associated high fat diet 22 23
0.14533791.15976062.html.plaintext.txt	11	hypothalamic feeding centers 8 analyze metabolic cues turn regulate appetite centers send direct specific projections olfactory structures especially olfactory bulb ob first integrative relay system 9 10 11 12 13 discovery orexin oxa b oxb hypocretin ii 11 13 two peptides derived prepropeptide contained neurons localized lateral hypothalamus perifornical area provided new insights regulation mechanisms feeding orexin ox neurons lateral hypothalamus perifornical area controlled changes circulating nutriment activated natural hypoglycemic conditions 14 insulin induced ones 15 whereas inhibited glucose signals related ingestion food 15 16 17 18 19 data led classification ox neurons lateral hypothalamus perifornical area glucose sensitive neurons 20 furthermore ox neurons stimulated increase circulating lipids thus ox neurons negatively related glucose level inversely related circulating fat 21 latter relation suggesting role peptide increased activity associated high fat diet 22 23
0.14533791.15976062.html.plaintext.txt	12	majority physiological studies reviews see refs 24 25 indicate orexins potent stimulators food intake 26 27 oxa effective oxb moreover peptides interact various neuronal pathways potentiate apparently divergent functions review see ref 28 currently two closely related g protein coupled receptor types termed type 1 orexin receptors orx1 type 2 orexin receptors orx2 identified although oxa affinity orx1 orx2 oxb 10 fold greater affinity orx2 13 29 30
0.14533791.15976062.html.plaintext.txt	13	majority physiological studies reviews see refs 24 25 indicate orexins potent stimulators food intake 26 27 oxa effective oxb moreover peptides interact various neuronal pathways potentiate apparently divergent functions review see ref 28 currently two closely related g protein coupled receptor types termed type 1 orexin receptors orx1 type 2 orexin receptors orx2 identified although oxa affinity orx1 orx2 oxb 10 fold greater affinity orx2 13 29 30
0.14533791.15976062.html.plaintext.txt	14	caillol et al 31 demonstrated ob immunoreactive oxa varicose fibers mainly around glomeruli mitral cell granule cell layers glomeruli spherical neuropiles lying ob periphery primary axons synapse mitral cells delimited gabaergic interneurons called periglomerular cells granule cells deep gabaergic inhibitory interneurons localization oxb labeling paralleled oxa however immunoreactivity orx1 orx2 detected mitraltufted cell bodies orx2 labeling faint 31 localization may support least partly data reporting ob mitral cell reactivity odors modulated according hunger satiation states rats 3
0.14533791.15976062.html.plaintext.txt	15	exploration ox actions ob network provide better understanding cross talk olfactory metabolic cues brain basis nutritional behavior study analyzed specifically ox action mitral cells putative cell targets ob 31 vitro patch clamp study actions oxa sb 334867 orx1 antagonist glaxosmithkline harlow essex uk tested spontaneous activity excitability mitral cells furthermore immunocytochemical study done clarify cellular subcellular localizations orx1 expressed orexin receptor ob addition data available early ontogenetic development orexin innervation orexin receptors ob electrophysiological studies slices performed 10 25 d old rats presence orx1 evaluated rt pcr experiments rats adults 10 25 postnatal days p old altogether data expected provide enlightenment neurochemical modulatory effect oxa ob activity reveal cell types bulbar network targets orexin innervations furthermore first functional study expected give rise preliminary hypotheses dealing role olfactory system regulation food intake processes
0.14533791.15976062.html.plaintext.txt	16	exploration ox actions ob network provide better understanding cross talk olfactory metabolic cues brain basis nutritional behavior study analyzed specifically ox action mitral cells putative cell targets ob 31 vitro patch clamp study actions oxa sb 334867 orx1 antagonist glaxosmithkline harlow essex uk tested spontaneous activity excitability mitral cells furthermore immunocytochemical study done clarify cellular subcellular localizations orx1 expressed orexin receptor ob addition data available early ontogenetic development orexin innervation orexin receptors ob electrophysiological studies slices performed 10 25 d old rats presence orx1 evaluated rt pcr experiments rats adults 10 25 postnatal days p old altogether data expected provide enlightenment neurochemical modulatory effect oxa ob activity reveal cell types bulbar network targets orexin innervations furthermore first functional study expected give rise preliminary hypotheses dealing role olfactory system regulation food intake processes
0.14533791.15976062.html.plaintext.txt	17	materials methods top abstract introduction materials methods results discussion references experiments done according european communities council directive 24 november 1986 86609eec
0.14533791.15976062.html.plaintext.txt	18	rt pcr analysis orexin receptor expression hypothalamus hypo ob animals tissue preparation experimental procedures carried minimize animal suffering number rats used male wistar rats breeding stock housed 12 h light 12 h dark cycles free access food water total three animals killed decapitation 10 d 25 d p10 p25 2 months adults weaning p21 young kept dam brain quickly removed hypo ob dissected ice
0.14533791.15976062.html.plaintext.txt	19	rt pcr analysis orexin receptor expression hypothalamus hypo ob animals tissue preparation experimental procedures carried minimize animal suffering number rats used male wistar rats breeding stock housed 12 h light 12 h dark cycles free access food water total three animals killed decapitation 10 d 25 d p10 p25 2 months adults weaning p21 young kept dam brain quickly removed hypo ob dissected ice
0.14533791.15976062.html.plaintext.txt	20	total rna isolation rt pcr analysis total rna isolated hypo ob using guanidium thiocyanate phenol chloroform extraction method 32 dnase treated roche molecular biochemicals meylan france cdna reverse transcribed 3 microg total rna 50 u superscript ii reverse transcriptase according manufacturer procedures life technologies inc brl cergy pontoise france control reaction omitting enzyme systematically included confirm absence genomic contamination internal standard using glyceraldehyde 3 phophate dehydrogenase gapdh referent housekeeping gene systematically included pcr amplification 1 microl reverse transcription aliquot added 20 microl reaction mixture containing pair primers gapdh primers 5 aaacccatcaccatcttcca 1057 1077 nm017008 low 5 aggggccatccacagtcttct 1417 1397 orx1 primers 5 cctgcctccagactatgagga 631 651 nm013064 low 5 atcttagggtagagttcatct 1206 1186 orx2 primers 5 gattccctccctcgtcgcaa 81 100 nm0130741 low 5 cagcgttcatcgcagactgta 700 681
0.14533791.15976062.html.plaintext.txt	21	total rna isolation rt pcr analysis total rna isolated hypo ob using guanidium thiocyanate phenol chloroform extraction method 32 dnase treated roche molecular biochemicals meylan france cdna reverse transcribed 3 microg total rna 50 u superscript ii reverse transcriptase according manufacturer procedures life technologies inc brl cergy pontoise france control reaction omitting enzyme systematically included confirm absence genomic contamination internal standard using glyceraldehyde 3 phophate dehydrogenase gapdh referent housekeeping gene systematically included pcr amplification 1 microl reverse transcription aliquot added 20 microl reaction mixture containing pair primers gapdh primers 5 aaacccatcaccatcttcca 1057 1077 nm017008 low 5 aggggccatccacagtcttct 1417 1397 orx1 primers 5 cctgcctccagactatgagga 631 651 nm013064 low 5 atcttagggtagagttcatct 1206 1186 orx2 primers 5 gattccctccctcgtcgcaa 81 100 nm0130741 low 5 cagcgttcatcgcagactgta 700 681
0.14533791.15976062.html.plaintext.txt	22	pcrs done according standard procedures using 05u taq dna polymerase promega charbonnieres france thermal cycler apparatus used following conditions 45 sec 94 c 45 sec 57 c 45 sec 72 c 23 gapdh 35 cycles orx1 orx2 pcr products 3 microl aliquot resolved 15 agarose gel 1x tae tris acetate edta buffer containing 1 microgml ethidium bromide molecular weight marker systematically included 1 kb dna ladder life technologies inc invitrogen cergy pontoise france gels photographed uv light ob pcr products 25 d old rats sequenced genome express paris france analyzed using blast programs
0.14533791.15976062.html.plaintext.txt	23	pcrs done according standard procedures using 05u taq dna polymerase promega charbonnieres france thermal cycler apparatus used following conditions 45 sec 94 c 45 sec 57 c 45 sec 72 c 23 gapdh 35 cycles orx1 orx2 pcr products 3 microl aliquot resolved 15 agarose gel 1x tae tris acetate edta buffer containing 1 microgml ethidium bromide molecular weight marker systematically included 1 kb dna ladder life technologies inc invitrogen cergy pontoise france gels photographed uv light ob pcr products 25 d old rats sequenced genome express paris france analyzed using blast programs
0.14533791.15976062.html.plaintext.txt	24	structural ultrastructural immunocytochemical study seven male wistar rats used light microscopy three adults rats 2 month old body weight 300 g two p10 two p25 animals deeply anesthetized pentobarbital 60 mgkg body weight ip sanofi paris france perfused transcardially 100 ml saline 150 ml freshly prepared fixative solution 4 paraformaldehyde 01 m pbs olfactory bulbs carefully dissected postfixed fixative 3 h room temperature cryoprotected saccharose 30 cut cryostat serial coronal sections 14 microm thick sections first treated 30 min 4 c 05 h2o2 pbs eliminate endogenous peroxidases carefully washed 1 h immersion solution 10 normal goat serum pbs room temperature rt used block nonspecific sites sections incubated 4 c 3 d primary antibody diluted 12000 pbs containing 1 normal goat serum 0025 triton x 100 01 bsa rabbit antiserum directed rathuman orx1 alpha diagnostic international cortec france controls sections incubated without primary antibody several washings pbs containing 1 nonfat freeze dried milk sections incubated biotinylated goat antirabbit igg vectastain elite kit vector laboratories burlingame ca buffer 1 2 h rt sections rinsed pbs incubated 1 h rt either avidin biotin peroxidase complex vectastain elite kit labeling visualized using 3 3 diaminobenzidine tetrahydrochloride solution intensified nickel peroxidase substrate kit vector laboratories streptavidin fluorescein 11000 vector laboratories 46 diamino 2 phenylindole dapi added 10 min 110000 pbs achieve nuclear counterstaining
0.14533791.15976062.html.plaintext.txt	25	structural ultrastructural immunocytochemical study seven male wistar rats used light microscopy three adults rats 2 month old body weight 300 g two p10 two p25 animals deeply anesthetized pentobarbital 60 mgkg body weight ip sanofi paris france perfused transcardially 100 ml saline 150 ml freshly prepared fixative solution 4 paraformaldehyde 01 m pbs olfactory bulbs carefully dissected postfixed fixative 3 h room temperature cryoprotected saccharose 30 cut cryostat serial coronal sections 14 microm thick sections first treated 30 min 4 c 05 h2o2 pbs eliminate endogenous peroxidases carefully washed 1 h immersion solution 10 normal goat serum pbs room temperature rt used block nonspecific sites sections incubated 4 c 3 d primary antibody diluted 12000 pbs containing 1 normal goat serum 0025 triton x 100 01 bsa rabbit antiserum directed rathuman orx1 alpha diagnostic international cortec france controls sections incubated without primary antibody several washings pbs containing 1 nonfat freeze dried milk sections incubated biotinylated goat antirabbit igg vectastain elite kit vector laboratories burlingame ca buffer 1 2 h rt sections rinsed pbs incubated 1 h rt either avidin biotin peroxidase complex vectastain elite kit labeling visualized using 3 3 diaminobenzidine tetrahydrochloride solution intensified nickel peroxidase substrate kit vector laboratories streptavidin fluorescein 11000 vector laboratories 46 diamino 2 phenylindole dapi added 10 min 110000 pbs achieve nuclear counterstaining
0.14533791.15976062.html.plaintext.txt	26	electron microscopy done three adult male wistar rats deeply anesthetized described transcardially perfused 200 ml saline followed 300 ml freshly prepared fixative solution paraformaldehyde 4 picric acid 02 glutaraldehyde 0125 01 m phosphate buffer brains dissected postfixed overnight 4 c fixative serial coronal sections 50 microm obtained vibratome vt1000s leica nussloch germany collected phosphate buffer immunocytochemical study performed free floating sections pbs using preembedding protocol previously described except triton x 100 omitted sections immersed 1 sodium borohydride nabh4 sigma aldrich saint quentin fallavier france pbs quench free aldehydic sites blocking nonspecific sites
0.14533791.15976062.html.plaintext.txt	27	electron microscopy done three adult male wistar rats deeply anesthetized described transcardially perfused 200 ml saline followed 300 ml freshly prepared fixative solution paraformaldehyde 4 picric acid 02 glutaraldehyde 0125 01 m phosphate buffer brains dissected postfixed overnight 4 c fixative serial coronal sections 50 microm obtained vibratome vt1000s leica nussloch germany collected phosphate buffer immunocytochemical study performed free floating sections pbs using preembedding protocol previously described except triton x 100 omitted sections immersed 1 sodium borohydride nabh4 sigma aldrich saint quentin fallavier france pbs quench free aldehydic sites blocking nonspecific sites
0.14533791.15976062.html.plaintext.txt	28	orx1 visualized using diaminobenzidine dab method adapted electron microscopy sections washed 005 m sucrosed tris buffer ph 76 incubated 005 dab substrate presence h2o2 reaction conducted stereomicroscope stopped immersion sections tris buffer immunostained sections selected osmicated 1 oso4 solution stained en bloc 1 uranyl acetate dehydrated graded series ethanol embedded epoxy resin lx112 ladd research industries inland europe conflanslanterne france semithin sections 1 2 microm obtained resin embedded material stained toluidine blue ultrathin sections 50 100 nm collected copper grids contrasted lead citrate observed philips suresne france cm12 electron microscope 80 kv accelerating voltage
0.14533791.15976062.html.plaintext.txt	29	patch clamp recording experiments slice preparation experiments performed 10 25 d old rats wistar animals killed decapitation head quickly immersed ice cold artificial cerebrospinal fluid acsf 2 4 c containing millimoles 125 nacl 4 kcl 25 nahco3 2 cacl2 125 nah2po4 1 mgcl2 ph 73 bubbled mixture 95 o2 5 co2 osmolarity adjusted 320 mosm glucose ob removed previously detailed 33 cut sagittal horizontal slices 250 350 microm thick using vibratome slices incubated gibb chamber 30 c 1 h stored rt electrophysiological recordings slices transferred experimental chamber 2 ml mounted upright microscope axioscope fs zeiss gottingen germany recordings slices continuously perfused oxygenated 30 c acsf 25 mlmin rate neurons visualized using water immersion x40 objective differential interference contrast optics nomarski edgewater nj infrared illumination hamamatsu camera hamamatsu photonics france massy france
0.14533791.15976062.html.plaintext.txt	30	patch clamp recording experiments slice preparation experiments performed 10 25 d old rats wistar animals killed decapitation head quickly immersed ice cold artificial cerebrospinal fluid acsf 2 4 c containing millimoles 125 nacl 4 kcl 25 nahco3 2 cacl2 125 nah2po4 1 mgcl2 ph 73 bubbled mixture 95 o2 5 co2 osmolarity adjusted 320 mosm glucose ob removed previously detailed 33 cut sagittal horizontal slices 250 350 microm thick using vibratome slices incubated gibb chamber 30 c 1 h stored rt electrophysiological recordings slices transferred experimental chamber 2 ml mounted upright microscope axioscope fs zeiss gottingen germany recordings slices continuously perfused oxygenated 30 c acsf 25 mlmin rate neurons visualized using water immersion x40 objective differential interference contrast optics nomarski edgewater nj infrared illumination hamamatsu camera hamamatsu photonics france massy france
0.14533791.15976062.html.plaintext.txt	31	electrophysiological recordings whole cell recording technique used patch pipettes pulled borosilicate glass outer diameter 15 mm inner diameter 117 mm clark electromedical instrument phymep paris france without internal filament fired polished recording pipettes tip resistance 2 4 m seal resistance always greater 3 g recording pipette solution contained millimoles 1214 kmeso4 136 kcl 4 atpna 01 gtpna 10 hepes 1 mgcl2 ph set 74 naoh osmolarity 310 mosmol glucose experiments reported values membrane potential values correction junction potential
0.14533791.15976062.html.plaintext.txt	32	electrophysiological recordings whole cell recording technique used patch pipettes pulled borosilicate glass outer diameter 15 mm inner diameter 117 mm clark electromedical instrument phymep paris france without internal filament fired polished recording pipettes tip resistance 2 4 m seal resistance always greater 3 g recording pipette solution contained millimoles 1214 kmeso4 136 kcl 4 atpna 01 gtpna 10 hepes 1 mgcl2 ph set 74 naoh osmolarity 310 mosmol glucose experiments reported values membrane potential values correction junction potential
0.14533791.15976062.html.plaintext.txt	33	bipolar concentric electrode placed olfactory nerve layer near recorded mitraltufted cell stimulate olfactory nerve monophasic square pulses delivered stimulus isolation unit
0.14533791.15976062.html.plaintext.txt	34	bipolar concentric electrode placed olfactory nerve layer near recorded mitraltufted cell stimulate olfactory nerve monophasic square pulses delivered stimulus isolation unit
0.14533791.15976062.html.plaintext.txt	35	voltage current measurements neuron activity performed axoclamp 2b amplifier axon instruments foster city ca experiments controlled pc pentium iii computer using 12 bit ad da converters digidata 1200b axon instruments sampling frequency 30 khz clampex software version 81 data presented mean plus minus sd
0.14533791.15976062.html.plaintext.txt	36	voltage current measurements neuron activity performed axoclamp 2b amplifier axon instruments foster city ca experiments controlled pc pentium iii computer using 12 bit ad da converters digidata 1200b axon instruments sampling frequency 30 khz clampex software version 81 data presented mean plus minus sd
0.14533791.15976062.html.plaintext.txt	37	oxa bachem voisins le brettoneux france aliquoted stored 20 c oxa action mitral cells tested switching acsf solution 1 min one containing oxa 10 200 nm see refs 34 35 36 solutions perfused tissue 25 mlmin experiments performed presence tetrodotoxin ttx 1 microm tocris fisher bioblock scientific illkirch france blocks voltage gated sodium channels picrotoxin 50 microm sigma bicuculline 10 microm sigma also used block chloride conductance gabaa receptors respectively orx1 blocked sb 334867 10 microm glaxosmithkline see refs 30 37 38
0.14533791.15976062.html.plaintext.txt	38	oxa bachem voisins le brettoneux france aliquoted stored 20 c oxa action mitral cells tested switching acsf solution 1 min one containing oxa 10 200 nm see refs 34 35 36 solutions perfused tissue 25 mlmin experiments performed presence tetrodotoxin ttx 1 microm tocris fisher bioblock scientific illkirch france blocks voltage gated sodium channels picrotoxin 50 microm sigma bicuculline 10 microm sigma also used block chloride conductance gabaa receptors respectively orx1 blocked sb 334867 10 microm glaxosmithkline see refs 30 37 38
0.14533791.15976062.html.plaintext.txt	39	results top abstract introduction materials methods results discussion references rt pcr analysis orexin receptor expression ob rt pcr ob samples revealed single band expected size sequence orx1 556 bp orx2 620 bp mrnas attesting presence mrnas ob rats aged 10 25 d 2 months fig 1 relative abundance orx1 orx2 mrnas seemed lower ob compared hypo gapdh gene equally amplified 361 bp fragment tissues albeit nonquantitative levels receptors mrna dramatically change development
0.14533791.15976062.html.plaintext.txt	40	view larger version 47k fig 1 detection different orexin receptors mrna rt pcr analysis hypo ob tissues pcr products gapdh orx1 orx2 obtained hypo ob samples 10 25 d old 10 25 adult rats ad run ethidium bromide stained 15 agarose gel products expected size controlled sequencing pcr products derived ob25 samples o control without dna matrix mwm molecular weight marker 1 kb dna ladder 512506 bp band specified one representative rat experimental point shown n 3
0.14533791.15976062.html.plaintext.txt	41	structural ultrastructural immunocytochemical study light microscopic localization orx1 immunoreactivity ob caillol et al 31 showed orx1 seems expressed higher levels orx2 protein level present study focused orx1 observations confirmed refined previous description orx1 localization ob 31 light microscopic level orx1 immunoreactive cells identified dark staining due presence dab nickel reaction product green fluorescence cytoplasm fig 2f p10 p25 adult rats orx1 distributed laminar pattern orx1 immunoreactivity obvious cell bodies glomerular fig 2 b e mitral cell granule cell layers fig 2 c f immunolabeling homogeneous along mitral cell layer immunoreactive mitral cells clustered patches way glomeruli orx1 immunoreactive whereas others devoid immunolabeling often orx1 immunoreactive glomeruli located immunoreactive zones mitral cell layer glomerular layer immunoreactive cell bodies found base glomerulus external plexiform layer neurons rather elongated shape whereas others slightly smaller round round neurons also observed around glomerulus according location neurons could correspond external tufted cells periglomerular cells pgs respectively semifine sections brown dots probably corresponding mitral cell dendrites appeared dispersed external plexiform layer epl inside glomeruli sections primary antiserum omitted immunolabeling observed
0.14533791.15976062.html.plaintext.txt	42	view larger version 122k fig 2 light microscopic localization orx1 immunoreactivity ob presence orx1 ob checked semithin sections obtained 50 microm sections embedded epoxy resin adults d thin sections 14 microm p10 rat e p25 rat f semithin sections observed either stained toluidine blue 1 microm thick c without counterstaining 2 microm thick b d presence orx1 visualized dark dab d dab nickel staining spread cytoplasm immunoreactive ir cells e green fluorescence f blue staining 46 diamino 2 phenylindole nuclear coloration orx1 ir cell bodies identified layers except olfactory nerve layer glomerular layer b x40 immersion ir cell bodies observed around glomeruli large elongated cell bodies mostly located basis glomeruli could external tufted cell large arrows whereas small round cell bodies border could identified pg cells thin arrows inside glomeruli brown dots likely mitral cells dendrites arrowheads mitral cell layer cytoplasm mitral cells highly ir large arrows c d x40 immersion mitral cells express orx1 arrowheads c d sections mitral cell nucleus apparent devoid immunolabeling c d granule cells orx1 ir e f epl punctiform dab labeling thin arrows 2d corresponded presumably mitral cell dendrites bc blood capillary gcl granular cell layer gl glomeruli mcl mitral cell layer n nucleus
0.14533791.15976062.html.plaintext.txt	43	ultrastructural localization orx1 immunoreactivity ob electron microscopy observations confirmed light microscopy observations ultrastrutural level presence orx1 visualized electron dense dab deposits identification immunoreactive elements based descriptions pinching powell 39 40 price powell 41
0.14533791.15976062.html.plaintext.txt	44	ultrastructural localization orx1 immunoreactivity ob electron microscopy observations confirmed light microscopy observations ultrastrutural level presence orx1 visualized electron dense dab deposits identification immunoreactive elements based descriptions pinching powell 39 40 price powell 41
0.14533791.15976062.html.plaintext.txt	45	deep ob orx1 expressed granule cell bodies localized cytoplasm neighborhood plasma membrane fig 3a mitral cell layer rather mitral cell bodies characterized typical abundant stacks rough endoplasmic reticulum orx1 labeled however orx1 immunoreactive mitral cells labeling obvious consisted numerous patches localized cisternae endoplasmic reticulum neighborhood plasma membrane indicating orx1 locally synthesized folded membrane fig 3b epl immunolabeling shown mitral cell granule cell dendrites fig 3c reciprocal synapses orx1 immunoreactive mitral cells granule cell dendrites could observed fig 3d accumulation labeling near synapse noted
0.14533791.15976062.html.plaintext.txt	46	view larger version 164k fig 3 ultrastructural localization orx1 granule cell layer mitral cell layer epl ob ultrastructural level presence orx1 visualized electron dense dab deposits arrows granule cell layer x10500 orx1 immunoreactivity identified numerous granule cell bodies labeling either cytoplasmic close plasma membrane mitral cell layer b x11000 mitral cells exhibited punctuated labeling also cytoplasmic close plasma membrane epl c x7000 orx1 immunoreactivity found mitral cell granule cell dendrites cases d x17500 orx1 immunoreactive gemmules granule cell observed establishing synaptic contact mitral cell dendrites reciprocal synapses arrowheads rer rough endoplasmic reticulum gcg gemmule granule cell gc granule cell m mitochondria mcd mitral cell dendrite mc mitral cell gcd granule cell dendrite v synaptic vesicle
0.14533791.15976062.html.plaintext.txt	47	glomerular layer immunolabeling found cell bodies processes orx1 immunoreactive neurons observed periphery glomeruli small round cells almost completely filled nuclei surrounded thin rim cytoplasm fig 4a ultrastructural features corresponded pgs base glomerulus infraglomerular area immunoreactive neurons identified slightly larger pgs cytoplasm abundant showed well developed granular endoplasmic reticulum fig 4b basis description pinching powell 40 neurons identified external tufted cells glomerular neuropil showed numerous orx1 immunoreactive processes strongly immunoreactive dendritic shafts observed given regular arrangement neurotubules identified main dendritic shafts tufted cells shown numerous dendrites mitraltufted cells surrounded olfactory neurons terminals orx1 immunoreactive fig 4 c d gemmules pg also orx1 immunoreactive fig 4e glomerular neuropil terminals olfactory axons never orx1 immunoreactive
0.14533791.15976062.html.plaintext.txt	48	glomerular layer immunolabeling found cell bodies processes orx1 immunoreactive neurons observed periphery glomeruli small round cells almost completely filled nuclei surrounded thin rim cytoplasm fig 4a ultrastructural features corresponded pgs base glomerulus infraglomerular area immunoreactive neurons identified slightly larger pgs cytoplasm abundant showed well developed granular endoplasmic reticulum fig 4b basis description pinching powell 40 neurons identified external tufted cells glomerular neuropil showed numerous orx1 immunoreactive processes strongly immunoreactive dendritic shafts observed given regular arrangement neurotubules identified main dendritic shafts tufted cells shown numerous dendrites mitraltufted cells surrounded olfactory neurons terminals orx1 immunoreactive fig 4 c d gemmules pg also orx1 immunoreactive fig 4e glomerular neuropil terminals olfactory axons never orx1 immunoreactive
0.14533791.15976062.html.plaintext.txt	49	view larger version 166k fig 4 ultrastructural localization orx1 glomerular layer ob ultrastructural level presence orx1 visualized electron dense dab deposits arrows glomerular layer x12000 dab electron dense deposits arrows found small cells exhibiting large nucleus surrounded thin rim cytoplasm cells located around glomeruli identified pgs basis glomeruli infraglomerular layer area b x19000 larger cells characterized stacks rer also orx1 immunoreactive ultrastructural characteristics correspond external tuft cell glomerular neuropile c x28000 d x29000 orx1 immunoreactive dendrites mitraltufted cells numerous surrounded orn terminals showing synaptic contacts c curved arrows gemmules kind typical varicosities termed ob anatomists see ref 39 pgs also orx1 immunoreactive e x17000 etc external tufted cell g glomerulus m mitochondria mtcd mitraltufted cell dendrite orn olfactory receptor neuron rer rough endoplasmic reticulum v synaptic vesicles pgg gemmule periglomerular cell
0.14533791.15976062.html.plaintext.txt	50	patch clamp recording experiments whole cell recordings obtained 204 mitral cells strictly located mitral cell layer cell identification based location electrophysiological properties morphology size mitral cells showed average resting potential 60 plus minus 4 mv mean input resistance 74 plus minus 38 m
0.14533791.15976062.html.plaintext.txt	51	patch clamp recording experiments whole cell recordings obtained 204 mitral cells strictly located mitral cell layer cell identification based location electrophysiological properties morphology size mitral cells showed average resting potential 60 plus minus 4 mv mean input resistance 74 plus minus 38 m
0.14533791.15976062.html.plaintext.txt	52	among 204 mitral cells 61 30 responsive oxa current clamp mode bath application oxa induced hyperpolarization n 46 23 depolarization n 15 7 mitral cells two types response observed two distinct subsets oxa induced hyperpolarizations long lasting small amplitudes 100 nm hyperpolarizations 3 plus minus 2 mv mean amplitude occurred 30 plus minus 95 sec delay lasted 95 plus minus 57 sec spontaneously active cells n 12 hyperpolarizations caused complete cessation spontaneous spikes excitatory postsynaptic potentials epsp fig 5 b
0.14533791.15976062.html.plaintext.txt	53	among 204 mitral cells 61 30 responsive oxa current clamp mode bath application oxa induced hyperpolarization n 46 23 depolarization n 15 7 mitral cells two types response observed two distinct subsets oxa induced hyperpolarizations long lasting small amplitudes 100 nm hyperpolarizations 3 plus minus 2 mv mean amplitude occurred 30 plus minus 95 sec delay lasted 95 plus minus 57 sec spontaneously active cells n 12 hyperpolarizations caused complete cessation spontaneous spikes excitatory postsynaptic potentials epsp fig 5 b
0.14533791.15976062.html.plaintext.txt	54	view larger version 39k fig 5 inhibitory action oxa mitral cells 20 nm oxa horizontal bar totally abolished mitral cell spontaneous activity control activity recovered rinsing period 120 sec b mitral cell showing spontaneous activity composed spikes epsps abolished oxa 10 nm b1 b3 enlargement 2 sec periods focusing epsps b1 spontaneous epsps control b2 disappearance epsps oxa b3 recovery spontaneous epsps rinsing mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	55	oxa induced hyperpolarizations reproducible cells tested successive applications n 3 data shown abolished ttx fast na channel blocker added acsf n 2 fig 6 b fig 6 c d seen oxa caused cessation spontaneous firing control whereas presence bicuculline slowed spontaneous firing bicuculline decreased amplitude oxa hyperpolarizing responses 17 75 n 14 picrotoxin n 5 similar effects bicuculline data shown acsf perfusion contained sb 334867 orx1 antagonist hyperpolarizing responses completely blocked n 4 fig 7 b altogether results indicate hyperpolarizing effect oxa indirect effect oxa may act orx1 gabaergic neurons would act turn mitral cell gabaa receptors consistent hypothesis bicuculline decreased oxa hyperpolarizing effect mitral cells
0.14533791.15976062.html.plaintext.txt	56	view larger version 22k fig 6 inhibitory action oxa may indirect oxa 200 nm hyperpolarized silent mitral cell b hyperpolarizing effect oxa abolished ttx 1 microm c oxa 20 nm hyperpolarized spontaneously active mitral cell 15 mv horizontal scale bar 20 sec vertical scale bar 5 mv d hyperpolarizing effect oxa maintained bicuculline 10 microm reduced 05 mv mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	57	view larger version 27k fig 7 characterization orexin receptor type involved mitral cell hyperpolarizing responses oxa 200 nm hyperpolarized mitral cell control condition b sb 334867 orx1 antagonist 10 microm blocked completely oxa induced hyperpolarization mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	58	distinct set 14 mitral cells bath application oxa induced long lasting small amplitude depolarizations fig 8a 25 nm oxa depolarizations 2 plus minus 06 mv mean amplitude occurred 33 plus minus 18 sec delay lasted 241 plus minus 84 sec orexin depolarizations insensitive ttx n 2 fig 8b examine depolarizing effect detail subsequent experiments conducted voltage clamp conditions membrane potential voltage clamped near resting level oxa produced inward current whose delay duration matched oxa induced depolarizations fig 9a inward current blocked sb 334867 n 3 fig 9b experiments indicate oxa depolarizing action mitral cells direct mediated orx1
0.14533791.15976062.html.plaintext.txt	59	view larger version 30k fig 8 oxa depolarizes mitral cell oxa 25 nm depolarized mitral cell 4 mv b depolarization prevented ttx mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	60	view larger version 28k fig 9 orx1 involved oxa induced inward current oxa induced slow inward current b sb 334867 10 microm abolished current vh holding potential mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	61	among 46 mitral cells hyperpolarized oxa 42 submitted electrical stimulation applied olfactory nerves complete protocol described ref 33 21 mitral cells responsive stimulation recorded cell excitation threshold determined control condition stimulation intensity adjusted elicit one spike per shock stable latency oxa perfused recording chamber effect mitral cell response parameters threshold latency number spikes analyzed function time four mitral cells olfactory nerve stimulation excitability decreased oxa fig 10 although affected 17
0.14533791.15976062.html.plaintext.txt	62	among 46 mitral cells hyperpolarized oxa 42 submitted electrical stimulation applied olfactory nerves complete protocol described ref 33 21 mitral cells responsive stimulation recorded cell excitation threshold determined control condition stimulation intensity adjusted elicit one spike per shock stable latency oxa perfused recording chamber effect mitral cell response parameters threshold latency number spikes analyzed function time four mitral cells olfactory nerve stimulation excitability decreased oxa fig 10 although affected 17
0.14533791.15976062.html.plaintext.txt	63	view larger version 9k fig 10 effect oxa mitral cell responses evoked olfactory nerve stimulation three superimposed control responses olfactory nerve stimulation one spike per stimulation b five minutes perfusion 100 nm oxa solution hyperpolarized cell 69 mv stimulations failed induce action potential c partial recovery control excitability two spikes three stimulations obtained rinsing period 10 min mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	64	discussion top abstract introduction materials methods results discussion references past studies shown orexin fibers receptors adult rat ob 9 10 11 12 13 31 however data development orexin innervation orexin receptor expression available tissue rt pcr experiments present information orexin receptor mrna ob early postnatal development results indicate orx1 orx2 expressed early 10 d birth p10 presence shown adult stage control tissues hypo ob although quantitative rt pcr could lead us definitive conclusion study suggests orx1 orx2 expressed lower level ob compared hypo noteworthy results show stable level orx1 expression weaning well adults brain tissues hypoglossal neurons 42 hypothalamus 43 show higher expression levels p20 25 stable level thereafter functional point view van den pol et al 44 report orexin system functional early brain development show p10 orexin induces robust synaptic activity hypothalamic neurons altogether results hypothalamic structures convinced us perform electrophysiological recordings p10 25 rats
0.14533791.15976062.html.plaintext.txt	65	discussion top abstract introduction materials methods results discussion references past studies shown orexin fibers receptors adult rat ob 9 10 11 12 13 31 however data development orexin innervation orexin receptor expression available tissue rt pcr experiments present information orexin receptor mrna ob early postnatal development results indicate orx1 orx2 expressed early 10 d birth p10 presence shown adult stage control tissues hypo ob although quantitative rt pcr could lead us definitive conclusion study suggests orx1 orx2 expressed lower level ob compared hypo noteworthy results show stable level orx1 expression weaning well adults brain tissues hypoglossal neurons 42 hypothalamus 43 show higher expression levels p20 25 stable level thereafter functional point view van den pol et al 44 report orexin system functional early brain development show p10 orexin induces robust synaptic activity hypothalamic neurons altogether results hypothalamic structures convinced us perform electrophysiological recordings p10 25 rats
0.14533791.15976062.html.plaintext.txt	66	furthermore anatomical results appears cellular localization orx1 similar preweaning adult rats light microscopic level immunocytochemical study confirms localization orx1 mitraltufted cell bodies reported caillol et al 31 ultrastructural level localization orexin receptors widely studied one recent publication arcuate nucleus 45 results agreement study showing orx1 localized cell bodies well pre postsynaptic levels study part labeling localized rough endoplasmic reticulum suggesting local synthesis orx1 orx1 immunoreactivity also shown mitraltufted cell dendrites running epl bodies processes external tuft cells periglomerular granule cells thus orx1 seems expressed ob cell categories systematic homogeneous way indeed orx1 labeling homogeneously distributed neither along mitral cell layer glomerular layer interestingly orx1 immunoreactive mitral cell bodies found cases adjacent orx1 immunoreactive glomeruli although observation needs documented may suggest columnar organization orexin receptive cells ob
0.14533791.15976062.html.plaintext.txt	67	furthermore anatomical results appears cellular localization orx1 similar preweaning adult rats light microscopic level immunocytochemical study confirms localization orx1 mitraltufted cell bodies reported caillol et al 31 ultrastructural level localization orexin receptors widely studied one recent publication arcuate nucleus 45 results agreement study showing orx1 localized cell bodies well pre postsynaptic levels study part labeling localized rough endoplasmic reticulum suggesting local synthesis orx1 orx1 immunoreactivity also shown mitraltufted cell dendrites running epl bodies processes external tuft cells periglomerular granule cells thus orx1 seems expressed ob cell categories systematic homogeneous way indeed orx1 labeling homogeneously distributed neither along mitral cell layer glomerular layer interestingly orx1 immunoreactive mitral cell bodies found cases adjacent orx1 immunoreactive glomeruli although observation needs documented may suggest columnar organization orexin receptive cells ob
0.14533791.15976062.html.plaintext.txt	68	optimize vitro neuron survival electrophysiological recordings performed 10 25 d old rats period surrounding weaning period ingestive behavior evolves type food changes liquid diet full fat solid diet less fat however experimental conditions observed weaning progressive developing rats suck mothers nipples eat solid food available ad libitum dam furthermore recordings 75 made 20 25 d old rats obvious variability due different ages rats observed mitral cell reactivity oxa
0.14533791.15976062.html.plaintext.txt	69	optimize vitro neuron survival electrophysiological recordings performed 10 25 d old rats period surrounding weaning period ingestive behavior evolves type food changes liquid diet full fat solid diet less fat however experimental conditions observed weaning progressive developing rats suck mothers nipples eat solid food available ad libitum dam furthermore recordings 75 made 20 25 d old rats obvious variability due different ages rats observed mitral cell reactivity oxa
0.14533791.15976062.html.plaintext.txt	70	results show oxa modulates mitral cell activity 61 mitral cells 30 shown modulated oxa 7 23 depolarized hyperpolarized respectively results agreement immunocytochemical observations indicate rather mitral cells orx1 immunoreactive
0.14533791.15976062.html.plaintext.txt	71	results show oxa modulates mitral cell activity 61 mitral cells 30 shown modulated oxa 7 23 depolarized hyperpolarized respectively results agreement immunocytochemical observations indicate rather mitral cells orx1 immunoreactive
0.14533791.15976062.html.plaintext.txt	72	oxa shown exert two opposite effects two distinct sets mitral cells either direct depolarizing effect inducing ttx insensitive inward current indirect hyperpolarizing effect however oxa effects blocked sb 334867 demonstrated involvement orx1 fig 11
0.14533791.15976062.html.plaintext.txt	73	oxa shown exert two opposite effects two distinct sets mitral cells either direct depolarizing effect inducing ttx insensitive inward current indirect hyperpolarizing effect however oxa effects blocked sb 334867 demonstrated involvement orx1 fig 11
0.14533791.15976062.html.plaintext.txt	74	view larger version 34k fig 11 oxa action mitral cells rat ob network olfactory mucosa olfactory receptor neurons orn send axons ob terminating glomeruli glo spherical neuropiles lying ob periphery within glomeruli axons synapse primary dendrites pd mitral cells mc mitral cells make reciprocal dendrodendritic synapses two categories gabaergic inhibitory interneurons pd pgs secondary dendrites sd granule cells gc mitral cell activity modulated double gabaergic control sending axon olfactory cortex orx1 found expressed subsets mc pg gc cells dark gray tufted cells tc light gray receptors localized soma processes neurons left diagram schematizes indirect hyperpolarizing action oxa mc oxa acting orx1 hypothesized depolarize gabaergic inhibitory interneurons pgs gcs dark gray turn would inhibit mcs white via gaba release acting gabaa receptors localized mc within glomeruli part oxa indirect hyperpolarizing action also ascribed action gaba released pgs gabab receptors localized orn axons mcs pd right diagram schematizes direct depolarizing action oxa mc oxa acting orx1 expressed subset mitral cells hypothesized depolarize mc dark gray
0.14533791.15976062.html.plaintext.txt	75	hyperpolarizing action oxa sufficient completely shut mitral cell spontaneous activity antagonized voltage gated na channel blocker ttx latter observation supports oxa action indirect oxa indirect effects reported brain area like substantia nigra 34 laterodorsal tegmental nucleus 46 hypo 47 raphe nucleus 43 oxa effects either excitatory inhibitory
0.14533791.15976062.html.plaintext.txt	76	hyperpolarizing action oxa sufficient completely shut mitral cell spontaneous activity antagonized voltage gated na channel blocker ttx latter observation supports oxa action indirect oxa indirect effects reported brain area like substantia nigra 34 laterodorsal tegmental nucleus 46 hypo 47 raphe nucleus 43 oxa effects either excitatory inhibitory
0.14533791.15976062.html.plaintext.txt	77	show oxa hyperpolarizing response partly antagonized gabaa receptor antagonist bicuculline result indicates gabaergic interneurons involved oxa induced hyperpolarization mitral cells immunocytochemical observations pg granule cell bodies express orx1 support gabaergic interneurons could contacted orexin fibers localized mainly glomerular layer feebly granule cell layer 31 indeed pg granule cells main interneurons two layers mainly gabaergic 49 50 shown inhibit mitral cells activation gabaa receptors 51 52 along line gabaergic interneurons excited oxa may act metabotropic gabab receptors indeed gabab receptor activation reported elsewhere abolish completely spontaneous activity mitral cells decrease mitral cell excitability electrical shocks applied olfactory nerve layer 33 53 54
0.14533791.15976062.html.plaintext.txt	78	show oxa hyperpolarizing response partly antagonized gabaa receptor antagonist bicuculline result indicates gabaergic interneurons involved oxa induced hyperpolarization mitral cells immunocytochemical observations pg granule cell bodies express orx1 support gabaergic interneurons could contacted orexin fibers localized mainly glomerular layer feebly granule cell layer 31 indeed pg granule cells main interneurons two layers mainly gabaergic 49 50 shown inhibit mitral cells activation gabaa receptors 51 52 along line gabaergic interneurons excited oxa may act metabotropic gabab receptors indeed gabab receptor activation reported elsewhere abolish completely spontaneous activity mitral cells decrease mitral cell excitability electrical shocks applied olfactory nerve layer 33 53 54
0.14533791.15976062.html.plaintext.txt	79	present study oxa also observed decrease mitral cell excitability electrical shocks effect oxa induced gaba release may act extrasynaptic presynaptic gabab receptors located primary afferent axons 55 56 strongly suspected act depressing neurotransmitter release 54 57 58 59 60 hand decreasing mitral cell spontaneous activity oxa induced gaba release may act gabab receptors located either soma dendritic intraglomerular tuft rat mitral cells 55 56 one mechanisms gabab would silence spontaneous activity may gabab would slightly hyperpolarize mitral cells rest shifting cell polarization state state latter signaling steady silent state 61 dopamine gaba colocalized pg interneurons 62 63 64 dopamine also would good candidate support oxa indirect inhibition mitral cells consistent hypothesis frog ob dopamine found inhibit mitral cell spontaneous activity 65 coaction gaba dopamine cannot ruled
0.14533791.15976062.html.plaintext.txt	80	present study oxa also observed decrease mitral cell excitability electrical shocks effect oxa induced gaba release may act extrasynaptic presynaptic gabab receptors located primary afferent axons 55 56 strongly suspected act depressing neurotransmitter release 54 57 58 59 60 hand decreasing mitral cell spontaneous activity oxa induced gaba release may act gabab receptors located either soma dendritic intraglomerular tuft rat mitral cells 55 56 one mechanisms gabab would silence spontaneous activity may gabab would slightly hyperpolarize mitral cells rest shifting cell polarization state state latter signaling steady silent state 61 dopamine gaba colocalized pg interneurons 62 63 64 dopamine also would good candidate support oxa indirect inhibition mitral cells consistent hypothesis frog ob dopamine found inhibit mitral cell spontaneous activity 65 coaction gaba dopamine cannot ruled
0.14533791.15976062.html.plaintext.txt	81	especially interesting fact electrophysiological results fully consistent vivo study 48 authors recorded unit extracellular activity mitral cells anesthetized rats whereas applied oxa directly ob surface lateral ventricle types applications shown induce decrease spontaneous rate cells increase others distinct cells noteworthy vivo vitro studies oxa induces two types opposite actions mitral cell spontaneous activity
0.14533791.15976062.html.plaintext.txt	82	especially interesting fact electrophysiological results fully consistent vivo study 48 authors recorded unit extracellular activity mitral cells anesthetized rats whereas applied oxa directly ob surface lateral ventricle types applications shown induce decrease spontaneous rate cells increase others distinct cells noteworthy vivo vitro studies oxa induces two types opposite actions mitral cell spontaneous activity
0.14533791.15976062.html.plaintext.txt	83	conclusion study brings information ontogenetic expression orexin receptors rat ob clarifies orx1 structural ultrastructural localization within network addition vitro recordings demonstrate oxa acts mitral cells directly indirectly inducing apparently opposite effects direct depolarizing effect could mediated orx1 located mitral cell bodies dendrites orx1 located pg granular cells could responsible indirect hyperpolarizing action oxa via gaba induced release
0.14533791.15976062.html.plaintext.txt	84	conclusion study brings information ontogenetic expression orexin receptors rat ob clarifies orx1 structural ultrastructural localization within network addition vitro recordings demonstrate oxa acts mitral cells directly indirectly inducing apparently opposite effects direct depolarizing effect could mediated orx1 located mitral cell bodies dendrites orx1 located pg granular cells could responsible indirect hyperpolarizing action oxa via gaba induced release
0.14533791.15976062.html.plaintext.txt	85	altogether data provide new insights apprehending mechanisms olfactory system involved regulation food intake behavior hungry animals hypothalamic ox neurons stimulated hypoglycemia 14 probably increase release centrifugal pathways electrophysiological data detail ox action ob indeed acting directly increasing output neuron background activity indirectly inhibitory interneuron networks ox depress excite mitral cells two opposite actions shown occur two distinct mitral cell sets ox may provide selective dual actions olfactory information processing favoring mitral cells involved food odor processing silencing others involved duality action could result increasing signal noise ratio may increase olfactory detection power hypothesis fully agrees behavioral experiments progress research team indeed preliminary results indicate olfactory detection thresholds rats enhanced oxa intracerebral injection
0.14533791.15976062.html.plaintext.txt	86	altogether data provide new insights apprehending mechanisms olfactory system involved regulation food intake behavior hungry animals hypothalamic ox neurons stimulated hypoglycemia 14 probably increase release centrifugal pathways electrophysiological data detail ox action ob indeed acting directly increasing output neuron background activity indirectly inhibitory interneuron networks ox depress excite mitral cells two opposite actions shown occur two distinct mitral cell sets ox may provide selective dual actions olfactory information processing favoring mitral cells involved food odor processing silencing others involved duality action could result increasing signal noise ratio may increase olfactory detection power hypothesis fully agrees behavioral experiments progress research team indeed preliminary results indicate olfactory detection thresholds rats enhanced oxa intracerebral injection
0.14533791.15976062.html.plaintext.txt	87	acknowledgments thank glaxosmithkline harlow essex uk generous gift sb 334867 professor edwin griff university cincinnati cincinnati oh careful reading english
0.14533791.15976062.html.plaintext.txt	88	footnotes first published online june 23 2005
0.14533791.15976062.html.plaintext.txt	89	abbreviations acsf artificial cerebrospinal fluid dab diaminobenzidine epl external plexiform layer epsp excitatory postsynaptic potential gaba aminobutyric acid gabaergic neurons use gaba neurotransmitter gapdh glyceraldehyde 3 phophate dehydrogenase hypo hypothalamus ob olfactory bulb orx1 orexin receptor 1 orx2 orexin receptor 2 ox orexin oxa orexin oxb orexin b p postnatal day pg periglomerular cell rt room temperature ttx tetrodotoxin
0.14533791.15976062.html.plaintext.txt	90	accepted publication june 8 2005
0.14533791.15976062.html.plaintext.txt	91	references top abstract introduction materials methods results discussion references chaput m holley 1976 olfactory bulb responsiveness food odour stomach distension rat chem senses 2198 201 pager j 1974 selective modulation olfactory input suppressed lesions anterior limb anterior commisure physiol behav 13523 526crossrefmedline pager j 1974 selective modulation olfactory bulb electrical activity relation learning palatability hungry satiated rats physiol behav 12189 195crossrefmedline pager j 1978 ascending olfactory information centrifugal influxes contributing nutritional modification rat mitral cell responses brain res 140251 271crossrefmedline pager j giachetti holley le magnen j 1972 selective control olfactory bulb electrical activity relation food deprivation satiety rats physiol behav 9573 579crossrefmedline giachetti mac leod p le magnen j 1970 influence hunger satiety states responses olfactory bulb rats j physiol paris 62suppl 2280 281 le magnen j 1999 increased food intake induced rats changes satiating sensory input food first published french 1956 appetite 3333 35crossrefmedline bernardis ll bellinger ll 1996 lateral hypothalamic area revisited ingestive behavior neurosci biobehav rev 20189 287crossrefmedline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451crossrefmedline date y ueta y yamashita h yamaguchi h matsukara kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett 2nd fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text peyron c tighe d vanden pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richarson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92696 moriguchi sakurai nambu yanagisawa m goto k 1999 neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264101 104crossrefmedline griffond b risold py jacquemard c colard c fellmann d 1999 insulin induced hypoglycemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 26277 80crossrefmedline briski kp sylvester pw 2001 hypothalamic orexin immunopositive neurons express fos response central glucopenia neuroreport 12531 534crossrefmedline cai xj denis r vernon rg clapham jc wilson arch jr williams g 2001 food restriction selectively increases hypothalamic orexin b levels lactating rats regul pept 97163 168crossrefmedline cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g 1999 hypothalamic orexin expression modulation blood glucose feeding diabetes 482132 2137abstract yamanaka muraki y tsujino n goto k sakurai 2003 regulation orexin neurons monoaminergic cholinergic systems biochem biophys res commun 303120 129crossrefmedline bahjaoui bouhaddi m fellmann d griffond b bugnon c 1994 insulin treatment stimulates rat melanin concentrating hormone producing neurons neuropeptides 27251 258crossrefmedline wortley ke chang gq davydova z leibowitz sf 2003 peptides regulate food intake orexin gene expression increased states hypertriglyceridemia j physiol regul integr comp physiol 284r1454 r1465 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n 1999 orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 9610911 10916abstractfree full text ida nakahara k katayama murakami n nakazato m 1999 effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821526 529crossrefmedline leibowitz sf wortley ke 2004 hypothalamic control energy balance different peptides different functions peptides 25473 504crossrefmedline rodgers rj ishii y halford jc blundell je 2002 orexins appetite regulation neuropeptides 36303 325crossrefmedline edwards cm abusnana sunter d murphy kg ghatei ma bloom sr 1999 effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 160r7 r12 lubkin m stricker krongrad 1998 independent feeding metabolic actions orexins mice biochem biophys res commun 253241 245crossrefmedline mondal ms nakazato m matsukura 2000 orexins hypocretins novel hypothalamic peptides divergent functions biochem cell biol 78299 305crossrefmedline smart d jerman jc brough sj neville wa jewitt f porter ra 2000 hypocretins weak agonists recombinant human orexin 1 orexin 2 receptors br j pharmacol 1291289 1291crossrefmedline smart d jerman jc brough sj rushton sl murdock pr jewitt f elshourbagy na ellis ce middlemiss dn brown f 1999 characterization recombinant human orexin receptor pharmacology chinese hamster ovary cell line using flipr br j pharmacol 1281 3crossrefmedline caillol m aioun j baly c persuy ma salesse r 2003 localization orexins receptors rat olfactory system possible modulation olfactory perception neuropeptide synthetized centrally locally brain res 96048 61crossrefmedline chomczynski p sacchi n 1987 single step method rna isolation acid guanidinium thiocyanate phenol chloroform extraction anal biochem 162156 159crossrefmedline palouzier paulignan b duchamp viret p hardy ab duchamp 2002 gabab mediated inhibition mitral cell activity rat olfactory bulb whole cell patch clamp study vitro neuroscience 111241 250crossrefmedline korotkova tm eriksson ks haas hl brown re 2002 selective excitation gabaergic neurons substantia nigra rat orexinhypocretin vitro regul pept 10483 89crossrefmedline korotkova tm sergeeva oa eriksson ks haas hl brown re 2003 excitation ventral tegmental area dopaminergic nondopaminergic neurons orexinshypocretins j neurosci 237 11abstractfree full text yang b ferguson av 2002 orexin depolarizes dissociated rat area postrema neurons activation nonselective cationic conductance j neurosci 226303 6308abstractfree full text soffin em evans ml gill ch harries mh benham cd davies ch 2002 sb 334867 antagonises orexin mediated excitation locus coeruleus neuropharmacology 42127 133crossrefmedline matsuo k kaibara m uezono y hayashi h taniyama k nakane y 2002 involvement cholinergic neurons orexin induced contraction guinea pig ileum eur j pharmacol 452105 109crossrefmedline pinching aj powell tps 1971 neuron types glomerular layer olfactory bulb j cell sci 9305 345medline pinching aj powell tps 1971 neuropil periglomerular region olfactory bulb j cell sci 9379 409medline price jl powell tps 1970 synaptology granule cells olfactory bulb j cell sci 7125 155medline volgin dv saghir m kubin l 2002 developmental changes orexin 2 receptor mrna hypoglossal motoneurons neuroreport 13433 436crossrefmedline liu rj van den pol aghajanian gk 2002 hypocretins orexins regulate serotonin neurons dorsal raphe nucleus excitatory direct inhibitory indirect actions j neurosci 229453 9464abstractfree full text van den pol patrylo pr ghosh pk gao xb 2001 lateral hypothalamus early developmental expression response hypocretin orexin j comp neurol 433349 363crossrefmedline guan xb suzuki r funahashi h wang qp kageyama h uehara k yamada tsurugano shioda 2002 ultrastructural localization orexin 1 receptor pre post synaptic neurones rat arcuate nucleus neurosci lett 329209 212crossrefmedline burlet tyler cj leonard cs 2002 direct indirect excitation laterodorsal tegmental neurons hypocretinorexin peptides implications wakefulness narcolepsy j neurosci 222862 2872abstractfree full text follwell mj ferguson av 2002 cellular mechanisms orexin actions paraventricular nucleus neurones rat hypothalamus j physiol 545855 867abstractfree full text apelbaum perrut chaput m 2005 orexin effects olfactory bulb spontaneous activity odor responsiveness freely breathing rats regul pept 12949 61crossrefmedline mugnaini e oertel wh wouterlood ff 1984 immunocytochemical localization gaba neurons dopamine neurons rat main accessory olfactory bulbs neurosci lett 47221 226crossrefmedline ribak ce vaughn je saito k barber b roberts e 1977 glutamate decarboxylase localization neurons olfactory bulb brain res 1261 18crossrefmedline duchamp viret p duchamp chaput m 1993 gabaergic control odor induced activity frog olfactory bulb electrophysiological study picrotoxin bicuculline neuroscience 53111 120crossrefmedline jahr ce nicoll ra 1982 intracellular analysis dendrodendritic inhibition turtle vitro olfactory bulb j physiol 326213 234medline duchamp viret p delaleu jc duchamp 2000 gabab mediated action frog olfactory bulb makes odor responses salient neuroscience 97771 777crossrefmedline nickell wt behbehani mm shipley mt 1994 evidence gabab mediated inhibition transmission olfactory nerve mitral cells rat olfactory bulb brain res bull 35119 123crossrefmedline bonino m cantino d sassoe pognetto m 1999 cellular subcellular localization aminobutyric acid b receptors rat olfactory bulb neuroscience letters 274195 198crossrefmedline margeta mitrovic m mitrovic riley rc jan ly basbaum ai 1999 immunohistochemical localization gabab receptors rat central nervous system j comp neurol 405299 32130co2 6 1203abstractfree full text potapov aa 1985 baclofen inhibition synaptic transmission frog olfactory glomeruli neirofiziologiya 17834 837 potapov aa trepakov vv 1986 two types gaba receptors intact olfactory bulb primordial hippocampus frog pharmacological data bull exp biol med 101323 326crossref wachowiak m cohen lb 1999 presynaptic inhibition primary olfactory afferents mediated different mechanisms lobster turtle j neurosci 198808 8817abstractfree full text heyward p ennis m keller shipley mt 2001 membrane bistability olfactory bulb mitral cells j neurosci 215311 5320abstractfree full text gall c hendry shc seroogy kb jones eg haycock jw 1987 evidence coexistence gaba dopamine neurons rat olfactory bulb j comp neurol 266307 318crossrefmedline kosaka k toida k margolis fl kosaka 1997 chemically defined neuron groups subpopulations glomerular layer rat main olfactory bulb 2 prominent differences intraglomerular dendritic arborization relationship olfactory nerve terminals neuroscience 76775 786crossrefmedline kosaka hataguchi y hama k nagatsu wu jy 1985 coexistence immunoreactivities glutamate decarboxylase tyrosine hydroxylase neurons periglomerular region rat main olfactory bulb possible coexistence aminobutyric acid gaba dopamine brain res 343166 171crossrefmedline duchamp viret p coronas v delaleu jc moyse e duchamp 1997 dopaminergic modulation mitral cell activity frog olfactory bulb combined radioligand binding electrophysiological study neuroscience 79203 216crossrefmedline article abstract full text pdf versions article 14694042 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles hardy b articles duchamp viret p articles citing article pubmed pubmed citation articles hardy b articles duchamp viret p
0.14533791.15976062.html.plaintext.txt	92	references top abstract introduction materials methods results discussion references chaput m holley 1976 olfactory bulb responsiveness food odour stomach distension rat chem senses 2198 201 pager j 1974 selective modulation olfactory input suppressed lesions anterior limb anterior commisure physiol behav 13523 526crossrefmedline pager j 1974 selective modulation olfactory bulb electrical activity relation learning palatability hungry satiated rats physiol behav 12189 195crossrefmedline pager j 1978 ascending olfactory information centrifugal influxes contributing nutritional modification rat mitral cell responses brain res 140251 271crossrefmedline pager j giachetti holley le magnen j 1972 selective control olfactory bulb electrical activity relation food deprivation satiety rats physiol behav 9573 579crossrefmedline giachetti mac leod p le magnen j 1970 influence hunger satiety states responses olfactory bulb rats j physiol paris 62suppl 2280 281 le magnen j 1999 increased food intake induced rats changes satiating sensory input food first published french 1956 appetite 3333 35crossrefmedline bernardis ll bellinger ll 1996 lateral hypothalamic area revisited ingestive behavior neurosci biobehav rev 20189 287crossrefmedline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451crossrefmedline date y ueta y yamashita h yamaguchi h matsukara kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett 2nd fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text peyron c tighe d vanden pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richarson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92696 moriguchi sakurai nambu yanagisawa m goto k 1999 neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264101 104crossrefmedline griffond b risold py jacquemard c colard c fellmann d 1999 insulin induced hypoglycemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 26277 80crossrefmedline briski kp sylvester pw 2001 hypothalamic orexin immunopositive neurons express fos response central glucopenia neuroreport 12531 534crossrefmedline cai xj denis r vernon rg clapham jc wilson arch jr williams g 2001 food restriction selectively increases hypothalamic orexin b levels lactating rats regul pept 97163 168crossrefmedline cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g 1999 hypothalamic orexin expression modulation blood glucose feeding diabetes 482132 2137abstract yamanaka muraki y tsujino n goto k sakurai 2003 regulation orexin neurons monoaminergic cholinergic systems biochem biophys res commun 303120 129crossrefmedline bahjaoui bouhaddi m fellmann d griffond b bugnon c 1994 insulin treatment stimulates rat melanin concentrating hormone producing neurons neuropeptides 27251 258crossrefmedline wortley ke chang gq davydova z leibowitz sf 2003 peptides regulate food intake orexin gene expression increased states hypertriglyceridemia j physiol regul integr comp physiol 284r1454 r1465 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n 1999 orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 9610911 10916abstractfree full text ida nakahara k katayama murakami n nakazato m 1999 effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821526 529crossrefmedline leibowitz sf wortley ke 2004 hypothalamic control energy balance different peptides different functions peptides 25473 504crossrefmedline rodgers rj ishii y halford jc blundell je 2002 orexins appetite regulation neuropeptides 36303 325crossrefmedline edwards cm abusnana sunter d murphy kg ghatei ma bloom sr 1999 effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 160r7 r12 lubkin m stricker krongrad 1998 independent feeding metabolic actions orexins mice biochem biophys res commun 253241 245crossrefmedline mondal ms nakazato m matsukura 2000 orexins hypocretins novel hypothalamic peptides divergent functions biochem cell biol 78299 305crossrefmedline smart d jerman jc brough sj neville wa jewitt f porter ra 2000 hypocretins weak agonists recombinant human orexin 1 orexin 2 receptors br j pharmacol 1291289 1291crossrefmedline smart d jerman jc brough sj rushton sl murdock pr jewitt f elshourbagy na ellis ce middlemiss dn brown f 1999 characterization recombinant human orexin receptor pharmacology chinese hamster ovary cell line using flipr br j pharmacol 1281 3crossrefmedline caillol m aioun j baly c persuy ma salesse r 2003 localization orexins receptors rat olfactory system possible modulation olfactory perception neuropeptide synthetized centrally locally brain res 96048 61crossrefmedline chomczynski p sacchi n 1987 single step method rna isolation acid guanidinium thiocyanate phenol chloroform extraction anal biochem 162156 159crossrefmedline palouzier paulignan b duchamp viret p hardy ab duchamp 2002 gabab mediated inhibition mitral cell activity rat olfactory bulb whole cell patch clamp study vitro neuroscience 111241 250crossrefmedline korotkova tm eriksson ks haas hl brown re 2002 selective excitation gabaergic neurons substantia nigra rat orexinhypocretin vitro regul pept 10483 89crossrefmedline korotkova tm sergeeva oa eriksson ks haas hl brown re 2003 excitation ventral tegmental area dopaminergic nondopaminergic neurons orexinshypocretins j neurosci 237 11abstractfree full text yang b ferguson av 2002 orexin depolarizes dissociated rat area postrema neurons activation nonselective cationic conductance j neurosci 226303 6308abstractfree full text soffin em evans ml gill ch harries mh benham cd davies ch 2002 sb 334867 antagonises orexin mediated excitation locus coeruleus neuropharmacology 42127 133crossrefmedline matsuo k kaibara m uezono y hayashi h taniyama k nakane y 2002 involvement cholinergic neurons orexin induced contraction guinea pig ileum eur j pharmacol 452105 109crossrefmedline pinching aj powell tps 1971 neuron types glomerular layer olfactory bulb j cell sci 9305 345medline pinching aj powell tps 1971 neuropil periglomerular region olfactory bulb j cell sci 9379 409medline price jl powell tps 1970 synaptology granule cells olfactory bulb j cell sci 7125 155medline volgin dv saghir m kubin l 2002 developmental changes orexin 2 receptor mrna hypoglossal motoneurons neuroreport 13433 436crossrefmedline liu rj van den pol aghajanian gk 2002 hypocretins orexins regulate serotonin neurons dorsal raphe nucleus excitatory direct inhibitory indirect actions j neurosci 229453 9464abstractfree full text van den pol patrylo pr ghosh pk gao xb 2001 lateral hypothalamus early developmental expression response hypocretin orexin j comp neurol 433349 363crossrefmedline guan xb suzuki r funahashi h wang qp kageyama h uehara k yamada tsurugano shioda 2002 ultrastructural localization orexin 1 receptor pre post synaptic neurones rat arcuate nucleus neurosci lett 329209 212crossrefmedline burlet tyler cj leonard cs 2002 direct indirect excitation laterodorsal tegmental neurons hypocretinorexin peptides implications wakefulness narcolepsy j neurosci 222862 2872abstractfree full text follwell mj ferguson av 2002 cellular mechanisms orexin actions paraventricular nucleus neurones rat hypothalamus j physiol 545855 867abstractfree full text apelbaum perrut chaput m 2005 orexin effects olfactory bulb spontaneous activity odor responsiveness freely breathing rats regul pept 12949 61crossrefmedline mugnaini e oertel wh wouterlood ff 1984 immunocytochemical localization gaba neurons dopamine neurons rat main accessory olfactory bulbs neurosci lett 47221 226crossrefmedline ribak ce vaughn je saito k barber b roberts e 1977 glutamate decarboxylase localization neurons olfactory bulb brain res 1261 18crossrefmedline duchamp viret p duchamp chaput m 1993 gabaergic control odor induced activity frog olfactory bulb electrophysiological study picrotoxin bicuculline neuroscience 53111 120crossrefmedline jahr ce nicoll ra 1982 intracellular analysis dendrodendritic inhibition turtle vitro olfactory bulb j physiol 326213 234medline duchamp viret p delaleu jc duchamp 2000 gabab mediated action frog olfactory bulb makes odor responses salient neuroscience 97771 777crossrefmedline nickell wt behbehani mm shipley mt 1994 evidence gabab mediated inhibition transmission olfactory nerve mitral cells rat olfactory bulb brain res bull 35119 123crossrefmedline bonino m cantino d sassoe pognetto m 1999 cellular subcellular localization aminobutyric acid b receptors rat olfactory bulb neuroscience letters 274195 198crossrefmedline margeta mitrovic m mitrovic riley rc jan ly basbaum ai 1999 immunohistochemical localization gabab receptors rat central nervous system j comp neurol 405299 32130co2 6 1203abstractfree full text potapov aa 1985 baclofen inhibition synaptic transmission frog olfactory glomeruli neirofiziologiya 17834 837 potapov aa trepakov vv 1986 two types gaba receptors intact olfactory bulb primordial hippocampus frog pharmacological data bull exp biol med 101323 326crossref wachowiak m cohen lb 1999 presynaptic inhibition primary olfactory afferents mediated different mechanisms lobster turtle j neurosci 198808 8817abstractfree full text heyward p ennis m keller shipley mt 2001 membrane bistability olfactory bulb mitral cells j neurosci 215311 5320abstractfree full text gall c hendry shc seroogy kb jones eg haycock jw 1987 evidence coexistence gaba dopamine neurons rat olfactory bulb j comp neurol 266307 318crossrefmedline kosaka k toida k margolis fl kosaka 1997 chemically defined neuron groups subpopulations glomerular layer rat main olfactory bulb 2 prominent differences intraglomerular dendritic arborization relationship olfactory nerve terminals neuroscience 76775 786crossrefmedline kosaka hataguchi y hama k nagatsu wu jy 1985 coexistence immunoreactivities glutamate decarboxylase tyrosine hydroxylase neurons periglomerular region rat main olfactory bulb possible coexistence aminobutyric acid gaba dopamine brain res 343166 171crossrefmedline duchamp viret p coronas v delaleu jc moyse e duchamp 1997 dopaminergic modulation mitral cell activity frog olfactory bulb combined radioligand binding electrophysiological study neuroscience 79203 216crossrefmedline article abstract full text pdf versions article 14694042 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles hardy b articles duchamp viret p articles citing article pubmed pubmed citation articles hardy b articles duchamp viret p
0.14533791.15976062.html.plaintext.txt	93	home help feedback subscriptions archive search table contents endocrinology endocrine reviews j clin end metab molecular endocrinology recent prog horm res endocrine journals
0.14565748.12351581.html.plaintext.txt	0	allelic structure common disease desmond j smith12 aldons j lusis345
0.14565748.12351581.html.plaintext.txt	1	1department molecular medical pharmacology 2crump institute molecular imaging 3department microbiology immunology molecular genetics 4department medicine 5department human genetics university california los angeles ca 90095 usa
0.14565748.12351581.html.plaintext.txt	2	received june 28 2002 accepted july 27 2002
0.14565748.12351581.html.plaintext.txt	3	abstract top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references better understanding allelic structure common human disease loci may help identification responsible genes thus topic considerable practical importance alleles locus account majority disease risk screening causative factors greatly simplified contrast large numbers independent alleles responsible dramatic improvements genotyping speed necessary placing dream personalized medicine far future review evidence optimistic pessimistic viewpoints discussed appears neither position proved disproved available evidence indicates common diseases due least part genes small number disease associated alleles
0.14565748.12351581.html.plaintext.txt	4	one early dreams human genome project goal personalized medicine vision individual would compact disk containing unique dna sequence guiding myriad decisions lifestyle disease prevention treatment conceivably even career choice present dna sequencing technology nowhere near cheap enough fast enough allow dream nevertheless genotyping technologies made dramatic strides last decade technologies may fast enough allow interrogation relevant disease alleles given individual feasibility approach depends critically allelic structure human disease genes 30 000 genes make important contributions disease susceptibility 1000 alleles gene total 3x107 genotypings reliably performed daunting prospect however 1000 genes make appreciable contributions human disease genes 4 relevant alleles number genotypings performed 4000 highly feasible review look present knowledge allelic complexity human disease genes well providing brief glance future
0.14565748.12351581.html.plaintext.txt	5	one early dreams human genome project goal personalized medicine vision individual would compact disk containing unique dna sequence guiding myriad decisions lifestyle disease prevention treatment conceivably even career choice present dna sequencing technology nowhere near cheap enough fast enough allow dream nevertheless genotyping technologies made dramatic strides last decade technologies may fast enough allow interrogation relevant disease alleles given individual feasibility approach depends critically allelic structure human disease genes 30 000 genes make important contributions disease susceptibility 1000 alleles gene total 3x107 genotypings reliably performed daunting prospect however 1000 genes make appreciable contributions human disease genes 4 relevant alleles number genotypings performed 4000 highly feasible review look present knowledge allelic complexity human disease genes well providing brief glance future
0.14565748.12351581.html.plaintext.txt	6	properties allelic space top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references perhaps oversimplified aid visualizing properties human disease genes provided figure 1 figure depicts three dimensional allelic space axes disease frequency number responsible loci mean number alleles locus regarding second axis number responsible loci genetic traits traditionally divided monogenic single gene simple trait polygenic many genes multifactorial complex interactions multiple genes environment single locus responsible monogenic disorders identification relevant loci usually straightforward provided sufficient number multiplex families available contrast genetics complex traits remains murky success identifying responsible loci elusive many genes environment conspire together series complicated epistatic synergistic relationships cause final disease phenotype general number loci identified linkage given complex disease trait less 10 linkage expected identify major contributing loci since exceptions genes responsible complex traits yet identified remains open question number alleles locus
0.14565748.12351581.html.plaintext.txt	7	view larger version 25k figure 1 allelic space three dimensional space provides aid visualizing possible structures polymorphism human disease genes monogenic disorders rare diseases green bar complex allelic spectra high number alleles per locus common diseases yellow bar simple spectra low number alleles per locus special cases gray bar exist situations heterozygous advantage population bottlenecks common complex disease traits situation less clear two extreme models interaction model cdcv hypothesis dark blue bar genetic heterogeneity model red bar however two extreme models also formally possible small number loci large number alleles cyan bar large number loci large number alleles magenta bar considerations human population genetics 2 suggest one four extreme models small number loci large number alleles cyan bar unlikely however present data insufficient confidently place complex disease traits remaining three extremes indicated two dimensional gray surface figure following examples employed 2 10 monogenic rare retinoblastoma monogenic common glucose 6 phosphate dehydrogenase deficiency south china monogenic special case ss thalassemia sardinia complex interaction model alzheimers disease speculative complex genetic heterogeneity model colon cancer speculative known examples yet exist two hypothetical cases common complex diseases caused small number loci large number alleles large number loci large number alleles clarity disease frequencies monogenic common complex disorders rounded 10 1 within one order magnitude known frequency cases complex diseases alzheimers disease colon cancer assigned values number loci number alleles per locus highly speculative purposes figure assumed alzheimers disease example interaction model whereas colon cancer example genetic heterogeneity model although assumptions conjectural evidence favor genetic heterogeneity model cancer 10
0.14565748.12351581.html.plaintext.txt	8	two extreme models usually envisaged complex disease traits fig 1 1 one idea common alleles handful loci interact cause disease referred interaction model common diseasecommon variant cdcv hypothesis competing notion rare alleles numerous loci single handedly cause disease referred genetic heterogeneity model two extreme models also formally possible complex disease traits caused small number loci large number alleles caused large number loci large number alleles fig 1 one last two alternatives small number loci large number alleles rendered unlikely considerations human population structure see however remaining three extremes complex disease traits could occupy middle ground
0.14565748.12351581.html.plaintext.txt	9	inferences human population structure top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references reich lander 2 provided simple framework understanding allelic spectra number frequency disease predisposing alleles human disease genes addition work provides justification cdcv hypothesis
0.14565748.12351581.html.plaintext.txt	10	large amount evidence suggesting dramatic expansion human population 18 000 150 000 years 700 6000 generations ago resulted increased effective population size 104 individuals present size 6x109 assume expansion one allele rare disease gene one allele common gene fig 2a notable exceptions available evidence suggests fairly similar mutation rates genes 10 6 10 5 per gene per generation 3 7 rare disease number individuals expanded population still small hence relative terms quickly swamped newly mutated alleles contrast population reservoir common disease gene large takes long time alleles taken new mutations addition face similar mutation rates lower prevalence rare diseases implies higher allele disappearance rate negative selection diseases common diseases effects reservoir effect selection pressure imply population expansion allelic spectra became diverse much quickly rare diseases common long run however expected spectra rare common diseases become equally diverse fig 2b reich lander estimate intermediate stage presently exists population rare diseases diverse allelic structure common disorders simple structure prediction theory rare disorders largely consist recent alleles whereas common disorders consist old ancestral alleles
0.14565748.12351581.html.plaintext.txt	11	large amount evidence suggesting dramatic expansion human population 18 000 150 000 years 700 6000 generations ago resulted increased effective population size 104 individuals present size 6x109 assume expansion one allele rare disease gene one allele common gene fig 2a notable exceptions available evidence suggests fairly similar mutation rates genes 10 6 10 5 per gene per generation 3 7 rare disease number individuals expanded population still small hence relative terms quickly swamped newly mutated alleles contrast population reservoir common disease gene large takes long time alleles taken new mutations addition face similar mutation rates lower prevalence rare diseases implies higher allele disappearance rate negative selection diseases common diseases effects reservoir effect selection pressure imply population expansion allelic spectra became diverse much quickly rare diseases common long run however expected spectra rare common diseases become equally diverse fig 2b reich lander estimate intermediate stage presently exists population rare diseases diverse allelic structure common disorders simple structure prediction theory rare disorders largely consist recent alleles whereas common disorders consist old ancestral alleles
0.14565748.12351581.html.plaintext.txt	12	view larger version 14k figure 2 human population structure dramatic population expansion leads increased numbers individuals single allele rare 5 squares common 25 circles disease gene rare disease gene strong negative selection three alleles disappear population replaced three new alleles thus 25 40 alleles represent ancestral allele contrast common disease gene much less strong negative selection one allele lost replaced three new alleles proportion ancestral alleles hence 2427 89 consequently common disease gene much simpler allelic structure present population rare gene b graphical depiction population expansion leads proportionate increases single allele common disease gene red rare disease gene blue present human population rapid loss alleles smaller population reservoir rare disease gene lead allelic spectrum gene becoming relatively much diverse common gene however far distant future equilibrium common disease gene expected catch rare gene allelic spectra genes equally diverse
0.14565748.12351581.html.plaintext.txt	13	allelic structure simple diseases top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references since 1000 mendelian monogenic disease genes identified understanding complexity considerable general rare diseases strong negative selection exhibit large allelic diversity 8 exception pattern high allelic diversity rare disorders alleles also provide heterozygous advantage one example provided thalassemias confer resistance malaria arisen strong positive selective pressure conferred single alleles ensures relatively rapid spread population another exception high allelic diversity rare disorders occurs population bottleneck results greatly simplified spectra example among finnish ashkenazi jewish populations numerous examples disease individual alleles show greatly elevated frequencies compared populations overall monogenic disorders good agreement theoretical predictions reich lander 2 available data
0.14565748.12351581.html.plaintext.txt	14	allelic structure complex diseases top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references common complex disorders relatively data diversity allelic spectra due difficulty identifying responsible genes known examples however tend support interaction model cdcv hypothesis since genes small number common disease associated alleles table 1 couple possible exceptions genesloci listed table 1 confirmed multiple studies unlikely represent type 1 errors noted however listed genes may fully representative common disease genes since genes small number common alleles would easier identify association genes large number rare alleles
0.14565748.12351581.html.plaintext.txt	15	view table table 1 three lines evidence supporting common diseasecommon variant hypothesis another valid test cdcv hypothesis examine genetic complexity quantitative traits related common disease blood pressure body mass index plasma lipids one well studied group phenotypes comprises levels compositions plasma lipoproteins strongly associated coronary heart disease exception mutations ldl receptor underlie familial hypercholesterolemia relatively common monogenic disorder known variations associated traits due small number common alleles table 1
0.14565748.12351581.html.plaintext.txt	16	corollary cdcv hypothesis individual carry susceptibility genes numerous disorders point difficult examine systematically humans although clearly older individuals frequently suffer host common maladies convincing example provided surveying inbred mouse strains differences disease related traits table 1 lists common diseases related traits differing two inbred strains dba2j c57bl6j many traits analyzed genetic crosses two strains known due multiple quantitative trait loci qtl one might argue since mice maintained continuous brother sister mating many generations numerous mutations fixed responsible trait differences counter argument however fact number loci observed dba2jxc57bl6j cross also observed crosses strains cases loci syntenic human loci corresponding traits 9
0.14565748.12351581.html.plaintext.txt	17	corollary cdcv hypothesis individual carry susceptibility genes numerous disorders point difficult examine systematically humans although clearly older individuals frequently suffer host common maladies convincing example provided surveying inbred mouse strains differences disease related traits table 1 lists common diseases related traits differing two inbred strains dba2j c57bl6j many traits analyzed genetic crosses two strains known due multiple quantitative trait loci qtl one might argue since mice maintained continuous brother sister mating many generations numerous mutations fixed responsible trait differences counter argument however fact number loci observed dba2jxc57bl6j cross also observed crosses strains cases loci syntenic human loci corresponding traits 9
0.14565748.12351581.html.plaintext.txt	18	apart examples rapid fall disease rates relatives affected observed common diseases argues interaction model heterogeneity model addition many common diseases exhibit high ratio relative risk monozygotic twins dizygotic twins also consistent genetics multifactorial threshold model 210 however exceptions example common disease familial combined hyperlipidemia prevalence 1 2 exhibits apparent dominant mode inheritance many generations yet clearly complex 11 furthermore inheritance cancers ways consistent heterogeneity model see
0.14565748.12351581.html.plaintext.txt	19	apart examples rapid fall disease rates relatives affected observed common diseases argues interaction model heterogeneity model addition many common diseases exhibit high ratio relative risk monozygotic twins dizygotic twins also consistent genetics multifactorial threshold model 210 however exceptions example common disease familial combined hyperlipidemia prevalence 1 2 exhibits apparent dominant mode inheritance many generations yet clearly complex 11 furthermore inheritance cancers ways consistent heterogeneity model see
0.14565748.12351581.html.plaintext.txt	20	challenges cdcv hypothesis also area cancer presented breast cancer genes brca1 brca2 12 loci contribute relatively common genetic disorder many different rare mutations even ashkenazi population see addition even cdcv hypothesis true disease genes may dominated alleles large numbers minor alleles case cystic fibrosis 67 disease alleles caucasian population accounted single mutation nevertheless total number known disease alleles exceeds 100 8
0.14565748.12351581.html.plaintext.txt	21	challenges cdcv hypothesis also area cancer presented breast cancer genes brca1 brca2 12 loci contribute relatively common genetic disorder many different rare mutations even ashkenazi population see addition even cdcv hypothesis true disease genes may dominated alleles large numbers minor alleles case cystic fibrosis 67 disease alleles caucasian population accounted single mutation nevertheless total number known disease alleles exceeds 100 8
0.14565748.12351581.html.plaintext.txt	22	common diseases similar allelic structure top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references general allelic architecture various diseases classes genes may differ depending biological mechanisms involved mitchison 13 made analogy mutations coding regions hardware mutations regulatory regions software divides genes extrovert concerned outside world eg immunoglobulins olfactory receptors numerous introvert genes concerned cellular homeostasis eg transcription signal transduction neurotransmission mitchison suggests extrovert genes hardware variation coding regions common introvert genes genetic variation mild effects occurs software regulatory regions many instances promoter variation software found pharmacogenomics psychiatry 14 one example provided 44 bp insertiondeletion polymorphism promoter region human serotonin transporter 5 htt gene polymorphism associated affective illness anxiety related traits also alters 5 htt gene expression since short promoter less active long promoter another example promoter polymorphism found 5 lipoxygenase 5 lo gene gene displays variations number gc rich sp1 egr 1 transcription factor binding sites influence promoter efficiency methylation 15 resulting variations 5 lo levels may relevant inflammatory response asthma 16
0.14565748.12351581.html.plaintext.txt	23	pertinent note whereas understanding kinds variations occur mendelian diseases extensive knowledge variations explain common disease limited relevant transcriptional regulation one approach identification common disease gene candidates survey cases controls using expression array analysis regard noteworthy one third known common disease genes table 1 affect expression levels 8
0.14565748.12351581.html.plaintext.txt	24	pertinent note whereas understanding kinds variations occur mendelian diseases extensive knowledge variations explain common disease limited relevant transcriptional regulation one approach identification common disease gene candidates survey cases controls using expression array analysis regard noteworthy one third known common disease genes table 1 affect expression levels 8
0.14565748.12351581.html.plaintext.txt	25	interesting evidence inheritance cancers distinct common diseases provided risch 10 exceptions different cancers roughly familial relative risk frr although frr increases early age onset traditionally studies attribute large environmental component cancer relevant evidence includes observations dramatic shifts cancer incidence due population migrations however careful evaluation twin family studies suggest genetics also plays large part cancer risk 10 key quantity rmd frr ratio monozygotic mz dizygotic dz twins idea mz dz twins comparable sharing environmental factors difference concordance rates mz dz twins must reflect genetic factors disease due single rare dominant gene rmd2 recessive rare gene rmd4 diminishes toward 2 allele common multiple loci rmd become large cancers rmd2 compared much higher ratios many complex diseases schizophrenia multiple sclerosis autism data consistent either rare dominant alleles additive gene effects cancer rather interactive multigenic model
0.14565748.12351581.html.plaintext.txt	26	interesting evidence inheritance cancers distinct common diseases provided risch 10 exceptions different cancers roughly familial relative risk frr although frr increases early age onset traditionally studies attribute large environmental component cancer relevant evidence includes observations dramatic shifts cancer incidence due population migrations however careful evaluation twin family studies suggest genetics also plays large part cancer risk 10 key quantity rmd frr ratio monozygotic mz dizygotic dz twins idea mz dz twins comparable sharing environmental factors difference concordance rates mz dz twins must reflect genetic factors disease due single rare dominant gene rmd2 recessive rare gene rmd4 diminishes toward 2 allele common multiple loci rmd become large cancers rmd2 compared much higher ratios many complex diseases schizophrenia multiple sclerosis autism data consistent either rare dominant alleles additive gene effects cancer rather interactive multigenic model
0.14565748.12351581.html.plaintext.txt	27	linkage disequilibrium top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references related cvcd hypothesis idea diagnostic costs reduced manageable levels using linkage disequilibrium idea great population expansion sufficiently recent large blocks haplotypes likely conserved genomes true would greatly reduce density single nucleotide polymorphisms snps required association studies expense genotyping implicit assumption approach common haplotypes responsible common diseases
0.14565748.12351581.html.plaintext.txt	28	estimates extent ld obtained sampling various restricted genomic regions 17 well 51 autosomal regions spanning total 13 megabases 18 addition somatic cell genetics used analyze ld entire chromosome 21 19 ld sampling average distance useful ld preserved 50 60 kb however considerable variability loci ld found far away 500 kb regions useful disequilibrium found chromosome 21 study found considerable linkage disequilibrium long blocks conserved haplotypes interestingly greater 80 haplotype structure could defined less 10 snps based studies appears extent linkage disequilibrium genome region population specific
0.14565748.12351581.html.plaintext.txt	29	estimates extent ld obtained sampling various restricted genomic regions 17 well 51 autosomal regions spanning total 13 megabases 18 addition somatic cell genetics used analyze ld entire chromosome 21 19 ld sampling average distance useful ld preserved 50 60 kb however considerable variability loci ld found far away 500 kb regions useful disequilibrium found chromosome 21 study found considerable linkage disequilibrium long blocks conserved haplotypes interestingly greater 80 haplotype structure could defined less 10 snps based studies appears extent linkage disequilibrium genome region population specific
0.14565748.12351581.html.plaintext.txt	30	dark side linkage disequilibrium revealed recent study identify genes chromosome 5 involved crohns disease 20 although region linkage disequilibrium associated disease identified lack recombination events within relevant haplotype block precluded identification responsible gene thus although existence large haplotype blocks good news point view cheap diagnostics may hinder definitive identification responsible genes associated biological insights situation use alternate populations may come rescue allowing subdivision large regions linkage disequilibrium narcolepsy possible identify recombination event japanese family broke haplotype block hla region allowing finer mapping responsible gene 21 alternatively scientists may rely animal models mouse ultimately identify causative gene
0.14565748.12351581.html.plaintext.txt	31	dark side linkage disequilibrium revealed recent study identify genes chromosome 5 involved crohns disease 20 although region linkage disequilibrium associated disease identified lack recombination events within relevant haplotype block precluded identification responsible gene thus although existence large haplotype blocks good news point view cheap diagnostics may hinder definitive identification responsible genes associated biological insights situation use alternate populations may come rescue allowing subdivision large regions linkage disequilibrium narcolepsy possible identify recombination event japanese family broke haplotype block hla region allowing finer mapping responsible gene 21 alternatively scientists may rely animal models mouse ultimately identify causative gene
0.14565748.12351581.html.plaintext.txt	32	future human genetics top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references despite continued improvements genotyping speed power technologies unlimited present hopes focused exploiting structure human population realize dream individualized genotyping population structure results recent dramatic expansion theorized result simple allelic spectra common disease genes considerable linkage disequilibrium presently insufficient data know whether expectations realized although promising hints
0.14565748.12351581.html.plaintext.txt	33	although particular alleles haplotypes may numerically rare population whole nevertheless likely individual harbor significant number variants addition estimates gene mutation rates imply individual three de novo gene mutations within genome thus even interaction model proves true loci personalized medicine still benefit individually tailored genotyping
0.14565748.12351581.html.plaintext.txt	34	although particular alleles haplotypes may numerically rare population whole nevertheless likely individual harbor significant number variants addition estimates gene mutation rates imply individual three de novo gene mutations within genome thus even interaction model proves true loci personalized medicine still benefit individually tailored genotyping
0.14565748.12351581.html.plaintext.txt	35	distinctions interaction genetic heterogeneity models restated using following question human population would rather know rare severe genetic mutations eg nonsense frameshift non synonymous would rather know common variations present limitations speed genotyping lack knowledge genetic causation common human disease best choice two alternatives unclear course optimal situation would know answer questions thus need ever rapid genotyping sequencing technologies likely continue foreseeable future
0.14565748.12351581.html.plaintext.txt	36	acknowledgements work supported grants us nih hl028481 hl030568 da015802
0.14565748.12351581.html.plaintext.txt	37	footnotes correspondence addressed pharmacology ucla school medicine 23 120 chs box 951735 los angeles ca 90095 1735 usa tel 1 3102060086 fax 1 3108256267 email dsmithatmednetuclaedu u d correspondence may also addressed aj lusis microbiology immunology molecular genetics ucla 3730 mrl box 951679 los angeles ca 90095 1679 usa tel 1 3108251359 fax 1 3107947345 email jlusisatmednetuclaedu
0.14565748.12351581.html.plaintext.txt	38	footnotes correspondence addressed pharmacology ucla school medicine 23 120 chs box 951735 los angeles ca 90095 1735 usa tel 1 3102060086 fax 1 3108256267 email dsmithatmednetuclaedu u d correspondence may also addressed aj lusis microbiology immunology molecular genetics ucla 3730 mrl box 951679 los angeles ca 90095 1679 usa tel 1 3108251359 fax 1 3107947345 email jlusisatmednetuclaedu
0.14565748.12351581.html.plaintext.txt	39	references top abstract properties allelic space inferences human population allelic structure simple allelic structure complex common diseases linkage disequilibrium future human references 1 peltonen l palotie lange k 2000 use population isolates mapping complex traits nat rev genet 1 182 190isimedline
0.14565748.12351581.html.plaintext.txt	40	6 peltomaki p 2001 deficient dna mismatch repair common etiologic risk factor colon cancer hum mol genet 10 735 740abstractfree full text
0.14565748.12351581.html.plaintext.txt	41	7 sakanaranarayanan k 1998 ionizing radiation genetic risks ix estimates frequencies mendelian diseases spontaneous mutation rates human populations 1998 perspective mutat res 411 129 178isimedline
0.14565748.12351581.html.plaintext.txt	42	8 online mendelian inheritance man httpwwwncbinlmnihgovomim
0.14565748.12351581.html.plaintext.txt	43	10 risch n 2001 genetic epidemiology cancer interpreting family twin studies implications molecular genetic approaches cancer epidemiol biomarkers prev 10 733 741abstractfree full text
0.14565748.12351581.html.plaintext.txt	44	13 mitchison 1997 partitioning genetic variation regulatory coding gene segments predominance software variation genes encoding introvert proteins immunogenetics 46 46 52isimedline
0.14565748.12351581.html.plaintext.txt	45	14 catalano m 2001 functionally gene linked polymorphic regions genetically controlled neurotransmitters metabolism eur neuropsychopharmacol 11 431 439isimedline
0.16537316.15829503.html.plaintext.txt	0	sine exonic insertion ptpla gene leads multiple splicing defects segregates autosomal recessive centronuclear myopathy dogs manuel pele1 laurent tiret1 jean louis kessler1 stephane blot23 jean jacques panthier1
0.16537316.15829503.html.plaintext.txt	1	1umr 955 inra enva de genetique moleculaire et cellulaire 2laboratoire de neurobiologie ecole nationale veterinaire dalfort 7 avenue du general de gaulle 94704 maisons alfort cedex france 3inserm emi e00 11 94000 creteil france
0.16537316.15829503.html.plaintext.txt	2	correspondence addressed tel 33 143967275 fax 33 143967169 email ltiretatvet alfortfr
0.16537316.15829503.html.plaintext.txt	3	correspondence addressed tel 33 143967275 fax 33 143967169 email ltiretatvet alfortfr
0.16537316.15829503.html.plaintext.txt	4	received february 8 2005 revised march 30 2005 accepted april 6 2005
0.16537316.15829503.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods supplementary material references human centronuclear myotubular myopathies belong genetically heterogeneous nosological group clinical variability ranging fatal disorder mild weakness severe x linked form attributed 200 different mutations myotubularin encoding gene mtm1 contrast reports regarding molecular etiology linkage studies autosomal forms disease labrador retrievers affected spontaneous centronuclear myopathy cnm clinical histological features human disorder represent first model recessive autosomal centronuclear myopathy previously mapped cnm locus centromeric region canine chromosome 2 gene mtm1 family maps human homologous chromosomal region described herein disease associated insertion within ptpla exon 2 found alleles affected labradors single allele obligate carriers inserted trna derived short interspersed repeat element sine striking effect maturation ptpla mrna whereby spliced partially exonized involved multiple exon skipping result amount wild type transcripts falls 1 affected muscles example therefore recapitulates cumulative sine associated transcriptional defects previously described exclusive consequences independent mutations although function ptpla metazoa remains unknown characterization hypomorphic mutation labradors centronuclear myopathy provides new clues molecular complexity skeletal myofiber homeostasis results also suggest impaired ptpla signaling might implicated human myopathies
0.16537316.15829503.html.plaintext.txt	6	abstract top abstract introduction results discussion materials methods supplementary material references human centronuclear myotubular myopathies belong genetically heterogeneous nosological group clinical variability ranging fatal disorder mild weakness severe x linked form attributed 200 different mutations myotubularin encoding gene mtm1 contrast reports regarding molecular etiology linkage studies autosomal forms disease labrador retrievers affected spontaneous centronuclear myopathy cnm clinical histological features human disorder represent first model recessive autosomal centronuclear myopathy previously mapped cnm locus centromeric region canine chromosome 2 gene mtm1 family maps human homologous chromosomal region described herein disease associated insertion within ptpla exon 2 found alleles affected labradors single allele obligate carriers inserted trna derived short interspersed repeat element sine striking effect maturation ptpla mrna whereby spliced partially exonized involved multiple exon skipping result amount wild type transcripts falls 1 affected muscles example therefore recapitulates cumulative sine associated transcriptional defects previously described exclusive consequences independent mutations although function ptpla metazoa remains unknown characterization hypomorphic mutation labradors centronuclear myopathy provides new clues molecular complexity skeletal myofiber homeostasis results also suggest impaired ptpla signaling might implicated human myopathies
0.16537316.15829503.html.plaintext.txt	7	introduction top abstract introduction results discussion materials methods supplementary material references nosological group human centronuclear myopathy omim 160150 defined heterogeneous forms inherited muscular disorders share common clinical histological features hallmarks disease include generalized muscle weakness ptosis ophthalmoplegia externa areflexia muscular atrophy affecting predominantly type 1 myofibers nuclei centralization pale central zones variably staining granules 1 3 genetic heterogeneity correlated onset severity disease significant proportion infants affected severe x linked form called myotubular myopathy xlmtm omim 310400 die months age following respiratory failure 45 eighty percent survivors become dependent artificial ventilation suffer medical complications 5 autosomal dominant recessive forms omim 255200 run milder course recessive form intermediate x linked dominant forms 26 xlmtm locus initially mapped xq28 7 mutations myotubularin mtm1 gene associated disease 8 date spectrum 200 disease associated mutations mtm1 account severe mild phenotype observed xlmtm patients 9 mtm1 encodes myotubularin contains consensus sequence tyrosine phosphatase catalytic site 8 however protein seems essentially act muscles phosphoinositide phosphatase specifically dephosphorylates lipid second messengers phosphatidylinositol 3 phosphate ptdins3p 10 12 phosphatidylinositol 35 bisphosphate ptdins35p2 1314 myotubularin first identified member large protein family comprises 13 known members human named myotubularin related 1 13 mtmr1 mtmr13 mutations mtmr2 mtmr13 associated charcot marie tooth demyelinating diseases 15 17 reinforce central role phosphoinositides neuromuscular homeostasis reviewed 18 mtm1 protein family encompasses active inactive members recent reports suggested functional cooperation two groups 18 23 besides characterized etiology xlmtm significant molecular data autosomal forms reported far
0.16537316.15829503.html.plaintext.txt	8	introduction top abstract introduction results discussion materials methods supplementary material references nosological group human centronuclear myopathy omim 160150 defined heterogeneous forms inherited muscular disorders share common clinical histological features hallmarks disease include generalized muscle weakness ptosis ophthalmoplegia externa areflexia muscular atrophy affecting predominantly type 1 myofibers nuclei centralization pale central zones variably staining granules 1 3 genetic heterogeneity correlated onset severity disease significant proportion infants affected severe x linked form called myotubular myopathy xlmtm omim 310400 die months age following respiratory failure 45 eighty percent survivors become dependent artificial ventilation suffer medical complications 5 autosomal dominant recessive forms omim 255200 run milder course recessive form intermediate x linked dominant forms 26 xlmtm locus initially mapped xq28 7 mutations myotubularin mtm1 gene associated disease 8 date spectrum 200 disease associated mutations mtm1 account severe mild phenotype observed xlmtm patients 9 mtm1 encodes myotubularin contains consensus sequence tyrosine phosphatase catalytic site 8 however protein seems essentially act muscles phosphoinositide phosphatase specifically dephosphorylates lipid second messengers phosphatidylinositol 3 phosphate ptdins3p 10 12 phosphatidylinositol 35 bisphosphate ptdins35p2 1314 myotubularin first identified member large protein family comprises 13 known members human named myotubularin related 1 13 mtmr1 mtmr13 mutations mtmr2 mtmr13 associated charcot marie tooth demyelinating diseases 15 17 reinforce central role phosphoinositides neuromuscular homeostasis reviewed 18 mtm1 protein family encompasses active inactive members recent reports suggested functional cooperation two groups 18 23 besides characterized etiology xlmtm significant molecular data autosomal forms reported far
0.16537316.15829503.html.plaintext.txt	9	spontaneous cases labrador retrievers suffering congenital form hereditary myopathy hereditary myopathy labrador retriever hmlr first described usa 1976 24 later groups across world 25 29 myopathy transmitted autosomal recessive disease 28 30 clinical features male female pups include hypotonia generalized muscle weakness abnormal postures stiff hopping gait exercise intolerance increased collapse exposed cold see movie published supplementary material hmg online examination evidence skeletal muscle atrophy particularly involving muscles head tendinous areflexia metabolic shape remodeling muscles observed type 2 fibers deficiency predominance atrophic hypertrophic type 1 fibers 24252829 reported cases histopathological evaluation muscle biopsies demonstrated characteristic centralization myonuclei often located areas devoid myofibrils mitochondrial aggregation centronuclear myopathy cnm therefore proposed alternative name hmlr 29 knowledge spontaneous animal model human autosomal centronuclear myopathies
0.16537316.15829503.html.plaintext.txt	10	spontaneous cases labrador retrievers suffering congenital form hereditary myopathy hereditary myopathy labrador retriever hmlr first described usa 1976 24 later groups across world 25 29 myopathy transmitted autosomal recessive disease 28 30 clinical features male female pups include hypotonia generalized muscle weakness abnormal postures stiff hopping gait exercise intolerance increased collapse exposed cold see movie published supplementary material hmg online examination evidence skeletal muscle atrophy particularly involving muscles head tendinous areflexia metabolic shape remodeling muscles observed type 2 fibers deficiency predominance atrophic hypertrophic type 1 fibers 24252829 reported cases histopathological evaluation muscle biopsies demonstrated characteristic centralization myonuclei often located areas devoid myofibrils mitochondrial aggregation centronuclear myopathy cnm therefore proposed alternative name hmlr 29 knowledge spontaneous animal model human autosomal centronuclear myopathies
0.16537316.15829503.html.plaintext.txt	11	previously described experimental pedigree labrador retrievers segregating centronuclear myopathy cnm locus mapped highly significant lod score 993 000 181 cm segment centromeric region canine chromosome 2 cfa2 29 region forms shuffled block synteny human chromosome segment 10p15 10p111 31 interestingly gene mtm1 family maps human chromosome 10p 12
0.16537316.15829503.html.plaintext.txt	12	previously described experimental pedigree labrador retrievers segregating centronuclear myopathy cnm locus mapped highly significant lod score 993 000 181 cm segment centromeric region canine chromosome 2 cfa2 29 region forms shuffled block synteny human chromosome segment 10p15 10p111 31 interestingly gene mtm1 family maps human chromosome 10p 12
0.16537316.15829503.html.plaintext.txt	13	purpose study identify plausible candidate genes within cnm interval characterize disease causing mutation one genes report mutation gene encoding protein tyrosine phosphatase like member ptpla perfectly segregates cnm labrador retrievers experimental pedigree indeed trna like short interspersed repeat element sine insertion identified exon 2 ptpla leads multiple transcriptional alterations sine containing ptpla allele moreover disclose original complex disease associated mutation multiple transcriptional defects arising trna like sine insertion
0.16537316.15829503.html.plaintext.txt	14	purpose study identify plausible candidate genes within cnm interval characterize disease causing mutation one genes report mutation gene encoding protein tyrosine phosphatase like member ptpla perfectly segregates cnm labrador retrievers experimental pedigree indeed trna like short interspersed repeat element sine insertion identified exon 2 ptpla leads multiple transcriptional alterations sine containing ptpla allele moreover disclose original complex disease associated mutation multiple transcriptional defects arising trna like sine insertion
0.16537316.15829503.html.plaintext.txt	15	results top abstract introduction results discussion materials methods supplementary material references candidate gene selection using human genome resources ncbi map viewer identified 208 genes within cnm region data shown none member mtm1 family hence focused genes expressed skeletal muscles temporal window compatible early postnatal symptoms diagnosed affected dogs among genes ptpla shown expressed embryogenesis murine myogenic precursors 32 adult skeletal muscles mouse human 3233 furthermore ptpla annotated phosphatase coding gene ptpla protein contains putative phosphatase like domain proline instead arginine catalytic site motif characteristics similar myotubularin mutated responsible human xlmtm
0.16537316.15829503.html.plaintext.txt	16	results top abstract introduction results discussion materials methods supplementary material references candidate gene selection using human genome resources ncbi map viewer identified 208 genes within cnm region data shown none member mtm1 family hence focused genes expressed skeletal muscles temporal window compatible early postnatal symptoms diagnosed affected dogs among genes ptpla shown expressed embryogenesis murine myogenic precursors 32 adult skeletal muscles mouse human 3233 furthermore ptpla annotated phosphatase coding gene ptpla protein contains putative phosphatase like domain proline instead arginine catalytic site motif characteristics similar myotubularin mutated responsible human xlmtm
0.16537316.15829503.html.plaintext.txt	17	mutation identification segregation experimental pedigree detailed structure canine ptpla gene phylogenetic analysis ptpla family members described elsewhere pele et al manuscript preparation following data taken consideration designing experiments detailed subsequently canine ptpla spans 20 kb contains seven exons fig 1a structure shared human 33 murine orthologs see ensembl gene id ensmusg00000063275 dog skeletal muscles ptpla transcripts exist two isoforms fig 1b differing retention ptplafl full length embl accession aj876904 exclusion exon 5 ptplad5 deleted exon 5 embl accession aj876905 ptplafl transcript encodes putative protein 249 amino acids contains four transmembrane domains putative tyrosine phosphatase like hcx2gx2p catalytic site fig 1c exon 5 skipping ptplad5 transcript leads frame disruption premature translation termination resulting predicted ptplad5 protein contains two transmembrane domains putative tyrosine phosphatase like hcx2gx2p catalytic site ptplafl ptplad5 proteins share common 125 amino acids n terminus domain differ c terminus regions 124 amino acids 11 amino acids length respectively fig 1c
0.16537316.15829503.html.plaintext.txt	18	view larger version 30k figure 1 canine ptpla gene structure gene drawn follows seven exons indicated vertical bars size individual exons introns indicated horizontal bar respectively b skeletal muscle ptpla transcripts exist two isoforms differing retention ptplafl full length exclusion ptplad5 exon 5 deleted isoform exon 5 box represents exon number indicated probe used southern spans seven exons gene covers 69 full length cdna c sequences ptplafl ptplad5 proteins inferred corresponding mrnas predicted transmembrane domains indicated drawings prosite bar indicates putative protein tyrosine phosphatase like site
0.16537316.15829503.html.plaintext.txt	19	gene searched specific polymorphism would segregate disease experimental pedigree genomic dna wild type wt cnm healthy carriers cnm affected cnm labradors digested hybridized probe encompassing ptpla cdna shown fig 1b bamhi restriction fragment length polymorphism rflp detected dna samples cnm cnm dogs seen dna samples cnm dogs furthermore rflp perfectly segregated disease data shown
0.16537316.15829503.html.plaintext.txt	20	gene searched specific polymorphism would segregate disease experimental pedigree genomic dna wild type wt cnm healthy carriers cnm affected cnm labradors digested hybridized probe encompassing ptpla cdna shown fig 1b bamhi restriction fragment length polymorphism rflp detected dna samples cnm cnm dogs seen dna samples cnm dogs furthermore rflp perfectly segregated disease data shown
0.16537316.15829503.html.plaintext.txt	21	using pcr rt pcr amplified individual exons ptpla genomic dna rnas skeletal muscles pcr rt pcr amplifications carried samples healthy carrier cnm affected cnm dog figure 2 illustrates results obtained exons 1 2 pcr rt pcr amplifications exon 1 using ex1f1 ex1r1 primers fig 2a led single 123 bp fragment corresponding exon 1 fig 2b lanes 2 4 123 bp signal weaker rnas cnm muscles used template rt pcr reaction compared rnas cnm muscles fig 2b compare lanes 3 4 pcr amplification exon 2 using genomic dna cnm dog template ex2f1 ex2r1 primers yielded two products 105 341 bp respectively fig 2b lane 5 105 bp product normal size exon 2 fragment expected primers 105 bp fragment also obtained rnas cnm muscles used template rt pcr reaction detected rnas cnm muscles used fig 2b lanes 6 7 respectively
0.16537316.15829503.html.plaintext.txt	22	using pcr rt pcr amplified individual exons ptpla genomic dna rnas skeletal muscles pcr rt pcr amplifications carried samples healthy carrier cnm affected cnm dog figure 2 illustrates results obtained exons 1 2 pcr rt pcr amplifications exon 1 using ex1f1 ex1r1 primers fig 2a led single 123 bp fragment corresponding exon 1 fig 2b lanes 2 4 123 bp signal weaker rnas cnm muscles used template rt pcr reaction compared rnas cnm muscles fig 2b compare lanes 3 4 pcr amplification exon 2 using genomic dna cnm dog template ex2f1 ex2r1 primers yielded two products 105 341 bp respectively fig 2b lane 5 105 bp product normal size exon 2 fragment expected primers 105 bp fragment also obtained rnas cnm muscles used template rt pcr reaction detected rnas cnm muscles used fig 2b lanes 6 7 respectively
0.16537316.15829503.html.plaintext.txt	23	view larger version 60k figure 2 mutation analysis ptpla segregation cnm pedigree location pcr primers indicated black arrows b size marker lane 1 100 bp ladder pcr genomic dna lanes 2 5 rt pcr muscular mrnas lanes 3 4 6 7 healthy carrier cnm affected dog cnm using ex1f1ex1r1 lanes 2 4 ex2f1ex2r1 lanes 5 7 primer pairs insertion within exon 2 ptpla seen cnm dog genomic samples c pcr amplification genomic dna representative panel healthy unrelated labradors cnm lanes 2 4 healthy carriers cnm lanes 5 7 affected labradors cnm lanes 8 10 cnm pedigree using ex2f2 ex3r1 primers size marker lanes 1 11 100 bp ladder
0.16537316.15829503.html.plaintext.txt	24	view larger version 60k figure 2 mutation analysis ptpla segregation cnm pedigree location pcr primers indicated black arrows b size marker lane 1 100 bp ladder pcr genomic dna lanes 2 5 rt pcr muscular mrnas lanes 3 4 6 7 healthy carrier cnm affected dog cnm using ex1f1ex1r1 lanes 2 4 ex2f1ex2r1 lanes 5 7 primer pairs insertion within exon 2 ptpla seen cnm dog genomic samples c pcr amplification genomic dna representative panel healthy unrelated labradors cnm lanes 2 4 healthy carriers cnm lanes 5 7 affected labradors cnm lanes 8 10 cnm pedigree using ex2f2 ex3r1 primers size marker lanes 1 11 100 bp ladder
0.16537316.15829503.html.plaintext.txt	25	characterize 341 bp fragment pcr amplifications exon 2 intron 2 using ex2f2 ex3r1 primers performed genomic dna 61 individuals six generation experimental pedigree 29 three unrelated healthy cnm labradors representative panel resulting pcr products presented fig 2c complete amplifications 46 animals among 22 affected dogs provided supplementary material fig s1 pcr using dna wt cnm dogs template yielded single 282 bp product lanes 2 4 pcr performed affected cnm dogs dna contained single 518 bp product lanes 8 10 finally pcr using cnm dogs dna yielded 282 518 bp products lanes 5 7 explain size shift seen genomic dna cnm cnm dogs used templates cloned sequenced 518 bp product contained 236 bp antisense canine trna like sine embl accession aj876906 flanked sides 13 bp direct duplication insertion site fig 3 comparison repeatmasker libraries known vertebrate carnivore specific repeat elements sine sequence found within ptpla best aligned sineccf repeats sinelys subfamily first described minnick et al 34 using trnascan identified glutamine anticodon within trna like sequence sine finally sequence analysis revealed bamhi restriction site within insertion explained rflp previously described
0.16537316.15829503.html.plaintext.txt	26	characterize 341 bp fragment pcr amplifications exon 2 intron 2 using ex2f2 ex3r1 primers performed genomic dna 61 individuals six generation experimental pedigree 29 three unrelated healthy cnm labradors representative panel resulting pcr products presented fig 2c complete amplifications 46 animals among 22 affected dogs provided supplementary material fig s1 pcr using dna wt cnm dogs template yielded single 282 bp product lanes 2 4 pcr performed affected cnm dogs dna contained single 518 bp product lanes 8 10 finally pcr using cnm dogs dna yielded 282 518 bp products lanes 5 7 explain size shift seen genomic dna cnm cnm dogs used templates cloned sequenced 518 bp product contained 236 bp antisense canine trna like sine embl accession aj876906 flanked sides 13 bp direct duplication insertion site fig 3 comparison repeatmasker libraries known vertebrate carnivore specific repeat elements sine sequence found within ptpla best aligned sineccf repeats sinelys subfamily first described minnick et al 34 using trnascan identified glutamine anticodon within trna like sequence sine finally sequence analysis revealed bamhi restriction site within insertion explained rflp previously described
0.16537316.15829503.html.plaintext.txt	27	view larger version 30k figure 3 structure inserted sine nucleotide sequence trna like sine depicted large black letters small grey letters correspond ptpla exon 2 sequence 13 bp direct duplication insertion site underlined bamhi restriction site ggatcc detected southern blots shown bold characters grey boxes indicate repeated splicing donors acceptors allow proper splicing sine circles highlight cryptic splicing sites leading variant v1 synthesis fig 4
0.16537316.15829503.html.plaintext.txt	28	view larger version 30k figure 3 structure inserted sine nucleotide sequence trna like sine depicted large black letters small grey letters correspond ptpla exon 2 sequence 13 bp direct duplication insertion site underlined bamhi restriction site ggatcc detected southern blots shown bold characters grey boxes indicate repeated splicing donors acceptors allow proper splicing sine circles highlight cryptic splicing sites leading variant v1 synthesis fig 4
0.16537316.15829503.html.plaintext.txt	29	strengthen causative link insertion centronuclear myopathy 18 dogs 14 breeds 20 mongrels six additional unrelated healthy french labradors screened presence sine 44 tested dogs lacked insertion data shown finally blast analysis conducted boxer genome assembly httpwwwncbinlmnihgovgenomeseqcfablasthtml sine inserted within ptpla exon 2 genome
0.16537316.15829503.html.plaintext.txt	30	strengthen causative link insertion centronuclear myopathy 18 dogs 14 breeds 20 mongrels six additional unrelated healthy french labradors screened presence sine 44 tested dogs lacked insertion data shown finally blast analysis conducted boxer genome assembly httpwwwncbinlmnihgovgenomeseqcfablasthtml sine inserted within ptpla exon 2 genome
0.16537316.15829503.html.plaintext.txt	31	hence sine insertion seemed highly specific labrador retriever pedigree segregating centronuclear myopathy developed alfort school veterinary medicine using standard nomenclature system human mutations 35 ptpla corresponding genomic sequence boxer genome assembly mutation called ptpla g9459 9460ins236 hereafter referred ptplaalf
0.16537316.15829503.html.plaintext.txt	32	hence sine insertion seemed highly specific labrador retriever pedigree segregating centronuclear myopathy developed alfort school veterinary medicine using standard nomenclature system human mutations 35 ptpla corresponding genomic sequence boxer genome assembly mutation called ptpla g9459 9460ins236 hereafter referred ptplaalf
0.16537316.15829503.html.plaintext.txt	33	sine insertion leads aberrant splicing pattern skeletal muscles alu insertions frequently associated human diseases insertions occurred within introns causing either close hand exon skipping eg 36 39 incorporation alu sequences mature mrna splicing mediated process called exonization 36 sine insertions within coding sequences reported may lead specific skipping mutated exon eg 3640 frame disruption premature translation termination signal eg 364142
0.16537316.15829503.html.plaintext.txt	34	sine insertion leads aberrant splicing pattern skeletal muscles alu insertions frequently associated human diseases insertions occurred within introns causing either close hand exon skipping eg 36 39 incorporation alu sequences mature mrna splicing mediated process called exonization 36 sine insertions within coding sequences reported may lead specific skipping mutated exon eg 3640 frame disruption premature translation termination signal eg 364142
0.16537316.15829503.html.plaintext.txt	35	test putative transcriptional defects resulting sine insertion within ptpla exon 2 ptpla transcripts amplified rt pcr using sequences exon 1 exon 7 primers rnas skeletal muscles cnm cnm cnm dogs templates ptplafl ptplad5 transcripts amplified cnm cnm samples fig 4a lanes 1 2 contrast ladder like profile seven rt pcr products obtained cnm samples fig 4a lane 3 seven amplicons cloned sequenced precisely determine acceptor donor splicing sites used synthesis corresponding transcripts cnm muscles fig 4b figure 4c proposes classification ptpla transcripts based splicing profile predicted proteins far cnm dogs concerned rt pcr products corresponding ptplafl ptplad5 wt isoforms observed indicates sine occasionally spliced furthermore point mutation could detected transcripts indicating wt cnm associated ptpla alleles differ sine insertion rt pcr product v1 corresponds splicing variant carried partial 25 bp deletion ptpla exon 2 well 154 bp exonization 3 region inserted sine analysis sine sequence confirmed presence cryptic splicing donor acceptor sites could lead either proper splicing insertion transcripts ptplafl ptplad5 variant v1 fig 3 4b remaining variants v2 v5 lacked internal exons variants arose exon skipping involving respectively exon 2 v2 exons 2 3 v3 exons 2 3 4 v4 exons 2 3 4 5 v5 fig 4b
0.16537316.15829503.html.plaintext.txt	36	test putative transcriptional defects resulting sine insertion within ptpla exon 2 ptpla transcripts amplified rt pcr using sequences exon 1 exon 7 primers rnas skeletal muscles cnm cnm cnm dogs templates ptplafl ptplad5 transcripts amplified cnm cnm samples fig 4a lanes 1 2 contrast ladder like profile seven rt pcr products obtained cnm samples fig 4a lane 3 seven amplicons cloned sequenced precisely determine acceptor donor splicing sites used synthesis corresponding transcripts cnm muscles fig 4b figure 4c proposes classification ptpla transcripts based splicing profile predicted proteins far cnm dogs concerned rt pcr products corresponding ptplafl ptplad5 wt isoforms observed indicates sine occasionally spliced furthermore point mutation could detected transcripts indicating wt cnm associated ptpla alleles differ sine insertion rt pcr product v1 corresponds splicing variant carried partial 25 bp deletion ptpla exon 2 well 154 bp exonization 3 region inserted sine analysis sine sequence confirmed presence cryptic splicing donor acceptor sites could lead either proper splicing insertion transcripts ptplafl ptplad5 variant v1 fig 3 4b remaining variants v2 v5 lacked internal exons variants arose exon skipping involving respectively exon 2 v2 exons 2 3 v3 exons 2 3 4 v4 exons 2 3 4 5 v5 fig 4b
0.16537316.15829503.html.plaintext.txt	37	view larger version 34k figure 4 splicing alterations ptplaalf mutated allele rt pcr amplification ptpla using mrna skeletal muscle cnm lane 1 cnm lane 2 cnm lane 3 dogs primers depicted b b schematic representation transcripts sine containing ptplaalf allele skeletal muscles affected dogs lane 3 dashed lines represent inferred splicing profiles transcript c classification seven splicing variants fl d5 v1 v2 v3 v4 v5 according splicing profiles predicted proteins darts indicate positions premature stop condons
0.16537316.15829503.html.plaintext.txt	38	view larger version 34k figure 4 splicing alterations ptplaalf mutated allele rt pcr amplification ptpla using mrna skeletal muscle cnm lane 1 cnm lane 2 cnm lane 3 dogs primers depicted b b schematic representation transcripts sine containing ptplaalf allele skeletal muscles affected dogs lane 3 dashed lines represent inferred splicing profiles transcript c classification seven splicing variants fl d5 v1 v2 v3 v4 v5 according splicing profiles predicted proteins darts indicate positions premature stop condons
0.16537316.15829503.html.plaintext.txt	39	assess biological impact sine induced splicing defects amino acid sequences inferred transcript ptplafl ptplad5 proteins deduced transcripts ptplafl ptplad5 respectively frameshift mutations found variants v1 v2 v3 v4 hence leading truncated forms ptpla finally exons 1 6 frame variant v5 sequence encodes small truncated protein lacking ptpl site fig 4c
0.16537316.15829503.html.plaintext.txt	40	assess biological impact sine induced splicing defects amino acid sequences inferred transcript ptplafl ptplad5 proteins deduced transcripts ptplafl ptplad5 respectively frameshift mutations found variants v1 v2 v3 v4 hence leading truncated forms ptpla finally exons 1 6 frame variant v5 sequence encodes small truncated protein lacking ptpl site fig 4c
0.16537316.15829503.html.plaintext.txt	41	sine insertion within ptpla ptplaalf allele strongly affected splicing mechanisms however quite surprisingly aggt sequence contained within 13 bp repeats flanking insertion fig 3 allowed proper splicing sine thus leading wt transcripts
0.16537316.15829503.html.plaintext.txt	42	sine insertion within ptpla ptplaalf allele strongly affected splicing mechanisms however quite surprisingly aggt sequence contained within 13 bp repeats flanking insertion fig 3 allowed proper splicing sine thus leading wt transcripts
0.16537316.15829503.html.plaintext.txt	43	trna like sine sufficient alter splicing test whether sine responsible characterized splicing defects performed ex vivo analyses using exon trapping experiments two ptpla genomic fragments spanning intron 1 intron 4 differed absence presence sine insertion cloned pspl3 exon trapping vector fig 5a plasmids termed pcos cnm pcos wt respectively transfected cos 7 cells resulting transcripts analyzed rt pcr pcos wt plasmid used rt pcr nested pcr products corresponded properly spliced transcript containing ptpla exons 2 3 4 flanked two 5 3 ss globin exons vector fig 5b saci digestion confirmed presence ptpla exon 4 fig 5b contrast smaller products observed rt pcr nested pcr total rnas cos 7 cells transfected sine containing plasmid pcos cnm used template saci digestion suggested ptpla exon 4 present products fig 5b hypothesis confirmed sequence analysis indeed smaller size transcripts resulted absence ptpla exon 2 additional rt pcr experiments revealed low level wt transcript containing ptpla exons 2 3 4 data shown
0.16537316.15829503.html.plaintext.txt	44	trna like sine sufficient alter splicing test whether sine responsible characterized splicing defects performed ex vivo analyses using exon trapping experiments two ptpla genomic fragments spanning intron 1 intron 4 differed absence presence sine insertion cloned pspl3 exon trapping vector fig 5a plasmids termed pcos cnm pcos wt respectively transfected cos 7 cells resulting transcripts analyzed rt pcr pcos wt plasmid used rt pcr nested pcr products corresponded properly spliced transcript containing ptpla exons 2 3 4 flanked two 5 3 ss globin exons vector fig 5b saci digestion confirmed presence ptpla exon 4 fig 5b contrast smaller products observed rt pcr nested pcr total rnas cos 7 cells transfected sine containing plasmid pcos cnm used template saci digestion suggested ptpla exon 4 present products fig 5b hypothesis confirmed sequence analysis indeed smaller size transcripts resulted absence ptpla exon 2 additional rt pcr experiments revealed low level wt transcript containing ptpla exons 2 3 4 data shown
0.16537316.15829503.html.plaintext.txt	45	view larger version 37k figure 5 sine induced splicing defects transfected cos 7 cells pspl3 vector sequence genomic structure wt pcos wt insert sine containing pcos cnm insert sequences depicted boxes correspond exons full lines correspond intronic plasmidic sequences white black vertical arrow heads indicate locations splicing donor acceptor sites respectively b rt pcr amplification total rnas pcos wt pcos cnm transfected cells using sd6sa2 primer pair followed nested pcr using sd2sa4 primer pair sd6 sa2 sd2 sa4 primers depicted pcr products digested saci loaded onto agarose gel
0.16537316.15829503.html.plaintext.txt	46	view larger version 37k figure 5 sine induced splicing defects transfected cos 7 cells pspl3 vector sequence genomic structure wt pcos wt insert sine containing pcos cnm insert sequences depicted boxes correspond exons full lines correspond intronic plasmidic sequences white black vertical arrow heads indicate locations splicing donor acceptor sites respectively b rt pcr amplification total rnas pcos wt pcos cnm transfected cells using sd6sa2 primer pair followed nested pcr using sd2sa4 primer pair sd6 sa2 sd2 sa4 primers depicted pcr products digested saci loaded onto agarose gel
0.16537316.15829503.html.plaintext.txt	47	thus precise splicing sine inserted sequence skipping mutated exon 2 induced ex vivo using 15 kb mini ptplaalf allele recapitulating splicing defects seen complete ptplaalf allele transcribed muscle cells vivo
0.16537316.15829503.html.plaintext.txt	48	thus precise splicing sine inserted sequence skipping mutated exon 2 induced ex vivo using 15 kb mini ptplaalf allele recapitulating splicing defects seen complete ptplaalf allele transcribed muscle cells vivo
0.16537316.15829503.html.plaintext.txt	49	quantification ptpla transcripts affected dogs muscles seven splicing variants resulting transcription ptplaalf allele detected cnm muscles two wt isoforms ptplafl ptplad5 determine total amount ptpla transcripts proportion wt ptpla transcripts cnm muscles performed quantitative analyses using real time rt pcr ptpla transcripts identified cnm cnm muscles contained exons 6 7 fig 4b hence specific primer pair encompassing sequences exons 6 7 designed quantify total amount ptpla transcripts fig 6a contrast exon 2 either deleted partially skipped aberrant ptpla transcripts cnm fig 4b hence specific forward primer designed 25 bp exon 2 fragment specific wt transcripts used combination reverse primer located within exon 4 quantify amount wt transcripts fig 6a
0.16537316.15829503.html.plaintext.txt	50	quantification ptpla transcripts affected dogs muscles seven splicing variants resulting transcription ptplaalf allele detected cnm muscles two wt isoforms ptplafl ptplad5 determine total amount ptpla transcripts proportion wt ptpla transcripts cnm muscles performed quantitative analyses using real time rt pcr ptpla transcripts identified cnm cnm muscles contained exons 6 7 fig 4b hence specific primer pair encompassing sequences exons 6 7 designed quantify total amount ptpla transcripts fig 6a contrast exon 2 either deleted partially skipped aberrant ptpla transcripts cnm fig 4b hence specific forward primer designed 25 bp exon 2 fragment specific wt transcripts used combination reverse primer located within exon 4 quantify amount wt transcripts fig 6a
0.16537316.15829503.html.plaintext.txt	51	view larger version 21k figure 6 quantitative analysis ptpla expression skeletal muscles affected labradors genomic structure sine containing ptplaalf allele reminded black arrows indicate location primers used rt pcr amplification wt ptplafl ptplad5 isoforms wt empty arrows indicate primer pair used rt pcr amplification ptpla transcripts histograms show normalized proportion ptpla wt isoforms b ptpla transcripts c calculated quantitative real time rt pcr experiments using mrnas skeletal muscles cnm cnm labradors
0.16537316.15829503.html.plaintext.txt	52	view larger version 21k figure 6 quantitative analysis ptpla expression skeletal muscles affected labradors genomic structure sine containing ptplaalf allele reminded black arrows indicate location primers used rt pcr amplification wt ptplafl ptplad5 isoforms wt empty arrows indicate primer pair used rt pcr amplification ptpla transcripts histograms show normalized proportion ptpla wt isoforms b ptpla transcripts c calculated quantitative real time rt pcr experiments using mrnas skeletal muscles cnm cnm labradors
0.16537316.15829503.html.plaintext.txt	53	five healthy cnm controls five affected cnm dogs included analysis amounts ptpla transcript normalized tata box binding protein tbp muscular phosphofructo kinase mpfk housekeeping gene transcripts amounts ptpla transcripts cnm cnm muscles compared histograms summarizing results presented fig 6b ptpla transcripts detected muscles cnm dogs represented 35 348 plus minus 24 amount ptpla transcripts found muscles cnm dogs furthermore ptplafl ptplad5 transcripts cnm muscles represented 1 08 plus minus 003 ptplafl ptplad5 transcripts expressed cnm muscles statistical analysis based pair wise fixed reallocation randomization tests 43 confirmed observed differences highly significant p0001 analyses
0.16537316.15829503.html.plaintext.txt	54	five healthy cnm controls five affected cnm dogs included analysis amounts ptpla transcript normalized tata box binding protein tbp muscular phosphofructo kinase mpfk housekeeping gene transcripts amounts ptpla transcripts cnm cnm muscles compared histograms summarizing results presented fig 6b ptpla transcripts detected muscles cnm dogs represented 35 348 plus minus 24 amount ptpla transcripts found muscles cnm dogs furthermore ptplafl ptplad5 transcripts cnm muscles represented 1 08 plus minus 003 ptplafl ptplad5 transcripts expressed cnm muscles statistical analysis based pair wise fixed reallocation randomization tests 43 confirmed observed differences highly significant p0001 analyses
0.16537316.15829503.html.plaintext.txt	55	conclusion ptplaalf allele transcribed cnm affected muscles rather low efficiency 35 total transcripts compared healthy cnm muscles furthermore transcription mainly led abnormal transcripts either premature stop codons codons encoding truncated protein finally transcription ptplaalf allele also led normal wt transcripts although low level 1
0.16537316.15829503.html.plaintext.txt	56	conclusion ptplaalf allele transcribed cnm affected muscles rather low efficiency 35 total transcripts compared healthy cnm muscles furthermore transcription mainly led abnormal transcripts either premature stop codons codons encoding truncated protein finally transcription ptplaalf allele also led normal wt transcripts although low level 1
0.16537316.15829503.html.plaintext.txt	57	discussion top abstract introduction results discussion materials methods supplementary material references labrador retriever centronuclear myopathy perfectly mimics clinical histological features human autosomal dominant recessive forms centronuclear myopathy date neither genetic linkage molecular data available two forms human disease best knowledge canine centronuclear myopathy labrador retrievers spontaneous animal model disease described far previously mapped canine cnm locus 181 cm interval within centromeric region cfa2 report identification canine gene ptpla likely plays critical role pathogenesis centronuclear myopathy seen labrador retrievers ptpla shown expressed early myogenic precursors mouse embryogenesis 32 afterwards adult skeletal muscles mouse 32 human 33
0.16537316.15829503.html.plaintext.txt	58	discussion top abstract introduction results discussion materials methods supplementary material references labrador retriever centronuclear myopathy perfectly mimics clinical histological features human autosomal dominant recessive forms centronuclear myopathy date neither genetic linkage molecular data available two forms human disease best knowledge canine centronuclear myopathy labrador retrievers spontaneous animal model disease described far previously mapped canine cnm locus 181 cm interval within centromeric region cfa2 report identification canine gene ptpla likely plays critical role pathogenesis centronuclear myopathy seen labrador retrievers ptpla shown expressed early myogenic precursors mouse embryogenesis 32 afterwards adult skeletal muscles mouse 32 human 33
0.16537316.15829503.html.plaintext.txt	59	experiments ptpla expressed canine skeletal muscles tested stages birth adulthood data shown temporal expression pattern compatible clinical histological evolution disease affected dogs furthermore observed homozygous trna like sine insertion within ptpla exon 2 affected dogs human genome alu elements abundant sines numerous alu insertions genes associated hereditary disorders 36 cases demonstrated directly causative disease lack detectable mutation rarity alu insertions strongly suggest likely candidate case labrador retriever centronuclear myopathy two lines reasoning suggest sine exonic insertion responsible disease first sine insertion identified pedigree labrador retriever perfectly segregates disease sampled 47 healthy dogs 15 pure mixed breeds failed detect insertion particular sine insertion found nine healthy french labrador retrievers unrelated experimental pedigree presence retroposed sine within ptpla therefore highly correlated segregation centronuclear myopathy french labrador retrievers second compellingly show repeat element insertion severely affects splicing corresponding sine containing ptplaalf allele provide strong evidence trna like sine responsible cumulative transcriptional abnormalities based four following features sine properly spliced although low level 1 ii partial exonization sine iii exon skipping involving several exons iv total amount ptpla transcripts markedly reduced taken together observations show exonic sine insertion within ptpla gene cnm dogs acts hypomorphic mutation existing data ongoing experiments help us confirm sine insertion within ptpla causative event leading canine centronuclear myopathy first experimental pedigree established two affected labradors unrelated 11 generations 29 found dogs homozygotes insertion within ptpla exon 2 genotyping additional affected labradors coming alfort clinics allow us reinforce association sine insertion cnm also believe close clinical histopathological relationships exist centronuclear myopathy found french labrador retrievers hmlr identified dogs countries 29 although precisely determined yet number generations common ancestors affected labradors usa france higher affected french dogs amplifying sine insertion affected labrador retrievers usa country reinforce sine insertion causative disease mutation founder effect finally characterization mutations ptpla similar phenotype either transgenic mice human patients affected autosomal recessive cnm would provide strong evidence ptpla plays central role etiology centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	60	experiments ptpla expressed canine skeletal muscles tested stages birth adulthood data shown temporal expression pattern compatible clinical histological evolution disease affected dogs furthermore observed homozygous trna like sine insertion within ptpla exon 2 affected dogs human genome alu elements abundant sines numerous alu insertions genes associated hereditary disorders 36 cases demonstrated directly causative disease lack detectable mutation rarity alu insertions strongly suggest likely candidate case labrador retriever centronuclear myopathy two lines reasoning suggest sine exonic insertion responsible disease first sine insertion identified pedigree labrador retriever perfectly segregates disease sampled 47 healthy dogs 15 pure mixed breeds failed detect insertion particular sine insertion found nine healthy french labrador retrievers unrelated experimental pedigree presence retroposed sine within ptpla therefore highly correlated segregation centronuclear myopathy french labrador retrievers second compellingly show repeat element insertion severely affects splicing corresponding sine containing ptplaalf allele provide strong evidence trna like sine responsible cumulative transcriptional abnormalities based four following features sine properly spliced although low level 1 ii partial exonization sine iii exon skipping involving several exons iv total amount ptpla transcripts markedly reduced taken together observations show exonic sine insertion within ptpla gene cnm dogs acts hypomorphic mutation existing data ongoing experiments help us confirm sine insertion within ptpla causative event leading canine centronuclear myopathy first experimental pedigree established two affected labradors unrelated 11 generations 29 found dogs homozygotes insertion within ptpla exon 2 genotyping additional affected labradors coming alfort clinics allow us reinforce association sine insertion cnm also believe close clinical histopathological relationships exist centronuclear myopathy found french labrador retrievers hmlr identified dogs countries 29 although precisely determined yet number generations common ancestors affected labradors usa france higher affected french dogs amplifying sine insertion affected labrador retrievers usa country reinforce sine insertion causative disease mutation founder effect finally characterization mutations ptpla similar phenotype either transgenic mice human patients affected autosomal recessive cnm would provide strong evidence ptpla plays central role etiology centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	61	human related x linked myotubular myopathy attributed truncating missense mutations mtm1 gene encoding myotubularin 8944 classical tissue specific gene targeting inactivation mtm1 mouse confirmed absence muscular expression mtm1 affect myogenesis induces lethal degeneration skeletal muscles 4 weeks age 45 myotubularin phosphatase dual activity specifically dephosphorylates subpools phosphatidylinositols pis 10111314 pis implicated number physiological processes including cell proliferation death motility cytoskeletal regulation intracellular vesicle trafficking 46 ptpla first annotated mouse human basis putative protein tyrosine phosphatase like catalytic site proline replacing arginine consensus hcx26x2r sequence 3233 ptpla protein shares sequence homology mtm1 protein family data shown quite surprisingly canine cnm associated histopathological features closely resemble observed human murine xlmtm hence ptpla protein may involved pi dependent functional signaling pathway mtm1 least skeletal muscle hypothesis addressed testing putative ptpla phosphatase activity andor investigating functional interactions ptpla mtm1 proteins analyzing example subcellular localization mtm1 muscles affected labrador subcellular localization ptpla muscles mtm1 mice
0.16537316.15829503.html.plaintext.txt	62	human related x linked myotubular myopathy attributed truncating missense mutations mtm1 gene encoding myotubularin 8944 classical tissue specific gene targeting inactivation mtm1 mouse confirmed absence muscular expression mtm1 affect myogenesis induces lethal degeneration skeletal muscles 4 weeks age 45 myotubularin phosphatase dual activity specifically dephosphorylates subpools phosphatidylinositols pis 10111314 pis implicated number physiological processes including cell proliferation death motility cytoskeletal regulation intracellular vesicle trafficking 46 ptpla first annotated mouse human basis putative protein tyrosine phosphatase like catalytic site proline replacing arginine consensus hcx26x2r sequence 3233 ptpla protein shares sequence homology mtm1 protein family data shown quite surprisingly canine cnm associated histopathological features closely resemble observed human murine xlmtm hence ptpla protein may involved pi dependent functional signaling pathway mtm1 least skeletal muscle hypothesis addressed testing putative ptpla phosphatase activity andor investigating functional interactions ptpla mtm1 proteins analyzing example subcellular localization mtm1 muscles affected labrador subcellular localization ptpla muscles mtm1 mice
0.16537316.15829503.html.plaintext.txt	63	work presented show sine insertion detected within ptpla exon 2 associated various transcriptional features first sine insertion flanked direct duplication insertion site characteristic retroposition mechanism sines duplicated sequence contains aggt tetranucleotide sine acquired uncommon intron like status 5 splicing donor site gt 3 splicing acceptor site ag allowing proper excision although generates complete normal mature ptpla transcripts mechanism seems poorly efficient 1 wt ptpla transcripts detected muscles affected cnm labradors compared healthy cnm dogs precise elimination sine observed vivo reproduced ex vivo addition exceptionally fine removal parasitic sequence repeat element insertion deleterious consequences transcription sine containing ptplaalf allele indeed provide evidence splicing machinery recognizes cryptic splice sites within sine exon 2 sequences yields mature elongated transcript containing partially exonized sine sequence concomitantly exon skipping involving either exon 2 alone combination exons results several ptpla truncated transcripts ptplaalf associated aberrant exon skipping could undoubtedly attributed sine sequence reproduced ex vivo splicing experiments alu insertions associated diseases 36 394247 insertions either associated exonization repeat element sequences specific exon skipping strikingly work presented highlights two mutational mechanisms previously reported independent defects necessarily mutually exclusive systematic dichotomy observed exonization exon skipping mechanisms may depend splicing regulatory elements either contained inserted alu sequence located genomic vicinity alternatively technical limitations might prevented identification concomittant subtle transcriptional aberrations previously reported studies owing transcriptional defects associated sine insertion ptpla tempting speculate repeat element contains splicing regulatory motifs strong enough drive exonization exon skipping furthermore sine associated exon skipping previously reported refer skipping single exon example alu insertion exon 22 human bcra2 gene induces alternative skipping exon may play role development breast cancer 48 surprisingly labradors affected centronuclear myopathy sine targeted exon 2 also exons 3 4 5 abnormally skipped muscular transcripts introns 2 3 canine ptpla 183 76 bp length respectively may thus assume sine hampers spliceosome machinery recognize normal consensus splicing sites modifying spatial conformation transcripts andor specific interaction rna regulatory proteins abnormal skipping exons 3 4 would thus result closeness sine finally one ptpla abnormal transcripts bear disruption reading frame princeps studies yeast human paved way nonsense mediated mrna decay nmd surveillance mechanism eliminates transcripts containing premature termination codons 4950 reduced total amount 35 ptpla transcripts detected muscles cnm dogs using real time rt pcr analyses could therefore result nmd leading degradation ptpla abnormal transcripts
0.16537316.15829503.html.plaintext.txt	64	work presented show sine insertion detected within ptpla exon 2 associated various transcriptional features first sine insertion flanked direct duplication insertion site characteristic retroposition mechanism sines duplicated sequence contains aggt tetranucleotide sine acquired uncommon intron like status 5 splicing donor site gt 3 splicing acceptor site ag allowing proper excision although generates complete normal mature ptpla transcripts mechanism seems poorly efficient 1 wt ptpla transcripts detected muscles affected cnm labradors compared healthy cnm dogs precise elimination sine observed vivo reproduced ex vivo addition exceptionally fine removal parasitic sequence repeat element insertion deleterious consequences transcription sine containing ptplaalf allele indeed provide evidence splicing machinery recognizes cryptic splice sites within sine exon 2 sequences yields mature elongated transcript containing partially exonized sine sequence concomitantly exon skipping involving either exon 2 alone combination exons results several ptpla truncated transcripts ptplaalf associated aberrant exon skipping could undoubtedly attributed sine sequence reproduced ex vivo splicing experiments alu insertions associated diseases 36 394247 insertions either associated exonization repeat element sequences specific exon skipping strikingly work presented highlights two mutational mechanisms previously reported independent defects necessarily mutually exclusive systematic dichotomy observed exonization exon skipping mechanisms may depend splicing regulatory elements either contained inserted alu sequence located genomic vicinity alternatively technical limitations might prevented identification concomittant subtle transcriptional aberrations previously reported studies owing transcriptional defects associated sine insertion ptpla tempting speculate repeat element contains splicing regulatory motifs strong enough drive exonization exon skipping furthermore sine associated exon skipping previously reported refer skipping single exon example alu insertion exon 22 human bcra2 gene induces alternative skipping exon may play role development breast cancer 48 surprisingly labradors affected centronuclear myopathy sine targeted exon 2 also exons 3 4 5 abnormally skipped muscular transcripts introns 2 3 canine ptpla 183 76 bp length respectively may thus assume sine hampers spliceosome machinery recognize normal consensus splicing sites modifying spatial conformation transcripts andor specific interaction rna regulatory proteins abnormal skipping exons 3 4 would thus result closeness sine finally one ptpla abnormal transcripts bear disruption reading frame princeps studies yeast human paved way nonsense mediated mrna decay nmd surveillance mechanism eliminates transcripts containing premature termination codons 4950 reduced total amount 35 ptpla transcripts detected muscles cnm dogs using real time rt pcr analyses could therefore result nmd leading degradation ptpla abnormal transcripts
0.16537316.15829503.html.plaintext.txt	65	deleterious effects repeat elements already reported dogs example intronic sine insertion within hypocretin receptor 2 doberman pinschers induces exon skipping leading narcolepsy 51 date relatively canine diseases characterized genomic level examples narcolepsy hemophilia centronuclear myopathy diseases associated insertion repeat elements seem well represented low average divergence sineccf repeats dogs high percentage bimorphic loci respect presence absence sine insertion 67 115 dogs different breed indicate expansion sines recent still active process 52 ewen kirkness personal communication high incidence disease associated insertions dogs may explained recent expansion repeat sequences represent 31 canine genome 52 comparison finding 406 gross insertion duplication mutations human genetic mutation database contains 44 090 characterized human mutations suggests alu insertions occur lower rate hardly contribute 009 human genetic diseases besides deleterious consequences gene expression insertions sines dogs observed bimorphism may contribute interbreed intrabreed modulation gene expression accompanying physiological phenotypic diversity 52 functional effects ptpla mutation reported present paper disclose rare example single sine insertion several modifications rna processing provides molecular basis dynamic evolutionary mechanism gene control mobile elements reviewed 53
0.16537316.15829503.html.plaintext.txt	66	deleterious effects repeat elements already reported dogs example intronic sine insertion within hypocretin receptor 2 doberman pinschers induces exon skipping leading narcolepsy 51 date relatively canine diseases characterized genomic level examples narcolepsy hemophilia centronuclear myopathy diseases associated insertion repeat elements seem well represented low average divergence sineccf repeats dogs high percentage bimorphic loci respect presence absence sine insertion 67 115 dogs different breed indicate expansion sines recent still active process 52 ewen kirkness personal communication high incidence disease associated insertions dogs may explained recent expansion repeat sequences represent 31 canine genome 52 comparison finding 406 gross insertion duplication mutations human genetic mutation database contains 44 090 characterized human mutations suggests alu insertions occur lower rate hardly contribute 009 human genetic diseases besides deleterious consequences gene expression insertions sines dogs observed bimorphism may contribute interbreed intrabreed modulation gene expression accompanying physiological phenotypic diversity 52 functional effects ptpla mutation reported present paper disclose rare example single sine insertion several modifications rna processing provides molecular basis dynamic evolutionary mechanism gene control mobile elements reviewed 53
0.16537316.15829503.html.plaintext.txt	67	conclusion work presented shows exonic sine insertion within ptpla gene cnm dogs acts hypomorphic mutation recapitulates sine dependent mutational molecular mechanisms results also illustrate relevance canine model genetic studies indeed major advances development canine genomic genetic resources reported recently soon available integrated 4249 marker fishrh map 31 ii publication 15x poodle genome 52 iii partial annotation 76x canine genome assembly identification 500 000 snps kerstin lindblad toh personal communication iv 10 000 gene map canine genome help assembly sequence useful comparative mapping christophe hitte personal communication resources provide long awaited means mapping genes underlying striking diversity among breeds morphology behavior well canine disease genes
0.16537316.15829503.html.plaintext.txt	68	conclusion work presented shows exonic sine insertion within ptpla gene cnm dogs acts hypomorphic mutation recapitulates sine dependent mutational molecular mechanisms results also illustrate relevance canine model genetic studies indeed major advances development canine genomic genetic resources reported recently soon available integrated 4249 marker fishrh map 31 ii publication 15x poodle genome 52 iii partial annotation 76x canine genome assembly identification 500 000 snps kerstin lindblad toh personal communication iv 10 000 gene map canine genome help assembly sequence useful comparative mapping christophe hitte personal communication resources provide long awaited means mapping genes underlying striking diversity among breeds morphology behavior well canine disease genes
0.16537316.15829503.html.plaintext.txt	69	materials methods top abstract introduction results discussion materials methods supplementary material references mrna extraction biceps femoris cdna synthesis frozen muscular biopsies 150 mg grinded mortar containing liquid nitrogen resulting powder resuspended 1 ml dynabeads mrna direct kit lysingbinding buffer dynal incubated 55 degrees c proteinase k 2 h crude extracts centrifuged 5000g 5 min polya mrna isolation supernatant performed using dynabeads mrna direct kit dynal first strand cdna generated 200 ng polya mrnas using superscript ii reverse transcriptase 200 u invitrogen anchored oligodt25 16 microm q biogen rnase inhibitor 40 u rnaseout invitrogen synthesis cdna performed 55 degrees c 90 min followed 20 min rnase h treatment 4 u invitrogen
0.16537316.15829503.html.plaintext.txt	70	materials methods top abstract introduction results discussion materials methods supplementary material references mrna extraction biceps femoris cdna synthesis frozen muscular biopsies 150 mg grinded mortar containing liquid nitrogen resulting powder resuspended 1 ml dynabeads mrna direct kit lysingbinding buffer dynal incubated 55 degrees c proteinase k 2 h crude extracts centrifuged 5000g 5 min polya mrna isolation supernatant performed using dynabeads mrna direct kit dynal first strand cdna generated 200 ng polya mrnas using superscript ii reverse transcriptase 200 u invitrogen anchored oligodt25 16 microm q biogen rnase inhibitor 40 u rnaseout invitrogen synthesis cdna performed 55 degrees c 90 min followed 20 min rnase h treatment 4 u invitrogen
0.16537316.15829503.html.plaintext.txt	71	mutation screening ptpla locus segregation analysis centronuclear myopathic canines primers designed 5 3 ends ptpla exons 1 2 used amplify exons healthy carriers cnm affected dogs cnm samples pcr rt pcr performed genomic dna polya mrnas respectively using following primer pairs exon1 ex1f1 5 gacgaggacggcaccaac 3ex1r1 5 ggtcatggcatgttgtaga 3 exon 2 ex2f1 5 gctattgccatggtacgtttt 3ex2r1 5 aagcaaggcaaatgtttgga 3 cycling conditions 94 degrees c 2 min 35 cycles 94 degrees c 30 60 degrees c exon 1 50 degrees c exon 2 30 72 degrees c 1 min 72 degrees c 5 min initial detection sine insertion new primers specific exon 2 ex2f2 5 ggaaaaaggaacacacaaagg 3 exon 3 ex3r1 5 accaattaaacagtggactat 3 designed detect sine insertion following pcr amplification genomic dna pcr conditions 94 degrees c 3 min two cycles 94 degrees c 30 57 degrees c 30 72 degrees c 2 min two cycles 94 degrees c 30 55 degrees c 30 72 degrees c 2 min two cycles 94 degrees c 30 53 degrees c 30 72 degrees c 2 min 29 cycles 94 degrees c 30 50 degrees c 30 72 degrees c 2 min 72 degrees c 5 min
0.16537316.15829503.html.plaintext.txt	72	mutation screening ptpla locus segregation analysis centronuclear myopathic canines primers designed 5 3 ends ptpla exons 1 2 used amplify exons healthy carriers cnm affected dogs cnm samples pcr rt pcr performed genomic dna polya mrnas respectively using following primer pairs exon1 ex1f1 5 gacgaggacggcaccaac 3ex1r1 5 ggtcatggcatgttgtaga 3 exon 2 ex2f1 5 gctattgccatggtacgtttt 3ex2r1 5 aagcaaggcaaatgtttgga 3 cycling conditions 94 degrees c 2 min 35 cycles 94 degrees c 30 60 degrees c exon 1 50 degrees c exon 2 30 72 degrees c 1 min 72 degrees c 5 min initial detection sine insertion new primers specific exon 2 ex2f2 5 ggaaaaaggaacacacaaagg 3 exon 3 ex3r1 5 accaattaaacagtggactat 3 designed detect sine insertion following pcr amplification genomic dna pcr conditions 94 degrees c 3 min two cycles 94 degrees c 30 57 degrees c 30 72 degrees c 2 min two cycles 94 degrees c 30 55 degrees c 30 72 degrees c 2 min two cycles 94 degrees c 30 53 degrees c 30 72 degrees c 2 min 29 cycles 94 degrees c 30 50 degrees c 30 72 degrees c 2 min 72 degrees c 5 min
0.16537316.15829503.html.plaintext.txt	73	cloning sequencing sine insertion pcr products extracted 1 seakem gtg agarose tebu gels using nucleospin extract ii macherey nagel ligated pcr4 topo plasmid invitrogen following manufacturers recommendations inserts sequenced using t3 t7 primers
0.16537316.15829503.html.plaintext.txt	74	cloning sequencing sine insertion pcr products extracted 1 seakem gtg agarose tebu gels using nucleospin extract ii macherey nagel ligated pcr4 topo plasmid invitrogen following manufacturers recommendations inserts sequenced using t3 t7 primers
0.16537316.15829503.html.plaintext.txt	75	splicing pattern analysis ptplaalf allele ptpla transcripts amplified rt pcr using muscular polya mrnas samples cnm cnm cnm dogs template ex1f2 5 ctacaacatcgccatgacc 3 ex7r 5 cacctctccatgaagcacct 3 primers pcr conditions 94 degrees c 2 min two cycles 94 degrees c 20 62 degrees c 30 72 degrees c 2 min three cycles 94 degrees c 20 60 degrees c 30 72 degrees c 2 min 35 cycles 94 degrees c 20 58 degrees c 30 72 degrees c 2 min 72 degrees c 5 min rt pcr products either visualized using standard electrophoresis techniques distinct fragments purified cloned sequenced described earlier
0.16537316.15829503.html.plaintext.txt	76	splicing pattern analysis ptplaalf allele ptpla transcripts amplified rt pcr using muscular polya mrnas samples cnm cnm cnm dogs template ex1f2 5 ctacaacatcgccatgacc 3 ex7r 5 cacctctccatgaagcacct 3 primers pcr conditions 94 degrees c 2 min two cycles 94 degrees c 20 62 degrees c 30 72 degrees c 2 min three cycles 94 degrees c 20 60 degrees c 30 72 degrees c 2 min 35 cycles 94 degrees c 20 58 degrees c 30 72 degrees c 2 min 72 degrees c 5 min rt pcr products either visualized using standard electrophoresis techniques distinct fragments purified cloned sequenced described earlier
0.16537316.15829503.html.plaintext.txt	77	ex vivo splicing experiments primers containing ecori noti restriction sites designed 3 end ptpla intron 1 int1f 5 cggaattccgcagatgctcaaccacccag 3 5 end ptpla intron 4 int4r 5 ttgcggccgcaacccttccaacttttcatttagtctt 3 used amplify wt sine containing cnm genomic inserts amplified fragments checked size ligated pspl3 vector using standard ecorinoti double digestion ligation protocol resulting pcos wt pcos cnm plasmids transfected cos 7 cells follows cells grown 37 degrees c 8 co2 dmem medium gibco supplemented 10 fetal calf serum d deutscher penicilin 100 uml invitrogen streptomycin 100 microgml invitrogen 80 confluence cells trypsinated centrifuged resuspended final concentration 1x107 cellsml cells incubated ice 10 min 2 microg plasmids electroporation 200 25 microf 15 kv performed 04 mm cuvettes using biorad genepulser electroporated cells grown using standard cell culture conditions 48 h 37 degrees c 8 co2 total rna extraction transfected cos 7 cells done using trizol reagent invitrogen according manufacturers recommendation first strand cdna synthesis performed described earlier amplification performed using sa2 5 atctcagtggtatttgtgagc 3 sd6 5 tctgagtcacctggacaacc 3 primers 300 fold dilution first pcr used template nested pcr using sa4 5 cacctgaggagtgaattggtcg 3 sd2 5 gtgacctgcactgtgacaagc 3 primer pair pcr conditions 94 degrees c 2 min 20 cycles 94 degrees c 1 min 60 degrees c first pcr 63 degrees c nested pcr 1 min 72 degrees c 2 min 72 degrees c 5 min
0.16537316.15829503.html.plaintext.txt	78	ex vivo splicing experiments primers containing ecori noti restriction sites designed 3 end ptpla intron 1 int1f 5 cggaattccgcagatgctcaaccacccag 3 5 end ptpla intron 4 int4r 5 ttgcggccgcaacccttccaacttttcatttagtctt 3 used amplify wt sine containing cnm genomic inserts amplified fragments checked size ligated pspl3 vector using standard ecorinoti double digestion ligation protocol resulting pcos wt pcos cnm plasmids transfected cos 7 cells follows cells grown 37 degrees c 8 co2 dmem medium gibco supplemented 10 fetal calf serum d deutscher penicilin 100 uml invitrogen streptomycin 100 microgml invitrogen 80 confluence cells trypsinated centrifuged resuspended final concentration 1x107 cellsml cells incubated ice 10 min 2 microg plasmids electroporation 200 25 microf 15 kv performed 04 mm cuvettes using biorad genepulser electroporated cells grown using standard cell culture conditions 48 h 37 degrees c 8 co2 total rna extraction transfected cos 7 cells done using trizol reagent invitrogen according manufacturers recommendation first strand cdna synthesis performed described earlier amplification performed using sa2 5 atctcagtggtatttgtgagc 3 sd6 5 tctgagtcacctggacaacc 3 primers 300 fold dilution first pcr used template nested pcr using sa4 5 cacctgaggagtgaattggtcg 3 sd2 5 gtgacctgcactgtgacaagc 3 primer pair pcr conditions 94 degrees c 2 min 20 cycles 94 degrees c 1 min 60 degrees c first pcr 63 degrees c nested pcr 1 min 72 degrees c 2 min 72 degrees c 5 min
0.16537316.15829503.html.plaintext.txt	79	real time rt pcr analyses prior first strand cdna synthesis genomic dna removed 200 ng mrna samples using dna free kit ambion three independent cdna samples skeletal muscle healthy golden retriever cnm used internal calibrator normalize data independent reactions primer pair sequences mgcl2 final concentrations used presented supplementary material table s1 annealing temperature 64 degrees c samples real time pcr reactions performed lightcycler roche using cdna dilutions specific primers 04 microm lc faststart dna master sybr green kit according manufacturers recommendations sample evaluated crossing points cp automatically calculated using second derivative maximum method lightcycler software standard curves primer pair generated using duplicated 4 fold dilution series calibrator sample corresponding pcr efficiencies indicated supplementary material table s1
0.16537316.15829503.html.plaintext.txt	80	real time rt pcr analyses prior first strand cdna synthesis genomic dna removed 200 ng mrna samples using dna free kit ambion three independent cdna samples skeletal muscle healthy golden retriever cnm used internal calibrator normalize data independent reactions primer pair sequences mgcl2 final concentrations used presented supplementary material table s1 annealing temperature 64 degrees c samples real time pcr reactions performed lightcycler roche using cdna dilutions specific primers 04 microm lc faststart dna master sybr green kit according manufacturers recommendations sample evaluated crossing points cp automatically calculated using second derivative maximum method lightcycler software standard curves primer pair generated using duplicated 4 fold dilution series calibrator sample corresponding pcr efficiencies indicated supplementary material table s1
0.16537316.15829503.html.plaintext.txt	81	five healthy labradors cnm five affected labradors cnm samples tested duplicates experiment included calibrator based internal controls used normalize calculated cp value sample supplementary material table s2 relative expression analyses efficiency correction performed using rest software described pfaffl et al43 tbp mpfk expression levels significantly different healthy carriers cnm affected dogs cnm used references expression ratios calculated target using healthy carriers controls affected dogs samples two thousands randomization tests performed assess statistical significance observed differences transcript amounts control cnm affected dog samples
0.16537316.15829503.html.plaintext.txt	82	five healthy labradors cnm five affected labradors cnm samples tested duplicates experiment included calibrator based internal controls used normalize calculated cp value sample supplementary material table s2 relative expression analyses efficiency correction performed using rest software described pfaffl et al43 tbp mpfk expression levels significantly different healthy carriers cnm affected dogs cnm used references expression ratios calculated target using healthy carriers controls affected dogs samples two thousands randomization tests performed assess statistical significance observed differences transcript amounts control cnm affected dog samples
0.16537316.15829503.html.plaintext.txt	83	bioinformatics primers designed using primer3 software httpfrodowimiteducgi binprimer3primer3wwwcgi blast searches human genome canine genome assemblies performed nbci blast page httpwwwncbinlmnihgovblast sequence alignments performed using cap dialign2 softwares freely available infobiogen services home page httpwwwinfobiogenfrservicesmenuservhtml canine tbp mpfk sequences retrieved srs database httpsrsebiacuk quantitative expression analysis rest software downloaded gene quantification academic industrial information platform qpcr httpwwwgene quantificationcom
0.16537316.15829503.html.plaintext.txt	84	supplementary material top abstract introduction results discussion materials methods supplementary material references supplementary material available hmg online
0.16537316.15829503.html.plaintext.txt	85	acknowledgements thank denis houzelstein umr 7592 institut jacques monod helpful discussions real time pcr analysis stephanie le bras technical expertise exon trapping experiments members umr 955 assistance molecular techniques kelly rogers pasteur institute ewen kirkness institute genome research improving manuscript also thank jean laurent thibaud nicolas granger uetm medical expertise xavier cauchois stephanie le mevel ingrid gruyer serge kouame taking care animals work received financial support association francaise contre les myopathies afm
0.16537316.15829503.html.plaintext.txt	86	acknowledgements thank denis houzelstein umr 7592 institut jacques monod helpful discussions real time pcr analysis stephanie le bras technical expertise exon trapping experiments members umr 955 assistance molecular techniques kelly rogers pasteur institute ewen kirkness institute genome research improving manuscript also thank jean laurent thibaud nicolas granger uetm medical expertise xavier cauchois stephanie le mevel ingrid gruyer serge kouame taking care animals work received financial support association francaise contre les myopathies afm
0.16537316.15829503.html.plaintext.txt	87	references top abstract introduction results discussion materials methods supplementary material references karpati g carpenter nelson rf 1970 type muscle fibre atrophy central nuclei rare familial neuromuscular disease j neurol sci 10 489 500crossrefisimedline
0.16537316.15829503.html.plaintext.txt	88	toker 2002 phosphoinositides signal transduction cell mol life sci 59 761 779crossrefisimedline
0.16720255.15271651.html.plaintext.txt	0	orexin stimulate food intake old rats saeko takano12 setsuko kanai1 hiroko hosoya1 minoru ohta1 hiroshi uematsu2 kyoko miyasaka1
0.16720255.15271651.html.plaintext.txt	1	1department clinical physiology tokyo metropolitan institute gerontology tokyo 173 0015 2gerodontology department gerodontology division gerontology gerodontology graduate school tokyo medical dental university tokyo 113 8549 japan
0.16720255.15271651.html.plaintext.txt	2	submitted 13 may 2004 accepted final form 13 july 2004
0.16720255.15271651.html.plaintext.txt	3	abstract top abstract materials methods results discussion grants references aging associated progressive decrease appetite food intake b orexins expressed specific neurons lateral hypothalamic area implicated regulation sleep feeding study stimulatory effect intracerebroventricular administration orexins food intake compared young 4 mo old old 25 27 mo old male wistar rats stainless steel cannula implanted stereotactically left lateral ventricle 7 day recovery period different doses 0 30 nmol orexins injected left lateral ventricle without anesthesia food water consumptions measured 1 2 4 h injection protein levels orexin receptors specific receptor orexin ox1r receptor orexin b ox2r hypothalamus determined western blot analysis compared young old rats intracerebroventricular administration orexin stimulated food intake dose dependent manner young rats however effects observed dose old rats protein level ox1r hypothalamus significantly lower old rats young rats although protein level ox2r comparable groups results present study indicate function orexin system diminished old rats decrease ox1r protein level hypothalamus could responsible orexin lack stimulation food intake old rats
0.16720255.15271651.html.plaintext.txt	4	abstract top abstract materials methods results discussion grants references aging associated progressive decrease appetite food intake b orexins expressed specific neurons lateral hypothalamic area implicated regulation sleep feeding study stimulatory effect intracerebroventricular administration orexins food intake compared young 4 mo old old 25 27 mo old male wistar rats stainless steel cannula implanted stereotactically left lateral ventricle 7 day recovery period different doses 0 30 nmol orexins injected left lateral ventricle without anesthesia food water consumptions measured 1 2 4 h injection protein levels orexin receptors specific receptor orexin ox1r receptor orexin b ox2r hypothalamus determined western blot analysis compared young old rats intracerebroventricular administration orexin stimulated food intake dose dependent manner young rats however effects observed dose old rats protein level ox1r hypothalamus significantly lower old rats young rats although protein level ox2r comparable groups results present study indicate function orexin system diminished old rats decrease ox1r protein level hypothalamus could responsible orexin lack stimulation food intake old rats
0.16720255.15271651.html.plaintext.txt	5	age anorexia aging brain hypothalamus orexin receptor
0.16720255.15271651.html.plaintext.txt	6	aging associated progressive decrease appetite food intake 14 15 decline food intake often happens healthy elderly persons predisposes pathological weight loss protein energy malnutrition thereby raising morbidity mortality reasons decline food intake multifactorial although sensitivity cck classic neuropeptide shows satiety effect enhanced old animals 21 mechanism underlying effect elucidated 12
0.16720255.15271651.html.plaintext.txt	7	aging associated progressive decrease appetite food intake 14 15 decline food intake often happens healthy elderly persons predisposes pathological weight loss protein energy malnutrition thereby raising morbidity mortality reasons decline food intake multifactorial although sensitivity cck classic neuropeptide shows satiety effect enhanced old animals 21 mechanism underlying effect elucidated 12
0.16720255.15271651.html.plaintext.txt	8	orexins appetite stimulating peptides discovered 1998 18 classified orexin orexin b neuropeptides endogenous ligands orphan g protein coupled receptor orexin 33 amino acids orexin b 28 amino acids peptides produced single precursor polypeptide preproorexin two orexin receptor subtypes identified orexin 1 receptor ox1r selective orexin whereas orexin 2 receptor ox2r nonselective receptor orexin b neuropeptide agonists
0.16720255.15271651.html.plaintext.txt	9	orexins appetite stimulating peptides discovered 1998 18 classified orexin orexin b neuropeptides endogenous ligands orphan g protein coupled receptor orexin 33 amino acids orexin b 28 amino acids peptides produced single precursor polypeptide preproorexin two orexin receptor subtypes identified orexin 1 receptor ox1r selective orexin whereas orexin 2 receptor ox2r nonselective receptor orexin b neuropeptide agonists
0.16720255.15271651.html.plaintext.txt	10	orexins expressed almost exclusively lateral hypothalamic area 18 region classically implicated control mammalian feeding behavior 19 administered centrally rats peptides stimulate food consumption dose dependently 18 addition preproorexin mrna level upregulated fasting 18 findings suggested orexin neuropeptide system plays significant role feeding behavior orexins therefore categorized orexigenic appetite stimulating factors moreover reported 13 orexin stimulates pancreatic exocrine secretion via vagal efferent nerves orexin may important candidate mediator cephalic phase secretory response feeding
0.16720255.15271651.html.plaintext.txt	11	orexins expressed almost exclusively lateral hypothalamic area 18 region classically implicated control mammalian feeding behavior 19 administered centrally rats peptides stimulate food consumption dose dependently 18 addition preproorexin mrna level upregulated fasting 18 findings suggested orexin neuropeptide system plays significant role feeding behavior orexins therefore categorized orexigenic appetite stimulating factors moreover reported 13 orexin stimulates pancreatic exocrine secretion via vagal efferent nerves orexin may important candidate mediator cephalic phase secretory response feeding
0.16720255.15271651.html.plaintext.txt	12	present study determine mechanism age associated decrease appetite food intake compared food intake young old male rats indication stimulatory effect intracerebroventricular administration orexins also examined protein expression orexin receptors hypothalamus important region brain regulation food intake
0.16720255.15271651.html.plaintext.txt	13	present study determine mechanism age associated decrease appetite food intake compared food intake young old male rats indication stimulatory effect intracerebroventricular administration orexins also examined protein expression orexin receptors hypothalamus important region brain regulation food intake
0.16720255.15271651.html.plaintext.txt	14	materials methods top abstract materials methods results discussion grants references animal procedures accord guiding principles care use animals approved physiological society japan procedures also approved ethics committee animal experimentation tokyo metropolitan institute gerontology
0.16720255.15271651.html.plaintext.txt	15	materials methods top abstract materials methods results discussion grants references animal procedures accord guiding principles care use animals approved physiological society japan procedures also approved ethics committee animal experimentation tokyo metropolitan institute gerontology
0.16720255.15271651.html.plaintext.txt	16	materials synthetic orexin 33 amino acid peptide orexin b 28 amino acid peptide purchased peptide institute osaka japan stainless steel cannula 22 gauge guide cannula 28 gauge insert plastic one roanoke va used study western blot analysis used primary antibody ox1r ox1r11 ox2r ox2r11 alpha diagnostic international san antonio tx secondary anti rabbit igg horseradish peroxidase linked whole antibody amersham life sciences piscataway nj
0.16720255.15271651.html.plaintext.txt	17	animals young 4 mo old 260 335 g body wt old 25 27 mo old 365 440 g body wt wistar rats purchased shizuoka jikken dobutsu shizuoka japan 4 wk age maintained specific pathogen free aging farm institute given commercial rat chow crf 1 oriental yeast tokyo japan kept room controlled temperature 23 plus minus 1 degrees c 1212 h light dark cycle starting 0800
0.16720255.15271651.html.plaintext.txt	18	surgical preparations rats anesthetized intraperitoneal injection pentobarbital sodium 3 4 mg100 g body wt intracerebroventricular injection orexins stainless steel cannula implanted stereotactically left lateral ventricle using following coordinates bregma anteroposterior 10 mm lateral 13 mm ventral 40 mm 9 10 11 13
0.16720255.15271651.html.plaintext.txt	19	operation rats maintained individual cages 1 ratcage conditions controlled temperature 24 degrees c illumination 1212 h light dark cycle 7 days rat provided food water ad libitum mock injected handled 10 min daily minimize injection induced stress throughout 7 day recovery period
0.16720255.15271651.html.plaintext.txt	20	operation rats maintained individual cages 1 ratcage conditions controlled temperature 24 degrees c illumination 1212 h light dark cycle 7 days rat provided food water ad libitum mock injected handled 10 min daily minimize injection induced stress throughout 7 day recovery period
0.16720255.15271651.html.plaintext.txt	21	effects orexins food water intake measured food water consumptions young old rats nighttime 1730 0930 total 16 h without treatment comparison
0.16720255.15271651.html.plaintext.txt	22	effects orexins food water intake measured food water consumptions young old rats nighttime 1730 0930 total 16 h without treatment comparison
0.16720255.15271651.html.plaintext.txt	23	orexins dissolved 1 bsasaline 7 day recovery period experiment conducted without overnight fasting 1000 190 200 g rat chow crf 1 water supplied orexins injected intracerebroventriculaly different doses orexin 025 10 30 nmol10 microl injected subsequently respective 7 day recovery period one rat addition 300 nmol10 microl administered old rats confirm biological effect effect orexin b 10 30 nmol10 microl also determined another animal physiological saline administered vehicle injection given 20 using 50 microl hamilton microsyringe injectors left place 10 injection ensure complete dispersal peptide remaining chow water weighed 1 2 4 h injection estimate food intake water consumption time points
0.16720255.15271651.html.plaintext.txt	24	orexins dissolved 1 bsasaline 7 day recovery period experiment conducted without overnight fasting 1000 190 200 g rat chow crf 1 water supplied orexins injected intracerebroventriculaly different doses orexin 025 10 30 nmol10 microl injected subsequently respective 7 day recovery period one rat addition 300 nmol10 microl administered old rats confirm biological effect effect orexin b 10 30 nmol10 microl also determined another animal physiological saline administered vehicle injection given 20 using 50 microl hamilton microsyringe injectors left place 10 injection ensure complete dispersal peptide remaining chow water weighed 1 2 4 h injection estimate food intake water consumption time points
0.16720255.15271651.html.plaintext.txt	25	end experiment rat killed black ink injected lateral ventricle success cannulation verified visualization
0.16720255.15271651.html.plaintext.txt	26	end experiment rat killed black ink injected lateral ventricle success cannulation verified visualization
0.16720255.15271651.html.plaintext.txt	27	determination orexin receptors western blot analysis young n 3 old n 3 rats killed guillotine 1000 1100 without treatment whole brains immediately removed hypothalamus quickly dissected stored 80 degrees c later experiments dissection hypothalamus carried according method gispen et al 3 tissue sample separately homogenized lysis buffer
0.16720255.15271651.html.plaintext.txt	28	determination orexin receptors western blot analysis young n 3 old n 3 rats killed guillotine 1000 1100 without treatment whole brains immediately removed hypothalamus quickly dissected stored 80 degrees c later experiments dissection hypothalamus carried according method gispen et al 3 tissue sample separately homogenized lysis buffer
0.16720255.15271651.html.plaintext.txt	29	respective hypothalamus homogenates 100 microg protein ox1r 200 microg protein ox2r separated sds 10 polyacrylamide gel proteins electrophoretically transferred polyvinylidene difluoride membrane bio rad hercules ca blocked 5 skim milk 1 h room temperature
0.16720255.15271651.html.plaintext.txt	30	respective hypothalamus homogenates 100 microg protein ox1r 200 microg protein ox2r separated sds 10 polyacrylamide gel proteins electrophoretically transferred polyvinylidene difluoride membrane bio rad hercules ca blocked 5 skim milk 1 h room temperature
0.16720255.15271651.html.plaintext.txt	31	membrane incubated polyclonal rabbit antibody 1500 ox1r11 1400 ox2r21 alpha diagnostics international san antonio tx overnight 4 degrees c three washes membrane incubated secondary anti rabbit igg 125000 ox1r 130000 ox2r 1 h room temperature three additional washes immunoreactive bands detected using enhanced chemiluminescence assay system plus amersham biosciences little chalfont uk 5
0.16720255.15271651.html.plaintext.txt	32	membrane incubated polyclonal rabbit antibody 1500 ox1r11 1400 ox2r21 alpha diagnostics international san antonio tx overnight 4 degrees c three washes membrane incubated secondary anti rabbit igg 125000 ox1r 130000 ox2r 1 h room temperature three additional washes immunoreactive bands detected using enhanced chemiluminescence assay system plus amersham biosciences little chalfont uk 5
0.16720255.15271651.html.plaintext.txt	33	autoradiograms underwent semiquantitative densitometric analysis data expressed means plus minus se optical density immunoreactive bands calculated using nih image software package
0.16720255.15271651.html.plaintext.txt	34	autoradiograms underwent semiquantitative densitometric analysis data expressed means plus minus se optical density immunoreactive bands calculated using nih image software package
0.16720255.15271651.html.plaintext.txt	35	statistical analysis results expressed means plus minus se results analyzed one way anova repeated measures multiple anova manova followed fishers protected least significant difference test p 005 considered significant
0.16720255.15271651.html.plaintext.txt	36	results top abstract materials methods results discussion grants references food water consumptions nighttime young old rats food intake old rats significantly less young rats 10798 plus minus 1080 g mean plus minus se old rats vs 13716 plus minus 0524 g young rats p 005 whereas water consumption different two groups 18695 plus minus 1472 g mean plus minus se old rats vs 18484 plus minus 0825 g young rats
0.16720255.15271651.html.plaintext.txt	37	results top abstract materials methods results discussion grants references food water consumptions nighttime young old rats food intake old rats significantly less young rats 10798 plus minus 1080 g mean plus minus se old rats vs 13716 plus minus 0524 g young rats p 005 whereas water consumption different two groups 18695 plus minus 1472 g mean plus minus se old rats vs 18484 plus minus 0825 g young rats
0.16720255.15271651.html.plaintext.txt	38	body weight old rats significantly higher young rats indicated values food water intake relative body weight g100 g body wt food consumption nighttime significantly less old rats young rats p 00001 fig 1a similarly water consumption old rats significantly less young rats p 005 fig 1b
0.16720255.15271651.html.plaintext.txt	39	body weight old rats significantly higher young rats indicated values food water intake relative body weight g100 g body wt food consumption nighttime significantly less old rats young rats p 00001 fig 1a similarly water consumption old rats significantly less young rats p 005 fig 1b
0.16720255.15271651.html.plaintext.txt	40	view larger version 10k fig 1 food water consumptions nighttime food intake water intake b young old rats 1 night food water intake shown relative body weight values means plus minus se number rats group indicated parentheses p 005 p 00001 significant difference young rats anova followed fishers protected least significant difference test
0.16720255.15271651.html.plaintext.txt	41	effects orexin food water intake analysis multiple comparison test repeated measures manova revealed intracerebroventricular injection orexin stimulated food intake dose dependent manner 1 2 4 h young rats although effect 025 nmol orexin significant fig 2a integrated food intake 4 h period shown fig 2b 1 3 nmol orexin significantly increased food intake
0.16720255.15271651.html.plaintext.txt	42	effects orexin food water intake analysis multiple comparison test repeated measures manova revealed intracerebroventricular injection orexin stimulated food intake dose dependent manner 1 2 4 h young rats although effect 025 nmol orexin significant fig 2a integrated food intake 4 h period shown fig 2b 1 3 nmol orexin significantly increased food intake
0.16720255.15271651.html.plaintext.txt	43	view larger version 34k fig 2 effect intracerebroventricular injection orexin food intake time course effect injection 025 10 30 nmol young rats food intake measured 1 2 4 h injection b effect integrated food intake 4 h young rats c time course effect injection 025 10 30 30 nmol food intake old rats significant effect observed d effect integrated food intake 4 h old rats significant effect observed food intake shown relative body weight values means plus minus se number rats group indicated parentheses p 005 p 0001 significant difference saline control
0.16720255.15271651.html.plaintext.txt	44	contrast significant increase observed old rats even higher doses 1 3 30 nmol applied fig 2 c d
0.16720255.15271651.html.plaintext.txt	45	two higher doses orexin tended increase water intake young rats difference significant f 2843 p 00522 4 h water intake fig 3 b effect dose observed old rats fig 3 c d
0.16720255.15271651.html.plaintext.txt	46	view larger version 37k fig 3 effect intracerebroventricular injection orexin water intake significant effect observed results time course effect injection 025 10 30 nmol water intake young rats water intake measured 1 2 4 h injection b effect integrated water intake 4 h young rats c time course effect injection 025 10 30 30 nmol water intake old rats d effect integrated water intake 4 h old rats water intake shown relative body weight values means plus minus se number rats group indicated parentheses
0.16720255.15271651.html.plaintext.txt	47	effects orexin b food water intake intracerebroventricular injection orexin b slightly increased food intake young old rats effect significant integrated food intake 4 h shown fig 4 b orexin b stimulate water intake dose either young old rats fig 4 c d
0.16720255.15271651.html.plaintext.txt	48	effects orexin b food water intake intracerebroventricular injection orexin b slightly increased food intake young old rats effect significant integrated food intake 4 h shown fig 4 b orexin b stimulate water intake dose either young old rats fig 4 c d
0.16720255.15271651.html.plaintext.txt	49	view larger version 24k fig 4 effect intracerebroventricular injection orexin b food water intake significant effect observed results effect injection 10 30 nmol integrated food intake 4 h young rats b effect integrated food intake 4 h old rats c effect injection 10 30 nmol integrated water intake 4 h young rats d effect integrated water intake 4 h old rats food water intake shown relative body weight values means plus minus se number rats group indicated parentheses
0.16720255.15271651.html.plaintext.txt	50	determination orexin receptors western blot analysis using anti ox1r antibody ox1r11 detected specific bands corresponding 54 kda fig 5a intensity band hypothalamus old rats significantly lower young rats anova p 005 vs young
0.16720255.15271651.html.plaintext.txt	51	determination orexin receptors western blot analysis using anti ox1r antibody ox1r11 detected specific bands corresponding 54 kda fig 5a intensity band hypothalamus old rats significantly lower young rats anova p 005 vs young
0.16720255.15271651.html.plaintext.txt	52	view larger version 18k fig 5 western blot analysis showing optical density western blot analysis orexin 1 receptor ox1r selective orexin orexin 2 receptor ox2r selective orexin b b hypothalamus young old rats band intensity expressed optical density values means plus minus se number rats group indicated parentheses example western blot analysis presented top b p 005 significant difference young rats anova followed fishers protected least significant difference test
0.16720255.15271651.html.plaintext.txt	53	western blot analysis using anti ox2r antibody ox2r11 detected three bands hypothalamus young old rats 79 53 43 kda ox2r pure protein 525 kda 1 compared intensity 53 kda immunosignal young old rats fig 5b intensity 53 kda bands higher old rats compared young ones difference significant
0.16720255.15271651.html.plaintext.txt	54	western blot analysis using anti ox2r antibody ox2r11 detected three bands hypothalamus young old rats 79 53 43 kda ox2r pure protein 525 kda 1 compared intensity 53 kda immunosignal young old rats fig 5b intensity 53 kda bands higher old rats compared young ones difference significant
0.16720255.15271651.html.plaintext.txt	55	discussion top abstract materials methods results discussion grants references present study showed intracerebroventricular injection orexin 3 nmol stimulated food intake dose dependent manner young rats previously reported 4 18 20 22 however effect observed old rats distinguish whether old rats response orexin blunted orexin response effect 10 fold higher dose 30 nmol orexin determined old rats stimulation observed therefore concluded old rats true insensitivity feeding effect orexin
0.16720255.15271651.html.plaintext.txt	56	discussion top abstract materials methods results discussion grants references present study showed intracerebroventricular injection orexin 3 nmol stimulated food intake dose dependent manner young rats previously reported 4 18 20 22 however effect observed old rats distinguish whether old rats response orexin blunted orexin response effect 10 fold higher dose 30 nmol orexin determined old rats stimulation observed therefore concluded old rats true insensitivity feeding effect orexin
0.16720255.15271651.html.plaintext.txt	57	examine mechanism underlying effect orexin measured protein levels receptor hypothalamus compared levels young old rats protein level ox1r significantly lower old rats young band intensity old rats 45 less young rats result indicates decrease ox1r protein level hypothalamus could responsible lack orexin stimulatory effect food intake old rats however cannot answer question 50 reduction protein level ox1r would yield 100 reduction behavioral response several neural pathways involved orexigenic action orexins 16 aging change pathways might implicated
0.16720255.15271651.html.plaintext.txt	58	examine mechanism underlying effect orexin measured protein levels receptor hypothalamus compared levels young old rats protein level ox1r significantly lower old rats young band intensity old rats 45 less young rats result indicates decrease ox1r protein level hypothalamus could responsible lack orexin stimulatory effect food intake old rats however cannot answer question 50 reduction protein level ox1r would yield 100 reduction behavioral response several neural pathways involved orexigenic action orexins 16 aging change pathways might implicated
0.16720255.15271651.html.plaintext.txt	59	another hypothesis age related decrease food intake orexin secondary phenomenon due decline ability orexin increase arousal problem discussed previous reports 16 22 24 although record awakening time present study muroya et al 16 reported changes food intake independent changes sleepwake cycles moreover selective ox1r antagonist sb 334867 reduced orexin induced food intake 4 previously abnormality ox2r shown cause canine narcolepsy 7 ox2r expression decrease age study decrease food intake old rats seem depend level arousal
0.16720255.15271651.html.plaintext.txt	60	another hypothesis age related decrease food intake orexin secondary phenomenon due decline ability orexin increase arousal problem discussed previous reports 16 22 24 although record awakening time present study muroya et al 16 reported changes food intake independent changes sleepwake cycles moreover selective ox1r antagonist sb 334867 reduced orexin induced food intake 4 previously abnormality ox2r shown cause canine narcolepsy 7 ox2r expression decrease age study decrease food intake old rats seem depend level arousal
0.16720255.15271651.html.plaintext.txt	61	previous study 6 reported central administration orexins stimulated water intake significantly however observed two higher doses orexin significantly increase water intake even young rats differences study kunii et al 6 present study different doses orexin applied experimental conditions kunii et al 6 determined effects 3 30 nmol orexins whereas used 025 3 nmol also measured water intake without feeding whereas measured water food consumptions simultaneously
0.16720255.15271651.html.plaintext.txt	62	previous study 6 reported central administration orexins stimulated water intake significantly however observed two higher doses orexin significantly increase water intake even young rats differences study kunii et al 6 present study different doses orexin applied experimental conditions kunii et al 6 determined effects 3 30 nmol orexins whereas used 025 3 nmol also measured water intake without feeding whereas measured water food consumptions simultaneously
0.16720255.15271651.html.plaintext.txt	63	recent study 17 reported preproorexin gene expression contents orexins rat brain decreased course aging also report 25 site specific decrease immunostaining orexin observed locus coeruleus old cats reports indicate deterioration orexin system old animals measure orexin content brain whether content decreased age remains unknown however orexin bind ox1r ox2r specificity ox1r orexin high 18 age associated change ox1r could biologically important orexin observation leads us propose age associated decline ox1r may related age associated decline appetite food intake
0.16720255.15271651.html.plaintext.txt	64	recent study 17 reported preproorexin gene expression contents orexins rat brain decreased course aging also report 25 site specific decrease immunostaining orexin observed locus coeruleus old cats reports indicate deterioration orexin system old animals measure orexin content brain whether content decreased age remains unknown however orexin bind ox1r ox2r specificity ox1r orexin high 18 age associated change ox1r could biologically important orexin observation leads us propose age associated decline ox1r may related age associated decline appetite food intake
0.16720255.15271651.html.plaintext.txt	65	hand orexin b showed significant effect either young old rats present observation compatible previous studies 2 8 central orexin b less effective stimulant food intake orexin protein level ox2r significantly different young old rats terao et al 23 measured mrna levels ox1r ox2r eight brain regions 3 12 18 24 mo old c57bl6 mice observed declining trend ox2r mrna level hypothalamus although age related change ox1r mrna expression differences might due species difference although precise mechanism unknown
0.16720255.15271651.html.plaintext.txt	66	hand orexin b showed significant effect either young old rats present observation compatible previous studies 2 8 central orexin b less effective stimulant food intake orexin protein level ox2r significantly different young old rats terao et al 23 measured mrna levels ox1r ox2r eight brain regions 3 12 18 24 mo old c57bl6 mice observed declining trend ox2r mrna level hypothalamus although age related change ox1r mrna expression differences might due species difference although precise mechanism unknown
0.16720255.15271651.html.plaintext.txt	67	conclusion function orexin system stimulating feeding behavior reduced old rats compared young ones decrease ox1r protein level hypothalamus could responsible orexin lack stimulatory effect food intake old rats
0.16720255.15271651.html.plaintext.txt	68	conclusion function orexin system stimulating feeding behavior reduced old rats compared young ones decrease ox1r protein level hypothalamus could responsible orexin lack stimulatory effect food intake old rats
0.16720255.15271651.html.plaintext.txt	69	grants top abstract materials methods results discussion grants references research supported part health sciences research grants h13 21ebm 018 ministry health labour welfare japan
0.16720255.15271651.html.plaintext.txt	70	footnotes address reprint requests correspondence k miyasaka dept clinical physiology tokyo metropolitan institute gerontology 35 2 sakaecho itabashiku tokyo 173 0015 japan e mail miyasakaattmigorjp u d
0.16720255.15271651.html.plaintext.txt	71	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.16720255.15271651.html.plaintext.txt	72	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.16720255.15271651.html.plaintext.txt	73	references top abstract materials methods results discussion grants references cluderay je harrison dc hervieu gj protein distribution orexin 2 receptor rat central nervous system regul pept 104 131 144 2002crossrefisimedline dube mg kalra sp kalra ps food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842 473 477 1999crossrefisimedline gispen wh schotman p de kloet er brain rna hypophysectomy topographical study neuroendocrinology 9 285 296 1972crossrefisimedline haynes ac jackson b chapman h tadayyon m johns porter ra arch jr selective orexin 1 receptor antagonist reduces food consumption male female rats regul pept 96 45 51 2000crossrefisimedline irving ea harrison dc babbs aj mayes ac campbell ca hunter aj upton n parsons aa increased cortical expression orexin 1 receptor following permanent middle cerebral artery occlusion rat neurosci lett 324 53 56 2002crossrefisimedline kunii k yamanaka nambu matsuzaki goto k sakurai orexinshypocretins regulate drinking behaviour brain res 842 256 261 1999crossrefisimedline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline masuda m kanai miyasaka k central somatostatin prevents vagal efferent nerve excitation produced trh 2 deoxy d glucose j physiol gastrointest liver physiol 272 g351 g356 1997abstractfree full text masuda m kanai miyasaka k inhibitory effect central dopamine basal pancreatic secretion conscious rats j physiol gastrointest liver physiol 274 g29 g34 1998abstractfree full text masuda m kanai miyasaka k funakoshi somatostatin inhibits pancreatic exocrine secretion centrally via sympathetic nerves conscious rats j auton nerv syst 56 31 37 1995crossrefisimedline miyasaka k kanai masuda m ohta m kawanami matsumoto m funakoshi gene expressions cholecystokinin cck cck receptors satiety effect young old male rats arch gerontol geriatr 21 147 155 1995crossrefisi miyasaka k masuda m kanai sato n kurosawa m funakoshi central orexin stimulates pancreatic exocrine secretion via vagus pancreas 25 400 404 2002crossrefisimedline morley je decreased food intake aging j gerontol biol sci med sci 56 81 88 2001abstractfree full text morley je silver aj anorexia elderly neurobiol aging 9 9 16 1988isimedline muroya funahashi h yamanaka kohno d uramura k nambu shibahara m kuramochi m takigawa m yanagisawa m sakurai shioda yada orexins hypocretins directly interact neuropeptide y pomc glucose responsive neurons regulate ca2 signaling reciprocal manner leptin orexigenic neuronal pathways mediobasal hypothalamus eur j neurosci 19 1524 1534 2004crossrefisimedline porkka heiskanen alanko l kalinchuk heiskanen stenberg d effect age prepro orexin gene expression contents orexin b rat brain neurobiol aging 25 231 238 2004crossrefisimedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline saper cb swanson lw cowan wm autoradiographic study efferent connections lateral hypothalamic area rat j comp neurol 183 689 706 1979isimedline shiraishi oomura y sasaki k wayner mj effects leptin orexin food intake feeding related hypothalamic neurons physiol behav 71 251 261 2000crossrefisimedline silver aj morley je role cck regulation food intake prog neurobiol 36 23 34 1991crossrefisimedline smart d haynes ac williams g arch jr orexins treatment obesity eur j pharmacol 440 199 212 2002crossrefisimedline terao apte deshpande morairty freund yr kilduff ts age related decline hypocretin orexin receptor 2 messenger rna levels mouse brain neurosci lett 332 190 194 2002crossrefisimedline willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001crossrefisimedline zhang jh sampogna morales fr chase mh age related changes hypocretin orexin immunoreactivity cat brainstem brain res 930 206 211 2002crossrefisimedline
0.16720255.15271651.html.plaintext.txt	74	references top abstract materials methods results discussion grants references cluderay je harrison dc hervieu gj protein distribution orexin 2 receptor rat central nervous system regul pept 104 131 144 2002crossrefisimedline dube mg kalra sp kalra ps food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842 473 477 1999crossrefisimedline gispen wh schotman p de kloet er brain rna hypophysectomy topographical study neuroendocrinology 9 285 296 1972crossrefisimedline haynes ac jackson b chapman h tadayyon m johns porter ra arch jr selective orexin 1 receptor antagonist reduces food consumption male female rats regul pept 96 45 51 2000crossrefisimedline irving ea harrison dc babbs aj mayes ac campbell ca hunter aj upton n parsons aa increased cortical expression orexin 1 receptor following permanent middle cerebral artery occlusion rat neurosci lett 324 53 56 2002crossrefisimedline kunii k yamanaka nambu matsuzaki goto k sakurai orexinshypocretins regulate drinking behaviour brain res 842 256 261 1999crossrefisimedline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline masuda m kanai miyasaka k central somatostatin prevents vagal efferent nerve excitation produced trh 2 deoxy d glucose j physiol gastrointest liver physiol 272 g351 g356 1997abstractfree full text masuda m kanai miyasaka k inhibitory effect central dopamine basal pancreatic secretion conscious rats j physiol gastrointest liver physiol 274 g29 g34 1998abstractfree full text masuda m kanai miyasaka k funakoshi somatostatin inhibits pancreatic exocrine secretion centrally via sympathetic nerves conscious rats j auton nerv syst 56 31 37 1995crossrefisimedline miyasaka k kanai masuda m ohta m kawanami matsumoto m funakoshi gene expressions cholecystokinin cck cck receptors satiety effect young old male rats arch gerontol geriatr 21 147 155 1995crossrefisi miyasaka k masuda m kanai sato n kurosawa m funakoshi central orexin stimulates pancreatic exocrine secretion via vagus pancreas 25 400 404 2002crossrefisimedline morley je decreased food intake aging j gerontol biol sci med sci 56 81 88 2001abstractfree full text morley je silver aj anorexia elderly neurobiol aging 9 9 16 1988isimedline muroya funahashi h yamanaka kohno d uramura k nambu shibahara m kuramochi m takigawa m yanagisawa m sakurai shioda yada orexins hypocretins directly interact neuropeptide y pomc glucose responsive neurons regulate ca2 signaling reciprocal manner leptin orexigenic neuronal pathways mediobasal hypothalamus eur j neurosci 19 1524 1534 2004crossrefisimedline porkka heiskanen alanko l kalinchuk heiskanen stenberg d effect age prepro orexin gene expression contents orexin b rat brain neurobiol aging 25 231 238 2004crossrefisimedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline saper cb swanson lw cowan wm autoradiographic study efferent connections lateral hypothalamic area rat j comp neurol 183 689 706 1979isimedline shiraishi oomura y sasaki k wayner mj effects leptin orexin food intake feeding related hypothalamic neurons physiol behav 71 251 261 2000crossrefisimedline silver aj morley je role cck regulation food intake prog neurobiol 36 23 34 1991crossrefisimedline smart d haynes ac williams g arch jr orexins treatment obesity eur j pharmacol 440 199 212 2002crossrefisimedline terao apte deshpande morairty freund yr kilduff ts age related decline hypocretin orexin receptor 2 messenger rna levels mouse brain neurosci lett 332 190 194 2002crossrefisimedline willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001crossrefisimedline zhang jh sampogna morales fr chase mh age related changes hypocretin orexin immunoreactivity cat brainstem brain res 930 206 211 2002crossrefisimedline
0.17200397.15961555.html.plaintext.txt	0	orexin expression function glucocorticoid manipulation stress feeding studies gemma k ford kamal al barazanji shelagh wilson declan n c jones michael harbuz david jessop
0.17200397.15961555.html.plaintext.txt	1	henry wellcome laboratory integrative neuroscience endocrinology gkf msh dsj university bristol bristol bs1 3ny united kingdom department biology dncj psychiatry centre excellence drug discovery cedd discovery research sw glaxosmithkline harlow essex cm19 5aw united kingdom metabolic diseases kaa b metabolic viral diseases cedd glaxosmithkline research triangle park north carolina 27709
0.17200397.15961555.html.plaintext.txt	2	address correspondence requests reprints dr m harbuz henry wellcome laboratory integrative neuroscience endocrinology dorothy hodgkin building whitson street bristol bs1 3ny united kingdom e mail msharbuzatbrisacuk u d
0.17200397.15961555.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references investigated effects glucocorticoid manipulation orexin induced feeding prepro orexin mrna levels lateral hypothalamic area lha rat brain adrenalectomy adx reduced orexin induced feeding 4 h 60 compared shams effect reversed corticosterone cort replacement adx effect prepro orexin mrna levels lha either morning evening however message regulated cort morning evening increased number emulsion grains per cell lha suggests specific increase prepro orexin mrna due increased number cells expressing message prepro orexin mrna levels lha elevated 4 h injection lipopolysaccharide compared saline injected controls partial complete abolition orexin induced feeding adx suggests orexin induced feeding may mediated glucocorticoid dependent glucocorticoid independent pathways morning increased prepro orexin mrna cort replacement demonstrates orexin expression sensitive increased concentrations glucocorticoids however lack effect adx prepro orexin mrna levels suggests endogenous glucocorticoids involved tonic regulation basal prepro orexin expression overall data constitute body evidence integrated relationship central orexin expression stress glucocorticoid manipulation feeding patterns rat
0.17200397.15961555.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references investigated effects glucocorticoid manipulation orexin induced feeding prepro orexin mrna levels lateral hypothalamic area lha rat brain adrenalectomy adx reduced orexin induced feeding 4 h 60 compared shams effect reversed corticosterone cort replacement adx effect prepro orexin mrna levels lha either morning evening however message regulated cort morning evening increased number emulsion grains per cell lha suggests specific increase prepro orexin mrna due increased number cells expressing message prepro orexin mrna levels lha elevated 4 h injection lipopolysaccharide compared saline injected controls partial complete abolition orexin induced feeding adx suggests orexin induced feeding may mediated glucocorticoid dependent glucocorticoid independent pathways morning increased prepro orexin mrna cort replacement demonstrates orexin expression sensitive increased concentrations glucocorticoids however lack effect adx prepro orexin mrna levels suggests endogenous glucocorticoids involved tonic regulation basal prepro orexin expression overall data constitute body evidence integrated relationship central orexin expression stress glucocorticoid manipulation feeding patterns rat
0.17200397.15961555.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references orexin ox ox b also known hypocretins closely related neuropeptides derived single gene processed 130 residue 131 residues humans prepro ox precursor protein 1 ox 33 residue peptide identical sequence humans rodents whereas human rat ox b differ two residues ox ox b activate two g protein coupled receptors known ox 1 ox 2 ox 1 receptor greater affinity ox ox b whereas ox 2 receptor similar affinity ligands central nervous system cns distribution orexins similar rats humans lateral hypothalamic area lha predominant region synthesis 1
0.17200397.15961555.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references orexin ox ox b also known hypocretins closely related neuropeptides derived single gene processed 130 residue 131 residues humans prepro ox precursor protein 1 ox 33 residue peptide identical sequence humans rodents whereas human rat ox b differ two residues ox ox b activate two g protein coupled receptors known ox 1 ox 2 ox 1 receptor greater affinity ox ox b whereas ox 2 receptor similar affinity ligands central nervous system cns distribution orexins similar rats humans lateral hypothalamic area lha predominant region synthesis 1
0.17200397.15961555.html.plaintext.txt	7	lha long implicated feeding behavior initial observations highlighted role orexins stimulating appetite 2 however clear orexins also involved regulation sleep arousal locomotor activity neuroendocrine responses 3 4 therefore orexigenic activity may secondary behavioral traits influence feeding behavioral studies orexins modulate stress related behavior grooming chewing inedible material 5 6 7 orexin containing neurones project lha many cns areas involved mediating stress including paraventricular nucleus pvn hypothalamus arcuate nucleus arc locus coeruleus 8 9 10 ox 1 ox 2 receptors widely differentially distributed throughout cns including pvn suprachiasmatic nucleus supraoptic nucleus arc hypothalamus also locus coeruleus hippocampus 11 12 13 14 areas individual synergistic involvement regulating circadian rhythm behavioral neuroendocrine responses stressors
0.17200397.15961555.html.plaintext.txt	8	lha long implicated feeding behavior initial observations highlighted role orexins stimulating appetite 2 however clear orexins also involved regulation sleep arousal locomotor activity neuroendocrine responses 3 4 therefore orexigenic activity may secondary behavioral traits influence feeding behavioral studies orexins modulate stress related behavior grooming chewing inedible material 5 6 7 orexin containing neurones project lha many cns areas involved mediating stress including paraventricular nucleus pvn hypothalamus arcuate nucleus arc locus coeruleus 8 9 10 ox 1 ox 2 receptors widely differentially distributed throughout cns including pvn suprachiasmatic nucleus supraoptic nucleus arc hypothalamus also locus coeruleus hippocampus 11 12 13 14 areas individual synergistic involvement regulating circadian rhythm behavioral neuroendocrine responses stressors
0.17200397.15961555.html.plaintext.txt	9	hypothalamo pituitary adrenal hpa axis one principal pathways mediating neuroendocrine responses stress hypothalamic neuropeptides corticotropin releasing factor crf arginine vasopressin avp stimulate release proopiomelanocortin derived peptide acth anterior pituitary consequent release glucocorticoids adrenal cortex corticosterone cort principal glucocorticoid rodents acts glucocorticoid receptors hippocampus hypothalamus mineralocorticoid receptors within hippocampus negatively regulate hpa axis activity 15 many studies demonstrated orexins influence hpa axis activity plasma acth cort concentrations elevated rats intracerebroventricular icv ox administration 5 16 17 18 19 20 21 22 23 accompanied induction c fos mrna 17 avp crf mrnas 20 parvocellular subdivision pvn addition vitro studies revealed release crf peptide avp hypothalamic explants 19 ox b also reported stimulate hpa axis activity 16 orexin expression rat lha increased stressors immobilization 23 cold stress 23 hypoglycemia 24 reduced secretion plasma acth cortisol reported patients narcolepsy 25 condition associated orexin deficiency therefore considerable evidence orexins modulate hpa axis activity orexin expression responsive alterations hpa axis activity
0.17200397.15961555.html.plaintext.txt	10	hypothalamo pituitary adrenal hpa axis one principal pathways mediating neuroendocrine responses stress hypothalamic neuropeptides corticotropin releasing factor crf arginine vasopressin avp stimulate release proopiomelanocortin derived peptide acth anterior pituitary consequent release glucocorticoids adrenal cortex corticosterone cort principal glucocorticoid rodents acts glucocorticoid receptors hippocampus hypothalamus mineralocorticoid receptors within hippocampus negatively regulate hpa axis activity 15 many studies demonstrated orexins influence hpa axis activity plasma acth cort concentrations elevated rats intracerebroventricular icv ox administration 5 16 17 18 19 20 21 22 23 accompanied induction c fos mrna 17 avp crf mrnas 20 parvocellular subdivision pvn addition vitro studies revealed release crf peptide avp hypothalamic explants 19 ox b also reported stimulate hpa axis activity 16 orexin expression rat lha increased stressors immobilization 23 cold stress 23 hypoglycemia 24 reduced secretion plasma acth cortisol reported patients narcolepsy 25 condition associated orexin deficiency therefore considerable evidence orexins modulate hpa axis activity orexin expression responsive alterations hpa axis activity
0.17200397.15961555.html.plaintext.txt	11	well documented glucocorticoid administration stimulates feeding conversely glucocorticoid deficiency results loss appetite weight loss adrenalectomized adx rats exhibit decreased feeding reversed cort administration 26 27 therefore orexins may exert direct effect appetite regulation within hypothalamus may act indirectly stimulate feeding increased cort secretion test hypothesis designed experiments investigate effect adx without cort replacement ox induced feeding determine whether endogenous cort involved ox induced feeding behavior also investigated effects glucocorticoid manipulation orexin expression morning evening determine whether orexin expression exhibits diurnal rhythm expression 28 29 may correlated diurnal rhythm hpa axis activity finally investigated effects orexin expression lipopolysaccharide lps immunological stressor elicits robust prolonged activation hpa axis 30 31
0.17200397.15961555.html.plaintext.txt	12	well documented glucocorticoid administration stimulates feeding conversely glucocorticoid deficiency results loss appetite weight loss adrenalectomized adx rats exhibit decreased feeding reversed cort administration 26 27 therefore orexins may exert direct effect appetite regulation within hypothalamus may act indirectly stimulate feeding increased cort secretion test hypothesis designed experiments investigate effect adx without cort replacement ox induced feeding determine whether endogenous cort involved ox induced feeding behavior also investigated effects glucocorticoid manipulation orexin expression morning evening determine whether orexin expression exhibits diurnal rhythm expression 28 29 may correlated diurnal rhythm hpa axis activity finally investigated effects orexin expression lipopolysaccharide lps immunological stressor elicits robust prolonged activation hpa axis 30 31
0.17200397.15961555.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references animals adult male sprague dawley rats 200 250 g charles river margate kent uk housed individually controlled light temperature 21 plus minus 2 c free access water standard rat pelleted chow maintained 12 h light 12 h dark cycle lights 0600 h procedures carried accordance animals scientific procedures act 1986 united kingdom
0.17200397.15961555.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references animals adult male sprague dawley rats 200 250 g charles river margate kent uk housed individually controlled light temperature 21 plus minus 2 c free access water standard rat pelleted chow maintained 12 h light 12 h dark cycle lights 0600 h procedures carried accordance animals scientific procedures act 1986 united kingdom
0.17200397.15961555.html.plaintext.txt	15	surgical procedures intracerebroventricular cannulation rats anesthetized im injection domitor medetomidine hcl 004 ml per 100 g pfizer sandwich kent uk ip injection sublimaze fentanyl 09 ml per 100 g janssen cilag high wycombe buckinghamshire uk rats positioned stereotaxic frame implanted 22 gauge stainless steel guide cannula left lateral ventricle brain sterile conditions cannula secured surface skull jeweler screws dental cement stereotaxic coordinates left brain ventricle follows 08 mm caudal bregma 15 mm lateral midline 41 mm vertical skull surface incisor bar 32 mm zero completion surgery anesthesia reversed ip 5050 mixture antisedan atipamezole hcl 002 ml per 100 g pfizer nubain nalbuphine hcl 002 ml per 100 g dupont pharmaceuticals stevenage hertfordshire uk implantation guide cannula correct placement checked using gravitational flow sterile saline filled cannula
0.17200397.15961555.html.plaintext.txt	16	surgical procedures intracerebroventricular cannulation rats anesthetized im injection domitor medetomidine hcl 004 ml per 100 g pfizer sandwich kent uk ip injection sublimaze fentanyl 09 ml per 100 g janssen cilag high wycombe buckinghamshire uk rats positioned stereotaxic frame implanted 22 gauge stainless steel guide cannula left lateral ventricle brain sterile conditions cannula secured surface skull jeweler screws dental cement stereotaxic coordinates left brain ventricle follows 08 mm caudal bregma 15 mm lateral midline 41 mm vertical skull surface incisor bar 32 mm zero completion surgery anesthesia reversed ip 5050 mixture antisedan atipamezole hcl 002 ml per 100 g pfizer nubain nalbuphine hcl 002 ml per 100 g dupont pharmaceuticals stevenage hertfordshire uk implantation guide cannula correct placement checked using gravitational flow sterile saline filled cannula
0.17200397.15961555.html.plaintext.txt	17	adrenalectomy rats bilaterally adx via dorsal approach small incision made along midline back rib cage connective tissue fat displaced small hole made muscle either side back using blunt cut scissors adrenals excised curved forceps adrenal checked remained intact excision animals complete removal adrenals considered adx surgery adx animals immediately given 09 saline drink maintain salt balance surgery sham animals identical adrenals removed animals allowed 7 d postoperative recovery handled daily
0.17200397.15961555.html.plaintext.txt	18	effects glucocorticoids ox induced feeding thirty two rats bilaterally adx whereas 16 rats subjected sham adx animals returned home cages adx animals immediately given 09 saline whereas two groups adx rats given 09 saline supplemented cort sigma poole dorset uk either 25 mgliter low cort 125 mgliter high cort concentrations cort selected within basal physiological range endogenous cort 27 morning experimentation sham adx animals divided two groups n 9 equal mean body weights receive icv injection either ox 30 micrograt 5 microl 09 saline saline dose equivalent 8 nmol falls within accepted range 3 30 nmol 2 used extensively low cort high cort replacement groups also received icv injection either ox 30 micrograt saline icv injection cannula extension tubing preloaded drug vehicle inserted guide cannula injections given period 1 min needle left position minute ensure complete dispersal peptide injections given 0900 1000 h preweighed food pellets water bottles supplied icv injection food intake determined 1 2 3 4 h time points icv injection 4 h rats killed decapitation trunk blood collected chilled edta tubes ice centrifugation collect plasma acth measured ria prior extraction plasma seppak columns 32 assay sensitivity 10 pgml total cort measured unextracted plasma house ria 33 radioactive tracer i125 cort icn biomedicals basingstoke hampshire uk specific activity 037 mbq sensitivity assay 5 ngml acth cort primary antisera kindly supplied g makara hungarian academy sciences budapest hungary samples either acth cort processed assay intraassay variation less 10
0.17200397.15961555.html.plaintext.txt	19	effects glucocorticoids ox induced feeding thirty two rats bilaterally adx whereas 16 rats subjected sham adx animals returned home cages adx animals immediately given 09 saline whereas two groups adx rats given 09 saline supplemented cort sigma poole dorset uk either 25 mgliter low cort 125 mgliter high cort concentrations cort selected within basal physiological range endogenous cort 27 morning experimentation sham adx animals divided two groups n 9 equal mean body weights receive icv injection either ox 30 micrograt 5 microl 09 saline saline dose equivalent 8 nmol falls within accepted range 3 30 nmol 2 used extensively low cort high cort replacement groups also received icv injection either ox 30 micrograt saline icv injection cannula extension tubing preloaded drug vehicle inserted guide cannula injections given period 1 min needle left position minute ensure complete dispersal peptide injections given 0900 1000 h preweighed food pellets water bottles supplied icv injection food intake determined 1 2 3 4 h time points icv injection 4 h rats killed decapitation trunk blood collected chilled edta tubes ice centrifugation collect plasma acth measured ria prior extraction plasma seppak columns 32 assay sensitivity 10 pgml total cort measured unextracted plasma house ria 33 radioactive tracer i125 cort icn biomedicals basingstoke hampshire uk specific activity 037 mbq sensitivity assay 5 ngml acth cort primary antisera kindly supplied g makara hungarian academy sciences budapest hungary samples either acth cort processed assay intraassay variation less 10
0.17200397.15961555.html.plaintext.txt	20	distribution prepro ox expression lateral hypothalamus two male sprague dawley rats killed decapitation brains removed stored 80 c sectioning coronal brain sections 12 microm collected lha pvn cryostat immediately stored 80 c two sections collected every four sections 48 50 sections collected animal prepro ox expression investigated using situ hybridization performed described previously 34 35 sections warmed room temperature 10 min fixed 4 formaldehyde 5 min washed twice pbs incubated 025 acetic anhydride 01 m triethanolamine09 nacl 10 min sections dehydrated graded ethanol washes 70 1 min 80 1 min 95 2 min 100 1 min delipidated chloroform 100 5 min rehydrated 100 1 min 95 1 min ethanol drying air probe used 33 mer oligonucleotide complementary nucleotides 242 275 exonic sequence rat prepro ox mrna 5 tgcccgcggcgtggttgccagctccgtgcaaca 3 genbank accession af041241 probes labeled 3 end 35s atp column purified nuctrap probe purification columns stratagene uk probes labeled specific activity 14x 1018 dpmmol forty five microliters hybridization buffer 50 formamide 4x saline sodium citrate ssc 05 mgml sheared single stranded salmon sperm dna 025 mgml yeast trna 05 x denhardt solution 10 dextran sulfate containing labeled probe 100000 cpm applied slide hybridization performed overnight 37 c sections experiment processed time sections washed four times 55 c 1x ssc 1x ssc 015 m nacl0015 m sodium citrate ph 70 followed two 30 min washes room temperature 1x ssc remove nonspecific binding two brief rinses distilled water sections air dried exposed amersham hyperfilmmp amersham international aylesbury buckinghamshire uk together 14c labeled standard 14 d autoradiographic images probe bound brain sections analyzed using densitometry method described previously 35 using image software results presented arbitrary values prepro ox expression lha
0.17200397.15961555.html.plaintext.txt	21	distribution prepro ox expression lateral hypothalamus two male sprague dawley rats killed decapitation brains removed stored 80 c sectioning coronal brain sections 12 microm collected lha pvn cryostat immediately stored 80 c two sections collected every four sections 48 50 sections collected animal prepro ox expression investigated using situ hybridization performed described previously 34 35 sections warmed room temperature 10 min fixed 4 formaldehyde 5 min washed twice pbs incubated 025 acetic anhydride 01 m triethanolamine09 nacl 10 min sections dehydrated graded ethanol washes 70 1 min 80 1 min 95 2 min 100 1 min delipidated chloroform 100 5 min rehydrated 100 1 min 95 1 min ethanol drying air probe used 33 mer oligonucleotide complementary nucleotides 242 275 exonic sequence rat prepro ox mrna 5 tgcccgcggcgtggttgccagctccgtgcaaca 3 genbank accession af041241 probes labeled 3 end 35s atp column purified nuctrap probe purification columns stratagene uk probes labeled specific activity 14x 1018 dpmmol forty five microliters hybridization buffer 50 formamide 4x saline sodium citrate ssc 05 mgml sheared single stranded salmon sperm dna 025 mgml yeast trna 05 x denhardt solution 10 dextran sulfate containing labeled probe 100000 cpm applied slide hybridization performed overnight 37 c sections experiment processed time sections washed four times 55 c 1x ssc 1x ssc 015 m nacl0015 m sodium citrate ph 70 followed two 30 min washes room temperature 1x ssc remove nonspecific binding two brief rinses distilled water sections air dried exposed amersham hyperfilmmp amersham international aylesbury buckinghamshire uk together 14c labeled standard 14 d autoradiographic images probe bound brain sections analyzed using densitometry method described previously 35 using image software results presented arbitrary values prepro ox expression lha
0.17200397.15961555.html.plaintext.txt	22	effect adrenalectomy glucocorticoid manipulation prepro ox expression lateral hypothalamus fifteen rats bilaterally adx described whereas 12 rats subjected sham adx eight animals given 09 saline whereas seven adx rats eight sham adx rats given 09 saline supplemented cort high cort 125 mgliter described remaining sham adx animals given tap water drink animals placed regimen 7 d handled daily morning experiment rats killed decapitation brains removed trunk blood collected chilled edta tubes ice acth cort rias described sections cut cryostat two lha areas determined distribution study lha1 bregma 230 mm interaural 670 mm lha2 bregma 256 mm interaural 644 mm atlas paxinos watson 36 nine consecutive coronal lateral hypothalamic brain sections collected spanning 108 microm slide three sections encompassing 84 microm lha allow apparent variation prepro ox expression demonstrated present lha results distribution study prepro ox mrna measurement situ hybridization performed described adx adx cort hybridized sections dipped autoradiographic emulsion exposed 4 c 1 wk sections processed time slides developed fixed counterstained methyl green
0.17200397.15961555.html.plaintext.txt	23	seven emulsion dipped slides per treatment analyzed cellular level counting number labeled cells silver grains per cell least two five cells per section minimum eight cells per slide three sections per slide randomly selected x200 magnification microscope leica heidelberg germany saved images silver grains counted hand microscope images enlarged 100 photo editor microsoft redmond ca silver grains dotted onto plastic sheets attached monitor screen counted silver grains individual cell counted three times manner sixty one 67 cells counted treatment
0.17200397.15961555.html.plaintext.txt	24	seven emulsion dipped slides per treatment analyzed cellular level counting number labeled cells silver grains per cell least two five cells per section minimum eight cells per slide three sections per slide randomly selected x200 magnification microscope leica heidelberg germany saved images silver grains counted hand microscope images enlarged 100 photo editor microsoft redmond ca silver grains dotted onto plastic sheets attached monitor screen counted silver grains individual cell counted three times manner sixty one 67 cells counted treatment
0.17200397.15961555.html.plaintext.txt	25	effect diurnal variation prepro ox expression adx rats given glucocorticoid replacement thirty three rats bilaterally adx whereas 13 rats subjected sham adx described previously seventeen adx rats given 09 saline whereas 16 given 09 saline supplemented cort 125 mgliter sham animals supplied tap water drink animals left regimen 7 d handled daily morning experimentation five sham eight adx seven adx cort rats killed decapitation morning 0900 1000 h remaining animals killed evening 1800 h brains trunk blood collected described previously prepro ox measurements sectioning performed described
0.17200397.15961555.html.plaintext.txt	26	effect diurnal variation prepro ox expression adx rats given glucocorticoid replacement thirty three rats bilaterally adx whereas 13 rats subjected sham adx described previously seventeen adx rats given 09 saline whereas 16 given 09 saline supplemented cort 125 mgliter sham animals supplied tap water drink animals left regimen 7 d handled daily morning experimentation five sham eight adx seven adx cort rats killed decapitation morning 0900 1000 h remaining animals killed evening 1800 h brains trunk blood collected described previously prepro ox measurements sectioning performed described
0.17200397.15961555.html.plaintext.txt	27	effects lps injection prepro ox mrna animals received ip injection 0900 1000 h either lps 250 micrograt 05 ml 09 saline escherichia coli serotype 055b5 sigma saline animals killed decapitation 4 h injection brains trunk blood collected prepro ox mrna measured described plasma acth cort measured rias
0.17200397.15961555.html.plaintext.txt	28	statistics statistical comparisons multiple groups made using fisher protected least significant difference test one way anova lps study student test used values expressed mean plus minus sem p 005 considered significant analyses generated using statview
0.17200397.15961555.html.plaintext.txt	29	statistics statistical comparisons multiple groups made using fisher protected least significant difference test one way anova lps study student test used values expressed mean plus minus sem p 005 considered significant analyses generated using statview
0.17200397.15961555.html.plaintext.txt	30	results top abstract introduction materials methods results discussion references effects glucocorticoids ox induced feeding plasma acth cort measured confirm success adx four h icv injection adx rats concentrations cort limit detection 5 ngml compared sham vehicle group 31 plus minus 7 ngml sham ox group 24 plus minus 8 ngml significant difference plasma cort concentrations sham ox sham vehicle groups plasma cort concentrations low cort high cort replacement groups 71 plus minus 11 73 plus minus 06 ngml respectively plasma acth concentrations significantly elevated adx groups compared sham groups increase acth attenuated high cort low cort replacement table 1
0.17200397.15961555.html.plaintext.txt	31	results top abstract introduction materials methods results discussion references effects glucocorticoids ox induced feeding plasma acth cort measured confirm success adx four h icv injection adx rats concentrations cort limit detection 5 ngml compared sham vehicle group 31 plus minus 7 ngml sham ox group 24 plus minus 8 ngml significant difference plasma cort concentrations sham ox sham vehicle groups plasma cort concentrations low cort high cort replacement groups 71 plus minus 11 73 plus minus 06 ngml respectively plasma acth concentrations significantly elevated adx groups compared sham groups increase acth attenuated high cort low cort replacement table 1
0.17200397.15961555.html.plaintext.txt	32	view table table 1 plasma acth concentrations pgml 4 h intracerebroventricular administration orexin saline
0.17200397.15961555.html.plaintext.txt	33	4 h food intake significantly greater sham ox 41 plus minus 06 g group compared sham vehicle group 03 plus minus 02 g fig 1 adx significantly reduced ox induced food intake 21 plus minus 07 g 60 reduction reversed high cort 49 plus minus 08 g low cort replacement food intake significantly greater adx ox rats 21 plus minus 07 g compared sham vehicle 03 plus minus 02 g adx vehicle 06 plus minus 03 g groups
0.17200397.15961555.html.plaintext.txt	34	view larger version 26k fig 1 effect adx corticosterone replacement cumulative food intake 4 h single icv injection ox 30 micrograt vehicle 5 microlrat conscious rats values mean plus minus sem n 7 8group p 005 compared adx vehicle sham vehicle groups p 005 compared adx orexin group p 005 compared adx vehicle group
0.17200397.15961555.html.plaintext.txt	35	distribution prepro ox expression lateral hypothalamus considerable variation prepro ox mrna expression levels throughout lha fig 2 however sections collected caudal pvn area 134 mm end anterior commissure profile expression tended peak trough around similar areas cases prepro ox levels overlapped two animals areas lh1 lh2 areas overlap prepro ox mrna two brains clearly defined anatomically therefore permitted greater reproducibility
0.17200397.15961555.html.plaintext.txt	36	view larger version 25k fig 2 comparison prepro ox mrna distribution lha two control rats lha1 lha2 represent areas sectioned prepro ox mrna measurement
0.17200397.15961555.html.plaintext.txt	37	effect adrenalectomy glucocorticoid manipulation prepro ox expression lateral hypothalamus concentrations plasma cort measured confirm success adx adx rats concentrations plasma cort limit assay detection 5 ngml compared sham group 21 plus minus 11 ngml adx animals cort replacement cort concentrations 43 plus minus 12 ngml compared sham cort group 126 plus minus 53 ngml
0.17200397.15961555.html.plaintext.txt	38	effect adrenalectomy glucocorticoid manipulation prepro ox expression lateral hypothalamus concentrations plasma cort measured confirm success adx adx rats concentrations plasma cort limit assay detection 5 ngml compared sham group 21 plus minus 11 ngml adx animals cort replacement cort concentrations 43 plus minus 12 ngml compared sham cort group 126 plus minus 53 ngml
0.17200397.15961555.html.plaintext.txt	39	effect adx prepro ox mrna levels lha1 fig 3a lha2 fig 3b areas compared sham animals sham adx groups cort replacement significantly elevated levels prepro ox mrna lha1 lha2 compared sham adx groups without cort replacement
0.17200397.15961555.html.plaintext.txt	40	view larger version 38k fig 3 morning levels prepro ox mrna lha1 lha2 b rats 7 d adx sham surgery without corticosterone replacement mrna levels expressed percentage control group mean plus minus sem n 5 6group p 005 compared sham group p 005 compared adx
0.17200397.15961555.html.plaintext.txt	41	representative autoradiographic images prepro ox mrna expression distribution lha2 area shown fig 4 treatment groups photomicrographs emulsion dipped slides showing prepro ox mrna expression individual cells shown fig 5 images demonstrate prepro ox mrna expressed cells different size number silver grains per cell individual prepro ox gene expressing cells emulsion dipped slides significantly p 0001 increased lha adx rats receiving cort replacement compared adx rats fig 6 amount orexin expression remarkably consistent given treatment 125 plus minus 4 grainscell adx group compared 187 plus minus 6 grainscell adx cort group significant difference number cells expressing prepro ox mrna adx 61 cells adxcort 67 cells counted selected fields view
0.17200397.15961555.html.plaintext.txt	42	representative autoradiographic images prepro ox mrna expression distribution lha2 area shown fig 4 treatment groups photomicrographs emulsion dipped slides showing prepro ox mrna expression individual cells shown fig 5 images demonstrate prepro ox mrna expressed cells different size number silver grains per cell individual prepro ox gene expressing cells emulsion dipped slides significantly p 0001 increased lha adx rats receiving cort replacement compared adx rats fig 6 amount orexin expression remarkably consistent given treatment 125 plus minus 4 grainscell adx group compared 187 plus minus 6 grainscell adx cort group significant difference number cells expressing prepro ox mrna adx 61 cells adxcort 67 cells counted selected fields view
0.17200397.15961555.html.plaintext.txt	43	view larger version 103k fig 4 representative autoradiographic images prepro ox mrna distribution lha2 adx cort replaced adx adx cort rats 12 microm brain coronal sections
0.17200397.15961555.html.plaintext.txt	44	view larger version 43k fig 5 photomicrographs emulsion dipped slides hybridized 35s labeled oligonucleotide probe complementary mrna prepro ox lha2 adx cort replaced adx adx cort rats lateral hypothalamic cells counterstained 01 methyl green 12 microm brain coronal sections
0.17200397.15961555.html.plaintext.txt	45	view larger version 19k fig 6 number prepro ox emulsion grains per cell lha rats 7 d adx surgery without cort replacement values mean plus minus sem n 7group eight nine cells counted per animal p 0001 compared adx group
0.17200397.15961555.html.plaintext.txt	46	effect diurnal variation orexin expression adrenalectomized rats glucocorticoid replacement plasma cort concentrations sham animals significantly higher p 0001 evening 111 plus minus 24 ngml compared morning 20 plus minus 8 ngml plasma cort morning evening adx groups limit detection 5 ngml cort replacement adx animals resulted similar morning 43 plus minus 12 ngml evening concentrations 36 plus minus 14 ngml significantly different morning concentrations sham group
0.17200397.15961555.html.plaintext.txt	47	effect diurnal variation orexin expression adrenalectomized rats glucocorticoid replacement plasma cort concentrations sham animals significantly higher p 0001 evening 111 plus minus 24 ngml compared morning 20 plus minus 8 ngml plasma cort morning evening adx groups limit detection 5 ngml cort replacement adx animals resulted similar morning 43 plus minus 12 ngml evening concentrations 36 plus minus 14 ngml significantly different morning concentrations sham group
0.17200397.15961555.html.plaintext.txt	48	adx effect morning levels prepro ox mrna lha1 whereas cort replacement regulated orexin mrna sham adx groups fig 3a consistent observation significant effect adx prepro ox mrna expression lha1 area morning evening fig 7 cort replacement significantly elevated prepro ox mrna levels morning compared sham adx groups increase observed evening fig 7
0.17200397.15961555.html.plaintext.txt	49	view larger version 35k fig 7 morning 0900 h evening 1800 h levels prepro ox mrna lha2 adx rats 7 d surgery without cort replacement values mean plus minus sem n 5 9group p 001 compared groups
0.17200397.15961555.html.plaintext.txt	50	effect lps stress prepro ox expression lps evoked 4 fold increase plasma cort concentrations 184 plus minus 44 ngml compared saline controls 49 plus minus 17 ngml significant 60 increase prepro ox mrna expression lha1 4 h lps injection compared saline injected rats fig 8
0.17200397.15961555.html.plaintext.txt	51	effect lps stress prepro ox expression lps evoked 4 fold increase plasma cort concentrations 184 plus minus 44 ngml compared saline controls 49 plus minus 17 ngml significant 60 increase prepro ox mrna expression lha1 4 h lps injection compared saline injected rats fig 8
0.17200397.15961555.html.plaintext.txt	52	view larger version 15k fig 8 levels prepro ox mrna lha1 4 h ip injection lps 250 microg mrna expressed percentage control group mean plus minus sem n 7group p 001 compared saline treated animals
0.17200397.15961555.html.plaintext.txt	53	discussion top abstract introduction materials methods results discussion references data reveal integrated relationship central orexin expression endogenous glucocorticoid concentrations feeding patterns rat observation central administration ox increases food intake agreement groups demonstrated ox stimulates feeding early light phase intact rats 2 37 38 demonstrate first time glucocorticoids exert important influence ox induced feeding behavior adx significantly reduces orexin induced feeding phenomenon reversible cort replacement physiological concentrations data provide evidence endogenous cort exert important influence ox induced food intake however adx completely block ox induced feeding results 60 reduction suggests pathway mediating orexin induced food intake independent glucocorticoids
0.17200397.15961555.html.plaintext.txt	54	discussion top abstract introduction materials methods results discussion references data reveal integrated relationship central orexin expression endogenous glucocorticoid concentrations feeding patterns rat observation central administration ox increases food intake agreement groups demonstrated ox stimulates feeding early light phase intact rats 2 37 38 demonstrate first time glucocorticoids exert important influence ox induced feeding behavior adx significantly reduces orexin induced feeding phenomenon reversible cort replacement physiological concentrations data provide evidence endogenous cort exert important influence ox induced food intake however adx completely block ox induced feeding results 60 reduction suggests pathway mediating orexin induced food intake independent glucocorticoids
0.17200397.15961555.html.plaintext.txt	55	one recent study investigated effect adx ox induced feeding 39 contrast findings investigators observed effect adx ox induced food intake 2 h period 39 may due suboptimal doses ox employed dose range 15 6 nmol compared 8 nmol present study latter dose considered optimal ox induced feeding behavior 2 findings may also result shorter period food intake studied maximum 2 h compared maximum 4 h study paper drazen et al 39 seems evident adx associated decreased food intake higher doses ox 2 h time point small increase food intake response ox sham rats permit adx effect reach significance larger dose orexin used elicited greater food intake sham rats compared observed drazen et al 39 consequently able observe significant reproducible decrease orexin induced food intake adx rats
0.17200397.15961555.html.plaintext.txt	56	one recent study investigated effect adx ox induced feeding 39 contrast findings investigators observed effect adx ox induced food intake 2 h period 39 may due suboptimal doses ox employed dose range 15 6 nmol compared 8 nmol present study latter dose considered optimal ox induced feeding behavior 2 findings may also result shorter period food intake studied maximum 2 h compared maximum 4 h study paper drazen et al 39 seems evident adx associated decreased food intake higher doses ox 2 h time point small increase food intake response ox sham rats permit adx effect reach significance larger dose orexin used elicited greater food intake sham rats compared observed drazen et al 39 consequently able observe significant reproducible decrease orexin induced food intake adx rats
0.17200397.15961555.html.plaintext.txt	57	initially experiment performed adx sham groups given orexin saline consequent observation significant decrease orexin induced food intake adx group repeated experiment expanded include low cort high cort replacement groups observations reproducible time points full study repeated 40 together ability physiological concentrations cort reverse effects adx orexin induced food intake increases confidence endogenous glucocorticoids exert physiologically relevant control orexin induced feeding behavior
0.17200397.15961555.html.plaintext.txt	58	initially experiment performed adx sham groups given orexin saline consequent observation significant decrease orexin induced food intake adx group repeated experiment expanded include low cort high cort replacement groups observations reproducible time points full study repeated 40 together ability physiological concentrations cort reverse effects adx orexin induced food intake increases confidence endogenous glucocorticoids exert physiologically relevant control orexin induced feeding behavior
0.17200397.15961555.html.plaintext.txt	59	observation orexin induced food intake decreased 60 adx rats evidence significant component eating behavior dependent endogenous cort known cort directly stimulate appetite 41 indirect effects appetite cort mediated hypothalamic neuropeptides well understood number mechanisms may invoked explain relationship among cort ox food intake cort may stimulate endogenous orexin expression action glucocorticoid receptors within lha intermediary nuclei may act via orexin peptide release within pvnarc areas hypothalamus cort may stimulate food intake consequent orexin activation hpa axis activity also possibility cort may exert effect food intake via peptides modulate appetite rather directly orexins well defined pathway glucocorticoid feedback crf expression pvn release median eminence 42 crf inhibits food intake therefore increased cort could increase food intake inhibitory action crf orexin induced feeding enhanced crf receptor antagonist suggesting crf involvement 43 neuropeptide y npy also possible mediator orexin induced feeding glucocorticoid manipulation results marked similarity orexin npy effects feeding adx reduced npy induced food intake 60 similar effects adx orexin induced feeding reversed cort replacement 44 npy potent known inducer food intake 45 orexin induced feeding blocked y1 receptor antagonist 46 therefore conceivable orexin exerts principal glucocorticoid dependent actions food intake npy direct effects cort npy orexin expression explains observations however observed 40 increase food intake response ox adx rats complete absence cort strong evidence glucocorticoid independent central pathway direct orexin induced food intake may mediated npy
0.17200397.15961555.html.plaintext.txt	60	observation orexin induced food intake decreased 60 adx rats evidence significant component eating behavior dependent endogenous cort known cort directly stimulate appetite 41 indirect effects appetite cort mediated hypothalamic neuropeptides well understood number mechanisms may invoked explain relationship among cort ox food intake cort may stimulate endogenous orexin expression action glucocorticoid receptors within lha intermediary nuclei may act via orexin peptide release within pvnarc areas hypothalamus cort may stimulate food intake consequent orexin activation hpa axis activity also possibility cort may exert effect food intake via peptides modulate appetite rather directly orexins well defined pathway glucocorticoid feedback crf expression pvn release median eminence 42 crf inhibits food intake therefore increased cort could increase food intake inhibitory action crf orexin induced feeding enhanced crf receptor antagonist suggesting crf involvement 43 neuropeptide y npy also possible mediator orexin induced feeding glucocorticoid manipulation results marked similarity orexin npy effects feeding adx reduced npy induced food intake 60 similar effects adx orexin induced feeding reversed cort replacement 44 npy potent known inducer food intake 45 orexin induced feeding blocked y1 receptor antagonist 46 therefore conceivable orexin exerts principal glucocorticoid dependent actions food intake npy direct effects cort npy orexin expression explains observations however observed 40 increase food intake response ox adx rats complete absence cort strong evidence glucocorticoid independent central pathway direct orexin induced food intake may mediated npy
0.17200397.15961555.html.plaintext.txt	61	situ hybridization histochemistry confirmed prepro orexin expression restricted lha extensions perifornical nucleus posterior hypothalamic areas agreement previously reported studies 37 novel finding distribution study prepro ox mrna expression measured coronal sequential sections running 1044 microm throughout lha shows considerable differences sections emphasizing importance consistent choice sections hybridization measuring prepro ox mrna lha treatment groups observation confirms need use anatomical markers ensure consistency sectioning samples
0.17200397.15961555.html.plaintext.txt	62	situ hybridization histochemistry confirmed prepro orexin expression restricted lha extensions perifornical nucleus posterior hypothalamic areas agreement previously reported studies 37 novel finding distribution study prepro ox mrna expression measured coronal sequential sections running 1044 microm throughout lha shows considerable differences sections emphasizing importance consistent choice sections hybridization measuring prepro ox mrna lha treatment groups observation confirms need use anatomical markers ensure consistency sectioning samples
0.17200397.15961555.html.plaintext.txt	63	observed regulation morning evening prepro ox mrna lha cort administration increased blood cort may regulate orexin expression large population glucocorticoid receptor positive cells within lha 47 48 emulsion staining established significant difference number cells expressing prepro ox treatment groups therefore increases prepro ox mrna observed response cort represent increased expression prepro ox within cells lha slight increase prepro ox mrna expression sham group evening compared morning although statistically significant plasma cort levels significantly increased evening compared morning sham animals agreement previous studies demonstrating diurnal variations hpa axis activity 49 however important note cort levels similar morning evening replacement groups significantly different morning levels sham animals possible increase evening prepro ox expression although statistically significant may consequence circadian increase endogenous circulating cort increase may sufficient mask stimulatory effects orexin expression exogenous cort investigations interrelationships circadian cycles hpa axis activity orexin expression undoubtedly shed light regulatory mechanisms controlling highly integrated modalities sleep wake patterns feeding behavior
0.17200397.15961555.html.plaintext.txt	64	observed regulation morning evening prepro ox mrna lha cort administration increased blood cort may regulate orexin expression large population glucocorticoid receptor positive cells within lha 47 48 emulsion staining established significant difference number cells expressing prepro ox treatment groups therefore increases prepro ox mrna observed response cort represent increased expression prepro ox within cells lha slight increase prepro ox mrna expression sham group evening compared morning although statistically significant plasma cort levels significantly increased evening compared morning sham animals agreement previous studies demonstrating diurnal variations hpa axis activity 49 however important note cort levels similar morning evening replacement groups significantly different morning levels sham animals possible increase evening prepro ox expression although statistically significant may consequence circadian increase endogenous circulating cort increase may sufficient mask stimulatory effects orexin expression exogenous cort investigations interrelationships circadian cycles hpa axis activity orexin expression undoubtedly shed light regulatory mechanisms controlling highly integrated modalities sleep wake patterns feeding behavior
0.17200397.15961555.html.plaintext.txt	65	found effect adx alone orexin expression lha suggests basal orexin expression rats tonic regulation endogenous glucocorticoids contrast decrease prepro ox mrna expression 5 d adx reported 50 however data hpa axis activity presented study difficult determine effectiveness adx surgery addition information sections sliced within lha given variability prepro ox expression observed throughout lha important choice section justified well defined decrease orexin expression adx reversed dexamethasone replacement 50 observation consistent data demonstrating cort regulation orexin expression sham animals decrease prepro ox mrna levels lha 10 d adx also reported phenomenon could reversed cort 39
0.17200397.15961555.html.plaintext.txt	66	found effect adx alone orexin expression lha suggests basal orexin expression rats tonic regulation endogenous glucocorticoids contrast decrease prepro ox mrna expression 5 d adx reported 50 however data hpa axis activity presented study difficult determine effectiveness adx surgery addition information sections sliced within lha given variability prepro ox expression observed throughout lha important choice section justified well defined decrease orexin expression adx reversed dexamethasone replacement 50 observation consistent data demonstrating cort regulation orexin expression sham animals decrease prepro ox mrna levels lha 10 d adx also reported phenomenon could reversed cort 39
0.17200397.15961555.html.plaintext.txt	67	discrepancies data published reports effects adx prepro ox mrna expression lha 39 50 lack agreement effects exogenous glucocorticoids may due methodological differences experiment used 7 d adx cort replacement compared previous studies using 5 d adx dexamethasone 50 10 d adx cort 39 instructive compare discrepancies literature npy expression adx although general consensus npy regulated glucocorticoids reports differ effects npy expression eliminating endogenous cortisosterone adx short term adx 4 d alter npy peptide levels arc pvn 51 whereas group observed long term adx 12 d deceased npy peptide levels areas 52 adx 7 d effect npy immunoreactivity hypothalamic areas one notable exception pvn 53 longer term adx 12 d effect prepro npy mrna arc 54 peptide levels measured study either dexamethasone cort replacement regulated npy mrna dexamethasone much potent 53 therefore effects glucocorticoid manipulation orexin expression npy may dependent period adx concentration type glucocorticoid whether orexin peptide mrna measured specifically defined hypothalamic site selected analysis
0.17200397.15961555.html.plaintext.txt	68	discrepancies data published reports effects adx prepro ox mrna expression lha 39 50 lack agreement effects exogenous glucocorticoids may due methodological differences experiment used 7 d adx cort replacement compared previous studies using 5 d adx dexamethasone 50 10 d adx cort 39 instructive compare discrepancies literature npy expression adx although general consensus npy regulated glucocorticoids reports differ effects npy expression eliminating endogenous cortisosterone adx short term adx 4 d alter npy peptide levels arc pvn 51 whereas group observed long term adx 12 d deceased npy peptide levels areas 52 adx 7 d effect npy immunoreactivity hypothalamic areas one notable exception pvn 53 longer term adx 12 d effect prepro npy mrna arc 54 peptide levels measured study either dexamethasone cort replacement regulated npy mrna dexamethasone much potent 53 therefore effects glucocorticoid manipulation orexin expression npy may dependent period adx concentration type glucocorticoid whether orexin peptide mrna measured specifically defined hypothalamic site selected analysis
0.17200397.15961555.html.plaintext.txt	69	finally demonstrated single injection lps immunological stressor regulate prepro ox mrna expression lha increases prepro ox mrna reported response stressors robustly stimulate hpa axis immobilization cold stress 23 hypoglycemia 24 present study expands repertoire stressors include immune mediated stress lps potent stimulator hpa axis activity subsequently cort release possible increase prepro ox mrna may result increasing blood cort concentrations work necessary elucidate whether increased orexin response lps direct result lps induced cort release indirectly response increased cytokines
0.17200397.15961555.html.plaintext.txt	70	finally demonstrated single injection lps immunological stressor regulate prepro ox mrna expression lha increases prepro ox mrna reported response stressors robustly stimulate hpa axis immobilization cold stress 23 hypoglycemia 24 present study expands repertoire stressors include immune mediated stress lps potent stimulator hpa axis activity subsequently cort release possible increase prepro ox mrna may result increasing blood cort concentrations work necessary elucidate whether increased orexin response lps direct result lps induced cort release indirectly response increased cytokines
0.17200397.15961555.html.plaintext.txt	71	may briefly speculate physiological importance increased orexin expression response immunological stimulus orexins demonstrated analgesic properties inflammatory induced hyperalgesia ox 1 receptor antagonist sb 334867 reduces ox mediated analgesia 55 suggests may hypothalamic mechanism involving orexin analgesic agent neurogenic pain also possible onset inflammation acute phase response lps plays crucial role important maintain homeostatic control peripheral release inflammatory cytokines increased secretion cort immunological stimulus activate hypothalamic components drive hpa axis activity including orexins
0.17200397.15961555.html.plaintext.txt	72	may briefly speculate physiological importance increased orexin expression response immunological stimulus orexins demonstrated analgesic properties inflammatory induced hyperalgesia ox 1 receptor antagonist sb 334867 reduces ox mediated analgesia 55 suggests may hypothalamic mechanism involving orexin analgesic agent neurogenic pain also possible onset inflammation acute phase response lps plays crucial role important maintain homeostatic control peripheral release inflammatory cytokines increased secretion cort immunological stimulus activate hypothalamic components drive hpa axis activity including orexins
0.17200397.15961555.html.plaintext.txt	73	conclusion data establish ox induced feeding prepro ox mrna expression sensitive glucocorticoid manipulation regulation prepro ox expression response cort may circadian related levels increased morning evening however studies required determine mechanisms underlying data observations highlight interdependence orexins hpa axis activity provide insights role glucocorticoids regulating centrally mediated orexin induced feeding orexin expression within brain
0.17200397.15961555.html.plaintext.txt	74	conclusion data establish ox induced feeding prepro ox mrna expression sensitive glucocorticoid manipulation regulation prepro ox expression response cort may circadian related levels increased morning evening however studies required determine mechanisms underlying data observations highlight interdependence orexins hpa axis activity provide insights role glucocorticoids regulating centrally mediated orexin induced feeding orexin expression within brain
0.17200397.15961555.html.plaintext.txt	75	footnotes work supported needham cooper trust uk glaxosmithkline neuroendocrine charitable trust uk phd studentship gkf
0.17200397.15961555.html.plaintext.txt	76	results work presented part 85th annual meeting endocrine society philadelphia pennsylvania june 2003 abstract p3 193
0.17200397.15961555.html.plaintext.txt	77	first published online june 16 2005
0.17200397.15961555.html.plaintext.txt	78	abbreviations adx adrenalectomized arc arcuate nucleus avp arginine vasopressin cns central nervous system cort corticosterone crf corticotropin releasing factor hpa hypothalamo pituitary adrenal icv intracerebroventricular lha lateral hypothalamic area lps lipopolysaccharide npy neuropeptide y ox orexin pvn paraventricular nucleus ssc saline sodium citrate
0.17200397.15961555.html.plaintext.txt	79	accepted publication june 6 2005
0.17200397.15961555.html.plaintext.txt	80	references top abstract introduction materials methods results discussion references willie jt chemelli rm sinton cm yanagisawa m 2001 eat sleep orexin regulation feeding wakefulness annu rev neurosci 24429 458crossrefmedline sakurai amemiya ishi m matsuzak chemell rm tanaka h williams sc richardson ja kozlowsk gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behaviour cell 92573 595crossrefmedline taheri bloom 2001 orexinshypocretins waking scientific world clin endocrinol oxf 54421 429crossrefmedline taylor mm samson wk 2003 side orexins endocrine metabolic actions j physiol endocrinol metab 284e13 e17 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dnc smith mi piper dc hunter aj porter ra upton n 1999 orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 9610911 10916abstractfree full text espana ra plahn berridge cw 2002 circadian dependent circadian independent behavioral actions hypocretinorexin brain res 94224 236crossref duxon ms stretton j starr k jones dnc holland v riley g jerman j brough smart d johns chan w porter ra upton n 2001 evidence orexin evoked grooming rat mediated orexin 1 ox1 receptors downstream 5 ht2c receptor involvement psychopharmacology berl 153203 209crossrefmedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text horvath tl peyron c diano ivanov aston jones g kilduff ts van den pol 1999 hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system j comp neurol 415145 15933co2 u 144crossrefmedline backberg m hervieu g wilson meister b 2002 orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15315 328crossrefmedline hervieu gj cluderay je harrison dc roberts jc leslie ra 2001 gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103777 797crossrefmedline trivedi p yu h macneil dj van der ploeg lh guan xm 1998 distribution orexin receptor mrna rat brain febs lett 43871 75crossrefmedline buckingham jc cowell m gillies ge herbison ae steel jh 1997 neuroendocrine system anatomy physiology responses stress buckingham jc cowell m gillies ge eds stress stress hormones immune system london john wiley sons 9 47 jaszberenyi m bujdoso e pataki telegdy g 2000 effects orexins hypothalamic pituitary adrenal system j neuroendocrinol 121174 1178crossrefmedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h 2000 centrally administered orexinhypocretin activates hpa axis rats neuroreport 111977 1980medline jones dnc gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n 2001 effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153210 218crossrefmedline russell sh small cj dakin cl abbott cr morgan dg ghatei ma bloom sr 2001 central effects orexin hypothalamic pituitary adrenal axis vivo vitro male rats j neuroendocrinol 13561 566crossrefmedline al barazanji ka wilson baker j jessop ds harbuz ms 2001 central orexin activates hypothalamic pituitary adrenal axis stimulates hypothalamic corticotropin releasing factor arginine vasopressin neurones conscious rats j neuroendocrinol 13421 424crossrefmedline samson wk taylor mm follwell m ferguson av 2002 orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 10497 103crossrefmedline brunton pj russell ja 2003 hypothalamic pituitary adrenal responses centrally administered orexin suppressed pregnant rats j neuroendocrinol 15633 637crossrefmedline ida nakahara k murakami hanada r nakazato m murakami n 2000 possible involvement orexin stress reaction rats biochem biophys res commun 270318 323crossrefmedline griffond b risold py jacquemard c colard c fellmann d 1999 insulin induced hypoglycemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 26277 80crossrefmedline kok sw roelfsema f overeem lammers gj strijers rl frolich m meinders ae pijl h 2002 dynamics pituitary adrenal ensemble hypocretin deficient narcoleptic humans blunted basal adrenocorticotropin release evidence normal time keeping master pacemaker j clin endocrinol metab 875085 5091abstractfree full text dallman mf strack akana sf bradbury mj hanson es scribner ka smith m 1993 feast famine critical role glucocorticoids insulin daily energy flow front neuroendocrinol 14303 347crossrefmedline dallman mf akana sf strack hanson es sebastian rj 1995 neural network regulates energy balance responsive glucocorticoids insulin also regulates hpa axis responsivity site proximal crf neurons ann ny acad sci 771730 742abstract taheri sunter d dakin c moyes seal l gardiner j rossi m ghatei bloom 2000 diurnal variation orexin immunoreactivity prepro orexin mrna rat central nervous system neurosci lett 279109 112crossrefmedline fujiki n yoshida y ripley b honda k mignot e nishino 2001 changes csf hypocretin 1 orexin levels rats across 24 hours response food deprivation neuroreport 12993 997crossrefmedline harbuz ms lightman sl 1992 stress hypothalamo pituitary adrenal axis acute chronic immunological activation j endocrinol 134327 329medline turnbull av rivier cl 1999 regulation hypothalamic pituitary adrenal axis cytokines actions mechanisms action physiol rev 791 71abstractfree full text jessop ds eckland dja todd k lightman sl 1989 osmotic regulation hypothalamo neurointermediate lobe corticotrophin releasing factor 41 rat j endocrinol 120119 124abstract harbuz ms jessop ds lightman sl chowdrey hs 1994 effects restraint hypertonic saline stress corticotrophin releasing factor arginine vasopressin proenkephalin mrnas cfy sprague dawley wistar strains rat brain res 6676 12crossrefmedline young 3rd ws mezey e siegel re 1986b quantitative situ hybridization histochemistry reveals increased levels corticotropin releasing factor mrna adrenalectomy rats neurosci lett 70198 203 harbuz ms lightman sl 1989 responses hypothalamic pituitary mrna physical psychological stress rat j endocrinol 12705 711 paxinos g watson c 1998 rat brain stereotaxic coordinates 4th ed london academic press edwards cmb abusnana sunter d murphy kg ghatei ma bloom sr 1999 effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 1607 12crossref haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr 1999 effects single chronic intracerebroventricular administration orexins feeding rat peptides 201099 1105crossrefmedline drazen dl coolen lm strader ad wortman md woods sc seeley rj 2004 differential effects adrenalectomy melanin concentrating hormone orexin endocrinology 1453404 3412abstractfree full text ford gk al barazanji ka wilson harbuz ms jessop ds 2002 effects glucocorticoid manipulation orexin induced food intake rats br j pharmacol proc suppl 135109p tataranni pa larson de snitker young jb flatt jp ravussin e 1996 effects glucocorticoids energy metabolism food intake humans j physiol 271e317 e325 dallman mf akana sf strack scribner ks pecoraro n la fleur se houshyar h gomez f 2004 chronic stress induced effects corticosterone brain direct indirect ann ny acad sci 1018141 150abstractfree full text ida nakahara k kuroiwa fukui k nakazato m murakami murakami n 2000 corticotropin releasing factor neuropeptide y involved effect orexin hypocretin food intake rats neurosci lett 293119 122crossrefmedline stanley bg lanthier d chin leibowitz sf 1989 suppression neuropeptide y elicited eating adrenalectomy hypophysectomy reversal corticosterone brain res 50132 36crossrefmedline kalra sp dube mg pu xu b horvath tl kalra ps 1999 interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 2068 100abstractfree full text jain mr horvath tl kalra ps kalra sp 2000 evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 8719 24crossrefmedline cintra zoli m rosen l agnati lf okret wikstrom ac gustaffsson ja fuxe k 1994 mapping computer assisted morphometry microdensitometry glucocorticoid receptor immunoreactive neurons glial cells rat central nervous system neuroscience 62843 897crossrefmedline morimoto m morita n ozawa h yokoyama k kawata m 1996 distribution glucocorticoid receptor immunoreactivity mrna rat brain immunohistochemical situ hybridization study neurosci res 26235 269crossrefmedline watts ag tanimura sanchez watts g 2004 corticotropin releasing hormone arginine vasopressin gene transcription hypothalamic paraventricular nucleus unstressed rats daily rhythms interactions corticosterone endocrinology 145529 540abstractfree full text stricker krongrad beck b 2002 modulation hypothalamic hypocretinorexin mrna expression glucocorticoids biochem biophys res commun 296129 133crossrefmedline rivet jm castagne v corder r gaillard r mormede p 1989 study influence stress adrenalectomy central peripheral neuropeptide y levels comparison catecholamines neuroendocrinology 50413 420medline pralong fp corder r gaillard rc 1993 effects chronic glucocorticoid excess adrenalectomy stress neuropeptide y individual rat hypothalamic nuclei neuropeptides 25223 231crossrefmedline akabayashi watanabe y wahlestedt c mcewen bs paez x leibowitz sf 1994 hypothalamic neuropeptide y gene expression receptor activity relation circulating corticosterone adrenalectomized rats brain res 665201 212crossrefmedline larsen p jessop d chowdrey h lightman mikkelsen j 1994 chronic administration glucocorticoids directly upregulates prepro neuropeptide y y1 receptor mrna levels arcuate nucleus rat j neuroendocrinol 6153 160medline bingham davey pt babbs aj irving ea sammons mj wyles m jeffrey p cutler l riba johns porter ra upton n hunter aj parsons aa 2001 orexin hypothalamic peptide analgesic properties pain 9281 90crossrefmedline article abstract full text pdf versions article 14693724 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles ford g k articles jessop d articles citing article pubmed pubmed citation articles ford g k articles jessop d
0.17200397.15961555.html.plaintext.txt	81	references top abstract introduction materials methods results discussion references willie jt chemelli rm sinton cm yanagisawa m 2001 eat sleep orexin regulation feeding wakefulness annu rev neurosci 24429 458crossrefmedline sakurai amemiya ishi m matsuzak chemell rm tanaka h williams sc richardson ja kozlowsk gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behaviour cell 92573 595crossrefmedline taheri bloom 2001 orexinshypocretins waking scientific world clin endocrinol oxf 54421 429crossrefmedline taylor mm samson wk 2003 side orexins endocrine metabolic actions j physiol endocrinol metab 284e13 e17 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dnc smith mi piper dc hunter aj porter ra upton n 1999 orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 9610911 10916abstractfree full text espana ra plahn berridge cw 2002 circadian dependent circadian independent behavioral actions hypocretinorexin brain res 94224 236crossref duxon ms stretton j starr k jones dnc holland v riley g jerman j brough smart d johns chan w porter ra upton n 2001 evidence orexin evoked grooming rat mediated orexin 1 ox1 receptors downstream 5 ht2c receptor involvement psychopharmacology berl 153203 209crossrefmedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text horvath tl peyron c diano ivanov aston jones g kilduff ts van den pol 1999 hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system j comp neurol 415145 15933co2 u 144crossrefmedline backberg m hervieu g wilson meister b 2002 orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15315 328crossrefmedline hervieu gj cluderay je harrison dc roberts jc leslie ra 2001 gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103777 797crossrefmedline trivedi p yu h macneil dj van der ploeg lh guan xm 1998 distribution orexin receptor mrna rat brain febs lett 43871 75crossrefmedline buckingham jc cowell m gillies ge herbison ae steel jh 1997 neuroendocrine system anatomy physiology responses stress buckingham jc cowell m gillies ge eds stress stress hormones immune system london john wiley sons 9 47 jaszberenyi m bujdoso e pataki telegdy g 2000 effects orexins hypothalamic pituitary adrenal system j neuroendocrinol 121174 1178crossrefmedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h 2000 centrally administered orexinhypocretin activates hpa axis rats neuroreport 111977 1980medline jones dnc gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n 2001 effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153210 218crossrefmedline russell sh small cj dakin cl abbott cr morgan dg ghatei ma bloom sr 2001 central effects orexin hypothalamic pituitary adrenal axis vivo vitro male rats j neuroendocrinol 13561 566crossrefmedline al barazanji ka wilson baker j jessop ds harbuz ms 2001 central orexin activates hypothalamic pituitary adrenal axis stimulates hypothalamic corticotropin releasing factor arginine vasopressin neurones conscious rats j neuroendocrinol 13421 424crossrefmedline samson wk taylor mm follwell m ferguson av 2002 orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 10497 103crossrefmedline brunton pj russell ja 2003 hypothalamic pituitary adrenal responses centrally administered orexin suppressed pregnant rats j neuroendocrinol 15633 637crossrefmedline ida nakahara k murakami hanada r nakazato m murakami n 2000 possible involvement orexin stress reaction rats biochem biophys res commun 270318 323crossrefmedline griffond b risold py jacquemard c colard c fellmann d 1999 insulin induced hypoglycemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 26277 80crossrefmedline kok sw roelfsema f overeem lammers gj strijers rl frolich m meinders ae pijl h 2002 dynamics pituitary adrenal ensemble hypocretin deficient narcoleptic humans blunted basal adrenocorticotropin release evidence normal time keeping master pacemaker j clin endocrinol metab 875085 5091abstractfree full text dallman mf strack akana sf bradbury mj hanson es scribner ka smith m 1993 feast famine critical role glucocorticoids insulin daily energy flow front neuroendocrinol 14303 347crossrefmedline dallman mf akana sf strack hanson es sebastian rj 1995 neural network regulates energy balance responsive glucocorticoids insulin also regulates hpa axis responsivity site proximal crf neurons ann ny acad sci 771730 742abstract taheri sunter d dakin c moyes seal l gardiner j rossi m ghatei bloom 2000 diurnal variation orexin immunoreactivity prepro orexin mrna rat central nervous system neurosci lett 279109 112crossrefmedline fujiki n yoshida y ripley b honda k mignot e nishino 2001 changes csf hypocretin 1 orexin levels rats across 24 hours response food deprivation neuroreport 12993 997crossrefmedline harbuz ms lightman sl 1992 stress hypothalamo pituitary adrenal axis acute chronic immunological activation j endocrinol 134327 329medline turnbull av rivier cl 1999 regulation hypothalamic pituitary adrenal axis cytokines actions mechanisms action physiol rev 791 71abstractfree full text jessop ds eckland dja todd k lightman sl 1989 osmotic regulation hypothalamo neurointermediate lobe corticotrophin releasing factor 41 rat j endocrinol 120119 124abstract harbuz ms jessop ds lightman sl chowdrey hs 1994 effects restraint hypertonic saline stress corticotrophin releasing factor arginine vasopressin proenkephalin mrnas cfy sprague dawley wistar strains rat brain res 6676 12crossrefmedline young 3rd ws mezey e siegel re 1986b quantitative situ hybridization histochemistry reveals increased levels corticotropin releasing factor mrna adrenalectomy rats neurosci lett 70198 203 harbuz ms lightman sl 1989 responses hypothalamic pituitary mrna physical psychological stress rat j endocrinol 12705 711 paxinos g watson c 1998 rat brain stereotaxic coordinates 4th ed london academic press edwards cmb abusnana sunter d murphy kg ghatei ma bloom sr 1999 effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 1607 12crossref haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr 1999 effects single chronic intracerebroventricular administration orexins feeding rat peptides 201099 1105crossrefmedline drazen dl coolen lm strader ad wortman md woods sc seeley rj 2004 differential effects adrenalectomy melanin concentrating hormone orexin endocrinology 1453404 3412abstractfree full text ford gk al barazanji ka wilson harbuz ms jessop ds 2002 effects glucocorticoid manipulation orexin induced food intake rats br j pharmacol proc suppl 135109p tataranni pa larson de snitker young jb flatt jp ravussin e 1996 effects glucocorticoids energy metabolism food intake humans j physiol 271e317 e325 dallman mf akana sf strack scribner ks pecoraro n la fleur se houshyar h gomez f 2004 chronic stress induced effects corticosterone brain direct indirect ann ny acad sci 1018141 150abstractfree full text ida nakahara k kuroiwa fukui k nakazato m murakami murakami n 2000 corticotropin releasing factor neuropeptide y involved effect orexin hypocretin food intake rats neurosci lett 293119 122crossrefmedline stanley bg lanthier d chin leibowitz sf 1989 suppression neuropeptide y elicited eating adrenalectomy hypophysectomy reversal corticosterone brain res 50132 36crossrefmedline kalra sp dube mg pu xu b horvath tl kalra ps 1999 interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 2068 100abstractfree full text jain mr horvath tl kalra ps kalra sp 2000 evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 8719 24crossrefmedline cintra zoli m rosen l agnati lf okret wikstrom ac gustaffsson ja fuxe k 1994 mapping computer assisted morphometry microdensitometry glucocorticoid receptor immunoreactive neurons glial cells rat central nervous system neuroscience 62843 897crossrefmedline morimoto m morita n ozawa h yokoyama k kawata m 1996 distribution glucocorticoid receptor immunoreactivity mrna rat brain immunohistochemical situ hybridization study neurosci res 26235 269crossrefmedline watts ag tanimura sanchez watts g 2004 corticotropin releasing hormone arginine vasopressin gene transcription hypothalamic paraventricular nucleus unstressed rats daily rhythms interactions corticosterone endocrinology 145529 540abstractfree full text stricker krongrad beck b 2002 modulation hypothalamic hypocretinorexin mrna expression glucocorticoids biochem biophys res commun 296129 133crossrefmedline rivet jm castagne v corder r gaillard r mormede p 1989 study influence stress adrenalectomy central peripheral neuropeptide y levels comparison catecholamines neuroendocrinology 50413 420medline pralong fp corder r gaillard rc 1993 effects chronic glucocorticoid excess adrenalectomy stress neuropeptide y individual rat hypothalamic nuclei neuropeptides 25223 231crossrefmedline akabayashi watanabe y wahlestedt c mcewen bs paez x leibowitz sf 1994 hypothalamic neuropeptide y gene expression receptor activity relation circulating corticosterone adrenalectomized rats brain res 665201 212crossrefmedline larsen p jessop d chowdrey h lightman mikkelsen j 1994 chronic administration glucocorticoids directly upregulates prepro neuropeptide y y1 receptor mrna levels arcuate nucleus rat j neuroendocrinol 6153 160medline bingham davey pt babbs aj irving ea sammons mj wyles m jeffrey p cutler l riba johns porter ra upton n hunter aj parsons aa 2001 orexin hypothalamic peptide analgesic properties pain 9281 90crossrefmedline article abstract full text pdf versions article 14693724 recent author manuscript pdf purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles ford g k articles jessop d articles citing article pubmed pubmed citation articles ford g k articles jessop d
0.17200397.15961555.html.plaintext.txt	82	home help feedback subscriptions archive search table contents endocrinology endocrine reviews j clin end metab molecular endocrinology recent prog horm res endocrine journals
0.18602495.16160021.html.plaintext.txt	0	shared genetic risk factors obstructive sleep apnea obesity sanjay r patel
0.18602495.16160021.html.plaintext.txt	1	division sleep medicine brigham women hospital boston massachusetts
0.18602495.16160021.html.plaintext.txt	2	abstract top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references obesity obstructive sleep apnea osa complex disorders multiple risk factors interact complicated fashion determine overall phenotype addition environmental risk factors disorder strong genetic basis likely due summation small moderate effects large number genetic loci obesity strong risk factor sleep apnea data suggest sleep apnea may influence obesity therefore surprising many susceptibility genes obesity osa shared current research suggests approximately half genetic variance apnea hypopnea index shared obesity phenotypes genetic polymorphisms increase weight also risk factors apnea addition given interrelated pathways regulating weight intermediate phenotypes sleep apnea ventilatory control upper airway muscle function sleep characteristics likely genes pleiotropic effects independently impacting obesity osa traits genetic loci likely interact obesity influence development osa gene environment type effect conversely environmental stressors intermittent hypoxia sleep fragmentation produced osa may interact obesity susceptibility genes modulate importance loci defining obesity related traits
0.18602495.16160021.html.plaintext.txt	3	susceptibility genes pleiotropy gene x environment effects
0.18602495.16160021.html.plaintext.txt	4	obstructive sleep apnea osa disorder characterized repetitive collapse upper airway sleep one common respiratory disorders estimated prevalence 24 9 among middle aged american men women respectively 92 obesity modern western society also extremely common 2002 nearly one third us adults met clinical criteria obesity prevalence appears increasing 27
0.18602495.16160021.html.plaintext.txt	5	obstructive sleep apnea osa disorder characterized repetitive collapse upper airway sleep one common respiratory disorders estimated prevalence 24 9 among middle aged american men women respectively 92 obesity modern western society also extremely common 2002 nearly one third us adults met clinical criteria obesity prevalence appears increasing 27
0.18602495.16160021.html.plaintext.txt	6	obesity osa often colocalize surprise perhaps male gender obesity strongest risk factor development osa relative stable weight 10 increase weight 4 yr associated sixfold increase risk developing moderate severe osa 58 weight loss trials found significant reductions apnea severity moderate weight loss 69 74 however mechanisms obesity causes osa completely defined many potential pathways hypothesized 93 perhaps obvious fat deposition neck airway lumen may lead increased collapsibility upper airway addition adiposity chest abdomen may result reductions lung volumes recent studies suggest reduced lung volume may independently predispose upper airway collapse 37 another possible mechanism relating obesity sleep apnea via hormonal effects adipose tissue leptin hormone produced adipose tissue important effects weight regulation stimulating hypothalamic satiety centers 6 34 57 human obesity typically associated elevated leptin levels suggesting state leptin resistance 15 besides regulating weight leptin may important effects ventilatory drive leptin deficient mice hypoventilate blunted response hypercapnia 53 84 administration leptin corrects abnormalities independent changes weight 53 effects ventilatory control elevated leptin levels underlying leptin resistant state may play pathogenic role development osa
0.18602495.16160021.html.plaintext.txt	7	obesity osa often colocalize surprise perhaps male gender obesity strongest risk factor development osa relative stable weight 10 increase weight 4 yr associated sixfold increase risk developing moderate severe osa 58 weight loss trials found significant reductions apnea severity moderate weight loss 69 74 however mechanisms obesity causes osa completely defined many potential pathways hypothesized 93 perhaps obvious fat deposition neck airway lumen may lead increased collapsibility upper airway addition adiposity chest abdomen may result reductions lung volumes recent studies suggest reduced lung volume may independently predispose upper airway collapse 37 another possible mechanism relating obesity sleep apnea via hormonal effects adipose tissue leptin hormone produced adipose tissue important effects weight regulation stimulating hypothalamic satiety centers 6 34 57 human obesity typically associated elevated leptin levels suggesting state leptin resistance 15 besides regulating weight leptin may important effects ventilatory drive leptin deficient mice hypoventilate blunted response hypercapnia 53 84 administration leptin corrects abnormalities independent changes weight 53 effects ventilatory control elevated leptin levels underlying leptin resistant state may play pathogenic role development osa
0.18602495.16160021.html.plaintext.txt	8	also possible osa may play causal role development obesity osa patients elevated leptin levels compared weight matched controls osa treatment lowers levels 39 53 55 findings suggest osa may cause leptin resistance thus propensity weight gain sleep disruption common result osa reduce serum leptin levels also increases levels appetite stimulating hormone ghrelin 76 82 findings associated increases hunger appetite scores 76 epidemiological studies consistently implicate reduced sleep risk factor development obesity 36 47 70 82 87 89 although overall weight appear fall treatment osa one study find amount fat inside abdominal cavity visceral fat diminishes 10 fat compartment appears unique hormonal effects amount visceral adipose tissue strongly associated metabolic complications obesity insulin resistance dyslipidemia measures subcutaneous fat overall obesity 28 29
0.18602495.16160021.html.plaintext.txt	9	also possible osa may play causal role development obesity osa patients elevated leptin levels compared weight matched controls osa treatment lowers levels 39 53 55 findings suggest osa may cause leptin resistance thus propensity weight gain sleep disruption common result osa reduce serum leptin levels also increases levels appetite stimulating hormone ghrelin 76 82 findings associated increases hunger appetite scores 76 epidemiological studies consistently implicate reduced sleep risk factor development obesity 36 47 70 82 87 89 although overall weight appear fall treatment osa one study find amount fat inside abdominal cavity visceral fat diminishes 10 fat compartment appears unique hormonal effects amount visceral adipose tissue strongly associated metabolic complications obesity insulin resistance dyslipidemia measures subcutaneous fat overall obesity 28 29
0.18602495.16160021.html.plaintext.txt	10	familial aggregation obesity sleep apnea top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references obesity large part genetically determined known almost three decades 26 large twin study estimated heritability weight 78 79 say 78 variability weight across population explained shared intrafamilial factors subsequent studies demonstrated adopted children body size closely resembling biological parents adopted parents 80 studies finland united kingdom estimated heritability body mass index bmi 60 80 42 61 linkage obesity related phenotypes investigated 50 genomewide scans date dozens candidate loci genes identified 3 59
0.18602495.16160021.html.plaintext.txt	11	similarly familial factors known influence osa risk nearly 25 years 77 since several groups quantified familial risk osa studying widely different populations studies identified strong heritable component osa 30 32 49 62 66 family based studies suggest risk osa approximately twice great among relatives apneic persons 30 66 addition dose response relationship exists risk osa increases increasing number apneic relatives 66 quantitative apnea related phenotypes also demonstrate substantial heritability study elderly twins found heritability respiratory disturbance index oxygen desaturation index nearly 40 7
0.18602495.16160021.html.plaintext.txt	12	similarly familial factors known influence osa risk nearly 25 years 77 since several groups quantified familial risk osa studying widely different populations studies identified strong heritable component osa 30 32 49 62 66 family based studies suggest risk osa approximately twice great among relatives apneic persons 30 66 addition dose response relationship exists risk osa increases increasing number apneic relatives 66 quantitative apnea related phenotypes also demonstrate substantial heritability study elderly twins found heritability respiratory disturbance index oxygen desaturation index nearly 40 7
0.18602495.16160021.html.plaintext.txt	13	shared susceptibility genes top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references given strong genetic components obesity apnea phenotypes well tight association multiple interweaving links two diseases would surprising exist common susceptibility genes obesity osa fact suggested familial aggregation osa may simply reflection found obesity clearly case even controlling bmi significant familial aggregation osa persists 32 66 furthermore study nonobese apneic patients also demonstrated strong heritability osa 49 case surprise given pathophysiological pathways apnea development craniofacial structure ventilatory control also demonstrated heritable component 13 32 49 63 65 thus susceptibility genes osa exclusively genes modulating obesity mean however overlap exists
0.18602495.16160021.html.plaintext.txt	14	clearly given strong effect obesity osa pathogenesis genetic variant predisposes obesity secondarily also lead development osa thus obesity gene might also considered apnea gene however obesity monolithic process clearly forms obesity important role pathogenesis sleep apnea example fat deposition neck much important fat deposition limbs 17 android fat deposition pattern excess subcutaneous truncal abdominal fat visceral adiposity also found closely predict osa overall obesity 31 72 therefore genetic polymorphisms influence fat deposition sites important osa genes wealth evidence fat distribution pattern phenotypes genetically driven large differences patterns fat deposition exist across inbred strains cattle suggesting important role genetics 83 among humans even correction overall obesity measures fat deposition pattern aggregate within families ratio subscapular skinfold thickness subscapular plus suprailiac thicknesses measure android fat pattern reported heritability 43 71 measures central obesity bmi adjusted waist circumference ratio trunk extremity skinfold ratio heritabilities 29 48 40 findings strongly support hypothesis genetic polymorphisms specifically promote fat deposition subcutaneous regions torso around abdominal viscera mechanism variants would promote development obesity osa
0.18602495.16160021.html.plaintext.txt	15	clearly given strong effect obesity osa pathogenesis genetic variant predisposes obesity secondarily also lead development osa thus obesity gene might also considered apnea gene however obesity monolithic process clearly forms obesity important role pathogenesis sleep apnea example fat deposition neck much important fat deposition limbs 17 android fat deposition pattern excess subcutaneous truncal abdominal fat visceral adiposity also found closely predict osa overall obesity 31 72 therefore genetic polymorphisms influence fat deposition sites important osa genes wealth evidence fat distribution pattern phenotypes genetically driven large differences patterns fat deposition exist across inbred strains cattle suggesting important role genetics 83 among humans even correction overall obesity measures fat deposition pattern aggregate within families ratio subscapular skinfold thickness subscapular plus suprailiac thicknesses measure android fat pattern reported heritability 43 71 measures central obesity bmi adjusted waist circumference ratio trunk extremity skinfold ratio heritabilities 29 48 40 findings strongly support hypothesis genetic polymorphisms specifically promote fat deposition subcutaneous regions torso around abdominal viscera mechanism variants would promote development obesity osa
0.18602495.16160021.html.plaintext.txt	16	another type potential genetic interaction obesity osa one particular polymorphism leads obesity osa independent mechanisms fig 1 example impacting leptin function genetic polymorphism may reduce satiety also increase ventilatory instability referred genetic pleiotropy pleiotropic genetic effects clearly described situations well known example apoe locus codes apolipoprotein e 4 allele apoe important risk factor atherosclerotic heart disease well alzheimer dementia 24 91 circadian regulatory gene clock also appears influence multiple biological systems clock knockout mice profound disruptions circadian rhythmicity surprising animals would abnormal timings feeding activity 88 addition however mutant animals demonstrate overall increase caloric intake associated phenotype obesity metabolic syndrome 85 similarly given large number neurological metabolic mechanical overlaps obesity osa likely polymorphism affecting one biochemical system may affect risk disorders via multiple paths example disruptions orexin system could potentially result common link obesity osa orexinergic neurons lateral hypothalamus play important role sustaining wakefulness projections wake promoting areas brain 21 loss neurons associated narcolepsy phenotype 60 neurons name orexin implies also play important role stimulating appetite projecting arcuate nucleus hypothalamus 68 thus mutations affecting orexin orexin receptor proteins involved downstream signaling orexin binding might simultaneously affect metabolic sleep related function several potential candidate genes listed table 1
0.18602495.16160021.html.plaintext.txt	17	view larger version 13k fig 1 obesity sleep apnea heavily influenced underlying genotype susceptibility genes act directly one phenotype causal relationships obesity sleep apnea indirect effects loci pleiotropic effects impacting susceptibility obesity sleep apnea via independent mechanisms
0.18602495.16160021.html.plaintext.txt	18	view table table 1 candidate genes might link genetic mechanisms obesity sleep apnea either pleiotropy gene x environment interactions
0.18602495.16160021.html.plaintext.txt	19	recently reported linkage scans cleveland family study represent first genomewide linkage studies osa phenotypes 54 55 results provide insight possible genetic overlaps obesity osa linkage apnea hypopnea index ahi measure osa bmi measure obesity tested across autosomal chromosomes caucasian african american cohort heritability ahi groups 33 whereas heritability bmi 50 controlling bmi significant heritability ahi remained supporting notion genetic susceptibility osa completely defined weight multivariate modeling larger subset cleveland family study obesity measures bmi serum leptin explained 50 55 genetic variance ahi 56 suggests half genetic determinants ahi obesity related half obesity independent
0.18602495.16160021.html.plaintext.txt	20	recently reported linkage scans cleveland family study represent first genomewide linkage studies osa phenotypes 54 55 results provide insight possible genetic overlaps obesity osa linkage apnea hypopnea index ahi measure osa bmi measure obesity tested across autosomal chromosomes caucasian african american cohort heritability ahi groups 33 whereas heritability bmi 50 controlling bmi significant heritability ahi remained supporting notion genetic susceptibility osa completely defined weight multivariate modeling larger subset cleveland family study obesity measures bmi serum leptin explained 50 55 genetic variance ahi 56 suggests half genetic determinants ahi obesity related half obesity independent
0.18602495.16160021.html.plaintext.txt	21	linkage findings described logarithmic odds lod score measure odds ratio linkage linkage although none linkage findings either racial group achieved genomewide significance lod 33 46 several regions intermediate lod scores indicative possible linkage setting complex multifactorial diseases obesity osa 90 furthermore change linkage evidence ahi adjustment bmi provides insight mechanisms action susceptibility locus present among caucasians lod score 14 found ahi 17 bmi chromosome 12p 54 adjustment bmi maximal lod ahi region dropped 04 whereas lod bmi adjusted ahi fell 02 data suggest susceptibility gene ahi exists region likely mediates effect apnea via obesity hand maximal lod ahi 14 found 19q linkage evidence bmi region 54 adjustment bmi effect ahi lod suggesting susceptibility gene region exerts effect ahi obesity independent mechanisms
0.18602495.16160021.html.plaintext.txt	22	linkage findings described logarithmic odds lod score measure odds ratio linkage linkage although none linkage findings either racial group achieved genomewide significance lod 33 46 several regions intermediate lod scores indicative possible linkage setting complex multifactorial diseases obesity osa 90 furthermore change linkage evidence ahi adjustment bmi provides insight mechanisms action susceptibility locus present among caucasians lod score 14 found ahi 17 bmi chromosome 12p 54 adjustment bmi maximal lod ahi region dropped 04 whereas lod bmi adjusted ahi fell 02 data suggest susceptibility gene ahi exists region likely mediates effect apnea via obesity hand maximal lod ahi 14 found 19q linkage evidence bmi region 54 adjustment bmi effect ahi lod suggesting susceptibility gene region exerts effect ahi obesity independent mechanisms
0.18602495.16160021.html.plaintext.txt	23	different pattern linkage findings found short arm chromosome 2 among caucasians maximal lod ahi 16 bmi 31 region suggesting susceptibility locus phenotypes might exist region 54 however adjustment bmi dropped lod ahi 13 suggesting obesity effect locus fully explain apnea effect may represent two independent loci one influencing ahi one bmi another possibility one locus 2p regulating ahi bmi via independent mechanisms strong candidate gene phenotypes region proopiomelanocortin pomc pomc locus found 2p233 encodes number hormones including melanocyte stimulating hormone msh pomc neurons arcuate nucleus hypothalamus important energy homeostasis via msh leptin anorexic activity mediated via depolarization neurons use msh agonist decreases body fat leptin levels humans 16 25 obesity phenotypes consistently linked pomc locus 14 33 38 67 haplotypes gene associated leptin levels 38 50 severe mutations gene produce severe childhood obesity phenotype 44 leptin effects ventilatory drive mouse models also mediated via msh suggesting pathway may independently predispose apnea well 64
0.18602495.16160021.html.plaintext.txt	24	different pattern linkage findings found short arm chromosome 2 among caucasians maximal lod ahi 16 bmi 31 region suggesting susceptibility locus phenotypes might exist region 54 however adjustment bmi dropped lod ahi 13 suggesting obesity effect locus fully explain apnea effect may represent two independent loci one influencing ahi one bmi another possibility one locus 2p regulating ahi bmi via independent mechanisms strong candidate gene phenotypes region proopiomelanocortin pomc pomc locus found 2p233 encodes number hormones including melanocyte stimulating hormone msh pomc neurons arcuate nucleus hypothalamus important energy homeostasis via msh leptin anorexic activity mediated via depolarization neurons use msh agonist decreases body fat leptin levels humans 16 25 obesity phenotypes consistently linked pomc locus 14 33 38 67 haplotypes gene associated leptin levels 38 50 severe mutations gene produce severe childhood obesity phenotype 44 leptin effects ventilatory drive mouse models also mediated via msh suggesting pathway may independently predispose apnea well 64
0.18602495.16160021.html.plaintext.txt	25	evidence pleiotropy also exists chromosome 8q among african americans cleveland family study peak lod scores 13 16 ahi bmi respectively 55 controlling bmi ahi lod dropped 11 suggesting obesity apnea promoting effects region independent potential candidate locus region coh1 gene 8q22 23 gene encodes transmembrane protein presumed role vesicle mediated sorting intracellular protein transport basis structure 43 severe mutations gene associated cohen syndrome autosomal recessive condition characterized truncal obesity 9 findings include facial dysmorphism mental retardation ocular anomalies craniofacial abnormalities include microcephaly facial hypotonia laryngomalacia could predispose osa thus mutations gene milder common may play role via separate pathways contributing nonsyndromic forms obesity osa
0.18602495.16160021.html.plaintext.txt	26	evidence pleiotropy also exists chromosome 8q among african americans cleveland family study peak lod scores 13 16 ahi bmi respectively 55 controlling bmi ahi lod dropped 11 suggesting obesity apnea promoting effects region independent potential candidate locus region coh1 gene 8q22 23 gene encodes transmembrane protein presumed role vesicle mediated sorting intracellular protein transport basis structure 43 severe mutations gene associated cohen syndrome autosomal recessive condition characterized truncal obesity 9 findings include facial dysmorphism mental retardation ocular anomalies craniofacial abnormalities include microcephaly facial hypotonia laryngomalacia could predispose osa thus mutations gene milder common may play role via separate pathways contributing nonsyndromic forms obesity osa
0.18602495.16160021.html.plaintext.txt	27	serotoninergic system another common pathway could link obesity osa serotonin important effects stimulation satiety centers arcuate nucleus 5 addition serotonin potentiates hypoglossal neural output increases upper airway dilator muscle activity 45 75 thus reductions serotoninergic activity increasing appetite could promote obesity lowering muscle tone upper airway could promote osa linkage haplotype association studies finnish population suggest serotonin related gene xq24 associated obesity 51 81 slc6a14 gene encodes sodium chloride dependent transporter neutral cationic amino acids appears play important role transport tryptophan precursor serotonin central nervous system 73 french study confirmed association polymorphism obesity association hunger satiety scores also found 19 whether polymorphism associated osa via independent obesity effects yet studied osa linkage scans reported thus far included sex chromosomes
0.18602495.16160021.html.plaintext.txt	28	serotoninergic system another common pathway could link obesity osa serotonin important effects stimulation satiety centers arcuate nucleus 5 addition serotonin potentiates hypoglossal neural output increases upper airway dilator muscle activity 45 75 thus reductions serotoninergic activity increasing appetite could promote obesity lowering muscle tone upper airway could promote osa linkage haplotype association studies finnish population suggest serotonin related gene xq24 associated obesity 51 81 slc6a14 gene encodes sodium chloride dependent transporter neutral cationic amino acids appears play important role transport tryptophan precursor serotonin central nervous system 73 french study confirmed association polymorphism obesity association hunger satiety scores also found 19 whether polymorphism associated osa via independent obesity effects yet studied osa linkage scans reported thus far included sex chromosomes
0.18602495.16160021.html.plaintext.txt	29	gene x environment interaction top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references another potential method genetic interaction obesity osa form gene environment effect adverse effects obesity osa thought environmental stressors fig 2 methods obesity predisposes osa influenced individual underlying genetic susceptibility increase fat deposition around upper airway likely produce apnea individuals lower ability respond stressor due reduced upper airway dilator muscle tone conversely obesogenic effects osa may influenced underlying genetic milieu genetic polymorphisms may modulate effect exposure sleep fragmentation osa leptin ghrelin dynamics polymorphisms might influence effect hormonal perturbations producing weight gain
0.18602495.16160021.html.plaintext.txt	30	view larger version 24k fig 2 sleep apnea susceptibility genes may interact obesity numerous mechanisms influence sleep apnea predisposition genetic polymorphisms may modulate degree obesity alters ventilatory drive reduces lung volume narrows upper airway polymorphisms may affect degree stresses result development sleep apnea similarly obesity susceptibility genes may interact sleep apnea potential effect obesity
0.18602495.16160021.html.plaintext.txt	31	peroxisome proliferator activated receptor pparg gene located chromosome 3p25 encodes protein key component nuclear transcription factor important adipocyte differentiation 4 variants gene implicated risk factors development obesity 4 18 20 48 86 hypoxia known suppress pparg gene transcription 94 95 importance mild defect pparg function may become magnified setting recurrent exposure hypoxia osa thus pparg allelic variants may play much important role determining obesity phenotypes individuals osa osa may play much important role promoting weight gain among mutation pparg
0.18602495.16160021.html.plaintext.txt	32	peroxisome proliferator activated receptor pparg gene located chromosome 3p25 encodes protein key component nuclear transcription factor important adipocyte differentiation 4 variants gene implicated risk factors development obesity 4 18 20 48 86 hypoxia known suppress pparg gene transcription 94 95 importance mild defect pparg function may become magnified setting recurrent exposure hypoxia osa thus pparg allelic variants may play much important role determining obesity phenotypes individuals osa osa may play much important role promoting weight gain among mutation pparg
0.18602495.16160021.html.plaintext.txt	33	similarly effects uncoupling protein 1 ucp1 ucp2 two obesity candidate genes may influenced osa genes encode uncoupling proteins mitochondrial proton channels divert energy atp synthesis thermogenesis 2 activation increases energy consumption polymorphisms genes associated obesity phenotypes 8 12 22 23 52 interestingly sleep deprivation rodent models shown increase expression ucp1 ucp2 11 41 suggesting sleep disruption osa may influence expression genes thus relative importance variant loci determining obesity risk
0.18602495.16160021.html.plaintext.txt	34	similarly effects uncoupling protein 1 ucp1 ucp2 two obesity candidate genes may influenced osa genes encode uncoupling proteins mitochondrial proton channels divert energy atp synthesis thermogenesis 2 activation increases energy consumption polymorphisms genes associated obesity phenotypes 8 12 22 23 52 interestingly sleep deprivation rodent models shown increase expression ucp1 ucp2 11 41 suggesting sleep disruption osa may influence expression genes thus relative importance variant loci determining obesity risk
0.18602495.16160021.html.plaintext.txt	35	future directions top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references appear multiple causal pathways linking obesity sleep apnea although obesity clearly strong risk factor osa research needed better define potential risk osa carries promoting weight gain diseases also clearly strong genetic basis although work begun identify specific genetic polymorphisms confer risk development disorders clearly much needs accomplished arena recent workshop sponsored american thoracic society laid recommendations future research aimed dissecting genetic bases sleep disordered breathing 78 chief objective development novel phenotypes including biomarkers closely reflect one molecular pathways rather overarching syndrome defined ahi simpler phenotypes could amenable genetic analysis fewer sources variance global measure apnea holds true obesity research use specific phenotypes fat deposition patterns would provide better insight molecular mechanisms underlying obesity also better understanding obesity osa interrelate
0.18602495.16160021.html.plaintext.txt	36	use dense single nucleotide polymorphism maps allow better resolution linkage findings narrow candidate loci better understanding neurobiology molecular pathways underlying obesity sleep apnea also allow rational selection candidate genes test association disorders ultimately use gene knockout animal models important establish causality identified associations performing genetic studies important simultaneously consider disorders given close relationship methodology conducting bivariate linkage scans already developed evidence suggest strategy powerful traditional univariate approaches 1 many genetic variants influence development osa causing obesity vice versa likely also variants pleiotropic effects predisposing obesity osa via independent mechanisms identifying genes understanding function provide novel insights shared pathogenesis diseases finally possibility genetic polymorphisms may affect susceptibility disease confers toward ignored incorporating model gene x environment interaction future study designs along understanding effects obesity osa allow better delineation osa susceptibility genes vice versa similarly use model along information genetics obesity would allow complete understanding osa may impact obesity
0.18602495.16160021.html.plaintext.txt	37	use dense single nucleotide polymorphism maps allow better resolution linkage findings narrow candidate loci better understanding neurobiology molecular pathways underlying obesity sleep apnea also allow rational selection candidate genes test association disorders ultimately use gene knockout animal models important establish causality identified associations performing genetic studies important simultaneously consider disorders given close relationship methodology conducting bivariate linkage scans already developed evidence suggest strategy powerful traditional univariate approaches 1 many genetic variants influence development osa causing obesity vice versa likely also variants pleiotropic effects predisposing obesity osa via independent mechanisms identifying genes understanding function provide novel insights shared pathogenesis diseases finally possibility genetic polymorphisms may affect susceptibility disease confers toward ignored incorporating model gene x environment interaction future study designs along understanding effects obesity osa allow better delineation osa susceptibility genes vice versa similarly use model along information genetics obesity would allow complete understanding osa may impact obesity
0.18602495.16160021.html.plaintext.txt	38	grants top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references research support provided american heart association scientist development grant national heart lung blood institute grant hl 60292
0.18602495.16160021.html.plaintext.txt	39	footnotes address reprint requests correspondence r patel bwh sleep disorders program bidmc brigham women hospital 75 francis st boston ma 02115 e mail spatelatpartnersorg u d
0.18602495.16160021.html.plaintext.txt	40	references top abstract familial aggregation obesity shared susceptibility genes gene x environment interaction future directions grants references almasy l dyer td blangero j bivariate quantitative trait linkage analysis pleiotropy versus co incident linkages genet epidemiol 14 953 958 199733co2 e 2198 2002abstractfree full text bell cg walley aj froguel p genetics human obesity nat rev gen 6 221 234 2005isimedline berger j moller de mechanisms action ppars annu rev med 53 409 435 2002crossrefisimedline blundell je goodson halford jc regulation appetite role leptin signalling systems drive satiety int j obes relat metab disord 25 suppl 1 s29 s34 2001crossref campfield la smith fj guisez y devos r burn p recombinant mouse ob protein evidence peripheral signal linking adiposity central neural networks science 269 546 549 1995isimedline carmelli d colrain im swan ge bliwise dl genetic environmental influences sleep disordered breathing older male twins sleep 27 917 922 2004isimedline cassell pg neverova m janmohamed uwakwe n qureshi mccarthy mi saker pj albon l kopelman p noonan k easlick j ramachandran snehalatha c pecqueur c ricquier d warden c hitman ga uncoupling protein 2 gene variant associated raised body mass index type ii diabetes diabetologia 42 688 692 1999crossrefisimedline chandler ke kidd al gazali l kolehmainen j lehesjoki ae black gc clayton smith j diagnostic criteria clinical characteristics natural history cohen syndrome j med genet 40 233 241 2003abstractfree full text chin k shimizu k nakamura noboru n masuzaki h ogawa y mishima m nakamura nakao k ohi m changes intra abdominal visceral fat serum leptin levels patients obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy circulation 100 706 712 1999abstractfree full text cirelli c tononi g uncoupling proteins sleep deprivation arch ital biol 142 541 549 2004isimedline clement k ruiz j cassard doulcier bouillaud f ricquier d basdevant guy grand b froguel p additive effect g 3826 variant uncoupling protein gene trp64arg mutation beta 3 adrenergic receptor gene weight gain morbid obesity int j obes relat metab disord 20 1062 1066 1996medline collins dd scoggin ch zwillich cw weil jv hereditary aspects decreased hypoxic response j clin invest 62 105 110 1978isimedline comuzzie ag hixson je almasy l mitchell bd mahaney mc dyer td stern mp maccluer jw blangero j major quantitative trait locus determining serum leptin levels fat mass located human chromosome 2 nat genet 15 273 276 1997crossrefisimedline considine rv sinha mk heiman ml kriauciunas stephens tw nyce mr ohannesian jp marco cc mckee lj bauer tl caro jf serum immunoreactive leptin concentrations normal weight obese humans n engl j med 334 292 295 1996abstractfree full text cowley ma smart jl rubinstein m cerdan mg diano horvath tl cone rd low mj leptin activates anorixegenic pomc neurons neural network arcuate nucleus nature 411 480 484 2001crossrefisimedline davies rj ali nj stradling jr neck circumference clinical features diagnosis obstructive sleep apnoea syndrome thorax 47 101 105 1992abstract deeb ss fajas l nemoto m pihlajamaki j mykkanen l kuusisto j laakso m fujimoto w auwerx j pro12ala substitution ppargamma2 associated decreased receptor activity lower body mass index improved insulin sensitivity nat genet 20 284 287 1998crossrefisimedline durand e boutin p meyre d charles ma clement k dina c froguel p polymorphisms amino acid transporter solute carrier family 6 neurotransmitter transporter member 14 gene contribute polygenic obesity french caucasians diabetes 53 2483 2486 2004abstractfree full text ek j urhammer sa sorensen ti andersen auwerx j pedersen o homozygosity pro12ala variant peroxisome proliferation activated receptor gamma2 ppar gamma2 divergent modulating effects body mass index obese lean caucasian men diabetologia 42 892 895 1999crossrefisimedline espana ra scammell te sleep neurobiology clinician sleep 27 811 820 2004isimedline esterbauer h schneitler c oberkofler h ebenbichler c paulweber b sandhofer f ladurner g hell e strosberg ad patsch jr krempler f patsch w common polymorphism promoter ucp2 associated decreased risk obesity middle aged humans nat genet 28 178 83 2001crossrefisimedline evans d minouchehr hagemann g mann wa wendt d wolf beisiegel u frequency interaction polymorphisms beta3 adrenergic receptor uncoupling proteins 1 2 obesity germans int j obes relat metab disord 24 1239 1245 2000crossrefmedline farrer la cupples la haines jl hyman b kukull wa mayeux r myers rh pericak vance ma risch n van duijn cm effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama 278 1349 1356 1997abstract fehm hl smolnik r kern w mcgregor gp bickel u born j melanocortin melanocyte stimulating hormoneadrenocorticotropin4 10 decreases body fat humans j clin endocrinol metab 86 1144 1148 2001abstractfree full text feinleib m garrison rj fabsitz r christian jc hrubec z borhani kannel wb rosenman r schwartz jt wagner jo nhlbi twin study cardiovascular disease risk factors methodology summary results j epidemiol 106 284 285 1977isimedline flegal km carroll md ogden cl johnson cl prevalence trends obesity among us adults 1999 2000 jama 288 1723 1727 2002abstractfree full text fujioka matsuzawa y tokunaga k kawamoto kobatake keno y kotani k yoshida tarui improvement glucose lipid metabolism associated selective reduction intra abdominal visceral fat premenopausal women visceral fat obesity int j obes 15 853 859 1991isimedline fujioka matsuzawa y tokunaga k tarui contribution intra abdominal fat accumulation impairment glucose lipid metabolism human obesity metabolism 36 54 59 1987crossrefisimedline gislason johannsson jh haraldsson olafsdottir br jonsdottir h kong frigge ml jonsdottir gm hakonarson h gulcher j stefansson k familial predisposition cosegregation analysis adult obstructive sleep apnea sudden infant death syndrome j respir crit care med 166 833 838 2002abstractfree full text grunstein r wilcox yang ts gould y hedner j snoring sleep apnoea men association central obesity hypertension int j obes relat metab disord 17 533 540 1993medline guilleminault c partinen m hollman k powell n stoohs r familial aggregates obstructive sleep apnea syndrome chest 107 1545 1551 1995abstractfree full text hager j dina c francke dubois houari m vatin v vaillant e lorentz n basdevant clement k guy grand b froguel p genome wide scan human obesity genes reveals major susceptibility locus chromosome 10 nat genet 20 304 308 1998crossrefisimedline halaas jl gajiwala ks maffei m cohen sl chait bt rabinowitz d lallone rl burley sk friedman jm weight reducing effects plasma protein encoded obese gene science 269 543 546 1995isimedline harsch ia konturek pc koebnick c kuehnlein pp fuchs fs pour schahin wiest gh hahn eg lohmann ficker jh leptin ghrelin levels patients obstructive sleep apnoea effect cpap treatment eur respir j 22 251 257 2003abstractfree full text hasler g buysse dj klaghofer r gamma ajdacic v eich d rossler w angst j association sleep duration obesity young adults 13 year prospective study sleep 27 661 666 2004isimedline heinzer rc stanchina ml malhotra fogel rb patel sr jordan schory k white dp lung volume continuous positive airway pressure requirements obstructive sleep apnea j respir crit care med 172 114 117 2005abstractfree full text hixson je almasy l cole birnbaum mitchell bd mahaney mc stern mp maccluer jw blangero j comuzzie ag normal variation leptin levels associated polymorphisms proopiomelanocortin gene pomc j clin endocrinol metab 84 3187 3191 1999abstractfree full text ip msm lam ksl ho cm tsang kwt lam wk serum leptin vascular risk factors obstructive sleep apnea chest 118 580 586 2000abstractfree full text katzmarzyk pt malina rm perusse l rice province ma rao dc bouchard c familial resemblance fatness fat distribution j hum biol 12 395 404 200030co2 j e74 2005abstractfree full text koeppen schomerus g wardle j plomin r genetic analysis weight overweight 4 year old twin pairs int j obes relat metab disord 25 838 844 2001medline kolehmainen j black gc saarinen chandler k clayton smith j traskelin al perveen r kivitie kallio norio r warburg m fryns jp de la chapelle lehesjoki ae cohen syndrome caused mutations novel gene coh1 encoding transmembrane protein presumed role vesicle mediated sorting intracellular protein transport j hum genet 72 1359 1369 2003crossrefisimedline krude h biebermann h luck w horn r brabant g gruters severe early onset obesity adrenal insufficiency red hair pigmentation caused pomc mutations humans nat genet 19 155 157 1998crossrefisimedline kubin l tojima h davies ro pack ai serotonergic excitatory drive hypoglossal motoneurons decerebrate cat neurosci lett 139 243 248 1992crossrefisimedline lander e kruglyak l genetic dissection complex traits guidelines interpreting reporting linkage results nat genet 11 241 247 1995crossrefisimedline locard e mamelle n billette miginiac m munoz f rey risk factors obesity five year old population parental versus environmental factor int j obes relat metab disord 16 721 729 1992medline masud ye effect peroxisome proliferator activated receptor gamma gene pro12ala variant body mass index meta analysis j med genet 40 773 780 2003free full text mathur r douglas nj family studies patients sleep apnea hypopnea syndrome ann intern med 122 174 178 1995abstractfree full text miraglia del giudice e cirillo g santoro n d urso l carbone mt di toro r perrone l molecular screening proopiomelanocortin pomc gene italian obese children report three new mutations int j obes relat metab disord 25 61 67 2001crossrefmedline ohman m oksanen l kaprio j koskenvuo m mustajoki p rissanen salmi j kontula k peltonen l genome wide linkage scan obesity finnish sibpairs reveals linkage chromosome xq24 j clin endocrinol metab 85 3183 3190 2000abstractfree full text oppert jm vohl mc chagnon m dionne ft cassard doulcier ricquier d perusse l bouchard c dna polymorphism uncoupling protein ucp gene human body fat int j obes relat metab disord 18 526 531 1994medline o donnell cp schaub cd haines berkowitz de tankersley cg schwartz ar smith pl leptin prevents respiratory depression obesity j respir crit care med 159 1477 1484 1999abstractfree full text palmer lj buxbaum sg larkin e patel sr elston rc tishler pv redline whole genome scan obstructive sleep apnea obesity j hum genet 72 340 350 2003crossrefisimedline palmer lj buxbaum sg larkin ek patel sr elston rc tishler pv redline whole genome scan obstructive sleep apnea obesity african american families j respir crit care med 169 1314 1321 2004abstractfree full text patel sr larkin ek palmer lj tishler pv elston rc white dp redline shared genetic variance sleep apnea related metabolic traits abstract j respir crit care med 169 a759 2004 pelleymounter ma cullen mj baker mb hecht r winters d boone collins f effects obese gene product body weight regulation obob mice science 269 540 543 1995isimedline peppard pe young palta m dempsey j skatrud j longitudinal study moderate weight change sleep disordered breathing jama 284 3015 3021 2000abstractfree full text perusse l rankinen zuberi chagnon yc weisnagel sj argyropoulos g walts b snyder ee bouchard c human obesity gene map 2004 update obes res 13 381 490 2005 peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6 991 997 2000crossrefisimedline pietilainen kh kaprio j rissanen winter rimpela viken rj rose rj distribution heritability bmi finnish adolescents aged 16y 17y study 4884 twins 2509 singletons int j obes relat metab disord 23 107 115 1999crossrefmedline pillar g lavie p assessment role inheritance sleep apnea syndrome j respir crit care med 151 688 691 1995abstract pillar g schnall rp peled n oliven lavie p impaired respiratory response resistive loading sleep healthy offspring patients obstructive sleep apnea j respir crit care med 155 1602 1608 1997abstract polotsky vy smaldone mc scharf mt li j tankersley cg smith pl schwartz ar o donnell cp impact interrupted leptin pathways ventilatory control j appl physiol 96 991 998 2004abstractfree full text redline leitner j arnold j tishler pv altose md ventilatory control abnormalities familial sleep apnea j respir crit care med 156 155 160 1997abstractfree full text redline tishler pv tosteson td williamson j kump k browner ferrette v krejci p familial aggregation obstructive sleep apnea j respir crit care med 151 682 687 1995abstract rotimi cn comuzzie ag lowe wl luke blangero j cooper rs quantitative trait locus chromosome 2 serum leptin levels confirmed african americans diabetes 48 643 644 1999free full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998crossrefisimedline schwartz ar gold ar schubert n stryzak wise ra permutt smith pl effect weight loss upper airway collapsibility obstructive sleep apnea rev respir dis 144 494 498 1991isimedline sekine m yamagami handa k saito nanri kawaminami k tokui n yoshida k kagamimori dose response relationship short sleeping hours childhood obesity results toyama birth cohort study child care health dev 28 163 170 2002crossrefisimedline selby jv newman b quesenberry cp jr fabsitz rr king mc meaney fj evidence genetic influence central body fat middle aged twins hum biol 61 179 194 1989isimedline sharma sk kurian malik v mohan banga pandey rm handa kk mukhopadhyay stepped approach prediction obstructive sleep apnea overtly asymptomatic obese subjects hospital based study sleep med 5 351 357 2004crossrefisimedline sloan jl mager cloning functional expression human na cl dependent neutral cationic amino acid transporter b0 j biol chem 274 23740 23745 1999abstractfree full text smith pl gold ar meyers da haponik ef bleecker er weight loss mildly moderately obese patients obstructive sleep apnea ann intern med 103 850 855 1985isimedline sood liu x liu h nolan p horner rl 5 ht hypoglossal motor nucleus respiratory control genioglossus muscle anesthetized rats respir physiol neurobiol 138 205 221 2003crossrefisimedline spiegel k tasali e penev p van cauter e sleep curtailment healthy young men associated decreased leptin levels elevated ghrelin levels increased hunger appetite ann intern med 141 846 850 2004abstractfree full text strohl kp saunders na feldman nt hallett m obstructive sleep apnea family members n engl j med 299 969 973 1978abstract strohl kp tankersley c cohen mm elston rc gozal d haddad g jacob h kiley j kinane b lifton rp mignot e mockrin neubauer j redline finding genetic mechanisms syndromes sleep disordered breathing ats statement new york american thoracic society 1999 httpwwwthoracicorgstatementssleepdisordersleepasp stunkard aj foch tt hrubec z twin study human obesity jama 256 51 54 1986abstract stunkard aj sorenson ti hanis c teasdale tw chakraborty r schull wj schulsinger f adoption study human obesity n engl j med 314 193 198 1986abstract suviolahti e oksanen lj ohman m cantor rm ridderstrale m tuomi kaprio j rissanen mustajoki p jousilahti p vartiainen e silander k kilpikari r salomaa v groop l kontula k peltonen l pajukanta p slc6a14 gene shows evidence association obesity j clin invest 112 1762 1772 2003abstractfree full text taheri lin l austin d young mignot e short sleep duration associated reduced leptin elevated ghrelin increased body mass index plos med 1 210 217 2004crossrefisi talamantes ma long cr smith gc jenkins tg ellis wc cartwright tc characterization cattle five breed diallel vi fat deposition patterns serially slaughtered bulls j anim sci 62 1259 1266 1986isimedline tankersley cg o donnell c daood mj watchko jf mitzner w schwartz smith p leptin attenuates respiratory complications associated obese phenotype j appl physiol 85 2261 2269 1998abstractfree full text turek fw joshu c kohsaka lin e ivanova g mcdearmon e laposky losee olson easton jensen dr eckel rh takahashi js bass j obesity metabolic syndrome circadian clock mutant mice science 308 1043 1045 2005 valve r sivenius k miettinen r pihlajamaki j rissanen deeb ss auwerx j uusitupa m laakso m two polymorphisms peroxisome proliferator activated receptor gamma gene associated severe overweight among obese women j clin endocrinol metab 84 3708 3712 1999abstractfree full text vioque j torres quiles j time spent watching television sleep duration obesity adults living valencia spain int j obes relat metab disord 24 1683 1688 2000crossrefmedline vitaterna mh king dp chang kornhauser jm lowrey pl mcdonald jd dove wf pinto lh turek fw takahashi js mutagenesis mapping mouse gene clock essential circadian behavior science 264 719 725 1994isimedline von kries r toschke wurmser h sauerwald koletzko b reduced risk overweight obesity 5 6 year old children duration sleep cross sectional study int j obes relat metab disord 26 710 716 2002crossrefmedline weeks de conley yp mah ts paul morse l ngo chang j dailey jp ferrell re gorin mb full genome scan age related maculopathy hum mol genet 9 1329 1349 2000abstractfree full text wilson pw schaefer ej larson mg ordovas jm apolipoprotein e alleles risk coronary disease meta analysis arterioscler thromb vasc biol 16 1250 1255 1996abstractfree full text young palta m dempsey j skatrud j weber badr occurrence sleep disordered breathing among middle aged adults n engl j med 328 1230 1235 1993abstractfree full text young peppard pe gottlieb dj epidemiology obstructive sleep apnea j respir crit care med 165 1217 1239 2002abstractfree full text yun z maecker hl johnson rs giaccia aj inhibition ppar gamma 2 gene expression hif 1 regulated gene dec1stra13 mechanism regulation adipogenesis hypoxia dev cell 2 331 341 2002crossrefisimedline zhou lechpammer greenberger j glowacki j hypoxia inhibition adipocytogenesis human bone marrow stromal cells requires tgfbetasmad3 signaling j biol chem 280 22688 22696 2005abstractfree full text
0.18766233.15687100.html.plaintext.txt	0	food deprivation differentially modulates orexin receptor expression signaling rat hypothalamus adrenal cortex emmanouil karteris1 rachel j machado1 jing chen1 sevasti zervou1 edward w hillhouse3 harpal randeva12
0.18766233.15687100.html.plaintext.txt	1	food deprivation differentially modulates orexin receptor expression signaling rat hypothalamus adrenal cortex emmanouil karteris1 rachel j machado1 jing chen1 sevasti zervou1 edward w hillhouse3 harpal randeva12
0.18766233.15687100.html.plaintext.txt	2	1biomedical research institute department biological sciences 2warwick medical school university warwick coventry 3the deans office medical school university leeds leeds united kingdom
0.18766233.15687100.html.plaintext.txt	3	submitted 2 august 2004 accepted final form 10 january 2005
0.18766233.15687100.html.plaintext.txt	4	abstract top abstract materials methods results discussion grants references although starvation induced biochemical metabolic changes perceived hypothalamus adrenal gland plays key role integration metabolic activity energy balance implicating feeding major synchronizer rhythms hypothalamic pituitary adrenal hpa axis given orexins involved regulating food intake activating hpa axis hypothesized food deprivation acute challenge systems regulate energy balance elicit changes orexin receptor signaling hypothalamic adrenal levels food deprivation induced orexin type 1 ox1r 2 ox2r receptors mrna protein levels hypothalamus addition fivefold increase prepro orexin mrna cleaved peptides b also elevated protein level interestingly adrenal ox1r ox2r levels significantly reduced food deprived animals whereas expression prepro orexin adrenal gland either state food deprivation exerted differential effect oxr g protein coupling hypothalamus food deprived rats compared controls significant increase coupling orexin receptors gq gs go demonstrated whereas coupling gi relatively less however adrenal cortex food deprived animal decreased coupling orexin receptors gs go gq increased coupling gi subsequent second messenger studies campip3 supported findings data indicate food deprivation differential effects orexin receptor expression signaling characteristics hypothalamic adrenocortical levels findings suggest orexins potential metabolic regulators within hpa axis centrally peripherally
0.18766233.15687100.html.plaintext.txt	5	abstract top abstract materials methods results discussion grants references although starvation induced biochemical metabolic changes perceived hypothalamus adrenal gland plays key role integration metabolic activity energy balance implicating feeding major synchronizer rhythms hypothalamic pituitary adrenal hpa axis given orexins involved regulating food intake activating hpa axis hypothesized food deprivation acute challenge systems regulate energy balance elicit changes orexin receptor signaling hypothalamic adrenal levels food deprivation induced orexin type 1 ox1r 2 ox2r receptors mrna protein levels hypothalamus addition fivefold increase prepro orexin mrna cleaved peptides b also elevated protein level interestingly adrenal ox1r ox2r levels significantly reduced food deprived animals whereas expression prepro orexin adrenal gland either state food deprivation exerted differential effect oxr g protein coupling hypothalamus food deprived rats compared controls significant increase coupling orexin receptors gq gs go demonstrated whereas coupling gi relatively less however adrenal cortex food deprived animal decreased coupling orexin receptors gs go gq increased coupling gi subsequent second messenger studies campip3 supported findings data indicate food deprivation differential effects orexin receptor expression signaling characteristics hypothalamic adrenocortical levels findings suggest orexins potential metabolic regulators within hpa axis centrally peripherally
0.18766233.15687100.html.plaintext.txt	6	starvation induced biochemical metabolic changes perceived hypothalamus turn coordinates behavioral autonomic neuroendocrine responses stimuli 1 studies rodents shown food deprivation induces marked acth corticosterone responses implicating feeding major synchronizer rhythms hypothalamic pituitary adrenal hpa axis 2 3 besides nutritional states neuropeptides corticotropin releasing hormone neuropeptide y npy known regulate hpa system feeding behavior several signals known regulate hpa system hypoglycemia potent activator hpa axis reflecting strong functional relationship hypothalamic feeding centers hpa axis 4 leptin whose concentrations governed nutritional status inhibitory effect plasma corticosterone rats 5
0.18766233.15687100.html.plaintext.txt	7	starvation induced biochemical metabolic changes perceived hypothalamus turn coordinates behavioral autonomic neuroendocrine responses stimuli 1 studies rodents shown food deprivation induces marked acth corticosterone responses implicating feeding major synchronizer rhythms hypothalamic pituitary adrenal hpa axis 2 3 besides nutritional states neuropeptides corticotropin releasing hormone neuropeptide y npy known regulate hpa system feeding behavior several signals known regulate hpa system hypoglycemia potent activator hpa axis reflecting strong functional relationship hypothalamic feeding centers hpa axis 4 leptin whose concentrations governed nutritional status inhibitory effect plasma corticosterone rats 5
0.18766233.15687100.html.plaintext.txt	8	recently orexin orexin b b produced neurons localized lateral dorsal hypothalamic area perifornical hypothalamus 6 implicated central regulation feeding energy homeostasis 7 33 residue peptide b 28 residue peptide proteolytically cleaved common precursor prepro orexin share 46 amino acid sequence homology besides playing role regulation feeding energy homeostasis orexins reported exert divergent physiological actions 8 12 orexins orchestrate actions binding activating two types g protein coupled receptors orexin 1 receptor ox1r orexin 2 receptor ox2r display 64 homology amino acid sequence 6 ox1r preferentially binds whereas ox2r binds b apparently similar affinity 6
0.18766233.15687100.html.plaintext.txt	9	recently orexin orexin b b produced neurons localized lateral dorsal hypothalamic area perifornical hypothalamus 6 implicated central regulation feeding energy homeostasis 7 33 residue peptide b 28 residue peptide proteolytically cleaved common precursor prepro orexin share 46 amino acid sequence homology besides playing role regulation feeding energy homeostasis orexins reported exert divergent physiological actions 8 12 orexins orchestrate actions binding activating two types g protein coupled receptors orexin 1 receptor ox1r orexin 2 receptor ox2r display 64 homology amino acid sequence 6 ox1r preferentially binds whereas ox2r binds b apparently similar affinity 6
0.18766233.15687100.html.plaintext.txt	10	hypothalamus levels prepro orexin messenger rna regulated several nutritional states signals fasting 6 insulin induced hypoglycemia 13 14 increase prepro orexin mrna rat lateral hypothalamic area whereas leptin converse effect 15 interestingly fasting leptin also regulate hypothalamic expression orexin receptors 15 16 findings observation intracerebroventricular administration b stimulates food consumption rats 6 suggests physiological role neuropeptides mediators regulation feeding particularly response energy deprivation
0.18766233.15687100.html.plaintext.txt	11	hypothalamus levels prepro orexin messenger rna regulated several nutritional states signals fasting 6 insulin induced hypoglycemia 13 14 increase prepro orexin mrna rat lateral hypothalamic area whereas leptin converse effect 15 interestingly fasting leptin also regulate hypothalamic expression orexin receptors 15 16 findings observation intracerebroventricular administration b stimulates food consumption rats 6 suggests physiological role neuropeptides mediators regulation feeding particularly response energy deprivation
0.18766233.15687100.html.plaintext.txt	12	although hypothalamus considered cornerstone maintenance energy homeostasis adrenal gland plays role integration metabolic activity energy balance example studies food deprived rats suggested hpa axis integral larger hypothalamic system mediates energy flow 2 animals catabolic activity quickly predominates reinforced elevated corticosterone driven hypothalamic control acth implicating adrenal activity metabolic regulator 3 addition hypothalamic effects nutritional signals leptin npy direct action adrenal level via receptors including modulation corticosteroid secretion 17 18 interest rat adrenals express orexin receptors 19 orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylyl cyclase dependent signaling cascade 20
0.18766233.15687100.html.plaintext.txt	13	although hypothalamus considered cornerstone maintenance energy homeostasis adrenal gland plays role integration metabolic activity energy balance example studies food deprived rats suggested hpa axis integral larger hypothalamic system mediates energy flow 2 animals catabolic activity quickly predominates reinforced elevated corticosterone driven hypothalamic control acth implicating adrenal activity metabolic regulator 3 addition hypothalamic effects nutritional signals leptin npy direct action adrenal level via receptors including modulation corticosteroid secretion 17 18 interest rat adrenals express orexin receptors 19 orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylyl cyclase dependent signaling cascade 20
0.18766233.15687100.html.plaintext.txt	14	expression orexin receptors rat human adrenals well documented rat receptors expressed adrenal cortex interestingly highest amount ox2r mrna found adrenal gland male rats four times higher brain ox2r mrna levels 19 situ hybridization revealed ox2r mrna localized primarily zona glomerulosa zona reticularis whereas expression adrenal medulla 19
0.18766233.15687100.html.plaintext.txt	15	expression orexin receptors rat human adrenals well documented rat receptors expressed adrenal cortex interestingly highest amount ox2r mrna found adrenal gland male rats four times higher brain ox2r mrna levels 19 situ hybridization revealed ox2r mrna localized primarily zona glomerulosa zona reticularis whereas expression adrenal medulla 19
0.18766233.15687100.html.plaintext.txt	16	view findings observation changes orexin levels closely related nutritional status rather state hunger satiety 21 hypothesizsed activation orexin receptors adrenal level may explain acth independent rise corticosterone seen starved rats sought investigate hypothalamus adrenal gland 1 whether levels orexins receptors ox1r ox2r differ fed food deprived rats assessing expression mrna protein level 2 elucidate whether nutritional status elicits functional changes ox1r ox2r studying g protein coupling subsequent activation second messenger pathways
0.18766233.15687100.html.plaintext.txt	17	view findings observation changes orexin levels closely related nutritional status rather state hunger satiety 21 hypothesizsed activation orexin receptors adrenal level may explain acth independent rise corticosterone seen starved rats sought investigate hypothalamus adrenal gland 1 whether levels orexins receptors ox1r ox2r differ fed food deprived rats assessing expression mrna protein level 2 elucidate whether nutritional status elicits functional changes ox1r ox2r studying g protein coupling subsequent activation second messenger pathways
0.18766233.15687100.html.plaintext.txt	18	materials methods top abstract materials methods results discussion grants references animal preparation
0.18766233.15687100.html.plaintext.txt	19	university warwick uk ethics committee use care animals approved procedures described adult male initially 250 g wistar rats housed groups two n 6 group environmentally controlled conditions 22 plus minus 2 degrees c humidity 40 60 1212 h light dark schedule lights 0600 rats allowed unrestricted access standard laboratory pellet rodent diet 131 kcalg crm biosure cambridge uk access tap water subjected study week habituation conditions rats randomly distributed two groups first group allowed eat freelyad libitum second group food deprived 24 h beginning onset dark cycle lights 1800 groups animals killed co2 inhalation cervical dislocation following day 1800
0.18766233.15687100.html.plaintext.txt	20	university warwick uk ethics committee use care animals approved procedures described adult male initially 250 g wistar rats housed groups two n 6 group environmentally controlled conditions 22 plus minus 2 degrees c humidity 40 60 1212 h light dark schedule lights 0600 rats allowed unrestricted access standard laboratory pellet rodent diet 131 kcalg crm biosure cambridge uk access tap water subjected study week habituation conditions rats randomly distributed two groups first group allowed eat freelyad libitum second group food deprived 24 h beginning onset dark cycle lights 1800 groups animals killed co2 inhalation cervical dislocation following day 1800
0.18766233.15687100.html.plaintext.txt	21	hypothalamic adrenal dissection
0.18766233.15687100.html.plaintext.txt	22	isolate hypothalamus animals decapitated brains removed rapidly hypothalamus defined posterior margin optic chiasm anterior margin mamillary bodies depth 2 3 mm dissected adrenal cortex fractions freed adipose tissue separated inner adrenomedullary tissue pressure glass plates upon removal tissues immediately snap frozen liquid nitrogen samples stored 70 degrees c use
0.18766233.15687100.html.plaintext.txt	23	isolate hypothalamus animals decapitated brains removed rapidly hypothalamus defined posterior margin optic chiasm anterior margin mamillary bodies depth 2 3 mm dissected adrenal cortex fractions freed adipose tissue separated inner adrenomedullary tissue pressure glass plates upon removal tissues immediately snap frozen liquid nitrogen samples stored 70 degrees c use
0.18766233.15687100.html.plaintext.txt	24	assay plasma corticosterone concentration
0.18766233.15687100.html.plaintext.txt	25	plasma corticosterone levels fed n 6 group ie co2cervical dislocation food deprived rats n 6 group measured radioimmunoassay amersham life sciences buckinghamshire uk range radioimmunoassay specific corticosterone 078 200 ngml
0.18766233.15687100.html.plaintext.txt	26	total rna extraction cdna synthesis
0.18766233.15687100.html.plaintext.txt	27	total rna prepared individual samples using rneasy total rna kit qiagen crawley uk according manufacturers guidelines first strand cdna synthesis performed using rnase reverse transcriptase gibco brl paisley uk according manufacturers recommendation
0.18766233.15687100.html.plaintext.txt	28	total rna prepared individual samples using rneasy total rna kit qiagen crawley uk according manufacturers guidelines first strand cdna synthesis performed using rnase reverse transcriptase gibco brl paisley uk according manufacturers recommendation
0.18766233.15687100.html.plaintext.txt	29	quantitative pcr performed roche light cycler system roche molecular biochemicals manheim germany pcr reactions carried reaction mixture consisting 50 microl reaction buffer 20 mm mgcl2 biogene kimbolton uk 10 microl primer 1 ng microl 25 microl cdna 05 microl light cycler sybr gold biogene
0.18766233.15687100.html.plaintext.txt	30	quantitative pcr performed roche light cycler system roche molecular biochemicals manheim germany pcr reactions carried reaction mixture consisting 50 microl reaction buffer 20 mm mgcl2 biogene kimbolton uk 10 microl primer 1 ng microl 25 microl cdna 05 microl light cycler sybr gold biogene
0.18766233.15687100.html.plaintext.txt	31	protocol conditions consisted denaturation 95 degrees c 15 followed 40 cycles 94 degrees c 1 58 degrees c 5 72 degrees c 12 followed melting curve analysis analysis quantitative amounts genes interest standardized housekeeping gene actin negative control reactions preparations lacking rna reverse transcriptase used place cdna quantitative analysis cdnas six fed six food deprived rats used serial dilutions hypothalamic adrenal cdnas provided template line best fit plotted used standard curve demonstrate accuracy reproducibility analysis quantification data analyzed using light cycler analysis software rna levels expressed ratio using delta delta method comparing relative expression results treatments real time pcr 22
0.18766233.15687100.html.plaintext.txt	32	protocol conditions consisted denaturation 95 degrees c 15 followed 40 cycles 94 degrees c 1 58 degrees c 5 72 degrees c 12 followed melting curve analysis analysis quantitative amounts genes interest standardized housekeeping gene actin negative control reactions preparations lacking rna reverse transcriptase used place cdna quantitative analysis cdnas six fed six food deprived rats used serial dilutions hypothalamic adrenal cdnas provided template line best fit plotted used standard curve demonstrate accuracy reproducibility analysis quantification data analyzed using light cycler analysis software rna levels expressed ratio using delta delta method comparing relative expression results treatments real time pcr 22
0.18766233.15687100.html.plaintext.txt	33	resultant pcr products sequenced automated dna sequencer sequence data analyzed using blast nucleic acid database searches national center biotechnology information
0.18766233.15687100.html.plaintext.txt	34	preparation hypothalamic adrenocortical membranes
0.18766233.15687100.html.plaintext.txt	35	rat hypothalami adrenal cortex obtained food deprived control male wistar rats described tissues homogenized dulbeccos phosphate buffered saline containing 10 mm mgcl2 2 mm egta 15 gl bovine serum albumin bsa wtvol 015 mm bacitracin 1 mm phenylmethylsulfonyl fluoride pmsf ph 72 extraction buffer 22 degrees c homogenate centrifuged 800 g 30 min 4 degrees c pellet discarded supernatant spun 45000 g 60 min 4 degrees c resultant pellet washed resuspended extraction buffer spun 45000 g 60 min 4 degrees c final pellet resuspended 5 ml extraction buffer use homogenizer protein concentration membrane suspension determined using bicinchoninic acid method bsa standard 23
0.18766233.15687100.html.plaintext.txt	36	rat hypothalami adrenal cortex obtained food deprived control male wistar rats described tissues homogenized dulbeccos phosphate buffered saline containing 10 mm mgcl2 2 mm egta 15 gl bovine serum albumin bsa wtvol 015 mm bacitracin 1 mm phenylmethylsulfonyl fluoride pmsf ph 72 extraction buffer 22 degrees c homogenate centrifuged 800 g 30 min 4 degrees c pellet discarded supernatant spun 45000 g 60 min 4 degrees c resultant pellet washed resuspended extraction buffer spun 45000 g 60 min 4 degrees c final pellet resuspended 5 ml extraction buffer use homogenizer protein concentration membrane suspension determined using bicinchoninic acid method bsa standard 23
0.18766233.15687100.html.plaintext.txt	37	hypothalamic n 6 group ie fed food deprived 100 microg adrenocortical membranes n 6 group 100 microg centrifuged 15000 g 15 min 4 degrees c supernatant discarded resultant pellets solubilized laemmli buffer 5 m urea 017 m sodium dodecyl sulfate sds 04 m dithiothreitol dtt 50 mm tris hcl ph 80 mixed placed boiling water bath 5 min allowed cool room temperature
0.18766233.15687100.html.plaintext.txt	38	samples separated 12 sds polyacrylamide gel proteins electrophoretically transferred nitrocellulose membrane 250 ma 1 h transfer buffer containing 20 mm tris 150 mm glycine 20 methanol filter blocked pbs containing 01 tween 20 5 milk powder wtvol 2 h room temperature three washes pbs 01 tween nitrocellulose membranes incubated primary antibody ox1r ox2r santa cruz biotechnology santa cruz ca primary antisera used 11000 dilution pbs 01 tween 1 h room temperature filters washed thoroughly 30 min pbs 01 tween incubation secondary anti rabbit horseradish peroxidase conjugated immunoglobulin 12000 1 h room temperature washing 30 min pbs 01 tween antibody complexes visualized previously described 24 ensure specificity also performed preabsorption ox1r ox2r blocking peptides santa cruz biotechnology prior western blotting detection b similar procedures followed using specific non cross reactive antibodies phoenix peptides belmont ma total hypothalamic adrenal lysate ensure protein amount loaded samples used western blotting used antibodies housekeeping gene actin santa cruz biotechnology
0.18766233.15687100.html.plaintext.txt	39	samples separated 12 sds polyacrylamide gel proteins electrophoretically transferred nitrocellulose membrane 250 ma 1 h transfer buffer containing 20 mm tris 150 mm glycine 20 methanol filter blocked pbs containing 01 tween 20 5 milk powder wtvol 2 h room temperature three washes pbs 01 tween nitrocellulose membranes incubated primary antibody ox1r ox2r santa cruz biotechnology santa cruz ca primary antisera used 11000 dilution pbs 01 tween 1 h room temperature filters washed thoroughly 30 min pbs 01 tween incubation secondary anti rabbit horseradish peroxidase conjugated immunoglobulin 12000 1 h room temperature washing 30 min pbs 01 tween antibody complexes visualized previously described 24 ensure specificity also performed preabsorption ox1r ox2r blocking peptides santa cruz biotechnology prior western blotting detection b similar procedures followed using specific non cross reactive antibodies phoenix peptides belmont ma total hypothalamic adrenal lysate ensure protein amount loaded samples used western blotting used antibodies housekeeping gene actin santa cruz biotechnology
0.18766233.15687100.html.plaintext.txt	40	treatment membranes pertussis cholera toxins
0.18766233.15687100.html.plaintext.txt	41	pertussis 50 microgml cholera 150 microgml toxin preactivated 005 m tris buffer ph 75 containing 20 mm dtt 50 mm glycine 45 min 37 degrees c final volume 50 microl cooled ice 20 min hypothalamic adrenal membranes n 3 group 100 microg incubated 20 mm tris ph 75 containing 1 mm edta 1 mm dtt 1 mm atp 1 mm gtp 5 mm mgcl2 10 mm thymidine 10 microm nad 5 microci 32pnad together preactivated toxins reactions carried 37 degrees c 30 min incubations terminated 07 ml ice cold 20 mm tris buffer ph 75 containing 1 mm edta control samples prepared incubating membranes medium absence toxin termination samples centrifuged 13000 rpm 20 min pellets washed respun three times resultant pellets resuspended 100 microl 2 sds 320 microl buffer containing 1 volvol triton x 100 1 deoxycholate 05 wtvol sds 150 mm nacl 10 mm tris hcl ph 74 1 mm dtt 1 mm edta 02 mm pmsf 10 microgml aprotinin resuspended samples centrifuged 11000 rpm 10 min room temperature resulting supernatants equally aliquoted 200 microl aliquots 10 microl gi gs antisera new england nuclear dupont boston ma added left continuous agitation 2 h followed addition 60 microl protein sepharose per tube agitation overnight 4 degrees c samples centrifuged 12000 rpm 10 min pellets solubilized laemmli buffer mixed placed boiling water bath 5 min cooling room temperature sample loaded onto sds 12 polyacrylamide gel electrophoresis gels dried autoradiographed using kodak x ray film assess extent adp ribosylation
0.18766233.15687100.html.plaintext.txt	42	synthesis 32pgtp azidoanilide photoaffinity labeling g subunits
0.18766233.15687100.html.plaintext.txt	43	gtp azidoanilide gtp aa synthesized using method previously described 23 hypothalamic adrenocortical membranes n 3 group 150 microg incubated 3 min 30 degrees c 100 nm buffer 50 mm hepes 30 mm kcl 10 mm mgcl2 1 mm benzamidine 01 mm edta followed addition 5 microm gdp 6 microci gtp aa incubation 3 min 30 degrees c darkened room membranes placed ice collected centrifugation 15000 g 15 min 4 degrees c supernatant carefully removed membrane pellet resuspended 120 microll modified buffer 16 mg dtt 5 ml buffer samples vortexed irradiated 5 min 4 degrees c ultraviolet light 254 nm distance 5 cm cross link gtp aa g proteins immunoprecipitation using 10 microl undiluted g protein antisera new england nuclear dupont subunit carried previously described 24 samples subjected gel electrophoresis using discontinuous sds page slab gels 10 running 5 stacking gels stained coomassie blue dried using slab gel dryer exposed fuji x ray film 70 degrees c 2 5 days intensifying screens
0.18766233.15687100.html.plaintext.txt	44	gtp azidoanilide gtp aa synthesized using method previously described 23 hypothalamic adrenocortical membranes n 3 group 150 microg incubated 3 min 30 degrees c 100 nm buffer 50 mm hepes 30 mm kcl 10 mm mgcl2 1 mm benzamidine 01 mm edta followed addition 5 microm gdp 6 microci gtp aa incubation 3 min 30 degrees c darkened room membranes placed ice collected centrifugation 15000 g 15 min 4 degrees c supernatant carefully removed membrane pellet resuspended 120 microll modified buffer 16 mg dtt 5 ml buffer samples vortexed irradiated 5 min 4 degrees c ultraviolet light 254 nm distance 5 cm cross link gtp aa g proteins immunoprecipitation using 10 microl undiluted g protein antisera new england nuclear dupont subunit carried previously described 24 samples subjected gel electrophoresis using discontinuous sds page slab gels 10 running 5 stacking gels stained coomassie blue dried using slab gel dryer exposed fuji x ray film 70 degrees c 2 5 days intensifying screens
0.18766233.15687100.html.plaintext.txt	45	camp inositol triphosphate second messenger studies
0.18766233.15687100.html.plaintext.txt	46	camp camp studies using commercially available kit new england nuclear dupont hypothalamic adrenocortical membrane suspensions n 3 group 100 microg incubated increasing concentrations amount camp incubate determined radioimmunoassay previously described 25 standard camp concentrations covering range 0138 100 pmolml used determination standard curve radioimmunoassay interassay coefficient variation 8 camp assay buffer without membrane preparations used negative control
0.18766233.15687100.html.plaintext.txt	47	inositol triphosphate inositol triphosphate ip3 assay amersham pharmacia biotech little chalfont uk hypothalamic adrenocortical membranes incubated increasing concentrations followed addition 200 microl ip3 generation buffer previously described 24 membranes incubated 3 min 37 degrees c reaction terminated addition 1 m ice cold trichloroacetic acid followed extraction inositol phosphates neutralization ip3 levels estimated radioimmunoassay basis displacement 3hip3 specific bovine adrenocortical ip3 binding proteins interassay coefficient variation 87
0.18766233.15687100.html.plaintext.txt	48	data shown means plus minus sd measurement real time pcr measurements photoaffinity labeling western immunoblotting results evaluated groups using two tailed students test significance determined level p 005 western immunoblotting photoaffinity labeling experiments densities measured using scanning densitometer coupled scanning software imagequant molecular dynamics amersham pharmacia little chalfont uk second messenger measurements one way analysis variance used followed dunnetts test compare treatment dose
0.18766233.15687100.html.plaintext.txt	49	data shown means plus minus sd measurement real time pcr measurements photoaffinity labeling western immunoblotting results evaluated groups using two tailed students test significance determined level p 005 western immunoblotting photoaffinity labeling experiments densities measured using scanning densitometer coupled scanning software imagequant molecular dynamics amersham pharmacia little chalfont uk second messenger measurements one way analysis variance used followed dunnetts test compare treatment dose
0.18766233.15687100.html.plaintext.txt	50	results top abstract materials methods results discussion grants references effect food deprivation corticosterone level
0.18766233.15687100.html.plaintext.txt	51	plasma corticosterone levels almost twofold higher p 001 food deprived rats 51 plus minus 29 ngml compared fed ones 28 plus minus 27 ngml measured radioimmunoassay fig 1a given rats killed co2 inhalation corticosterone levels rats killed cervical dislocation also measured two subgroups compared appeared apparent differences two different methods killing animals thus suggesting model co2 inhalation constitute additional stress factor fig 1a
0.18766233.15687100.html.plaintext.txt	52	plasma corticosterone levels almost twofold higher p 001 food deprived rats 51 plus minus 29 ngml compared fed ones 28 plus minus 27 ngml measured radioimmunoassay fig 1a given rats killed co2 inhalation corticosterone levels rats killed cervical dislocation also measured two subgroups compared appeared apparent differences two different methods killing animals thus suggesting model co2 inhalation constitute additional stress factor fig 1a
0.18766233.15687100.html.plaintext.txt	53	view larger version 26k fig 1 significant upregulation p 001 corticosterone production food deprived rats n 6 compared fed ones n 6 method sacrificing exert effects corticosterone levels 2 groups b significant increase prepro orexin mrna levels food deprived hypothalamus rat n 6 differences mrna expression seen large difference amplification efficiency demonstrated delay amplification intercept cycle fed rat sample c western blot analysis b rat hypothalamic lysates lane 1 corresponds positive control b lane 2 corresponds fed hypothalamus lane 3 corresponds food deprived hypothalamic lysates quantification immunocomplexes revealed significant increase protein expression b food deprivation conditions n 6 p 005 p 001
0.18766233.15687100.html.plaintext.txt	54	effect food deprivation peptide receptor expression hypothalamus
0.18766233.15687100.html.plaintext.txt	55	peptide expression serial dilutions hypothalamic cdna provided template line best fit plotted used standard curve demonstrate accuracy reproducibility analysis melting curve analysis pcr products presented fluorescence time dfdt temperature degrees c melting curve analysis showed single melting maximum 8920 degrees c prepro orexin gene single melting maximum 9030 degrees c actin gene thus confirming product specificity data shown
0.18766233.15687100.html.plaintext.txt	56	fivefold increase prepro orexin message p 001 hypothalami food deprived animals fig 1b compared controls mrna changes prepro orexin peptide also confirmed immunoblotting analysis protein expression b significantly p 001 p 005 respectively increased food deprivation fig 1c
0.18766233.15687100.html.plaintext.txt	57	fivefold increase prepro orexin message p 001 hypothalami food deprived animals fig 1b compared controls mrna changes prepro orexin peptide also confirmed immunoblotting analysis protein expression b significantly p 001 p 005 respectively increased food deprivation fig 1c
0.18766233.15687100.html.plaintext.txt	58	receptor expression compared controls oxr1 oxr2 mrna significantly p 005 increased hypothalamus food deprived rat fig 2a increases similar forms orexin receptors 25 fold increase ox1r 2 fold increase ox2r protein expression oxr1 oxr2 confirmed immunoblotting using specific goat polyclonal antibodies fig 2b oxr1 antibody raised peptide mapping carboxy terminus oxr1 rat origin whereas oxr2 antibody raised peptide mapping amino terminus ox2r human origin rat cross reactive detected protein ox1r apparent molecular mass 50 kda whereas ox2r detected 40 kda peptide specificity response confirmed preincubation ox1r ox2r antibodies blocking peptides fig 2b protein expression reflected mrna data fig 2a significant increase p 001 receptors food deprived animals fig 2c compared controls
0.18766233.15687100.html.plaintext.txt	59	view larger version 33k fig 2 significant upregulation ox1r ox2r mrna levels food deprived hypothalamus n 6 rat compared fed ones n 6 assessed real time pcr b western blot analysis membrane protein extracts rat adrenal lane 3 hypothalamus lane 4 demonstrate antibody orexin 1 receptor ox1r recognized band apparent molecular mass 50 kda similarly specific ox2r antibody used recognized single band apparent molecular mass 40 kda bands appeared specific orexin receptors antibodies preabsorbed respective blocking peptides lanes 1 2 rat adrenal hypothalamus respectively apparent immunodetection c western blot analysis ox1r ox2r hypothalamic membranes fed n 6 food deprived rats n 6 quantification immunocomplexes revealed significant increase protein expression orexin receptors food deprivation conditions whereas protein levels housekeeping gene actin appeared unaltered p 001
0.18766233.15687100.html.plaintext.txt	60	effect food deprivation orexin receptor expression adrenal cortex
0.18766233.15687100.html.plaintext.txt	61	interestingly findings adrenal cortex marked contrast observed hypothalamus quantitative analysis pcr products rat adrenal cortex showed ox1r ox2r levels significantly p 005 p 001 respectively reduced food deprived animals compared controls fig 3a decrease profound ox2r 4 fold whereas ox1r demonstrated twofold decrease fig 3a similarly ox1r ox2r protein levels significantly decreased p 005 p 001 respectively adrenal cortex food deprived animals compared controls decrease pronounced oxr2 groups studied protein levels actin remained unaltered fig 3b
0.18766233.15687100.html.plaintext.txt	62	interestingly findings adrenal cortex marked contrast observed hypothalamus quantitative analysis pcr products rat adrenal cortex showed ox1r ox2r levels significantly p 005 p 001 respectively reduced food deprived animals compared controls fig 3a decrease profound ox2r 4 fold whereas ox1r demonstrated twofold decrease fig 3a similarly ox1r ox2r protein levels significantly decreased p 005 p 001 respectively adrenal cortex food deprived animals compared controls decrease pronounced oxr2 groups studied protein levels actin remained unaltered fig 3b
0.18766233.15687100.html.plaintext.txt	63	view larger version 36k fig 3 significant updownregulation ox1r ox2r mrna levels food deprived rat adrenal cortex n 6 compared fed adrenals assessed real time pcr changes mrna expression shown differences amplification efficiency demonstrated delay amplification intercept cycle food deprived cdnas b western blot analysis ox1r ox2r adrenal membranes fed n 6 food deprived n 6 rats quantification immunocomplexes revealed significant decrease protein expression orexin receptors food deprivation conditions whereas protein levels house keeping gene actin appeared unaltered changes agreement mrna data p 005 p 001
0.18766233.15687100.html.plaintext.txt	64	cholera toxin treatment incubating membranes cholera toxin resulted incorporation 32padp ribose two bands 45 47 kda hypothalamic adrenal membranes apparent differences incorporation probe fed food deprived preparations tissues fig 4a
0.18766233.15687100.html.plaintext.txt	65	view larger version 25k fig 4 adp ribosylation cholera toxin ctx hypothalamic h n 3 adrenal n 3 membrane gs subunits membranes incubated 150 microgml ctx protein precipitation samples denatured applied 12 sds polyacrylamide gel incorporation label resulted detection 2 bands 45 47 kda hypothalamic adrenal membranes respectively apparent difference fed food deprived samples b adp ribosylation pertussis toxin ptx hypothalamic n 3 adrenal n 3 membrane gi subunits protein precipitation samples denatured applied 12 sds polyacrylamide gel incorporation label resulted detection single band 41 kda hypothalamic adrenal membranes apparent difference fed food deprived samples c autoradiograph induced photolabeling 32pgtp azidoanilide 32pgtp aa gs subunits rat hypothalamic adrenal membranes membranes incubated 32pgtp aa different concentrations 10 11 10 7m followed uv cross linking immunoprecipitation gs specific antibody proteins resolved sds page gels followed autoradiography immunodetected bands quantified scanning densitometric analysis identical results obtained 3 independent experiments means plus minus sd p 005 vs basal activity p 005 vs adrenal membranes
0.18766233.15687100.html.plaintext.txt	66	pertussis toxin treatment treatment hypothalamic adrenal membranes pertussis toxin resulted incorporation 32padp ribose single band apparent molecular masses 41 kda fig 4b incorporation label seen either hypothalamic adrenal tissues absence pertussis toxin similarly detectable differences fed food deprived gi subunits data confirm functional integrity g protein subunits also reveal nutritional status interfere expression signaling proteins
0.18766233.15687100.html.plaintext.txt	67	functional analysis g protein activation effects food deprivation
0.18766233.15687100.html.plaintext.txt	68	determine g proteins coupled orexin receptors food deprived fed state hypothalamic adrenocortical membranes labeled gtp aa presence absence followed immunoprecipitation specific g subunit antibodies gs gi gq go
0.18766233.15687100.html.plaintext.txt	69	optimal labeling g subunits gtp aa requires receptor activation heterotrimeric g proteins release bound gdp binding gtp aa dependent gdp concentration gtp affinity g subunit agonist incubation time 26 therefore conditions labeling g subunits established empirically demonstrated optimum labeling obtained presence 5 microm gdp data shown induced labeling gtp aa time dependent optimal incubation time 3 min data shown using gs subunit paradigm able demonstrate coupling orexin receptors upon challenge dose dependent maximal activation concentration 100 nm fig 4c
0.18766233.15687100.html.plaintext.txt	70	optimal labeling g subunits gtp aa requires receptor activation heterotrimeric g proteins release bound gdp binding gtp aa dependent gdp concentration gtp affinity g subunit agonist incubation time 26 therefore conditions labeling g subunits established empirically demonstrated optimum labeling obtained presence 5 microm gdp data shown induced labeling gtp aa time dependent optimal incubation time 3 min data shown using gs subunit paradigm able demonstrate coupling orexin receptors upon challenge dose dependent maximal activation concentration 100 nm fig 4c
0.18766233.15687100.html.plaintext.txt	71	specificity immunoprecipitating properties gs antibody assessed comparing migration positions orexin induced gtp aa photoaffinity labeled g proteins adp ribosylated using 32pnad cholera toxin demonstrate protein band radiolabeled immunoprecipitated specific antibody surprisingly photoaffinity 32pgtp aa experiment indicated orexin receptors hypothalamus adrenal cortex preferentially activate 45 kda form gs protein observation requires investigation
0.18766233.15687100.html.plaintext.txt	72	specificity immunoprecipitating properties gs antibody assessed comparing migration positions orexin induced gtp aa photoaffinity labeled g proteins adp ribosylated using 32pnad cholera toxin demonstrate protein band radiolabeled immunoprecipitated specific antibody surprisingly photoaffinity 32pgtp aa experiment indicated orexin receptors hypothalamus adrenal cortex preferentially activate 45 kda form gs protein observation requires investigation
0.18766233.15687100.html.plaintext.txt	73	hypothalamus treatment hypothalamic membranes 100 nm revealed orexin receptors coupled multiple g proteins including go gi gs lesser extent gq control group fig 5a food deprived rats however change profile g protein activation compared controls significant increase coupling orexin receptors gq gs go whereas less coupling orexin receptors gi fig 5a quantification immunocomplexes shown fig 5b
0.18766233.15687100.html.plaintext.txt	74	view larger version 37k fig 5 autoradiograph agonist induced photolabeling g protein subunits gtp aa hypothalamic adrenal cortex membranes fed rats n 3 group incubated gtp aa 100 nm experiment repeated food deprived rats n 3 group uv cross linking g protein subunits immunoprecipitated specific antisera gs gq gi go resolved 12 sds polyacrylamide gels immunodetected bands quantified scanning densitometric analysis data expressed means plus minus sd optical density od units expressed ratio treated untreated membranes rat hypothalamus b rat adrenal cortex c p 005 p 001
0.18766233.15687100.html.plaintext.txt	75	adrenal cortex treatment adrenocortical membranes 100 nm revealed similar promiscuity g protein profile adrenal orexin receptors control group fed rats increased labeling gs gq go gi fig 5a hypothalamus food deprivation modulated g protein activation profile interestingly food deprived animal decreased coupling orexin receptors gs go increased gi whereas coupling toward gq fig 5a quantification immunocomplexes shown fig 5c
0.18766233.15687100.html.plaintext.txt	76	functional analysis intracellular second messenger generation effects food deprivation
0.18766233.15687100.html.plaintext.txt	77	addition g protein data dissected signaling characteristics orexin receptors hypothalamus adrenal cortex measuring second messengers camp ip3 controls food deprived animals upon stimulation different concentrations
0.18766233.15687100.html.plaintext.txt	78	hypothalamus test ability activate hypothalamic adenylyl cyclase determined effect camp production hypothalamic membranes fed rats incubated 10 pm 100 nm 30 min 25 degrees c significant increase camp production increase found dose dependent whereas maximal response 55 plus minus 5 basal observed concentration 100 nm fig 6a response amplified food deprived rat 100 nm treatment induced camp response 95 plus minus 5 basal fig 6a
0.18766233.15687100.html.plaintext.txt	79	view larger version 18k fig 6 camp inositol triphosphate ip3 b accumulation rat hypothalamic membranes 100 microg protein presence different concentrations results expressed means plus minus sd 3 independent experiments camp c ip3 d accumulation rat adrenal cortex membranes 100 microg protein presence different concentrations orexin results expressed means plus minus sd 3 independent experiments p 005 p 001 vs basal activity p 005 food deprived vs control treatments hypothalamus adrenal cortex
0.18766233.15687100.html.plaintext.txt	80	similarly found treatment hypothalamic membranes induced rapid ip3 turnover dose dependent manner effect threshold 1 nm maximum response 100 nm 30 plus minus 4 basal fig 6b consistent g protein labeling studies significant p 001 increase ip3 production hypothalami food deprived rats compared controls 70 plus minus 7 basal fig 6b
0.18766233.15687100.html.plaintext.txt	81	similarly found treatment hypothalamic membranes induced rapid ip3 turnover dose dependent manner effect threshold 1 nm maximum response 100 nm 30 plus minus 4 basal fig 6b consistent g protein labeling studies significant p 001 increase ip3 production hypothalami food deprived rats compared controls 70 plus minus 7 basal fig 6b
0.18766233.15687100.html.plaintext.txt	82	adrenal cortex similarly rat adrenocortical membranes fed rats incubated 001 nm 100 nm significant increase camp ip3 production fig 6 c d increases appeared dose dependent maximum response 100 nm camp 78 plus minus 8 basal 10 nm ip3 50 plus minus 7 basal however food deprived animals compared controls treatment adrenocortical membranes induced modest response toward camp production significant 100 nm apparent effect toward ip3 turnover fig 6 c d findings keeping photoaffinity labeling experiments
0.18766233.15687100.html.plaintext.txt	83	discussion top abstract materials methods results discussion grants references present study demonstrate effects food deprivation 24 h orexins orexin receptor expression rat hypothalamus adrenal cortex mrna protein levels addition present differential effects stressful nutritional stimulus signaling characteristics orexin receptors tissues
0.18766233.15687100.html.plaintext.txt	84	discussion top abstract materials methods results discussion grants references present study demonstrate effects food deprivation 24 h orexins orexin receptor expression rat hypothalamus adrenal cortex mrna protein levels addition present differential effects stressful nutritional stimulus signaling characteristics orexin receptors tissues
0.18766233.15687100.html.plaintext.txt	85	hypothalamus plays major role regulation food intake energy balance integrating multiple anorexigenic orexigenic signals including elicited orexins 21 27 similar role adrenal gland possible given expresses receptors leptin npy 28 orexin 19 29 regulators energy homeostasis agreement previous studies 6 15 able show levels prepro orexin mrna influenced nutritional status upregulated upon fasting hypothalamus detailed analysis protein level confirmed cleaved bioactive peptides b upregulated food deprivation previous studies fasted lactating rats demonstrated hypothalamic b levels raised 10 fold controls nonfasted whereas showed change 30 differences due rodent strain used sex metabolic status duration food deprivation
0.18766233.15687100.html.plaintext.txt	86	hypothalamus plays major role regulation food intake energy balance integrating multiple anorexigenic orexigenic signals including elicited orexins 21 27 similar role adrenal gland possible given expresses receptors leptin npy 28 orexin 19 29 regulators energy homeostasis agreement previous studies 6 15 able show levels prepro orexin mrna influenced nutritional status upregulated upon fasting hypothalamus detailed analysis protein level confirmed cleaved bioactive peptides b upregulated food deprivation previous studies fasted lactating rats demonstrated hypothalamic b levels raised 10 fold controls nonfasted whereas showed change 30 differences due rodent strain used sex metabolic status duration food deprivation
0.18766233.15687100.html.plaintext.txt	87	food deprivation leads changes activity hpa axis within 3 h increase corticosterone 3 findings interest given orexins stimulate hpa axis administered centrally 31 furthermore orexin neurons sensitive nutritional signals insulin glucose alter food deprivation 3 hypothalamic orexin neurons express leptin receptors prepro orexin expression fasting leptin also regulate hypothalamic expression orexin receptors 15 16 32
0.18766233.15687100.html.plaintext.txt	88	food deprivation leads changes activity hpa axis within 3 h increase corticosterone 3 findings interest given orexins stimulate hpa axis administered centrally 31 furthermore orexin neurons sensitive nutritional signals insulin glucose alter food deprivation 3 hypothalamic orexin neurons express leptin receptors prepro orexin expression fasting leptin also regulate hypothalamic expression orexin receptors 15 16 32
0.18766233.15687100.html.plaintext.txt	89	numerous studies mapped detail expression orexin orexin receptors hypothalamic level trivedi et al 33 demonstrated within hypothalamus ox1r mrna abundant ventromedial hypothalamic nucleus whereas ox2r predominantly expressed paraventricular nucleus another study shown 20 h fasting levels rat ox1r mrna significantly increased ventromedial hypothalamic nuclei medial division amygdala whereas levels ox2r mrna augmented arcuate nucleus remained unchanged dorsomedial hypothalamic nucleus paraventricular hypothalamic nucleus amygdala following fasting 16 three different studies 34 13 15 indicated prepro orexin upregulated hypothalamus upon food deprivation lateral hypothalamic area rat agreement studies noted fasting hypothalamic ox1r ox2r gene expression induced given detailed analysis studies provided shifted interest expression protein level provide new evidence changes also mirrored protein level assessed semiquantitative western blotting analysis
0.18766233.15687100.html.plaintext.txt	90	previous studies 3 4 shown food deprivation switches feeding responses adrenocortical responses time food presentation appears potent synchronizer phase plasma corticosteroid levels light dark cycle 35 observations interest given orexins circadian dependent actions orexins known increase corticosterone production rats 20 cortisol human adrenocortical cells 36 however view data conclude adrenal orexin receptors influence mediate rise corticosterone levels seen food deprivation conditions
0.18766233.15687100.html.plaintext.txt	91	previous studies 3 4 shown food deprivation switches feeding responses adrenocortical responses time food presentation appears potent synchronizer phase plasma corticosteroid levels light dark cycle 35 observations interest given orexins circadian dependent actions orexins known increase corticosterone production rats 20 cortisol human adrenocortical cells 36 however view data conclude adrenal orexin receptors influence mediate rise corticosterone levels seen food deprivation conditions
0.18766233.15687100.html.plaintext.txt	92	well documented food deprivation induces multiple metabolic changes may directly influence orexin receptor expression adrenal gland example negative correlation testosterone levels fasting 37 studies laboratory shown testosterone levels also decrease following 24 h food deprivation unpublished observations interestingly gonadectomized rats significant downregulation adrenal ox2r effect reversed upon testosterone replacement 38 although regulation adrenal orexin receptors gonadal steroids directly relevant findings suggests changes orexin receptor expression may secondary phenomenon following initial food deprivation induced alterations
0.18766233.15687100.html.plaintext.txt	93	well documented food deprivation induces multiple metabolic changes may directly influence orexin receptor expression adrenal gland example negative correlation testosterone levels fasting 37 studies laboratory shown testosterone levels also decrease following 24 h food deprivation unpublished observations interestingly gonadectomized rats significant downregulation adrenal ox2r effect reversed upon testosterone replacement 38 although regulation adrenal orexin receptors gonadal steroids directly relevant findings suggests changes orexin receptor expression may secondary phenomenon following initial food deprivation induced alterations
0.18766233.15687100.html.plaintext.txt	94	future studies concentrate elucidating central peripheral actions orexins done systematically deleting ox1r andor ox2r tissue specific fashion using cre loxp system use approach model generated bearing neuronal adrenal specific deletions orexin receptors
0.18766233.15687100.html.plaintext.txt	95	future studies concentrate elucidating central peripheral actions orexins done systematically deleting ox1r andor ox2r tissue specific fashion using cre loxp system use approach model generated bearing neuronal adrenal specific deletions orexin receptors
0.18766233.15687100.html.plaintext.txt	96	data indicate orexin signaling may enhanced response energy deficit sensed hypothalamus possibly predominantly via ox1r time decreased adrenal cortex orexins act two distinct g protein coupled receptors transduce intracellular signals activating heterotrimeric g proteins likely multiple second messenger systems involved orexins shown increase intracellular calcium influx 6 39 40 41 also suggestion ox2r coupled inhibitory gi protein 42 shown first time native orexin receptors hypothalamus activate four types g proteins namely gs gq go gi response although gi go two major inhibitory signaling pathways rat brain previously shown multiple subtypes g proteins couple g protein coupled receptor systems 43 food deprivation altered g protein coupling profile findings supported functional assays camp ip3 assays reflecting g protein coupling status research needed investigate whether subunits implicated activating second messengers also assess effects b g protein signaling
0.18766233.15687100.html.plaintext.txt	97	data indicate orexin signaling may enhanced response energy deficit sensed hypothalamus possibly predominantly via ox1r time decreased adrenal cortex orexins act two distinct g protein coupled receptors transduce intracellular signals activating heterotrimeric g proteins likely multiple second messenger systems involved orexins shown increase intracellular calcium influx 6 39 40 41 also suggestion ox2r coupled inhibitory gi protein 42 shown first time native orexin receptors hypothalamus activate four types g proteins namely gs gq go gi response although gi go two major inhibitory signaling pathways rat brain previously shown multiple subtypes g proteins couple g protein coupled receptor systems 43 food deprivation altered g protein coupling profile findings supported functional assays camp ip3 assays reflecting g protein coupling status research needed investigate whether subunits implicated activating second messengers also assess effects b g protein signaling
0.18766233.15687100.html.plaintext.txt	98	although demonstrated functional orexin receptors human fetal adult adrenal glands 23 44 first report g proteins coupling orexin receptors rat adrenal cortex interestingly note downregulation g proteins apart gi response upon food deprivation second messenger studies confirmed findings minimal response toward camp production none ip3 adrenal cortex food deprived rat findings support observations rat adrenocortical cells stimulates corticosterone release via camp pathway 20
0.18766233.15687100.html.plaintext.txt	99	although demonstrated functional orexin receptors human fetal adult adrenal glands 23 44 first report g proteins coupling orexin receptors rat adrenal cortex interestingly note downregulation g proteins apart gi response upon food deprivation second messenger studies confirmed findings minimal response toward camp production none ip3 adrenal cortex food deprived rat findings support observations rat adrenocortical cells stimulates corticosterone release via camp pathway 20
0.18766233.15687100.html.plaintext.txt	100	despite demonstrating first time rat orexin receptors couple differentially several g protein subunits activate multiple second messengers caution exercised interpret changes given plethora different cell types reside within hypothalamus adrenal gland distinctions made specific subpopulations brain regions adrenal zones data provide evidence signaling characteristics orexin receptors food deprivation total hypothalamic adrenal preparations
0.18766233.15687100.html.plaintext.txt	101	despite demonstrating first time rat orexin receptors couple differentially several g protein subunits activate multiple second messengers caution exercised interpret changes given plethora different cell types reside within hypothalamus adrenal gland distinctions made specific subpopulations brain regions adrenal zones data provide evidence signaling characteristics orexin receptors food deprivation total hypothalamic adrenal preparations
0.18766233.15687100.html.plaintext.txt	102	conclusion study indicates nutritional changes like food deprivation exert differential effects orexin receptor expression signaling characteristics hypothalamic adrenocortical levels however significance novel findings particular differential expression g protein activation upon food deprivation hypothalamus adrenal cortex needs elucidation
0.18766233.15687100.html.plaintext.txt	103	conclusion study indicates nutritional changes like food deprivation exert differential effects orexin receptor expression signaling characteristics hypothalamic adrenocortical levels however significance novel findings particular differential expression g protein activation upon food deprivation hypothalamus adrenal cortex needs elucidation
0.18766233.15687100.html.plaintext.txt	104	grants top abstract materials methods results discussion grants references work supported research grants h randeva general charities coventry research teaching development fund university warwick clinical endocrinology trust uk
0.18766233.15687100.html.plaintext.txt	105	footnotes address reprint requests correspondence e karteris biomedical research institute univ warwick gibbet hill rd coventry cv4 7al uk e mail ekkarterisatwarwickacuk u d
0.18766233.15687100.html.plaintext.txt	106	footnotes address reprint requests correspondence e karteris biomedical research institute univ warwick gibbet hill rd coventry cv4 7al uk e mail ekkarterisatwarwickacuk u d
0.18766233.15687100.html.plaintext.txt	107	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.18766233.15687100.html.plaintext.txt	108	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.18766233.15687100.html.plaintext.txt	109	references top abstract materials methods results discussion grants references schwartz mw dallman mf woods sc hypothalamus response starvation implications study wasting disorders j physiol regul integr comp physiol 269 r949 r957 1995abstractfree full text akana sf strack hanson es dallman mf regulation activity hypothalamic pituitary adrenal axis integral larger hypothalamic system determines caloric flow endocrinology 135 1125 1134 1994abstract dallman mf akana sf bhatnagar bell choi chu horsley c levin n meijer o soriano lr strack viau v starvation early signals sensors sequelae endocrinology 140 4015 4023 1999abstractfree full text guillaume v grino m conte devlox b boudouresque f oliver c corticotropin releasing factor secretion increases rat hypophyseal portal blood insulin induced hypoglycaemia neuroendocrinology 49 676 679 1989isimedline ahima rs prabakaran d mantzoros c qu d lowell b maratos flier e flier js role leptin neuroendocrine response fasting nature 382 250 253 1996crossrefisimedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behaviour cell 92 573 585 1998crossrefisimedline kalra sp dube mg pu xu b horvath tl kalra ps interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 20 68 100 1999abstractfree full text ida nakahara k katayama murakami n nakazato m effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neurpeptide y various behavioural aspects rats brain res 821 526 529 1999crossrefisimedline samson wk gosnell b chang jk resch zt murphy tc cardiovascular regulatory actions hypocretins brain brain res 831 248 253 1999crossrefisimedline takahashi n okumura yamada h kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999crossrefisimedline pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinising hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998crossrefisimedline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999crossrefisimedline cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g hypothalamic orexin expression modulation blood glucose feeding diabetes 48 2132 2137 1999abstract griffond b risold py jacquemard c colard c fellman d insulin induced hypoglycaemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 262 77 80 1999crossrefisimedline lopez m seoane l garcia mc lago f casanueva ff senaris r dieguez c leptin regulation prepro orexin orexin receptor mrna levels hypothalamus biochem biophys res commun 269 41 45 2000crossrefisimedline lu xy bagnol d burke akil h watson sj differential distribution regulation ox1 ox2 orexinhypocretin receptor messenger rna brain upon fasting horm behav 37 335 344 2000crossrefisimedline bornstein sr uhlmann k haidan ehrhart bornstein m scherbaum wa evidence novel peripheral action leptin metabolic signal adrenal gland leptin inhibits cortisol release directly diabetes 46 1235 1238 1997abstract nussdorfer gg gottardo g neuropeptide y family peptides autocrine regulation adrenocortical function horm metab res 30 368 373 1998isimedline johren o neidert sj kummer m dendorfer dominiak p prepro orexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 142 3324 3331 2001abstractfree full text malendowicz lk tortorella c nussdorfer gg orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylate cyclase dependent signaling cascade j steroid biochem mol biol 70 185 188 1999crossrefisimedline lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline pfaffl mw new mathematical model relative quantification real time rt pcr nucleic acids res 1 e45 2000crossref smith pk krohn ri hermanson gt mallia ak gartner fh provenzano md fujimoto ek goeke nm olson bj klenk dc measurement protein using bicinchoninic acid anal biochem 15076 85 1985crossrefisimedline randeva hs karteris e grammatopoulos d hillhouse ew expression orexin functional orexin type 2 receptors human adult adrenals implications adrenal function energy homeostasis j clin endocrinol metab 86 4808 4813 2001abstractfree full text karteris e papadopoulou n grammatopoulos dk hillhouse ew expression signalling characteristics corticotrophin releasing hormone receptors implantation phase human endometrium j mol endocrinol 32 21 32 2004abstractfree full text offermanns schultz g rosenthal w identification receptor activated g proteins photoreactive gtp analog alpha 32pgtp azidoanilide methods enzymol 195 286 301 1991isimedline balasko m szelenyi z szekely m central thermoregulatory effects neuropeptide y orexin rats acta physiol hung 86 219 222 1999medline cao gy considine rv lynn rb leptin receptors adrenal medulla rat j physiol endocrinol metab 273 e448 e452 1997abstractfree full text nanmoku isobe k sakurai yamanaka takekoshi k kawakami y ishii k goto k nakai orexins suppress catecholamine synthesis secretion cultured pc12 cells biochem biophys res commun 274 310 315 2000crossrefisimedline cai xj denis r vernon rg clapham jc wilson arch jr williams g food restriction selectively increases hypothalamic orexin b levels lactating rats regul pept 97 163 168 2001crossrefisimedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h centrally administered orexinhypocretin activates hpa axis rats neuroreport 11 1977 1980 2000isimedline yamanaka beuckmann ct willie jt hara j tsujino n mieda m tominaga m yagami k sugiyama f goto k yanagisawa m sakurai hypothalamic orexin neurons regulate arousal according energy balance mice neuron 38 701 13 2003crossrefisimedline trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 43871 5 1998crossrefisimedline lopez m seoane l senaris rm dieguez c prepro orexin mrna levels rat hypothalamus orexin receptors mrna levels rat hypothalamus adrenal gland influenced thyroid status neurosci lett 300 171 175 2001crossrefisimedline krieger dt hauser h comparison synchronisation circadian corticosteroid rhythms photoperiod food proc natl acad sci usa 75 1577 1581 1978abstract mazzocchi g malendowicz lk gottardo l aragona f nussdorfer gg orexin stimulates cortisol secretion human adrenocortical cells activation adenylate cyclase dependent signaling cascade j clin endocrinol metab 86 778 782 2001abstractfree full text bergendahl m perheentupa huhtaniemi effect short term starvation reproductive hormone gene expression secretion receptor levels male rats j endocrinol 121 409 417 1989abstract johren o bruggemann n dendorfer dominiak p gonadal steroids differentially regulate messenger ribonucleic acid expression pituitary orexin type 1 receptors adrenal orexin type 2 receptors endocrinology 144 1219 1225 2003abstractfree full text eriksson ks sergeeva o brown re haas hl orexinhypocretin excites histaminergic neurons tuberomammillary nucleus j neurosci 21 9273 9279 2001abstractfree full text lund pe shariatmadari r uustare detheux m parmentier m kukkonen jp akerman ke orexin ox1 receptor activates novel ca2 influx pathway necessary coupling phospholipase c j biol chem 275 30806 30812 2000abstractfree full text van den pol gao xb obrietan k kilduff ts belousov ab presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 18 7962 7971 1998abstractfree full text martin g fabre v siggins gr de lecea l interaction hypocretins neurotransmitters nucleus accumbens regul pept 104 111 117 2002crossrefisimedline grammatopoulos dk randeva hs levine ma kanellopoulou ka hillhouse ew rat cerebral cortex corticotropin releasing hormone receptors evidence receptor coupling multiple g proteins j neurochem 2 509 519 2001 karteris e randeva hs grammatopoulos dk jaffe rb hillhouse ew expression coupling characteristics crh orexin type 2 receptors human fetal adrenals j clin endocrinol metab 86 4512 4519 2001abstractfree full text article abstract full text pdf versions article 2886e1089 recent 003512004v1 alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager search citing articles isi web science 3 google scholar articles karteris e articles randeva h articles citing article pubmed pubmed citation articles karteris e articles randeva h
0.18766233.15687100.html.plaintext.txt	110	references top abstract materials methods results discussion grants references schwartz mw dallman mf woods sc hypothalamus response starvation implications study wasting disorders j physiol regul integr comp physiol 269 r949 r957 1995abstractfree full text akana sf strack hanson es dallman mf regulation activity hypothalamic pituitary adrenal axis integral larger hypothalamic system determines caloric flow endocrinology 135 1125 1134 1994abstract dallman mf akana sf bhatnagar bell choi chu horsley c levin n meijer o soriano lr strack viau v starvation early signals sensors sequelae endocrinology 140 4015 4023 1999abstractfree full text guillaume v grino m conte devlox b boudouresque f oliver c corticotropin releasing factor secretion increases rat hypophyseal portal blood insulin induced hypoglycaemia neuroendocrinology 49 676 679 1989isimedline ahima rs prabakaran d mantzoros c qu d lowell b maratos flier e flier js role leptin neuroendocrine response fasting nature 382 250 253 1996crossrefisimedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behaviour cell 92 573 585 1998crossrefisimedline kalra sp dube mg pu xu b horvath tl kalra ps interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 20 68 100 1999abstractfree full text ida nakahara k katayama murakami n nakazato m effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neurpeptide y various behavioural aspects rats brain res 821 526 529 1999crossrefisimedline samson wk gosnell b chang jk resch zt murphy tc cardiovascular regulatory actions hypocretins brain brain res 831 248 253 1999crossrefisimedline takahashi n okumura yamada h kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999crossrefisimedline pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinising hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998crossrefisimedline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999crossrefisimedline cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g hypothalamic orexin expression modulation blood glucose feeding diabetes 48 2132 2137 1999abstract griffond b risold py jacquemard c colard c fellman d insulin induced hypoglycaemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 262 77 80 1999crossrefisimedline lopez m seoane l garcia mc lago f casanueva ff senaris r dieguez c leptin regulation prepro orexin orexin receptor mrna levels hypothalamus biochem biophys res commun 269 41 45 2000crossrefisimedline lu xy bagnol d burke akil h watson sj differential distribution regulation ox1 ox2 orexinhypocretin receptor messenger rna brain upon fasting horm behav 37 335 344 2000crossrefisimedline bornstein sr uhlmann k haidan ehrhart bornstein m scherbaum wa evidence novel peripheral action leptin metabolic signal adrenal gland leptin inhibits cortisol release directly diabetes 46 1235 1238 1997abstract nussdorfer gg gottardo g neuropeptide y family peptides autocrine regulation adrenocortical function horm metab res 30 368 373 1998isimedline johren o neidert sj kummer m dendorfer dominiak p prepro orexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 142 3324 3331 2001abstractfree full text malendowicz lk tortorella c nussdorfer gg orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylate cyclase dependent signaling cascade j steroid biochem mol biol 70 185 188 1999crossrefisimedline lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline pfaffl mw new mathematical model relative quantification real time rt pcr nucleic acids res 1 e45 2000crossref smith pk krohn ri hermanson gt mallia ak gartner fh provenzano md fujimoto ek goeke nm olson bj klenk dc measurement protein using bicinchoninic acid anal biochem 15076 85 1985crossrefisimedline randeva hs karteris e grammatopoulos d hillhouse ew expression orexin functional orexin type 2 receptors human adult adrenals implications adrenal function energy homeostasis j clin endocrinol metab 86 4808 4813 2001abstractfree full text karteris e papadopoulou n grammatopoulos dk hillhouse ew expression signalling characteristics corticotrophin releasing hormone receptors implantation phase human endometrium j mol endocrinol 32 21 32 2004abstractfree full text offermanns schultz g rosenthal w identification receptor activated g proteins photoreactive gtp analog alpha 32pgtp azidoanilide methods enzymol 195 286 301 1991isimedline balasko m szelenyi z szekely m central thermoregulatory effects neuropeptide y orexin rats acta physiol hung 86 219 222 1999medline cao gy considine rv lynn rb leptin receptors adrenal medulla rat j physiol endocrinol metab 273 e448 e452 1997abstractfree full text nanmoku isobe k sakurai yamanaka takekoshi k kawakami y ishii k goto k nakai orexins suppress catecholamine synthesis secretion cultured pc12 cells biochem biophys res commun 274 310 315 2000crossrefisimedline cai xj denis r vernon rg clapham jc wilson arch jr williams g food restriction selectively increases hypothalamic orexin b levels lactating rats regul pept 97 163 168 2001crossrefisimedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h centrally administered orexinhypocretin activates hpa axis rats neuroreport 11 1977 1980 2000isimedline yamanaka beuckmann ct willie jt hara j tsujino n mieda m tominaga m yagami k sugiyama f goto k yanagisawa m sakurai hypothalamic orexin neurons regulate arousal according energy balance mice neuron 38 701 13 2003crossrefisimedline trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 43871 5 1998crossrefisimedline lopez m seoane l senaris rm dieguez c prepro orexin mrna levels rat hypothalamus orexin receptors mrna levels rat hypothalamus adrenal gland influenced thyroid status neurosci lett 300 171 175 2001crossrefisimedline krieger dt hauser h comparison synchronisation circadian corticosteroid rhythms photoperiod food proc natl acad sci usa 75 1577 1581 1978abstract mazzocchi g malendowicz lk gottardo l aragona f nussdorfer gg orexin stimulates cortisol secretion human adrenocortical cells activation adenylate cyclase dependent signaling cascade j clin endocrinol metab 86 778 782 2001abstractfree full text bergendahl m perheentupa huhtaniemi effect short term starvation reproductive hormone gene expression secretion receptor levels male rats j endocrinol 121 409 417 1989abstract johren o bruggemann n dendorfer dominiak p gonadal steroids differentially regulate messenger ribonucleic acid expression pituitary orexin type 1 receptors adrenal orexin type 2 receptors endocrinology 144 1219 1225 2003abstractfree full text eriksson ks sergeeva o brown re haas hl orexinhypocretin excites histaminergic neurons tuberomammillary nucleus j neurosci 21 9273 9279 2001abstractfree full text lund pe shariatmadari r uustare detheux m parmentier m kukkonen jp akerman ke orexin ox1 receptor activates novel ca2 influx pathway necessary coupling phospholipase c j biol chem 275 30806 30812 2000abstractfree full text van den pol gao xb obrietan k kilduff ts belousov ab presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 18 7962 7971 1998abstractfree full text martin g fabre v siggins gr de lecea l interaction hypocretins neurotransmitters nucleus accumbens regul pept 104 111 117 2002crossrefisimedline grammatopoulos dk randeva hs levine ma kanellopoulou ka hillhouse ew rat cerebral cortex corticotropin releasing hormone receptors evidence receptor coupling multiple g proteins j neurochem 2 509 519 2001 karteris e randeva hs grammatopoulos dk jaffe rb hillhouse ew expression coupling characteristics crh orexin type 2 receptors human fetal adrenals j clin endocrinol metab 86 4512 4519 2001abstractfree full text article abstract full text pdf versions article 2886e1089 recent 003512004v1 alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager search citing articles isi web science 3 google scholar articles karteris e articles randeva h articles citing article pubmed pubmed citation articles karteris e articles randeva h
0.18766233.15687100.html.plaintext.txt	111	home help feedback subscriptions archive search table contents visit aps journals online copyright 2005 american physiological society
0.18986537.11878678.html.plaintext.txt	0	editorial central noradrenergic neurones mechanism general anaesthesia k hirota kushikata
0.18986537.11878678.html.plaintext.txt	1	modern anaesthetics main safe predictable use highly efficient moreover could argued without properties major advances surgical practice often highlighted media could taken place however example pharmacology production anaesthetic state remains somewhat mystery mystery results controversies related existence unitary anaesthetic target site direct observation clinical anaesthesia seems unlikely different anaesthetic agents produce different types anaesthesia gabaa receptors long held unifying cellular target exceptions others also suggested editorial consider evidence support role noradrenergic transmission wiring target anaesthetic action clear role system analgesia considered
0.18986537.11878678.html.plaintext.txt	2	modern anaesthetics main safe predictable use highly efficient moreover could argued without properties major advances surgical practice often highlighted media could taken place however example pharmacology production anaesthetic state remains somewhat mystery mystery results controversies related existence unitary anaesthetic target site direct observation clinical anaesthesia seems unlikely different anaesthetic agents produce different types anaesthesia gabaa receptors long held unifying cellular target exceptions others also suggested editorial consider evidence support role noradrenergic transmission wiring target anaesthetic action clear role system analgesia considered
0.18986537.11878678.html.plaintext.txt	3	norepinephrine major central nervous system neurotransmitter brainstem noradrenergic neurones great importance regulation range behaviours including sleep wake cycle feeding thermoregulation attention motor activity growth development1 addition many studies suggesting noradrenergic systems may involved production anaesthetic state brain a1 a2 a5 a7 noradrenergic clusters constituting lateral tegmental area project thalamus hypothalamus2 locus coeruleus a6 cluster distinct lateral tegmental area innervates cerebral cortex hippocampus cerebellum spinal cord 2
0.18986537.11878678.html.plaintext.txt	4	norepinephrine major central nervous system neurotransmitter brainstem noradrenergic neurones great importance regulation range behaviours including sleep wake cycle feeding thermoregulation attention motor activity growth development1 addition many studies suggesting noradrenergic systems may involved production anaesthetic state brain a1 a2 a5 a7 noradrenergic clusters constituting lateral tegmental area project thalamus hypothalamus2 locus coeruleus a6 cluster distinct lateral tegmental area innervates cerebral cortex hippocampus cerebellum spinal cord 2
0.18986537.11878678.html.plaintext.txt	5	activity locus coeruleus neurones slow regular wakefulness3 contrast animal becomes drowsy entering slow wave rem sleep decrease discharge rate rem sleep neurones silent3 interestingly noradrenergic projections cerebrocortex originate locus coeruleus3
0.18986537.11878678.html.plaintext.txt	6	activity locus coeruleus neurones slow regular wakefulness3 contrast animal becomes drowsy entering slow wave rem sleep decrease discharge rate rem sleep neurones silent3 interestingly noradrenergic projections cerebrocortex originate locus coeruleus3
0.18986537.11878678.html.plaintext.txt	7	preoptic area receives input locus coeruleus a6 lateral tegmental group a1 a2 a5 a7 noradrenergic neurones 4 addition neurones preoptic area project back locus coeruleus5 area plays important role sleep hypnosis role noradrenergic neurones area previous studies6 suggest norepinephrine neurones preoptic area may contribute wakefulness direct activation injection norepinephrine area inhibits sleep however several studies also suggest norepinephrine neurones may involved induction sleep7 8 mohan kumar colleagues7 reported microinjection norepinephrine medial preoptic area destruction ventral noradrenergic bundle induced sleep group also reported mild reduction sleep increase wakefulness destruction catecholaminergic terminals medial preoptic area bilateral intracerebral injection 6 hydroxydopamine8 thus appears noradrenergic fibres medial preoptic area may hypnogenic
0.18986537.11878678.html.plaintext.txt	8	preoptic area receives input locus coeruleus a6 lateral tegmental group a1 a2 a5 a7 noradrenergic neurones 4 addition neurones preoptic area project back locus coeruleus5 area plays important role sleep hypnosis role noradrenergic neurones area previous studies6 suggest norepinephrine neurones preoptic area may contribute wakefulness direct activation injection norepinephrine area inhibits sleep however several studies also suggest norepinephrine neurones may involved induction sleep7 8 mohan kumar colleagues7 reported microinjection norepinephrine medial preoptic area destruction ventral noradrenergic bundle induced sleep group also reported mild reduction sleep increase wakefulness destruction catecholaminergic terminals medial preoptic area bilateral intracerebral injection 6 hydroxydopamine8 thus appears noradrenergic fibres medial preoptic area may hypnogenic
0.18986537.11878678.html.plaintext.txt	9	central noradrenergic neurones regulated ss adrenergic receptors reported 1 adrenoceptor antagonist prazosin given orally increased active waking slow wave sleep decreased paradoxical sleep rat9 contrast 1 adrenoceptor stimulation systemic methoxamine increased aroused wakefulness decreased slow wave sleep paradoxical sleep cats10 addition prazosin increased 1 agonist st 587 decreased duration thiopental anaesthesia rats11 matsumoto colleagues also reported direct intracerebroventricular administration methoxamine dose dependently reduced pentobarbital anaesthesia time mice12 central physiological effects 2 agonists attributed 2 adrenoceptors present locus coeruleus13 rats microinjection 2 agonist dexmedetomedine locus coeruleus per se produces anaesthesia defined loss righting reflex14 2 agonists also reduce anaesthetic requirement human many species15 contrast data 2 antagonist yohimbine decreases sleep16 anaesthesia time15 variety non human species
0.18986537.11878678.html.plaintext.txt	10	central noradrenergic neurones regulated ss adrenergic receptors reported 1 adrenoceptor antagonist prazosin given orally increased active waking slow wave sleep decreased paradoxical sleep rat9 contrast 1 adrenoceptor stimulation systemic methoxamine increased aroused wakefulness decreased slow wave sleep paradoxical sleep cats10 addition prazosin increased 1 agonist st 587 decreased duration thiopental anaesthesia rats11 matsumoto colleagues also reported direct intracerebroventricular administration methoxamine dose dependently reduced pentobarbital anaesthesia time mice12 central physiological effects 2 agonists attributed 2 adrenoceptors present locus coeruleus13 rats microinjection 2 agonist dexmedetomedine locus coeruleus per se produces anaesthesia defined loss righting reflex14 2 agonists also reduce anaesthetic requirement human many species15 contrast data 2 antagonist yohimbine decreases sleep16 anaesthesia time15 variety non human species
0.18986537.11878678.html.plaintext.txt	11	angel group showed propranolol non selective ss antagonist dose dependently increased sleep time16 thiopental anaesthesia time11 rats however failed show effect selective ss1 antagonists metoprolol atenolol11 17 also studied role ss2 adrenoceptors sleep general anaesthesia11 16 17 found selective ss2 antagonist ici 118551 increased sleep time16 duration thiopental anaesthesia17 collectively data indicate effects non selective antagonist propranolol may mediated via ss2 adrenoceptors
0.18986537.11878678.html.plaintext.txt	12	angel group showed propranolol non selective ss antagonist dose dependently increased sleep time16 thiopental anaesthesia time11 rats however failed show effect selective ss1 antagonists metoprolol atenolol11 17 also studied role ss2 adrenoceptors sleep general anaesthesia11 16 17 found selective ss2 antagonist ici 118551 increased sleep time16 duration thiopental anaesthesia17 collectively data indicate effects non selective antagonist propranolol may mediated via ss2 adrenoceptors
0.18986537.11878678.html.plaintext.txt	13	recently identified rat hypothalamus neuropeptides orexin b18 endogenous agonists g protein coupled orexin 1 ox1 ox2 receptors18 orexin equal affinity ox1 ox2 orexin b higher affinity ox2 orexins receptors widely distributed brain18 orexins activate locus coeruleus noradrenergic system activation may increase arousal locomotor activity19 addition several reports20 suggest link orexin receptors narcolepsy therefore modulation noradrenergic neurones orexins receptors may contribute control sleep wake cycle moreover suggest neuropeptides receptors may also involved general anaesthesia although remains examined
0.18986537.11878678.html.plaintext.txt	14	recently identified rat hypothalamus neuropeptides orexin b18 endogenous agonists g protein coupled orexin 1 ox1 ox2 receptors18 orexin equal affinity ox1 ox2 orexin b higher affinity ox2 orexins receptors widely distributed brain18 orexins activate locus coeruleus noradrenergic system activation may increase arousal locomotor activity19 addition several reports20 suggest link orexin receptors narcolepsy therefore modulation noradrenergic neurones orexins receptors may contribute control sleep wake cycle moreover suggest neuropeptides receptors may also involved general anaesthesia although remains examined
0.18986537.11878678.html.plaintext.txt	15	based considerations others began systematic evaluation range anaesthetic agents central norepinephrine release using vivo microdialysis techniques mizuno colleagues reported intraperitoneal pentobarbital inhibited norepinephrine release medial preoptic area rats4 addition shown systemic administration midazolam propofol significantly reduced norepinephrine release medial prefrontal cortex21 pentobarbital ineffective22 noradrenergic neurones prefrontal cortex receive innervation locus coeruleus3 activity noradrenergic neurones prefrontal cortex indirectly reflects locus coeruleus activity thus anaesthetics activate enhance gabaa receptors may reduce noradrenergic neuronal activity contrast ketamine21 22 nitrous oxide xenon23 nmda receptor antagonistic actions markedly increased norepinephrine release prefrontal cortex preoptic area rats clearly anaesthetic modulation norepinephrine release depends type anaesthetic might argue noradrenergic transmission anaesthetic target however already mentioned unitary site highly unlikely loss consciousness results reduction cerebral activity also result cerebral excitation occurs convulsions addition sleepiness induced hypothermia also increased body temperature activates heat sensitive neurones preoptic area24 feel wakefulness may occur set range range exceeded unconsciousness may occur support hypothesis found physostigmine reported antagonize ketamine anaesthesia reduced duration ketamine anaesthesia ketamine increased norepinephrine release rat prefrontal cortex25
0.18986537.11878678.html.plaintext.txt	16	based considerations others began systematic evaluation range anaesthetic agents central norepinephrine release using vivo microdialysis techniques mizuno colleagues reported intraperitoneal pentobarbital inhibited norepinephrine release medial preoptic area rats4 addition shown systemic administration midazolam propofol significantly reduced norepinephrine release medial prefrontal cortex21 pentobarbital ineffective22 noradrenergic neurones prefrontal cortex receive innervation locus coeruleus3 activity noradrenergic neurones prefrontal cortex indirectly reflects locus coeruleus activity thus anaesthetics activate enhance gabaa receptors may reduce noradrenergic neuronal activity contrast ketamine21 22 nitrous oxide xenon23 nmda receptor antagonistic actions markedly increased norepinephrine release prefrontal cortex preoptic area rats clearly anaesthetic modulation norepinephrine release depends type anaesthetic might argue noradrenergic transmission anaesthetic target however already mentioned unitary site highly unlikely loss consciousness results reduction cerebral activity also result cerebral excitation occurs convulsions addition sleepiness induced hypothermia also increased body temperature activates heat sensitive neurones preoptic area24 feel wakefulness may occur set range range exceeded unconsciousness may occur support hypothesis found physostigmine reported antagonize ketamine anaesthesia reduced duration ketamine anaesthesia ketamine increased norepinephrine release rat prefrontal cortex25
0.18986537.11878678.html.plaintext.txt	17	collectively data presented editorial provide compelling evidence favour role noradrenergic transmission control wakefulness production mysterious anaesthetic state
0.18986537.11878678.html.plaintext.txt	18	university hirosaki school medicine
0.18986537.11878678.html.plaintext.txt	19	1 steriade m mccarley rw neurotransmitter modulated ionic currents brainstem neurons targets steriade m mccarley rw eds brainstem control wakefulness sleep new york plenum press 1990 164 203
0.18986537.11878678.html.plaintext.txt	20	2 nieuwenhuys r survey chemically defined cell groups pathways nieuwenhuys r ed chemoarchitecture brain berlin springer verlag 1985 7 113
0.18986537.11878678.html.plaintext.txt	21	3 berridge cw abercrombie ed relationship locus coeruleus discharge rates rates norepinephrine release within neocortex assessed vivo microdialysis neuroscience1999 93 1263 70isimedline
0.18986537.11878678.html.plaintext.txt	22	4 mizuno ito e kimura f pentobarbital sodium inhibits release noradrenaline medial preoptic area neurosci lett1994 170 111 3isimedline
0.18986537.11878678.html.plaintext.txt	23	5 osaka matsumura h noradrenergic inputs sleep related neurons preoptic area locus coeruleus ventrolateral medulla rat neurosci res 1994 19 39 50isimedline
0.18986537.11878678.html.plaintext.txt	24	6 osaka matsumura h noradrenaline inhibits preoptic sleep active neurons 2 receptors rat neurosci res1995 21 323 30isimedline
0.18986537.11878678.html.plaintext.txt	25	7 mohan kumar v sharma r wadhwa manchanda sk sleep inducing function noradrenergic fibers medial preoptic area brain res bull 1993 32 153 8isimedline
0.18986537.11878678.html.plaintext.txt	26	7 mohan kumar v sharma r wadhwa manchanda sk sleep inducing function noradrenergic fibers medial preoptic area brain res bull 1993 32 153 8isimedline
0.18986537.11878678.html.plaintext.txt	27	8 ramesh v mohan kumar v changes sleep wakefulness 6 hydroxydopamine lesion preoptic area neuroscience 2000 98 549 53isimedline
0.18986537.11878678.html.plaintext.txt	28	9 kleinlogel h effects selective alpha 1 adrenoceptor blocker prazocin eeg sleep waking stages rat neuropsychobiology1989 21 100 3isimedline
0.18986537.11878678.html.plaintext.txt	29	10 hilakivi leoppavuori effects methoxamine alpha 1 adrenoceptor agonist prazosin alpha 1 antagonist stages sleep waking cycle cat acta physiol scand 1984 120 363 72isimedline
0.18986537.11878678.html.plaintext.txt	30	11 mason st angel anaesthesia role adrenergic mechanisms eur j pharmacol 1983 91 29 39isimedline
0.18986537.11878678.html.plaintext.txt	31	12 matsumoto k kohno si ojima k watanabe h flumazenil fg7142 reverses decrease pentobarbital sleep caused activation central noradrenergic systems mice brain res 1997 754 325 28isimedline
0.18986537.11878678.html.plaintext.txt	32	12 matsumoto k kohno si ojima k watanabe h flumazenil fg7142 reverses decrease pentobarbital sleep caused activation central noradrenergic systems mice brain res 1997 754 325 28isimedline
0.18986537.11878678.html.plaintext.txt	33	13 callodo lf stamford ja spatiotemporal interaction 2 autoreceptors noradrenaline transporters rat locus coeruleus implications volume transmission j neurochem 2000 74 2350 8isimedline
0.18986537.11878678.html.plaintext.txt	34	14 nacif coelhoc correa sales c chang ll maze m perturbation ion channel conductance alters hypnotic response 2 adrenergic agonist dexmedetomidine locus coeruleus rat anesthesiology 1994 81 1527 34isimedline
0.18986537.11878678.html.plaintext.txt	35	14 nacif coelhoc correa sales c chang ll maze m perturbation ion channel conductance alters hypnotic response 2 adrenergic agonist dexmedetomidine locus coeruleus rat anesthesiology 1994 81 1527 34isimedline
0.18986537.11878678.html.plaintext.txt	36	15 maze m tranquilli w alpha 2 adrenergic agonists defining role clinical anesthesia anesthesiology 1991 74 581 605isimedline
0.18986537.11878678.html.plaintext.txt	37	16 angel majeed ab alterations sleeping time rat induced drugs modulate central monoaminergic systems br j anaesth 1990 64 594 600abstract
0.18986537.11878678.html.plaintext.txt	38	17 mason st angel brain noradrenaline anaesthesia characterization beta receptor neuropharmacology 1983 22 1065 9isimedline
0.18986537.11878678.html.plaintext.txt	39	18 smart d orexins new family neuropeptides br j anaesth1999 83 695 7free full text
0.18986537.11878678.html.plaintext.txt	40	19 hagan jj leslie ra patel et al orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 1999 96 10911 6abstractfree full text
0.18986537.11878678.html.plaintext.txt	41	19 hagan jj leslie ra patel et al orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 1999 96 10911 6abstractfree full text
0.18986537.11878678.html.plaintext.txt	42	20 lin l faraco j li r et al sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 1999 98 365 76isimedline
0.18986537.11878678.html.plaintext.txt	43	20 lin l faraco j li r et al sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 1999 98 365 76isimedline
0.18986537.11878678.html.plaintext.txt	44	21 kubota k hirota k yoshida h et al effects sedatives noradrenaline release medial prefrontal cortex rats gabaa receptor activator vs nmda receptor inhibitor psychopharmacology 1999 146 335 8isimedline
0.18986537.11878678.html.plaintext.txt	45	21 kubota k hirota k yoshida h et al effects sedatives noradrenaline release medial prefrontal cortex rats gabaa receptor activator vs nmda receptor inhibitor psychopharmacology 1999 146 335 8isimedline
0.18986537.11878678.html.plaintext.txt	46	22 kubota anzawa n hirota k yoshida h matsuki effects ketamine pentobarbital norepinephrine release median frontal cortex rats j anaesth 1999 46 388 92abstract
0.18986537.11878678.html.plaintext.txt	47	22 kubota anzawa n hirota k yoshida h matsuki effects ketamine pentobarbital norepinephrine release median frontal cortex rats j anaesth 1999 46 388 92abstract
0.18986537.11878678.html.plaintext.txt	48	23 yoshida h kushikata kubota hirota k ishihara h matsuki increased norepinephrine release anterior posterior hypothalamus following xenon inhalation j anesth 2001 48 651 5abstractfree full text
0.18986537.11878678.html.plaintext.txt	49	23 yoshida h kushikata kubota hirota k ishihara h matsuki increased norepinephrine release anterior posterior hypothalamus following xenon inhalation j anesth 2001 48 651 5abstractfree full text
0.18986537.11878678.html.plaintext.txt	50	24 alam mn mcginity d szymusiak r neuronal discharge preopticanterior hypothalamus thermosensitive neurons relation nrem sleep j physiol 1995 269 r1240 9abstractfree full text
0.18986537.11878678.html.plaintext.txt	51	24 alam mn mcginity d szymusiak r neuronal discharge preopticanterior hypothalamus thermosensitive neurons relation nrem sleep j physiol 1995 269 r1240 9abstractfree full text
0.18986537.11878678.html.plaintext.txt	52	25 kubota k hirota k anzawa n yoshida h takahashi matsuki physostigmine antagonizes ketamine induced noradrenaline release medial prefrontal cortex rats brain res 1999 840 175 8isimedline
0.18986537.11878678.html.plaintext.txt	53	25 kubota k hirota k anzawa n yoshida h takahashi matsuki physostigmine antagonizes ketamine induced noradrenaline release medial prefrontal cortex rats brain res 1999 840 175 8isimedline
0.20187694.15557013.html.plaintext.txt	0	orexin stimulates breathing via medullary spinal pathways john k young1 mingfei wu1 kebreten f manaye1 prabha kc1 joanne allard1 serdia o mack1 musa haxhiu12
0.20187694.15557013.html.plaintext.txt	1	orexin stimulates breathing via medullary spinal pathways john k young1 mingfei wu1 kebreten f manaye1 prabha kc1 joanne allard1 serdia o mack1 musa haxhiu12
0.20187694.15557013.html.plaintext.txt	2	1howard university specialized neuroscience research program departments physiology anatomy washington district columbia 2departments pediatrics anatomy case western university cleveland ohio
0.20187694.15557013.html.plaintext.txt	3	submitted 20 august 2004 accepted final form 10 november 2004
0.20187694.15557013.html.plaintext.txt	4	abstract top abstract materials methods results discussion grants references central neuronal network regulates respiration may include hypothalamic neurons produce orexin peptide influences sleep arousal experiments investigated 1 projections orexin containing neurons pre botzinger region rostral ventrolateral medulla regulates rhythmic breathing phrenic motoneurons innervate diaphragm 2 presence orexin receptors pre botzinger region phrenic motoneurons 3 physiological effects orexin administered pre botzinger region phrenic nuclei c3 c4 levels found orexin containing fibers within pre botzinger complex however 05 orexin containing neurons projected pre botzinger region whereas 29 orexin containing neurons innervated phrenic nucleus neurons pre botzinger region phrenic nucleus stained orexin receptors activation orexin receptors microperfusion orexin either site produced dose dependent significant p 005 increase diaphragm electromyographic activity data indicate orexin regulates respiratory activity may role pathophysiology sleep related respiratory disorders
0.20187694.15557013.html.plaintext.txt	5	abstract top abstract materials methods results discussion grants references central neuronal network regulates respiration may include hypothalamic neurons produce orexin peptide influences sleep arousal experiments investigated 1 projections orexin containing neurons pre botzinger region rostral ventrolateral medulla regulates rhythmic breathing phrenic motoneurons innervate diaphragm 2 presence orexin receptors pre botzinger region phrenic motoneurons 3 physiological effects orexin administered pre botzinger region phrenic nuclei c3 c4 levels found orexin containing fibers within pre botzinger complex however 05 orexin containing neurons projected pre botzinger region whereas 29 orexin containing neurons innervated phrenic nucleus neurons pre botzinger region phrenic nucleus stained orexin receptors activation orexin receptors microperfusion orexin either site produced dose dependent significant p 005 increase diaphragm electromyographic activity data indicate orexin regulates respiratory activity may role pathophysiology sleep related respiratory disorders
0.20187694.15557013.html.plaintext.txt	6	hypothalamus pre botzinger region phrenic motor neurons orexin 1 receptors sleep apnea
0.20187694.15557013.html.plaintext.txt	7	breathing active neurally controlled process regulated neural mechanisms adjust respiratory related drive behavioral state metabolic demands organism hypothalamic neurons part controlling system play important role regulation breathing rate depth 14 26
0.20187694.15557013.html.plaintext.txt	8	breathing active neurally controlled process regulated neural mechanisms adjust respiratory related drive behavioral state metabolic demands organism hypothalamic neurons part controlling system play important role regulation breathing rate depth 14 26
0.20187694.15557013.html.plaintext.txt	9	neurons lateral hypothalamus synthesize orexin orexin b also called hypocretin 1 hcrt 1 hypocretin 2 hcrt 2 peptide neurotransmitters processed common precursor prepro orexin encoded gene localized human chromosome 17q2 orexin containing neurons affect autonomic neuroendocrine sleep wakefulness neuroregulatory systems turn could potentially influence breathing 9 13 16 19
0.20187694.15557013.html.plaintext.txt	10	neurons lateral hypothalamus synthesize orexin orexin b also called hypocretin 1 hcrt 1 hypocretin 2 hcrt 2 peptide neurotransmitters processed common precursor prepro orexin encoded gene localized human chromosome 17q2 orexin containing neurons affect autonomic neuroendocrine sleep wakefulness neuroregulatory systems turn could potentially influence breathing 9 13 16 19
0.20187694.15557013.html.plaintext.txt	11	orexins stimulate target cells via two orexin g protein coupled receptors orexin r1 orexin r2 40 proposed orexin containing neurons promote wakefulness excitation cholinergic neurons basal forebrain release acetylcholine thereby contribute cortical activation wakefulness however causality associations remains determined wakefulness often accompanied behavioral activation suppression rapid eye movement sleep occurs inhibition cholinergic neurons laterodorsal tegmental pedunculopontine nuclei 49
0.20187694.15557013.html.plaintext.txt	12	orexins stimulate target cells via two orexin g protein coupled receptors orexin r1 orexin r2 40 proposed orexin containing neurons promote wakefulness excitation cholinergic neurons basal forebrain release acetylcholine thereby contribute cortical activation wakefulness however causality associations remains determined wakefulness often accompanied behavioral activation suppression rapid eye movement sleep occurs inhibition cholinergic neurons laterodorsal tegmental pedunculopontine nuclei 49
0.20187694.15557013.html.plaintext.txt	13	central nervous system orexin containing neurons innervate multiple sites including cell groups brain stem spinal cord involved regulation cardiovascular functions 10 19 25 43 45 however information projections orexin containing neurons respiratory related brain stem regions spinal cord motoneurons innervate respiratory muscles diaphragm furthermore known whether brain stem region involved generation inspiratory rhythmic activity pre botzinger complex ventrolateral medulla andor inspiratory motoneurons phrenic motor neurons express orexin receptors 42 hypothesized orexin containing neurons involved arousal also participate respiratory control via direct projections pre botzinger complex phrenic motor neurons
0.20187694.15557013.html.plaintext.txt	14	central nervous system orexin containing neurons innervate multiple sites including cell groups brain stem spinal cord involved regulation cardiovascular functions 10 19 25 43 45 however information projections orexin containing neurons respiratory related brain stem regions spinal cord motoneurons innervate respiratory muscles diaphragm furthermore known whether brain stem region involved generation inspiratory rhythmic activity pre botzinger complex ventrolateral medulla andor inspiratory motoneurons phrenic motor neurons express orexin receptors 42 hypothesized orexin containing neurons involved arousal also participate respiratory control via direct projections pre botzinger complex phrenic motor neurons
0.20187694.15557013.html.plaintext.txt	15	materials methods top abstract materials methods results discussion grants references animals
0.20187694.15557013.html.plaintext.txt	16	experimental protocols approved howard university institutional animal care use committee experiments performed male sprague dawley rats harlan indianapolis 300 350 g according national institutes health guide care use laboratory animals male rats chosen reduce potential effects hormonal cycling females
0.20187694.15557013.html.plaintext.txt	17	experimental protocols approved howard university institutional animal care use committee experiments performed male sprague dawley rats harlan indianapolis 300 350 g according national institutes health guide care use laboratory animals male rats chosen reduce potential effects hormonal cycling females
0.20187694.15557013.html.plaintext.txt	18	present study distribution neurons express orexin 1 receptors within rostral ventrolateral medulla cervical spinal cord determined define whether phrenic motor neurons express orexin receptors animals n 3 rats anesthetized pentobarbital sodium 40 mgkg retrograde tracer cholera toxin b subunit 01 ctb list biological laboratories campbell ca injected costal region diaphragm 10 sites 300 nlsite procedure specifically identifies phrenic motoneurons project diaphragm seven days ctb injections animals deeply anesthetized 50 mgkg ip pentobarbital rapidly perfused transcardially 09 buffered saline followed 4 paraformaldehyde 01 m pbs ph 74 perfused brains removed animals postfixed 4 paraformaldehyde 01 m pbs ph 74 24 h 4 degrees c cryoprotection immersion 30 sucrose 01 m pbs 4 degrees c 48 h 40 microm thick frozen sections brains prepared using leitz microtome
0.20187694.15557013.html.plaintext.txt	19	present study distribution neurons express orexin 1 receptors within rostral ventrolateral medulla cervical spinal cord determined define whether phrenic motor neurons express orexin receptors animals n 3 rats anesthetized pentobarbital sodium 40 mgkg retrograde tracer cholera toxin b subunit 01 ctb list biological laboratories campbell ca injected costal region diaphragm 10 sites 300 nlsite procedure specifically identifies phrenic motoneurons project diaphragm seven days ctb injections animals deeply anesthetized 50 mgkg ip pentobarbital rapidly perfused transcardially 09 buffered saline followed 4 paraformaldehyde 01 m pbs ph 74 perfused brains removed animals postfixed 4 paraformaldehyde 01 m pbs ph 74 24 h 4 degrees c cryoprotection immersion 30 sucrose 01 m pbs 4 degrees c 48 h 40 microm thick frozen sections brains prepared using leitz microtome
0.20187694.15557013.html.plaintext.txt	20	experiments immunostaining procedures orexin receptors performed sequentially rather simultaneously previous studies laboratory demonstrated approach provides better specificity lower background staining 26 briefly enhance immunoreactivity free floating sections brain stem cervical spinal cord c3 c5 region washed pbs incubated 10 mm citric acid 37 degrees c 1 h followed three washes pbs incubation 30 min pbs triton solution containing 1 normal serum block nonspecific binding sites wash sections incubated 24 h 4 degrees c pbs triton solution containing rabbit anti orexin 1 receptor antibody chemicon international 1400 dilution sections rinsed incubated 2 h 1200 dilution goat anti rabbit igg conjugated alexa fluro 488 fluorescein isothiocyanate fitc molecular probes eugene
0.20187694.15557013.html.plaintext.txt	21	experiments immunostaining procedures orexin receptors performed sequentially rather simultaneously previous studies laboratory demonstrated approach provides better specificity lower background staining 26 briefly enhance immunoreactivity free floating sections brain stem cervical spinal cord c3 c5 region washed pbs incubated 10 mm citric acid 37 degrees c 1 h followed three washes pbs incubation 30 min pbs triton solution containing 1 normal serum block nonspecific binding sites wash sections incubated 24 h 4 degrees c pbs triton solution containing rabbit anti orexin 1 receptor antibody chemicon international 1400 dilution sections rinsed incubated 2 h 1200 dilution goat anti rabbit igg conjugated alexa fluro 488 fluorescein isothiocyanate fitc molecular probes eugene
0.20187694.15557013.html.plaintext.txt	22	briefly second step sections rinsed pbs stained ctb sections placed primary polyclonal antibody solution 120 000 dilution goat anti ctb pbs triton list biological laboratories 48 h 4 degrees c sections washed twice pbs incubated 2 h 1200 solution donkey anti goat igg conjugated alexa fluro 594 texas red molecular probes sections washed mounted gelatinalum coated glass slides drop vecta shield vector laboratories burlingame ca applied air dried sections slides coverslipped
0.20187694.15557013.html.plaintext.txt	23	briefly second step sections rinsed pbs stained ctb sections placed primary polyclonal antibody solution 120 000 dilution goat anti ctb pbs triton list biological laboratories 48 h 4 degrees c sections washed twice pbs incubated 2 h 1200 solution donkey anti goat igg conjugated alexa fluro 594 texas red molecular probes sections washed mounted gelatinalum coated glass slides drop vecta shield vector laboratories burlingame ca applied air dried sections slides coverslipped
0.20187694.15557013.html.plaintext.txt	24	selected sections medulla oblongata also stained orexin 1 receptors peroxidase labeled antibody diaminobenzidine chromogen abc technique described control experiments experiment done determine whether primary secondary antibodies produced false positive results experiments sections stained possible combinations primary secondary antibodies single immunoprobe omitted omission primary secondary antibodies resulted absence labeling demonstrating false positive results obtained reagents slides viewed bright field fluorescence microscope olympus ax70 olympus america equipped adequate filter systems observe texas red green fitc fluorescence colocalization ctb orexin 1 receptors identified alternating filters view texas red fitc fluorescence analyzing merged images exact sites qualitative approach problem attempt quantitatively estimate total numbers identifiable phrenic motor neurons c3 c5 percentage phrenic motor neurons stained positively orexin receptors
0.20187694.15557013.html.plaintext.txt	25	selected sections medulla oblongata also stained orexin 1 receptors peroxidase labeled antibody diaminobenzidine chromogen abc technique described control experiments experiment done determine whether primary secondary antibodies produced false positive results experiments sections stained possible combinations primary secondary antibodies single immunoprobe omitted omission primary secondary antibodies resulted absence labeling demonstrating false positive results obtained reagents slides viewed bright field fluorescence microscope olympus ax70 olympus america equipped adequate filter systems observe texas red green fitc fluorescence colocalization ctb orexin 1 receptors identified alternating filters view texas red fitc fluorescence analyzing merged images exact sites qualitative approach problem attempt quantitatively estimate total numbers identifiable phrenic motor neurons c3 c5 percentage phrenic motor neurons stained positively orexin receptors
0.20187694.15557013.html.plaintext.txt	26	second set experiments orexin containing lateral hypothalamic cells project phrenic nucleus identified neuroanatomic tracing anesthetized animals n 3 rats ctb unilaterally injected ventral horn cervical spinal cord extending c3 c5 total 300 nl 01 solution previously described 26 injections made glass micropipette 40 60 microm diameter 06 mm midline 14 mm dorsal surface spinal cord seven days ctb injections animals perfused brains prepared outlined
0.20187694.15557013.html.plaintext.txt	27	second set experiments orexin containing lateral hypothalamic cells project phrenic nucleus identified neuroanatomic tracing anesthetized animals n 3 rats ctb unilaterally injected ventral horn cervical spinal cord extending c3 c5 total 300 nl 01 solution previously described 26 injections made glass micropipette 40 60 microm diameter 06 mm midline 14 mm dorsal surface spinal cord seven days ctb injections animals perfused brains prepared outlined
0.20187694.15557013.html.plaintext.txt	28	third set experiments three experimental subjects projections orexin containing neurons pre botzinger complex determined unilateral microinjection ctb 1230 mm caudal bregma 22 mm lateral midline 08 mm dorsal ventral surface ventrolateral medulla oblongata right site 100 nl 01 ctb coordinates used previous studies laboratory examine respiration regulating neurons possessing neurokinin 1 receptors within called pre botzinger complex region 26 42 coordinates later utilized microinjection either orexin toluidine blue marker dye see histological inspection sections confirmed injection site caudal facial nuclei rostral level hypoglossal nuclei within anatomic borders pre botzinger complex see also fig 2 seven days injection animals deeply anesthetized perfused described brains removed processed immunohistochemically ctb orexin labeling transverse sections whole brain animal cut 40 microm immunohistochemical procedures used previously described 26 staining tissue sections hypothalamus briefly free floating sections washed pbs containing 03 triton x 100 1 5 series tissue sections exposed 30 min pbs triton solution containing 1 bsa block nonspecific binding sites wash tissue placed overnight 4 degrees c primary polyclonal antibody solution 12000 dilution rabbit anti orexin 1 normal goat serum pbs triton oncogene research products 48 h 4 degrees c sections washed twice pbs incubated 2 h solution biotinylated goat anti rabbit secondary antibody vector laboratories sections washed pbs incubated 60 min avidin biotin peroxidase complex recommended supplier
0.20187694.15557013.html.plaintext.txt	29	view larger version 116k fig 2 schematic diagram area medulla investigated 123 mm posterior bregma 37 paired section showing distribution toluidine blue dye microperfused using coordinates volume used infuse orexin boxed region shows area examined higher magnifications b c d calibration bar 05 mm amb ambiguus prbo pre botzinger complex sol solitary tract ml medial lemniscus py pyramid sp5 spinal tract 5 b orexin immunoreactive beaded axons present within region pre botzinger complex calibration bar 50 microm c low magnification view medulla showing orexin receptor immunoreactivity brown nucleus ambiguus subjacent neurons pre botzinger complex section counterstained thionin calibration bar 250 microm d higher magnification view neurons nucleus ambiguus immunoreactive orexin receptors calibration bar 50 microm
0.20187694.15557013.html.plaintext.txt	30	identify retrogradely labeled neurons within lateral hypothalamus produce orexin labeled orexin sections washed pbs placed primary polyclonal antibody solution 120000 dilution goat anti ctb pbs triton 48 h 4 degrees c sections washed twice pbs incubated 2 h 1200 solution donkey anti goat igg conjugated alexa fluro 594 texas red molecular probes sections washed mounted gelatinalum coated glass slides drop vecta shield vector laboratories applied air dried sections slides coverslipped sections viewed either bright field microscopy orexin immunoreactivity brown diaminobenzidine precipitate fluorescence microscopy ctb immunoreactivity red fluorescence digitized bright field images merged fluorescence images using imaging software detect double labeled cells sigma scan pro spss chicago il
0.20187694.15557013.html.plaintext.txt	31	identify retrogradely labeled neurons within lateral hypothalamus produce orexin labeled orexin sections washed pbs placed primary polyclonal antibody solution 120000 dilution goat anti ctb pbs triton 48 h 4 degrees c sections washed twice pbs incubated 2 h 1200 solution donkey anti goat igg conjugated alexa fluro 594 texas red molecular probes sections washed mounted gelatinalum coated glass slides drop vecta shield vector laboratories applied air dried sections slides coverslipped sections viewed either bright field microscopy orexin immunoreactivity brown diaminobenzidine precipitate fluorescence microscopy ctb immunoreactivity red fluorescence digitized bright field images merged fluorescence images using imaging software detect double labeled cells sigma scan pro spss chicago il
0.20187694.15557013.html.plaintext.txt	32	rats anesthetized urethane 12 gkg carotid artery external jugular vein catheterized recording blood pressure heart rate administering fluid anesthetic one tenth initial concentration per hour bilateral vagotomy tracheotomy rats placed stereotaxic apparatus prone position diaphragm electromyographic activity demg recorded via bipolar electrodes placed costal diaphragm animals ventilated o2 pump rate provided 30 total ventilatory activity obtained 7 co2 o2 previously described 14 26
0.20187694.15557013.html.plaintext.txt	33	rats anesthetized urethane 12 gkg carotid artery external jugular vein catheterized recording blood pressure heart rate administering fluid anesthetic one tenth initial concentration per hour bilateral vagotomy tracheotomy rats placed stereotaxic apparatus prone position diaphragm electromyographic activity demg recorded via bipolar electrodes placed costal diaphragm animals ventilated o2 pump rate provided 30 total ventilatory activity obtained 7 co2 o2 previously described 14 26
0.20187694.15557013.html.plaintext.txt	34	investigate effects orexin phrenic motoneurons cervical spinal cord segment c3 c5 exposed laminectomy dura opened retracted n 5 rats control values recorded spinal cord segment microperfused 5 microl saline orexin dissolved saline applied surface cord respiratory variables recorded 5 min solution respiratory cardiovascular responses three doses orexin 4 40 200 microgml sterile saline studied doses corresponded doses proven effective stimulating neuronal firing andor arousal studies eg ref 19
0.20187694.15557013.html.plaintext.txt	35	investigate effects orexin phrenic motoneurons cervical spinal cord segment c3 c5 exposed laminectomy dura opened retracted n 5 rats control values recorded spinal cord segment microperfused 5 microl saline orexin dissolved saline applied surface cord respiratory variables recorded 5 min solution respiratory cardiovascular responses three doses orexin 4 40 200 microgml sterile saline studied doses corresponded doses proven effective stimulating neuronal firing andor arousal studies eg ref 19
0.20187694.15557013.html.plaintext.txt	36	examine medullary effects orexin 200 nl either saline three doses orexin microinjected pre botzinger complex additional five rats via hamilton syringe coordinates described respiratory variables recorded described finally end physiological experiments three five rats microinjected medullary stereotaxic coordinates 200 nl 1 toluidine blue mark anatomic location perfusion site rats perfused brains sectioned medullary sections dried onto slides counterstained 01 basic fuchsin mounted vecta shield without exposure slides alcohol procedure avoided elution marker dye toluidine blue sections alcohol
0.20187694.15557013.html.plaintext.txt	37	examine medullary effects orexin 200 nl either saline three doses orexin microinjected pre botzinger complex additional five rats via hamilton syringe coordinates described respiratory variables recorded described finally end physiological experiments three five rats microinjected medullary stereotaxic coordinates 200 nl 1 toluidine blue mark anatomic location perfusion site rats perfused brains sectioned medullary sections dried onto slides counterstained 01 basic fuchsin mounted vecta shield without exposure slides alcohol procedure avoided elution marker dye toluidine blue sections alcohol
0.20187694.15557013.html.plaintext.txt	38	moving average demg used determine amplitude well frequency inspiratory bursts respiratory responses quantified averaging parameters control period 10 consecutive breaths 10 breaths peak response microperfusion saline increasing concentrations orexin blood pressure heart rate measured control period peak changes occurred orexin administration average values means plus minus sd analyzed variables compared analysis variance repeated measures tukeys protected tests statistical significance considered achieved p 005
0.20187694.15557013.html.plaintext.txt	39	moving average demg used determine amplitude well frequency inspiratory bursts respiratory responses quantified averaging parameters control period 10 consecutive breaths 10 breaths peak response microperfusion saline increasing concentrations orexin blood pressure heart rate measured control period peak changes occurred orexin administration average values means plus minus sd analyzed variables compared analysis variance repeated measures tukeys protected tests statistical significance considered achieved p 005
0.20187694.15557013.html.plaintext.txt	40	results top abstract materials methods results discussion grants references neuroanatomic experiments
0.20187694.15557013.html.plaintext.txt	41	connectivity orexin ir neurons phrenic motor nucleus spinal cord ctb injection spinal phrenic nucleus retrogradely labeled cells abundant lateral hypothalamus dorsal fornix distribution showed considerable overlap distribution orexin immunoreactive ir neurons lateral hypothalamus rats 386 orexin ir cells 173 ctb labeled cells examined total 11 double labeled cells mainly concentrated portion orexin ir neurons dorsolateral fornix found fig 1
0.20187694.15557013.html.plaintext.txt	42	connectivity orexin ir neurons phrenic motor nucleus spinal cord ctb injection spinal phrenic nucleus retrogradely labeled cells abundant lateral hypothalamus dorsal fornix distribution showed considerable overlap distribution orexin immunoreactive ir neurons lateral hypothalamus rats 386 orexin ir cells 173 ctb labeled cells examined total 11 double labeled cells mainly concentrated portion orexin ir neurons dorsolateral fornix found fig 1
0.20187694.15557013.html.plaintext.txt	43	view larger version 97k fig 1 schematic diagram area hypothalamus investigated 22 mm posterior bregma 37 boxed region shows location orexin immunoreactive neurons b bright field microscopy lateral hypothalamus showing orexin immunoreactive neurons brown labeled diaminobenzidine c field b viewed fluorescence microscopy show neurons retrogradely labeled ctb rhodamine labeled antibody infused phrenic motor nucleus d b digitally combined neurons labeled ctb appear white whereas orexin immunoreactive neuron also labeled ctb appears red arrow calibration bar 100 microm f fornix
0.20187694.15557013.html.plaintext.txt	44	connectivity orexin ir neurons pre botzinger complex ctb injection pre botzinger complex labeled cells tended located somewhat closer third ventricle cells projecting phrenic motor nucleus hypothalamic area 227 orexin ir cells 362 ctb labeled cells examined one cell double labeled however orexin containing fibers observed pre botzinger complex region rostral ventrolateral medulla fig 2
0.20187694.15557013.html.plaintext.txt	45	connectivity orexin ir neurons pre botzinger complex ctb injection pre botzinger complex labeled cells tended located somewhat closer third ventricle cells projecting phrenic motor nucleus hypothalamic area 227 orexin ir cells 362 ctb labeled cells examined one cell double labeled however orexin containing fibers observed pre botzinger complex region rostral ventrolateral medulla fig 2
0.20187694.15557013.html.plaintext.txt	46	detection orexin 1 receptors immunoreactivity present neurons nucleus ambiguus nearby areas ventrolateral medulla roughly corresponding pre botzinger complex fig 2c area precisely corresponds region recently reported contain unusually dense accumulation orexin ir fibers 12
0.20187694.15557013.html.plaintext.txt	47	detection orexin 1 receptors immunoreactivity present neurons nucleus ambiguus nearby areas ventrolateral medulla roughly corresponding pre botzinger complex fig 2c area precisely corresponds region recently reported contain unusually dense accumulation orexin ir fibers 12
0.20187694.15557013.html.plaintext.txt	48	immunocytochemistry orexin receptor protein showed positive staining neurons phrenic motor nucleus identified retrograde transport ctb diaphragm fig 3
0.20187694.15557013.html.plaintext.txt	49	view larger version 67k fig 3 diagram location phrenic motor neurons boxed region segment c4 spinal cord 32 b phrenic motor neurons ventral horn spinal cord retrogradely labeled ctb infused diaphragm green fitc labeled secondary antibody calibration bar 50 microm c view b displaying section showing red fluorescence rhodamine labeled secondary antibody sites orexin receptor immunoreactivity d b c digitally combined double labeled cells demonstrate phrenic motor neurons possess orexin receptors
0.20187694.15557013.html.plaintext.txt	50	physiological effect orexin receptor activation respiratory drive analyze effects microinjection orexin pre botzinger complex changes induced orexin expressed percentage baseline discharge compared fig 4 analysis showed two higher doses orexin elicited statistically significant changes peak demg compared response saline p 005 40 microgml 200 microgml tukeys protected test analysis variance toluidine blue dye infusion confirmed anatomic position infusion site within pre botzinger complex fig 2 close inspection infusion site microscope showed intense color dye confined area diameter 200 microm dye could detected farther 500 microm away center infusion site
0.20187694.15557013.html.plaintext.txt	51	physiological effect orexin receptor activation respiratory drive analyze effects microinjection orexin pre botzinger complex changes induced orexin expressed percentage baseline discharge compared fig 4 analysis showed two higher doses orexin elicited statistically significant changes peak demg compared response saline p 005 40 microgml 200 microgml tukeys protected test analysis variance toluidine blue dye infusion confirmed anatomic position infusion site within pre botzinger complex fig 2 close inspection infusion site microscope showed intense color dye confined area diameter 200 microm dye could detected farther 500 microm away center infusion site
0.20187694.15557013.html.plaintext.txt	52	view larger version 18k fig 4 mean peak integrated respiratory diaphragmatic voltages expressed percent deviations electromyographic values observed baseline recording diaphragm respiratory responses microperfusion 40 200 microg orexin ventrolateral medulla significantly different responses saline 4 microgml orexin p 005 protected test b breathing rates 5 treatment conditions
0.20187694.15557013.html.plaintext.txt	53	heart rates blood pressure values rats study 5 higher previous experiences slightly elevated typical values reported others eg ref 10 exact explanation although values may related specific experimental conditions employed ie multiple vascular cannulae vagotomy tracheal cannula etc statistically significant effects orexin heart rate blood pressure detected table 1 recording single rat representative group differences treatment conditions shown fig 5
0.20187694.15557013.html.plaintext.txt	54	view table table 1 cardiovascular variables following microperfusion test solutions pre botzinger complex rostral ventrolateral medulla
0.20187694.15557013.html.plaintext.txt	55	view larger version 28k fig 5 respiratory activity rat 13 microperfusion saline ventrolateral medulla application 40 microgml orexin medulla b demg integrated electromyographic activity diaphragm
0.20187694.15557013.html.plaintext.txt	56	similarly microperfusion two higher doses orexin onto spinal cord elicited statistically significant changes peak demg compared response saline p 005 40 microgml p 001 200 microgml statistically significant changes p 005 breathing rate treatment conditions detected fig 6 orexin produced slight statistically significant increase heart rate p 005 4 40 microgml p 001 200 microgml orexin table 2 recording single rat representative mean results shown fig 7
0.20187694.15557013.html.plaintext.txt	57	similarly microperfusion two higher doses orexin onto spinal cord elicited statistically significant changes peak demg compared response saline p 005 40 microgml p 001 200 microgml statistically significant changes p 005 breathing rate treatment conditions detected fig 6 orexin produced slight statistically significant increase heart rate p 005 4 40 microgml p 001 200 microgml orexin table 2 recording single rat representative mean results shown fig 7
0.20187694.15557013.html.plaintext.txt	58	view larger version 20k fig 6 mean peak integrated respiratory diaphragmatic voltages expressed percent changes electromyographic values observed baseline recording diaphragm respiratory responses application 40 200 microgml orexin onto spinal cord significantly different responses saline 4 microgml orexin p 005 p 001 protected test b breathing rates 5 treatment conditions
0.20187694.15557013.html.plaintext.txt	59	view table table 2 cardiovascular variables following microperfusion test solutions phrenic motor nucleus spinal cord
0.20187694.15557013.html.plaintext.txt	60	view larger version 33k fig 7 respiratory activity rat 5 application saline spinal cord application 200 microgml orexin spinal cord b
0.20187694.15557013.html.plaintext.txt	61	discussion top abstract materials methods results discussion grants references hypothalamic orexin producing neurons brain stem spinal cord respiratory related network
0.20187694.15557013.html.plaintext.txt	62	results study showed first time discrete population orexin ir neurons lateral hypothalamus projects ventrolateral medulla phrenic nuclei findings extend previous reports demonstrating long descending orexin containing axonal projections innervate spinal cord 13 24 however results suggest direct synaptic contact pre botzinger neurons orexin ir neurons infrequent despite presence numerous orexin containing fibers region
0.20187694.15557013.html.plaintext.txt	63	results study showed first time discrete population orexin ir neurons lateral hypothalamus projects ventrolateral medulla phrenic nuclei findings extend previous reports demonstrating long descending orexin containing axonal projections innervate spinal cord 13 24 however results suggest direct synaptic contact pre botzinger neurons orexin ir neurons infrequent despite presence numerous orexin containing fibers region
0.20187694.15557013.html.plaintext.txt	64	conceivably apparent projection subset lateral hypothalamic orexin containing neurons pre botzinger neurons phrenic nuclei could partly due nonspecific labeling produced diffusion retrograde tracer regions contain nonrespiratory related cells andor uptake tracer descending fibers orexin neurons innervate intermediate cell column thoracolumbar portion spinal cord 24 addition ctb may also taken fibers passage however ctb continues regarded useful retrograde tracer even recent neuroanatomic studies 11 furthermore results accord reports transsynaptic transport pseudorabies virus diaphragm lateral hypothalamus 18 21 27
0.20187694.15557013.html.plaintext.txt	65	conceivably apparent projection subset lateral hypothalamic orexin containing neurons pre botzinger neurons phrenic nuclei could partly due nonspecific labeling produced diffusion retrograde tracer regions contain nonrespiratory related cells andor uptake tracer descending fibers orexin neurons innervate intermediate cell column thoracolumbar portion spinal cord 24 addition ctb may also taken fibers passage however ctb continues regarded useful retrograde tracer even recent neuroanatomic studies 11 furthermore results accord reports transsynaptic transport pseudorabies virus diaphragm lateral hypothalamus 18 21 27
0.20187694.15557013.html.plaintext.txt	66	considerable numbers orexin containing fibers present within rostral ventrolateral medulla rat finding accordance recent data orexin containing neurons innervate vagal preganglionic cells within nucleus ambiguus 12 however found little retrograde transport ctb infused area hypothalamic orexin ir neurons ctb labeled cells mostly located medial orexin ir neurons ctb taken synaptic vesicles possibility exists synapses pre botzinger complex neurons orexinergic fibers passage may sparse may orexin released passing fibers nonsynaptically activates receptors orexin circulating within cerebrospinal fluid may activate neurons contain orexin receptors volume transmission analogy effects endogenously released catecholamines region 2 23 medullary neurons ventral compact portion nucleus ambiguus study also immunoreactive orexin receptors may belong external loose portion nucleus ambiguus vagal preganglionic neurons may contribute control respiration pre botzinger complex else may directly involved control respiratory timing diversity function orexin sensitive neurons medulla may explain stimulatory effects orexin respiratory amplitude apparent lack effect respiratory timing
0.20187694.15557013.html.plaintext.txt	67	considerable numbers orexin containing fibers present within rostral ventrolateral medulla rat finding accordance recent data orexin containing neurons innervate vagal preganglionic cells within nucleus ambiguus 12 however found little retrograde transport ctb infused area hypothalamic orexin ir neurons ctb labeled cells mostly located medial orexin ir neurons ctb taken synaptic vesicles possibility exists synapses pre botzinger complex neurons orexinergic fibers passage may sparse may orexin released passing fibers nonsynaptically activates receptors orexin circulating within cerebrospinal fluid may activate neurons contain orexin receptors volume transmission analogy effects endogenously released catecholamines region 2 23 medullary neurons ventral compact portion nucleus ambiguus study also immunoreactive orexin receptors may belong external loose portion nucleus ambiguus vagal preganglionic neurons may contribute control respiration pre botzinger complex else may directly involved control respiratory timing diversity function orexin sensitive neurons medulla may explain stimulatory effects orexin respiratory amplitude apparent lack effect respiratory timing
0.20187694.15557013.html.plaintext.txt	68	orexin receptor expression brain stem spinal cord respiratory related neurons
0.20187694.15557013.html.plaintext.txt	69	results present study showed neurons within rostral ventrolateral medullary region corresponding pre botzinger complex stain positively orexin receptors finding accord numerous studies orexin receptors found throughout brain stem rostral brain regions 6 7 15 19 28 46 furthermore findings first time indicate identified phrenic motor neurons express orexin receptors
0.20187694.15557013.html.plaintext.txt	70	results present study showed neurons within rostral ventrolateral medullary region corresponding pre botzinger complex stain positively orexin receptors finding accord numerous studies orexin receptors found throughout brain stem rostral brain regions 6 7 15 19 28 46 furthermore findings first time indicate identified phrenic motor neurons express orexin receptors
0.20187694.15557013.html.plaintext.txt	71	respiratory effects orexin activation
0.20187694.15557013.html.plaintext.txt	72	orexin microinjected pre botzinger region administered topically cervical spinal cord increased demg without affecting discharge frequency bilaterally vagotomized rats increase peak integrated moving average activity diaphragm without changes respiratory timing indicates neurons involved regulation tidal volume activity inspiratory pumping muscles independent frequency discharge however results exclude critical role inspiratory rhythm generating cells pre botzinger complex control respiratory timing 17
0.20187694.15557013.html.plaintext.txt	73	orexin microinjected pre botzinger region administered topically cervical spinal cord increased demg without affecting discharge frequency bilaterally vagotomized rats increase peak integrated moving average activity diaphragm without changes respiratory timing indicates neurons involved regulation tidal volume activity inspiratory pumping muscles independent frequency discharge however results exclude critical role inspiratory rhythm generating cells pre botzinger complex control respiratory timing 17
0.20187694.15557013.html.plaintext.txt	74	orexin may also affect respiration via projections sites eg may cause increase respiratory drive via activation hypothalamic neurons project pre botzinger complex phrenic nuclei 14 26 29 41 50 furthermore activity upper airway dilating muscles genioglossus muscle could affected via direct projections orexin containing neurons hypoglossal motoneurons activation orexin 1 receptors expressed hypoglossal motor cells innervate muscle 48 addition dense orexinergic projections innervate intermediolateral cell column spinal cord majority sympathetic preganglionic neuronal cell bodies reside 13 46 indicates lateral hypothalamic orexinergic neurons may act directly different brain stem spinal cord cell groups providing parallel control cardiovascular respiratory related output neurons behavioral state control defensive responses energy homeostasis 22 42
0.20187694.15557013.html.plaintext.txt	75	orexin topically applied spinal cord slight significant effects heart rate findings accord data showing intracisternal intrathecal injections orexin b provoke dose related increase heart rate sympathetic neuronal activity urethane anesthetized rats orexin given routes could activate multiple central nervous system spinal orexin sensitive sites including excitatory brain stem neurons spinal cord sympathetic preganglionic neurons 3 10 observed effects medullary infusions orexin heart rate possibly rats vagotomized 12
0.20187694.15557013.html.plaintext.txt	76	orexin topically applied spinal cord slight significant effects heart rate findings accord data showing intracisternal intrathecal injections orexin b provoke dose related increase heart rate sympathetic neuronal activity urethane anesthetized rats orexin given routes could activate multiple central nervous system spinal orexin sensitive sites including excitatory brain stem neurons spinal cord sympathetic preganglionic neurons 3 10 observed effects medullary infusions orexin heart rate possibly rats vagotomized 12
0.20187694.15557013.html.plaintext.txt	77	physiological effects observed study showed reliable dose response curve obtained using relatively high concentrations orexin possibly responses could part pharmacological blockade results pretreatment orexin antagonist eg sb 334867 would required completely eliminate possibility could partly non orexin receptor mediated 5
0.20187694.15557013.html.plaintext.txt	78	physiological effects observed study showed reliable dose response curve obtained using relatively high concentrations orexin possibly responses could part pharmacological blockade results pretreatment orexin antagonist eg sb 334867 would required completely eliminate possibility could partly non orexin receptor mediated 5
0.20187694.15557013.html.plaintext.txt	79	physiological relevance findings
0.20187694.15557013.html.plaintext.txt	80	orexin neurons provide link central nervous system mechanisms coordinate sleep wakefulness states central nervous system control autonomic functions via multiple projections 38 neurons also shown present study involved regulation breathing activity via projections brain stem spinal cord respiratory related network presumably orexin r1 signaling pathway accord recent report stimulation perifornical lateral hypothalamus elicits increases respiratory activity response diminished mice genetically engineered lack orexin 25 humans orexin proves stimulate respiration deficit orexin action may contribute decrease respiratory drive sleeping review see ref 23 assumption consistent recent findings indicating orexin plays important role maintenance wakefulness reviews see refs 28 49
0.20187694.15557013.html.plaintext.txt	81	orexin neurons provide link central nervous system mechanisms coordinate sleep wakefulness states central nervous system control autonomic functions via multiple projections 38 neurons also shown present study involved regulation breathing activity via projections brain stem spinal cord respiratory related network presumably orexin r1 signaling pathway accord recent report stimulation perifornical lateral hypothalamus elicits increases respiratory activity response diminished mice genetically engineered lack orexin 25 humans orexin proves stimulate respiration deficit orexin action may contribute decrease respiratory drive sleeping review see ref 23 assumption consistent recent findings indicating orexin plays important role maintenance wakefulness reviews see refs 28 49
0.20187694.15557013.html.plaintext.txt	82	decreased influence orexin brain regions regulate sleep breathing could cause simultaneous decreases arousal respiratory drive recently reported patients sleep apnea decreased blood levels orexin relative controls 34 mechanisms could produce decreased production orexin unknown may related apparent link obesity sleep apnea well known obesity prominent risk factor sleep apnea 30 56 diabetes mellitus hyperglycemia also appear provoke sleep apnea 47 seems likely metabolic alterations provoked obesity possibly elevations circulating nutrient molecules could partly explain association obesity sleep apnea
0.20187694.15557013.html.plaintext.txt	83	decreased influence orexin brain regions regulate sleep breathing could cause simultaneous decreases arousal respiratory drive recently reported patients sleep apnea decreased blood levels orexin relative controls 34 mechanisms could produce decreased production orexin unknown may related apparent link obesity sleep apnea well known obesity prominent risk factor sleep apnea 30 56 diabetes mellitus hyperglycemia also appear provoke sleep apnea 47 seems likely metabolic alterations provoked obesity possibly elevations circulating nutrient molecules could partly explain association obesity sleep apnea
0.20187694.15557013.html.plaintext.txt	84	genetic diet induced obesity rodents blood concentrations number circulating molecules elevated increased effect glucose free fatty acids leptin hypothalamic function could provoke altered activity orexin containing neurons 1 4 8 20 35 36 39 51 52 54 55 thus orexin containing neurons may key component connection obesity sleep apnea study required investigate hypothesis
0.20187694.15557013.html.plaintext.txt	85	genetic diet induced obesity rodents blood concentrations number circulating molecules elevated increased effect glucose free fatty acids leptin hypothalamic function could provoke altered activity orexin containing neurons 1 4 8 20 35 36 39 51 52 54 55 thus orexin containing neurons may key component connection obesity sleep apnea study required investigate hypothesis
0.20187694.15557013.html.plaintext.txt	86	summary hypothalamic orexin containing neurons part brain stem spinal cord respiratory related network orexin acting via orexin r1 expressed pre botzinger neurons phrenic nuclei increases respiratory drive indicates orexin orexin r1 pathway may play important role linking central nervous system nuclei involved regulation sleep wakefulness states central nervous system control respiration alterations regulatory system could lead autonomic dysfunctions sleep related respiratory disorders
0.20187694.15557013.html.plaintext.txt	87	summary hypothalamic orexin containing neurons part brain stem spinal cord respiratory related network orexin acting via orexin r1 expressed pre botzinger neurons phrenic nuclei increases respiratory drive indicates orexin orexin r1 pathway may play important role linking central nervous system nuclei involved regulation sleep wakefulness states central nervous system control respiration alterations regulatory system could lead autonomic dysfunctions sleep related respiratory disorders
0.20187694.15557013.html.plaintext.txt	88	grants top abstract materials methods results discussion grants references preliminary account findings appeared abstract form 53 study supported national institutes health grants ninds 1 u54 ns39407 ncrr hl 5027 m haxhiu ro1 nso45859to o mack howard university mordecai w johnson research support grant j k young
0.20187694.15557013.html.plaintext.txt	89	grants top abstract materials methods results discussion grants references preliminary account findings appeared abstract form 53 study supported national institutes health grants ninds 1 u54 ns39407 ncrr hl 5027 m haxhiu ro1 nso45859to o mack howard university mordecai w johnson research support grant j k young
0.20187694.15557013.html.plaintext.txt	90	footnotes address reprint requests correspondence j k young dept anatomy howard univ college medicine 520 w st nw washington dc 20059 e mail jyoungathowardedu u d
0.20187694.15557013.html.plaintext.txt	91	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.20187694.15557013.html.plaintext.txt	92	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.20187694.15557013.html.plaintext.txt	93	references top abstract materials methods results discussion grants references adam ja menheere pp van dielen fm soeters pb buurman wa greve jw decreased plasma orexin levels obese individuals int j obes relat metab disord 26 274 276 2002crossrefmedline angati lf zoli m stromberg fuxe k intercellular communication brain wiring versus volume transmission neuroscience 69 711 726 1995crossrefisimedline antunes vr brailoiu gc kwok eh scruggs p dun nj orexinhypocretins excite rat sympathetic preganglionic neurons vivo vitro j physiol regul integr comp physiol 281 r1801 r1807 2001abstractfree full text beck b richy hypothalamic hypocretinorexin neuropeptide y divergent interaction energy depletion leptin biochem biophys res commun 258 119 122 1999crossrefisimedline bernard r lydic r baghdoyan ha hypocretin 1 causes g protein activation increases ach release rat pons eur j neurosci 18 1775 1785 2003crossrefisimedline bourgin p huitron resendiz spier ad fabre v morte b criado jr sutcliffe jg henriksen sj de lecea l hypocretin 1 modulates rapid eye movement sleep activation locus coeruleus neurons j neurosci 20 7760 7765 2000abstractfree full text brown re sergeeva oa eriksson ks haas hl convergent excitation dorsal raphe serotonin neurons multiple arousal systems orexinhypocretin histamine noradrenaline j neurosci 22 8850 8859 2002abstractfree full text cai xj evans ml lister ca leslie ra arch jr wilson williams g hypoglycemia activates orexin neurons selectively increases hypothalamic orexin b levels responses inhibited feeding possibly mediated nucleus solitary tract diabetes 50 105 112 2001abstractfree full text chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999crossrefisimedline chen ct hwang ll chang jk dun nj pressor effects orexins injected intracisternally rostral ventrolateral medulla anesthetized rats j physiol regul integr comp physiol 278 r692 r697 2000abstractfree full text chen aston jones g axonal collateral collateral transport tract tracers brain neurons false anterograde labeling useful tool neuroscience 82 1151 1163 1998crossrefisimedline ciriello j de oliveira cvr cardiac effects hypocretin 1 nucleus ambiguus j physiol regul integr comp physiol 284 r1611 r1620 2003abstractfree full text date y mondal ms matsukura nakazato m distribution orexin orexin b hypocretins rat spinal cord neurosci lett 288 87 90 2000crossrefisimedline dreshaj ia haxhiu ma martin rj young jk basomedial hypothalamus modulates ventilatory response hypoxia neonatal rats pediatr res 53 945 949 2003abstractfree full text eriksson ks sergeeva o brown re haas hl orexinhypocretin excites histaminergic neurons tuberomammillary nucleus j neurosci 21 9273 9279 2001abstractfree full text espana ra baldo ba kelley ae berridge cw wake promoting sleep suppressing actions hypocretin orexin basal forebrain sites action neuroscience 106 699 715 2001crossrefisimedline feldman jl mitchell gs nattie ee breathing rhythmicity plasticity chemosensitivity annu rev neurosci 26 239 266 2003crossrefisimedline gaytan sp pasaro r coulon p bevengut m hilaire g identification central nervous system neurons innervating respiratory muscles mouse transneuronal tracing study brain res bull 57 335 339 2002crossrefisimedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dnc smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hakansson m de lecea l sutcliffe jg yanagisawa m meister b leptin receptor stat3 immunoreactivities hypocretinorexin neurones lateral hypothalamus j neuroendocrinol 11 653 663 1999crossrefisimedline haxhiu ma jansen cherniack ns loewy ad cns innervation airway related parasympathetic preganglionic neurons transneuronal labeling study using pseudorabies virus brain res 618 115 134 1993crossrefisimedline haxhiu ma mack wilson cg feng p strohl kp sleep networks anatomic physiologic connections respiratory control front biosci 8 946 962 2003 haxhiu ma neziri b yamamoto bk ferguson dg massari vj catecholaminergic microcircuitry controlling output airway related vagal preganglionic neurons j appl physiol 94 1999 2009 2003abstractfree full text hervieu gj cluderay je harrison dc roberts jc leslie ra gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103 777 797 2001crossrefisimedline kayaba y nakamura kasuya y ohuchi yanagisawa m komuro fukuda y kuwaki attenuated defense response low basal blood pressure orexin knockout mice j physiol regul integr comp physiol 285 r581 r593 2003abstractfree full text kc p haxhiu ma tolentino silva fp wu m trouth co mack paraventricular vasopressin containing neurons project brain stem spinal cord respiratory related sites respir physiol neurobiol 133 75 88 2002crossrefisimedline krout ke mettenleiter tc loewy ad single cns neurons link central motor cardiosympathetic systems double virus tracing study neuroscience 118 853 866 2003crossrefisimedline kukkonen jp holmqvist ammoun akerman ke functions orexinergichypocretinergic system j physiol cell physiol 283 c1567 c1591 2002abstractfree full text mack kc p wu m coleman br tolentino silva fp haxhiu ma paraventricular oxytocin neurons involved neural modulation breathing j appl physiol 92 826 834 2002abstractfree full text manzella d parillo m razzino gnasso p buonanno gargiulo caputi m paolisso g soluble leptin receptor insulin resistance determinant sleep apnea int j obes relat metab disord 26 370 375 2002crossrefmedline matsumura k tsuchihashi abe central orexin augments sympathoadrenal outflow conscious rabbits hypertension 37 1382 1387 2001abstractfree full text molander c grant g spinal cord architecture rat nervous system edited paxinos g san diego ca academic 1995 fig 117a nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999crossrefisimedline nishijima sakurai arihara takahashi k plasma orexin like immunoreactivity patients sleep apnea hypopnea syndrome peptides 24 407 411 2003crossrefisimedline odonnell cp tankersley cg polotsky vp schwartz ar smith pl leptin obesity respiratory function respir physiol 119 163 170 2000crossrefisimedline ouedraogo r naslund e kirchgessner al glucose regulates release orexin endocrine pancreas diabetes 52 111 117 2003abstractfree full text paxinos g watson c rat brain stereotaxic coordinates san diego ca academic 1998 fig 30 peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text powis je bains js ferguson av leptin depolarizes rat hypothalamic paraventricular nucleus neurons j physiol regul integr comp physiol 274 r1468 r1472 1998abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998crossrefisimedline samson wk taylor mm follwell m ferguson av orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 104 97 103 2002crossrefisimedline smith jc ellenberger hh ballanyi k richter dw feldman jl pre botzinger complex brainstem region may generate respiratory rhythm mammals science 254 726 729 1991isimedline sunter d morgan edwards cmb dakin cl murphy kg gardiner j taheri rayes e bloom sr orexins effects behavior localisation orexin receptor 2 messenger ribonucleic acid rat brainstem brain res 907 27 34 2001crossrefisimedline sutcliffe jg de lecea l asleep quite awake nat med 10 673 674 2004crossrefisimedline takahashi n okumura hiroto y kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999crossrefisimedline van den pol ghosh pk liu rj li y aghajanian gk gao xb hypocretin orexin enhances neuron activity cell synchrony developing mouse gfp expressing locus coeruleus j physiol 541 169 185 2002abstractfree full text villa mp multari g montesano m pagani j cervoni m midulla f ceror e ronchetti r sleep apnoea children diabetes mellitus effect glycaemic control diabetologia 43 696 702 2000crossrefisimedline volgin dv saghir m kubin l developmental changes orexin 2 receptor mrna hypoglossal motoneurons neuroreport 13 433 436 2002crossrefisimedline xi mc morales fr chase mh effects sleep wakefulness injection hypocretin 1 orexin laterodorsal tegmental nucleus cat brain res 901 259 264 2001crossrefisimedline yeh er erokwu b lamanna jc haxhiu ma paraventricular nucleus hypothalamus influences respiratory timing activity rat neurosci lett 232 63 66 1997crossrefisimedline young jk anatomical relationship specialized astrocytes leptin sensitive neurons j anat 201 85 90 2002crossrefisimedline young jk grizard j sensitivity satiating taste qualities glucose obese zucker rats physiol behav 34 415 421 1985crossrefisimedline young jk haxhiu ma allard j zaidi sia manaye kf projections orexin ir neurons respiratory control regions soc neurosci abstr program 1716 2002 young jk mckenzie jc glut2 immunoreactivity gomori positive astrocytes hypothalamus j histochem cytochem 52 1519 1524 2004abstractfree full text young jk nance dm gorski ra effects diet upon hypothalamic vulnerability goldthioglucose male mice brain res bull 4 69 74 1978crossrefisi young peppard pe gottlieb dj epidemiology obstructive sleep apnea population health perspective j respir crit care med 165 1217 1239 2002abstractfree full text
0.20187694.15557013.html.plaintext.txt	94	references top abstract materials methods results discussion grants references adam ja menheere pp van dielen fm soeters pb buurman wa greve jw decreased plasma orexin levels obese individuals int j obes relat metab disord 26 274 276 2002crossrefmedline angati lf zoli m stromberg fuxe k intercellular communication brain wiring versus volume transmission neuroscience 69 711 726 1995crossrefisimedline antunes vr brailoiu gc kwok eh scruggs p dun nj orexinhypocretins excite rat sympathetic preganglionic neurons vivo vitro j physiol regul integr comp physiol 281 r1801 r1807 2001abstractfree full text beck b richy hypothalamic hypocretinorexin neuropeptide y divergent interaction energy depletion leptin biochem biophys res commun 258 119 122 1999crossrefisimedline bernard r lydic r baghdoyan ha hypocretin 1 causes g protein activation increases ach release rat pons eur j neurosci 18 1775 1785 2003crossrefisimedline bourgin p huitron resendiz spier ad fabre v morte b criado jr sutcliffe jg henriksen sj de lecea l hypocretin 1 modulates rapid eye movement sleep activation locus coeruleus neurons j neurosci 20 7760 7765 2000abstractfree full text brown re sergeeva oa eriksson ks haas hl convergent excitation dorsal raphe serotonin neurons multiple arousal systems orexinhypocretin histamine noradrenaline j neurosci 22 8850 8859 2002abstractfree full text cai xj evans ml lister ca leslie ra arch jr wilson williams g hypoglycemia activates orexin neurons selectively increases hypothalamic orexin b levels responses inhibited feeding possibly mediated nucleus solitary tract diabetes 50 105 112 2001abstractfree full text chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999crossrefisimedline chen ct hwang ll chang jk dun nj pressor effects orexins injected intracisternally rostral ventrolateral medulla anesthetized rats j physiol regul integr comp physiol 278 r692 r697 2000abstractfree full text chen aston jones g axonal collateral collateral transport tract tracers brain neurons false anterograde labeling useful tool neuroscience 82 1151 1163 1998crossrefisimedline ciriello j de oliveira cvr cardiac effects hypocretin 1 nucleus ambiguus j physiol regul integr comp physiol 284 r1611 r1620 2003abstractfree full text date y mondal ms matsukura nakazato m distribution orexin orexin b hypocretins rat spinal cord neurosci lett 288 87 90 2000crossrefisimedline dreshaj ia haxhiu ma martin rj young jk basomedial hypothalamus modulates ventilatory response hypoxia neonatal rats pediatr res 53 945 949 2003abstractfree full text eriksson ks sergeeva o brown re haas hl orexinhypocretin excites histaminergic neurons tuberomammillary nucleus j neurosci 21 9273 9279 2001abstractfree full text espana ra baldo ba kelley ae berridge cw wake promoting sleep suppressing actions hypocretin orexin basal forebrain sites action neuroscience 106 699 715 2001crossrefisimedline feldman jl mitchell gs nattie ee breathing rhythmicity plasticity chemosensitivity annu rev neurosci 26 239 266 2003crossrefisimedline gaytan sp pasaro r coulon p bevengut m hilaire g identification central nervous system neurons innervating respiratory muscles mouse transneuronal tracing study brain res bull 57 335 339 2002crossrefisimedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dnc smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hakansson m de lecea l sutcliffe jg yanagisawa m meister b leptin receptor stat3 immunoreactivities hypocretinorexin neurones lateral hypothalamus j neuroendocrinol 11 653 663 1999crossrefisimedline haxhiu ma jansen cherniack ns loewy ad cns innervation airway related parasympathetic preganglionic neurons transneuronal labeling study using pseudorabies virus brain res 618 115 134 1993crossrefisimedline haxhiu ma mack wilson cg feng p strohl kp sleep networks anatomic physiologic connections respiratory control front biosci 8 946 962 2003 haxhiu ma neziri b yamamoto bk ferguson dg massari vj catecholaminergic microcircuitry controlling output airway related vagal preganglionic neurons j appl physiol 94 1999 2009 2003abstractfree full text hervieu gj cluderay je harrison dc roberts jc leslie ra gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103 777 797 2001crossrefisimedline kayaba y nakamura kasuya y ohuchi yanagisawa m komuro fukuda y kuwaki attenuated defense response low basal blood pressure orexin knockout mice j physiol regul integr comp physiol 285 r581 r593 2003abstractfree full text kc p haxhiu ma tolentino silva fp wu m trouth co mack paraventricular vasopressin containing neurons project brain stem spinal cord respiratory related sites respir physiol neurobiol 133 75 88 2002crossrefisimedline krout ke mettenleiter tc loewy ad single cns neurons link central motor cardiosympathetic systems double virus tracing study neuroscience 118 853 866 2003crossrefisimedline kukkonen jp holmqvist ammoun akerman ke functions orexinergichypocretinergic system j physiol cell physiol 283 c1567 c1591 2002abstractfree full text mack kc p wu m coleman br tolentino silva fp haxhiu ma paraventricular oxytocin neurons involved neural modulation breathing j appl physiol 92 826 834 2002abstractfree full text manzella d parillo m razzino gnasso p buonanno gargiulo caputi m paolisso g soluble leptin receptor insulin resistance determinant sleep apnea int j obes relat metab disord 26 370 375 2002crossrefmedline matsumura k tsuchihashi abe central orexin augments sympathoadrenal outflow conscious rabbits hypertension 37 1382 1387 2001abstractfree full text molander c grant g spinal cord architecture rat nervous system edited paxinos g san diego ca academic 1995 fig 117a nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999crossrefisimedline nishijima sakurai arihara takahashi k plasma orexin like immunoreactivity patients sleep apnea hypopnea syndrome peptides 24 407 411 2003crossrefisimedline odonnell cp tankersley cg polotsky vp schwartz ar smith pl leptin obesity respiratory function respir physiol 119 163 170 2000crossrefisimedline ouedraogo r naslund e kirchgessner al glucose regulates release orexin endocrine pancreas diabetes 52 111 117 2003abstractfree full text paxinos g watson c rat brain stereotaxic coordinates san diego ca academic 1998 fig 30 peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text powis je bains js ferguson av leptin depolarizes rat hypothalamic paraventricular nucleus neurons j physiol regul integr comp physiol 274 r1468 r1472 1998abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998crossrefisimedline samson wk taylor mm follwell m ferguson av orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 104 97 103 2002crossrefisimedline smith jc ellenberger hh ballanyi k richter dw feldman jl pre botzinger complex brainstem region may generate respiratory rhythm mammals science 254 726 729 1991isimedline sunter d morgan edwards cmb dakin cl murphy kg gardiner j taheri rayes e bloom sr orexins effects behavior localisation orexin receptor 2 messenger ribonucleic acid rat brainstem brain res 907 27 34 2001crossrefisimedline sutcliffe jg de lecea l asleep quite awake nat med 10 673 674 2004crossrefisimedline takahashi n okumura hiroto y kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999crossrefisimedline van den pol ghosh pk liu rj li y aghajanian gk gao xb hypocretin orexin enhances neuron activity cell synchrony developing mouse gfp expressing locus coeruleus j physiol 541 169 185 2002abstractfree full text villa mp multari g montesano m pagani j cervoni m midulla f ceror e ronchetti r sleep apnoea children diabetes mellitus effect glycaemic control diabetologia 43 696 702 2000crossrefisimedline volgin dv saghir m kubin l developmental changes orexin 2 receptor mrna hypoglossal motoneurons neuroreport 13 433 436 2002crossrefisimedline xi mc morales fr chase mh effects sleep wakefulness injection hypocretin 1 orexin laterodorsal tegmental nucleus cat brain res 901 259 264 2001crossrefisimedline yeh er erokwu b lamanna jc haxhiu ma paraventricular nucleus hypothalamus influences respiratory timing activity rat neurosci lett 232 63 66 1997crossrefisimedline young jk anatomical relationship specialized astrocytes leptin sensitive neurons j anat 201 85 90 2002crossrefisimedline young jk grizard j sensitivity satiating taste qualities glucose obese zucker rats physiol behav 34 415 421 1985crossrefisimedline young jk haxhiu ma allard j zaidi sia manaye kf projections orexin ir neurons respiratory control regions soc neurosci abstr program 1716 2002 young jk mckenzie jc glut2 immunoreactivity gomori positive astrocytes hypothalamus j histochem cytochem 52 1519 1524 2004abstractfree full text young jk nance dm gorski ra effects diet upon hypothalamic vulnerability goldthioglucose male mice brain res bull 4 69 74 1978crossrefisi young peppard pe gottlieb dj epidemiology obstructive sleep apnea population health perspective j respir crit care med 165 1217 1239 2002abstractfree full text
0.20854747.15870393.html.plaintext.txt	0	genetic modifiers interact cpefat affect body weight adiposity hyperglycemia gayle b collin1 terry p maddatu1 aunak sen12 jurgen k naggert1
0.20854747.15870393.html.plaintext.txt	1	1 jackson laboratory bar harbor maine 2 department epidemiology biostatistics university california san francisco california
0.20854747.15870393.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion grants references obesity type ii diabetes complex diseases human population existence large number contributing loci gene gene well gene environment interactions make difficult identify disease genes underlying complex traits mouse models obesity type ii diabetes murine fat mutation genetic crosses used dissect genetic complexity influencing observed phenotypes underlying defect fat mutant ser202pro change carboxypeptidase e cpe enzyme responsible final proteolytic processing step prohormone intermediates hrsj hrs inbred strain background mice homozygous fat mutation exhibit early onset hyperinsulinemia followed postpubertal moderate obesity without hyperglycemia contrast c57blksj bks genetic background fatfat mice become severely obese hyperinsulinemic hyperglycemic therefore cpefat genetic model fat mutation necessary sufficient development obesity type ii diabetes related metabolic disorders dissect susceptibility loci responsible modifying obesity diabetes associated traits characterized genetically phenotypically fatfat male progeny large intercross bks hrs fatfat hrs mice four major loci mapped including locus body weight body weight 1 chromosome 14 locus hyperglycemia fat induced diabetes 1 chromosome 19 locus hyperglycemia hyperinsulinemia hypercholesterolemia fat induced diabetes 2 chromosome 5 locus adiposity body weight fat induced adiposity 1 chromosome 11 identification interacting genetic determinants obesity type ii diabetes may allow better definition obesitydiabetes related hormone signaling pathways ultimately may provide new insights pathogenesis complex diseases
0.20854747.15870393.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion grants references obesity type ii diabetes complex diseases human population existence large number contributing loci gene gene well gene environment interactions make difficult identify disease genes underlying complex traits mouse models obesity type ii diabetes murine fat mutation genetic crosses used dissect genetic complexity influencing observed phenotypes underlying defect fat mutant ser202pro change carboxypeptidase e cpe enzyme responsible final proteolytic processing step prohormone intermediates hrsj hrs inbred strain background mice homozygous fat mutation exhibit early onset hyperinsulinemia followed postpubertal moderate obesity without hyperglycemia contrast c57blksj bks genetic background fatfat mice become severely obese hyperinsulinemic hyperglycemic therefore cpefat genetic model fat mutation necessary sufficient development obesity type ii diabetes related metabolic disorders dissect susceptibility loci responsible modifying obesity diabetes associated traits characterized genetically phenotypically fatfat male progeny large intercross bks hrs fatfat hrs mice four major loci mapped including locus body weight body weight 1 chromosome 14 locus hyperglycemia fat induced diabetes 1 chromosome 19 locus hyperglycemia hyperinsulinemia hypercholesterolemia fat induced diabetes 2 chromosome 5 locus adiposity body weight fat induced adiposity 1 chromosome 11 identification interacting genetic determinants obesity type ii diabetes may allow better definition obesitydiabetes related hormone signaling pathways ultimately may provide new insights pathogenesis complex diseases
0.20854747.15870393.html.plaintext.txt	4	quantitative trait loci type ii diabetes
0.20854747.15870393.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion grants references obesity related metabolic disorders insulin resistance type ii diabetes major health problems human population presumably genetic dissection complex traits humans difficult polygenic nature genetic heterogeneity gene gene gene environmental interactions disease traits 4 7 23 reason genetic studies obesity diabetes extended use mouse models mouse constitutes useful model system large number animals bred controlling genetic environmental influences advantages necessary study epistatic effects mutated genes susceptibility loci
0.20854747.15870393.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion grants references obesity related metabolic disorders insulin resistance type ii diabetes major health problems human population presumably genetic dissection complex traits humans difficult polygenic nature genetic heterogeneity gene gene gene environmental interactions disease traits 4 7 23 reason genetic studies obesity diabetes extended use mouse models mouse constitutes useful model system large number animals bred controlling genetic environmental influences advantages necessary study epistatic effects mutated genes susceptibility loci
0.20854747.15870393.html.plaintext.txt	7	five single gene mutations result obese phenotype identified mice one fat mutation fat mutation single nucleotide change carboxypeptidase e cpe gene resulting 202ser pro change cpe protein fat mice 22 cpe gene cpe encodes enzyme responsible processing hormones insulin proopiomelanocortin cpe present high concentrations secretory granules pancreatic islets required excision residual dibasic residues remaining carboxy terminal end propeptides processing endolytic prohormone convertases pcsk1 pcsk2 10 mutation cpefat renders enzyme unstable ultimately degraded endoplasmic reticulum reduction cpe activity turn leads decrease biologically active hormones insulin cpe defects also observed tissues including hypothalamus suggests number additional prohormones may implicated obesity phenotype neuropeptides melanin stimulating hormone 3 melanin concentrating hormone 25
0.20854747.15870393.html.plaintext.txt	8	five single gene mutations result obese phenotype identified mice one fat mutation fat mutation single nucleotide change carboxypeptidase e cpe gene resulting 202ser pro change cpe protein fat mice 22 cpe gene cpe encodes enzyme responsible processing hormones insulin proopiomelanocortin cpe present high concentrations secretory granules pancreatic islets required excision residual dibasic residues remaining carboxy terminal end propeptides processing endolytic prohormone convertases pcsk1 pcsk2 10 mutation cpefat renders enzyme unstable ultimately degraded endoplasmic reticulum reduction cpe activity turn leads decrease biologically active hormones insulin cpe defects also observed tissues including hypothalamus suggests number additional prohormones may implicated obesity phenotype neuropeptides melanin stimulating hormone 3 melanin concentrating hormone 25
0.20854747.15870393.html.plaintext.txt	9	fat mutation initially arose inbred hrsj hrs strain 7 hrs fatfat mice exhibit early chronic hyperinsulinemia followed mature onset obesity without hyperglycemia fat mutation transferred c57blksj bks background male mice harboring mutation homozygous state became hyperglycemic sixth backcross generation n6 addition bks fatfat mice exhibit elevated plasma triglyceride high density lipoprotein hdl total cholesterol levels background strain difference respect diabetes development demonstrates cpefat necessary sufficient development diabesity obesitydiabetes cpefat model susceptibility loci must interact fat produce hyperglycemia metabolic phenotypes observed bks fatfat mice dissect susceptibility loci interacting cpefat performed genetic analysis male mice homozygous cpefat mutation large bks x hrshr f1 cpefat intercross inbred hrs strain also carries mutation hairless gene hr temporal phenotypes body weight plasma glucose constructed sets derived phenotypes capture key aspects longitudinal measurements rate flux severity phenotype present outcome genome wide screen susceptibility loci interact cpefat development obesity diabetes related disorders
0.20854747.15870393.html.plaintext.txt	10	fat mutation initially arose inbred hrsj hrs strain 7 hrs fatfat mice exhibit early chronic hyperinsulinemia followed mature onset obesity without hyperglycemia fat mutation transferred c57blksj bks background male mice harboring mutation homozygous state became hyperglycemic sixth backcross generation n6 addition bks fatfat mice exhibit elevated plasma triglyceride high density lipoprotein hdl total cholesterol levels background strain difference respect diabetes development demonstrates cpefat necessary sufficient development diabesity obesitydiabetes cpefat model susceptibility loci must interact fat produce hyperglycemia metabolic phenotypes observed bks fatfat mice dissect susceptibility loci interacting cpefat performed genetic analysis male mice homozygous cpefat mutation large bks x hrshr f1 cpefat intercross inbred hrs strain also carries mutation hairless gene hr temporal phenotypes body weight plasma glucose constructed sets derived phenotypes capture key aspects longitudinal measurements rate flux severity phenotype present outcome genome wide screen susceptibility loci interact cpefat development obesity diabetes related disorders
0.20854747.15870393.html.plaintext.txt	11	materials methods top abstract introduction materials methods results discussion grants references mice mice study ad libitum fed nih31 diet 6 fat pmi feeds st louis mo provided unlimited access water hcl acidified ph 28 32 temperature humidity controlled setting 1212 h light dark cycle fatfat mice difficulty breeding ovaries hyperglycemic female insipient congenic bkshrs cpefatcpefat mice bks fatfat cohorts ii backcross n6 cohort iii backcross n10 transplanted nodcb17 prkdascidj homozygous female mice recipients mated hrshr male mice hrs stock maintained jackson laboratory hr x hr matings f1 offspring intercrossed produce total 2838 f2 mice 3 cohorts although obesity observed male female bks fatfat mice hyperglycemia females rare therefore selected f2 fatfat male progeny quantitative trait loci qtl analysis
0.20854747.15870393.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion grants references mice mice study ad libitum fed nih31 diet 6 fat pmi feeds st louis mo provided unlimited access water hcl acidified ph 28 32 temperature humidity controlled setting 1212 h light dark cycle fatfat mice difficulty breeding ovaries hyperglycemic female insipient congenic bkshrs cpefatcpefat mice bks fatfat cohorts ii backcross n6 cohort iii backcross n10 transplanted nodcb17 prkdascidj homozygous female mice recipients mated hrshr male mice hrs stock maintained jackson laboratory hr x hr matings f1 offspring intercrossed produce total 2838 f2 mice 3 cohorts although obesity observed male female bks fatfat mice hyperglycemia females rare therefore selected f2 fatfat male progeny quantitative trait loci qtl analysis
0.20854747.15870393.html.plaintext.txt	13	phenotypic measurements body weights mice weighed monthly termination 24 cohorts ii iii 30 wk cohort age see table 1 schedule phenotypic measurements
0.20854747.15870393.html.plaintext.txt	14	phenotypic measurements body weights mice weighed monthly termination 24 cohorts ii iii 30 wk cohort age see table 1 schedule phenotypic measurements
0.20854747.15870393.html.plaintext.txt	15	view table table 1 schedule phenotypic measurements f2 intercross progeny
0.20854747.15870393.html.plaintext.txt	16	biochemical assays whole blood collected via orbital sinus biweekly 7 10 using edta coated capillary tube samples centrifuged plasma used biochemical assays plasma glucose cholesterol triglyceride levels measured using commercial colorimetric assays sigma st louis mo roche indianapolis determine hdl cholesterol levels low density low density lipoprotein particles precipitated polyethylene glycol 15 determine plasma triglyceride levels free glycerol subtracted total glycerol content plasma insulin levels measured using radioimmunoassay kit linco st louis mi plasma glucose levels monitored biweekly whereas lipid insulin levels determined 16 wk age termination
0.20854747.15870393.html.plaintext.txt	17	necropsies subcutaneous rostral caudal retroperitoneal epididymal fat pads isolated weighed termination total fat pad weights defined sum fat pads described adiposity indexes calculated dividing total fat pad weight carcass weight multiplying 100 addition fat pad weights body lengths nose tail girths animals measured
0.20854747.15870393.html.plaintext.txt	18	allele specific pcr dna isolated tail tissue using proteinase k digestion salt precipitation 28 cpefat hr segregating f2 intercross progeny dnas pcr amplified allele specific primers determine genotypes loci pcr conditions cpe primers previously described 19 cycling conditions pcr amplification hr follows 94 degrees c 2 min followed 49 cycles 94 degrees c 20 50 degrees c 30 72 degrees c 30 final extension done 72 degrees c 7 min pcrs done 10 microl volume containing 1x pcr buffer roche 100 ng genomic dna 15 mm mgcl2 200 nm dntps 025 units taq polymerase 02 microm primer f1 5 agggaggtcagagcctctg 3 01 microm primer r15 ggtcctcctgtttgcttgg 3 01 microm primer f2 5 gccactccttgaacctgtg 3 dnas separated 3 metaphor 1 agarose gel bma rockland stained ethidium bromide examined ultraviolet light dna heterozygous hr animals yielded two fragments 910 581 bps respectively
0.20854747.15870393.html.plaintext.txt	19	genome scan identify polymorphic regions bks hrs strains across genome dna parental bks fatfat n6 bks fatfat n10 hrs mice typed single stranded length polymorphism sslp markers research genetics using pcr assays previously described 14 initially total 87 sslp markers average spacing 20 cm tested genome scan largest gap 47 cm markers d1mit26 d1mit17 marker information available upon request additional markers tested chromosomal regions showing significant linkage resolution detected 187 markers tested scan region chromosome 17 differed bks fatfat n6 n10 animals n6 animals hrs genotype d17mit142 whereas n10 animals segregating hrs bks alleles areas hrs contaminated regions may exist 2 genome 2 bks modifying qtl may missed 2838 f2 mice generated intercross dna 282 fatfat f2 male progeny pcr amplified 10 fatfat male mice instead expected 125 available mice died early lost completion study approximately 83 possible genotypes complete determine whether qtl modified trait absence cpe defect genome scan performed dna 48 f2 fat 24 f2 mice
0.20854747.15870393.html.plaintext.txt	20	statistical analysis data analysis data thoroughly examined mice exhibiting spontaneous extraneous ailments malocclusions animals removed data set analysis phenotypic profiles f2 progeny obtained using one way anova examining longitudinal data male f2 fatfat mice noted different patterns disease progression example mice became hyperglycemic early sustained hyperglycemia others transiently hyperglycemic others showed slow moderate rise plasma glucose levels address longitudinal nature phenotypes created derived phenotypes body weight plasma glucose allowed us obtain results clear biological interpretation ie detect modifiers act early late disease process change affect rate disease progression curvature affect disease severity final remain constitutively expressed throughout time course average also makes results comparable future studies may measure body weight progression different time points even irregular time intervals constructed following sets derived phenotypes
0.20854747.15870393.html.plaintext.txt	21	statistical analysis data analysis data thoroughly examined mice exhibiting spontaneous extraneous ailments malocclusions animals removed data set analysis phenotypic profiles f2 progeny obtained using one way anova examining longitudinal data male f2 fatfat mice noted different patterns disease progression example mice became hyperglycemic early sustained hyperglycemia others transiently hyperglycemic others showed slow moderate rise plasma glucose levels address longitudinal nature phenotypes created derived phenotypes body weight plasma glucose allowed us obtain results clear biological interpretation ie detect modifiers act early late disease process change affect rate disease progression curvature affect disease severity final remain constitutively expressed throughout time course average also makes results comparable future studies may measure body weight progression different time points even irregular time intervals constructed following sets derived phenotypes
0.20854747.15870393.html.plaintext.txt	22	body weight let bi log body weight week
0.20854747.15870393.html.plaintext.txt	23	plasma glucose let gi log plasma glucose level mouse week
0.20854747.15870393.html.plaintext.txt	24	view larger version 18k fig 1 schematic showing derived phenotypes body weight bw plasma glucose pg b
0.20854747.15870393.html.plaintext.txt	25	multiple imputation method sen churchill 26 used perform one dimensional two dimensional genome scans derived phenotypes adiposity one dimensional genome scan also commonly referred genome scan survey single locus models explaining phenotype amounts performing anova every locus complete genotype information available examine much phenotypic variation explained genetic variation every locus summarize statistical evidence locus affects phenotype lod score two dimensional genome scan survey two locus models explaining phenotype examined much phenotypic variation explained genetic variation every pair loci genome one dimensional two dimensional scans included additive cohort effect three cohorts mice method analysis able combine overall evidence favor locus three cohorts respecting differences rationale combining crosses previously reported used studies 1 8 17 31 genotypes chromosome 8 linked fat mutation distal chromosome 17 cohort ii animals hrs genotype hence excluded genome analysis genome scans two stage model selection procedure followed
0.20854747.15870393.html.plaintext.txt	26	multiple imputation method sen churchill 26 used perform one dimensional two dimensional genome scans derived phenotypes adiposity one dimensional genome scan also commonly referred genome scan survey single locus models explaining phenotype amounts performing anova every locus complete genotype information available examine much phenotypic variation explained genetic variation every locus summarize statistical evidence locus affects phenotype lod score two dimensional genome scan survey two locus models explaining phenotype examined much phenotypic variation explained genetic variation every pair loci genome one dimensional two dimensional scans included additive cohort effect three cohorts mice method analysis able combine overall evidence favor locus three cohorts respecting differences rationale combining crosses previously reported used studies 1 8 17 31 genotypes chromosome 8 linked fat mutation distal chromosome 17 cohort ii animals hrs genotype hence excluded genome analysis genome scans two stage model selection procedure followed
0.20854747.15870393.html.plaintext.txt	27	locus locus pair selection locus locus pair selection previously described 29 loci cleared 5 permutation test threshold one dimensional scans selected selected locus pairs follows pairs cleared 5 permutation test threshold two dimensional scan full two locus model subjected secondary tests determine whether loci pair acting additively compared two locus additive model single locus models dropping locus turn comparison used nominal p value 0002 corresponds approximately 5 permutation test threshold one dimensional genome scan tested interaction component two locus model using nominal p value 00001 corresponds 5 permutation test threshold interaction test
0.20854747.15870393.html.plaintext.txt	28	backward elimination backward elimination previously described 5 loci locus pairs selected previous stage put together multiple qtl model additive cohort effect always included multiple qtl model multiple qtl model formed selecting marker closest locus genotypes missing markers multiple imputation method 26 used account missing genotypes basic idea missing genotypes probabilistically inferred genotypes nearby markers done simulating missing genotype marker conditional flanking typed markers account uncertainty knowledge true genotypes number imputations 26 used term model including cohort effect dropped change lod score noted corresponds type iii anova nominal p value change lod score 0002 main effects 00001 interactions term dropped procedure continued term could dropped
0.20854747.15870393.html.plaintext.txt	29	test whether major qtls specific fatfat animals performed anova test fatfat non fatfat male progeny selected nearest typed marker fatfat non fatfat progeny d19mit66 260 cm initial plasma glucose fat induced diabetes 1 find1 d5mit95 680 cm average plasma glucose find2 d11mit35 476 cm adiposity index fat induced adiposity 1 fina1 d14mit5 225 cm final body weight body weight 1 bwt1 plasma glucose measured 20 wk non fatfat mice redefined average glucose measurement animals average plasma glucose levels 4 8 12 16 24 wk test phenotype definitions three phenotypes left unchanged individuals missing phenotypes genotypes discarded anovas performed qtl marker genotype separately fatfat non fatfat animals
0.20854747.15870393.html.plaintext.txt	30	test whether major qtls specific fatfat animals performed anova test fatfat non fatfat male progeny selected nearest typed marker fatfat non fatfat progeny d19mit66 260 cm initial plasma glucose fat induced diabetes 1 find1 d5mit95 680 cm average plasma glucose find2 d11mit35 476 cm adiposity index fat induced adiposity 1 fina1 d14mit5 225 cm final body weight body weight 1 bwt1 plasma glucose measured 20 wk non fatfat mice redefined average glucose measurement animals average plasma glucose levels 4 8 12 16 24 wk test phenotype definitions three phenotypes left unchanged individuals missing phenotypes genotypes discarded anovas performed qtl marker genotype separately fatfat non fatfat animals
0.20854747.15870393.html.plaintext.txt	31	mutation analysis total rna prepared whole brain c57blksj hrsj mouse tissues homogenized rna isolated treatment trizol life technologies according manufacturers protocol cdna generated using superscript one step rt pcr kit life technologies gaithersburg md pcr primers mutation analysis orexinhypocretin hcrt carboxypeptidase d genes cpd designed sequences public database national center biotechnology information pcr amplification cdna performed using expand template system roche amplified products separated 1 12 gel excised purified using nucleospin columns clontech palo alto ca sequenced abi prism 3700 using forward reverse primers
0.20854747.15870393.html.plaintext.txt	32	mutation analysis total rna prepared whole brain c57blksj hrsj mouse tissues homogenized rna isolated treatment trizol life technologies according manufacturers protocol cdna generated using superscript one step rt pcr kit life technologies gaithersburg md pcr primers mutation analysis orexinhypocretin hcrt carboxypeptidase d genes cpd designed sequences public database national center biotechnology information pcr amplification cdna performed using expand template system roche amplified products separated 1 12 gel excised purified using nucleospin columns clontech palo alto ca sequenced abi prism 3700 using forward reverse primers
0.20854747.15870393.html.plaintext.txt	33	results top abstract introduction materials methods results discussion grants references segregation traits f2 male progeny investigate effects cpefat mutation traits phenotypic data 76 fatfat 48 fat 61 intercross progeny cohort collected means compared different genotypic groups table 2 summarizes mean values metabolic features examined f2 progeny cohort increased adiposity hyperglycemia hyperinsulinemia hypercholesteremia observed fatfat homozygotes compared fat heterozygous wild type mice significant difference means physiological parameters observed f2 fatfat fat progeny large variation f2 fatfat progeny suggest background genes playing important role modifying trait phenotypes addition fact hrs fatfat mice exhibit elevated plasma glucose 7 supports idea cpefat necessary sufficient development diabesity mouse models carrying cpe defect
0.20854747.15870393.html.plaintext.txt	34	results top abstract introduction materials methods results discussion grants references segregation traits f2 male progeny investigate effects cpefat mutation traits phenotypic data 76 fatfat 48 fat 61 intercross progeny cohort collected means compared different genotypic groups table 2 summarizes mean values metabolic features examined f2 progeny cohort increased adiposity hyperglycemia hyperinsulinemia hypercholesteremia observed fatfat homozygotes compared fat heterozygous wild type mice significant difference means physiological parameters observed f2 fatfat fat progeny large variation f2 fatfat progeny suggest background genes playing important role modifying trait phenotypes addition fact hrs fatfat mice exhibit elevated plasma glucose 7 supports idea cpefat necessary sufficient development diabesity mouse models carrying cpe defect
0.20854747.15870393.html.plaintext.txt	35	view table table 2 phenotypic profiles parental bks fatfat n10 n6 hrs fatfat f2 fatfat fat mice cohort
0.20854747.15870393.html.plaintext.txt	36	body weight adiposity general fatfat mice significantly higher body weights fat mice heterozygous effect body weight fat mice evident time period examined expected adiposity indexes fatfat mutant mice much higher nonobese controls whereas fat mice tended toward higher adiposity levels significantly different normal littermates interestingly significant differences body length girth also observed three subgroups
0.20854747.15870393.html.plaintext.txt	37	hyperglycemia f2 fat mice normoglycemic total 282 f2 fatfat males cohorts iii monitored plasma glucose levels 253 abnormal levels plasma glucose 225 mgdl fifty eight percent defined diabetic chronically diabetic plasma glucose 300 mgdl 2 timepoints termination plasma glucose levels ranged 61 1020 mgdl mean 3120 plus minus 1699 mgdl different forms diabetes onset observed f2 generation mice transiently diabetic early whereas others became diabetic later life
0.20854747.15870393.html.plaintext.txt	38	hyperlipidemia hyperinsulinemia f2 fatfat mice developed chronic hyperinsulinemia plasma insulin 5 ngml mild moderate hyperlipidemia 30 wk age plasma insulin levels elevated 30 fold total cholesterol levels nearly doubled f2 fatfat mice compared nonobese littermates
0.20854747.15870393.html.plaintext.txt	39	hyperlipidemia hyperinsulinemia f2 fatfat mice developed chronic hyperinsulinemia plasma insulin 5 ngml mild moderate hyperlipidemia 30 wk age plasma insulin levels elevated 30 fold total cholesterol levels nearly doubled f2 fatfat mice compared nonobese littermates
0.20854747.15870393.html.plaintext.txt	40	qtl mapping loci interacting cpefat genome scan analysis qtl analysis data logarithmically transformed stabilize variance resulting phenotypic distributions much symmetric shown fig 2 frequency distribution body weight varies age whereas frequency distribution plasma glucose remains homogenous 8 24 wk age disease progressions examined animals individually different patterns observed body weight plasma glucose make observations biologically meaningful derived data phenotype different categories detect modifiers affecting rate flux severity disease progression see materials methods
0.20854747.15870393.html.plaintext.txt	41	qtl mapping loci interacting cpefat genome scan analysis qtl analysis data logarithmically transformed stabilize variance resulting phenotypic distributions much symmetric shown fig 2 frequency distribution body weight varies age whereas frequency distribution plasma glucose remains homogenous 8 24 wk age disease progressions examined animals individually different patterns observed body weight plasma glucose make observations biologically meaningful derived data phenotype different categories detect modifiers affecting rate flux severity disease progression see materials methods
0.20854747.15870393.html.plaintext.txt	42	view larger version 25k fig 2 frequency distributions bws pg levels b f2 fatfat male mice biweekly time intervals length horizontal lines corresponds number observations
0.20854747.15870393.html.plaintext.txt	43	total 87 sslp markers used genotype total 282 fatfat male progeny results one two dimensional scans shown fig 3 table 3 summary major qtls positions presented whereas table 4 type iii anova table corresponding multiple qtl model selected trait shown
0.20854747.15870393.html.plaintext.txt	44	total 87 sslp markers used genotype total 282 fatfat male progeny results one two dimensional scans shown fig 3 table 3 summary major qtls positions presented whereas table 4 type iii anova table corresponding multiple qtl model selected trait shown
0.20854747.15870393.html.plaintext.txt	45	view larger version 32k fig 3 genome scan plots one dimensional traits chromosomes containing significant markers shown bold b allelic plots significant quanitative trait loci qtl adiposity bw pg plasma insulin total cholesterol derived phenotypes c allelic plot significant interactive qtl bw two dimensional scan
0.20854747.15870393.html.plaintext.txt	46	view table table 3 summary major qtl adiposity body weight pg plasma insulin blood cholesterol detected f2 bks x hrs fatfat mice
0.20854747.15870393.html.plaintext.txt	47	view table table 4 multiple qtl models type iii anova traits
0.20854747.15870393.html.plaintext.txt	48	adiposity major qtl cpefat induced adiposity fina1 identified chromosome 11 f2 fatfat male progeny peak lod score d11mit242 qtl analysis individual fat pad weights detected qtls rostral caudal epididymal fat pads region chromosome 11 mice homozygous bks derived allele d11mit242 significantly higher fat depot weights fig 3b littermates
0.20854747.15870393.html.plaintext.txt	49	body weight f2 male progeny major locus body weight bwt1 identified chromosome 14 tightly linked hr determine effects hr various traits f2 intercross progeny fatfat fat mice genotyped allele specific primers hr mutation mean values traits compared table 5 three genetic subgroups mice homozygous hr mutation significantly reduced body weight measurements suggests bwt1 acting independently fat body weight addition fatfat fat hr mice lowered total cholesterol plasma insulin levels shown
0.20854747.15870393.html.plaintext.txt	50	view table table 5 body weight bks x hrs f2 fatfat fat mice segregated hr
0.20854747.15870393.html.plaintext.txt	51	identified locus chromosome 18 interacts bwt1 lower body weight intra allelic interaction heterosis heterozygosity chromosome 18 strongest epistatic effect body weight mice homozygous hrs derived allele bwt1 fig 3c chromosome 18 locus showed significant effect body weights interacting bwt1 independent effect body weight measurements major locus weight gain maximum lod score 50 d11mit23 overlapped adiposity locus fina1 also detected mice homozygous bks derived alleles bb largest weight gains compared heterozygous bh homozygous hh hrs littermates fig 3b
0.20854747.15870393.html.plaintext.txt	52	identified locus chromosome 18 interacts bwt1 lower body weight intra allelic interaction heterosis heterozygosity chromosome 18 strongest epistatic effect body weight mice homozygous hrs derived allele bwt1 fig 3c chromosome 18 locus showed significant effect body weights interacting bwt1 independent effect body weight measurements major locus weight gain maximum lod score 50 d11mit23 overlapped adiposity locus fina1 also detected mice homozygous bks derived alleles bb largest weight gains compared heterozygous bh homozygous hh hrs littermates fig 3b
0.20854747.15870393.html.plaintext.txt	53	hyperglycemia hyperinsulinemia hypercholesterolemia two loci cpefat induced diabetes find1 find2 detected chromosomes 19 5 respectively fig 3 b find2 mice homozygous bks derived alleles bb exhibited higher plasma glucose levels bh homozygous hh littermates whereas find1 presence hrs allele resulted elevated plasma glucose levels find2 locus found affect metabolic features besides plasma glucose insulin total cholesterol levels use backward elimination multiple qtl model locus including find2 identified interaction find1 fact significant interaction detected find1 surprising hrs fatfat mice become diabetic hr segregated crosses hypothesized find1 effect plasma glucose may dependent hr genotype chromosome 14 compared plasma glucose means mice homozygous hrs derived allele find1 two genotypic cohorts bb hh d14mit115 marker tightly linked hr locus table 6 suspected mice homozygous hrs derived allele find1 homozygous bks derived allele d14mit115 significantly higher plasma glucose levels mice homozygous hrs derived alleles find1 d14mit115
0.20854747.15870393.html.plaintext.txt	54	hyperglycemia hyperinsulinemia hypercholesterolemia two loci cpefat induced diabetes find1 find2 detected chromosomes 19 5 respectively fig 3 b find2 mice homozygous bks derived alleles bb exhibited higher plasma glucose levels bh homozygous hh littermates whereas find1 presence hrs allele resulted elevated plasma glucose levels find2 locus found affect metabolic features besides plasma glucose insulin total cholesterol levels use backward elimination multiple qtl model locus including find2 identified interaction find1 fact significant interaction detected find1 surprising hrs fatfat mice become diabetic hr segregated crosses hypothesized find1 effect plasma glucose may dependent hr genotype chromosome 14 compared plasma glucose means mice homozygous hrs derived allele find1 two genotypic cohorts bb hh d14mit115 marker tightly linked hr locus table 6 suspected mice homozygous hrs derived allele find1 homozygous bks derived allele d14mit115 significantly higher plasma glucose levels mice homozygous hrs derived alleles find1 d14mit115
0.20854747.15870393.html.plaintext.txt	55	view table table 6 comparison pg levels bb hh genotypes d14mit115
0.20854747.15870393.html.plaintext.txt	56	significant loci plasma insulin 24 wk total cholesterol 16 wk detected chromosome 5 find2 fig 3 c f2 mice homozygous bks derived allele d5mit95 significantly higher total cholesterol levels lower plasma insulin levels
0.20854747.15870393.html.plaintext.txt	57	evaluation major qtl fat progeny determine whether major qtl identified acted modifiers cpefat mutation performed anovas qtl marker genotype separately fatfat non fatfat male intercross progeny table 7 fatfat mice significant effect also observed bwt1 fat mice d14mit5 marker linked hr locus however none qtls find1 find2 fina1 showed strong effect non fatfat male progeny consistent modifier hypothesis
0.20854747.15870393.html.plaintext.txt	58	evaluation major qtl fat progeny determine whether major qtl identified acted modifiers cpefat mutation performed anovas qtl marker genotype separately fatfat non fatfat male intercross progeny table 7 fatfat mice significant effect also observed bwt1 fat mice d14mit5 marker linked hr locus however none qtls find1 find2 fina1 showed strong effect non fatfat male progeny consistent modifier hypothesis
0.20854747.15870393.html.plaintext.txt	59	view table table 7 anova results major qtl effects cpefatcpefat cpefat cpe mice
0.20854747.15870393.html.plaintext.txt	60	evaluation candidate genes region spanning fina1 includes attractive biological candidates hcrt cpd orexin positive neurons localized lateral hypothalamus project throughout brain orexin knockout mice exhibit narcoleptic phenotype suggests orexin may function regulation arousal sleep wake cycle 6 however intraventricular injection orexin peptide increases feeding c57bl6j mice 18 carboxypeptidase d similar enzymatic activity cpe might functionally complement cpe deficit cell types mutation analysis coding regions hcrt cpd mrna hrs bks mice detected sequence differences although promotor regions examined mrna abundance differ judged amount ethidium bromide stained rt pcr product obtained two strains
0.20854747.15870393.html.plaintext.txt	61	evaluation candidate genes region spanning fina1 includes attractive biological candidates hcrt cpd orexin positive neurons localized lateral hypothalamus project throughout brain orexin knockout mice exhibit narcoleptic phenotype suggests orexin may function regulation arousal sleep wake cycle 6 however intraventricular injection orexin peptide increases feeding c57bl6j mice 18 carboxypeptidase d similar enzymatic activity cpe might functionally complement cpe deficit cell types mutation analysis coding regions hcrt cpd mrna hrs bks mice detected sequence differences although promotor regions examined mrna abundance differ judged amount ethidium bromide stained rt pcr product obtained two strains
0.20854747.15870393.html.plaintext.txt	62	discussion top abstract introduction materials methods results discussion grants references obesity complex multifactorial disease human population often associated increased susceptibility comorbidities type ii diabetes atherosclerosis hypertension 30 susceptibility bkshrs fatfat mice resistance hrs fatfat mice type ii diabetes make mutant fat mouse useful model study gene interactions development diabesity study two major loci hyperglycemia find2 find1 identified chromosomes 5 19 respectively f2 fatfat mice homozygous bks derived allele find2 increased susceptibility mice homozygous hrs derived allele resistant hyperglycemia hence hypothesize find2 may locus protects hrs fatfat mice developing diabetes known previously bks genetic background diabetogenic 7 c57blksj x c57bl6j leprdbleprdb intercross two putative loci hyperglycemia identified chromosomes 8 17 qtl detected chromosome 5 21 disparity may due differences db fat mutations interacting bks background alternatively chromosome 8 locus may lie close cpe locus bkshrs mice used may carry addition subset mice analyzed bks x b6 intercross 20 highest plasma glucose lowest plasma glucose levels thus find2 locus chromosome 5 locus may missed
0.20854747.15870393.html.plaintext.txt	63	bks x hrs f2 fatfat mice homozygous hrs allele find1 elevated plasma glucose levels hrs fatfat mice become hyperglycemic implies find1 interacting additional loci bks background multiple qtl model detect locus interacting find1 however observe association plasma glucose levels mice homozygous hh find1 genotype near hr locus chromosome 14 suggests hr gene closely linked gene may effect find1 expression addition loci closely linked cpe locus chromosome 8 cannot ruled mice analyzed homozygous cpefat diabetes susceptibility loci found interval find1 distal mouse chromosome 19 several rodent experiments 11 12 16 27 whether loci due mutations gene remains determined
0.20854747.15870393.html.plaintext.txt	64	bks x hrs f2 fatfat mice homozygous hrs allele find1 elevated plasma glucose levels hrs fatfat mice become hyperglycemic implies find1 interacting additional loci bks background multiple qtl model detect locus interacting find1 however observe association plasma glucose levels mice homozygous hh find1 genotype near hr locus chromosome 14 suggests hr gene closely linked gene may effect find1 expression addition loci closely linked cpe locus chromosome 8 cannot ruled mice analyzed homozygous cpefat diabetes susceptibility loci found interval find1 distal mouse chromosome 19 several rodent experiments 11 12 16 27 whether loci due mutations gene remains determined
0.20854747.15870393.html.plaintext.txt	65	major qtl body weight bwt1 identified chromosome 14 lod peak bwt1 close vicinity hr making hr plausible candidate allele typing hr allele f2 progeny showed hrhr mutant mice significantly lower mean body weight values haired mice hairless hrs mice hrs hrhr mice also lower mean adipose depot body weights normally haired albino hrs littermates 20 previously shown hairless mice higher metabolic rate normally haired albino mice 9 attributed greater energy requirement thermoregulation mice lacking body hair however recently discovered hr gene product acts corepressor thyroid hormone receptor 24 hr mutation might therefore mimic effects thyroid hormone energy metabolism altogether data suggest hr responsible lowered body weight hrs hrhr mice hr gene explains variance observed f2 fatfat males acts independently fat locus currently published reports adiposity human patients congenital alopecia artrichia carrying mutations hr gene unclear whether hr mutations effect metabolism humans mice
0.20854747.15870393.html.plaintext.txt	66	major qtl body weight bwt1 identified chromosome 14 lod peak bwt1 close vicinity hr making hr plausible candidate allele typing hr allele f2 progeny showed hrhr mutant mice significantly lower mean body weight values haired mice hairless hrs mice hrs hrhr mice also lower mean adipose depot body weights normally haired albino hrs littermates 20 previously shown hairless mice higher metabolic rate normally haired albino mice 9 attributed greater energy requirement thermoregulation mice lacking body hair however recently discovered hr gene product acts corepressor thyroid hormone receptor 24 hr mutation might therefore mimic effects thyroid hormone energy metabolism altogether data suggest hr responsible lowered body weight hrs hrhr mice hr gene explains variance observed f2 fatfat males acts independently fat locus currently published reports adiposity human patients congenital alopecia artrichia carrying mutations hr gene unclear whether hr mutations effect metabolism humans mice
0.20854747.15870393.html.plaintext.txt	67	major locus fina1 chromosome 11 strongly associated adiposity genome scan f2 fatfat mice fact fina1 observed lean controls implies fina1 locus epistatically interacting fat thereby masking effects hr adipose depot distribution f2 fatfat mutant mice interval fina1 still fairly large includes intriguing candidates hcrt cpd although sequence variations observed coding regions genes possibility promoter defects needs exploration
0.20854747.15870393.html.plaintext.txt	68	major locus fina1 chromosome 11 strongly associated adiposity genome scan f2 fatfat mice fact fina1 observed lean controls implies fina1 locus epistatically interacting fat thereby masking effects hr adipose depot distribution f2 fatfat mutant mice interval fina1 still fairly large includes intriguing candidates hcrt cpd although sequence variations observed coding regions genes possibility promoter defects needs exploration
0.20854747.15870393.html.plaintext.txt	69	study carried genetic analysis complex phenotype caused prohormone processing defect fat mutant mice use novel method analyzing modifier genes involved different patterns disease progression rate fluctuation severity also show many phenotypes observed fat mice ameliorated action major modifier genes obesity often associated alterations neuropeptide levels identification diabesity associated modifier qtl also lead better understanding biological pathways neuropeptides may involved common forms obesity
0.20854747.15870393.html.plaintext.txt	70	study carried genetic analysis complex phenotype caused prohormone processing defect fat mutant mice use novel method analyzing modifier genes involved different patterns disease progression rate fluctuation severity also show many phenotypes observed fat mice ameliorated action major modifier genes obesity often associated alterations neuropeptide levels identification diabesity associated modifier qtl also lead better understanding biological pathways neuropeptides may involved common forms obesity
0.20854747.15870393.html.plaintext.txt	71	grants top abstract introduction materials methods results discussion grants references study supported national institute diabetes digestive kidney diseases grants dk 46977 dk 53278 institutional shared services supported national cancer institute cancer center support grant ca 34196
0.20854747.15870393.html.plaintext.txt	72	grants top abstract introduction materials methods results discussion grants references study supported national institute diabetes digestive kidney diseases grants dk 46977 dk 53278 institutional shared services supported national cancer institute cancer center support grant ca 34196
0.20854747.15870393.html.plaintext.txt	73	acknowledgments gratefully acknowledge technical assistance theolyn gilley jay young
0.20854747.15870393.html.plaintext.txt	74	footnotes article published online print see web site date publication httpphysiolgenomicsphysiologyorg
0.20854747.15870393.html.plaintext.txt	75	footnotes article published online print see web site date publication httpphysiolgenomicsphysiologyorg
0.20854747.15870393.html.plaintext.txt	76	address reprint requests correspondence j k naggert jackson laboratory 600 main st bar harbor 04609 e mail jknatjaxorg u d
0.20854747.15870393.html.plaintext.txt	77	references top abstract introduction materials methods results discussion grants references almind k kulkarni rn lannon sm kahn cr identification interactive loci linked insulin leptin mice genetic resistance diabetes 52 1535 1543 2003abstractfree full text bailey d pure inbred strains mice immunol today 3 210 214 1982crossrefisi berman y mzhavia n polonskaia devi la impaired prohormone convertases cpefatcpefat mice j biol chem 276 1466 1473 2001abstractfree full text brockmann ga bevova mr using mouse models dissect genetics obesity trends genet 18 367 376 2002crossrefisimedline broman kw speed tp model selection approach identification quantitative trait loci experimental crosses j royal stat soc b 64 641 656 731 775 2002crossrefisi chemelli rm willie jt sinton cm elmquist jk scamell lee c richardson ja williams sc xiong y narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999crossrefisimedline coleman dl eicher em fat fat tubby tub two autosomal recessive mutations causing obesity syndromes mouse j hered 81 424 427 1990isimedline dipetrillo k tsaih sw sheehan johns c kelmenson p gavras h churchill ga paigen b genetic analysis blood pressure c3hhej swrj mice physiol genomics 17 215 220 2004abstractfree full text donnelly ht oxygen consumption activity body fat normal hairless mice lab anim 16 167 171 1982isimedline fricker ld berman yl leiter el devi la carboxypeptidase e activity deficient mice fat mutation effect peptide processing j biol chem 271 30619 30624 1996abstractfree full text galli j li ls glasser ostenson cg jiao h fakhrai rad h jacob hj lander es lutherman h genetic analysis non insulin dependent diabetes mellitus gk rat nat genet 12 31 37 1996crossrefisimedline gauguier d froguel p oarent v bernard c bihoreau mt portha b james mr penicaud l lathrop m ktorza chromosomal mapping genetic loci associated non insulin dependent diabetes gk rat nat genet 12 38 43 1996crossrefisimedline gloyn al mccarthy mi genetics type 2 diabetes best pract res clin endocrinol metab 15 293 308 2001crossrefisimedline ikeda zheng qy rosenstiel p maddatu zuberi ar roopenian dc north ma naggert jk johnson kr nishina pm genetic modification hearing tubby mice evidence existence major gene moth1 protects tubby mice hearing loss hum mol genet 8 1761 1767 1999abstractfree full text izzo c grillo f murador e improved method determination high density lipoprotein cholesterol isolationof high density lipoproteins use polyethylene glycol 6000 clin chem 27 371 374 1981abstractfree full text kim jh sen avery cs simpson e chandler p nishina pm churchill ga naggert jk genetic analysis new mouse model non insulin dependent diabetes genomics 74 273 286 2001crossrefisimedline li r lyons ma wittenburg h paigen b churchill ga combining data multiple inbred line crosses improves power resolution quantitative trait loci mapping genetics 169 1699 1709 2005abstractfree full text lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline maddatu tp naggert jk allele specific pcr assays tub cpefat mutations mamm genome 8 857 858 1997crossrefisimedline mount le metabolic rate thermal insulation albino hairless mice j physiol 217 315 326 1971isimedline mu jl naggert jk svenson kl collin gb kim jh mcfarland c nishina pm levine dm williams kj paigen b quantitative trait loci analysis differences susceptibility atherosclerosis diabetes inbred mouse strains c57bl6j c57blksj j lipid res 40 1328 1335 1999abstractfree full text naggert jk fricker ld varlamov o nishina pm rouille y steiner df carroll rj paigen bj leiter eh hyperproinsulinaemia obese fatfat mice associated carboxypeptidase e mutation reduces enzyme activity nat genet 10 135 142 1995isimedline pomp d genetic dissection obesity polygenic animal models behav genet 27 285 306 1997crossrefisimedline potter gb beaudoin iiigmj derenzo cl zarach jm chen sh thompson cc hairless gene mutated congenital hair loss disorders encodes novel nuclear receptor corepressor genes dev 15 2687 2701 2001abstractfree full text rovere c viale nahon j kitabgi p impaired processing brain proneurotensin promelanin concentrating hormone obese fatfat mice endocrinology 137 2954 2958 1996abstract sen churchill ga statistical framework quantitative trait mapping genetics 159 371 387 2001abstractfree full text stoehr jp nadler st schueler kl rabaglia yandell bs metz sa attie ad genetic obesity unmasks nonlinear interactions murine type 2 diabetes susceptibility loci diabetes 49 1946 1954 2000abstract strauss wm preparation genomic dna mammalian tissue current protocols molecular biology new york wiley 1998 p 221 223 sugiyama f churchill ga higgins dc johns c makaritsis kp gavras h paigen b concordance murine quantitative trait loci salt induced hypertension rat human loci genomics 71 70 77 2001crossrefisimedline watkins pj cardiovascular disease hypertension lipids bmj 326 874 876 2003free full text zou f yandell bs fine jp statistical issues analysis quantitative traits combined crosses genetics 158 1339 1346 2001abstractfree full text
0.20854747.15870393.html.plaintext.txt	78	references top abstract introduction materials methods results discussion grants references almind k kulkarni rn lannon sm kahn cr identification interactive loci linked insulin leptin mice genetic resistance diabetes 52 1535 1543 2003abstractfree full text bailey d pure inbred strains mice immunol today 3 210 214 1982crossrefisi berman y mzhavia n polonskaia devi la impaired prohormone convertases cpefatcpefat mice j biol chem 276 1466 1473 2001abstractfree full text brockmann ga bevova mr using mouse models dissect genetics obesity trends genet 18 367 376 2002crossrefisimedline broman kw speed tp model selection approach identification quantitative trait loci experimental crosses j royal stat soc b 64 641 656 731 775 2002crossrefisi chemelli rm willie jt sinton cm elmquist jk scamell lee c richardson ja williams sc xiong y narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999crossrefisimedline coleman dl eicher em fat fat tubby tub two autosomal recessive mutations causing obesity syndromes mouse j hered 81 424 427 1990isimedline dipetrillo k tsaih sw sheehan johns c kelmenson p gavras h churchill ga paigen b genetic analysis blood pressure c3hhej swrj mice physiol genomics 17 215 220 2004abstractfree full text donnelly ht oxygen consumption activity body fat normal hairless mice lab anim 16 167 171 1982isimedline fricker ld berman yl leiter el devi la carboxypeptidase e activity deficient mice fat mutation effect peptide processing j biol chem 271 30619 30624 1996abstractfree full text galli j li ls glasser ostenson cg jiao h fakhrai rad h jacob hj lander es lutherman h genetic analysis non insulin dependent diabetes mellitus gk rat nat genet 12 31 37 1996crossrefisimedline gauguier d froguel p oarent v bernard c bihoreau mt portha b james mr penicaud l lathrop m ktorza chromosomal mapping genetic loci associated non insulin dependent diabetes gk rat nat genet 12 38 43 1996crossrefisimedline gloyn al mccarthy mi genetics type 2 diabetes best pract res clin endocrinol metab 15 293 308 2001crossrefisimedline ikeda zheng qy rosenstiel p maddatu zuberi ar roopenian dc north ma naggert jk johnson kr nishina pm genetic modification hearing tubby mice evidence existence major gene moth1 protects tubby mice hearing loss hum mol genet 8 1761 1767 1999abstractfree full text izzo c grillo f murador e improved method determination high density lipoprotein cholesterol isolationof high density lipoproteins use polyethylene glycol 6000 clin chem 27 371 374 1981abstractfree full text kim jh sen avery cs simpson e chandler p nishina pm churchill ga naggert jk genetic analysis new mouse model non insulin dependent diabetes genomics 74 273 286 2001crossrefisimedline li r lyons ma wittenburg h paigen b churchill ga combining data multiple inbred line crosses improves power resolution quantitative trait loci mapping genetics 169 1699 1709 2005abstractfree full text lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline maddatu tp naggert jk allele specific pcr assays tub cpefat mutations mamm genome 8 857 858 1997crossrefisimedline mount le metabolic rate thermal insulation albino hairless mice j physiol 217 315 326 1971isimedline mu jl naggert jk svenson kl collin gb kim jh mcfarland c nishina pm levine dm williams kj paigen b quantitative trait loci analysis differences susceptibility atherosclerosis diabetes inbred mouse strains c57bl6j c57blksj j lipid res 40 1328 1335 1999abstractfree full text naggert jk fricker ld varlamov o nishina pm rouille y steiner df carroll rj paigen bj leiter eh hyperproinsulinaemia obese fatfat mice associated carboxypeptidase e mutation reduces enzyme activity nat genet 10 135 142 1995isimedline pomp d genetic dissection obesity polygenic animal models behav genet 27 285 306 1997crossrefisimedline potter gb beaudoin iiigmj derenzo cl zarach jm chen sh thompson cc hairless gene mutated congenital hair loss disorders encodes novel nuclear receptor corepressor genes dev 15 2687 2701 2001abstractfree full text rovere c viale nahon j kitabgi p impaired processing brain proneurotensin promelanin concentrating hormone obese fatfat mice endocrinology 137 2954 2958 1996abstract sen churchill ga statistical framework quantitative trait mapping genetics 159 371 387 2001abstractfree full text stoehr jp nadler st schueler kl rabaglia yandell bs metz sa attie ad genetic obesity unmasks nonlinear interactions murine type 2 diabetes susceptibility loci diabetes 49 1946 1954 2000abstract strauss wm preparation genomic dna mammalian tissue current protocols molecular biology new york wiley 1998 p 221 223 sugiyama f churchill ga higgins dc johns c makaritsis kp gavras h paigen b concordance murine quantitative trait loci salt induced hypertension rat human loci genomics 71 70 77 2001crossrefisimedline watkins pj cardiovascular disease hypertension lipids bmj 326 874 876 2003free full text zou f yandell bs fine jp statistical issues analysis quantitative traits combined crosses genetics 158 1339 1346 2001abstractfree full text
0.21321544.12639935.html.plaintext.txt	0	ghrelin induced food intake mediated via orexin pathway koji toshinai yukari date noboru murakami mitsushi shimada muhtashan mondal takuya shimbara jian lian guan qing ping wang hisayuki funahashi takeshi sakurai seiji shioda shigeru matsukura kenji kangawa masamitsu nakazato
0.21321544.12639935.html.plaintext.txt	1	ghrelin induced food intake mediated via orexin pathway koji toshinai yukari date noboru murakami mitsushi shimada muhtashan mondal takuya shimbara jian lian guan qing ping wang hisayuki funahashi takeshi sakurai seiji shioda shigeru matsukura kenji kangawa masamitsu nakazato
0.21321544.12639935.html.plaintext.txt	2	department internal medicine kt yd msm ts sm mn miyazaki medical college miyazaki 889 1692 japan department veterinary physiology nm university miyazaki miyazaki 889 2151 japan first department internal medicine ms oita medical university oita 879 5593 japan department anatomy j lg q pw hf ss showa university school medicine tokyo 142 8555 japan department pharmacology university tsukuba ts ibaraki 305 8575 japan national cardiovascular center research institute yd kk osaka 565 8565 japan
0.21321544.12639935.html.plaintext.txt	3	address correspondence requests reprints masamitsu nakazato md phd third department internal medicine miyazaki medical college kiyotake miyazaki 889 1692 japan e mail nakazatoatpostmiyazaki medacjp u d
0.21321544.12639935.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references hypothalamus regulates energy intake integrating degree starvation satiation status environment variety neuronal blood derived signals ghrelin peptide produced stomach hypothalamus stimulates feeding gh secretion centrally administered ghrelin exerts orexigenic activity neuropeptide y npy agouti related protein systems interaction ghrelin hypothalamic orexigenic peptides however clarified investigated anatomical interactions functional relationship ghrelin two orexigenic peptides orexin melanin concentrating hormone mch present lateral hypothalamus ghrelin immunoreactive axonal terminals made direct synaptic contacts orexin producing neurons intracerebroventricular administration ghrelin induced fos expression marker neuronal activation orexin producing neurons mch producing neurons ghrelin remained competent induce fos expression orexin producing neurons following pretreatment anti npy igg pretreatment anti orexin igg anti orexin b igg anti mch igg attenuated ghrelin induced feeding administration npy receptor antagonist attenuated ghrelin induced feeding rats treated anti orexin iggs ghrelin induced feeding also suppressed orexin knockout mice study identifies novel hypothalamic pathway links ghrelin orexin regulation feeding behavior energy homeostasis
0.21321544.12639935.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references hypothalamus regulates energy intake integrating degree starvation satiation status environment variety neuronal blood derived signals ghrelin peptide produced stomach hypothalamus stimulates feeding gh secretion centrally administered ghrelin exerts orexigenic activity neuropeptide y npy agouti related protein systems interaction ghrelin hypothalamic orexigenic peptides however clarified investigated anatomical interactions functional relationship ghrelin two orexigenic peptides orexin melanin concentrating hormone mch present lateral hypothalamus ghrelin immunoreactive axonal terminals made direct synaptic contacts orexin producing neurons intracerebroventricular administration ghrelin induced fos expression marker neuronal activation orexin producing neurons mch producing neurons ghrelin remained competent induce fos expression orexin producing neurons following pretreatment anti npy igg pretreatment anti orexin igg anti orexin b igg anti mch igg attenuated ghrelin induced feeding administration npy receptor antagonist attenuated ghrelin induced feeding rats treated anti orexin iggs ghrelin induced feeding also suppressed orexin knockout mice study identifies novel hypothalamic pathway links ghrelin orexin regulation feeding behavior energy homeostasis
0.21321544.12639935.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references ghrelin originally isolated human rat stomach cognate endogenous ligand gh secretagogue receptor ghs r ref 1 28 amino acid peptide posttranslational n octanoyl modification indispensable activity ghrelin stimulates gh release peripherally centrally administered rats applied directly rat primary pituitary cells 1 2 3 addition ghrelin administration increases food intake body weight gain 3 4 5 6 7 8 9 whereas ghrelin secretion regulated negative energy balance conditions including starvation insulin induced hypoglycemia cachexia anorexia nervosa regulated conditions positive energy balance feeding hyperglycemia obesity 10 11 12 13 14 gastric ghrelin enters brain across blood brain barrier 15 recently stomach derived ghrelin signals starvation reported relayed hindbrain via vagus afferent nerve 16
0.21321544.12639935.html.plaintext.txt	7	although ghrelin predominantly produced endocrine cells stomach 17 18 also synthesized hypothalamic arcuate nucleus 1 19 critical region feeding ghrelin receptor however extensively distributed throughout brain areas lateral hypothalamus lh arcuate nucleus 20 21 areas contain several subsets neurons produce neuropeptides implicated feeding regulation including neuropeptide y npy agouti related protein agrp cocaine amphetamine regulated transcript proopiomelanocortin melanin concentrating hormone mch orexins orexin orexin b also termed hypocretins 22 23 centrally administered ghrelin may interact peptides regulate food intake energy homeostasis although mechanism ghrelin orexigenic activity related npy agrp pathways 6 7 24 interaction ghrelin energy regulating systems unclear
0.21321544.12639935.html.plaintext.txt	8	although ghrelin predominantly produced endocrine cells stomach 17 18 also synthesized hypothalamic arcuate nucleus 1 19 critical region feeding ghrelin receptor however extensively distributed throughout brain areas lateral hypothalamus lh arcuate nucleus 20 21 areas contain several subsets neurons produce neuropeptides implicated feeding regulation including neuropeptide y npy agouti related protein agrp cocaine amphetamine regulated transcript proopiomelanocortin melanin concentrating hormone mch orexins orexin orexin b also termed hypocretins 22 23 centrally administered ghrelin may interact peptides regulate food intake energy homeostasis although mechanism ghrelin orexigenic activity related npy agrp pathways 6 7 24 interaction ghrelin energy regulating systems unclear
0.21321544.12639935.html.plaintext.txt	9	orexin b produced 130 amino acid prepro orexin precursor lh 46 amino acid sequence identity stimulate food intake 25 mch 19 amino acid neuropeptide whose neurons coextensive colocalized orexin neurons lh 26 also stimulates feeding centrally administered 27 using electron microscope immunohistochemistry immunofluorescence microscopy investigated anatomical distributions ghrelin orexin mch also examined ghrelin induced expression c fos marker neuronal activation 28 orexin mch expressing neurons investigate functional relationship ghrelin orexins mch examined effect pretreatment anti orexin b iggs anti mch igg ghrelin inducing feeding also studied ghrelin induced food intake orexin knockout mice demonstrate ghrelin interacts orexin system induce feeding
0.21321544.12639935.html.plaintext.txt	10	orexin b produced 130 amino acid prepro orexin precursor lh 46 amino acid sequence identity stimulate food intake 25 mch 19 amino acid neuropeptide whose neurons coextensive colocalized orexin neurons lh 26 also stimulates feeding centrally administered 27 using electron microscope immunohistochemistry immunofluorescence microscopy investigated anatomical distributions ghrelin orexin mch also examined ghrelin induced expression c fos marker neuronal activation 28 orexin mch expressing neurons investigate functional relationship ghrelin orexins mch examined effect pretreatment anti orexin b iggs anti mch igg ghrelin inducing feeding also studied ghrelin induced food intake orexin knockout mice demonstrate ghrelin interacts orexin system induce feeding
0.21321544.12639935.html.plaintext.txt	11	materials methods top abstract introduction materials methods results discussion references animals animals housed individually plastic cages 22 plus minus 1 c 12 h light 12 h dark cycle light 0700 1900 h given standard laboratory chow water ad libitum male wistar rats weighing 300 350 g charles river japan inc shiga japan orexin knockout mice 12 wk old male generated targeted mutation embryonic stem cells 29 wild type littermates used accordance guidelines japanese physiological society animal care following anesthesia ip injection sodium pentobarbital abbot laboratories chicago il intracerebroventricular icv cannula implanted lateral cerebral ventricle described 30 31 proper placement cannulae verified upon completion experiment dye administration animals demonstrating progressive weight gain surgery used subsequent experiments
0.21321544.12639935.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references animals animals housed individually plastic cages 22 plus minus 1 c 12 h light 12 h dark cycle light 0700 1900 h given standard laboratory chow water ad libitum male wistar rats weighing 300 350 g charles river japan inc shiga japan orexin knockout mice 12 wk old male generated targeted mutation embryonic stem cells 29 wild type littermates used accordance guidelines japanese physiological society animal care following anesthesia ip injection sodium pentobarbital abbot laboratories chicago il intracerebroventricular icv cannula implanted lateral cerebral ventricle described 30 31 proper placement cannulae verified upon completion experiment dye administration animals demonstrating progressive weight gain surgery used subsequent experiments
0.21321544.12639935.html.plaintext.txt	13	electron microscope immunohistochemistry forty eight hours perfusion three wistar rats injected colchicine 200 microg per rat lateral ventricles increase immunostaining ghrelin orexin expressing neurons following anesthesia ip injection sodium pentobarbital rats perfused ascending aorta 10 min 100 ml 09 saline 40 min 500 ml fixative 4 paraformaldehyde 01 m phosphate buffer ph 74 brain removed immediately postfixed fixative 2 4 h 4 c brain cut 30 40 microm thick sections using oxford vibratome oxford instruments abingdon uk sections incubated 12 h rabbit anti ghrelin antiserum g606 final dilution 132000 ref 17 4 c visualized avidin biotin complex abc method vectastain elite abc kit vector laboratories inc burlingame ca using 002 33 diaminobenzidine tetrahydrochloride dab sigma st louis mo 0005 hydrogen peroxide 50 mm tris hcl ph 76 sections subjected either direct observation light microscope silver gold intensification sgi ref 19 sections treated sgi incubated goat anti orexin antiserum santa cruz biotechnology inc santa cruz ca dilution 120000 24 h 4 c visualized abc orexin labeling performed using dab without sgi examination electron microscopy sections postfixed 1 oso4 01 m phosphate buffer ph 74 1 h 4 c dehydrated graded series ethanol concentrations embedded epon araldite structure probe inc west chester pa ultrathin sections cut examined h 7000 electron microscope hitachi tokyo japan control anti ghrelin antiserum either omitted replaced normal rabbit goat serum
0.21321544.12639935.html.plaintext.txt	14	electron microscope immunohistochemistry forty eight hours perfusion three wistar rats injected colchicine 200 microg per rat lateral ventricles increase immunostaining ghrelin orexin expressing neurons following anesthesia ip injection sodium pentobarbital rats perfused ascending aorta 10 min 100 ml 09 saline 40 min 500 ml fixative 4 paraformaldehyde 01 m phosphate buffer ph 74 brain removed immediately postfixed fixative 2 4 h 4 c brain cut 30 40 microm thick sections using oxford vibratome oxford instruments abingdon uk sections incubated 12 h rabbit anti ghrelin antiserum g606 final dilution 132000 ref 17 4 c visualized avidin biotin complex abc method vectastain elite abc kit vector laboratories inc burlingame ca using 002 33 diaminobenzidine tetrahydrochloride dab sigma st louis mo 0005 hydrogen peroxide 50 mm tris hcl ph 76 sections subjected either direct observation light microscope silver gold intensification sgi ref 19 sections treated sgi incubated goat anti orexin antiserum santa cruz biotechnology inc santa cruz ca dilution 120000 24 h 4 c visualized abc orexin labeling performed using dab without sgi examination electron microscopy sections postfixed 1 oso4 01 m phosphate buffer ph 74 1 h 4 c dehydrated graded series ethanol concentrations embedded epon araldite structure probe inc west chester pa ultrathin sections cut examined h 7000 electron microscope hitachi tokyo japan control anti ghrelin antiserum either omitted replaced normal rabbit goat serum
0.21321544.12639935.html.plaintext.txt	15	immunofluorescence double staining following perfusion 2 paraformaldehyde brains three wistar rats removed immersed 12 h fixative 4 c samples transferred 30 solution sucrose brains quickly frozen tissue tek oct compound sakura finetechnical co ltd tokyo japan cut 7 microm thick coronal sections cryostat microm hm 500 microm heidelberg germany sections incubated 2 d goat anti orexin antiserum dilution 110000 4 c alexa 488 conjugated donkey antigoat igg antibody molecular probes inc eugene dilution 1400 2 h washing phosphate buffer saline ph 74 samples incubated 2 d rabbit anti ghrelin antibody 4 c slides incubated alexa 546 labeled goat antirabbit igg antibody molecular probes inc dilution 1400 samples observed olympus ax 70 fluorescence microscope olympus co ltd tokyo japan
0.21321544.12639935.html.plaintext.txt	16	immunofluorescence double staining following perfusion 2 paraformaldehyde brains three wistar rats removed immersed 12 h fixative 4 c samples transferred 30 solution sucrose brains quickly frozen tissue tek oct compound sakura finetechnical co ltd tokyo japan cut 7 microm thick coronal sections cryostat microm hm 500 microm heidelberg germany sections incubated 2 d goat anti orexin antiserum dilution 110000 4 c alexa 488 conjugated donkey antigoat igg antibody molecular probes inc eugene dilution 1400 2 h washing phosphate buffer saline ph 74 samples incubated 2 d rabbit anti ghrelin antibody 4 c slides incubated alexa 546 labeled goat antirabbit igg antibody molecular probes inc dilution 1400 samples observed olympus ax 70 fluorescence microscope olympus co ltd tokyo japan
0.21321544.12639935.html.plaintext.txt	17	fos expression ghrelin peptide institute inc osaka japan 500 pmol10 microl saline saline injected icv rats n 3 per group 90 min transcardial perfusion 4 paraformaldehyde fixative also rats n 3 per group administered anti npy igg peptide institute inc 05 microg5 microl saline control serum igg 05 microg5 microl saline icv 3 h icv ghrelin 500 pmol10 microl saline administration amount anti npy igg 05 microg sufficient suppress ghrelin induced feeding 7 following transcardial perfusion 90 min later tuberal hypothalamus cut 40 microm thick sections sections incubated 2 d goat anti fos antiserum santa cruz biotechnology inc dilution 11500 stained abc proportion hypothalamic sections additionally stained either rabbit anti orexin antiserum 32 rabbit anti mch antiserum phoenix pharmaceuticals inc belmont ca dilution 1200 quantitated number neurons orexin mch fos colocalization light microscope counting two randomly selected visual fields two sections rat
0.21321544.12639935.html.plaintext.txt	18	fos expression ghrelin peptide institute inc osaka japan 500 pmol10 microl saline saline injected icv rats n 3 per group 90 min transcardial perfusion 4 paraformaldehyde fixative also rats n 3 per group administered anti npy igg peptide institute inc 05 microg5 microl saline control serum igg 05 microg5 microl saline icv 3 h icv ghrelin 500 pmol10 microl saline administration amount anti npy igg 05 microg sufficient suppress ghrelin induced feeding 7 following transcardial perfusion 90 min later tuberal hypothalamus cut 40 microm thick sections sections incubated 2 d goat anti fos antiserum santa cruz biotechnology inc dilution 11500 stained abc proportion hypothalamic sections additionally stained either rabbit anti orexin antiserum 32 rabbit anti mch antiserum phoenix pharmaceuticals inc belmont ca dilution 1200 quantitated number neurons orexin mch fos colocalization light microscope counting two randomly selected visual fields two sections rat
0.21321544.12639935.html.plaintext.txt	19	food intake rabbit anti orexin anti orexin b antisera produced described elsewhere 32 purified anti orexin igg anti orexin b igg affi gel protein affinity bio rad laboratories inc hercules ca either cnbr sepharose coupled bio rad laboratories inc orexin orexin b affinity chromatography determined quantity purified igg using dc protein assay kit bio rad laboratories inc anti orexin igg cross react orexin b anti orexin b cross react orexin two iggs given concurrently icv administration rats n 8 10 per group given icv administration anti orexin igg 025 microg anti orexin b igg 025 microg anti mch igg 05 microg control serum igg 05 microg 1900 h measured dark phase food intake 12 h ghrelin 200 pmol injected icv 1100 h rats n 10 12 per group 3 h icv administration anti orexin b iggs 025 microg anti mch igg 05 microg control serum igg 05 microg 2 h food intake measured ghrelin 200 pmol also administrated rats n 6 8 per group icv concurrently either npy receptor antagonist 1229u91 30 microg y1 npy receptor antagonist 33 kind gift banyu pharmaceuticals tokyo japan control serum igg 3 h icv administration either anti orexin b iggs 025 microg control serum igg 05 microg ghrelin 200 pmol2 microl saline also administered icv orexin knockout mice n 7 wild type lettermates n 7 following injection rats mice returned cages food intake measured 2 h treatment
0.21321544.12639935.html.plaintext.txt	20	food intake rabbit anti orexin anti orexin b antisera produced described elsewhere 32 purified anti orexin igg anti orexin b igg affi gel protein affinity bio rad laboratories inc hercules ca either cnbr sepharose coupled bio rad laboratories inc orexin orexin b affinity chromatography determined quantity purified igg using dc protein assay kit bio rad laboratories inc anti orexin igg cross react orexin b anti orexin b cross react orexin two iggs given concurrently icv administration rats n 8 10 per group given icv administration anti orexin igg 025 microg anti orexin b igg 025 microg anti mch igg 05 microg control serum igg 05 microg 1900 h measured dark phase food intake 12 h ghrelin 200 pmol injected icv 1100 h rats n 10 12 per group 3 h icv administration anti orexin b iggs 025 microg anti mch igg 05 microg control serum igg 05 microg 2 h food intake measured ghrelin 200 pmol also administrated rats n 6 8 per group icv concurrently either npy receptor antagonist 1229u91 30 microg y1 npy receptor antagonist 33 kind gift banyu pharmaceuticals tokyo japan control serum igg 3 h icv administration either anti orexin b iggs 025 microg control serum igg 05 microg ghrelin 200 pmol2 microl saline also administered icv orexin knockout mice n 7 wild type lettermates n 7 following injection rats mice returned cages food intake measured 2 h treatment
0.21321544.12639935.html.plaintext.txt	21	statistical analysis means plus minus sem determined one way anova followed unpaired test differences considered significant p 005
0.21321544.12639935.html.plaintext.txt	22	statistical analysis means plus minus sem determined one way anova followed unpaired test differences considered significant p 005
0.21321544.12639935.html.plaintext.txt	23	results top abstract introduction materials methods results discussion references immunoelectron microscopy immunofluoroscence double staining ghrelin immunoreactive neuronal axons terminals contained large dense cored synaptic vesicles indicated dab sgi reaction products fig 1 b orexin expression visualized dab labeled structures seen light dark gray fig 1 b orexin producing neurons dendritic processes often received synapses ghrelin containing axon terminals fig 1 b positive dab reaction products detected anti ghrelin antiserum omitted replaced normal rabbit goat serum data shown
0.21321544.12639935.html.plaintext.txt	24	view larger version 93k figure 1 innervation ghrelin immunoreactive axons orexin producing neurons b electron micrographs whereas c d immunofluorescent micrographs ghrelin immunoreactive axon terminal g makes synapse arrow orexin immunoreactive perikaryon o perikaryon contains many dense cored vesicles closed arrowheads immunopositive orexin m mitochondria b ghrelin immunoreactive axon terminal g makes symmetrical synapse arrow orexin immunoreactive dendrite od ghrelin immunoreactive axon terminal contains immunopositive dense cored vesicles open arrowhead c ghrelin producing neurons red fluorescence orexin producing neurons green fluorescence localized arcuate nucleus lh respectively d higher magnification area outlined c ghrelin immunoreactive fibers red found close proximity orexin producing neurons green arrows indicate apposition ghrelin fibers orexin neurons arc arcuate nucleus f fornix vmh ventromedial hypothalamus iii third ventricle scale bars 02 microm b 02 microm c 100 microm d 10 microm
0.21321544.12639935.html.plaintext.txt	25	view larger version 93k figure 1 innervation ghrelin immunoreactive axons orexin producing neurons b electron micrographs whereas c d immunofluorescent micrographs ghrelin immunoreactive axon terminal g makes synapse arrow orexin immunoreactive perikaryon o perikaryon contains many dense cored vesicles closed arrowheads immunopositive orexin m mitochondria b ghrelin immunoreactive axon terminal g makes symmetrical synapse arrow orexin immunoreactive dendrite od ghrelin immunoreactive axon terminal contains immunopositive dense cored vesicles open arrowhead c ghrelin producing neurons red fluorescence orexin producing neurons green fluorescence localized arcuate nucleus lh respectively d higher magnification area outlined c ghrelin immunoreactive fibers red found close proximity orexin producing neurons green arrows indicate apposition ghrelin fibers orexin neurons arc arcuate nucleus f fornix vmh ventromedial hypothalamus iii third ventricle scale bars 02 microm b 02 microm c 100 microm d 10 microm
0.21321544.12639935.html.plaintext.txt	26	ghrelin expressing neurons predominantly found hypothalamic arcuate nucleus whereas orexin producing neurons restricted lh fig 1c dense populations ghrelin containing fibers small number orexin containing fibers identified arcuate nucleus fig 1c ghrelin fibers also found lh fig 1d subpopulations ghrelin immunoreactive terminals directly contacted orexin containing neurons lh fig 1d
0.21321544.12639935.html.plaintext.txt	27	fos expression following icv administration ghrelin fos immunoreactive neurons observed lh ghrelin found induce fos expression 23 plus minus 8 orexin immunoreactive neurons double immunohistochemistry fig 2a ghrelin however induce fos expression mch immunoreactive neurons fig 2b despite pretreatment anti npy control serum igg ghrelin remained capable inducing fos expression orexin immunoreactive neurons fig 2 c d
0.21321544.12639935.html.plaintext.txt	28	fos expression following icv administration ghrelin fos immunoreactive neurons observed lh ghrelin found induce fos expression 23 plus minus 8 orexin immunoreactive neurons double immunohistochemistry fig 2a ghrelin however induce fos expression mch immunoreactive neurons fig 2b despite pretreatment anti npy control serum igg ghrelin remained capable inducing fos expression orexin immunoreactive neurons fig 2 c d
0.21321544.12639935.html.plaintext.txt	29	view larger version 116k figure 2 fos expression determined immunohistochemistry lh following icv administration ghrelin costaining arrows fos dark blue black orexin brown neurons rats given ghrelin b fos dark blue black expressed mch containing neurons arrows brown following ghrelin administration c costaining arrows fos dark blue black orexin brown ghrelin treated rats following anti npy igg 05 microg administration d costaining arrows fos dark blue black orexin brown ghrelin treated rats following control igg 05 microg administration rats received 500 pmol ghrelin scale bars 50 microm
0.21321544.12639935.html.plaintext.txt	30	view larger version 116k figure 2 fos expression determined immunohistochemistry lh following icv administration ghrelin costaining arrows fos dark blue black orexin brown neurons rats given ghrelin b fos dark blue black expressed mch containing neurons arrows brown following ghrelin administration c costaining arrows fos dark blue black orexin brown ghrelin treated rats following anti npy igg 05 microg administration d costaining arrows fos dark blue black orexin brown ghrelin treated rats following control igg 05 microg administration rats received 500 pmol ghrelin scale bars 50 microm
0.21321544.12639935.html.plaintext.txt	31	effects orexins mch ghrelin induced feeding coadministered anti orexin igg anti orexin b igg block activities orexins first examined effect anti orexin b iggs anti mch igg suppression feeding significantly reduced dark phase food intake comparison control igg treatment fig 3 next investigated effect endogenous orexin mch blockade ghrelin induced feeding ghrelin increased 2 h food intake rats following icv administration control igg fig 4 pretreatment anti orexin b iggs however reduced ghrelin induced food intake one half level seen rats given control igg ghrelin fig 4 pretreatment anti mch igg affect ghrelin induced feeding fig 4 ghrelin induced food intake orexin deficient mice significantly reduced comparison wild type littermates fig 5 y1 npy receptor antagonist affect 2 h food intake coadministration ghrelin y1 npy receptor antagonist also reduced ghrelin induced feeding 41 fig 6 combination ghrelin y1 npy receptor antagonist coadministration icv administration anti orexin b iggs additively reduced ghrelin induced feeding 87 fig 6
0.21321544.12639935.html.plaintext.txt	32	effects orexins mch ghrelin induced feeding coadministered anti orexin igg anti orexin b igg block activities orexins first examined effect anti orexin b iggs anti mch igg suppression feeding significantly reduced dark phase food intake comparison control igg treatment fig 3 next investigated effect endogenous orexin mch blockade ghrelin induced feeding ghrelin increased 2 h food intake rats following icv administration control igg fig 4 pretreatment anti orexin b iggs however reduced ghrelin induced food intake one half level seen rats given control igg ghrelin fig 4 pretreatment anti mch igg affect ghrelin induced feeding fig 4 ghrelin induced food intake orexin deficient mice significantly reduced comparison wild type littermates fig 5 y1 npy receptor antagonist affect 2 h food intake coadministration ghrelin y1 npy receptor antagonist also reduced ghrelin induced feeding 41 fig 6 combination ghrelin y1 npy receptor antagonist coadministration icv administration anti orexin b iggs additively reduced ghrelin induced feeding 87 fig 6
0.21321544.12639935.html.plaintext.txt	33	view larger version 21k figure 3 effect icv administration anti orexin 025 microg b 025 microg iggs anti mch igg 05 microg 12 h dark phase food intake 1900 0700 h p 0001 vs control igg
0.21321544.12639935.html.plaintext.txt	34	view larger version 21k figure 3 effect icv administration anti orexin 025 microg b 025 microg iggs anti mch igg 05 microg 12 h dark phase food intake 1900 0700 h p 0001 vs control igg
0.21321544.12639935.html.plaintext.txt	35	view larger version 17k figure 4 effect administration anti orexin 025 microg b 025 microg iggs anti mch igg 05 microg ghrelin induced feeding two hour food intake measured ghrelin treated 200 pmol rats following either anti orexin b iggs control igg b two hour food intake ghrelin treated 200 pmol rats following anti mch igg control igg p 0001 vs nontreatment p 005 vs ghrelin control igg
0.21321544.12639935.html.plaintext.txt	36	view larger version 17k figure 4 effect administration anti orexin 025 microg b 025 microg iggs anti mch igg 05 microg ghrelin induced feeding two hour food intake measured ghrelin treated 200 pmol rats following either anti orexin b iggs control igg b two hour food intake ghrelin treated 200 pmol rats following anti mch igg control igg p 0001 vs nontreatment p 005 vs ghrelin control igg
0.21321544.12639935.html.plaintext.txt	37	view larger version 17k figure 5 effect icv ghrelin 200 pmol vehicle injection feeding orexin knockout mice wild type littermates p 001 p 0001 vs control vehicle p 005 vs wild type littermates
0.21321544.12639935.html.plaintext.txt	38	view larger version 17k figure 5 effect icv ghrelin 200 pmol vehicle injection feeding orexin knockout mice wild type littermates p 001 p 0001 vs control vehicle p 005 vs wild type littermates
0.21321544.12639935.html.plaintext.txt	39	view larger version 16k figure 6 suppressive effect y1 antagonist y1 npy receptor antagonist anti orexin 025 microg b 025 microg iggs ghrelin induced feeding p 0001 vs control vehicle control igg p 001 p 0001 vs y1 antagonist control igg p 0001 ghrelin control igg p 001 vs ghrelin y1 antagonist control igg
0.21321544.12639935.html.plaintext.txt	40	view larger version 16k figure 6 suppressive effect y1 antagonist y1 npy receptor antagonist anti orexin 025 microg b 025 microg iggs ghrelin induced feeding p 0001 vs control vehicle control igg p 001 p 0001 vs y1 antagonist control igg p 0001 ghrelin control igg p 001 vs ghrelin y1 antagonist control igg
0.21321544.12639935.html.plaintext.txt	41	discussion top abstract introduction materials methods results discussion references study demonstrates synaptic contact ghrelin containing axons orexin producing neurons rat hypothalamus addition identified functional interaction ghrelin orexins icv administration ghrelin stimulates gh secretion food intake 1 2 3 4 5 6 7 8 9 ghrelin induced feeding thought occur independently gh icv administered ghrelin also increased food intake spontaneous gh deficient rats 6 7 ghrelin stimulates feeding npy agrp 6 7 orexigenic peptides colocalized neurons hypothalamic arcuate nucleus 34 ghrelin receptor mrna expressed npyagrp neurons arcuate nucleus 35 centrally administered ghrelin induced fos expression approximately 40 npyagrp neurons 7 increased npy agrp mrna levels 5 6 7 24
0.21321544.12639935.html.plaintext.txt	42	discussion top abstract introduction materials methods results discussion references study demonstrates synaptic contact ghrelin containing axons orexin producing neurons rat hypothalamus addition identified functional interaction ghrelin orexins icv administration ghrelin stimulates gh secretion food intake 1 2 3 4 5 6 7 8 9 ghrelin induced feeding thought occur independently gh icv administered ghrelin also increased food intake spontaneous gh deficient rats 6 7 ghrelin stimulates feeding npy agrp 6 7 orexigenic peptides colocalized neurons hypothalamic arcuate nucleus 34 ghrelin receptor mrna expressed npyagrp neurons arcuate nucleus 35 centrally administered ghrelin induced fos expression approximately 40 npyagrp neurons 7 increased npy agrp mrna levels 5 6 7 24
0.21321544.12639935.html.plaintext.txt	43	ghrelin receptor mrna also present lh rats 21 region implicated regulation feeding behavior energy homeostasis animals lh lesions exhibit decreased food intake 36 37 whereas electrical stimulation lh satiated state promotes feeding 37 38 orexin mch orexigenic neuropeptides synthesized specifically lh 22 25 26 27 32 39 40 ghrelin fibers project lh synapse orexin immunoreactive neurons icv administration ghrelin induced fos expression orexin expressing neurons mch expressing neurons result consistent recent finding icv administration ghrp 6 synthetic gh releasing hexapeptide binds ghrelin receptor 41 induced fos similar neuronal pattern 9 findings indicate ghrelin may stimulate feeding orexin system npy agrp systems
0.21321544.12639935.html.plaintext.txt	44	ghrelin receptor mrna also present lh rats 21 region implicated regulation feeding behavior energy homeostasis animals lh lesions exhibit decreased food intake 36 37 whereas electrical stimulation lh satiated state promotes feeding 37 38 orexin mch orexigenic neuropeptides synthesized specifically lh 22 25 26 27 32 39 40 ghrelin fibers project lh synapse orexin immunoreactive neurons icv administration ghrelin induced fos expression orexin expressing neurons mch expressing neurons result consistent recent finding icv administration ghrp 6 synthetic gh releasing hexapeptide binds ghrelin receptor 41 induced fos similar neuronal pattern 9 findings indicate ghrelin may stimulate feeding orexin system npy agrp systems
0.21321544.12639935.html.plaintext.txt	45	several peptidergic monoaminergic systems participate regulation feeding energy homeostasis hypothalamus link neuronal circuits npy fibers directly project orexin neurons 42 43 icv injection anti orexin antiserum npy injection significantly attenuated npy induced feeding 44 indicating npy interacts orexin anatomically functionally ghrelin induces feeding activation npy system sought investigate activation orexin producing neurons ghrelin via npy system therefore examined ghrelin induced fos expression orexin producing neurons following pretreatment anti npy igg ghrelin remained competent induce fos expression orexin producing neurons following pretreatment anti npy igg suggesting ghrelin activates orexin producing neurons manner independent npy
0.21321544.12639935.html.plaintext.txt	46	several peptidergic monoaminergic systems participate regulation feeding energy homeostasis hypothalamus link neuronal circuits npy fibers directly project orexin neurons 42 43 icv injection anti orexin antiserum npy injection significantly attenuated npy induced feeding 44 indicating npy interacts orexin anatomically functionally ghrelin induces feeding activation npy system sought investigate activation orexin producing neurons ghrelin via npy system therefore examined ghrelin induced fos expression orexin producing neurons following pretreatment anti npy igg ghrelin remained competent induce fos expression orexin producing neurons following pretreatment anti npy igg suggesting ghrelin activates orexin producing neurons manner independent npy
0.21321544.12639935.html.plaintext.txt	47	orexin regulates feeding energy homeostasis also sleep wakefulness neuroendocrine homeostasis autonomic functions 25 29 40 45 46 ghrelin induced fos expression approximately 23 orexin immunoreactive neurons 33 orexin immunoreactive neurons glucosensitive 47 subset neurons express receptor leptin 42 satiation signal produced adipocytes part orexin expressing neurons may play crucial role regulation feeding energy homeostasis
0.21321544.12639935.html.plaintext.txt	48	orexin regulates feeding energy homeostasis also sleep wakefulness neuroendocrine homeostasis autonomic functions 25 29 40 45 46 ghrelin induced fos expression approximately 23 orexin immunoreactive neurons 33 orexin immunoreactive neurons glucosensitive 47 subset neurons express receptor leptin 42 satiation signal produced adipocytes part orexin expressing neurons may play crucial role regulation feeding energy homeostasis
0.21321544.12639935.html.plaintext.txt	49	investigate functional relationship ghrelin either orexins mch examined effect anti orexin b iggs anti mch igg pretreatment ghrelin induced feeding food intake induced ghrelin attenuated anti orexin b iggs anti mch igg pretreatment addition ghrelin induced food intake mice deficient orexin significantly lower seen wild type littermates data suggest centrally administered ghrelin increases food intake action orexin system date six functional npy receptors y1 y6 identified 48 49 npy stimulates feeding predominantly y1 npy receptor 33 50 icv injection y1 npy receptor antagonist significantly reduced ghrelin induced food intake moreover coadministration ghrelin y1 npy receptor antagonist following anti orexin b iggs pretreatment abolished ghrelin induced feeding therefore ghrelin likely interacts npy orexin systems induce feeding
0.21321544.12639935.html.plaintext.txt	50	investigate functional relationship ghrelin either orexins mch examined effect anti orexin b iggs anti mch igg pretreatment ghrelin induced feeding food intake induced ghrelin attenuated anti orexin b iggs anti mch igg pretreatment addition ghrelin induced food intake mice deficient orexin significantly lower seen wild type littermates data suggest centrally administered ghrelin increases food intake action orexin system date six functional npy receptors y1 y6 identified 48 49 npy stimulates feeding predominantly y1 npy receptor 33 50 icv injection y1 npy receptor antagonist significantly reduced ghrelin induced food intake moreover coadministration ghrelin y1 npy receptor antagonist following anti orexin b iggs pretreatment abolished ghrelin induced feeding therefore ghrelin likely interacts npy orexin systems induce feeding
0.21321544.12639935.html.plaintext.txt	51	feeding behavior involves complicated integration large number learning memory cognitive emotional somatosensorimotor autonomic events icv administration ghrelin strongly induces fos hypothalamus brain stem hippocampus dentate gyrus piriform cortex 7 centrally administered ghrelin may regulate feeding energy homeostasis direct activation orexin npy pathways also influences learning memory state mood formation emotion investigation ghrelin interactions neuronal systems provide novel insights regulation feeding energy homeostasis
0.21321544.12639935.html.plaintext.txt	52	feeding behavior involves complicated integration large number learning memory cognitive emotional somatosensorimotor autonomic events icv administration ghrelin strongly induces fos hypothalamus brain stem hippocampus dentate gyrus piriform cortex 7 centrally administered ghrelin may regulate feeding energy homeostasis direct activation orexin npy pathways also influences learning memory state mood formation emotion investigation ghrelin interactions neuronal systems provide novel insights regulation feeding energy homeostasis
0.21321544.12639935.html.plaintext.txt	53	footnotes study supported part 21st century coe program grants aid ministry education culture sports science technology japan ministry health labor welfare japan uehara memorial foundation ono medical research foundation mitsui life social welfare foundation yamanouchi foundation research metabolic disorders mn foundation growth science japan narishige research foundation yd
0.21321544.12639935.html.plaintext.txt	54	abbreviations abc avidin biotin complex agrp agouti related protein dab 33 diaminobenzidine tetrahydrochloride ghs r gh secretagogue receptor icv intracerebroventricular lh lateral hypothalamus mch melanin concentrating hormone npy neuropeptide y sgi silver gold intensification
0.21321544.12639935.html.plaintext.txt	55	accepted publication december 11 2002
0.21321544.12639935.html.plaintext.txt	56	references top abstract introduction materials methods results discussion references kojima m hosoda h date y nakazato m matsuo h kangawa k 1999 ghrelin novel growth hormone releasing acylated peptide stomach nature 402656 660crossrefmedline date y murakami n kojima m kuroiwa matsukura kangawa k nakazato m 2000 central effects novel acylated peptide ghrelin growth hormone release rats biochem biophys res commun 275477 480crossrefmedline wren small cj ward hl murphy kg dakin cld taheri kennedy ar roberts gh morgan dga ghatei ma bloom sr 2000 novel hypothalamic peptide ghrelin stimulates food intake growth hormone secretion endocrinology 1414325 4328abstractfree full text tschop m smiley dl heiman m 2000 ghrelin induces adiposity rodents nature 407908 913crossrefmedline asakawa inui kaga yuzuriha h nagata ueno n makino fujimiya m niijima fujino ma kasuga m 2001 ghrelin appetite stimulatory signal stomach structural resemblance motilin gastroenterology 120337 345medline shintani m ogawa y ebihara k aizawa abe m miyanaga f takaya k hayashi inoue g hosoda k kojima m kangawa k nakao k 2001 ghrelin endogenous growth hormone secretagogue novel orexigenic peptide antagonizes leptin action activation hypothalamic neuropeptide yy1 receptor pathway diabetes 50227 232abstractfree full text nakazato m murakami n date y kojima m matsuo h kangawa k matsukura 2001 role ghrelin central regulation feeding nature 409194 198crossrefmedline wren small cj abbptt cr dhillo ws seal lj cohen rl batterham rl ward hl taheri stanley sa ghatei ma bloom sr 2001 ghrelin causes hyperphagia obesity rats diabetes 502540 2547abstractfree full text lawrence cb snape ac baudoin fm luckman sm 2002 acute central ghrelin gh secretagogues induce feeding activate brain appetite centers endocrinology 143155 162abstractfree full text tschop m weyer c tataranni pa devanarayan v ravussin e heiman ml 2001 circulating ghrelin levels decreased human obesity diabetes 50707 709abstractfree full text nagaya n uematsu m kojima m date y nakazato m okumura h hosoda h shimizu w yamagishi m oya h koh h yutani c kangawa k 2001 elevated circulating level ghrelin cachexia associated chronic heart failure relationships ghrelin anaboliccatabolic factors circulation 1042034 2038abstractfree full text toshinai k mondal ms nakazato m date y murakami n kojima m kangawa k matsukura 2001 upregulation ghrelin expression stomach upon fasting insulin induced hypoglycemia leptin administration biochem biophys res commun 2811220 1225crossrefmedline inui 2001 ghrelin orexigenic somatotrophic signal stomach nat rev neurosci 2551 560crossrefmedline shiiya nakazato m mizuta m date y mondal ms tanaka m nozoe hosoda h kangawa k matsukura 2002 plasma ghrelin levels lean obese humans effect glucose ghrelin secretion j clin endocrinol metab 87240 244abstractfree full text banks wa tschop m robinson sm heiman ml 2002 extent direction ghrelin transport across blood brain barrier determined unique primary structure j pharmacol exp therap 302822 827abstractfree full text date y murakami n toshinai k matsukura niijima matsuo h kangawa k nakazato m 2002 role gastric afferent vagal nerve ghrelin induced feeding growth hormone secretion gastroenterology 1231120 1128crossrefmedline date y kojima m hosoda h sawaguchi mondal ms suganuma matsukura kangawa k nakazato m 2000 ghrelin novel growth hormone releasing acylated peptide synthesized distinct endocrine cell type gastrointestinal tracts rats humans endocrinology 1414255 4261abstractfree full text dornonville de la cour c bjorkqvist m sandvik ak bakke zhao cm chen d hakanson r 2001 like cells rat stomach contain ghrelin operate gastrin control regul pept 99141 150crossrefmedline lu guan jl wang qp uehara k yamada goto n date y nakazato m kojima m kangawa k shioda 2002 immunocytochemical observation ghrelin containing neurons rat arcuate nucleus neurosci lett 321157 160crossrefmedline guan xm yu h palyha oc mckee kk feighner sd sirinathsinghji dj smith rg van del ploeg lh howard ad 1997 distribution mrna encoding growth hormone secretagogue receptor brain peripheral tissues brain res mol brain res 4823 29crossrefmedline mitchell v bouret beauvillain jc schilling perret m kordon c epelbaum j 2001 comparative distribution mrna encoding growth hormone secretagogue receptor ghs r microcebus murinus primate lemurian rat forebrain pituitary j comp neurol 429469 48530co2 327abstractfree full text schwartz mw woods sc porte jr d seeley rj baskin dg 2000 central nervous system control food intake nature 404661 671medline kamegai j tamura h shimizu ishii sugihara h wakabayashi 2001 chronic central infusion ghrelin increases hypothalamic neuropeptide y agouti related protein mrna levels body weight rats diabetes 502438 2443abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jrs buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline elias cf saper cb maratos flier e tritos na lee c kelly j tatro jb hoffman ge ollmann mm barsh gs sakurai yanagisawa m elmquist jk 1998 chemically defined projections linking mediobasal hypothalamus lateral hypothalamic area j comp neurol 402442 45930co2 r 246crossrefmedline sagar sm sharp fr curran 1988 expression c fos protein brain metabolic mapping cellular level science 2401328 1331medline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451medline ida nakahara k katayama murakami n nakazato m 1999 effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821526 552crossrefmedline kanatani mashiko murai n sugimoto n ito j fukuroda fukami morin n macneil dj van der ploeg lh saga y nishimura ihara m 2000 role y1 receptor regulation neuropeptide y mediated feeding comparison wild type y1 receptor deficient y5 receptor deficient mice endocrinology 1411011 1016abstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text kanatani ishihara asahi tanaka ozaki ihara m 1996 potent neuropeptide y y1 receptor antagonist 1229u91 blockade neuropeptide y induced physiological food intake endocrinology 1373177 3182abstract hahn tm breininger jf baskin dg schwartz mw 1998 coexpression agrp npy fasting activated hypothalamic neurons nat neurosci 1271 272crossrefmedline willesen mg kristensen p romer j 1999 co localization growth hormone secretagogue receptor npy mrna arcuate nucleus rat neuroendocrinology 70306 316crossrefmedline oomura y 1980 input output organization hypothalamus relating food intake behavior morgane pj panksepp j eds handbook hypothalamus vol 2 new york marcel dekker 557 620 bernardis ll bellinger ll 1996 lateral hypothalamic area revisited ingestive behavior neurosci biobehav rev 20189 287crossrefmedline takaki aou oomura y okada e hori 1992 feeding suppression elicited electrical chemical stimulations monkey hypothalamus j physiol 262r586 r594 bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245medline clegg dj air el woods sc seeley rj 2002 eating elicited orexin melanin concentrating hormone opioid mediated endocrinology 1432995 3000abstractfree full text luckman sm rosenzweig dickson sl 1999 activation arcuate nucleus neurons systemic administration leptin growth hormone releasing peptide 6 normal fasted rats neuroendocrinology 7093 100crossrefmedline horvath tl diano van den pol 1999 synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 191072 1087abstractfree full text broberger c de lecea l sutcliffe jg hokfelt 1998 hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402460 47430co2 273medline shirasaka nakazato m matsukura takasaki m kannan h 1999 sympathetic cardiovascular actions orexins conscious rats j physiol 277r1780 r1785 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376medline moriguchi sakurai nambu yanagisawa m goto k 1999 neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264101 104crossrefmedline inui 2000 transgenic approach study body weight regulation pharmacol rev 5235 61abstractfree full text michel mc beck sickinger doods hc herzog h larhammar d quirion r schwartz westfall 1998 xvi international union pharmacology recommendations nomenclature neuropeptide y peptide yy pancreatic polypeptide receptors pharmacol rev 50143 150abstractfree full text wieland ha engel w eberlein w rudolf k doods hn 1998 subtype selectivity novel nonpeptide neuropeptide y y1 receptor antagonist bibo3304 effect feeding rodents br j pharmacol 125549 555abstract
0.21321544.12639935.html.plaintext.txt	57	references top abstract introduction materials methods results discussion references kojima m hosoda h date y nakazato m matsuo h kangawa k 1999 ghrelin novel growth hormone releasing acylated peptide stomach nature 402656 660crossrefmedline date y murakami n kojima m kuroiwa matsukura kangawa k nakazato m 2000 central effects novel acylated peptide ghrelin growth hormone release rats biochem biophys res commun 275477 480crossrefmedline wren small cj ward hl murphy kg dakin cld taheri kennedy ar roberts gh morgan dga ghatei ma bloom sr 2000 novel hypothalamic peptide ghrelin stimulates food intake growth hormone secretion endocrinology 1414325 4328abstractfree full text tschop m smiley dl heiman m 2000 ghrelin induces adiposity rodents nature 407908 913crossrefmedline asakawa inui kaga yuzuriha h nagata ueno n makino fujimiya m niijima fujino ma kasuga m 2001 ghrelin appetite stimulatory signal stomach structural resemblance motilin gastroenterology 120337 345medline shintani m ogawa y ebihara k aizawa abe m miyanaga f takaya k hayashi inoue g hosoda k kojima m kangawa k nakao k 2001 ghrelin endogenous growth hormone secretagogue novel orexigenic peptide antagonizes leptin action activation hypothalamic neuropeptide yy1 receptor pathway diabetes 50227 232abstractfree full text nakazato m murakami n date y kojima m matsuo h kangawa k matsukura 2001 role ghrelin central regulation feeding nature 409194 198crossrefmedline wren small cj abbptt cr dhillo ws seal lj cohen rl batterham rl ward hl taheri stanley sa ghatei ma bloom sr 2001 ghrelin causes hyperphagia obesity rats diabetes 502540 2547abstractfree full text lawrence cb snape ac baudoin fm luckman sm 2002 acute central ghrelin gh secretagogues induce feeding activate brain appetite centers endocrinology 143155 162abstractfree full text tschop m weyer c tataranni pa devanarayan v ravussin e heiman ml 2001 circulating ghrelin levels decreased human obesity diabetes 50707 709abstractfree full text nagaya n uematsu m kojima m date y nakazato m okumura h hosoda h shimizu w yamagishi m oya h koh h yutani c kangawa k 2001 elevated circulating level ghrelin cachexia associated chronic heart failure relationships ghrelin anaboliccatabolic factors circulation 1042034 2038abstractfree full text toshinai k mondal ms nakazato m date y murakami n kojima m kangawa k matsukura 2001 upregulation ghrelin expression stomach upon fasting insulin induced hypoglycemia leptin administration biochem biophys res commun 2811220 1225crossrefmedline inui 2001 ghrelin orexigenic somatotrophic signal stomach nat rev neurosci 2551 560crossrefmedline shiiya nakazato m mizuta m date y mondal ms tanaka m nozoe hosoda h kangawa k matsukura 2002 plasma ghrelin levels lean obese humans effect glucose ghrelin secretion j clin endocrinol metab 87240 244abstractfree full text banks wa tschop m robinson sm heiman ml 2002 extent direction ghrelin transport across blood brain barrier determined unique primary structure j pharmacol exp therap 302822 827abstractfree full text date y murakami n toshinai k matsukura niijima matsuo h kangawa k nakazato m 2002 role gastric afferent vagal nerve ghrelin induced feeding growth hormone secretion gastroenterology 1231120 1128crossrefmedline date y kojima m hosoda h sawaguchi mondal ms suganuma matsukura kangawa k nakazato m 2000 ghrelin novel growth hormone releasing acylated peptide synthesized distinct endocrine cell type gastrointestinal tracts rats humans endocrinology 1414255 4261abstractfree full text dornonville de la cour c bjorkqvist m sandvik ak bakke zhao cm chen d hakanson r 2001 like cells rat stomach contain ghrelin operate gastrin control regul pept 99141 150crossrefmedline lu guan jl wang qp uehara k yamada goto n date y nakazato m kojima m kangawa k shioda 2002 immunocytochemical observation ghrelin containing neurons rat arcuate nucleus neurosci lett 321157 160crossrefmedline guan xm yu h palyha oc mckee kk feighner sd sirinathsinghji dj smith rg van del ploeg lh howard ad 1997 distribution mrna encoding growth hormone secretagogue receptor brain peripheral tissues brain res mol brain res 4823 29crossrefmedline mitchell v bouret beauvillain jc schilling perret m kordon c epelbaum j 2001 comparative distribution mrna encoding growth hormone secretagogue receptor ghs r microcebus murinus primate lemurian rat forebrain pituitary j comp neurol 429469 48530co2 327abstractfree full text schwartz mw woods sc porte jr d seeley rj baskin dg 2000 central nervous system control food intake nature 404661 671medline kamegai j tamura h shimizu ishii sugihara h wakabayashi 2001 chronic central infusion ghrelin increases hypothalamic neuropeptide y agouti related protein mrna levels body weight rats diabetes 502438 2443abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jrs buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline elias cf saper cb maratos flier e tritos na lee c kelly j tatro jb hoffman ge ollmann mm barsh gs sakurai yanagisawa m elmquist jk 1998 chemically defined projections linking mediobasal hypothalamus lateral hypothalamic area j comp neurol 402442 45930co2 r 246crossrefmedline sagar sm sharp fr curran 1988 expression c fos protein brain metabolic mapping cellular level science 2401328 1331medline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451medline ida nakahara k katayama murakami n nakazato m 1999 effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821526 552crossrefmedline kanatani mashiko murai n sugimoto n ito j fukuroda fukami morin n macneil dj van der ploeg lh saga y nishimura ihara m 2000 role y1 receptor regulation neuropeptide y mediated feeding comparison wild type y1 receptor deficient y5 receptor deficient mice endocrinology 1411011 1016abstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text kanatani ishihara asahi tanaka ozaki ihara m 1996 potent neuropeptide y y1 receptor antagonist 1229u91 blockade neuropeptide y induced physiological food intake endocrinology 1373177 3182abstract hahn tm breininger jf baskin dg schwartz mw 1998 coexpression agrp npy fasting activated hypothalamic neurons nat neurosci 1271 272crossrefmedline willesen mg kristensen p romer j 1999 co localization growth hormone secretagogue receptor npy mrna arcuate nucleus rat neuroendocrinology 70306 316crossrefmedline oomura y 1980 input output organization hypothalamus relating food intake behavior morgane pj panksepp j eds handbook hypothalamus vol 2 new york marcel dekker 557 620 bernardis ll bellinger ll 1996 lateral hypothalamic area revisited ingestive behavior neurosci biobehav rev 20189 287crossrefmedline takaki aou oomura y okada e hori 1992 feeding suppression elicited electrical chemical stimulations monkey hypothalamus j physiol 262r586 r594 bittencourt jc presse f arias c peto c vaughan j nahon jl vale w sawchenko pe 1992 melanin concentrating hormone system rat brain immuno hybridization histochemical characterization j comp neurol 319218 245medline clegg dj air el woods sc seeley rj 2002 eating elicited orexin melanin concentrating hormone opioid mediated endocrinology 1432995 3000abstractfree full text luckman sm rosenzweig dickson sl 1999 activation arcuate nucleus neurons systemic administration leptin growth hormone releasing peptide 6 normal fasted rats neuroendocrinology 7093 100crossrefmedline horvath tl diano van den pol 1999 synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 191072 1087abstractfree full text broberger c de lecea l sutcliffe jg hokfelt 1998 hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402460 47430co2 273medline shirasaka nakazato m matsukura takasaki m kannan h 1999 sympathetic cardiovascular actions orexins conscious rats j physiol 277r1780 r1785 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376medline moriguchi sakurai nambu yanagisawa m goto k 1999 neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264101 104crossrefmedline inui 2000 transgenic approach study body weight regulation pharmacol rev 5235 61abstractfree full text michel mc beck sickinger doods hc herzog h larhammar d quirion r schwartz westfall 1998 xvi international union pharmacology recommendations nomenclature neuropeptide y peptide yy pancreatic polypeptide receptors pharmacol rev 50143 150abstractfree full text wieland ha engel w eberlein w rudolf k doods hn 1998 subtype selectivity novel nonpeptide neuropeptide y y1 receptor antagonist bibo3304 effect feeding rodents br j pharmacol 125549 555abstract
0.2210986.14656716.html.plaintext.txt	0	orexin hypocretin 1 injected hypothalamic paraventricular nucleus spontaneous physical activity rats kohji kiwaki1 catherine m kotz234 chuanfeng wang2 lorraine lanningham foster1 james levine13
0.2210986.14656716.html.plaintext.txt	1	orexin hypocretin 1 injected hypothalamic paraventricular nucleus spontaneous physical activity rats kohji kiwaki1 catherine m kotz234 chuanfeng wang2 lorraine lanningham foster1 james levine13
0.2210986.14656716.html.plaintext.txt	2	1endocrine research unit mayo clinic mayo foundation rochester 55905 2veterans affairs medical center 3minnesota obesity center minneapolis 55417 4departments food science nutrition university minnesota saint paul minnesota 55108
0.2210986.14656716.html.plaintext.txt	3	submitted 24 march 2003 accepted final form 21 november 2003
0.2210986.14656716.html.plaintext.txt	4	abstract top abstract materials methods results discussion grants references humans nonexercise activity thermogenesis neat increases positive energy balance mediator interaction positive energy balance physical activity unknown study address hypothesis orexin acts hypothalamic paraventricular nucleus pvn increase nonfeeding associated physical activity pvn cannulated rats injected either orexin vehicle light dark cycle spontaneous physical activity spa measured using arrays infrared activity sensors night vision videotaped recording vtr o2 consumption co2 production measured indirect calorimetry feeding behavior assessed vtr regardless time point injection orexin 1 nmol associated dramatic increases spa 2 h injection orexin 627 plus minus 195 x 103 beam break count n 24 vehicle 185 plus minus 113 x 103 n 38 increase spa accompanied compatible increase o2 consumption duration feeding increased orexin injected early light phase accounted 35 plus minus 25 increased physical activity dose response experiment increases spa correlated dose orexin linearly 2 nmol pvn injections orexin receptor antagonist sb 334867 associated decreases spa attenuated effects pvn injected orexin thus orexin act pvn increase nonfeeding associated physical activity suggesting neuropeptide might mediator neat
0.2210986.14656716.html.plaintext.txt	5	abstract top abstract materials methods results discussion grants references humans nonexercise activity thermogenesis neat increases positive energy balance mediator interaction positive energy balance physical activity unknown study address hypothesis orexin acts hypothalamic paraventricular nucleus pvn increase nonfeeding associated physical activity pvn cannulated rats injected either orexin vehicle light dark cycle spontaneous physical activity spa measured using arrays infrared activity sensors night vision videotaped recording vtr o2 consumption co2 production measured indirect calorimetry feeding behavior assessed vtr regardless time point injection orexin 1 nmol associated dramatic increases spa 2 h injection orexin 627 plus minus 195 x 103 beam break count n 24 vehicle 185 plus minus 113 x 103 n 38 increase spa accompanied compatible increase o2 consumption duration feeding increased orexin injected early light phase accounted 35 plus minus 25 increased physical activity dose response experiment increases spa correlated dose orexin linearly 2 nmol pvn injections orexin receptor antagonist sb 334867 associated decreases spa attenuated effects pvn injected orexin thus orexin act pvn increase nonfeeding associated physical activity suggesting neuropeptide might mediator neat
0.2210986.14656716.html.plaintext.txt	6	energy expenditure hypothalamus obesity nonexercise activity thermogenesis
0.2210986.14656716.html.plaintext.txt	7	obesity affects one third american population second leading cause death united states smoking 1 treatment obesity proven difficult intractability may due fact energy balance regulated multiple complex mechanisms fully understood 4 maintenance body weight achieved intricate balance energy intake expenditure found changes nonexercise activity thermogenesis neat mediate resistance weight gain overfeeding sedentary adults 32 evidence spontaneous physical activity spa familial 63 shows marked interindividual differences contribution daily energy expenditure 49 however mediator interaction overfeeding physical activity unknown
0.2210986.14656716.html.plaintext.txt	8	obesity affects one third american population second leading cause death united states smoking 1 treatment obesity proven difficult intractability may due fact energy balance regulated multiple complex mechanisms fully understood 4 maintenance body weight achieved intricate balance energy intake expenditure found changes nonexercise activity thermogenesis neat mediate resistance weight gain overfeeding sedentary adults 32 evidence spontaneous physical activity spa familial 63 shows marked interindividual differences contribution daily energy expenditure 49 however mediator interaction overfeeding physical activity unknown
0.2210986.14656716.html.plaintext.txt	9	orexins b also known hypocretin 1 2 recently identified neuropeptides synthesized exclusively lateral hypothalamus area classically believed crucial feeding center 25 initial interest neuropeptides concentrated orexigenic actions since central injection orexins increased food intake prepro orexin mrna shown upregulated fasting 50 apart appetite regulation orexins implicated central nervous system cns regulation arousal sleep cardiovascular function temperature metabolic rate locomotor activity pituitary secretion glucose homeostasis gastric acid secretion 17 37 48 51 53 58 edwards et al 12 reported following intracerebroventricular administration orexin hypothalamic c fos marker neuronal activation highly expressed hypothalamic paraventricular nucleus pvn orexin injected directly pvn stimulated food intake although effect powerful authors suggested pvn might primary site action orexins orexigenic role rather orexins might perform role via pvn pvn demonstrated one sites innervated orexin containing neurons 39 44 express orexin receptor 2 36 62
0.2210986.14656716.html.plaintext.txt	10	orexins b also known hypocretin 1 2 recently identified neuropeptides synthesized exclusively lateral hypothalamus area classically believed crucial feeding center 25 initial interest neuropeptides concentrated orexigenic actions since central injection orexins increased food intake prepro orexin mrna shown upregulated fasting 50 apart appetite regulation orexins implicated central nervous system cns regulation arousal sleep cardiovascular function temperature metabolic rate locomotor activity pituitary secretion glucose homeostasis gastric acid secretion 17 37 48 51 53 58 edwards et al 12 reported following intracerebroventricular administration orexin hypothalamic c fos marker neuronal activation highly expressed hypothalamic paraventricular nucleus pvn orexin injected directly pvn stimulated food intake although effect powerful authors suggested pvn might primary site action orexins orexigenic role rather orexins might perform role via pvn pvn demonstrated one sites innervated orexin containing neurons 39 44 express orexin receptor 2 36 62
0.2210986.14656716.html.plaintext.txt	11	observations intrigued us wondered whether spontaneous physical activity spa random rather intricately regulated cns furthermore would propose interaction overfeeding physical activity undergoes processing within hypothalamus due role energy homeostasis
0.2210986.14656716.html.plaintext.txt	12	observations intrigued us wondered whether spontaneous physical activity spa random rather intricately regulated cns furthermore would propose interaction overfeeding physical activity undergoes processing within hypothalamus due role energy homeostasis
0.2210986.14656716.html.plaintext.txt	13	study address hypothesis orexin acts pvn increase spa independently feeding behavior approach inject orexin pvn measure spa thermogenesis feeding behavior use arrays infrared activity sensors indirect calorimetry infrared 24 h videotaping additionally observed effects orexin receptor antagonist selective orexin 1 receptor ox1r sb 334867 injected pvn
0.2210986.14656716.html.plaintext.txt	14	study address hypothesis orexin acts pvn increase spa independently feeding behavior approach inject orexin pvn measure spa thermogenesis feeding behavior use arrays infrared activity sensors indirect calorimetry infrared 24 h videotaping additionally observed effects orexin receptor antagonist selective orexin 1 receptor ox1r sb 334867 injected pvn
0.2210986.14656716.html.plaintext.txt	15	materials methods top abstract materials methods results discussion grants references animals
0.2210986.14656716.html.plaintext.txt	16	male sprague dawley rats charles river wilmington ma 250 300 g time surgery housed individually cages 1212 h light dark photocycle lights 700 room 22 plus minus 2 degrees c food laboratory rodents diet 5001 pmi nutrition international st louis mo water allowed ad libitum protocol approved mayo foundation institutional animal care use committee
0.2210986.14656716.html.plaintext.txt	17	male sprague dawley rats charles river wilmington ma 250 300 g time surgery housed individually cages 1212 h light dark photocycle lights 700 room 22 plus minus 2 degrees c food laboratory rodents diet 5001 pmi nutrition international st louis mo water allowed ad libitum protocol approved mayo foundation institutional animal care use committee
0.2210986.14656716.html.plaintext.txt	18	cannulation verification placement
0.2210986.14656716.html.plaintext.txt	19	rats anesthetized ketamine xylazine mixture 10010 mgkg body wt ip fitted 28 gauge stainless steel cannula placed right pvn stereotaxic coordinates determined rat brain atlas paxinos watson 42 follows 05 mm lateral 19 mm posterior bregma 73 mm skull surface injector extended 1 mm beyond end guide cannula cannulations incisor bar set 33 mm ear bars least 10 days elapsed following surgery experimental trials experiments brains dissected stored 10 formaldehyde solution placement verification histology verification performed blinded fashion whereby physical activity data unknown histologist cannula deemed incorrect actual injection site farther 025 mm away targeted site rationale based diffusion coefficients injection volume delivered 40 previous data 28 60 rats misplaced cannulas excluded data analysis studies 1 3 number rats listed experimental design represents number rats final analysis cannulas correctly placed
0.2210986.14656716.html.plaintext.txt	20	rats anesthetized ketamine xylazine mixture 10010 mgkg body wt ip fitted 28 gauge stainless steel cannula placed right pvn stereotaxic coordinates determined rat brain atlas paxinos watson 42 follows 05 mm lateral 19 mm posterior bregma 73 mm skull surface injector extended 1 mm beyond end guide cannula cannulations incisor bar set 33 mm ear bars least 10 days elapsed following surgery experimental trials experiments brains dissected stored 10 formaldehyde solution placement verification histology verification performed blinded fashion whereby physical activity data unknown histologist cannula deemed incorrect actual injection site farther 025 mm away targeted site rationale based diffusion coefficients injection volume delivered 40 previous data 28 60 rats misplaced cannulas excluded data analysis studies 1 3 number rats listed experimental design represents number rats final analysis cannulas correctly placed
0.2210986.14656716.html.plaintext.txt	21	orexin phoenix pharmaceuticals mountain view ca dissolved artificial cerebrospinal fluid acsf dose orexin 1 nmol used study based previous studies observed feeding pvn injection orexin 10 12 56
0.2210986.14656716.html.plaintext.txt	22	orexin phoenix pharmaceuticals mountain view ca dissolved artificial cerebrospinal fluid acsf dose orexin 1 nmol used study based previous studies observed feeding pvn injection orexin 10 12 56
0.2210986.14656716.html.plaintext.txt	23	sb 334867 1 2 methylbenzoxazol 6 yl 3 15naphthyridin 4 yl urea hydrochloride synthesized glaxosmithkline 11 19 dissolved 5 dmso acsf sb 334867 50 fold higher affinity ox1r orexin 2 receptor ox2r 11
0.2210986.14656716.html.plaintext.txt	24	sb 334867 1 2 methylbenzoxazol 6 yl 3 15naphthyridin 4 yl urea hydrochloride synthesized glaxosmithkline 11 19 dissolved 5 dmso acsf sb 334867 50 fold higher affinity ox1r orexin 2 receptor ox2r 11
0.2210986.14656716.html.plaintext.txt	25	injection cannulas 33 gauge purchased plastics one roanoke va fabricated inserted maximum depth protrude 10 mm beyond tip guide cannulas volume 05 microl either orexin dissolved acsf acsf alone studies 1 2 either orexin dissolved 5 dmso acsf sb 334867 5 dmso acsf 5 dmso acsf alone study 3 injected slowly 30 injector left place additional 10 ensure extrusion tip minimize distribution drug upward cannula tract injection cannula withdrawn stylet replaced injections unilateral right pvn total number injections animal one three study 1 seven eight studies 2 3 previous studies demonstrated lack demonstrable tissue damage 50 repeated injections measured gliosis around injection site 46 injection sites examined light microscopy tissue damage present studies none found compared spa first second third injection pvn 1 nmol orexin vehicle study 1 significant difference data shown
0.2210986.14656716.html.plaintext.txt	26	injection cannulas 33 gauge purchased plastics one roanoke va fabricated inserted maximum depth protrude 10 mm beyond tip guide cannulas volume 05 microl either orexin dissolved acsf acsf alone studies 1 2 either orexin dissolved 5 dmso acsf sb 334867 5 dmso acsf 5 dmso acsf alone study 3 injected slowly 30 injector left place additional 10 ensure extrusion tip minimize distribution drug upward cannula tract injection cannula withdrawn stylet replaced injections unilateral right pvn total number injections animal one three study 1 seven eight studies 2 3 previous studies demonstrated lack demonstrable tissue damage 50 repeated injections measured gliosis around injection site 46 injection sites examined light microscopy tissue damage present studies none found compared spa first second third injection pvn 1 nmol orexin vehicle study 1 significant difference data shown
0.2210986.14656716.html.plaintext.txt	27	measurement o2 consumption co2 production spa duration feeding behavior
0.2210986.14656716.html.plaintext.txt	28	o2 consumption co2 production measured using customized high precision single chamber indirect calorimeter columbus instruments columbus oh reported previously 29 33 thermogenesis calculated o2 consumption co2 production calibration calorimeter performed measurement animal placed inside cylindrical calorimeter chamber acrylic diameter 30 cm height 20 cm volume 15 liters along food water bowls study 1 without food water studies 2 3 chamber lid attached sealed room air pumped atmospheric pressure chamber 0802 lmin data o2 consumption co2 production collected every minute 24 h stored personal computer data point identified time stamp
0.2210986.14656716.html.plaintext.txt	29	o2 consumption co2 production measured using customized high precision single chamber indirect calorimeter columbus instruments columbus oh reported previously 29 33 thermogenesis calculated o2 consumption co2 production calibration calorimeter performed measurement animal placed inside cylindrical calorimeter chamber acrylic diameter 30 cm height 20 cm volume 15 liters along food water bowls study 1 without food water studies 2 3 chamber lid attached sealed room air pumped atmospheric pressure chamber 0802 lmin data o2 consumption co2 production collected every minute 24 h stored personal computer data point identified time stamp
0.2210986.14656716.html.plaintext.txt	30	spa measured simultaneously o2 consumption co2 production measurements measurements performed using customized high precision racks collimated infrared activity sensors columbus instruments placed around acrylic chamber 45 collimated beams infrared light crossing 30 cm diameter cage allowing detection 1 cm movement three orthogonal axes photosensors registered activity unit time beam interrupted fashion activity detected simultaneously three axes forward backward side side data spa summed every minute stored pc use time stamp identification data thereby derived simultaneously o2 consumption spa animal minute minute 24 h measurement period duration spa defined duration activity sensors read greater zero
0.2210986.14656716.html.plaintext.txt	31	spa measured simultaneously o2 consumption co2 production measurements measurements performed using customized high precision racks collimated infrared activity sensors columbus instruments placed around acrylic chamber 45 collimated beams infrared light crossing 30 cm diameter cage allowing detection 1 cm movement three orthogonal axes photosensors registered activity unit time beam interrupted fashion activity detected simultaneously three axes forward backward side side data spa summed every minute stored pc use time stamp identification data thereby derived simultaneously o2 consumption spa animal minute minute 24 h measurement period duration spa defined duration activity sensors read greater zero
0.2210986.14656716.html.plaintext.txt	32	8 mm charge coupled device video camera infrared digital time recording capabilities used measuring feeding behavior experiments videotaped overhead duration feeding behavior measured investigators blinded whether animal received orexin acsf
0.2210986.14656716.html.plaintext.txt	33	8 mm charge coupled device video camera infrared digital time recording capabilities used measuring feeding behavior experiments videotaped overhead duration feeding behavior measured investigators blinded whether animal received orexin acsf
0.2210986.14656716.html.plaintext.txt	34	test days rats first acclimated experimental 15 liter cylindrical cages 24 h food water pots placed floor cylindrical cage access ad libitum acclimation period pots prevented tipping using purposely built acrylic plate designed unmanned animal room sound plus light proof locked throughout experiments
0.2210986.14656716.html.plaintext.txt	35	test days rats first acclimated experimental 15 liter cylindrical cages 24 h food water pots placed floor cylindrical cage access ad libitum acclimation period pots prevented tipping using purposely built acrylic plate designed unmanned animal room sound plus light proof locked throughout experiments
0.2210986.14656716.html.plaintext.txt	36	study 1 effect orexin injected different time points spa o2 consumption feeding behavior three separate experiments rats injected 1 nmol orexin n 15 volume 05 microl acsf n 22 different times day experiment 1 injection 800 400 pm n 5 orexin 1200 acsf experiment 2 injection 200 pm n 6 orexin acsf experiment 3 injection 1200 pm 700 pm n 4 orexin acsf o2 consumption measured experiment 1 food water pots placed floor cage access ad libitum observation twenty four hour food consumption measured weighing food 800 experiment 1 200 pm experiment 2 1200 noon experiment 3
0.2210986.14656716.html.plaintext.txt	37	study 1 effect orexin injected different time points spa o2 consumption feeding behavior three separate experiments rats injected 1 nmol orexin n 15 volume 05 microl acsf n 22 different times day experiment 1 injection 800 400 pm n 5 orexin 1200 acsf experiment 2 injection 200 pm n 6 orexin acsf experiment 3 injection 1200 pm 700 pm n 4 orexin acsf o2 consumption measured experiment 1 food water pots placed floor cage access ad libitum observation twenty four hour food consumption measured weighing food 800 experiment 1 200 pm experiment 2 1200 noon experiment 3
0.2210986.14656716.html.plaintext.txt	38	study 2 relationship dose orexin effect spa thermogenesis rat n 5 injected intervals 24 h different doses orexin 00625 0125 025 05 1 2 nmol vehicle light cycle order injections different doses orexin vehicle randomized injections spa thermogenesis measured 2 h food water provided 2 h 2 h observation
0.2210986.14656716.html.plaintext.txt	39	study 2 relationship dose orexin effect spa thermogenesis rat n 5 injected intervals 24 h different doses orexin 00625 0125 025 05 1 2 nmol vehicle light cycle order injections different doses orexin vehicle randomized injections spa thermogenesis measured 2 h food water provided 2 h 2 h observation
0.2210986.14656716.html.plaintext.txt	40	study 3 effect sb 334867 spa thermogenesis two injections spaced 5 min apart 1 vehicle plus vehicle 2 20 microg sb 334867 plus vehicle 3 vehicle plus 1 nmol orexin 4 20 microg sb 334867 plus 1 nmol orexin given rat n 5 intervals 24 h light cycle order injections 1 4 randomized injections spa thermogenesis measured 2 h food water provided 2 h 2 h observation
0.2210986.14656716.html.plaintext.txt	41	study 3 effect sb 334867 spa thermogenesis two injections spaced 5 min apart 1 vehicle plus vehicle 2 20 microg sb 334867 plus vehicle 3 vehicle plus 1 nmol orexin 4 20 microg sb 334867 plus 1 nmol orexin given rat n 5 intervals 24 h light cycle order injections 1 4 randomized injections spa thermogenesis measured 2 h food water provided 2 h 2 h observation
0.2210986.14656716.html.plaintext.txt	42	results expressed means plus minus se figs 1 2 3 4 5 6 spa o2 consumption thermogenesis feeding behavior analyzed using mann whitneys u test comparison spa induced orexin different time points made kruskal wallis rank test correlation orexin induced spa feeding behavior analyzed spearmans rank correlation test correlation spa thermogenesis dose response experiment analyzed pearsons correlation test p 005 considered statistically significant
0.2210986.14656716.html.plaintext.txt	43	view larger version 31k fig 1 twenty four hour time course effect orexin spontaneous physical activity spa o2 consumption b rats received paraventricular nucleus pvn injection artificial cerebrospinal fluid acsf 1 nmol orexin 800 400 pm arrows indicate injections spa shown mean total beam breaks plus minus se 1 h group left difference mean spa orexin group acsf group right o2 consumption shown mean mlkg body wt plus minus se 1 h group b left difference mean o2 consumption orexin group acsf group b right significant difference respective acsf control group orexin group acsf group orexin group acsf group open horizontal bars lights period filled horizontal bars lights period
0.2210986.14656716.html.plaintext.txt	44	view larger version 20k fig 2 effect orexin injection different time points spa b feeding behavior c rats received pvn injection acsf 1 nmol orexin different times 800 400 pm experiment 1 200 pm experiment 2 1200 noon 700 pm experiment 3 data means plus minus se shown total beam breaks 2 h injection duration spa 2 h injection b total duration feeding behavior 2 h injection c significant difference respective acsf control group
0.2210986.14656716.html.plaintext.txt	45	view larger version 18k fig 3 effect orexin spa duration feeding behavior spa duration feeding 2 h pvn injection orexin animal across 3 experiments plotted spa represented beam break count duration min b
0.2210986.14656716.html.plaintext.txt	46	view larger version 36k fig 4 relationship dose orexin effect spa thermogenesis b rats received pvn injection acsf different dose orexin light cycle data means plus minus se shown total beam breaks 2 h injection thermogenesis 2 h injection b significant difference respective acsf vehicle control group
0.2210986.14656716.html.plaintext.txt	47	view larger version 26k fig 5 effect orexin receptor antagonist sb 334867 spa thermogenesis b rats received pvn injection vehicle vehicle 20 microg sb 334867 vehicle vehicle 1 nmol orexin 20 microg sb 334867 1 nmol orexin light cycle data means plus minus se shown total beam breaks 2 h injection thermogenesis 2 h injection b significant difference 2 groups
0.2210986.14656716.html.plaintext.txt	48	view larger version 48k fig 6 photomicrograph histological verification correct placement injections hypothalamic pvn diagrams coronal section depicting actual injection sites b v3 3rd ventricle opt optic tract sites deemed correctly located sites deemed incorrectly located b section b number top left shows anteroposterior distance bregma
0.2210986.14656716.html.plaintext.txt	49	results top abstract materials methods results discussion grants references effect orexin spa o2 consumption
0.2210986.14656716.html.plaintext.txt	50	adult male sprague dawley rats microinjected right lateral pvn 1 nmol orexin vehicle acsf different times day experiment 1 injections 800 400 pm experiment 2 200 pm experiment 3 1200 noon 700 pm light 700 light 700 pm figure 1 represents mean 24 h time course spa fig 1a oxygen consumption fig 1b experiment 1 orexin associated increase spa 1 2 h injection followed decrease spa 1 3 h afterward pattern spa observed orexin injections experiments 2 3 data shown transition o2 consumption response orexin similar spa orexin associated increase o2 consumption 1 2 h injection regardless time point injection orexin associated dramatic increases spa 2 h injection fig 2 b experiments combined mean plus minus sd spa 2 h injection follows orexin 627 plus minus 195 x 103 beam break count vehicle 185 plus minus 113 x 103 injections 24 orexin treated animals 38 acsf treated animals interestingly difference total spa 24 h orexin vehicle three experiments orexin 380 plus minus 086 x 104 beam break count n 15 vehicle 360 plus minus 052 x 104 beam break count n 22 types orexin induced physical activity primarily intense grooming face washing behavior secondarily rearing searching behavior behaviors appeared immediately 5 min injections review videotaped recording apparent intensity orexin induced behavior greater similar types spontaneous activities grooming rearing observed absence experimental manipulations
0.2210986.14656716.html.plaintext.txt	51	adult male sprague dawley rats microinjected right lateral pvn 1 nmol orexin vehicle acsf different times day experiment 1 injections 800 400 pm experiment 2 200 pm experiment 3 1200 noon 700 pm light 700 light 700 pm figure 1 represents mean 24 h time course spa fig 1a oxygen consumption fig 1b experiment 1 orexin associated increase spa 1 2 h injection followed decrease spa 1 3 h afterward pattern spa observed orexin injections experiments 2 3 data shown transition o2 consumption response orexin similar spa orexin associated increase o2 consumption 1 2 h injection regardless time point injection orexin associated dramatic increases spa 2 h injection fig 2 b experiments combined mean plus minus sd spa 2 h injection follows orexin 627 plus minus 195 x 103 beam break count vehicle 185 plus minus 113 x 103 injections 24 orexin treated animals 38 acsf treated animals interestingly difference total spa 24 h orexin vehicle three experiments orexin 380 plus minus 086 x 104 beam break count n 15 vehicle 360 plus minus 052 x 104 beam break count n 22 types orexin induced physical activity primarily intense grooming face washing behavior secondarily rearing searching behavior behaviors appeared immediately 5 min injections review videotaped recording apparent intensity orexin induced behavior greater similar types spontaneous activities grooming rearing observed absence experimental manipulations
0.2210986.14656716.html.plaintext.txt	52	effect orexin feeding behavior
0.2210986.14656716.html.plaintext.txt	53	known orexin associated increased feeding behavior duration feeding behavior 2 h injection measured blinded fashion using videotaped recording five time points throughout day one time point 800 duration feeding behavior longer orexin injected animals acsf fig 2c effect orexin feeding behavior accounted 35 plus minus 25 n 5 increase spa time point figure 3 represents relationship spa duration feeding behavior 2 h injection experiments correlation spa duration feeding behavior induced orexin three experiments difference 24 h food consumption acsf orexin orexin 241 plus minus 48 g n 15 vehicle 257 plus minus 29 g n 22
0.2210986.14656716.html.plaintext.txt	54	known orexin associated increased feeding behavior duration feeding behavior 2 h injection measured blinded fashion using videotaped recording five time points throughout day one time point 800 duration feeding behavior longer orexin injected animals acsf fig 2c effect orexin feeding behavior accounted 35 plus minus 25 n 5 increase spa time point figure 3 represents relationship spa duration feeding behavior 2 h injection experiments correlation spa duration feeding behavior induced orexin three experiments difference 24 h food consumption acsf orexin orexin 241 plus minus 48 g n 15 vehicle 257 plus minus 29 g n 22
0.2210986.14656716.html.plaintext.txt	55	relationship dose orexin effect spa thermogenesis
0.2210986.14656716.html.plaintext.txt	56	establish dose response relationship different doses orexin 00625 2 nmol injected pvn 2 h injection spa thermogenesis measured without food water spa fig 4a thermogenesis fig 4b well correlated dose orexin examined range orexin 0125 nmol associated significant increase spa lower dose 00625 nmol associated significant increase thermogenesis strong correlation spa difference spa orexin vehicle thermogenesis difference thermogenesis orexin vehicle r 0774 p 00001 n 30
0.2210986.14656716.html.plaintext.txt	57	establish dose response relationship different doses orexin 00625 2 nmol injected pvn 2 h injection spa thermogenesis measured without food water spa fig 4a thermogenesis fig 4b well correlated dose orexin examined range orexin 0125 nmol associated significant increase spa lower dose 00625 nmol associated significant increase thermogenesis strong correlation spa difference spa orexin vehicle thermogenesis difference thermogenesis orexin vehicle r 0774 p 00001 n 30
0.2210986.14656716.html.plaintext.txt	58	effect sb 334867 spa thermogenesis
0.2210986.14656716.html.plaintext.txt	59	establish specificity effect orexin pvn orexin receptor antagonist sb 334867 injected pvn sb 334867 20 microg associated decreases spa partially attenuated effect orexin spa fig 5a thermogenesis fig 5b
0.2210986.14656716.html.plaintext.txt	60	establish specificity effect orexin pvn orexin receptor antagonist sb 334867 injected pvn sb 334867 20 microg associated decreases spa partially attenuated effect orexin spa fig 5a thermogenesis fig 5b
0.2210986.14656716.html.plaintext.txt	61	verification injection sites
0.2210986.14656716.html.plaintext.txt	62	figure 6a illustrates example histological verification correct location injections pvn figure 6b illustrates map actual injection sites demonstrates injections deemed correctly incorrectly located animals underwent histological confirmation cannula placement investigators blinded orexin response nine incorrectly cannulated rats mean plus minus sd spa 2 h injection follows 1 nmol orexin 228 plus minus 117 x 103 beam break count vehicle 217 plus minus 139 x 103 injections 15 orexin 8 vehicle significant difference spa orexin vehicle animals
0.2210986.14656716.html.plaintext.txt	63	figure 6a illustrates example histological verification correct location injections pvn figure 6b illustrates map actual injection sites demonstrates injections deemed correctly incorrectly located animals underwent histological confirmation cannula placement investigators blinded orexin response nine incorrectly cannulated rats mean plus minus sd spa 2 h injection follows 1 nmol orexin 228 plus minus 117 x 103 beam break count vehicle 217 plus minus 139 x 103 injections 15 orexin 8 vehicle significant difference spa orexin vehicle animals
0.2210986.14656716.html.plaintext.txt	64	discussion top abstract materials methods results discussion grants references energy cost associated spa may carefully modulated rather spontaneous proposed potential mediator spa orexin furthermore thought orexin might mediate effect via pvn address hypothesis orexin pvn mediates spa injected rats orexin vehicle control monitored spa use infrared beams videotape recording data demonstrated orexin animals cannula sited pvn associated dramatic increases spa 2 h injection 2 h spa return baseline animals appeared compensate become sedentary controls next 1 3 h increases spa 2 h injection dose dependent incorrectly cannulated rats increase spa observed orexin injection data demonstrate potential role orexin pvn spa moreover demonstrate spa may intricately modulated neurohumoral factors hypothalamus
0.2210986.14656716.html.plaintext.txt	65	discussion top abstract materials methods results discussion grants references energy cost associated spa may carefully modulated rather spontaneous proposed potential mediator spa orexin furthermore thought orexin might mediate effect via pvn address hypothesis orexin pvn mediates spa injected rats orexin vehicle control monitored spa use infrared beams videotape recording data demonstrated orexin animals cannula sited pvn associated dramatic increases spa 2 h injection 2 h spa return baseline animals appeared compensate become sedentary controls next 1 3 h increases spa 2 h injection dose dependent incorrectly cannulated rats increase spa observed orexin injection data demonstrate potential role orexin pvn spa moreover demonstrate spa may intricately modulated neurohumoral factors hypothalamus
0.2210986.14656716.html.plaintext.txt	66	establish specificity effect orexin pvn observed effect orexin receptor antagonist sb 334867 injected pvn decreases spa followed antagonist injection partially blocked effect orexin spa thermogenesis sb 334867 50 fold higher affinity ox1r ox2r 11 rat brain differential expression ox1r ox2r reported ox2r predominantly expressed pvn 36 62 ox1r considered selective receptor orexin ox2r considered nonselective receptor orexin orexin b despite lower affinity ox2r high concentration sb 334867 site pvn might attenuate effect orexin via block ox2r however also reported intraperitoneal injection compound attenuated orexin evoked grooming 11 selective ox2r antagonist needed verify role receptor subtype effect orexin pvn
0.2210986.14656716.html.plaintext.txt	67	establish specificity effect orexin pvn observed effect orexin receptor antagonist sb 334867 injected pvn decreases spa followed antagonist injection partially blocked effect orexin spa thermogenesis sb 334867 50 fold higher affinity ox1r ox2r 11 rat brain differential expression ox1r ox2r reported ox2r predominantly expressed pvn 36 62 ox1r considered selective receptor orexin ox2r considered nonselective receptor orexin orexin b despite lower affinity ox2r high concentration sb 334867 site pvn might attenuate effect orexin via block ox2r however also reported intraperitoneal injection compound attenuated orexin evoked grooming 11 selective ox2r antagonist needed verify role receptor subtype effect orexin pvn
0.2210986.14656716.html.plaintext.txt	68	data consistent observations regarding neurohumoral role orexin central orexin systems may critical regulators sleepwake states based neuroanatomic genetic data 7 8 13 34 41 44 specifically orexin may activate arousal centers 17 observations pvn injected orexin induces spa compatible fact orexin acts maintain waking state 47 behaviors observed response orexin injection consistent wakefulness namely intense grooming face washing behavior rearing searching activity several reports also describe immediate increase grooming face washing activity locomotor activity intracerebroventricular injection orexin 17 21 22 24 38 additionally reports showing relationship endogenous orexin locomotor activity kiyashchenko et al 27 showed orexin release cerebrospinal fluid higher active waking quiet waking cats estabrooke et al 15 reported fos expression orexin neurons correlated locomotor activity rats moreover hara et al 18 showed genetic ablation orexin neurons mice resulted decrease spontaneous motor activity transgenic mice became obese despite hypophagia reports also strongly suggest orexin plays role regulation spa
0.2210986.14656716.html.plaintext.txt	69	data consistent observations regarding neurohumoral role orexin central orexin systems may critical regulators sleepwake states based neuroanatomic genetic data 7 8 13 34 41 44 specifically orexin may activate arousal centers 17 observations pvn injected orexin induces spa compatible fact orexin acts maintain waking state 47 behaviors observed response orexin injection consistent wakefulness namely intense grooming face washing behavior rearing searching activity several reports also describe immediate increase grooming face washing activity locomotor activity intracerebroventricular injection orexin 17 21 22 24 38 additionally reports showing relationship endogenous orexin locomotor activity kiyashchenko et al 27 showed orexin release cerebrospinal fluid higher active waking quiet waking cats estabrooke et al 15 reported fos expression orexin neurons correlated locomotor activity rats moreover hara et al 18 showed genetic ablation orexin neurons mice resulted decrease spontaneous motor activity transgenic mice became obese despite hypophagia reports also strongly suggest orexin plays role regulation spa
0.2210986.14656716.html.plaintext.txt	70	corticotropin releasing factor crf suggested involved orexin induced behaviors 21 known grooming behavior closely associated environmental stress 16 intracerebroventricular administration orexin increases plasma corticosterone 17 31 adreno corticotropin levels 23 52 intracerebroventricular administration crf increased grooming behavior 30 intracerebroventricular administration helical crf crf antagonist blocked orexin induced behaviors specifically grooming face washing 22 terms brain concentration crf synthesized mainly pvn 55 peptide also thought integral energy balance pvn one sites densely innervated orexin containing neurons expresses ox2r 8 36 62 thus results consistent thesis orexin stimulates specific behaviors via crf dopaminergic system also suggested mediate orexin induced activity grooming behavior involvement ventral tegmental area dopaminergic system intraventricularly administered orexin induced hyperactivity rats demonstrated 38 study needed determine downstream pathways orexin induced hyperactivity
0.2210986.14656716.html.plaintext.txt	71	corticotropin releasing factor crf suggested involved orexin induced behaviors 21 known grooming behavior closely associated environmental stress 16 intracerebroventricular administration orexin increases plasma corticosterone 17 31 adreno corticotropin levels 23 52 intracerebroventricular administration crf increased grooming behavior 30 intracerebroventricular administration helical crf crf antagonist blocked orexin induced behaviors specifically grooming face washing 22 terms brain concentration crf synthesized mainly pvn 55 peptide also thought integral energy balance pvn one sites densely innervated orexin containing neurons expresses ox2r 8 36 62 thus results consistent thesis orexin stimulates specific behaviors via crf dopaminergic system also suggested mediate orexin induced activity grooming behavior involvement ventral tegmental area dopaminergic system intraventricularly administered orexin induced hyperactivity rats demonstrated 38 study needed determine downstream pathways orexin induced hyperactivity
0.2210986.14656716.html.plaintext.txt	72	known orexin injected pvn induces feeding however data demonstrate pvn injected orexin induced feeding behavior injected early light cycle feeding behavior minimal control animals relation magnitude orexin induced spa duration feeding behavior words pvn injected orexin increase spa without induction feeding behavior elevation activity without concomitant feeding behavior consistent previous studies examining effect orexin injected lateral hypothalamus another brain site integral energy homeostasis 20 early light cycle feeding induced pvn injected orexin study agreement data others indicating orexin injected ventricles lateral hypothalamus stimulates feeding light cycle 20 67 reason stimulation feeding orexin injection occurs light cycle remains unclear demonstrated orexin injected lateral hypothalamus twofold greater feeding response orexin food restricted rats high level rate feeding 60 thus level andor rate feeding unlikely related lack feeding orexin dark cycle espana et al 14 reported orexin induced icv administration feeding largely circadian dependent orexin induced increase grooming moderately circadian dependent authors suggested possibility increase feeding appeared largely reflect wake increase actions reports regarding orexin injection pvn shown variable results 10 12 56 edwards et al 12 reported pvn injected orexin 003 03 nmol stimulated food intake although effect powerful dube et al 10 showed 1 nmol orexin injected pvn stimulated food intake reported behavioral effects feeding drinking differences dose orexin 003 1 nmol injected light cycle reports generally moderate effect orexin feeding may explain discrepant results feeding response three reports present study injected 1 nmol orexin observed increased feeding injected early light cycle also observed remarkably increased physical activity observation contrasts somewhat dube et al however examine spa recorded animals behavior using videotaped recording quantified activity using arrays infrared activity sensors results suggest orexin pvn acts predominantly increase nonfeeding physical activity
0.2210986.14656716.html.plaintext.txt	73	known orexin injected pvn induces feeding however data demonstrate pvn injected orexin induced feeding behavior injected early light cycle feeding behavior minimal control animals relation magnitude orexin induced spa duration feeding behavior words pvn injected orexin increase spa without induction feeding behavior elevation activity without concomitant feeding behavior consistent previous studies examining effect orexin injected lateral hypothalamus another brain site integral energy homeostasis 20 early light cycle feeding induced pvn injected orexin study agreement data others indicating orexin injected ventricles lateral hypothalamus stimulates feeding light cycle 20 67 reason stimulation feeding orexin injection occurs light cycle remains unclear demonstrated orexin injected lateral hypothalamus twofold greater feeding response orexin food restricted rats high level rate feeding 60 thus level andor rate feeding unlikely related lack feeding orexin dark cycle espana et al 14 reported orexin induced icv administration feeding largely circadian dependent orexin induced increase grooming moderately circadian dependent authors suggested possibility increase feeding appeared largely reflect wake increase actions reports regarding orexin injection pvn shown variable results 10 12 56 edwards et al 12 reported pvn injected orexin 003 03 nmol stimulated food intake although effect powerful dube et al 10 showed 1 nmol orexin injected pvn stimulated food intake reported behavioral effects feeding drinking differences dose orexin 003 1 nmol injected light cycle reports generally moderate effect orexin feeding may explain discrepant results feeding response three reports present study injected 1 nmol orexin observed increased feeding injected early light cycle also observed remarkably increased physical activity observation contrasts somewhat dube et al however examine spa recorded animals behavior using videotaped recording quantified activity using arrays infrared activity sensors results suggest orexin pvn acts predominantly increase nonfeeding physical activity
0.2210986.14656716.html.plaintext.txt	74	levels spa humans cluster families 63 mice within strains 5 observations suggest identifiable genetic components may exist account variance neat additionally observed neat increase positive energy balance 32 recently decreased plasma orexin levels obese individuals demonstrated 2 orexin pass blood brain barrier 26 peripheral orexin levels might reflect cns levels mouse hypothalamus age related decline ox2r messenger rna levels shown 59 known old rats decreased activity 43 decline orexin obesity aging may support hypothesis orexin pvn mediator neat lubkin stricker krongrad 35 reported intracerebroventricular injection orexin resulted increase metabolic rate dependent increase activity mice measured o2 consumption co2 production indirect calorimetry increased o2 consumption accompanied increased activity thermogenic response orexin clearly tracks orexin effect spa thus consider increase o2 consumption thermogenesis result increase spa associated orexin reason contrast may due differences injection site studies site specific injections reach much limited receptor population ventricular injections ventricular injection unknown injectate ultimately predominantly reaches thus effects observed could result stimulation receptors multiple locations
0.2210986.14656716.html.plaintext.txt	75	levels spa humans cluster families 63 mice within strains 5 observations suggest identifiable genetic components may exist account variance neat additionally observed neat increase positive energy balance 32 recently decreased plasma orexin levels obese individuals demonstrated 2 orexin pass blood brain barrier 26 peripheral orexin levels might reflect cns levels mouse hypothalamus age related decline ox2r messenger rna levels shown 59 known old rats decreased activity 43 decline orexin obesity aging may support hypothesis orexin pvn mediator neat lubkin stricker krongrad 35 reported intracerebroventricular injection orexin resulted increase metabolic rate dependent increase activity mice measured o2 consumption co2 production indirect calorimetry increased o2 consumption accompanied increased activity thermogenic response orexin clearly tracks orexin effect spa thus consider increase o2 consumption thermogenesis result increase spa associated orexin reason contrast may due differences injection site studies site specific injections reach much limited receptor population ventricular injections ventricular injection unknown injectate ultimately predominantly reaches thus effects observed could result stimulation receptors multiple locations
0.2210986.14656716.html.plaintext.txt	76	unlike neuropeptide y potent orexigenic hypothermic signal clearly defined pattern energy balance states orexin activity energy balance states appears complicated studies show difference orexin activity fasting 3 45 65 whereas others show elevated orexin expression activity fasting 50 66 69 orexin activity states positive energy balance thoroughly tested one study showed high fat feeding increased gene expression orexin 64 consistent hypothesis increased orexin activity positive energy balance however studies obese animal models show either decreases orexin expression activity 6 54 68 change 57 61 conflicting data likely represent complicated role orexin energy balance although orexin administration stimulates feeding also elevates activity perhaps predominantly enhances thermogenesis therefore one cannot simply place orexin class obesity promoting neuropeptides basis feeding stimulatory properties clearly illustrated data hara et al 18 demonstrated loss orexin activity resulted obese animal model although animals ate less also much less active obese state animals study indicates decreased energy expenditure brought loss orexin function clearly potent hypophagia affecting energy balance thus although present data others 18 64 indicate positive energy balance may stimulate orexin studies examining endogenous orexin activity lean obese animal models overfeeding paradigms help determine role orexin plays modulating neat
0.2210986.14656716.html.plaintext.txt	77	unlike neuropeptide y potent orexigenic hypothermic signal clearly defined pattern energy balance states orexin activity energy balance states appears complicated studies show difference orexin activity fasting 3 45 65 whereas others show elevated orexin expression activity fasting 50 66 69 orexin activity states positive energy balance thoroughly tested one study showed high fat feeding increased gene expression orexin 64 consistent hypothesis increased orexin activity positive energy balance however studies obese animal models show either decreases orexin expression activity 6 54 68 change 57 61 conflicting data likely represent complicated role orexin energy balance although orexin administration stimulates feeding also elevates activity perhaps predominantly enhances thermogenesis therefore one cannot simply place orexin class obesity promoting neuropeptides basis feeding stimulatory properties clearly illustrated data hara et al 18 demonstrated loss orexin activity resulted obese animal model although animals ate less also much less active obese state animals study indicates decreased energy expenditure brought loss orexin function clearly potent hypophagia affecting energy balance thus although present data others 18 64 indicate positive energy balance may stimulate orexin studies examining endogenous orexin activity lean obese animal models overfeeding paradigms help determine role orexin plays modulating neat
0.2210986.14656716.html.plaintext.txt	78	summary injection orexin pvn dramatically increases spa increase spa 2 h occurs regardless time injection effect orexin spa appears predominantly increase general activity however concur others orexin via pvn also stimulates feeding behavior orexin therefore appears neurohumoral mediator spa neat feeding role physiology energy balance requires investigation
0.2210986.14656716.html.plaintext.txt	79	summary injection orexin pvn dramatically increases spa increase spa 2 h occurs regardless time injection effect orexin spa appears predominantly increase general activity however concur others orexin via pvn also stimulates feeding behavior orexin therefore appears neurohumoral mediator spa neat feeding role physiology energy balance requires investigation
0.2210986.14656716.html.plaintext.txt	80	grants top abstract materials methods results discussion grants references work supported national institute diabetes digestive kidney diseases grants dk 56650 dk 63226 dk 57573 department veterans affairs novo nordisk bagsv230rd denmark
0.2210986.14656716.html.plaintext.txt	81	acknowledgments thank mary mullet expert technical assistance stereotaxic surgery shelly k mccrady lana nysse technical help
0.2210986.14656716.html.plaintext.txt	82	acknowledgments thank mary mullet expert technical assistance stereotaxic surgery shelly k mccrady lana nysse technical help
0.2210986.14656716.html.plaintext.txt	83	footnotes address reprint requests correspondence j levine endocrine research unit joseph 5 194 mayo clinic rochester 200 first st sw rochester mn 55905 e mail levinejamesatmayoedu u d
0.2210986.14656716.html.plaintext.txt	84	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.2210986.14656716.html.plaintext.txt	85	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.2210986.14656716.html.plaintext.txt	86	references top abstract materials methods results discussion grants references anonymous surgeon generals report physical activity health centers disease control prevention jama 276 522 1996crossrefisimedline adam ja menheere pp van dielen fm soeters pb buurman wa greve jw decreased plasma orexin levels obese individuals int j obes relat metab disord 26 274 276 2002crossrefmedline bertile f oudart h criscuolo f maho yl raclot hypothalamic gene expression long term fasted rats relationship body fat biochem biophys res commun 303 1106 13 2003crossrefisimedline bray ga bouchard c james wpt handbook obesity new york dekker 1998 brownlow bs petro feinglos mn surwit rs role motor activity diet induced obesity c57bl6j mice physiol behav 60 37 41 1996crossrefisimedline cai xj lister ca buckingham re pickavance l wilding j arch jr wilson williams g regulation orexin gene expression severe obesity rats studies zucker fatty zucker diabetic fatty rats effects rosiglitazone brain res mol brain res 77 131 137 2000isimedline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999isimedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text diano horvath b urbanski hf sotonyi p horvath tl fasting activates nonhuman primate hypocretin orexin system postsynaptic targets endocrinology 144 3774 3778 2003abstractfree full text dube mg kalra sp kalra ps food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842 473 477 1999crossrefisimedline duxon ms stretton j starr k jones dn holland v riley g jerman j brough smart d johns chan w porter ra upton n evidence orexin evoked grooming rat mediated orexin 1 ox1 receptors downstream 5 ht2c receptor involvement psychopharmacology berl 153 203 209 2001crossrefisimedline edwards cm abusnana sunter d murphy kg ghatei ma bloom sr effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 160 r7 r12 1999abstract espana ra baldo ba kelley ae berridge cw wake promoting sleep suppressing actions hypocretin orexin basal forebrain sites action neuroscience 106 699 715 2001crossrefisimedline espana ra plahn berridge cw circadian dependent circadian independent behavioral actions hypocretinorexin brain res 943 224 236 2002crossrefisimedline estabrooke iv mccarthy mt ko e chou tc chemelli rm yanagisawa m saper cb scammell te fos expression orexin neurons varies behavioral state j neurosci 21 1656 1662 2001abstractfree full text gispen wh isaacson rl acth induced excessive grooming rat pharmacol ther 12 209 246 1981crossrefisimedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001crossrefisimedline haynes ac jackson b chapman h tadayyon m johns porter ra arch jr selective orexin 1 receptor antagonist reduces food consumption male female rats regul pept 96 45 51 2000crossrefisimedline haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr effects single chronic intracerebroventricular administration orexins feeding rat peptides 20 1099 1105 1999crossrefisimedline ida nakahara k katayama murakami n nakazato m effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821 526 529 1999crossrefisimedline ida nakahara k murakami hanada r nakazato m murakami n possible involvement orexin stress reaction rats biochem biophys res commun 270 318 323 2000crossrefisimedline jaszberenyi m bujdoso e pataki telegdy g effects orexins hypothalamic pituitary adrenal system j neuroendocrinol 12 1174 1178 2000crossrefisimedline jones dn gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153 210 218 2001crossrefisimedline kalra sp dube mg pu xu b horvath tl kalra ps interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 20 68 100 1999abstractfree full text kastin aj akerstrom v orexin orexin b rapidly enters brain blood simple diffusion j pharmacol exp ther 289 219 223 1999abstractfree full text kiyashchenko li mileykovskiy maidment n lam ha wu mf john j peever j siegel jm release hypocretin orexin waking sleep states j neurosci 22 5282 5286 2002abstractfree full text kotz cm glass mj levine billington cj regional effect naltrexone nucleus solitary tract blockade npy induced feeding j physiol regul integr comp physiol 278 r499 r503 2000abstractfree full text kotz cm teske ja levine ja wang c feeding activity induced orexin lateral hypothalamus rats regul pept 104 27 32 2002crossrefisimedline krahn dd gosnell ba levine morley je behavioral effects corticotropin releasing factor localization characterization central effects brain res 443 63 69 1988crossrefisimedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h centrally administered orexinhypocretin activates hpa axis rats neuroreport 11 1977 1980 2000isimedline levine ja eberhardt nl jensen md role nonexercise activity thermogenesis resistance fat gain humans science 283 212 214 1999abstractfree full text levine ja nygren j short kr nair ks effect hyperthyroidism spontaneous physical activity energy expenditure rats j appl physiol 94 165 170 2003abstractfree full text lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk differential expression orexin receptors 1 2 rat brain j comp neurol 435 6 25 2001crossrefisimedline moriguchi sakurai nambu yanagisawa m goto k neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264 101 104 1999crossrefisimedline nakamura uramura k nambu yada goto k yanagisawa m sakurai orexin induced hyperlocomotion stereotypy mediated dopaminergic system brain res 873 181 187 2000crossrefisimedline nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999crossrefisimedline nicholson c diffusion injected volume substance brain tissue arbitrary volume fraction tortuosity brain res 333 325 329 1985crossrefisimedline nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000crossrefisimedline paxinos g watson c rat brain stereotaxic coordinates orlando fl academic 1997 peng mt kang m circadian rhythms patterns running wheel activity feeding drinking behaviors old male rats physiol behav 33 615 620 1984crossrefisimedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text phillips singh d li q takeuchi ohkubo sharp pj boswell fasting differentially regulates expression agouti related peptide pro opiomelanocortin prepro orexin vasoactive intestinal polypeptide mrnas hypothalamus japanese quail cell tissue res 313 217 225 2003crossrefisimedline picker mj allen rm morgan d levine ohare e cleary jp effects neuropeptide y discriminative stimulus antinociceptive properties morphine pharmacol biochem behav 64 161 164 1999crossrefisimedline piper dc upton n smith mi hunter aj novel brain neuropeptide orexin modulates sleep wake cycle rats eur j neurosci 12 726 730 2000crossrefisimedline pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998crossrefisimedline rising r harper fontvielle ferraro rt spraul m ravussin e determinants total daily energy expenditure variability physical activity j clin nutr 59 800 804 1994abstract sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline samson wk gosnell b chang jk resch zt murphy tc cardiovascular regulatory actions hypocretins brain brain res 831 248 253 1999crossrefisimedline samson wk taylor mm follwell m ferguson av orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 104 97 103 2002crossrefisimedline siegel jm narcolepsy key role hypocretins orexins cell 98 409 412 1999isimedline stricker krongrad richy beck b orexinshypocretins obob mouse hypothalamic gene expression peptide content metabolic effects regul pept 104 11 20 2002crossrefisimedline swanson lw sawchenko pe lind rw regulation multiple peptides crf parvocellular neurosecretory neurons implications stress response prog brain res 68 169 190 1986isimedline sweet dc levine billington cj kotz cm feeding response central orexins brain res 821 535 538 1999crossrefisimedline taheri gardiner j hafizi murphy k dakin c seal l small c ghatei m bloom orexin immunoreactivity preproorexin mrna brain zucker wky rats neuroreport 12 459 464 2001isimedline takahashi n okumura yamada h kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999crossrefisimedline terao apte deshpande morairty freund yr kilduff ts age related decline hypocretin orexin receptor 2 messenger rna levels mouse brain neurosci lett 332 190 194 2002crossrefisimedline thorpe aj mullet ma wang cf kotz cm regional metabolic circadian specificity lateral hypothalamus orexin feeding stimulation j physiol regul integr comp physiol 284 r1409 r1417 2003abstractfree full text tritos na mastaitis jw kokkotou e maratos flier e characterization melanin concentrating hormone preproorexin expression murine hypothalamus brain res 895 160 166 2001crossrefisimedline trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 438 71 75 1998crossrefisimedline webb p annis jf troutman sj jr energy balance man measured direct indirect calorimetry j clin nutr 33 1287 1298 1980abstract wortley ke chang gq davydova z leibowitz sf peptides regulate food intake orexin gene expression increased states hypertriglyceridemia j physiol regul integr comp physiol 284 r1454 r1465 2003abstractfree full text wu mf john j maidment n lam ha siegel jm hypocretin release normal narcoleptic dogs food sleep deprivation eating movement j physiol regul integr comp physiol 283 r1079 r1086 2002abstractfree full text yamanaka beuckmann ct willie jt hara j tsujino n mieda m tominaga m yagami k sugiyama f goto k yanagisawa m sakurai hypothalamic orexin neurons regulate arousal according energy balance mice neuron 38 701 713 2003isimedline yamanaka sakurai katsumoto yanagisawa m goto k chronic intracerebroventricular administration orexin rats increases food intake daytime effect body weight brain res 849 248 252 1999crossrefisimedline yamamoto y ueta y date y nakazato m hara y serino r nomura m shibuya matsukura yamashita h regulation prepro orexin gene expression genetically obese mice brain res mol brain res 65 14 22 1999isimedline yamamoto y ueta y serino r nomura m shibuya yamashita h effects food restriction hypothalamic prepro orexin gene expression genetically obese mice brain res bull 51 515 521 2000crossrefisimedline
0.2210986.14656716.html.plaintext.txt	87	references top abstract materials methods results discussion grants references anonymous surgeon generals report physical activity health centers disease control prevention jama 276 522 1996crossrefisimedline adam ja menheere pp van dielen fm soeters pb buurman wa greve jw decreased plasma orexin levels obese individuals int j obes relat metab disord 26 274 276 2002crossrefmedline bertile f oudart h criscuolo f maho yl raclot hypothalamic gene expression long term fasted rats relationship body fat biochem biophys res commun 303 1106 13 2003crossrefisimedline bray ga bouchard c james wpt handbook obesity new york dekker 1998 brownlow bs petro feinglos mn surwit rs role motor activity diet induced obesity c57bl6j mice physiol behav 60 37 41 1996crossrefisimedline cai xj lister ca buckingham re pickavance l wilding j arch jr wilson williams g regulation orexin gene expression severe obesity rats studies zucker fatty zucker diabetic fatty rats effects rosiglitazone brain res mol brain res 77 131 137 2000isimedline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999isimedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text diano horvath b urbanski hf sotonyi p horvath tl fasting activates nonhuman primate hypocretin orexin system postsynaptic targets endocrinology 144 3774 3778 2003abstractfree full text dube mg kalra sp kalra ps food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842 473 477 1999crossrefisimedline duxon ms stretton j starr k jones dn holland v riley g jerman j brough smart d johns chan w porter ra upton n evidence orexin evoked grooming rat mediated orexin 1 ox1 receptors downstream 5 ht2c receptor involvement psychopharmacology berl 153 203 209 2001crossrefisimedline edwards cm abusnana sunter d murphy kg ghatei ma bloom sr effect orexins food intake comparison neuropeptide y melanin concentrating hormone galanin j endocrinol 160 r7 r12 1999abstract espana ra baldo ba kelley ae berridge cw wake promoting sleep suppressing actions hypocretin orexin basal forebrain sites action neuroscience 106 699 715 2001crossrefisimedline espana ra plahn berridge cw circadian dependent circadian independent behavioral actions hypocretinorexin brain res 943 224 236 2002crossrefisimedline estabrooke iv mccarthy mt ko e chou tc chemelli rm yanagisawa m saper cb scammell te fos expression orexin neurons varies behavioral state j neurosci 21 1656 1662 2001abstractfree full text gispen wh isaacson rl acth induced excessive grooming rat pharmacol ther 12 209 246 1981crossrefisimedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001crossrefisimedline haynes ac jackson b chapman h tadayyon m johns porter ra arch jr selective orexin 1 receptor antagonist reduces food consumption male female rats regul pept 96 45 51 2000crossrefisimedline haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr effects single chronic intracerebroventricular administration orexins feeding rat peptides 20 1099 1105 1999crossrefisimedline ida nakahara k katayama murakami n nakazato m effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821 526 529 1999crossrefisimedline ida nakahara k murakami hanada r nakazato m murakami n possible involvement orexin stress reaction rats biochem biophys res commun 270 318 323 2000crossrefisimedline jaszberenyi m bujdoso e pataki telegdy g effects orexins hypothalamic pituitary adrenal system j neuroendocrinol 12 1174 1178 2000crossrefisimedline jones dn gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153 210 218 2001crossrefisimedline kalra sp dube mg pu xu b horvath tl kalra ps interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 20 68 100 1999abstractfree full text kastin aj akerstrom v orexin orexin b rapidly enters brain blood simple diffusion j pharmacol exp ther 289 219 223 1999abstractfree full text kiyashchenko li mileykovskiy maidment n lam ha wu mf john j peever j siegel jm release hypocretin orexin waking sleep states j neurosci 22 5282 5286 2002abstractfree full text kotz cm glass mj levine billington cj regional effect naltrexone nucleus solitary tract blockade npy induced feeding j physiol regul integr comp physiol 278 r499 r503 2000abstractfree full text kotz cm teske ja levine ja wang c feeding activity induced orexin lateral hypothalamus rats regul pept 104 27 32 2002crossrefisimedline krahn dd gosnell ba levine morley je behavioral effects corticotropin releasing factor localization characterization central effects brain res 443 63 69 1988crossrefisimedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h centrally administered orexinhypocretin activates hpa axis rats neuroreport 11 1977 1980 2000isimedline levine ja eberhardt nl jensen md role nonexercise activity thermogenesis resistance fat gain humans science 283 212 214 1999abstractfree full text levine ja nygren j short kr nair ks effect hyperthyroidism spontaneous physical activity energy expenditure rats j appl physiol 94 165 170 2003abstractfree full text lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998crossrefisimedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk differential expression orexin receptors 1 2 rat brain j comp neurol 435 6 25 2001crossrefisimedline moriguchi sakurai nambu yanagisawa m goto k neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264 101 104 1999crossrefisimedline nakamura uramura k nambu yada goto k yanagisawa m sakurai orexin induced hyperlocomotion stereotypy mediated dopaminergic system brain res 873 181 187 2000crossrefisimedline nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999crossrefisimedline nicholson c diffusion injected volume substance brain tissue arbitrary volume fraction tortuosity brain res 333 325 329 1985crossrefisimedline nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000crossrefisimedline paxinos g watson c rat brain stereotaxic coordinates orlando fl academic 1997 peng mt kang m circadian rhythms patterns running wheel activity feeding drinking behaviors old male rats physiol behav 33 615 620 1984crossrefisimedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text phillips singh d li q takeuchi ohkubo sharp pj boswell fasting differentially regulates expression agouti related peptide pro opiomelanocortin prepro orexin vasoactive intestinal polypeptide mrnas hypothalamus japanese quail cell tissue res 313 217 225 2003crossrefisimedline picker mj allen rm morgan d levine ohare e cleary jp effects neuropeptide y discriminative stimulus antinociceptive properties morphine pharmacol biochem behav 64 161 164 1999crossrefisimedline piper dc upton n smith mi hunter aj novel brain neuropeptide orexin modulates sleep wake cycle rats eur j neurosci 12 726 730 2000crossrefisimedline pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998crossrefisimedline rising r harper fontvielle ferraro rt spraul m ravussin e determinants total daily energy expenditure variability physical activity j clin nutr 59 800 804 1994abstract sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline samson wk gosnell b chang jk resch zt murphy tc cardiovascular regulatory actions hypocretins brain brain res 831 248 253 1999crossrefisimedline samson wk taylor mm follwell m ferguson av orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 104 97 103 2002crossrefisimedline siegel jm narcolepsy key role hypocretins orexins cell 98 409 412 1999isimedline stricker krongrad richy beck b orexinshypocretins obob mouse hypothalamic gene expression peptide content metabolic effects regul pept 104 11 20 2002crossrefisimedline swanson lw sawchenko pe lind rw regulation multiple peptides crf parvocellular neurosecretory neurons implications stress response prog brain res 68 169 190 1986isimedline sweet dc levine billington cj kotz cm feeding response central orexins brain res 821 535 538 1999crossrefisimedline taheri gardiner j hafizi murphy k dakin c seal l small c ghatei m bloom orexin immunoreactivity preproorexin mrna brain zucker wky rats neuroreport 12 459 464 2001isimedline takahashi n okumura yamada h kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999crossrefisimedline terao apte deshpande morairty freund yr kilduff ts age related decline hypocretin orexin receptor 2 messenger rna levels mouse brain neurosci lett 332 190 194 2002crossrefisimedline thorpe aj mullet ma wang cf kotz cm regional metabolic circadian specificity lateral hypothalamus orexin feeding stimulation j physiol regul integr comp physiol 284 r1409 r1417 2003abstractfree full text tritos na mastaitis jw kokkotou e maratos flier e characterization melanin concentrating hormone preproorexin expression murine hypothalamus brain res 895 160 166 2001crossrefisimedline trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 438 71 75 1998crossrefisimedline webb p annis jf troutman sj jr energy balance man measured direct indirect calorimetry j clin nutr 33 1287 1298 1980abstract wortley ke chang gq davydova z leibowitz sf peptides regulate food intake orexin gene expression increased states hypertriglyceridemia j physiol regul integr comp physiol 284 r1454 r1465 2003abstractfree full text wu mf john j maidment n lam ha siegel jm hypocretin release normal narcoleptic dogs food sleep deprivation eating movement j physiol regul integr comp physiol 283 r1079 r1086 2002abstractfree full text yamanaka beuckmann ct willie jt hara j tsujino n mieda m tominaga m yagami k sugiyama f goto k yanagisawa m sakurai hypothalamic orexin neurons regulate arousal according energy balance mice neuron 38 701 713 2003isimedline yamanaka sakurai katsumoto yanagisawa m goto k chronic intracerebroventricular administration orexin rats increases food intake daytime effect body weight brain res 849 248 252 1999crossrefisimedline yamamoto y ueta y date y nakazato m hara y serino r nomura m shibuya matsukura yamashita h regulation prepro orexin gene expression genetically obese mice brain res mol brain res 65 14 22 1999isimedline yamamoto y ueta y serino r nomura m shibuya yamashita h effects food restriction hypothalamic prepro orexin gene expression genetically obese mice brain res bull 51 515 521 2000crossrefisimedline
0.22697699.15746258.html.plaintext.txt	0	dual regulatory effects orexins sympathetic nerve activity innervating brown adipose tissue rats tohru yasuda takayuki masaki tetsuya kakuma masahide hara tomoko nawata isao katsuragi hironobu yoshimatsu
0.22697699.15746258.html.plaintext.txt	1	department internal medicine faculty medicine oita university hasama oita 879 5593 japan
0.22697699.15746258.html.plaintext.txt	2	address correspondence requests reprints professor hironobu yoshimatsu md phd department internal medicine faculty medicine oita university 1 1 idaigaoka hasama oita 879 5593 japan e mail hiroyatoita medacjp u d
0.22697699.15746258.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references study examined orexin regulates activity sympathetic nerves innervate brown adipose tissue bat rats infusion orexin dose 03 nmol third cerebral ventricle decreased bat sympathetic nerve activity compared effect pbs p 005 whereas infusion orexin b dose caused significant increase p 005 pretreatment third cerebral ventricle injection 224 micromolkg fluoromethylhistidine irreversible inhibitor histamine synthesizing enzyme histidine decarboxylase attenuated orexin b induced response bat sympathetic nerve activity induced orexin results indicate orexins may regulate bat energy expenditure thermogenesis dual effects sympathetic nerve activity particular orexin b regulates bat sympathetic nerve activity via neuronal histamine hypothalamus
0.22697699.15746258.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references study examined orexin regulates activity sympathetic nerves innervate brown adipose tissue bat rats infusion orexin dose 03 nmol third cerebral ventricle decreased bat sympathetic nerve activity compared effect pbs p 005 whereas infusion orexin b dose caused significant increase p 005 pretreatment third cerebral ventricle injection 224 micromolkg fluoromethylhistidine irreversible inhibitor histamine synthesizing enzyme histidine decarboxylase attenuated orexin b induced response bat sympathetic nerve activity induced orexin results indicate orexins may regulate bat energy expenditure thermogenesis dual effects sympathetic nerve activity particular orexin b regulates bat sympathetic nerve activity via neuronal histamine hypothalamus
0.22697699.15746258.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references orexin orexin b hypothalamic neuropeptides derived 130 amino acid precursor prepro orexin potent agonists orexin 1 ox1 orexin 2 ox2 receptors orexin neurons located lateral hypothalamic area lha innervate almost regions brain except cerebellum 1 2 especially dense projections observed specific regions thalamus limbic system aminergic nuclei noradrenergic locus coeruleus lc serotonergic raphe nucleus histaminergic tuberomammillary nucleus tmn 3 4 concomitantly presence orexin receptors identified nuclei namely ox1r lc ox2r tmn 5 hypothalamic histamine neurons cell bodies tmn shown involved regulation variety physiological functions feeding behavior drinking behavior thermoregulation well autonomic nervous neuroendocrine systems 6 orexin histamine signaling pathway plays important role regulation sleep wakefulness cycle although involvement hypothalamic functions remains unclear 7
0.22697699.15746258.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references orexin orexin b hypothalamic neuropeptides derived 130 amino acid precursor prepro orexin potent agonists orexin 1 ox1 orexin 2 ox2 receptors orexin neurons located lateral hypothalamic area lha innervate almost regions brain except cerebellum 1 2 especially dense projections observed specific regions thalamus limbic system aminergic nuclei noradrenergic locus coeruleus lc serotonergic raphe nucleus histaminergic tuberomammillary nucleus tmn 3 4 concomitantly presence orexin receptors identified nuclei namely ox1r lc ox2r tmn 5 hypothalamic histamine neurons cell bodies tmn shown involved regulation variety physiological functions feeding behavior drinking behavior thermoregulation well autonomic nervous neuroendocrine systems 6 orexin histamine signaling pathway plays important role regulation sleep wakefulness cycle although involvement hypothalamic functions remains unclear 7
0.22697699.15746258.html.plaintext.txt	7	brown adipose tissue bat plays major role energy expenditure thermogenesis via function uncoupling protein 1 regulation energy expenditure bat control sympathetic nervous system higher brain structures discrete hypothalamic nuclei various orexigenic anorexigenic neuropeptides regulate bat metabolism affecting efferent sympathetic nerve activity 8 9 10 11 hypothalamic neuronal histamine anorexigenic substance increases bat sympathetic nerve activity 12 orexins affect energy balance thermoregulation orexin shown induce hypothermia food intake orexins increase renal sympathetic nerve activity 13 14 15 16 therefore highly probable orexins regulate bat energy expenditure thermogenesis influencing sympathetic nerve activity thus hypothesized hypothalamic neuronal histamine may mediate orexin signals sympathetic nerves innervate bat close relationship two systems recognized anatomically functionally 17 18 study therefore examined effects central administration orexins electrophysiological sympathetic nerve activity bat modulation responses neuronal histamine
0.22697699.15746258.html.plaintext.txt	8	brown adipose tissue bat plays major role energy expenditure thermogenesis via function uncoupling protein 1 regulation energy expenditure bat control sympathetic nervous system higher brain structures discrete hypothalamic nuclei various orexigenic anorexigenic neuropeptides regulate bat metabolism affecting efferent sympathetic nerve activity 8 9 10 11 hypothalamic neuronal histamine anorexigenic substance increases bat sympathetic nerve activity 12 orexins affect energy balance thermoregulation orexin shown induce hypothermia food intake orexins increase renal sympathetic nerve activity 13 14 15 16 therefore highly probable orexins regulate bat energy expenditure thermogenesis influencing sympathetic nerve activity thus hypothesized hypothalamic neuronal histamine may mediate orexin signals sympathetic nerves innervate bat close relationship two systems recognized anatomically functionally 17 18 study therefore examined effects central administration orexins electrophysiological sympathetic nerve activity bat modulation responses neuronal histamine
0.22697699.15746258.html.plaintext.txt	9	materials methods top abstract introduction materials methods results discussion references animals mature male sprague dawley rats 8 10 wk old seac yoshitomi fukuoka japan maintained 12 h light 12 h dark photoperiod lights 0700 h room controlled temperature 21 plus minus 1 c humidity 55 plus minus 5 rats allowed free access food pelleted rodent chow ce 2 clea japan tokyo japan water studies conducted accordance oita medical university guidelines based national institutes health guide care use laboratory animals
0.22697699.15746258.html.plaintext.txt	10	materials methods top abstract introduction materials methods results discussion references animals mature male sprague dawley rats 8 10 wk old seac yoshitomi fukuoka japan maintained 12 h light 12 h dark photoperiod lights 0700 h room controlled temperature 21 plus minus 1 c humidity 55 plus minus 5 rats allowed free access food pelleted rodent chow ce 2 clea japan tokyo japan water studies conducted accordance oita medical university guidelines based national institutes health guide care use laboratory animals
0.22697699.15746258.html.plaintext.txt	11	reagents orexin orexin b fluoromethylhistidine fmh purchased sigma chemical co st louis mo dissolved pbs final concentrations 30 microm 30 microm 67 mm respectively solution freshly prepared day use ph solution adjusted 64 72
0.22697699.15746258.html.plaintext.txt	12	cerebroventricular cannula implantation rat fixed stereotaxic apparatus narishige tokyo japan sodium pentobarbital anesthesia 45 mgkg ip stainless steel guide cannula 23 gauge surgically implanted third cerebral ventricle i3vt stainless steel wire stylet 29 gauge left place guide cannula maintain patency prevent leakage cerebrospinal fluid surgery carried least 1 wk infusion test solutions details surgical procedure described elsewhere 19
0.22697699.15746258.html.plaintext.txt	13	cerebroventricular cannula implantation rat fixed stereotaxic apparatus narishige tokyo japan sodium pentobarbital anesthesia 45 mgkg ip stainless steel guide cannula 23 gauge surgically implanted third cerebral ventricle i3vt stainless steel wire stylet 29 gauge left place guide cannula maintain patency prevent leakage cerebrospinal fluid surgery carried least 1 wk infusion test solutions details surgical procedure described elsewhere 19
0.22697699.15746258.html.plaintext.txt	14	measurement sympathetic nerve activity electrophysiological recordings made anesthesia urethane 08 gkg chloralose 80 mgkg using 20 cannulated rats dissection fine branches sympathetic nerves innervate interscapular bat nerves transected entered bat nerve activity measured using pair silver wire electrodes immersed mixture liquid paraffin white petroleum jelly prevent dehydration nerve tissue action potentials amplified filtered low high frequency cutoffs nerve signal distinguished background noise using window discriminator nerve activity analyzed based values obtained conversion raw data standard pulses using analog digital converter impulses integrated rate meter reset time 5 sec recorded using chart recorder details nerve recording technique described elsewhere 8 20 determination background firing rate sympathetic nerves changes nerve activity measured 60 min bolus i3vt infusion orexin 0 3 nmolrat 10 microlmin 10 min orexin b 0 3 nmolrat 10 microlmin 10 min fmh 0 3 micromolkg 10 microlmin 10 min pbs n 4 treatment doses orexins fmh determined previous studies 21 22 preliminary study infusions orexins performed 2 h pretreatment fmh 1300 h nerve activity measured 10 min intervals beginning 20 min continuing 60 min administration test solution nerve activity values recorded administration test solution expressed percentage difference baseline value 0 min baseline 100 figures signifies 60 min averages score bat sympathetic nerve activity orexin treatment analysis dose dependence orexins intracerebroventricular icv pbs icv infusion performed sympathetic nerve activity bat recorded 20 40 min infusion
0.22697699.15746258.html.plaintext.txt	15	measurement sympathetic nerve activity electrophysiological recordings made anesthesia urethane 08 gkg chloralose 80 mgkg using 20 cannulated rats dissection fine branches sympathetic nerves innervate interscapular bat nerves transected entered bat nerve activity measured using pair silver wire electrodes immersed mixture liquid paraffin white petroleum jelly prevent dehydration nerve tissue action potentials amplified filtered low high frequency cutoffs nerve signal distinguished background noise using window discriminator nerve activity analyzed based values obtained conversion raw data standard pulses using analog digital converter impulses integrated rate meter reset time 5 sec recorded using chart recorder details nerve recording technique described elsewhere 8 20 determination background firing rate sympathetic nerves changes nerve activity measured 60 min bolus i3vt infusion orexin 0 3 nmolrat 10 microlmin 10 min orexin b 0 3 nmolrat 10 microlmin 10 min fmh 0 3 micromolkg 10 microlmin 10 min pbs n 4 treatment doses orexins fmh determined previous studies 21 22 preliminary study infusions orexins performed 2 h pretreatment fmh 1300 h nerve activity measured 10 min intervals beginning 20 min continuing 60 min administration test solution nerve activity values recorded administration test solution expressed percentage difference baseline value 0 min baseline 100 figures signifies 60 min averages score bat sympathetic nerve activity orexin treatment analysis dose dependence orexins intracerebroventricular icv pbs icv infusion performed sympathetic nerve activity bat recorded 20 40 min infusion
0.22697699.15746258.html.plaintext.txt	16	statistical analysis differences among groups assessed using two way anova post hoc fisher protected least significant difference test two sided p value less 005 considered statistically significant statistical analysis dose dependence assessed spearman correlation coefficient rank
0.22697699.15746258.html.plaintext.txt	17	statistical analysis differences among groups assessed using two way anova post hoc fisher protected least significant difference test two sided p value less 005 considered statistically significant statistical analysis dose dependence assessed spearman correlation coefficient rank
0.22697699.15746258.html.plaintext.txt	18	results top abstract introduction materials methods results discussion references dose dependent effects orexins bat sympathetic nerve activity observed dose dependent effects orexin orexin b bat sympathetic nerve activity changes dependent doses orexins given icv orexin 0 nmol 1000 plus minus 45 003 nmol 874 plus minus 61 03 nmol 632 plus minus 64 3 nmol 474 plus minus 69 p 001 orexin b 0 nmol 1000 plus minus 53 003 nmol 1352 plus minus 73 03 nmol 2408 plus minus 112 3 nmol 3220 plus minus 210 p 001 table 1
0.22697699.15746258.html.plaintext.txt	19	results top abstract introduction materials methods results discussion references dose dependent effects orexins bat sympathetic nerve activity observed dose dependent effects orexin orexin b bat sympathetic nerve activity changes dependent doses orexins given icv orexin 0 nmol 1000 plus minus 45 003 nmol 874 plus minus 61 03 nmol 632 plus minus 64 3 nmol 474 plus minus 69 p 001 orexin b 0 nmol 1000 plus minus 53 003 nmol 1352 plus minus 73 03 nmol 2408 plus minus 112 3 nmol 3220 plus minus 210 p 001 table 1
0.22697699.15746258.html.plaintext.txt	20	view table table 1 dose dependent effects orexin orexin b bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	21	effect i3vt infusion orexin bat sympathetic nerve activity figure 1a shows typical response bat sympathetic nerve activity infusion orexin i3vt sympathetic nerve activity rapidly decreased central administration orexin changes sympathetic nerve activity response orexin treatment differed significantly induced pbs p 005 fig 1b
0.22697699.15746258.html.plaintext.txt	22	effect i3vt infusion orexin bat sympathetic nerve activity figure 1a shows typical response bat sympathetic nerve activity infusion orexin i3vt sympathetic nerve activity rapidly decreased central administration orexin changes sympathetic nerve activity response orexin treatment differed significantly induced pbs p 005 fig 1b
0.22697699.15746258.html.plaintext.txt	23	view larger version 20k fig 1 rate meter plots bat sympathetic nerve activity infusion orexin 03 nmol i3vt vertical axis shows nerve impulses per 5 sec horizontal bars 10 min time scale bold horizontal bar orexin infusion b percentage differences sympathetic nerve activity baseline 100 i3vt infusion orexin 03 nmol pbs control group baseline 100 signifies 60 min averages score bat sympathetic nerve activity orexin treatment data means plus minus sem n 4 per group orexin treated animals control p 005 p 001 vs control
0.22697699.15746258.html.plaintext.txt	24	effect pretreatment fmh changes bat sympathetic nerve activity induced orexin figure 2a shows typical responses bat sympathetic nerve activity infusion orexin rats pretreated infusion fmh i3vt mean changes sympathetic nerve activity induced orexin pretreatment fmh shown fig 2b sympathetic nerve activity decreased rapidly central administration orexin pretreated rats changes differed significantly induced pbs p 005 differ significantly induced orexin rats pretreated pbs p 005
0.22697699.15746258.html.plaintext.txt	25	effect pretreatment fmh changes bat sympathetic nerve activity induced orexin figure 2a shows typical responses bat sympathetic nerve activity infusion orexin rats pretreated infusion fmh i3vt mean changes sympathetic nerve activity induced orexin pretreatment fmh shown fig 2b sympathetic nerve activity decreased rapidly central administration orexin pretreated rats changes differed significantly induced pbs p 005 differ significantly induced orexin rats pretreated pbs p 005
0.22697699.15746258.html.plaintext.txt	26	view larger version 22k fig 2 rate meter plots bat sympathetic nerve activity i3vt injection orexin 03 nmol 2 h pretreatment fmh 067 micromol vertical axis shows nerve impulses per 5 sec horizontal bars 10 min time scale bold bar orexin infusion b percentage differences sympathetic nerve activity baseline i3vt injection orexin 03 nmol orexin 03 nmol fmh 067 micromol pretreatment pbs control baseline 100 signifies 60 min averages score bat sympathetic nerve activity orexin treatment data means plus minus sem n 4 per group orexin treated animals orexin treated animals fmh pretreatment control p 005 p 001 vs control
0.22697699.15746258.html.plaintext.txt	27	effect i3vt infusion orexin b bat sympathetic nerve activity typical response bat sympathetic nerve activity i3vt infusion orexin b shown fig 3a sympathetic nerve activity gradually increased central administration orexin b mean change sympathetic nerve activity response orexin b treatment statistically significant compared induced pbs p 005 fig 3b
0.22697699.15746258.html.plaintext.txt	28	view larger version 17k fig 3 rate meter plots bat sympathetic nerve activity infusion orexin b 03 nmol i3vt vertical axis shows nerve impulses per 5 sec horizontal bars 10 min time scale bold horizontal bar orexin b infusion b percentage differences sympathetic nerve activity baseline i3vt infusion orexin b 03 nmol pbs baseline 100 signifies 60 min averages score bat sympathetic nerve activity orexin treatment data means plus minus sem n 4 per group orexin b treated animals control p 005 p 001 vs control
0.22697699.15746258.html.plaintext.txt	29	effect pretreatment fmh changes bat sympathetic nerve activity induced orexin b figure 4a shows typical responses bat sympathetic nerve activity infusion orexin b rats pretreated infusion fmh i3vt sympathetic nerve activity gradually increased central administration orexin b rats pretreated fmh changes sympathetic nerve activity response orexin b significantly attenuated pretreated rats compared induced orexin b rats pretreated pbs p 005 fig 4b
0.22697699.15746258.html.plaintext.txt	30	effect pretreatment fmh changes bat sympathetic nerve activity induced orexin b figure 4a shows typical responses bat sympathetic nerve activity infusion orexin b rats pretreated infusion fmh i3vt sympathetic nerve activity gradually increased central administration orexin b rats pretreated fmh changes sympathetic nerve activity response orexin b significantly attenuated pretreated rats compared induced orexin b rats pretreated pbs p 005 fig 4b
0.22697699.15746258.html.plaintext.txt	31	view larger version 20k fig 4 rate meter plots bat sympathetic nerve activity i3vt injection orexin b 03 nmol 2 h pretreatment fmh 067 micromol vertical axis shows nerve impulses per 5 sec horizontal bars 10 min time scale bold bar orexin b infusion b percentage differences sympathetic nerve activity baseline 100 i3vt injection orexin b 03 nmol orexin b 03 nmol fmh 067 micromol pretreatment pbs control data means plus minus sem n 4 per group orexin b treated animals orexin b treated animals fmh pretreatment control p 005 p 001 vs control p 005 p 001 vs fmh pretreatment
0.22697699.15746258.html.plaintext.txt	32	discussion top abstract introduction materials methods results discussion references study demonstrated i3vt infusion orexin orexin b dose dependently decreased increased bat sympathetic nerve activity anesthetized rats respectively depletion neuronal histamine pretreatment fmh attenuated sympathetic nerve responses induced orexin b induced orexin indicating action orexin b mediated neuronal histamine thus likely dual effects orexin bat sympathetic nerve may depend differences peptide subtype andor target neuronal substance present discussion orexin differentiates actions sympathetic nerves well effects neuronal histamine
0.22697699.15746258.html.plaintext.txt	33	discussion top abstract introduction materials methods results discussion references study demonstrated i3vt infusion orexin orexin b dose dependently decreased increased bat sympathetic nerve activity anesthetized rats respectively depletion neuronal histamine pretreatment fmh attenuated sympathetic nerve responses induced orexin b induced orexin indicating action orexin b mediated neuronal histamine thus likely dual effects orexin bat sympathetic nerve may depend differences peptide subtype andor target neuronal substance present discussion orexin differentiates actions sympathetic nerves well effects neuronal histamine
0.22697699.15746258.html.plaintext.txt	34	actions orexins mediated via two g protein coupled receptors ox1r ox2r 1 2 receptor binding affinity orexin 10 100 times greater orexin b ox1r whereas orexins equipotent ox2r 2 23 24 25 distinct expression patterns two receptor subtypes identified throughout brain 5 considering i3vt infusion site used study target site binding orexin receptors may either hypothalamus brain stem standpoint ventromedial hypothalamic nucleus a5 cell group lc express high levels ox1r mrna may candidates targets orexin nuclei identified central origins efferent pathways bat 26
0.22697699.15746258.html.plaintext.txt	35	actions orexins mediated via two g protein coupled receptors ox1r ox2r 1 2 receptor binding affinity orexin 10 100 times greater orexin b ox1r whereas orexins equipotent ox2r 2 23 24 25 distinct expression patterns two receptor subtypes identified throughout brain 5 considering i3vt infusion site used study target site binding orexin receptors may either hypothalamus brain stem standpoint ventromedial hypothalamic nucleus a5 cell group lc express high levels ox1r mrna may candidates targets orexin nuclei identified central origins efferent pathways bat 26
0.22697699.15746258.html.plaintext.txt	36	hand high density expression ox2r observed arcuate nucleus arc lha paraventricular nucleus pvn ventral premammillary nucleus tmn moderate expression levels found medial preoptic area dorsal motor nucleus vagus 5 pvn medial preoptic area identified major hypothalamic origins efferent pathways bat neuroanatomical study 26 fact chemical stimulation nuclei increased bat sympathetic nerve activity 8 arc lha especially orexin neurons pvn direct neuronal projections intermediolateral cell column spinal cord location sympathetic preganglionic neurons identified 27 28 among nuclei cumulative evidence indicates importance lha arc orexin ox2r signaling suppress bat sympathetic nerve activity electrophysiological studies demonstrated excitatory effect orexin lha neuronal activity inhibitory influence area bat sympathetic nerve activity 8 indicating lha target site orexin regulation sympathetic innervation bat
0.22697699.15746258.html.plaintext.txt	37	hand high density expression ox2r observed arcuate nucleus arc lha paraventricular nucleus pvn ventral premammillary nucleus tmn moderate expression levels found medial preoptic area dorsal motor nucleus vagus 5 pvn medial preoptic area identified major hypothalamic origins efferent pathways bat neuroanatomical study 26 fact chemical stimulation nuclei increased bat sympathetic nerve activity 8 arc lha especially orexin neurons pvn direct neuronal projections intermediolateral cell column spinal cord location sympathetic preganglionic neurons identified 27 28 among nuclei cumulative evidence indicates importance lha arc orexin ox2r signaling suppress bat sympathetic nerve activity electrophysiological studies demonstrated excitatory effect orexin lha neuronal activity inhibitory influence area bat sympathetic nerve activity 8 indicating lha target site orexin regulation sympathetic innervation bat
0.22697699.15746258.html.plaintext.txt	38	contrast suppressive effects orexin central administration orexin b present study increased bat sympathetic nerve activity addition orexin b induced response attenuated histamine depletion caused pretreatment fmh described presence orexin neurons well orexin receptor oxr2 identified tmn site origin histamine neurons 29 demonstrated neuronal histamine mediates orexin signaling regulation sleep wakefulness cycle 30 finally central administration histamine shown increase bat sympathetic nerve activity 12 taken together evidence suggests highly probable orexin b regulates bat sympathetic nerve activity excitatory manner ox2r tmn unpublished observation demonstrated fmh treatment neuropeptide y antagonist influenced orexin b induced feeding andor sympathetic nerve activity results suggested neuronal histamine neuropeptide y might closely involved orexin b induced feeding behavior sympathetic nerve activity study necessary clarify details mechanism
0.22697699.15746258.html.plaintext.txt	39	contrast suppressive effects orexin central administration orexin b present study increased bat sympathetic nerve activity addition orexin b induced response attenuated histamine depletion caused pretreatment fmh described presence orexin neurons well orexin receptor oxr2 identified tmn site origin histamine neurons 29 demonstrated neuronal histamine mediates orexin signaling regulation sleep wakefulness cycle 30 finally central administration histamine shown increase bat sympathetic nerve activity 12 taken together evidence suggests highly probable orexin b regulates bat sympathetic nerve activity excitatory manner ox2r tmn unpublished observation demonstrated fmh treatment neuropeptide y antagonist influenced orexin b induced feeding andor sympathetic nerve activity results suggested neuronal histamine neuropeptide y might closely involved orexin b induced feeding behavior sympathetic nerve activity study necessary clarify details mechanism
0.22697699.15746258.html.plaintext.txt	40	considering present previous studies results suggest oxr hypothalamus brain stem may mediate orexin induced effect bat sympathetic nerve activity addition modulation oxr outside hypothalamus cerebral cortex spinal cord cisterna magna also possible previous studies demonstrated orexin could direct effects level sympathetic preganglionic neurons 31 beyond bat sympathetic nerve activity studies examine sympathetic nerve activity renal lumber nerves may merited
0.22697699.15746258.html.plaintext.txt	41	considering present previous studies results suggest oxr hypothalamus brain stem may mediate orexin induced effect bat sympathetic nerve activity addition modulation oxr outside hypothalamus cerebral cortex spinal cord cisterna magna also possible previous studies demonstrated orexin could direct effects level sympathetic preganglionic neurons 31 beyond bat sympathetic nerve activity studies examine sympathetic nerve activity renal lumber nerves may merited
0.22697699.15746258.html.plaintext.txt	42	functional studies recently demonstrated central administration orexin orexin b induces hypothermia hyperthermia respectively 14 15 results consistent present study time course bat thermogenesis assessed local bat temperature similar observed bat sympathetic nerve activity 32 hand previous studies demonstrated orexin induced hyperthermic response unanesthetized animals 33 34 well known arousal state muscle movement affect body temperature unanesthetized condition administration orexin induced increase arousal level consequent arbitrary movements may elevate body temperature possibility anesthesia might modulate bat sympathetic nerve activity thermogenesis anesthesia factor sole mechanism regulating arousal state body temperature present study limited acute phase orexins effects anesthetized rats possible differences state arousal may determine effect orexins body temperature addition timing infusion might influence orexin induced sympathetic nerve activity effects orexins clearly dependent sleep wake cycle 30
0.22697699.15746258.html.plaintext.txt	43	functional studies recently demonstrated central administration orexin orexin b induces hypothermia hyperthermia respectively 14 15 results consistent present study time course bat thermogenesis assessed local bat temperature similar observed bat sympathetic nerve activity 32 hand previous studies demonstrated orexin induced hyperthermic response unanesthetized animals 33 34 well known arousal state muscle movement affect body temperature unanesthetized condition administration orexin induced increase arousal level consequent arbitrary movements may elevate body temperature possibility anesthesia might modulate bat sympathetic nerve activity thermogenesis anesthesia factor sole mechanism regulating arousal state body temperature present study limited acute phase orexins effects anesthetized rats possible differences state arousal may determine effect orexins body temperature addition timing infusion might influence orexin induced sympathetic nerve activity effects orexins clearly dependent sleep wake cycle 30
0.22697699.15746258.html.plaintext.txt	44	summary demonstrated central administration orexins induces dual effects bat sympathetic nerve activity inhibition orexin stimulation orexin b hypothalamic neuronal histamine involved latter response bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	45	summary demonstrated central administration orexins induces dual effects bat sympathetic nerve activity inhibition orexin stimulation orexin b hypothalamic neuronal histamine involved latter response bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	46	footnotes work supported grants aid 136770067 japanese ministry education science culture research grants intractable diseases japanese ministry health welfare 2001 2002 work also supported part grant smoking research foundation venture business laboratory oita university grants 16922171 japan society promotion science
0.22697699.15746258.html.plaintext.txt	47	footnotes work supported grants aid 136770067 japanese ministry education science culture research grants intractable diseases japanese ministry health welfare 2001 2002 work also supported part grant smoking research foundation venture business laboratory oita university grants 16922171 japan society promotion science
0.22697699.15746258.html.plaintext.txt	48	first published online march 3 2005
0.22697699.15746258.html.plaintext.txt	49	abbreviations arc arcuate nucleus bat brown adipose tissue fmh fluoromethylhistidine i3vt third cerebral ventricle icv intracerebroventricular lc locus coeruleus lha lateral hypothalamic area ox1 orexin 1 ox2 orexin 2 ox1r ox1 receptor ox2r ox2 receptor pvn paraventricular nucleus tmn tuberomammillary nucleus
0.22697699.15746258.html.plaintext.txt	50	accepted publication february 16 2005
0.22697699.15746258.html.plaintext.txt	51	references top abstract introduction materials methods results discussion references de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett 2nd fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585crossrefmedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text nambu sakurai mizukami k hosoya y yanagisawa m goto k 1999 distribution orexin neurons adult rat brain brain res 827243 260crossrefmedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk 2001 differential expression orexin receptors 1 2 rat brain j comp neurol 4356 25crossrefmedline wada h inagaki n itowi n yamatodani 1991 histaminergic neuron system morphological features possible functions agents actions suppl 3311 27medline huang zl qu wm li wd mochizuki eguchi n watanabe urade y hayaishi o 2001 arousal effect orexin depends activation histaminergic system proc natl acad sci usa 989965 9970abstractfree full text yoshimatsu h egawa m bray ga 1993 sympathetic nerve activity discrete hypothalamic injections l glutamate brain res 601121 128crossrefmedline yoshimatsu h egawa m bray ga 1992 effects cholecystokinin sympathetic activity interscapular brown adipose tissue brain res 597298 303crossrefmedline egawa m yoshimatsu h bray ga 1991 neuropeptide y suppresses sympathetic activity interscapular brown adipose tissue rats j physiol 260r328 r334 egawa m yoshimatsu h bray ga 1990 preoptic area injection corticotropin releasing hormone stimulates sympathetic activity j physiol 259r799 r806 yasuda masaki sakata yoshimatsu h 2004 hypothalamic neuronal histamine regulates sympathetic nerve activity expression uncoupling protein 1 mrna brown adipose tissue rats neuroscience 125535 540crossrefmedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text szekely m petervari e balasko m hernadi uzsoki b 2002 effects orexins energy balance thermoregulation regul pept 10447 53crossrefmedline jaszberenyi m bujdoso e kiss e pataki telegdy g 2002 role npy mediation orexin induced hypothermia regul pept 10455 59crossrefmedline shirasaka nakazato m matsukura takasaki m kannan h 1999 sympathetic cardiovascular actions orexins conscious rats j physiol 277r1780 r1785 yamanaka tsujino n funahashi h honda k guan jl wang qp tominaga m goto k shioda sakurai 2002 orexins activate histaminergic neurons via orexin 2 receptor biochem biophys res commun 2901237 1245crossrefmedline ishizuka yamamoto y yamatodani 2002 effect orexin b histamine release anterior hypothalamus rats neurosci lett 32393 96crossrefmedline sakata tsutsui k fukushima m arase k kita h oomura y ohki k nicolaidis 1981 feeding hyperglycemia induced 15 anhydroglucitol rat physiol behav 27401 405crossrefmedline niijima 1989 nervous regulation metabolism prog neurobiol 33135 147crossrefmedline russell sh small cj sunter d morgan dakin cl cohen ma bloom sr 2002 chronic intraparaventricular nuclear administration orexin male rats alter thyroid axis uncoupling protein 1 brown adipose tissue regul pept 10461 68crossrefmedline yoshimatsu h itateyama e kondou hidaka tajima d kurokawa m sakata 1999 hypothalamic neuronal histamine target leptin action feeding behavior central nervous system diabetes 481342 1346 okumura takeuchi motomura w yamada h egashira si asahi kanatani ihara m kohgo y 2001 requirement intact disulfide bonds orexin induced stimulation gastric acid secretion mediated ox1 receptor activation biochem biophys res commun 280976 981crossrefmedline holmqvist akerman ke kukkonen jp 2002 orexin signaling recombinant neuron like cells febs lett 52611 14crossrefmedline smart d 1999 orexins new family neuropeptides br j anaesth 83695 697free full text bamshad m song ck bartness tj 1999 cns origins sympathetic nervous system outflow brown adipose tissue j physiol 276r1569 r1578 elias cf lee c kelly j aschkenasi c ahima rs couceyro pr kuhar mj saper cb elmquist jk 1998 leptin activates hypothalamic cart neurons projecting spinal cord neuron 211375 1385crossrefmedline van den pol 1999 hypothalamic hypocretin orexin robust innervation spinal cord j neurosci 193171 3182abstractfree full text inagaki n yamatodani ando yamamoto m tohyama m watanabe wada hj 1988 organization histaminergic fibers rat brain comp neurol 273283 300medline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376crossrefmedline van den pol gao xb obrietan k kilduff ts belousov ab 1998 presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text yasuda masaki kakuma yoshimatsu h 2003 centrally administered ghrelin suppresses sympathetic nerve activity brown adipose tissue rats neurosci lett 34975 78crossrefmedline yoshimichi g yoshimatsu h masaki sakata 2001 orexin regulates body temperature coordination arousal status exp biol med maywood 226468 476abstractfree full text monda m viggiano de luca v 2003 paradoxical effect orexin hypophagia induced hyperthermia brain res 961220 228crossrefmedline
0.22697699.15746258.html.plaintext.txt	52	references top abstract introduction materials methods results discussion references de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett 2nd fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585crossrefmedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text nambu sakurai mizukami k hosoya y yanagisawa m goto k 1999 distribution orexin neurons adult rat brain brain res 827243 260crossrefmedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk 2001 differential expression orexin receptors 1 2 rat brain j comp neurol 4356 25crossrefmedline wada h inagaki n itowi n yamatodani 1991 histaminergic neuron system morphological features possible functions agents actions suppl 3311 27medline huang zl qu wm li wd mochizuki eguchi n watanabe urade y hayaishi o 2001 arousal effect orexin depends activation histaminergic system proc natl acad sci usa 989965 9970abstractfree full text yoshimatsu h egawa m bray ga 1993 sympathetic nerve activity discrete hypothalamic injections l glutamate brain res 601121 128crossrefmedline yoshimatsu h egawa m bray ga 1992 effects cholecystokinin sympathetic activity interscapular brown adipose tissue brain res 597298 303crossrefmedline egawa m yoshimatsu h bray ga 1991 neuropeptide y suppresses sympathetic activity interscapular brown adipose tissue rats j physiol 260r328 r334 egawa m yoshimatsu h bray ga 1990 preoptic area injection corticotropin releasing hormone stimulates sympathetic activity j physiol 259r799 r806 yasuda masaki sakata yoshimatsu h 2004 hypothalamic neuronal histamine regulates sympathetic nerve activity expression uncoupling protein 1 mrna brown adipose tissue rats neuroscience 125535 540crossrefmedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text szekely m petervari e balasko m hernadi uzsoki b 2002 effects orexins energy balance thermoregulation regul pept 10447 53crossrefmedline jaszberenyi m bujdoso e kiss e pataki telegdy g 2002 role npy mediation orexin induced hypothermia regul pept 10455 59crossrefmedline shirasaka nakazato m matsukura takasaki m kannan h 1999 sympathetic cardiovascular actions orexins conscious rats j physiol 277r1780 r1785 yamanaka tsujino n funahashi h honda k guan jl wang qp tominaga m goto k shioda sakurai 2002 orexins activate histaminergic neurons via orexin 2 receptor biochem biophys res commun 2901237 1245crossrefmedline ishizuka yamamoto y yamatodani 2002 effect orexin b histamine release anterior hypothalamus rats neurosci lett 32393 96crossrefmedline sakata tsutsui k fukushima m arase k kita h oomura y ohki k nicolaidis 1981 feeding hyperglycemia induced 15 anhydroglucitol rat physiol behav 27401 405crossrefmedline niijima 1989 nervous regulation metabolism prog neurobiol 33135 147crossrefmedline russell sh small cj sunter d morgan dakin cl cohen ma bloom sr 2002 chronic intraparaventricular nuclear administration orexin male rats alter thyroid axis uncoupling protein 1 brown adipose tissue regul pept 10461 68crossrefmedline yoshimatsu h itateyama e kondou hidaka tajima d kurokawa m sakata 1999 hypothalamic neuronal histamine target leptin action feeding behavior central nervous system diabetes 481342 1346 okumura takeuchi motomura w yamada h egashira si asahi kanatani ihara m kohgo y 2001 requirement intact disulfide bonds orexin induced stimulation gastric acid secretion mediated ox1 receptor activation biochem biophys res commun 280976 981crossrefmedline holmqvist akerman ke kukkonen jp 2002 orexin signaling recombinant neuron like cells febs lett 52611 14crossrefmedline smart d 1999 orexins new family neuropeptides br j anaesth 83695 697free full text bamshad m song ck bartness tj 1999 cns origins sympathetic nervous system outflow brown adipose tissue j physiol 276r1569 r1578 elias cf lee c kelly j aschkenasi c ahima rs couceyro pr kuhar mj saper cb elmquist jk 1998 leptin activates hypothalamic cart neurons projecting spinal cord neuron 211375 1385crossrefmedline van den pol 1999 hypothalamic hypocretin orexin robust innervation spinal cord j neurosci 193171 3182abstractfree full text inagaki n yamatodani ando yamamoto m tohyama m watanabe wada hj 1988 organization histaminergic fibers rat brain comp neurol 273283 300medline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376crossrefmedline van den pol gao xb obrietan k kilduff ts belousov ab 1998 presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text yasuda masaki kakuma yoshimatsu h 2003 centrally administered ghrelin suppresses sympathetic nerve activity brown adipose tissue rats neurosci lett 34975 78crossrefmedline yoshimichi g yoshimatsu h masaki sakata 2001 orexin regulates body temperature coordination arousal status exp biol med maywood 226468 476abstractfree full text monda m viggiano de luca v 2003 paradoxical effect orexin hypophagia induced hyperthermia brain res 961220 228crossrefmedline
0.23939125.12519822.html.plaintext.txt	0	time wake individual variation sleep needs scott rivkees
0.23939125.12519822.html.plaintext.txt	1	yale child health research center yale university new haven connecticut 06520
0.23939125.12519822.html.plaintext.txt	2	address correspondence requests reprints scott rivkees md yale child health research center yale university new haven connecticut 06520
0.23939125.12519822.html.plaintext.txt	3	novel important set clinical studies reported issue jcem aeschbach et al 1 examined long short sleepers sleep greater 9 h less 6 h per night respectively assessing melatonin cortisol levels monitoring body temperature found longer biological night long sleepers short sleepers characterized greater duration nocturnal melatonin secretion later early morning temperature nadirs cortisol peaks 1 thus physiological processes mark output circadian timing system parallel sleep duration
0.23939125.12519822.html.plaintext.txt	4	novel important set clinical studies reported issue jcem aeschbach et al 1 examined long short sleepers sleep greater 9 h less 6 h per night respectively assessing melatonin cortisol levels monitoring body temperature found longer biological night long sleepers short sleepers characterized greater duration nocturnal melatonin secretion later early morning temperature nadirs cortisol peaks 1 thus physiological processes mark output circadian timing system parallel sleep duration
0.23939125.12519822.html.plaintext.txt	5	findings aeschbach et al 1 give credence everyday observations sleep needs vary individually suggest amount sleep need reflects intrinsic factors observations also underlie difficult change sleep patterns fighting inherent physiology
0.23939125.12519822.html.plaintext.txt	6	findings aeschbach et al 1 give credence everyday observations sleep needs vary individually suggest amount sleep need reflects intrinsic factors observations also underlie difficult change sleep patterns fighting inherent physiology
0.23939125.12519822.html.plaintext.txt	7	notion one sleep duration intrinsically determined widespread implications many disciplines including industry healthcare education sleep debt caused sleep deprivation recognized cause industrial accidents impaired worker productivity 2 example roadway accidents common sleep deprived truck drivers 3 productivity air traffic controllers adversely affected shift work well 4
0.23939125.12519822.html.plaintext.txt	8	notion one sleep duration intrinsically determined widespread implications many disciplines including industry healthcare education sleep debt caused sleep deprivation recognized cause industrial accidents impaired worker productivity 2 example roadway accidents common sleep deprived truck drivers 3 productivity air traffic controllers adversely affected shift work well 4
0.23939125.12519822.html.plaintext.txt	9	excessive work hours medical house officers work night call raised concern patient safety understandably issue caught scrutiny legislators regulatory agencies 5 efforts resulted new policies limit work hours medical staff
0.23939125.12519822.html.plaintext.txt	10	excessive work hours medical house officers work night call raised concern patient safety understandably issue caught scrutiny legislators regulatory agencies 5 efforts resulted new policies limit work hours medical staff
0.23939125.12519822.html.plaintext.txt	11	curtailing sleep adults name productivity educational system cutting sleep children adolescents many educational districts school day begins early morning hours 6 uncommon see children standing street corners awaiting school buses early morning darkness reflecting fact difficult advance hands one biological clock irrespective age adverse effects reduced sleep early morning awakening academic performance increasingly recognized children adolescents 6
0.23939125.12519822.html.plaintext.txt	12	curtailing sleep adults name productivity educational system cutting sleep children adolescents many educational districts school day begins early morning hours 6 uncommon see children standing street corners awaiting school buses early morning darkness reflecting fact difficult advance hands one biological clock irrespective age adverse effects reduced sleep early morning awakening academic performance increasingly recognized children adolescents 6
0.23939125.12519822.html.plaintext.txt	13	live society control photic environment simple flip switch convenient clap hands using alarm clocks planned schedules believe override natural sleep needs believe comfortably live lives synchrony 24 h light dark cycle reverse days nights without penalty however reflected ever increasing number businesses devoted optimizing schedules shift workers difficult willfully change sleep habits hands circadian clock
0.23939125.12519822.html.plaintext.txt	14	live society control photic environment simple flip switch convenient clap hands using alarm clocks planned schedules believe override natural sleep needs believe comfortably live lives synchrony 24 h light dark cycle reverse days nights without penalty however reflected ever increasing number businesses devoted optimizing schedules shift workers difficult willfully change sleep habits hands circadian clock
0.23939125.12519822.html.plaintext.txt	15	thought exposing shift workers bright light night circadian clock could reset yet unless stringent efforts made limit daytime lighting exposure resetting biological clock occur melatonin cortisol rhythms may remain phase periods sleep wakefulness 7 individuals working night may thus phase optimal periods alertness task performance efforts develop agents reset circadian clock ie jet lag drugs also largely unrealized 8 despite popular hype melatonin conveniently shift circadian phase data support notion striking show modest effects best 9 10
0.23939125.12519822.html.plaintext.txt	16	thought exposing shift workers bright light night circadian clock could reset yet unless stringent efforts made limit daytime lighting exposure resetting biological clock occur melatonin cortisol rhythms may remain phase periods sleep wakefulness 7 individuals working night may thus phase optimal periods alertness task performance efforts develop agents reset circadian clock ie jet lag drugs also largely unrealized 8 despite popular hype melatonin conveniently shift circadian phase data support notion striking show modest effects best 9 10
0.23939125.12519822.html.plaintext.txt	17	difficult change one circadian phase observations aeschbach et al 1 provide basis difficult change sleep habits duration biological night varies individually may difficult individuals adapt condensed sleep schedules others strategies guidelines aimed improving health productivity shift workers may therefore effective individuals ineffective others
0.23939125.12519822.html.plaintext.txt	18	difficult change one circadian phase observations aeschbach et al 1 provide basis difficult change sleep habits duration biological night varies individually may difficult individuals adapt condensed sleep schedules others strategies guidelines aimed improving health productivity shift workers may therefore effective individuals ineffective others
0.23939125.12519822.html.plaintext.txt	19	biological basis variability sleep duration unknown present remains intriguing issue evolving body evidence suggests sleep cycle circadian rhythmicity integrally related circadian system influencing timing duration sleep expressed circadian rhythms like sleep wake cycle rhythms hormone production generated regulated biological clock located suprachiasmatic nuclei scn anterior hypothalamus 11 damage nuclei results episodes sleep wakefulness occurring throughout 24 h day rather consolidated night scn damage also results increase total duration sleep primates 12
0.23939125.12519822.html.plaintext.txt	20	biological basis variability sleep duration unknown present remains intriguing issue evolving body evidence suggests sleep cycle circadian rhythmicity integrally related circadian system influencing timing duration sleep expressed circadian rhythms like sleep wake cycle rhythms hormone production generated regulated biological clock located suprachiasmatic nuclei scn anterior hypothalamus 11 damage nuclei results episodes sleep wakefulness occurring throughout 24 h day rather consolidated night scn damage also results increase total duration sleep primates 12
0.23939125.12519822.html.plaintext.txt	21	past decade dissection molecular hands circadian clock lead fascinating new insights generation circadian rhythms seems related complex interaction handful transcriptional regulators kinases resulting 24 h cycles protein expression action scn 11 mammals factors include proteins period clock cry bmal casein kinase 1 11 mutations factors discovered recently
0.23939125.12519822.html.plaintext.txt	22	past decade dissection molecular hands circadian clock lead fascinating new insights generation circadian rhythms seems related complex interaction handful transcriptional regulators kinases resulting 24 h cycles protein expression action scn 11 mammals factors include proteins period clock cry bmal casein kinase 1 11 mutations factors discovered recently
0.23939125.12519822.html.plaintext.txt	23	humans mutations period 2 associated advanced circadian phase syndrome 13 individuals condition wake early morning retire bed early evening hours animals mutations clock result abnormal disorganized sleep problems 14 mutations casein kinase 1 result short circadian day period 15
0.23939125.12519822.html.plaintext.txt	24	humans mutations period 2 associated advanced circadian phase syndrome 13 individuals condition wake early morning retire bed early evening hours animals mutations clock result abnormal disorganized sleep problems 14 mutations casein kinase 1 result short circadian day period 15
0.23939125.12519822.html.plaintext.txt	25	whereas possible localize circadian clock mammals discrete region brain brain regions involved sleep organization far diffuse involving complex subcortical networks 16 similar clock gene mutations providing insights biological basis circadian rhythmicity discovery novel proteins also provided insights pathogenesis sleep disorders 17 18 19 inability produce respond orexinhypocretin found cause narcolepsy 17 likely seminal discovery lead new diagnostic tests treatment disorder 17
0.23939125.12519822.html.plaintext.txt	26	whereas possible localize circadian clock mammals discrete region brain brain regions involved sleep organization far diffuse involving complex subcortical networks 16 similar clock gene mutations providing insights biological basis circadian rhythmicity discovery novel proteins also provided insights pathogenesis sleep disorders 17 18 19 inability produce respond orexinhypocretin found cause narcolepsy 17 likely seminal discovery lead new diagnostic tests treatment disorder 17
0.23939125.12519822.html.plaintext.txt	27	coupling knowledge basic clock sleep mechanisms powerful genetic approaches permit identification specific genes small cohorts likely identification elucidation factors regulate duration timing sleep 18 continued characterization individual variation sleep identification families cohorts unusual sleep circadian properties also greatly enhance genetic approaches regard thus may someday learn individuals ability stay watch david letterman 11 o clock news whereas others retire news 10 o clock
0.23939125.12519822.html.plaintext.txt	28	coupling knowledge basic clock sleep mechanisms powerful genetic approaches permit identification specific genes small cohorts likely identification elucidation factors regulate duration timing sleep 18 continued characterization individual variation sleep identification families cohorts unusual sleep circadian properties also greatly enhance genetic approaches regard thus may someday learn individuals ability stay watch david letterman 11 o clock news whereas others retire news 10 o clock
0.23939125.12519822.html.plaintext.txt	29	society industry medicine becoming increasingly aware importance sleep proper timing sleep cycles reflected sleep work hour related laws however compared advances understanding basic sleep circadian physiology molecular biology public attention arena lagged considerably readily manipulate photic environment yet stubbornly recognize difficult overcome mother nature change timing amount sleep need increasingly seem value alarm clocks internal clocks thus important challenge modern fluid society able accommodate normal circadian cycle individual sleep requirements name progress productivity
0.23939125.12519822.html.plaintext.txt	30	society industry medicine becoming increasingly aware importance sleep proper timing sleep cycles reflected sleep work hour related laws however compared advances understanding basic sleep circadian physiology molecular biology public attention arena lagged considerably readily manipulate photic environment yet stubbornly recognize difficult overcome mother nature change timing amount sleep need increasingly seem value alarm clocks internal clocks thus important challenge modern fluid society able accommodate normal circadian cycle individual sleep requirements name progress productivity
0.23939125.12519822.html.plaintext.txt	31	abbreviation scn suprachiasmatic nuclei
0.23939125.12519822.html.plaintext.txt	32	aeschbach d sher l postolache tt matthews jr jackson ma wehr ta 2003 longer biological night long sleepers short sleepers j clin endocrinol metab 8826 30abstractfree full text bonnet mh arand dl 1995 chronically sleep deprived sleep 18908 911medline braver er pantula jf 1998 sleep long haul truck drivers n engl j med 338389 discussion 391free full text luna td 1997 air traffic controller shiftwork implications aviation safety review aviat space environ med 6869 79medline gaba dm howard sk 2002 fatigue among clinicians safety patients n engl j med 3471249 1255free full text carskadon ma wolfson ar acebo c tzischinsky o seifer r 1998 adolescent sleep patterns circadian timing sleepiness transition early school days sleep 21871 881medline czeisler ca johnson mp duffy jf brown en ronda jm kronauer re 1990 exposure bright light darkness treat physiologic maladaptation night work n engl j med 3221253 1259abstract dawson d armstrong sm 1996 chronobiotics drugs shift rhythms pharmacol ther 6915 36crossrefmedline hao h rivkees 2000 melatonin shift circadian phase baboons j clin endocrinol metab 853618 3622abstractfree full text sharkey km eastman ci 2002 melatonin phase shifts human circadian rhythms placebo controlled simulated night work study j physiol regul integr comp physiol 282r454 r63 reppert sm weaver dr 2002 coordination circadian timing mammals nature 418935 941crossrefmedline edgar dm dement wc fuller ca 1993 effect scn lesions sleep squirrel monkeys evidence opponent processes sleep wake regulation j neurosci 131065 1079abstract toh kl jones cr y eide ej hinz wa virshup dm ptacek lj fu yh 2001 hper2 phosphorylation site mutation familial advanced sleep phase syndrome science 2911040 1043abstractfree full text naylor e bergmann bm krauski k zee pc takahashi js vitaterna mh turek fw 2000 circadian clock mutation alters sleep homeostasis mouse j neurosci 208138 8143abstractfree full text eide ej virshup dm 2001 casein kinase another cog circadian clockworks chronobiol int 18389 398crossrefmedline pace schott ef hobson ja 2002 neurobiology sleep genetics cellular physiology subcortical networks nat rev neurosci 3591 605medline taheri zeitzer jm mignot e 2002 role hypocretins orexins sleep regulation narcolepsy annu rev neurosci 25283 313crossrefmedline tafti m franken p 2002 invited review genetic dissection sleep j appl physiol 921339 1347abstractfree full text franken p chollet d tafti m 2001 homeostatic regulation sleep need genetic control j neurosci 212610 2621abstractfree full text article full text pdf submit related letter editor purchase article view shopping cart alert article cited alert eletters posted alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles rivkees articles citing article pubmed pubmed citation articles rivkees
0.23939125.12519822.html.plaintext.txt	33	aeschbach d sher l postolache tt matthews jr jackson ma wehr ta 2003 longer biological night long sleepers short sleepers j clin endocrinol metab 8826 30abstractfree full text bonnet mh arand dl 1995 chronically sleep deprived sleep 18908 911medline braver er pantula jf 1998 sleep long haul truck drivers n engl j med 338389 discussion 391free full text luna td 1997 air traffic controller shiftwork implications aviation safety review aviat space environ med 6869 79medline gaba dm howard sk 2002 fatigue among clinicians safety patients n engl j med 3471249 1255free full text carskadon ma wolfson ar acebo c tzischinsky o seifer r 1998 adolescent sleep patterns circadian timing sleepiness transition early school days sleep 21871 881medline czeisler ca johnson mp duffy jf brown en ronda jm kronauer re 1990 exposure bright light darkness treat physiologic maladaptation night work n engl j med 3221253 1259abstract dawson d armstrong sm 1996 chronobiotics drugs shift rhythms pharmacol ther 6915 36crossrefmedline hao h rivkees 2000 melatonin shift circadian phase baboons j clin endocrinol metab 853618 3622abstractfree full text sharkey km eastman ci 2002 melatonin phase shifts human circadian rhythms placebo controlled simulated night work study j physiol regul integr comp physiol 282r454 r63 reppert sm weaver dr 2002 coordination circadian timing mammals nature 418935 941crossrefmedline edgar dm dement wc fuller ca 1993 effect scn lesions sleep squirrel monkeys evidence opponent processes sleep wake regulation j neurosci 131065 1079abstract toh kl jones cr y eide ej hinz wa virshup dm ptacek lj fu yh 2001 hper2 phosphorylation site mutation familial advanced sleep phase syndrome science 2911040 1043abstractfree full text naylor e bergmann bm krauski k zee pc takahashi js vitaterna mh turek fw 2000 circadian clock mutation alters sleep homeostasis mouse j neurosci 208138 8143abstractfree full text eide ej virshup dm 2001 casein kinase another cog circadian clockworks chronobiol int 18389 398crossrefmedline pace schott ef hobson ja 2002 neurobiology sleep genetics cellular physiology subcortical networks nat rev neurosci 3591 605medline taheri zeitzer jm mignot e 2002 role hypocretins orexins sleep regulation narcolepsy annu rev neurosci 25283 313crossrefmedline tafti m franken p 2002 invited review genetic dissection sleep j appl physiol 921339 1347abstractfree full text franken p chollet d tafti m 2001 homeostatic regulation sleep need genetic control j neurosci 212610 2621abstractfree full text article full text pdf submit related letter editor purchase article view shopping cart alert article cited alert eletters posted alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager request copyright permission google scholar articles rivkees articles citing article pubmed pubmed citation articles rivkees
0.23939125.12519822.html.plaintext.txt	34	home help feedback subscriptions archive search table contents endocrinology endocrine reviews j clin end metab molecular endocrinology recent prog horm res endocrine journals
0.27402496.12639903.html.plaintext.txt	0	gonadal steroids differentially regulate messenger ribonucleic acid expression pituitary orexin type 1 receptors adrenal orexin type 2 receptors olaf johren norbert bruggemann andreas dendorfer peter dominiak
0.27402496.12639903.html.plaintext.txt	1	institute experimental clinical pharmacology toxicology university clinic lubeck d 23538 lubeck germany
0.27402496.12639903.html.plaintext.txt	2	address correspondence requests reprints olaf johren phd institute experimental clinical pharmacology toxicology university clinic lubeck ratzeburger allee 160 d 23538 lubeck germany e mail joehrenatmedinfmu luebeckde u d
0.27402496.12639903.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references hypothalamic prepro orexin well pituitary adrenal orexin receptors gender specifically expressed assess regulation gonadal steroids investigated effect 17ss estradiol female testosterone male rats prepro orexin orexin receptor mrna expression rats either sham operated gonadectomized subsequently treated placebo 17ss estradiol testosterone 21 d tissue mrna levels prepro orexin orexin type 1 ox1 orexin type 2 ox2 receptors measured using quantitative real time rt pcr
0.27402496.12639903.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references hypothalamic prepro orexin well pituitary adrenal orexin receptors gender specifically expressed assess regulation gonadal steroids investigated effect 17ss estradiol female testosterone male rats prepro orexin orexin receptor mrna expression rats either sham operated gonadectomized subsequently treated placebo 17ss estradiol testosterone 21 d tissue mrna levels prepro orexin orexin type 1 ox1 orexin type 2 ox2 receptors measured using quantitative real time rt pcr
0.27402496.12639903.html.plaintext.txt	5	female rats pituitary ox1 receptor mrna levels increased 12 fold ovariectomy compared sham operated rats increase pituitary ox1 receptor mrna inhibited treatment 17ss estradiol adrenal mrna levels ox2 receptors ovariectomized rats increased 2 fold compared sham operated rats also reduced treatment 17ss estradiol male rats orchidectomy increased mrna levels pituitary ox1 receptors compared sham operated rats contrast adrenal ox2 receptor mrna reduced orchidectomy testosterone treatment reversed effect orchidectomy pituitary ox1 adrenal ox2 receptors hypothalamus differences found mrna levels prepro orexin ox1 ox2 receptors sham operated placebo treated steroid treated female male rats
0.27402496.12639903.html.plaintext.txt	6	female rats pituitary ox1 receptor mrna levels increased 12 fold ovariectomy compared sham operated rats increase pituitary ox1 receptor mrna inhibited treatment 17ss estradiol adrenal mrna levels ox2 receptors ovariectomized rats increased 2 fold compared sham operated rats also reduced treatment 17ss estradiol male rats orchidectomy increased mrna levels pituitary ox1 receptors compared sham operated rats contrast adrenal ox2 receptor mrna reduced orchidectomy testosterone treatment reversed effect orchidectomy pituitary ox1 adrenal ox2 receptors hypothalamus differences found mrna levels prepro orexin ox1 ox2 receptors sham operated placebo treated steroid treated female male rats
0.27402496.12639903.html.plaintext.txt	7	results indicate gonadal steroids differentially regulate pituitary ox1 receptors adrenal ox2 receptors male female rats may contribute specific sex dependent neuroendocrine endocrine actions orexins
0.27402496.12639903.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references orexin orexin b isolated endogenous ligands orphan g protein coupled receptor 1 peptides derive common precursor prepro orexin identical independently cloned prepro hypocretin 2 prepro orexin selectively expressed lateral hypothalamic area region involved control feeding behavior 1 2 consequently orexins shown stimulate food intake rats injected brain ventricles prepro orexin mrna regulated lateral hypothalamus fasting 1 orexin hypocretin containing neurons project numerous areas throughout brain spinal cord suggesting involvement orexins regulation multiple physiological functions besides effect feeding behavior 3 4 5 6 7 areas include cerebral cortex limbic system locus coeruleus brain stem regions also hypothalamus accordingly orexins shown regulate autonomic functions like heart rate blood pressure 8 9 sleep wake behavior arousal 10 11 12 various neuroendocrine systems 13 14 15 16
0.27402496.12639903.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references orexin orexin b isolated endogenous ligands orphan g protein coupled receptor 1 peptides derive common precursor prepro orexin identical independently cloned prepro hypocretin 2 prepro orexin selectively expressed lateral hypothalamic area region involved control feeding behavior 1 2 consequently orexins shown stimulate food intake rats injected brain ventricles prepro orexin mrna regulated lateral hypothalamus fasting 1 orexin hypocretin containing neurons project numerous areas throughout brain spinal cord suggesting involvement orexins regulation multiple physiological functions besides effect feeding behavior 3 4 5 6 7 areas include cerebral cortex limbic system locus coeruleus brain stem regions also hypothalamus accordingly orexins shown regulate autonomic functions like heart rate blood pressure 8 9 sleep wake behavior arousal 10 11 12 various neuroendocrine systems 13 14 15 16
0.27402496.12639903.html.plaintext.txt	10	two subtypes orexin receptors namely ox1 ox2 receptors cloned 1 expression patterns rat brain good agreement widespread projections orexin immunoreactive neurons 17 18 within hypothalamus ox1 receptor mrna detected areas like medial preoptic nucleus anterior hypothalamic nucleus ventromedial nucleus whereas ox2 receptor mrna found regions paraventricular arcuate nucleus 18 therefore effects intracerebroventricularly icv injected orexins plasma hormones acth prolactin lh gh 13 14 15 16 may mediated affecting synthesis andor liberation releasing hormones addition orexins may directly influence pituitary hormones orexinergic nerve fibers present median eminence pituitary gland orexin receptors detected pituitary gland 4 19 20 indeed orexins shown stimulate crh gnrh release hypothalamus 21 also inhibit releasing hormone stimulated acth lh release pituitary 22 23 inhibitory action orexin gnrh stimulated pituitary lh release observed proestrous female rats male rats 22 moreover female rats effect icv injected orexins dependent status ovarian steroids 16 furthermore whereas ovariectomized ovx rats treated 17ss estradiol e2 progesterone icv orexin increased plasma lh levels untreated ovx rats orexin decreased plasma lh levels 16 one explanation bimodal action orexins lh release possible regulation orexin receptors estrogens interestingly recently detected sexually dimorphic expression peripheral orexin receptors higher mrna levels ox1 receptors pituitary ox2 receptors adrenal glands male rats compared female rats 20
0.27402496.12639903.html.plaintext.txt	11	two subtypes orexin receptors namely ox1 ox2 receptors cloned 1 expression patterns rat brain good agreement widespread projections orexin immunoreactive neurons 17 18 within hypothalamus ox1 receptor mrna detected areas like medial preoptic nucleus anterior hypothalamic nucleus ventromedial nucleus whereas ox2 receptor mrna found regions paraventricular arcuate nucleus 18 therefore effects intracerebroventricularly icv injected orexins plasma hormones acth prolactin lh gh 13 14 15 16 may mediated affecting synthesis andor liberation releasing hormones addition orexins may directly influence pituitary hormones orexinergic nerve fibers present median eminence pituitary gland orexin receptors detected pituitary gland 4 19 20 indeed orexins shown stimulate crh gnrh release hypothalamus 21 also inhibit releasing hormone stimulated acth lh release pituitary 22 23 inhibitory action orexin gnrh stimulated pituitary lh release observed proestrous female rats male rats 22 moreover female rats effect icv injected orexins dependent status ovarian steroids 16 furthermore whereas ovariectomized ovx rats treated 17ss estradiol e2 progesterone icv orexin increased plasma lh levels untreated ovx rats orexin decreased plasma lh levels 16 one explanation bimodal action orexins lh release possible regulation orexin receptors estrogens interestingly recently detected sexually dimorphic expression peripheral orexin receptors higher mrna levels ox1 receptors pituitary ox2 receptors adrenal glands male rats compared female rats 20
0.27402496.12639903.html.plaintext.txt	12	clarify effect gonadal steroids orexin system analyzed mrna expression prepro orexin well ox1 ox2 receptors hypothalamus pituitary adrenal glands sham operated gonadectomized male female rats influence subsequent e2 treatment using quantitative real time pcr
0.27402496.12639903.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references animals treatments ovx sham operated female wistar rats 8 wk old well orchidectomized orx sham operated male rats 8 wk old purchased charles river sulzfeld germany operated facilities supplier rats kept controlled conditions 12 h dark 12 h light cycle free access standard diet water one week surgery rats anesthetized pentobarbital 40 mg kg 1 ip implanted sc 21 d release hormone pellets innovative research america sarasota fl sham operated rats received placebo plac pellets sham plac n 8 ovx female rats received either plac pellets ovx plac n 8 e2 pellets ovx e2 n 8 concentrations 01 mg e2pellet orx male rats received either plac pellets orx plac n 8 testosterone pellets orx n 8 concentrations 50 mg tpellet three weeks pellet implantation rats weighed killed decapitation trunk blood collected ice serum processed blood aliquoted stored 20 c assayed orexin e2 levels brains pituitaries adrenal glands isolated frozen immediately isopentane 30 c stored 80 c use hypothalami dissected according palkovits brownstein 24 animal protocols complied nih guide care use laboratory animals approved ministerium fur umwelt natur und forsten schleswig holstein germany animal protocol 9z01
0.27402496.12639903.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references animals treatments ovx sham operated female wistar rats 8 wk old well orchidectomized orx sham operated male rats 8 wk old purchased charles river sulzfeld germany operated facilities supplier rats kept controlled conditions 12 h dark 12 h light cycle free access standard diet water one week surgery rats anesthetized pentobarbital 40 mg kg 1 ip implanted sc 21 d release hormone pellets innovative research america sarasota fl sham operated rats received placebo plac pellets sham plac n 8 ovx female rats received either plac pellets ovx plac n 8 e2 pellets ovx e2 n 8 concentrations 01 mg e2pellet orx male rats received either plac pellets orx plac n 8 testosterone pellets orx n 8 concentrations 50 mg tpellet three weeks pellet implantation rats weighed killed decapitation trunk blood collected ice serum processed blood aliquoted stored 20 c assayed orexin e2 levels brains pituitaries adrenal glands isolated frozen immediately isopentane 30 c stored 80 c use hypothalami dissected according palkovits brownstein 24 animal protocols complied nih guide care use laboratory animals approved ministerium fur umwelt natur und forsten schleswig holstein germany animal protocol 9z01
0.27402496.12639903.html.plaintext.txt	15	rna isolation cdna synthesis total rna isolated tissue homogenates guanidinium isothiocyanate method purified using silica gel based spin columns rneasy kit qiagen gmbh hilden germany digestion genomic dna treatment deoxyribonuclease qiagen first strand cdna synthesized 1 microg total rna presence 5 mm mgcl2 10 mm tris hcl ph 90 50 mm kcl 01 triton x 100 1 mm deoxy ntps 1 u microl rnasin 05 microg oligo deoxythymidine15 primer 15 u avian myeloblastosis virus reverse transcriptase promega gmbh mannheim germany validate successful deoxyribonuclease treatment reverse transcriptase omitted control reactions absence pcr amplified dna fragments samples indicated isolation rna free genomic dna
0.27402496.12639903.html.plaintext.txt	16	rna isolation cdna synthesis total rna isolated tissue homogenates guanidinium isothiocyanate method purified using silica gel based spin columns rneasy kit qiagen gmbh hilden germany digestion genomic dna treatment deoxyribonuclease qiagen first strand cdna synthesized 1 microg total rna presence 5 mm mgcl2 10 mm tris hcl ph 90 50 mm kcl 01 triton x 100 1 mm deoxy ntps 1 u microl rnasin 05 microg oligo deoxythymidine15 primer 15 u avian myeloblastosis virus reverse transcriptase promega gmbh mannheim germany validate successful deoxyribonuclease treatment reverse transcriptase omitted control reactions absence pcr amplified dna fragments samples indicated isolation rna free genomic dna
0.27402496.12639903.html.plaintext.txt	17	quantitative real time pcr amplify prepro orexin ox1 ox2 receptor glyceraldehyde 3 phosphate dehydrogenase gapdh cdna sense antisense oligonucleotide primers designed based published cdna sequences 1 25 using primer3 software rozen h j skaletsky code available httpwww genomewimitedugenome softwareotherprimer3html oligonucleotides obtained invitrogen gmbh karlsruhe germany sequences primers follows 5 gcc gtc tct acg aac tgt tg 3 prepro orexin sense 5 cga gga gag ggg aaa gtt ag 3 prepro orexin antisense 5 ccc tca act cca gtc cta gc 3 ox1 sense 5 cag gga ggg cct ata att ga 3 ox1 antisense 5 caa tgt tgt tgg ggt gct ta 3 ox2 sense 5 tcc ccc tct cat aaa ctt gg 3 ox2 antisense 5 ctc cct caa gat tgt cag ca 3 gapdh sense 5 gtt cag ctc tgg gat gac ct 3 gapdh antisense
0.27402496.12639903.html.plaintext.txt	18	quantitative measurement prepro orexin ox1 ox2 receptor gapdh cdna performed kinetic pcr using sybr green fluorescent dye eurogentec sa seraing belgium described previously 20 sample analyzed triplicate geneamp 5700 sequence detection system pe applied biosystems weiterstadt germany along specific standards template controls monitor contaminating dna reaction consisted 100 ng cdna 03 microm primers 10 mm tris hcl 50 mm kcl 3 mm mgcl2 02 mm deoxy ntps 125 u hot goldstar dna polymerase eurogentec final volume 50 microl denaturation 95 c 10 min cdna products amplified 40 cycles cycle consisting denaturation 95 c 30 sec annealing extension 60 c 60 sec accumulating dna products monitored geneamp 5700 sequence detection system data stored continuously reaction product purity confirmed dissociation curve analysis agarose gel electrophoresis presence ethidium bromide identity amplified cdna fragments confirmed restriction analysis furthermore amplified prepro orexin ox1 ox2 receptor gapdh cdna fragments cloned using ta cloning kit invitrogen identities nucleotide sequences confirmed
0.27402496.12639903.html.plaintext.txt	19	quantitative measurement prepro orexin ox1 ox2 receptor gapdh cdna performed kinetic pcr using sybr green fluorescent dye eurogentec sa seraing belgium described previously 20 sample analyzed triplicate geneamp 5700 sequence detection system pe applied biosystems weiterstadt germany along specific standards template controls monitor contaminating dna reaction consisted 100 ng cdna 03 microm primers 10 mm tris hcl 50 mm kcl 3 mm mgcl2 02 mm deoxy ntps 125 u hot goldstar dna polymerase eurogentec final volume 50 microl denaturation 95 c 10 min cdna products amplified 40 cycles cycle consisting denaturation 95 c 30 sec annealing extension 60 c 60 sec accumulating dna products monitored geneamp 5700 sequence detection system data stored continuously reaction product purity confirmed dissociation curve analysis agarose gel electrophoresis presence ethidium bromide identity amplified cdna fragments confirmed restriction analysis furthermore amplified prepro orexin ox1 ox2 receptor gapdh cdna fragments cloned using ta cloning kit invitrogen identities nucleotide sequences confirmed
0.27402496.12639903.html.plaintext.txt	20	calculations initial mrna copy numbers sample made according cycle threshold ct method 26 dilutions known amounts cloned prepro orexin ox1 ox2 receptor cdna fragments used generate standard curves 20 ct sample calculated fluorescence threshold rn 03 using geneamp 5700 sequence detection system software automatic baseline setting detection limit gene interest 20 copies per 100 ng cdna copy numbers prepro orexin ox1 ox2 receptor mrna normalized using gapdh mrna levels differences observed treatment groups gapdh mrna levels
0.27402496.12639903.html.plaintext.txt	21	calculations initial mrna copy numbers sample made according cycle threshold ct method 26 dilutions known amounts cloned prepro orexin ox1 ox2 receptor cdna fragments used generate standard curves 20 ct sample calculated fluorescence threshold rn 03 using geneamp 5700 sequence detection system software automatic baseline setting detection limit gene interest 20 copies per 100 ng cdna copy numbers prepro orexin ox1 ox2 receptor mrna normalized using gapdh mrna levels differences observed treatment groups gapdh mrna levels
0.27402496.12639903.html.plaintext.txt	22	rias concentrations plasma e2 measured using 125i ria kits icn biomedicals inc eschwege germany two extractions 200 microl serum 1 ml ether evaporation sample reconstituted 100 microl ria buffer 25 microl samples assayed duplicate according manufacturer instructions intraassay interassay variations less 6 10 respectively
0.27402496.12639903.html.plaintext.txt	23	plasma orexin extracted adsorption phenyl silica isolute spe international sorbent technology mid glamorgan uk elution 60 acetonitrile 1 trifluoroacetic acid samples concentrated lyophilization orexin concentrations determined specific ria according manufacturer instructions peninsula laboratories inc belmont ca detection limit assay 3 pgtube based amount orexin produced least 10 tracer displacement samples analyzed within assay intraassay variability less 10
0.27402496.12639903.html.plaintext.txt	24	plasma orexin extracted adsorption phenyl silica isolute spe international sorbent technology mid glamorgan uk elution 60 acetonitrile 1 trifluoroacetic acid samples concentrated lyophilization orexin concentrations determined specific ria according manufacturer instructions peninsula laboratories inc belmont ca detection limit assay 3 pgtube based amount orexin produced least 10 tracer displacement samples analyzed within assay intraassay variability less 10
0.27402496.12639903.html.plaintext.txt	25	statistics data presented mean plus minus sem differences treatment groups estimated one way variance analysis anova followed bonferroni posttest using graphpad software inc san diego ca prism software p 005 indicated statistically significant differences
0.27402496.12639903.html.plaintext.txt	26	statistics data presented mean plus minus sem differences treatment groups estimated one way variance analysis anova followed bonferroni posttest using graphpad software inc san diego ca prism software p 005 indicated statistically significant differences
0.27402496.12639903.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references specific amplification prepro orexin ox1 ox2 receptor mrna hypothalamus pituitary adrenal axis real time pcr amplification cdna hypothalamus male female rats prepro orexin ox1 ox2 receptor specific primers resulted pcr products expected size fig 1 amplification products observed template controls h2o analyzed simultaneously assays indicating absence contaminating dna fig 1 restriction analysis amplified cdna fragments confirmed identity published cdna clones prepro orexin ox1 ox2 receptors fig 1 size restriction pattern amplified cdna ox1 ox2 receptors also confirmed pituitary adrenal glands shown amplification prepro orexin ox1 ox2 receptors hypothalamus pituitary adrenal gland achieved within exponential phase pcr fig 2 background fluorescence template control samples typically surpass rn value 03 less 35 cycles fig 2
0.27402496.12639903.html.plaintext.txt	28	view larger version 27k figure 1 amplification restriction analysis cdna fragments expected size 303 bp prepro orexin 260 bp ox1 receptor b 314 bp ox2 receptor c pvuii cuts prepro orexin cdna fragments 136 167 bp fragments alu cuts ox1 receptor cdna fragments four fragments 20 bp visible gel 51 bp 59 bp 130 bp b ox2 receptor cdna fragments two fragments size 89 bp 225 bp c treatment restriction enzyme m dna size marker indicated base pairs left
0.27402496.12639903.html.plaintext.txt	29	view larger version 27k figure 1 amplification restriction analysis cdna fragments expected size 303 bp prepro orexin 260 bp ox1 receptor b 314 bp ox2 receptor c pvuii cuts prepro orexin cdna fragments 136 167 bp fragments alu cuts ox1 receptor cdna fragments four fragments 20 bp visible gel 51 bp 59 bp 130 bp b ox2 receptor cdna fragments two fragments size 89 bp 225 bp c treatment restriction enzyme m dna size marker indicated base pairs left
0.27402496.12639903.html.plaintext.txt	30	view larger version 17k figure 2 amplification plots prepro orexin ox1 receptor mrna b ox2 receptor mrna c hypothalamus pituitary adrenal gland male rats n 8 fluorescence measured pcr every cycle using geneamp 5700 sequence detection system sample ct determined automatically rn 03 reached template controls h2o used estimate background amplification pituitary adrenal significant amounts prepro orexin mrna previously detected 20 real time pcr prepro orexin performed organs
0.27402496.12639903.html.plaintext.txt	31	view larger version 17k figure 2 amplification plots prepro orexin ox1 receptor mrna b ox2 receptor mrna c hypothalamus pituitary adrenal gland male rats n 8 fluorescence measured pcr every cycle using geneamp 5700 sequence detection system sample ct determined automatically rn 03 reached template controls h2o used estimate background amplification pituitary adrenal significant amounts prepro orexin mrna previously detected 20 real time pcr prepro orexin performed organs
0.27402496.12639903.html.plaintext.txt	32	expression prepro orexin mrna hypothalamus male female rats effect gonadectomy hormone treatment high mrna levels prepro orexin found hypothalamus female fig 3a male fig 3b rats quantitative real time pcr using ct method differences detected mrna levels hypothalamic prepro orexin sham operated control rats gonadectomized rats treated plac steroid treated female male rats fig 3
0.27402496.12639903.html.plaintext.txt	33	view larger version 18k figure 3 effects ovx e2 treatment orx treatment b hypothalamic prepro orexin mrna levels shown means plus minus sem n 8 sham sham operated rats
0.27402496.12639903.html.plaintext.txt	34	view larger version 18k figure 3 effects ovx e2 treatment orx treatment b hypothalamic prepro orexin mrna levels shown means plus minus sem n 8 sham sham operated rats
0.27402496.12639903.html.plaintext.txt	35	expression ox1 ox2 receptor mrna female rats effect ovariectomy e2 treatment high mrna levels ox1 ox2 receptors found hypothalamus female rats fig 4 pituitary gland sham operated female rats significant amounts ox1 receptor mrna present fig 4a whereas low mrna levels ox2 receptors detected fig 4b adrenal gland female rats found low mrna levels ox1 receptors high mrna levels ox2 receptors fig 4
0.27402496.12639903.html.plaintext.txt	36	view larger version 32k figure 4 effects ovx e2 treatment hypothalamic pituitary adrenal ox1 ox2 receptor mrna levels female rats shown means plus minus sem n 8 note different scales p 005 p 0001
0.27402496.12639903.html.plaintext.txt	37	view larger version 32k figure 4 effects ovx e2 treatment hypothalamic pituitary adrenal ox1 ox2 receptor mrna levels female rats shown means plus minus sem n 8 note different scales p 005 p 0001
0.27402496.12639903.html.plaintext.txt	38	hypothalamus female rats differences detected mrna levels ox1 ox2 receptors sham operated control rats ovx rats ovx rats treated e2 21 d fig 4 pituitary gland plac treated ovx rats ox1 receptor mrna levels significantly higher compared plac treated sham operated rats fig 4a treatment ovx rats e2 completely reversed ovx induced increase mrna levels pituitary ox1 receptors fig 4a control rats low amounts ox2 receptor mrna found pituitary glands plac e2 treated ovx rats fig 4b adrenal glands substantial differences mrna levels ox1 receptors treatment groups fig 4a however ox2 receptor mrna levels significantly higher plac treated ovx rats compared plac treated sham operated rats significantly reduced e2 treatment ovx rats fig 4b
0.27402496.12639903.html.plaintext.txt	39	expression ox1 ox2 receptor mrna male rats effect orx treatment ox1 ox2 receptor mrna detected high levels hypothalamus male rats fig 5 pituitary gland high mrna levels ox1 receptors low mrna levels ox2 receptors present male rats fig 5 contrast low levels adrenal ox1 receptor mrna fig 5a high mrna levels ox2 receptors detected adrenal gland male rats fig 5b
0.27402496.12639903.html.plaintext.txt	40	view larger version 31k figure 5 effects orx treatment hypothalamic pituitary adrenal ox1 ox2 receptor mrna levels male rats shown means plus minus sem n 8 note different scales p 005 p 0001
0.27402496.12639903.html.plaintext.txt	41	view larger version 31k figure 5 effects orx treatment hypothalamic pituitary adrenal ox1 ox2 receptor mrna levels male rats shown means plus minus sem n 8 note different scales p 005 p 0001
0.27402496.12639903.html.plaintext.txt	42	differences detected amounts ox1 ox2 receptor mrna hypothalamus male sham operated control rats orx rats orx rats treated 21 d fig 5 pituitary mrna levels ox1 receptors significantly regulated mrna levels adrenal ox2 receptors significantly regulated plac treated orx rats compared sham operated rats fig 5 effects orchidectomy pituitary adrenal glands reversed treatment orx rats fig 5 differences observed low amounts pituitary ox2 adrenal ox1 receptor mrna treatment groups male rats fig 5
0.27402496.12639903.html.plaintext.txt	43	effect gonadectomy hormone treatment plasma hormones body weight ovariectomy reduced subsequent treatment ovx rats e2 significantly increased plasma e2 levels table 1 plasma levels undetectable orchidectomy restored treatment table 2 differences plasma orexin levels observed sham operated ovx e2 treated female rats table 1 male rats showed slight significant reduction plasma orexin levels orx compared sham operated rats treatment orx rats restored plasma orexin levels table 2
0.27402496.12639903.html.plaintext.txt	44	effect gonadectomy hormone treatment plasma hormones body weight ovariectomy reduced subsequent treatment ovx rats e2 significantly increased plasma e2 levels table 1 plasma levels undetectable orchidectomy restored treatment table 2 differences plasma orexin levels observed sham operated ovx e2 treated female rats table 1 male rats showed slight significant reduction plasma orexin levels orx compared sham operated rats treatment orx rats restored plasma orexin levels table 2
0.27402496.12639903.html.plaintext.txt	45	view table table 1 plasma e2 concentrations plasma orexin concentrations body weights sham operated ovx female rats treated placebo e2
0.27402496.12639903.html.plaintext.txt	46	view table table 2 plasma concentrations plasma orexin concentrations body weights sham operated orx male rats treated placebo
0.27402496.12639903.html.plaintext.txt	47	body weight significantly increased female rats ovariectomy whereas treatment e2 21 d suppressed weight gain table 1 differences body weight observed male sham operated control rats orx rats orx rats treated 21 d table 2
0.27402496.12639903.html.plaintext.txt	48	body weight significantly increased female rats ovariectomy whereas treatment e2 21 d suppressed weight gain table 1 differences body weight observed male sham operated control rats orx rats orx rats treated 21 d table 2
0.27402496.12639903.html.plaintext.txt	49	discussion top abstract introduction materials methods results discussion references recently found profound differences mrna levels pituitary ox1 adrenal ox2 receptors male female rats 20 addition mrna expression hypothalamic prepro orexin higher female rats 27 present results confirm expression ox1 receptors pituitary ox2 receptors adrenal gland 20 28 29 30 31 furthermore show first time gonadal steroids affect mrna expression ox1 ox2 receptors pituitary adrenal glands regulation ovariectomy regulation e2 pituitary ox1 adrenal ox2 receptors female rats accordance much lower mrna levels receptors intact female rats compared male rats 20 addition regulated adrenal ox2 receptor mrna male rats whereas pituitary ox1 receptor mrna regulated thus lower pituitary ox1 receptor mrna levels female rats 20 may explained inhibitory actions e2 female rats adrenal inhibitory actions e2 female rats stimulatory actions male rats may contribute differences ox2 receptor mrna levels female male rats 20
0.27402496.12639903.html.plaintext.txt	50	discussion top abstract introduction materials methods results discussion references recently found profound differences mrna levels pituitary ox1 adrenal ox2 receptors male female rats 20 addition mrna expression hypothalamic prepro orexin higher female rats 27 present results confirm expression ox1 receptors pituitary ox2 receptors adrenal gland 20 28 29 30 31 furthermore show first time gonadal steroids affect mrna expression ox1 ox2 receptors pituitary adrenal glands regulation ovariectomy regulation e2 pituitary ox1 adrenal ox2 receptors female rats accordance much lower mrna levels receptors intact female rats compared male rats 20 addition regulated adrenal ox2 receptor mrna male rats whereas pituitary ox1 receptor mrna regulated thus lower pituitary ox1 receptor mrna levels female rats 20 may explained inhibitory actions e2 female rats adrenal inhibitory actions e2 female rats stimulatory actions male rats may contribute differences ox2 receptor mrna levels female male rats 20
0.27402496.12639903.html.plaintext.txt	51	addition effects energy homeostasis considerable evidence orexins regulate activity hypothalamo pituitary gonadal axis 16 22 32 33 34 icv injected orexins increased plasma lh concentrations ovarian steroid treated female rats whereas untreated ovx rats plasma lh reduced initially shown pu et al 16 bimodal response appears part mediated gnrh orexin stimulates gnrh release hypothalamic explants male proestrous female rats 21 22 addition orexin containing neurons project several hypothalamic nuclei including areas involved regulation gnrh orexin receptors present 3 4 35 36 however orexin receptors also present pituitary gland direct effect orexins assumed ovarian steroid treated rats stimulatory effect icv orexins pituitary lh release observed already low doses whereas high dose orexin necessary suppress release lh absence ovarian steroids 16 32 could possible orexins injected icv high doses reach pituitary gland diffusion portal circulation stimulate pituitary ox1 receptors regulated absence ovarian steroids shown results although significant effect orexin basal lh release dispersed pituitary cells orexin inhibited gnrh induced release lh isolated pituitary cells proestrous female rats 22 thus orexins may differentially regulate activity hypothalamo pituitary gonadal axis exerting contrary effects hypothalamus pituitary gland estrogen dependent bimodal actions orexins lh release female rats may caused regulation ox1 receptors low e2 levels receptor dependent regulation hormone release well established peptides angiotensin ii 37 38
0.27402496.12639903.html.plaintext.txt	52	addition effects energy homeostasis considerable evidence orexins regulate activity hypothalamo pituitary gonadal axis 16 22 32 33 34 icv injected orexins increased plasma lh concentrations ovarian steroid treated female rats whereas untreated ovx rats plasma lh reduced initially shown pu et al 16 bimodal response appears part mediated gnrh orexin stimulates gnrh release hypothalamic explants male proestrous female rats 21 22 addition orexin containing neurons project several hypothalamic nuclei including areas involved regulation gnrh orexin receptors present 3 4 35 36 however orexin receptors also present pituitary gland direct effect orexins assumed ovarian steroid treated rats stimulatory effect icv orexins pituitary lh release observed already low doses whereas high dose orexin necessary suppress release lh absence ovarian steroids 16 32 could possible orexins injected icv high doses reach pituitary gland diffusion portal circulation stimulate pituitary ox1 receptors regulated absence ovarian steroids shown results although significant effect orexin basal lh release dispersed pituitary cells orexin inhibited gnrh induced release lh isolated pituitary cells proestrous female rats 22 thus orexins may differentially regulate activity hypothalamo pituitary gonadal axis exerting contrary effects hypothalamus pituitary gland estrogen dependent bimodal actions orexins lh release female rats may caused regulation ox1 receptors low e2 levels receptor dependent regulation hormone release well established peptides angiotensin ii 37 38
0.27402496.12639903.html.plaintext.txt	53	addition effect gnrh induced lh release direct actions orexin pituitary gland possible although effects orexins basal acth observed male female rats samson taylor 23 reported inhibitory effect orexins crh stimulated acth release vitro finding supported localization orexin receptors human corticotrope pituitary cells 30 interestingly acth response stress depends gonadal steroids male female rats 39 40 role orexins responses remains unclear however findings strong regulation pituitary ox1 receptors e2 lesser degree imply far undefined hormonal regulation orexin actions pituitary gland male female rats
0.27402496.12639903.html.plaintext.txt	54	addition effect gnrh induced lh release direct actions orexin pituitary gland possible although effects orexins basal acth observed male female rats samson taylor 23 reported inhibitory effect orexins crh stimulated acth release vitro finding supported localization orexin receptors human corticotrope pituitary cells 30 interestingly acth response stress depends gonadal steroids male female rats 39 40 role orexins responses remains unclear however findings strong regulation pituitary ox1 receptors e2 lesser degree imply far undefined hormonal regulation orexin actions pituitary gland male female rats
0.27402496.12639903.html.plaintext.txt	55	adrenal gland found high mrna levels ox2 receptors accordance previous findings also showed much higher amounts ox2 receptor mrna male rats compared female rats 20 interestingly gonadal hormones differentially affected mrna levels adrenal ox2 receptors e2 reduced mrna levels ox2 receptors whereas increased mrna levels ox2 receptors therefore e2 female rats male rats may contribute observed sex differences adrenal ox2 receptor mrna expression inconsistent data exist regarding localization adrenal orexin receptors rats ox1 ox2 receptor like immunoreactivity found adrenal medulla cortex 28 contrast quantitative pcr showed much higher levels ox2 receptor mrna selectively localized adrenal cortex rat situ hybridization 20 results supported findings randeva et al 31 found ox2 receptors ox1 receptors selectively cortex human adrenals using rt pcr situ hybridization immunostaining others however described ox1 receptors cortex ox2 receptors medulla human adrenal 41 orexins stimulate adrenal glucocorticoid release rats humans 42 43 glucocorticoids play unique role energy homeostasis intriguing speculate male rats orexins may regulate glucose metabolism via regulation glucocorticoids interestingly found increased levels plasma orexin male rats contrast female rats plasma orexin levels unchanged e2 experiments needed clarify possible dependent functions adrenal orexin system
0.27402496.12639903.html.plaintext.txt	56	adrenal gland found high mrna levels ox2 receptors accordance previous findings also showed much higher amounts ox2 receptor mrna male rats compared female rats 20 interestingly gonadal hormones differentially affected mrna levels adrenal ox2 receptors e2 reduced mrna levels ox2 receptors whereas increased mrna levels ox2 receptors therefore e2 female rats male rats may contribute observed sex differences adrenal ox2 receptor mrna expression inconsistent data exist regarding localization adrenal orexin receptors rats ox1 ox2 receptor like immunoreactivity found adrenal medulla cortex 28 contrast quantitative pcr showed much higher levels ox2 receptor mrna selectively localized adrenal cortex rat situ hybridization 20 results supported findings randeva et al 31 found ox2 receptors ox1 receptors selectively cortex human adrenals using rt pcr situ hybridization immunostaining others however described ox1 receptors cortex ox2 receptors medulla human adrenal 41 orexins stimulate adrenal glucocorticoid release rats humans 42 43 glucocorticoids play unique role energy homeostasis intriguing speculate male rats orexins may regulate glucose metabolism via regulation glucocorticoids interestingly found increased levels plasma orexin male rats contrast female rats plasma orexin levels unchanged e2 experiments needed clarify possible dependent functions adrenal orexin system
0.27402496.12639903.html.plaintext.txt	57	thus far unclear whether rats adrenal ox2 receptors stimulated circulating orexins whether orexins locally produced adrenal gland described randeva et al 31 humans presence orexin plasma described rats humans circulating orexins may activate adrenal orexin receptors 20 44 although source plasma orexins currently uncertain orexin producing neurons project median eminence may therefore contribute plasma orexins 29
0.27402496.12639903.html.plaintext.txt	58	contrast lower mrna levels orexin receptors pituitary adrenal glands female rats compared male rats prepro orexin ox1 receptor mrna levels elevated hypothalamus female rats 20 27 present study could reveal changes hypothalamic prepro orexin orexin receptor mrna gonadectomy hormonal treatment male female rats results female rats accordance findings russell et al 22 showing effect estrogens hypothalamic prepro orexin mrna female rats addition male sheep e2 affect prepro orexin mrna levels 45 thus factors may responsible observed differences male female rats may concluded central hypothalamic expression prepro orexin orexin receptors control ovarian steroids however orexin receptor subtypes distinctively expressed hypothalamic nuclei 18 discrete changes orexin receptor mrna levels specific hypothalamic nuclei might detectable analyzing whole hypothalamic extracts using rt pcr cannot completely ruled results
0.27402496.12639903.html.plaintext.txt	59	contrast lower mrna levels orexin receptors pituitary adrenal glands female rats compared male rats prepro orexin ox1 receptor mrna levels elevated hypothalamus female rats 20 27 present study could reveal changes hypothalamic prepro orexin orexin receptor mrna gonadectomy hormonal treatment male female rats results female rats accordance findings russell et al 22 showing effect estrogens hypothalamic prepro orexin mrna female rats addition male sheep e2 affect prepro orexin mrna levels 45 thus factors may responsible observed differences male female rats may concluded central hypothalamic expression prepro orexin orexin receptors control ovarian steroids however orexin receptor subtypes distinctively expressed hypothalamic nuclei 18 discrete changes orexin receptor mrna levels specific hypothalamic nuclei might detectable analyzing whole hypothalamic extracts using rt pcr cannot completely ruled results
0.27402496.12639903.html.plaintext.txt	60	estrogens divergent effects food intake energy expenditure body weight plasma levels estrogens correlate positively whereas plasma levels correlate negatively body fat mass 46 findings weight gain ovariectomy accordance previous observations 47 reduced weight female rats e2 replacement may attributed somewhat higher plasma e2 levels e2 treated female rats comparison sham operated female rats 47 studies bernardis et al 48 showed ovx could influence body weight independently food intake separately central mechanisms study regulation orexin receptors gonadal steroids appears limited peripheral organs thus peripheral orexin system particularly adrenal ox2 receptors may contribute sex specific regulations energy homeostasis
0.27402496.12639903.html.plaintext.txt	61	estrogens divergent effects food intake energy expenditure body weight plasma levels estrogens correlate positively whereas plasma levels correlate negatively body fat mass 46 findings weight gain ovariectomy accordance previous observations 47 reduced weight female rats e2 replacement may attributed somewhat higher plasma e2 levels e2 treated female rats comparison sham operated female rats 47 studies bernardis et al 48 showed ovx could influence body weight independently food intake separately central mechanisms study regulation orexin receptors gonadal steroids appears limited peripheral organs thus peripheral orexin system particularly adrenal ox2 receptors may contribute sex specific regulations energy homeostasis
0.27402496.12639903.html.plaintext.txt	62	summary results show e2 differentially regulate mrna expression pituitary ox1 adrenal ox2 receptors female male rats thus addition ability orexins regulate reproductive system sex steroids may affect actions orexins like peptides regulating energy homeostasis reproductive functions 49 orexins may play important role coordinating systems may also sex dependently influence orexin related functions like autonomic system sleeping behavior
0.27402496.12639903.html.plaintext.txt	63	summary results show e2 differentially regulate mrna expression pituitary ox1 adrenal ox2 receptors female male rats thus addition ability orexins regulate reproductive system sex steroids may affect actions orexins like peptides regulating energy homeostasis reproductive functions 49 orexins may play important role coordinating systems may also sex dependently influence orexin related functions like autonomic system sleeping behavior
0.27402496.12639903.html.plaintext.txt	64	acknowledgments authors wish thank c eichholz real time pcr assistance g vierke ria assistance
0.27402496.12639903.html.plaintext.txt	65	acknowledgments authors wish thank c eichholz real time pcr assistance g vierke ria assistance
0.27402496.12639903.html.plaintext.txt	66	footnotes abbreviations ct cycle threshold e2 17ss estradiol gapdh glyceraldehyde 3 phosphate dehydrogenase icv intracerebroventricular orx orchidectomized ovx ovariectomized ox1 orexin type 1 ox2 orexin type 2 plac placebo rn fluorescence threshold testosterone
0.27402496.12639903.html.plaintext.txt	67	accepted publication december 18 2002
0.27402496.12639903.html.plaintext.txt	68	references top abstract introduction materials methods results discussion references sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text van den pol 1999 hypothalamic hypocretin orexin robust innervation spinal cord j neurosci 193171 3182abstractfree full text harrison ta chen ct dun nj chang jk 1999 hypothalamic orexin immunoreactive neurons project rat dorsal medulla neurosci lett 27317 20crossrefmedline cutler dj morris r sheridhar v wattam ta holmes patel arch jr wilson buckingham re evans ml leslie ra williams g 1999 differential distribution orexin orexin b immunoreactivity rat brain spinal cord peptides 201455 1470crossrefmedline samson wk gosnell b chang jk resch zt murphy tc 1999 cardiovascular regulatory actions hypocretins brain brain res 831248 253crossrefmedline shirasaka nakazato m matsukura takasaki m kannan h 1999 sympathetic cardiovascular actions orexins conscious rats j physiol 277r1780 r1785 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376medline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451medline peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e 2000 mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6991 997crossrefmedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n 1999 orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 9610911 10916abstractfree full text ida nakahara k murakami hanada r nakazato m murakami n 2000 possible involvement orexin stress reaction rats biochem biophys res commun 270318 323crossrefmedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h 2000 centrally administered orexinhypocretin activates hpa axis rats neuroreport 111977 1980medline pu jain mr kalra ps kalra sp 1998 orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78133 136crossrefmedline trivedi p yu h macneil dj van der ploeg lh guan xm 1998 distribution orexin receptor mrna rat brain febs lett 43871 75crossrefmedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk 2001 differential expression orexin receptors 1 2 rat brain j comp neurol 4356 25crossrefmedline nambu sakurai mizukami k hosoya y yanagisawa m goto k 1999 distribution orexin neurons adult rat brain brain res 827243 260crossrefmedline johren o neidert sj kummer m dendorfer dominiak p 2001 prepro orexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 1423324 3331abstractfree full text russell sh kim ms small cj abbott cr morgan dg taheri murphy kg todd jf ghatei ma bloom sr 2000 central administration orexin suppresses basal domperidone stimulated plasma prolactin j neuroendocrinol 121213 1218crossrefmedline russell sh small cj kennedy ar stanley sa seth murphy kg taheri ghatei ma bloom sr 2001 orexin interactions hypothalamo pituitary gonadal axis endocrinology 1425294 5302abstractfree full text samson wk taylor mm 2001 hypocretinorexin suppresses corticotroph responsiveness vitro j physiol regul integr comp physiol 281r1140 r1145 palkovits m brownstein mj 1988 maps guide microdissection rat brain new york elsevier tso jy sun xh kao th reece ks wu r 1985 isolation characterization rat human glyceraldehyde 3 phosphate dehydrogenase cdnas genomic complexity molecular evolution gene nucleic acids res 132485 2502abstract higuchi r fockler c dollinger g watson r 1993 kinetic pcr analysis real time monitoring dna amplification reactions biotechnology 111026 1030medline johren o neidert sj kummer m dominiak p 2002 sexually dimorphic expression prepro orexin mrna rat hypothalamus peptides 231177 1180crossrefmedline lopez m senaris r gallego r garcia caballero lago f seoane l casanueva f dieguez c 1999 orexin receptors expressed adrenal medulla rat endocrinology 1405991 5994abstractfree full text date y mondal ms matsukura ueta y yamashita h kaiya h kangawa k nakazato m 2000 distribution orexinhypocretin rat median eminence pituitary brain res mol brain res 761 6medline blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casanueva f dieguez c beiras 2001 cellular localization orexin receptors human pituitary j clin endocrinol metab 861616 1619abstractfree full text randeva hs karteris e grammatopoulos d hillhouse ew 2001 expression orexin functional orexin type 2 receptors human adult adrenals implications adrenal function energy homeostasis j clin endocrinol metab 864808 4813abstractfree full text tamura irahara m tezuka m kiyokawa m aono 1999 orexins orexigenic hypothalamic neuropeptides suppress pulsatile secretion luteinizing hormone ovariectomized female rats biochem biophys res commun 264759 762crossrefmedline kohsaka watanobe h kakizaki y suda schioth hb 2001 significant participation orexin potent orexigenic peptide preovulatory luteinizing hormone prolactin surges rat brain res 898166 170crossrefmedline furuta m funabashi kimura f 2002 suppressive action orexin pulsatile luteinizing hormone secretion potentiated low dose estrogen ovariectomized rats neuroendocrinology 75151 157crossrefmedline van den pol gao xb obrietan k kilduff ts belousov ab 1998 presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text iqbal j pompolo sakurai clarke ij 2001 evidence orexin containing neurones provide direct input gonadotropin releasing hormone neurones ovine hypothalamus j neuroendocrinol 131033 1041crossrefmedline steele mk mccann sm negro vilar 1982 modulation dopamine estradiol central effects angiotensin ii anterior pituitary hormone release endocrinology 111722 729medline johren o sanvitto gl egidy g saavedra jm 1997 angiotensin ii at1a receptor mrna expression induced estrogen progesterone dopaminergic neurons female rat arcuate nucleus j neurosci 178283 8292abstractfree full text viau v meaney mj 1991 variations hypothalamic pituitary adrenal response stress estrous cycle rat endocrinology 1292503 2511abstract handa rj nunley km lorens sa louie jp mcgivern rf bollnow mr 1994 androgen regulation adrenocorticotropin corticosterone secretion male rat following novelty foot shock stressors physiol behav 55117 124crossrefmedline blanco m garcia caballero fraga m gallego r cuevas j forteza j beiras dieguez c 2002 cellular localization orexin receptors human adrenal gland adrenocortical adenomas pheochromocytomas regul pept 104161 165crossrefmedline malendowicz lk tortorella c nussdorfer gg 1999 orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylate cyclase dependent signaling cascade j steroid biochem mol biol 70185 188crossrefmedline mazzocchi g malendowicz lk gottardo l aragona f nussdorfer gg 2001 orexin stimulates cortisol secretion human adrenocortical cells activation adenylate cyclase dependent signaling cascade j clin endocrinol metab 86778 782abstractfree full text arihara z takahashi k murakami o totsune k sone m satoh f ito mouri 2001 immunoreactive orexin human plasma peptides 22139 142crossrefmedline archer za findlay pa rhind sm mercer jg adam cl 2002 orexin gene expression regulation photoperiod sheep hypothalamus regul pept 10441 45crossrefmedline mystkowski p schwartz mw 2000 gonadal steroids energy homeostasis leptin era nutrition 16937 946crossrefmedline wade gn 1975 effects ovarian hormones food intake body weight female rats j comp physiol psychol 88183 193medline bernardis ll bellinger ll goldman jk mackenzie r 1981 dorsomedial hypothalamic lesions weaning ovariectomy maturity somatic metabolic changes physiol behav 2691 98crossrefmedline kalra sp kalra ps 1996 nutritional infertility role interconnected hypothalamic neuropeptide y galanin opioid network front neuroendocrinol 17371 401crossrefmedline
0.27402496.12639903.html.plaintext.txt	69	references top abstract introduction materials methods results discussion references sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts 1998 neurons containing hypocretin orexin project multiple neuronal systems j neurosci 189996 10015abstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text van den pol 1999 hypothalamic hypocretin orexin robust innervation spinal cord j neurosci 193171 3182abstractfree full text harrison ta chen ct dun nj chang jk 1999 hypothalamic orexin immunoreactive neurons project rat dorsal medulla neurosci lett 27317 20crossrefmedline cutler dj morris r sheridhar v wattam ta holmes patel arch jr wilson buckingham re evans ml leslie ra williams g 1999 differential distribution orexin orexin b immunoreactivity rat brain spinal cord peptides 201455 1470crossrefmedline samson wk gosnell b chang jk resch zt murphy tc 1999 cardiovascular regulatory actions hypocretins brain brain res 831248 253crossrefmedline shirasaka nakazato m matsukura takasaki m kannan h 1999 sympathetic cardiovascular actions orexins conscious rats j physiol 277r1780 r1785 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376medline chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451medline peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e 2000 mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6991 997crossrefmedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n 1999 orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 9610911 10916abstractfree full text ida nakahara k murakami hanada r nakazato m murakami n 2000 possible involvement orexin stress reaction rats biochem biophys res commun 270318 323crossrefmedline kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h 2000 centrally administered orexinhypocretin activates hpa axis rats neuroreport 111977 1980medline pu jain mr kalra ps kalra sp 1998 orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78133 136crossrefmedline trivedi p yu h macneil dj van der ploeg lh guan xm 1998 distribution orexin receptor mrna rat brain febs lett 43871 75crossrefmedline marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk 2001 differential expression orexin receptors 1 2 rat brain j comp neurol 4356 25crossrefmedline nambu sakurai mizukami k hosoya y yanagisawa m goto k 1999 distribution orexin neurons adult rat brain brain res 827243 260crossrefmedline johren o neidert sj kummer m dendorfer dominiak p 2001 prepro orexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 1423324 3331abstractfree full text russell sh kim ms small cj abbott cr morgan dg taheri murphy kg todd jf ghatei ma bloom sr 2000 central administration orexin suppresses basal domperidone stimulated plasma prolactin j neuroendocrinol 121213 1218crossrefmedline russell sh small cj kennedy ar stanley sa seth murphy kg taheri ghatei ma bloom sr 2001 orexin interactions hypothalamo pituitary gonadal axis endocrinology 1425294 5302abstractfree full text samson wk taylor mm 2001 hypocretinorexin suppresses corticotroph responsiveness vitro j physiol regul integr comp physiol 281r1140 r1145 palkovits m brownstein mj 1988 maps guide microdissection rat brain new york elsevier tso jy sun xh kao th reece ks wu r 1985 isolation characterization rat human glyceraldehyde 3 phosphate dehydrogenase cdnas genomic complexity molecular evolution gene nucleic acids res 132485 2502abstract higuchi r fockler c dollinger g watson r 1993 kinetic pcr analysis real time monitoring dna amplification reactions biotechnology 111026 1030medline johren o neidert sj kummer m dominiak p 2002 sexually dimorphic expression prepro orexin mrna rat hypothalamus peptides 231177 1180crossrefmedline lopez m senaris r gallego r garcia caballero lago f seoane l casanueva f dieguez c 1999 orexin receptors expressed adrenal medulla rat endocrinology 1405991 5994abstractfree full text date y mondal ms matsukura ueta y yamashita h kaiya h kangawa k nakazato m 2000 distribution orexinhypocretin rat median eminence pituitary brain res mol brain res 761 6medline blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casanueva f dieguez c beiras 2001 cellular localization orexin receptors human pituitary j clin endocrinol metab 861616 1619abstractfree full text randeva hs karteris e grammatopoulos d hillhouse ew 2001 expression orexin functional orexin type 2 receptors human adult adrenals implications adrenal function energy homeostasis j clin endocrinol metab 864808 4813abstractfree full text tamura irahara m tezuka m kiyokawa m aono 1999 orexins orexigenic hypothalamic neuropeptides suppress pulsatile secretion luteinizing hormone ovariectomized female rats biochem biophys res commun 264759 762crossrefmedline kohsaka watanobe h kakizaki y suda schioth hb 2001 significant participation orexin potent orexigenic peptide preovulatory luteinizing hormone prolactin surges rat brain res 898166 170crossrefmedline furuta m funabashi kimura f 2002 suppressive action orexin pulsatile luteinizing hormone secretion potentiated low dose estrogen ovariectomized rats neuroendocrinology 75151 157crossrefmedline van den pol gao xb obrietan k kilduff ts belousov ab 1998 presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text iqbal j pompolo sakurai clarke ij 2001 evidence orexin containing neurones provide direct input gonadotropin releasing hormone neurones ovine hypothalamus j neuroendocrinol 131033 1041crossrefmedline steele mk mccann sm negro vilar 1982 modulation dopamine estradiol central effects angiotensin ii anterior pituitary hormone release endocrinology 111722 729medline johren o sanvitto gl egidy g saavedra jm 1997 angiotensin ii at1a receptor mrna expression induced estrogen progesterone dopaminergic neurons female rat arcuate nucleus j neurosci 178283 8292abstractfree full text viau v meaney mj 1991 variations hypothalamic pituitary adrenal response stress estrous cycle rat endocrinology 1292503 2511abstract handa rj nunley km lorens sa louie jp mcgivern rf bollnow mr 1994 androgen regulation adrenocorticotropin corticosterone secretion male rat following novelty foot shock stressors physiol behav 55117 124crossrefmedline blanco m garcia caballero fraga m gallego r cuevas j forteza j beiras dieguez c 2002 cellular localization orexin receptors human adrenal gland adrenocortical adenomas pheochromocytomas regul pept 104161 165crossrefmedline malendowicz lk tortorella c nussdorfer gg 1999 orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylate cyclase dependent signaling cascade j steroid biochem mol biol 70185 188crossrefmedline mazzocchi g malendowicz lk gottardo l aragona f nussdorfer gg 2001 orexin stimulates cortisol secretion human adrenocortical cells activation adenylate cyclase dependent signaling cascade j clin endocrinol metab 86778 782abstractfree full text arihara z takahashi k murakami o totsune k sone m satoh f ito mouri 2001 immunoreactive orexin human plasma peptides 22139 142crossrefmedline archer za findlay pa rhind sm mercer jg adam cl 2002 orexin gene expression regulation photoperiod sheep hypothalamus regul pept 10441 45crossrefmedline mystkowski p schwartz mw 2000 gonadal steroids energy homeostasis leptin era nutrition 16937 946crossrefmedline wade gn 1975 effects ovarian hormones food intake body weight female rats j comp physiol psychol 88183 193medline bernardis ll bellinger ll goldman jk mackenzie r 1981 dorsomedial hypothalamic lesions weaning ovariectomy maturity somatic metabolic changes physiol behav 2691 98crossrefmedline kalra sp kalra ps 1996 nutritional infertility role interconnected hypothalamic neuropeptide y galanin opioid network front neuroendocrinol 17371 401crossrefmedline
0.30595517.15525658.html.plaintext.txt	0	orexin loss huntingtons disease asa petersen1 joana gil1 marion lc maat schieman2 maria bjorkqvist3 heikki tanila4 ines m arauacutejo5 ruben smith1 natalija popovic1 nils wierup6 per norlen7 jia yi li1 raymund ac roos2 frank sundler6 hindrik mulder3 patrik brundin1
0.30595517.15525658.html.plaintext.txt	1	1department physiological sciences section neuronal survival bmc a10 22184 lund sweden 2department neurology lumc leiden netherlands 3department cell molecular biology lund sweden 4department neuroscience neurology university kuopiodepartment neurology kuopio university hospital finland 5center neuroscience cell biology department zoology coimbra portugal 6department physiological sciences section neuroendocrine cell biology lund sweden 7department experimental clinical pharmacology institute laboratory medicine lund university hospital lund sweden
0.30595517.15525658.html.plaintext.txt	2	correspondence addressed tel 46 462220525 fax 46 462220531 email asapetersenatmphyluse
0.30595517.15525658.html.plaintext.txt	3	correspondence addressed tel 46 462220525 fax 46 462220531 email asapetersenatmphyluse
0.30595517.15525658.html.plaintext.txt	4	received september 26 2004 accepted october 22 2004
0.30595517.15525658.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods supplementary material references huntingtons disease hd devastating neurodegenerative disorder caused expanded cag repeat gene encoding huntingtin protein unknown function mutant huntingtin forms intracellular aggregates associated neuronal death select brain regions studied mouse model r62 hd replicates many features disease reported exhibit little neuronal death describe first time dramatic atrophy loss orexin neurons lateral hypothalamus r62 mice importantly also found significant atrophy loss orexin neurons huntington patients like animal models patients impaired orexin function r62 mice narcoleptic number orexin neurons lateral hypothalamus levels orexin cerebrospinal fluid reduced 72 end stage r62 mice compared wild type littermates suggesting orexin could used biomarker reflecting neurodegeneration results show loss orexin novel potentially important pathology hd
0.30595517.15525658.html.plaintext.txt	6	abstract top abstract introduction results discussion materials methods supplementary material references huntingtons disease hd devastating neurodegenerative disorder caused expanded cag repeat gene encoding huntingtin protein unknown function mutant huntingtin forms intracellular aggregates associated neuronal death select brain regions studied mouse model r62 hd replicates many features disease reported exhibit little neuronal death describe first time dramatic atrophy loss orexin neurons lateral hypothalamus r62 mice importantly also found significant atrophy loss orexin neurons huntington patients like animal models patients impaired orexin function r62 mice narcoleptic number orexin neurons lateral hypothalamus levels orexin cerebrospinal fluid reduced 72 end stage r62 mice compared wild type littermates suggesting orexin could used biomarker reflecting neurodegeneration results show loss orexin novel potentially important pathology hd
0.30595517.15525658.html.plaintext.txt	7	introduction top abstract introduction results discussion materials methods supplementary material references huntingtons disease hd hereditary neurodegenerative disorder characterized personality changes motor disturbances cognitive decline weight loss 1 caused cag triplet repeat expansion gene encoding huntingtin 2 protein unclear function albeit essential cell survival development 3 adult life 4 descriptions neuropathology emphasize neurodegeneration neostriatum cerebral cortex appearance intraneuronal aggregates misfolded huntingtin 56 addition significant neuronal death also described tuber nucleus lateral hypothalamus 78
0.30595517.15525658.html.plaintext.txt	8	introduction top abstract introduction results discussion materials methods supplementary material references huntingtons disease hd hereditary neurodegenerative disorder characterized personality changes motor disturbances cognitive decline weight loss 1 caused cag triplet repeat expansion gene encoding huntingtin 2 protein unclear function albeit essential cell survival development 3 adult life 4 descriptions neuropathology emphasize neurodegeneration neostriatum cerebral cortex appearance intraneuronal aggregates misfolded huntingtin 56 addition significant neuronal death also described tuber nucleus lateral hypothalamus 78
0.30595517.15525658.html.plaintext.txt	9	studied animal model hd r62 mouse expresses exon 1 human mutant hd gene 150 cag repeats 9 advanced stages mice display several clinical features reminiscent hd include impaired motor coordination tremor changes open field behavior progressive weight loss increased incidence epileptic seizures 10 unclear reasons die prematurely age 12 15 weeks brains exhibit high frequency intraneuronal nuclear inclusions polyglutamine containing protein far relatively little cell death scattered neurons undergoing dark degeneration described 1112
0.30595517.15525658.html.plaintext.txt	10	studied animal model hd r62 mouse expresses exon 1 human mutant hd gene 150 cag repeats 9 advanced stages mice display several clinical features reminiscent hd include impaired motor coordination tremor changes open field behavior progressive weight loss increased incidence epileptic seizures 10 unclear reasons die prematurely age 12 15 weeks brains exhibit high frequency intraneuronal nuclear inclusions polyglutamine containing protein far relatively little cell death scattered neurons undergoing dark degeneration described 1112
0.30595517.15525658.html.plaintext.txt	11	neuropathological studies end stage hd patients demonstrated 90 neuronal loss tuber nucleus lateral hypothalamus 78 humans region particularly enriched nmda receptors 13 implicates involvement excitotoxic cell death repeatedly suggested play role pathogenesis hd brain regions 114 interestingly recent study showed slice cultures rat lateral hypothalamus neurons containing peptide orexin also known hypocretin particularly susceptible excitotoxic damage 15 orexin b synthesized precursor gene expressed neurons cell bodies concentrated lateral hypothalamus 1617 neurons project widely throughout central nervous system particular dense projections monoaminergic centers thought interact autonomic neuroendocrine arousal systems excitatory effects orexin reviewed 18 importantly studies mice null mutation gene orexin 19 one receptors 20 well transgenic mice targeted ablation orexin neurons 21 revealed severe disturbances sleep wakefulness similar narcoleptic symptoms humans 22 subsequent studies shown human narcolepsy patients reduced levels orexin cerebrospinal fluid csf 23 cases number orexin neurons lateral hypothalamus reduced 24 taken together findings strongly implicate orexin system sleep regulation
0.30595517.15525658.html.plaintext.txt	12	neuropathological studies end stage hd patients demonstrated 90 neuronal loss tuber nucleus lateral hypothalamus 78 humans region particularly enriched nmda receptors 13 implicates involvement excitotoxic cell death repeatedly suggested play role pathogenesis hd brain regions 114 interestingly recent study showed slice cultures rat lateral hypothalamus neurons containing peptide orexin also known hypocretin particularly susceptible excitotoxic damage 15 orexin b synthesized precursor gene expressed neurons cell bodies concentrated lateral hypothalamus 1617 neurons project widely throughout central nervous system particular dense projections monoaminergic centers thought interact autonomic neuroendocrine arousal systems excitatory effects orexin reviewed 18 importantly studies mice null mutation gene orexin 19 one receptors 20 well transgenic mice targeted ablation orexin neurons 21 revealed severe disturbances sleep wakefulness similar narcoleptic symptoms humans 22 subsequent studies shown human narcolepsy patients reduced levels orexin cerebrospinal fluid csf 23 cases number orexin neurons lateral hypothalamus reduced 24 taken together findings strongly implicate orexin system sleep regulation
0.30595517.15525658.html.plaintext.txt	13	describe first time progressive loss orexin neurons ultrastructural signs neurodegeneration lateral hypothalamus r62 mice importantly also observed significant reduction number orexin positive neurons well significant atrophy remaining orexin neurons lateral hypothalamus hd patients also report significant reduction orexin levels r62 mouse csf suggests measuring csf levels orexin hd patients could novel means assess disease progression potential effect novel therapies
0.30595517.15525658.html.plaintext.txt	14	describe first time progressive loss orexin neurons ultrastructural signs neurodegeneration lateral hypothalamus r62 mice importantly also observed significant reduction number orexin positive neurons well significant atrophy remaining orexin neurons lateral hypothalamus hd patients also report significant reduction orexin levels r62 mouse csf suggests measuring csf levels orexin hd patients could novel means assess disease progression potential effect novel therapies
0.30595517.15525658.html.plaintext.txt	15	results top abstract introduction results discussion materials methods supplementary material references orexin loss r62 mice quantified progressive reduction number orexin containing neurons lateral hypothalamus r62 compared wild type mice fig 1a e reduction apparent 35 weeks age progressed significantly time fig 1e remaining orexin neurons significantly atrophied r62 mice compared wild type assessed measuring cross sectional surface area cell bodies fig 1f 125 weeks age 7 neurons lateral hypothalamus orexin immunoreactive wild type mice compared 2 r62 mice confirm cell loss lateral hypothalamus reduced orexin surviving cells adjacent sections processed cresyl violet neun immunohistochemistry 125 weeks age found significant reduction number cresyl violet stained cells 4381 plus minus 345mm2 versus 5363 plus minus 193mm2 students test p 005 neun immunopositive neurons 3138 plus minus 167mm2 versus 3704 plus minus 143mm2 students test p 005 r62 mice compared wild type controls interestingly percentage cells lost lateral hypothalamus 125 week old r62 compared age matched wild type mice 15 cells immunopositive neuron specific marker neun 72 orexin neurons using transmission electron microscopy observed frequent ultrastructural signs neurodegeneration lateral hypothalamus r62 mice neurons displaying dark neuron degeneration fig 2 previously described brain regions r62 mice 11 gliosis apparent 125 weeks age r62 mice assessed hypothalamic sections processed glial fibrillary acidic protein gfap immunohistochemistry data shown
0.30595517.15525658.html.plaintext.txt	16	view larger version 104k figure 1 progressive loss atrophy orexin neurons r62 mice sections lateral hypothalamus processed orexin immunohistochemistry wild type c r62 b d mice 125 weeks age scale bar 200 microm 20 microm c progressive reduction density orexin immunopositive neurons e n4 9 per genotype per age two factor anova genotype p 00001 f 1449468 age p 00001 f 3444010 agexgenotype p 00001 f 3442812 cross sectional surface area somata orexin positive neurons f n4 per genotype r62 mice compared wild type littermates f two factor anova genotype p 00001 f 1242350 age p 00001 f 3241391 agexgenotype p001 f 324449 values represent mean plus minus sem
0.30595517.15525658.html.plaintext.txt	17	view larger version 104k figure 1 progressive loss atrophy orexin neurons r62 mice sections lateral hypothalamus processed orexin immunohistochemistry wild type c r62 b d mice 125 weeks age scale bar 200 microm 20 microm c progressive reduction density orexin immunopositive neurons e n4 9 per genotype per age two factor anova genotype p 00001 f 1449468 age p 00001 f 3444010 agexgenotype p 00001 f 3442812 cross sectional surface area somata orexin positive neurons f n4 per genotype r62 mice compared wild type littermates f two factor anova genotype p 00001 f 1242350 age p 00001 f 3241391 agexgenotype p001 f 324449 values represent mean plus minus sem
0.30595517.15525658.html.plaintext.txt	18	view larger version 127k figure 2 dark neuron degeneration r62 lateral hypothalamus transmission electron micrographs lateral hypothalamus 12 week old wild type mouse r62 mouse b showing examples dark degenerating nerve cell bodies r62 mouse scale bar 5 microm
0.30595517.15525658.html.plaintext.txt	19	view larger version 127k figure 2 dark neuron degeneration r62 lateral hypothalamus transmission electron micrographs lateral hypothalamus 12 week old wild type mouse r62 mouse b showing examples dark degenerating nerve cell bodies r62 mouse scale bar 5 microm
0.30595517.15525658.html.plaintext.txt	20	also studied frequency huntingtin inclusions orexin immunopositive neurons r62 mice 35 week old r62 mice none orexin neurons lateral hypothalamus contained em48 immunopositive inclusions whereas 75 weeks 50 plus minus 6 orexin positive neurons em48 positive average 775 plus minus 5 neun immunopositive neurons 125 week old r62 lateral hypothalamus displayed em48 immunoreactive inclusions whereas 57 plus minus 5 remaining orexin positive neurons contained inclusions students test p 005
0.30595517.15525658.html.plaintext.txt	21	using radioimmunoassay ria found significant reduction orexin b levels r62 compared wild type mice 125 weeks age hypothalamus remaining brain tissue students test p 005 table 1 latter result indicates projections orexin neurons throughout cns affected importantly found severe loss orexin immunoreactive fibers around third ventricle subcommisural organ region comprising pineal gland 25 125 week old r62 mice fig 3 also examined whether orexin levels measured mouse csf could used biomarker disease compartment readily monitored living patients indeed found marked reduction orexin csf 12 week old r62 mice 586 plus minus 174 pgml n4 compared wild type littermates 2078 plus minus 130 pgml n4 students test p00005
0.30595517.15525658.html.plaintext.txt	22	using radioimmunoassay ria found significant reduction orexin b levels r62 compared wild type mice 125 weeks age hypothalamus remaining brain tissue students test p 005 table 1 latter result indicates projections orexin neurons throughout cns affected importantly found severe loss orexin immunoreactive fibers around third ventricle subcommisural organ region comprising pineal gland 25 125 week old r62 mice fig 3 also examined whether orexin levels measured mouse csf could used biomarker disease compartment readily monitored living patients indeed found marked reduction orexin csf 12 week old r62 mice 586 plus minus 174 pgml n4 compared wild type littermates 2078 plus minus 130 pgml n4 students test p00005
0.30595517.15525658.html.plaintext.txt	23	view table figure 3 loss orexin fibers r62 pineal region photomicrographs pineal region around third ventricle 12 week old wild type mouse r62 b mouse showing loss orexin fibers r62 mouse scale bar 100 microm pc posterior commisure sco subcommisural organ 3v third ventricle
0.30595517.15525658.html.plaintext.txt	24	narcoleptic episodes r62 mice performed infrared video recordings mice different ages first 4 h dark cycle analyze whether orexin loss r62 mice would result appearance narcoleptic episodes 19 35 weeks age r62 mice indistinguishable wild type controls periods hyperactivity intense exploratory behavior intercalated prolonged periods rest normal sleeping fig 4a however 75 weeks age observed several periods brief behavioral arrest r62 mice 1 8 episodes per mouse group median6 n5 fig 4a episodes characterized sudden interruption purposeful motor activity associated change posture maintained throughout episode closely resembled narcoleptic episodes described orexin knockout mice 19 115 125 weeks episodes became even frequent 4 h observed 11 14 group median11 n3 10 14 episodes behavioral arrest per mouse group median13 n3 respectively fig 4a 125 weeks age episodes occurred first third hours dark phase duration varied 3 214 group average62 n3 example distribution episodes one r62 mouse illustrated fig 4b
0.30595517.15525658.html.plaintext.txt	25	view larger version 27k figure 4 characterization narcoleptic episodes r62 mice analyses narcoleptic episodes performed first 4 h dark phase active period mice total number narcoleptic episodes increases age r62 mice different mice used time point b duration narcoleptic episodes one 125 week old r62 mouse time occurred illustrated vertical lines c total number narcoleptic episodes per mouse divided three different categories 125 week old r62 mice n3 insert table shows mean duration different categories narcoleptic episodes d typical eegemg recording narcoleptic episode 125 week old r62 mouse showing reduced emg activity epileptic activity eeg arrows indicate beginning end narcoleptic episode contrast eegemg recording resting wild type mice display continued low level emg activity even mouse ambulatory arrow indicates beginning period
0.30595517.15525658.html.plaintext.txt	26	view larger version 27k figure 4 characterization narcoleptic episodes r62 mice analyses narcoleptic episodes performed first 4 h dark phase active period mice total number narcoleptic episodes increases age r62 mice different mice used time point b duration narcoleptic episodes one 125 week old r62 mouse time occurred illustrated vertical lines c total number narcoleptic episodes per mouse divided three different categories 125 week old r62 mice n3 insert table shows mean duration different categories narcoleptic episodes d typical eegemg recording narcoleptic episode 125 week old r62 mouse showing reduced emg activity epileptic activity eeg arrows indicate beginning end narcoleptic episode contrast eegemg recording resting wild type mice display continued low level emg activity even mouse ambulatory arrow indicates beginning period
0.30595517.15525658.html.plaintext.txt	27	analyze behavior end stage mice 125 weeks divided episodes behavioral arrest three different categories according severity 1 periods movement 2 periods movement abruptsudden change posture beginning episode 3 episodes involving loss muscular tone andor sudden collapse head neck occasionally causing mouse fall completely onto side r62 mice studied n3 showed episodes movement 5 9 episodes per mouse group median7 two animals also exhibited abrupt sudden changes posture interestingly three mice displayed interpreted narcoleptic episodes complete falls onto side 4 5 falls per mouse group median4 fig 4c episodes followed sudden bouts locomotion typically hyperactive compared wild type control mice example 125 week old r62 mouse displaying severe narcoleptic episode viewed online supplementary material also evaluated behavior 12 week old r62 mice daytime mice normally largely spend sleeping interestingly light phase diurnal cycle r62 mice generally spent less time sleeping wild type mice exhibited repeated sudden episodes behavioral arrest sometimes associated abrupt change posture episodes never seen wild type littermate controls data shown
0.30595517.15525658.html.plaintext.txt	28	analyze behavior end stage mice 125 weeks divided episodes behavioral arrest three different categories according severity 1 periods movement 2 periods movement abruptsudden change posture beginning episode 3 episodes involving loss muscular tone andor sudden collapse head neck occasionally causing mouse fall completely onto side r62 mice studied n3 showed episodes movement 5 9 episodes per mouse group median7 two animals also exhibited abrupt sudden changes posture interestingly three mice displayed interpreted narcoleptic episodes complete falls onto side 4 5 falls per mouse group median4 fig 4c episodes followed sudden bouts locomotion typically hyperactive compared wild type control mice example 125 week old r62 mouse displaying severe narcoleptic episode viewed online supplementary material also evaluated behavior 12 week old r62 mice daytime mice normally largely spend sleeping interestingly light phase diurnal cycle r62 mice generally spent less time sleeping wild type mice exhibited repeated sudden episodes behavioral arrest sometimes associated abrupt change posture episodes never seen wild type littermate controls data shown
0.30595517.15525658.html.plaintext.txt	29	r62 mice known seizure prone 9 subjected different group 125 week old r62 n4 wild type n2 mice eegemg recordings order confirm observed episodes behavioral arrest interpreted narcolepsy caused epileptiform brain activity mice videorecorded eegemg activities assessed episodes behavioral arrest scored video eeg recordings revealed epileptiform electrographic activity type episodes motor arrest rather eeg characterized small amplitude theta activity reduced emg signal neck muscles fig 4d contrast wild type mice occasionally paused movements emg activity decreased fig 4d
0.30595517.15525658.html.plaintext.txt	30	r62 mice known seizure prone 9 subjected different group 125 week old r62 n4 wild type n2 mice eegemg recordings order confirm observed episodes behavioral arrest interpreted narcolepsy caused epileptiform brain activity mice videorecorded eegemg activities assessed episodes behavioral arrest scored video eeg recordings revealed epileptiform electrographic activity type episodes motor arrest rather eeg characterized small amplitude theta activity reduced emg signal neck muscles fig 4d contrast wild type mice occasionally paused movements emg activity decreased fig 4d
0.30595517.15525658.html.plaintext.txt	31	orexin loss human hd brains ensure loss orexin containing neurons also relevant human hd examined lateral hypothalamus hd affected individuals average number orexin positive neurons per square millimeter section showing highest density orexin positive neurons subject given table 2 control brains healthy individuals average number orexin positive neurons per square millimeter estimated 62 plus minus 4 neurons corresponding areas brains hd affected individuals grade ii iv average number orexin positive neurons 45 plus minus 1mm2 students test p 0005 fig 5a b table 2 also significant neuronal atrophy detected reduction average cross sectional surface area orexin cell bodies hd patients 230 plus minus 33 microm2 compared controls 363 plus minus 8 microm2 students test p 005
0.30595517.15525658.html.plaintext.txt	32	orexin loss human hd brains ensure loss orexin containing neurons also relevant human hd examined lateral hypothalamus hd affected individuals average number orexin positive neurons per square millimeter section showing highest density orexin positive neurons subject given table 2 control brains healthy individuals average number orexin positive neurons per square millimeter estimated 62 plus minus 4 neurons corresponding areas brains hd affected individuals grade ii iv average number orexin positive neurons 45 plus minus 1mm2 students test p 0005 fig 5a b table 2 also significant neuronal atrophy detected reduction average cross sectional surface area orexin cell bodies hd patients 230 plus minus 33 microm2 compared controls 363 plus minus 8 microm2 students test p 005
0.30595517.15525658.html.plaintext.txt	33	view table figure 5 reduction orexin neurons hd patients representative photographs orexin immunopositive neurons lateral hypothalamus control individual hd patient b illustration shows atrophy individual neurons reduction orexin immunopositive neurons hd patient brain compared control brain scale bar 500 microm
0.30595517.15525658.html.plaintext.txt	34	discussion top abstract introduction results discussion materials methods supplementary material references hd neuronal death select brain regions transgenic hd mouse models provided insight possible disease mechanisms part reproduced extent specific patterns cell death occur hd also true r62 mouse reported exhibit minor cell loss neostriatum cerebral cortex 1112 besides loss retinal cells 26 paucity intracerebral neuronal death r62 mice suggests mouse model poor analogy hd patients consequently clinical relevance r62 mouse questioned nevertheless currently widely used mouse model hd research 20 published reports testing novel therapies model 27 first time demonstrate progressive neuronal loss brains r62 mice neuronal population located lateral hypothalamus contains orexin also found significant depletion orexin hypothalamic tissue samples cell bodies located parts brain receive orexin projections including pineal region importantly also significant loss atrophy orexin immunostained neurons lateral hypothalamus hd patients extending earlier reports loss unidentified neurons structure hd 7 small number hd brains examined study obvious correlation vonsattel grade loss orexin neurons vonsattel scale neuropathological changes based cell loss striatum 28 given degenerative changes hypothalamus follow similar time course whether hypothalamic cell death including orexin loss occurs early human disease whether correlated motor cognitive sleep weight loss symptoms remain studied
0.30595517.15525658.html.plaintext.txt	35	discussion top abstract introduction results discussion materials methods supplementary material references hd neuronal death select brain regions transgenic hd mouse models provided insight possible disease mechanisms part reproduced extent specific patterns cell death occur hd also true r62 mouse reported exhibit minor cell loss neostriatum cerebral cortex 1112 besides loss retinal cells 26 paucity intracerebral neuronal death r62 mice suggests mouse model poor analogy hd patients consequently clinical relevance r62 mouse questioned nevertheless currently widely used mouse model hd research 20 published reports testing novel therapies model 27 first time demonstrate progressive neuronal loss brains r62 mice neuronal population located lateral hypothalamus contains orexin also found significant depletion orexin hypothalamic tissue samples cell bodies located parts brain receive orexin projections including pineal region importantly also significant loss atrophy orexin immunostained neurons lateral hypothalamus hd patients extending earlier reports loss unidentified neurons structure hd 7 small number hd brains examined study obvious correlation vonsattel grade loss orexin neurons vonsattel scale neuropathological changes based cell loss striatum 28 given degenerative changes hypothalamus follow similar time course whether hypothalamic cell death including orexin loss occurs early human disease whether correlated motor cognitive sleep weight loss symptoms remain studied
0.30595517.15525658.html.plaintext.txt	36	connections narcoleptic like episodes loss orexin neurons lateral hypothalamus r62 mice deficits orexin neurotransmission known result behavior reminiscent narcolepsy mice dogs 19 2129 interestingly frequency duration general appearance narcoleptic episodes seen r62 mice similar observed genetically modified mice lacking orexin carrying mutant orexin receptors 19 21 furthermore correlation progressive loss orexin neurons gradual onset narcoleptic phenotype r62 mice taken together striking motor arrests r62 mice likely direct consequence observed loss orexin neurons
0.30595517.15525658.html.plaintext.txt	37	connections narcoleptic like episodes loss orexin neurons lateral hypothalamus r62 mice deficits orexin neurotransmission known result behavior reminiscent narcolepsy mice dogs 19 2129 interestingly frequency duration general appearance narcoleptic episodes seen r62 mice similar observed genetically modified mice lacking orexin carrying mutant orexin receptors 19 21 furthermore correlation progressive loss orexin neurons gradual onset narcoleptic phenotype r62 mice taken together striking motor arrests r62 mice likely direct consequence observed loss orexin neurons
0.30595517.15525658.html.plaintext.txt	38	loss hypothalamic orexin containing neurons hd r62 mouse model clearly sensitive expression expanded polyglutamine protein mouse rat models expressing ataxin 3 construct increased number cag repeats control orexin promoter exhibited adult onset degeneration hypothalamic orexin neurons 2130 possibly expanded polyglutamine stretches disturb functions crucial interacting proteins thus huntingtin associated protein 1 hap 1 partner huntingtin unknown function enriched hypothalamus null mutant mice hap 1 die early owing impaired feeding exhibit hypothalamic degeneration 31 study transgenic mouse model expressing first 171 amino acids huntingtin 82 glutamines n171 82q mice also showed hap 1 depletion degeneration neurons hypothalamus although transmitter identity dying neurons models established degenerative phenomena included lateral hypothalamus another explanation selective vulnerability hypothalamic orexin containing neurons may related expression nmda receptors recently shown exposure rat hypothalamic cultures excitotoxicity resulted specific loss orexin neurons 15 excitotoxicity widely regarded likely contributor cell death hd 114 evidence functional changes glutamatergic pathways r62 mice several levels release transmitter inactivation receptor composition intracellular signaling neurons receiving glutamatergic input 32 37 despite little cell death striatum r62 mice possibly striatal neurons gradually develop resistance damage due protracted low grade excitotoxic stress 38 resistance acute excitotoxic damage correlated number neurons exhibiting intranuclear inclusions r62 striatum 35 proportion generally lower lateral hypothalamus 57 study compared striatum 95 39
0.30595517.15525658.html.plaintext.txt	39	loss hypothalamic orexin containing neurons hd r62 mouse model clearly sensitive expression expanded polyglutamine protein mouse rat models expressing ataxin 3 construct increased number cag repeats control orexin promoter exhibited adult onset degeneration hypothalamic orexin neurons 2130 possibly expanded polyglutamine stretches disturb functions crucial interacting proteins thus huntingtin associated protein 1 hap 1 partner huntingtin unknown function enriched hypothalamus null mutant mice hap 1 die early owing impaired feeding exhibit hypothalamic degeneration 31 study transgenic mouse model expressing first 171 amino acids huntingtin 82 glutamines n171 82q mice also showed hap 1 depletion degeneration neurons hypothalamus although transmitter identity dying neurons models established degenerative phenomena included lateral hypothalamus another explanation selective vulnerability hypothalamic orexin containing neurons may related expression nmda receptors recently shown exposure rat hypothalamic cultures excitotoxicity resulted specific loss orexin neurons 15 excitotoxicity widely regarded likely contributor cell death hd 114 evidence functional changes glutamatergic pathways r62 mice several levels release transmitter inactivation receptor composition intracellular signaling neurons receiving glutamatergic input 32 37 despite little cell death striatum r62 mice possibly striatal neurons gradually develop resistance damage due protracted low grade excitotoxic stress 38 resistance acute excitotoxic damage correlated number neurons exhibiting intranuclear inclusions r62 striatum 35 proportion generally lower lateral hypothalamus 57 study compared striatum 95 39
0.30595517.15525658.html.plaintext.txt	40	implications findings characterization death orexin neurons may shed light cellular events leading neuronal death hd addition monitoring loss orexin containing neurons lateral hypothalamus may also important index measure therapeutic efficacy novel drugs r62 mice changes sleep behavior occurrence narcoleptic episodes constitute functional outcome parameter follow although studies showing hd patients actually suffer symptoms similar narcolepsy reported far sleep patterns disturbed 40 indeed hd patients abnormal sleepwake cycle r62 mice exhibit progressive disruption circadian rhythms caused dysregulation circadian rhythm genes suprachiasmatic nucleus hypothalamus j morton personal communication importantly found orexin fibers lost r62 pineal region involved regulating circadian rhythm via connections suprachiasmatic nucleus
0.30595517.15525658.html.plaintext.txt	41	implications findings characterization death orexin neurons may shed light cellular events leading neuronal death hd addition monitoring loss orexin containing neurons lateral hypothalamus may also important index measure therapeutic efficacy novel drugs r62 mice changes sleep behavior occurrence narcoleptic episodes constitute functional outcome parameter follow although studies showing hd patients actually suffer symptoms similar narcolepsy reported far sleep patterns disturbed 40 indeed hd patients abnormal sleepwake cycle r62 mice exhibit progressive disruption circadian rhythms caused dysregulation circadian rhythm genes suprachiasmatic nucleus hypothalamus j morton personal communication importantly found orexin fibers lost r62 pineal region involved regulating circadian rhythm via connections suprachiasmatic nucleus
0.30595517.15525658.html.plaintext.txt	42	hd state biomarkers available plasma csf measurements substances secreted sites neuropathology hypothalamus feasible identification affected neuronal subpopulation opens new possibilities identify marker end stage r62 mice number orexin neurons lateral hypothalamus levels orexin csf reduced 72 compared wild type littermates suggests orexin could used biomarker reflecting hypothalamic neurodegeneration considering substantial loss atrophy orexin also human condition hypothesize symptomatic hd patients reduced csf orexin levels levels considered diagnostic narcolepsy healthy individuals normal orexin values csf 200 pgml orexin levels 110 pgml diagnostic narcolepsy 41 one predict similar decrease hd patients study shows hd patients vonsattel grade ii iii around 43 cag repeats ie mild moderate cases completely lost 30 orexin neurons remaining 70 neurons undergone atrophy neuronal cross sectional area 40 representing even greater percentage loss volume cell taken together suggest reduction total cell volume atrophy cell death considered would lead reduction csf levels orexin diagnostic levels narcolepsy considering scenario csf orexin levels could constitute novel biomarker assess disease progression effectiveness therapeutic interventions hd currently biomarker lacking hd
0.30595517.15525658.html.plaintext.txt	43	hd state biomarkers available plasma csf measurements substances secreted sites neuropathology hypothalamus feasible identification affected neuronal subpopulation opens new possibilities identify marker end stage r62 mice number orexin neurons lateral hypothalamus levels orexin csf reduced 72 compared wild type littermates suggests orexin could used biomarker reflecting hypothalamic neurodegeneration considering substantial loss atrophy orexin also human condition hypothesize symptomatic hd patients reduced csf orexin levels levels considered diagnostic narcolepsy healthy individuals normal orexin values csf 200 pgml orexin levels 110 pgml diagnostic narcolepsy 41 one predict similar decrease hd patients study shows hd patients vonsattel grade ii iii around 43 cag repeats ie mild moderate cases completely lost 30 orexin neurons remaining 70 neurons undergone atrophy neuronal cross sectional area 40 representing even greater percentage loss volume cell taken together suggest reduction total cell volume atrophy cell death considered would lead reduction csf levels orexin diagnostic levels narcolepsy considering scenario csf orexin levels could constitute novel biomarker assess disease progression effectiveness therapeutic interventions hd currently biomarker lacking hd
0.30595517.15525658.html.plaintext.txt	44	materials methods top abstract introduction results discussion materials methods supplementary material references transgenic animals used transgenic hd mice r62 line wild type littermates jackson laboratories bar harbor usa obtained crossing transgenic males females background strain cbaxc57bl6 genotype assessed using polymerase chain reaction assay 9 mice housed groups ad libitum access food water 12 h lightdark cycle experimental procedures approved regional ethical committee lund sweden
0.30595517.15525658.html.plaintext.txt	45	materials methods top abstract introduction results discussion materials methods supplementary material references transgenic animals used transgenic hd mice r62 line wild type littermates jackson laboratories bar harbor usa obtained crossing transgenic males females background strain cbaxc57bl6 genotype assessed using polymerase chain reaction assay 9 mice housed groups ad libitum access food water 12 h lightdark cycle experimental procedures approved regional ethical committee lund sweden
0.30595517.15525658.html.plaintext.txt	46	human hd brains evaluated formalin fixed brains five hd patients age 69 plus minus 6 years four controls age 64 plus minus 10 years leiden university hospital brain bank table 2
0.30595517.15525658.html.plaintext.txt	47	immunohistochemistry r62 mice wild type littermates 35 75 115 125 weeks age perfused 4 paraformaldehyde coronal sections 30 microm cut six series throughout brains using microtome tissue wild typecontrols r62hd subjects processed parallel immunohistochemistry control staining intensity times processed free floating mouse sections primary antibodies following markers orexin diluted 1 700 mouse tissue phoenix pharm inc belmont ca usa neun diluted 1 1000 chemicon temecula ca usa gfap 1 700 dako nissl stain cresyl violet icn biomedicals inc aurora oh usa double labeling employed mouse anti em48 antibody 1 500 chemicon shown specific also mouse tissue 42 anti orexin antibody paraffin embedded human brain sections 15 microm immunohistochemically processed orexin 1 5000 human tissue phoenix pharm
0.30595517.15525658.html.plaintext.txt	48	cell measurements morphological analyses performed blind coded slides using olympus cast grid system olympus danmark albertslund denmark composed olympus bh2 microscope x y step motor run ibm personal computer density orexin neurons lateral hypothalamus assessed three sections largest number orexin immunopositive neurons per mouse ages n4 9 per genotype per age outer borders areas orexin immunopositive neurons first delineated area assessed olympus cast grid system using systematic random sampling technique number profiles assessed 25 areas technique used mice profiles characterized intense dark staining throughout cell body counted included independently size shape soma cells atrophied see results average density orexin positive neurons three sections mouse used statistical analysis cross sectional soma area orexin neurons assessed 30 randomly selected orexin immunopositive neurons three sections four mice per genotype age using olympus cast grid system areas total number cells neurons em48 positive neurons analyzed 125 week old mice presence em48 immunopositive inclusions orexin neurons analyzed 100 randomly selected orexin neurons three mentioned sections four mice per genotype ages 35 75 125 weeks human brains compared sections containing orexin positive cells individual selected section estimated show highest density orexin positive cells section orexin positive cells counted four different fields delineated 1 mm2 ocular grid measured cross sectional soma area orexin cell bodies 20 orexin positive neuronsindividual using olympus cast grid system
0.30595517.15525658.html.plaintext.txt	49	cell measurements morphological analyses performed blind coded slides using olympus cast grid system olympus danmark albertslund denmark composed olympus bh2 microscope x y step motor run ibm personal computer density orexin neurons lateral hypothalamus assessed three sections largest number orexin immunopositive neurons per mouse ages n4 9 per genotype per age outer borders areas orexin immunopositive neurons first delineated area assessed olympus cast grid system using systematic random sampling technique number profiles assessed 25 areas technique used mice profiles characterized intense dark staining throughout cell body counted included independently size shape soma cells atrophied see results average density orexin positive neurons three sections mouse used statistical analysis cross sectional soma area orexin neurons assessed 30 randomly selected orexin immunopositive neurons three sections four mice per genotype age using olympus cast grid system areas total number cells neurons em48 positive neurons analyzed 125 week old mice presence em48 immunopositive inclusions orexin neurons analyzed 100 randomly selected orexin neurons three mentioned sections four mice per genotype ages 35 75 125 weeks human brains compared sections containing orexin positive cells individual selected section estimated show highest density orexin positive cells section orexin positive cells counted four different fields delineated 1 mm2 ocular grid measured cross sectional soma area orexin cell bodies 20 orexin positive neuronsindividual using olympus cast grid system
0.30595517.15525658.html.plaintext.txt	50	radioimmunoassay hypothalami dissected 125 week old mice n7 per genotype csf withdrawn cisterna magna 12 week old mice n4 per genotype used peptide extraction using commercially available 125i ria kits phoenix pharm orexin csf brain tissue orexin b brain tissue measured duplicate samples assayed levels determined known standard
0.30595517.15525658.html.plaintext.txt	51	radioimmunoassay hypothalami dissected 125 week old mice n7 per genotype csf withdrawn cisterna magna 12 week old mice n4 per genotype used peptide extraction using commercially available 125i ria kits phoenix pharm orexin csf brain tissue orexin b brain tissue measured duplicate samples assayed levels determined known standard
0.30595517.15525658.html.plaintext.txt	52	electron microscopy mice 12 weeks age n2 per genotype perfused 0075 m sorensen buffer containing 3 parafomaldehyde 1 glutaraldehyde hypothalami dissected fixed overnight fixative rinsed sorensen buffer post fixed 1 h 1 oso4 buffer dehydrated acetone embedded polybed 812 ultrathin sections cut placed copper grids contrasted 05 lead citrate 4 uranyl acetate specimens examined philips cm10 transmission electron microscope
0.30595517.15525658.html.plaintext.txt	53	electron microscopy mice 12 weeks age n2 per genotype perfused 0075 m sorensen buffer containing 3 parafomaldehyde 1 glutaraldehyde hypothalami dissected fixed overnight fixative rinsed sorensen buffer post fixed 1 h 1 oso4 buffer dehydrated acetone embedded polybed 812 ultrathin sections cut placed copper grids contrasted 05 lead citrate 4 uranyl acetate specimens examined philips cm10 transmission electron microscope
0.30595517.15525658.html.plaintext.txt	54	scoring narcoleptic episodes videorecorded scored narcoleptic episodes 19 r62 wild type mice following ages 35 n5 75 n5 115 n3 125 n3 different mice used age briefly mice habituated 3 h individual glass cylinders covered bedding material recorded first 4 h dark cycle sony ccd infrared videocamera behavioral experiment one r62 mouse one wild type mouse videorecorded simultaneously scoring episodes carried two investigators blinded mouse genotype protocol used evaluate behavior 12 week old r62 mice n4 light phase diurnal cycle
0.30595517.15525658.html.plaintext.txt	55	eegemg recordings 10 weeks age mice n4 r62 n2 wild type implanted recording electrodes one cortical screw electrode attached right parietal bone record eeg wire electrode insulated copper 250 microm diameter tip exposed 15 mm belden st louis mi usa attached occipital bone neck muscles record emg electrodes referred ground frontal screw electrode two additional anchor screws attached onto left parietal frontal bones three way connector plastic one roanoke va usa fixed screws dental acrylic cement 12 15 days following electrode implantation pairs mice wild type r62 videotaped eegemg recorded continuously chart 363 powerlabmaclab adinstruments arhus denmark first 4 h dark cycle videotapes scored narcoleptic episodes eeg parameters analyzed chart 363 software
0.30595517.15525658.html.plaintext.txt	56	eegemg recordings 10 weeks age mice n4 r62 n2 wild type implanted recording electrodes one cortical screw electrode attached right parietal bone record eeg wire electrode insulated copper 250 microm diameter tip exposed 15 mm belden st louis mi usa attached occipital bone neck muscles record emg electrodes referred ground frontal screw electrode two additional anchor screws attached onto left parietal frontal bones three way connector plastic one roanoke va usa fixed screws dental acrylic cement 12 15 days following electrode implantation pairs mice wild type r62 videotaped eegemg recorded continuously chart 363 powerlabmaclab adinstruments arhus denmark first 4 h dark cycle videotapes scored narcoleptic episodes eeg parameters analyzed chart 363 software
0.30595517.15525658.html.plaintext.txt	57	statistics data analyzed one two factor anova appropriate un paired students tests using statview 54 package abacus concepts berkeley ca usa data presented mean median plus minus sem
0.30595517.15525658.html.plaintext.txt	58	statistics data analyzed one two factor anova appropriate un paired students tests using statview 54 package abacus concepts berkeley ca usa data presented mean median plus minus sem
0.30595517.15525658.html.plaintext.txt	59	supplementary material top abstract introduction results discussion materials methods supplementary material references supplementary material available hmg online
0.30595517.15525658.html.plaintext.txt	60	acknowledgements grateful birgit haraldsson britt lindberg elsy ling bengt mattsson paul mohapel britt marie nilsson laurent roybon excellent technical assistance ap supported swedish brain foundation national board health welfare sweden jg fellowship foundation science technology fct portugal sfrhbd60682001 ia supported short term fellowship federation european biochemical societies febs mb hm supported cure hd initiative swedish research council fs nw swedish research council np supported grant biodegradable controlled drug delivery systems treatment brain diseases bcdds qlrt 2000 02226 rtd eu project quality life management living resources pb supported swedish research council hereditary disease foundation european union concerted action consortium early pathogenetic markers slow neurodegenerative diseases epsnd qlk6 ct 2000 00384
0.30595517.15525658.html.plaintext.txt	61	footnotes authors wish known opinion first two authors regarded joint first authors
0.30595517.15525658.html.plaintext.txt	62	references top abstract introduction results discussion materials methods supplementary material references petersen brundin p 2002 huntingtons disease mystery unfolds int rev neurobiol 53 315 339isimedline
0.30595517.15525658.html.plaintext.txt	63	huntingtons disease collaborative research group 1993 novel gene containing trinucleotide repeat expanded unstable huntingtons disease chromosomes cell 72 971 983isimedline
0.30595517.15525658.html.plaintext.txt	64	huntingtons disease collaborative research group 1993 novel gene containing trinucleotide repeat expanded unstable huntingtons disease chromosomes cell 72 971 983isimedline
0.32579625.12933647.html.plaintext.txt	0	fasting activates nonhuman primate hypocretin orexin system postsynaptic targets sabrina diano balazs horvath henryk f urbanski peter sotonyi tamas l horvath
0.32579625.12933647.html.plaintext.txt	1	fasting activates nonhuman primate hypocretin orexin system postsynaptic targets sabrina diano balazs horvath henryk f urbanski peter sotonyi tamas l horvath
0.32579625.12933647.html.plaintext.txt	2	departments obstetrics gynecology sd tlh neurobiology bh tlh yale university school medicine new haven connecticut 06520 division neuroscience hfu oregon regional primate research center beaverton oregon 97006 department anatomy histology ps szent istvan university school veterinary medicine budapest hungary 1071
0.32579625.12933647.html.plaintext.txt	3	address correspondence requests reprints tamas l horvath department obstetrics gynecology yale medical school 333 cedar street fmb 339 new haven connecticut 06520 e mail tamashorvathatyaleedu u d
0.32579625.12933647.html.plaintext.txt	4	address correspondence requests reprints tamas l horvath department obstetrics gynecology yale medical school 333 cedar street fmb 339 new haven connecticut 06520 e mail tamashorvathatyaleedu u d
0.32579625.12933647.html.plaintext.txt	5	rodents hypocretin hcrt also called orexin influences variety endocrine autonomic metabolic functions present study undertaken determine whether hcrt producing circuit involved hypothalamic regulation homeostasis primates well studied female monkeys cercopithecus aethiops either fed fasted 24 h immunocytochemistry revealed hcrt producing perikarya exclusively lateral hypothalamus perifornical region dorsomedial hypothalamus monkey brain hcrt axons axon terminals present different parts hypothalamus adjacent forebrain thalamic nuclei 24 h fast resulted approximately 50 decline circulating leptin levels significantly elevated c fos expression perifornical region dorsomedial ventromedial arcuate nuclei medial preoptic area dorsomedial nucleus perifornical region fasted monkeys three times hcrt neurons expressed nuclear c fos normally fed controls neurons different parts hypothalamus basal forebrain expressed c fos contain hcrt targets hcrt immunopositive boutons establishing asymmetric synapses arcuate nucleus subsets hcrt targeted c fos expressing cells contained neuropeptide y present study provides first experimental evidence implicate hcrt hypothalamic regulation homeostasis primates fact lateral hypothalamic cells leptin receptors activated metabolic challenge innervate diverse brain regions indicates hcrt system may key integrator environmental cues regulation diverse brain activity
0.32579625.12933647.html.plaintext.txt	6	rodents hypocretin hcrt also called orexin influences variety endocrine autonomic metabolic functions present study undertaken determine whether hcrt producing circuit involved hypothalamic regulation homeostasis primates well studied female monkeys cercopithecus aethiops either fed fasted 24 h immunocytochemistry revealed hcrt producing perikarya exclusively lateral hypothalamus perifornical region dorsomedial hypothalamus monkey brain hcrt axons axon terminals present different parts hypothalamus adjacent forebrain thalamic nuclei 24 h fast resulted approximately 50 decline circulating leptin levels significantly elevated c fos expression perifornical region dorsomedial ventromedial arcuate nuclei medial preoptic area dorsomedial nucleus perifornical region fasted monkeys three times hcrt neurons expressed nuclear c fos normally fed controls neurons different parts hypothalamus basal forebrain expressed c fos contain hcrt targets hcrt immunopositive boutons establishing asymmetric synapses arcuate nucleus subsets hcrt targeted c fos expressing cells contained neuropeptide y present study provides first experimental evidence implicate hcrt hypothalamic regulation homeostasis primates fact lateral hypothalamic cells leptin receptors activated metabolic challenge innervate diverse brain regions indicates hcrt system may key integrator environmental cues regulation diverse brain activity
0.32579625.12933647.html.plaintext.txt	7	energy homeostasis regulated discrete central nervous system circuits predominantly hypothalamic areas sensitive peripheral metabolic signals 1 great part current understanding human physiology disorders hypothalamus inferred rodent models whereas little known primate hypothalamic circuits control homeostasis particular clear whether peptidergic circuits known involved hypothalamic regulation rodent homeostasis similar functions primate brain
0.32579625.12933647.html.plaintext.txt	8	energy homeostasis regulated discrete central nervous system circuits predominantly hypothalamic areas sensitive peripheral metabolic signals 1 great part current understanding human physiology disorders hypothalamus inferred rodent models whereas little known primate hypothalamic circuits control homeostasis particular clear whether peptidergic circuits known involved hypothalamic regulation rodent homeostasis similar functions primate brain
0.32579625.12933647.html.plaintext.txt	9	hypocretin hcrt also called orexin peptide produced exclusively hypothalamus 2 3 4 emerged important regulator autonomic endocrine metabolic functions rodents 3 5 6 hcrt cells rats monkeys found express leptin receptor immunoreactivity provide synaptic input distinct hypothalamic brainstem circuits known participate central regulation endocrine metabolic autonomic systems 4 7 although determination synaptic interactions hcrt hypothalamic systems provided map via signals may travel within hypothalamus demonstrate whether signaling modality involved homeostatic regulation determination cytochemical identification c fos indicator cell activity different metabolic conditions may used
0.32579625.12933647.html.plaintext.txt	10	hypocretin hcrt also called orexin peptide produced exclusively hypothalamus 2 3 4 emerged important regulator autonomic endocrine metabolic functions rodents 3 5 6 hcrt cells rats monkeys found express leptin receptor immunoreactivity provide synaptic input distinct hypothalamic brainstem circuits known participate central regulation endocrine metabolic autonomic systems 4 7 although determination synaptic interactions hcrt hypothalamic systems provided map via signals may travel within hypothalamus demonstrate whether signaling modality involved homeostatic regulation determination cytochemical identification c fos indicator cell activity different metabolic conditions may used
0.32579625.12933647.html.plaintext.txt	11	metabolic challenge distinct populations hypothalamic neurons begin express c fos rats 8 well monkeys 9 using paradigm current study aimed determine whether monkey hypothalamus hcrt cells postsynaptic targets activated metabolic challenge fasting
0.32579625.12933647.html.plaintext.txt	12	metabolic challenge distinct populations hypothalamic neurons begin express c fos rats 8 well monkeys 9 using paradigm current study aimed determine whether monkey hypothalamus hcrt cells postsynaptic targets activated metabolic challenge fasting
0.32579625.12933647.html.plaintext.txt	13	light electron microscopic double immunostaining light microscopic double immunostaining hcrt c fos carried according previously published protocol sections incubated one primary antisera rabbit anti hcrt 12000 processed avidin biotin peroxidase technique immunoreaction visualized modified version nickel diaminobenzidine dab reaction 15 mg dab 012 mg glucose oxidase 12 mg ammonium chloride 600 microl 005 m nickel ammonium sulfate 600 microl 10 ss d glucose 30 ml pb resulting dark blue reaction product several rinses pb sections incubated sheep anti c fos 12000 cambridge research biochemicals inc wilmington de 24 h 4 c processed peroxidase anti peroxidase technique tissue bound peroxidase visualized dab reaction 15 mg dab 165 microl 03 h2o2 30 ml pb resulting light brown reaction product visualization tissue antigens sections processed electron microscopy 1 oso4 pb 30 min dehydrated increasing ethanol concentrations using 1 uranyl acetate 70 ethanol 30 min flat embedded araldite liquid release coated slides electron microscopy sciences fort washington pa
0.32579625.12933647.html.plaintext.txt	14	light electron microscopic double immunostaining light microscopic double immunostaining hcrt c fos carried according previously published protocol sections incubated one primary antisera rabbit anti hcrt 12000 processed avidin biotin peroxidase technique immunoreaction visualized modified version nickel diaminobenzidine dab reaction 15 mg dab 012 mg glucose oxidase 12 mg ammonium chloride 600 microl 005 m nickel ammonium sulfate 600 microl 10 ss d glucose 30 ml pb resulting dark blue reaction product several rinses pb sections incubated sheep anti c fos 12000 cambridge research biochemicals inc wilmington de 24 h 4 c processed peroxidase anti peroxidase technique tissue bound peroxidase visualized dab reaction 15 mg dab 165 microl 03 h2o2 30 ml pb resulting light brown reaction product visualization tissue antigens sections processed electron microscopy 1 oso4 pb 30 min dehydrated increasing ethanol concentrations using 1 uranyl acetate 70 ethanol 30 min flat embedded araldite liquid release coated slides electron microscopy sciences fort washington pa
0.32579625.12933647.html.plaintext.txt	15	specificity hcrt antisera thoroughly tested us others previous studies 2 4
0.32579625.12933647.html.plaintext.txt	16	analysis c fos expressing cells single double labeled c fos hcrt material estimate induction c fos expression primate hypothalamus 24 h fasting matching sections hypothalami control fasted monkeys coincubated vials either single immunostaining c fos double immunostaining c fos hcrt see ensure matching sections coprocessed sections selected using comparative assessment location following anatomical landmarks optic chiasm tract shape third ventricle anterior commissure fornix mammilo thalamic tract median eminence one group sections either control experimental marked placing notch one side tissue block vibratome sectioning analyzer blind code revealed collection counts immunostaining completed three sets coincubations six monkeys three control three experimental matching sections placed slides coverslipped analyzed using light microscopy number c fos immunolabeled cells labeled hcrt labeled antigens noted several nuclei hypothalamus see cells surface section counted guided stereotaxic atlas african green monkey 10 following hypothalamic areas analyzed medial preoptic area mpoa parvicellular magnocellular paraventricular nucleus arcuate infundibular nucleus arc dorsomedial hypothalamic nucleus ventromedial nucleus lateral hypothalamus perifornical region determining mean values student test used comparison significance concluded p 005
0.32579625.12933647.html.plaintext.txt	17	analysis c fos expressing cells single double labeled c fos hcrt material estimate induction c fos expression primate hypothalamus 24 h fasting matching sections hypothalami control fasted monkeys coincubated vials either single immunostaining c fos double immunostaining c fos hcrt see ensure matching sections coprocessed sections selected using comparative assessment location following anatomical landmarks optic chiasm tract shape third ventricle anterior commissure fornix mammilo thalamic tract median eminence one group sections either control experimental marked placing notch one side tissue block vibratome sectioning analyzer blind code revealed collection counts immunostaining completed three sets coincubations six monkeys three control three experimental matching sections placed slides coverslipped analyzed using light microscopy number c fos immunolabeled cells labeled hcrt labeled antigens noted several nuclei hypothalamus see cells surface section counted guided stereotaxic atlas african green monkey 10 following hypothalamic areas analyzed medial preoptic area mpoa parvicellular magnocellular paraventricular nucleus arcuate infundibular nucleus arc dorsomedial hypothalamic nucleus ventromedial nucleus lateral hypothalamus perifornical region determining mean values student test used comparison significance concluded p 005
0.32579625.12933647.html.plaintext.txt	18	light microscopic triple immunostaining hcrt present neuronal perikarya arc c fos expressed cell nuclei neuropeptide y npy expressed cytoplasm neurons triple labeled hypothalamic sections using triple labeling protocol 4 sections first incubated 24 h room temperature mixture hcrt c fos antisera processed avidin biotin peroxidase tissue bound peroxidase visualized nickel diaminobenzidine reaction resulting dark blue black color subsequently sections immunostained npy using sheep anti npy auspep pty ltd perkwille australia peroxidase antiperoxidase method tissue bound peroxidase visualized dab reaction give light brown reaction product
0.32579625.12933647.html.plaintext.txt	19	light microscopic triple immunostaining hcrt present neuronal perikarya arc c fos expressed cell nuclei neuropeptide y npy expressed cytoplasm neurons triple labeled hypothalamic sections using triple labeling protocol 4 sections first incubated 24 h room temperature mixture hcrt c fos antisera processed avidin biotin peroxidase tissue bound peroxidase visualized nickel diaminobenzidine reaction resulting dark blue black color subsequently sections immunostained npy using sheep anti npy auspep pty ltd perkwille australia peroxidase antiperoxidase method tissue bound peroxidase visualized dab reaction give light brown reaction product
0.32579625.12933647.html.plaintext.txt	20	leptin measurements blood samples collected morning serum stored frozen samples collected animals fasted leptin measured using primate leptin ria kit linco research inc st charles mo minimum detectable concentration 95 binding 07 ng ml interassay coefficient variation 6 serum samples assayed together single ria student test two tail probabilities used statistical comparisons leptin values two groups significance concluded p 005
0.32579625.12933647.html.plaintext.txt	21	leptin measurements blood samples collected morning serum stored frozen samples collected animals fasted leptin measured using primate leptin ria kit linco research inc st charles mo minimum detectable concentration 95 binding 07 ng ml interassay coefficient variation 6 serum samples assayed together single ria student test two tail probabilities used statistical comparisons leptin values two groups significance concluded p 005
0.32579625.12933647.html.plaintext.txt	22	circulating leptin levels fasted normally fed control african green monkeys circulating leptin level values differ fasted control groups 0 h 67 plus minus 09 vs 65 plus minus 07 ngml p 005 significantly lower fasted animals 24 h fast 25 plus minus 05 vs 63 plus minus 08 ngml p 005
0.32579625.12933647.html.plaintext.txt	23	hcrt hypothalamus overall pattern hcrt immunolabeling monkey corresponded earlier description 4 7 hcrt immunoreactive perikarya present exclusively lateral hypothalamus perifornical region lesser extent dorsomedial hypothalamus whereas projections abundant different hypothalamic nuclei detected obvious differences hcrt immunoreactivity hypothalamus control vs fasted animals
0.32579625.12933647.html.plaintext.txt	24	c fos accordance recent report 9 c fos immunoreactivity detected different parts hypothalamus fasted normally fed control monkeys control animals moderate number c fos labeled nuclei homogenously distributed mpoa periventricular regions paraventricular nucleus parvo magnocellular regions anterior hypothalamus suprachiasmatic arcuate dorsomedial ventromedial nuclei lateral hypothalamus perifornical region number c fos expressing cells individual hypothalamic subnuclei fasted monkeys distinctly different control values fig 1 c fasted animals significantly higher number c fos expressing cells detected mpoa 235 plus minus 22 vs 489 plus minus 35 p 005 lateral hypothalamus perifornical lh pf region 343 plus minus 17 vs 889 plus minus 41 p 005 fig 1 b arcuate 205 plus minus 34 vs 341 plus minus 42 p 005 dorsomedial nuclei 276 plus minus 41 vs 452 plus minus 26 p 005
0.32579625.12933647.html.plaintext.txt	25	view larger version 82k fig 1 light micrographs monkey perifornical region pf immunostaining c fos taken control fasted animals b bar scale 100 microm f fornix c bar graph showing number c fos immunoreactive nuclei different parts hypothalamus control white bars fasted black bars animals
0.32579625.12933647.html.plaintext.txt	26	addition differences albeit nonsignificant detected ventromedial 224 plus minus 36 vs 196 plus minus 13 p 005 parvicellular paraventricular 246 plus minus 27 vs 316 plus minus 39 p 005 magnocellular paraventricular hypothalamic nuclei 325 plus minus 40 vs 287 plus minus 33 p 005 however noted low sample values n 3 may mask significant differences might detected higher number animals studied
0.32579625.12933647.html.plaintext.txt	27	addition differences albeit nonsignificant detected ventromedial 224 plus minus 36 vs 196 plus minus 13 p 005 parvicellular paraventricular 246 plus minus 27 vs 316 plus minus 39 p 005 magnocellular paraventricular hypothalamic nuclei 325 plus minus 40 vs 287 plus minus 33 p 005 however noted low sample values n 3 may mask significant differences might detected higher number animals studied
0.32579625.12933647.html.plaintext.txt	28	c fos expression hcrt cells c fos immunoreactivity detected cell nuclei hcrt immunoreactive cells control 24 h fasted animals fig 2 d difference mean number hcrt labeled cells control fasted animals 502 plus minus 24 vs 535 plus minus 33 p 005 fig 2e however percentage hcrt cells expressing nuclear c fos robustly significantly elevated fasted animals compared control values p 005 control lh pf 135 plus minus 35 hcrt cells exhibited nuclear c fos labeling represented 268 total hcrt cells counted contrast fasted animals 418 plus minus 38 hcrt cells exhibited c fos immunoreactivity represented 781 total hcrt cells counted fig 2 number c fos expressing neurons contained hcrt control monkeys 135 plus minus 35 represented approximately 75 cells c fos immunopositive 182 plus minus 29 lh pf region ratio remains similar fasted animals 418 38 total c fos immunolabaled nuclei 562 plus minus 42 hcrt immunoreactive perikarya fig 2f
0.32579625.12933647.html.plaintext.txt	29	view larger version 77k fig 2 fasting induced c fos expression associated exclusively cell nuclei c perifornical region many nuclear c fos labeled cells red nuclei b d also immunopositive hcrt bar scales c 10 microm b 100 microm c d e bar graph showing c fos immunoreactive hcrt neurons white bars total hcrt neurons black bars counted control fasted animals f bar graph showing c fos immunoreactive hcrt neurons white bars total c fos immunolabeled neurons black bars counted control fasted animals
0.32579625.12933647.html.plaintext.txt	30	hypocretin axons synapse c fos containing cells analyzed light microscopy apparent control fasted animals c fos immunolabeled cells surrounded numerous hcrt immunopositive boutons fig 3a regions significant elevations c fos labeling fasting mpoa arc lh pf dorsomedial nucleus found c fos immunolabeled cells either control experimental group contacted numerous hcrt labeled axon terminals synaptic membrane specializations hcrt boutons c fos expressing cells asymmetrical contacts fig 3 b c arc increased c fos expression detected fasting hypothalamic npy producing cells located hcrt axons close proximity perikarya contained npy c fos fig 4
0.32579625.12933647.html.plaintext.txt	31	view larger version 173k fig 3 regions monkey hypothalamus c fos induction observed fasting cell nuclei hcrt boutons observed close apposition activated cells electron microscopy showed b c contacts synapses arrows c point membrane specializations bar scales 10 microm 1 microm b c
0.32579625.12933647.html.plaintext.txt	32	view larger version 134k fig 4 subset fasting activated hcrt targeted cells npy cells arc bar scale 10 microm
0.32579625.12933647.html.plaintext.txt	33	present study provides first suggestive evidence hcrt system nonhuman primates involved hypothalamic signal transduction associated metabolic alterations fact short term food withdrawal underlies robust activation transcriptional mechanisms primate lateral hypothalamic hcrt system together widespread distribution hcrt projections homeostatic centers beyond argues coordinating role hcrt autonomic endocrine metabolic processes assertion line evidence available role hcrt modulation food intake blood pressure arousal 3 5 6 11 12
0.32579625.12933647.html.plaintext.txt	34	present study provides first suggestive evidence hcrt system nonhuman primates involved hypothalamic signal transduction associated metabolic alterations fact short term food withdrawal underlies robust activation transcriptional mechanisms primate lateral hypothalamic hcrt system together widespread distribution hcrt projections homeostatic centers beyond argues coordinating role hcrt autonomic endocrine metabolic processes assertion line evidence available role hcrt modulation food intake blood pressure arousal 3 5 6 11 12
0.32579625.12933647.html.plaintext.txt	35	previous study 4 monkey arc found receive robust hcrt innervation hcrt axons heavily innervating npy cells 4 whether arc npy system may participate modulation hcrt food intake primates suggested rat 13 14 remains tested present observation hcrt input fasting activated npy cells african green monkey lends support possibility nevertheless also conceivable activation hcrt neurons fasting occurs secondary activation arc however arc npy cells likely protected blood brain barrier direct projection arc lateral hypothalamus robust nonhuman primate 4 may also plausible hcrt system heavily involved regulation sleepwake cycles disturbance sleep fasting affects hcrt neuronal function alternatively metabolic signals affect hcrt cells fasting sleep disturbances may consequence hcrt neuronal activation
0.32579625.12933647.html.plaintext.txt	36	previous study 4 monkey arc found receive robust hcrt innervation hcrt axons heavily innervating npy cells 4 whether arc npy system may participate modulation hcrt food intake primates suggested rat 13 14 remains tested present observation hcrt input fasting activated npy cells african green monkey lends support possibility nevertheless also conceivable activation hcrt neurons fasting occurs secondary activation arc however arc npy cells likely protected blood brain barrier direct projection arc lateral hypothalamus robust nonhuman primate 4 may also plausible hcrt system heavily involved regulation sleepwake cycles disturbance sleep fasting affects hcrt neuronal function alternatively metabolic signals affect hcrt cells fasting sleep disturbances may consequence hcrt neuronal activation
0.32579625.12933647.html.plaintext.txt	37	leptin receptor immunoreactivity detected primate lateral hypothalamic hcrt cells 4 leptin suggested cross blood brain barrier 15 thus observed induction c fos gene expression hcrt cells may direct consequence diminishing leptin levels observed short term fasting however fasting paradigms particularly used primates allow distinction effect particular hormones underlie complex responses variety endocrine mechanisms example rodent evidence available indicate circulating insulin andor glucose levels regulatory influence hypothalamic hcrt expression 16 future studies determine extent contribution involved humoral metabolic signals activation primate hcrt systems
0.32579625.12933647.html.plaintext.txt	38	leptin receptor immunoreactivity detected primate lateral hypothalamic hcrt cells 4 leptin suggested cross blood brain barrier 15 thus observed induction c fos gene expression hcrt cells may direct consequence diminishing leptin levels observed short term fasting however fasting paradigms particularly used primates allow distinction effect particular hormones underlie complex responses variety endocrine mechanisms example rodent evidence available indicate circulating insulin andor glucose levels regulatory influence hypothalamic hcrt expression 16 future studies determine extent contribution involved humoral metabolic signals activation primate hcrt systems
0.32579625.12933647.html.plaintext.txt	39	interestingly hypothalamic nuclei including arc lh pf dorsomedial nucleus mpoa short term fasting induced c fos expression robustly activated cells received multiple hcrt inputs rodents hcrt exerts excitatory postsynaptic currents 17 intracerebroventricular administration hcrt induces c fos expression manner dissimilar describe nonhuman primate 18 19 synaptic membrane specializations hcrt axons c fos expressing perikarya primate hypothalamus asymmetrical stimulatory synapses activation hypothalamic circuitry metabolic challenge may mediated part hcrt system
0.32579625.12933647.html.plaintext.txt	40	interestingly hypothalamic nuclei including arc lh pf dorsomedial nucleus mpoa short term fasting induced c fos expression robustly activated cells received multiple hcrt inputs rodents hcrt exerts excitatory postsynaptic currents 17 intracerebroventricular administration hcrt induces c fos expression manner dissimilar describe nonhuman primate 18 19 synaptic membrane specializations hcrt axons c fos expressing perikarya primate hypothalamus asymmetrical stimulatory synapses activation hypothalamic circuitry metabolic challenge may mediated part hcrt system
0.32579625.12933647.html.plaintext.txt	41	thank anthony van den pol providing hcrt antisera
0.32579625.12933647.html.plaintext.txt	42	work supported nih grant rr 14451 tlh albert szent gyorgyi fellow
0.32579625.12933647.html.plaintext.txt	43	abbreviations arc arcuate nucleus dab diaminobenzidine hcrt hypocretin lh pf lateral hypothalamus perifornical mpoa medial preoptic area npy neuropeptide y pb phosphate buffer
0.32579625.12933647.html.plaintext.txt	44	accepted publication june 24 2003
0.32579625.12933647.html.plaintext.txt	45	kalra sp xu b dube mg pu horvath tl kalra ps 1999 interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 2067 100 de lecea l kilduff ts peyron c gao xb foye pe danielson pe fukuhara c battenberg elf gautvik vt bartlett ii fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins two hypothalamic peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jrs buckingham re haynes ac carr sa annan rs mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline horvath tl diano van den pol 1999 synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 191072 1087abstractfree full text chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451medline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376medline horvath tl peyron c diano ivanov aston jones g kilduff ts van den pol 1999 hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system j comp neurol 415145 15933co2 u 231crossrefmedline caston balderrama al cameron jl hoffman ge 1998 immunocytochemical localization fos perfused nonhuman primate brain tissue fixation antisera selection j histochem cytochem 46547 556abstractfree full text contreras cm mexicano g guzman flores c 1981 stereotaxic brain atlas green monkey cecopithecus aethiops aethiops bol estud med biol 31383 428medline samson wk gosnell b chang jk resch zt murphy tc 1999 cardiovascular regulatory actions hypocretins brain brain res 83248 253 kukkonen jp holmqvist ammoun akerman ke 2002 functions orexinergichypocretinergic system j physiol cell physiol 283c1567 c1591 jain mr horvath tl kalra ps kalra sp 1999 evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 8719 24 lopez m seoane lm garcia mdel c dieguez c senaris r 2002 neuropeptide y agouti related peptide melanin concentrating hormone target peptide orexin feeding actions rat hypothalamus neuroendocrinology 7534 44crossrefmedline bjorbaek c elmquist jk michl p ahima rs vanbueren mccall al flier js 1998 expression leptin receptor isoform rat brain microvessels endocrinology 1393485 3491abstractfree full text cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g 1999 hypothalamic orexin expression modulation blood glucose feeding diabetes 112132 2137 van den pol gao xb obrietan k kilduff belousov 1998 pre postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text mullett ma billington cj levine kotz cm 2000 hypocretin lateral hypothalamus activates key feeding regulatory brain sites neuroreport 11103 108medline
0.32579625.12933647.html.plaintext.txt	46	kalra sp xu b dube mg pu horvath tl kalra ps 1999 interacting appetite regulating pathways hypothalamic regulation body weight endocr rev 2067 100 de lecea l kilduff ts peyron c gao xb foye pe danielson pe fukuhara c battenberg elf gautvik vt bartlett ii fs frankel wn van den pol bloom fe gautvik km sutcliffe jg 1998 hypocretins two hypothalamic peptides neuroexcitatory activity proc natl acad sci usa 95322 327abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jrs buckingham re haynes ac carr sa annan rs mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m 1998 orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92573 585medline horvath tl diano van den pol 1999 synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 191072 1087abstractfree full text chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m 1999 narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98437 451medline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e 1999 sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98365 376medline horvath tl peyron c diano ivanov aston jones g kilduff ts van den pol 1999 hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system j comp neurol 415145 15933co2 u 231crossrefmedline caston balderrama al cameron jl hoffman ge 1998 immunocytochemical localization fos perfused nonhuman primate brain tissue fixation antisera selection j histochem cytochem 46547 556abstractfree full text contreras cm mexicano g guzman flores c 1981 stereotaxic brain atlas green monkey cecopithecus aethiops aethiops bol estud med biol 31383 428medline samson wk gosnell b chang jk resch zt murphy tc 1999 cardiovascular regulatory actions hypocretins brain brain res 83248 253 kukkonen jp holmqvist ammoun akerman ke 2002 functions orexinergichypocretinergic system j physiol cell physiol 283c1567 c1591 jain mr horvath tl kalra ps kalra sp 1999 evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 8719 24 lopez m seoane lm garcia mdel c dieguez c senaris r 2002 neuropeptide y agouti related peptide melanin concentrating hormone target peptide orexin feeding actions rat hypothalamus neuroendocrinology 7534 44crossrefmedline bjorbaek c elmquist jk michl p ahima rs vanbueren mccall al flier js 1998 expression leptin receptor isoform rat brain microvessels endocrinology 1393485 3491abstractfree full text cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g 1999 hypothalamic orexin expression modulation blood glucose feeding diabetes 112132 2137 van den pol gao xb obrietan k kilduff belousov 1998 pre postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 187962 7971abstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m 1999 orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96748 753abstractfree full text mullett ma billington cj levine kotz cm 2000 hypocretin lateral hypothalamus activates key feeding regulatory brain sites neuroreport 11103 108medline
0.35575834.12419707.html.plaintext.txt	0	invited review functions orexinergichypocretinergic system jyrki p kukkonen1 tomas holmqvist1 sylwia ammoun1 karl e o akerman12
0.35575834.12419707.html.plaintext.txt	1	invited review functions orexinergichypocretinergic system jyrki p kukkonen1 tomas holmqvist1 sylwia ammoun1 karl e o akerman12
0.35575834.12419707.html.plaintext.txt	2	1 laboratory cell physiology department neuroscience division physiology uppsala university biomedical center se 75123 uppsala sweden 2 department neurobiology virtanen institute molecular sciences university kuopio bioteknia fin 70210 kuopio finland
0.35575834.12419707.html.plaintext.txt	3	abstract top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	4	orexin orexin b hypothalamic peptides act targets via two g protein coupled receptors ox1 ox2 receptors central nervous system cell bodies producing orexins localized narrow region within lateral hypothalamus project mainly regions involved feeding sleep autonomic functions via putative pre postsynaptic effects orexins increase synaptic activity regions isolated neurons cells expressing recombinant receptors orexins cause ca2 elevation mainly dependent influx activity orexinergic cells appears controlled feeding sleep related signals via variety neurotransmittershormones brain tissues orexins orexin receptors also found outside central nervous system particularly organs involved feeding energy metabolism eg gastrointestinal tract pancreas adrenal gland present review focus physiological properties cells secrete respond orexins
0.35575834.12419707.html.plaintext.txt	5	orexin orexin b hypothalamic peptides act targets via two g protein coupled receptors ox1 ox2 receptors central nervous system cell bodies producing orexins localized narrow region within lateral hypothalamus project mainly regions involved feeding sleep autonomic functions via putative pre postsynaptic effects orexins increase synaptic activity regions isolated neurons cells expressing recombinant receptors orexins cause ca2 elevation mainly dependent influx activity orexinergic cells appears controlled feeding sleep related signals via variety neurotransmittershormones brain tissues orexins orexin receptors also found outside central nervous system particularly organs involved feeding energy metabolism eg gastrointestinal tract pancreas adrenal gland present review focus physiological properties cells secrete respond orexins
0.35575834.12419707.html.plaintext.txt	6	sleep feeding calcium neuron neuroendocrine regulation
0.35575834.12419707.html.plaintext.txt	7	introduction top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	8	knowledge orexinergic system initiated 1998 two independent groups approaches reviewed refs 26 157 january 1998 group sutcliffe published study 37 predicted particular rat hypothalamic mrna species clone 35 ref 50 would code precursor peptide 130 amino acids aa length molecule would generate two separate peptides 39 29 aa lengths peptides named hypocretins basis hypothalamic localization proposed sequence similarity secretin family peptides however orexin b bears significant resemblance secretin precursor peptide would thus preprohypocretin two final peptides hypocretin hcrt 1 hcrt 2 simultaneously work group sutcliffe group yanagisawa 154 isolated hypothalamic 33 aa peptide activated orphan receptor hfgan72 receptor found also respond another peptide 28 aa length second receptor cloned basis sequence similarity hfgan72 receptor also responded isolated peptides ca2 elevation basis peptide sequences sakurai coworkers 154 cloned cdna precursor peptide 130 aa rat peptides named orexins increased food intake nonfasted rats injected lateral ventricle precursor peptide thus became preproorexin 33 28 aa final peptides orexin orexin b respectively receptors ox1 ox2 receptors preprohypocretin preproorexin found preferentially rat brain specifically hypothalamus 37 154 cellular systemic responses peptides observed rat application hcrt 2 increased postsynaptic current frequency rat hypothalamic neurons culture 37 orexin b increased food intake nonfasted rats 154
0.35575834.12419707.html.plaintext.txt	9	soon became clear peptides isolated two groups principle identical however error peptide sequences deduced de lecea coworkers 37 authors refer accepted sequences sakurai et al 154 de lecea et al 37 even using hypocretin nomenclature therefore current praxis makes preproorexin preprohypocretin orexin hcrt 1 orexin b hcrt 2 ox1 receptor hcrtr 1 ox2 receptor hcrtr 2 ongoing argument concerning nomenclature used avoid confusion sequences use orexin nomenclature throughout review
0.35575834.12419707.html.plaintext.txt	10	soon became clear peptides isolated two groups principle identical however error peptide sequences deduced de lecea coworkers 37 authors refer accepted sequences sakurai et al 154 de lecea et al 37 even using hypocretin nomenclature therefore current praxis makes preproorexin preprohypocretin orexin hcrt 1 orexin b hcrt 2 ox1 receptor hcrtr 1 ox2 receptor hcrtr 2 ongoing argument concerning nomenclature used avoid confusion sequences use orexin nomenclature throughout review
0.35575834.12419707.html.plaintext.txt	11	today wealth information concerning anatomic architecture orexinergic system well systemic effects orexins prominent well demonstrated effect orexins undoubtedly regulation sleepwakefulness reviewed refs 74 172 190 although many responses shown physiological significance less clear effects feeding behavior demonstrated multitude studies results somewhat contradictory current view orexins may rather regulate short term appetite energy metabolism feeding associated processes eg gastrointestinal functions mastication orexins also affect hormonal secretion well demonstrated effects hormones involved stress response energy metabolism glucocorticoids norepinephrine time information concerning regulatory mechanisms orexinergic systems targets cellular level lagging behind review try create comprehensive picture orexins proven putative physiological role main emphasis placed functional properties interactions orexin producing orexin responding cells
0.35575834.12419707.html.plaintext.txt	12	today wealth information concerning anatomic architecture orexinergic system well systemic effects orexins prominent well demonstrated effect orexins undoubtedly regulation sleepwakefulness reviewed refs 74 172 190 although many responses shown physiological significance less clear effects feeding behavior demonstrated multitude studies results somewhat contradictory current view orexins may rather regulate short term appetite energy metabolism feeding associated processes eg gastrointestinal functions mastication orexins also affect hormonal secretion well demonstrated effects hormones involved stress response energy metabolism glucocorticoids norepinephrine time information concerning regulatory mechanisms orexinergic systems targets cellular level lagging behind review try create comprehensive picture orexins proven putative physiological role main emphasis placed functional properties interactions orexin producing orexin responding cells
0.35575834.12419707.html.plaintext.txt	13	overview orexins orexin receptors top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	14	genetics chemistry orexins
0.35575834.12419707.html.plaintext.txt	15	mammalian human pig dog rat mouse preproorexin composed 130 131 aa 37 41 73 154 155 human preproorexin gene chromosome 17 thoroughly characterized 155 composed two exons latter includes whole coding region final peptides 32 kb promoter region preproorexin gene seems enough direct expression downstream gene lateral hypothalamus mouse 155 utilized cause selective depletion orexinergic neurons transgenic mice expressing preproorexin ataxin 3 fusion protein 60 mice orexinergic neurons progressively lost postnatally transcription essential part suggested 450 bp proximal gene 185
0.35575834.12419707.html.plaintext.txt	16	mammalian human pig dog rat mouse preproorexin composed 130 131 aa 37 41 73 154 155 human preproorexin gene chromosome 17 thoroughly characterized 155 composed two exons latter includes whole coding region final peptides 32 kb promoter region preproorexin gene seems enough direct expression downstream gene lateral hypothalamus mouse 155 utilized cause selective depletion orexinergic neurons transgenic mice expressing preproorexin ataxin 3 fusion protein 60 mice orexinergic neurons progressively lost postnatally transcription essential part suggested 450 bp proximal gene 185
0.35575834.12419707.html.plaintext.txt	17	cleavage one molecule preproorexin modification leads production one molecule orexin orexin b however hplc detection orexins human brain suggests two fivefold higher levels orexin b orexin several areas central nervous system cns 34 35 125 126 mammalian orexin rat 33 aa peptide two intrachain disulfide bridges orexin b 28 aa linear peptide fig 1a substantial sequence identity cooh termini peptides addition orexin b secretin contain identical stretch seven amino acids orexin b likely cooh terminally amidated nh2 terminal glutamine residue orexin may modified pyroglutamoyl residue 154 however posttranslational modifications experimentally verified rat orexin human pig dog rat mouse identical fig 1b whereas orexin b pig dog differs one amino acid orexin b rat mouse two amino acids human orexin b fig 1c three dimensional structure orexin known orexin b determined consist two helices 60 80 degrees angle 100
0.35575834.12419707.html.plaintext.txt	18	cleavage one molecule preproorexin modification leads production one molecule orexin orexin b however hplc detection orexins human brain suggests two fivefold higher levels orexin b orexin several areas central nervous system cns 34 35 125 126 mammalian orexin rat 33 aa peptide two intrachain disulfide bridges orexin b 28 aa linear peptide fig 1a substantial sequence identity cooh termini peptides addition orexin b secretin contain identical stretch seven amino acids orexin b likely cooh terminally amidated nh2 terminal glutamine residue orexin may modified pyroglutamoyl residue 154 however posttranslational modifications experimentally verified rat orexin human pig dog rat mouse identical fig 1b whereas orexin b pig dog differs one amino acid orexin b rat mouse two amino acids human orexin b fig 1c three dimensional structure orexin known orexin b determined consist two helices 60 80 degrees angle 100
0.35575834.12419707.html.plaintext.txt	19	view larger version 25k fig 1 alignment orexin orexin b peptide sequences different species c gray boxes indicate dissimilar amino acids compared human orexin variants cystine bridges orexin shown black lines d ox1 receptor antagonist sb 334867 hcrt hypocretin
0.35575834.12419707.html.plaintext.txt	20	orexin seems much higher stability orexin b physiological milieu 89 may explain orexin readily detected cerebrospinal fluid csf orexin b 148 orexin also displays much higher lipid solubility orexin b probably making orexin ain contrast orexin bblood brain barrier permeant 89 orexin immunoreactivity found putative endocrine release sites hypothalamus neurohypophysis pancreas see offering interesting possibility orexins could also act hormones cns periphery yet indirect evidence suggests orexin plasma originates peripheral sources 32 brain penetration intravenous orexin seen rat 11
0.35575834.12419707.html.plaintext.txt	21	orexin seems much higher stability orexin b physiological milieu 89 may explain orexin readily detected cerebrospinal fluid csf orexin b 148 orexin also displays much higher lipid solubility orexin b probably making orexin ain contrast orexin bblood brain barrier permeant 89 orexin immunoreactivity found putative endocrine release sites hypothalamus neurohypophysis pancreas see offering interesting possibility orexins could also act hormones cns periphery yet indirect evidence suggests orexin plasma originates peripheral sources 32 brain penetration intravenous orexin seen rat 11
0.35575834.12419707.html.plaintext.txt	22	orexins xenopus laevis also described 163 species preproorexin rather similar humans overall identity 56 xenopus orexin 31 aa long lacking two nh2 terminal amino acids seen human orexin contains 6 aa substitutions compared human orexin fig 1b xenopus orexin b 28 aa long contains 7 aa substitutions compared human orexin b fig 1c xenopus orexins supposed posttranslationally modified way rat orexins disulfide bridges cooh terminal amidation except xenopus orexin contain nh2 terminal pyroglutamoyl residue
0.35575834.12419707.html.plaintext.txt	23	orexins xenopus laevis also described 163 species preproorexin rather similar humans overall identity 56 xenopus orexin 31 aa long lacking two nh2 terminal amino acids seen human orexin contains 6 aa substitutions compared human orexin fig 1b xenopus orexin b 28 aa long contains 7 aa substitutions compared human orexin b fig 1c xenopus orexins supposed posttranslationally modified way rat orexins disulfide bridges cooh terminal amidation except xenopus orexin contain nh2 terminal pyroglutamoyl residue
0.35575834.12419707.html.plaintext.txt	24	orexin preproorexin mrna concentrations show circadian variation rats 1212 h light dark cycle 47 176 196 preproorexin mrna orexin concentration hypothalamus reach maximum around light onset somewhat later minimum light offset somewhat later measurements orexin pons intracisternal space also show diurnal variation time points shifted compared hypothalamus 47 176 contrast mondal et al 126 find circadian variation hypothalamic orexin b concentration time points 5 h dark 5 h light onset may unfortunately chosen light results ref 176 appear bilateral connections suprachiasmatic nucleus orexinergic neurons rat posterior hypothalamus 1 36 64 121 125 may indicate reciprocal regulation circadian rhythms
0.35575834.12419707.html.plaintext.txt	25	orexin preproorexin mrna concentrations show circadian variation rats 1212 h light dark cycle 47 176 196 preproorexin mrna orexin concentration hypothalamus reach maximum around light onset somewhat later minimum light offset somewhat later measurements orexin pons intracisternal space also show diurnal variation time points shifted compared hypothalamus 47 176 contrast mondal et al 126 find circadian variation hypothalamic orexin b concentration time points 5 h dark 5 h light onset may unfortunately chosen light results ref 176 appear bilateral connections suprachiasmatic nucleus orexinergic neurons rat posterior hypothalamus 1 36 64 121 125 may indicate reciprocal regulation circadian rhythms
0.35575834.12419707.html.plaintext.txt	26	two receptors responding orexin stimulation cloned receptors called ox1 ox2 receptors form subclass class g protein coupled receptors class peptide receptor orexin neuropeptide ff receptors orexin receptors receptors rather average g protein coupled receptors modestly long nh2 cooh termini neither long short i3 loops fig 2 ox1 receptor chromosome 1 425 aa long ox2 receptor chromosome 6 444 aa long humans overall 64 sequence identity gene identity one amino acid disputed based entrez search covering variety databases swissprot variety published references ox1 receptor aa 280 i3 loop either gly ala ox2 receptor aa 308 sixth transmembrane segment either val ile amino acids subject polymorphismsmutations also marked fig 2 see also narcolepsy disorder orexinergic system gene transcript receptor composed 5 untranslated region seven separate exons codes part final protein six introns high sequence identity 91 98 comparison made blast httpwwwncbinlmnihgovblast seen cloned mammalian species human pig dog rat mouse variants two neuropeptide ff receptors 14 28 closely related orexin receptors gross sequence identity low 31 35 human receptors longer stretches high identity found identity nearly similar degree observed neuropeptide ff receptor instance neuropeptide y npy receptors furthermore orexin receptors 28 31 identical many peptide receptors including npy y2 thyrotropin tsh releasing hormone trh nk2 tachykinin receptors therefore grouping orexin neuropeptide ff receptors family questionable
0.35575834.12419707.html.plaintext.txt	27	two receptors responding orexin stimulation cloned receptors called ox1 ox2 receptors form subclass class g protein coupled receptors class peptide receptor orexin neuropeptide ff receptors orexin receptors receptors rather average g protein coupled receptors modestly long nh2 cooh termini neither long short i3 loops fig 2 ox1 receptor chromosome 1 425 aa long ox2 receptor chromosome 6 444 aa long humans overall 64 sequence identity gene identity one amino acid disputed based entrez search covering variety databases swissprot variety published references ox1 receptor aa 280 i3 loop either gly ala ox2 receptor aa 308 sixth transmembrane segment either val ile amino acids subject polymorphismsmutations also marked fig 2 see also narcolepsy disorder orexinergic system gene transcript receptor composed 5 untranslated region seven separate exons codes part final protein six introns high sequence identity 91 98 comparison made blast httpwwwncbinlmnihgovblast seen cloned mammalian species human pig dog rat mouse variants two neuropeptide ff receptors 14 28 closely related orexin receptors gross sequence identity low 31 35 human receptors longer stretches high identity found identity nearly similar degree observed neuropeptide ff receptor instance neuropeptide y npy receptors furthermore orexin receptors 28 31 identical many peptide receptors including npy y2 thyrotropin tsh releasing hormone trh nk2 tachykinin receptors therefore grouping orexin neuropeptide ff receptors family questionable
0.35575834.12419707.html.plaintext.txt	28	view larger version 45k fig 2 human orexin receptor sequences putative 7 transmembrane plots sequences swissprot ref 154 putative transmembrane domains represented gpcrdb database ref 68 httpwwwgpcrorg7tm putative n glycosylation sites calculated netnglyc r gupta e jung brunak unpublished httpwwwcbsdtudkservicesnetnglyc putative phosphorylation sites protein kinase pka c pkc ca2calmodulin kinase ii camkii phosphobase ref 95 httpwwwcbsdtudkdatabasesphosphobase possible palmitoylated cysteines also shown amino acids may represent polymorphisms marked see orexin receptors narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	29	cellular responses orexins top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	30	original studies orexin receptors two cellular responses identified recombinantly expressed orexin receptor strongly elevated ca2 chinese hamster ovary cho k1 cells 154 whereas hypothalamic neurons increased action potential frequency observed 37 many systemic responses described thereafter molecular mechanisms cases investigated detail
0.35575834.12419707.html.plaintext.txt	31	original studies orexin receptors two cellular responses identified recombinantly expressed orexin receptor strongly elevated ca2 chinese hamster ovary cho k1 cells 154 whereas hypothalamic neurons increased action potential frequency observed 37 many systemic responses described thereafter molecular mechanisms cases investigated detail
0.35575834.12419707.html.plaintext.txt	32	ox1 ox2 receptors elevate ca2 recombinantly expressed cho cells 67 107 138 154 168 orexin receptors caused ca2 elevations high magnitude cell line devoid voltage gated ca2 channels thought couple phospholipase c inositol 145 trisphosphate ip3 ca2 release cascade via gq family g proteins orexins subsequently shown elevate intracellular ca2 neuronal cell cultures hypothalamus cortex 183 184 ca2 elevations neurons found independent intracellular release require extracellular ca2 fig 3 requirement extracellular ca2 typical property gq mediated response consists ca2 release intracellular stores followed capacitative ca2 entry refill stores observed ca2 elevation neurons blocked bisindoylmaleimide protein kinase c inhibitor therefore suggested orexin receptors would activate protein kinase c would phosphorylate thereby activate voltage gated ca2 channels 183 similar findings described uramura et al 181 isolated rat ventral tegmental neurons orexin determined elevate intracellular ca2 via activation nitrendipine conotoxin sensitive ca2 channels response also sensitive calphostin c inhibitor protein kinase c d609 inhibitor phosphatidylcholine specific phospholipase c suggested following activation sequence orexin receptor phosphatidylcholine specific phospholipase c protein kinase c n l type voltage gated ca2 channels influx ca2 ca2 elevation also measured cultured rat embryonic spinal cord neurons although source ca2 investigated 182 indirect evidence rat locus ceruleus tuberomamillary nucleus also suggests activation ca2 influx 44 70
0.35575834.12419707.html.plaintext.txt	33	ox1 ox2 receptors elevate ca2 recombinantly expressed cho cells 67 107 138 154 168 orexin receptors caused ca2 elevations high magnitude cell line devoid voltage gated ca2 channels thought couple phospholipase c inositol 145 trisphosphate ip3 ca2 release cascade via gq family g proteins orexins subsequently shown elevate intracellular ca2 neuronal cell cultures hypothalamus cortex 183 184 ca2 elevations neurons found independent intracellular release require extracellular ca2 fig 3 requirement extracellular ca2 typical property gq mediated response consists ca2 release intracellular stores followed capacitative ca2 entry refill stores observed ca2 elevation neurons blocked bisindoylmaleimide protein kinase c inhibitor therefore suggested orexin receptors would activate protein kinase c would phosphorylate thereby activate voltage gated ca2 channels 183 similar findings described uramura et al 181 isolated rat ventral tegmental neurons orexin determined elevate intracellular ca2 via activation nitrendipine conotoxin sensitive ca2 channels response also sensitive calphostin c inhibitor protein kinase c d609 inhibitor phosphatidylcholine specific phospholipase c suggested following activation sequence orexin receptor phosphatidylcholine specific phospholipase c protein kinase c n l type voltage gated ca2 channels influx ca2 ca2 elevation also measured cultured rat embryonic spinal cord neurons although source ca2 investigated 182 indirect evidence rat locus ceruleus tuberomamillary nucleus also suggests activation ca2 influx 44 70
0.35575834.12419707.html.plaintext.txt	34	view larger version 20k fig 3 extracellular ca2 dependence orexin stimulated ca2 response rat medial hypothalamic neurons culture data demonstrate extracellular ca2 dependence orexin stimulated ca2 response cells stimulated 1 microm rat hcrt 2 h presence 1 mm 0 mm 0 ca2egta extracellular ca2 concentration ca2o intracellular ca2 levels monitored fura 2 methodology shown response hypocretin 2 completely blocked removal extracellular ca2 experiment performed continuous presence 1 microm tetrodotoxin ttx rat hcrt 2 identical rat orexin b2 28 figure reproduced ref 183 permission copyright 1998 society neuroscience
0.35575834.12419707.html.plaintext.txt	35	general role ca2 influx orexin receptor mediated cellular responses neuronal cells ca2 influx observed fura 2 measurements 181 182 184 also suggested electrophysiological measurements 44 70 orexins may depolarize neurons via block k channels see depolarizing actions ca2 influx may even result indirect activation voltage gated ca2 channels situation may complex sites discussed
0.35575834.12419707.html.plaintext.txt	36	general role ca2 influx orexin receptor mediated cellular responses neuronal cells ca2 influx observed fura 2 measurements 181 182 184 also suggested electrophysiological measurements 44 70 orexins may depolarize neurons via block k channels see depolarizing actions ca2 influx may even result indirect activation voltage gated ca2 channels situation may complex sites discussed
0.35575834.12419707.html.plaintext.txt	37	view larger version 15k fig 4 extracellular ca2 dependence orexin stimulated ca2 response cho cells expressing human ox1 receptors cho hox1 reduction ca2o 140 nm shifts orexin concentration response curve 2 orders magnitude right b orexin mediated ca2 response blocked reducing driving force ca2 entry cho hox1 cell patch clamped whole cell configuration regulate membrane potential therefore driving force ca2 entry ca2 transients measured fura 2 gray boxes black bars indicate presence 10 nm orexin bath light gray box cells exposed orexin holding potential 60 mv dark gray box cells exposed orexin holding potential 50 40 mv inset voltage application profile ca2 response orexin seen negative holding potential indicates ca2 influx required response figure adapted ref 107
0.35575834.12419707.html.plaintext.txt	38	functional experiments indicate addition ca2 release activation store operated ca2 channels several types ca2 influx pathways activated g protein coupled receptors reviewed ref 7 although cases mechanisms clarified pathways may activated directly g protein subunits second messengers pathways may identical related transient receptor potential trp ion channel family reviewed ref 29 trp genes encode family 20 proteins many trp gene products form ca2 permeable nonselective cation channels members trp superfamily even inherent protein kinase adp ribose pyrophosphatase domains trp channels widely expressed mammalian cells activated gq coupled receptor stimulation activation mechanisms many cases unknown interesting see whether trp channels held responsible orexin receptor mediated ca2 influx
0.35575834.12419707.html.plaintext.txt	39	methodological considerations characterization receptor mediated electrical responses neuronal preparations performed common electrophysiological techniques many situations intracellular recordings difficult extracellular electrodes practical use likely induce much less cellular damage hand response measurements usually limited registration action potential frequency measurements intracellular electrodes normal microelectrodes performed feedback amplification allowing voltage current clamp free running mode case voltage changes monitored latter methods importantly offer better possibilities investigation mechanisms underlying electrical activity extracellular electrodes
0.35575834.12419707.html.plaintext.txt	40	recordings neurons usually performed slices similar preparations cells synaptically coupled cell measured thus target upstream signals rather responding directly orexins usual way eliminating secondary effects far upstream measured cell use tetrodotoxin ttx blocking voltage gated na channels hinders action potential propagation neurons however ttx instance block direct effects orexins presynaptic terminal immediately upstream cell investigated therefore ttx exclusively separate pre postsynaptic effects presynaptic voltage gated ca2 channelsand therefore transmitter releasecan blocked example co2 cd2 ni2 specific drugs toxins however orexin receptors may activate ca2 channels sensitive inhibitors see ca2 elevation hand blockers may also affect instance orexin activated ca2 channels voltage gated channels may lead block pre postsynaptic responses orexin example ni2 blocks voltage gated ca2 channel orexin activated non voltage gated ca2 channels 96 even naca2 exchanger 91 synaptic isolation performed using medium low extracellular ca2 03 mm high extracellular mg2 4 mm widely used method appears block electrically evoked synaptic transmission mechanistic basis unclear similarly unknown whether method would affect orexin mediated presynaptic responses mediated voltage gated ca2 channels ca2 release also difficult preclude possible postsynaptic effects
0.35575834.12419707.html.plaintext.txt	41	recordings neurons usually performed slices similar preparations cells synaptically coupled cell measured thus target upstream signals rather responding directly orexins usual way eliminating secondary effects far upstream measured cell use tetrodotoxin ttx blocking voltage gated na channels hinders action potential propagation neurons however ttx instance block direct effects orexins presynaptic terminal immediately upstream cell investigated therefore ttx exclusively separate pre postsynaptic effects presynaptic voltage gated ca2 channelsand therefore transmitter releasecan blocked example co2 cd2 ni2 specific drugs toxins however orexin receptors may activate ca2 channels sensitive inhibitors see ca2 elevation hand blockers may also affect instance orexin activated ca2 channels voltage gated channels may lead block pre postsynaptic responses orexin example ni2 blocks voltage gated ca2 channel orexin activated non voltage gated ca2 channels 96 even naca2 exchanger 91 synaptic isolation performed using medium low extracellular ca2 03 mm high extracellular mg2 4 mm widely used method appears block electrically evoked synaptic transmission mechanistic basis unclear similarly unknown whether method would affect orexin mediated presynaptic responses mediated voltage gated ca2 channels ca2 release also difficult preclude possible postsynaptic effects
0.35575834.12419707.html.plaintext.txt	42	methods give clearer separation pre postsynaptic responses dissociation cells removes presynaptic contacts however even case possible although unlikely responses mediated indirect messengers released neighboring cells measurement synaptic activity method often used studies receptor coupled mechanisms increaseddecreased frequency excitatory inhibitory postsynaptic currents epsc ipsc respectively orexins suggests stimulatory effect transmitter release ie presynaptic effect amplitude synaptic current increased difficult conclude whether response pre postsynaptic
0.35575834.12419707.html.plaintext.txt	43	methods give clearer separation pre postsynaptic responses dissociation cells removes presynaptic contacts however even case possible although unlikely responses mediated indirect messengers released neighboring cells measurement synaptic activity method often used studies receptor coupled mechanisms increaseddecreased frequency excitatory inhibitory postsynaptic currents epsc ipsc respectively orexins suggests stimulatory effect transmitter release ie presynaptic effect amplitude synaptic current increased difficult conclude whether response pre postsynaptic
0.35575834.12419707.html.plaintext.txt	44	increased synaptic activity common electrophysiological response orexins appears increase spontaneous evoked action potential frequency observed extracellular intracellular electrodes increased action potential frequency measured hypothalamus rat tuberomamillary nucleus magnocellular preoptic nucleus lateral hypothalamic glucose sensitive responsive indifferent neurons definition see responses orexinergic cells feeding stimuli arcuate nucleus paraventricular nucleus refs 8 42 44 103 147 159 164 165 195 brain stem rat locus ceruleus substantia nigra pars reticulata dorsal motor nucleus vagus mouse laterodorsal tegmental nucleus refs 15 19 56 70 75 93 170 spinal cord rat preganglionic sympathetic neurons intermediolateral cell column thoracic lumbar cord ref 3 peripheral neurons guinea pig ileal type submucosal neurons ref 92 contrast orexin suppresses firing rate glucose responsive neurons rat ventromedial hypothalamic nucleus antagonizing effect glucose 164 action potentials enhancement orexins blocked ttx 3 44 54 70 75 165 170 195 usually synaptic isolation low ca2 high mg2 8 42 93 147 voltage gated ca2 channel block cd2 170 latter data therefore suggest orexins would directly affect postsynaptic neurons sites reservations methodological shortcomings see also noted putative presynaptic block applied minority studies interestingly ttx insensitive response observed rat locus ceruleus hypocretin 2 orexin b depolarizes increases spontaneous firing frequency locus ceruleus slices 70 presence ttx spontaneous spikes vanish orexin b still causes small depolarization 34 mv electrical discharges although spikes slower spontaneous spikes spikes may caused ca2 channels ttx insensitive na channels
0.35575834.12419707.html.plaintext.txt	45	detailed analysis individual synaptic currents shows enhancement synaptic activity orexins increase spontaneous evoked epsc rat hypothalamus rat superficial dorsal horn mouse laterodorsal tegmental nucleus refs 19 37 49 54 183 184 ipsc rat hypothalamic superficial dorsal horn neurons refs 49 54 183 frequency epscs ipscs blocked ttx rat superficial dorsal horn mouse laterodorsal tegmental nucleus 19 54 rat hypothalamus 49 183 therefore orexin receptor mediating putative presynaptic responses may lie farther upstream rat superficial dorsal horn mouse laterodorsal tegmental nucleus sites depolarization mediated orexins persists presence ttx suggesting orexin receptors expressed cell investigated upstream neuron cases released transmitters causing postsynaptic currents investigated receptor blockers mouse laterodorsal tegmental neurons orexin mediated elevation epsc frequency attenuated ionotropic glutamate receptor block whereas postsynaptic depolarization response affected 19 rat embryonic hypothalamic neurons culture hypocretin 2 orexin b increases ipsc epsc frequency ttx insensitive manner 49 183 former blocked gabaa receptor block latter ionotropic glutamate receptor block rat superficial dorsal horn neurons orexin b mediated increase ipsc frequency inhibited glycine receptor block 54 amplitudes postsynaptic currents potentials also sometimes affected reported guinea pig ileal submucosal ganglia reduced excitatory postsynaptic potential epsp inhibitory postsynaptic potential ipsp amplitude ref 92 mouse laterodorsal tegmental nucleus increased epsc amplitude ref 19 rat arcuate nucleus increased ipsp amplitude ref 183 increased amplitude postsynaptic potentials currents specify pre postsynaptic mechanism cases
0.35575834.12419707.html.plaintext.txt	46	detailed analysis individual synaptic currents shows enhancement synaptic activity orexins increase spontaneous evoked epsc rat hypothalamus rat superficial dorsal horn mouse laterodorsal tegmental nucleus refs 19 37 49 54 183 184 ipsc rat hypothalamic superficial dorsal horn neurons refs 49 54 183 frequency epscs ipscs blocked ttx rat superficial dorsal horn mouse laterodorsal tegmental nucleus 19 54 rat hypothalamus 49 183 therefore orexin receptor mediating putative presynaptic responses may lie farther upstream rat superficial dorsal horn mouse laterodorsal tegmental nucleus sites depolarization mediated orexins persists presence ttx suggesting orexin receptors expressed cell investigated upstream neuron cases released transmitters causing postsynaptic currents investigated receptor blockers mouse laterodorsal tegmental neurons orexin mediated elevation epsc frequency attenuated ionotropic glutamate receptor block whereas postsynaptic depolarization response affected 19 rat embryonic hypothalamic neurons culture hypocretin 2 orexin b increases ipsc epsc frequency ttx insensitive manner 49 183 former blocked gabaa receptor block latter ionotropic glutamate receptor block rat superficial dorsal horn neurons orexin b mediated increase ipsc frequency inhibited glycine receptor block 54 amplitudes postsynaptic currents potentials also sometimes affected reported guinea pig ileal submucosal ganglia reduced excitatory postsynaptic potential epsp inhibitory postsynaptic potential ipsp amplitude ref 92 mouse laterodorsal tegmental nucleus increased epsc amplitude ref 19 rat arcuate nucleus increased ipsp amplitude ref 183 increased amplitude postsynaptic potentials currents specify pre postsynaptic mechanism cases
0.35575834.12419707.html.plaintext.txt	47	depolarizing actions depolarization inward current often measured response orexin application depolarization also results investigated without exception increased action potential frequency often depolarization studied presence ttx block disturbance fig 5 b depolarizations maximum magnitude 3 10 mv observedmainly free running electrodesin hypothalamus rat tuberomamillary nucleus paraventricular nucleus lateral hypothalamic glucose sensitive neurons refs 8 44 103 159 165 brain stem rat locus ceruleus dorsal motor nucleus vagus refs 56 70 75 80 170 spinal cord rat intermediolateral cell column ref 3 periphery guinea pig ileal type submucosal neurons ref 92 inward currents observed rat locus ceruleus 150 pa ref 170 dorsal motor nucleus vagus 30 pa ref 75 superficial dorsal horn 35 pa ref 54 mouse laterodorsal tegmental nucleus 20 pa ref 19
0.35575834.12419707.html.plaintext.txt	48	view larger version 49k fig 5 orexin mediated increase action potential frequency depolarization b rat hypothalamic tuberomamillary nucleus neurons slice preparation whole cell recordings performed intracellular microelectrodes free running mode cells stimulated 300 nm orexin indicated experiment b performed presence 300 nm ttx figure reproduced ref 44 copyright 2001 society neuroscience
0.35575834.12419707.html.plaintext.txt	49	orexin stimulated increases current probably reflect direct effects orexin evidence includes stable currents lack effect ttx synaptic block kinds elimination epscs mechanism depolarization rat lateral hypothalamic glucose sensitive neurons locus ceruleus autonomic preganglionic neurons intermediolateral cell column dorsal motor nucleus vagus guinea pig ileal type submucosal neurons increased input resistance 2 85 measured co occur depolarization 3 75 80 92 103 suggests orexins may inhibit k channels also suggested reduced afterhyperpolarization amplitude observed rat locus ceruleus guinea pig ileal submucosal ganglia 70 92 also current voltage relationship measured suggests k channel inhibition rat locus ceruleus dorsal motor nucleus vagus refs 75 80 hand orexins may activate ca2 dependent k channels suggested mouse peritoneal macrophages 76 interesting orexins instead inhibit slow afterhyperpolarization locus ceruleus thought depend ca2 activated k channels possible orexins elevate ca2 sites signals generated receptor activation counteract effect ca2 elevation
0.35575834.12419707.html.plaintext.txt	50	orexin stimulated increases current probably reflect direct effects orexin evidence includes stable currents lack effect ttx synaptic block kinds elimination epscs mechanism depolarization rat lateral hypothalamic glucose sensitive neurons locus ceruleus autonomic preganglionic neurons intermediolateral cell column dorsal motor nucleus vagus guinea pig ileal type submucosal neurons increased input resistance 2 85 measured co occur depolarization 3 75 80 92 103 suggests orexins may inhibit k channels also suggested reduced afterhyperpolarization amplitude observed rat locus ceruleus guinea pig ileal submucosal ganglia 70 92 also current voltage relationship measured suggests k channel inhibition rat locus ceruleus dorsal motor nucleus vagus refs 75 80 hand orexins may activate ca2 dependent k channels suggested mouse peritoneal macrophages 76 interesting orexins instead inhibit slow afterhyperpolarization locus ceruleus thought depend ca2 activated k channels possible orexins elevate ca2 sites signals generated receptor activation counteract effect ca2 elevation
0.35575834.12419707.html.plaintext.txt	51	cases reduced input resistance noise associated orexin induced depolarization seen rat tuberomamillary nucleus 44 rat lumbar spinal cord 54 mouse laterodorsal tegmental nucleus 19 hypothalamic histaminergic tuberomamillary nucleus orexin b depolarize increase firing rate 8 44 195 fig 5 b depolarization abolished removal extracellular na virtually unaffected increase extracellular k 44 pharmacological block naca2 exchanger reduces depolarization suggesting may mediated ca2 elevation induced activation electrogenic naca2 exchange residual depolarization blocked ni2 may suggest putatively underlying ca2 current also slightly depolarize cells even rat dorsal motor nucleus vagus part current appears depend na remaining part may caused k channel block 75
0.35575834.12419707.html.plaintext.txt	52	cases reduced input resistance noise associated orexin induced depolarization seen rat tuberomamillary nucleus 44 rat lumbar spinal cord 54 mouse laterodorsal tegmental nucleus 19 hypothalamic histaminergic tuberomamillary nucleus orexin b depolarize increase firing rate 8 44 195 fig 5 b depolarization abolished removal extracellular na virtually unaffected increase extracellular k 44 pharmacological block naca2 exchanger reduces depolarization suggesting may mediated ca2 elevation induced activation electrogenic naca2 exchange residual depolarization blocked ni2 may suggest putatively underlying ca2 current also slightly depolarize cells even rat dorsal motor nucleus vagus part current appears depend na remaining part may caused k channel block 75
0.35575834.12419707.html.plaintext.txt	53	finally clear change input resistance may seen rat hypothalamic paraventricular nucleus 165 locus ceruleus 56 170 intermediolateral cell column 3 could occur increased conductance caused opening ion channels na ca2 compensated closure channels k orexins rather affected transporters even single cell orexins may utilize several mechanisms depolarization 44 75
0.35575834.12419707.html.plaintext.txt	54	finally clear change input resistance may seen rat hypothalamic paraventricular nucleus 165 locus ceruleus 56 170 intermediolateral cell column 3 could occur increased conductance caused opening ion channels na ca2 compensated closure channels k orexins rather affected transporters even single cell orexins may utilize several mechanisms depolarization 44 75
0.35575834.12419707.html.plaintext.txt	55	summary orexin effects electrical activity neurons thus orexins often increase neuronal activity via presynaptic effects increased transmitter release via unknown mechanisms via postsynaptic depolarization block k channels activation cation channels electrogenic transporters effects putative k channel inhibition typical gq coupled receptors see eg refs 59 65 112 187 mechanisms may secondary ca2 elevation may depend activation nonselective cation channels like trp channels particular neurons orexins may also cause inhibition via increased inhibitory transmitter release via decreased postsynaptic effects excitatory transmitters unclear direct indirect roles ca2 transients play electrical responses orexins much effort put investigation date independent method measurement electrical activity effects orexins usually slow onset action 10 4 min recovery even slower see eg refs 3 9 19 44 54 75 93 103 159 165 195 studies performed slices preparation perfusion orexins may slow however rather superficial neurons patched obvious reason perfusate would reach neurons immediately furthermore similar slow onset 10 20 lag 1 min maximum delayed offset 2 min complete decay removal seen dissociated neurons 195 therefore possible orexins affect ion channels via eg phosphorylation rather direct g protein interaction results indicate involvement protein kinase c orexin responses 93 181 183 orexin b reported reduce n methyl d aspartate nmda induced current amplitude 19 enhance gaba induced current amplitude 48 dissociated rat nucleus accumbens cells 113 could also possibly phosphorylation dependent event
0.35575834.12419707.html.plaintext.txt	56	summary orexin effects electrical activity neurons thus orexins often increase neuronal activity via presynaptic effects increased transmitter release via unknown mechanisms via postsynaptic depolarization block k channels activation cation channels electrogenic transporters effects putative k channel inhibition typical gq coupled receptors see eg refs 59 65 112 187 mechanisms may secondary ca2 elevation may depend activation nonselective cation channels like trp channels particular neurons orexins may also cause inhibition via increased inhibitory transmitter release via decreased postsynaptic effects excitatory transmitters unclear direct indirect roles ca2 transients play electrical responses orexins much effort put investigation date independent method measurement electrical activity effects orexins usually slow onset action 10 4 min recovery even slower see eg refs 3 9 19 44 54 75 93 103 159 165 195 studies performed slices preparation perfusion orexins may slow however rather superficial neurons patched obvious reason perfusate would reach neurons immediately furthermore similar slow onset 10 20 lag 1 min maximum delayed offset 2 min complete decay removal seen dissociated neurons 195 therefore possible orexins affect ion channels via eg phosphorylation rather direct g protein interaction results indicate involvement protein kinase c orexin responses 93 181 183 orexin b reported reduce n methyl d aspartate nmda induced current amplitude 19 enhance gaba induced current amplitude 48 dissociated rat nucleus accumbens cells 113 could also possibly phosphorylation dependent event
0.35575834.12419707.html.plaintext.txt	57	discussed increased synaptic activity orexins may increase transmitter release indicated increaseddecreased synaptic potential frequency direct indications presynaptic effects orexins presence ttx rather certainly suggest presynaptic site orexin effects inhibition k stimulated serotonin release orexin b rat hypothalamic synaptosomes also directly shows presynaptic site action 140 also indirect indications orexin stimulated transmitter release vitro slice norepinephrine rat cerebral cortex ref 66 vivo microdialysis histamine rat anterior hypothalamus ref 79 studies cases impossible tell whether orexins directly affect releasing neurons upstream neurons complex mechanism suggested delayed 6 min response rat cerebrocortical slices
0.35575834.12419707.html.plaintext.txt	58	discussed increased synaptic activity orexins may increase transmitter release indicated increaseddecreased synaptic potential frequency direct indications presynaptic effects orexins presence ttx rather certainly suggest presynaptic site orexin effects inhibition k stimulated serotonin release orexin b rat hypothalamic synaptosomes also directly shows presynaptic site action 140 also indirect indications orexin stimulated transmitter release vitro slice norepinephrine rat cerebral cortex ref 66 vivo microdialysis histamine rat anterior hypothalamus ref 79 studies cases impossible tell whether orexins directly affect releasing neurons upstream neurons complex mechanism suggested delayed 6 min response rat cerebrocortical slices
0.35575834.12419707.html.plaintext.txt	59	camp elevation response orexin stimulation reported rat human adrenal cortices putatively via ox1 receptors 110 117 contrast primary cultures rat hypothalamic neurons elevation camp seen 183 elevation camp may occur several mechanisms depending isoform adenylyl cyclase expressed adenylyl cyclase isoforms differentially activated ca2 protein kinase c g protein subunits 171 expression adenylyl cyclase isoforms may different adrenal cortex hypothalamus g proteins might also expressed tissue specifically ox1 ox2 receptors could couple different g proteins ox2 receptors reported couple gi gs go gq proteins human fetal adrenal glands 88 gi gs gq go proteins adult human adrenal glands 146 measured gtp azidoanilide labeling method
0.35575834.12419707.html.plaintext.txt	60	camp elevation response orexin stimulation reported rat human adrenal cortices putatively via ox1 receptors 110 117 contrast primary cultures rat hypothalamic neurons elevation camp seen 183 elevation camp may occur several mechanisms depending isoform adenylyl cyclase expressed adenylyl cyclase isoforms differentially activated ca2 protein kinase c g protein subunits 171 expression adenylyl cyclase isoforms may different adrenal cortex hypothalamus g proteins might also expressed tissue specifically ox1 ox2 receptors could couple different g proteins ox2 receptors reported couple gi gs go gq proteins human fetal adrenal glands 88 gi gs gq go proteins adult human adrenal glands 146 measured gtp azidoanilide labeling method
0.35575834.12419707.html.plaintext.txt	61	orexin receptors may also couple protein kinase cascades involved cell growth differentiation death effects clearly seen orexin receptors expressed cho cells ammoun l korhonen l lindholm k e o akerman j p kukkonen unpublished observation one immediate indications rapid activation mitogen activated protein kinase mapk pathways seen ox1 receptor stimulation fig 6
0.35575834.12419707.html.plaintext.txt	62	orexin receptors may also couple protein kinase cascades involved cell growth differentiation death effects clearly seen orexin receptors expressed cho cells ammoun l korhonen l lindholm k e o akerman j p kukkonen unpublished observation one immediate indications rapid activation mitogen activated protein kinase mapk pathways seen ox1 receptor stimulation fig 6
0.35575834.12419707.html.plaintext.txt	63	view larger version 28k fig 6 mitogen activated protein kinase mapk activation response ox1 receptor stimulation cho hox1 cells ammoun l korhonen l lindholm k e o akerman j p kukkonen unpublished observation extracellular signal regulated kinase erk1 2 activation measured blotting respective phosphorylated species specific antibodies 3 100 nm orexin lead rapid 3 min activation mainly erk2 response clearly decreased 30 min time point lower concentration
0.35575834.12419707.html.plaintext.txt	64	ox1 ox2 receptors already shown original study different binding affinities orexin b 154 expressed recombinantly cho cells ox1 receptor 10 times higher affinity orexin orexin b whereas ox2 receptor binds orexin b equal affinity selectivity seen respect ca2 elevation thus orexin activates ox1 receptors 10 times potently orexin b 138 154 168 thus evidence selectivity ox1 receptor nonselectivity ox2 receptor orexin b based solely studies ca2 elevation recombinant cho cells difficult find exclusive expression one subtype tissue cases support selectivity found orexin 55 fold potent increasing electrical activity rat locus ceruleus ox1 expression dominates 170 isolated human adrenocortical cells ox1 mrna also predominantly found orexin orexin b stimulates cortisol secretion 117 tissues ox2 expression dominates rat tuberomamillary nucleus orexin b essentially equipotent stimulating electrical activity orexin b also equally potent releasing catecholamines human pheochromocytoma cells express ox2 mrna 116 hand putatively ox2 mediated adrenocorticotropic hormone acth release 10 fold less sensitive orexin b orexin 13 158 generally dangerous rely called selective agonists efficacies dependent receptor g protein expression levels pharmacological reasons chemical differences orexin b see genetics chemistry orexins conclusions receptor subtype involvement based potency orexin variants 42 113 138 158 probably avoided studies report higher potency orexin b orexin respect responses 76 85 unexplainable basis recombinant pharmacology even pharmacological selectivity respect interaction orexin b orexin receptor subtypes occur tissues physiological significance would unclear
0.35575834.12419707.html.plaintext.txt	65	ox1 ox2 receptors already shown original study different binding affinities orexin b 154 expressed recombinantly cho cells ox1 receptor 10 times higher affinity orexin orexin b whereas ox2 receptor binds orexin b equal affinity selectivity seen respect ca2 elevation thus orexin activates ox1 receptors 10 times potently orexin b 138 154 168 thus evidence selectivity ox1 receptor nonselectivity ox2 receptor orexin b based solely studies ca2 elevation recombinant cho cells difficult find exclusive expression one subtype tissue cases support selectivity found orexin 55 fold potent increasing electrical activity rat locus ceruleus ox1 expression dominates 170 isolated human adrenocortical cells ox1 mrna also predominantly found orexin orexin b stimulates cortisol secretion 117 tissues ox2 expression dominates rat tuberomamillary nucleus orexin b essentially equipotent stimulating electrical activity orexin b also equally potent releasing catecholamines human pheochromocytoma cells express ox2 mrna 116 hand putatively ox2 mediated adrenocorticotropic hormone acth release 10 fold less sensitive orexin b orexin 13 158 generally dangerous rely called selective agonists efficacies dependent receptor g protein expression levels pharmacological reasons chemical differences orexin b see genetics chemistry orexins conclusions receptor subtype involvement based potency orexin variants 42 113 138 158 probably avoided studies report higher potency orexin b orexin respect responses 76 85 unexplainable basis recombinant pharmacology even pharmacological selectivity respect interaction orexin b orexin receptor subtypes occur tissues physiological significance would unclear
0.35575834.12419707.html.plaintext.txt	66	molecular determinants required orexin peptides binding activation orexin receptors investigated cho cells comparison structures activities orexin b suggests nh2 terminal amino acids less important receptor binding activation cooh terminal amino acids 33 truncation orexin orexin a15 33 reduces potency ox1 ox2 receptors 20 60 fold 33 138 truncation successively abolishes ca2 response least ox1 33 mutation cystine forming cysteines alanines orexin reduces potency mutant peptides ox1 ox2 receptors 10 fold 138 however difficult judge whether effect due lost disulfide bridges exchanged cysteines one one replacement amino acid orexin a15 33 alanine alanine scan revealed regions particular importance orexin activation ox1 receptor particular leucines 19 20 cooh terminal aa 26 33 seem great importance 33 recently observed ammoun holmqvist r shariatmadari r oonk m detheux m parmentier k e o akerman j p kukkonen unpublished observations ox1 ox2 receptors approximately equally sensitive nh2 terminal truncation alanine scan orexin peptides amino acids importance largely described ref 33 changeremoval amino acids affects ox1 ox2 receptors interesting differences seen potency response interestingly none mutated peptides without activity antagonists
0.35575834.12419707.html.plaintext.txt	67	molecular determinants required orexin peptides binding activation orexin receptors investigated cho cells comparison structures activities orexin b suggests nh2 terminal amino acids less important receptor binding activation cooh terminal amino acids 33 truncation orexin orexin a15 33 reduces potency ox1 ox2 receptors 20 60 fold 33 138 truncation successively abolishes ca2 response least ox1 33 mutation cystine forming cysteines alanines orexin reduces potency mutant peptides ox1 ox2 receptors 10 fold 138 however difficult judge whether effect due lost disulfide bridges exchanged cysteines one one replacement amino acid orexin a15 33 alanine alanine scan revealed regions particular importance orexin activation ox1 receptor particular leucines 19 20 cooh terminal aa 26 33 seem great importance 33 recently observed ammoun holmqvist r shariatmadari r oonk m detheux m parmentier k e o akerman j p kukkonen unpublished observations ox1 ox2 receptors approximately equally sensitive nh2 terminal truncation alanine scan orexin peptides amino acids importance largely described ref 33 changeremoval amino acids affects ox1 ox2 receptors interesting differences seen potency response interestingly none mutated peptides without activity antagonists
0.35575834.12419707.html.plaintext.txt	68	xenopus orexin b proposed 10 fold higher affinity potency xenopus orexin human ox2 receptor expressed cho cells 163 xenopus orexin b equipotent human ox1 receptor synthetic peptides hcrt 1 hcrt 2 based originally described hypocretin sequences 37 shown 1000 fold less potent corresponding orexin peptides respect ca2 elevation recombinant cho cells 167
0.35575834.12419707.html.plaintext.txt	69	xenopus orexin b proposed 10 fold higher affinity potency xenopus orexin human ox2 receptor expressed cho cells 163 xenopus orexin b equipotent human ox1 receptor synthetic peptides hcrt 1 hcrt 2 based originally described hypocretin sequences 37 shown 1000 fold less potent corresponding orexin peptides respect ca2 elevation recombinant cho cells 167
0.35575834.12419707.html.plaintext.txt	70	50 studies cellular responses rather high concentrations 100 nm orexins used evoke response even ec50 values determined rather high eg 200 nm orexin rat locus ceruleus increased firing ref 170 hand even subnanomolar concentrations evoke responses eg ca2 response rat ventral tegmental neurons ref 130 resolve mechanical basis experiments could performed recombinant expression systems different expression levels measurement different responses another reason high concentrations required tissues may use orexin b ox1 receptor use hypocretins based original sequences weak potencies reported recombinant systems hold true tissues see
0.35575834.12419707.html.plaintext.txt	71	50 studies cellular responses rather high concentrations 100 nm orexins used evoke response even ec50 values determined rather high eg 200 nm orexin rat locus ceruleus increased firing ref 170 hand even subnanomolar concentrations evoke responses eg ca2 response rat ventral tegmental neurons ref 130 resolve mechanical basis experiments could performed recombinant expression systems different expression levels measurement different responses another reason high concentrations required tissues may use orexin b ox1 receptor use hypocretins based original sequences weak potencies reported recombinant systems hold true tissues see
0.35575834.12419707.html.plaintext.txt	72	moment reliable vivo selectivity obtained known orexin receptor agonists recently synthesis orexin receptor subtype selective antagonist reported 145 169 antagonist sb 334867 fig 1d displays 100 fold higher affinity ox1 ox2 receptor selectivity successfully utilized vivo experiments elucidate role ox1 receptors systemic effects orexins see systemic effects orexins unfortunately antagonist able block ox2 receptors available conclusions role ox1 receptors physiological processes based solely sb 334867 orexin receptor subtypes may overlapping interacting roles however sb 334867 uniquely useful tool orexin receptor investigations perspective unfortunate sb 334867 widely available orexin receptor researchers
0.35575834.12419707.html.plaintext.txt	73	moment reliable vivo selectivity obtained known orexin receptor agonists recently synthesis orexin receptor subtype selective antagonist reported 145 169 antagonist sb 334867 fig 1d displays 100 fold higher affinity ox1 ox2 receptor selectivity successfully utilized vivo experiments elucidate role ox1 receptors systemic effects orexins see systemic effects orexins unfortunately antagonist able block ox2 receptors available conclusions role ox1 receptors physiological processes based solely sb 334867 orexin receptor subtypes may overlapping interacting roles however sb 334867 uniquely useful tool orexin receptor investigations perspective unfortunate sb 334867 widely available orexin receptor researchers
0.35575834.12419707.html.plaintext.txt	74	recently variety peptide transmitters including secretin npy variants reported inhibit orexin binding membrane preparations endogenous recombinant cells expressing ox1 receptors even nanomolar affinity 87 results interpreted indicate interaction orexinergic npyergic systems see connections orexinergic pathways feeding regulating transmittershormones could occur orexin receptor level results binding could however verified functional experiments binding experiments intact cells 67 169 peptides secretin pituitary adenylate cyclase activating polypeptide pacap npy variants display detectable affinity activity ox1 ox2 receptors 67 169 suggested ref 67 likely peptides affect intracellular process instance g protein binding receptor required high affinity agonist binding therefore reduce orexin binding particular preparations therefore secretin used define specific orexin binding lead possibly erroneous conclusions 86 188
0.35575834.12419707.html.plaintext.txt	75	recently variety peptide transmitters including secretin npy variants reported inhibit orexin binding membrane preparations endogenous recombinant cells expressing ox1 receptors even nanomolar affinity 87 results interpreted indicate interaction orexinergic npyergic systems see connections orexinergic pathways feeding regulating transmittershormones could occur orexin receptor level results binding could however verified functional experiments binding experiments intact cells 67 169 peptides secretin pituitary adenylate cyclase activating polypeptide pacap npy variants display detectable affinity activity ox1 ox2 receptors 67 169 suggested ref 67 likely peptides affect intracellular process instance g protein binding receptor required high affinity agonist binding therefore reduce orexin binding particular preparations therefore secretin used define specific orexin binding lead possibly erroneous conclusions 86 188
0.35575834.12419707.html.plaintext.txt	76	distribution orexinergic cells orexin receptors top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	77	distribution orexinergic cells investigated molecular biological immunological methods give rather similar results main peptide investigated orexin comparison distribution orexin orexin b preproorexin suggests extensive colocalization therefore data pooled data orexin distribution originate rat investigated vertebrate species given similar results
0.35575834.12419707.html.plaintext.txt	78	distribution orexinergic cells investigated molecular biological immunological methods give rather similar results main peptide investigated orexin comparison distribution orexin orexin b preproorexin suggests extensive colocalization therefore data pooled data orexin distribution originate rat investigated vertebrate species given similar results
0.35575834.12419707.html.plaintext.txt	79	orexinergic cell bodies rat cns
0.35575834.12419707.html.plaintext.txt	80	rat brain orexinergic cell bodies found solely hypothalamus within hypothalamus cell bodies reside bilaterally symmetrically lateral parts probably abundantly perifornical areas 17 24 31 36 37 56 58 69 70 131 orexinergic cells interspersed among melanocyte concentrating hormone mch ergic cells 24 143 however overlap areas complete 17 mchergic cells clearly different orexinergic cells 17 43 58 143 although otherwise share properties orexinergic cells 1 69 71 isolated orexinergic cell bodies also reported median eminence posterior dorsal dorsomedial hypothalamus arcuate subincertal nuclei 24 31 143
0.35575834.12419707.html.plaintext.txt	81	rat brain orexinergic cell bodies found solely hypothalamus within hypothalamus cell bodies reside bilaterally symmetrically lateral parts probably abundantly perifornical areas 17 24 31 36 37 56 58 69 70 131 orexinergic cells interspersed among melanocyte concentrating hormone mch ergic cells 24 143 however overlap areas complete 17 mchergic cells clearly different orexinergic cells 17 43 58 143 although otherwise share properties orexinergic cells 1 69 71 isolated orexinergic cell bodies also reported median eminence posterior dorsal dorsomedial hypothalamus arcuate subincertal nuclei 24 31 143
0.35575834.12419707.html.plaintext.txt	82	orexinergic neurons variable size diameter cell body 15 40 microm shape spherical fusiform multipolar 24 31 36 131 assumed number 1100 3400 whole rat brain 61 143 orexinergic cells shown project orexinergic cells within hypothalamus 69 might different populations orexinergic cells within hypothalamus
0.35575834.12419707.html.plaintext.txt	83	orexinergic neurons variable size diameter cell body 15 40 microm shape spherical fusiform multipolar 24 31 36 131 assumed number 1100 3400 whole rat brain 61 143 orexinergic cells shown project orexinergic cells within hypothalamus 69 might different populations orexinergic cells within hypothalamus
0.35575834.12419707.html.plaintext.txt	84	preproorexin mrna protein even detected ependymal cell layer 97 143 orexin found choroid plexi 31 would interesting find whether expression occurs ependymal cells instance neuronal stem cells
0.35575834.12419707.html.plaintext.txt	85	preproorexin mrna protein even detected ependymal cell layer 97 143 orexin found choroid plexi 31 would interesting find whether expression occurs ependymal cells instance neuronal stem cells
0.35575834.12419707.html.plaintext.txt	86	orexinergic projections rat cns
0.35575834.12419707.html.plaintext.txt	87	orexinergic fibers visualized mainly using orexin immunohistochemistry orexin smooth varicose fibers observed 31 143 varicose fibers appear ones often seen although result might also caused easier detection kind processes studies investigating orexin b distribution report projection sites similar orexin 31 36
0.35575834.12419707.html.plaintext.txt	88	orexinergic fibers visualized mainly using orexin immunohistochemistry orexin smooth varicose fibers observed 31 143 varicose fibers appear ones often seen although result might also caused easier detection kind processes studies investigating orexin b distribution report projection sites similar orexin 31 36
0.35575834.12419707.html.plaintext.txt	89	despite low number orexinergic cell bodies hypothalamus orexinergic fibers project widely cns important orexinergic projection areas within hypothalamus two thalamic nuclei brain stem whole length spinal cord table 1 see also fig 7 interested readers recommended consult original papers detailed 24 31 34 36 37 61 69 71 97 125 126 154 182
0.35575834.12419707.html.plaintext.txt	90	despite low number orexinergic cell bodies hypothalamus orexinergic fibers project widely cns important orexinergic projection areas within hypothalamus two thalamic nuclei brain stem whole length spinal cord table 1 see also fig 7 interested readers recommended consult original papers detailed 24 31 34 36 37 61 69 71 97 125 126 154 182
0.35575834.12419707.html.plaintext.txt	91	view table table 1 orexin distribution rat central nervous system
0.35575834.12419707.html.plaintext.txt	92	view table table 1 orexin distribution rat central nervous system
0.35575834.12419707.html.plaintext.txt	93	view larger version 27k fig 7 orexinergic pathways according refs 24 31 34 36 37 61 69 71 125 126 154 182 orexin receptor mrna distribution according refs 111 180 rat minority sites shown density hatching 3 different levels indicates ox1 ox2 receptor mrna expression levels noted subregions within marked regions display different expression eg hypothalamus cannot shown figure data 2 references diverging even contradictory average taken arcn arcuate nucleus ca1 3 areas hippocampus cc cingulate cortex cmn centromedial nucleus dr dorsal raphe nucleus lc locus ceruleus median eminence mr median raphe nucleus nst nucleus solitary tract olfb olfactory bulb olft olfactory tubercle pvn paraventricular nucleus thalamus hypothalamus rm nucleus raphe magnus ro nucleus raphe obscurus scn suprachiasmatic nucleus son supraoptic nucleus stn spinal trigeminal nucleus tmn tuberomamillary nucleus vamn ventral anteromedial nucleus
0.35575834.12419707.html.plaintext.txt	94	orexins cns species
0.35575834.12419707.html.plaintext.txt	95	studies conducted species rat however studies performed results seem good agreement studies rat several vertebrate species table 2 orexinergic cells found hypothalamic areas similar rat cells assumed number 20000 50000 83000 dog human brain respectively 148 178 projection areas also appear similar rat species table 2 however studies limited areas investigated making full conclusions impossible also species orexinergic neurites often determined varicose
0.35575834.12419707.html.plaintext.txt	96	studies conducted species rat however studies performed results seem good agreement studies rat several vertebrate species table 2 orexinergic cells found hypothalamic areas similar rat cells assumed number 20000 50000 83000 dog human brain respectively 148 178 projection areas also appear similar rat species table 2 however studies limited areas investigated making full conclusions impossible also species orexinergic neurites often determined varicose
0.35575834.12419707.html.plaintext.txt	97	view table table 2 distribution orexinergic cells pathways species
0.35575834.12419707.html.plaintext.txt	98	view table table 2 distribution orexinergic cells pathways species
0.35575834.12419707.html.plaintext.txt	99	similarly orexins orexin receptor distribution investigated molecular biological immunological methods almost data originate rat altogether orexin receptors found projection sites orexinergic neurons see suggests orexinergic neurons contact many different transmitter systems see studies specified whether expression seen neurons cells although electrophysiological measurements whenever performed indicate activation neurons levels orexin receptors necessarily fully follow density orexinergic innervation cases synaptic contacts anatomically shown 48 55 70 195 localization orexinergic cellsprocesses close ventricular surfaces 24 31 97 143 suggests orexins could act paracrine endocrine fashion
0.35575834.12419707.html.plaintext.txt	100	similarly orexins orexin receptor distribution investigated molecular biological immunological methods almost data originate rat altogether orexin receptors found projection sites orexinergic neurons see suggests orexinergic neurons contact many different transmitter systems see studies specified whether expression seen neurons cells although electrophysiological measurements whenever performed indicate activation neurons levels orexin receptors necessarily fully follow density orexinergic innervation cases synaptic contacts anatomically shown 48 55 70 195 localization orexinergic cellsprocesses close ventricular surfaces 24 31 97 143 suggests orexins could act paracrine endocrine fashion
0.35575834.12419707.html.plaintext.txt	101	similar amounts ox1 ox2 mrna found rat brain whole ox1 ox2 receptor mrnas mostly show similar distribution although differences seen fig 7 interesting areas essentially one subtype expressed 111 180 however mrna expression may directly correspond receptor protein expression discussed van den pol et al 184 correlation receptor distribution different functions orexinergic system shown table 3 article review studies expression ox1 ox2 receptor protein rat cns published 30 64 particularly interesting finding expression ox2 receptor protein molecular granular layers cerebellum 30 earlier studies failed detect orexin receptors mrna cerebellum although orexinergic fibers projecting cerebellum otherwise immunohistochemical studies suggest distribution generally similar mrna measurements although differences seen instance greater overlap expression ox1 ox2 receptors suggested basis immunological studies situ hybridization discussed authors differences may degree related fact mrna measurements visualize expressing cell bodies whereas immunohistochemistry indicates actual cellular localization protein receptor mrna protein measurements semiquantitative rather quantitative allow absolute comparison subtype expression within site
0.35575834.12419707.html.plaintext.txt	102	view table table 3 orexin receptor mrna distribution respect postulated functions
0.35575834.12419707.html.plaintext.txt	103	view table table 3 orexin receptor mrna distribution respect postulated functions
0.35575834.12419707.html.plaintext.txt	104	coexpression connections orexins transmitters
0.35575834.12419707.html.plaintext.txt	105	despite partial overlap distribution orexinergic mchergic cell bodies coexpression peptides cells refs 17 58 143 figs 8 9 contrast essentially orexin prodynorphin expression colocalizes lateral hypothalamus 10 27 orexinergic neurons may also coexpress transmitters galanin 58 glutamate 1
0.35575834.12419707.html.plaintext.txt	106	view larger version 26k fig 8 connections lateral hypothalamic orexinergic neurons transmittershormones orexinergic cells also express dynorphin least also express ob rb long form leptin receptor leptin receptor activated promoter element stat3 subpopulations orexinergic cells may release galanin glutamate references see text thin black arrows indicate input orexinergic cells thick gray arrows indicate orexinergic output anatomic loci arcn lc laterodorsal tegmental nucleus ldtn lateral hypothalamus lh hypothalamic periventricular nucleus pevn preoptic area poa pvn raphe nuclei raphe n scn substantia nigra sn tmn ventral tegmental area vta ach acetylcholine agrp agouti gene related peptide avp arginine vasopressin cart cocaineamphetamine regulated transcript crf corticotropin releasing hormone da dopamine 5 ht 5 hydroxytryptamine serotonin glu glutamate ha histamine mch melanocyte concentrating hormone ne norepinephrine npy neuropeptide y pomc proopiomelanocortin sst somatostatin vip vasoactive intestinal peptide
0.35575834.12419707.html.plaintext.txt	107	view larger version 14k fig 9 connections orexins appetite regulating transmittershormones hypothalamus arrows marked indicate stimulation inhibition respectively neuronal activity release synthesis hormones affected site plus minus indicates either stimulatory inhibitory effects different conditions toward similar cells different anatomic loci unmarked arrows indicate connections unknown effects indicated text orexinergic neurons may either respond glucose reciprocal connections glucose sensitive gsn glucose responding grn neurons thus clear whether effect glucose neurons lh arcn direct mediated sensor neurons therefore glucose gsn grn grouped figure dotted line solid lines indicate anatomically defined hypothalamic areas
0.35575834.12419707.html.plaintext.txt	108	vasoactive intestinal peptide vip vasopressin npy containing neurons innervate orexinergic neurons hypothalamus refs 1 69 71 figs 8 9 hand orexinergic nerves lateral hypothalamus innervate neuronal circuits utilize many different transmitters instance norepinephrine dopamine serotonin histamine acetylcholine vasopressin vip somatostatin corticotropin releasing hormone crf npyagouti gene related peptide agrp proopiomelanocortin pomc cocaine amphetamine regulated transcript cart gaba mch glutamate figs 8 9 anatomy see eg refs 5 31 36 131 143 even functional responses orexins shown sites eg refs 9 18 19 42 44 49 56 70 80 93 113 130 159 165 170 183 195 see cellular responses orexins orexinergic neurons even make contact orexinergic neurons within hypothalamus 5 69
0.35575834.12419707.html.plaintext.txt	109	connections orexinergic pathways feeding regulating transmittershormones orexins first isolated appetite increasing peptides although view later disputed several hypothalamic sites involved regulation feeding lateral hypothalamic area parvocellular paraventricular nucleus ventromedial nucleus arcuate nucleus innervated orexinergic fibers lateral hypothalamic area see eg ref 36 ox1 ox2 receptors may expressed projection areas 111 abundant connections orexin feeding regulating transmittershormones leptin npy mch pomc cart galanin agrp figs 8 9 almost orexin positive cells also express leptin receptor even stat3the leptin receptor activated promoter elementand orexin coexpressed refs 58 69 fig 8 see also effects orexins gastrointestinal tract organs feedingenergy metabolism hand leptin receptor positive cells lateral hypothalamic areas orexinergic cell bodies lie orexin positive 58 cells express leptin receptors mchergic neurons lateral hypothalamus npy agrp pomc cartergic cells arcuate nucleus refs 69 57 58 119 fig 9 orexinergic fibers project npy pomcergic cells arcuate nucleus 69 hand npyagrp pomcergic fibers likely arcuate nucleus project orexin mchergic cells lateral hypothalamus 17 43 55 69 71 orexinergic cells lateral hypothalamus also contain feeding regulating transmitters dynorphin galanin refs 10 27 58 fig 9 may enhance effects orexins feeding
0.35575834.12419707.html.plaintext.txt	110	connections orexinergic pathways feeding regulating transmittershormones orexins first isolated appetite increasing peptides although view later disputed several hypothalamic sites involved regulation feeding lateral hypothalamic area parvocellular paraventricular nucleus ventromedial nucleus arcuate nucleus innervated orexinergic fibers lateral hypothalamic area see eg ref 36 ox1 ox2 receptors may expressed projection areas 111 abundant connections orexin feeding regulating transmittershormones leptin npy mch pomc cart galanin agrp figs 8 9 almost orexin positive cells also express leptin receptor even stat3the leptin receptor activated promoter elementand orexin coexpressed refs 58 69 fig 8 see also effects orexins gastrointestinal tract organs feedingenergy metabolism hand leptin receptor positive cells lateral hypothalamic areas orexinergic cell bodies lie orexin positive 58 cells express leptin receptors mchergic neurons lateral hypothalamus npy agrp pomc cartergic cells arcuate nucleus refs 69 57 58 119 fig 9 orexinergic fibers project npy pomcergic cells arcuate nucleus 69 hand npyagrp pomcergic fibers likely arcuate nucleus project orexin mchergic cells lateral hypothalamus 17 43 55 69 71 orexinergic cells lateral hypothalamus also contain feeding regulating transmitters dynorphin galanin refs 10 27 58 fig 9 may enhance effects orexins feeding
0.35575834.12419707.html.plaintext.txt	111	responses orexinergic cells feeding stimuli hypoglycemia induced various means shown increase c fos see orexin preproorexin mrna expression subpopulation orexinergic cells lateral hypothalamus 16 20 22 53 99 105 127 see also effects orexins gastrointestinal tract organs feedingenergy metabolism fasting also abolishes circadian variation csf orexin levels 47 lateral hypothalamic area well hypothalamic regions contains neurons activated decreased levels glucose glucose sensitive neurons neurons activated elevated levels glucose glucose responsive neurons ref 101 fig 9 study muroya et al 129 almost half histochemically defined orexinergic neurons rat lateral hypothalamus directly responded lowering extracellular glucose increase cytosolic ca2 thus glucose sensitive neurons lateral hypothalamus may orexinergic liu et al 103 identified glucose sensitive responsive indifferent populations among rat hypothalamic neurons responded orexin stimulation depolarization increased firing rate contrast orexin suppressed firing rate glucose responsive neurons rat ventromedial hypothalamic nucleus 164 orexinergic neurons may also make contact andor contacted glucose sensitive responsive neurons brain areas lateral hypothalamus ventromedial hypothalamus arcuate nucleus nucleus solitary tract ref 101 see also anatomic studies orexinergic projections
0.35575834.12419707.html.plaintext.txt	112	responses orexinergic cells feeding stimuli hypoglycemia induced various means shown increase c fos see orexin preproorexin mrna expression subpopulation orexinergic cells lateral hypothalamus 16 20 22 53 99 105 127 see also effects orexins gastrointestinal tract organs feedingenergy metabolism fasting also abolishes circadian variation csf orexin levels 47 lateral hypothalamic area well hypothalamic regions contains neurons activated decreased levels glucose glucose sensitive neurons neurons activated elevated levels glucose glucose responsive neurons ref 101 fig 9 study muroya et al 129 almost half histochemically defined orexinergic neurons rat lateral hypothalamus directly responded lowering extracellular glucose increase cytosolic ca2 thus glucose sensitive neurons lateral hypothalamus may orexinergic liu et al 103 identified glucose sensitive responsive indifferent populations among rat hypothalamic neurons responded orexin stimulation depolarization increased firing rate contrast orexin suppressed firing rate glucose responsive neurons rat ventromedial hypothalamic nucleus 164 orexinergic neurons may also make contact andor contacted glucose sensitive responsive neurons brain areas lateral hypothalamus ventromedial hypothalamus arcuate nucleus nucleus solitary tract ref 101 see also anatomic studies orexinergic projections
0.35575834.12419707.html.plaintext.txt	113	leptin thought one major negative regulators orexin expression hypothalamus see effects orexins feeding behavior probably directly via leptin receptors orexinergic cells via leptin receptors feeding controlling cells connected orexinergic cells see attempts elucidate leptin orexin interaction measurement orexin orexin mrna levels made rodent model systems defective leptin signaling fafa zucker rats dbdb mice devoid functional leptin receptors obob mice devoid leptin reviewed ref 21 results however contradictory conclusion drawn leptin necessarily required keep orexin expression low however also often knockout systems difficult evaluate physiological role possible multiple disturbances redundancy signaling compensatory mechanisms
0.35575834.12419707.html.plaintext.txt	114	leptin thought one major negative regulators orexin expression hypothalamus see effects orexins feeding behavior probably directly via leptin receptors orexinergic cells via leptin receptors feeding controlling cells connected orexinergic cells see attempts elucidate leptin orexin interaction measurement orexin orexin mrna levels made rodent model systems defective leptin signaling fafa zucker rats dbdb mice devoid functional leptin receptors obob mice devoid leptin reviewed ref 21 results however contradictory conclusion drawn leptin necessarily required keep orexin expression low however also often knockout systems difficult evaluate physiological role possible multiple disturbances redundancy signaling compensatory mechanisms
0.35575834.12419707.html.plaintext.txt	115	orexins orexin receptors outside cns
0.35575834.12419707.html.plaintext.txt	116	orexin immunoreactivity preproorexin mrna found variety peripheral organs mainly rat cells expressing orexins cases identified include neurons endocrine cells projections eg pituitary pineal gland may originate neurons hypothalamus peripheral neurons appear peripheral origin orexin receptorsreceptor mrna mainly found organs orexins cell types expressing orexin receptors might include least endocrine muscle nerve cells 84 92 108 117 133 even periphery expression subtypes varies different tissues
0.35575834.12419707.html.plaintext.txt	117	orexin immunoreactivity preproorexin mrna found variety peripheral organs mainly rat cells expressing orexins cases identified include neurons endocrine cells projections eg pituitary pineal gland may originate neurons hypothalamus peripheral neurons appear peripheral origin orexin receptorsreceptor mrna mainly found organs orexins cell types expressing orexin receptors might include least endocrine muscle nerve cells 84 92 108 117 133 even periphery expression subtypes varies different tissues
0.35575834.12419707.html.plaintext.txt	118	orexin orexin receptor immunoreactivity found gastrointestinal tract pancreas rat guinea pig human refs 92 133 tables 4 5 substantial levels orexin b ox1 ox2 mrna protein found rat pituitary 13 35 84 johren et al 84 found preproorexin ox1 mrna rat testis ox1 mrna ox2 mrna immunoreactivity found rat human adrenal glands 12 84 104 108 109 although subtype expression different layers somewhat disputed may differences species see eg ref 117 ox1 mrna found kidney thyroid ox2 mrna lung 84 orexinergic fibers extend cns toward rat pineal gland ox2 mrna detected pineal gland 121
0.35575834.12419707.html.plaintext.txt	119	view table table 4 orexins periphery
0.35575834.12419707.html.plaintext.txt	120	view table table 5 orexin receptors periphery
0.35575834.12419707.html.plaintext.txt	121	view table table 5 orexin receptors periphery
0.35575834.12419707.html.plaintext.txt	122	however expression preproorexin orexin receptor message stomach gut pancreas lung kidney pituitary adrenal gland disputed 31 84 154 differences may explained less sensitive methods northern blotting failing detect signal sensitive methods pcr situ hybridization contrast difficult explain opposite receptor subtype expression reported human adrenal cortex 117 146
0.35575834.12419707.html.plaintext.txt	123	however expression preproorexin orexin receptor message stomach gut pancreas lung kidney pituitary adrenal gland disputed 31 84 154 differences may explained less sensitive methods northern blotting failing detect signal sensitive methods pcr situ hybridization contrast difficult explain opposite receptor subtype expression reported human adrenal cortex 117 146
0.35575834.12419707.html.plaintext.txt	124	systemic effects orexins top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	125	location orexinergic cells projections contacts transmitter systems suggest role eating sleepwakefulness neuroendocrine autonomic functions sometimes difficult judge basis available experimental evidence whether particular systemic response orexins caused indirectly directly target organs cases direct effects orexins isolated organs even isolated cells demonstrated trying highlight kind evidence
0.35575834.12419707.html.plaintext.txt	126	location orexinergic cells projections contacts transmitter systems suggest role eating sleepwakefulness neuroendocrine autonomic functions sometimes difficult judge basis available experimental evidence whether particular systemic response orexins caused indirectly directly target organs cases direct effects orexins isolated organs even isolated cells demonstrated trying highlight kind evidence
0.35575834.12419707.html.plaintext.txt	127	effects orexins feeding behavior
0.35575834.12419707.html.plaintext.txt	128	original publication dealing orexins shown intracerebroventricular injection orexins induces feeding rats 154 injected different hypothalamic sites rat orexin effective narrow area perifornical area lateral hypothalamus dorsomedial paraventricular nuclei preoptic area arcuate ventromedial nucleus whereas orexin b inactive 39 173 hypothalamic nuclei possibly involved feeding responses orexins listed table 3 intraperitoneally injected ox1 receptor antagonist sb 334867 inhibits baseline feeding normal weight gain feeding response orexin injection hypothalamus 62 150 feeding stimulating effect fasting blocked intracisternally administered anti orexin antibodies 192 intraperitoneal sb 334867 62 suggests least ox1 receptor involved natural regulation feeding orexin receptor subtypes expressed nuclei involved regulation feeding refs 111 180 table 3 orexin increases c fos expression areas energy regulatory sites within hypothalamus limbic region hindbrain 128 mentioned see cellular responses orexins orexins belong regulatory network peptides including npy mch agrp galanin pomc products cart dynorphin regulate feeding behavior orexins appear act upstream npy antagonists npy y1 y5 receptors block orexin stimulated feeding 38 81
0.35575834.12419707.html.plaintext.txt	129	original publication dealing orexins shown intracerebroventricular injection orexins induces feeding rats 154 injected different hypothalamic sites rat orexin effective narrow area perifornical area lateral hypothalamus dorsomedial paraventricular nuclei preoptic area arcuate ventromedial nucleus whereas orexin b inactive 39 173 hypothalamic nuclei possibly involved feeding responses orexins listed table 3 intraperitoneally injected ox1 receptor antagonist sb 334867 inhibits baseline feeding normal weight gain feeding response orexin injection hypothalamus 62 150 feeding stimulating effect fasting blocked intracisternally administered anti orexin antibodies 192 intraperitoneal sb 334867 62 suggests least ox1 receptor involved natural regulation feeding orexin receptor subtypes expressed nuclei involved regulation feeding refs 111 180 table 3 orexin increases c fos expression areas energy regulatory sites within hypothalamus limbic region hindbrain 128 mentioned see cellular responses orexins orexins belong regulatory network peptides including npy mch agrp galanin pomc products cart dynorphin regulate feeding behavior orexins appear act upstream npy antagonists npy y1 y5 receptors block orexin stimulated feeding 38 81
0.35575834.12419707.html.plaintext.txt	130	degree orexins regulate long term food intake subject debate data indicate rather orexin induced food intake acute effect evened compensatory decrease food intake within 24 h see eg refs 38 63 194 speculated part orexin induced food intake secondary increased wakefulness activity therefore following increased energy expenditure general view emerging different results orexins may participate short term regulation energy homeostasis initiating feeding response falls glucose subsequent increase glucose leptin visceral signals would decrease orexin turn would terminate behavior food ingestion refs 22 53 reviewed refs 189 190 mapping orexinergic projections indicates orexins could also involved overall regulation feeding instance nucleus solitary tract sensory trigeminal nucleus lamina 1 10 sacral cord receive afferents mouth gastrointestinal tract dorsal motor nucleus vagus motor trigeminal nucleus intermediolateral cell column sacral parasympathetic nucleus give rise nerves innervate gastrointestinal tract muscles mastication 31 34 36 131 143 182 198 therefore tempting suggest central orexinergic nerves could involved primary eating process via sensory motor innervation mouth passage food gastrointestinal tract via sensory motor secretomotor innervation intestines peripheral orexinergic neurons endocrine release orexins eg enterochromaffin cells could affect intestinal motility endo exocrine secretion uptake sensory signaling gastrointestinal tract see effects orexins gastrointestinal tract organs feedingenergy metabolism direct data 6 106 124 175 186 197 indirect observations narcoleptic patients animal models 23 60 162 193 suggest orexins may affect metabolic rate heat loss related processes overall role energy metabolism also suggested effects orexins release hormones especially adrenal steroids see orexins autonomicendocrine functions
0.35575834.12419707.html.plaintext.txt	131	involvement orexins sleepwakefulness
0.35575834.12419707.html.plaintext.txt	132	regulation sleepwakefulness well demonstrated systemic effect orexinergic pathways anatomic level orexinergic neurons present project multitude nuclei different levels cns involved sleeparousal orexin receptorsreceptor mrnas observed areas ox1 ox2 receptor mrna expression within areas suggests receptor subtypes involved table 3
0.35575834.12419707.html.plaintext.txt	133	regulation sleepwakefulness well demonstrated systemic effect orexinergic pathways anatomic level orexinergic neurons present project multitude nuclei different levels cns involved sleeparousal orexin receptorsreceptor mrnas observed areas ox1 ox2 receptor mrna expression within areas suggests receptor subtypes involved table 3
0.35575834.12419707.html.plaintext.txt	134	injection orexin rat cerebral ventricles specific cns sites rat cat increases wakefulness decreases sleep 15 45 56 72 120 144 markedly effects seen decreased rapid eye movement rem sleep slow wave sleep episode number duration profound role histaminergic systems processes suggested results show effects orexin mouse blocked histamine h1 receptor antagonists gene disruption 72 195 narcoleptic dogs disrupted ox2 receptors decreased brain histamine content 134 ox2 receptor seems responsible orexin effects tuberomamillary nucleus even rat 44 195 expression c fos shown increase mainly orexin positive cells hypothalamus time normal waking rats c fos expression also increased sleep deprivation antinarcoleptic drugs metamphetamine mofanadil 23 46 161
0.35575834.12419707.html.plaintext.txt	135	injection orexin rat cerebral ventricles specific cns sites rat cat increases wakefulness decreases sleep 15 45 56 72 120 144 markedly effects seen decreased rapid eye movement rem sleep slow wave sleep episode number duration profound role histaminergic systems processes suggested results show effects orexin mouse blocked histamine h1 receptor antagonists gene disruption 72 195 narcoleptic dogs disrupted ox2 receptors decreased brain histamine content 134 ox2 receptor seems responsible orexin effects tuberomamillary nucleus even rat 44 195 expression c fos shown increase mainly orexin positive cells hypothalamus time normal waking rats c fos expression also increased sleep deprivation antinarcoleptic drugs metamphetamine mofanadil 23 46 161
0.35575834.12419707.html.plaintext.txt	136	cellular responses orexins observed areas involved sleep orexins excite neurons rat locus ceruleus 56 70 80 170 dorsal raphe nucleus 18 tuberomamillary nucleus 9 44 mouse laterodorsal tegmental nucleus 19 see cellular responses orexins even areas ox1 ox2 receptors seem overlapping roles orexinergic systems sleep wakefulness well knockout phenotypes discussed narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	137	cellular responses orexins observed areas involved sleep orexins excite neurons rat locus ceruleus 56 70 80 170 dorsal raphe nucleus 18 tuberomamillary nucleus 9 44 mouse laterodorsal tegmental nucleus 19 see cellular responses orexins even areas ox1 ox2 receptors seem overlapping roles orexinergic systems sleep wakefulness well knockout phenotypes discussed narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	138	orexins autonomicendocrine functions
0.35575834.12419707.html.plaintext.txt	139	orexinergic efferents project particular areas brain stem spinal cord suggest direct involvement autonomic afferents efferents pain transmission 11 31 34 122 182 autonomic effects manifested increased blood pressure heart rate intestinal motility see gastric acid secretion 138 177 sympathetic nerve activity 98 124 166 response intracerebroventricular orexin administered intravenously orexin induces analgesia thermal nociception paradigms 11 effect orexin blocked ox1 receptor antagonist sb 334867even baselinebut naloxone suggesting opiate independent mechanism
0.35575834.12419707.html.plaintext.txt	140	orexinergic efferents project particular areas brain stem spinal cord suggest direct involvement autonomic afferents efferents pain transmission 11 31 34 122 182 autonomic effects manifested increased blood pressure heart rate intestinal motility see gastric acid secretion 138 177 sympathetic nerve activity 98 124 166 response intracerebroventricular orexin administered intravenously orexin induces analgesia thermal nociception paradigms 11 effect orexin blocked ox1 receptor antagonist sb 334867even baselinebut naloxone suggesting opiate independent mechanism
0.35575834.12419707.html.plaintext.txt	141	orexins may affect water balance via effects drinking watersalt homeostasis mechanisms involved blood pressure regulation suggested anatomy projections 24 31 34 36 37 61 69 71 125 126 154 182 fact intracerebroventricular orexin b increase water intake rat 98 149 injection orexin b particular brain stem sites increases mean arterial pressure heart rate rat 3 25 156 166 extent effects may mediated increased release hormones norepinephrine 3 166
0.35575834.12419707.html.plaintext.txt	142	orexins may affect water balance via effects drinking watersalt homeostasis mechanisms involved blood pressure regulation suggested anatomy projections 24 31 34 36 37 61 69 71 125 126 154 182 fact intracerebroventricular orexin b increase water intake rat 98 149 injection orexin b particular brain stem sites increases mean arterial pressure heart rate rat 3 25 156 166 extent effects may mediated increased release hormones norepinephrine 3 166
0.35575834.12419707.html.plaintext.txt	143	release many hormones hypothalamus shown affected orexins orexins may regulate hypothalamo hypophysial hormone secretion indirectly via neuronal circuits even direct effect hypophysis possible orexins found median eminence 35 125 mrna orexin receptor subtypes found anterior intermediate hypophysial lobes 35 blanco et al 13 identify coexpression growth hormone ox1 receptors acidophil cells adenohypophysis coexpression acth ox2 receptors pars intermedia basophil cells adenohypophysis orexins orexin receptors also found low levels posterior hypophysial lobe altogether ox1 ox2 mrna expressed areas involved neuroendocrine regulation 111
0.35575834.12419707.html.plaintext.txt	144	release many hormones hypothalamus shown affected orexins orexins may regulate hypothalamo hypophysial hormone secretion indirectly via neuronal circuits even direct effect hypophysis possible orexins found median eminence 35 125 mrna orexin receptor subtypes found anterior intermediate hypophysial lobes 35 blanco et al 13 identify coexpression growth hormone ox1 receptors acidophil cells adenohypophysis coexpression acth ox2 receptors pars intermedia basophil cells adenohypophysis orexins orexin receptors also found low levels posterior hypophysial lobe altogether ox1 ox2 mrna expressed areas involved neuroendocrine regulation 111
0.35575834.12419707.html.plaintext.txt	145	stimulatory effect release multiple levels hypothalamo hypophysio adrenal axis reported see orexinergic regulation hypothalamo hypophysio adrenal axis stress response orexin injected intravenously directly hypothalamic paraventricular nucleus decreases tsh release rat 123 153 change seen plasma levels thyroid hormones 123 153 intracerebroventricular orexin decreases growth hormone release rat 56 effects release hormones also reported results equivocal release effects shown hypothalamic explants vitro orexin stimulates release neurotensin npy vip somatostatin luteinizing hormone releasing hormone lhrh decreases release trh effect release dopamine vasopressin mch 123 151 152
0.35575834.12419707.html.plaintext.txt	146	stimulatory effect release multiple levels hypothalamo hypophysio adrenal axis reported see orexinergic regulation hypothalamo hypophysio adrenal axis stress response orexin injected intravenously directly hypothalamic paraventricular nucleus decreases tsh release rat 123 153 change seen plasma levels thyroid hormones 123 153 intracerebroventricular orexin decreases growth hormone release rat 56 effects release hormones also reported results equivocal release effects shown hypothalamic explants vitro orexin stimulates release neurotensin npy vip somatostatin luteinizing hormone releasing hormone lhrh decreases release trh effect release dopamine vasopressin mch 123 151 152
0.35575834.12419707.html.plaintext.txt	147	orexinergic regulation hypothalamo hypophysio adrenal axis stress response intracerebroventricular administration orexin increases plasma levels crf acth corticosterone vasopressin epinephrine rat 2 56 78 82 83 85 151 152 crf release suggested mediated elevated npy acting y1 receptors 83 152 placing npy downstream orexins even system orexin even stimulate crf release vitro 151 crf receptor antagonist reported block orexin stimulated plasma corticosterone elevation rat 82 159 hand orexins reported inhibit crf stimulated acth release cultured rat adenohypophysial cells 158
0.35575834.12419707.html.plaintext.txt	148	orexinergic regulation hypothalamo hypophysio adrenal axis stress response intracerebroventricular administration orexin increases plasma levels crf acth corticosterone vasopressin epinephrine rat 2 56 78 82 83 85 151 152 crf release suggested mediated elevated npy acting y1 receptors 83 152 placing npy downstream orexins even system orexin even stimulate crf release vitro 151 crf receptor antagonist reported block orexin stimulated plasma corticosterone elevation rat 82 159 hand orexins reported inhibit crf stimulated acth release cultured rat adenohypophysial cells 158
0.35575834.12419707.html.plaintext.txt	149	orexins also reported stimulate release corticosteronecortisol 108 110 117 aldosterone 108 132 rat porcine human adrenal glandsadrenal cells vitro release independent acth 110 117 corticosteronecortisol release determined co occur camp elevation probably depend rat 110 human 117 together lack additivity orexin acth suggests peptides utilize mechanism glucocorticoid release 117 contrast direct effect rat adrenal slices seen jaszberenyi et al 82 study long term 7 day exposure orexin orexin b plasma levels aldosterone corticosterone crf acth elevated rat 108
0.35575834.12419707.html.plaintext.txt	150	orexins also reported stimulate release corticosteronecortisol 108 110 117 aldosterone 108 132 rat porcine human adrenal glandsadrenal cells vitro release independent acth 110 117 corticosteronecortisol release determined co occur camp elevation probably depend rat 110 human 117 together lack additivity orexin acth suggests peptides utilize mechanism glucocorticoid release 117 contrast direct effect rat adrenal slices seen jaszberenyi et al 82 study long term 7 day exposure orexin orexin b plasma levels aldosterone corticosterone crf acth elevated rat 108
0.35575834.12419707.html.plaintext.txt	151	release epinephrine norepinephrine rat adrenal medulla increased intracerebroventricular orexins 166 similar although smaller effect seen cultured porcine adrenal medullar cells 132 ox1 ox2 receptor mrna suggested expressed rat adrenal medulla 104 although studies present opposing views 84
0.35575834.12419707.html.plaintext.txt	152	release epinephrine norepinephrine rat adrenal medulla increased intracerebroventricular orexins 166 similar although smaller effect seen cultured porcine adrenal medullar cells 132 ox1 ox2 receptor mrna suggested expressed rat adrenal medulla 104 although studies present opposing views 84
0.35575834.12419707.html.plaintext.txt	153	orexin mediated increases crf acth corticosterone aldosterone vasopressin epinephrine release suggest orexins could mediate stress responses interesting context orexins increase particular stereotypic behavioral patterns grooming face washing burrowing may related activation stress response 40 45 77 78 orexin induced grooming inhibited ox1 receptor block sb 334867 40 crf receptor antagonist inhibits orexin induced face washing grooming 50 shift rest locomotor activity 70 80 78 involvement complex pathways highlighted inhibitory effects dopamine serotonin receptor antagonists 40 115 130 noted orexins increase wakefulness andor activity rat therefore important able separate effects stress response
0.35575834.12419707.html.plaintext.txt	154	orexin mediated increases crf acth corticosterone aldosterone vasopressin epinephrine release suggest orexins could mediate stress responses interesting context orexins increase particular stereotypic behavioral patterns grooming face washing burrowing may related activation stress response 40 45 77 78 orexin induced grooming inhibited ox1 receptor block sb 334867 40 crf receptor antagonist inhibits orexin induced face washing grooming 50 shift rest locomotor activity 70 80 78 involvement complex pathways highlighted inhibitory effects dopamine serotonin receptor antagonists 40 115 130 noted orexins increase wakefulness andor activity rat therefore important able separate effects stress response
0.35575834.12419707.html.plaintext.txt	155	effects orexins gastrointestinal tract organs feedingenergy metabolism gastrointestinal tract neurons endocrine cells may express orexins 92 133 neurons orexin immunoreactivity seen submucosal myenteric plexi orexinergic neurons plexi suggested sensory secretomotor basis coexpression markers vip choline acetyltransferase 92 133 neurites project orexin containing cells mucosa muscle layers submucosal blood vessels guinea pig orexin positive neurons submucosal myenteric plexi express leptin receptors well 92 fasting increases number orexin immunoreactive submucosal neurons guinea pig also become positive phospho camp response element binding protein pcreb 92 similar c fos expression indicates activation neurons suggesting fasting activates central peripheral orexinergic systems
0.35575834.12419707.html.plaintext.txt	156	effects orexins gastrointestinal tract organs feedingenergy metabolism gastrointestinal tract neurons endocrine cells may express orexins 92 133 neurons orexin immunoreactivity seen submucosal myenteric plexi orexinergic neurons plexi suggested sensory secretomotor basis coexpression markers vip choline acetyltransferase 92 133 neurites project orexin containing cells mucosa muscle layers submucosal blood vessels guinea pig orexin positive neurons submucosal myenteric plexi express leptin receptors well 92 fasting increases number orexin immunoreactive submucosal neurons guinea pig also become positive phospho camp response element binding protein pcreb 92 similar c fos expression indicates activation neurons suggesting fasting activates central peripheral orexinergic systems
0.35575834.12419707.html.plaintext.txt	157	also endocrine cells gut stomachsome enterochromaffin express serotonindisplay orexin immunoreactivity mouse rat guinea pig human 92 133 interestingly enterochromaffin cells rat also 1 express orexin receptors ox2 2 localized close proximity orexinergic nerve fibers 133 cellular level orexin induces electrical responses guinea pig submucosal neurons see cellular responses orexins thus orexinergic neurons gastrointestinal tract could affect intestinal secretion uptake endocrine secretion sensory signaling intestinal motility different effects intestinal motility patterns indeed measured mouse rat small intestine 133 160 guinea pig distal colon 92 different orexin receptor subtypes different distribution gastrointestinal tract ox1 receptor immunoreactivity solely expressed submucosal myenteric neurons whereas ox2 receptor immunoreactivity seen enterochromaffin cells rat 133
0.35575834.12419707.html.plaintext.txt	158	also endocrine cells gut stomachsome enterochromaffin express serotonindisplay orexin immunoreactivity mouse rat guinea pig human 92 133 interestingly enterochromaffin cells rat also 1 express orexin receptors ox2 2 localized close proximity orexinergic nerve fibers 133 cellular level orexin induces electrical responses guinea pig submucosal neurons see cellular responses orexins thus orexinergic neurons gastrointestinal tract could affect intestinal secretion uptake endocrine secretion sensory signaling intestinal motility different effects intestinal motility patterns indeed measured mouse rat small intestine 133 160 guinea pig distal colon 92 different orexin receptor subtypes different distribution gastrointestinal tract ox1 receptor immunoreactivity solely expressed submucosal myenteric neurons whereas ox2 receptor immunoreactivity seen enterochromaffin cells rat 133
0.35575834.12419707.html.plaintext.txt	159	energy metabolism regulated several hormones important pancreatic glucagon insulin hypophysial growth hormone glucocorticoids norepinephrine thyroid hormones effects orexins glucocorticoid growth hormone release discussed insulin release somewhat increased rat intracerebroventricular 114 subcutaneous 137 174 injection orexin also rat pancreas vitro 137 extrinsic neurons rat guinea pig pancreatic ganglia display orexin ox1 ox2 receptor immunoreactivity 92 plasma leptin also increased subcutaneous injection orexin b rat although suggested occur via increased insulin release 174
0.35575834.12419707.html.plaintext.txt	160	energy metabolism regulated several hormones important pancreatic glucagon insulin hypophysial growth hormone glucocorticoids norepinephrine thyroid hormones effects orexins glucocorticoid growth hormone release discussed insulin release somewhat increased rat intracerebroventricular 114 subcutaneous 137 174 injection orexin also rat pancreas vitro 137 extrinsic neurons rat guinea pig pancreatic ganglia display orexin ox1 ox2 receptor immunoreactivity 92 plasma leptin also increased subcutaneous injection orexin b rat although suggested occur via increased insulin release 174
0.35575834.12419707.html.plaintext.txt	161	narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	162	narcolepsy disorder short characterized abnormal inclusion rem sleep features muscle paralysis hallucinations waking state sleepwaking transition state addition hypersomnia often observed narcolepsy humans usually sporadic disease strong association major histocompatibility complex antigens especially hla drb115 hla dqa10102 hla dqb10602 long time suggested relate autoimmune process yet autoantibodies signs ongoing previous inflammation hard find reviewed refs 74 94 102 141 179 could however caused 1 fact postmortem narcoleptic brains usually investigated years disease onset 2 dispersed nature orexinergic cells orexin undetectable csf human narcoleptic patients 32 135 number orexinergic neurons postmortem narcoleptic brains much reduced 142 178 even signs gliosis observed 178 time mchergic neurons brain areas present normal numbers 142 178 together animal model systems see led hypothesis narcolepsy disease orexinergic neurons support one clearly debilitating preproorexin orexin receptor mutation found human subjects ref 142 see
0.35575834.12419707.html.plaintext.txt	163	narcolepsy disorder short characterized abnormal inclusion rem sleep features muscle paralysis hallucinations waking state sleepwaking transition state addition hypersomnia often observed narcolepsy humans usually sporadic disease strong association major histocompatibility complex antigens especially hla drb115 hla dqa10102 hla dqb10602 long time suggested relate autoimmune process yet autoantibodies signs ongoing previous inflammation hard find reviewed refs 74 94 102 141 179 could however caused 1 fact postmortem narcoleptic brains usually investigated years disease onset 2 dispersed nature orexinergic cells orexin undetectable csf human narcoleptic patients 32 135 number orexinergic neurons postmortem narcoleptic brains much reduced 142 178 even signs gliosis observed 178 time mchergic neurons brain areas present normal numbers 142 178 together animal model systems see led hypothesis narcolepsy disease orexinergic neurons support one clearly debilitating preproorexin orexin receptor mutation found human subjects ref 142 see
0.35575834.12419707.html.plaintext.txt	164	mouse depletion hypothalamus orexins results narcoleptic phenotype accomplished genetic disruption preproorexin gene orexin knockout mouse ref 23 genetic destruction orexinergic cells preproorexin ataxin 3 knockin mouse 60 toxic destruction orexinergic cells hypothalamic injection orexin b saporin conjugate 52
0.35575834.12419707.html.plaintext.txt	165	mouse depletion hypothalamus orexins results narcoleptic phenotype accomplished genetic disruption preproorexin gene orexin knockout mouse ref 23 genetic destruction orexinergic cells preproorexin ataxin 3 knockin mouse 60 toxic destruction orexinergic cells hypothalamic injection orexin b saporin conjugate 52
0.35575834.12419707.html.plaintext.txt	166	dogs narcolepsy mainly familial disorder recently familial canine narcolepsy doberman pinschers labrador retrievers shown caused mutations ox2 receptor gene 102 cases mutations cause premature amino acid chain termination expressed heterologously hek293 cells mutant receptors mainly remain intracellular compartments neither bind orexin activate ca2 mobilization 73 point mutation glu54lys nh2 terminusfirst transmembrane segment junction ox2 receptor also leads reduced orexin binding 400 fold reduced potency ca2 elevation expressed hek293 cells 73 10 reported mutations preproorexin ox2 receptor genes thought represent benign polymorphisms 73 sporadic cases canine narcolepsy suggested caused lack orexins 148
0.35575834.12419707.html.plaintext.txt	167	dogs narcolepsy mainly familial disorder recently familial canine narcolepsy doberman pinschers labrador retrievers shown caused mutations ox2 receptor gene 102 cases mutations cause premature amino acid chain termination expressed heterologously hek293 cells mutant receptors mainly remain intracellular compartments neither bind orexin activate ca2 mobilization 73 point mutation glu54lys nh2 terminusfirst transmembrane segment junction ox2 receptor also leads reduced orexin binding 400 fold reduced potency ca2 elevation expressed hek293 cells 73 10 reported mutations preproorexin ox2 receptor genes thought represent benign polymorphisms 73 sporadic cases canine narcolepsy suggested caused lack orexins 148
0.35575834.12419707.html.plaintext.txt	168	ox1 ox2 receptor gene abnormalities considered responsible human narcoleptic cases 26 single base changes 11 aa changes found healthy narcoleptic human subjects refs 139 142 see also genetics chemistry orexins introns coding regions supposed represent benign polymorphisms one polymorphism concerns reported sequence ox1 receptors aa 280 see genetics chemistry orexins although could sequencing error one mutation leu16arg found 5 signal peptide region human preproorexin gene probably results early onset severe narcolepsy 142 transiently expressed neuro 2a cells mutated peptide apparently accumulated tubular network presumably smooth endoplasmic reticulum er contrast wild type preproorexin appeared vesicles another point mutation 5 untranslated region may involved disease process presence particular type tissue antigen hla dr2 ref 51 insertion adenosine 593 promoter region found one narcoleptic patient although effect pathogenicity unclear 51
0.35575834.12419707.html.plaintext.txt	169	ox1 ox2 receptor gene abnormalities considered responsible human narcoleptic cases 26 single base changes 11 aa changes found healthy narcoleptic human subjects refs 139 142 see also genetics chemistry orexins introns coding regions supposed represent benign polymorphisms one polymorphism concerns reported sequence ox1 receptors aa 280 see genetics chemistry orexins although could sequencing error one mutation leu16arg found 5 signal peptide region human preproorexin gene probably results early onset severe narcolepsy 142 transiently expressed neuro 2a cells mutated peptide apparently accumulated tubular network presumably smooth endoplasmic reticulum er contrast wild type preproorexin appeared vesicles another point mutation 5 untranslated region may involved disease process presence particular type tissue antigen hla dr2 ref 51 insertion adenosine 593 promoter region found one narcoleptic patient although effect pathogenicity unclear 51
0.35575834.12419707.html.plaintext.txt	170	thus strong evidence narcolepsy caused reduced orexinergic signaling via either destruction orexinergic neurons defective orexin peptides receptors although larger population studies necessary confirm ox2 receptor appears especially involved dog would promote role nuclei relying receptor subtype tuberomamillary nucleus although possible ox1 ox2 receptors different distributions rats humans compared dogs
0.35575834.12419707.html.plaintext.txt	171	thus strong evidence narcolepsy caused reduced orexinergic signaling via either destruction orexinergic neurons defective orexin peptides receptors although larger population studies necessary confirm ox2 receptor appears especially involved dog would promote role nuclei relying receptor subtype tuberomamillary nucleus although possible ox1 ox2 receptors different distributions rats humans compared dogs
0.35575834.12419707.html.plaintext.txt	172	orexinergic disorders may also provide interesting information role orexins feeding patients narcolepsy show somewhat increased body mass index compared healthy subjects 162 two previously described kinds orexin transgenic mice hypophagic preproorexin knockout mice lean 23 opposed orexinergic neuron deficient mice obese 60 thus possible preproorexin knockout mice develop compensatory mechanisms weight regulation whereas orexinergic neuron deficient mice lose orexinergic neurons postnatally see genetics chemistry orexins able another interesting possibility recently proposed chou et al 27 essentially mouse lateral hypothalamic orexinergic neurons express dynorphin 10 27 removal orexinergic neuron deficient mice might responsible pronounced phenotype
0.35575834.12419707.html.plaintext.txt	173	orexinergic disorders may also provide interesting information role orexins feeding patients narcolepsy show somewhat increased body mass index compared healthy subjects 162 two previously described kinds orexin transgenic mice hypophagic preproorexin knockout mice lean 23 opposed orexinergic neuron deficient mice obese 60 thus possible preproorexin knockout mice develop compensatory mechanisms weight regulation whereas orexinergic neuron deficient mice lose orexinergic neurons postnatally see genetics chemistry orexins able another interesting possibility recently proposed chou et al 27 essentially mouse lateral hypothalamic orexinergic neurons express dynorphin 10 27 removal orexinergic neuron deficient mice might responsible pronounced phenotype
0.35575834.12419707.html.plaintext.txt	174	future perspectives top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	175	although anatomic architecture orexinergic system cns well characterized several open questions actual roles orexins central peripheral functions mechanisms action orexins cellular level orexin receptors identified presynaptic inhibitory orexin receptors brain limited access orexin responding neurons experimental problem several limitations concerning methods available characterization functional properties cells slice preparations acutely isolated cells model systems based cultured neurons even neuronal stem cells might provide important improvement studies orexin signaling cho cell lines available provided insight functions orexinergic system enabled screening orexin receptor ligands data obtained may relevant nervous system recombinant models based neurons neuronlike cells might therefore provide information signal pathways used orexins
0.35575834.12419707.html.plaintext.txt	176	although anatomic architecture orexinergic system cns well characterized several open questions actual roles orexins central peripheral functions mechanisms action orexins cellular level orexin receptors identified presynaptic inhibitory orexin receptors brain limited access orexin responding neurons experimental problem several limitations concerning methods available characterization functional properties cells slice preparations acutely isolated cells model systems based cultured neurons even neuronal stem cells might provide important improvement studies orexin signaling cho cell lines available provided insight functions orexinergic system enabled screening orexin receptor ligands data obtained may relevant nervous system recombinant models based neurons neuronlike cells might therefore provide information signal pathways used orexins
0.35575834.12419707.html.plaintext.txt	177	role orexin cells play regulation feeding available information suggests least one population orexinergic cells lateral hypothalamus directly monitors responds changes glucose concentration environment may also directly respond signals inhibiting feeding leptin orexinergic cells ones project areas brain involved feeding behavior orexin receptors expressed high numbers several regions within hypothalamus regulate release feeding related neurotransmitters regulation feeding seems complex involving many neuropeptides seems gross redundancy system blocking orexinergic system various means reduce feeding permanent deletion orexinergic system marginal controversial effects thus even increase rather expected decrease body mass may occur deletions different components orexinergic system
0.35575834.12419707.html.plaintext.txt	178	role orexin cells play regulation feeding available information suggests least one population orexinergic cells lateral hypothalamus directly monitors responds changes glucose concentration environment may also directly respond signals inhibiting feeding leptin orexinergic cells ones project areas brain involved feeding behavior orexin receptors expressed high numbers several regions within hypothalamus regulate release feeding related neurotransmitters regulation feeding seems complex involving many neuropeptides seems gross redundancy system blocking orexinergic system various means reduce feeding permanent deletion orexinergic system marginal controversial effects thus even increase rather expected decrease body mass may occur deletions different components orexinergic system
0.35575834.12419707.html.plaintext.txt	179	role orexins sleep seems clearer light connection narcoleptic phenotype orexin cell loss similar symptomatology occurring functional orexin orexin receptor loss context also appears quite clear major part orexin effects mediated via monoaminergic systems regulate cholinergic pathways involved initiation rem sleep reviewed eg refs 74 90 yet unclear activity orexinergic cells regulated use orexin antagonists hypnotics could prove rewarding many commonly used hypnotics interfere rem sleep cause tolerance addiction memory disturbances interesting question whether overlap cells regulating feeding sleep lateral hypothalamus instance feeding behavior associated arousal effects orexins possibilities future devise better pharmacological methods identification different orexinergic neurons well manipulating function hopefully give answers questions
0.35575834.12419707.html.plaintext.txt	180	role orexins sleep seems clearer light connection narcoleptic phenotype orexin cell loss similar symptomatology occurring functional orexin orexin receptor loss context also appears quite clear major part orexin effects mediated via monoaminergic systems regulate cholinergic pathways involved initiation rem sleep reviewed eg refs 74 90 yet unclear activity orexinergic cells regulated use orexin antagonists hypnotics could prove rewarding many commonly used hypnotics interfere rem sleep cause tolerance addiction memory disturbances interesting question whether overlap cells regulating feeding sleep lateral hypothalamus instance feeding behavior associated arousal effects orexins possibilities future devise better pharmacological methods identification different orexinergic neurons well manipulating function hopefully give answers questions
0.35575834.12419707.html.plaintext.txt	181	one intriguing questions concerns roles orexins play periphery act hormonesparacrine mediators presence orexins receptors many peripheral organs intestine endocrine pancreas adrenals pituitary suggests may case could orexins even transmit signals periphery cns discussed studies available suggest separate peripheral central orexinergic systems studies changes central orexin concentrations reflected periphery narcoleptics devoid central orexins orexins still found plasma may indicate plasma orexin levels reflect peripherally produced orexins peripheral orexin receptors similar central least adrenal cortical zona fasciculatareticularis orexin receptors appear couple camp elevation ca2 elevation reflect different receptor subtypesas suggested studiesor coupling different signal pathways cell lines primary cultures peripheral tissues provide lot missing information context
0.35575834.12419707.html.plaintext.txt	182	one intriguing questions concerns roles orexins play periphery act hormonesparacrine mediators presence orexins receptors many peripheral organs intestine endocrine pancreas adrenals pituitary suggests may case could orexins even transmit signals periphery cns discussed studies available suggest separate peripheral central orexinergic systems studies changes central orexin concentrations reflected periphery narcoleptics devoid central orexins orexins still found plasma may indicate plasma orexin levels reflect peripherally produced orexins peripheral orexin receptors similar central least adrenal cortical zona fasciculatareticularis orexin receptors appear couple camp elevation ca2 elevation reflect different receptor subtypesas suggested studiesor coupling different signal pathways cell lines primary cultures peripheral tissues provide lot missing information context
0.35575834.12419707.html.plaintext.txt	183	acknowledge van den pol et al 183 eriksson et al 44 allowed reproduction figs 3 5
0.35575834.12419707.html.plaintext.txt	184	study supported european union contract qlg3 ct 2002 00826 grants swedish medical research council cancer research fund sweden lars hierta foundation academy finland sigrid juselius foundation
0.35575834.12419707.html.plaintext.txt	185	address reprint requests correspondence j kukkonen dept neuroscience div physiology uppsala univ bmc po box 572 se 75123 uppsala sweden e mail jkukkoneatfysiologiuuse u d
0.35575834.12419707.html.plaintext.txt	186	references top abstract introduction overview orexins cellular responses orexins distribution orexinergic systemic effects orexins future perspectives references
0.35575834.12419707.html.plaintext.txt	187	1 abrahamson ee leak rk moore ry suprachiasmatic nucleus projects posterior hypothalamic arousal systems neuroreport 12 435 440 2001isimedline 2 al barazanji ka wilson baker j jessop ds harbuz ms central orexin activates hypothalamic pituitary adrenal axis stimulates hypothalamic corticotropin releasing factor arginine vasopressin neurones conscious rats j neuroendocrinol 13 421 424 2001isimedline 3 antunes vr brailoiu gc kwok eh scruggs p dun nj orexinshypocretins excite rat sympathetic preganglionic neurons vivo vitro j physiol regul integr comp physiol 281 r1801 r1807 2001abstractfree full text 4 arihara z takahashi k murakami o totsune k sone m satoh f ito hayashi y sasano h mouri orexin human brain tumor tissues ganglioneuroblastoma neuroblastoma peptides 21 565 570 2000isimedline 5 backberg m hervieu g wilson meister b orexin receptor 1 ox r1 immunoreactivity chemically identified neurons hypothalamus focus orexin targets involved control food water intake eur j neurosci 15 315 328 2002isimedline 6 balasko m szelenyi z szekely m central thermoregulatory effects neuropeptide y orexin rats acta physiol hung 86 219 222 1999medline 7 barritt gj receptor activated ca2 inflow animal cells variety pathways tailored meet different intracellular ca2 signalling requirements biochem j 337 153 169 1999isimedline 8 bayer l colard c nguyen nu risold py fellmann d griffond b alteration expression hypocretin orexin gene 2 deoxyglucose rat lateral hypothalamic area neuroreport 11 531 533 2000isimedline 9 bayer l eggermann e serafin m saint mleux b machard d jones b muhlethaler m orexins hypocretins directly excite tuberomammillary neurons eur j neurosci 14 1571 1575 2001isimedline 10 bayer l mairet coello g risold py griffond b orexinhypocretin neurons chemical phenotype possible interactions melanin concentrating hormone neurons regul pept 104 33 39 2002isimedline 11 bingham davey pt babbs aj irving ea sammons mj wyles m jeffrey p cutler l riba johns porter ra upton n hunter aj parsons aa orexin hypothalamic peptide analgesic properties pain 92 81 90 2001isimedline 12 blanco m garcia caballero fraga m gallego r cuevas j forteza j beiras dieguez c cellular localization orexin receptors human adrenal gland adrenocortical adenomas pheochromocytomas regul pept 104 161 165 2002isimedline 13 blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casanueva f dieguez c beiras cellular localization orexin receptors human pituitary j clin endocrinol metab 86 1616 1619 2001abstractfree full text 14 bonini ja jones ka adham n forray c artymyshyn r durkin mm smith ke tamm ja boteju lw lakhlani pp raddatz r yao wj ogozalek kl boyle n kouranova ev quan y vaysse pj wetzel jm branchek ta gerald c borowsky b identification characterization two g protein coupled receptors neuropeptide ff j biol chem 275 39324 39331 2000abstractfree full text 15 bourgin p huitron resendiz spier ad fabre v morte b criado jr sutcliffe jg henriksen sj de lecea l hypocretin 1 modulates rapid eye movement sleep activation locus coeruleus neurons j neurosci 20 7760 7765 2000abstractfree full text 16 briski kp sylvester pw hypothalamic orexin immunopositive neurons express fos response central glucopenia neuroreport 12 531 534 2001isimedline 17 broberger c de lecea l sutcliffe jg hokfelt hypocretinorexin melanin concentrating hormone expressing cells form distinct populations rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein systems j comp neurol 402 460 474 1998isimedline 18 brown re sergeeva o eriksson ks haas hl orexin excites serotonergic neurons dorsal raphe nucleus rat neuropharmacology 40 457 459 2001isimedline 19 burlet tyler cj leonard cs direct indirect excitation laterodorsal tegmental neurons hypocretinorexin peptides implications wakefulness narcolepsy j neurosci 22 2862 2872 2002abstractfree full text 20 cai xj evans ml lister ca leslie ra arch jr wilson williams g hypoglycemia activates orexin neurons selectively increases hypothalamic orexin b levels responses inhibited feeding possibly mediated nucleus solitary tract diabetes 50 105 112 2001abstractfree full text 21 cai xj liu xh evans m clapham jc wilson arch jr morris r williams g orexins feeding special occasions everyday occurrence regul pept 104 1 9 2002isimedline 22 cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g hypothalamic orexin expression modulation blood glucose feeding diabetes 48 2132 2137 1999abstract 23 chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999isimedline 24 chen ct dun sl kwok eh dun nj chang jk orexin like immunoreactivity rat brain neurosci lett 260 161 164 1999isimedline 25 chen ct hwang ll chang jk dun nj pressor effects orexins injected intracisternally rostral ventrolateral medulla anesthetized rats j physiol regul integr comp physiol 278 r692 r697 2000abstractfree full text 26 chicurel m neuroscience sandmans secrets nature 407 554 556 2000isimedline 27 chou tc lee ce lu j elmquist jk hara j willie jt beuckmann ct chemelli rm sakurai yanagisawa m saper cb scammell te orexin hypocretin neurons contain dynorphin j neurosci 21 rc168 2001abstractfree full text 28 cikos gregor p koppel j sequence tissue distribution novel g protein coupled receptor expressed prominently human placenta biochem biophys res commun 256 352 356 1999isimedline 29 clapham de runnels lw strubing c trp ion channel family nat rev neurosci 2 387 396 2001isimedline 30 cluderay je harrison dc hervieu gj protein distribution orexin 2 receptor rat central nervous system regul pept 104 131 144 2002isimedline 31 cutler dj morris r sheridhar v wattam ta holmes patel arch jr wilson buckingham re evans ml leslie ra williams g differential distribution orexin orexin b immunoreactivity rat brain spinal cord peptides 20 1455 1470 1999isimedline 32 dalal ma schuld haack m uhr m geisler p eisensehr noachtar pollmacher normal plasma levels orexin hypocretin 1 narcoleptic patients neurology 56 1749 1751 2001abstractfree full text 33 darker jg porter ra eggleston ds smart d brough sj sabido david c jerman jc structure activity analysis truncated orexin analogues orexin 1 receptor bioorg med chem lett 11 737 740 2001isimedline 34 date y mondal ms matsukura nakazato m distribution orexin orexin b hypocretins rat spinal cord neurosci lett 288 87 90 2000isimedline 35 date y mondal ms matsukura ueta y yamashita h kaiya h kangawa k nakazato m distribution orexinhypocretin rat median eminence pituitary brain res mol brain res 76 1 6 2000isimedline 36 date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text 37 de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95 322 327 1998abstractfree full text 38 dube mg horvath tl kalra ps kalra sp evidence npy y5 receptor involvement food intake elicited orexin sated rats peptides 21 1557 1560 2000isimedline 39 dube mg kalra sp kalra ps food intake elicited central administration orexinshypocretins identification hypothalamic sites action brain res 842 473 477 1999isimedline 40 duxon ms stretton j starr k jones dn holland v riley g jerman j brough smart d johns chan w porter ra upton n evidence orexin evoked grooming rat mediated orexin 1 ox1 receptors downstream 5 ht2c receptor involvement psychopharmacology berl 153 203 209 2001medline 41 dyer cj touchette kj carroll ja allee gl matteri rl cloning porcine prepro orexin cdna effects intramuscular injection synthetic porcine orexin b feed intake young pigs domest anim endocrinol 16 145 148 1999isimedline 42 eggermann e serafin m bayer l machard d saint mleux b jones muhlethaler m orexinshypocretins excite basal forebrain cholinergic neurones neuroscience 108 177 181 2001isimedline 43 elias cf saper cb maratos flier e tritos na lee c kelly j tatro jb hoffman ge ollmann mm barsh gs sakurai yanagisawa m elmquist jk chemically defined projections linking mediobasal hypothalamus lateral hypothalamic area j comp neurol 402 442 459 1998isimedline 44 eriksson ks sergeeva o brown re haas hl orexinhypocretin excites histaminergic neurons tuberomammillary nucleus j neurosci 21 9273 9279 2001abstractfree full text 45 espana ra baldo ba kelley ae berridge cw wake promoting sleep suppressing actions hypocretin orexin basal forebrain sites action neuroscience 106 699 715 2001isimedline 46 estabrooke iv mccarthy mt ko e chou tc chemelli rm yanagisawa m saper cb scammell te fos expression orexin neurons varies behavioral state j neurosci 21 1656 1662 2001abstractfree full text 47 fujiki n yoshida y ripley b honda k mignot e nishino changes csf hypocretin 1 orexin levels rats across 24 hours response food deprivation neuroreport 12 993 997 2001isimedline 48 fung sj yamuy j sampogna morales fr chase mh hypocretin orexin input trigeminal hypoglossal motoneurons cat double labeling immunohistochemical study brain res 903 257 262 2001isimedline 49 gao xb van den pol melanin concentrating hormone depresses synaptic activity glutamate gaba neurons rat lateral hypothalamus j physiol 533 237 252 2001abstractfree full text 50 gautvik km de lecea l gautvik vt danielson pe tranque p dopazo bloom fe sutcliffe jg overview prevalent hypothalamus specific mrnas identified directional tag pcr subtraction proc natl acad sci usa 93 8733 8738 1996abstractfree full text 51 gencik m dahmen n wieczorek kasten m bierbrauer j anghelescu szegedi menezes saecker epplen jt prepro orexin gene polymorphism associated narcolepsy neurology 56 115 117 2001abstractfree full text 52 gerashchenko d kohls md greco m waleh ns salin pascual r kilduff ts lappi da shiromani pj hypocretin 2 saporin lesions lateral hypothalamus produce narcoleptic like sleep behavior rat j neurosci 21 7273 7283 2001abstractfree full text 53 griffond b risold py jacquemard c colard c fellmann d insulin induced hypoglycemia increases preprohypocretin orexin mrna rat lateral hypothalamic area neurosci lett 262 77 80 1999isimedline 54 grudt tj van den pol perl er hypocretin 2 orexin b modulation superficial dorsal horn activity rat j physiol 538 517 525 2002abstractfree full text 55 guan jl saotome wang qp funahashi h hori tanaka shioda orexinergic innervation pomc containing neurons rat arcuate nucleus neuroreport 12 547 551 2001isimedline 56 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text 57 hakansson ml brown h ghilardi n skoda rc meister b leptin receptor immunoreactivity chemically defined target neurons hypothalamus j neurosci 18 559 572 1998abstractfree full text 58 hakansson m de lecea l sutcliffe jg yanagisawa m meister b leptin receptor stat3 immunoreactivities hypocretinorexin neurones lateral hypothalamus j neuroendocrinol 11 653 663 1999isimedline 59 hamilton se loose md qi m levey ai hille b mcknight gs idzerda rl nathanson nm disruption m1 receptor gene ablates muscarinic receptor dependent m current regulation seizure activity mice proc natl acad sci usa 94 13311 13316 1997abstractfree full text 60 hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001isimedline 61 harrison ta chen ct dun nj chang jk hypothalamic orexin immunoreactive neurons project rat dorsal medulla neurosci lett 273 17 20 1999isimedline 62 haynes ac jackson b chapman h tadayyon m johns porter ra arch jr selective orexin 1 receptor antagonist reduces food consumption male female rats regul pept 96 45 51 2000isimedline 63 haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr effects single chronic intracerebroventricular administration orexins feeding rat peptides 20 1099 1105 1999isimedline 64 hervieu gj cluderay je harrison dc roberts jc leslie ra gene expression protein distribution orexin 1 receptor rat brain spinal cord neuroscience 103 777 797 2001isimedline 65 hill jj peralta eg inhibition gi activated potassium channel girk14 gq coupled m1 muscarinic acetylcholine receptor j biol chem 276 5505 5510 2001abstractfree full text 66 hirota k kushikata kudo m kudo lambert dg matsuki orexin b evoke noradrenaline release rat cerebrocortical slices br j pharmacol 134 1461 1466 2001abstractfree full text 67 holmqvist akerman keo kukkonen jp high specificity human orexin receptors orexins neuropeptide y neuropeptides neurosci lett 305 177 180 2001isimedline 68 horn f weare j beukers mw horsch bairoch chen w edvardsen o campagne f vriend g gpcrdb information system g protein coupled receptors nucleic acids res 26 275 279 1998abstractfree full text 69 horvath tl diano van den pol synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 19 1072 1087 1999abstractfree full text 70 horvath tl peyron c diano ivanov aston jones g kilduff ts van den pol hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system j comp neurol 415 145 159 1999isimedline 71 horvath tl warden ch hajos m lombardi goglia f diano brain uncoupling protein 2 uncoupled neuronal mitochondria predict thermal synapses homeostatic centers j neurosci 19 10417 10427 1999abstractfree full text 72 huang zl qu wm li wd mochizuki eguchi n watanabe urade y hayaishi o arousal effect orexin depends activation histaminergic system proc natl acad sci usa 98 9965 9970 2001abstractfree full text 73 hungs m fan j lin l lin x maki ra mignot e identification functional analysis mutations hypocretin orexin genes narcoleptic canines genome res 11 531 539 2001abstractfree full text 74 hungs m mignot e hypocretinorexin sleep narcolepsy bioessays 23 397 408 2001isimedline 75 hwang ll chen ct dun nj mechanisms orexin induced depolarizations rat dorsal motor nucleus vagus neurones vitro j physiol 537 511 520 2001abstractfree full text 76 ichinose m asai m sawada m sasaki k oomura y induction outward current orexin b mouse peritoneal macrophages febs lett 440 51 54 1998isimedline 77 ida nakahara k katayama murakami n nakazato m effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activities rats brain res 821 526 529 1999isimedline 78 ida nakahara k murakami hanada r nakazato m murakami n possible involvement orexin stress reaction rats biochem biophys res commun 270 318 323 2000isimedline 79 ishizuka yamamoto y yamatodani effect orexin b histamine release anterior hypothalamus rats neurosci lett 323 93 96 2002isimedline 80 ivanov aston jones g hypocretinorexin depolarizes decreases potassium conductance locus coeruleus neurons neuroreport 11 1755 1758 2000isimedline 81 jain mr horvath tl kalra ps kalra sp evidence npy y1 receptors involved stimulation feeding orexins hypocretins sated rats regul pept 87 19 24 2000isimedline 82 jaszberenyi m bujdoso e pataki telegdy g effects orexins hypothalamic pituitary adrenal system j neuroendocrinol 12 1174 1178 2000isimedline 83 jaszberenyi m bujdoso e telegdy g role neuropeptide y orexin induced hypothalamic pituitary adrenal activation j neuroendocrinol 13 438 441 2001isimedline 84 johren o neidert sj kummer m dendorfer dominiak p prepro orexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 142 3324 3331 2001abstractfree full text 85 jones dn gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153 210 218 2001medline 86 kane jk parker sl matta sg fu y sharp bm li md nicotine regulates expression orexin receptors rat brain endocrinology 141 3623 3629 2000abstractfree full text 87 kane jk tanaka h parker sl yanagisawa m li md sensitivity orexin binding phospholipase c inhibitors neuropeptide y secretin biochem biophys res commun 272 959 965 2000isimedline 88 karteris e randeva hs grammatopoulos dk jaffe rb hillhouse ew expression coupling characteristics crh orexin type 2 receptors human fetal adrenals j clin endocrinol metab 86 4512 4519 2001abstractfree full text 89 kastin aj akerstrom v orexin orexin b rapidly enters brain blood simple diffusion j pharmacol exp ther 289 219 223 1999abstractfree full text 90 kilduff ts peyron c hypocretinorexin ligand receptor system implications sleep sleep disorders trends neurosci 23 359 365 2000isimedline 91 kimura j miyamae noma identification sodium calcium exchange current single ventricular cells guinea pig j physiol 384 199 222 1987abstract 92 kirchgessner al liu m orexin synthesis response gut neuron 24 941 951 1999isimedline 93 korotkova tm eriksson ks haas hl brown re selective excitation gabaergic neurons substantia nigra rat orexinhypocretin vitro regul pept 104 83 89 2002isimedline 94 krahn le black jl silber mh narcolepsy new understanding irresistible sleep mayo clin proc 76 185 194 2001isimedline 95 kreegipuu blom n brunak phosphobase database phosphorylation sites release 20 nucleic acids res 27 237 239 1999abstractfree full text 96 kukkonen jp akerman keo orexin receptors couple ca2 channels different store operated ca2 channels neuroreport 12 2017 2020 2001isimedline 97 kummer m neidert sj johren o dominiak p orexin hypocretin gene expression rat ependymal cells neuroreport 12 2117 2120 2001isimedline 98 kunii k yamanaka nambu matsuzaki goto k sakurai orexinshypocretins regulate drinking behaviour brain res 842 256 261 1999isimedline 99 kurose ueta y yamamoto y serino r ozaki y saito j nagata yamashita h effects restricted feeding activity hypothalamic orexin ox containing neurons ox2 receptor mrna level paraventricular nucleus rats regul pept 104 145 151 2002isimedline 100 lee jh bang e chae kj kim jy lee dw lee w solution structure new hypothalamic neuropeptide human hypocretin 2orexin b eur j biochem 266 831 839 1999abstractfree full text 101 levin dunn meynell aa routh vh brain glucose sensing body energy homeostasis role obesity diabetes j physiol regul integr comp physiol 276 r1223 r1231 1999abstractfree full text 102 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline 103 liu xh morris r spiller d white m williams g orexin preferentially excites glucose sensitive neurons lateral hypothalamus rat vitro diabetes 50 2431 2437 2001abstractfree full text 104 lopez m senaris r gallego r garcia caballero lago f seoane l casanueva f dieguez c orexin receptors expressed adrenal medulla rat endocrinology 140 5991 5994 1999abstractfree full text 105 lopez m seoane l garcia mc lago f casanueva ff senaris r dieguez c leptin regulation prepro orexin orexin receptor mrna levels hypothalamus biochem biophys res commun 269 41 45 2000isimedline 106 lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998isimedline 107 lund pe shariatmadari r uustare detheux m parmentier m kukkonen jp akerman keo orexin ox1 receptor activates novel ca2 influx pathway necessary coupling phospholipase c j biol chem 275 30806 30812 2000abstractfree full text 108 malendowicz lk hochol ziolkowska nowak m gottardo l nussdorfer gg prolonged orexin administration stimulates steroid hormone secretion acting directly rat adrenal gland int j mol med 7 401 404 2001isimedline 109 malendowicz lk jedrzejczak n belloni trejter m hochol nussdorfer gg effects orexins b secretory proliferative activity immature regenerating rat adrenal glands histol histopathol 16 713 717 2001isimedline 110 malendowicz lk tortorella c nussdorfer gg orexins stimulate corticosterone secretion rat adrenocortical cells activation adenylate cyclase dependent signaling cascade j steroid biochem mol biol 70 185 188 1999isimedline 111 marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk differential expression orexin receptors 1 2 rat brain j comp neurol 435 6 25 2001isimedline 112 mark md herlitze g protein mediated gating inward rectifier k channels eur j biochem 267 5830 5836 2000abstractfree full text 113 martin g fabre v siggins gr de lecea l interaction hypocretins neurotransmitters nucleus accumbens regul pept 104 111 117 2002isimedline 114 matsumura k tsuchihashi abe central orexin augments sympathoadrenal outflow conscious rabbits hypertension 37 1382 1387 2001abstractfree full text 115 matsuzaki sakurai kunii k nakamura yanagisawa m goto k involvement serotonergic system orexin induced behavioral alterations rats regul pept 104 119 123 2002isimedline 116 mazzocchi g malendowicz lk aragona f rebuffat p gottardo l nussdorfer gg human pheochromocytomas express orexin receptor type 2 gene display vitro secretory response orexins b j clin endocrinol metab 86 4818 4821 2001abstractfree full text 117 mazzocchi g malendowicz lk gottardo l aragona f nussdorfer gg orexin stimulates cortisol secretion human adrenocortical cells activation adenylate cyclase dependent signaling cascade j clin endocrinol metab 86 778 782 2001abstractfree full text 118 mcgranaghan pa piggins hd orexin like immunoreactivity hypothalamus thalamus syrian hamster mesocricetus auratus siberian hamster phodopus sungorus special reference circadian structures brain res 904 234 244 2001isimedline 119 meister b control food intake via leptin receptors hypothalamus vitam horm 59 265 304 2000medline 120 methippara mm alam mn szymusiak r mcginty d effects lateral preoptic area application orexin sleep wakefulness neuroreport 11 3423 3426 2000isimedline 121 mikkelsen jd hauser f delecea l sutcliffe jg kilduff ts calgari c pevet p simonneaux v hypocretin orexin rat pineal gland central transmitter effects noradrenaline induced release melatonin eur j neurosci 14 419 425 2001isimedline 122 mintz em van den pol casano aa albers distribution hypocretin orexin immunoreactivity central nervous system syrian hamsters mesocricetus auratus j chem neuroanat 21 225 238 2001isimedline 123 mitsuma hirooka y mori y kayama m adachi k rhue n ping j nogimori effects orexin thyrotropin releasing hormone thyrotropin secretion rats horm metab res 31 606 609 1999isimedline 124 monda m viggiano mondola p de luca v inhibition prostaglandin synthesis reduces hyperthermic reactions induced hypocretin 1orexin brain res 909 68 74 2001isimedline 125 mondal ms nakazato m date y murakami n hanada r sakata matsukura characterization orexin orexin b microdissected rat brain nuclei contents two obese rat models neurosci lett 273 45 48 1999isimedline 126 mondal ms nakazato m date y murakami n yanagisawa m matsukura widespread distribution orexin rat brain regulation upon fasting biochem biophys res commun 256 495 499 1999isimedline 127 moriguchi sakurai nambu yanagisawa m goto k neurons containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia neurosci lett 264 101 104 1999isimedline 128 mullett ma billington cj levine kotz cm hypocretin lateral hypothalamus activates key feeding regulatory brain sites neuroreport 11 103 108 2000isimedline 129 muroya uramura k sakurai takigawa m yada lowering glucose concentrations increases cytosolic ca2 orexin neurons rat lateral hypothalamus neurosci lett 309 165 168 2001isimedline 130 nakamura uramura k nambu yada goto k yanagisawa m sakurai orexin induced hyperlocomotion stereotypy mediated dopaminergic system brain res 873 181 187 2000isimedline 131 nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999isimedline 132 nanmoku isobe k sakurai yamanaka takekoshi k kawakami y goto k nakai effects orexin cultured porcine adrenal medullary cortex cells regul pept 104 125 130 2002isimedline 133 naslund e ehrstrom m ma j hellstrom pm kirchgessner al localization effects orexin fasting motility rat duodenum j physiol gastrointest liver physiol 282 g470 g479 2002abstractfree full text 134 nishino fujiki n ripley b sakurai e kato m watanabe mignot e yanai k decreased brain histamine content hypocretinorexin receptor 2 mutated narcoleptic dogs neurosci lett 313 125 128 2001isimedline 135 nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000isimedline 136 novak cm albers localization hypocretin like immunoreactivity brain diurnal rodent arvicanthis niloticus j chem neuroanat 23 49 58 2002isimedline 137 nowak kw mackowiak p switonska mm fabis m malendowicz lk acute orexin effects insulin secretion rat vivo vitro studies life sci 66 449 454 2000isimedline 138 okumura takeuchi motomura w yamada h egashira si asahi kanatani ihara m kohgo y requirement intact disulfide bonds orexin induced stimulation gastric acid secretion mediated ox1 receptor activation biochem biophys res commun 280 976 981 2001isimedline 139 olafsdottir br rye db scammell te matheson jk stefansson k gulcher jr polymorphisms hypocretinorexin pathway genes narcolepsy neurology 57 1896 1899 2001abstractfree full text 140 orlando g brunetti l di nisio c michelotto b recinella l ciabattoni g vacca m effects cocaine amphetamine regulated transcript peptide leptin orexins hypothalamic serotonin release eur j pharmacol 430 269 272 2001isimedline 141 overeem mignot e gert van dijk j lammers gj narcolepsy clinical features new pathophysiologic insights future perspectives j clin neurophysiol 18 78 105 2001isimedline 142 peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6 991 997 2000isimedline 143 peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text 144 piper dc upton n smith mi hunter aj novel brain neuropeptide orexin modulates sleep wake cycle rats eur j neurosci 12 726 730 2000isimedline 145 porter ra chan wn coulton johns hadley ms widdowson k jerman jc brough sj coldwell m smart d jewitt f jeffrey p austin n 13 biarylureas selective non peptide antagonists orexin 1 receptor bioorg med chem lett 11 1907 1910 2001isimedline 146 randeva hs karteris e grammatopoulos d hillhouse ew expression orexin functional orexin type 2 receptors human adult adrenals implications adrenal function energy homeostasis j clin endocrinol metab 86 4808 4813 2001abstractfree full text 147 rauch m riediger schmid ha simon e orexin activates leptin responsive neurons arcuate nucleus pflugers arch 440 699 703 2000isimedline 148 ripley b fujiki n okura m mignot e nishino hypocretin levels sporadic familial cases canine narcolepsy neurobiol dis 8 525 534 2001isimedline 149 rodgers rj halford jc nunes de souza rl canto de souza al piper dc arch jr blundell je dose response effects orexin food intake behavioural satiety sequence rats regul pept 96 71 84 2000isimedline 150 rodgers rj halford jc nunes de souza rl canto de souza al piper dc arch jr upton n porter ra johns blundell je sb 334867 selective orexin 1 receptor antagonist enhances behavioural satiety blocks hyperphagic effect orexin rats eur j neurosci 13 1444 1452 2001isimedline 151 russell sh kim ms small cj abbott cr morgan dg taheri murphy kg todd jf ghatei ma bloom sr central administration orexin suppresses basal domperidone stimulated plasma prolactin j neuroendocrinol 12 1213 1218 2000isimedline 152 russell sh small cj dakin cl abbott cr morgan dg ghatei ma bloom sr central effects orexin hypothalamic pituitary adrenal axis vivo vitro male rats j neuroendocrinol 13 561 566 2001isimedline 153 russell sh small cj sunter d morgan dakin cl cohen ma bloom sr chronic intraparaventricular nuclear administration orexin male rats alter thyroid axis uncoupling protein 1 brown adipose tissue regul pept 104 61 68 2002isimedline 154 sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline 155 sakurai moriguchi furuya k kajiwara n nakamura yanagisawa m goto k structure function human prepro orexin gene j biol chem 274 17771 17776 1999abstractfree full text 156 samson wk gosnell b chang jk resch zt murphy tc cardiovascular regulatory actions hypocretins brain brain res 831 248 253 1999isimedline 157 samson wk resch zt hypocretinorexin story trends endocrinol metab 11 257 262 2000isimedline 158 samson wk taylor mm hypocretinorexin suppresses corticotroph responsiveness vitro j physiol regul integr comp physiol 281 r1140 r1145 2001abstractfree full text 159 samson wk taylor mm follwell m ferguson av orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 104 97 103 2002isimedline 160 satoh y uchida m fujita nishio h takeuchi hata f possible role orexin nonadrenergic noncholinergic inhibitory response muscle mouse small intestine eur j pharmacol 428 337 342 2001isimedline 161 scammell te estabrooke iv mccarthy mt chemelli rm yanagisawa m miller ms saper cb hypothalamic arousal regions activated modafinil induced wakefulness j neurosci 20 8620 8628 2000abstractfree full text 162 schuld hebebrand j geller f pollmacher increased body mass index patients narcolepsy lancet 355 1274 1275 2000isimedline 163 shibahara m sakurai nambu takenouchi iwaasa h egashira si ihara m goto k structure tissue distribution pharmacological characterization xenopus orexins peptides 20 1169 1176 1999isimedline 164 shiraishi oomura y sasaki k wayner mj effects leptin orexin food intake feeding related hypothalamic neurons physiol behav 71 251 261 2000isimedline 165 shirasaka miyahara kunitake jin qh kato k takasaki m kannan h orexin depolarizes rat hypothalamic paraventricular nucleus neurons j physiol regul integr comp physiol 281 r1114 r1118 2001abstractfree full text 166 shirasaka nakazato m matsukura takasaki m kannan h sympathetic cardiovascular actions orexins conscious rats j physiol regul integr comp physiol 277 r1780 r1785 1999abstractfree full text 167 smart d jerman jc brough sj neville wa jewitt f porter ra hypocretins weak agonists recombinant human orexin 1 orexin 2 receptors br j pharmacol 129 1289 1291 2000abstractfree full text 168 smart d jerman jc brough sj rushton sl murdock pr jewitt f elshourbagy na ellis ce middlemiss dn brown f characterization recombinant human orexin receptor pharmacology chinese hamster ovary cell line using flipr br j pharmacol 128 1 3 1999abstractfree full text 169 smart d sabido david c brough sj jewitt f johns porter ra jerman jc sb 334867 first selective orexin 1 receptor antagonist br j pharmacol 132 1179 1182 2001abstractfree full text 170 soffin em evans ml gill ch harries mh benham cd davies ch sb 334867 antagonises orexin mediated excitation locus coeruleus neuropharmacology 42 127 133 2002isimedline 171 sunahara rk dessauer cw gilman ag complexity diversity mammalian adenylyl cyclases annu rev pharmacol toxicol 36 461 480 1996isimedline 172 sutcliffe jg de lecea l hypocretins excitatory neuromodulatory peptides multiple homeostatic systems including sleep feeding j neurosci res 62 161 168 2000isimedline 173 sweet dc levine billington cj kotz cm feeding response central orexins brain res 821 535 538 1999isimedline 174 switonska mm kaczmarek p malendowicz lk nowak kw orexins adipoinsular axis function rat regul pept 104 69 73 2002isimedline 175 szekely m petervari e balasko m hernadi uzsoki b effects orexins energy balance thermoregulation regul pept 104 47 53 2002isimedline 176 taheri sunter d dakin c moyes seal l gardiner j rossi m ghatei m bloom diurnal variation orexin immunoreactivity prepro orexin mrna rat central nervous system neurosci lett 279 109 112 2000isimedline 177 takahashi n okumura yamada h kohgo y stimulation gastric acid secretion centrally administered orexin conscious rats biochem biophys res commun 254 623 627 1999isimedline 178 thannickal tc moore ry nienhuis r ramanathan l gulyani aldrich m cornford m siegel jm reduced number hypocretin neurons human narcolepsy neuron 27 469 474 2000isimedline 179 thorpy m current concepts etiology diagnosis treatment narcolepsy sleep med 2 5 17 2001medline 180 trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 438 71 75 1998isimedline 181 uramura k funahashi h muroya shioda takigawa m yada orexin activates phospholipase c protein kinase c mediated ca2 signaling dopamine neurons ventral tegmental area neuroreport 12 1885 1889 2001isimedline 182 van den pol hypothalamic hypocretin orexin robust innervation spinal cord j neurosci 19 3171 3182 1999abstractfree full text 183 van den pol gao xb obrietan k kilduff ts belousov ab presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 18 7962 7971 1998abstractfree full text 184 van den pol patrylo pr ghosh pk gao xb lateral hypothalamus early developmental expression response hypocretin orexin j comp neurol 433 349 363 2001isimedline 185 waleh ns apte deshpande terao ding j kilduff ts modulation promoter region prepro hypocretin alpha interferon gene 262 123 128 2001isimedline 186 wang j osaka inoue energy expenditure intracerebroventricular administration orexin anesthetized rats neurosci lett 315 49 52 2001isimedline 187 wickman k clapham de ion channel regulation g proteins physiol rev 75 865 885 1995abstractfree full text 188 wieland ha soll rm doods hn stenkamp d hurnaus r lammle b beck sickinger ag sk n mc cell line expresses orexin binding site different recombinant orexin 1 type receptor eur j biochem 269 1128 1135 2002abstractfree full text 189 williams g harrold ja cutler dj hypothalamus regulation energy homeostasis lifting lid black box proc nutr soc 59 385 396 2000isimedline 190 willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001isimedline 191 xi mc morales fr chase mh effects sleep wakefulness injection hypocretin 1 orexin laterodorsal tegmental nucleus cat brain res 901 259 264 2001isimedline 192 yamada h okumura motomura w kobayashi y kohgo y inhibition food intake central injection anti orexin antibody fasted rats biochem biophys res commun 267 527 531 2000isimedline 193 yamamoto y ueta y date y nakazato m hara y serino r nomura m shibuya matsukura yamashita h regulation prepro orexin gene expression genetically obese mice brain res mol brain res 65 14 22 1999isimedline 194 yamanaka sakurai katsumoto yanagisawa m goto k chronic intracerebroventricular administration orexin rats increases food intake daytime effect body weight brain res 849 248 252 1999isimedline 195 yamanaka tsujino n funahashi h honda k guan jl wang qp tominaga m goto k shioda sakurai orexins activate histaminergic neurons via orexin 2 receptor biochem biophys res commun 290 1237 1245 2002isimedline 196 yoshida y fujiki n nakajima ripley b matsumura h yoneda h mignot e nishino fluctuation extracellular hypocretin 1 orexin levels rat relation light dark cycle sleep wake activities eur j neurosci 14 1075 1081 2001isimedline 197 yoshimichi g yoshimatsu h masaki sakata orexin regulates body temperature coordination arousal status exp biol med maywood 226 468 476 2001abstractfree full text 198 zhang j luo p orexin b immunoreactive fibers terminals innervate sensory motor neurons jaw elevator muscles rat synapse 44 106 110 2002isimedline
0.35575834.12419707.html.plaintext.txt	188	j physiol cell physiol 2836c1567 c1591 0363 614302 500 copyright 2002 american physiological society
0.35575834.12419707.html.plaintext.txt	189	j physiol cell physiol 2836c1567 c1591 0363 614302 500 copyright 2002 american physiological society
0.358711.12485808.html.plaintext.txt	0	minireview side orexins endocrine metabolic actions meghan m taylor willis k samson
0.358711.12485808.html.plaintext.txt	1	pharmacological physiological science st louis university school medicine st louis missouri 63104
0.358711.12485808.html.plaintext.txt	2	pharmacological physiological science st louis university school medicine st louis missouri 63104
0.358711.12485808.html.plaintext.txt	3	abstract top abstract introduction biological actions development orexin conclusions references
0.358711.12485808.html.plaintext.txt	4	although clear orexinhypocretin peptides significant physiologically relevant role sleepwakefulness broader picture emerged indicating metabolic actions may depend upon neural endocrine mechanisms manifestation ability exogenous peptide activate sympathetic tone increase locomotor activity alter feeding behavior together observed alterations functions knockout animals strongly suggests important neural actions endogenous orexinshypocretins likewise action exogenously administered peptides alter endocrine function particular corticotropin release mirrored potential endocrinopathies knockout animals thus pluripotent peptides hold great potential treatment human narcolepsy also provide insight coordinated regulation multiple physiological systems
0.358711.12485808.html.plaintext.txt	5	although clear orexinhypocretin peptides significant physiologically relevant role sleepwakefulness broader picture emerged indicating metabolic actions may depend upon neural endocrine mechanisms manifestation ability exogenous peptide activate sympathetic tone increase locomotor activity alter feeding behavior together observed alterations functions knockout animals strongly suggests important neural actions endogenous orexinshypocretins likewise action exogenously administered peptides alter endocrine function particular corticotropin release mirrored potential endocrinopathies knockout animals thus pluripotent peptides hold great potential treatment human narcolepsy also provide insight coordinated regulation multiple physiological systems
0.358711.12485808.html.plaintext.txt	6	food intake autonomic nervous system narcolepsy corticotropin corticosterone
0.358711.12485808.html.plaintext.txt	7	introduction top abstract introduction biological actions development orexin conclusions references
0.358711.12485808.html.plaintext.txt	8	remarkable convergence independent efforts occurred early 1998 la jolla dallas groups simultaneously reported predicted 6 elucidated 29 structures two peptides would become named hypocretins 6 alternatively orexins 29 peptides known processed prohormone recognized produced brain remarkably circumscribed location lateral hypothalamusperifornical area region known important feeding behavior 29 axonal projections multiple brain sites 4 6 21 25 29 38 predicted diversity biological actions clear beginning peptides exerted membrane effects similar recognized neurotransmitters 6 8 42 might significant role central nervous system cns regulation feeding behavior 13 29 31 simplicity peptides referred orexins orexin hypocretin 1 33 amino acid peptide two internal disulfide linkages pyroglutamyl residue nh2 terminus amidated cooh terminus orexin b hypocretin 2 28 amino acids length lacks internal disulfide bonds similarly amidated cooh terminus initial description orexins yanigisawas group sakurai et al ref 29 also identified two orexin receptors ox1r ox2r although g protein coupled receptors ox1r appears couple via gq11 subclass heteromeric receptors ox2r may couple either gq11 gio subclasses 29 42 clear ox1r prefers orexin ligand whereas ox2r binds orexin orexin b similar affinities 29 finally recognized addition broad projection field originating orexin producing neurons lateral hypothalamicperifornical area unique distributions ox1r ox2r subtypes exist 17 19 29 41 establishing potential development pharmacological agents interact uniquely single subclass orexin receptor therefore act selective agonists antagonists specific biological actions endogenous peptides
0.358711.12485808.html.plaintext.txt	9	remarkable convergence independent efforts occurred early 1998 la jolla dallas groups simultaneously reported predicted 6 elucidated 29 structures two peptides would become named hypocretins 6 alternatively orexins 29 peptides known processed prohormone recognized produced brain remarkably circumscribed location lateral hypothalamusperifornical area region known important feeding behavior 29 axonal projections multiple brain sites 4 6 21 25 29 38 predicted diversity biological actions clear beginning peptides exerted membrane effects similar recognized neurotransmitters 6 8 42 might significant role central nervous system cns regulation feeding behavior 13 29 31 simplicity peptides referred orexins orexin hypocretin 1 33 amino acid peptide two internal disulfide linkages pyroglutamyl residue nh2 terminus amidated cooh terminus orexin b hypocretin 2 28 amino acids length lacks internal disulfide bonds similarly amidated cooh terminus initial description orexins yanigisawas group sakurai et al ref 29 also identified two orexin receptors ox1r ox2r although g protein coupled receptors ox1r appears couple via gq11 subclass heteromeric receptors ox2r may couple either gq11 gio subclasses 29 42 clear ox1r prefers orexin ligand whereas ox2r binds orexin orexin b similar affinities 29 finally recognized addition broad projection field originating orexin producing neurons lateral hypothalamicperifornical area unique distributions ox1r ox2r subtypes exist 17 19 29 41 establishing potential development pharmacological agents interact uniquely single subclass orexin receptor therefore act selective agonists antagonists specific biological actions endogenous peptides
0.358711.12485808.html.plaintext.txt	10	biological actions orexinshypocretins top abstract introduction biological actions development orexin conclusions references
0.358711.12485808.html.plaintext.txt	11	although agreed exogenously applied orexin stimulate feeding orexin production determined metabolic state animal see review mieda yanagisawa ref 20 investigators recognize effects orexins less potent neuropeptide y npy see review smart et al ref 37 however must recognized multiple peptide systems interact control feeding response hierarchy within systems clearly established pretreatment npy antagonists significantly decreased feeding response exogenously administered orexin 7 44 suggesting npy neurons located downstream wiring diagram however evidence exist potential opposite true ie orexin neurons located farther downstream npy series circuit controlling feeding 22 strong evidence innervation npy neurons orexin terminals arcuate nucleus hypothalamus 5 11 central administration dose orexin stimulated feeding significantly increased npy mrna nuclear group well 16 convincing evidence physiologically relevant role endogenous orexins cns control feeding comes passive immunoneutralization studies compromise bioactivity endogenous orexin 22 43 neutralizing antibodies reduced feeding response overnight fast least one group access compound observed decreased feeding response exogenously applied orexin fast induced feeding administration relatively selective nonpeptide ox1r antagonist sb 334867 27 orexin knockout mice preprohormone gene deletion ate less wild type littermates 2 suggesting physiologically relevant role endogenous orexin regulation appetite however mice grew normally thus determinant growth body weight must compensate decreased feeding two excellent possibilities motor activity metabolic state
0.358711.12485808.html.plaintext.txt	12	although agreed exogenously applied orexin stimulate feeding orexin production determined metabolic state animal see review mieda yanagisawa ref 20 investigators recognize effects orexins less potent neuropeptide y npy see review smart et al ref 37 however must recognized multiple peptide systems interact control feeding response hierarchy within systems clearly established pretreatment npy antagonists significantly decreased feeding response exogenously administered orexin 7 44 suggesting npy neurons located downstream wiring diagram however evidence exist potential opposite true ie orexin neurons located farther downstream npy series circuit controlling feeding 22 strong evidence innervation npy neurons orexin terminals arcuate nucleus hypothalamus 5 11 central administration dose orexin stimulated feeding significantly increased npy mrna nuclear group well 16 convincing evidence physiologically relevant role endogenous orexins cns control feeding comes passive immunoneutralization studies compromise bioactivity endogenous orexin 22 43 neutralizing antibodies reduced feeding response overnight fast least one group access compound observed decreased feeding response exogenously applied orexin fast induced feeding administration relatively selective nonpeptide ox1r antagonist sb 334867 27 orexin knockout mice preprohormone gene deletion ate less wild type littermates 2 suggesting physiologically relevant role endogenous orexin regulation appetite however mice grew normally thus determinant growth body weight must compensate decreased feeding two excellent possibilities motor activity metabolic state
0.358711.12485808.html.plaintext.txt	13	early recognized orexins stimulated motor activity apparently increased arousal state 8 30 peptides also stimulate sympathetic nervous system activity 3 30 34 36 thought increase feeding might actually secondary increased arousal state metabolic demand 18 clear locomotor activity time spent awake state increased animals administered orexin 8 thus addition stimulating feeding peptides stimulated energy expenditure 45 things became much clearer yanagisawa colleagues chemelli et al ref 2 demonstrated technical expertise developing orexin gene knockout mouse model proved importance endogenous orexin system sleepwakefulness time cast doubt physiological relevance observed effects peptides feeding behavior metabolism mice displayed behavioral phenotype quite similar human canine models narcolepsy 2 15 25 distinct periods behavioral arrest intrusion rapid eye movement rem sleep normal waking state primary function orexins control feeding metabolic rate pharmacological studies suggested animals would expected display phenotypic changes reflective loss activities however mice reported otherwise phenotypically normal general metabolic state mirrored serum electrolytes glucose levels similar wild type littermates 14 15 wk age addition mice fertile thus pharmacological effects previously reported reproductive hormone 8 26 28 39 growth hormone 8 secretion appear physiological expression animals times studied
0.358711.12485808.html.plaintext.txt	14	early recognized orexins stimulated motor activity apparently increased arousal state 8 30 peptides also stimulate sympathetic nervous system activity 3 30 34 36 thought increase feeding might actually secondary increased arousal state metabolic demand 18 clear locomotor activity time spent awake state increased animals administered orexin 8 thus addition stimulating feeding peptides stimulated energy expenditure 45 things became much clearer yanagisawa colleagues chemelli et al ref 2 demonstrated technical expertise developing orexin gene knockout mouse model proved importance endogenous orexin system sleepwakefulness time cast doubt physiological relevance observed effects peptides feeding behavior metabolism mice displayed behavioral phenotype quite similar human canine models narcolepsy 2 15 25 distinct periods behavioral arrest intrusion rapid eye movement rem sleep normal waking state primary function orexins control feeding metabolic rate pharmacological studies suggested animals would expected display phenotypic changes reflective loss activities however mice reported otherwise phenotypically normal general metabolic state mirrored serum electrolytes glucose levels similar wild type littermates 14 15 wk age addition mice fertile thus pharmacological effects previously reported reproductive hormone 8 26 28 39 growth hormone 8 secretion appear physiological expression animals times studied
0.358711.12485808.html.plaintext.txt	15	development orexin neuron dropout model reveals potential physiological relevance endocrine metabolic action orexinshypocretins top abstract introduction biological actions development orexin conclusions references
0.358711.12485808.html.plaintext.txt	16	although embryonic orexin gene knockout mice provided key evidence pharmacological effects orexin sleepwakefulness potential physiological relevance drew attention investigators away endocrine metabolic effects peptides model entirely recapitulate pathology human narcolepsy 2 contrary recognized human narcolepsy almost cases frank lack orexin gene expression throughout life instead gradual loss orexin producing neurons hypothalamus aging 24 40 thus faithfully recreate mouse equivalent human model yanagisawa colleagues hara et al ref 9 yet another brilliant series experiments created mice harboring toxic ataxin 3 gene attached orexin promotor ataxin 3 gene encodes protein extended polyglutamine repeats caused apoptosis expressed transfected cells vitro 46 already 2 wk age expression transgene could detected orexin producing neurons 4 8 wk age majority orexin producing neurons eliminated similarly 8 wk age ataxin 3 transgenic mice preproorexin mrna could detected whereas expression two peptides known involved control feeding npy melanin concentrating hormone appeared normal 9
0.358711.12485808.html.plaintext.txt	17	although embryonic orexin gene knockout mice provided key evidence pharmacological effects orexin sleepwakefulness potential physiological relevance drew attention investigators away endocrine metabolic effects peptides model entirely recapitulate pathology human narcolepsy 2 contrary recognized human narcolepsy almost cases frank lack orexin gene expression throughout life instead gradual loss orexin producing neurons hypothalamus aging 24 40 thus faithfully recreate mouse equivalent human model yanagisawa colleagues hara et al ref 9 yet another brilliant series experiments created mice harboring toxic ataxin 3 gene attached orexin promotor ataxin 3 gene encodes protein extended polyglutamine repeats caused apoptosis expressed transfected cells vitro 46 already 2 wk age expression transgene could detected orexin producing neurons 4 8 wk age majority orexin producing neurons eliminated similarly 8 wk age ataxin 3 transgenic mice preproorexin mrna could detected whereas expression two peptides known involved control feeding npy melanin concentrating hormone appeared normal 9
0.358711.12485808.html.plaintext.txt	18	6 wk age orexinataxin 3 mice 9 observed display periods behavioral arrest similar previously reported investigators orexin knockout animals 2 fragmentation sleepwakefulness characteristic orexin knockout animals also observed orexinataxin 3 mice included increased frequency entry duration rem sleep thus mice delayed onset compromise orexin producing neurons faithfully mirrored situation human narcolepsy characterized slowly progressive disease due dropping orexin neurons lateral hypothalamus 40
0.358711.12485808.html.plaintext.txt	19	6 wk age orexinataxin 3 mice 9 observed display periods behavioral arrest similar previously reported investigators orexin knockout animals 2 fragmentation sleepwakefulness characteristic orexin knockout animals also observed orexinataxin 3 mice included increased frequency entry duration rem sleep thus mice delayed onset compromise orexin producing neurons faithfully mirrored situation human narcolepsy characterized slowly progressive disease due dropping orexin neurons lateral hypothalamus 40
0.358711.12485808.html.plaintext.txt	20	appearance alterations sleepwakefulness mice predictable however additional observations made group investigators surprises provide important insight potential endocrine metabolic actions endogenous orexins one might expected orexinataxin 3 mice aged would lose weight compared wild type controls due loss orexigenic action peptides instead even predicted decrease food intake became obese 9 obese phenotype might due fact orexinataxin 3 mice displayed decreased spontaneous motor activity dark phase compared controls thus energy expenditure might possibly less leading obesity would suggest ability exogenous peptide stimulate arousal sympathetic nervous system locomotor activity 3 8 30 36 earlier pharmacological studies physiological correlates
0.358711.12485808.html.plaintext.txt	21	appearance alterations sleepwakefulness mice predictable however additional observations made group investigators surprises provide important insight potential endocrine metabolic actions endogenous orexins one might expected orexinataxin 3 mice aged would lose weight compared wild type controls due loss orexigenic action peptides instead even predicted decrease food intake became obese 9 obese phenotype might due fact orexinataxin 3 mice displayed decreased spontaneous motor activity dark phase compared controls thus energy expenditure might possibly less leading obesity would suggest ability exogenous peptide stimulate arousal sympathetic nervous system locomotor activity 3 8 30 36 earlier pharmacological studies physiological correlates
0.358711.12485808.html.plaintext.txt	22	intriguing finding reported hara et al 9 orexinataxin 3 mice developed along obesity appeared late onset diabetes type 2 diabetes earlier work preproorexin gene knockout animals suggested alterations glucose homeostasis reports direct effects orexin insulin secretion isolated pancreatic islets cells one report intravenous administration orexin elevates circulating insulin glucose levels rats orexin stimulates insulin release vitro isolated perfused pancreas preparations 23 doses higher present gland circulation observed phenotype obesity diabetes orexinataxin 3 mice resembles situation human narcoleptic patients 10 35 also mirrors situation cortisol excess obesity result combination fat redistribution due altered insulin sensitivity increased appetite hypothesis orexinataxin 3 mice represent exactly pathology
0.358711.12485808.html.plaintext.txt	23	intriguing finding reported hara et al 9 orexinataxin 3 mice developed along obesity appeared late onset diabetes type 2 diabetes earlier work preproorexin gene knockout animals suggested alterations glucose homeostasis reports direct effects orexin insulin secretion isolated pancreatic islets cells one report intravenous administration orexin elevates circulating insulin glucose levels rats orexin stimulates insulin release vitro isolated perfused pancreas preparations 23 doses higher present gland circulation observed phenotype obesity diabetes orexinataxin 3 mice resembles situation human narcoleptic patients 10 35 also mirrors situation cortisol excess obesity result combination fat redistribution due altered insulin sensitivity increased appetite hypothesis orexinataxin 3 mice represent exactly pathology
0.358711.12485808.html.plaintext.txt	24	central administration orexin conscious rats resulted behavioral response similar stress response 8 30 included increased grooming motor activity eg searching behavior injections also resulted increased sympathetic nervous system tone reflected increased heart rate blood pressure 3 30 36 known whether orexinataxin 3 mice display reset depressed autonomic system important examine possibility similarly central administration orexin stimulated corticotropin acth corticosterone release 8 12 14 34 vivo action blocked pretreatment animals corticotropin releasing factor crf antagonist 12 34 crf recognized anorexigenicanxiogenic peptide 8 loss orexin neurons might predict decrease crf release hypothalamo pituitary portal vessels response stress also loss potential stimulatory action orexin crf neurons important shut feeding cues thus absence orexin less crf would released basal stimulated conditions animal addition feeding longer periods would become corticosterone deficient instead quite opposite observed animals ate less appeared experience corticosterone excess decreased feeding observed clearly might due loss orexigenic drive provided endogenous peptide might explain apparent corticosterone excess
0.358711.12485808.html.plaintext.txt	25	central administration orexin conscious rats resulted behavioral response similar stress response 8 30 included increased grooming motor activity eg searching behavior injections also resulted increased sympathetic nervous system tone reflected increased heart rate blood pressure 3 30 36 known whether orexinataxin 3 mice display reset depressed autonomic system important examine possibility similarly central administration orexin stimulated corticotropin acth corticosterone release 8 12 14 34 vivo action blocked pretreatment animals corticotropin releasing factor crf antagonist 12 34 crf recognized anorexigenicanxiogenic peptide 8 loss orexin neurons might predict decrease crf release hypothalamo pituitary portal vessels response stress also loss potential stimulatory action orexin crf neurons important shut feeding cues thus absence orexin less crf would released basal stimulated conditions animal addition feeding longer periods would become corticosterone deficient instead quite opposite observed animals ate less appeared experience corticosterone excess decreased feeding observed clearly might due loss orexigenic drive provided endogenous peptide might explain apparent corticosterone excess
0.358711.12485808.html.plaintext.txt	26	thought ability centrally administered orexin stimulate acth corticosterone release vivo 8 12 14 34 reflection generalized stress effect exogenous peptide 30 36 indication role endogenous orexin day day control hypothalamo pituitary adrenal axis instead identified direct anterior pituitary effects orexinshypocretins 32 potentially explain metabolic phenotype orexinataxin 3 mice 9 orexin immunopositive nerve terminals exist external lamina median eminence 4 site diffusion neuroendocrine factors hypophysial portal vessels connecting hypothalamus anterior lobe pituitary gland addition ox1r ox2r subtypes exist anterior lobe ox1r localized corticotrophs human gland 1 demonstrated significant inhibitory effect orexins crf stimulated acth release cultured anterior pituitary cells 32 effect appeared mediated ox1r subtype pkc dependent mechanism suggesting activation gq initiated signaling pathway 32 recently demonstrated orexin stimulated transient elevations intracellular inositol trisphosphate levels 33 ferguson samson v ferguson w k samson unpublished observations observed calcium transients fura 2 labeled crf responsive pituitary cells vitro v ferguson w k samson unpublished observations would suggest binding orexin ox1r corticotrophs results activation phospholipase c subsequent formation inositol trisphosphate diacylglycerol dag blocked inhibitory action orexin crf induced acth release pkc inhibitor calphostin c hypothesize formation dag results activation potassium channel resulting hyperpolarization corticotroph right shift crf concentration response curve hypothesis supported demonstration pretreatment cells concentration potassium channel inhibitor glyburide alter basal crf stimulated hormone release resulted complete reversal inhibitory effects orexin 33
0.358711.12485808.html.plaintext.txt	27	thought ability centrally administered orexin stimulate acth corticosterone release vivo 8 12 14 34 reflection generalized stress effect exogenous peptide 30 36 indication role endogenous orexin day day control hypothalamo pituitary adrenal axis instead identified direct anterior pituitary effects orexinshypocretins 32 potentially explain metabolic phenotype orexinataxin 3 mice 9 orexin immunopositive nerve terminals exist external lamina median eminence 4 site diffusion neuroendocrine factors hypophysial portal vessels connecting hypothalamus anterior lobe pituitary gland addition ox1r ox2r subtypes exist anterior lobe ox1r localized corticotrophs human gland 1 demonstrated significant inhibitory effect orexins crf stimulated acth release cultured anterior pituitary cells 32 effect appeared mediated ox1r subtype pkc dependent mechanism suggesting activation gq initiated signaling pathway 32 recently demonstrated orexin stimulated transient elevations intracellular inositol trisphosphate levels 33 ferguson samson v ferguson w k samson unpublished observations observed calcium transients fura 2 labeled crf responsive pituitary cells vitro v ferguson w k samson unpublished observations would suggest binding orexin ox1r corticotrophs results activation phospholipase c subsequent formation inositol trisphosphate diacylglycerol dag blocked inhibitory action orexin crf induced acth release pkc inhibitor calphostin c hypothesize formation dag results activation potassium channel resulting hyperpolarization corticotroph right shift crf concentration response curve hypothesis supported demonstration pretreatment cells concentration potassium channel inhibitor glyburide alter basal crf stimulated hormone release resulted complete reversal inhibitory effects orexin 33
0.358711.12485808.html.plaintext.txt	28	thus hypothesize significant physiologically relevant effect orexin hypothalamo pituitary adrenal axis exerted pituitary hypothalamic level loss physiologically relevant inhibitory effect peptide time orexin neurons degenerate would lead increased sensitivity corticotrophs crf resultant resetting corticosteroid release apparent corticosteroid excess might explain appearance diabetes reality situation decreased insulin sensitivity caused corticosterone excess certainly obese appearance mice would support hypothesis
0.358711.12485808.html.plaintext.txt	29	thus hypothesize significant physiologically relevant effect orexin hypothalamo pituitary adrenal axis exerted pituitary hypothalamic level loss physiologically relevant inhibitory effect peptide time orexin neurons degenerate would lead increased sensitivity corticotrophs crf resultant resetting corticosteroid release apparent corticosteroid excess might explain appearance diabetes reality situation decreased insulin sensitivity caused corticosterone excess certainly obese appearance mice would support hypothesis
0.358711.12485808.html.plaintext.txt	30	conclusions top abstract introduction biological actions development orexin conclusions references
0.358711.12485808.html.plaintext.txt	31	absence readily available selective ox1r ox2r antagonists inherent problems encountered passive immunoneutralization approaches resulted slow progress toward goal establishing physiological relevance described pharmacological actions orexins endocrine systems metabolism however observations study preproorexin gene knockout mice suggested several observed endocrine actions pharmacologically administered orexin likelihood without physiological correlate mice fertile apparently grew normally exception decreased activity food intakes addition alterations sleepwakefulness thus previously described effects exogenous peptide reproductive hormone growth hormone secretion reflected knockout mice 2 metabolic alterations recognized however animals expressing orexinataxin 3 gene product followed adulthood clearer picture physiological relevance pharmacological effects exogenously administered orexin began appear mice narcoleptic display decreased motor activity 9 addition obese diabetic model certainly provide additional insight control sleepwakefulness even importantly may provide information genesis forms insulin resistant diabetes particular associated excess corticosteroid production eg cushings disease may also stimulate clinical researchers examine possibility subset human narcoleptic individuals cushingoid finally mice provide model examine unique concordant actions peptides feeding energy utilization case orexin unlike orexigenic peptides 9 18 positive food intake energy expenditure
0.358711.12485808.html.plaintext.txt	32	absence readily available selective ox1r ox2r antagonists inherent problems encountered passive immunoneutralization approaches resulted slow progress toward goal establishing physiological relevance described pharmacological actions orexins endocrine systems metabolism however observations study preproorexin gene knockout mice suggested several observed endocrine actions pharmacologically administered orexin likelihood without physiological correlate mice fertile apparently grew normally exception decreased activity food intakes addition alterations sleepwakefulness thus previously described effects exogenous peptide reproductive hormone growth hormone secretion reflected knockout mice 2 metabolic alterations recognized however animals expressing orexinataxin 3 gene product followed adulthood clearer picture physiological relevance pharmacological effects exogenously administered orexin began appear mice narcoleptic display decreased motor activity 9 addition obese diabetic model certainly provide additional insight control sleepwakefulness even importantly may provide information genesis forms insulin resistant diabetes particular associated excess corticosteroid production eg cushings disease may also stimulate clinical researchers examine possibility subset human narcoleptic individuals cushingoid finally mice provide model examine unique concordant actions peptides feeding energy utilization case orexin unlike orexigenic peptides 9 18 positive food intake energy expenditure
0.358711.12485808.html.plaintext.txt	33	acknowledge financial support dean st louis university school medicine w k samson chairman department pharmacological physiological science m m taylor w k samson m m taylor predoctoral fellow supported grant heartland affiliate american heart association
0.358711.12485808.html.plaintext.txt	34	acknowledge financial support dean st louis university school medicine w k samson chairman department pharmacological physiological science m m taylor w k samson m m taylor predoctoral fellow supported grant heartland affiliate american heart association
0.358711.12485808.html.plaintext.txt	35	address reprint requests correspondence w k samson pharmacological physiological science st louis univ school medicine 1406 south grand blvd st louis mo 63104 e mail samsonwkatsluedu u d
0.358711.12485808.html.plaintext.txt	36	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.358711.12485808.html.plaintext.txt	37	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.358711.12485808.html.plaintext.txt	38	references top abstract introduction biological actions development orexin conclusions references
0.358711.12485808.html.plaintext.txt	39	1 blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casaneuva f dieguez c beiras cellular localization orexin receptors human pituitary j clin endocrinol metab 86 1616 1619 2001abstractfree full text 2 chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong x kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999isimedline 3 chen ct hwang ll chang jk dunn nj pressor effects orexins injected intracisternally rostral ventrolateral medulla anesthetized rats j physiol regul integr comp physiol 278 r692 r697 2000abstractfree full text 4 date y mondal ms matsukura ueta y yamashita h kaiya h kangawa k nakazato m distribution orexinhypocretin rat median eminence pituitary mol brain res 76 1 6 2000isimedline 5 date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text 6 de lecea l kilduff ts peyron c gao xb foye pe danielson pe fukuhara c battenberg elf gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95 322 327 1998abstractfree full text 7 dube mg horvath tl kalra ps kalra sp evidence neuropeptide y y5 receptor involvement food intake elicited orexin sated rats peptides 21 1557 1560 2001isi 8 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah aj hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text 9 hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001isimedline 10 honda y doi y nimomiya r ninomiya c increased frequency non insulin diabetes mellitus among narcoleptic patients sleep 9 254 259 1986isimedline 11 horvath tl diano van den pol synaptic interaction hypocretin orexin neuropeptide y cells rodent primate hypothalamus novel circuit implicated metabolic endocrine regulations j neurosci 19 1072 1087 1999abstractfree full text 12 jasberenyi m bujdoso e pataki telegdy g effects orexin hypothalamic pituitary adrenal system j neuroendocrinol 12 1174 1178 2000isimedline 13 kilduff ts peyron c hypocretinorexin ligand receptor system implications sleep sleep disorders trends neurosci 23 359 365 2000isimedline 14 kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h centrally administered orexinhypocretin activates hpa axis rats neuroreport 11 1977 1980 2000isimedline 15 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline 16 lopez m seoane lm del carmen garcia m dieguez c senaris r neuropeptide y agouti related peptide melanin concentrating hormone target peptide orexin feeding actions rat hypothalamus neuroendocrinology 75 34 44 2002isimedline 17 lu xy bagnol d burke akil h watson sj differential distribution ox1 ox2 orexinhypocretin receptor messenger rna brain upon fasting horm behav 37 335 344 2000isimedline 18 lubkin m stricker krongrad independent feeding metabolic actions orexins mice biochem biophys res commun 253 241 245 1998isimedline 19 marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk differential expression orexin receptors 1 2 rat brain j comp neurol 435 6 25 2001isimedline 20 mieda m yanagisawa m sleep feeding neuropeptides roles orexins orexin receptors curr opin neurobiol 12 339 346 2002isimedline 21 nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999isimedline 22 niimi m sato m taminato neuropeptide y central control feeding interactions orexin leptin endocrine 14 269 273 2001isimedline 23 nowak kw mackowiak p switonska mm fabis m malendowicz lk acute orexin effects insulin secretion rat vivo vitro studies life sci 66 449 454 2000isimedline 24 peyron c faraco j rogers w ripley b overeem charnay y nevismalov aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nature med 6 991 997 2000isimedline 25 peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text 26 pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998isimedline 27 rodgers rj halford jc nunes de souza rl canto de souza al piper dc arch jr upton n porter ra johns blundell je sb 334867 selective orexin 1 receptor antagonist enhances behavioural satiety blocks hyperphagic effect orexin rats eur j neurosci 13 1444 1452 2001isimedline 28 russell sh kim ms small cj abbott cr morgan dga taheri murphy kg todd jf ghatei ma bloom sr central administration orexin suppresses basal domperidone stimulated plasma prolactin j neuroendocrinol 12 1213 1218 2000isimedline 29 sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jrs buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline 30 samson wk gosnell b chang jk resch zt murphy tc cardiovascular regulatory actions hypocretins brain brain res 831 248 253 1999isimedline 31 samson wk resch zt hypocretinorexin story trends endocrinol metab 11 257 262 2000isimedline 32 samson wk taylor mm hypocretinorexin suppresses corticotroph responsiveness vitro j physiol regul integr comp physiol 281 r1140 r1145 2001abstractfree full text 33 samson wk taylor mm anderson jw ferguson av orexin inhibition crh stimulated acth secretion possible role potassium channel activation abstract proc ann mtg endocr soc 2002 or57 5 34 samson wk taylor mm folwell m ferguson av orexin actions hypothalamic paraventricular nucleus physiological consequences cellular correlates regul pept 104 97 103 2002isimedline 35 schuld hebebrand j geller f pollmaecher increased body mass index patients narcolepsy lancet 355 1274 1275 2000isimedline 36 shirasaka nakazato m matsukura takasaki m kannan h sympathetic cardiovascular actions orexins conscious rats j physiol regul integr comp physiol 277 r1780 r1785 1999abstractfree full text 37 smart d haynes ac williams g arch jrs orexins treatment obesity eur j pharmacol 440 199 212 2002isimedline 38 taheri mahmoodi sm opacka juffry j ghatei ma bloom sr distribution quantification immunoreactive orexin rat tissues febs lett 457 157 161 1999isimedline 39 tamura irahara m tezuka m kiyokawa m aono orexins orexigenic hypothalamic neuropeptides suppress pulsatile secretion luteinizing hormone ovariectomized female rats biochem biophys res commun 264 759 762 1999isimedline 40 thannickal tc moore ry nienhuis r ramanathan l gukyani aldrich m comford m siegel jm reduced number hypocretin neurons human narcolepsy neuron 27 469 474 2000isimedline 41 trivedi p yu h macneil dj van der ploeg lht guan xm distribution orexin receptor mrna rat brain febs lett 438 71 75 1998isimedline 42 van den pol gao xb obrietan k kilduff ts belousov ab presynaptic postsynaptic actions modulation neuroendocrine neurons new hypothalamic peptide hypocretinorexin j neurosci 18 7962 7971 1998abstractfree full text 43 yamada h okumura motomuran w kobayashi y kohgo y inhibition food intake central injection anti orexin antibody fasted rats biochem biophys res commun 267 527 531 2000isimedline 44 yamanaka kunii k nambu tsujino n sakai matsuzaki miwa y goto k sakurai orexin induced food intake involves neuropeptide y pathway brain res 859 404 409 2000isimedline 45 yoshimichi g yoshimatsu h masaki sakata orexin regulates body temperature coordination arousal status exp biol med 226 468 476 2001abstractfree full text 46 yoshizawa yamagishi y koseki n goto j yoshida h shibasaki f shoji kanazawa cell cycle arrest enhances vitro toxicity truncated machado joseph disease gene product expanded pyroglutamine stretch hum mol genet 9 69 78 2000abstractfree full text
0.358711.12485808.html.plaintext.txt	40	j physiol endocrinol metab 2841e13 e17 0193 184903 500 copyright 2003 american physiological society
0.358711.12485808.html.plaintext.txt	41	j physiol endocrinol metab 2841e13 e17 0193 184903 500 copyright 2003 american physiological society
0.4064973.15172887.html.plaintext.txt	0	pulsatile lh release diminished whereas fsh secretion normal hypocretin deficient narcoleptic men w kok1 f roelfsema2 overeem3 g j lammers3 m frolich1 e meinders1 h pijl1
0.4064973.15172887.html.plaintext.txt	1	departments 1general internal medicine 2endocrinology 3neurology leiden university medical center 2300 rc leiden netherlands
0.4064973.15172887.html.plaintext.txt	2	submitted 9 february 2004 accepted final form 27 may 2004
0.4064973.15172887.html.plaintext.txt	3	abstract top abstract methods results discussion references hypocretin orexin peptides involved regulation energy balance pituitary hormone release narcolepsy sleep disorder characterized disruption hypocretin neurotransmission pituitary lh secretion diminished hypocretin deficient animal models intracerebroventricular administration hypocretin 1 activates hypothalamo pituitary gonadal axis rats evaluated whether hypocretin deficiency affects gonadotropin release humans end deconvolved 24 h serum concentrations lh fsh seven hypocretin deficient narcoleptic males n seven controls c matched age body mass index sex basal plasma concentrations testosterone estradiol sex hormone binding globulin similar groups mean 24 h lh concentration significantly lower narcolepsy patients 30 plus minus 04 n vs 42 plus minus 03 c ul p 001 primarily due reduction pulsatile lh secretion 235 plus minus 16 n vs 343 plus minus 49 c u l 1 24 h 1 p 002 orderliness lh fsh secretion quantitated approximate entropy statistic greater patients controls contrast features fsh release similar narcoleptic control groups also lh fsh secretions response intravenous administration 100 microg gnrh similar patients controls data indicate endogenous hypocretins involved regulation hypothalamo pituitary gonadal axis activity humans particular reduced lh release face normal pituitary responsivity gnrh stimulation narcoleptic men suggests hypocretins promote endogenous gnrh secretion
0.4064973.15172887.html.plaintext.txt	4	abstract top abstract methods results discussion references hypocretin orexin peptides involved regulation energy balance pituitary hormone release narcolepsy sleep disorder characterized disruption hypocretin neurotransmission pituitary lh secretion diminished hypocretin deficient animal models intracerebroventricular administration hypocretin 1 activates hypothalamo pituitary gonadal axis rats evaluated whether hypocretin deficiency affects gonadotropin release humans end deconvolved 24 h serum concentrations lh fsh seven hypocretin deficient narcoleptic males n seven controls c matched age body mass index sex basal plasma concentrations testosterone estradiol sex hormone binding globulin similar groups mean 24 h lh concentration significantly lower narcolepsy patients 30 plus minus 04 n vs 42 plus minus 03 c ul p 001 primarily due reduction pulsatile lh secretion 235 plus minus 16 n vs 343 plus minus 49 c u l 1 24 h 1 p 002 orderliness lh fsh secretion quantitated approximate entropy statistic greater patients controls contrast features fsh release similar narcoleptic control groups also lh fsh secretions response intravenous administration 100 microg gnrh similar patients controls data indicate endogenous hypocretins involved regulation hypothalamo pituitary gonadal axis activity humans particular reduced lh release face normal pituitary responsivity gnrh stimulation narcoleptic men suggests hypocretins promote endogenous gnrh secretion
0.4064973.15172887.html.plaintext.txt	5	orexin luteinizing hormone follicle stimulating hormone testosterone estradiol circadian rhythm deconvolution analysis
0.4064973.15172887.html.plaintext.txt	6	narcolepsy characterized excessive daytime sleepiness cataplexy hypnagogic hallucinations sleep paralysis 30 caused progressive loss hypocretin neurons brain 28 31 hypocretin neuronal cell bodies located exclusively lateral hypothalamusperifornical area 41 axonal projections throughout central nervous system predict diverse biological actions 7 indeed hypocretin peptides 1 2 also called orexin b appear affect feeding behavior energy expenditure arousal autonomic outflow variety neuroendocrine ensembles 9 10 43 49 therefore apart well recognized neurological manifestations clinical syndrome hypocretin deficiency humans may encompass broad spectrum behavioral endocrine metabolic anomalies keeping postulate recently identified aberrations pituitary adrenal somatotropic ensembles circulating leptin concentrations hypocretin deficient narcoleptic men 15 17 29
0.4064973.15172887.html.plaintext.txt	7	narcolepsy characterized excessive daytime sleepiness cataplexy hypnagogic hallucinations sleep paralysis 30 caused progressive loss hypocretin neurons brain 28 31 hypocretin neuronal cell bodies located exclusively lateral hypothalamusperifornical area 41 axonal projections throughout central nervous system predict diverse biological actions 7 indeed hypocretin peptides 1 2 also called orexin b appear affect feeding behavior energy expenditure arousal autonomic outflow variety neuroendocrine ensembles 9 10 43 49 therefore apart well recognized neurological manifestations clinical syndrome hypocretin deficiency humans may encompass broad spectrum behavioral endocrine metabolic anomalies keeping postulate recently identified aberrations pituitary adrenal somatotropic ensembles circulating leptin concentrations hypocretin deficient narcoleptic men 15 17 29
0.4064973.15172887.html.plaintext.txt	8	septal preoptic arcuate nuclei among many brain sites receiving hypocretin inputs 7 26 32 46 nuclei involved control hypothalamo pituitary gonadal hpg axis 50 furthermore intracerebroventricular administration hypocretins acutely induces lh release ovarian steroid primed ovariectomized rats 37 also hypocretin 1 promotes gonadotropin releasing hormone gnrh release hypothalamic explants male rats 40 intracerebroventricular administration anti hypocretin antibody completely abolishes preovulatory lh surge intact female rats 14 thus available data suggest endogenous hypocretin peptides stimulate lh release rodents currently unknown whether peptides exert analogous effects humans far aware impact hypocretins fsh secretion investigated date
0.4064973.15172887.html.plaintext.txt	9	septal preoptic arcuate nuclei among many brain sites receiving hypocretin inputs 7 26 32 46 nuclei involved control hypothalamo pituitary gonadal hpg axis 50 furthermore intracerebroventricular administration hypocretins acutely induces lh release ovarian steroid primed ovariectomized rats 37 also hypocretin 1 promotes gonadotropin releasing hormone gnrh release hypothalamic explants male rats 40 intracerebroventricular administration anti hypocretin antibody completely abolishes preovulatory lh surge intact female rats 14 thus available data suggest endogenous hypocretin peptides stimulate lh release rodents currently unknown whether peptides exert analogous effects humans far aware impact hypocretins fsh secretion investigated date
0.4064973.15172887.html.plaintext.txt	10	present study conducted evaluate role endogenous hypocretins regulation gonadotropin release human specifically hypothesized hypocretin deficiency narcoleptic men would blunt spontaneous pituitary lh release
0.4064973.15172887.html.plaintext.txt	11	present study conducted evaluate role endogenous hypocretins regulation gonadotropin release human specifically hypothesized hypocretin deficiency narcoleptic men would blunt spontaneous pituitary lh release
0.4064973.15172887.html.plaintext.txt	12	methods top abstract methods results discussion references subjects
0.4064973.15172887.html.plaintext.txt	13	included seven male patients outpatient clinic department neurology leiden university diagnosis narcolepsy cataplexy made clinical grounds physician experienced narcolepsy g j lammers also result multiple sleep latency test typical narcolepsy patients 23 addition patients hla dr2dqb10602 positive 22 lacked hypocretin 1 cerebrospinal fluid measurements previously described 28 subjects free medication 3 patients discontinued medication 2 wk study two three narcoleptic subjects used psychostimulants methylfenidate modafinil one tricyclic antidepressant clomipramine
0.4064973.15172887.html.plaintext.txt	14	included seven male patients outpatient clinic department neurology leiden university diagnosis narcolepsy cataplexy made clinical grounds physician experienced narcolepsy g j lammers also result multiple sleep latency test typical narcolepsy patients 23 addition patients hla dr2dqb10602 positive 22 lacked hypocretin 1 cerebrospinal fluid measurements previously described 28 subjects free medication 3 patients discontinued medication 2 wk study two three narcoleptic subjects used psychostimulants methylfenidate modafinil one tricyclic antidepressant clomipramine
0.4064973.15172887.html.plaintext.txt	15	weight height subjects measured well waist hip circumference waist hip ratio whr used relative measure abdominal fat mass total body fat mass determined dual energy x ray absorptiometry hologic qdr4500 waltham ma seven male control subjects recruited advertisements local newspapers controls matched age body mass index total fat mass whr since narcoleptics moderately obese 16
0.4064973.15172887.html.plaintext.txt	16	weight height subjects measured well waist hip circumference waist hip ratio whr used relative measure abdominal fat mass total body fat mass determined dual energy x ray absorptiometry hologic qdr4500 waltham ma seven male control subjects recruited advertisements local newspapers controls matched age body mass index total fat mass whr since narcoleptics moderately obese 16
0.4064973.15172887.html.plaintext.txt	17	subjects eligible study exclusion hypertension defined repeated blood pressure measurement systolic 160 mmhg diastolic 90 mmhg known history pituitary disease recent body weight change 3 kg weight gain loss within previous 3 mo fasting blood glucose 70 mmoll written informed consent obtained subjects study approved ethics committee leiden university medical center
0.4064973.15172887.html.plaintext.txt	18	subjects admitted clinical research center morning drawing blood performed standardized dark light alimentary conditions 24 h study occasion three standardized meals served 0900 1300 1800 nutridrink 15 kcalml 1500 1800 kcalday macronutrient composition per 100 ml 5 g protein 65 g fat 179 g carbohydrate nutricia zoetermeer netherlands subjects remained sedentary throughout study except bathroom visits lights switched 2300
0.4064973.15172887.html.plaintext.txt	19	subjects admitted clinical research center morning drawing blood performed standardized dark light alimentary conditions 24 h study occasion three standardized meals served 0900 1300 1800 nutridrink 15 kcalml 1500 1800 kcalday macronutrient composition per 100 ml 5 g protein 65 g fat 179 g carbohydrate nutricia zoetermeer netherlands subjects remained sedentary throughout study except bathroom visits lights switched 2300
0.4064973.15172887.html.plaintext.txt	20	upon arrival intravenous cannula inserted antecubital vein 1 h start blood sampling performed 10 min intervals 24 h long line prevent sleep disturbance samples allowed clot centrifuged 4 degrees c 20 min serum frozen 20 degrees c assay sleep registration using portable electroencephalogram system porti twente medical systems enschede netherlands confirmed abnormally distributed 24 h total sleep well rem sleep narcoleptic subjects normal distribution sleep stages control subjects
0.4064973.15172887.html.plaintext.txt	21	upon arrival intravenous cannula inserted antecubital vein 1 h start blood sampling performed 10 min intervals 24 h long line prevent sleep disturbance samples allowed clot centrifuged 4 degrees c 20 min serum frozen 20 degrees c assay sleep registration using portable electroencephalogram system porti twente medical systems enschede netherlands confirmed abnormally distributed 24 h total sleep well rem sleep narcoleptic subjects normal distribution sleep stages control subjects
0.4064973.15172887.html.plaintext.txt	22	separate occasion blood drawn 0800 overnight fast measurement lh fsh testosterone estradiol sex hormone binding globulin shbg concentrations subsequently gnrh test performed 42 whereby 100 microg gonadoreline aventis pharma hoevelaken netherlands given intravenous bolus serum lh concentrations measured every 10 min 90 min thereafter
0.4064973.15172887.html.plaintext.txt	23	separate occasion blood drawn 0800 overnight fast measurement lh fsh testosterone estradiol sex hormone binding globulin shbg concentrations subsequently gnrh test performed 42 whereby 100 microg gonadoreline aventis pharma hoevelaken netherlands given intravenous bolus serum lh concentrations measured every 10 min 90 min thereafter
0.4064973.15172887.html.plaintext.txt	24	serum lh fsh concentrations measured time resolved immunofluorometric assays wallac turku finland coefficients variation cv 39 68 concentration range 55 147 ul lh 37 53 concentration range 51 413 ul fsh testosterone measured coated tube radioimmunoassay ria diagnostic products los angeles ca cv 106 186 concentration range 27 443 nmoll shbg measured immunoradiometric assay spectria espoo finland serum estradiol ria diagnostic systems laboratory webster tx samples gonadotropin 24 h profile processed assay procedure addition leptin concentration measured every 20 min sample ria linco research st charles mo detection limit assay 05 microgl cv 34 83 concentration range 49 256 microgl details leptin secretion narcolepsy previously published report 24 h mean leptin concentration relation lh parameters testosterone 15
0.4064973.15172887.html.plaintext.txt	25	deconvolution analysis deconvolution analysis 47 used estimate four secretory clearance measures interest 1 number locations secretory events 2 amplitudes secretory bursts 3 durations randomly dispersed lh fsh secretory bursts 4 endogenous single component subject specific plasma half lives lh fsh assumed gonadotropin distribution volumes lh fsh half lives time concentration invariant following parameters calculated half duration secretory bursts duration secretory burst half maximal amplitude hormone half life burst frequency amplitude secretory burst maximal secretory rate attained within burst mass secreted per burst basal secretion rate lh pulsatile secretion rate product burst frequency mean burst mass total secretion sum basal pulsatile based recent validation studies men deconvolution analysis carried 95 joint statistical confidence intervals calculated lh fsh amplitudes 13 25
0.4064973.15172887.html.plaintext.txt	26	approximate entropy univariate approximate entropy apen statistic developed quantify degree irregularity disorderliness time series 33 technically apen quantifies summed logarithmic likelihood templates length m patterns data similar within r remain similar within tolerance r next incremental comparison formally defined elsewhere 34 apen calculation provides single nonnegative number ensemble estimate relative process randomness wherein larger apen values denote greater irregularity cross apen x apen quantifies joint pattern synchrony two separate parallel time series standardization z score transformation 36 38 present analysis calculated x apen assuming r 20 sd individual time series m 1 hence use designation x apen 1 20 parameter set affords sensitive valid statistically well replicated apen x apen metrics assessing hormone time series length 35 36 apen x apen results reported ratio absolute value mean 1000 randomly shuffled data series values approaching 10 denoting complete randomness
0.4064973.15172887.html.plaintext.txt	27	statistical analysis results expressed means plus minus se unless stated otherwise students one tailed test used evaluate priori hypothesis lh secretion reduced narcoleptic men comparisons statistically evaluated two tailed students test kolmogorov smirnov test two samples appropriate statistical analysis performed using systat release 100 systat richmond ca
0.4064973.15172887.html.plaintext.txt	28	results top abstract methods results discussion references subjects
0.4064973.15172887.html.plaintext.txt	29	narcoleptic patients n controls c comparable age 461 plus minus 159 n vs 469 plus minus 161 c yr body mass index 283 plus minus 26 n vs 284 plus minus 22 c kgm2
0.4064973.15172887.html.plaintext.txt	30	gonadal steroid hormone concentrations similar narcoleptics controls testosterone 233 plus minus 18 n vs 199 plus minus 08 c nmoll p 011 estradiol 739 plus minus 58 n vs 783 plus minus 82 c pmoll p 018 shbg 285 plus minus 24 n vs 276 plus minus 23 c nmoll p 079 mean plasma lh concentration significantly lower narcoleptic patients 30 plus minus 04 n vs 42 plus minus 03 c ul p 001 whereas fsh concentration similar groups 37 plus minus 09 n vs 40 plus minus 04 c p 074 fig 1 shows 24 h serum lh fsh concentration vs time narcoleptic subjects controls
0.4064973.15172887.html.plaintext.txt	31	view larger version 42k fig 1 serum lh concentrations 7 narcoleptic subjects 7 controls blood samples drawn every 10 min 24 h b fsh concentrations data shown means se lights 2300 0800 meals served 0900 1300 1800
0.4064973.15172887.html.plaintext.txt	32	deconvolution derived parameter estimates lh fsh secretion elimination given tables 1 2 respectively pulsatile secretion lh diminished narcoleptic subjects 235 plus minus 16 n vs 343 plus minus 49 c u l 1 24 h 1 p 002 result concerted effects reduced burst frequency burst mass total lh secretion also less narcoleptic patients p 004 contrast features fsh release similar narcoleptics controls also plasma lh fsh half lives different groups representative 24 h lh fsh secretory profiles calculated deconvolution analysis corresponding curves serum concentration data shown figs 2 3 respectively
0.4064973.15172887.html.plaintext.txt	33	deconvolution derived parameter estimates lh fsh secretion elimination given tables 1 2 respectively pulsatile secretion lh diminished narcoleptic subjects 235 plus minus 16 n vs 343 plus minus 49 c u l 1 24 h 1 p 002 result concerted effects reduced burst frequency burst mass total lh secretion also less narcoleptic patients p 004 contrast features fsh release similar narcoleptics controls also plasma lh fsh half lives different groups representative 24 h lh fsh secretory profiles calculated deconvolution analysis corresponding curves serum concentration data shown figs 2 3 respectively
0.4064973.15172887.html.plaintext.txt	34	view table table 1 deconvolution derived features lh secretion
0.4064973.15172887.html.plaintext.txt	35	view table table 2 deconvolution derived features fsh secretion
0.4064973.15172887.html.plaintext.txt	36	view larger version 28k fig 2 representative 24 h lh secretory profiles c d corresponding plasma concentration series intrasample dose dependent standard deviations fitted curves calculated deconvolution b narcoleptic patient c matched control b d note decreased pulsatile secretion narcoleptic patient time depicted minutes elapsed 1st sample taken
0.4064973.15172887.html.plaintext.txt	37	view larger version 32k fig 3 representative 24 h fsh secretory profiles c d corresponding plasma concentration series intrasample dose dependent standard deviations fitted curves calculated deconvolution b narcoleptic patient c matched control b d time depicted minutes elapsed first sample taken
0.4064973.15172887.html.plaintext.txt	38	basal serum gonadotropin levels lh 32 plus minus 04 n vs 44 plus minus 04 c ul p 018 fsh 48 plus minus 11 n vs 38 plus minus 59 c ul p 043 maximal concentrations response gnrh stimulation lh 166 plus minus 28 n vs 228 plus minus 49 c ul p 027 fsh 93 plus minus 30 n vs 68 plus minus 09 c ul p 043 similar groups individual lh fsh responses displayed fig 4
0.4064973.15172887.html.plaintext.txt	39	view larger version 19k fig 4 individual lh tsh increases iv injection 100 microg lhrh 7 narcoleptic patients matched controls mean increases lh fsh respectively similar studied groups
0.4064973.15172887.html.plaintext.txt	40	mean 24 h leptin concentration patients 59 plus minus 11 microgl controls 112 plus minus 13 microgl p 001 significant correlations present 24 h lh secretion mean 24 h leptin concentration either combined groups r 007 separately patients r 020 controls r 039
0.4064973.15172887.html.plaintext.txt	41	24 h leptin concentration serum testosterone significant inverse linear correlation found displayed fig 5
0.4064973.15172887.html.plaintext.txt	42	view larger version 15k fig 5 linear relationship mean 24 h leptin concentration 20 min sampling serum testosterone concentration patients controls note inverse relationship measures
0.4064973.15172887.html.plaintext.txt	43	apen ratio values lh lower patients compared controls denoting regular secretion n 0653 plus minus 0035 c 0718 plus minus 0014 p 0046 individual data displayed fig 6 similarly apen ratio fsh also smaller patients 0837 plus minus 0032 vs 0927 plus minus 0020 p 003 x apen ratio lh fsh concentration series lower patients controls indicating increased synchrony hormones patients compared controls n 0725 plus minus 0017 c 0786 plus minus 0015 p 002 x apen ratio leptin concentration series 20 min data lh series 20 min data differ groups n 0889 plus minus 0021 c 0911 plus minus 0026 p 053
0.4064973.15172887.html.plaintext.txt	44	view larger version 15k fig 6 aproximate entropy apen ratios lh fsh secretion cross apen ratio lh fsh series lower values denote orderliness secretion
0.4064973.15172887.html.plaintext.txt	45	discussion top abstract methods results discussion references study shows average 24 h plasma lh concentration reduced hypocretin deficient narcoleptic men whereas gonadal steroid hormone levels normal reduction plasma lh concentration narcoleptics accounted diminution pulsatile lh release 30 compared healthy controls cannot attributed insensitivity pituitary gonadotrophs gnrh stimulation lh burst frequency burst mass reduced narcoleptic men contrast plasma fsh concentrations various features fsh secretion similar narcoleptics controls
0.4064973.15172887.html.plaintext.txt	46	discussion top abstract methods results discussion references study shows average 24 h plasma lh concentration reduced hypocretin deficient narcoleptic men whereas gonadal steroid hormone levels normal reduction plasma lh concentration narcoleptics accounted diminution pulsatile lh release 30 compared healthy controls cannot attributed insensitivity pituitary gonadotrophs gnrh stimulation lh burst frequency burst mass reduced narcoleptic men contrast plasma fsh concentrations various features fsh secretion similar narcoleptics controls
0.4064973.15172887.html.plaintext.txt	47	data suggest endogenous hypocretin peptides stimulate pulsatile lh release men particular fact spontaneous lh secretion blunted whereas pituitary responsiveness gnrh stimulation intact narcoleptic subjects suggests hypocretin deficiency primarily inhibits hypothalamic gnrh release inference agrees studies male rats showing hypocretin 1 promotes gnrh release hypothalamic explants 40 moreover hypocretin inputs abundant preoptic area contains many gnrh neurons 50 coexpress hypocretin 1 receptors direct contact hypocretin fibers 3 physiological anatomical observations obviously support notion hypocretin peptides involved regulation gnrh release fact fsh secretion diminished whereas lh release narcoleptic subjects may imply hypocretins specifically modulate gnrh burst frequency lh secretion particularly enhanced high frequency bursts whereas low frequency bursts predominantly promote fsh release 20
0.4064973.15172887.html.plaintext.txt	48	data suggest endogenous hypocretin peptides stimulate pulsatile lh release men particular fact spontaneous lh secretion blunted whereas pituitary responsiveness gnrh stimulation intact narcoleptic subjects suggests hypocretin deficiency primarily inhibits hypothalamic gnrh release inference agrees studies male rats showing hypocretin 1 promotes gnrh release hypothalamic explants 40 moreover hypocretin inputs abundant preoptic area contains many gnrh neurons 50 coexpress hypocretin 1 receptors direct contact hypocretin fibers 3 physiological anatomical observations obviously support notion hypocretin peptides involved regulation gnrh release fact fsh secretion diminished whereas lh release narcoleptic subjects may imply hypocretins specifically modulate gnrh burst frequency lh secretion particularly enhanced high frequency bursts whereas low frequency bursts predominantly promote fsh release 20
0.4064973.15172887.html.plaintext.txt	49	apen quantitates relative orderliness reproducibility subordinate nonpulsatile secretory patterns neurohormone time series reflects feedforward feedback adjustments driven pathophysiological changes interglandular communication view unchanged testosterone feedback signal patients increased lh fsh regularity increased synchrony hormones might reflect diminished gnrh input signal unchanged pituitary responsiveness toward neurohormone 48
0.4064973.15172887.html.plaintext.txt	50	apen quantitates relative orderliness reproducibility subordinate nonpulsatile secretory patterns neurohormone time series reflects feedforward feedback adjustments driven pathophysiological changes interglandular communication view unchanged testosterone feedback signal patients increased lh fsh regularity increased synchrony hormones might reflect diminished gnrh input signal unchanged pituitary responsiveness toward neurohormone 48
0.4064973.15172887.html.plaintext.txt	51	alternatively hypoleptinemia may blunt lh release narcoleptic patients previously shown 15 plasma leptin concentration considerably reduced narcoleptic men leptin emerged important modulator hpg axis 5 indeed leptin deficient obob mice hypogonadotropic sterile recombinant leptin administration rescues defects obob males 24 females 6 moreover circadian rhythm plasma leptin levels synchronous lh concentrations 18 reduction lh secretion induced fasting rat humans reversed leptin administration 1 4 8 data indicate leptin stimulates lh release genetic andor physiological alterations circulating leptin levels impact pituitary gonadotropin release context conceivable reduction plasma leptin concentration narcoleptics 15 involved diminution pituitary lh release patients mentioned could demonstrate linear correlation mean circulating leptin concentration lh production
0.4064973.15172887.html.plaintext.txt	52	alternatively hypoleptinemia may blunt lh release narcoleptic patients previously shown 15 plasma leptin concentration considerably reduced narcoleptic men leptin emerged important modulator hpg axis 5 indeed leptin deficient obob mice hypogonadotropic sterile recombinant leptin administration rescues defects obob males 24 females 6 moreover circadian rhythm plasma leptin levels synchronous lh concentrations 18 reduction lh secretion induced fasting rat humans reversed leptin administration 1 4 8 data indicate leptin stimulates lh release genetic andor physiological alterations circulating leptin levels impact pituitary gonadotropin release context conceivable reduction plasma leptin concentration narcoleptics 15 involved diminution pituitary lh release patients mentioned could demonstrate linear correlation mean circulating leptin concentration lh production
0.4064973.15172887.html.plaintext.txt	53	notwithstanding diminished lh production testosterone concentration unchanged patients recently become clear leptin involved local regulation testosterone synthesis secretion male rat gonad 44 direct evidence action humans available inverse relation serum testosterone leptin demonstrated 19 therefore inhibitory effect leptin testosterone adrenal hormone secretion might relevant narcoleptic patients narcoleptics exhibit 50 reduction circulating leptin concentration may unleash gonadal testosterone secretion compensate diminished lh drive 15 finding inverse relationship testosterone leptin subjects reinforces view
0.4064973.15172887.html.plaintext.txt	54	notwithstanding diminished lh production testosterone concentration unchanged patients recently become clear leptin involved local regulation testosterone synthesis secretion male rat gonad 44 direct evidence action humans available inverse relation serum testosterone leptin demonstrated 19 therefore inhibitory effect leptin testosterone adrenal hormone secretion might relevant narcoleptic patients narcoleptics exhibit 50 reduction circulating leptin concentration may unleash gonadal testosterone secretion compensate diminished lh drive 15 finding inverse relationship testosterone leptin subjects reinforces view
0.4064973.15172887.html.plaintext.txt	55	prepro orexin mrna orexin receptors expressed various endocrine nonendocrine tissues 11 instance orexins modulate directly human porcine adrenal stereoidogenic function 21 27 relevant present investigation recent finding mrna expression ox1 ox2 receptor male rat gonad 2 activation ox1 receptor stimulates testosterone secretion vivo vitro suggesting physiological modulating role orexin system concert leptin ghrelin testicular level 45 significance findings human physiology needs explored however ox1 ox2 receptor expression demonstrated male human reproductive system including testis suggesting orexins directly impact gonadal hormone release humans well rodents 12
0.4064973.15172887.html.plaintext.txt	56	prepro orexin mrna orexin receptors expressed various endocrine nonendocrine tissues 11 instance orexins modulate directly human porcine adrenal stereoidogenic function 21 27 relevant present investigation recent finding mrna expression ox1 ox2 receptor male rat gonad 2 activation ox1 receptor stimulates testosterone secretion vivo vitro suggesting physiological modulating role orexin system concert leptin ghrelin testicular level 45 significance findings human physiology needs explored however ox1 ox2 receptor expression demonstrated male human reproductive system including testis suggesting orexins directly impact gonadal hormone release humans well rodents 12
0.4064973.15172887.html.plaintext.txt	57	impact alterations hpg ensemble described fertility narcoleptic men remains definitely determined early reports suggested narcolepsy associated impaired fertility 39 since suggestions confirmed far aware moreover clinical impression narcoleptic male patients less fertile gonadal hormone concentrations plasma normal narcoleptics despite reduction lh levels thus seems unlikely partial hypogonadotropism observed clinical sequelae nevertheless view findings males warranted investigate narcoleptic females across menstrual cycle putative defects ovarian function
0.4064973.15172887.html.plaintext.txt	58	impact alterations hpg ensemble described fertility narcoleptic men remains definitely determined early reports suggested narcolepsy associated impaired fertility 39 since suggestions confirmed far aware moreover clinical impression narcoleptic male patients less fertile gonadal hormone concentrations plasma normal narcoleptics despite reduction lh levels thus seems unlikely partial hypogonadotropism observed clinical sequelae nevertheless view findings males warranted investigate narcoleptic females across menstrual cycle putative defects ovarian function
0.4064973.15172887.html.plaintext.txt	59	conclusion hypocretin deficient narcoleptic men reduced circulating lh levels brought diminution pulsatile lh release contrast fsh secretion normal patients pituitary sensitivity gnrh stimulation normal narcoleptics suggests reduction hypothalamic gnrh release underlies blunted lh secretion accordance view increased orderliness secretion gonadotropins hypocretin deficiency per se hypoleptinemia may involved changes hpg axis narcoleptic males
0.4064973.15172887.html.plaintext.txt	60	conclusion hypocretin deficient narcoleptic men reduced circulating lh levels brought diminution pulsatile lh release contrast fsh secretion normal patients pituitary sensitivity gnrh stimulation normal narcoleptics suggests reduction hypothalamic gnrh release underlies blunted lh secretion accordance view increased orderliness secretion gonadotropins hypocretin deficiency per se hypoleptinemia may involved changes hpg axis narcoleptic males
0.4064973.15172887.html.plaintext.txt	61	acknowledgments gratefully acknowledge skillful assistance e j m ladan eygenraam e c sierat van der steen study occasions
0.4064973.15172887.html.plaintext.txt	62	footnotes address reprint requests correspondence h pijl leiden univ medical center dept general internal medicine c1 r39 po box 9600 2300 rc leiden netherlands e mail hpijlatlumcnl u d
0.4064973.15172887.html.plaintext.txt	63	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4064973.15172887.html.plaintext.txt	64	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4064973.15172887.html.plaintext.txt	65	references top abstract methods results discussion references ahima rs prabakaran d mantzoros c qu d lowell b maratos flier e flier js role leptin neuroendocrine response fasting nature 382 250 252 1996crossrefisimedline barreirro ml pineda r navarro vm lopez m suominen js pinella l searis r toppara j aguilar e dieguez c tena sempera m orexin 1 receptor messenger ribonucleic acid expression stimulation testosterone secretion orexin rat testis endocrinology 145 2297 2306 2004abstractfree full text campbell re grove kl smith ms gonadotropin releasing hormone neurons coexpress orexin 1 receptor immunoreactivity receive direct contacts orexin fibers endocrinology 144 1542 1548 2003abstractfree full text han jl heist k depaoli veldhuis jd montzoros cs role falling leptin levels neuroendocrine metabolic adaptation short term starvation healthy men j clin invest 111 1409 1421 2003abstractfree full text chehab ff leptin regulator adipose mass reproduction trends pharmacol sci 21 309 314 2000crossrefisimedline chehab ff lim lu r correction sterility defect homozygous obese female mice treatment human recombinant leptin nat genet 12 318 320 1996isimedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text gonzalez lc pinilla l tena sempere m aguilar e leptin 116 130 stimulates prolactin luteinizing hormone secretion fasted adult male rats neuroendocrinology 70 213 220 1999crossrefisimedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001crossrefisimedline johren o neidert sj kummer m dendorfer dominiak p preproorexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 142 3324 3331 2001abstractfree full text karteris e chen j randeva hs expression human prepro orexin signalling characteristics orexin receptors male reproductive system j clin endocrinol metab 89 1957 1962 2004abstractfree full text keenan dm veldhuis jd disruption hypothalamic luteinizing hormone pulsing mechanism aging men j physiol regul integr comp physiol 281 r1917 r1924 2001abstractfree full text kohsaka watanabe h kakizaki y suda schioth hb significant participation orexin potent orexigenic peptide preovulatory luteinizing hormone prolactin surges rat brain res 898166 170 2001crossrefisimedline kok sw meinders ae overeem lammers gj roelfsema f frolich m pijl h reduction plasma leptin levels loss circadian rhythmicity hypocretin orexin deficient narcoleptic humans j clin endocrinol metab 87805 809 2002abstractfree full text kok sw overeem visscher tl lammers gj seidell jc pijl h meinders ae hypocretin deficiency narcoleptic humans associated abdominal obesity obes res 11 1147 1154 2003abstractfree full text kok sw roelfsema f overeem lammers gj strijers rl frolich m meinders ae pijl h dynamics pituitary adrenal ensemble hypocretin deficient narcoleptic humans blunted basal adrenocorticotropin release evidence normal time keeping master pacemaker j clin endocrinol metab 87 5085 5091 2002abstractfree full text licinio j negrao ab mantzoros c kaklamani v wong ml bongiorno pb mulla cearnal l veldhuis jd flier js mccann sm gold pw synchronicity frequently sampled 24 h concentrations circulating leptin luteinizing hormone estradiol healthy women proc natl acad sci usa 95 2541 2546 1998abstractfree full text luukkaa v pesonen u huhtaniemi lehtonen tilvis r tuomiletho j koulu m huupponen r inverse correlation serum testosterone leptin men j clin endocrinol metab 83 3243 3246 1998abstractfree full text marshall jc eagleson ca mccartney cr hypothalamic dysfunction mol cell endocrinol 186 227 230 2002crossrefisi mazzochi g malendowicz lk gottardo l aragona f nussdorfer gg orexin stimulates cortisol secretion human adrenal cortical cells activation adenylate cyclase dependent signalling cascade j clin endocrinol metab 86 778 782 2001abstractfree full text mignot e genetic familial aspects narcolepsy neurology 50 suppl 1 s16 s22 1998 mitler mm van den hoed j carskadon ma richardson g park r guilleminault c dement wc rem sleep episodes multiple sleep latency test narcoleptic patients electroencephalogr clin neurophysiol 46 479 481 1979crossrefisimedline mounzih k lu r chehab ff leptin treatment rescues sterility genetically obese obob males endocrinology 138 1190 1193 1997abstractfree full text mulligan iranmanesh veldhuis jd pulsatile iv infusion recombinant human lh leuprolide suppressed men unmasks impoverished leydig cell secretory responsiveness midphysiological lh drive aging male j clin endocrinol metab 86 5547 5553 2001abstractfree full text nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999crossrefisimedline nanmoku isobe k sakurai yamanaka takekoshi kawakami y goto k nakai effects orexin cultured porcine adrenal medullary cortex cells regul pept 104 125 130 2002crossrefisimedline nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000crossrefisimedline overeem kok sw lammers gj vein aa frolich m meinders ae roelfsema f pijl h somatotropic axis hypocretin deficient narcoleptic humans altered circadian distribution gh secretory events j physiol endocrinol metab 284 e641 e647 2003abstractfree full text overeem mignot e van dijk jg lammers gj narcolepsy clinical features new pathophysiologic insights future perspectives j clin neurophysiol 18 78 105 2001isimedline peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6 991 997 2000crossrefisimedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text pincus sm approximate entropy measure system complexity proc natl acad sci usa 88 2297 2301 1991abstract pincus sm goldberger al physiological time series analysis regularity quantifies j physiol heart circ physiol 266 h1643 h1656 1994abstractfree full text pincus sm hartman ml roelfsema f thorner mo veldhuis jd hormone pulsatility via coarse short time sampling j physiol endocrinol metab 277 e948 e957 1999abstractfree full text pincus sm mulligan iranmanesh gheorghiu godschalk m veldhuis jd older males secrete luteinizing hormone irregularly jointly asynchronously younger males proc natl acad sci usa 93 14100 14105 1996abstractfree full text pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998crossrefisimedline roelfsema f pincus sm veldhuis jd patients cushings disease secrete adrenocorticotropin cortisol jointly asynchronously healthy subjects j clin endocrinol metab 83 688 692 1998abstractfree full text roth b symptoms narcolepsy narcolepsy hypersomnia edited roth b broughton r basel karger 1980 p 82 93 russell sh small cj kennedy ar stanley sa seth murphy kg taheri ghatei ma bloom sr orexin interactions hypothalamo pituitary gonadal axis endocrinology 142 5294 5302 2001abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline snyder pj reitano jf utiger rd serum lh fsh responses synthetic gonadotropin releasing hormone normal men j clin endocrinol metab 41 938 945 1975abstract taylor mm samson wk side orexins endocrine metabolic actions j physiol endocrinol metab 284 e13 e17 2003abstractfree full text tena sempere m barreiro ml leptin male reproduction testis paradigm mol cell endocrinol 188 9 13 2002crossrefisimedline tena sempere m barreiro ml gonzales lc gaytan f zhang fp caminos je pinilla l casanueva ff dieguez c aguilar e novel expression functional role ghrelin rat testis endocrinology 143 717 725 2002abstractfree full text trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 438 71 75 1998 corrigenda febs lett 442 122 1999crossrefisimedline veldhuis jd carlson ml johnson ml pituitary gland secretes bursts appraising nature glandular secretory impulses simultaneous multiple parameter deconvolution plasma hormone concentrations proc natl acad sci usa 84 7686 7690 1987abstract veldhuis jd johnson ml veldhuis ol straume m pincus sm impact pulsatility ensemble orderliness approximate entropy neurohormone secretion j physiol regul integr comp physiol 281 r1975 r1985 2001abstractfree full text willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001crossrefisimedline wray development gonadotropin releasing hormone 1 neurons front neuroendocrinol 23 292 316 2002isimedline
0.4064973.15172887.html.plaintext.txt	66	references top abstract methods results discussion references ahima rs prabakaran d mantzoros c qu d lowell b maratos flier e flier js role leptin neuroendocrine response fasting nature 382 250 252 1996crossrefisimedline barreirro ml pineda r navarro vm lopez m suominen js pinella l searis r toppara j aguilar e dieguez c tena sempera m orexin 1 receptor messenger ribonucleic acid expression stimulation testosterone secretion orexin rat testis endocrinology 145 2297 2306 2004abstractfree full text campbell re grove kl smith ms gonadotropin releasing hormone neurons coexpress orexin 1 receptor immunoreactivity receive direct contacts orexin fibers endocrinology 144 1542 1548 2003abstractfree full text han jl heist k depaoli veldhuis jd montzoros cs role falling leptin levels neuroendocrine metabolic adaptation short term starvation healthy men j clin invest 111 1409 1421 2003abstractfree full text chehab ff leptin regulator adipose mass reproduction trends pharmacol sci 21 309 314 2000crossrefisimedline chehab ff lim lu r correction sterility defect homozygous obese female mice treatment human recombinant leptin nat genet 12 318 320 1996isimedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text gonzalez lc pinilla l tena sempere m aguilar e leptin 116 130 stimulates prolactin luteinizing hormone secretion fasted adult male rats neuroendocrinology 70 213 220 1999crossrefisimedline hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001crossrefisimedline johren o neidert sj kummer m dendorfer dominiak p preproorexin orexin receptor mrnas differentially expressed peripheral tissues male female rats endocrinology 142 3324 3331 2001abstractfree full text karteris e chen j randeva hs expression human prepro orexin signalling characteristics orexin receptors male reproductive system j clin endocrinol metab 89 1957 1962 2004abstractfree full text keenan dm veldhuis jd disruption hypothalamic luteinizing hormone pulsing mechanism aging men j physiol regul integr comp physiol 281 r1917 r1924 2001abstractfree full text kohsaka watanabe h kakizaki y suda schioth hb significant participation orexin potent orexigenic peptide preovulatory luteinizing hormone prolactin surges rat brain res 898166 170 2001crossrefisimedline kok sw meinders ae overeem lammers gj roelfsema f frolich m pijl h reduction plasma leptin levels loss circadian rhythmicity hypocretin orexin deficient narcoleptic humans j clin endocrinol metab 87805 809 2002abstractfree full text kok sw overeem visscher tl lammers gj seidell jc pijl h meinders ae hypocretin deficiency narcoleptic humans associated abdominal obesity obes res 11 1147 1154 2003abstractfree full text kok sw roelfsema f overeem lammers gj strijers rl frolich m meinders ae pijl h dynamics pituitary adrenal ensemble hypocretin deficient narcoleptic humans blunted basal adrenocorticotropin release evidence normal time keeping master pacemaker j clin endocrinol metab 87 5085 5091 2002abstractfree full text licinio j negrao ab mantzoros c kaklamani v wong ml bongiorno pb mulla cearnal l veldhuis jd flier js mccann sm gold pw synchronicity frequently sampled 24 h concentrations circulating leptin luteinizing hormone estradiol healthy women proc natl acad sci usa 95 2541 2546 1998abstractfree full text luukkaa v pesonen u huhtaniemi lehtonen tilvis r tuomiletho j koulu m huupponen r inverse correlation serum testosterone leptin men j clin endocrinol metab 83 3243 3246 1998abstractfree full text marshall jc eagleson ca mccartney cr hypothalamic dysfunction mol cell endocrinol 186 227 230 2002crossrefisi mazzochi g malendowicz lk gottardo l aragona f nussdorfer gg orexin stimulates cortisol secretion human adrenal cortical cells activation adenylate cyclase dependent signalling cascade j clin endocrinol metab 86 778 782 2001abstractfree full text mignot e genetic familial aspects narcolepsy neurology 50 suppl 1 s16 s22 1998 mitler mm van den hoed j carskadon ma richardson g park r guilleminault c dement wc rem sleep episodes multiple sleep latency test narcoleptic patients electroencephalogr clin neurophysiol 46 479 481 1979crossrefisimedline mounzih k lu r chehab ff leptin treatment rescues sterility genetically obese obob males endocrinology 138 1190 1193 1997abstractfree full text mulligan iranmanesh veldhuis jd pulsatile iv infusion recombinant human lh leuprolide suppressed men unmasks impoverished leydig cell secretory responsiveness midphysiological lh drive aging male j clin endocrinol metab 86 5547 5553 2001abstractfree full text nambu sakurai mizukami k hosoya y yanagisawa m goto k distribution orexin neurons adult rat brain brain res 827 243 260 1999crossrefisimedline nanmoku isobe k sakurai yamanaka takekoshi kawakami y goto k nakai effects orexin cultured porcine adrenal medullary cortex cells regul pept 104 125 130 2002crossrefisimedline nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000crossrefisimedline overeem kok sw lammers gj vein aa frolich m meinders ae roelfsema f pijl h somatotropic axis hypocretin deficient narcoleptic humans altered circadian distribution gh secretory events j physiol endocrinol metab 284 e641 e647 2003abstractfree full text overeem mignot e van dijk jg lammers gj narcolepsy clinical features new pathophysiologic insights future perspectives j clin neurophysiol 18 78 105 2001isimedline peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6 991 997 2000crossrefisimedline peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text pincus sm approximate entropy measure system complexity proc natl acad sci usa 88 2297 2301 1991abstract pincus sm goldberger al physiological time series analysis regularity quantifies j physiol heart circ physiol 266 h1643 h1656 1994abstractfree full text pincus sm hartman ml roelfsema f thorner mo veldhuis jd hormone pulsatility via coarse short time sampling j physiol endocrinol metab 277 e948 e957 1999abstractfree full text pincus sm mulligan iranmanesh gheorghiu godschalk m veldhuis jd older males secrete luteinizing hormone irregularly jointly asynchronously younger males proc natl acad sci usa 93 14100 14105 1996abstractfree full text pu jain mr kalra ps kalra sp orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner regul pept 78 133 136 1998crossrefisimedline roelfsema f pincus sm veldhuis jd patients cushings disease secrete adrenocorticotropin cortisol jointly asynchronously healthy subjects j clin endocrinol metab 83 688 692 1998abstractfree full text roth b symptoms narcolepsy narcolepsy hypersomnia edited roth b broughton r basel karger 1980 p 82 93 russell sh small cj kennedy ar stanley sa seth murphy kg taheri ghatei ma bloom sr orexin interactions hypothalamo pituitary gonadal axis endocrinology 142 5294 5302 2001abstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline snyder pj reitano jf utiger rd serum lh fsh responses synthetic gonadotropin releasing hormone normal men j clin endocrinol metab 41 938 945 1975abstract taylor mm samson wk side orexins endocrine metabolic actions j physiol endocrinol metab 284 e13 e17 2003abstractfree full text tena sempere m barreiro ml leptin male reproduction testis paradigm mol cell endocrinol 188 9 13 2002crossrefisimedline tena sempere m barreiro ml gonzales lc gaytan f zhang fp caminos je pinilla l casanueva ff dieguez c aguilar e novel expression functional role ghrelin rat testis endocrinology 143 717 725 2002abstractfree full text trivedi p yu h macneil dj van der ploeg lh guan xm distribution orexin receptor mrna rat brain febs lett 438 71 75 1998 corrigenda febs lett 442 122 1999crossrefisimedline veldhuis jd carlson ml johnson ml pituitary gland secretes bursts appraising nature glandular secretory impulses simultaneous multiple parameter deconvolution plasma hormone concentrations proc natl acad sci usa 84 7686 7690 1987abstract veldhuis jd johnson ml veldhuis ol straume m pincus sm impact pulsatility ensemble orderliness approximate entropy neurohormone secretion j physiol regul integr comp physiol 281 r1975 r1985 2001abstractfree full text willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001crossrefisimedline wray development gonadotropin releasing hormone 1 neurons front neuroendocrinol 23 292 316 2002isimedline
0.42022583.11842076.html.plaintext.txt	0	highlighted topics functional genomics sleep circadian rhythm invited review genetic dissection sleep mehdi tafti1 paul franken2
0.42022583.11842076.html.plaintext.txt	1	1 biochemistry clinical neurophysiology unit department psychiatry university geneva ch 1225 geneva switzerland 2 department biological sciences stanford university stanford california 94305
0.42022583.11842076.html.plaintext.txt	2	abstract top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	3	recent advances genomics open new avenues analysis complex behaviors sleep analysis mouse model species choice amenable high throughput phenotype genotype analysis use mouse model unprecedented progress understanding sleep physiology treatment sleep disorders awaited review intended provide overview available methods techniques genetic dissection sleep mice limits advantages different approaches discussed highlight necessity combining methods avoid erroneous interpretations gap understanding mechanisms sleep functions may bridged finding molecular bases
0.42022583.11842076.html.plaintext.txt	4	recent advances genomics open new avenues analysis complex behaviors sleep analysis mouse model species choice amenable high throughput phenotype genotype analysis use mouse model unprecedented progress understanding sleep physiology treatment sleep disorders awaited review intended provide overview available methods techniques genetic dissection sleep mice limits advantages different approaches discussed highlight necessity combining methods avoid erroneous interpretations gap understanding mechanisms sleep functions may bridged finding molecular bases
0.42022583.11842076.html.plaintext.txt	5	quantitative trait loci quantitative trait nucleotides mutagenesis transgenic mice gene knockout gene expression profiling gene translation regulation
0.42022583.11842076.html.plaintext.txt	6	introduction top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	7	sleep long standing question modern neuroscience still unable answer however substantial progress made understanding mechanisms underlying different aspects sleep physiology know neuronal substrates neurochemical messengers regulatory processes involved initiating maintaining sleep understanding sleep toward function molecular genetics bring new insights first give historical perspective genetics sleep continue review available methods genetic dissection sleep experimental approach used conjunction state art electrophysiological neuroanatomic pharmacological techniques already used great success sleep research also caution making premature interpretations molecular findings complex traits attempted within general physiology intact organism
0.42022583.11842076.html.plaintext.txt	8	sleep long standing question modern neuroscience still unable answer however substantial progress made understanding mechanisms underlying different aspects sleep physiology know neuronal substrates neurochemical messengers regulatory processes involved initiating maintaining sleep understanding sleep toward function molecular genetics bring new insights first give historical perspective genetics sleep continue review available methods genetic dissection sleep experimental approach used conjunction state art electrophysiological neuroanatomic pharmacological techniques already used great success sleep research also caution making premature interpretations molecular findings complex traits attempted within general physiology intact organism
0.42022583.11842076.html.plaintext.txt	9	classical genetics sleep top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	10	introduction molecular biology genetic studies traits phenotypes based either observation resemblance related individuals crossing experiments experimental individuals carrying divergent phenotypes simple laws discovered according simple monogenic autosomal recessive phenotypes segregate inherited basis assumptions molecular substrates ie genes however types traits far less prevalent cannot attributed influence single genes nevertheless shortly introduction electroencephalography eeg vogel 82 one first notice even complex phenotype like eeg strong genetic control segregation analysis pedigrees carrying rare eeg variants concordant classical genetic laws suggesting presence single gene effects 83 85 results twin studies also indicated eeg patterns monozygotic mz twins much higher resemblance dizygotic dz twins unrelated subjects 33 82 92 confirming highly complex functional brain phenotype might tightly controlled genes little affected environment
0.42022583.11842076.html.plaintext.txt	11	introduction molecular biology genetic studies traits phenotypes based either observation resemblance related individuals crossing experiments experimental individuals carrying divergent phenotypes simple laws discovered according simple monogenic autosomal recessive phenotypes segregate inherited basis assumptions molecular substrates ie genes however types traits far less prevalent cannot attributed influence single genes nevertheless shortly introduction electroencephalography eeg vogel 82 one first notice even complex phenotype like eeg strong genetic control segregation analysis pedigrees carrying rare eeg variants concordant classical genetic laws suggesting presence single gene effects 83 85 results twin studies also indicated eeg patterns monozygotic mz twins much higher resemblance dizygotic dz twins unrelated subjects 33 82 92 confirming highly complex functional brain phenotype might tightly controlled genes little affected environment
0.42022583.11842076.html.plaintext.txt	12	study genetics sleep approximately dated back publication geyer 1937 26 reported higher concordance sleep habits mz twins dz twins gedda 23 reported rare cases concordant long sleepers 15 h mz twins gedda brenci 24 first estimated heritability percentage variance explained additive effects genes sleep duration 30 authors later confirmed sleep duration highly similar twins living apart 25 discounting influence possible environmental effects recent observations twins indicated even pattern rapid eye movements present higher concordance mz dz twins 8 40 50 variance sleep duration presence sleep disorder accounted genetic effects 30 50 zung wilson 94 performed first polygraphic sleep recordings twins 1966 found temporal sequence sleep stages almost completely concordant mz twins 1983 1998 detailed polygraphic analyses performed twins studies reported surprising similarities mz twins 31 39 41 87 experimental genetics sleep mice pioneered valatx early 1970s time span 15 years valatxs group 72 77 conducted several crossing experiments recorded sleep hundreds inbred recombinant inbred ri hybrid mice mainly follow segregation paradoxical sleep ps amount studies together diallelique reciprocal crossing several inbred strains sleep experiment mice performed friedmann 22 clearly indicated although aspects sleep may follow simple segregation classical genetic laws cannot predict others
0.42022583.11842076.html.plaintext.txt	13	study genetics sleep approximately dated back publication geyer 1937 26 reported higher concordance sleep habits mz twins dz twins gedda 23 reported rare cases concordant long sleepers 15 h mz twins gedda brenci 24 first estimated heritability percentage variance explained additive effects genes sleep duration 30 authors later confirmed sleep duration highly similar twins living apart 25 discounting influence possible environmental effects recent observations twins indicated even pattern rapid eye movements present higher concordance mz dz twins 8 40 50 variance sleep duration presence sleep disorder accounted genetic effects 30 50 zung wilson 94 performed first polygraphic sleep recordings twins 1966 found temporal sequence sleep stages almost completely concordant mz twins 1983 1998 detailed polygraphic analyses performed twins studies reported surprising similarities mz twins 31 39 41 87 experimental genetics sleep mice pioneered valatx early 1970s time span 15 years valatxs group 72 77 conducted several crossing experiments recorded sleep hundreds inbred recombinant inbred ri hybrid mice mainly follow segregation paradoxical sleep ps amount studies together diallelique reciprocal crossing several inbred strains sleep experiment mice performed friedmann 22 clearly indicated although aspects sleep may follow simple segregation classical genetic laws cannot predict others
0.42022583.11842076.html.plaintext.txt	14	molecular genetics sleep top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	15	although classical genetic sleep studies favor strong genetic basis sleep still clue possible molecular mechanisms first attempts identify molecular basis sleep based assumption must genes change expression according behavioral state sleep vs wake andor time spent particular state closely related examples come circadian field dramatic changes expression several clock genes occur according strict circadian pattern reviewed ref 86 two process model sleep regulation 10 remarkable predictions homeostatic aspects sleep motivated first molecular investigation sleep sleep need intensity homeostatically regulated deprivation sleep lead change expression genes products necessary recovery least involved sleep regulation rhyner et al 54 performed first substractive hybridization sleep deprived vs control rats isolated several clones increased decreased relative expression among neurogranin dendrin later identified 47 48 sleep deprivation paradigm since become method choice gene expression experiments aimed uncovering molecular bases sleep regulatory processes reviewed ref 9 laboratory 56 already discussed several conceptual problems approach summary two major limitations first fact expression many genes varies vigilance state rather actively involved vigilance state regulation weakness correlative gene expression overcome confirming involvement identified genes loss function gain function experiments second high complexity mammalian brain mrna populations technical limitation however overcome recent developments gene expression profiling see nevertheless identification cortistatin orexin 12 13 specific actions sleep shows gene expression investigation highly successful
0.42022583.11842076.html.plaintext.txt	16	although classical genetic sleep studies favor strong genetic basis sleep still clue possible molecular mechanisms first attempts identify molecular basis sleep based assumption must genes change expression according behavioral state sleep vs wake andor time spent particular state closely related examples come circadian field dramatic changes expression several clock genes occur according strict circadian pattern reviewed ref 86 two process model sleep regulation 10 remarkable predictions homeostatic aspects sleep motivated first molecular investigation sleep sleep need intensity homeostatically regulated deprivation sleep lead change expression genes products necessary recovery least involved sleep regulation rhyner et al 54 performed first substractive hybridization sleep deprived vs control rats isolated several clones increased decreased relative expression among neurogranin dendrin later identified 47 48 sleep deprivation paradigm since become method choice gene expression experiments aimed uncovering molecular bases sleep regulatory processes reviewed ref 9 laboratory 56 already discussed several conceptual problems approach summary two major limitations first fact expression many genes varies vigilance state rather actively involved vigilance state regulation weakness correlative gene expression overcome confirming involvement identified genes loss function gain function experiments second high complexity mammalian brain mrna populations technical limitation however overcome recent developments gene expression profiling see nevertheless identification cortistatin orexin 12 13 specific actions sleep shows gene expression investigation highly successful
0.42022583.11842076.html.plaintext.txt	17	transgenic methods based random gene integration homologous recombination gave rise strong hope uncover molecular bases many phenotypes including complex ones techniques used address consequences overexpression ectopic expression time tissue specific expression gain loss function candidate gene potential advantages problems addressed several reviews recent review see ref 88 exception orexinhypocretin system see best knowledge single gene manipulation performed specifically investigate consequences sleep however many investigators field benefit availability transgenic models answer sleep related questions accumulated results indicate transgenic mice studies published thus far see table 1 report sleep related abnormalities strongly suggesting either nonspecific effects gene manipulations andor complex integrative nature sleep makes highly sensitive many physiological changes
0.42022583.11842076.html.plaintext.txt	18	transgenic methods based random gene integration homologous recombination gave rise strong hope uncover molecular bases many phenotypes including complex ones techniques used address consequences overexpression ectopic expression time tissue specific expression gain loss function candidate gene potential advantages problems addressed several reviews recent review see ref 88 exception orexinhypocretin system see best knowledge single gene manipulation performed specifically investigate consequences sleep however many investigators field benefit availability transgenic models answer sleep related questions accumulated results indicate transgenic mice studies published thus far see table 1 report sleep related abnormalities strongly suggesting either nonspecific effects gene manipulations andor complex integrative nature sleep makes highly sensitive many physiological changes
0.42022583.11842076.html.plaintext.txt	19	view table table 1 effects gene manipulation sleep
0.42022583.11842076.html.plaintext.txt	20	view table table 1 effects gene manipulation sleep
0.42022583.11842076.html.plaintext.txt	21	candidate gene approach top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	22	straightforward approach consider candidate gene based previous evidence implication sleep indicated sleep physiology pharmacology studies identified essential systems candidate genes chosen use approach studies differential expression tyrosine hydroxylase 53 growth hormone releasing hormone 6 interleukin 1 43 somatostatin 63 brain derived neurotrophic factor 5 shown play potential role sleep sleep studies transgenic mice table 1 also used approach powerful approach also combined recent techniques gene identification major disadvantage approach obviously nothing new learned terms sleep gene discovery
0.42022583.11842076.html.plaintext.txt	23	straightforward approach consider candidate gene based previous evidence implication sleep indicated sleep physiology pharmacology studies identified essential systems candidate genes chosen use approach studies differential expression tyrosine hydroxylase 53 growth hormone releasing hormone 6 interleukin 1 43 somatostatin 63 brain derived neurotrophic factor 5 shown play potential role sleep sleep studies transgenic mice table 1 also used approach powerful approach also combined recent techniques gene identification major disadvantage approach obviously nothing new learned terms sleep gene discovery
0.42022583.11842076.html.plaintext.txt	24	unique coincidental sleep related gene discovery concerns orexin system orexin b hypothalamic neuropeptides acting orexin 1 2 receptors first thought involved feeding behavior 13 55 mignots group 38 identified linkage analysis positional cloning mutations orexin 2 receptor gene cause canine narcolepsy animal model human sleep disorder narcolepsy independently almost simultaneously yanagisawas group 7 interested role orexins feeding behavior discovered mouse phenotype similar canine human narcolepsy targeted deletion preproorexin gene recently orexin system also implicated etiology human narcolepsy narcoleptic patients undetectable orexin levels cerebrospinal fluid 49 small number postmortem cases dramatic reduction number orexin containing neurons observed hypothalamus 51 65 unexpected observations led sakurais group 29 generate first transgenic mice specifically investigate role orexin system vigilance states transgenic mice carry promoter human preproorexin gene ligated truncated human ataxin 3 gene induce cell death specific expression transgene construct orexin containing neurons induces apoptosis 4 15 wk age adult orexinataxin 3 mice show narcolepsy hypophagia obesity 29 however although causal implication orexin system narcolepsy established direct causal involvement normal sleep regulation often claimed 3 14 28 34 64 89 91 remains elucidated
0.42022583.11842076.html.plaintext.txt	25	unique coincidental sleep related gene discovery concerns orexin system orexin b hypothalamic neuropeptides acting orexin 1 2 receptors first thought involved feeding behavior 13 55 mignots group 38 identified linkage analysis positional cloning mutations orexin 2 receptor gene cause canine narcolepsy animal model human sleep disorder narcolepsy independently almost simultaneously yanagisawas group 7 interested role orexins feeding behavior discovered mouse phenotype similar canine human narcolepsy targeted deletion preproorexin gene recently orexin system also implicated etiology human narcolepsy narcoleptic patients undetectable orexin levels cerebrospinal fluid 49 small number postmortem cases dramatic reduction number orexin containing neurons observed hypothalamus 51 65 unexpected observations led sakurais group 29 generate first transgenic mice specifically investigate role orexin system vigilance states transgenic mice carry promoter human preproorexin gene ligated truncated human ataxin 3 gene induce cell death specific expression transgene construct orexin containing neurons induces apoptosis 4 15 wk age adult orexinataxin 3 mice show narcolepsy hypophagia obesity 29 however although causal implication orexin system narcolepsy established direct causal involvement normal sleep regulation often claimed 3 14 28 34 64 89 91 remains elucidated
0.42022583.11842076.html.plaintext.txt	26	discovery new sleep genes top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	27	systematic search genes affecting particular phenotype needs cover whole genome organism genome wide search mapping experiments make priori assumptions gene systems involved although approach may lead already known physiological mechanisms strength unknown andor unexpected systems may discovered orexin success story canine narcolepsy unique best example approach field sleep research therefore genome wide search constitutes method choice discover new sleep genes
0.42022583.11842076.html.plaintext.txt	28	systematic search genes affecting particular phenotype needs cover whole genome organism genome wide search mapping experiments make priori assumptions gene systems involved although approach may lead already known physiological mechanisms strength unknown andor unexpected systems may discovered orexin success story canine narcolepsy unique best example approach field sleep research therefore genome wide search constitutes method choice discover new sleep genes
0.42022583.11842076.html.plaintext.txt	29	fundamental basis approach linkage disequilibrium closely localized genes gene affecting trait must addition gene genetic material tightly linked segregating generation generation together trait study therefore instead testing genes organism check cosegregation trait linkage one needs test small panel genes regular intervals throughout genome obtain sufficient information large chromosomal pieces transmitted single unit follow segregation genes must polymorphic nucleotide variation individual individual may case sequence gene may unknown powerful substitute provided highly polymorphic elements restriction fragment length polymorphisms rflps simple sequence length polymorphisms sslps single nucleotide polymorphisms snps forth mostly found noncoding genetic material polymorphic markers tested accurate mapping major question big effect gene detected mutations single gene eg orexin 2 receptor produce remarkable changes trait readily recognized eg monogenic autosomal recessive canine narcolepsy whereas natural variations genes controlling complex traits may subtle effects therefore genome wide approaches dissect complex traits highly sensitive detect genes variable effects trait
0.42022583.11842076.html.plaintext.txt	30	fundamental basis approach linkage disequilibrium closely localized genes gene affecting trait must addition gene genetic material tightly linked segregating generation generation together trait study therefore instead testing genes organism check cosegregation trait linkage one needs test small panel genes regular intervals throughout genome obtain sufficient information large chromosomal pieces transmitted single unit follow segregation genes must polymorphic nucleotide variation individual individual may case sequence gene may unknown powerful substitute provided highly polymorphic elements restriction fragment length polymorphisms rflps simple sequence length polymorphisms sslps single nucleotide polymorphisms snps forth mostly found noncoding genetic material polymorphic markers tested accurate mapping major question big effect gene detected mutations single gene eg orexin 2 receptor produce remarkable changes trait readily recognized eg monogenic autosomal recessive canine narcolepsy whereas natural variations genes controlling complex traits may subtle effects therefore genome wide approaches dissect complex traits highly sensitive detect genes variable effects trait
0.42022583.11842076.html.plaintext.txt	31	basically two major approaches available mutagenesis quantitative trait loci qtl analysis mutagenesis approach straightforward mutagen like n ethyl n nitrosurea used mutate random whole genome followed high throughput screening mutant offspring detect major effect given phenotype dominant recessive mutations screened way single gene mutation pathological condition mutated gene localized candidate gene positional cloning approaches used identification ultimately functional analysis performed gain loss function remarkable demonstration technique provided isolation clock one key mammalian circadian clock genes 1 35 81 however genetic screens approach fully penetrant dominant recessive mutations therefore cannot identify small effect sequence variations may turn essential aspects phenotype addition currently available technologies recording analyzing sleep thousands mice mutant screen seem feasible least single academic laboratory qtl analysis proposed powerful approach genetic dissection complex traits 11 17 36 although natural allelic variation genes small effect mapped qtl analysis final identification sequence variants quantitative trait nucleotides qtns ref 42 qtl region biologically significant effects phenotype may represent prohibitive efforts terms phenotyping genotyping excellent example qtl analysis understanding complex traits recently provided takahashis group 57 circadian behavior mice although molecular machinery circadian timekeeping system discovered mainly direct molecular techniques mutagenesis identified genes explain complexity observed circadian behavior instance none clock genes found involved approximately 1 h difference free running period balbc c57bl6 inbred mouse strains takahashis group 57 used qtl analysis balbc x c57bl6 cxb intercross discovered several new loci epistatic interaction
0.42022583.11842076.html.plaintext.txt	32	basically two major approaches available mutagenesis quantitative trait loci qtl analysis mutagenesis approach straightforward mutagen like n ethyl n nitrosurea used mutate random whole genome followed high throughput screening mutant offspring detect major effect given phenotype dominant recessive mutations screened way single gene mutation pathological condition mutated gene localized candidate gene positional cloning approaches used identification ultimately functional analysis performed gain loss function remarkable demonstration technique provided isolation clock one key mammalian circadian clock genes 1 35 81 however genetic screens approach fully penetrant dominant recessive mutations therefore cannot identify small effect sequence variations may turn essential aspects phenotype addition currently available technologies recording analyzing sleep thousands mice mutant screen seem feasible least single academic laboratory qtl analysis proposed powerful approach genetic dissection complex traits 11 17 36 although natural allelic variation genes small effect mapped qtl analysis final identification sequence variants quantitative trait nucleotides qtns ref 42 qtl region biologically significant effects phenotype may represent prohibitive efforts terms phenotyping genotyping excellent example qtl analysis understanding complex traits recently provided takahashis group 57 circadian behavior mice although molecular machinery circadian timekeeping system discovered mainly direct molecular techniques mutagenesis identified genes explain complexity observed circadian behavior instance none clock genes found involved approximately 1 h difference free running period balbc c57bl6 inbred mouse strains takahashis group 57 used qtl analysis balbc x c57bl6 cxb intercross discovered several new loci epistatic interaction
0.42022583.11842076.html.plaintext.txt	33	qtl analysis sleep amount distribution top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	34	complex nature sleep reflected high intra interspecies phenotypic variability instance 24 h amount sleep shows highly significant differences inbred mouse strains 21 22 74 shown akr mice sleep 3 h dba mice 24 h period 21 differences period circadian rhythms single gene many genes complex interactions may found account difference therefore initiated series experiments dissect different phenotypic aspects sleep mice qtl analysis table 2 summarizes main quantitative aspects sleep inbred strains mice differed note differences high low strains consistent two studies performed 25 years apart usually differences two extreme strains expressed standard deviations twice large ref 74 due smaller within strain standard deviations based repeated measures data ref 74 based 5 day continuous recordings instead single 24 h recordings ref 21
0.42022583.11842076.html.plaintext.txt	35	complex nature sleep reflected high intra interspecies phenotypic variability instance 24 h amount sleep shows highly significant differences inbred mouse strains 21 22 74 shown akr mice sleep 3 h dba mice 24 h period 21 differences period circadian rhythms single gene many genes complex interactions may found account difference therefore initiated series experiments dissect different phenotypic aspects sleep mice qtl analysis table 2 summarizes main quantitative aspects sleep inbred strains mice differed note differences high low strains consistent two studies performed 25 years apart usually differences two extreme strains expressed standard deviations twice large ref 74 due smaller within strain standard deviations based repeated measures data ref 74 based 5 day continuous recordings instead single 24 h recordings ref 21
0.42022583.11842076.html.plaintext.txt	36	view table table 2 difference amount sws ps extreme inbred mouse strains
0.42022583.11842076.html.plaintext.txt	37	view table table 2 difference amount sws ps extreme inbred mouse strains
0.42022583.11842076.html.plaintext.txt	38	qtl analysis performed several segregating mouse populations including intercross backcross advanced intercross backcross ri heterogeneous stocks 11 63 basically two inbred mouse strains differing trait interest crossed f1 offspring either intercrossed generate f2 backcrossed one progenitor strains generate backcross populations random intercross backcross generations performed generate advanced intercross backcross populations generate ri sets f2 mice brother x sister mated full homozygosity thereby fixing unique sets recombinations several inbred lines heterogeneous stocks generated intercrossing several inbred mouse strains many generations therefore represent higher rates recombination polymorphism useful fine mapping 44 63 although ris usually suitable qtl mapping due limited progenitor strains number qtls large effects may provide significant mapping accuracy fourfold increase recombination compared f2 population 11 also complex phenotypes high variability use ris advantageous several individuals per strain tested instead example single f2 animal therefore first step performed qtl analysis two ri sets seven cxb ris qtls identified amount ps chromosomes 5 7 12 17 61 toth williams 71 conducted similar study 13 cxb ris reported provisional qtls chromosomes 4 16 17 amount ps light period small number cxb ris n 7 13 none qtls identified could satisfy standard significance levels 37 also discrepancy two referenced works indicates linkage study replication needed especially findings based limited number animals andor strains recent review see also ref 69 qtl analysis 25 c57bl6 x dba2 bxd ris identified first significant qtl amount ps 12 h light period chromosome 1 60 estimated bxd ris 40 60 variance sleep amounts accounted additive effects 6 15 genes confirming polygenic basis differences sleep amounts
0.42022583.11842076.html.plaintext.txt	39	qtl analysis performed several segregating mouse populations including intercross backcross advanced intercross backcross ri heterogeneous stocks 11 63 basically two inbred mouse strains differing trait interest crossed f1 offspring either intercrossed generate f2 backcrossed one progenitor strains generate backcross populations random intercross backcross generations performed generate advanced intercross backcross populations generate ri sets f2 mice brother x sister mated full homozygosity thereby fixing unique sets recombinations several inbred lines heterogeneous stocks generated intercrossing several inbred mouse strains many generations therefore represent higher rates recombination polymorphism useful fine mapping 44 63 although ris usually suitable qtl mapping due limited progenitor strains number qtls large effects may provide significant mapping accuracy fourfold increase recombination compared f2 population 11 also complex phenotypes high variability use ris advantageous several individuals per strain tested instead example single f2 animal therefore first step performed qtl analysis two ri sets seven cxb ris qtls identified amount ps chromosomes 5 7 12 17 61 toth williams 71 conducted similar study 13 cxb ris reported provisional qtls chromosomes 4 16 17 amount ps light period small number cxb ris n 7 13 none qtls identified could satisfy standard significance levels 37 also discrepancy two referenced works indicates linkage study replication needed especially findings based limited number animals andor strains recent review see also ref 69 qtl analysis 25 c57bl6 x dba2 bxd ris identified first significant qtl amount ps 12 h light period chromosome 1 60 estimated bxd ris 40 60 variance sleep amounts accounted additive effects 6 15 genes confirming polygenic basis differences sleep amounts
0.42022583.11842076.html.plaintext.txt	40	qtl analysis sleep eeg top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	41	quantitative eeg analysis means fast fourier transform analysis robust technique evaluate functional changes central nervous system including changes vigilance states 2 slow wave sleep characterized oscillations delta 1 4 hz spindle 11 15 hz frequency ranges whereas ps especially rodents characterized theta oscillations 5 9 hz wakefulness encompasses variety behaviors characteristic eeg pattern waking eeg analysis twins demonstrated spectral profiles among heritable traits humans reviewed ref 79 heritability estimates ranging 75 90 80 shown several spectral characteristics sleep fig 1 differ significantly inbred mouse strains 20 among theta peak frequency ps showed highest difference inbred strains 80 interstrain variability could attributed genetic effects established intercross backcross cxb mice single gene may explain phenotypic variance major gene 62 high resolution qtl mapping needed localize underlying gene
0.42022583.11842076.html.plaintext.txt	42	quantitative eeg analysis means fast fourier transform analysis robust technique evaluate functional changes central nervous system including changes vigilance states 2 slow wave sleep characterized oscillations delta 1 4 hz spindle 11 15 hz frequency ranges whereas ps especially rodents characterized theta oscillations 5 9 hz wakefulness encompasses variety behaviors characteristic eeg pattern waking eeg analysis twins demonstrated spectral profiles among heritable traits humans reviewed ref 79 heritability estimates ranging 75 90 80 shown several spectral characteristics sleep fig 1 differ significantly inbred mouse strains 20 among theta peak frequency ps showed highest difference inbred strains 80 interstrain variability could attributed genetic effects established intercross backcross cxb mice single gene may explain phenotypic variance major gene 62 high resolution qtl mapping needed localize underlying gene
0.42022583.11842076.html.plaintext.txt	43	view larger version 45k fig 1 bottom 10 electroencephalogram eeg sample paradoxical sleep ps left slow wave sleep sws right 1 representative mouse inbred strains eeg characteristics differed ak akrj br c57brcdj c balbcbyj d2 dba2j ps eeg dominated theta oscillations 5 9 hz sws eeg composed delta 1 4 hz theta sigma 11 15 hz oscillations top relative contribution frequency eeg components quantified spectral analysis average theta frequency ps 15 hz faster br compared ak mice spectral profiles sws eeg c d2 mice display large differences relative contribution delta sigma frequency components spectral profiles based 4 epochs scored ps sws baseline 12 h light period n 7strain
0.42022583.11842076.html.plaintext.txt	44	another aspect sleep eeg considerable importance homeostatic regulation change delta power ie eeg power 1 4 hz range function prior wakefulness duration relative delta power used index sleep need sleep intensity mammalian species studied far sleep loss induces proportional predictable increase delta power differs significantly inbred mouse strains 18 21 used delta power rebound 6 h sleep deprivation map underlying genes bxd ris 18 results confirmed rate sleep need accumulates varies greatly genotype one significant qtl identified chromosome 13 accounted 50 genetic variance trait two examples suggest quantitative sleep eeg parameters stronger genetic control sleep amounts therefore suitable quantitative genetic dissection sleep amounts mammals may approximated techniques eeg use piezoelectric films would make high throughput genetic analysis feasible however success may limited due highly polygenic nature sleep amounts suggesting presence many genes small effects hand quantitative eeg analysis dramatically limits wide range use involves implantation recovery adaptation cabling time intensive analysis may turn successful due limited number underlying genes presence major genes
0.42022583.11842076.html.plaintext.txt	45	qtl molecular basis top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	46	qtl analysis map gene genetic effect large chromosomal region usually 20 30 cm large regions may contain single major gene several genes small effects also qtls may interact epistasis effect difficult detect qtl mapping experiments first step make sure region contains qtls large enough effect one possibility transfer qtl region one inbred strain background another inbred background repeated backcrossing selection make congenic strain reviewed sleep amount data available eight congenic strains generated transferring minor histocompatibility genes inbred strain balbc inbred background c57bl6 60 almost cases results indicated even transferred pieces chromosomes contained large effect qtl detected cxb ris clear effect could observed resulting congenic strain finding strongly suggests 1 many genes involved 2 interaction epistasis 3 even major qtl identified effect may vary genetic background genetic background due action modifier genes 45 qtl region verified next step finely map qtl smallest chromosomal region 11 17 amenable candidate gene analysis final identification functional qtns sequence variants difficult part since qtns may found every kilobases therefore combination several approaches necessary mapping candidate gene analysis high resolution qtl mapping conjunction future developments high throughput phenotyping genotyping availability whole genome sequences several major mouse strains identify candidate genes investigated candidate genes mutated either classical homologous recombination knockout newly developed serial nested chromosomal deletions 59 systematic crosses increasing decreasing qtl allele complete set mutants physically identify functional qtn qtns probably involved gene regulation rather mutations affecting protein function gene expression profiling high throughput genotyping technologies eg microarray taqman gene translation posttranslational protein analyses used uncover molecular mechanisms involved note finding molecular basis mutagenesis experiment follows approximately time labor intensive procedure
0.42022583.11842076.html.plaintext.txt	47	qtl analysis map gene genetic effect large chromosomal region usually 20 30 cm large regions may contain single major gene several genes small effects also qtls may interact epistasis effect difficult detect qtl mapping experiments first step make sure region contains qtls large enough effect one possibility transfer qtl region one inbred strain background another inbred background repeated backcrossing selection make congenic strain reviewed sleep amount data available eight congenic strains generated transferring minor histocompatibility genes inbred strain balbc inbred background c57bl6 60 almost cases results indicated even transferred pieces chromosomes contained large effect qtl detected cxb ris clear effect could observed resulting congenic strain finding strongly suggests 1 many genes involved 2 interaction epistasis 3 even major qtl identified effect may vary genetic background genetic background due action modifier genes 45 qtl region verified next step finely map qtl smallest chromosomal region 11 17 amenable candidate gene analysis final identification functional qtns sequence variants difficult part since qtns may found every kilobases therefore combination several approaches necessary mapping candidate gene analysis high resolution qtl mapping conjunction future developments high throughput phenotyping genotyping availability whole genome sequences several major mouse strains identify candidate genes investigated candidate genes mutated either classical homologous recombination knockout newly developed serial nested chromosomal deletions 59 systematic crosses increasing decreasing qtl allele complete set mutants physically identify functional qtn qtns probably involved gene regulation rather mutations affecting protein function gene expression profiling high throughput genotyping technologies eg microarray taqman gene translation posttranslational protein analyses used uncover molecular mechanisms involved note finding molecular basis mutagenesis experiment follows approximately time labor intensive procedure
0.42022583.11842076.html.plaintext.txt	48	conclusions top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	49	challenge finding molecular bases sleep requires demanding efforts terms genetic genomic resources also terms future developments high throughput phenotyping techniques enough effort financial resources given develop simplified automated sleep recording devices major limitation overcome high numbers qtl mutant screen experiments thus become feasible entire mouse genome sequence becomes available genome wide assessment spatial temporal expression genes identification every conceivable sequence variation provide speedy molecular analysis complex traits sleep genetics sleep may also complemented genetic analysis rest activity flies 27 considering still know little molecular basis sleep ineffective current treatments common sleep disorders insomnia hypersomnia believe molecular genetic approaches still best hope developing better therapies uncovering sleep functions review tried show many techniques combinations used answer basic questions however relying solely large effect genes revealed mutagenesis candidate gene approaches may bring erroneous interpretations complex polygenic nature sleep mechanisms
0.42022583.11842076.html.plaintext.txt	50	challenge finding molecular bases sleep requires demanding efforts terms genetic genomic resources also terms future developments high throughput phenotyping techniques enough effort financial resources given develop simplified automated sleep recording devices major limitation overcome high numbers qtl mutant screen experiments thus become feasible entire mouse genome sequence becomes available genome wide assessment spatial temporal expression genes identification every conceivable sequence variation provide speedy molecular analysis complex traits sleep genetics sleep may also complemented genetic analysis rest activity flies 27 considering still know little molecular basis sleep ineffective current treatments common sleep disorders insomnia hypersomnia believe molecular genetic approaches still best hope developing better therapies uncovering sleep functions review tried show many techniques combinations used answer basic questions however relying solely large effect genes revealed mutagenesis candidate gene approaches may bring erroneous interpretations complex polygenic nature sleep mechanisms
0.42022583.11842076.html.plaintext.txt	51	work m taftis laboratory supported swiss national science foundation grants 314575195 31 5600098 national heart lung blood institute grant hl 64148 supported p frankens work
0.42022583.11842076.html.plaintext.txt	52	address reprint requests correspondence m tafti hug belle idee biochemistry clinical neurophysiology unit chemin du petit bel air 2 ch 1225 chene bourg switzerland e mail taftiatcmuunigech u d
0.42022583.11842076.html.plaintext.txt	53	address reprint requests correspondence m tafti hug belle idee biochemistry clinical neurophysiology unit chemin du petit bel air 2 ch 1225 chene bourg switzerland e mail taftiatcmuunigech u d
0.42022583.11842076.html.plaintext.txt	54	references top abstract introduction classical genetics sleep molecular genetics sleep candidate gene approach discovery new sleep qtl analysis sleep qtl analysis qtl molecular conclusions references
0.42022583.11842076.html.plaintext.txt	55	1 antoch mp song ej chang vitaterna mh zhao y wilsbacher ld sangoram king dp pinto lh takahashi js functional identification mouse circadian clock gene transgenic bac rescue cell 89 655 667 1997isimedline 2 borbely aa baumann f brandeis d strauch lehmann d sleep deprivation effect sleep stages eeg power density man electroencephalogr clin neurophysiol 51 483 495 1981isimedline 3 bourgin p huitron resendiz spier ad fabre v morte b criado jr sutcliffe jg henriksen sj de lecea l hypocretin 1 modulates rapid eye movement sleep activation locus coeruleus neurons j neurosci 20 7760 7765 2000abstractfree full text 4 boutrel b franc b hen r hamon m adrien j key role 5 ht1b receptors regulation paradoxical sleep evidenced 5 ht1b knock mice j neurosci 19 3204 3212 1999abstractfree full text 5 bova r micheli mr qualadrucci p zucconi gg bdnf trkb mrnas oscillate rat brain light dark cycle brain res mol brain res 57 321 324 1998isimedline 6 bredow taishi p obel f guha thakurta n krueger jm hypothalamic growth hormone releasing hormone mrna varies across day rats neuroreport 7 2501 2505 1996isimedline 7 chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999isimedline 8 chouvet g blois r debilly g jouvet m structure occurrence rapid eye movements paradoxical sleep similar homozygotic twins cr seances acad sci iii 296 1063 1068 1983 9 cirelli c tononi g gene expression brain across sleep waking cycle brain res 885 303 321 2000isimedline 10 daan beersma dg borbely aa timing human sleep recovery process gated circadian pacemaker j physiol regulatory integrative comp physiol 246 r161 r183 1984abstractfree full text 11 darvasi experimental strategies genetic dissection complex traits animal models nat genet 18 19 24 1998isimedline 12 de lecea l criado jr prospero garcia o gautvik km schweitzer p danielson pe dunlop cl siggins gr henriksen sj sutcliffe jg cortical neuropeptide neuronal depressant sleep modulating properties nature 38 242 245 1996 13 de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs ii frankel wn van den pol bloom fe gautvik km sutcliffe jg hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95 322 327 1998abstractfree full text 14 estabrooke iv mccarthy mt ko e chou tc chemelli rm yanagisawa m saper cb scammell te fos expression orexin neurons varies behavioral state j neurosci 21 1656 1662 2001abstractfree full text 15 fang j wang y krueger jm mice lacking tnf 55 kda receptor fail sleep tnf treatment j neurosci 17 5949 5955 1997abstractfree full text 16 fang j wang y krueger jm effects interleukin 1 sleep mediated type receptor j physiol regulatory integrative comp physiol 274 r655 r660 1998abstractfree full text 17 flint j mott r finding molecular basis quantitative traits successes pitfalls nat rev genet 2 437 445 2001isimedline 18 franken p chollet d tafti m homeostatic regulation sleep need genetic control j neurosci 21 2610 2621 2001abstractfree full text 19 franken p lopez molina l marcacci l schibler u tafti m transcription factor dbp affects circadian sleep consolidation rhythmic eeg activity j neurosci 20 617 625 2000abstractfree full text 20 franken p malafosse tafti m genetic variation eeg activity sleep inbred mice j physiol regulatory integrative comp physiol 275 r1127 r1137 1998abstractfree full text 21 franken p malafosse tafti m genetic determinants sleep regulation inbred mice sleep 22 155 169 1999isimedline 22 friedmann jk diallel analysis genetic underpinnings mouse sleep physiol behav 12 169 175 1974isimedline 23 gedda l studio dei gemelli rome orizzonte medico 1951 p 538 24 gedda l brenci g sleep dream characteristics twins acta genet med gemellol roma 28 237 239 1979medline 25 gedda l brenci g twins living apart test progress report acta genet med gemellol roma 32 17 22 1983medline 26 geyer h ueber den schlaf von zwillingen z indukt abstamm verebungsl 78 524 527 1937 27 greenspan rj tononi g cirelli c shaw pj sleep fruit fly trends neurosci 24 142 145 2001isimedline 28 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text 29 hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai genetic ablation orexin neurons mice results narcolepsy hypophagia obesity neuron 30 345 354 2001isimedline 30 heath kendler ks eaves lj martin ng evidence genetic influences sleep disturbance sleep patterns twins sleep 13 318 335 1990isimedline 31 hori sleep characteristics twins jpn j psychiatry neurol 40 35 46 1986medline 32 huang zl qu wm li wd mochizuki eguchi n watanabe urade y hayaishi o arousal effect orexin depends activation histaminergic system proc natl acad sci usa 98 9965 9970 2001abstractfree full text 33 juel nielsen n harvald b electroencephalogram uniovular twins brought apart acta genet basel 8 57 64 1958medline 34 kilduff ts peyron c hypocretinorexin ligand receptor system implications sleep sleep disorders trends neurosci 23 359 365 2000isimedline 35 king dp zhao y sangoram wilsbacher ld tanaka m antoch mp steeves td vitaterna mh kornhauser jm lowrey pl turek fw takahashi js positional cloning mouse circadian clock gene cell 89 641 653 1997isimedline 36 lander es botstein d mapping mendelian factors underlying quantitative traits using rflp linkage maps genetics 121 185 199 1989abstractfree full text 37 lander es schork nj genetic dissection complex traits science 265 2037 2048 1994isimedline 38 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline 39 linkowski p eeg sleep patterns twins j sleep res 8 suppl1 11 13 1999isimedline 40 linkowski p kerkhofs m hauspie r mendlewicz j genetic determinants eeg sleep study twins living apart electroencephalogr clin neurophysiol 79 114 118 1991isimedline 41 linkowski p kerkhofs m hauspie r susanne c mendlewicz j eeg sleep patterns man twin study electroencephalogr clin neurophysiol 73 279 284 1989isimedline 42 lyman rf lai c mackay tf linkage disequilibrium mapping molecular polymorphisms scabrous locus associated naturally occurring variation bristle number drosophila melanogaster genet res 74 303 311 1999isimedline 43 mackiewicz m sollars pj ogilvie md pack ai modulation il 1 gene expression rat cns sleep deprivation neuroreport 7 529 533 1996isimedline 44 mott r talbot cj turri mg collins ac flint j new method fine mapping quantitative trait loci outbred animal stocks proc natl acad sci usa 97 12649 12654 2000abstractfree full text 45 nadeau jh modifier genes mice humans nat rev genet 2 165 174 2001isimedline 46 naylor e bergmann bm krauski k zee pc takahashi js vitaterna mh turek fw circadian clock mutation alters sleep homeostasis mouse j neurosci 20 8138 8143 2000abstractfree full text 47 neuner jehle m denizot jp borbely aa mallet j characterization sleep deprivation induced expression modulation dendrin novel dendritic protein rat brain neurons j neurosci res 46 138 151 1996isimedline 48 neuner jehle m rhyner ta borbely aa sleep deprivation differentially alters mrna protein levels neurogranin rat brain brain res 685 143 153 1995isimedline 49 nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000isimedline 50 partinen m kaprio j koskenvuo m putkonen p langinvainio h genetic environmental determination human sleep sleep 6 179 185 1983isimedline 51 peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6 991 997 2000isimedline 52 pinzar e kanaoka y inui eguchi n urade y hayaishi o prostaglandin d synthase gene involved regulation non rapid eye movement sleep proc natl acad sci usa 97 4903 4907 2000abstractfree full text 53 porkka heiskanen smith se taira urban jh levine je turek fw stenberg d noradrenergic activity rat brain rapid eye movement sleep deprivation rebound sleep j physiol regulatory integrative comp physiol 268 r1456 r1463 1995abstractfree full text 54 rhyner ta biguet nf berrard borbely aa mallet j efficient approach selective isolation specific transcripts complex brain mrna populations j neurosci res 16 167 181 1986isimedline 55 sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline 56 schibler u tafti m molecular approaches towards isolation sleep related genes j sleep res 8 suppl 1 1 10 1999 57 shimomura k low zeddies ss king dp steeves td whiteley kushla j zemenides pd lin vitaterna mh churchill ga takahashi js genome wide epistatic interaction analysis reveals complex genetic determinants circadian behavior mice genome res 11 959 980 2001abstractfree full text 58 shiromani pj basheer r thakkar j wagner d greco ma charness sleep wakefulness c fos fos b gene knockout mice brain res mol brain res 80 75 87 2000isimedline 59 su h wang x bradley nested chromosomal deletions induced retroviral vectors mice nat genet 24 92 95 2000isimedline 60 tafti m chollet d valatx jl franken p quantitative trait loci approach genetics sleep recombinant inbred mice j sleep res 8 suppl 1 37 43 1999isimedline 61 tafti m franken p kitahama k malafosse jouvet m valatx jl localization candidate genomic regions influencing paradoxical sleep mice neuroreport 8 3755 3758 1997isimedline 62 tafti m malafosse franken p genetic determinants theta rhythm mice j sleep res 7 suppl2 269 1998 63 talbot cj nicod cherny ss fulker dw collins ac flint j high resolution mapping quantitative trait loci outbred mice nat genet 21 305 308 1999isimedline 64 terao peyron c ding j wurts sw edgar dm heller hc kilduff ts prepro hypocretin prepro orexin expression unaffected short term sleep deprivation rats mice sleep 23 867 874 2000isimedline 65 thannickal tc moore ry nienhuis r ramanathan l gulyani aldrich m cornford m siegel jm reduced number hypocretin neurons human narcolepsy neuron 27 469 474 2000isimedline 66 tobler gaus se deboer achermann p fischer m rulicke moser m oesch b mcbride pa manson jc altered circadian activity rhythms sleep mice devoid prion protein nature 380 639 642 1996isimedline 67 tobler kopp c deboer rudolph u diazepam induced changes sleep role 1 gabaa receptor subtype proc natl acad sci usa 98 6464 6469 2001abstractfree full text 68 toppila j alanko l asikainen m tobler stenberg d porkka heiskanen sleep deprivation increases somatostatin growth hormone releasing hormone messenger rna rat hypothalamus j sleep res 6 171 178 1997isimedline 69 toth la identifying genetic influences sleep approach discovering mechanisms sleep regulation behav genet 31 39 46 2001isimedline 70 toth la opp mr cytokine microbially induced sleep responses interleukin 10 deficient mice j physiol regulatory integrative comp physiol 280 r1806 r1814 2001abstractfree full text 71 toth la williams rw quantitative genetic analysis slow wave sleep rapid eye movement sleep cxb recombinant inbred mice behav genet 29 329 337 1999isimedline 72 valatx jl possible embryonic origin sleep interstrain differences mouse maturation nervous system prog brain res 48 385 391 1978medline 73 valatx jl genetics model studying sleep waking cycle exp brain res suppl 8 135 145 1984 74 valatx jl bugat r facteurs genetiques dans le determinisme du cycle veille sommeil chez la souris brain res 69 315 330 1974isimedline 75 valatx jl bugat r jouvet m genetic studies sleep mice nature 238 226 227 1972isimedline 76 valatx jl cespuglio r paut l bailey dw etude genetique du sommeil paradoxal chez la souris liaison possible avec les genes de coloration waking sleeping 4 175 183 1980medline 77 valatx jl chouvet g kitahama k genetics sleep learning processes possible relationships genetics environment intelligence edited oliverio new york elsevier 1977 p 133 146 78 valatx jl douhet p bucchini d human insulin gene insertion mice effects sleep wake cycle j sleep res 8 suppl1 65 68 1999isimedline 79 van beijsterveldt ce boomsma di genetics human electroencephalogram eeg event related brain potentials erps review hum genet 94 319 330 1994isimedline 80 van beijsterveldt ce molenaar pc de geus ej boomsma di heritability human brain functioning assessed electroencephalography j hum genet 58 562 573 1996isimedline 81 vitaterna mh king dp chang kornhauser jm lowrey pl mcdonald jd dove wf pinto lh turek fw takahashi js mutagenesis mapping mouse gene clock essential circadian behavior science 264 719 725 1994isimedline 82 vogel f uber die erblichkeit des normalen electroencephalogramms stuttgart germany thieme 1958 83 vogel f genetic basis normal human electroencephalogram humangenetik 10 91 114 1970isimedline 84 vogel f zur genetischen grundlage fronto prazentraler b wellen gruppen im eeg des menschen humangenetik 2 227 237 1966isimedline 85 vogel f zur genetischen grundlage occipitaler langsamer b wellen gruppen im eeg des menschen humangenetik 2 238 245 1966isimedline 86 wager smith k kay sa circadian rhythm genetics flies mice humans nat genet 26 23 27 2000isimedline 87 webb wb campbell ss relationships sleep characteristics identical fraternal twins arch gen psychiatry 40 1093 1095 1983abstract 88 williams rs wagner pd transgenic animals integrative biology approaches interpretations outcome j appl physiol 88 1119 1126 2000abstractfree full text 89 willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001isimedline 90 wisor jp nishino sora uhl gh mignot e edgar dm dopaminergic role stimulant induced wakefulness j neurosci 21 1787 1794 2001abstractfree full text 91 xi m morales fr chase mh effects sleep wakefulness injection hypocretin 1 orexin laterodorsal tegmental nucleus cat brain res 901 259 264 2001isimedline 92 young jp lader mh fenton gw twin study genetic influences electroencephalogram j med genet 9 13 16 1972isimedline 93 zhang j obal f jr fang j collins bj krueger jm non rapid eye movement sleep suppressed transgenic mice deficiency somatotropic system neurosci lett 220 97 100 1996isimedline 94 zung ww wilson wp sleep dream patterns twins markov analysis genetic trait rec adv biol psychiatry 9 119 130 1966
0.42022583.11842076.html.plaintext.txt	56	j appl physiol 9231339 1347 8750 758702 500 copyright 2002 american physiological society
0.42022583.11842076.html.plaintext.txt	57	j appl physiol 9231339 1347 8750 758702 500 copyright 2002 american physiological society
0.44176623.15625087.html.plaintext.txt	0	altered setting pituitary thyroid ensemble hypocretin deficient narcoleptic men simon w kok1 ferdinand roelfsema2 sebastiaan overeem3 gert jan lammers3 marijke frolich1 edo meinders1 hanno pijl1
0.44176623.15625087.html.plaintext.txt	1	altered setting pituitary thyroid ensemble hypocretin deficient narcoleptic men simon w kok1 ferdinand roelfsema2 sebastiaan overeem3 gert jan lammers3 marijke frolich1 edo meinders1 hanno pijl1
0.44176623.15625087.html.plaintext.txt	2	departments 1general internal medicine 2endocrinology 3neurology leiden university medical center leiden netherlands
0.44176623.15625087.html.plaintext.txt	3	submitted 23 july 2004 accepted final form 16 december 2004
0.44176623.15625087.html.plaintext.txt	4	abstract top abstract methods results discussion references narcolepsy sleep disorder caused disruption hypocretin orexin neurotransmission injection hypocretin 1 acutely suppresses trh tsh release rats contrast subchronic administration appear affect hypothalamo pituitary thyroid ensemble animals explored 7 patients 7 controls whether hypocretin deficiency impacts circulating tsh levels circadian timing tsh release narcoleptic humans plasma tsh concentration profiles blood samples taken 10 min intervals 24 h tsh levels response trh injection analyzed cluster robust regression approximate entropy apen deconvolution circulating tsh levels lower patients primarily attributable lower pulse amplitude nadir concentrations tsh secretion correlated positively mean 24 h leptin levels r2 046 p 002 negatively amount sleep r2 029 p 0048 pattern synchrony 24 h leptin tsh concentrations demonstrated significant cross correlation cross apen analyses differences controls patients sleep onset closely associated fall circulating tsh features diurnal rhythmicity circulating tsh fluctuations similar patients controls acrophase occurring shortly midnight thyroxine triiodothyronine concentrations similar patients controls display diurnal rhythm response plasma tsh levels trh also similar groups sleep patterns narcoleptics significantly disorderly compared controls measured apen p 0006 summary circulating tsh concentrations low hypocretin deficient narcoleptic men could attributable low plasma leptin levels andor abnormal sleep wake cycle
0.44176623.15625087.html.plaintext.txt	5	abstract top abstract methods results discussion references narcolepsy sleep disorder caused disruption hypocretin orexin neurotransmission injection hypocretin 1 acutely suppresses trh tsh release rats contrast subchronic administration appear affect hypothalamo pituitary thyroid ensemble animals explored 7 patients 7 controls whether hypocretin deficiency impacts circulating tsh levels circadian timing tsh release narcoleptic humans plasma tsh concentration profiles blood samples taken 10 min intervals 24 h tsh levels response trh injection analyzed cluster robust regression approximate entropy apen deconvolution circulating tsh levels lower patients primarily attributable lower pulse amplitude nadir concentrations tsh secretion correlated positively mean 24 h leptin levels r2 046 p 002 negatively amount sleep r2 029 p 0048 pattern synchrony 24 h leptin tsh concentrations demonstrated significant cross correlation cross apen analyses differences controls patients sleep onset closely associated fall circulating tsh features diurnal rhythmicity circulating tsh fluctuations similar patients controls acrophase occurring shortly midnight thyroxine triiodothyronine concentrations similar patients controls display diurnal rhythm response plasma tsh levels trh also similar groups sleep patterns narcoleptics significantly disorderly compared controls measured apen p 0006 summary circulating tsh concentrations low hypocretin deficient narcoleptic men could attributable low plasma leptin levels andor abnormal sleep wake cycle
0.44176623.15625087.html.plaintext.txt	6	narcolepsy thyroid stimulating hormone orexin sleep entropy
0.44176623.15625087.html.plaintext.txt	7	narcolepsy neurological disorder characterized excessive daytime sleepiness eds hypnagogic hallucinations cataplexy sleep paralysis 41 affects 20 60 every 100000 subjects us europe 32 disruption hypocretin orexin neurotransmission underlies disease animals humans 28 39 hypocretins hypocretin 1 2 also called orexin b produced small group neurons lateral hypothalamus project widely throughout central nervous system cns 8 56 paraventricular nucleus pvn among various brain sites receive hypocretin input signals 7 nucleus harbors neurons synthesize thyrotropin releasing hormone trh involved regulation hypothalamo pituitary thyroid hpt axis 24 starvation thyroid hormone secretion suppressed 2 52 whereas preprohypocretin mrna upregulated lateral hypothalamus 4 led us hypothesize hypocretin neural circuits modulate activity hypothalamic trh neurons thereby impact hpt axis
0.44176623.15625087.html.plaintext.txt	8	narcolepsy neurological disorder characterized excessive daytime sleepiness eds hypnagogic hallucinations cataplexy sleep paralysis 41 affects 20 60 every 100000 subjects us europe 32 disruption hypocretin orexin neurotransmission underlies disease animals humans 28 39 hypocretins hypocretin 1 2 also called orexin b produced small group neurons lateral hypothalamus project widely throughout central nervous system cns 8 56 paraventricular nucleus pvn among various brain sites receive hypocretin input signals 7 nucleus harbors neurons synthesize thyrotropin releasing hormone trh involved regulation hypothalamo pituitary thyroid hpt axis 24 starvation thyroid hormone secretion suppressed 2 52 whereas preprohypocretin mrna upregulated lateral hypothalamus 4 led us hypothesize hypocretin neural circuits modulate activity hypothalamic trh neurons thereby impact hpt axis
0.44176623.15625087.html.plaintext.txt	9	studies putative effects hypocretin peptides hpt axis animals incomplete results conflicting single intravenous intracerebroventricular injection hypocretin 1 rats acutely decreased plasma tsh concentrations hypothalamic trh release 34 contrast several papers report hypocretin 1 measurable effect pituitary thyroid axis 16 20 53 54 whereas circulating tsh shown increase response central administration hypocretin 2 20 thus although topography hypocretin thyrotrope neural circuits suggests trh neuronal activity governed hypocretin input nature signal ie excitatory inhibitory remains unclear hypocretin 1 2 may differential effects result distinct chemical structure
0.44176623.15625087.html.plaintext.txt	10	studies putative effects hypocretin peptides hpt axis animals incomplete results conflicting single intravenous intracerebroventricular injection hypocretin 1 rats acutely decreased plasma tsh concentrations hypothalamic trh release 34 contrast several papers report hypocretin 1 measurable effect pituitary thyroid axis 16 20 53 54 whereas circulating tsh shown increase response central administration hypocretin 2 20 thus although topography hypocretin thyrotrope neural circuits suggests trh neuronal activity governed hypocretin input nature signal ie excitatory inhibitory remains unclear hypocretin 1 2 may differential effects result distinct chemical structure
0.44176623.15625087.html.plaintext.txt	11	previously reported circulating leptin levels low male narcoleptic patients 22 leptin stimulatory effects hpt axis conceivable relative hypoleptinemia downregulates hpt axis activity narcolepsy addition typical disruption sleep wake cycle associated narcolepsy may also impact tsh release sleep inhibits tsh secretion healthy subjects 42
0.44176623.15625087.html.plaintext.txt	12	previously reported circulating leptin levels low male narcoleptic patients 22 leptin stimulatory effects hpt axis conceivable relative hypoleptinemia downregulates hpt axis activity narcolepsy addition typical disruption sleep wake cycle associated narcolepsy may also impact tsh release sleep inhibits tsh secretion healthy subjects 42
0.44176623.15625087.html.plaintext.txt	13	gain insight regulation hpt axis hypocretin deficient humans analyzed 24 h plasma tsh thyroid hormone concentrations relation leptin sleep seven narcoleptic men seven healthy controls
0.44176623.15625087.html.plaintext.txt	14	methods top abstract methods results discussion references subjects
0.44176623.15625087.html.plaintext.txt	15	included seven male patients mean age 461 yr range 26 71 yr outpatient clinic department neurology leiden university medical center diagnosis narcolepsy cataplexy made clinical grounds physician experienced narcolepsy g j lammers multiple sleep latency testing showed results typical narcolepsy 33 patients hla dr2dqb10602 positive lacked hypocretin 1 cerebrospinal fluid measurements previously described 39 subjects free medication 3 patients discontinued medication 2 wk study two patients used psychostimulants methylfenidate modafinil one tricyclic antidepressant clomipramine treatment narcolepsy
0.44176623.15625087.html.plaintext.txt	16	included seven male patients mean age 461 yr range 26 71 yr outpatient clinic department neurology leiden university medical center diagnosis narcolepsy cataplexy made clinical grounds physician experienced narcolepsy g j lammers multiple sleep latency testing showed results typical narcolepsy 33 patients hla dr2dqb10602 positive lacked hypocretin 1 cerebrospinal fluid measurements previously described 39 subjects free medication 3 patients discontinued medication 2 wk study two patients used psychostimulants methylfenidate modafinil one tricyclic antidepressant clomipramine treatment narcolepsy
0.44176623.15625087.html.plaintext.txt	17	weight height subjects measured well waist hip circumference waist hip ratio whr used relative measure abdominal fat mass total body fat mass determined dual energy x ray absorptiometry qdr4500 hologic waltham ma seven male control subjects mean age 469 yr range 26 72 yr recruited advertisements local newspapers matched age body mass index bmi total fat mass whr since narcoleptics moderately obese 23
0.44176623.15625087.html.plaintext.txt	18	weight height subjects measured well waist hip circumference waist hip ratio whr used relative measure abdominal fat mass total body fat mass determined dual energy x ray absorptiometry qdr4500 hologic waltham ma seven male control subjects mean age 469 yr range 26 72 yr recruited advertisements local newspapers matched age body mass index bmi total fat mass whr since narcoleptics moderately obese 23
0.44176623.15625087.html.plaintext.txt	19	subjects eligible study exclusion hypertension defined repeated blood pressure measurement systolic 160 mmhg diastolic 90 mmhg known history pituitary disease recent weight change 3 kg weight gain loss within previous 3 mo fasting blood glucose 70 mmoll written informed consent obtained subjects study approved ethics committee leiden university medical center
0.44176623.15625087.html.plaintext.txt	20	subjects admitted clinical research center morning 24 h study occasion 24 h study occasion three standardized meals served 0900 1300 1800 nutridrink 15 kcalml 1500 1800 kcalday macronutrient composition per 100 ml 5 g protein 65 g fat 179 g carbohydrate nutricia zoetermeer netherlands subjects remained sedentary throughout study except bathroom visits lights switched 2300 upon arrival intravenous cannula inserted antecubital vein 1 h start blood sampling blood samples collected monovetten sarstedt etten leur netherlands three way stopcock attached 09 nacl heparin 1 uml infusion 500 ml24 h keep cannula clotting blood collected 10 min intervals 24 h sampled long line prevent sleep disturbance investigative manipulations samples clotted centrifuged 4 degrees c 20 min serum frozen 20 degrees c assay
0.44176623.15625087.html.plaintext.txt	21	subjects admitted clinical research center morning 24 h study occasion 24 h study occasion three standardized meals served 0900 1300 1800 nutridrink 15 kcalml 1500 1800 kcalday macronutrient composition per 100 ml 5 g protein 65 g fat 179 g carbohydrate nutricia zoetermeer netherlands subjects remained sedentary throughout study except bathroom visits lights switched 2300 upon arrival intravenous cannula inserted antecubital vein 1 h start blood sampling blood samples collected monovetten sarstedt etten leur netherlands three way stopcock attached 09 nacl heparin 1 uml infusion 500 ml24 h keep cannula clotting blood collected 10 min intervals 24 h sampled long line prevent sleep disturbance investigative manipulations samples clotted centrifuged 4 degrees c 20 min serum frozen 20 degrees c assay
0.44176623.15625087.html.plaintext.txt	22	plasma tsh concentration measured every sample total thyroxine t4 triiodothyronine t3 concentrations measured hourly relatively long plasma half lives plasma free t4 concentration measured morning
0.44176623.15625087.html.plaintext.txt	23	plasma tsh concentration measured every sample total thyroxine t4 triiodothyronine t3 concentrations measured hourly relatively long plasma half lives plasma free t4 concentration measured morning
0.44176623.15625087.html.plaintext.txt	24	separate occasion trh stimulation test carried five patients five controls fasting state 200 microg trh injected intravenously blood samples taken 10 min intervals 3 h
0.44176623.15625087.html.plaintext.txt	25	separate occasion trh stimulation test carried five patients five controls fasting state 200 microg trh injected intravenously blood samples taken 10 min intervals 3 h
0.44176623.15625087.html.plaintext.txt	26	thyroid hormone assays performed automated systems total t4 measured fluorescence immunoenzymometric assay fiema abbott diagnostics division hoofddorp netherlands t3 fluorescence enzymeimmunoassay feia abbott diagnostics division free t4 concentration measured electrochemoluminescence immunoassay roche diagnostics nederland almere netherlands tsh measured time resolved immunofluorometric assay wallac turku finland detection limit tsh assay 005 mul interassay coefficient variation cv 5 addition plasma leptin concentration measured every 20 min sample ria linco research st charles mo detection limit assay 05 microgl cv 34 83 concentration range 49 256 microgl detailed description circulating leptin levels narcoleptic men previously published 22 correlated 24 h mean leptin concentration tsh secretion also 20 min leptin data relation reconstituted 20 min plasma tsh profile
0.44176623.15625087.html.plaintext.txt	27	thyroid hormone assays performed automated systems total t4 measured fluorescence immunoenzymometric assay fiema abbott diagnostics division hoofddorp netherlands t3 fluorescence enzymeimmunoassay feia abbott diagnostics division free t4 concentration measured electrochemoluminescence immunoassay roche diagnostics nederland almere netherlands tsh measured time resolved immunofluorometric assay wallac turku finland detection limit tsh assay 005 mul interassay coefficient variation cv 5 addition plasma leptin concentration measured every 20 min sample ria linco research st charles mo detection limit assay 05 microgl cv 34 83 concentration range 49 256 microgl detailed description circulating leptin levels narcoleptic men previously published 22 correlated 24 h mean leptin concentration tsh secretion also 20 min leptin data relation reconstituted 20 min plasma tsh profile
0.44176623.15625087.html.plaintext.txt	28	24 h sampling procedure sleep recorded polygraphically using porti 5 ambulant electroencephalogram recording system twente medical systems international enschede netherlands scored eeg 2100 review software nihon kohden tokyo japan experienced technician blinded subject study visually scored sleep recordings 30 epochs means standardized criteria 49 present study used distribution amount sleep across 24 h
0.44176623.15625087.html.plaintext.txt	29	24 h sampling procedure sleep recorded polygraphically using porti 5 ambulant electroencephalogram recording system twente medical systems international enschede netherlands scored eeg 2100 review software nihon kohden tokyo japan experienced technician blinded subject study visually scored sleep recordings 30 epochs means standardized criteria 49 present study used distribution amount sleep across 24 h
0.44176623.15625087.html.plaintext.txt	30	cluster analysis cluster used detection discrete tsh peaks computerized pulse algorithm largely model free identifies statistically significant pulses relation dose dependent measurement error hormone time series present analysis 2 x 1 test cluster configuration used two data points test nadir one test peak statistic 20 downstrokes minimizes false positive false negative peaks locations widths significant concentration peaks identified total number peaks counted mean peak interval calculated minutes addition following pulse parameters determined peak height highest value attained within peak incremental peak amplitude difference peak height prepeak nadir area peak interpulse valleys identified regions embracing nadirs intervening upstrokes total area curve also calculated well summed pulse areas 59
0.44176623.15625087.html.plaintext.txt	31	deconvolution analysis 24 h tsh secretion rate calculated pulse deconvolution method waveform independent used estimating hormone secretion rate time point well total 24 h rate 60 method requires priori specification plasma half life present analysis used two compartment model fast component 18 plus minus 3 min slow component 90 plus minus 5 min fractional contribution 032 slow component overall decay data kindly provided dr j d veldhuis mayo clinic rochester mn mass tsh released trh injection also calculated deconvolution separarate occasion patients received 200 microg trh intravenously morning blood samples drawn injection 10 min intervals 180 min
0.44176623.15625087.html.plaintext.txt	32	approximate entropy univariate approximate entropy apen statistic developed quantify degree irregularity disorderliness time series 44 62 technically apen quantifies summed logarithmic likelihood templates length m patterns data similar within r remain similar within tolerance r next incremental comparison formally defined elsewhere 45 apen calculation provides single nonnegative number ensemble estimate relative process randomness wherein larger apen values denote greater irregularity cross apen x apen quantifies joint pattern synchrony two separate parallel time series standardization z score transformation 47 51 present analysis calculated x apen leptin tsh sleep tsh assuming r 20 sd individual time series m 1 hence use designation x apen 1 20 parameter set affords sensitive valid statistically well replicated apen x apen metrics assessing hormone time series length 46 apen x apen results reported absolute values ratio absolute value mean 1000 randomly shuffled data series values approaching 10 denote complete randomness
0.44176623.15625087.html.plaintext.txt	33	nyctohemeral 24 h rhythmicity diurnal variations plasma tsh concentrations calculated data fitted robust curve fitting algorithm 3 5 acrophase maximal value fitted curve amplitude rhythm defined one half difference nocturnal zenith daytime nadir relative amplitude maximal percent increase nadir value
0.44176623.15625087.html.plaintext.txt	34	nyctohemeral 24 h rhythmicity diurnal variations plasma tsh concentrations calculated data fitted robust curve fitting algorithm 3 5 acrophase maximal value fitted curve amplitude rhythm defined one half difference nocturnal zenith daytime nadir relative amplitude maximal percent increase nadir value
0.44176623.15625087.html.plaintext.txt	35	sleep tsh concentrations relation sleep onset decrease tsh concentration quantified hypergeometric joint binomial distribution 61 program calculates probability events pulses time series two occur randomly
0.44176623.15625087.html.plaintext.txt	36	results presented means plus minus se unless stated otherwise comparisons made two tailed students test unpaired data necessary logarithmic transformation limit variability addition used kolmogorov smirnov test relations variables analyzed regression techniques calculations performed systat version 11 systat richmond ca p 005 considered significant
0.44176623.15625087.html.plaintext.txt	37	results presented means plus minus se unless stated otherwise comparisons made two tailed students test unpaired data necessary logarithmic transformation limit variability addition used kolmogorov smirnov test relations variables analyzed regression techniques calculations performed systat version 11 systat richmond ca p 005 considered significant
0.44176623.15625087.html.plaintext.txt	38	results top abstract methods results discussion references plasma hormone concentrations
0.44176623.15625087.html.plaintext.txt	39	figure 1 shows average 24 h serum tsh concentration vs time narcoleptic subjects n matched controls c mean 24 h plasma tsh concentration significantly lower narcoleptic patients 158 plus minus 027 n vs 288 plus minus 036 c mul p 0014 contrast mean hourly plasma total t4 t3 different patients controls table 1 also basal free t4 measurements similar groups 144 plus minus 040 n vs 150 plus minus 093 c pmoll p 055 circadian plasma t4 t3 levels display significant diurnal rhythm
0.44176623.15625087.html.plaintext.txt	40	figure 1 shows average 24 h serum tsh concentration vs time narcoleptic subjects n matched controls c mean 24 h plasma tsh concentration significantly lower narcoleptic patients 158 plus minus 027 n vs 288 plus minus 036 c mul p 0014 contrast mean hourly plasma total t4 t3 different patients controls table 1 also basal free t4 measurements similar groups 144 plus minus 040 n vs 150 plus minus 093 c pmoll p 055 circadian plasma t4 t3 levels display significant diurnal rhythm
0.44176623.15625087.html.plaintext.txt	41	view larger version 36k fig 1 twenty four hour thyroid stimulating hormone tsh concentrations 7 narcoleptic patients 7 controls data shown means se bars
0.44176623.15625087.html.plaintext.txt	42	view table table 1 mean 24 h serum tsh thyroid hormone concentrations narcoleptic patients healthy controls
0.44176623.15625087.html.plaintext.txt	43	results cluster analysis summarized table 2 tsh pulse frequency mean pulse interval differ patients controls mean pulse area smaller patients controls primarily caused diminution pulse height pulse amplitude integrated total area tsh curve auc also lower patients controls 2260 plus minus 390 vs 4140 plus minus 520 mul p 0013 mean nadir concentration 50 lower patients controls
0.44176623.15625087.html.plaintext.txt	44	results cluster analysis summarized table 2 tsh pulse frequency mean pulse interval differ patients controls mean pulse area smaller patients controls primarily caused diminution pulse height pulse amplitude integrated total area tsh curve auc also lower patients controls 2260 plus minus 390 vs 4140 plus minus 520 mul p 0013 mean nadir concentration 50 lower patients controls
0.44176623.15625087.html.plaintext.txt	45	view table table 2 cluster analysis 24 h serum tsh concentration series narcolepsy controls
0.44176623.15625087.html.plaintext.txt	46	acrophase time maximal tsh occurred 2439 plus minus 078 h patients 2428 plus minus 048 h controls p 091 nadir concentrations reached 1527 plus minus 114 h patients 1518 plus minus 061 h controls p 094 amplitude rhythm smaller patients controls 048 plus minus 013 vs 100 plus minus 026 mul p 0009 percent increase tsh concentration similar two groups 93 plus minus 16 vs 115 plus minus 21 p 043 examples representative tsh profiles fitted curves shown fig 2
0.44176623.15625087.html.plaintext.txt	47	view larger version 34k fig 2 plasma tsh concentration series 2 patients top 2 controls bottom locally weighted robust regression line data points also shown percentage wakefulness calculated 10 min bins displayed top panels
0.44176623.15625087.html.plaintext.txt	48	different occasion response tsh trh investigated total mass tsh released calculated deconvolution analysis 271 plus minus 50 mul patients 244 plus minus 49 mul controls p 039 fig 3 basal levels 20 plus minus 017 mul patients 325 plus minus 038 mul controls p 002 maximal tsh values reached 20 30 min trh injection different patients controls 20 min p 024 30 min p 030
0.44176623.15625087.html.plaintext.txt	49	different occasion response tsh trh investigated total mass tsh released calculated deconvolution analysis 271 plus minus 50 mul patients 244 plus minus 49 mul controls p 039 fig 3 basal levels 20 plus minus 017 mul patients 325 plus minus 038 mul controls p 002 maximal tsh values reached 20 30 min trh injection different patients controls 20 min p 024 30 min p 030
0.44176623.15625087.html.plaintext.txt	50	view larger version 15k fig 3 tsh increase injection 100 microg thyrotropin releasing hormone trh 5 narcoleptic patients 5 controls basal tsh concentrations differed significantly p 002 maximal values 20 30 min different total tsh mass secreted similar patients controls data shown means plus minus se
0.44176623.15625087.html.plaintext.txt	51	figure 4 shows correlation leptin tsh concentrations synchronicity leptin tsh series similar patients controls x apen score leptin leading tsh 1750 plus minus 0024 patients 1650 plus minus 0067 controls p 023 expressed ratio random series x apen ratio patients 0902 plus minus 0024 controls 0870 plus minus 0016 p 031 ratios differed significantly random series 4 sds linear relation mean 24 h leptin concentration 24 h tsh secretion rate determined deconvolution analysis depicted fig 5
0.44176623.15625087.html.plaintext.txt	52	figure 4 shows correlation leptin tsh concentrations synchronicity leptin tsh series similar patients controls x apen score leptin leading tsh 1750 plus minus 0024 patients 1650 plus minus 0067 controls p 023 expressed ratio random series x apen ratio patients 0902 plus minus 0024 controls 0870 plus minus 0016 p 031 ratios differed significantly random series 4 sds linear relation mean 24 h leptin concentration 24 h tsh secretion rate determined deconvolution analysis depicted fig 5
0.44176623.15625087.html.plaintext.txt	53	view larger version 30k fig 4 regression tsh leptin concentrations 7 narcoleptic patients 7 controls data represent samples obtained 20 min intervals 24 h study
0.44176623.15625087.html.plaintext.txt	54	view larger version 13k fig 5 linear regression mean 24 h leptin concentration tsh secretion estimated deconvolution analysis narcoleptic patients shown circles controls triangles
0.44176623.15625087.html.plaintext.txt	55	narcoleptic patients slept longer sampling protocol median duration 761 h range 41 207 h controls 36 h range 30 66 h p 0047 fig 2 sleep patterns expressed percentage awake tsh concentration profiles displayed two patients two controls patients controls except one highly significant concordance sleep onset decrease tsh concentrations present p values ranging 0002 0000001 total sleep duration correlated negatively 24 h tsh secretion r2 0287 p 0048 relation sleep tsh concentrations also explored apen analyses sleep apen 1 20 apen 1 20 ratio significantly increased compared controls denoting increased sleep disorderliness narcoleptic patients fig 6 x apen analysis demonstrated coupling sleep tsh controls patients mutual differences
0.44176623.15625087.html.plaintext.txt	56	view larger version 16k fig 6 approximate entropy apen cross apen x apen sleep joint synchrony sleep tsh 7 narcoleptic n patients 7 age body fat mass matched controls c statistical comparisons made 2 tailed students test unpaired data
0.44176623.15625087.html.plaintext.txt	57	discussion top abstract methods results discussion references present paper presents first detailed description plasma tsh concentration profiles hypocretin deficient narcoleptic humans average tsh concentration significantly lower narcoleptic men specifically attributable reduction tsh pulse amplitude whereas number tsh pulses similar patients controls circadian fluctuation plasma tsh concentrations comparable narcoleptics controls circulating leptin tsh secretion appeared correlate positively whereas sleep inversely associated tsh release despite significantly lower plasma tsh concentration narcoleptics t4 t3 concentrations similar patients controls
0.44176623.15625087.html.plaintext.txt	58	discussion top abstract methods results discussion references present paper presents first detailed description plasma tsh concentration profiles hypocretin deficient narcoleptic humans average tsh concentration significantly lower narcoleptic men specifically attributable reduction tsh pulse amplitude whereas number tsh pulses similar patients controls circadian fluctuation plasma tsh concentrations comparable narcoleptics controls circulating leptin tsh secretion appeared correlate positively whereas sleep inversely associated tsh release despite significantly lower plasma tsh concentration narcoleptics t4 t3 concentrations similar patients controls
0.44176623.15625087.html.plaintext.txt	59	tsh synthesis secretion primarily regulated trh feedforward input feedback inhibition thyroid hormones host hormones neurotransmitters including somatostatin catecholamines various cytokines leptin modulate neuroendocrine ensemble 13 58 addition sleep inhibitory effect tsh secretion 1 42 trh synthesized thyrotropic area pvn anterior pituitary acts promote tsh secretion endocrine paracrine mechanisms respectively 58 although hypocretin neuronal cell bodies heavily project pvn 43 currently unknown whether hypocretin axons actually synapse trh neurons therefore uncertain whether hypocretins directly modulate trh synthesis release thus affect tsh secretion also experiments investigating impact exogenous hypocretin peptides tsh release rodents yielded inconclusive results intracerebroventricular intravenous injection hypocretin 1 either reduced plasma tsh levels showed effect tsh andor trh release 16 34 53 54 thus seems unlikely hypocretin deficiency per se inhibits trh secretion reduce tsh levels narcoleptic humans
0.44176623.15625087.html.plaintext.txt	60	tsh synthesis secretion primarily regulated trh feedforward input feedback inhibition thyroid hormones host hormones neurotransmitters including somatostatin catecholamines various cytokines leptin modulate neuroendocrine ensemble 13 58 addition sleep inhibitory effect tsh secretion 1 42 trh synthesized thyrotropic area pvn anterior pituitary acts promote tsh secretion endocrine paracrine mechanisms respectively 58 although hypocretin neuronal cell bodies heavily project pvn 43 currently unknown whether hypocretin axons actually synapse trh neurons therefore uncertain whether hypocretins directly modulate trh synthesis release thus affect tsh secretion also experiments investigating impact exogenous hypocretin peptides tsh release rodents yielded inconclusive results intracerebroventricular intravenous injection hypocretin 1 either reduced plasma tsh levels showed effect tsh andor trh release 16 34 53 54 thus seems unlikely hypocretin deficiency per se inhibits trh secretion reduce tsh levels narcoleptic humans
0.44176623.15625087.html.plaintext.txt	61	22 previously showed circulating leptin levels 50 lower narcoleptic patients controls matched age body fat mass show circulating leptin levels tsh secretion rates correlated positively narcoleptic men studies revealed leptin intimately involved regulation hpt axis specifically reduction circulating leptin mediates inhibition hpt axis activity starvation 13 leptin acts primarily integrate activities neuronal circuits orchestrate energy balance 40 context leptin activates melanocyte stimulating hormone msh cocaine amphetamine regulated transcript cart whereas inhibits neuropeptide y npy agouti related peptide agrp trh neurons receive functional inputs neurotransmitters 10 12 25 26 57 npyagrp inhibit trh release 21 whereas mshcart promote trh secretion 11 21 addition leptin directly stimulate prepro trh mrna synthesis processing promote trh release via activation leptin receptors trh neurons 37 moreover fact leptin leptin receptors expressed rodent anterior pituitary cells suggests leptin may also impact tsh secretion directly 19 diurnal pulsatile leptin tsh levels exhibit strong pattern synchrony healthy humans whereas tsh release gets disorganized circadian rhythm phase shifted leptin deficient human subjects 31 present study also demonstrate strong pattern synchrony leptin tsh patients controls data clearly suggest leptin involved regulation tsh release rodents humans thus fact tsh release rates positively correlated circulating leptin levels present study supports certainly prove contention hypoleptinemia blunts tsh secretion narcoleptic patients
0.44176623.15625087.html.plaintext.txt	62	22 previously showed circulating leptin levels 50 lower narcoleptic patients controls matched age body fat mass show circulating leptin levels tsh secretion rates correlated positively narcoleptic men studies revealed leptin intimately involved regulation hpt axis specifically reduction circulating leptin mediates inhibition hpt axis activity starvation 13 leptin acts primarily integrate activities neuronal circuits orchestrate energy balance 40 context leptin activates melanocyte stimulating hormone msh cocaine amphetamine regulated transcript cart whereas inhibits neuropeptide y npy agouti related peptide agrp trh neurons receive functional inputs neurotransmitters 10 12 25 26 57 npyagrp inhibit trh release 21 whereas mshcart promote trh secretion 11 21 addition leptin directly stimulate prepro trh mrna synthesis processing promote trh release via activation leptin receptors trh neurons 37 moreover fact leptin leptin receptors expressed rodent anterior pituitary cells suggests leptin may also impact tsh secretion directly 19 diurnal pulsatile leptin tsh levels exhibit strong pattern synchrony healthy humans whereas tsh release gets disorganized circadian rhythm phase shifted leptin deficient human subjects 31 present study also demonstrate strong pattern synchrony leptin tsh patients controls data clearly suggest leptin involved regulation tsh release rodents humans thus fact tsh release rates positively correlated circulating leptin levels present study supports certainly prove contention hypoleptinemia blunts tsh secretion narcoleptic patients
0.44176623.15625087.html.plaintext.txt	63	diminished dopaminergic tone may also blunt tsh secretion narcoleptic subjects diminution trh release studies using canine model narcolepsy suggest hypoactivity dopaminergic noradrenergic circuits among major pathophysiological mechanisms narcolepsy 38 recent vivo brain imaging studies humans support notion 9 disease currently treated symptomatically drugs enhance monoaminergic ie dopamine norepinephrine neurotransmissions 38 vitro vivo studies clearly show hypocretin peptides stimulate dopaminergic neurons various brain sites 16 36 also suggests hypocretin deficiency may silence dopaminergic circuits dopamine promotes trh release via hypothalamic dopamine d2 receptors 27 therefore hypocretin deficiency may blunt trh thereby tsh release diminution dopaminergic neurotransmission hypothalamus however role dopamine regulation tsh secretion complex view fact monoamine inhibits tsh release level pituitary 6 14 observation implies reduced dopaminergic tone would lead increase circulating tsh narcoleptic subjects context seems important mention prolactin secretion also controlled dopamine pituitary level altered narcoleptic patients w kok unpublished observation thus role dopamine pathophysiology low plasma tsh levels narcoleptic humans remains uncertain
0.44176623.15625087.html.plaintext.txt	64	diminished dopaminergic tone may also blunt tsh secretion narcoleptic subjects diminution trh release studies using canine model narcolepsy suggest hypoactivity dopaminergic noradrenergic circuits among major pathophysiological mechanisms narcolepsy 38 recent vivo brain imaging studies humans support notion 9 disease currently treated symptomatically drugs enhance monoaminergic ie dopamine norepinephrine neurotransmissions 38 vitro vivo studies clearly show hypocretin peptides stimulate dopaminergic neurons various brain sites 16 36 also suggests hypocretin deficiency may silence dopaminergic circuits dopamine promotes trh release via hypothalamic dopamine d2 receptors 27 therefore hypocretin deficiency may blunt trh thereby tsh release diminution dopaminergic neurotransmission hypothalamus however role dopamine regulation tsh secretion complex view fact monoamine inhibits tsh release level pituitary 6 14 observation implies reduced dopaminergic tone would lead increase circulating tsh narcoleptic subjects context seems important mention prolactin secretion also controlled dopamine pituitary level altered narcoleptic patients w kok unpublished observation thus role dopamine pathophysiology low plasma tsh levels narcoleptic humans remains uncertain
0.44176623.15625087.html.plaintext.txt	65	clinical features narcolepsy also suggest trh deficiency hypoleptinemia unknown causes may involved pathophysiology disease eds cataplexy reflections depressed activity cns accordingly current options treatment narcolepsy include cns stimulants eds antidepressants cataplexy 41 trh receptors distributed widely cns 15 trh diverse neuromodulating actions 15 48 among many features cns stimulant antidepressant effects 18 29 interestingly chronic administration trh analog increases wakefulness ameliorates cataplexy narcoleptic dogs 50 may imply diminished trh tone involved pathogenesis narcoleptic symptoms however fact circulating prolactin levels normal narcoleptic humans unpublished observation argues exclude primary trh deficiency patients trh involved regulation prolactin release
0.44176623.15625087.html.plaintext.txt	66	clinical features narcolepsy also suggest trh deficiency hypoleptinemia unknown causes may involved pathophysiology disease eds cataplexy reflections depressed activity cns accordingly current options treatment narcolepsy include cns stimulants eds antidepressants cataplexy 41 trh receptors distributed widely cns 15 trh diverse neuromodulating actions 15 48 among many features cns stimulant antidepressant effects 18 29 interestingly chronic administration trh analog increases wakefulness ameliorates cataplexy narcoleptic dogs 50 may imply diminished trh tone involved pathogenesis narcoleptic symptoms however fact circulating prolactin levels normal narcoleptic humans unpublished observation argues exclude primary trh deficiency patients trh involved regulation prolactin release
0.44176623.15625087.html.plaintext.txt	67	sleep inhibitory effect tsh release demonstrated human normal light dark cycle sleep light dark cycle manipulations 1 17 underlying neuroendocrine mechanisms known present study sleep plasma tsh levels inversely associated sleep periods invariably followed reduction tsh concentration patients controls suggesting hypocretins involved coupling sleep tsh release present data also suggest fact patients slept longer controls may contributed reduction tsh levels
0.44176623.15625087.html.plaintext.txt	68	sleep inhibitory effect tsh release demonstrated human normal light dark cycle sleep light dark cycle manipulations 1 17 underlying neuroendocrine mechanisms known present study sleep plasma tsh levels inversely associated sleep periods invariably followed reduction tsh concentration patients controls suggesting hypocretins involved coupling sleep tsh release present data also suggest fact patients slept longer controls may contributed reduction tsh levels
0.44176623.15625087.html.plaintext.txt	69	hypersensitivity thyroid gland tsh stimulation may also contribute alterations pituitary thyroid ensemble described despite fact tsh levels reduced narcoleptic subjects plasma t4 t3 concentrations similar healthy controls completely within normal range may imply thyroid sensitive tsh stimulation narcoleptics unfortunately study yield data support notion thyroid hypersensitivity tsh may brought reduction sympathetic tone patients 55 tsh induced t4 release inhibited 1 adrenergic receptor stimulation 30 35 putative resetting pituitary thyroid axis could fully explain observations case fact thyroid hormone levels within normal range narcoleptics indicates patients euthyroid however remains established whether ensemble acts appropriately conditions greater metabolic demands growth cold adaptation pregnancy
0.44176623.15625087.html.plaintext.txt	70	hypersensitivity thyroid gland tsh stimulation may also contribute alterations pituitary thyroid ensemble described despite fact tsh levels reduced narcoleptic subjects plasma t4 t3 concentrations similar healthy controls completely within normal range may imply thyroid sensitive tsh stimulation narcoleptics unfortunately study yield data support notion thyroid hypersensitivity tsh may brought reduction sympathetic tone patients 55 tsh induced t4 release inhibited 1 adrenergic receptor stimulation 30 35 putative resetting pituitary thyroid axis could fully explain observations case fact thyroid hormone levels within normal range narcoleptics indicates patients euthyroid however remains established whether ensemble acts appropriately conditions greater metabolic demands growth cold adaptation pregnancy
0.44176623.15625087.html.plaintext.txt	71	data clearly show apen statistic appropriately detect disorderliness sleep patterns narcoleptic humans thus conceivable application apen analysis sleep patterns effect drug therapy sleep disorders physiological studies sleep related neuroendocrine phenomena might contribute understanding complicated networks involved
0.44176623.15625087.html.plaintext.txt	72	data clearly show apen statistic appropriately detect disorderliness sleep patterns narcoleptic humans thus conceivable application apen analysis sleep patterns effect drug therapy sleep disorders physiological studies sleep related neuroendocrine phenomena might contribute understanding complicated networks involved
0.44176623.15625087.html.plaintext.txt	73	conclusion present study shows circulating tsh concentrations reduced face normal plasma thyroid hormone concentrations hypocretin deficient narcoleptic humans hypoleptinemia disorderly sleep episodes longer duration may involved pathophysiology neuroendocrine feature narcolepsy
0.44176623.15625087.html.plaintext.txt	74	conclusion present study shows circulating tsh concentrations reduced face normal plasma thyroid hormone concentrations hypocretin deficient narcoleptic humans hypoleptinemia disorderly sleep episodes longer duration may involved pathophysiology neuroendocrine feature narcolepsy
0.44176623.15625087.html.plaintext.txt	75	view larger version 53k fig 7 acknowledgments gratefully acknowledge work performed following collaborators e j m ladan eygenraam e c sierat van der steen technical support m van dijk besling h g haasnoot van der bent performing tsh t4 t3 assays
0.44176623.15625087.html.plaintext.txt	76	footnotes address reprint requests correspondence h pijl leiden univ medical center dept general internal medicine c1 r39 po box 9600 2300 rc leiden netherlands e mail hpijlatlumcnl u d
0.44176623.15625087.html.plaintext.txt	77	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.44176623.15625087.html.plaintext.txt	78	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.44176623.15625087.html.plaintext.txt	79	references top abstract methods results discussion references allan js czeisler ca persistence circadian thyrotropin rhythm constant conditions light induced shifts circadian phase j clin endocrinol metab 79 508 512 1994abstract blake ng johnson mr eckland dj foster oj lightman sl effect food deprivation altered thyroid status hypothalamic pituitary thyroid axis rat j endocrinol 133 183 188 1992abstract buxton om frank sa lhermite baleriaux m leproult r turek fw van cauter e roles intensity duration nocturnal exercise causing phase delays human circadian rhythms j physiol endocrinol metab 273 e536 e542 1997abstractfree full text cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g hypothalamic orexin expression modulation blood glucose feeding diabetes 48 2132 2137 1999abstract cleveland ws robust locally weighted regression smoothing scatter plots j stat assoc 74 829 836 1979isi cooper ds klibanski ridgway ec dopaminergic modulation tsh subunits vivo vitro studies clin endocrinol oxf 18 265 275 1983isimedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95 322 327 1998abstractfree full text eisensehr linke r tatsch k von lindeiner h kharraz b gildehaus fj eberle r pollmacher schuld noachtar alteration striatal dopaminergic system human narcolepsy neurology 60 1817 1819 2003abstractfree full text fekete c kelly j mihaly e sarkar rand wm legradi g emerson ch lechan rm neuropeptide y central inhibitory action hypothalamic pituitary thyroid axis endocrinology 142 2606 2613 2001abstractfree full text fekete c legradi g mihaly e huang qh tatro jb rand wm emerson ch lechan rm alpha melanocyte stimulating hormone contained nerve terminals innervating thyrotropin releasing hormone synthesizing neurons hypothalamic paraventricular nucleus prevents fasting induced suppression prothyrotropin releasing hormone gene expression j neurosci 20 1550 1558 2000abstractfree full text fekete c mihaly e luo lg kelly j clausen jt mao q rand wm moss lg kuhar m emerson ch jackson im lechan rm association cocaine amphetamine regulated transcript immunoreactive elements thyrotropin releasing hormone synthesizing neurons hypothalamic paraventricular nucleus role regulation hypothalamic pituitary thyroid axis fasting j neurosci 20 9224 9234 2000abstractfree full text flier js harris m hollenberg leptin nutrition thyroid wherefore wiring j clin invest 105 859 861 2000free full text foord sm peters j scanlon mf rees sb hall r dopaminergic control tsh secretion isolated rat pituitary cells febs lett 121 257 259 1980crossrefisimedline gershengorn mc osman r molecular cellular biology thyrotropin releasing hormone receptors physiol rev 76 175 191 1996abstractfree full text hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hirschfeld u moreno reyes r akseki e lhermite baleriaux m leproult r copinschi g van cauter e progressive elevation plasma thyrotropin adaptation simulated jet lag effects treatment bright light zolpidem j clin endocrinol metab 81 3270 3277 1996abstract jackson im thyrotropin releasing hormone n engl j med 306 145 155 1982isimedline jin l zhang burguera bg couce osamura ry kulig e lloyd rv leptin leptin receptor expression rat mouse pituitary cells endocrinology 141 333 339 2000abstractfree full text jones dn gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153 210 218 2001crossrefisimedline kim ms small cj stanley sa morgan dg seal lj kong wm edwards cm abusnana sunter d ghatei ma bloom sr central melanocortin system affects hypothalamo pituitary thyroid axis may mediate effect leptin j clin invest 105 1005 1011 2000abstractfree full text kok sw meinders ae overeem lammers gj roelfsema f frolich m pijl h reduction plasma leptin levels loss circadian rhythmicity hypocretin orexin deficient narcoleptic humans j clin endocrinol metab 87 805 809 2002abstractfree full text kok sw overeem visscher tl lammers gj seidell jc pijl h meinders ae hypocretin deficiency narcoleptic humans associated abdominal obesity obes res 11 1147 1154 2003abstractfree full text lechan rm jackson im immunohistochemical localization thyrotropin releasing hormone rat hypothalamus pituitary endocrinology 111 55 65 1982abstract legradi g lechan rm arcuate nucleus major source neuropeptide y innervation thyrotropin releasing hormone neurons hypothalamic paraventricular nucleus endocrinology 139 3262 3270 1998abstractfree full text legradi g lechan rm agouti related protein containing nerve terminals innervate thyrotropin releasing hormone neurons hypothalamic paraventricular nucleus endocrinology 140 3643 3652 1999abstractfree full text lewis bm dieguez c lewis md scanlon mf dopamine stimulates release thyrotrophin releasing hormone perfused intact rat hypothalamus via hypothalamic d2 receptors j endocrinol 115 419 424 1987abstract lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999crossrefisimedline lloyd rl pekary ae sattin amundson antidepressant effects thyrotropin releasing hormone analogues using rodent model depression pharmacol biochem behav 70 15 22 2001crossrefisimedline maayan ml sellitto rv volpert em dopamine l dopa inhibition thyrotropin stimulated thyroidal thyroxine release endocrinology 118 632 636 1986abstract mantzoros cs ozata m negrao ab suchard ma ziotopoulou m caglayan elashoff rm cogswell rj negro p liberty v wong ml veldhuis j ozdemir ic gold pw flier js licinio j synchronicity frequently sampled thyrotropin tsh leptin concentrations healthy adults leptin deficient subjects evidence possible partial tsh regulation leptin humans j clin endocrinol metab 86 3284 3291 2001abstractfree full text mignot e genetic familial aspects narcolepsy neurology 50 s16 s22 1998isimedline mitler mm van den hoed j carskadon ma richardson g park r guilleminault c dement wc rem sleep episodes multple sleep latency test narcoleptic patients electroencephalogr clin neurophysiol 46 479 481 1979crossrefisimedline mitsuma hirooka y mori y kayama m adachi k rhue n ping j nogimori effects orexin thyrotropin releasing hormone thyrotropin secretion rats horm metab res 31 606 609 1999isimedline muraki uzumaki h nakadate kato r involvement alpha 1 adrenergic receptors inhibitory effect catecholamines thyrotropin induced release thyroxine mouse thyroid endocrinology 110 51 54 1982abstract nakamura uramura k nambu yada goto k yanagisawa m sakurai orexin induced hyperlocomotion stereotypy mediated dopaminergic system brain res 873 181 187 2000crossrefisimedline nillni ea vaslet c harris m hollenberg bjorbak c flier js leptin regulates prothyrotropin releasing hormone biosynthesis evidence direct indirect pathways j biol chem 275 36124 36133 2000abstractfree full text nishino okura m mignot e narcolepsy genetic predisposition neuropharmacological mechanisms sleep med rev 4 57 99 2000crossrefisimedline nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000crossrefisimedline niswender kd schwartz mw insulin leptin revisited adiposity signals overlapping physiological intracellular signaling capabilities front neuroendocrinol 24 1 10 2003crossrefisimedline overeem mignot e van dijk jg lammers gj narcolepsy clinical features new pathophysiologic insights future perspectives j clin neurophysiol 18 78 105 2001isimedline parker dc pekary ae hershman jm effect normal reversed sleep wake cycles upon nyctohemeral rhythmicity plasma thyrotropin evidence suggestive inhibitory influence sleep j clin endocrinol metab 43 318 329 1976abstract peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text pincus sm approximate entropy measure system complexity proc natl acad sci usa 88 2297 2301 1991abstractfree full text pincus sm goldberger al physiological time series analysis regularity quantify j physiol heart circ physiol 266 h1643 h1656 1994abstractfree full text pincus sm hartman ml roelfsema f thorner mo veldhuis jd hormone pulsatility discrimination via course short time sampling j physiol endocrinol metab 277 e948 e957 1999abstractfree full text pincus sm mulligan iranmanesh gheorghiu godschalk m veldhuis jd older males secrete luteinizing hormone testosterone irregularly jointly asynchronously younger males proc natl acad sci usa 93 14100 14105 1996abstractfree full text prokai l central nervous system effects thyrotropin releasing hormone analogues opportunities perspectives drug discovery development prog drug res 59 133 169 2002medline rechtschaffen kales manual standardized terminology techniques scoring system sleep stages human subjects los angeles ucla brain information servicebrain research institute 1968 riehl j honda k kwan m hong j mignot e nishino chronic oral administration cg 3703 thyrotropin releasing hormone analog increases wake decreases cataplexy canine narcolepsy neuropsychopharmacol 23 34 45 2000crossrefisimedline roelfsema f pincus sm veldhuis jd patients cushings disease secrete adrenocorticotropin cortisol jointly asynchronously healthy subjects j clin endocrinol metab 83 688 692 1998abstractfree full text romijn ja adriaanse r brabant g prank k endert e wiersinga wm pulsatile secretion thyrotropin fasting decrease thyrotropin pulse amplitude j clin endocrinol metab 70 1631 1636 1990abstract russell sh kim ms small cj abbott cr morgan dg taheri murphy kg todd jf ghatei ma bloom sr central administration orexin suppresses basal domperidone stimulated plasma prolactin j neuroendocrinol 12 1213 1218 2000crossrefisimedline russell sh small cj sunter d morgan dakin cl cohen ma bloom sr chronic intraparaventricular nuclear administration orexin male rats alter thyroid axis uncoupling protein 1 brown adipose tissue regul pept 104 61 68 2002crossrefisimedline sachs c kaijser l autonomic regulation cardiopulmonary functions sleep apnea syndrome narcolepsy sleep 5 227 238 1982isimedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998crossrefisimedline sarkar legradi g lechan rm intracerebroventricular administration alpha melanocyte stimulating hormone increases phosphorylation creb trh crh producing neurons hypothalamic paraventricular nucleus brain res 945 50 59 2002crossrefisimedline scanlon mf toft ad regulation thyrotropin secretion werner ingbars thyroid fundamental clinical text edited braverman le utiger rd philadelphia pa lippincott williams wilkins 2000 p 234 253 veldhuis jd johnson m cluster analysis simple versatile robust algorithm endocrine pulse detection j physiol endocrinol metab 250 e486 e493 1986abstractfree full text veldhuis jd johnson ml deconvolution analysis hormone data methods enzymol 210 539 575 1992isimedline veldhuis jd johnson ml seneta e iranmanesh temporal coupling among luteinizing hormone follicle stimulating hormone beta endorphin cortisol pulse episodes vivo acta endocrinol copenh 126 193 200 1992medline veldhuis jd pincus sm orderliness hormone release patterns complementary measure conventional pulsatile circadian analyses eur j endocrinol 138 358 362 1998free full text article abstract full text pdf versions article 2885e892 recent 003272004v1 alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager search citing articles isi web science 1 google scholar articles kok w articles pijl h articles citing article pubmed pubmed citation articles kok w articles pijl h
0.44176623.15625087.html.plaintext.txt	80	references top abstract methods results discussion references allan js czeisler ca persistence circadian thyrotropin rhythm constant conditions light induced shifts circadian phase j clin endocrinol metab 79 508 512 1994abstract blake ng johnson mr eckland dj foster oj lightman sl effect food deprivation altered thyroid status hypothalamic pituitary thyroid axis rat j endocrinol 133 183 188 1992abstract buxton om frank sa lhermite baleriaux m leproult r turek fw van cauter e roles intensity duration nocturnal exercise causing phase delays human circadian rhythms j physiol endocrinol metab 273 e536 e542 1997abstractfree full text cai xj widdowson ps harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g hypothalamic orexin expression modulation blood glucose feeding diabetes 48 2132 2137 1999abstract cleveland ws robust locally weighted regression smoothing scatter plots j stat assoc 74 829 836 1979isi cooper ds klibanski ridgway ec dopaminergic modulation tsh subunits vivo vitro studies clin endocrinol oxf 18 265 275 1983isimedline date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m orexins orexigenic hypothalamic peptides interact autonomic neuroendocrine neuroregulatory systems proc natl acad sci usa 96 748 753 1999abstractfree full text de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn van den pol bloom fe gautvik km sutcliffe jg hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95 322 327 1998abstractfree full text eisensehr linke r tatsch k von lindeiner h kharraz b gildehaus fj eberle r pollmacher schuld noachtar alteration striatal dopaminergic system human narcolepsy neurology 60 1817 1819 2003abstractfree full text fekete c kelly j mihaly e sarkar rand wm legradi g emerson ch lechan rm neuropeptide y central inhibitory action hypothalamic pituitary thyroid axis endocrinology 142 2606 2613 2001abstractfree full text fekete c legradi g mihaly e huang qh tatro jb rand wm emerson ch lechan rm alpha melanocyte stimulating hormone contained nerve terminals innervating thyrotropin releasing hormone synthesizing neurons hypothalamic paraventricular nucleus prevents fasting induced suppression prothyrotropin releasing hormone gene expression j neurosci 20 1550 1558 2000abstractfree full text fekete c mihaly e luo lg kelly j clausen jt mao q rand wm moss lg kuhar m emerson ch jackson im lechan rm association cocaine amphetamine regulated transcript immunoreactive elements thyrotropin releasing hormone synthesizing neurons hypothalamic paraventricular nucleus role regulation hypothalamic pituitary thyroid axis fasting j neurosci 20 9224 9234 2000abstractfree full text flier js harris m hollenberg leptin nutrition thyroid wherefore wiring j clin invest 105 859 861 2000free full text foord sm peters j scanlon mf rees sb hall r dopaminergic control tsh secretion isolated rat pituitary cells febs lett 121 257 259 1980crossrefisimedline gershengorn mc osman r molecular cellular biology thyrotropin releasing hormone receptors physiol rev 76 175 191 1996abstractfree full text hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text hirschfeld u moreno reyes r akseki e lhermite baleriaux m leproult r copinschi g van cauter e progressive elevation plasma thyrotropin adaptation simulated jet lag effects treatment bright light zolpidem j clin endocrinol metab 81 3270 3277 1996abstract jackson im thyrotropin releasing hormone n engl j med 306 145 155 1982isimedline jin l zhang burguera bg couce osamura ry kulig e lloyd rv leptin leptin receptor expression rat mouse pituitary cells endocrinology 141 333 339 2000abstractfree full text jones dn gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp johns porter ra hagan jj hunter aj upton n effects centrally administered orexin b orexin role orexin 1 receptors orexin b induced hyperactivity psychopharmacology berl 153 210 218 2001crossrefisimedline kim ms small cj stanley sa morgan dg seal lj kong wm edwards cm abusnana sunter d ghatei ma bloom sr central melanocortin system affects hypothalamo pituitary thyroid axis may mediate effect leptin j clin invest 105 1005 1011 2000abstractfree full text kok sw meinders ae overeem lammers gj roelfsema f frolich m pijl h reduction plasma leptin levels loss circadian rhythmicity hypocretin orexin deficient narcoleptic humans j clin endocrinol metab 87 805 809 2002abstractfree full text kok sw overeem visscher tl lammers gj seidell jc pijl h meinders ae hypocretin deficiency narcoleptic humans associated abdominal obesity obes res 11 1147 1154 2003abstractfree full text lechan rm jackson im immunohistochemical localization thyrotropin releasing hormone rat hypothalamus pituitary endocrinology 111 55 65 1982abstract legradi g lechan rm arcuate nucleus major source neuropeptide y innervation thyrotropin releasing hormone neurons hypothalamic paraventricular nucleus endocrinology 139 3262 3270 1998abstractfree full text legradi g lechan rm agouti related protein containing nerve terminals innervate thyrotropin releasing hormone neurons hypothalamic paraventricular nucleus endocrinology 140 3643 3652 1999abstractfree full text lewis bm dieguez c lewis md scanlon mf dopamine stimulates release thyrotrophin releasing hormone perfused intact rat hypothalamus via hypothalamic d2 receptors j endocrinol 115 419 424 1987abstract lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999crossrefisimedline lloyd rl pekary ae sattin amundson antidepressant effects thyrotropin releasing hormone analogues using rodent model depression pharmacol biochem behav 70 15 22 2001crossrefisimedline maayan ml sellitto rv volpert em dopamine l dopa inhibition thyrotropin stimulated thyroidal thyroxine release endocrinology 118 632 636 1986abstract mantzoros cs ozata m negrao ab suchard ma ziotopoulou m caglayan elashoff rm cogswell rj negro p liberty v wong ml veldhuis j ozdemir ic gold pw flier js licinio j synchronicity frequently sampled thyrotropin tsh leptin concentrations healthy adults leptin deficient subjects evidence possible partial tsh regulation leptin humans j clin endocrinol metab 86 3284 3291 2001abstractfree full text mignot e genetic familial aspects narcolepsy neurology 50 s16 s22 1998isimedline mitler mm van den hoed j carskadon ma richardson g park r guilleminault c dement wc rem sleep episodes multple sleep latency test narcoleptic patients electroencephalogr clin neurophysiol 46 479 481 1979crossrefisimedline mitsuma hirooka y mori y kayama m adachi k rhue n ping j nogimori effects orexin thyrotropin releasing hormone thyrotropin secretion rats horm metab res 31 606 609 1999isimedline muraki uzumaki h nakadate kato r involvement alpha 1 adrenergic receptors inhibitory effect catecholamines thyrotropin induced release thyroxine mouse thyroid endocrinology 110 51 54 1982abstract nakamura uramura k nambu yada goto k yanagisawa m sakurai orexin induced hyperlocomotion stereotypy mediated dopaminergic system brain res 873 181 187 2000crossrefisimedline nillni ea vaslet c harris m hollenberg bjorbak c flier js leptin regulates prothyrotropin releasing hormone biosynthesis evidence direct indirect pathways j biol chem 275 36124 36133 2000abstractfree full text nishino okura m mignot e narcolepsy genetic predisposition neuropharmacological mechanisms sleep med rev 4 57 99 2000crossrefisimedline nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000crossrefisimedline niswender kd schwartz mw insulin leptin revisited adiposity signals overlapping physiological intracellular signaling capabilities front neuroendocrinol 24 1 10 2003crossrefisimedline overeem mignot e van dijk jg lammers gj narcolepsy clinical features new pathophysiologic insights future perspectives j clin neurophysiol 18 78 105 2001isimedline parker dc pekary ae hershman jm effect normal reversed sleep wake cycles upon nyctohemeral rhythmicity plasma thyrotropin evidence suggestive inhibitory influence sleep j clin endocrinol metab 43 318 329 1976abstract peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text pincus sm approximate entropy measure system complexity proc natl acad sci usa 88 2297 2301 1991abstractfree full text pincus sm goldberger al physiological time series analysis regularity quantify j physiol heart circ physiol 266 h1643 h1656 1994abstractfree full text pincus sm hartman ml roelfsema f thorner mo veldhuis jd hormone pulsatility discrimination via course short time sampling j physiol endocrinol metab 277 e948 e957 1999abstractfree full text pincus sm mulligan iranmanesh gheorghiu godschalk m veldhuis jd older males secrete luteinizing hormone testosterone irregularly jointly asynchronously younger males proc natl acad sci usa 93 14100 14105 1996abstractfree full text prokai l central nervous system effects thyrotropin releasing hormone analogues opportunities perspectives drug discovery development prog drug res 59 133 169 2002medline rechtschaffen kales manual standardized terminology techniques scoring system sleep stages human subjects los angeles ucla brain information servicebrain research institute 1968 riehl j honda k kwan m hong j mignot e nishino chronic oral administration cg 3703 thyrotropin releasing hormone analog increases wake decreases cataplexy canine narcolepsy neuropsychopharmacol 23 34 45 2000crossrefisimedline roelfsema f pincus sm veldhuis jd patients cushings disease secrete adrenocorticotropin cortisol jointly asynchronously healthy subjects j clin endocrinol metab 83 688 692 1998abstractfree full text romijn ja adriaanse r brabant g prank k endert e wiersinga wm pulsatile secretion thyrotropin fasting decrease thyrotropin pulse amplitude j clin endocrinol metab 70 1631 1636 1990abstract russell sh kim ms small cj abbott cr morgan dg taheri murphy kg todd jf ghatei ma bloom sr central administration orexin suppresses basal domperidone stimulated plasma prolactin j neuroendocrinol 12 1213 1218 2000crossrefisimedline russell sh small cj sunter d morgan dakin cl cohen ma bloom sr chronic intraparaventricular nuclear administration orexin male rats alter thyroid axis uncoupling protein 1 brown adipose tissue regul pept 104 61 68 2002crossrefisimedline sachs c kaijser l autonomic regulation cardiopulmonary functions sleep apnea syndrome narcolepsy sleep 5 227 238 1982isimedline sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998crossrefisimedline sarkar legradi g lechan rm intracerebroventricular administration alpha melanocyte stimulating hormone increases phosphorylation creb trh crh producing neurons hypothalamic paraventricular nucleus brain res 945 50 59 2002crossrefisimedline scanlon mf toft ad regulation thyrotropin secretion werner ingbars thyroid fundamental clinical text edited braverman le utiger rd philadelphia pa lippincott williams wilkins 2000 p 234 253 veldhuis jd johnson m cluster analysis simple versatile robust algorithm endocrine pulse detection j physiol endocrinol metab 250 e486 e493 1986abstractfree full text veldhuis jd johnson ml deconvolution analysis hormone data methods enzymol 210 539 575 1992isimedline veldhuis jd johnson ml seneta e iranmanesh temporal coupling among luteinizing hormone follicle stimulating hormone beta endorphin cortisol pulse episodes vivo acta endocrinol copenh 126 193 200 1992medline veldhuis jd pincus sm orderliness hormone release patterns complementary measure conventional pulsatile circadian analyses eur j endocrinol 138 358 362 1998free full text article abstract full text pdf versions article 2885e892 recent 003272004v1 alert article cited alert correction posted citation map services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal download citation manager search citing articles isi web science 1 google scholar articles kok w articles pijl h articles citing article pubmed pubmed citation articles kok w articles pijl h
0.44176623.15625087.html.plaintext.txt	81	home help feedback subscriptions archive search table contents visit aps journals online copyright 2005 american physiological society
0.5774776.12453828.html.plaintext.txt	0	somatotropic axis hypocretin deficient narcoleptic humans altered circadian distribution gh secretory events sebastiaan overeem1 simon w kok2 gert jan lammers1 alla vein1 marijke frolich2 arend e meinders2 ferdinand roelfsema3 hanno pijl2
0.5774776.12453828.html.plaintext.txt	1	somatotropic axis hypocretin deficient narcoleptic humans altered circadian distribution gh secretory events sebastiaan overeem1 simon w kok2 gert jan lammers1 alla vein1 marijke frolich2 arend e meinders2 ferdinand roelfsema3 hanno pijl2
0.5774776.12453828.html.plaintext.txt	2	1 department neurology clinical neurophysiology 2 department general internal medicine 3 department endocrinology leiden university medical center 2300 rc leiden netherlands
0.5774776.12453828.html.plaintext.txt	3	abstract top abstract introduction methods results discussion references
0.5774776.12453828.html.plaintext.txt	4	narcolepsy sleep disorder caused impaired hypocretin orexin neurotransmission growth hormone gh secretion may altered narcolepsy various reasons slow wave sleep episodes closely associated gh secretory events randomly dispersed 24 h narcoleptics furthermore hypocretins may inhibit pituitary gh release assessed function somatotropic axis narcolepsy deconvolving 24 h 10 min sampling interval plasma gh concentration profiles seven hypocretin deficient narcoleptic patients seven healthy controls matched age sex body weight basal pulsatile gh secretion rate secretagogue induced gh release similar patients controls however narcoleptics secreted 50 total production daytime whereas controls secreted 25 day also gh output pattern narcoleptics significantly less regular propose hypocretin deficiency disrupts circadian distribution hypothalamic gh releasing hormone release narcoleptic patients simultaneously cause daytime gh release promote propensity fall asleep day
0.5774776.12453828.html.plaintext.txt	5	narcolepsy sleep disorder caused impaired hypocretin orexin neurotransmission growth hormone gh secretion may altered narcolepsy various reasons slow wave sleep episodes closely associated gh secretory events randomly dispersed 24 h narcoleptics furthermore hypocretins may inhibit pituitary gh release assessed function somatotropic axis narcolepsy deconvolving 24 h 10 min sampling interval plasma gh concentration profiles seven hypocretin deficient narcoleptic patients seven healthy controls matched age sex body weight basal pulsatile gh secretion rate secretagogue induced gh release similar patients controls however narcoleptics secreted 50 total production daytime whereas controls secreted 25 day also gh output pattern narcoleptics significantly less regular propose hypocretin deficiency disrupts circadian distribution hypothalamic gh releasing hormone release narcoleptic patients simultaneously cause daytime gh release promote propensity fall asleep day
0.5774776.12453828.html.plaintext.txt	6	introduction top abstract introduction methods results discussion references
0.5774776.12453828.html.plaintext.txt	7	narcolepsy primarily affects organization regulation sleep wakefulness main symptoms excessive daytime sleepiness cataplexy fragmented nocturnal sleep 20 narcolepsy caused disruption hypocretin orexin mediated neurotransmission 7 16 21 vast majority human patients lack hypocretin cerebrospinal fluid csf 17 18 28 autoimmune mediated destruction hypocretin neurons currently presumed principal cause narcolepsy humans 21 30
0.5774776.12453828.html.plaintext.txt	8	narcolepsy primarily affects organization regulation sleep wakefulness main symptoms excessive daytime sleepiness cataplexy fragmented nocturnal sleep 20 narcolepsy caused disruption hypocretin orexin mediated neurotransmission 7 16 21 vast majority human patients lack hypocretin cerebrospinal fluid csf 17 18 28 autoimmune mediated destruction hypocretin neurons currently presumed principal cause narcolepsy humans 21 30
0.5774776.12453828.html.plaintext.txt	9	sleep activity somatotropic axis intimately related 33 particular slow wave sleep sws associated pituitary growth hormone gh release healthy individuals major gh secretory event occurs often shortly sleep onset close temporal association first period sws conversely sleep deprivation consistently associated reduction circulating gh levels age related decline sws accompanied marked decrease gh secretion 32
0.5774776.12453828.html.plaintext.txt	10	sleep activity somatotropic axis intimately related 33 particular slow wave sleep sws associated pituitary growth hormone gh release healthy individuals major gh secretory event occurs often shortly sleep onset close temporal association first period sws conversely sleep deprivation consistently associated reduction circulating gh levels age related decline sws accompanied marked decrease gh secretion 32
0.5774776.12453828.html.plaintext.txt	11	sws episodes randomly distributed 24 h narcoleptic patients healthy subjects 5 6 circadian distribution gh secretory events may altered hypocretin deficient narcoleptic humans moreover intracerebroventricular injection hypocretin 1 causes dose dependent reduction plasma gh rats 13 hypocretin deficiency may exert direct excitatory effect gh release narcoleptics
0.5774776.12453828.html.plaintext.txt	12	sws episodes randomly distributed 24 h narcoleptic patients healthy subjects 5 6 circadian distribution gh secretory events may altered hypocretin deficient narcoleptic humans moreover intracerebroventricular injection hypocretin 1 causes dose dependent reduction plasma gh rats 13 hypocretin deficiency may exert direct excitatory effect gh release narcoleptics
0.5774776.12453828.html.plaintext.txt	13	limited number studies assessed status somatotropic axis narcoleptic humans general studies suggested rise plasma gh concentrations around sleep onset markedly dampened even absent narcolepsy 2 8 15 hypothesized intrinsic disturbance sws andor frequent occurrence sleep onset rapid eye movement rem periods underlies alterations gh secretion narcoleptic humans 33 however interpretation data obtained early studies hampered methodological imperfections particularly respect selection control subjects eg matched age andor body mass index bmi moreover course time novel analytical techniques deconvolution approximate entropy apen developed allow estimation pituitary gh secretion rate quantification orderliness release process basis frequently sampled plasma gh concentration time series 24 34 38
0.5774776.12453828.html.plaintext.txt	14	limited number studies assessed status somatotropic axis narcoleptic humans general studies suggested rise plasma gh concentrations around sleep onset markedly dampened even absent narcolepsy 2 8 15 hypothesized intrinsic disturbance sws andor frequent occurrence sleep onset rapid eye movement rem periods underlies alterations gh secretion narcoleptic humans 33 however interpretation data obtained early studies hampered methodological imperfections particularly respect selection control subjects eg matched age andor body mass index bmi moreover course time novel analytical techniques deconvolution approximate entropy apen developed allow estimation pituitary gh secretion rate quantification orderliness release process basis frequently sampled plasma gh concentration time series 24 34 38
0.5774776.12453828.html.plaintext.txt	15	evaluate impact disturbance circadian slow wave sleep distribution andor hypocretin deficiency various features pulsatile gh secretion humans deconvolved 24 h plasma gh concentration profiles narcoleptic patients healthy controls matched age sex bmi specifically hypothesized circadian distribution peaks troughs plasma gh concentrations would disrupted total daily gh production would increased narcoleptic patients
0.5774776.12453828.html.plaintext.txt	16	evaluate impact disturbance circadian slow wave sleep distribution andor hypocretin deficiency various features pulsatile gh secretion humans deconvolved 24 h plasma gh concentration profiles narcoleptic patients healthy controls matched age sex bmi specifically hypothesized circadian distribution peaks troughs plasma gh concentrations would disrupted total daily gh production would increased narcoleptic patients
0.5774776.12453828.html.plaintext.txt	17	methods top abstract introduction methods results discussion references
0.5774776.12453828.html.plaintext.txt	18	subjects included seven male patients outpatient clinic department neurology physician experienced narcolepsy g j lammers made clinical diagnosis narcolepsy cataplexy diagnosis confirmed multiple sleep latency testing showed results typical narcolepsy 1 patients hla dqb10602 positive confirmed patients hypocretin deficient hypocretin 1 undetectable csf direct radioimmunoassay ria previously described 28 subjects except three two using psychostimulants one using clomipramine discontinued medication 2 wk study free medication
0.5774776.12453828.html.plaintext.txt	19	weight height subjects measured well waist hip circumference waist halfway lowest rib crista iliaca hip maximum circumference standing position waist hip ratio whr used relative measure abdominal fat mass total body fat mass determined dual energy x ray absorptiometry hologic qdr4500 waltham ma 3
0.5774776.12453828.html.plaintext.txt	20	weight height subjects measured well waist hip circumference waist halfway lowest rib crista iliaca hip maximum circumference standing position waist hip ratio whr used relative measure abdominal fat mass total body fat mass determined dual energy x ray absorptiometry hologic qdr4500 waltham ma 3
0.5774776.12453828.html.plaintext.txt	21	recruited seven male control subjects advertisements local newspapers controls matched age bmi total fat mass whr controls take medication history sleep disorders
0.5774776.12453828.html.plaintext.txt	22	recruited seven male control subjects advertisements local newspapers controls matched age bmi total fat mass whr controls take medication history sleep disorders
0.5774776.12453828.html.plaintext.txt	23	subjects eligible study exclusion hypertension defined repeated blood pressure measurement showing systolic pressure 140 mmhg diastolic pressure 90 mmhg known history endocrine disease recent weight change 3 kg weight gain loss within last 3 mo fasting blood glucose 70 mmoll
0.5774776.12453828.html.plaintext.txt	24	study protocol approved medical ethics committee leiden university medical center subjects gave written informed consent participate
0.5774776.12453828.html.plaintext.txt	25	study protocol approved medical ethics committee leiden university medical center subjects gave written informed consent participate
0.5774776.12453828.html.plaintext.txt	26	experimental protocol investigations performed clinical research center crc department general internal medicine subjects admitted crc prepared sleep registration 24 h study occasion three standardized meals served 0900 1300 1800 nutridrink 15 kcalml 1500 1800 kcalday macronutrient composition per 100 ml 5 g protein 65 g fat 179 g carbohydrate nutricia zoetermeer netherlands subjects remained sedentary throughout study except bathroom visits lights switched 2300
0.5774776.12453828.html.plaintext.txt	27	intravenous cannula inserted antecubital vein 1 h start blood sampling blood samples taken three way stopcock attached extended line prevent sleep disturbances manipulations investigators catheter kept patent 09 nacl heparin 1 uml drip 500 ml24 h blood collected monovetten tubes sarstedt etten leur netherlands 10 min intervals 24 h allowed clot centrifuged 4 degrees c 20 min within hour collection serum frozen 20 degrees c assays performed serum igf igf binding protein 3 igfbp 3 concentrations measured early morning sample
0.5774776.12453828.html.plaintext.txt	28	intravenous cannula inserted antecubital vein 1 h start blood sampling blood samples taken three way stopcock attached extended line prevent sleep disturbances manipulations investigators catheter kept patent 09 nacl heparin 1 uml drip 500 ml24 h blood collected monovetten tubes sarstedt etten leur netherlands 10 min intervals 24 h allowed clot centrifuged 4 degrees c 20 min within hour collection serum frozen 20 degrees c assays performed serum igf igf binding protein 3 igfbp 3 concentrations measured early morning sample
0.5774776.12453828.html.plaintext.txt	29	24 h sampling procedure 0900 next morning 50 microg gh releasing hormone ghrh given intravenous bolus serum gh concentrations measured blood samples taken every 10 min 90 min bolus injection 31
0.5774776.12453828.html.plaintext.txt	30	assays serum gh concentrations measured using sensitive time resolved immunofluorometric assay wallac turku finland assay specific 22 kda gh isoform human biosynthetic gh pharmacia uppsala sweden diluted bovine calf serum used standard calibrated world health organization first international reference preparation 80 505 1 microg 26 mu detection limit assay defined value 2 sd mean value zero standard 003 mul interassay coefficients variation varied 27 82 gh concentration range 01 100 mul samples one subject measured assay total serum igf igfbp 3 concentrations measured ria previously described 23
0.5774776.12453828.html.plaintext.txt	31	sleep recording analysis 24 h sampling procedure sleep recorded polygraphically using porti 5 ambulant electroencephalogram recording system twente medical systems international enschede netherlands scored eeg 2100 review software nihon kohden tokyo japan experienced technician blinded subject study visually scored sleep recordings 30 epochs means standardized criteria 27 nocturnal sleep onset identified first epoch stages ii iii iv rem sleep lights provided subsequent interval scored wake sleep period defined time sleep onset final awakening morning sleep efficiency calculated percentage sleep period actually spent asleep
0.5774776.12453828.html.plaintext.txt	32	data analysis gh time series used multiple parameter deconvolution analysis estimate various specific measures pulsatile secretion half life basis simultaneous consideration serum hormone concentrations dose dependent intrasample variances 35 37 results expressed milliunits per liter distribution volume muld following parameters estimated gh series number secretory bursts secretory burst half duration duration half maximal amplitude burst amplitude mean mass secreted per burst hormone half life pulsatile secretion rate basal secretion rate total secretion per 24 h furthermore quantified amount gh secreted 0900 2300 2300 0900 3 h sleep onset first secretory burst sleep onset
0.5774776.12453828.html.plaintext.txt	33	quantified minute minute regularity serial orderliness gh secretion use apen statistic scale model independent metric 24 apen estimates regularity subordinate nonpulsatile patterns data yields information complementary deconvolution techniques 25 39 greater regularity yields smaller apen values whereas greater independence among sequential values time series yields larger apen values applied normalized apen parameters m 1 r 20 intraseries sd previously validated gh series length 26 apen ratio delineates orderliness concentration time series compared apen score associated maximal randomness time series estimated computer simulation thus apen ratio equal 1 reflects maximal randomness time series study smaller apen ratios denote greater regularity
0.5774776.12453828.html.plaintext.txt	34	quantified minute minute regularity serial orderliness gh secretion use apen statistic scale model independent metric 24 apen estimates regularity subordinate nonpulsatile patterns data yields information complementary deconvolution techniques 25 39 greater regularity yields smaller apen values whereas greater independence among sequential values time series yields larger apen values applied normalized apen parameters m 1 r 20 intraseries sd previously validated gh series length 26 apen ratio delineates orderliness concentration time series compared apen score associated maximal randomness time series estimated computer simulation thus apen ratio equal 1 reflects maximal randomness time series study smaller apen ratios denote greater regularity
0.5774776.12453828.html.plaintext.txt	35	gh release response ghrh injection determined using deconvolution analysis see
0.5774776.12453828.html.plaintext.txt	36	unless otherwise stated results expressed means plus minus se median values shown parentheses comparisons made using unpaired two tailed students test log transformation gh concentrationsecretion data differences groups considered significant p 005 statistical calculations performed using spss windows release 90 systat release 10 spss chicago il
0.5774776.12453828.html.plaintext.txt	37	unless otherwise stated results expressed means plus minus se median values shown parentheses comparisons made using unpaired two tailed students test log transformation gh concentrationsecretion data differences groups considered significant p 005 statistical calculations performed using spss windows release 90 systat release 10 spss chicago il
0.5774776.12453828.html.plaintext.txt	38	results top abstract introduction methods results discussion references
0.5774776.12453828.html.plaintext.txt	39	subject characteristics clinical characteristics subjects study shown table 1 note mean bmi subjects overweight range ie 25 30 kgm2 expected narcoleptic patients 8 participants well matched anthropometric variables potentially influencing gh secretion including bmi body composition
0.5774776.12453828.html.plaintext.txt	40	view table table 1 clinical characteristics study subjects
0.5774776.12453828.html.plaintext.txt	41	view table table 1 clinical characteristics study subjects
0.5774776.12453828.html.plaintext.txt	42	sleep analysis duration sleep period differ patients 405 plus minus 30 min controls 383 plus minus 41 min p 067 groups relatively low sleep efficiency narcolepsy 64 plus minus 64 controls 72 plus minus 49 p 041 resulting 263 plus minus 32 min nocturnal sleep patients 274 plus minus 36 min controls p 082 however relative amount nocturnal stage sleep 50 higher narcoleptics 218 plus minus 25 vs 145 plus minus 17 p 004 suggests fragmented nocturnal sleep amount sws night differ patients controls 251 plus minus 93 vs 224 plus minus 69 min p 082 none control subjects slept daytime contrast narcoleptics took least two daytime naps average 33 naps average 148 plus minus 61 min daytime sleep episodes spent sws 404 plus minus 41 min spent rem sleep
0.5774776.12453828.html.plaintext.txt	43	gh secretion figure 1 illustrates 24 h sleep pattern patient individual control together concomitant serum gh concentration profiles deconvolution based estimates gh secretion rates 24 h mean serum concentration gh significantly different narcoleptic patients controls 135 plus minus 042 mul vs 086 plus minus 021 mul respectively p 031 likewise serum igf igfbp 3 concentrations differ groups data shown
0.5774776.12453828.html.plaintext.txt	44	view larger version 19k fig 1 example 24 h growth hormone gh profiles narcoleptic patient 31 yr old individual control 33 yr old b plotted top bottom hypnogram pattern wakefulness sleep stages serum gh concentration conc mul 10 min intervals gh secretory rate secr mu l1 min1 estimated multiparameter deconvolution note occurrence 3 daytime naps patient
0.5774776.12453828.html.plaintext.txt	45	deconvolution derived 24 h gh secretion parameters summarized table 2 patients narcolepsy differ controls respect basal secretion rate total number gh peaks peak amplitude area consequently total production gh different two groups fig 2 however distribution gh secretory events 24 h differed considerably groups narcoleptics secreted almost one half total pulsatile production day whereas controls produced one quarter day pulsatile release daytime fraction total pulsatile release 048 plus minus 005 vs 026 plus minus 005 respectively p 001
0.5774776.12453828.html.plaintext.txt	46	deconvolution derived 24 h gh secretion parameters summarized table 2 patients narcolepsy differ controls respect basal secretion rate total number gh peaks peak amplitude area consequently total production gh different two groups fig 2 however distribution gh secretory events 24 h differed considerably groups narcoleptics secreted almost one half total pulsatile production day whereas controls produced one quarter day pulsatile release daytime fraction total pulsatile release 048 plus minus 005 vs 026 plus minus 005 respectively p 001
0.5774776.12453828.html.plaintext.txt	47	view table table 2 secretory parameters 24 h serum gh narcolepsy patients controls
0.5774776.12453828.html.plaintext.txt	48	view table table 2 secretory parameters 24 h serum gh narcolepsy patients controls
0.5774776.12453828.html.plaintext.txt	49	view larger version 9k fig 2 total 24 h gh secretion patients controls ld liter distribution volume individual levels shown together mean value
0.5774776.12453828.html.plaintext.txt	50	sleep onset gh secretion assessed determination gh production first 3 h sleep quantifying first gh pulse sleep onset narcoleptics controls secreted approximately one third total 24 h gh production first 3 h sleep 291 plus minus 48 vs 260 plus minus 81 p 034 amount secreted first secretory event sleep onset also similar groups 100 plus minus 39 vs 103 plus minus 69 muld p 048
0.5774776.12453828.html.plaintext.txt	51	sleep onset gh secretion assessed determination gh production first 3 h sleep quantifying first gh pulse sleep onset narcoleptics controls secreted approximately one third total 24 h gh production first 3 h sleep 291 plus minus 48 vs 260 plus minus 81 p 034 amount secreted first secretory event sleep onset also similar groups 100 plus minus 39 vs 103 plus minus 69 muld p 048
0.5774776.12453828.html.plaintext.txt	52	total amount gh released per day strongly correlated total 24 h amount sws controls r2 069 p 002 fig 3 relationship remained intact narcoleptics r2 074 p 001 fig 3 contrast gh release correlated total amount rem sleep either group r2 044 p 02 r2 036 p 01 narcoleptics controls respectively
0.5774776.12453828.html.plaintext.txt	53	view larger version 19k fig 3 correlation total amount slow wave sleep 24 h total gh secretion patients controls groups combined slopes regression lines significantly different groups
0.5774776.12453828.html.plaintext.txt	54	gh secretion pattern less orderly narcoleptic patients may reflect disruption ghrh feedforward inputs see discussion apen120 values 059 plus minus 008 vs 036 plus minus 003 p 002 apen ratio 047 plus minus 004 vs 037 plus minus 001 p 003 increased patient group reflecting decrease serial orderliness gh secretion
0.5774776.12453828.html.plaintext.txt	55	gh secretion pattern less orderly narcoleptic patients may reflect disruption ghrh feedforward inputs see discussion apen120 values 059 plus minus 008 vs 036 plus minus 003 p 002 apen ratio 047 plus minus 004 vs 037 plus minus 001 p 003 increased patient group reflecting decrease serial orderliness gh secretion
0.5774776.12453828.html.plaintext.txt	56	narcoleptic patients responded ghrh injection secreting amounts gh similar control subjects use multiparameter deconvolution gh secretion ghrh injection calculated 565 plus minus 234 median 345 502 plus minus 114 median 489 muld patients controls respectively p 072
0.5774776.12453828.html.plaintext.txt	57	narcoleptic patients responded ghrh injection secreting amounts gh similar control subjects use multiparameter deconvolution gh secretion ghrh injection calculated 565 plus minus 234 median 345 502 plus minus 114 median 489 muld patients controls respectively p 072
0.5774776.12453828.html.plaintext.txt	58	discussion top abstract introduction methods results discussion references
0.5774776.12453828.html.plaintext.txt	59	assessed 24 h sleep patterns gh secretion profiles conjointly well defined group narcoleptic patients controls matched various confounding variables patients several daytime naps including sws episodes whereas sleep confined nighttime controls total daily gh production strongly correlated total time sws narcoleptic patients controls alike fig 3 result dispersion gh secretory events slow wave sleep epochs 24 h altered concomitantly narcoleptics secreted larger fraction total gh production day 48 vs 26 controls gh output pattern significantly less regular narcoleptic patients expectations basal pulsatile gh production secretagogue induced gh release similar patients controls fig 2
0.5774776.12453828.html.plaintext.txt	60	assessed 24 h sleep patterns gh secretion profiles conjointly well defined group narcoleptic patients controls matched various confounding variables patients several daytime naps including sws episodes whereas sleep confined nighttime controls total daily gh production strongly correlated total time sws narcoleptic patients controls alike fig 3 result dispersion gh secretory events slow wave sleep epochs 24 h altered concomitantly narcoleptics secreted larger fraction total gh production day 48 vs 26 controls gh output pattern significantly less regular narcoleptic patients expectations basal pulsatile gh production secretagogue induced gh release similar patients controls fig 2
0.5774776.12453828.html.plaintext.txt	61	previous studies examined plasma gh concentrations patients narcolepsy results studies generally suggested gh release spontaneous 24 h secretagogue induced blunted narcoleptics 2 8 15 however interpretation data obtained studies hampered potential imperfections regarding selection control subjects example two studies 2 15 body weight participants reported third study 8 include healthy control subjects know narcoleptic patients tend obese 9 gh production profoundly reduced abdominally obese humans 23 36 also age reported two studies 2 15 one 15 narcoleptic patients 10 yr older controls 32 vs 24 yr may also biased results 32 present study control subjects carefully matched respect age sex bmi body fat distribution preclude analogous bias therefore believe data presented present paper conclusive previous study whether narcolepsy per se impacts gh secretion moreover narcoleptic patients present study confirmed hypocretin deficient possible determine previous studies hypocretin peptides unknown time thus present data pertain specifically hypocretin deficient narcoleptic humans results clearly argue reduction spontaneous secretagogue induced gh secretion human narcolepsy
0.5774776.12453828.html.plaintext.txt	62	previous studies examined plasma gh concentrations patients narcolepsy results studies generally suggested gh release spontaneous 24 h secretagogue induced blunted narcoleptics 2 8 15 however interpretation data obtained studies hampered potential imperfections regarding selection control subjects example two studies 2 15 body weight participants reported third study 8 include healthy control subjects know narcoleptic patients tend obese 9 gh production profoundly reduced abdominally obese humans 23 36 also age reported two studies 2 15 one 15 narcoleptic patients 10 yr older controls 32 vs 24 yr may also biased results 32 present study control subjects carefully matched respect age sex bmi body fat distribution preclude analogous bias therefore believe data presented present paper conclusive previous study whether narcolepsy per se impacts gh secretion moreover narcoleptic patients present study confirmed hypocretin deficient possible determine previous studies hypocretin peptides unknown time thus present data pertain specifically hypocretin deficient narcoleptic humans results clearly argue reduction spontaneous secretagogue induced gh secretion human narcolepsy
0.5774776.12453828.html.plaintext.txt	63	learn regulation gh secretion sleep results study first onset nocturnal sleep remains important correlate gh release even numerous naps interrupted daytime wakefulness narcoleptics controls 30 total daily gh secretion occurred 3 h nocturnal sleep onset second relationship sws gh release remains robust even sleep fragmented randomly dispersed 24 h strong positive highly significant correlation variables observed narcoleptics controls third dispersion gh secretory events sleep epochs 24 h appears altered analogously narcoleptic patients slow wave sleep time gh secretion day finally endogenous hypocretins significantly impact amount gh produced daily humans
0.5774776.12453828.html.plaintext.txt	64	learn regulation gh secretion sleep results study first onset nocturnal sleep remains important correlate gh release even numerous naps interrupted daytime wakefulness narcoleptics controls 30 total daily gh secretion occurred 3 h nocturnal sleep onset second relationship sws gh release remains robust even sleep fragmented randomly dispersed 24 h strong positive highly significant correlation variables observed narcoleptics controls third dispersion gh secretory events sleep epochs 24 h appears altered analogously narcoleptic patients slow wave sleep time gh secretion day finally endogenous hypocretins significantly impact amount gh produced daily humans
0.5774776.12453828.html.plaintext.txt	65	hypocretin peptides hypocretin 1 2 also known orexin b produced exclusively small number neurons located perifornical area hypothalamus 10 29 hypocretin neurons connect nuclei within hypothalamus including arcuate nucleus pituitary 22 explain impact energy balance several neuroendocrine ensembles reviews see refs 20 41 intracerebroventricular administration hypocretin 1 causes dose dependent decrease plasma gh rats 13 furthermore recently reported somatotropic cells human pituitary express hypocretin receptor 1 4 data suggest hypocretins directly blunt gh secretion therefore hypothesized hypocretin deficiency would enhance total daily gh production narcoleptic humans results support contention narcoleptic patients produced normal total amounts gh fig 2 however believe data support thesis hypocretin deficiency disrupts circadian dispersion hypothalamic ghrh release normally confines sleep gh secretion night
0.5774776.12453828.html.plaintext.txt	66	hypocretin peptides hypocretin 1 2 also known orexin b produced exclusively small number neurons located perifornical area hypothalamus 10 29 hypocretin neurons connect nuclei within hypothalamus including arcuate nucleus pituitary 22 explain impact energy balance several neuroendocrine ensembles reviews see refs 20 41 intracerebroventricular administration hypocretin 1 causes dose dependent decrease plasma gh rats 13 furthermore recently reported somatotropic cells human pituitary express hypocretin receptor 1 4 data suggest hypocretins directly blunt gh secretion therefore hypothesized hypocretin deficiency would enhance total daily gh production narcoleptic humans results support contention narcoleptic patients produced normal total amounts gh fig 2 however believe data support thesis hypocretin deficiency disrupts circadian dispersion hypothalamic ghrh release normally confines sleep gh secretion night
0.5774776.12453828.html.plaintext.txt	67	sleep activity somatotropic axis intimately related 33 reproducible gh secretory event humans occurs around nocturnal sleep onset close temporal association first epoch sws see ref 33 secretion gh controlled mainly two hypothalamic peptides ghrh somatostatin 12 14 large body evidence suggests ghrh simultaneously promotes sleep gh release explain consistent association sleep gh secretion see ref 19 references therein present study shows dual regulatory effect ghrh probably intact narcoleptics sws gh release remain closely associated patients fig 3 inference may imply circadian distribution hypothalamic ghrh release disrupted narcolepsy simultaneously cause diurnal gh secretion enhance daytime sleepiness specifically hypocretin system particularly active day 11 may normally inhibit hypothalamic ghrh secretion promote arousal reduce pituitary gh output conversely diminution hypocretin tonus night 11 may relax inhibitory restraint ghrh release dampen arousal increase gh output scenario hypocretin deficiency particularly enhances ghrh release day system normally peak activity concurrently promote daytime gh secretion compromise daytime wakefulness narcoleptic patients
0.5774776.12453828.html.plaintext.txt	68	sleep activity somatotropic axis intimately related 33 reproducible gh secretory event humans occurs around nocturnal sleep onset close temporal association first epoch sws see ref 33 secretion gh controlled mainly two hypothalamic peptides ghrh somatostatin 12 14 large body evidence suggests ghrh simultaneously promotes sleep gh release explain consistent association sleep gh secretion see ref 19 references therein present study shows dual regulatory effect ghrh probably intact narcoleptics sws gh release remain closely associated patients fig 3 inference may imply circadian distribution hypothalamic ghrh release disrupted narcolepsy simultaneously cause diurnal gh secretion enhance daytime sleepiness specifically hypocretin system particularly active day 11 may normally inhibit hypothalamic ghrh secretion promote arousal reduce pituitary gh output conversely diminution hypocretin tonus night 11 may relax inhibitory restraint ghrh release dampen arousal increase gh output scenario hypocretin deficiency particularly enhances ghrh release day system normally peak activity concurrently promote daytime gh secretion compromise daytime wakefulness narcoleptic patients
0.5774776.12453828.html.plaintext.txt	69	irregular gh output pattern found narcoleptics also supports notion hypothalamic ghrh release may enhanced disorder serial orderliness pulsatile gh release determined apen statistic reflects balance feedforward feedback inputs somatotropic neuroendocrine ensemble 40 present study gh output irregular narcoleptic patients healthy controls suggests negative feedback restraint somatotropic activity muted andor positive feedforward inputs enhanced narcolepsy 40
0.5774776.12453828.html.plaintext.txt	70	irregular gh output pattern found narcoleptics also supports notion hypothalamic ghrh release may enhanced disorder serial orderliness pulsatile gh release determined apen statistic reflects balance feedforward feedback inputs somatotropic neuroendocrine ensemble 40 present study gh output irregular narcoleptic patients healthy controls suggests negative feedback restraint somatotropic activity muted andor positive feedforward inputs enhanced narcolepsy 40
0.5774776.12453828.html.plaintext.txt	71	conclusion study documents irregular release normal amounts gh hypocretin deficient narcoleptic humans addition circadian dispersion gh secretory events altered narcoleptics relatively large fraction total production occurs daytime propose altered circadian distribution ghrh release brought hypocretin deficiency simultaneously causes increased daytime gh secretion enhanced daytime sleepiness narcolepsy
0.5774776.12453828.html.plaintext.txt	72	conclusion study documents irregular release normal amounts gh hypocretin deficient narcoleptic humans addition circadian dispersion gh secretory events altered narcoleptics relatively large fraction total production occurs daytime propose altered circadian distribution ghrh release brought hypocretin deficiency simultaneously causes increased daytime gh secretion enhanced daytime sleepiness narcolepsy
0.5774776.12453828.html.plaintext.txt	73	thank following efforts completion study e j m ladan eygenraam e c sierat van der steen technical support study occasions m van dijk besling j h g haasnoot van der bent performing gh measurements p j van someren c g kramer r h m reijntjes technical assistance analysis visualization parts data
0.5774776.12453828.html.plaintext.txt	74	address reprint requests correspondence h pijl leiden univ medical center dept general internal medicine c1 r39 po box 9600 2300 rc leiden netherlands e mail hpijlatlumcnl u d
0.5774776.12453828.html.plaintext.txt	75	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5774776.12453828.html.plaintext.txt	76	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5774776.12453828.html.plaintext.txt	77	first published november 26 2002101152ajpendo004212002
0.5774776.12453828.html.plaintext.txt	78	received 1 october 2002 accepted final form 22 november 2002
0.5774776.12453828.html.plaintext.txt	79	references top abstract introduction methods results discussion references
0.5774776.12453828.html.plaintext.txt	80	1 american sleep disorders association international classification sleep disorders diagnostic coding manual revised rochester mn american sleep disorders association 1997 2 besset bonardet billiard m descomps b de paulet ac passouant p circadian patterns growth hormone cortisol secretions narcoleptic patients chronobiologia 6 19 31 1979isimedline 3 blake gm fogelman technical principles dual energy x ray absorptiometry semin nucl med 27 210 228 1997isimedline 4 blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casanueva f dieguez c beiras cellular localization orexin receptors human pituitary j clin endocrinol metab 86 1616 1619 2001abstractfree full text 5 broughton r dunham w newman j lutley k duschesne p rivers m ambulatory 24 hour sleep wake monitoring narcolepsy cataplexy compared matched controls electroencephalogr clin neurophysiol 70 473 481 1988isimedline 6 broughton r krupa boucher b rivers m mullington j impaired circadian waking arousal narcolepsy cataplexy online sleep res 1 159 165 1998 7 chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m narcolepsy orexin knockout mice molecular genetics sleep regulation cell 98 437 451 1999isimedline 8 clark rw schmidt hs malarkey wb disordered growth hormone prolactin secretion primary disorders sleep neurology 29 855 861 1979abstract 9 dahmen n bierbrauer j kasten m increased prevalence obesity narcoleptic patients relatives eur arch psychiatry clin neurosci 251 85 89 2001isimedline 10 de lecea l kilduff ts peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett fs frankel wn den pol bloom fe gautvik km sutcliffe jg hypocretins hypothalamus specific peptides neuroexcitatory activity proc natl acad sci usa 95 322 327 1998abstractfree full text 11 fujiki n yoshida y ripley b honda k mignot e nishino changes csf hypocretin 1 orexin levels rats across 24 hours response food deprivation neuroreport 12 993 997 2001isimedline 12 giustina veldhuis jd pathophysiology neuroregulation growth hormone secretion experimental animals human endocr rev 19 717 797 1998abstractfree full text 13 hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n orexin activates locus coeruleus cell firing increases arousal rat proc natl acad sci usa 96 10911 10916 1999abstractfree full text 14 hartman ml veldhuis jd thorner mo normal control growth hormone secretion horm res 40 37 47 1993isimedline 15 higuchi takahashi y takahashi k niimi y miyasita twenty four hour secretory patterns growth hormone prolactin cortisol narcolepsy j clin endocrinol metab 49 197 204 1979abstract 16 lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor 2 gene cell 98 365 376 1999isimedline 17 nishino ripley b overeem lammers gj mignot e hypocretin orexin deficiency human narcolepsy lancet 355 39 40 2000isimedline 18 nishino ripley b overeem nevsimalova lammers gj vankova j okun m rogers w brooks mignot e low cerebrospinal fluid hypocretin orexin altered energy homeostasis human narcolepsy ann neurol 50 381 388 2001isimedline 19 obal f jr fang j taishi p kacsoh b gardi j krueger jm deficiency growth hormone releasing hormone signaling associated sleep alterations dwarf rat j neurosci 21 2912 2918 2001abstractfree full text 20 overeem mignot e van dijk jg lammers gj narcolepsy clinical features new pathophysiologic insights future perspectives j clin neurophysiol 18 78 105 2001isimedline 21 peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e mutation case early onset narcolepsy generalized absence hypocretin peptides human narcoleptic brains nat med 6 991 997 2000isimedline 22 peyron c tighe dk den pol de lecea l heller hc sutcliffe jg kilduff ts neurons containing hypocretin orexin project multiple neuronal systems j neurosci 18 9996 10015 1998abstractfree full text 23 pijl h langendonk jg burggraaf j frolich m cohen af veldhuis jd meinders ae altered neuroregulation gh secretion viscerally obese premenopausal women j clin endocrinol metab 86 5509 5515 2001abstractfree full text 24 pincus sm approximate entropy measure system complexity proc natl acad sci usa 88 2297 2301 1991abstract 25 pincus sm gevers ef robinson ic van den bg roelfsema f hartman ml veldhuis jd females secrete growth hormone process irregularity males humans rats j physiol endocrinol metab 270 e107 e115 1996abstractfree full text 26 pincus sm hartman ml roelfsema f thorner mo veldhuis jd hormone pulsatility discrimination via coarse short time sampling j physiol endocrinol metab 277 e948 e957 1999abstractfree full text 27 rechtschaffen kales manual standardized terminology techniques scoring system sleep stages human subjects los angeles ca ucla brain information servicebrain research institute 1968 28 ripley b overeem fujiki n nevsimalova uchino m yesavage j di monte d dohi k melberg lammers gj nishida y roelandse fw hungs m mignot e nishino csf hypocretinorexin levels narcolepsy neurological conditions neurology 57 2253 2258 2001abstractfree full text 29 sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan rs mcnulty de liu ws terrett ja elshourbagy na bergsma dj yanagisawa m orexins orexin receptors family hypothalamic neuropeptides g protein coupled receptors regulate feeding behavior cell 92 573 585 1998isimedline 30 thannickal tc moore ry nienhuis r ramanathan l gulyani aldrich m cornford m siegel jm reduced number hypocretin neurons human narcolepsy neuron 27 469 474 2000isimedline 31 thorner mo vance ml evans ws rogol ad rivier j vale w blizzard rm clinical studies ghrh man horm res 24 91 98 1986isimedline 32 van cauter e leproult r plat l age related changes slow wave sleep rem sleep relationship growth hormone cortisol levels healthy men jama 284 861 868 2000abstractfree full text 33 van cauter e plat l copinschi g interrelations sleep somatotropic axis sleep 21 553 566 1998isimedline 34 veldhuis jd new modalities understanding dynamic regulation somatotropic gh axis explication gender differences gh neuroregulation human j pediatr endocrinol metab 9 suppl3 237 253 1996isimedline 35 veldhuis jd carlson ml johnson ml pituitary gland secretes bursts appraising nature glandular secretory impulses simultaneous multiple parameter deconvolution plasma hormone concentrations proc natl acad sci usa 84 7686 7690 1987abstract 36 veldhuis jd iranmanesh ho kk waters mj johnson ml lizarralde g dual defects pulsatile growth hormone secretion clearance subserve hyposomatotropism obesity man j clin endocrinol metab 72 51 59 1991abstract 37 veldhuis jd johnson ml deconvolution analysis hormone data methods enzymol 210 539 575 1992isimedline 38 veldhuis jd johnson ml analytical methods evaluating episodic secretory activity within neuroendocrine axes neurosci biobehav rev 18 605 612 1994isimedline 39 veldhuis jd pincus sm orderliness hormone release patterns complementary measure conventional pulsatile circadian analyses eur j endocrinol 138 358 362 1998isimedline 40 veldhuis jd straume m iranmanesh mulligan jaffe c barkan johnson ml pincus secretory process regularity monitors neuroendocrine feedback feedforward signaling strength humans j physiol regul integr comp physiol 280 r721 r729 2001abstractfree full text 41 willie jt chemelli rm sinton cm yanagisawa m eat sleep orexin regulation feeding wakefulness annu rev neurosci 24 429 458 2001isimedline
0.5774776.12453828.html.plaintext.txt	81	j physiol endocrinol metab 2843e641 e647 0193 184903 500 copyright 2003 american physiological society
0.5774776.12453828.html.plaintext.txt	82	j physiol endocrinol metab 2843e641 e647 0193 184903 500 copyright 2003 american physiological society
